black african american f 70 $nan$hematology blood inr(pt)  2.2  $acetaminophen  650  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; lorazepam  1  mg ; milk of magnesia  30  ml ; loxapine succinate  50  mg ; warfarin  8  mg ; quetiapine extended-release  100  mg ; 
insomnia, unspecified altered mental status anorexia unspecified psychosis personal history of venous thrombosis and embolism personal history of pulmonary embolism rash and other nonspecific skin eruption personal history of venous thrombosis and embolism long-term (current) use of anticoagulants syncope and collapse depressive disorder, not elsewhere classified chronic venous embolism and thrombosis of deep vessels of distal lower extremity anemia, unspecified urinary tract infection, site not specified hypopotassemia personal history of venous thrombosis and embolism long-term (current) use of anticoagulants major depressive affective disorder, recurrent episode, unspecified personal history of venous thrombosis and embolism hyperosmolality and/or hypernatremia hypopotassemia acute venous embolism and thrombosis of deep vessels of proximal lower extremity acute kidney failure, unspecified unspecified protein-calorie malnutrition major depressive affective disorder, single episode, severe, specified as with psychotic behavior acute venous embolism and thrombosis of deep vessels of distal lower extremity anemia, unspecified thrombocytopenia, unspecified long-term (current) use of anticoagulants urinary tract infection, site not specified
black african american f 70 $nan$hematology blood inr(pt)  1.9  $acetaminophen  650  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; lorazepam  1  mg ; milk of magnesia  30  ml ; loxapine succinate  50  mg ; quetiapine extended-release  100  mg ; 
insomnia, unspecified altered mental status anorexia unspecified psychosis personal history of venous thrombosis and embolism personal history of pulmonary embolism rash and other nonspecific skin eruption personal history of venous thrombosis and embolism long-term (current) use of anticoagulants syncope and collapse depressive disorder, not elsewhere classified chronic venous embolism and thrombosis of deep vessels of distal lower extremity anemia, unspecified urinary tract infection, site not specified hypopotassemia personal history of venous thrombosis and embolism long-term (current) use of anticoagulants major depressive affective disorder, recurrent episode, unspecified personal history of venous thrombosis and embolism hyperosmolality and/or hypernatremia hypopotassemia acute venous embolism and thrombosis of deep vessels of proximal lower extremity acute kidney failure, unspecified unspecified protein-calorie malnutrition major depressive affective disorder, single episode, severe, specified as with psychotic behavior acute venous embolism and thrombosis of deep vessels of distal lower extremity anemia, unspecified thrombocytopenia, unspecified long-term (current) use of anticoagulants urinary tract infection, site not specified
black african american f 70 $nan$hematology blood inr(pt)  1.6  $acetaminophen  650  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; lorazepam  1  mg ; milk of magnesia  30  ml ; loxapine succinate  50  mg ; 
insomnia, unspecified altered mental status anorexia unspecified psychosis personal history of venous thrombosis and embolism personal history of pulmonary embolism rash and other nonspecific skin eruption personal history of venous thrombosis and embolism long-term (current) use of anticoagulants syncope and collapse depressive disorder, not elsewhere classified chronic venous embolism and thrombosis of deep vessels of distal lower extremity anemia, unspecified urinary tract infection, site not specified hypopotassemia personal history of venous thrombosis and embolism long-term (current) use of anticoagulants major depressive affective disorder, recurrent episode, unspecified personal history of venous thrombosis and embolism hyperosmolality and/or hypernatremia hypopotassemia acute venous embolism and thrombosis of deep vessels of proximal lower extremity acute kidney failure, unspecified unspecified protein-calorie malnutrition major depressive affective disorder, single episode, severe, specified as with psychotic behavior acute venous embolism and thrombosis of deep vessels of distal lower extremity anemia, unspecified thrombocytopenia, unspecified long-term (current) use of anticoagulants urinary tract infection, site not specified
black african american f 70 $nan$hematology blood inr(pt)  1.4  $acetaminophen  650  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; lorazepam  1  mg ; milk of magnesia  30  ml ; loxapine succinate  50  mg ; 
insomnia, unspecified altered mental status anorexia unspecified psychosis personal history of venous thrombosis and embolism personal history of pulmonary embolism rash and other nonspecific skin eruption personal history of venous thrombosis and embolism long-term (current) use of anticoagulants syncope and collapse depressive disorder, not elsewhere classified chronic venous embolism and thrombosis of deep vessels of distal lower extremity anemia, unspecified urinary tract infection, site not specified hypopotassemia personal history of venous thrombosis and embolism long-term (current) use of anticoagulants major depressive affective disorder, recurrent episode, unspecified personal history of venous thrombosis and embolism hyperosmolality and/or hypernatremia hypopotassemia acute venous embolism and thrombosis of deep vessels of proximal lower extremity acute kidney failure, unspecified unspecified protein-calorie malnutrition major depressive affective disorder, single episode, severe, specified as with psychotic behavior acute venous embolism and thrombosis of deep vessels of distal lower extremity anemia, unspecified thrombocytopenia, unspecified long-term (current) use of anticoagulants urinary tract infection, site not specified
black african american f 70 $nan$hematology blood inr(pt)  1.5  $acetaminophen  650  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; lorazepam  1  mg ; milk of magnesia  30  ml ; loxapine succinate  50  mg ; 
insomnia, unspecified altered mental status anorexia unspecified psychosis personal history of venous thrombosis and embolism personal history of pulmonary embolism rash and other nonspecific skin eruption personal history of venous thrombosis and embolism long-term (current) use of anticoagulants syncope and collapse depressive disorder, not elsewhere classified chronic venous embolism and thrombosis of deep vessels of distal lower extremity anemia, unspecified urinary tract infection, site not specified hypopotassemia personal history of venous thrombosis and embolism long-term (current) use of anticoagulants major depressive affective disorder, recurrent episode, unspecified personal history of venous thrombosis and embolism hyperosmolality and/or hypernatremia hypopotassemia acute venous embolism and thrombosis of deep vessels of proximal lower extremity acute kidney failure, unspecified unspecified protein-calorie malnutrition major depressive affective disorder, single episode, severe, specified as with psychotic behavior acute venous embolism and thrombosis of deep vessels of distal lower extremity anemia, unspecified thrombocytopenia, unspecified long-term (current) use of anticoagulants urinary tract infection, site not specified
black african american f 70 $nan$hematology blood inr(pt)  1.8  $acetaminophen  650  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; lorazepam  1  mg ; milk of magnesia  30  ml ; loxapine succinate  50  mg ; 
insomnia, unspecified altered mental status anorexia unspecified psychosis personal history of venous thrombosis and embolism personal history of pulmonary embolism rash and other nonspecific skin eruption personal history of venous thrombosis and embolism long-term (current) use of anticoagulants syncope and collapse depressive disorder, not elsewhere classified chronic venous embolism and thrombosis of deep vessels of distal lower extremity anemia, unspecified urinary tract infection, site not specified hypopotassemia personal history of venous thrombosis and embolism long-term (current) use of anticoagulants major depressive affective disorder, recurrent episode, unspecified personal history of venous thrombosis and embolism hyperosmolality and/or hypernatremia hypopotassemia acute venous embolism and thrombosis of deep vessels of proximal lower extremity acute kidney failure, unspecified unspecified protein-calorie malnutrition major depressive affective disorder, single episode, severe, specified as with psychotic behavior acute venous embolism and thrombosis of deep vessels of distal lower extremity anemia, unspecified thrombocytopenia, unspecified long-term (current) use of anticoagulants urinary tract infection, site not specified
white m 72 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  335  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood glucose  105  mg dl$nan
 
white m 72 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ns  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  325-650  mg ; heparin  5000  unit ; docusate sodium  100  mg ; valsartan  80  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; tramadol (ultram)  25  mg ; senna  2  tab ; quetiapine fumarate  25  mg ; 
 
white m 72 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ns  1000  ml ; heparin  5000  unit ; docusate sodium  100  mg ; valsartan  80  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; tramadol (ultram)  25  mg ; senna  2  tab ; quetiapine fumarate  25  mg ; 
 
white m 72 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ns  1000  ml ; heparin  5000  unit ; docusate sodium  100  mg ; valsartan  80  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; tramadol (ultram)  25  mg ; senna  2  tab ; quetiapine fumarate  25  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; multivitamins  1  tab ; pneumococcal vac polyvalent  0.5  ml ; 
 
black african american f 68 $temp  98.2  heartrate  97.0  resprate  20.0  o2sat  90.0  sbp  133.0  dbp  73.0  rhythm    pain    $hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  119  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  10.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  118  mg dl; chemistry blood lactate dehydrogenase (ld)  206  iu l; chemistry blood albumin  2.8  g dl; chemistry blood % hemoglobin a1c  5.9  %$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; lactated ringers  1000  ml ; hydrocortisone na succ.  100  mg ; artificial tears preserv. free  1-2  drop ; sodium chloride nasal  1-2  spry ; vitamin d  1000  unit ; calcium carbonate  500  mg ; 0.45% sodium chloride  1000  ml ; hydrocortisone na succ.  50  mg ; aspirin  81  mg ; 
prediabetes body mass index (bmi) 45.0-49.9, adult fall resulting in striking against other object hematuria, unspecified obesity, unspecified other disorders of pituitary gland spinal stenosis, lumbar region without neurogenic claudication secondary hyperparathyroidism of renal origin other hyperlipidemia psoriasis, unspecified chronic kidney disease, stage 3 (moderate) metabolic syndrome other adrenocortical insufficiency other specified disorders of bone density and structure, other site encounter for immunization acute kidney failure with tubular necrosis personal history of colonic polyps vitamin d deficiency, unspecified personal history of (healed) stress fracture gastro-esophageal reflux disease without esophagitis other specified disorders of veins urge incontinence dry eye syndrome of unspecified lacrimal gland pemphigoid, unspecified dehydration obstructive sleep apnea (adult) (pediatric) cushing's syndrome, unspecified venous insufficiency (chronic) (peripheral)
black african american f 68 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  119  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  99  mg dl; chemistry blood albumin  2.9  g dl$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; artificial tears preserv. free  1-2  drop ; sodium chloride nasal  1-2  spry ; vitamin d  1000  unit ; 0.45% sodium chloride  1000  ml ; hydrocortisone na succ.  50  mg ; aspirin  81  mg ; pravastatin  20  mg ; famotidine  20  mg ; sodium chloride 0.9%  1000  ml ; 
prediabetes body mass index (bmi) 45.0-49.9, adult fall resulting in striking against other object hematuria, unspecified obesity, unspecified other disorders of pituitary gland spinal stenosis, lumbar region without neurogenic claudication secondary hyperparathyroidism of renal origin other hyperlipidemia psoriasis, unspecified chronic kidney disease, stage 3 (moderate) metabolic syndrome other adrenocortical insufficiency other specified disorders of bone density and structure, other site encounter for immunization acute kidney failure with tubular necrosis personal history of colonic polyps vitamin d deficiency, unspecified personal history of (healed) stress fracture gastro-esophageal reflux disease without esophagitis other specified disorders of veins urge incontinence dry eye syndrome of unspecified lacrimal gland pemphigoid, unspecified dehydration obstructive sleep apnea (adult) (pediatric) cushing's syndrome, unspecified venous insufficiency (chronic) (peripheral)
black african american f 68 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  73  mg dl; chemistry blood albumin  2.9  g dl$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; artificial tears preserv. free  1-2  drop ; sodium chloride nasal  1-2  spry ; vitamin d  1000  unit ; aspirin  81  mg ; pravastatin  20  mg ; famotidine  20  mg ; sodium chloride 0.9%  1000  ml ; hydrocortisone na succ.  25  mg ; hydrocortisone  20  mg ; 
prediabetes body mass index (bmi) 45.0-49.9, adult fall resulting in striking against other object hematuria, unspecified obesity, unspecified other disorders of pituitary gland spinal stenosis, lumbar region without neurogenic claudication secondary hyperparathyroidism of renal origin other hyperlipidemia psoriasis, unspecified chronic kidney disease, stage 3 (moderate) metabolic syndrome other adrenocortical insufficiency other specified disorders of bone density and structure, other site encounter for immunization acute kidney failure with tubular necrosis personal history of colonic polyps vitamin d deficiency, unspecified personal history of (healed) stress fracture gastro-esophageal reflux disease without esophagitis other specified disorders of veins urge incontinence dry eye syndrome of unspecified lacrimal gland pemphigoid, unspecified dehydration obstructive sleep apnea (adult) (pediatric) cushing's syndrome, unspecified venous insufficiency (chronic) (peripheral)
black african american f 68 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  132  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  71  mg dl$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; artificial tears preserv. free  1-2  drop ; sodium chloride nasal  1-2  spry ; vitamin d  1000  unit ; aspirin  81  mg ; pravastatin  20  mg ; famotidine  20  mg ; hydrocortisone  10  mg ; 
prediabetes body mass index (bmi) 45.0-49.9, adult fall resulting in striking against other object hematuria, unspecified obesity, unspecified other disorders of pituitary gland spinal stenosis, lumbar region without neurogenic claudication secondary hyperparathyroidism of renal origin other hyperlipidemia psoriasis, unspecified chronic kidney disease, stage 3 (moderate) metabolic syndrome other adrenocortical insufficiency other specified disorders of bone density and structure, other site encounter for immunization acute kidney failure with tubular necrosis personal history of colonic polyps vitamin d deficiency, unspecified personal history of (healed) stress fracture gastro-esophageal reflux disease without esophagitis other specified disorders of veins urge incontinence dry eye syndrome of unspecified lacrimal gland pemphigoid, unspecified dehydration obstructive sleep apnea (adult) (pediatric) cushing's syndrome, unspecified venous insufficiency (chronic) (peripheral)
black african american f 68 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; artificial tears preserv. free  1-2  drop ; sodium chloride nasal  1-2  spry ; vitamin d  1000  unit ; aspirin  81  mg ; pravastatin  20  mg ; famotidine  20  mg ; hydrocortisone  5  mg ; 
prediabetes body mass index (bmi) 45.0-49.9, adult fall resulting in striking against other object hematuria, unspecified obesity, unspecified other disorders of pituitary gland spinal stenosis, lumbar region without neurogenic claudication secondary hyperparathyroidism of renal origin other hyperlipidemia psoriasis, unspecified chronic kidney disease, stage 3 (moderate) metabolic syndrome other adrenocortical insufficiency other specified disorders of bone density and structure, other site encounter for immunization acute kidney failure with tubular necrosis personal history of colonic polyps vitamin d deficiency, unspecified personal history of (healed) stress fracture gastro-esophageal reflux disease without esophagitis other specified disorders of veins urge incontinence dry eye syndrome of unspecified lacrimal gland pemphigoid, unspecified dehydration obstructive sleep apnea (adult) (pediatric) cushing's syndrome, unspecified venous insufficiency (chronic) (peripheral)
white f 57 $temp  97.3  heartrate  92.0  resprate  16.0  o2sat  100.0  sbp  118.0  dbp  74.0  rhythm    pain  0  ; temp    heartrate  101.0  resprate  18.0  o2sat  100.0  sbp  180.0  dbp  70.0  rhythm    pain    ; temp    heartrate  101.0  resprate  15.0  o2sat  100.0  sbp  129.0  dbp  74.0  rhythm    pain    ; temp  98.0  heartrate  100.0  resprate  18.0  o2sat  100.0  sbp  139.0  dbp  56.0  rhythm    pain  0  ; temp  98.7  heartrate  99.0  resprate  15.0  o2sat  100.0  sbp  173.0  dbp  72.0  rhythm    pain  0  ; temp  98.3  heartrate  103.0  resprate  23.0  o2sat  100.0  sbp  145.0  dbp  63.0  rhythm    pain  0  $hematology blood hematocrit  17.9  %; hematology blood hemoglobin  5.8  g dl; hematology blood platelet count  277  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  68  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  288  mg dl$nan
atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status personal history of nicotine dependence cr(e)st syndrome chronic kidney disease, unspecified long term (current) use of antithrombotics/antiplatelets type 1 diabetes mellitus with diabetic chronic kidney disease hyperlipidemia, unspecified type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema obstructive sleep apnea (adult) (pediatric) hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other specified abnormal findings of blood chemistry chronic systolic (congestive) heart failure long term (current) use of insulin presence of coronary angioplasty implant and graft hypothyroidism, unspecified chronic gout, unspecified, without tophus (tophi) urinary tract infection, site not specified benign neoplasm of pancreas type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy neuromuscular dysfunction of bladder, unspecified anemia in chronic kidney disease gastroparesis gastro-esophageal reflux disease without esophagitis other fall from one level to another in water transport injuring occupant of other watercraft -- crew occlusion and stenosis of unspecified cerebral artery type 1 diabetes mellitus with diabetic neuropathy, unspecified cr(e)st syndrome acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure other neuromuscular dysfunction of bladder gout, unspecified type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy personal history of nicotine dependence other forms of acute ischemic heart disease hyperlipidemia, unspecified orthostatic hypotension diaphragmatic hernia without obstruction or gangrene kidney transplant rejection disease of pancreas, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease obstructive sleep apnea (adult) (pediatric) type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema chronic kidney disease, unspecified hypomagnesemia traumatic subarachnoid hemorrhage with loss of consciousness of unspecified duration, subsequent encounter long term (current) use of insulin type 1 diabetes mellitus with hyperglycemia hypothyroidism, unspecified
white f 57 $temp  98.5  heartrate  92.0  resprate  18.0  o2sat  98.0  sbp  159.0  dbp  70.0  rhythm    pain  0  ; temp    heartrate  94.0  resprate  16.0  o2sat  98.0  sbp  213.0  dbp  78.0  rhythm    pain  0  ; temp    heartrate  93.0  resprate  20.0  o2sat  98.0  sbp  229.0  dbp  90.0  rhythm    pain  0  ; temp    heartrate  90.0  resprate  18.0  o2sat  99.0  sbp  200.0  dbp  81.0  rhythm    pain  0  ; temp    heartrate  90.0  resprate  18.0  o2sat  98.0  sbp  215.0  dbp  94.0  rhythm    pain  0  ; temp    heartrate    resprate    o2sat    sbp  193.0  dbp  89.0  rhythm    pain    ; temp    heartrate  92.0  resprate  16.0  o2sat  99.0  sbp  158.0  dbp  77.0  rhythm    pain  0  ; temp  97.9  heartrate  95.0  resprate  18.0  o2sat  99.0  sbp  153.0  dbp  69.0  rhythm    pain  0  $hematology blood hematocrit  28.0  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  269  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  70  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  112  mg dl; chemistry blood lactate dehydrogenase (ld)  236  iu l; chemistry blood albumin  3.0  g dl$insulin  16  unit ; sodium chloride 0.9%  flush  3-10  ml ; artificial tears  1-2  drop ; aspirin  81  mg ; cyclosporine (neoral) modified  25  mg ; multivitamins  1  tab ; promethazine  25  mg ; senna  8.6-50  mg ; ticagrelor  90  mg ; vitamin d  2000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ceftriaxone  1  gm ; insulin  0  unit ; metoprolol tartrate  12.5  mg ; calcium carbonate  500  mg ; mycophenolate mofetil  500  mg ; omeprazole  40  mg ; ranolazine er  500  mg ; cilostazol  25  mg ; heparin  5000  unit ; trimethobenzamide  300  mg ; 
atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status personal history of nicotine dependence cr(e)st syndrome chronic kidney disease, unspecified long term (current) use of antithrombotics/antiplatelets type 1 diabetes mellitus with diabetic chronic kidney disease hyperlipidemia, unspecified type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema obstructive sleep apnea (adult) (pediatric) hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other specified abnormal findings of blood chemistry chronic systolic (congestive) heart failure long term (current) use of insulin presence of coronary angioplasty implant and graft hypothyroidism, unspecified chronic gout, unspecified, without tophus (tophi) urinary tract infection, site not specified benign neoplasm of pancreas type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy neuromuscular dysfunction of bladder, unspecified anemia in chronic kidney disease gastroparesis gastro-esophageal reflux disease without esophagitis other fall from one level to another in water transport injuring occupant of other watercraft -- crew occlusion and stenosis of unspecified cerebral artery type 1 diabetes mellitus with diabetic neuropathy, unspecified cr(e)st syndrome acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure other neuromuscular dysfunction of bladder gout, unspecified type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy personal history of nicotine dependence other forms of acute ischemic heart disease hyperlipidemia, unspecified orthostatic hypotension diaphragmatic hernia without obstruction or gangrene kidney transplant rejection disease of pancreas, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease obstructive sleep apnea (adult) (pediatric) type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema chronic kidney disease, unspecified hypomagnesemia traumatic subarachnoid hemorrhage with loss of consciousness of unspecified duration, subsequent encounter long term (current) use of insulin type 1 diabetes mellitus with hyperglycemia hypothyroidism, unspecified
white f 57 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  275  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  70  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  200  mg dl$sodium chloride 0.9%  flush  3-10  ml ; artificial tears  1-2  drop ; aspirin  81  mg ; cyclosporine (neoral) modified  25  mg ; multivitamins  1  tab ; promethazine  25  mg ; senna  8.6-50  mg ; ticagrelor  90  mg ; vitamin d  2000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ceftriaxone  1  gm ; metoprolol tartrate  12.5  mg ; calcium carbonate  500  mg ; mycophenolate mofetil  500  mg ; omeprazole  40  mg ; ranolazine er  500  mg ; cilostazol  25  mg ; heparin  5000  unit ; trimethobenzamide  300  mg ; calcitriol  0.25  mcg ; ferrous sulfate  325  mg ; folic acid  1  mg ; levothyroxine sodium  125  mcg ; lidocaine 5% patch  1  ptch ; prednisone  5  mg ; cilostazol  50  mg ; allopurinol  150  mg ; sodium chloride 0.9%  1000  ml ; 
atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status personal history of nicotine dependence cr(e)st syndrome chronic kidney disease, unspecified long term (current) use of antithrombotics/antiplatelets type 1 diabetes mellitus with diabetic chronic kidney disease hyperlipidemia, unspecified type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema obstructive sleep apnea (adult) (pediatric) hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other specified abnormal findings of blood chemistry chronic systolic (congestive) heart failure long term (current) use of insulin presence of coronary angioplasty implant and graft hypothyroidism, unspecified chronic gout, unspecified, without tophus (tophi) urinary tract infection, site not specified benign neoplasm of pancreas type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy neuromuscular dysfunction of bladder, unspecified anemia in chronic kidney disease gastroparesis gastro-esophageal reflux disease without esophagitis other fall from one level to another in water transport injuring occupant of other watercraft -- crew occlusion and stenosis of unspecified cerebral artery type 1 diabetes mellitus with diabetic neuropathy, unspecified cr(e)st syndrome acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure other neuromuscular dysfunction of bladder gout, unspecified type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy personal history of nicotine dependence other forms of acute ischemic heart disease hyperlipidemia, unspecified orthostatic hypotension diaphragmatic hernia without obstruction or gangrene kidney transplant rejection disease of pancreas, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease obstructive sleep apnea (adult) (pediatric) type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema chronic kidney disease, unspecified hypomagnesemia traumatic subarachnoid hemorrhage with loss of consciousness of unspecified duration, subsequent encounter long term (current) use of insulin type 1 diabetes mellitus with hyperglycemia hypothyroidism, unspecified
white f 57 $nan$hematology blood hematocrit  27.3  %; hematology blood hematocrit  26.2  %; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  308  k ul; hematology blood platelet count  328  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood creatinine  2.8  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.4  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  70  mg dl; chemistry blood urea nitrogen  68  mg dl; chemistry blood urea nitrogen  71  mg dl; hematology blood inr(pt)  0.8  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  433  mg dl; chemistry blood glucose  303  mg dl; chemistry blood glucose  337  mg dl$sodium chloride 0.9%  flush  3-10  ml ; artificial tears  1-2  drop ; aspirin  81  mg ; cyclosporine (neoral) modified  25  mg ; multivitamins  1  tab ; promethazine  25  mg ; senna  8.6-50  mg ; ticagrelor  90  mg ; vitamin d  2000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoprolol tartrate  12.5  mg ; calcium carbonate  500  mg ; mycophenolate mofetil  500  mg ; omeprazole  40  mg ; ranolazine er  500  mg ; cilostazol  25  mg ; heparin  5000  unit ; trimethobenzamide  300  mg ; calcitriol  0.25  mcg ; ferrous sulfate  325  mg ; folic acid  1  mg ; levothyroxine sodium  125  mcg ; lidocaine 5% patch  1  ptch ; prednisone  5  mg ; cilostazol  50  mg ; allopurinol  150  mg ; sodium chloride 0.9%  1000  ml ; insulin  12  unit ; potassium chloride  40  meq ; lactated ringers  1000  ml ; 
atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status personal history of nicotine dependence cr(e)st syndrome chronic kidney disease, unspecified long term (current) use of antithrombotics/antiplatelets type 1 diabetes mellitus with diabetic chronic kidney disease hyperlipidemia, unspecified type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema obstructive sleep apnea (adult) (pediatric) hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other specified abnormal findings of blood chemistry chronic systolic (congestive) heart failure long term (current) use of insulin presence of coronary angioplasty implant and graft hypothyroidism, unspecified chronic gout, unspecified, without tophus (tophi) urinary tract infection, site not specified benign neoplasm of pancreas type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy neuromuscular dysfunction of bladder, unspecified anemia in chronic kidney disease gastroparesis gastro-esophageal reflux disease without esophagitis other fall from one level to another in water transport injuring occupant of other watercraft -- crew occlusion and stenosis of unspecified cerebral artery type 1 diabetes mellitus with diabetic neuropathy, unspecified cr(e)st syndrome acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure other neuromuscular dysfunction of bladder gout, unspecified type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy personal history of nicotine dependence other forms of acute ischemic heart disease hyperlipidemia, unspecified orthostatic hypotension diaphragmatic hernia without obstruction or gangrene kidney transplant rejection disease of pancreas, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease obstructive sleep apnea (adult) (pediatric) type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema chronic kidney disease, unspecified hypomagnesemia traumatic subarachnoid hemorrhage with loss of consciousness of unspecified duration, subsequent encounter long term (current) use of insulin type 1 diabetes mellitus with hyperglycemia hypothyroidism, unspecified
white f 57 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; artificial tears  1-2  drop ; aspirin  81  mg ; cyclosporine (neoral) modified  25  mg ; multivitamins  1  tab ; promethazine  25  mg ; senna  8.6-50  mg ; ticagrelor  90  mg ; vitamin d  2000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoprolol tartrate  12.5  mg ; calcium carbonate  500  mg ; mycophenolate mofetil  500  mg ; omeprazole  40  mg ; ranolazine er  500  mg ; cilostazol  25  mg ; heparin  5000  unit ; trimethobenzamide  300  mg ; calcitriol  0.25  mcg ; ferrous sulfate  325  mg ; folic acid  1  mg ; levothyroxine sodium  125  mcg ; lidocaine 5% patch  1  ptch ; prednisone  5  mg ; cilostazol  50  mg ; allopurinol  150  mg ; insulin  12  unit ; potassium chloride  40  meq ; lactated ringers  1000  ml ; insulin  25  unit ; insulin  14  unit ; 
atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status personal history of nicotine dependence cr(e)st syndrome chronic kidney disease, unspecified long term (current) use of antithrombotics/antiplatelets type 1 diabetes mellitus with diabetic chronic kidney disease hyperlipidemia, unspecified type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema obstructive sleep apnea (adult) (pediatric) hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other specified abnormal findings of blood chemistry chronic systolic (congestive) heart failure long term (current) use of insulin presence of coronary angioplasty implant and graft hypothyroidism, unspecified chronic gout, unspecified, without tophus (tophi) urinary tract infection, site not specified benign neoplasm of pancreas type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy neuromuscular dysfunction of bladder, unspecified anemia in chronic kidney disease gastroparesis gastro-esophageal reflux disease without esophagitis other fall from one level to another in water transport injuring occupant of other watercraft -- crew occlusion and stenosis of unspecified cerebral artery type 1 diabetes mellitus with diabetic neuropathy, unspecified cr(e)st syndrome acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure other neuromuscular dysfunction of bladder gout, unspecified type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy personal history of nicotine dependence other forms of acute ischemic heart disease hyperlipidemia, unspecified orthostatic hypotension diaphragmatic hernia without obstruction or gangrene kidney transplant rejection disease of pancreas, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease obstructive sleep apnea (adult) (pediatric) type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema chronic kidney disease, unspecified hypomagnesemia traumatic subarachnoid hemorrhage with loss of consciousness of unspecified duration, subsequent encounter long term (current) use of insulin type 1 diabetes mellitus with hyperglycemia hypothyroidism, unspecified
white f 91 $nan$hematology blood hematocrit  34.6  %; hematology blood hematocrit  36.0  %; hematology blood hemoglobin  10.5  g dl; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  114  k ul; hematology blood platelet count  141  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry urine chloride, urine  12  meq l; chemistry urine creatinine, urine  20  mg dl; chemistry urine potassium, urine  10  meq l; chemistry urine sodium, urine  15  meq l; chemistry urine urea nitrogen, urine  199  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  142  mg dl; chemistry blood albumin  2.8  g dl; blood gas blood free calcium  1.07  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood lactate  1.2  mmol l$bag  100  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; heparin  5000  unit ; d5w  250  ml ; dopamine  400  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; magnesium sulfate  4  gm ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; vial  1  vial ; pantoprazole  40  mg ; sterile water  100  ml ; 0.9% sodium chloride  1000  ml ; 5% dextrose  250  ml ; norepinephrine  8  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; metoprolol tartrate  5  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; 
 
white f 91 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  123  mg dl; chemistry blood lactate dehydrogenase (ld)  250  iu l; blood gas blood lactate  1.4  mmol l$bag  100  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; heparin  5000  unit ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; magnesium sulfate  4  gm ; vial  1  vial ; pantoprazole  40  mg ; sterile water  100  ml ; 0.9% sodium chloride  1000  ml ; 5% dextrose  250  ml ; norepinephrine  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; metoprolol tartrate  5  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; phenylephrine  60  mg ; senna  1  tab ; 
 
white f 91 $nan$hematology blood hematocrit  27.1  %; hematology blood hematocrit  27.9  %; hematology blood hemoglobin  8.5  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  140  k ul; hematology blood platelet count  145  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  73  mg dl; chemistry blood glucose  71  mg dl; blood gas blood free calcium  1.20  mmol l; blood gas blood lactate  0.8  mmol l$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; heparin  5000  unit ; vial  1  vial ; pantoprazole  40  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; phenylephrine  60  mg ; senna  1  tab ; docusate sodium  100  mg ; morphine sulfate  2-4  mg ; docusate sodium (liquid)  100  mg ; furosemide  40  mg ; 
 
white f 91 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  131  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  71  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; phenylephrine  60  mg ; senna  1  tab ; morphine sulfate  2-4  mg ; docusate sodium (liquid)  100  mg ; furosemide  40  mg ; acetaminophen  500-1000  mg ; 
 
white f 91 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  122  k ul; chemistry blood creatinine  1.4  mg dl; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  73  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; phenylephrine  60  mg ; senna  1  tab ; morphine sulfate  2-4  mg ; docusate sodium (liquid)  100  mg ; acetaminophen  500-1000  mg ; furosemide  10  mg ; 
 
white f 91 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  145  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  30  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  93  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; senna  1  tab ; morphine sulfate  2-4  mg ; docusate sodium (liquid)  100  mg ; acetaminophen  500-1000  mg ; metoprolol tartrate  12.5  mg ; heparin flush (10 units ml)  1  ml ; olanzapine (disintegrating tablet)  2.5  mg ; 
 
white f 91 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  89  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; senna  1  tab ; morphine sulfate  2-4  mg ; docusate sodium (liquid)  100  mg ; acetaminophen  500-1000  mg ; heparin flush (10 units ml)  1  ml ; olanzapine (disintegrating tablet)  2.5  mg ; bag  50  ml ; magnesium sulfate  2  gm ; d5 1 2ns  1000  ml ; metoprolol succinate xl  50  mg ; 
 
white f 91 $nan$hematology blood hematocrit  30.1  %; hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  175  k ul; hematology blood platelet count  160  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  9  meq l; chemistry blood anion gap  8  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  85  mg dl; chemistry blood glucose  85  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; senna  1  tab ; morphine sulfate  2-4  mg ; docusate sodium (liquid)  100  mg ; acetaminophen  500-1000  mg ; heparin flush (10 units ml)  1  ml ; olanzapine (disintegrating tablet)  2.5  mg ; d5 1 2ns  1000  ml ; metoprolol succinate xl  50  mg ; 5% dextrose  500  ml ; potassium chloride (powder)  40  meq ; 
 
white f 91 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  168  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  106  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; senna  1  tab ; morphine sulfate  2-4  mg ; docusate sodium (liquid)  100  mg ; acetaminophen  500-1000  mg ; heparin flush (10 units ml)  1  ml ; olanzapine (disintegrating tablet)  2.5  mg ; metoprolol succinate xl  50  mg ; 5% dextrose  500  ml ; potassium chloride (powder)  40  meq ; 
 
white f 91 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; senna  1  tab ; morphine sulfate  2-4  mg ; docusate sodium (liquid)  100  mg ; acetaminophen  500-1000  mg ; heparin flush (10 units ml)  1  ml ; olanzapine (disintegrating tablet)  2.5  mg ; metoprolol succinate xl  50  mg ; 
 
black african american m 72 $nan$nan$aspirin ec  81  mg ; fluticasone propionate nasal  1  spry ; omeprazole  40  mg ; lisinopril  5  mg ; tamsulosin  0.4  mg ; 
 
black african american m 72 $nan$hematology blood hematocrit  43.5  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  119  mg dl$aspirin ec  81  mg ; fluticasone propionate nasal  1  spry ; omeprazole  40  mg ; lisinopril  5  mg ; tamsulosin  0.4  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; fexofenadine  60  mg ; lorazepam  1  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen w codeine  1-2  tab ; 
 
black african american m 72 $nan$nan$aspirin ec  81  mg ; fluticasone propionate nasal  1  spry ; omeprazole  40  mg ; lisinopril  5  mg ; tamsulosin  0.4  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; fexofenadine  60  mg ; lorazepam  1  mg ; acetaminophen  650  mg ; oxycodone sr (oxycontin)  10  mg ; 
 
black african american m 72 $nan$nan$aspirin ec  81  mg ; fluticasone propionate nasal  1  spry ; omeprazole  40  mg ; lisinopril  5  mg ; tamsulosin  0.4  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; fexofenadine  60  mg ; lorazepam  1  mg ; acetaminophen  650  mg ; oxycodone sr (oxycontin)  10  mg ; prednisone  60  mg ; heparin  5000  unit ; bacitracin polymyxin b sulfate opht. oint  1  appl ; ciprofloxacin 0.3% ophth soln  1-2  drop ; 
 
black african american m 72 $nan$nan$aspirin ec  81  mg ; fluticasone propionate nasal  1  spry ; omeprazole  40  mg ; lisinopril  5  mg ; tamsulosin  0.4  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; fexofenadine  60  mg ; lorazepam  1  mg ; acetaminophen  650  mg ; oxycodone sr (oxycontin)  10  mg ; prednisone  60  mg ; heparin  5000  unit ; bacitracin polymyxin b sulfate opht. oint  1  appl ; ciprofloxacin 0.3% ophth soln  1-2  drop ; insulin  0  unit ; 
 
black african american m 72 $nan$nan$aspirin ec  81  mg ; fluticasone propionate nasal  1  spry ; omeprazole  40  mg ; lisinopril  5  mg ; tamsulosin  0.4  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; fexofenadine  60  mg ; lorazepam  1  mg ; acetaminophen  650  mg ; oxycodone sr (oxycontin)  10  mg ; prednisone  60  mg ; heparin  5000  unit ; bacitracin polymyxin b sulfate opht. oint  1  appl ; ciprofloxacin 0.3% ophth soln  1-2  drop ; insulin  0  unit ; 
 
black african american m 72 $nan$nan$aspirin ec  81  mg ; fluticasone propionate nasal  1  spry ; omeprazole  40  mg ; lisinopril  5  mg ; tamsulosin  0.4  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; fexofenadine  60  mg ; lorazepam  1  mg ; acetaminophen  650  mg ; oxycodone sr (oxycontin)  10  mg ; prednisone  60  mg ; heparin  5000  unit ; bacitracin polymyxin b sulfate opht. oint  1  appl ; insulin  0  unit ; 
 
unknown m 59 $nan$nan$acetaminophen  1000  mg ; gabapentin  1200  mg ; celecoxib  400  mg ; methadone  15  mg ; tamsulosin  0.4  mg ; bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; oxycodone (immediate release)  5-10  mg ; lamotrigine  100  mg ; lamotrigine  200  mg ; trazodone  300  mg ; diazepam  5  mg ; hydromorphone (dilaudid)  20  mg ; famotidine  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; 
 
unknown m 59 $nan$nan$methadone  15  mg ; tamsulosin  0.4  mg ; bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; oxycodone (immediate release)  5-10  mg ; lamotrigine  100  mg ; lamotrigine  200  mg ; trazodone  300  mg ; diazepam  5  mg ; famotidine  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; oxycodone (immediate release)  5-15  mg ; hydromorphone (dilaudid)  1  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; tizanidine  2  mg ; clonazepam  1  mg ; 
 
unknown m 59 $nan$nan$tamsulosin  0.4  mg ; bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; lamotrigine  100  mg ; lamotrigine  200  mg ; trazodone  300  mg ; famotidine  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; tizanidine  2  mg ; clonazepam  1  mg ; methadone  20  mg ; magnesium citrate  300  ml ; fleet enema (mineral oil)  1  enema ; 
 
unknown m 59 $nan$nan$tamsulosin  0.4  mg ; bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; lamotrigine  100  mg ; lamotrigine  200  mg ; trazodone  300  mg ; famotidine  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; tizanidine  2  mg ; clonazepam  1  mg ; methadone  20  mg ; magnesium citrate  300  ml ; fleet enema (mineral oil)  1  enema ; fleet enema (saline)  1  enema ; polyethylene glycol  17  g ; lactulose  30  ml ; syringe  0.6  ml ; methylnaltrexone  12  mg ; 
 
unknown m 59 $nan$nan$tamsulosin  0.4  mg ; bisacodyl  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; lamotrigine  100  mg ; lamotrigine  200  mg ; trazodone  300  mg ; famotidine  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; tizanidine  2  mg ; clonazepam  1  mg ; methadone  20  mg ; fleet enema (saline)  1  enema ; polyethylene glycol  17  g ; lactulose  30  ml ; syringe  0.6  ml ; methylnaltrexone  12  mg ; hydromorphone (dilaudid)  2-4  mg ; 
 
white f 87 $temp  97.7  heartrate  80.0  resprate  18.0  o2sat  94.0  sbp  186.0  dbp  86.0  rhythm    pain  5  ; temp  98.9  heartrate  88.0  resprate  18.0  o2sat    sbp  147.0  dbp  85.0  rhythm    pain  4  $hematology blood hematocrit  36.3  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  237  k ul; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  11.1  mg dl; chemistry blood glucose  116  mg dl$lactated ringers  1000  ml ; 
hyperlipidemia, unspecified acute on chronic systolic (congestive) heart failure tobacco use left bundle-branch block, unspecified long term (current) use of antithrombotics/antiplatelets acute kidney failure, unspecified other intervertebral disc displacement, lumbar region emphysema, unspecified long term (current) use of aspirin hypoxemia do not resuscitate collapsed vertebra, not elsewhere classified, lumbar region, initial encounter for fracture atherosclerotic heart disease of native coronary artery without angina pectoris nonrheumatic mitral (valve) insufficiency ischemic cardiomyopathy essential (primary) hypertension presence of coronary angioplasty implant and graft old myocardial infarction old myocardial infarction other specified forms of chronic ischemic heart disease deviated nasal septum unspecified essential hypertension percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified tobacco use disorder constipation, unspecified acute posthemorrhagic anemia personal history of other malignant neoplasm of skin atrial fibrillation epistaxis other and unspecified hyperlipidemia other left bundle branch block coronary atherosclerosis of native coronary artery long-term (current) use of aspirin long-term (current) use of anticoagulants do not resuscitate status anticoagulants causing adverse effects in therapeutic use mitral valve disorders percutaneous transluminal coronary angioplasty status acute posthemorrhagic anemia mitral valve disorders congestive heart failure, unspecified long-term (current) use of anticoagulants personal history of other malignant neoplasm of skin angiodysplasia of stomach and duodenum with hemorrhage acquired coagulation factor deficiency hypopotassemia other and unspecified hyperlipidemia
white f 87 $temp  97.8  heartrate  89.0  resprate  16.0  o2sat  94.0  sbp  155.0  dbp  60.0  rhythm    pain    $hematology blood hematocrit  38.8  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.5  ; hematology urine wbc  1  # hpf; chemistry blood glucose  80  mg dl$lactated ringers  1000  ml ; trazodone  25  mg ; influenza vaccine quadrivalent  0.5  ml ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; oxycodone (immediate release)  2.5-5  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; calcitonin salmon  200  unit ; vitamin d  1000  unit ; 5% dextrose  50  ml ; phytonadione  5  mg ; metoprolol succinate xl  50  mg ; torsemide  10  mg ; 
hyperlipidemia, unspecified acute on chronic systolic (congestive) heart failure tobacco use left bundle-branch block, unspecified long term (current) use of antithrombotics/antiplatelets acute kidney failure, unspecified other intervertebral disc displacement, lumbar region emphysema, unspecified long term (current) use of aspirin hypoxemia do not resuscitate collapsed vertebra, not elsewhere classified, lumbar region, initial encounter for fracture atherosclerotic heart disease of native coronary artery without angina pectoris nonrheumatic mitral (valve) insufficiency ischemic cardiomyopathy essential (primary) hypertension presence of coronary angioplasty implant and graft old myocardial infarction old myocardial infarction other specified forms of chronic ischemic heart disease deviated nasal septum unspecified essential hypertension percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified tobacco use disorder constipation, unspecified acute posthemorrhagic anemia personal history of other malignant neoplasm of skin atrial fibrillation epistaxis other and unspecified hyperlipidemia other left bundle branch block coronary atherosclerosis of native coronary artery long-term (current) use of aspirin long-term (current) use of anticoagulants do not resuscitate status anticoagulants causing adverse effects in therapeutic use mitral valve disorders percutaneous transluminal coronary angioplasty status acute posthemorrhagic anemia mitral valve disorders congestive heart failure, unspecified long-term (current) use of anticoagulants personal history of other malignant neoplasm of skin angiodysplasia of stomach and duodenum with hemorrhage acquired coagulation factor deficiency hypopotassemia other and unspecified hyperlipidemia
white f 87 $nan$hematology blood inr(pt)  1.1  $lactated ringers  1000  ml ; trazodone  25  mg ; influenza vaccine quadrivalent  0.5  ml ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; oxycodone (immediate release)  2.5-5  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; calcitonin salmon  200  unit ; vitamin d  1000  unit ; 5% dextrose  50  ml ; phytonadione  5  mg ; metoprolol succinate xl  50  mg ; torsemide  10  mg ; warfarin  4  mg ; ondansetron  4  mg ; clindamycin  600  mg ; 
hyperlipidemia, unspecified acute on chronic systolic (congestive) heart failure tobacco use left bundle-branch block, unspecified long term (current) use of antithrombotics/antiplatelets acute kidney failure, unspecified other intervertebral disc displacement, lumbar region emphysema, unspecified long term (current) use of aspirin hypoxemia do not resuscitate collapsed vertebra, not elsewhere classified, lumbar region, initial encounter for fracture atherosclerotic heart disease of native coronary artery without angina pectoris nonrheumatic mitral (valve) insufficiency ischemic cardiomyopathy essential (primary) hypertension presence of coronary angioplasty implant and graft old myocardial infarction old myocardial infarction other specified forms of chronic ischemic heart disease deviated nasal septum unspecified essential hypertension percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified tobacco use disorder constipation, unspecified acute posthemorrhagic anemia personal history of other malignant neoplasm of skin atrial fibrillation epistaxis other and unspecified hyperlipidemia other left bundle branch block coronary atherosclerosis of native coronary artery long-term (current) use of aspirin long-term (current) use of anticoagulants do not resuscitate status anticoagulants causing adverse effects in therapeutic use mitral valve disorders percutaneous transluminal coronary angioplasty status acute posthemorrhagic anemia mitral valve disorders congestive heart failure, unspecified long-term (current) use of anticoagulants personal history of other malignant neoplasm of skin angiodysplasia of stomach and duodenum with hemorrhage acquired coagulation factor deficiency hypopotassemia other and unspecified hyperlipidemia
white f 87 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood glucose  66  mg dl$lactated ringers  1000  ml ; trazodone  25  mg ; influenza vaccine quadrivalent  0.5  ml ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  2.5-5  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; calcitonin salmon  200  unit ; vitamin d  1000  unit ; metoprolol succinate xl  50  mg ; torsemide  10  mg ; warfarin  4  mg ; ondansetron  4  mg ; clindamycin  600  mg ; bag  1  bag ; magnesium sulfate  2  gm ; 
hyperlipidemia, unspecified acute on chronic systolic (congestive) heart failure tobacco use left bundle-branch block, unspecified long term (current) use of antithrombotics/antiplatelets acute kidney failure, unspecified other intervertebral disc displacement, lumbar region emphysema, unspecified long term (current) use of aspirin hypoxemia do not resuscitate collapsed vertebra, not elsewhere classified, lumbar region, initial encounter for fracture atherosclerotic heart disease of native coronary artery without angina pectoris nonrheumatic mitral (valve) insufficiency ischemic cardiomyopathy essential (primary) hypertension presence of coronary angioplasty implant and graft old myocardial infarction old myocardial infarction other specified forms of chronic ischemic heart disease deviated nasal septum unspecified essential hypertension percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified tobacco use disorder constipation, unspecified acute posthemorrhagic anemia personal history of other malignant neoplasm of skin atrial fibrillation epistaxis other and unspecified hyperlipidemia other left bundle branch block coronary atherosclerosis of native coronary artery long-term (current) use of aspirin long-term (current) use of anticoagulants do not resuscitate status anticoagulants causing adverse effects in therapeutic use mitral valve disorders percutaneous transluminal coronary angioplasty status acute posthemorrhagic anemia mitral valve disorders congestive heart failure, unspecified long-term (current) use of anticoagulants personal history of other malignant neoplasm of skin angiodysplasia of stomach and duodenum with hemorrhage acquired coagulation factor deficiency hypopotassemia other and unspecified hyperlipidemia
white f 87 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  3.0  ; chemistry blood glucose  145  mg dl$lactated ringers  1000  ml ; trazodone  25  mg ; influenza vaccine quadrivalent  0.5  ml ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  2.5-5  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; calcitonin salmon  200  unit ; vitamin d  1000  unit ; metoprolol succinate xl  50  mg ; torsemide  10  mg ; warfarin  4  mg ; ondansetron  4  mg ; bag  1  bag ; magnesium sulfate  2  gm ; 
hyperlipidemia, unspecified acute on chronic systolic (congestive) heart failure tobacco use left bundle-branch block, unspecified long term (current) use of antithrombotics/antiplatelets acute kidney failure, unspecified other intervertebral disc displacement, lumbar region emphysema, unspecified long term (current) use of aspirin hypoxemia do not resuscitate collapsed vertebra, not elsewhere classified, lumbar region, initial encounter for fracture atherosclerotic heart disease of native coronary artery without angina pectoris nonrheumatic mitral (valve) insufficiency ischemic cardiomyopathy essential (primary) hypertension presence of coronary angioplasty implant and graft old myocardial infarction old myocardial infarction other specified forms of chronic ischemic heart disease deviated nasal septum unspecified essential hypertension percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified tobacco use disorder constipation, unspecified acute posthemorrhagic anemia personal history of other malignant neoplasm of skin atrial fibrillation epistaxis other and unspecified hyperlipidemia other left bundle branch block coronary atherosclerosis of native coronary artery long-term (current) use of aspirin long-term (current) use of anticoagulants do not resuscitate status anticoagulants causing adverse effects in therapeutic use mitral valve disorders percutaneous transluminal coronary angioplasty status acute posthemorrhagic anemia mitral valve disorders congestive heart failure, unspecified long-term (current) use of anticoagulants personal history of other malignant neoplasm of skin angiodysplasia of stomach and duodenum with hemorrhage acquired coagulation factor deficiency hypopotassemia other and unspecified hyperlipidemia
white f 87 $nan$hematology blood hematocrit  24.2  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  2.9  ; chemistry blood glucose  123  mg dl$lactated ringers  1000  ml ; trazodone  25  mg ; influenza vaccine quadrivalent  0.5  ml ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  2.5-5  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; calcitonin salmon  200  unit ; vitamin d  1000  unit ; metoprolol succinate xl  50  mg ; torsemide  10  mg ; warfarin  4  mg ; ondansetron  4  mg ; 
hyperlipidemia, unspecified acute on chronic systolic (congestive) heart failure tobacco use left bundle-branch block, unspecified long term (current) use of antithrombotics/antiplatelets acute kidney failure, unspecified other intervertebral disc displacement, lumbar region emphysema, unspecified long term (current) use of aspirin hypoxemia do not resuscitate collapsed vertebra, not elsewhere classified, lumbar region, initial encounter for fracture atherosclerotic heart disease of native coronary artery without angina pectoris nonrheumatic mitral (valve) insufficiency ischemic cardiomyopathy essential (primary) hypertension presence of coronary angioplasty implant and graft old myocardial infarction old myocardial infarction other specified forms of chronic ischemic heart disease deviated nasal septum unspecified essential hypertension percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified tobacco use disorder constipation, unspecified acute posthemorrhagic anemia personal history of other malignant neoplasm of skin atrial fibrillation epistaxis other and unspecified hyperlipidemia other left bundle branch block coronary atherosclerosis of native coronary artery long-term (current) use of aspirin long-term (current) use of anticoagulants do not resuscitate status anticoagulants causing adverse effects in therapeutic use mitral valve disorders percutaneous transluminal coronary angioplasty status acute posthemorrhagic anemia mitral valve disorders congestive heart failure, unspecified long-term (current) use of anticoagulants personal history of other malignant neoplasm of skin angiodysplasia of stomach and duodenum with hemorrhage acquired coagulation factor deficiency hypopotassemia other and unspecified hyperlipidemia
white f 62 $nan$hematology blood hematocrit  32.9  %; hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; bupivacaine 0.5%  4  ml hr ; hydromorphone (dilaudid)  12.5  mg ; ketorolac  15  mg ; metoclopramide  10  mg ; lr  1000  ml ; ns  500  ml ; potassium chloride  40  meq ; sw  50  ml ; magnesium sulfate  2  gm ; heparin  5000  unit ; bupivacaine 0.5%  5  ml hr ; 
 
white f 62 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  12.5  mg ; ketorolac  15  mg ; metoclopramide  10  mg ; lr  1000  ml ; ns  500  ml ; potassium chloride  40  meq ; sw  50  ml ; magnesium sulfate  2  gm ; heparin  5000  unit ; bupivacaine 0.5%  5  ml hr ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; prochlorperazine  10  mg ; 
 
white f 62 $nan$hematology blood hematocrit  31.1  %$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  12.5  mg ; ketorolac  15  mg ; metoclopramide  10  mg ; heparin  5000  unit ; bupivacaine 0.5%  5  ml hr ; prochlorperazine  10  mg ; oxycodone-acetaminophen  1-2  tab ; 
 
white f 62 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ketorolac  15  mg ; metoclopramide  10  mg ; heparin  5000  unit ; bupivacaine 0.5%  5  ml hr ; oxycodone-acetaminophen  1-2  tab ; senna  1  tab ; docusate sodium  100  mg ; 
 
white m 59 $nan$hematology blood hematocrit  22.9  %; hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  3.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  51  mg dl; hematology blood inr(pt)  1.2  ; chemistry urine creatinine, urine  198  mg dl; hematology urine wbc  8  # hpf; chemistry blood calcium, total  6.9  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  114  mg dl; chemistry blood lactate dehydrogenase (ld)  459  iu l; chemistry blood albumin  1.9  g dl; hematology blood bands  0  %; chemistry urine protein creatinine ratio  0.2  ratio$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; oxycodone sr (oxycontin)  10  mg ; syringe  1  ml ; heparin sodium  5000  unit ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; 
ostium secundum type atrial septal defect abnormal coagulation profile herpes simplex without mention of complication dehydration hemorrhage of gastrointestinal tract, unspecified nausea with vomiting mucositis (ulcerative) due to antineoplastic therapy personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use acidosis long-term (current) use of anticoagulants acute kidney failure with lesion of tubular necrosis malignant neoplasm of extrahepatic bile ducts anticoagulants causing adverse effects in therapeutic use secondary and unspecified malignant neoplasm of intrathoracic lymph nodes secondary malignant neoplasm of lung secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes diarrhea
white m 59 $nan$hematology blood hematocrit  27.7  %; hematology blood hematocrit  21.8  %; hematology blood hematocrit  21.6  %; hematology blood hematocrit  28.7  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood calcium, total  5.3  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  71  mg dl; chemistry blood lactate dehydrogenase (ld)  376  iu l; chemistry blood albumin  1.5  g dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; oxycodone sr (oxycontin)  10  mg ; syringe  1  ml ; heparin sodium  5000  unit ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sw  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  4  g ; potassium chloride  60  meq ; 
ostium secundum type atrial septal defect abnormal coagulation profile herpes simplex without mention of complication dehydration hemorrhage of gastrointestinal tract, unspecified nausea with vomiting mucositis (ulcerative) due to antineoplastic therapy personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use acidosis long-term (current) use of anticoagulants acute kidney failure with lesion of tubular necrosis malignant neoplasm of extrahepatic bile ducts anticoagulants causing adverse effects in therapeutic use secondary and unspecified malignant neoplasm of intrathoracic lymph nodes secondary malignant neoplasm of lung secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes diarrhea
white m 59 $nan$hematology blood hematocrit  33.4  %; hematology blood hematocrit  35.0  %; hematology blood hematocrit  33.3  %; hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  137  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  89  mg dl; chemistry blood glucose  107  mg dl; chemistry blood lactate dehydrogenase (ld)  485  iu l; chemistry blood albumin  1.9  g dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; oxycodone sr (oxycontin)  10  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sw  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  4  g ; potassium chloride  60  meq ; 
ostium secundum type atrial septal defect abnormal coagulation profile herpes simplex without mention of complication dehydration hemorrhage of gastrointestinal tract, unspecified nausea with vomiting mucositis (ulcerative) due to antineoplastic therapy personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use acidosis long-term (current) use of anticoagulants acute kidney failure with lesion of tubular necrosis malignant neoplasm of extrahepatic bile ducts anticoagulants causing adverse effects in therapeutic use secondary and unspecified malignant neoplasm of intrathoracic lymph nodes secondary malignant neoplasm of lung secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes diarrhea
white m 59 $nan$hematology blood hematocrit  32.5  %; hematology blood hematocrit  32.5  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  116  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry urine chloride, urine  21  meq l; chemistry urine creatinine, urine  124  mg dl; chemistry urine creatinine, urine  58  mg dl; chemistry urine potassium, urine  38  meq l; chemistry urine sodium, urine  12  meq l; chemistry urine sodium, urine  37  meq l; chemistry urine urea nitrogen, urine  544  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  525  iu l$furosemide  40  mg ; 
ostium secundum type atrial septal defect abnormal coagulation profile herpes simplex without mention of complication dehydration hemorrhage of gastrointestinal tract, unspecified nausea with vomiting mucositis (ulcerative) due to antineoplastic therapy personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use acidosis long-term (current) use of anticoagulants acute kidney failure with lesion of tubular necrosis malignant neoplasm of extrahepatic bile ducts anticoagulants causing adverse effects in therapeutic use secondary and unspecified malignant neoplasm of intrathoracic lymph nodes secondary malignant neoplasm of lung secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes diarrhea
white m 59 $nan$hematology blood hematocrit  34.7  %; hematology blood hematocrit  31.6  %; hematology blood hematocrit  29.3  %; hematology blood hematocrit  32.3  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  103  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  94  mg dl; chemistry blood lactate dehydrogenase (ld)  399  iu l; chemistry blood albumin  1.7  g dl$sw  200  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; 
ostium secundum type atrial septal defect abnormal coagulation profile herpes simplex without mention of complication dehydration hemorrhage of gastrointestinal tract, unspecified nausea with vomiting mucositis (ulcerative) due to antineoplastic therapy personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use acidosis long-term (current) use of anticoagulants acute kidney failure with lesion of tubular necrosis malignant neoplasm of extrahepatic bile ducts anticoagulants causing adverse effects in therapeutic use secondary and unspecified malignant neoplasm of intrathoracic lymph nodes secondary malignant neoplasm of lung secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes diarrhea
white m 59 $nan$nan$sw  200  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; 
ostium secundum type atrial septal defect abnormal coagulation profile herpes simplex without mention of complication dehydration hemorrhage of gastrointestinal tract, unspecified nausea with vomiting mucositis (ulcerative) due to antineoplastic therapy personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use acidosis long-term (current) use of anticoagulants acute kidney failure with lesion of tubular necrosis malignant neoplasm of extrahepatic bile ducts anticoagulants causing adverse effects in therapeutic use secondary and unspecified malignant neoplasm of intrathoracic lymph nodes secondary malignant neoplasm of lung secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes diarrhea
black african american f 58 $temp    heartrate  135.0  resprate  18.0  o2sat  100.0  sbp  114.0  dbp  56.0  rhythm    pain  unable  ; temp    heartrate  137.0  resprate  19.0  o2sat  100.0  sbp  105.0  dbp  55.0  rhythm    pain  unable  ; temp    heartrate  120.0  resprate  19.0  o2sat  100.0  sbp  108.0  dbp  51.0  rhythm    pain  unable  ; temp  99.8  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    ; temp    heartrate  125.0  resprate  18.0  o2sat  100.0  sbp  104.0  dbp  55.0  rhythm    pain    ; temp    heartrate  120.0  resprate  20.0  o2sat  100.0  sbp  106.0  dbp  49.0  rhythm    pain    ; temp    heartrate  82.0  resprate    o2sat  100.0  sbp  58.0  dbp  32.0  rhythm    pain    ; temp    heartrate  81.0  resprate    o2sat  100.0  sbp  49.0  dbp  21.0  rhythm    pain    ; temp    heartrate  76.0  resprate    o2sat    sbp  57.0  dbp  36.0  rhythm    pain    ; temp    heartrate  67.0  resprate    o2sat    sbp  59.0  dbp  45.0  rhythm    pain    ; temp    heartrate  87.0  resprate    o2sat    sbp  70.0  dbp  48.0  rhythm    pain    ; temp    heartrate  83.0  resprate  18.0  o2sat  100.0  sbp  84.0  dbp  41.0  rhythm    pain  unable to assess  ; temp    heartrate  87.0  resprate    o2sat    sbp  70.0  dbp  31.0  rhythm    pain    ; temp    heartrate  88.0  resprate    o2sat    sbp  88.0  dbp  63.0  rhythm    pain    ; temp    heartrate  96.0  resprate  29.0  o2sat    sbp  123.0  dbp  68.0  rhythm    pain  unable  ; temp    heartrate  111.0  resprate  35.0  o2sat  99.0  sbp  119.0  dbp  90.0  rhythm    pain    ; temp    heartrate  115.0  resprate  23.0  o2sat  100.0  sbp  82.0  dbp  56.0  rhythm    pain    ; temp    heartrate  104.0  resprate  20.0  o2sat  100.0  sbp  126.0  dbp  66.0  rhythm    pain    ; temp    heartrate  119.0  resprate  26.0  o2sat  100.0  sbp  125.0  dbp  106.0  rhythm    pain    ; temp    heartrate  114.0  resprate  21.0  o2sat  100.0  sbp  114.0  dbp  83.0  rhythm    pain    ; temp    heartrate  113.0  resprate  26.0  o2sat  100.0  sbp  142.0  dbp  66.0  rhythm    pain    ; temp    heartrate  116.0  resprate  18.0  o2sat  100.0  sbp  141.0  dbp  65.0  rhythm    pain    ; temp  100.0  heartrate  117.0  resprate  22.0  o2sat  100.0  sbp  155.0  dbp  74.0  rhythm    pain  unable to assess  $hematology blood hematocrit  40.9  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  168  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  196  mg dl; chemistry blood albumin  4.4  g dl; blood gas blood lactate  5.4  mmol l$nan
other pancytopenia benign essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other chest pain urinary tract infection, site not specified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal epilepsy, unspecified, without mention of intractable epilepsy personal history of malignant neoplasm of breast constipation, unspecified obstructive hydrocephalus subendocardial infarction, subsequent episode of care aphasia hemiplegia, unspecified, affecting unspecified side 
black african american f 58 $temp    heartrate  110.0  resprate  12.0  o2sat    sbp  137.0  dbp  78.0  rhythm    pain    $hematology blood hematocrit  35.9  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  96  mg dl; chemistry blood lactate dehydrogenase (ld)  380  iu l; chemistry blood albumin  3.3  g dl; chemistry blood albumin  3.3  g dl$lorazepam  2  mg ; 0.9% sodium chloride  250  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; norepinephrine  8  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; phenytoin sodium (iv)  100  mg ; 5% dextrose  100  ml ; acyclovir  700  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; acetaminophen  650  mg ; insulin  0  unit ; phenytoin sodium  500  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; phosphorus  500  mg ; 
other pancytopenia benign essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other chest pain urinary tract infection, site not specified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal epilepsy, unspecified, without mention of intractable epilepsy personal history of malignant neoplasm of breast constipation, unspecified obstructive hydrocephalus subendocardial infarction, subsequent episode of care aphasia hemiplegia, unspecified, affecting unspecified side 
black african american f 58 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  111  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  138  mg dl; chemistry blood albumin  3.3  g dl$lorazepam  2  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; phenytoin sodium (iv)  100  mg ; 5% dextrose  100  ml ; acyclovir  700  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; acetaminophen  650  mg ; insulin  0  unit ; phenytoin sodium  500  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; phosphorus  500  mg ; sodium chloride 0.9%  flush  10  ml ; artificial tear ointment  1  appl ; levetiracetam  500  mg ; propofol  10  mg ; propofol  1000  mg ; levetiracetam  1500  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; 
other pancytopenia benign essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other chest pain urinary tract infection, site not specified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal epilepsy, unspecified, without mention of intractable epilepsy personal history of malignant neoplasm of breast constipation, unspecified obstructive hydrocephalus subendocardial infarction, subsequent episode of care aphasia hemiplegia, unspecified, affecting unspecified side 
black african american f 58 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  111  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine chloride, urine  189  meq l; chemistry urine creatinine, urine  74  mg dl; chemistry urine potassium, urine  38  meq l; chemistry urine sodium, urine  152  meq l; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  132  mg dl; chemistry blood glucose  150  mg dl$lorazepam  2  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; phenytoin sodium (iv)  100  mg ; 5% dextrose  100  ml ; acyclovir  700  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; acetaminophen  650  mg ; insulin  0  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sodium chloride 0.9%  flush  10  ml ; artificial tear ointment  1  appl ; levetiracetam  500  mg ; propofol  10  mg ; propofol  1000  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; hydrocortisone cream 0.5%  1  appl ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; neutra-phos  2  pkt ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; phosphorus  250  mg ; 
other pancytopenia benign essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other chest pain urinary tract infection, site not specified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal epilepsy, unspecified, without mention of intractable epilepsy personal history of malignant neoplasm of breast constipation, unspecified obstructive hydrocephalus subendocardial infarction, subsequent episode of care aphasia hemiplegia, unspecified, affecting unspecified side 
black african american f 58 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  107  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  147  mg dl; chemistry blood albumin  3.1  g dl$lorazepam  2  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; sodium chloride 0.9%  flush  3  ml ; phenytoin sodium (iv)  100  mg ; 5% dextrose  100  ml ; acyclovir  700  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; acetaminophen  650  mg ; insulin  0  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sodium chloride 0.9%  flush  10  ml ; artificial tear ointment  1  appl ; propofol  1000  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; hydrocortisone cream 0.5%  1  appl ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; neutra-phos  2  pkt ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; phosphorus  250  mg ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; sodium chloride 0.9%  flush  10-20  ml ; 0.9% sodium chloride  50  ml ; fosphenytoin  100  mg pe ; 
other pancytopenia benign essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other chest pain urinary tract infection, site not specified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal epilepsy, unspecified, without mention of intractable epilepsy personal history of malignant neoplasm of breast constipation, unspecified obstructive hydrocephalus subendocardial infarction, subsequent episode of care aphasia hemiplegia, unspecified, affecting unspecified side 
black african american f 58 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  117  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  109  mg dl$lorazepam  2  mg ; sodium chloride 0.9%  flush  3  ml ; 5% dextrose  100  ml ; acyclovir  700  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; acetaminophen  650  mg ; insulin  0  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sodium chloride 0.9%  flush  10  ml ; artificial tear ointment  1  appl ; propofol  1000  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; hydrocortisone cream 0.5%  1  appl ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; sodium chloride 0.9%  flush  10-20  ml ; 0.9% sodium chloride  50  ml ; fosphenytoin  100  mg pe ; d5 1 2ns  1000  ml ; 
other pancytopenia benign essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other chest pain urinary tract infection, site not specified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal epilepsy, unspecified, without mention of intractable epilepsy personal history of malignant neoplasm of breast constipation, unspecified obstructive hydrocephalus subendocardial infarction, subsequent episode of care aphasia hemiplegia, unspecified, affecting unspecified side 
black african american f 58 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  116  mg dl$lorazepam  2  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; acetaminophen  650  mg ; insulin  0  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sodium chloride 0.9%  flush  10  ml ; artificial tear ointment  1  appl ; propofol  1000  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; hydrocortisone cream 0.5%  1  appl ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; sodium chloride 0.9%  flush  10-20  ml ; 0.9% sodium chloride  50  ml ; fosphenytoin  100  mg pe ; d5 1 2ns  1000  ml ; 
other pancytopenia benign essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other chest pain urinary tract infection, site not specified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal epilepsy, unspecified, without mention of intractable epilepsy personal history of malignant neoplasm of breast constipation, unspecified obstructive hydrocephalus subendocardial infarction, subsequent episode of care aphasia hemiplegia, unspecified, affecting unspecified side 
black african american f 58 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  148  k ul; chemistry blood albumin  3.1  g dl; chemistry blood albumin  3.1  g dl$acetaminophen  650  mg ; artificial tear ointment  1  appl ; hydrocortisone cream 0.5%  1  appl ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; sodium chloride 0.9%  flush  10-20  ml ; phenytoin (suspension)  100  mg ; lorazepam  0.5-2  mg ; phenytoin sodium  100  mg ; 
other pancytopenia benign essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other chest pain urinary tract infection, site not specified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal epilepsy, unspecified, without mention of intractable epilepsy personal history of malignant neoplasm of breast constipation, unspecified obstructive hydrocephalus subendocardial infarction, subsequent episode of care aphasia hemiplegia, unspecified, affecting unspecified side 
black african american f 58 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  179  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  121  mg dl; chemistry blood albumin  3.0  g dl$acetaminophen  650  mg ; artificial tear ointment  1  appl ; hydrocortisone cream 0.5%  1  appl ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; sodium chloride 0.9%  flush  10-20  ml ; phenytoin (suspension)  100  mg ; lorazepam  0.5-2  mg ; phenytoin sodium  100  mg ; phenytoin sodium  300  mg ; phenytoin (suspension)  130  mg ; phenytoin sodium  130  mg ; 
other pancytopenia benign essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other chest pain urinary tract infection, site not specified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal epilepsy, unspecified, without mention of intractable epilepsy personal history of malignant neoplasm of breast constipation, unspecified obstructive hydrocephalus subendocardial infarction, subsequent episode of care aphasia hemiplegia, unspecified, affecting unspecified side 
black african american f 58 $nan$chemistry blood bilirubin, total  0.2  mg dl; chemistry blood albumin  3.1  g dl$acetaminophen  650  mg ; artificial tear ointment  1  appl ; hydrocortisone cream 0.5%  1  appl ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; sodium chloride 0.9%  flush  10-20  ml ; lorazepam  0.5-2  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; heparin sodium  25,000  unit ; 
other pancytopenia benign essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other chest pain urinary tract infection, site not specified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal epilepsy, unspecified, without mention of intractable epilepsy personal history of malignant neoplasm of breast constipation, unspecified obstructive hydrocephalus subendocardial infarction, subsequent episode of care aphasia hemiplegia, unspecified, affecting unspecified side 
black african american f 58 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  227  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  91  mg dl; chemistry blood albumin  3.1  g dl$5% dextrose  250  ml ; acetaminophen  650  mg ; artificial tear ointment  1  appl ; hydrocortisone cream 0.5%  1  appl ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; sodium chloride 0.9%  flush  10-20  ml ; lorazepam  0.5-2  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; heparin sodium  25,000  unit ; 
other pancytopenia benign essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other chest pain urinary tract infection, site not specified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal epilepsy, unspecified, without mention of intractable epilepsy personal history of malignant neoplasm of breast constipation, unspecified obstructive hydrocephalus subendocardial infarction, subsequent episode of care aphasia hemiplegia, unspecified, affecting unspecified side 
black african american f 58 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  88  mg dl; chemistry blood albumin  3.2  g dl$acetaminophen  650  mg ; artificial tear ointment  1  appl ; hydrocortisone cream 0.5%  1  appl ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; sodium chloride 0.9%  flush  10-20  ml ; lorazepam  0.5-2  mg ; 
other pancytopenia benign essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other chest pain urinary tract infection, site not specified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal epilepsy, unspecified, without mention of intractable epilepsy personal history of malignant neoplasm of breast constipation, unspecified obstructive hydrocephalus subendocardial infarction, subsequent episode of care aphasia hemiplegia, unspecified, affecting unspecified side 
black african american f 58 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  127  mg dl; chemistry blood albumin  3.0  g dl$acetaminophen  650  mg ; artificial tear ointment  1  appl ; hydrocortisone cream 0.5%  1  appl ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; sodium chloride 0.9%  flush  10-20  ml ; lorazepam  0.5-2  mg ; d5ns  1000  ml ; enoxaparin sodium  70  mg ; phenytoin infatab  200  mg ; 
other pancytopenia benign essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other chest pain urinary tract infection, site not specified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal epilepsy, unspecified, without mention of intractable epilepsy personal history of malignant neoplasm of breast constipation, unspecified obstructive hydrocephalus subendocardial infarction, subsequent episode of care aphasia hemiplegia, unspecified, affecting unspecified side 
black african american f 58 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  262  mg dl; chemistry blood albumin  2.9  g dl$acetaminophen  650  mg ; artificial tear ointment  1  appl ; hydrocortisone cream 0.5%  1  appl ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; sodium chloride 0.9%  flush  10-20  ml ; lorazepam  0.5-2  mg ; enoxaparin sodium  70  mg ; phenytoin infatab  200  mg ; warfarin  3  mg ; 
other pancytopenia benign essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other chest pain urinary tract infection, site not specified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal epilepsy, unspecified, without mention of intractable epilepsy personal history of malignant neoplasm of breast constipation, unspecified obstructive hydrocephalus subendocardial infarction, subsequent episode of care aphasia hemiplegia, unspecified, affecting unspecified side 
black african american f 58 $nan$hematology blood inr(pt)  1.5  ; chemistry blood albumin  3.2  g dl$acetaminophen  650  mg ; artificial tear ointment  1  appl ; hydrocortisone cream 0.5%  1  appl ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; lorazepam  0.5-2  mg ; enoxaparin sodium  70  mg ; phenytoin infatab  200  mg ; warfarin  3  mg ; 
other pancytopenia benign essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other chest pain urinary tract infection, site not specified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal epilepsy, unspecified, without mention of intractable epilepsy personal history of malignant neoplasm of breast constipation, unspecified obstructive hydrocephalus subendocardial infarction, subsequent episode of care aphasia hemiplegia, unspecified, affecting unspecified side 
black african american f 58 $nan$nan$acetaminophen  650  mg ; artificial tear ointment  1  appl ; hydrocortisone cream 0.5%  1  appl ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; lorazepam  0.5-2  mg ; enoxaparin sodium  70  mg ; phenytoin infatab  200  mg ; warfarin  2  mg ; 
other pancytopenia benign essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other chest pain urinary tract infection, site not specified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal epilepsy, unspecified, without mention of intractable epilepsy personal history of malignant neoplasm of breast constipation, unspecified obstructive hydrocephalus subendocardial infarction, subsequent episode of care aphasia hemiplegia, unspecified, affecting unspecified side 
white f 86 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  273  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  121  mg dl; blood gas blood free calcium  1.23  mmol l; blood gas blood free calcium  0.99  mmol l; blood gas blood lactate  0.8  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood chloride, whole blood  109  meq l; blood gas blood chloride, whole blood  109  meq l; blood gas blood glucose  119  mg dl; blood gas blood glucose  106  mg dl; blood gas blood hematocrit, calculated  28  %; blood gas blood hematocrit, calculated  27  %; blood gas blood hemoglobin  9.2  g dl; blood gas blood hemoglobin  8.9  g dl; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  2.6  meq l; blood gas blood sodium, whole blood  142  meq l; blood gas blood sodium, whole blood  141  meq l$dorzolamide 2% timolol 0.5% ophth.  1  drop ; latanoprost 0.005% ophth. soln.  1  drop ; 
 
white f 86 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  286  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  117  mg dl$dorzolamide 2% timolol 0.5% ophth.  1  drop ; latanoprost 0.005% ophth. soln.  1  drop ; fluoxetine  20  mg ; nifedipine cr  90  mg ; multivitamins  1  tab ; omeprazole  40  mg ; simvastatin  20  mg ; vitamin d  400  unit ; furosemide  20  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; hydralazine  10  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.5-2  mg ; diazepam  2  mg ; calcium carbonate  500  mg ; acetaminophen  1000  mg ; gabapentin  300  mg ; docusate sodium  100  mg ; heparin  5000  unit ; senna  2  tab ; 
 
white f 86 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  307  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  99  mg dl$dorzolamide 2% timolol 0.5% ophth.  1  drop ; latanoprost 0.005% ophth. soln.  1  drop ; fluoxetine  20  mg ; nifedipine cr  90  mg ; multivitamins  1  tab ; omeprazole  40  mg ; simvastatin  20  mg ; vitamin d  400  unit ; furosemide  20  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; hydralazine  10  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.5-2  mg ; calcium carbonate  500  mg ; acetaminophen  1000  mg ; gabapentin  300  mg ; docusate sodium  100  mg ; heparin  5000  unit ; senna  2  tab ; calcium gluconate  2  g ; magnesium sulfate  2  gm ; 
 
white f 86 $nan$nan$dorzolamide 2% timolol 0.5% ophth.  1  drop ; latanoprost 0.005% ophth. soln.  1  drop ; fluoxetine  20  mg ; nifedipine cr  90  mg ; multivitamins  1  tab ; omeprazole  40  mg ; simvastatin  20  mg ; vitamin d  400  unit ; furosemide  20  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; hydralazine  10  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.5-2  mg ; calcium carbonate  500  mg ; acetaminophen  1000  mg ; gabapentin  300  mg ; docusate sodium  100  mg ; heparin  5000  unit ; senna  2  tab ; 0.9% sodium chloride  1  bag ; neutra-phos  2  pkt ; 
 
other f 27 $nan$nan$influenza virus vaccine  0.5  ml ; docusate sodium  100  mg ; calcium carbonate  500  mg ; acetaminophen  500-1000  mg ; prenatal vitamins  1  tab ; 
 
white f 66 $temp  98.4  heartrate  72.0  resprate  18.0  o2sat    sbp  130.0  dbp  62.0  rhythm    pain  10  $chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  101  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; pantoprazole  40  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; insulin  25  unit ; fish oil (omega 3)  1000  mg ; heparin  5000  unit ; docusate sodium  100  mg ; aspirin  325  mg ; clopidogrel  75  mg ; atorvastatin  20  mg ; vitamin d  400  unit ; simvastatin  40  mg ; citalopram  40  mg ; lidocaine 5% patch  1  ptch ; levothyroxine sodium  100  mcg ; clonazepam  0.5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
 
white f 66 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  281  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  252  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; pantoprazole  40  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; insulin  25  unit ; fish oil (omega 3)  1000  mg ; heparin  5000  unit ; docusate sodium  100  mg ; aspirin  325  mg ; clopidogrel  75  mg ; vitamin d  400  unit ; simvastatin  40  mg ; citalopram  40  mg ; lidocaine 5% patch  1  ptch ; levothyroxine sodium  100  mcg ; clonazepam  0.5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; amitriptyline  25  mg ; 
 
white f 66 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; pantoprazole  40  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; insulin  25  unit ; fish oil (omega 3)  1000  mg ; heparin  5000  unit ; docusate sodium  100  mg ; aspirin  325  mg ; clopidogrel  75  mg ; vitamin d  400  unit ; simvastatin  40  mg ; citalopram  40  mg ; lidocaine 5% patch  1  ptch ; levothyroxine sodium  100  mcg ; clonazepam  0.5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; amitriptyline  25  mg ; 0.9% sodium chloride  1000  ml ; ibuprofen  400  mg ; ibuprofen  600  mg ; cepacol (menthol)  1  loz ; insulin  28  unit ; 
 
white m 42 $nan$nan$fluoxetine  30  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; morphine sulfate  50  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; ondansetron  4  mg ; clonazepam  1  mg ; morphine sulfate  2-4  mg ; 
 
white m 42 $nan$nan$fluoxetine  30  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; morphine sulfate  50  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; ondansetron  4  mg ; clonazepam  1  mg ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   10  mg ; 
 
other f 60 $nan$nan$triamterene-hydrochlorothiazide  1  cap ; pravastatin  20  mg ; aspirin  81  mg ; omeprazole  20  mg ; 
displacement of lumbar intervertebral disc without myelopathy unspecified essential hypertension esophageal reflux other and unspecified hyperlipidemia displacement of lumbar intervertebral disc without myelopathy 
other f 60 $nan$hematology blood hematocrit  37.1  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  389  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  98  mg dl$triamterene-hydrochlorothiazide  1  cap ; pravastatin  20  mg ; aspirin  81  mg ; omeprazole  20  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; senna  1  tab ; acetaminophen  325  mg ; docusate sodium  100  mg ; diphenhydramine  25-50  mg ; 
displacement of lumbar intervertebral disc without myelopathy unspecified essential hypertension esophageal reflux other and unspecified hyperlipidemia displacement of lumbar intervertebral disc without myelopathy 
other f 60 $nan$nan$triamterene-hydrochlorothiazide  1  cap ; pravastatin  20  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; senna  1  tab ; acetaminophen  325  mg ; docusate sodium  100  mg ; diphenhydramine  25-50  mg ; hydromorphone (dilaudid)  2-4  mg ; 
displacement of lumbar intervertebral disc without myelopathy unspecified essential hypertension esophageal reflux other and unspecified hyperlipidemia displacement of lumbar intervertebral disc without myelopathy 
other f 60 $nan$nan$triamterene-hydrochlorothiazide  1  cap ; pravastatin  20  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; senna  1  tab ; acetaminophen  325  mg ; docusate sodium  100  mg ; diphenhydramine  25-50  mg ; hydromorphone (dilaudid)  2-4  mg ; 
displacement of lumbar intervertebral disc without myelopathy unspecified essential hypertension esophageal reflux other and unspecified hyperlipidemia displacement of lumbar intervertebral disc without myelopathy 
white m 78 $nan$hematology blood hematocrit  32.0  %; hematology blood hematocrit  30.8  %; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  359  k ul; hematology blood platelet count  324  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  116  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; levothyroxine sodium  100  mcg ; metformin xr (glucophage xr)  1500  mg ; simvastatin  40  mg ; iso-osmotic dextrose  50  ml ; clindamycin  600  mg ; ciprofloxacin hcl  500  mg ; 
nonrheumatic mitral (valve) insufficiency other acute osteomyelitis, left ankle and foot type 2 diabetes mellitus with foot ulcer hypothyroidism, unspecified sepsis, unspecified organism major osseous defect, left ankle and foot unsteadiness on feet non-pressure chronic ulcer of left heel and midfoot with bone involvement without evidence of necrosis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with other specified complication streptococcus, group b, as the cause of diseases classified elsewhere hyperlipidemia, unspecified paroxysmal atrial fibrillation methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere long term (current) use of oral hypoglycemic drugs orthostatic hypotension hypothyroidism, unspecified type 2 diabetes mellitus with foot ulcer non-pressure chronic ulcer of left heel and midfoot with other specified severity hyperlipidemia, unspecified hyperlipidemia, unspecified cellulitis of right lower limb type 2 diabetes mellitus with foot ulcer long term (current) use of oral hypoglycemic drugs type 2 diabetes mellitus with diabetic neuropathy, unspecified non-pressure chronic ulcer of right heel and midfoot with necrosis of bone type 2 diabetes mellitus with other specified complication hypothyroidism, unspecified cutaneous abscess of right foot other acute osteomyelitis, right ankle and foot type 2 diabetes mellitus with foot ulcer osteoarthritis of knee, unspecified insect bite (nonvenomous) of left ear, initial encounter hypothyroidism, unspecified unspecified place or not applicable bitten or stung by nonvenomous insect and other nonvenomous arthropods, initial encounter hyperlipidemia, unspecified non-pressure chronic ulcer of left heel and midfoot with unspecified severity disruption of internal operation (surgical) wound diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure polyneuropathy in diabetes other bone involvement in diseases classified elsewhere pathologic fracture of other specified site unspecified osteomyelitis, ankle and foot unspecified acquired hypothyroidism
white m 78 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  307  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  97  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; levothyroxine sodium  100  mcg ; metformin xr (glucophage xr)  1500  mg ; simvastatin  40  mg ; iso-osmotic dextrose  50  ml ; clindamycin  600  mg ; ciprofloxacin hcl  500  mg ; 
nonrheumatic mitral (valve) insufficiency other acute osteomyelitis, left ankle and foot type 2 diabetes mellitus with foot ulcer hypothyroidism, unspecified sepsis, unspecified organism major osseous defect, left ankle and foot unsteadiness on feet non-pressure chronic ulcer of left heel and midfoot with bone involvement without evidence of necrosis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with other specified complication streptococcus, group b, as the cause of diseases classified elsewhere hyperlipidemia, unspecified paroxysmal atrial fibrillation methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere long term (current) use of oral hypoglycemic drugs orthostatic hypotension hypothyroidism, unspecified type 2 diabetes mellitus with foot ulcer non-pressure chronic ulcer of left heel and midfoot with other specified severity hyperlipidemia, unspecified hyperlipidemia, unspecified cellulitis of right lower limb type 2 diabetes mellitus with foot ulcer long term (current) use of oral hypoglycemic drugs type 2 diabetes mellitus with diabetic neuropathy, unspecified non-pressure chronic ulcer of right heel and midfoot with necrosis of bone type 2 diabetes mellitus with other specified complication hypothyroidism, unspecified cutaneous abscess of right foot other acute osteomyelitis, right ankle and foot type 2 diabetes mellitus with foot ulcer osteoarthritis of knee, unspecified insect bite (nonvenomous) of left ear, initial encounter hypothyroidism, unspecified unspecified place or not applicable bitten or stung by nonvenomous insect and other nonvenomous arthropods, initial encounter hyperlipidemia, unspecified non-pressure chronic ulcer of left heel and midfoot with unspecified severity disruption of internal operation (surgical) wound diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure polyneuropathy in diabetes other bone involvement in diseases classified elsewhere pathologic fracture of other specified site unspecified osteomyelitis, ankle and foot unspecified acquired hypothyroidism
white m 78 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  107  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; levothyroxine sodium  100  mcg ; metformin xr (glucophage xr)  1500  mg ; simvastatin  40  mg ; iso-osmotic dextrose  50  ml ; clindamycin  600  mg ; ciprofloxacin hcl  500  mg ; senna  8.6  mg ; 
nonrheumatic mitral (valve) insufficiency other acute osteomyelitis, left ankle and foot type 2 diabetes mellitus with foot ulcer hypothyroidism, unspecified sepsis, unspecified organism major osseous defect, left ankle and foot unsteadiness on feet non-pressure chronic ulcer of left heel and midfoot with bone involvement without evidence of necrosis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with other specified complication streptococcus, group b, as the cause of diseases classified elsewhere hyperlipidemia, unspecified paroxysmal atrial fibrillation methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere long term (current) use of oral hypoglycemic drugs orthostatic hypotension hypothyroidism, unspecified type 2 diabetes mellitus with foot ulcer non-pressure chronic ulcer of left heel and midfoot with other specified severity hyperlipidemia, unspecified hyperlipidemia, unspecified cellulitis of right lower limb type 2 diabetes mellitus with foot ulcer long term (current) use of oral hypoglycemic drugs type 2 diabetes mellitus with diabetic neuropathy, unspecified non-pressure chronic ulcer of right heel and midfoot with necrosis of bone type 2 diabetes mellitus with other specified complication hypothyroidism, unspecified cutaneous abscess of right foot other acute osteomyelitis, right ankle and foot type 2 diabetes mellitus with foot ulcer osteoarthritis of knee, unspecified insect bite (nonvenomous) of left ear, initial encounter hypothyroidism, unspecified unspecified place or not applicable bitten or stung by nonvenomous insect and other nonvenomous arthropods, initial encounter hyperlipidemia, unspecified non-pressure chronic ulcer of left heel and midfoot with unspecified severity disruption of internal operation (surgical) wound diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure polyneuropathy in diabetes other bone involvement in diseases classified elsewhere pathologic fracture of other specified site unspecified osteomyelitis, ankle and foot unspecified acquired hypothyroidism
white m 78 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  278  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; levothyroxine sodium  100  mcg ; metformin xr (glucophage xr)  1500  mg ; simvastatin  40  mg ; iso-osmotic dextrose  50  ml ; clindamycin  600  mg ; ciprofloxacin hcl  500  mg ; senna  8.6  mg ; 
nonrheumatic mitral (valve) insufficiency other acute osteomyelitis, left ankle and foot type 2 diabetes mellitus with foot ulcer hypothyroidism, unspecified sepsis, unspecified organism major osseous defect, left ankle and foot unsteadiness on feet non-pressure chronic ulcer of left heel and midfoot with bone involvement without evidence of necrosis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with other specified complication streptococcus, group b, as the cause of diseases classified elsewhere hyperlipidemia, unspecified paroxysmal atrial fibrillation methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere long term (current) use of oral hypoglycemic drugs orthostatic hypotension hypothyroidism, unspecified type 2 diabetes mellitus with foot ulcer non-pressure chronic ulcer of left heel and midfoot with other specified severity hyperlipidemia, unspecified hyperlipidemia, unspecified cellulitis of right lower limb type 2 diabetes mellitus with foot ulcer long term (current) use of oral hypoglycemic drugs type 2 diabetes mellitus with diabetic neuropathy, unspecified non-pressure chronic ulcer of right heel and midfoot with necrosis of bone type 2 diabetes mellitus with other specified complication hypothyroidism, unspecified cutaneous abscess of right foot other acute osteomyelitis, right ankle and foot type 2 diabetes mellitus with foot ulcer osteoarthritis of knee, unspecified insect bite (nonvenomous) of left ear, initial encounter hypothyroidism, unspecified unspecified place or not applicable bitten or stung by nonvenomous insect and other nonvenomous arthropods, initial encounter hyperlipidemia, unspecified non-pressure chronic ulcer of left heel and midfoot with unspecified severity disruption of internal operation (surgical) wound diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure polyneuropathy in diabetes other bone involvement in diseases classified elsewhere pathologic fracture of other specified site unspecified osteomyelitis, ankle and foot unspecified acquired hypothyroidism
white m 78 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  109  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; levothyroxine sodium  100  mcg ; metformin xr (glucophage xr)  1500  mg ; simvastatin  40  mg ; iso-osmotic dextrose  50  ml ; clindamycin  600  mg ; ciprofloxacin hcl  500  mg ; senna  8.6  mg ; 
nonrheumatic mitral (valve) insufficiency other acute osteomyelitis, left ankle and foot type 2 diabetes mellitus with foot ulcer hypothyroidism, unspecified sepsis, unspecified organism major osseous defect, left ankle and foot unsteadiness on feet non-pressure chronic ulcer of left heel and midfoot with bone involvement without evidence of necrosis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with other specified complication streptococcus, group b, as the cause of diseases classified elsewhere hyperlipidemia, unspecified paroxysmal atrial fibrillation methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere long term (current) use of oral hypoglycemic drugs orthostatic hypotension hypothyroidism, unspecified type 2 diabetes mellitus with foot ulcer non-pressure chronic ulcer of left heel and midfoot with other specified severity hyperlipidemia, unspecified hyperlipidemia, unspecified cellulitis of right lower limb type 2 diabetes mellitus with foot ulcer long term (current) use of oral hypoglycemic drugs type 2 diabetes mellitus with diabetic neuropathy, unspecified non-pressure chronic ulcer of right heel and midfoot with necrosis of bone type 2 diabetes mellitus with other specified complication hypothyroidism, unspecified cutaneous abscess of right foot other acute osteomyelitis, right ankle and foot type 2 diabetes mellitus with foot ulcer osteoarthritis of knee, unspecified insect bite (nonvenomous) of left ear, initial encounter hypothyroidism, unspecified unspecified place or not applicable bitten or stung by nonvenomous insect and other nonvenomous arthropods, initial encounter hyperlipidemia, unspecified non-pressure chronic ulcer of left heel and midfoot with unspecified severity disruption of internal operation (surgical) wound diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure polyneuropathy in diabetes other bone involvement in diseases classified elsewhere pathologic fracture of other specified site unspecified osteomyelitis, ankle and foot unspecified acquired hypothyroidism
white m 78 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; levothyroxine sodium  100  mcg ; metformin xr (glucophage xr)  1500  mg ; simvastatin  40  mg ; iso-osmotic dextrose  50  ml ; clindamycin  600  mg ; ciprofloxacin hcl  500  mg ; senna  8.6  mg ; 
nonrheumatic mitral (valve) insufficiency other acute osteomyelitis, left ankle and foot type 2 diabetes mellitus with foot ulcer hypothyroidism, unspecified sepsis, unspecified organism major osseous defect, left ankle and foot unsteadiness on feet non-pressure chronic ulcer of left heel and midfoot with bone involvement without evidence of necrosis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with other specified complication streptococcus, group b, as the cause of diseases classified elsewhere hyperlipidemia, unspecified paroxysmal atrial fibrillation methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere long term (current) use of oral hypoglycemic drugs orthostatic hypotension hypothyroidism, unspecified type 2 diabetes mellitus with foot ulcer non-pressure chronic ulcer of left heel and midfoot with other specified severity hyperlipidemia, unspecified hyperlipidemia, unspecified cellulitis of right lower limb type 2 diabetes mellitus with foot ulcer long term (current) use of oral hypoglycemic drugs type 2 diabetes mellitus with diabetic neuropathy, unspecified non-pressure chronic ulcer of right heel and midfoot with necrosis of bone type 2 diabetes mellitus with other specified complication hypothyroidism, unspecified cutaneous abscess of right foot other acute osteomyelitis, right ankle and foot type 2 diabetes mellitus with foot ulcer osteoarthritis of knee, unspecified insect bite (nonvenomous) of left ear, initial encounter hypothyroidism, unspecified unspecified place or not applicable bitten or stung by nonvenomous insect and other nonvenomous arthropods, initial encounter hyperlipidemia, unspecified non-pressure chronic ulcer of left heel and midfoot with unspecified severity disruption of internal operation (surgical) wound diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure polyneuropathy in diabetes other bone involvement in diseases classified elsewhere pathologic fracture of other specified site unspecified osteomyelitis, ankle and foot unspecified acquired hypothyroidism
white m 78 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; levothyroxine sodium  100  mcg ; metformin xr (glucophage xr)  1500  mg ; simvastatin  40  mg ; iso-osmotic dextrose  50  ml ; clindamycin  600  mg ; ciprofloxacin hcl  500  mg ; senna  8.6  mg ; 
nonrheumatic mitral (valve) insufficiency other acute osteomyelitis, left ankle and foot type 2 diabetes mellitus with foot ulcer hypothyroidism, unspecified sepsis, unspecified organism major osseous defect, left ankle and foot unsteadiness on feet non-pressure chronic ulcer of left heel and midfoot with bone involvement without evidence of necrosis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with other specified complication streptococcus, group b, as the cause of diseases classified elsewhere hyperlipidemia, unspecified paroxysmal atrial fibrillation methicillin susceptible staphylococcus aureus infection as the cause of diseases classified elsewhere long term (current) use of oral hypoglycemic drugs orthostatic hypotension hypothyroidism, unspecified type 2 diabetes mellitus with foot ulcer non-pressure chronic ulcer of left heel and midfoot with other specified severity hyperlipidemia, unspecified hyperlipidemia, unspecified cellulitis of right lower limb type 2 diabetes mellitus with foot ulcer long term (current) use of oral hypoglycemic drugs type 2 diabetes mellitus with diabetic neuropathy, unspecified non-pressure chronic ulcer of right heel and midfoot with necrosis of bone type 2 diabetes mellitus with other specified complication hypothyroidism, unspecified cutaneous abscess of right foot other acute osteomyelitis, right ankle and foot type 2 diabetes mellitus with foot ulcer osteoarthritis of knee, unspecified insect bite (nonvenomous) of left ear, initial encounter hypothyroidism, unspecified unspecified place or not applicable bitten or stung by nonvenomous insect and other nonvenomous arthropods, initial encounter hyperlipidemia, unspecified non-pressure chronic ulcer of left heel and midfoot with unspecified severity disruption of internal operation (surgical) wound diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure polyneuropathy in diabetes other bone involvement in diseases classified elsewhere pathologic fracture of other specified site unspecified osteomyelitis, ankle and foot unspecified acquired hypothyroidism
white m 74 $temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    ; temp    heartrate    resprate    o2sat    sbp  123.0  dbp  69.0  rhythm    pain    ; temp    heartrate  77.0  resprate  16.0  o2sat  100.0  sbp  162.0  dbp  70.0  rhythm    pain    $nan$aspirin  81  mg ; 
obstructive sleep apnea (adult) (pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits presence of prosthetic heart valve hyperlipidemia, unspecified disorder of kidney and ureter, unspecified personal history of nicotine dependence essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants occlusion and stenosis of left carotid artery hypothyroidism, unspecified 
white m 74 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  117  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  123  mg dl$losartan potassium  100  mg ; aspirin  81  mg ; hydralazine  10-20  mg ; metoprolol tartrate  5  mg ; lidocaine jelly 2% (glydo)  1  appl ; levothyroxine sodium  100  mcg ; propofol  1000  mg ; lactated ringers  1000  ml ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; heparin  5000  unit ; simvastatin  20  mg ; mouth care oral rinse  7-15  ml ; acetaminophen  500-1000  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; isosorbide dinitrate  10  mg ; ondansetron  4  mg ; 
obstructive sleep apnea (adult) (pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits presence of prosthetic heart valve hyperlipidemia, unspecified disorder of kidney and ureter, unspecified personal history of nicotine dependence essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants occlusion and stenosis of left carotid artery hypothyroidism, unspecified 
white m 74 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  126  mg dl$losartan potassium  100  mg ; aspirin  81  mg ; hydralazine  10-20  mg ; metoprolol tartrate  5  mg ; lidocaine jelly 2% (glydo)  1  appl ; levothyroxine sodium  100  mcg ; heparin  5000  unit ; simvastatin  20  mg ; mouth care oral rinse  7-15  ml ; acetaminophen  500-1000  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; isosorbide dinitrate  10  mg ; ondansetron  4  mg ; metoprolol tartrate  50  mg ; isosorbide mononitrate (extended release)  30  mg ; atenolol  50  mg ; heparin  1600-3300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; 
obstructive sleep apnea (adult) (pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits presence of prosthetic heart valve hyperlipidemia, unspecified disorder of kidney and ureter, unspecified personal history of nicotine dependence essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants occlusion and stenosis of left carotid artery hypothyroidism, unspecified 
white m 74 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  137  mg dl$aspirin  81  mg ; metoprolol tartrate  5  mg ; levothyroxine sodium  100  mcg ; simvastatin  20  mg ; acetaminophen  500-1000  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; ondansetron  4  mg ; isosorbide mononitrate (extended release)  30  mg ; atenolol  50  mg ; olanzapine  2.5  mg ; d5 1 2ns  1000  ml ; tamsulosin  0.4  mg ; 
obstructive sleep apnea (adult) (pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits presence of prosthetic heart valve hyperlipidemia, unspecified disorder of kidney and ureter, unspecified personal history of nicotine dependence essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants occlusion and stenosis of left carotid artery hypothyroidism, unspecified 
white m 74 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  189  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  127  mg dl$aspirin  81  mg ; metoprolol tartrate  5  mg ; levothyroxine sodium  100  mcg ; simvastatin  20  mg ; acetaminophen  500-1000  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; ondansetron  4  mg ; isosorbide mononitrate (extended release)  30  mg ; atenolol  50  mg ; olanzapine  2.5  mg ; tamsulosin  0.4  mg ; bisacodyl  10  mg ; fleet enema (mineral oil)  1  enema ; acetaminophen  1000  mg ; metoclopramide  10  mg ; sodium chloride 0.9%  flush  3-10  ml ; 
obstructive sleep apnea (adult) (pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits presence of prosthetic heart valve hyperlipidemia, unspecified disorder of kidney and ureter, unspecified personal history of nicotine dependence essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants occlusion and stenosis of left carotid artery hypothyroidism, unspecified 
white m 74 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  186  k ul; hematology blood inr(pt)  1.2  $aspirin  81  mg ; levothyroxine sodium  100  mcg ; simvastatin  20  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; ondansetron  4  mg ; isosorbide mononitrate (extended release)  30  mg ; atenolol  50  mg ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3-10  ml ; trazodone  25  mg ; ipratropium-albuterol neb  1  neb ; 
obstructive sleep apnea (adult) (pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits presence of prosthetic heart valve hyperlipidemia, unspecified disorder of kidney and ureter, unspecified personal history of nicotine dependence essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants occlusion and stenosis of left carotid artery hypothyroidism, unspecified 
white m 74 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  224  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  218  mg dl$aspirin  81  mg ; levothyroxine sodium  100  mcg ; simvastatin  20  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; ondansetron  4  mg ; isosorbide mononitrate (extended release)  30  mg ; atenolol  50  mg ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3-10  ml ; trazodone  25  mg ; ipratropium-albuterol neb  1  neb ; 
obstructive sleep apnea (adult) (pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits presence of prosthetic heart valve hyperlipidemia, unspecified disorder of kidney and ureter, unspecified personal history of nicotine dependence essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants occlusion and stenosis of left carotid artery hypothyroidism, unspecified 
white m 74 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  155  mg dl$aspirin  81  mg ; levothyroxine sodium  100  mcg ; simvastatin  20  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; ondansetron  4  mg ; isosorbide mononitrate (extended release)  30  mg ; atenolol  50  mg ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3-10  ml ; trazodone  25  mg ; bag  1  bag ; magnesium sulfate  4  gm ; potassium chloride  20  meq ; warfarin  2.5  mg ; 
obstructive sleep apnea (adult) (pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits presence of prosthetic heart valve hyperlipidemia, unspecified disorder of kidney and ureter, unspecified personal history of nicotine dependence essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants occlusion and stenosis of left carotid artery hypothyroidism, unspecified 
white m 74 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  148  mg dl$aspirin  81  mg ; levothyroxine sodium  100  mcg ; simvastatin  20  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; ondansetron  4  mg ; isosorbide mononitrate (extended release)  30  mg ; atenolol  50  mg ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3-10  ml ; trazodone  25  mg ; bag  1  bag ; magnesium sulfate  4  gm ; potassium chloride  20  meq ; warfarin  2.5  mg ; 
obstructive sleep apnea (adult) (pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits presence of prosthetic heart valve hyperlipidemia, unspecified disorder of kidney and ureter, unspecified personal history of nicotine dependence essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants occlusion and stenosis of left carotid artery hypothyroidism, unspecified 
white m 74 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  225  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  155  mg dl$aspirin  81  mg ; levothyroxine sodium  100  mcg ; simvastatin  20  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; ondansetron  4  mg ; isosorbide mononitrate (extended release)  30  mg ; atenolol  50  mg ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3-10  ml ; trazodone  25  mg ; warfarin  2.5  mg ; magnesium sulfate  2  gm ; 
obstructive sleep apnea (adult) (pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits presence of prosthetic heart valve hyperlipidemia, unspecified disorder of kidney and ureter, unspecified personal history of nicotine dependence essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants occlusion and stenosis of left carotid artery hypothyroidism, unspecified 
white m 74 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  241  k ul; hematology blood inr(pt)  1.2  $aspirin  81  mg ; levothyroxine sodium  100  mcg ; simvastatin  20  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; ondansetron  4  mg ; isosorbide mononitrate (extended release)  30  mg ; atenolol  50  mg ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3-10  ml ; trazodone  25  mg ; magnesium sulfate  2  gm ; warfarin  3.75  mg ; 
obstructive sleep apnea (adult) (pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits presence of prosthetic heart valve hyperlipidemia, unspecified disorder of kidney and ureter, unspecified personal history of nicotine dependence essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants occlusion and stenosis of left carotid artery hypothyroidism, unspecified 
white m 74 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  237  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  164  mg dl$aspirin  81  mg ; levothyroxine sodium  100  mcg ; simvastatin  20  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; ondansetron  4  mg ; isosorbide mononitrate (extended release)  30  mg ; atenolol  50  mg ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3-10  ml ; trazodone  25  mg ; magnesium sulfate  2  gm ; warfarin  3.75  mg ; dextromethorphan polistirex  30  mg ; warfarin  5  mg ; 
obstructive sleep apnea (adult) (pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits presence of prosthetic heart valve hyperlipidemia, unspecified disorder of kidney and ureter, unspecified personal history of nicotine dependence essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants occlusion and stenosis of left carotid artery hypothyroidism, unspecified 
white m 74 $nan$hematology blood inr(pt)  1.4  $aspirin  81  mg ; levothyroxine sodium  100  mcg ; simvastatin  20  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; ondansetron  4  mg ; isosorbide mononitrate (extended release)  30  mg ; atenolol  50  mg ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3-10  ml ; trazodone  25  mg ; warfarin  3.75  mg ; dextromethorphan polistirex  30  mg ; warfarin  5  mg ; 
obstructive sleep apnea (adult) (pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits presence of prosthetic heart valve hyperlipidemia, unspecified disorder of kidney and ureter, unspecified personal history of nicotine dependence essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants occlusion and stenosis of left carotid artery hypothyroidism, unspecified 
white m 74 $nan$hematology blood inr(pt)  1.8  $aspirin  81  mg ; levothyroxine sodium  100  mcg ; simvastatin  20  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; ondansetron  4  mg ; isosorbide mononitrate (extended release)  30  mg ; atenolol  50  mg ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3-10  ml ; trazodone  25  mg ; warfarin  3.75  mg ; dextromethorphan polistirex  30  mg ; warfarin  7.5  mg ; 
obstructive sleep apnea (adult) (pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits presence of prosthetic heart valve hyperlipidemia, unspecified disorder of kidney and ureter, unspecified personal history of nicotine dependence essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants occlusion and stenosis of left carotid artery hypothyroidism, unspecified 
white m 74 $nan$hematology blood inr(pt)  2.8  $aspirin  81  mg ; levothyroxine sodium  100  mcg ; simvastatin  20  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; ondansetron  4  mg ; isosorbide mononitrate (extended release)  30  mg ; atenolol  50  mg ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3-10  ml ; trazodone  25  mg ; warfarin  3.75  mg ; dextromethorphan polistirex  30  mg ; warfarin  7.5  mg ; 
obstructive sleep apnea (adult) (pediatric) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits presence of prosthetic heart valve hyperlipidemia, unspecified disorder of kidney and ureter, unspecified personal history of nicotine dependence essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants occlusion and stenosis of left carotid artery hypothyroidism, unspecified 
white f 68 $nan$nan$atorvastatin  10  mg ; hydrochlorothiazide  25  mg ; sertraline  50  mg ; omeprazole  20  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; acetaminophen  325-650  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; oxycodone-acetaminophen  1-2  tab ; lorazepam  0.5  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; 
 
white f 68 $nan$nan$atorvastatin  10  mg ; hydrochlorothiazide  25  mg ; sertraline  50  mg ; omeprazole  20  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; oxycodone-acetaminophen  1-2  tab ; lorazepam  0.5  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; cephalexin  500  mg ; hydrocodone-acetaminophen  1  tab ; 
 
white m 55 $nan$nan$fexofenadine  180  mg ; cyanocobalamin  100  mcg ; folic acid  1  mg ; aspirin  325  mg ; simvastatin  80  mg ; omeprazole  40  mg ; venlafaxine xr  37.5  mg ; thiamine  100  mg ; 
 
white m 55 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  117  mg dl$fexofenadine  180  mg ; cyanocobalamin  100  mcg ; folic acid  1  mg ; aspirin  325  mg ; simvastatin  80  mg ; omeprazole  40  mg ; venlafaxine xr  37.5  mg ; thiamine  100  mg ; heparin  5000  unit ; ursodiol  300  mg ; clonazepam  1  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; diazepam  5  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; nitroglycerin sl  0.3  mg ; vitamin d  50,000  unit ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; finasteride  5  mg ; acetaminophen  1000  mg ; 0.9% sodium chloride  1000  ml ; 
 
white m 55 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  87  mg dl$fexofenadine  180  mg ; cyanocobalamin  100  mcg ; folic acid  1  mg ; aspirin  325  mg ; simvastatin  80  mg ; omeprazole  40  mg ; venlafaxine xr  37.5  mg ; thiamine  100  mg ; heparin  5000  unit ; ursodiol  300  mg ; clonazepam  1  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; diazepam  5  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; nitroglycerin sl  0.3  mg ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; finasteride  5  mg ; acetaminophen  1000  mg ; 0.9% sodium chloride  1000  ml ; 
 
white m 55 $nan$hematology blood hematocrit  37.3  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  83  mg dl$fexofenadine  180  mg ; cyanocobalamin  100  mcg ; folic acid  1  mg ; aspirin  325  mg ; simvastatin  80  mg ; omeprazole  40  mg ; venlafaxine xr  37.5  mg ; thiamine  100  mg ; heparin  5000  unit ; ursodiol  300  mg ; clonazepam  1  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; diazepam  5  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; nitroglycerin sl  0.3  mg ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; finasteride  5  mg ; acetaminophen  1000  mg ; 
 
white m 55 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  231  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood glucose  108  mg dl$fexofenadine  180  mg ; cyanocobalamin  100  mcg ; folic acid  1  mg ; aspirin  325  mg ; simvastatin  80  mg ; omeprazole  40  mg ; venlafaxine xr  37.5  mg ; thiamine  100  mg ; heparin  5000  unit ; ursodiol  300  mg ; clonazepam  1  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; diazepam  5  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; nitroglycerin sl  0.3  mg ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; finasteride  5  mg ; acetaminophen  1000  mg ; ibuprofen  600  mg ; 
 
white m 55 $nan$nan$fexofenadine  180  mg ; cyanocobalamin  100  mcg ; folic acid  1  mg ; aspirin  325  mg ; simvastatin  80  mg ; omeprazole  40  mg ; venlafaxine xr  37.5  mg ; thiamine  100  mg ; heparin  5000  unit ; ursodiol  300  mg ; clonazepam  1  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; diazepam  5  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; nitroglycerin sl  0.3  mg ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; finasteride  5  mg ; ibuprofen  600  mg ; lorazepam  1  mg ; 
 
white m 55 $nan$nan$fexofenadine  180  mg ; cyanocobalamin  100  mcg ; folic acid  1  mg ; aspirin  325  mg ; simvastatin  80  mg ; omeprazole  40  mg ; venlafaxine xr  37.5  mg ; thiamine  100  mg ; heparin  5000  unit ; ursodiol  300  mg ; clonazepam  1  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; diazepam  5  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; nitroglycerin sl  0.3  mg ; zolpidem tartrate  5  mg ; dextrose 50%  12.5  gm ; finasteride  5  mg ; ibuprofen  600  mg ; lorazepam  1  mg ; 
 
white m 47 $nan$hematology blood hematocrit  42.1  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  72  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  113  mg dl; chemistry blood lactate dehydrogenase (ld)  207  iu l$sodium chloride 0.9%  flush  3  ml ; multivitamin iv  10  ml ; thiamine  100  mg ; 5% dextrose  1000  ml ; folic acid  1  mg ; diazepam  10  mg ; heparin  5000  unit ; acetaminophen  650  mg ; multivitamins w minerals  1  tab ; lisinopril  10  mg ; 0.9% sodium chloride  1000  ml ; bag  50  ml ; magnesium sulfate  4  gm ; 
essential and other specified forms of tremor abdominal pain, other specified site acute alcoholic intoxication in alcoholism, continuous disturbance of skin sensation tobacco use disorder tachycardia, unspecified benign essential hypertension acidosis other chest pain alcohol withdrawal depressive disorder, not elsewhere classified esophageal reflux other specified disorders of liver palpitations open wound of face, unspecified site, without mention of complication benign essential hypertension depressive disorder, not elsewhere classified esophageal reflux other specified metabolic disorders other convulsions acute alcoholic intoxication in alcoholism, continuous unspecified fall alcohol withdrawal alcohol withdrawal contact dermatitis and other eczema, unspecified cause unspecified essential hypertension other and unspecified alcohol dependence, continuous nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] other chronic nonalcoholic liver disease alcoholic gastritis, without mention of hemorrhage depressive disorder, not elsewhere classified elevated blood pressure reading without diagnosis of hypertension thrombocytopenia, unspecified other and unspecified alcohol dependence, continuous alcohol withdrawal 
white m 47 $nan$nan$sodium chloride 0.9%  flush  3  ml ; multivitamin iv  10  ml ; thiamine  100  mg ; 5% dextrose  1000  ml ; folic acid  1  mg ; diazepam  10  mg ; heparin  5000  unit ; acetaminophen  650  mg ; multivitamins w minerals  1  tab ; lisinopril  10  mg ; 0.9% sodium chloride  1000  ml ; bag  50  ml ; magnesium sulfate  4  gm ; 
essential and other specified forms of tremor abdominal pain, other specified site acute alcoholic intoxication in alcoholism, continuous disturbance of skin sensation tobacco use disorder tachycardia, unspecified benign essential hypertension acidosis other chest pain alcohol withdrawal depressive disorder, not elsewhere classified esophageal reflux other specified disorders of liver palpitations open wound of face, unspecified site, without mention of complication benign essential hypertension depressive disorder, not elsewhere classified esophageal reflux other specified metabolic disorders other convulsions acute alcoholic intoxication in alcoholism, continuous unspecified fall alcohol withdrawal alcohol withdrawal contact dermatitis and other eczema, unspecified cause unspecified essential hypertension other and unspecified alcohol dependence, continuous nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] other chronic nonalcoholic liver disease alcoholic gastritis, without mention of hemorrhage depressive disorder, not elsewhere classified elevated blood pressure reading without diagnosis of hypertension thrombocytopenia, unspecified other and unspecified alcohol dependence, continuous alcohol withdrawal 
white m 59 $temp  97.1  heartrate  91.0  resprate  20.0  o2sat  98.0  sbp  115.0  dbp  84.0  rhythm    pain  unable to access  ; temp    heartrate  88.0  resprate  20.0  o2sat  96.0  sbp  159.0  dbp  98.0  rhythm    pain  uta  ; temp    heartrate  103.0  resprate  33.0  o2sat  99.0  sbp  174.0  dbp  102.0  rhythm    pain  uta  ; temp    heartrate  98.0  resprate  34.0  o2sat  98.0  sbp  172.0  dbp  96.0  rhythm    pain  uta  ; temp    heartrate  94.0  resprate  25.0  o2sat  100.0  sbp  165.0  dbp  98.0  rhythm    pain  uta  ; temp    heartrate  90.0  resprate  27.0  o2sat  95.0  sbp  148.0  dbp  80.0  rhythm    pain  uta  ; temp    heartrate  90.0  resprate  24.0  o2sat  94.0  sbp  136.0  dbp  74.0  rhythm    pain  uta  ; temp    heartrate  80.0  resprate  26.0  o2sat  96.0  sbp  148.0  dbp  72.0  rhythm    pain  uta  $hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  323  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  117  mg dl; chemistry blood albumin  3.1  g dl; blood gas blood lactate  1.5  mmol l$nan
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $temp  98.3  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    ; temp    heartrate  89.0  resprate  22.0  o2sat  94.0  sbp  119.0  dbp  89.0  rhythm    pain    ; temp  98.3  heartrate  81.0  resprate  18.0  o2sat  95.0  sbp  138.0  dbp  72.0  rhythm    pain  uta  $hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  348  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine creatinine, urine  28  mg dl; chemistry urine sodium, urine  48  meq l; chemistry urine urea nitrogen, urine  247  mg dl; hematology urine wbc  4  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  84  mg dl; chemistry blood lactate dehydrogenase (ld)  232  iu l; chemistry urine protein creatinine ratio  0.3  mg mg$iso-osmotic dextrose  50  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; ascorbic acid  500  mg ; docusate sodium  100  mg ; vitamin d  1000  unit ; lactated ringers  1000  ml ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; clindamycin  900  mg ; senna  8.6  mg ; bisacodyl  10  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; furosemide  20  mg ; lorazepam  1  mg ; doxycycline hyclate  100  mg ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  376  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  122  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; furosemide  40  mg ; olanzapine  5  mg ; olanzapine  2.5-5  mg ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  399  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  108  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; furosemide  40  mg ; olanzapine  5  mg ; olanzapine  2.5-5  mg ; furosemide  80  mg ; haloperidol  5  mg ; vial  1  vial ; ceftriaxone  1  gm ; ramelteon  4  mg ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  402  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  139  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; furosemide  80  mg ; haloperidol  5  mg ; vial  1  vial ; ceftriaxone  1  gm ; ramelteon  4  mg ; ramelteon  8  mg ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  463  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  75  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; vial  1  vial ; ceftriaxone  1  gm ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; furosemide  60  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  467  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry urine creatinine, urine  36  mg dl; chemistry urine sodium, urine  82  meq l; chemistry urine urea nitrogen, urine  212  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; vial  1  vial ; ceftriaxone  1  gm ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; furosemide  60  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; potassium chloride  40  meq ; potassium chloride (powder)  40  meq ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; potassium chloride (powder)  40  meq ; torsemide  40  mg ; torsemide  60  mg ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  450  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry urine creatinine, urine  115  mg dl; chemistry urine urea nitrogen, urine  813  mg dl; hematology urine wbc  19  # hpf; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  117  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; torsemide  40  mg ; torsemide  60  mg ; potassium chloride (powder)  60  meq ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  445  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  420  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  409  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  101  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  383  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  356  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  110  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  362  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  78  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; lidocaine jelly 2% (glydo)  1  appl ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  362  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  348  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  129  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  374  k ul$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  78  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; tramadol  25  mg ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  362  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  107  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; tramadol  25  mg ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  376  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry urine creatinine, urine  21  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  103  mg dl; chemistry urine protein creatinine ratio  0.2  mg mg$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; tramadol  25  mg ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  388  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  127  mg dl; chemistry blood lactate dehydrogenase (ld)  260  iu l; chemistry blood albumin  2.8  g dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; tramadol  25  mg ; sulfameth trimethoprim ds  2  tab ; amoxicillin  500  mg ; haloperidol  1  mg ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  382  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  108  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; tramadol  25  mg ; sulfameth trimethoprim ds  2  tab ; haloperidol  1  mg ; triamcinolone acetonide 0.1% ointment  1  appl ; haloperidol  2  mg ; potassium chloride (powder)  100  meq ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  317  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  91  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; tramadol  25  mg ; sulfameth trimethoprim ds  2  tab ; triamcinolone acetonide 0.1% ointment  1  appl ; haloperidol  2  mg ; potassium chloride (powder)  100  meq ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; 0.9% sodium chloride  50  ml ; daptomycin  600  mg ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  402  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; tramadol  25  mg ; triamcinolone acetonide 0.1% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; 0.9% sodium chloride  50  ml ; daptomycin  600  mg ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  456  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  86  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; tramadol  25  mg ; triamcinolone acetonide 0.1% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; 0.9% sodium chloride  50  ml ; daptomycin  600  mg ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  469  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  95  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; tramadol  25  mg ; triamcinolone acetonide 0.1% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; 0.9% sodium chloride  50  ml ; daptomycin  600  mg ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  528  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; tramadol  25  mg ; triamcinolone acetonide 0.1% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; 0.9% sodium chloride  50  ml ; daptomycin  600  mg ; iohexol 240 (omnipaque 240)  40  ml ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  531  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; tramadol  25  mg ; triamcinolone acetonide 0.1% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; 0.9% sodium chloride  50  ml ; daptomycin  600  mg ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  580  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  179  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; tramadol  25  mg ; triamcinolone acetonide 0.1% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; 0.9% sodium chloride  50  ml ; daptomycin  600  mg ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  578  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  123  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; triamcinolone acetonide 0.1% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; 0.9% sodium chloride  50  ml ; daptomycin  600  mg ; potassium chloride  60  meq ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  602  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  93  mg dl; chemistry blood lactate dehydrogenase (ld)  227  iu l; chemistry blood albumin  3.4  g dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; triamcinolone acetonide 0.1% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; 0.9% sodium chloride  50  ml ; daptomycin  600  mg ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; triamcinolone acetonide 0.1% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  33.4  %; hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  473  k ul; hematology blood platelet count  537  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  139  mg dl; hematology blood bands  0  %; blood gas blood lactate  1.8  mmol l$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  0.5  mg ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; lorazepam  1  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; triamcinolone acetonide 0.1% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  34.7  %; hematology blood hematocrit  29.4  %; hematology blood hemoglobin  11.0  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  531  k ul; hematology blood platelet count  412  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  134  mg dl; chemistry blood glucose  185  mg dl; blood gas blood lactate  0.8  mmol l$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; triamcinolone acetonide 0.1% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  423  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; triamcinolone acetonide 0.1% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; ondansetron odt  4  mg ; calcium carbonate  500  mg ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  431  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  130  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; triamcinolone acetonide 0.1% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; ondansetron odt  4  mg ; calcium carbonate  500  mg ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  403  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  91  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; triamcinolone acetonide 0.1% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  34.4  %; hematology blood hematocrit  34.0  %; hematology blood hemoglobin  11.0  g dl; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  448  k ul; hematology blood platelet count  447  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood glucose  93  mg dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; triamcinolone acetonide 0.1% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  442  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  110  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; triamcinolone acetonide 0.1% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; ciprofloxacin hcl  250  mg ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  458  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; triamcinolone acetonide 0.1% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; ciprofloxacin hcl  250  mg ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  491  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  2  mg ; zinc sulfate  220  mg ; senna  8.6  mg ; bisacodyl  10  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; triamcinolone acetonide 0.1% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; ciprofloxacin hcl  250  mg ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  491  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  7  mg dl; hematology urine wbc  9  # hpf; chemistry blood glucose  87  mg dl; blood gas blood lactate  1.1  mmol l$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  2  mg ; senna  8.6  mg ; bisacodyl  10  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; triamcinolone acetonide 0.1% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; ciprofloxacin hcl  250  mg ; multivitamins w minerals  1  tab ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  487  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  2  mg ; senna  8.6  mg ; bisacodyl  10  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; triamcinolone acetonide 0.1% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; ciprofloxacin hcl  250  mg ; multivitamins w minerals  1  tab ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  441  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  110  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  2  mg ; senna  8.6  mg ; bisacodyl  10  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; triamcinolone acetonide 0.1% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; ciprofloxacin hcl  250  mg ; multivitamins w minerals  1  tab ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white m 59 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  456  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  82  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ascorbic acid  500  mg ; vitamin d  1000  unit ; heparin  5000  unit ; cetirizine  20  mg ; citalopram  30  mg ; latanoprost 0.005% ophth. soln.  1  drop ; lorazepam  2  mg ; senna  8.6  mg ; bisacodyl  10  mg ; ramelteon  8  mg ; miconazole powder 2%  1  appl ; triamcinolone acetonide 0.1% ointment  1  appl ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; multivitamins w minerals  1  tab ; 
other place in hospital as the place of occurrence of the external cause autistic disorder methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere nonrheumatic mitral (valve) insufficiency anxiety disorder, unspecified other ischiorectal abscess cellulitis of buttock patient room in hospital as the place of occurrence of the external cause disorientation, unspecified slurred speech adult-onset still's disease gangrene, not elsewhere classified adverse effect of penicillins, initial encounter other fatigue adverse effect of other systemic antibiotics, initial encounter bipolar disorder, unspecified adverse effect of benzodiazepines, initial encounter ataxia, unspecified acute kidney failure with tubular necrosis cutaneous abscess of buttock autistic disorder, current or active state pressure ulcer, buttock cellulitis and abscess of buttock other acquired absence of organ cellulitis and abscess of leg, except foot pressure ulcer, unspecified stage bipolar disorder, unspecified mitral valve disorders mitral valve disorders pressure ulcer, buttock autistic disorder, current or active state edema pressure ulcer, stage iii bipolar disorder, unspecified unspecified intellectual disabilities constipation, unspecified polyarticular juvenile rheumatoid arthritis, chronic or unspecified autistic disorder, current or active state unspecified episodic mood disorder mitral valve disorders moderate intellectual disabilities bipolar disorder, unspecified cellulitis and abscess of buttock 
white f 80 $temp    heartrate  115.0  resprate  18.0  o2sat  95.0  sbp  99.0  dbp  58.0  rhythm    pain  4  ; temp    heartrate    resprate  16.0  o2sat  97.0  sbp  106.0  dbp  63.0  rhythm    pain  sleep  ; temp    heartrate  120.0  resprate  18.0  o2sat  97.0  sbp  82.0  dbp  60.0  rhythm    pain  2  ; temp    heartrate    resprate    o2sat    sbp  96.0  dbp  68.0  rhythm    pain    ; temp  97.4  heartrate  122.0  resprate  18.0  o2sat  96.0  sbp  91.0  dbp  72.0  rhythm    pain  sleep  $hematology blood hematocrit  35.6  %; hematology blood hematocrit  33.1  %; hematology blood hemoglobin  10.8  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  300  k ul; hematology blood platelet count  259  k ul; chemistry blood anion gap  27  meq l; chemistry blood anion gap  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  81  meq l; chemistry blood chloride  76  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  71  mg dl; chemistry blood urea nitrogen  79  mg dl; hematology blood inr(pt)  1.4  ; chemistry urine chloride, urine  20  meq l; chemistry urine creatinine, urine  72  mg dl; chemistry urine urea nitrogen, urine  378  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  123  mg dl; chemistry blood glucose  131  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; lactated ringers  1000  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; ns  100  ml ; metronidazole  500  mg ; heparin flush (10 units ml)  2  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftazidime  1  g ; sodium chloride 0.9%  1000  ml ; 
hip joint replacement ventral, unspecified, hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas car passenger injured in collision with van in traffic accident acute pancreatitis acquired hypertrophic pyloric stenosis car passenger injured in collision with van in traffic accident nausea with vomiting acute pancreatitis nonspecific abnormal results of function study of liver family history of diabetes mellitus calculus of gallbladder and bile duct with acute and chronic cholecystitis, with obstruction hip joint replacement pedal cycle driver injured in noncollision transport accident in nontraffic accident
white f 80 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  230  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  82  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  6.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  90  mg dl; chemistry blood lactate dehydrogenase (ld)  228  iu l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; ns  100  ml ; metronidazole  500  mg ; heparin flush (10 units ml)  2  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftazidime  1  g ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; metoprolol tartrate  2.5  mg ; vial  1  vial ; pantoprazole  40  mg ; acetaminophen iv  1000  mg ; 
hip joint replacement ventral, unspecified, hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas car passenger injured in collision with van in traffic accident acute pancreatitis acquired hypertrophic pyloric stenosis car passenger injured in collision with van in traffic accident nausea with vomiting acute pancreatitis nonspecific abnormal results of function study of liver family history of diabetes mellitus calculus of gallbladder and bile duct with acute and chronic cholecystitis, with obstruction hip joint replacement pedal cycle driver injured in noncollision transport accident in nontraffic accident
white f 80 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  189  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  2.5  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  79  mg dl; hematology blood inr(pt)  1.2  ; chemistry urine creatinine, urine  54  mg dl; chemistry blood calcium, total  6.8  mg dl; chemistry blood glucose  69  mg dl; chemistry urine protein creatinine ratio  1.5  mg mg; chemistry urine albumin, urine  18.6  mg dl; chemistry urine albumin creatinine, urine  344.4  mg g$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  20  ml ; vial  1  vial ; pantoprazole  40  mg ; acetaminophen iv  1000  mg ; sodium chloride 0.9%  flush  10-20  ml ; sterile water  100  ml ; potassium chloride  40  meq ; d5ns  1000  ml ; sterile water  50  ml ; potassium chloride  20  meq ; potassium chloride  60  meq ; 0.9% sodium chloride  500  ml ; 
hip joint replacement ventral, unspecified, hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas car passenger injured in collision with van in traffic accident acute pancreatitis acquired hypertrophic pyloric stenosis car passenger injured in collision with van in traffic accident nausea with vomiting acute pancreatitis nonspecific abnormal results of function study of liver family history of diabetes mellitus calculus of gallbladder and bile duct with acute and chronic cholecystitis, with obstruction hip joint replacement pedal cycle driver injured in noncollision transport accident in nontraffic accident
white f 80 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  63  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  90  mg dl; chemistry blood lactate dehydrogenase (ld)  247  iu l; chemistry blood albumin  2.5  g dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  20  ml ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; 0.9% sodium chloride  500  ml ; diltiazem  10  mg ; moviprep  1  l ; 0.9% sodium chloride  250  ml ; metoprolol tartrate  25  mg ; metoprolol tartrate  12.5  mg ; 
hip joint replacement ventral, unspecified, hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas car passenger injured in collision with van in traffic accident acute pancreatitis acquired hypertrophic pyloric stenosis car passenger injured in collision with van in traffic accident nausea with vomiting acute pancreatitis nonspecific abnormal results of function study of liver family history of diabetes mellitus calculus of gallbladder and bile duct with acute and chronic cholecystitis, with obstruction hip joint replacement pedal cycle driver injured in noncollision transport accident in nontraffic accident
white f 80 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  48  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  74  mg dl; chemistry blood lactate dehydrogenase (ld)  265  iu l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  20  ml ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; 0.9% sodium chloride  500  ml ; diltiazem  10  mg ; moviprep  1  l ; metoprolol tartrate  25  mg ; furosemide  40  mg ; volumen (barium sulfate 0.1% suspension)  900  ml ; metoprolol tartrate  37.5  mg ; 
hip joint replacement ventral, unspecified, hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas car passenger injured in collision with van in traffic accident acute pancreatitis acquired hypertrophic pyloric stenosis car passenger injured in collision with van in traffic accident nausea with vomiting acute pancreatitis nonspecific abnormal results of function study of liver family history of diabetes mellitus calculus of gallbladder and bile duct with acute and chronic cholecystitis, with obstruction hip joint replacement pedal cycle driver injured in noncollision transport accident in nontraffic accident
white f 80 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  194  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  109  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  20  ml ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; furosemide  40  mg ; volumen (barium sulfate 0.1% suspension)  900  ml ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; furosemide  20  mg ; neutra-phos  1  pkt ; 
hip joint replacement ventral, unspecified, hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas car passenger injured in collision with van in traffic accident acute pancreatitis acquired hypertrophic pyloric stenosis car passenger injured in collision with van in traffic accident nausea with vomiting acute pancreatitis nonspecific abnormal results of function study of liver family history of diabetes mellitus calculus of gallbladder and bile duct with acute and chronic cholecystitis, with obstruction hip joint replacement pedal cycle driver injured in noncollision transport accident in nontraffic accident
white f 80 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  223  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.4  ; chemistry urine creatinine, urine  45  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  108  mg dl; chemistry urine protein creatinine ratio  0.6  mg mg; chemistry urine albumin, urine  3.6  mg dl; chemistry urine albumin creatinine, urine  80.0  mg g$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  20  ml ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; furosemide  20  mg ; neutra-phos  1  pkt ; acetaminophen (liquid)  650  mg ; 
hip joint replacement ventral, unspecified, hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas car passenger injured in collision with van in traffic accident acute pancreatitis acquired hypertrophic pyloric stenosis car passenger injured in collision with van in traffic accident nausea with vomiting acute pancreatitis nonspecific abnormal results of function study of liver family history of diabetes mellitus calculus of gallbladder and bile duct with acute and chronic cholecystitis, with obstruction hip joint replacement pedal cycle driver injured in noncollision transport accident in nontraffic accident
white f 80 $nan$hematology blood hematocrit  27.5  %; hematology blood hematocrit  29.2  %; hematology blood hematocrit  30.5  %; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  192  k ul; hematology blood platelet count  223  k ul; hematology blood platelet count  228  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  101  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  159  mg dl; chemistry blood lactate dehydrogenase (ld)  242  iu l; chemistry blood albumin  2.4  g dl; blood gas blood lactate  1.1  mmol l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  20  ml ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; acetaminophen (liquid)  650  mg ; ipratropium bromide neb  1  neb ; levalbuterol neb  0.63  mg ; metoprolol tartrate  5  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; cefepime  2  g ; 
hip joint replacement ventral, unspecified, hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas car passenger injured in collision with van in traffic accident acute pancreatitis acquired hypertrophic pyloric stenosis car passenger injured in collision with van in traffic accident nausea with vomiting acute pancreatitis nonspecific abnormal results of function study of liver family history of diabetes mellitus calculus of gallbladder and bile duct with acute and chronic cholecystitis, with obstruction hip joint replacement pedal cycle driver injured in noncollision transport accident in nontraffic accident
white f 80 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  28  mg dl; hematology urine wbc  40  # hpf; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  124  mg dl; blood gas blood free calcium  1.09  mmol l; blood gas blood lactate  1.3  mmol l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  20  ml ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; acetaminophen (liquid)  650  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; cefepime  2  g ; digoxin  0.0625  mg ; digoxin  0.5  mg ; 
hip joint replacement ventral, unspecified, hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas car passenger injured in collision with van in traffic accident acute pancreatitis acquired hypertrophic pyloric stenosis car passenger injured in collision with van in traffic accident nausea with vomiting acute pancreatitis nonspecific abnormal results of function study of liver family history of diabetes mellitus calculus of gallbladder and bile duct with acute and chronic cholecystitis, with obstruction hip joint replacement pedal cycle driver injured in noncollision transport accident in nontraffic accident
white f 80 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  120  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  20  ml ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; acetaminophen (liquid)  650  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; albumin 25% (12.5g   50ml)  25  g ; digoxin  0.25  mg ; 
hip joint replacement ventral, unspecified, hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas car passenger injured in collision with van in traffic accident acute pancreatitis acquired hypertrophic pyloric stenosis car passenger injured in collision with van in traffic accident nausea with vomiting acute pancreatitis nonspecific abnormal results of function study of liver family history of diabetes mellitus calculus of gallbladder and bile duct with acute and chronic cholecystitis, with obstruction hip joint replacement pedal cycle driver injured in noncollision transport accident in nontraffic accident
white f 80 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  102  mg dl; blood gas blood lactate  1.3  mmol l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  20  ml ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; acetaminophen (liquid)  650  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; 
hip joint replacement ventral, unspecified, hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas car passenger injured in collision with van in traffic accident acute pancreatitis acquired hypertrophic pyloric stenosis car passenger injured in collision with van in traffic accident nausea with vomiting acute pancreatitis nonspecific abnormal results of function study of liver family history of diabetes mellitus calculus of gallbladder and bile duct with acute and chronic cholecystitis, with obstruction hip joint replacement pedal cycle driver injured in noncollision transport accident in nontraffic accident
white f 80 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  20  mg dl; hematology urine wbc  30  # hpf; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  113  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  20  ml ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; acetaminophen (liquid)  650  mg ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; midodrine  10  mg ; midodrine  5  mg ; metoprolol tartrate  6.25  mg ; 
hip joint replacement ventral, unspecified, hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas car passenger injured in collision with van in traffic accident acute pancreatitis acquired hypertrophic pyloric stenosis car passenger injured in collision with van in traffic accident nausea with vomiting acute pancreatitis nonspecific abnormal results of function study of liver family history of diabetes mellitus calculus of gallbladder and bile duct with acute and chronic cholecystitis, with obstruction hip joint replacement pedal cycle driver injured in noncollision transport accident in nontraffic accident
white f 80 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  140  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  20  ml ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10-20  ml ; acetaminophen (liquid)  650  mg ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; midodrine  5  mg ; metoprolol tartrate  6.25  mg ; 
hip joint replacement ventral, unspecified, hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas car passenger injured in collision with van in traffic accident acute pancreatitis acquired hypertrophic pyloric stenosis car passenger injured in collision with van in traffic accident nausea with vomiting acute pancreatitis nonspecific abnormal results of function study of liver family history of diabetes mellitus calculus of gallbladder and bile duct with acute and chronic cholecystitis, with obstruction hip joint replacement pedal cycle driver injured in noncollision transport accident in nontraffic accident
white f 80 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  227  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  88  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  10-20  ml ; acetaminophen (liquid)  650  mg ; midodrine  5  mg ; metoprolol tartrate  6.25  mg ; 
hip joint replacement ventral, unspecified, hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas car passenger injured in collision with van in traffic accident acute pancreatitis acquired hypertrophic pyloric stenosis car passenger injured in collision with van in traffic accident nausea with vomiting acute pancreatitis nonspecific abnormal results of function study of liver family history of diabetes mellitus calculus of gallbladder and bile duct with acute and chronic cholecystitis, with obstruction hip joint replacement pedal cycle driver injured in noncollision transport accident in nontraffic accident
white f 80 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  133  mg dl; chemistry blood glucose  104  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  10-20  ml ; acetaminophen (liquid)  650  mg ; midodrine  5  mg ; metoprolol tartrate  6.25  mg ; 
hip joint replacement ventral, unspecified, hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas car passenger injured in collision with van in traffic accident acute pancreatitis acquired hypertrophic pyloric stenosis car passenger injured in collision with van in traffic accident nausea with vomiting acute pancreatitis nonspecific abnormal results of function study of liver family history of diabetes mellitus calculus of gallbladder and bile duct with acute and chronic cholecystitis, with obstruction hip joint replacement pedal cycle driver injured in noncollision transport accident in nontraffic accident
white f 80 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  223  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  110  mg dl; chemistry blood glucose  114  mg dl; chemistry blood albumin  2.2  g dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  10-20  ml ; acetaminophen (liquid)  650  mg ; midodrine  5  mg ; metoprolol tartrate  6.25  mg ; 
hip joint replacement ventral, unspecified, hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas car passenger injured in collision with van in traffic accident acute pancreatitis acquired hypertrophic pyloric stenosis car passenger injured in collision with van in traffic accident nausea with vomiting acute pancreatitis nonspecific abnormal results of function study of liver family history of diabetes mellitus calculus of gallbladder and bile duct with acute and chronic cholecystitis, with obstruction hip joint replacement pedal cycle driver injured in noncollision transport accident in nontraffic accident
white f 80 $nan$hematology blood hematocrit  23.8  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  118  mg dl; chemistry blood glucose  160  mg dl$bag  2  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  10-20  ml ; acetaminophen (liquid)  650  mg ; midodrine  5  mg ; 
hip joint replacement ventral, unspecified, hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas car passenger injured in collision with van in traffic accident acute pancreatitis acquired hypertrophic pyloric stenosis car passenger injured in collision with van in traffic accident nausea with vomiting acute pancreatitis nonspecific abnormal results of function study of liver family history of diabetes mellitus calculus of gallbladder and bile duct with acute and chronic cholecystitis, with obstruction hip joint replacement pedal cycle driver injured in noncollision transport accident in nontraffic accident
white f 80 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  144  mg dl$bag  2  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  10-20  ml ; acetaminophen (liquid)  650  mg ; midodrine  5  mg ; 
hip joint replacement ventral, unspecified, hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas car passenger injured in collision with van in traffic accident acute pancreatitis acquired hypertrophic pyloric stenosis car passenger injured in collision with van in traffic accident nausea with vomiting acute pancreatitis nonspecific abnormal results of function study of liver family history of diabetes mellitus calculus of gallbladder and bile duct with acute and chronic cholecystitis, with obstruction hip joint replacement pedal cycle driver injured in noncollision transport accident in nontraffic accident
white f 80 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  flush  10-20  ml ; acetaminophen (liquid)  650  mg ; midodrine  5  mg ; 
hip joint replacement ventral, unspecified, hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas car passenger injured in collision with van in traffic accident acute pancreatitis acquired hypertrophic pyloric stenosis car passenger injured in collision with van in traffic accident nausea with vomiting acute pancreatitis nonspecific abnormal results of function study of liver family history of diabetes mellitus calculus of gallbladder and bile duct with acute and chronic cholecystitis, with obstruction hip joint replacement pedal cycle driver injured in noncollision transport accident in nontraffic accident
white f 80 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  10-20  ml ; acetaminophen (liquid)  650  mg ; midodrine  5  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; docusate sodium  100  mg ; 
hip joint replacement ventral, unspecified, hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas car passenger injured in collision with van in traffic accident acute pancreatitis acquired hypertrophic pyloric stenosis car passenger injured in collision with van in traffic accident nausea with vomiting acute pancreatitis nonspecific abnormal results of function study of liver family history of diabetes mellitus calculus of gallbladder and bile duct with acute and chronic cholecystitis, with obstruction hip joint replacement pedal cycle driver injured in noncollision transport accident in nontraffic accident
white f 80 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  10-20  ml ; acetaminophen (liquid)  650  mg ; midodrine  5  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; docusate sodium  100  mg ; 
hip joint replacement ventral, unspecified, hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas car passenger injured in collision with van in traffic accident acute pancreatitis acquired hypertrophic pyloric stenosis car passenger injured in collision with van in traffic accident nausea with vomiting acute pancreatitis nonspecific abnormal results of function study of liver family history of diabetes mellitus calculus of gallbladder and bile duct with acute and chronic cholecystitis, with obstruction hip joint replacement pedal cycle driver injured in noncollision transport accident in nontraffic accident
white f 59 $temp    heartrate  66.0  resprate  15.0  o2sat  99.0  sbp  133.0  dbp  86.0  rhythm    pain  4  ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  2  ; temp    heartrate  60.0  resprate  18.0  o2sat  100.0  sbp  123.0  dbp  78.0  rhythm    pain  2  ; temp    heartrate  64.0  resprate  19.0  o2sat  99.0  sbp  103.0  dbp  64.0  rhythm    pain    ; temp    heartrate  67.0  resprate  20.0  o2sat  99.0  sbp  133.0  dbp  87.0  rhythm    pain    ; temp    heartrate  61.0  resprate  15.0  o2sat  99.0  sbp  113.0  dbp  68.0  rhythm    pain    ; temp    heartrate  66.0  resprate  18.0  o2sat  100.0  sbp  123.0  dbp  72.0  rhythm    pain    ; temp  98.5  heartrate  61.0  resprate  14.0  o2sat  100.0  sbp  119.0  dbp  70.0  rhythm    pain  0  $hematology blood hematocrit  39.5  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  224  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  95  mg dl; chemistry blood % hemoglobin a1c  4.7  %$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; albuterol inhaler  1-2  puff ; levothyroxine sodium  50  mcg ; vitamin e  1000  unit ; heparin  5000  unit ; nitroglycerin sl  0.3  mg ; aspirin  325  mg ; symbicort  2  puff ; 
acute appendicitis without mention of peritonitis family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident disorder of bone and cartilage, unspecified other and unspecified hyperlipidemia unspecified acquired hypothyroidism esophageal reflux unspecified essential hypertension
white f 59 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  91  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; albuterol inhaler  1-2  puff ; levothyroxine sodium  50  mcg ; vitamin e  1000  unit ; heparin  5000  unit ; nitroglycerin sl  0.3  mg ; aspirin  325  mg ; symbicort  2  puff ; sodium chloride 0.9%  1000  ml ; atorvastatin  80  mg ; aspirin  81  mg ; losartan potassium  50  mg ; 
acute appendicitis without mention of peritonitis family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident disorder of bone and cartilage, unspecified other and unspecified hyperlipidemia unspecified acquired hypothyroidism esophageal reflux unspecified essential hypertension
white f 59 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; albuterol inhaler  1-2  puff ; levothyroxine sodium  50  mcg ; vitamin e  1000  unit ; heparin  5000  unit ; nitroglycerin sl  0.3  mg ; symbicort  2  puff ; losartan potassium  50  mg ; atorvastatin  10  mg ; 
acute appendicitis without mention of peritonitis family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident disorder of bone and cartilage, unspecified other and unspecified hyperlipidemia unspecified acquired hypothyroidism esophageal reflux unspecified essential hypertension
hispanic latino f 42 $nan$hematology blood hematocrit  28.3  %; hematology blood hematocrit  29.5  %; hematology blood hematocrit  11.1  %; hematology blood hemoglobin  3.5  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  127  k ul; hematology blood platelet count  132  k ul; hematology blood platelet count  70  k ul; hematology blood inr(pt)  2.6  ; hematology blood inr(pt)  1.0  $ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; sodium chloride 0.9%  flush  3  ml ; 
vasa previa complicating labor and delivery, delivered, with or without mention of antepartum condition premature separation of placenta, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn cord around neck, with compression, complicating labor and delivery, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident elderly multigravida, delivered with or without mention of antepartum condition polyhydramnios, delivered, with or without mention of antepartum condition 
hispanic latino f 42 $nan$nan$ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; sodium chloride 0.9%  flush  3  ml ; enoxaparin sodium  40  mg ; 
vasa previa complicating labor and delivery, delivered, with or without mention of antepartum condition premature separation of placenta, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn cord around neck, with compression, complicating labor and delivery, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident elderly multigravida, delivered with or without mention of antepartum condition polyhydramnios, delivered, with or without mention of antepartum condition 
hispanic latino f 42 $nan$nan$ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; sodium chloride 0.9%  flush  3  ml ; enoxaparin sodium  40  mg ; 
vasa previa complicating labor and delivery, delivered, with or without mention of antepartum condition premature separation of placenta, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn cord around neck, with compression, complicating labor and delivery, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident elderly multigravida, delivered with or without mention of antepartum condition polyhydramnios, delivered, with or without mention of antepartum condition 
white f 57 $nan$blood gas blood free calcium  1.11  mmol l; blood gas blood lactate  0.6  mmol l; blood gas blood chloride, whole blood  104  meq l; blood gas blood glucose  192  mg dl; blood gas blood hematocrit, calculated  27  %; blood gas blood hemoglobin  8.9  g dl; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood sodium, whole blood  137  meq l$nan
aortocoronary bypass status old myocardial infarction atherosclerosis of native arteries of the extremities with ulceration long-term (current) use of insulin ulcer of other part of lower limb other toe(s) amputation status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities unspecified essential hypertension atherosclerosis of native arteries of the extremities with intermittent claudication aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft chronic kidney disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type i [juvenile type], not stated as uncontrolled aortocoronary bypass status chronic kidney disease, unspecified atherosclerosis of native arteries of the extremities with intermittent claudication other toe(s) amputation status coronary atherosclerosis of unspecified type of vessel, native or graft chronic airway obstruction, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified 
white f 57 $nan$hematology blood hematocrit  27.7  %; hematology blood hematocrit  26.2  %; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  207  k ul; hematology blood platelet count  196  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  199  mg dl; chemistry blood glucose  107  mg dl; blood gas blood free calcium  1.06  mmol l; blood gas blood free calcium  1.19  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  0.6  mmol l; blood gas blood lactate  0.8  mmol l; blood gas blood chloride, whole blood  106  meq l; blood gas blood chloride, whole blood  108  meq l; blood gas blood chloride, whole blood  107  meq l; blood gas blood glucose  199  mg dl; blood gas blood glucose  182  mg dl; blood gas blood glucose  177  mg dl; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  29  %; blood gas blood hematocrit, calculated  29  %; blood gas blood hemoglobin  10.5  g dl; blood gas blood hemoglobin  9.5  g dl; blood gas blood hemoglobin  9.8  g dl; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood sodium, whole blood  137  meq l; blood gas blood sodium, whole blood  137  meq l$simvastatin  40  mg ; aspirin  325  mg ; citalopram hydrobromide  20  mg ; metoprolol succinate xl  25  mg ; heparin flush (10 units ml)  1  ml ; metoprolol tartrate  5  mg ; lr  1000  ml ; sw  50  ml ; magnesium sulfate  2  gm ; insulin  0  unit ; hydromorphone (dilaudid)  0.5-2  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; d5ns  1000  ml ; heparin  5000  unit ; 
aortocoronary bypass status old myocardial infarction atherosclerosis of native arteries of the extremities with ulceration long-term (current) use of insulin ulcer of other part of lower limb other toe(s) amputation status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities unspecified essential hypertension atherosclerosis of native arteries of the extremities with intermittent claudication aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft chronic kidney disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type i [juvenile type], not stated as uncontrolled aortocoronary bypass status chronic kidney disease, unspecified atherosclerosis of native arteries of the extremities with intermittent claudication other toe(s) amputation status coronary atherosclerosis of unspecified type of vessel, native or graft chronic airway obstruction, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified 
white f 57 $nan$nan$simvastatin  40  mg ; aspirin  325  mg ; citalopram hydrobromide  20  mg ; heparin flush (10 units ml)  1  ml ; metoprolol tartrate  5  mg ; sw  50  ml ; magnesium sulfate  2  gm ; insulin  0  unit ; docusate sodium  100  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; d5ns  1000  ml ; heparin  5000  unit ; acetaminophen  500-1000  mg ; 
aortocoronary bypass status old myocardial infarction atherosclerosis of native arteries of the extremities with ulceration long-term (current) use of insulin ulcer of other part of lower limb other toe(s) amputation status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities unspecified essential hypertension atherosclerosis of native arteries of the extremities with intermittent claudication aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft chronic kidney disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type i [juvenile type], not stated as uncontrolled aortocoronary bypass status chronic kidney disease, unspecified atherosclerosis of native arteries of the extremities with intermittent claudication other toe(s) amputation status coronary atherosclerosis of unspecified type of vessel, native or graft chronic airway obstruction, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified 
white f 57 $nan$nan$simvastatin  40  mg ; citalopram hydrobromide  20  mg ; heparin flush (10 units ml)  1  ml ; insulin  0  unit ; docusate sodium  100  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; heparin  5000  unit ; acetaminophen  500-1000  mg ; morphine sulfate ir  15  mg ; 
aortocoronary bypass status old myocardial infarction atherosclerosis of native arteries of the extremities with ulceration long-term (current) use of insulin ulcer of other part of lower limb other toe(s) amputation status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities unspecified essential hypertension atherosclerosis of native arteries of the extremities with intermittent claudication aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft chronic kidney disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type i [juvenile type], not stated as uncontrolled aortocoronary bypass status chronic kidney disease, unspecified atherosclerosis of native arteries of the extremities with intermittent claudication other toe(s) amputation status coronary atherosclerosis of unspecified type of vessel, native or graft chronic airway obstruction, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified 
white f 57 $nan$chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.4  meq l$simvastatin  40  mg ; citalopram hydrobromide  20  mg ; heparin flush (10 units ml)  1  ml ; insulin  0  unit ; docusate sodium  100  mg ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  500-1000  mg ; morphine sulfate ir  15  mg ; 
aortocoronary bypass status old myocardial infarction atherosclerosis of native arteries of the extremities with ulceration long-term (current) use of insulin ulcer of other part of lower limb other toe(s) amputation status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities unspecified essential hypertension atherosclerosis of native arteries of the extremities with intermittent claudication aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft chronic kidney disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type i [juvenile type], not stated as uncontrolled aortocoronary bypass status chronic kidney disease, unspecified atherosclerosis of native arteries of the extremities with intermittent claudication other toe(s) amputation status coronary atherosclerosis of unspecified type of vessel, native or graft chronic airway obstruction, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified 
white f 57 $nan$nan$simvastatin  40  mg ; citalopram hydrobromide  20  mg ; heparin flush (10 units ml)  1  ml ; insulin  0  unit ; docusate sodium  100  mg ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  500-1000  mg ; lisinopril  10  mg ; oxycodone-acetaminophen  1-2  tab ; 
aortocoronary bypass status old myocardial infarction atherosclerosis of native arteries of the extremities with ulceration long-term (current) use of insulin ulcer of other part of lower limb other toe(s) amputation status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of artery of the extremities unspecified essential hypertension atherosclerosis of native arteries of the extremities with intermittent claudication aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft chronic kidney disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type i [juvenile type], not stated as uncontrolled aortocoronary bypass status chronic kidney disease, unspecified atherosclerosis of native arteries of the extremities with intermittent claudication other toe(s) amputation status coronary atherosclerosis of unspecified type of vessel, native or graft chronic airway obstruction, not elsewhere classified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified 
white f 69 $temp    heartrate  85.0  resprate  16.0  o2sat  100.0  sbp  124.0  dbp  50.0  rhythm    pain  0  $hematology blood hematocrit  27.9  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  124  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  66  mg dl; blood gas blood lactate  1.4  mmol l$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; clobetasol propionate 0.05% ointment  1  appl ; fluticasone propionate nasal  1  spry ; hydrocerin  1  appl ; pantoprazole  40  mg ; tiotropium bromide  1  cap ; rosuvastatin calcium  20  mg ; lorazepam  0.5  mg ; heparin  5000  unit ; 
arteritis, unspecified unspecified disorder of kidney and ureter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of tobacco use eosinophilia other specified antibiotics causing adverse effects in therapeutic use chronic kidney disease, unspecified peripheral vascular disease, unspecified esophageal reflux abdominal aneurysm without mention of rupture chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia pure hypercholesterolemia other specified antibiotics causing adverse effects in therapeutic use dermatitis due to drugs and medicines taken internally chronic kidney disease, stage iii (moderate) solitary pulmonary nodule home accidents peripheral vascular disease, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified fever, unspecified other pancytopenia esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction chronic airway obstruction, not elsewhere classified other arterial embolism and thrombosis of abdominal aorta personal history of tobacco use other and unspecified hyperlipidemia hypovolemia arteritis, unspecified other specified cardiac dysrhythmias abdominal aneurysm without mention of rupture acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified occlusion and stenosis of carotid artery without mention of cerebral infarction fever, unspecified hypovolemia hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified family history of other cardiovascular diseases other and unspecified hyperlipidemia chronic kidney disease, unspecified arteritis, unspecified anemia, unspecified peripheral vascular disease, unspecified orthostatic hypotension esophageal reflux personal history of tobacco use abdominal aneurysm without mention of rupture
white f 69 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry urine creatinine, urine  99  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  88  mg dl; chemistry urine protein creatinine ratio  0.5  mg mg$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; clobetasol propionate 0.05% ointment  1  appl ; fluticasone propionate nasal  1  spry ; hydrocerin  1  appl ; pantoprazole  40  mg ; tiotropium bromide  1  cap ; rosuvastatin calcium  20  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; potassium chloride  20  meq ; minocycline  100  mg ; sodium chloride 0.9%  1000  ml ; 
arteritis, unspecified unspecified disorder of kidney and ureter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of tobacco use eosinophilia other specified antibiotics causing adverse effects in therapeutic use chronic kidney disease, unspecified peripheral vascular disease, unspecified esophageal reflux abdominal aneurysm without mention of rupture chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia pure hypercholesterolemia other specified antibiotics causing adverse effects in therapeutic use dermatitis due to drugs and medicines taken internally chronic kidney disease, stage iii (moderate) solitary pulmonary nodule home accidents peripheral vascular disease, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified fever, unspecified other pancytopenia esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction chronic airway obstruction, not elsewhere classified other arterial embolism and thrombosis of abdominal aorta personal history of tobacco use other and unspecified hyperlipidemia hypovolemia arteritis, unspecified other specified cardiac dysrhythmias abdominal aneurysm without mention of rupture acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified occlusion and stenosis of carotid artery without mention of cerebral infarction fever, unspecified hypovolemia hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified family history of other cardiovascular diseases other and unspecified hyperlipidemia chronic kidney disease, unspecified arteritis, unspecified anemia, unspecified peripheral vascular disease, unspecified orthostatic hypotension esophageal reflux personal history of tobacco use abdominal aneurysm without mention of rupture
white f 69 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  169  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  72  mg dl$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; clobetasol propionate 0.05% ointment  1  appl ; fluticasone propionate nasal  1  spry ; hydrocerin  1  appl ; pantoprazole  40  mg ; tiotropium bromide  1  cap ; rosuvastatin calcium  20  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; potassium chloride  20  meq ; minocycline  100  mg ; sodium chloride 0.9%  1000  ml ; midodrine  2.5  mg ; midodrine  5  mg ; 
arteritis, unspecified unspecified disorder of kidney and ureter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of tobacco use eosinophilia other specified antibiotics causing adverse effects in therapeutic use chronic kidney disease, unspecified peripheral vascular disease, unspecified esophageal reflux abdominal aneurysm without mention of rupture chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia pure hypercholesterolemia other specified antibiotics causing adverse effects in therapeutic use dermatitis due to drugs and medicines taken internally chronic kidney disease, stage iii (moderate) solitary pulmonary nodule home accidents peripheral vascular disease, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified fever, unspecified other pancytopenia esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction chronic airway obstruction, not elsewhere classified other arterial embolism and thrombosis of abdominal aorta personal history of tobacco use other and unspecified hyperlipidemia hypovolemia arteritis, unspecified other specified cardiac dysrhythmias abdominal aneurysm without mention of rupture acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified occlusion and stenosis of carotid artery without mention of cerebral infarction fever, unspecified hypovolemia hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified family history of other cardiovascular diseases other and unspecified hyperlipidemia chronic kidney disease, unspecified arteritis, unspecified anemia, unspecified peripheral vascular disease, unspecified orthostatic hypotension esophageal reflux personal history of tobacco use abdominal aneurysm without mention of rupture
white f 69 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  63  mg dl$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; clobetasol propionate 0.05% ointment  1  appl ; fluticasone propionate nasal  1  spry ; hydrocerin  1  appl ; pantoprazole  40  mg ; tiotropium bromide  1  cap ; rosuvastatin calcium  20  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; minocycline  100  mg ; midodrine  5  mg ; methylphenidate (ritalin)  5  mg ; 
arteritis, unspecified unspecified disorder of kidney and ureter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of tobacco use eosinophilia other specified antibiotics causing adverse effects in therapeutic use chronic kidney disease, unspecified peripheral vascular disease, unspecified esophageal reflux abdominal aneurysm without mention of rupture chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia pure hypercholesterolemia other specified antibiotics causing adverse effects in therapeutic use dermatitis due to drugs and medicines taken internally chronic kidney disease, stage iii (moderate) solitary pulmonary nodule home accidents peripheral vascular disease, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified fever, unspecified other pancytopenia esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction chronic airway obstruction, not elsewhere classified other arterial embolism and thrombosis of abdominal aorta personal history of tobacco use other and unspecified hyperlipidemia hypovolemia arteritis, unspecified other specified cardiac dysrhythmias abdominal aneurysm without mention of rupture acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified occlusion and stenosis of carotid artery without mention of cerebral infarction fever, unspecified hypovolemia hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified family history of other cardiovascular diseases other and unspecified hyperlipidemia chronic kidney disease, unspecified arteritis, unspecified anemia, unspecified peripheral vascular disease, unspecified orthostatic hypotension esophageal reflux personal history of tobacco use abdominal aneurysm without mention of rupture
white f 69 $nan$chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  82  mg dl$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; clobetasol propionate 0.05% ointment  1  appl ; fluticasone propionate nasal  1  spry ; hydrocerin  1  appl ; pantoprazole  40  mg ; tiotropium bromide  1  cap ; rosuvastatin calcium  20  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; minocycline  100  mg ; methylphenidate (ritalin)  5  mg ; 
arteritis, unspecified unspecified disorder of kidney and ureter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of tobacco use eosinophilia other specified antibiotics causing adverse effects in therapeutic use chronic kidney disease, unspecified peripheral vascular disease, unspecified esophageal reflux abdominal aneurysm without mention of rupture chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia pure hypercholesterolemia other specified antibiotics causing adverse effects in therapeutic use dermatitis due to drugs and medicines taken internally chronic kidney disease, stage iii (moderate) solitary pulmonary nodule home accidents peripheral vascular disease, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified fever, unspecified other pancytopenia esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction chronic airway obstruction, not elsewhere classified other arterial embolism and thrombosis of abdominal aorta personal history of tobacco use other and unspecified hyperlipidemia hypovolemia arteritis, unspecified other specified cardiac dysrhythmias abdominal aneurysm without mention of rupture acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified occlusion and stenosis of carotid artery without mention of cerebral infarction fever, unspecified hypovolemia hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified family history of other cardiovascular diseases other and unspecified hyperlipidemia chronic kidney disease, unspecified arteritis, unspecified anemia, unspecified peripheral vascular disease, unspecified orthostatic hypotension esophageal reflux personal history of tobacco use abdominal aneurysm without mention of rupture
white f 69 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  76  mg dl; chemistry blood albumin  2.3  g dl; chemistry blood % hemoglobin a1c  4.9  %$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; clobetasol propionate 0.05% ointment  1  appl ; fluticasone propionate nasal  1  spry ; hydrocerin  1  appl ; pantoprazole  40  mg ; tiotropium bromide  1  cap ; rosuvastatin calcium  20  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; minocycline  100  mg ; methylphenidate (ritalin)  5  mg ; fludrocortisone acetate  0.1  mg ; 
arteritis, unspecified unspecified disorder of kidney and ureter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of tobacco use eosinophilia other specified antibiotics causing adverse effects in therapeutic use chronic kidney disease, unspecified peripheral vascular disease, unspecified esophageal reflux abdominal aneurysm without mention of rupture chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia pure hypercholesterolemia other specified antibiotics causing adverse effects in therapeutic use dermatitis due to drugs and medicines taken internally chronic kidney disease, stage iii (moderate) solitary pulmonary nodule home accidents peripheral vascular disease, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified fever, unspecified other pancytopenia esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction chronic airway obstruction, not elsewhere classified other arterial embolism and thrombosis of abdominal aorta personal history of tobacco use other and unspecified hyperlipidemia hypovolemia arteritis, unspecified other specified cardiac dysrhythmias abdominal aneurysm without mention of rupture acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified occlusion and stenosis of carotid artery without mention of cerebral infarction fever, unspecified hypovolemia hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified family history of other cardiovascular diseases other and unspecified hyperlipidemia chronic kidney disease, unspecified arteritis, unspecified anemia, unspecified peripheral vascular disease, unspecified orthostatic hypotension esophageal reflux personal history of tobacco use abdominal aneurysm without mention of rupture
white f 69 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  113  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  117  mg dl$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; clobetasol propionate 0.05% ointment  1  appl ; fluticasone propionate nasal  1  spry ; hydrocerin  1  appl ; pantoprazole  40  mg ; tiotropium bromide  1  cap ; rosuvastatin calcium  20  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; minocycline  100  mg ; methylphenidate (ritalin)  5  mg ; captopril  6.25  mg ; lorazepam  0.25  mg ; fludrocortisone acetate  0.2  mg ; miconazole powder 2%  1  appl ; 
arteritis, unspecified unspecified disorder of kidney and ureter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of tobacco use eosinophilia other specified antibiotics causing adverse effects in therapeutic use chronic kidney disease, unspecified peripheral vascular disease, unspecified esophageal reflux abdominal aneurysm without mention of rupture chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia pure hypercholesterolemia other specified antibiotics causing adverse effects in therapeutic use dermatitis due to drugs and medicines taken internally chronic kidney disease, stage iii (moderate) solitary pulmonary nodule home accidents peripheral vascular disease, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified fever, unspecified other pancytopenia esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction chronic airway obstruction, not elsewhere classified other arterial embolism and thrombosis of abdominal aorta personal history of tobacco use other and unspecified hyperlipidemia hypovolemia arteritis, unspecified other specified cardiac dysrhythmias abdominal aneurysm without mention of rupture acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified occlusion and stenosis of carotid artery without mention of cerebral infarction fever, unspecified hypovolemia hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified family history of other cardiovascular diseases other and unspecified hyperlipidemia chronic kidney disease, unspecified arteritis, unspecified anemia, unspecified peripheral vascular disease, unspecified orthostatic hypotension esophageal reflux personal history of tobacco use abdominal aneurysm without mention of rupture
white f 69 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  136  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood calcium, total  11.0  mg dl; chemistry blood glucose  118  mg dl$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; clobetasol propionate 0.05% ointment  1  appl ; fluticasone propionate nasal  1  spry ; hydrocerin  1  appl ; pantoprazole  40  mg ; tiotropium bromide  1  cap ; heparin  5000  unit ; acetaminophen  325-650  mg ; minocycline  100  mg ; lorazepam  0.25  mg ; fludrocortisone acetate  0.2  mg ; miconazole powder 2%  1  appl ; ondansetron  4  mg ; rosuvastatin calcium  40  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 
arteritis, unspecified unspecified disorder of kidney and ureter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of tobacco use eosinophilia other specified antibiotics causing adverse effects in therapeutic use chronic kidney disease, unspecified peripheral vascular disease, unspecified esophageal reflux abdominal aneurysm without mention of rupture chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia pure hypercholesterolemia other specified antibiotics causing adverse effects in therapeutic use dermatitis due to drugs and medicines taken internally chronic kidney disease, stage iii (moderate) solitary pulmonary nodule home accidents peripheral vascular disease, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified fever, unspecified other pancytopenia esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction chronic airway obstruction, not elsewhere classified other arterial embolism and thrombosis of abdominal aorta personal history of tobacco use other and unspecified hyperlipidemia hypovolemia arteritis, unspecified other specified cardiac dysrhythmias abdominal aneurysm without mention of rupture acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified occlusion and stenosis of carotid artery without mention of cerebral infarction fever, unspecified hypovolemia hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified family history of other cardiovascular diseases other and unspecified hyperlipidemia chronic kidney disease, unspecified arteritis, unspecified anemia, unspecified peripheral vascular disease, unspecified orthostatic hypotension esophageal reflux personal history of tobacco use abdominal aneurysm without mention of rupture
white f 69 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  80  mg dl; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  1.7  mmol l$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; clobetasol propionate 0.05% ointment  1  appl ; fluticasone propionate nasal  1  spry ; hydrocerin  1  appl ; pantoprazole  40  mg ; tiotropium bromide  1  cap ; heparin  5000  unit ; acetaminophen  325-650  mg ; minocycline  100  mg ; fludrocortisone acetate  0.2  mg ; miconazole powder 2%  1  appl ; ondansetron  4  mg ; rosuvastatin calcium  40  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 
arteritis, unspecified unspecified disorder of kidney and ureter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of tobacco use eosinophilia other specified antibiotics causing adverse effects in therapeutic use chronic kidney disease, unspecified peripheral vascular disease, unspecified esophageal reflux abdominal aneurysm without mention of rupture chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia pure hypercholesterolemia other specified antibiotics causing adverse effects in therapeutic use dermatitis due to drugs and medicines taken internally chronic kidney disease, stage iii (moderate) solitary pulmonary nodule home accidents peripheral vascular disease, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified fever, unspecified other pancytopenia esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction chronic airway obstruction, not elsewhere classified other arterial embolism and thrombosis of abdominal aorta personal history of tobacco use other and unspecified hyperlipidemia hypovolemia arteritis, unspecified other specified cardiac dysrhythmias abdominal aneurysm without mention of rupture acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified occlusion and stenosis of carotid artery without mention of cerebral infarction fever, unspecified hypovolemia hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified family history of other cardiovascular diseases other and unspecified hyperlipidemia chronic kidney disease, unspecified arteritis, unspecified anemia, unspecified peripheral vascular disease, unspecified orthostatic hypotension esophageal reflux personal history of tobacco use abdominal aneurysm without mention of rupture
white f 69 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  118  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  41  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  94  mg dl$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; clobetasol propionate 0.05% ointment  1  appl ; fluticasone propionate nasal  1  spry ; hydrocerin  1  appl ; pantoprazole  40  mg ; tiotropium bromide  1  cap ; acetaminophen  325-650  mg ; minocycline  100  mg ; fludrocortisone acetate  0.2  mg ; miconazole powder 2%  1  appl ; ondansetron  4  mg ; rosuvastatin calcium  40  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; 
arteritis, unspecified unspecified disorder of kidney and ureter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of tobacco use eosinophilia other specified antibiotics causing adverse effects in therapeutic use chronic kidney disease, unspecified peripheral vascular disease, unspecified esophageal reflux abdominal aneurysm without mention of rupture chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia pure hypercholesterolemia other specified antibiotics causing adverse effects in therapeutic use dermatitis due to drugs and medicines taken internally chronic kidney disease, stage iii (moderate) solitary pulmonary nodule home accidents peripheral vascular disease, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified fever, unspecified other pancytopenia esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction chronic airway obstruction, not elsewhere classified other arterial embolism and thrombosis of abdominal aorta personal history of tobacco use other and unspecified hyperlipidemia hypovolemia arteritis, unspecified other specified cardiac dysrhythmias abdominal aneurysm without mention of rupture acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified occlusion and stenosis of carotid artery without mention of cerebral infarction fever, unspecified hypovolemia hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified family history of other cardiovascular diseases other and unspecified hyperlipidemia chronic kidney disease, unspecified arteritis, unspecified anemia, unspecified peripheral vascular disease, unspecified orthostatic hypotension esophageal reflux personal history of tobacco use abdominal aneurysm without mention of rupture
white f 69 $nan$hematology blood hematocrit  26.1  %; hematology blood hematocrit  25.2  %; hematology blood hematocrit  24.5  %; hematology blood hematocrit  29.4  %; hematology blood hemoglobin  8.7  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  106  k ul; hematology blood platelet count  103  k ul; hematology blood platelet count  104  k ul; hematology blood platelet count  141  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood creatinine  2.6  mg dl; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.3  ; chemistry urine chloride, urine  18  meq l; chemistry urine creatinine, urine  77  mg dl; chemistry urine potassium, urine  55  meq l; chemistry urine sodium, urine  15  meq l; hematology urine wbc  4  # hpf; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  6.9  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  58  mg dl; chemistry blood glucose  139  mg dl; chemistry blood glucose  94  mg dl; chemistry blood lactate dehydrogenase (ld)  405  iu l; chemistry blood albumin  1.9  g dl; hematology blood bands  2  %; hematology blood bands  6  %; hematology blood bands  8  %; chemistry urine protein creatinine ratio  1.0  mg mg; blood gas blood free calcium  0.93  mmol l; blood gas blood lactate  2.9  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  3.4  mmol l$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; clobetasol propionate 0.05% ointment  1  appl ; fluticasone propionate nasal  1  spry ; hydrocerin  1  appl ; pantoprazole  40  mg ; tiotropium bromide  1  cap ; acetaminophen  325-650  mg ; minocycline  100  mg ; fludrocortisone acetate  0.2  mg ; miconazole powder 2%  1  appl ; ondansetron  4  mg ; rosuvastatin calcium  40  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; metronidazole (flagyl)  500  mg ; d5w  300  ml ; linezolid  600  mg ; cefepime  500  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 5% dextrose  100  ml ; vasopressin  40  unit ; dextrose 50%  25  gm ; 
arteritis, unspecified unspecified disorder of kidney and ureter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of tobacco use eosinophilia other specified antibiotics causing adverse effects in therapeutic use chronic kidney disease, unspecified peripheral vascular disease, unspecified esophageal reflux abdominal aneurysm without mention of rupture chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia pure hypercholesterolemia other specified antibiotics causing adverse effects in therapeutic use dermatitis due to drugs and medicines taken internally chronic kidney disease, stage iii (moderate) solitary pulmonary nodule home accidents peripheral vascular disease, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified fever, unspecified other pancytopenia esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction chronic airway obstruction, not elsewhere classified other arterial embolism and thrombosis of abdominal aorta personal history of tobacco use other and unspecified hyperlipidemia hypovolemia arteritis, unspecified other specified cardiac dysrhythmias abdominal aneurysm without mention of rupture acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified occlusion and stenosis of carotid artery without mention of cerebral infarction fever, unspecified hypovolemia hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified family history of other cardiovascular diseases other and unspecified hyperlipidemia chronic kidney disease, unspecified arteritis, unspecified anemia, unspecified peripheral vascular disease, unspecified orthostatic hypotension esophageal reflux personal history of tobacco use abdominal aneurysm without mention of rupture
white f 69 $nan$hematology blood hematocrit  23.8  %; hematology blood hematocrit  24.8  %; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  108  k ul; hematology blood platelet count  120  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  24  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood bicarbonate  10  meq l; chemistry blood bicarbonate  10  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.7  ; hematology urine wbc  4  # hpf; chemistry blood calcium, total  6.6  mg dl; chemistry blood calcium, total  6.6  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  63  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  118  mg dl; chemistry blood lactate dehydrogenase (ld)  745  iu l; chemistry blood albumin  1.8  g dl; hematology blood bands  0  %; blood gas blood free calcium  1.00  mmol l; blood gas blood free calcium  1.01  mmol l; blood gas blood free calcium  0.99  mmol l; blood gas blood lactate  3.4  mmol l; blood gas blood lactate  3.6  mmol l; blood gas blood lactate  4.4  mmol l; blood gas blood lactate  4.6  mmol l; blood gas blood lactate  3.7  mmol l; blood gas blood glucose  128  mg dl; blood gas blood glucose  147  mg dl; blood gas blood hematocrit, calculated  24  %; blood gas blood hemoglobin  8.1  g dl$0.9% sodium chloride  50  ml ; senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; clobetasol propionate 0.05% ointment  1  appl ; fluticasone propionate nasal  1  spry ; hydrocerin  1  appl ; pantoprazole  40  mg ; tiotropium bromide  1  cap ; acetaminophen  325-650  mg ; fludrocortisone acetate  0.2  mg ; miconazole powder 2%  1  appl ; rosuvastatin calcium  40  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 5% dextrose  100  ml ; vasopressin  40  unit ; dextrose 50%  25  gm ; vial  1  vial ; ns  100  ml ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; sterile water  50  ml ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; acetaminophen iv  1000  mg ; bisacodyl  10  mg ; magnesium citrate  150  ml ; 5% dextrose  50  ml ; thiamine  100  mg ; hydrocortisone na succ.  100  mg ; sodium chloride 0.9%  flush  10  ml ; 
arteritis, unspecified unspecified disorder of kidney and ureter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of tobacco use eosinophilia other specified antibiotics causing adverse effects in therapeutic use chronic kidney disease, unspecified peripheral vascular disease, unspecified esophageal reflux abdominal aneurysm without mention of rupture chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia pure hypercholesterolemia other specified antibiotics causing adverse effects in therapeutic use dermatitis due to drugs and medicines taken internally chronic kidney disease, stage iii (moderate) solitary pulmonary nodule home accidents peripheral vascular disease, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified fever, unspecified other pancytopenia esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction chronic airway obstruction, not elsewhere classified other arterial embolism and thrombosis of abdominal aorta personal history of tobacco use other and unspecified hyperlipidemia hypovolemia arteritis, unspecified other specified cardiac dysrhythmias abdominal aneurysm without mention of rupture acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified occlusion and stenosis of carotid artery without mention of cerebral infarction fever, unspecified hypovolemia hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified family history of other cardiovascular diseases other and unspecified hyperlipidemia chronic kidney disease, unspecified arteritis, unspecified anemia, unspecified peripheral vascular disease, unspecified orthostatic hypotension esophageal reflux personal history of tobacco use abdominal aneurysm without mention of rupture
white f 69 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  20  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood creatinine  2.8  mg dl; chemistry blood creatinine  3.1  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  1.7  ; hematology urine wbc  0  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, indirect  0.2  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  103  mg dl; chemistry blood glucose  81  mg dl; chemistry blood lactate dehydrogenase (ld)  1261  iu l; hematology blood bands  2  %; blood gas blood free calcium  1.05  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood lactate  4.0  mmol l; blood gas blood lactate  3.5  mmol l; blood gas blood lactate  5.2  mmol l; chemistry blood bilirubin, direct  1.0  mg dl$0.9% sodium chloride  50  ml ; senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; clobetasol propionate 0.05% ointment  1  appl ; fluticasone propionate nasal  1  spry ; hydrocerin  1  appl ; tiotropium bromide  1  cap ; acetaminophen  325-650  mg ; miconazole powder 2%  1  appl ; rosuvastatin calcium  40  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 5% dextrose  100  ml ; vasopressin  40  unit ; dextrose 50%  25  gm ; vial  1  vial ; ns  100  ml ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; sterile water  50  ml ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; acetaminophen iv  1000  mg ; bisacodyl  10  mg ; magnesium citrate  150  ml ; 5% dextrose  50  ml ; thiamine  100  mg ; sodium chloride 0.9%  flush  10  ml ; cholestyramine  4  gm ; lidocaine jelly 2% (urojet)  1  appl ; nystatin cream  1  appl ; lactated ringers  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; promethazine  6.25  mg ; 
arteritis, unspecified unspecified disorder of kidney and ureter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of tobacco use eosinophilia other specified antibiotics causing adverse effects in therapeutic use chronic kidney disease, unspecified peripheral vascular disease, unspecified esophageal reflux abdominal aneurysm without mention of rupture chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia pure hypercholesterolemia other specified antibiotics causing adverse effects in therapeutic use dermatitis due to drugs and medicines taken internally chronic kidney disease, stage iii (moderate) solitary pulmonary nodule home accidents peripheral vascular disease, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified fever, unspecified other pancytopenia esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction chronic airway obstruction, not elsewhere classified other arterial embolism and thrombosis of abdominal aorta personal history of tobacco use other and unspecified hyperlipidemia hypovolemia arteritis, unspecified other specified cardiac dysrhythmias abdominal aneurysm without mention of rupture acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified occlusion and stenosis of carotid artery without mention of cerebral infarction fever, unspecified hypovolemia hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified family history of other cardiovascular diseases other and unspecified hyperlipidemia chronic kidney disease, unspecified arteritis, unspecified anemia, unspecified peripheral vascular disease, unspecified orthostatic hypotension esophageal reflux personal history of tobacco use abdominal aneurysm without mention of rupture
white f 69 $nan$hematology blood hematocrit  23.3  %; hematology blood hematocrit  16.6  %; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  5.5  g dl; hematology blood platelet count  129  k ul; hematology blood platelet count  107  k ul; chemistry blood anion gap  27  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  11  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  3.2  mg dl; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood glucose  50  mg dl; chemistry blood glucose  163  mg dl; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.01  mmol l; blood gas blood free calcium  0.96  mmol l; blood gas blood lactate  6.3  mmol l; blood gas blood lactate  6.5  mmol l; blood gas blood lactate  6.3  mmol l; blood gas blood lactate  8.7  mmol l; blood gas blood glucose  131  mg dl$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; clobetasol propionate 0.05% ointment  1  appl ; fluticasone propionate nasal  1  spry ; hydrocerin  1  appl ; tiotropium bromide  1  cap ; acetaminophen  325-650  mg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 5% dextrose  100  ml ; vasopressin  40  unit ; dextrose 50%  25  gm ; vial  1  vial ; ns  100  ml ; sterile water  50  ml ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 5% dextrose  50  ml ; thiamine  100  mg ; sodium chloride 0.9%  flush  10  ml ; cholestyramine  4  gm ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; promethazine  6.25  mg ; phytonadione  10  mg ; vancomycin oral liquid  125  mg ; albumin 25% (12.5g   50ml)  25  g ; d5w  250  ml ; dopamine  400  mg ; hydromorphone (dilaudid)  0.125  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; epinephrine  2  mg ; 
arteritis, unspecified unspecified disorder of kidney and ureter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of tobacco use eosinophilia other specified antibiotics causing adverse effects in therapeutic use chronic kidney disease, unspecified peripheral vascular disease, unspecified esophageal reflux abdominal aneurysm without mention of rupture chronic airway obstruction, not elsewhere classified other and unspecified hyperlipidemia pure hypercholesterolemia other specified antibiotics causing adverse effects in therapeutic use dermatitis due to drugs and medicines taken internally chronic kidney disease, stage iii (moderate) solitary pulmonary nodule home accidents peripheral vascular disease, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified fever, unspecified other pancytopenia esophageal reflux occlusion and stenosis of carotid artery without mention of cerebral infarction chronic airway obstruction, not elsewhere classified other arterial embolism and thrombosis of abdominal aorta personal history of tobacco use other and unspecified hyperlipidemia hypovolemia arteritis, unspecified other specified cardiac dysrhythmias abdominal aneurysm without mention of rupture acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified occlusion and stenosis of carotid artery without mention of cerebral infarction fever, unspecified hypovolemia hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified family history of other cardiovascular diseases other and unspecified hyperlipidemia chronic kidney disease, unspecified arteritis, unspecified anemia, unspecified peripheral vascular disease, unspecified orthostatic hypotension esophageal reflux personal history of tobacco use abdominal aneurysm without mention of rupture
black african american m 39 $nan$nan$amlodipine  10  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; heparin  5000  unit ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; hydromorphone (dilaudid)  20  mg ; labetalol  10  mg ; labetalol  200  mg ; 
calculus of bile duct without mention of cholecystitis, with obstruction other and unspecified hyperlipidemia unspecified essential hypertension tobacco use disorder
black african american m 39 $nan$nan$amlodipine  10  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; heparin  5000  unit ; ondansetron  4  mg ; hydromorphone (dilaudid)  20  mg ; labetalol  200  mg ; acetaminophen  325-650  mg ; 
calculus of bile duct without mention of cholecystitis, with obstruction other and unspecified hyperlipidemia unspecified essential hypertension tobacco use disorder
black african american m 39 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  102  mg dl$amlodipine  10  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; heparin  5000  unit ; ondansetron  4  mg ; hydromorphone (dilaudid)  20  mg ; labetalol  200  mg ; acetaminophen  325-650  mg ; 
calculus of bile duct without mention of cholecystitis, with obstruction other and unspecified hyperlipidemia unspecified essential hypertension tobacco use disorder
black african american m 39 $nan$nan$amlodipine  10  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; heparin  5000  unit ; ondansetron  4  mg ; hydromorphone (dilaudid)  20  mg ; labetalol  200  mg ; acetaminophen  325-650  mg ; 
calculus of bile duct without mention of cholecystitis, with obstruction other and unspecified hyperlipidemia unspecified essential hypertension tobacco use disorder
black african american m 39 $nan$nan$amlodipine  10  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; heparin  5000  unit ; ondansetron  4  mg ; hydromorphone (dilaudid)  20  mg ; labetalol  200  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   10  mg ; 
calculus of bile duct without mention of cholecystitis, with obstruction other and unspecified hyperlipidemia unspecified essential hypertension tobacco use disorder
white f 66 $nan$nan$iso-osmotic dextrose  50  ml ; cefazolin  2  g ; sodium chloride 0.9%  flush  3-10  ml ; 
 
white f 66 $nan$nan$iso-osmotic dextrose  50  ml ; cefazolin  2  g ; sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; oxycodone (immediate release)  5  mg ; acetaminophen  1000  mg ; gabapentin  100  mg ; tamsulosin  0.4  mg ; famotidine  20  mg ; senna  8.6  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; aspirin  81  mg ; atorvastatin  20  mg ; levothyroxine sodium  100  mcg ; levothyroxine sodium  75  mcg ; amlodipine  5  mg ; valsartan  160  mg ; hydrochlorothiazide  25  mg ; oxycodone (immediate release)  2.5  mg ; 
 
white f 67 $nan$nan$vitamin d  400  unit ; enoxaparin sodium  30  mg ; morphine sulfate  50  mg ; lr  1000  ml ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; senna  1  tab ; ondansetron  4  mg ; tramadol (ultram)  50  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
iron deficiency anemia, unspecified esophageal reflux person boarding or alighting a pedal cycle injured in collision with fixed or stationary object unspecified essential hypertension accidents occurring in unspecified place other chest pain bariatric surgery status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified metabolic disorders unspecified fall closed fracture of unspecified part of humerus family history of ischemic heart disease diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chest pain, unspecified bariatric surgery status 
white f 67 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  234  k ul$vitamin d  400  unit ; enoxaparin sodium  30  mg ; morphine sulfate  50  mg ; lr  1000  ml ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; senna  1  tab ; ondansetron  4  mg ; tramadol (ultram)  50  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; diphenhydramine  25  mg ; acetaminophen  1000  mg ; lorazepam  0.5  mg ; 
iron deficiency anemia, unspecified esophageal reflux person boarding or alighting a pedal cycle injured in collision with fixed or stationary object unspecified essential hypertension accidents occurring in unspecified place other chest pain bariatric surgery status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified metabolic disorders unspecified fall closed fracture of unspecified part of humerus family history of ischemic heart disease diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chest pain, unspecified bariatric surgery status 
white f 67 $nan$nan$vitamin d  400  unit ; enoxaparin sodium  30  mg ; lr  1000  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; senna  1  tab ; ondansetron  4  mg ; tramadol (ultram)  50  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; diphenhydramine  25  mg ; acetaminophen  1000  mg ; lorazepam  0.5  mg ; 
iron deficiency anemia, unspecified esophageal reflux person boarding or alighting a pedal cycle injured in collision with fixed or stationary object unspecified essential hypertension accidents occurring in unspecified place other chest pain bariatric surgery status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified metabolic disorders unspecified fall closed fracture of unspecified part of humerus family history of ischemic heart disease diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chest pain, unspecified bariatric surgery status 
white f 22 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  260  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  3  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  114  mg dl; chemistry blood albumin  4.1  g dl$insulin  0  unit ; sw  200  ml ; potassium chloride  20  meq ; ns  500  ml ; potassium chloride  40  meq ; ns  1000  ml ; potassium chloride  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; ns  200  ml ; fluconazole  400  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam na  2.25  g ; fentanyl citrate  25-100  mcg ; propofol  1000  mg ; propofol  200  mg ; sw  150  ml ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; haloperidol  1-2  mg ; 
 
white f 22 $nan$hematology blood hematocrit  33.2  %; hematology blood hematocrit  36.3  %; hematology blood hemoglobin  11.7  g dl; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  238  k ul; hematology blood platelet count  280  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  111  mg dl; chemistry blood glucose  114  mg dl; chemistry blood lactate dehydrogenase (ld)  162  iu l; chemistry blood albumin  3.7  g dl$fentanyl citrate  25-100  mcg ; propofol  200  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; haloperidol  1-2  mg ; haloperidol  5  mg ; aripiprazole  5  mg ; sodium chloride 0.9%  flush  3  ml ; potassium phosphate  30  mmol ; 
 
white f 22 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3  ml ; potassium phosphate  30  mmol ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; benztropine mesylate  1  mg ; diphenhydramine  25  mg ; 
 
white f 22 $nan$nan$sodium chloride 0.9%  flush  3  ml ; haloperidol  2  mg ; phenaseptic throat spray  1  spry ; 
 
white f 22 $nan$nan$sodium chloride 0.9%  flush  3  ml ; haloperidol  2  mg ; phenaseptic throat spray  1  spry ; 
 
white f 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; 
 
white f 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  gm ; morphine sulfate  100  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; 
 
white f 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  gm ; morphine sulfate  100  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; aspirin  121.5  mg ; heparin  5000  unit ; docusate sodium  100  mg ; 
 
white f 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  gm ; morphine sulfate  100  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; aspirin  121.5  mg ; heparin  5000  unit ; docusate sodium  100  mg ; hydromorphone (dilaudid)  2-4  mg ; ondansetron  4-8  mg ; 
 
white f 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  gm ; acetaminophen  650  mg ; aspirin  121.5  mg ; heparin  5000  unit ; docusate sodium  100  mg ; hydromorphone (dilaudid)  2-4  mg ; ondansetron  4-8  mg ; 
 
white f 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; aspirin  121.5  mg ; heparin  5000  unit ; docusate sodium  100  mg ; hydromorphone (dilaudid)  2-4  mg ; ondansetron  4-8  mg ; cephalexin  500  mg ; 
 
hispanic latino m 43 $temp    heartrate  59.0  resprate  16.0  o2sat  97.0  sbp  117.0  dbp  69.0  rhythm    pain  0  ; temp    heartrate  64.0  resprate  16.0  o2sat  98.0  sbp  112.0  dbp  60.0  rhythm    pain  0  ; temp  98.6  heartrate  68.0  resprate  16.0  o2sat  98.0  sbp  116.0  dbp  66.0  rhythm    pain    ; temp    heartrate  67.0  resprate  18.0  o2sat  99.0  sbp  94.0  dbp  40.0  rhythm    pain  0  ; temp  98.4  heartrate  72.0  resprate  17.0  o2sat  99.0  sbp  96.0  dbp  50.0  rhythm    pain  0  ; temp    heartrate  72.0  resprate  18.0  o2sat  100.0  sbp  108.0  dbp  61.0  rhythm    pain  0  $hematology blood hematocrit  42.5  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  79  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood glucose  148  mg dl; blood gas blood lactate  3.6  mmol l; blood gas blood lactate  3.6  mmol l; blood gas blood lactate  3.9  mmol l; blood gas blood lactate  4.7  mmol l$sodium chloride 0.9%  flush  3  ml ; acyclovir  400  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; lisinopril  5  mg ; aspirin  81  mg ; dexamethasone  4  mg ; fish oil (omega 3)  1000  mg ; metoprolol succinate xl  25  mg ; omeprazole  40  mg ; pravastatin  40  mg ; ampicillin-sulbactam  1.5  g ; acyclovir  800  mg ; lopinavir-ritonavir  2  tab ; senna  1  tab ; docusate sodium  100  mg ; 
cough unspecified essential hypertension other and unspecified hyperlipidemia asymptomatic human immunodeficiency virus [hiv] infection status other chest pain personal history of peptic ulcer disease percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery other and unspecified escherichia coli [e. coli] goiter, unspecified urinary tract infection, site not specified other malignant lymphomas, unspecified site, extranodal and solid organ sites
hispanic latino m 43 $nan$hematology blood hematocrit  44.8  %; hematology blood hemoglobin  15.0  g dl; hematology blood platelet count  86  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  168  mg dl; chemistry blood lactate dehydrogenase (ld)  194  iu l$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; lisinopril  5  mg ; aspirin  81  mg ; dexamethasone  4  mg ; fish oil (omega 3)  1000  mg ; metoprolol succinate xl  25  mg ; omeprazole  40  mg ; pravastatin  40  mg ; ampicillin-sulbactam  1.5  g ; acyclovir  800  mg ; lopinavir-ritonavir  2  tab ; senna  1  tab ; docusate sodium  100  mg ; emtricitabine-tenofovir (truvada)  1  tab ; 
cough unspecified essential hypertension other and unspecified hyperlipidemia asymptomatic human immunodeficiency virus [hiv] infection status other chest pain personal history of peptic ulcer disease percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery other and unspecified escherichia coli [e. coli] goiter, unspecified urinary tract infection, site not specified other malignant lymphomas, unspecified site, extranodal and solid organ sites
white m 67 $temp  98.9  heartrate  60.0  resprate  16.0  o2sat  100.0  sbp  125.0  dbp  70.0  rhythm    pain  4-8 10  ; temp  98.7  heartrate  64.0  resprate  16.0  o2sat  100.0  sbp  128.0  dbp  80.0  rhythm    pain  4 10  $nan$enoxaparin sodium  40  mg ; lisinopril  40  mg ; hydrochlorothiazide  25  mg ; metoprolol succinate xl  300  mg ; 
 
white m 67 $temp  98.5  heartrate  78.0  resprate  16.0  o2sat  98.0  sbp  129.0  dbp  77.0  rhythm    pain  3  $nan$enoxaparin sodium  40  mg ; lisinopril  40  mg ; hydrochlorothiazide  25  mg ; metoprolol succinate xl  300  mg ; docusate sodium  100  mg ; senna  1  tab ; metoprolol tartrate  100  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; clonazepam  2  mg ; oxycodone-acetaminophen  2  tab ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  20  mg ; hydromorphone (dilaudid)  0.5  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; morphine sulfate  1-5  mg ; prochlorperazine  2.5-5  mg ; haloperidol  0.25-0.5  mg ; hydromorphone (dilaudid)  0.2-0.6  mg ; acetaminophen iv  1000  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; 
 
white m 67 $nan$nan$enoxaparin sodium  40  mg ; docusate sodium  100  mg ; senna  1  tab ; metoprolol tartrate  100  mg ; oxycodone (immediate release)   5-10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; clonazepam  2  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.5  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; hydrochlorothiazide  12.5  mg ; lisinopril  20  mg ; 
 
white m 67 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  156  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  112  mg dl$enoxaparin sodium  40  mg ; docusate sodium  100  mg ; senna  1  tab ; metoprolol tartrate  100  mg ; oxycodone (immediate release)   5-10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; clonazepam  2  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.5  mg ; hydrochlorothiazide  12.5  mg ; lisinopril  20  mg ; 
 
white f 65 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  307  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  88  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$ns  500  ml ; ns  1000  ml ; 1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; insulin  0  unit ; ciprofloxacin hcl  500  mg ; fluticasone-salmeterol (250 50)   1  inh ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; metronidazole (flagyl)  500  mg ; furosemide  20  mg ; atorvastatin  20  mg ; aspirin  325  mg ; n-acetylcysteine  1  dose ; 
 
white f 65 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; insulin  0  unit ; ciprofloxacin hcl  500  mg ; fluticasone-salmeterol (250 50)   1  inh ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; metronidazole (flagyl)  500  mg ; furosemide  20  mg ; atorvastatin  20  mg ; aspirin  325  mg ; 
 
white f 79 $temp    heartrate  145.0  resprate  16.0  o2sat  95.0  sbp  108.0  dbp  61.0  rhythm    pain    ; temp  99.0  heartrate  145.0  resprate  15.0  o2sat  96.0  sbp  111.0  dbp  64.0  rhythm    pain    ; temp    heartrate  142.0  resprate  18.0  o2sat  96.0  sbp  106.0  dbp  68.0  rhythm    pain    $hematology blood hematocrit  23.5  %; hematology blood hematocrit  24.9  %; hematology blood hematocrit  24.9  %; hematology blood hemoglobin  7.2  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  76  k ul; hematology blood platelet count  78  k ul; hematology blood platelet count  81  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood chloride  115  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  52  mg dl; chemistry blood urea nitrogen  50  mg dl; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry urine chloride, urine  71  meq l; chemistry urine creatinine, urine  34  mg dl; chemistry urine potassium, urine  45  meq l; chemistry urine sodium, urine  45  meq l; chemistry urine urea nitrogen, urine  263  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  30  mg dl; chemistry blood glucose  83  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  376  iu l; chemistry blood albumin  1.6  g dl; hematology blood bands  24  %; hematology blood bands  20  %; blood gas blood free calcium  1.24  mmol l; blood gas blood free calcium  1.28  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood lactate  2.8  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood chloride, whole blood  117  meq l; blood gas blood glucose  77  mg dl; blood gas blood hematocrit, calculated  21  %; blood gas blood hemoglobin  7.0  g dl; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood sodium, whole blood  134  meq l$senna  1  tab ; 0.9% sodium chloride  250  ml ; sodium phosphate  30  mmol ; influenza virus vaccine  0.5  ml ; bisacodyl  10  mg ; hydromorphone (dilaudid)  0.5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; 0.9% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; bag  150  ml ; magnesium sulfate  6  gm ; morphine sulfate  4  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; morphine sulfate  2-6  mg ; pantoprazole  40  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; heparin  5000  unit ; methadone  5  mg ; levothyroxine sodium  75  mcg ; prednisone  5  mg ; 0.9% sodium chloride  500  ml ; sodium chloride 0.9%  flush  3  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; docusate sodium  100  mg ; lactated ringers  1000  ml ; 
congestive heart failure, unspecified dehydration acquired absence of both cervix and uterus personal history of tobacco use hydronephrosis polymyalgia rheumatica hip joint replacement personal history of venous thrombosis and embolism chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of steroids chronic kidney disease, unspecified acquired absence of intestine (large) (small) personal history of peptic ulcer disease acute kidney failure, unspecified other chronic pain arthrodesis status other chest pain car passenger injured in collision with van in traffic accident other ureteric obstruction old myocardial infarction rheumatoid arthritis gout, unspecified person boarding or alighting a car injured in collision with railway train or railway vehicle esophageal reflux other and unspecified hyperlipidemia
white f 79 $nan$hematology blood hematocrit  22.0  %; hematology blood hematocrit  29.4  %; hematology blood hematocrit  30.2  %; hematology blood hemoglobin  6.8  g dl; hematology blood platelet count  75  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood chloride  116  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood urea nitrogen  50  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  81  mg dl; chemistry blood glucose  68  mg dl; blood gas blood free calcium  1.27  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.8  mmol l$senna  1  tab ; influenza virus vaccine  0.5  ml ; bisacodyl  10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; acetaminophen  325-650  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; pantoprazole  40  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; heparin  5000  unit ; levothyroxine sodium  75  mcg ; prednisone  5  mg ; sodium chloride 0.9%  flush  3  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; docusate sodium  100  mg ; lactated ringers  1000  ml ; dextrose 50%  12.5  gm ; syringe  0.4  ml ; methadone  4  mg ; lansoprazole oral disintegrating tab  30  mg ; zinc sulfate  220  mg ; ascorbic acid  500  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 
congestive heart failure, unspecified dehydration acquired absence of both cervix and uterus personal history of tobacco use hydronephrosis polymyalgia rheumatica hip joint replacement personal history of venous thrombosis and embolism chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of steroids chronic kidney disease, unspecified acquired absence of intestine (large) (small) personal history of peptic ulcer disease acute kidney failure, unspecified other chronic pain arthrodesis status other chest pain car passenger injured in collision with van in traffic accident other ureteric obstruction old myocardial infarction rheumatoid arthritis gout, unspecified person boarding or alighting a car injured in collision with railway train or railway vehicle esophageal reflux other and unspecified hyperlipidemia
white f 79 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  94  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood bicarbonate  10  meq l; chemistry blood chloride  114  meq l; chemistry blood chloride  116  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  56  mg dl; chemistry blood urea nitrogen  57  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  3  # hpf; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  150  mg dl; chemistry blood glucose  77  mg dl; hematology blood bands  0  %; blood gas blood free calcium  1.43  mmol l; blood gas blood free calcium  1.37  mmol l; blood gas blood lactate  2.6  mmol l; blood gas blood lactate  1.7  mmol l$senna  1  tab ; influenza virus vaccine  0.5  ml ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; heparin  5000  unit ; levothyroxine sodium  75  mcg ; prednisone  5  mg ; sodium chloride 0.9%  flush  3  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; dextrose 50%  12.5  gm ; lansoprazole oral disintegrating tab  30  mg ; zinc sulfate  220  mg ; ascorbic acid  500  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; metoprolol tartrate  12.5  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; methylprednisolone sodium succ  125  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; 
congestive heart failure, unspecified dehydration acquired absence of both cervix and uterus personal history of tobacco use hydronephrosis polymyalgia rheumatica hip joint replacement personal history of venous thrombosis and embolism chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of steroids chronic kidney disease, unspecified acquired absence of intestine (large) (small) personal history of peptic ulcer disease acute kidney failure, unspecified other chronic pain arthrodesis status other chest pain car passenger injured in collision with van in traffic accident other ureteric obstruction old myocardial infarction rheumatoid arthritis gout, unspecified person boarding or alighting a car injured in collision with railway train or railway vehicle esophageal reflux other and unspecified hyperlipidemia
white f 79 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  97  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  60  mg dl; hematology blood inr(pt)  1.4  ; chemistry urine chloride, urine  38  meq l; chemistry urine creatinine, urine  77  mg dl; chemistry urine potassium, urine  47  meq l; chemistry urine sodium, urine  30  meq l; chemistry urine urea nitrogen, urine  216  mg dl; hematology urine wbc  12  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  226  mg dl; hematology blood bands  1  %; blood gas blood free calcium  1.28  mmol l; blood gas blood free calcium  1.24  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood glucose  185  mg dl$senna  1  tab ; influenza virus vaccine  0.5  ml ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; heparin  5000  unit ; levothyroxine sodium  75  mcg ; prednisone  5  mg ; sodium chloride 0.9%  flush  3  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; dextrose 50%  12.5  gm ; lansoprazole oral disintegrating tab  30  mg ; zinc sulfate  220  mg ; ascorbic acid  500  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; metoprolol tartrate  12.5  mg ; methylprednisolone sodium succ  125  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; lactated ringers  500  ml ; 5% dextrose  100  ml ; furosemide  500  mg ; furosemide  40  mg ; acetaminophen  1000  mg ; 
congestive heart failure, unspecified dehydration acquired absence of both cervix and uterus personal history of tobacco use hydronephrosis polymyalgia rheumatica hip joint replacement personal history of venous thrombosis and embolism chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of steroids chronic kidney disease, unspecified acquired absence of intestine (large) (small) personal history of peptic ulcer disease acute kidney failure, unspecified other chronic pain arthrodesis status other chest pain car passenger injured in collision with van in traffic accident other ureteric obstruction old myocardial infarction rheumatoid arthritis gout, unspecified person boarding or alighting a car injured in collision with railway train or railway vehicle esophageal reflux other and unspecified hyperlipidemia
white f 79 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  83  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  66  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  222  mg dl; hematology blood bands  7  %; blood gas blood free calcium  1.28  mmol l; blood gas blood lactate  1.9  mmol l$senna  1  tab ; influenza virus vaccine  0.5  ml ; bisacodyl  10  mg ; heparin  5000  unit ; levothyroxine sodium  75  mcg ; prednisone  5  mg ; sodium chloride 0.9%  flush  3  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; dextrose 50%  12.5  gm ; lansoprazole oral disintegrating tab  30  mg ; zinc sulfate  220  mg ; ascorbic acid  500  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lactated ringers  500  ml ; glucagon  1  mg ; insulin  0  unit ; cefepime  1  g ; 
congestive heart failure, unspecified dehydration acquired absence of both cervix and uterus personal history of tobacco use hydronephrosis polymyalgia rheumatica hip joint replacement personal history of venous thrombosis and embolism chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of steroids chronic kidney disease, unspecified acquired absence of intestine (large) (small) personal history of peptic ulcer disease acute kidney failure, unspecified other chronic pain arthrodesis status other chest pain car passenger injured in collision with van in traffic accident other ureteric obstruction old myocardial infarction rheumatoid arthritis gout, unspecified person boarding or alighting a car injured in collision with railway train or railway vehicle esophageal reflux other and unspecified hyperlipidemia
white f 79 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  87  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  10  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  3.2  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  79  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  167  mg dl; hematology blood bands  7  %$senna  1  tab ; influenza virus vaccine  0.5  ml ; bisacodyl  10  mg ; heparin  5000  unit ; levothyroxine sodium  75  mcg ; prednisone  5  mg ; sodium chloride 0.9%  flush  3  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; dextrose 50%  12.5  gm ; lansoprazole oral disintegrating tab  30  mg ; zinc sulfate  220  mg ; ascorbic acid  500  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; glucagon  1  mg ; insulin  0  unit ; cefepime  1  g ; morphine sulfate  2  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; phenylephrine  60  mg ; morphine sulfate  1-4  mg ; morphine sulfate  100  mg ; lorazepam  0.5-2  mg ; acetaminophen iv  1000  mg ; scopolamine patch  1  ptch ; lorazepam  1-2  mg ; 
congestive heart failure, unspecified dehydration acquired absence of both cervix and uterus personal history of tobacco use hydronephrosis polymyalgia rheumatica hip joint replacement personal history of venous thrombosis and embolism chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of steroids chronic kidney disease, unspecified acquired absence of intestine (large) (small) personal history of peptic ulcer disease acute kidney failure, unspecified other chronic pain arthrodesis status other chest pain car passenger injured in collision with van in traffic accident other ureteric obstruction old myocardial infarction rheumatoid arthritis gout, unspecified person boarding or alighting a car injured in collision with railway train or railway vehicle esophageal reflux other and unspecified hyperlipidemia
white f 79 $nan$nan$sodium chloride 0.9%  flush  3  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; morphine sulfate  2  mg ; phenylephrine  60  mg ; acetaminophen iv  1000  mg ; scopolamine patch  1  ptch ; lorazepam  1-2  mg ; 
congestive heart failure, unspecified dehydration acquired absence of both cervix and uterus personal history of tobacco use hydronephrosis polymyalgia rheumatica hip joint replacement personal history of venous thrombosis and embolism chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of steroids chronic kidney disease, unspecified acquired absence of intestine (large) (small) personal history of peptic ulcer disease acute kidney failure, unspecified other chronic pain arthrodesis status other chest pain car passenger injured in collision with van in traffic accident other ureteric obstruction old myocardial infarction rheumatoid arthritis gout, unspecified person boarding or alighting a car injured in collision with railway train or railway vehicle esophageal reflux other and unspecified hyperlipidemia
black african american m 44 $nan$hematology blood hematocrit  33.4  %; hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.8  g dl; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  227  k ul; hematology blood platelet count  224  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  91  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  148  iu l; chemistry blood lactate dehydrogenase (ld)  140  iu l; chemistry blood albumin  4.3  g dl; chemistry blood albumin  3.9  g dl$sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; acyclovir  400  mg ; polyethylene glycol  17  g ; omeprazole  20  mg ; sulfameth trimethoprim ss  1  tab ; ondansetron  8  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; 0.9% sodium chloride  500  ml ; rituximab  700  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; doxorubicin  21  mg ; vincristine (oncovin)  0.6  mg ; 0.9% sodium chloride  1000  ml ; etoposide  110  mg ; 
hyperglycemia, unspecified hypotension, unspecified diffuse large b-cell lymphoma, intrathoracic lymph nodes other pulmonary embolism without acute cor pulmonale drug induced constipation abnormal results of liver function studies polydipsia chronic embolism and thrombosis of superior vena cava patient room in hospital as the place of occurrence of the external cause family history of diabetes mellitus long term (current) use of antithrombotics/antiplatelets other hodgkin lymphoma, intrathoracic lymph nodes adverse effect of glucocorticoids and synthetic analogues, initial encounter encounter for antineoplastic chemotherapy pericardial effusion (noninflammatory) chronic embolism and thrombosis of other specified veins esophageal obstruction other secondary pulmonary hypertension compression of vein chronic embolism and thrombosis of inferior vena cava adverse effect of antineoplastic and immunosuppressive drugs, initial encounter body mass index (bmi) 20.0-20.9, adult acute embolism and thrombosis of right axillary vein malignant pleural effusion compression of vein pericardial effusion (noninflammatory) pulmonary hypertension, unspecified acute embolism and thrombosis of right subclavian vein acute embolism and thrombosis of inferior vena cava other pulmonary embolism without acute cor pulmonale esophageal obstruction acute embolism and thrombosis of right internal jugular vein encounter for immunization abnormal weight loss other hodgkin lymphoma, intrathoracic lymph nodes hypotension, unspecified diffuse large b-cell lymphoma, intrathoracic lymph nodes 
black african american m 44 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  233  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  208  mg dl; chemistry blood lactate dehydrogenase (ld)  158  iu l; chemistry blood albumin  4.0  g dl$sodium chloride 0.9%  flush  3-10  ml ; acyclovir  400  mg ; polyethylene glycol  17  g ; omeprazole  20  mg ; sulfameth trimethoprim ss  1  tab ; ondansetron  8  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; 0.9% sodium chloride  500  ml ; rituximab  700  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; doxorubicin  21  mg ; vincristine (oncovin)  0.6  mg ; 0.9% sodium chloride  1000  ml ; etoposide  110  mg ; docusate sodium  100  mg ; senna  8.6  mg ; enoxaparin sodium  60  mg ; prednisone  100  mg ; 0.9% sodium chloride  150  ml ; fosaprepitant  150  mg ; neutra-phos  1  pkt ; magnesium oxide  400  mg ; 
hyperglycemia, unspecified hypotension, unspecified diffuse large b-cell lymphoma, intrathoracic lymph nodes other pulmonary embolism without acute cor pulmonale drug induced constipation abnormal results of liver function studies polydipsia chronic embolism and thrombosis of superior vena cava patient room in hospital as the place of occurrence of the external cause family history of diabetes mellitus long term (current) use of antithrombotics/antiplatelets other hodgkin lymphoma, intrathoracic lymph nodes adverse effect of glucocorticoids and synthetic analogues, initial encounter encounter for antineoplastic chemotherapy pericardial effusion (noninflammatory) chronic embolism and thrombosis of other specified veins esophageal obstruction other secondary pulmonary hypertension compression of vein chronic embolism and thrombosis of inferior vena cava adverse effect of antineoplastic and immunosuppressive drugs, initial encounter body mass index (bmi) 20.0-20.9, adult acute embolism and thrombosis of right axillary vein malignant pleural effusion compression of vein pericardial effusion (noninflammatory) pulmonary hypertension, unspecified acute embolism and thrombosis of right subclavian vein acute embolism and thrombosis of inferior vena cava other pulmonary embolism without acute cor pulmonale esophageal obstruction acute embolism and thrombosis of right internal jugular vein encounter for immunization abnormal weight loss other hodgkin lymphoma, intrathoracic lymph nodes hypotension, unspecified diffuse large b-cell lymphoma, intrathoracic lymph nodes 
black african american m 44 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  140  mg dl; chemistry blood lactate dehydrogenase (ld)  145  iu l; chemistry blood albumin  3.8  g dl$acyclovir  400  mg ; polyethylene glycol  17  g ; omeprazole  20  mg ; sulfameth trimethoprim ss  1  tab ; ondansetron  8  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; doxorubicin  21  mg ; vincristine (oncovin)  0.6  mg ; 0.9% sodium chloride  1000  ml ; etoposide  110  mg ; docusate sodium  100  mg ; senna  8.6  mg ; enoxaparin sodium  60  mg ; prednisone  100  mg ; 0.9% sodium chloride  150  ml ; fosaprepitant  150  mg ; neutra-phos  1  pkt ; magnesium oxide  400  mg ; 
hyperglycemia, unspecified hypotension, unspecified diffuse large b-cell lymphoma, intrathoracic lymph nodes other pulmonary embolism without acute cor pulmonale drug induced constipation abnormal results of liver function studies polydipsia chronic embolism and thrombosis of superior vena cava patient room in hospital as the place of occurrence of the external cause family history of diabetes mellitus long term (current) use of antithrombotics/antiplatelets other hodgkin lymphoma, intrathoracic lymph nodes adverse effect of glucocorticoids and synthetic analogues, initial encounter encounter for antineoplastic chemotherapy pericardial effusion (noninflammatory) chronic embolism and thrombosis of other specified veins esophageal obstruction other secondary pulmonary hypertension compression of vein chronic embolism and thrombosis of inferior vena cava adverse effect of antineoplastic and immunosuppressive drugs, initial encounter body mass index (bmi) 20.0-20.9, adult acute embolism and thrombosis of right axillary vein malignant pleural effusion compression of vein pericardial effusion (noninflammatory) pulmonary hypertension, unspecified acute embolism and thrombosis of right subclavian vein acute embolism and thrombosis of inferior vena cava other pulmonary embolism without acute cor pulmonale esophageal obstruction acute embolism and thrombosis of right internal jugular vein encounter for immunization abnormal weight loss other hodgkin lymphoma, intrathoracic lymph nodes hypotension, unspecified diffuse large b-cell lymphoma, intrathoracic lymph nodes 
black african american m 44 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  142  mg dl; chemistry blood lactate dehydrogenase (ld)  122  iu l; chemistry blood albumin  3.8  g dl$acyclovir  400  mg ; polyethylene glycol  17  g ; omeprazole  20  mg ; sulfameth trimethoprim ss  1  tab ; ondansetron  8  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; doxorubicin  21  mg ; vincristine (oncovin)  0.6  mg ; 0.9% sodium chloride  1000  ml ; etoposide  110  mg ; docusate sodium  100  mg ; senna  8.6  mg ; enoxaparin sodium  60  mg ; prednisone  100  mg ; 
hyperglycemia, unspecified hypotension, unspecified diffuse large b-cell lymphoma, intrathoracic lymph nodes other pulmonary embolism without acute cor pulmonale drug induced constipation abnormal results of liver function studies polydipsia chronic embolism and thrombosis of superior vena cava patient room in hospital as the place of occurrence of the external cause family history of diabetes mellitus long term (current) use of antithrombotics/antiplatelets other hodgkin lymphoma, intrathoracic lymph nodes adverse effect of glucocorticoids and synthetic analogues, initial encounter encounter for antineoplastic chemotherapy pericardial effusion (noninflammatory) chronic embolism and thrombosis of other specified veins esophageal obstruction other secondary pulmonary hypertension compression of vein chronic embolism and thrombosis of inferior vena cava adverse effect of antineoplastic and immunosuppressive drugs, initial encounter body mass index (bmi) 20.0-20.9, adult acute embolism and thrombosis of right axillary vein malignant pleural effusion compression of vein pericardial effusion (noninflammatory) pulmonary hypertension, unspecified acute embolism and thrombosis of right subclavian vein acute embolism and thrombosis of inferior vena cava other pulmonary embolism without acute cor pulmonale esophageal obstruction acute embolism and thrombosis of right internal jugular vein encounter for immunization abnormal weight loss other hodgkin lymphoma, intrathoracic lymph nodes hypotension, unspecified diffuse large b-cell lymphoma, intrathoracic lymph nodes 
black african american m 44 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  131  mg dl; chemistry blood lactate dehydrogenase (ld)  118  iu l; chemistry blood albumin  3.7  g dl$acyclovir  400  mg ; polyethylene glycol  17  g ; omeprazole  20  mg ; sulfameth trimethoprim ss  1  tab ; ondansetron  8  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; doxorubicin  21  mg ; vincristine (oncovin)  0.6  mg ; 0.9% sodium chloride  1000  ml ; etoposide  110  mg ; docusate sodium  100  mg ; senna  8.6  mg ; enoxaparin sodium  60  mg ; prednisone  100  mg ; potassium chloride  40  meq ; 0.9% sodium chloride  250  ml ; cyclophosphamide  1620  mg ; 
hyperglycemia, unspecified hypotension, unspecified diffuse large b-cell lymphoma, intrathoracic lymph nodes other pulmonary embolism without acute cor pulmonale drug induced constipation abnormal results of liver function studies polydipsia chronic embolism and thrombosis of superior vena cava patient room in hospital as the place of occurrence of the external cause family history of diabetes mellitus long term (current) use of antithrombotics/antiplatelets other hodgkin lymphoma, intrathoracic lymph nodes adverse effect of glucocorticoids and synthetic analogues, initial encounter encounter for antineoplastic chemotherapy pericardial effusion (noninflammatory) chronic embolism and thrombosis of other specified veins esophageal obstruction other secondary pulmonary hypertension compression of vein chronic embolism and thrombosis of inferior vena cava adverse effect of antineoplastic and immunosuppressive drugs, initial encounter body mass index (bmi) 20.0-20.9, adult acute embolism and thrombosis of right axillary vein malignant pleural effusion compression of vein pericardial effusion (noninflammatory) pulmonary hypertension, unspecified acute embolism and thrombosis of right subclavian vein acute embolism and thrombosis of inferior vena cava other pulmonary embolism without acute cor pulmonale esophageal obstruction acute embolism and thrombosis of right internal jugular vein encounter for immunization abnormal weight loss other hodgkin lymphoma, intrathoracic lymph nodes hypotension, unspecified diffuse large b-cell lymphoma, intrathoracic lymph nodes 
black african american m 44 $nan$nan$acyclovir  400  mg ; polyethylene glycol  17  g ; omeprazole  20  mg ; sulfameth trimethoprim ss  1  tab ; ondansetron  8  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; doxorubicin  21  mg ; vincristine (oncovin)  0.6  mg ; 0.9% sodium chloride  1000  ml ; etoposide  110  mg ; docusate sodium  100  mg ; senna  8.6  mg ; enoxaparin sodium  60  mg ; prednisone  100  mg ; potassium chloride  40  meq ; 0.9% sodium chloride  250  ml ; cyclophosphamide  1620  mg ; 
hyperglycemia, unspecified hypotension, unspecified diffuse large b-cell lymphoma, intrathoracic lymph nodes other pulmonary embolism without acute cor pulmonale drug induced constipation abnormal results of liver function studies polydipsia chronic embolism and thrombosis of superior vena cava patient room in hospital as the place of occurrence of the external cause family history of diabetes mellitus long term (current) use of antithrombotics/antiplatelets other hodgkin lymphoma, intrathoracic lymph nodes adverse effect of glucocorticoids and synthetic analogues, initial encounter encounter for antineoplastic chemotherapy pericardial effusion (noninflammatory) chronic embolism and thrombosis of other specified veins esophageal obstruction other secondary pulmonary hypertension compression of vein chronic embolism and thrombosis of inferior vena cava adverse effect of antineoplastic and immunosuppressive drugs, initial encounter body mass index (bmi) 20.0-20.9, adult acute embolism and thrombosis of right axillary vein malignant pleural effusion compression of vein pericardial effusion (noninflammatory) pulmonary hypertension, unspecified acute embolism and thrombosis of right subclavian vein acute embolism and thrombosis of inferior vena cava other pulmonary embolism without acute cor pulmonale esophageal obstruction acute embolism and thrombosis of right internal jugular vein encounter for immunization abnormal weight loss other hodgkin lymphoma, intrathoracic lymph nodes hypotension, unspecified diffuse large b-cell lymphoma, intrathoracic lymph nodes 
white m 69 $nan$nan$amlodipine  10  mg ; citalopram hydrobromide  40  mg ; ferrous sulfate  325  mg ; multivitamins  1  cap ; clopidogrel  75  mg ; simvastatin  40  mg ; 
vascular dementia, uncomplicated end stage renal disease anemia in chronic kidney disease accidental fall on or from other stairs or steps hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease sprain of neck awaiting organ transplant status other disorders of plasma-protein metabolism, not elsewhere classified aortocoronary bypass status open wound of external ear, unspecified site, without mention of complication staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus aortocoronary bypass status retention of urine, unspecified vascular dementia, uncomplicated hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pneumonia, organism unspecified other constipation unspecified hereditary and idiopathic peripheral neuropathy chronic systolic heart failure chronic kidney disease, stage iv (severe) congestive heart failure, unspecified urinary tract infection, site not specified anemia in chronic kidney disease acute kidney failure with lesion of tubular necrosis
white m 69 $nan$hematology blood hematocrit  20.7  %; hematology blood hematocrit  20.6  %; hematology blood hematocrit  20.8  %; hematology blood hemoglobin  6.7  g dl; hematology blood hemoglobin  6.8  g dl; hematology blood hemoglobin  6.8  g dl; hematology blood platelet count  331  k ul; hematology blood platelet count  342  k ul; hematology blood platelet count  355  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  21  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  7.6  mg dl; chemistry blood creatinine  7.7  mg dl; chemistry blood creatinine  7.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  92  mg dl; chemistry blood urea nitrogen  90  mg dl; chemistry blood urea nitrogen  88  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine creatinine, urine  65  mg dl; chemistry urine sodium, urine  32  meq l; chemistry urine urea nitrogen, urine  492  mg dl; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  160  mg dl; chemistry blood glucose  94  mg dl; chemistry blood glucose  102  mg dl; chemistry blood albumin  3.9  g dl; hematology urine glucose  tr  mg dl; hematology urine bilirubin  neg  mg dl$amlodipine  10  mg ; citalopram hydrobromide  40  mg ; ferrous sulfate  325  mg ; multivitamins  1  cap ; clopidogrel  75  mg ; simvastatin  40  mg ; sevelamer  800  mg ; dipyridamole-aspirin  1  cap ; doxazosin  4  mg ; labetalol  100  mg ; docusate sodium  100  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; gabapentin  300  mg ; pantoprazole  40  mg ; calcitriol  0.25  mcg ; oxycodone-acetaminophen  1  tab ; senna  1  tab ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; nephrocaps  1  cap ; 
vascular dementia, uncomplicated end stage renal disease anemia in chronic kidney disease accidental fall on or from other stairs or steps hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease sprain of neck awaiting organ transplant status other disorders of plasma-protein metabolism, not elsewhere classified aortocoronary bypass status open wound of external ear, unspecified site, without mention of complication staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus aortocoronary bypass status retention of urine, unspecified vascular dementia, uncomplicated hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pneumonia, organism unspecified other constipation unspecified hereditary and idiopathic peripheral neuropathy chronic systolic heart failure chronic kidney disease, stage iv (severe) congestive heart failure, unspecified urinary tract infection, site not specified anemia in chronic kidney disease acute kidney failure with lesion of tubular necrosis
white m 69 $nan$hematology blood hematocrit  23.0  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  311  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  7.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  86  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  84  mg dl$amlodipine  10  mg ; citalopram hydrobromide  40  mg ; clopidogrel  75  mg ; simvastatin  40  mg ; dipyridamole-aspirin  1  cap ; doxazosin  4  mg ; labetalol  100  mg ; docusate sodium  100  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; gabapentin  300  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; nephrocaps  1  cap ; sevelamer  1600  mg ; 
vascular dementia, uncomplicated end stage renal disease anemia in chronic kidney disease accidental fall on or from other stairs or steps hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease sprain of neck awaiting organ transplant status other disorders of plasma-protein metabolism, not elsewhere classified aortocoronary bypass status open wound of external ear, unspecified site, without mention of complication staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus aortocoronary bypass status retention of urine, unspecified vascular dementia, uncomplicated hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pneumonia, organism unspecified other constipation unspecified hereditary and idiopathic peripheral neuropathy chronic systolic heart failure chronic kidney disease, stage iv (severe) congestive heart failure, unspecified urinary tract infection, site not specified anemia in chronic kidney disease acute kidney failure with lesion of tubular necrosis
white m 69 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  304  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  7.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  88  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  69  mg dl; chemistry blood lactate dehydrogenase (ld)  219  iu l$amlodipine  10  mg ; citalopram hydrobromide  40  mg ; clopidogrel  75  mg ; simvastatin  40  mg ; dipyridamole-aspirin  1  cap ; doxazosin  4  mg ; labetalol  100  mg ; docusate sodium  100  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; gabapentin  300  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; nephrocaps  1  cap ; sevelamer  1600  mg ; 
vascular dementia, uncomplicated end stage renal disease anemia in chronic kidney disease accidental fall on or from other stairs or steps hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease sprain of neck awaiting organ transplant status other disorders of plasma-protein metabolism, not elsewhere classified aortocoronary bypass status open wound of external ear, unspecified site, without mention of complication staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus aortocoronary bypass status retention of urine, unspecified vascular dementia, uncomplicated hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pneumonia, organism unspecified other constipation unspecified hereditary and idiopathic peripheral neuropathy chronic systolic heart failure chronic kidney disease, stage iv (severe) congestive heart failure, unspecified urinary tract infection, site not specified anemia in chronic kidney disease acute kidney failure with lesion of tubular necrosis
white m 69 $nan$hematology blood hematocrit  29.2  %; hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.8  g dl; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  304  k ul; hematology blood platelet count  310  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  5.2  mg dl; chemistry blood creatinine  4.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood urea nitrogen  45  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  87  mg dl; chemistry blood glucose  103  mg dl$amlodipine  10  mg ; citalopram hydrobromide  40  mg ; clopidogrel  75  mg ; simvastatin  40  mg ; dipyridamole-aspirin  1  cap ; doxazosin  4  mg ; labetalol  100  mg ; docusate sodium  100  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; gabapentin  300  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; nephrocaps  1  cap ; sevelamer  1600  mg ; 
vascular dementia, uncomplicated end stage renal disease anemia in chronic kidney disease accidental fall on or from other stairs or steps hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease sprain of neck awaiting organ transplant status other disorders of plasma-protein metabolism, not elsewhere classified aortocoronary bypass status open wound of external ear, unspecified site, without mention of complication staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus aortocoronary bypass status retention of urine, unspecified vascular dementia, uncomplicated hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pneumonia, organism unspecified other constipation unspecified hereditary and idiopathic peripheral neuropathy chronic systolic heart failure chronic kidney disease, stage iv (severe) congestive heart failure, unspecified urinary tract infection, site not specified anemia in chronic kidney disease acute kidney failure with lesion of tubular necrosis
white m 69 $nan$nan$amlodipine  10  mg ; citalopram hydrobromide  40  mg ; clopidogrel  75  mg ; simvastatin  40  mg ; dipyridamole-aspirin  1  cap ; doxazosin  4  mg ; labetalol  100  mg ; docusate sodium  100  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; gabapentin  300  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; nephrocaps  1  cap ; sevelamer  1600  mg ; 
vascular dementia, uncomplicated end stage renal disease anemia in chronic kidney disease accidental fall on or from other stairs or steps hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease sprain of neck awaiting organ transplant status other disorders of plasma-protein metabolism, not elsewhere classified aortocoronary bypass status open wound of external ear, unspecified site, without mention of complication staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus aortocoronary bypass status retention of urine, unspecified vascular dementia, uncomplicated hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pneumonia, organism unspecified other constipation unspecified hereditary and idiopathic peripheral neuropathy chronic systolic heart failure chronic kidney disease, stage iv (severe) congestive heart failure, unspecified urinary tract infection, site not specified anemia in chronic kidney disease acute kidney failure with lesion of tubular necrosis
black african american f 93 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  0.9  ; hematology urine wbc  20  # hpf; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  80  mg dl; chemistry blood lactate dehydrogenase (ld)  191  iu l; chemistry blood albumin  3.5  g dl; chemistry blood % hemoglobin a1c  6.0  %$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  5  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; insulin  0  unit ; heparin  5000  unit ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; aspirin  300  mg ; aspirin  325  mg ; senna  1  tab ; olanzapine (disintegrating tablet)  2.5  mg ; docusate sodium  100  mg ; 
pain in limb difficulty in walking unspecified essential hypertension 
black african american f 93 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  84  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  5  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; insulin  0  unit ; heparin  5000  unit ; aspirin  325  mg ; senna  1  tab ; olanzapine (disintegrating tablet)  2.5  mg ; docusate sodium  100  mg ; 
pain in limb difficulty in walking unspecified essential hypertension 
black african american f 93 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  5  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; insulin  0  unit ; heparin  5000  unit ; aspirin  325  mg ; senna  1  tab ; docusate sodium  100  mg ; 
pain in limb difficulty in walking unspecified essential hypertension 
black african american f 93 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  5  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; insulin  0  unit ; heparin  5000  unit ; aspirin  325  mg ; senna  1  tab ; docusate sodium  100  mg ; lisinopril  5  mg ; lisinopril  10  mg ; furosemide  10  mg ; 
pain in limb difficulty in walking unspecified essential hypertension 
black african american f 93 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  5  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; insulin  0  unit ; heparin  5000  unit ; aspirin  325  mg ; senna  1  tab ; docusate sodium  100  mg ; lisinopril  10  mg ; furosemide  10  mg ; 
pain in limb difficulty in walking unspecified essential hypertension 
black african american f 93 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  5  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; insulin  0  unit ; heparin  5000  unit ; aspirin  325  mg ; senna  1  tab ; docusate sodium  100  mg ; lisinopril  10  mg ; furosemide  10  mg ; 
pain in limb difficulty in walking unspecified essential hypertension 
black african american f 93 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  5  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; insulin  0  unit ; heparin  5000  unit ; aspirin  325  mg ; senna  1  tab ; docusate sodium  100  mg ; lisinopril  10  mg ; furosemide  10  mg ; 
pain in limb difficulty in walking unspecified essential hypertension 
unknown f 37 $nan$nan$naloxone  40-80  mcg ; ketorolac  15-30  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; oxycodone (immediate release)  5-10  mg ; prochlorperazine  2.5-5  mg ; promethazine  3.125-6.25  mg ; 5% dextrose  50  ml ; prochlorperazine  25  mg ; 
 
unknown f 37 $nan$nan$naloxone  40-80  mcg ; ketorolac  15-30  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; oxycodone (immediate release)  5-10  mg ; prochlorperazine  2.5-5  mg ; promethazine  3.125-6.25  mg ; 5% dextrose  50  ml ; prochlorperazine  25  mg ; 
 
unknown f 37 $nan$nan$naloxone  40-80  mcg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; oxycodone (immediate release)  5-10  mg ; prochlorperazine  2.5-5  mg ; promethazine  3.125-6.25  mg ; levothyroxine sodium  50  mcg ; 
 
unknown f 37 $nan$nan$naloxone  40-80  mcg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; oxycodone (immediate release)  5-10  mg ; prochlorperazine  2.5-5  mg ; promethazine  3.125-6.25  mg ; levothyroxine sodium  50  mcg ; 
 
unknown f 37 $nan$nan$naloxone  40-80  mcg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; oxycodone (immediate release)  5-10  mg ; prochlorperazine  2.5-5  mg ; promethazine  3.125-6.25  mg ; levothyroxine sodium  50  mcg ; 
 
other m 61 $nan$blood gas blood free calcium  1.06  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood chloride, whole blood  103  meq l; blood gas blood glucose  92  mg dl; blood gas blood hematocrit, calculated  36  %; blood gas blood hemoglobin  12.1  g dl; blood gas blood potassium, whole blood  3.3  meq l; blood gas blood sodium, whole blood  134  meq l$0.9% sodium chloride  100  ml ; levetiracetam  750  mg ; simvastatin  10  mg ; labetalol  100  mg ; lisinopril  10  mg ; senna  17.2  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; hydralazine  10-20  mg ; levetiracetam  1000  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; dexamethasone  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; morphine sulfate  1-2  mg ; insulin  0  unit ; oxycodone (immediate release)  5  mg ; labetalol  10  mg ; 
essential (primary) hypertension unspecified convulsions postprocedural hypothyroidism cerebral edema personal history of pulmonary embolism personal history of malignant neoplasm of thyroid malignant neoplasm of parietal lobe type 2 diabetes mellitus without complications other convulsions postsurgical hypothyroidism malignant neoplasm of temporal lobe diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension other chronic nonalcoholic liver disease malignant neoplasm of temporal lobe diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified disorders of biliary tract acute pancreatitis psoriatic arthropathy calculus of bile duct without mention of cholecystitis, without mention of obstruction other specified disorders of thyroid disorder of bone and cartilage, unspecified personal history of pulmonary embolism psoriatic arthropathy calculus of gallbladder with other cholecystitis, without mention of obstruction malignant neoplasm of temporal lobe unspecified acquired hypothyroidism disorder of bone and cartilage, unspecified personal history of pulmonary embolism other and unspecified hyperlipidemia unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled fever presenting with conditions classified elsewhere unspecified acquired hypothyroidism other and unspecified hyperlipidemia pneumonia, organism unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other convulsions benign essential hypertension malignant neoplasm of brain, unspecified hematuria, unspecified psoriatic arthropathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia other chronic pulmonary heart diseases disorder of bone and cartilage, unspecified psoriatic arthropathy malignant neoplasm of temporal lobe
other m 61 $nan$hematology blood hematocrit  40.8  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  174  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  157  mg dl$simvastatin  10  mg ; labetalol  100  mg ; lisinopril  10  mg ; senna  17.2  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; hydralazine  10-20  mg ; levetiracetam  1000  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; dexamethasone  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; morphine sulfate  1-2  mg ; insulin  0  unit ; oxycodone (immediate release)  5  mg ; labetalol  10  mg ; oxycodone (immediate release)  5-10  mg ; morphine sulfate  1-5  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; levothyroxine sodium  150  mcg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; docusate sodium  100  mg ; heparin  5000  unit ; 
essential (primary) hypertension unspecified convulsions postprocedural hypothyroidism cerebral edema personal history of pulmonary embolism personal history of malignant neoplasm of thyroid malignant neoplasm of parietal lobe type 2 diabetes mellitus without complications other convulsions postsurgical hypothyroidism malignant neoplasm of temporal lobe diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension other chronic nonalcoholic liver disease malignant neoplasm of temporal lobe diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified disorders of biliary tract acute pancreatitis psoriatic arthropathy calculus of bile duct without mention of cholecystitis, without mention of obstruction other specified disorders of thyroid disorder of bone and cartilage, unspecified personal history of pulmonary embolism psoriatic arthropathy calculus of gallbladder with other cholecystitis, without mention of obstruction malignant neoplasm of temporal lobe unspecified acquired hypothyroidism disorder of bone and cartilage, unspecified personal history of pulmonary embolism other and unspecified hyperlipidemia unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled fever presenting with conditions classified elsewhere unspecified acquired hypothyroidism other and unspecified hyperlipidemia pneumonia, organism unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other convulsions benign essential hypertension malignant neoplasm of brain, unspecified hematuria, unspecified psoriatic arthropathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia other chronic pulmonary heart diseases disorder of bone and cartilage, unspecified psoriatic arthropathy malignant neoplasm of temporal lobe
other m 61 $nan$hematology blood hematocrit  39.7  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  171  mg dl$simvastatin  10  mg ; labetalol  100  mg ; lisinopril  10  mg ; senna  17.2  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; levetiracetam  1000  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; insulin  0  unit ; oxycodone (immediate release)  5-10  mg ; morphine sulfate  1-5  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; levothyroxine sodium  150  mcg ; docusate sodium  100  mg ; heparin  5000  unit ; dexamethasone  3  mg ; 
essential (primary) hypertension unspecified convulsions postprocedural hypothyroidism cerebral edema personal history of pulmonary embolism personal history of malignant neoplasm of thyroid malignant neoplasm of parietal lobe type 2 diabetes mellitus without complications other convulsions postsurgical hypothyroidism malignant neoplasm of temporal lobe diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension other chronic nonalcoholic liver disease malignant neoplasm of temporal lobe diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified disorders of biliary tract acute pancreatitis psoriatic arthropathy calculus of bile duct without mention of cholecystitis, without mention of obstruction other specified disorders of thyroid disorder of bone and cartilage, unspecified personal history of pulmonary embolism psoriatic arthropathy calculus of gallbladder with other cholecystitis, without mention of obstruction malignant neoplasm of temporal lobe unspecified acquired hypothyroidism disorder of bone and cartilage, unspecified personal history of pulmonary embolism other and unspecified hyperlipidemia unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled fever presenting with conditions classified elsewhere unspecified acquired hypothyroidism other and unspecified hyperlipidemia pneumonia, organism unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other convulsions benign essential hypertension malignant neoplasm of brain, unspecified hematuria, unspecified psoriatic arthropathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia other chronic pulmonary heart diseases disorder of bone and cartilage, unspecified psoriatic arthropathy malignant neoplasm of temporal lobe
other m 61 $nan$nan$simvastatin  10  mg ; labetalol  100  mg ; lisinopril  10  mg ; senna  17.2  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; insulin  0  unit ; oxycodone (immediate release)  5-10  mg ; morphine sulfate  1-5  mg ; levothyroxine sodium  150  mcg ; docusate sodium  100  mg ; heparin  5000  unit ; dexamethasone  3  mg ; metformin (glucophage)  500  mg ; 
essential (primary) hypertension unspecified convulsions postprocedural hypothyroidism cerebral edema personal history of pulmonary embolism personal history of malignant neoplasm of thyroid malignant neoplasm of parietal lobe type 2 diabetes mellitus without complications other convulsions postsurgical hypothyroidism malignant neoplasm of temporal lobe diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension other chronic nonalcoholic liver disease malignant neoplasm of temporal lobe diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified disorders of biliary tract acute pancreatitis psoriatic arthropathy calculus of bile duct without mention of cholecystitis, without mention of obstruction other specified disorders of thyroid disorder of bone and cartilage, unspecified personal history of pulmonary embolism psoriatic arthropathy calculus of gallbladder with other cholecystitis, without mention of obstruction malignant neoplasm of temporal lobe unspecified acquired hypothyroidism disorder of bone and cartilage, unspecified personal history of pulmonary embolism other and unspecified hyperlipidemia unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled fever presenting with conditions classified elsewhere unspecified acquired hypothyroidism other and unspecified hyperlipidemia pneumonia, organism unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other convulsions benign essential hypertension malignant neoplasm of brain, unspecified hematuria, unspecified psoriatic arthropathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia other chronic pulmonary heart diseases disorder of bone and cartilage, unspecified psoriatic arthropathy malignant neoplasm of temporal lobe
white f 29 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  165  mg dl$iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; docusate sodium  100  mg ; levetiracetam  500  mg ; 0.9% sodium chloride  100  ml ; senna  17.2  mg ; sodium chloride 0.9%  1000  ml ; hydralazine  10-20  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; morphine sulfate  1-5  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  325-650  mg ; dexamethasone  4  mg ; labetalol  10-20  mg ; clevidipine  25  mg ; promethazine  12.5  mg ; metoclopramide  10  mg ; scopolamine patch  1  ptch ; heparin  5000  unit ; 
nausea alone constipation, unspecified anomalies of cerebrovascular system 
white f 29 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  136  mg dl$iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; docusate sodium  100  mg ; levetiracetam  500  mg ; senna  17.2  mg ; sodium chloride 0.9%  1000  ml ; hydralazine  10-20  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; morphine sulfate  1-5  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  325-650  mg ; dexamethasone  4  mg ; labetalol  10-20  mg ; promethazine  12.5  mg ; metoclopramide  10  mg ; scopolamine patch  1  ptch ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; methocarbamol  500  mg ; cepastat (phenol) lozenge  2  loz ; diazepam  2  mg ; diazepam  5  mg ; ketorolac  30  mg ; 
nausea alone constipation, unspecified anomalies of cerebrovascular system 
white f 29 $nan$nan$iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; docusate sodium  100  mg ; levetiracetam  500  mg ; senna  17.2  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  325-650  mg ; metoclopramide  10  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; methocarbamol  500  mg ; cepastat (phenol) lozenge  2  loz ; diazepam  5  mg ; dexamethasone  3  mg ; 
nausea alone constipation, unspecified anomalies of cerebrovascular system 
unknown m 28 $nan$nan$lorazepam  1  mg ; albuterol inhaler  1-2  puff ; ibuprofen  400  mg ; potassium chloride  20  meq ; neutra-phos  1  pkt ; nicotine patch  14  mg ; sertraline  100  mg ; hydroxyzine  50  mg ; nicotine polacrilex  2  mg ; 
fall on stairs or ladders in water transport injuring unspecified person other disorders of phosphorus metabolism attention-deficit hyperactivity disorder, unspecified type asphyxiation due to hanging, intentional self-harm, initial encounter personal history of self-harm nicotine dependence, cigarettes, uncomplicated unspecified asthma, uncomplicated abnormal weight loss intentional self-harm by other specified means, initial encounter hypokalemia unspecified place in apartment as the place of occurrence of the external cause cannabis use, unspecified, uncomplicated major depressive disorder, single episode, severe without psychotic features cocaine use, unspecified, uncomplicated
unknown m 28 $nan$chemistry blood bilirubin, total  0.5  mg dl$albuterol inhaler  1-2  puff ; ibuprofen  400  mg ; potassium chloride  20  meq ; neutra-phos  1  pkt ; nicotine patch  14  mg ; sertraline  100  mg ; hydroxyzine  50  mg ; nicotine polacrilex  2  mg ; mirtazapine  15  mg ; 
fall on stairs or ladders in water transport injuring unspecified person other disorders of phosphorus metabolism attention-deficit hyperactivity disorder, unspecified type asphyxiation due to hanging, intentional self-harm, initial encounter personal history of self-harm nicotine dependence, cigarettes, uncomplicated unspecified asthma, uncomplicated abnormal weight loss intentional self-harm by other specified means, initial encounter hypokalemia unspecified place in apartment as the place of occurrence of the external cause cannabis use, unspecified, uncomplicated major depressive disorder, single episode, severe without psychotic features cocaine use, unspecified, uncomplicated
unknown m 28 $nan$nan$albuterol inhaler  1-2  puff ; ibuprofen  400  mg ; nicotine patch  14  mg ; hydroxyzine  50  mg ; nicotine polacrilex  2  mg ; mirtazapine  15  mg ; sertraline  25  mg ; 
fall on stairs or ladders in water transport injuring unspecified person other disorders of phosphorus metabolism attention-deficit hyperactivity disorder, unspecified type asphyxiation due to hanging, intentional self-harm, initial encounter personal history of self-harm nicotine dependence, cigarettes, uncomplicated unspecified asthma, uncomplicated abnormal weight loss intentional self-harm by other specified means, initial encounter hypokalemia unspecified place in apartment as the place of occurrence of the external cause cannabis use, unspecified, uncomplicated major depressive disorder, single episode, severe without psychotic features cocaine use, unspecified, uncomplicated
unknown m 28 $nan$nan$albuterol inhaler  1-2  puff ; ibuprofen  400  mg ; nicotine patch  14  mg ; hydroxyzine  50  mg ; nicotine polacrilex  2  mg ; mirtazapine  15  mg ; sertraline  25  mg ; 
fall on stairs or ladders in water transport injuring unspecified person other disorders of phosphorus metabolism attention-deficit hyperactivity disorder, unspecified type asphyxiation due to hanging, intentional self-harm, initial encounter personal history of self-harm nicotine dependence, cigarettes, uncomplicated unspecified asthma, uncomplicated abnormal weight loss intentional self-harm by other specified means, initial encounter hypokalemia unspecified place in apartment as the place of occurrence of the external cause cannabis use, unspecified, uncomplicated major depressive disorder, single episode, severe without psychotic features cocaine use, unspecified, uncomplicated
unknown m 28 $nan$nan$albuterol inhaler  1-2  puff ; ibuprofen  400  mg ; nicotine patch  14  mg ; hydroxyzine  50  mg ; nicotine polacrilex  2  mg ; mirtazapine  15  mg ; sertraline  25  mg ; 
fall on stairs or ladders in water transport injuring unspecified person other disorders of phosphorus metabolism attention-deficit hyperactivity disorder, unspecified type asphyxiation due to hanging, intentional self-harm, initial encounter personal history of self-harm nicotine dependence, cigarettes, uncomplicated unspecified asthma, uncomplicated abnormal weight loss intentional self-harm by other specified means, initial encounter hypokalemia unspecified place in apartment as the place of occurrence of the external cause cannabis use, unspecified, uncomplicated major depressive disorder, single episode, severe without psychotic features cocaine use, unspecified, uncomplicated
unknown m 28 $nan$nan$albuterol inhaler  1-2  puff ; ibuprofen  400  mg ; nicotine patch  14  mg ; hydroxyzine  50  mg ; nicotine polacrilex  2  mg ; mirtazapine  15  mg ; sertraline  150  mg ; 
fall on stairs or ladders in water transport injuring unspecified person other disorders of phosphorus metabolism attention-deficit hyperactivity disorder, unspecified type asphyxiation due to hanging, intentional self-harm, initial encounter personal history of self-harm nicotine dependence, cigarettes, uncomplicated unspecified asthma, uncomplicated abnormal weight loss intentional self-harm by other specified means, initial encounter hypokalemia unspecified place in apartment as the place of occurrence of the external cause cannabis use, unspecified, uncomplicated major depressive disorder, single episode, severe without psychotic features cocaine use, unspecified, uncomplicated
white f 82 $nan$hematology blood hematocrit  23.9  %; hematology blood hematocrit  24.3  %; hematology blood hematocrit  22.0  %; hematology blood hemoglobin  7.2  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  352  k ul; hematology blood platelet count  387  k ul; hematology blood platelet count  329  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.8  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  532  mg dl; chemistry blood glucose  98  mg dl; chemistry blood lactate dehydrogenase (ld)  282  iu l; chemistry blood albumin  2.7  g dl; blood gas blood lactate  1.9  mmol l$iso-osmotic dextrose  200  ml ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; aspirin  325  mg ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; azithromycin  500  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen  650  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  1000  mg ; gabapentin  100  mg ; tramadol (ultram)  50  mg ; insulin  15  unit ; metoprolol tartrate  2.5  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; sodium polystyrene sulfonate  30  gm ; furosemide  20  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; creon 12  2  cap ; docusate sodium  100  mg ; ascorbic acid  500  mg ; calcium carbonate  500  mg ; insulin  10  unit ; aspirin  81  mg ; omeprazole  40  mg ; simvastatin  10  mg ; vitamin d  800  unit ; fish oil (omega 3)  1000  mg ; atorvastatin  80  mg ; heparin  800  unit ; heparin sodium  25,000  unit ; metoprolol tartrate  12.5  mg ; donepezil  5  mg ; 
other and unspecified angina pectoris malignant neoplasm of kidney, except pelvis anemia in neoplastic disease neoplasm related pain (acute) (chronic) diarrhea background diabetic retinopathy secondary malignant neoplasm of bone and bone marrow polyneuropathy in diabetes diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia do not resuscitate status diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled benign essential hypertension esophageal reflux
white f 82 $nan$hematology blood hematocrit  25.3  %; hematology blood hematocrit  26.3  %; hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  327  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  247  mg dl$iso-osmotic dextrose  200  ml ; 5% dextrose  250  ml ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; aspirin  325  mg ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; azithromycin  500  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  1000  mg ; gabapentin  100  mg ; tramadol (ultram)  50  mg ; insulin  15  unit ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; sodium polystyrene sulfonate  30  gm ; furosemide  20  mg ; docusate sodium (liquid)  100  mg ; creon 12  2  cap ; docusate sodium  100  mg ; ascorbic acid  500  mg ; calcium carbonate  500  mg ; aspirin  81  mg ; omeprazole  40  mg ; vitamin d  800  unit ; fish oil (omega 3)  1000  mg ; atorvastatin  80  mg ; heparin  800  unit ; heparin sodium  25,000  unit ; metoprolol tartrate  12.5  mg ; donepezil  5  mg ; sodium chloride 0.9%  flush  3  ml ; furosemide  40  mg ; losartan potassium  25  mg ; bag  50  ml ; magnesium sulfate  2  gm ; 
other and unspecified angina pectoris malignant neoplasm of kidney, except pelvis anemia in neoplastic disease neoplasm related pain (acute) (chronic) diarrhea background diabetic retinopathy secondary malignant neoplasm of bone and bone marrow polyneuropathy in diabetes diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia do not resuscitate status diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled benign essential hypertension esophageal reflux
white f 82 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  355  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  254  mg dl$5% dextrose  250  ml ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; azithromycin  500  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  1000  mg ; gabapentin  100  mg ; tramadol (ultram)  50  mg ; creon 12  2  cap ; docusate sodium  100  mg ; ascorbic acid  500  mg ; calcium carbonate  500  mg ; aspirin  81  mg ; omeprazole  40  mg ; vitamin d  800  unit ; fish oil (omega 3)  1000  mg ; atorvastatin  80  mg ; heparin sodium  25,000  unit ; metoprolol tartrate  12.5  mg ; donepezil  5  mg ; sodium chloride 0.9%  flush  3  ml ; furosemide  40  mg ; losartan potassium  25  mg ; bag  50  ml ; magnesium sulfate  2  gm ; ondansetron  4  mg ; morphine sulfate  1  mg ; metoprolol tartrate  25  mg ; 
other and unspecified angina pectoris malignant neoplasm of kidney, except pelvis anemia in neoplastic disease neoplasm related pain (acute) (chronic) diarrhea background diabetic retinopathy secondary malignant neoplasm of bone and bone marrow polyneuropathy in diabetes diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia do not resuscitate status diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled benign essential hypertension esophageal reflux
white f 82 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  333  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  213  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; azithromycin  500  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; gabapentin  100  mg ; creon 12  2  cap ; docusate sodium  100  mg ; ascorbic acid  500  mg ; calcium carbonate  500  mg ; aspirin  81  mg ; omeprazole  40  mg ; vitamin d  800  unit ; fish oil (omega 3)  1000  mg ; atorvastatin  80  mg ; donepezil  5  mg ; sodium chloride 0.9%  flush  3  ml ; losartan potassium  25  mg ; ondansetron  4  mg ; morphine sulfate  1  mg ; metoprolol tartrate  25  mg ; insulin  16  unit ; 
other and unspecified angina pectoris malignant neoplasm of kidney, except pelvis anemia in neoplastic disease neoplasm related pain (acute) (chronic) diarrhea background diabetic retinopathy secondary malignant neoplasm of bone and bone marrow polyneuropathy in diabetes diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia do not resuscitate status diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled benign essential hypertension esophageal reflux
white f 82 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  325  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  121  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; azithromycin  500  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; gabapentin  100  mg ; creon 12  2  cap ; docusate sodium  100  mg ; ascorbic acid  500  mg ; calcium carbonate  500  mg ; aspirin  81  mg ; omeprazole  40  mg ; vitamin d  800  unit ; fish oil (omega 3)  1000  mg ; atorvastatin  80  mg ; donepezil  5  mg ; sodium chloride 0.9%  flush  3  ml ; losartan potassium  25  mg ; ondansetron  4  mg ; insulin  16  unit ; metoprolol tartrate  50  mg ; 
other and unspecified angina pectoris malignant neoplasm of kidney, except pelvis anemia in neoplastic disease neoplasm related pain (acute) (chronic) diarrhea background diabetic retinopathy secondary malignant neoplasm of bone and bone marrow polyneuropathy in diabetes diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia do not resuscitate status diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled benign essential hypertension esophageal reflux
white f 82 $nan$hematology blood hematocrit  24.9  %; hematology blood hematocrit  27.0  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  326  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  164  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; azithromycin  500  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; gabapentin  100  mg ; creon 12  2  cap ; docusate sodium  100  mg ; ascorbic acid  500  mg ; calcium carbonate  500  mg ; aspirin  81  mg ; omeprazole  40  mg ; vitamin d  800  unit ; fish oil (omega 3)  1000  mg ; atorvastatin  80  mg ; donepezil  5  mg ; sodium chloride 0.9%  flush  3  ml ; losartan potassium  25  mg ; ondansetron  4  mg ; metoprolol tartrate  50  mg ; heparin  3000  unit ; morphine sulfate  1-2  mg ; nitroglycerin sl  0.3  mg ; isosorbide dinitrate  10  mg ; 
other and unspecified angina pectoris malignant neoplasm of kidney, except pelvis anemia in neoplastic disease neoplasm related pain (acute) (chronic) diarrhea background diabetic retinopathy secondary malignant neoplasm of bone and bone marrow polyneuropathy in diabetes diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia do not resuscitate status diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled benign essential hypertension esophageal reflux
white f 82 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  314  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  171  mg dl; chemistry blood glucose  188  mg dl$bisacodyl  10  mg ; senna  1  tab ; azithromycin  500  mg ; ipratropium bromide neb  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; gabapentin  100  mg ; creon 12  2  cap ; docusate sodium  100  mg ; ascorbic acid  500  mg ; calcium carbonate  500  mg ; aspirin  81  mg ; omeprazole  40  mg ; vitamin d  800  unit ; fish oil (omega 3)  1000  mg ; atorvastatin  80  mg ; donepezil  5  mg ; sodium chloride 0.9%  flush  3  ml ; losartan potassium  25  mg ; ondansetron  4  mg ; metoprolol tartrate  50  mg ; morphine sulfate  1-2  mg ; nitroglycerin sl  0.3  mg ; isosorbide dinitrate  10  mg ; neutra-phos  1  pkt ; 
other and unspecified angina pectoris malignant neoplasm of kidney, except pelvis anemia in neoplastic disease neoplasm related pain (acute) (chronic) diarrhea background diabetic retinopathy secondary malignant neoplasm of bone and bone marrow polyneuropathy in diabetes diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia do not resuscitate status diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled benign essential hypertension esophageal reflux
white f 82 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  332  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  191  mg dl$bisacodyl  10  mg ; senna  1  tab ; azithromycin  500  mg ; ipratropium bromide neb  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; gabapentin  100  mg ; creon 12  2  cap ; docusate sodium  100  mg ; ascorbic acid  500  mg ; calcium carbonate  500  mg ; aspirin  81  mg ; omeprazole  40  mg ; vitamin d  800  unit ; fish oil (omega 3)  1000  mg ; atorvastatin  80  mg ; donepezil  5  mg ; sodium chloride 0.9%  flush  3  ml ; losartan potassium  25  mg ; ondansetron  4  mg ; metoprolol tartrate  50  mg ; morphine sulfate  1-2  mg ; isosorbide dinitrate  10  mg ; neutra-phos  1  pkt ; isosorbide dinitrate  20  mg ; metoprolol tartrate  75  mg ; oxycodone (immediate release)   2.5  mg ; 
other and unspecified angina pectoris malignant neoplasm of kidney, except pelvis anemia in neoplastic disease neoplasm related pain (acute) (chronic) diarrhea background diabetic retinopathy secondary malignant neoplasm of bone and bone marrow polyneuropathy in diabetes diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia do not resuscitate status diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled benign essential hypertension esophageal reflux
white f 82 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  346  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  203  mg dl$bisacodyl  10  mg ; senna  1  tab ; ipratropium bromide neb  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; gabapentin  100  mg ; creon 12  2  cap ; docusate sodium  100  mg ; ascorbic acid  500  mg ; calcium carbonate  500  mg ; aspirin  81  mg ; omeprazole  40  mg ; vitamin d  800  unit ; fish oil (omega 3)  1000  mg ; atorvastatin  80  mg ; donepezil  5  mg ; sodium chloride 0.9%  flush  3  ml ; losartan potassium  25  mg ; ondansetron  4  mg ; morphine sulfate  1-2  mg ; isosorbide dinitrate  20  mg ; oxycodone (immediate release)   2.5  mg ; simethicone  40-80  mg ; metoprolol succinate xl  150  mg ; metoprolol tartrate  150  mg ; 
other and unspecified angina pectoris malignant neoplasm of kidney, except pelvis anemia in neoplastic disease neoplasm related pain (acute) (chronic) diarrhea background diabetic retinopathy secondary malignant neoplasm of bone and bone marrow polyneuropathy in diabetes diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia do not resuscitate status diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled benign essential hypertension esophageal reflux
white f 82 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  339  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  123  mg dl$bisacodyl  10  mg ; senna  1  tab ; ipratropium bromide neb  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; gabapentin  100  mg ; creon 12  2  cap ; docusate sodium  100  mg ; ascorbic acid  500  mg ; calcium carbonate  500  mg ; aspirin  81  mg ; omeprazole  40  mg ; vitamin d  800  unit ; fish oil (omega 3)  1000  mg ; atorvastatin  80  mg ; donepezil  5  mg ; sodium chloride 0.9%  flush  3  ml ; losartan potassium  25  mg ; ondansetron  4  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)   2.5  mg ; simethicone  40-80  mg ; metoprolol tartrate  150  mg ; isosorbide mononitrate (extended release)  60  mg ; 
other and unspecified angina pectoris malignant neoplasm of kidney, except pelvis anemia in neoplastic disease neoplasm related pain (acute) (chronic) diarrhea background diabetic retinopathy secondary malignant neoplasm of bone and bone marrow polyneuropathy in diabetes diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia do not resuscitate status diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled benign essential hypertension esophageal reflux
white f 42 $nan$hematology blood hematocrit  39.2  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  135  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  71  mg dl; chemistry blood albumin  3.7  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; syringe  0.2  ml ; folic acid  1  mg ; zolpidem tartrate  5  mg ; calcium carbonate  500  mg ; lansoprazole oral disintegrating tab  30  mg ; lorazepam  1  mg ; vitamin d  1000  unit ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  0.125  mg ; acetaminophen  1000  mg ; prednisone  10  mg ; tramadol (ultram)  50  mg ; diphenhydramine  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; potassium chloride  20  meq ; bag  1  bag ; magnesium sulfate  2  gm ; 
 
white f 42 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  96  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  90  mg dl; chemistry blood lactate dehydrogenase (ld)  115  iu l; chemistry blood albumin  3.4  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; syringe  0.2  ml ; folic acid  1  mg ; calcium carbonate  500  mg ; lansoprazole oral disintegrating tab  30  mg ; vitamin d  1000  unit ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  0.125  mg ; acetaminophen  1000  mg ; prednisone  10  mg ; diphenhydramine  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; potassium chloride  20  meq ; bag  1  bag ; magnesium sulfate  2  gm ; ondansetron  4  mg ; syringe (chemo)  1  ml ; methotrexate sodium  25  mg ; 
 
white f 42 $nan$hematology blood hematocrit  37.0  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  101  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; syringe  0.2  ml ; folic acid  1  mg ; calcium carbonate  500  mg ; lansoprazole oral disintegrating tab  30  mg ; vitamin d  1000  unit ; acetaminophen  1000  mg ; prednisone  10  mg ; diphenhydramine  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; ondansetron  4  mg ; syringe (chemo)  1  ml ; methotrexate sodium  25  mg ; magnesium citrate  300  ml ; moviprep  1  l ; argatroban  50  mg ; cyanocobalamin  1000  mcg ; 
 
white f 42 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  106  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  89  mg dl$sodium chloride 0.9%  flush  3  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; syringe  0.2  ml ; folic acid  1  mg ; calcium carbonate  500  mg ; lansoprazole oral disintegrating tab  30  mg ; vitamin d  1000  unit ; acetaminophen  1000  mg ; prednisone  10  mg ; diphenhydramine  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; cyanocobalamin  1000  mcg ; cholestyramine  4  gm ; cosyntropin  250  mcg ; 
 
white f 42 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  105  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  79  mg dl$sodium chloride 0.9%  flush  3  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; syringe  0.2  ml ; folic acid  1  mg ; calcium carbonate  500  mg ; lansoprazole oral disintegrating tab  30  mg ; vitamin d  1000  unit ; prednisone  10  mg ; diphenhydramine  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; cholestyramine  4  gm ; cosyntropin  250  mcg ; enoxaparin sodium  75  mg ; 
 
white f 42 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  92  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  85  mg dl; chemistry blood albumin  3.4  g dl$sodium chloride 0.9%  flush  3  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; syringe  0.2  ml ; folic acid  1  mg ; calcium carbonate  500  mg ; lansoprazole oral disintegrating tab  30  mg ; vitamin d  1000  unit ; prednisone  10  mg ; diphenhydramine  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; cholestyramine  4  gm ; enoxaparin sodium  80  mg ; 
 
white f 42 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  94  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  120  mg dl; chemistry blood albumin  3.3  g dl$sodium chloride 0.9%  flush  3  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; syringe  0.2  ml ; folic acid  1  mg ; calcium carbonate  500  mg ; lansoprazole oral disintegrating tab  30  mg ; vitamin d  1000  unit ; diphenhydramine  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; cholestyramine  4  gm ; enoxaparin sodium  80  mg ; prednisone  2.5  mg ; prednisone  5  mg ; 
 
white f 42 $nan$nan$sodium chloride 0.9%  flush  3  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; syringe  0.2  ml ; folic acid  1  mg ; calcium carbonate  500  mg ; lansoprazole oral disintegrating tab  30  mg ; vitamin d  1000  unit ; diphenhydramine  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; cholestyramine  4  gm ; enoxaparin sodium  80  mg ; prednisone  2.5  mg ; prednisone  5  mg ; 
 
white m 69 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  102  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  138  mg dl$heparin  5000  unit ; lactated ringers  1000  ml ; ns  100  ml ; metronidazole  500  mg ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; metoprolol tartrate  5  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; omeprazole  40  mg ; metoprolol succinate xl  50  mg ; 
unspecified essential hypertension acute pancreatitis postprocedural fever old myocardial infarction atrial fibrillation personal history of tobacco use other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery esophageal reflux cyst and pseudocyst of pancreas other and unspecified hyperlipidemia old myocardial infarction acute pancreatitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled knee joint replacement cholangitis cyst and pseudocyst of pancreas coronary atherosclerosis of native coronary artery unspecified essential hypertension knee joint replacement long-term (current) use of aspirin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of tobacco use esophageal reflux coronary atherosclerosis of native coronary artery personal history of venous thrombosis and embolism chronic pancreatitis percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia loss of weight cyst and pseudocyst of pancreas old myocardial infarction unspecified essential hypertension atrial fibrillation personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits body mass index 26.0-26.9, adult long-term (current) use of antiplatelet/antithrombotic atrial fibrillation knee joint replacement cyst and pseudocyst of pancreas cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin coronary atherosclerosis of native coronary artery duodenitis, without mention of hemorrhage other and unspecified hyperlipidemia personal history of tobacco use old myocardial infarction
white m 69 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  93  k ul; hematology blood platelet count  74  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  145  mg dl; chemistry blood albumin  3.5  g dl$heparin  5000  unit ; lactated ringers  1000  ml ; ns  100  ml ; metronidazole  500  mg ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; metoprolol tartrate  5  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; omeprazole  40  mg ; metoprolol succinate xl  50  mg ; oxycodone (immediate release)  5  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; ciprofloxacin hcl  500  mg ; 
unspecified essential hypertension acute pancreatitis postprocedural fever old myocardial infarction atrial fibrillation personal history of tobacco use other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery esophageal reflux cyst and pseudocyst of pancreas other and unspecified hyperlipidemia old myocardial infarction acute pancreatitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled knee joint replacement cholangitis cyst and pseudocyst of pancreas coronary atherosclerosis of native coronary artery unspecified essential hypertension knee joint replacement long-term (current) use of aspirin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of tobacco use esophageal reflux coronary atherosclerosis of native coronary artery personal history of venous thrombosis and embolism chronic pancreatitis percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia loss of weight cyst and pseudocyst of pancreas old myocardial infarction unspecified essential hypertension atrial fibrillation personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits body mass index 26.0-26.9, adult long-term (current) use of antiplatelet/antithrombotic atrial fibrillation knee joint replacement cyst and pseudocyst of pancreas cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin coronary atherosclerosis of native coronary artery duodenitis, without mention of hemorrhage other and unspecified hyperlipidemia personal history of tobacco use old myocardial infarction
white m 69 $nan$nan$lactated ringers  1000  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; omeprazole  40  mg ; metoprolol succinate xl  50  mg ; oxycodone (immediate release)  5  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; ciprofloxacin hcl  500  mg ; 
unspecified essential hypertension acute pancreatitis postprocedural fever old myocardial infarction atrial fibrillation personal history of tobacco use other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery esophageal reflux cyst and pseudocyst of pancreas other and unspecified hyperlipidemia old myocardial infarction acute pancreatitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled knee joint replacement cholangitis cyst and pseudocyst of pancreas coronary atherosclerosis of native coronary artery unspecified essential hypertension knee joint replacement long-term (current) use of aspirin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of tobacco use esophageal reflux coronary atherosclerosis of native coronary artery personal history of venous thrombosis and embolism chronic pancreatitis percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia loss of weight cyst and pseudocyst of pancreas old myocardial infarction unspecified essential hypertension atrial fibrillation personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits body mass index 26.0-26.9, adult long-term (current) use of antiplatelet/antithrombotic atrial fibrillation knee joint replacement cyst and pseudocyst of pancreas cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin coronary atherosclerosis of native coronary artery duodenitis, without mention of hemorrhage other and unspecified hyperlipidemia personal history of tobacco use old myocardial infarction
white f 76 $nan$nan$risperidone  3  mg ; duloxetine  60  mg ; pioglitazone  15  mg ; omeprazole  20  mg ; risperidone  1  mg ; risperidone  2  mg ; 
 
white f 76 $nan$hematology blood hematocrit  23.4  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  134  mg dl$senna  1  tab ; risperidone  3  mg ; duloxetine  60  mg ; pioglitazone  15  mg ; omeprazole  20  mg ; risperidone  1  mg ; risperidone  2  mg ; multivitamins  1  cap ; vitamin d  400  unit ; ferrous sulfate  325  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; dextrose 50%  12.5  gm ; glucagon  1  mg ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; naproxen  500  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; benztropine mesylate  0.5  mg ; metformin (glucophage)  500  mg ; acetaminophen  1000  mg ; lactulose  30  ml ; insulin  0  unit ; risperidone  4  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  25  mg ; simvastatin  10  mg ; enoxaparin sodium  30  mg ; 
 
white f 76 $nan$hematology blood hematocrit  23.3  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  149  k ul; chemistry blood albumin  2.8  g dl$duloxetine  60  mg ; pioglitazone  15  mg ; omeprazole  20  mg ; risperidone  1  mg ; risperidone  2  mg ; multivitamins  1  cap ; vitamin d  400  unit ; ferrous sulfate  325  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; oxycodone (immediate release)   5-10  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; dextrose 50%  12.5  gm ; glucagon  1  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; naproxen  500  mg ; calcium carbonate  500  mg ; benztropine mesylate  0.5  mg ; metformin (glucophage)  500  mg ; acetaminophen  1000  mg ; lactulose  30  ml ; quetiapine fumarate  100  mg ; quetiapine fumarate  25  mg ; simvastatin  10  mg ; enoxaparin sodium  30  mg ; sw  100  ml ; magnesium sulfate  4  gm ; 
 
white f 76 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  163  k ul$duloxetine  60  mg ; pioglitazone  15  mg ; omeprazole  20  mg ; risperidone  1  mg ; risperidone  2  mg ; multivitamins  1  cap ; vitamin d  400  unit ; ferrous sulfate  325  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; oxycodone (immediate release)   5-10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; naproxen  500  mg ; calcium carbonate  500  mg ; benztropine mesylate  0.5  mg ; metformin (glucophage)  500  mg ; acetaminophen  1000  mg ; lactulose  30  ml ; quetiapine fumarate  100  mg ; quetiapine fumarate  25  mg ; simvastatin  10  mg ; enoxaparin sodium  30  mg ; sw  100  ml ; magnesium sulfate  4  gm ; lactulose  45  ml ; 
 
white f 76 $nan$nan$duloxetine  60  mg ; pioglitazone  15  mg ; omeprazole  20  mg ; risperidone  1  mg ; risperidone  2  mg ; multivitamins  1  cap ; vitamin d  400  unit ; ferrous sulfate  325  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; oxycodone (immediate release)   5-10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; calcium carbonate  500  mg ; benztropine mesylate  0.5  mg ; metformin (glucophage)  500  mg ; acetaminophen  1000  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  25  mg ; simvastatin  10  mg ; enoxaparin sodium  30  mg ; lactulose  45  ml ; 
 
white f 39 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  86  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; clonazepam  0.75  mg ; ferrous sulfate  325  mg ; omeprazole  20  mg ; oxcarbazepine  600  mg ; oxcarbazepine  450  mg ; pregabalin  25  mg ; pregabalin  75  mg ; propranolol  20  mg ; quetiapine fumarate  25  mg ; naproxen  500  mg ; tecfidera  240  mg ; sertraline  100  mg ; sertraline  50  mg ; nicotine patch  14  mg ; 0.9% sodium chloride  100  ml ; ferric gluconate  125  mg ; 
rash and other nonspecific skin eruption tobacco use disorder iron deficiency anemia, unspecified multiple sclerosis hypovolemia epilepsy, unspecified, without mention of intractable epilepsy hyposmolality and/or hyponatremia autoimmune hepatitis long-term (current) use of other medications psychogenic vaginismus tobacco use disorder esophageal reflux other alteration of consciousness multiple sclerosis depressive disorder, not elsewhere classified obesity, unspecified anxiety state, unspecified generalized convulsive epilepsy, without mention of intractable epilepsy unspecified essential hypertension autoimmune hepatitis other convulsions other alteration of consciousness unspecified essential hypertension depressive disorder, not elsewhere classified multiple sclerosis autoimmune hepatitis esophageal reflux anxiety state, unspecified tobacco use disorder tobacco use disorder unspecified viral meningitis unspecified essential hypertension multiple sclerosis other convulsions
white f 39 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  83  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; clonazepam  0.75  mg ; ferrous sulfate  325  mg ; omeprazole  20  mg ; oxcarbazepine  600  mg ; oxcarbazepine  450  mg ; pregabalin  25  mg ; pregabalin  75  mg ; propranolol  20  mg ; quetiapine fumarate  25  mg ; naproxen  500  mg ; tecfidera  240  mg ; sertraline  100  mg ; sertraline  50  mg ; nicotine patch  14  mg ; 0.9% sodium chloride  100  ml ; ferric gluconate  125  mg ; 
rash and other nonspecific skin eruption tobacco use disorder iron deficiency anemia, unspecified multiple sclerosis hypovolemia epilepsy, unspecified, without mention of intractable epilepsy hyposmolality and/or hyponatremia autoimmune hepatitis long-term (current) use of other medications psychogenic vaginismus tobacco use disorder esophageal reflux other alteration of consciousness multiple sclerosis depressive disorder, not elsewhere classified obesity, unspecified anxiety state, unspecified generalized convulsive epilepsy, without mention of intractable epilepsy unspecified essential hypertension autoimmune hepatitis other convulsions other alteration of consciousness unspecified essential hypertension depressive disorder, not elsewhere classified multiple sclerosis autoimmune hepatitis esophageal reflux anxiety state, unspecified tobacco use disorder tobacco use disorder unspecified viral meningitis unspecified essential hypertension multiple sclerosis other convulsions
white f 39 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; clonazepam  0.75  mg ; ferrous sulfate  325  mg ; omeprazole  20  mg ; oxcarbazepine  600  mg ; oxcarbazepine  450  mg ; pregabalin  25  mg ; pregabalin  75  mg ; propranolol  20  mg ; quetiapine fumarate  25  mg ; naproxen  500  mg ; tecfidera  240  mg ; sertraline  100  mg ; sertraline  50  mg ; nicotine patch  14  mg ; 
rash and other nonspecific skin eruption tobacco use disorder iron deficiency anemia, unspecified multiple sclerosis hypovolemia epilepsy, unspecified, without mention of intractable epilepsy hyposmolality and/or hyponatremia autoimmune hepatitis long-term (current) use of other medications psychogenic vaginismus tobacco use disorder esophageal reflux other alteration of consciousness multiple sclerosis depressive disorder, not elsewhere classified obesity, unspecified anxiety state, unspecified generalized convulsive epilepsy, without mention of intractable epilepsy unspecified essential hypertension autoimmune hepatitis other convulsions other alteration of consciousness unspecified essential hypertension depressive disorder, not elsewhere classified multiple sclerosis autoimmune hepatitis esophageal reflux anxiety state, unspecified tobacco use disorder tobacco use disorder unspecified viral meningitis unspecified essential hypertension multiple sclerosis other convulsions
white f 31 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  315  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  120  mg dl; chemistry blood lactate dehydrogenase (ld)  196  iu l; chemistry blood albumin  3.8  g dl$viaflex bag  655.4  ml ; heparin flush (100 units ml)  5  ml ; acetaminophen  1000  mg ; acetaminophen-caff-butalbital  1-2  tab ; caphosol  30  ml ; gelclair  15  ml ; lorazepam  1  mg ; polyethylene glycol  17  g ; sertraline  75  mg ; trazodone  75  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; ondansetron  8  mg ; sodium bicarbonate  90  meq ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; sodium bicarbonate  1300  mg ; sodium bicarbonate  25  meq ; methotrexate  15,760  mg ; lorazepam  1-2  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; norethindrone (contraceptive)  0.35  mg ; phosphorus  250  mg ; 
diffuse large b-cell lymphoma, lymph nodes of head, face, and neck diffuse large b-cell lymphoma, extranodal and solid organ sites major depressive disorder, single episode, unspecified radial styloid tenosynovitis [de quervain] personal history of malignant melanoma of skin insomnia, unspecified encounter for antineoplastic chemotherapy bilateral primary osteoarthritis of knee nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] headache nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] anesthesia of skin encounter for antineoplastic chemotherapy major depressive disorder, single episode, unspecified insomnia, unspecified trigeminal neuralgia personal history of malignant melanoma of skin radial styloid tenosynovitis [de quervain] diffuse large b-cell lymphoma, lymph nodes of head, face, and neck bilateral primary osteoarthritis of knee diffuse large b-cell lymphoma, lymph nodes of head, face, and neck bilateral primary osteoarthritis of knee nausea other disorders of trigeminal nerve fall on stairs or ladders in water transport injuring unspecified person insomnia, unspecified major depressive disorder, single episode, unspecified headache diffuse large b-cell lymphoma, extranodal and solid organ sites herpesviral infection, unspecified other disorders of phosphorus metabolism personal history of malignant melanoma of skin unspecified b-cell lymphoma, extranodal and solid organ sites greater than 42 weeks gestation of pregnancy encounter for antineoplastic chemotherapy headache allergic rhinitis due to pollen malignant neoplasm complicating the puerperium insomnia, unspecified personal history of malignant melanoma of skin adverse effect of antineoplastic and immunosuppressive drugs, initial encounter nausea nasal congestion major depressive disorder, single episode, unspecified nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] personal history of malignant melanoma of skin other specified diseases and conditions complicating pregnancy, childbirth and the puerperium encounter for antineoplastic chemotherapy
white f 31 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  312  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  106  mg dl; chemistry blood albumin  4.0  g dl$sterile water  100  ml ; viaflex bag  655.4  ml ; heparin flush (100 units ml)  5  ml ; acetaminophen  1000  mg ; acetaminophen-caff-butalbital  1-2  tab ; caphosol  30  ml ; gelclair  15  ml ; polyethylene glycol  17  g ; sertraline  75  mg ; trazodone  75  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; ondansetron  8  mg ; sodium bicarbonate  90  meq ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; sodium bicarbonate  1300  mg ; sodium bicarbonate  25  meq ; methotrexate  15,760  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; norethindrone (contraceptive)  0.35  mg ; phosphorus  250  mg ; 0.9% sodium chloride  50  ml ; leucovorin calcium  40  mg ; leucovorin calcium  100  mg ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 
diffuse large b-cell lymphoma, lymph nodes of head, face, and neck diffuse large b-cell lymphoma, extranodal and solid organ sites major depressive disorder, single episode, unspecified radial styloid tenosynovitis [de quervain] personal history of malignant melanoma of skin insomnia, unspecified encounter for antineoplastic chemotherapy bilateral primary osteoarthritis of knee nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] headache nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] anesthesia of skin encounter for antineoplastic chemotherapy major depressive disorder, single episode, unspecified insomnia, unspecified trigeminal neuralgia personal history of malignant melanoma of skin radial styloid tenosynovitis [de quervain] diffuse large b-cell lymphoma, lymph nodes of head, face, and neck bilateral primary osteoarthritis of knee diffuse large b-cell lymphoma, lymph nodes of head, face, and neck bilateral primary osteoarthritis of knee nausea other disorders of trigeminal nerve fall on stairs or ladders in water transport injuring unspecified person insomnia, unspecified major depressive disorder, single episode, unspecified headache diffuse large b-cell lymphoma, extranodal and solid organ sites herpesviral infection, unspecified other disorders of phosphorus metabolism personal history of malignant melanoma of skin unspecified b-cell lymphoma, extranodal and solid organ sites greater than 42 weeks gestation of pregnancy encounter for antineoplastic chemotherapy headache allergic rhinitis due to pollen malignant neoplasm complicating the puerperium insomnia, unspecified personal history of malignant melanoma of skin adverse effect of antineoplastic and immunosuppressive drugs, initial encounter nausea nasal congestion major depressive disorder, single episode, unspecified nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] personal history of malignant melanoma of skin other specified diseases and conditions complicating pregnancy, childbirth and the puerperium encounter for antineoplastic chemotherapy
white f 31 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  292  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  106  mg dl; chemistry blood albumin  3.8  g dl$sterile water  100  ml ; heparin flush (100 units ml)  5  ml ; acetaminophen  1000  mg ; acetaminophen-caff-butalbital  1-2  tab ; caphosol  30  ml ; gelclair  15  ml ; polyethylene glycol  17  g ; sertraline  75  mg ; trazodone  75  mg ; ondansetron  8  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; sodium bicarbonate  1300  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; norethindrone (contraceptive)  0.35  mg ; phosphorus  250  mg ; 0.9% sodium chloride  50  ml ; leucovorin calcium  40  mg ; leucovorin calcium  100  mg ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sodium chloride 0.9%  1000  ml ; 
diffuse large b-cell lymphoma, lymph nodes of head, face, and neck diffuse large b-cell lymphoma, extranodal and solid organ sites major depressive disorder, single episode, unspecified radial styloid tenosynovitis [de quervain] personal history of malignant melanoma of skin insomnia, unspecified encounter for antineoplastic chemotherapy bilateral primary osteoarthritis of knee nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] headache nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] anesthesia of skin encounter for antineoplastic chemotherapy major depressive disorder, single episode, unspecified insomnia, unspecified trigeminal neuralgia personal history of malignant melanoma of skin radial styloid tenosynovitis [de quervain] diffuse large b-cell lymphoma, lymph nodes of head, face, and neck bilateral primary osteoarthritis of knee diffuse large b-cell lymphoma, lymph nodes of head, face, and neck bilateral primary osteoarthritis of knee nausea other disorders of trigeminal nerve fall on stairs or ladders in water transport injuring unspecified person insomnia, unspecified major depressive disorder, single episode, unspecified headache diffuse large b-cell lymphoma, extranodal and solid organ sites herpesviral infection, unspecified other disorders of phosphorus metabolism personal history of malignant melanoma of skin unspecified b-cell lymphoma, extranodal and solid organ sites greater than 42 weeks gestation of pregnancy encounter for antineoplastic chemotherapy headache allergic rhinitis due to pollen malignant neoplasm complicating the puerperium insomnia, unspecified personal history of malignant melanoma of skin adverse effect of antineoplastic and immunosuppressive drugs, initial encounter nausea nasal congestion major depressive disorder, single episode, unspecified nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] personal history of malignant melanoma of skin other specified diseases and conditions complicating pregnancy, childbirth and the puerperium encounter for antineoplastic chemotherapy
white f 56 $temp  97.7  heartrate  67.0  resprate  18.0  o2sat  98.0  sbp  114.0  dbp  80.0  rhythm    pain  0  $hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  133  mg dl$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; acetaminophen  650  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; celecoxib  400  mg ; levetiracetam  500  mg ; levothyroxine sodium  75  mcg ; lorazepam  0.5  mg ; losartan potassium  50  mg ; dexamethasone  2  mg ; levetiracetam  1000  mg ; 
cerebral edema malignant neoplasm of parietal lobe family history of malignant neoplasm of gastrointestinal tract unspecified acquired hypothyroidism intracerebral hemorrhage other convulsions personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other and unspecified hyperlipidemia esophageal reflux pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident compression of brain benign neoplasm of colon
white f 56 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  231  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  108  mg dl$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; acetaminophen  650  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; levothyroxine sodium  75  mcg ; lorazepam  0.5  mg ; losartan potassium  50  mg ; dexamethasone  2  mg ; levetiracetam  1000  mg ; influenza vaccine quadrivalent  0.5  ml ; levetiracetam  1500  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; heparin  5000  unit ; 
cerebral edema malignant neoplasm of parietal lobe family history of malignant neoplasm of gastrointestinal tract unspecified acquired hypothyroidism intracerebral hemorrhage other convulsions personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other and unspecified hyperlipidemia esophageal reflux pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident compression of brain benign neoplasm of colon
white f 56 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  106  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; levothyroxine sodium  75  mcg ; lorazepam  0.5  mg ; losartan potassium  50  mg ; dexamethasone  2  mg ; influenza vaccine quadrivalent  0.5  ml ; levetiracetam  1500  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; heparin  5000  unit ; 
cerebral edema malignant neoplasm of parietal lobe family history of malignant neoplasm of gastrointestinal tract unspecified acquired hypothyroidism intracerebral hemorrhage other convulsions personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other and unspecified hyperlipidemia esophageal reflux pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident compression of brain benign neoplasm of colon
white f 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; levothyroxine sodium  75  mcg ; lorazepam  0.5  mg ; losartan potassium  50  mg ; dexamethasone  2  mg ; influenza vaccine quadrivalent  0.5  ml ; levetiracetam  1500  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; heparin  5000  unit ; dexamethasone  6  mg ; 
cerebral edema malignant neoplasm of parietal lobe family history of malignant neoplasm of gastrointestinal tract unspecified acquired hypothyroidism intracerebral hemorrhage other convulsions personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other and unspecified hyperlipidemia esophageal reflux pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident compression of brain benign neoplasm of colon
hispanic latino m 75 $nan$hematology blood hematocrit  44.9  %; hematology blood hemoglobin  15.0  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  2.2  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  219  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; tramadol  25  mg ; verapamil sr  120  mg ; folic acid  1  mg ; metoprolol succinate xl  100  mg ; atorvastatin  40  mg ; cyanocobalamin  1000  mcg ; glipizide xl  10  mg ; ramelteon  8  mg ; 
 
hispanic latino m 75 $nan$hematology blood hematocrit  46.9  %; hematology blood hemoglobin  15.7  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  10.0  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  205  mg dl; chemistry blood glucose  162  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; tramadol  25  mg ; verapamil sr  120  mg ; folic acid  1  mg ; metoprolol succinate xl  100  mg ; atorvastatin  40  mg ; cyanocobalamin  1000  mcg ; glipizide xl  10  mg ; ramelteon  8  mg ; labetalol  10-20  mg ; magnesium oxide  400  mg ; bag  1  bag ; magnesium sulfate  4  gm ; 
 
hispanic latino m 75 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  159  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; tramadol  25  mg ; verapamil sr  120  mg ; folic acid  1  mg ; metoprolol succinate xl  100  mg ; atorvastatin  40  mg ; cyanocobalamin  1000  mcg ; glipizide xl  10  mg ; ramelteon  8  mg ; labetalol  10-20  mg ; magnesium oxide  400  mg ; bag  1  bag ; magnesium sulfate  4  gm ; heparin  5000  unit ; 
 
hispanic latino m 75 $nan$hematology blood hematocrit  39.7  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  130  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; tramadol  25  mg ; verapamil sr  120  mg ; folic acid  1  mg ; metoprolol succinate xl  100  mg ; atorvastatin  40  mg ; cyanocobalamin  1000  mcg ; glipizide xl  10  mg ; ramelteon  8  mg ; labetalol  10-20  mg ; magnesium oxide  400  mg ; heparin  5000  unit ; 
 
other f 39 $temp  98.0  heartrate  115.0  resprate  16.0  o2sat  97.0  sbp  130.0  dbp  93.0  rhythm    pain  4  ; temp  98.7  heartrate  92.0  resprate  18.0  o2sat  98.0  sbp  135.0  dbp  86.0  rhythm    pain  4  ; temp  98.3  heartrate  102.0  resprate  18.0  o2sat  100.0  sbp  132.0  dbp  88.0  rhythm    pain    ; temp  97.6  heartrate  92.0  resprate  18.0  o2sat  100.0  sbp  124.0  dbp  76.0  rhythm    pain  6  ; temp  98.1  heartrate  95.0  resprate  18.0  o2sat  98.0  sbp  114.0  dbp  78.0  rhythm    pain  5  $blood gas blood lactate  1.4  mmol l$lisinopril  10  mg ; escitalopram oxalate  20  mg ; 
 
other f 39 $temp  98.2  heartrate  99.0  resprate  18.0  o2sat  100.0  sbp  135.0  dbp  85.0  rhythm    pain  7  $hematology blood hematocrit  28.9  %; hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.5  g dl; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  184  k ul; hematology blood platelet count  215  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  151  mg dl$lisinopril  10  mg ; escitalopram oxalate  20  mg ; lactated ringers  1000  ml ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron odt  8  mg ; lorazepam  0.5  mg ; acetaminophen  650  mg ; oxycodone (immediate release)  5  mg ; vial  1  vial ; ceftriaxone  2  gm ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ranitidine  150  mg ; heparin  5000  unit ; insulin  20  unit ; sodium chloride 0.9%  flush  10  ml ; ibuprofen  400  mg ; atenolol  50  mg ; 
 
other f 39 $nan$nan$lisinopril  10  mg ; escitalopram oxalate  20  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron odt  8  mg ; lorazepam  0.5  mg ; acetaminophen  650  mg ; oxycodone (immediate release)  5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ranitidine  150  mg ; heparin  5000  unit ; insulin  20  unit ; sodium chloride 0.9%  flush  10  ml ; ibuprofen  400  mg ; atenolol  50  mg ; 
 
other f 39 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  126  mg dl$lisinopril  10  mg ; escitalopram oxalate  20  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron odt  8  mg ; lorazepam  0.5  mg ; acetaminophen  650  mg ; oxycodone (immediate release)  5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ranitidine  150  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; atenolol  50  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; heparin sodium  500  unit ; syringe (0.9% sodium chloride)  5  ml ; vancomycin antibiotic lock  2.5  mg ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; 
 
other f 39 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  286  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  157  mg dl$lisinopril  10  mg ; escitalopram oxalate  20  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron odt  8  mg ; lorazepam  0.5  mg ; acetaminophen  650  mg ; oxycodone (immediate release)  5  mg ; ranitidine  150  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; atenolol  50  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; heparin sodium  500  unit ; syringe (0.9% sodium chloride)  5  ml ; vancomycin antibiotic lock  2.5  mg ; vancomycin-heparin lock  10  mg ; heparin sodium  50  unit ; vancomycin antibiotic lock  10  mg ; 
 
other f 39 $nan$nan$lisinopril  10  mg ; escitalopram oxalate  20  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron odt  8  mg ; lorazepam  0.5  mg ; acetaminophen  650  mg ; oxycodone (immediate release)  5  mg ; ranitidine  150  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; atenolol  50  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; heparin sodium  50  unit ; vancomycin antibiotic lock  10  mg ; 0.9% sodium chloride  50  ml ; daptomycin  480  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 
 
other f 39 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  313  k ul$lisinopril  10  mg ; escitalopram oxalate  20  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron odt  8  mg ; lorazepam  0.5  mg ; acetaminophen  650  mg ; oxycodone (immediate release)  5  mg ; ranitidine  150  mg ; heparin  5000  unit ; atenolol  50  mg ; 0.9% sodium chloride  50  ml ; daptomycin  480  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; 
 
other f 39 $nan$nan$lisinopril  10  mg ; escitalopram oxalate  20  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron odt  8  mg ; lorazepam  0.5  mg ; acetaminophen  650  mg ; oxycodone (immediate release)  5  mg ; ranitidine  150  mg ; heparin  5000  unit ; atenolol  50  mg ; 0.9% sodium chloride  50  ml ; daptomycin  480  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; 
 
white m 63 $temp    heartrate  65.0  resprate  16.0  o2sat  97.0  sbp  125.0  dbp  55.0  rhythm    pain  6  ; temp    heartrate  70.0  resprate  16.0  o2sat  98.0  sbp  108.0  dbp  58.0  rhythm    pain  5  ; temp  98.4  heartrate  66.0  resprate  14.0  o2sat  99.0  sbp  115.0  dbp  62.0  rhythm    pain    $nan$aspirin  81  mg ; 
anemia in chronic kidney disease diverticulosis of colon (without mention of hemorrhage) kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure polycystic kidney, unspecified type chronic glomerulonephritis with unspecified pathological lesion in kidney hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease complications of transplanted kidney personal history of other malignant neoplasm of skin end stage renal disease disorders of phosphorus metabolism renal dialysis status attention to colostomy other complications due to renal dialysis device, implant, and graft surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids unspecified occupant of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident end stage renal disease accidental puncture or laceration during a procedure, not elsewhere classified peritoneal adhesions (postoperative) (postinfection) perforation of intestine other fluid overload complications of transplanted kidney surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acidosis acute kidney failure, unspecified other iatrogenic hypotension polycystic kidney, unspecified type acute venous embolism and thrombosis of internal jugular veins unspecified protein-calorie malnutrition intestinal bypass or anastomosis status unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident precipitous drop in hematocrit long-term (current) use of steroids surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation toxic encephalopathy postoperative shock, not elsewhere classified other ascites mechanical complication of other vascular device, implant, and graft peritonitis (acute) generalized diverticulosis of colon (without mention of hemorrhage) surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute respiratory failure
white m 63 $temp  96.8  heartrate  60.0  resprate  16.0  o2sat  99.0  sbp  112.0  dbp  62.0  rhythm    pain  4  $hematology blood hematocrit  42.8  %; hematology blood hematocrit  45.6  %; hematology blood hemoglobin  13.2  g dl; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  121  k ul; hematology blood platelet count  131  k ul; chemistry blood anion gap  28  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  10.6  mg dl; chemistry blood creatinine  6.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  103  mg dl; chemistry blood urea nitrogen  44  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  174  mg dl; chemistry blood glucose  63  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  1  mg ; heparin  5000  unit ; calcitriol  0.5  mcg ; calcium acetate  667  mg ; nephrocaps  1  cap ; sodium bicarbonate  975  mg ; oxycodone (immediate release)   5  mg ; hydromorphone (dilaudid)  0.5-1.0  mg ; docusate sodium  100  mg ; senna  8.6  mg ; folic acid  1  mg ; cyanocobalamin  50  mcg ; sodium chloride 0.9%  1000  ml ; lidocaine 1%  1  ml ; heparin (hemodialysis)  1000  unit ; heparin (hemodialysis)  500  unit ; ferric gluconate  125  mg ; 
anemia in chronic kidney disease diverticulosis of colon (without mention of hemorrhage) kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure polycystic kidney, unspecified type chronic glomerulonephritis with unspecified pathological lesion in kidney hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease complications of transplanted kidney personal history of other malignant neoplasm of skin end stage renal disease disorders of phosphorus metabolism renal dialysis status attention to colostomy other complications due to renal dialysis device, implant, and graft surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids unspecified occupant of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident end stage renal disease accidental puncture or laceration during a procedure, not elsewhere classified peritoneal adhesions (postoperative) (postinfection) perforation of intestine other fluid overload complications of transplanted kidney surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acidosis acute kidney failure, unspecified other iatrogenic hypotension polycystic kidney, unspecified type acute venous embolism and thrombosis of internal jugular veins unspecified protein-calorie malnutrition intestinal bypass or anastomosis status unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident precipitous drop in hematocrit long-term (current) use of steroids surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation toxic encephalopathy postoperative shock, not elsewhere classified other ascites mechanical complication of other vascular device, implant, and graft peritonitis (acute) generalized diverticulosis of colon (without mention of hemorrhage) surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute respiratory failure
white m 63 $nan$hematology blood hematocrit  43.0  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  113  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  7.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  56  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  85  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; calcitriol  0.5  mcg ; calcium acetate  667  mg ; nephrocaps  1  cap ; sodium bicarbonate  975  mg ; oxycodone (immediate release)   5  mg ; hydromorphone (dilaudid)  0.5-1.0  mg ; docusate sodium  100  mg ; senna  8.6  mg ; folic acid  1  mg ; cyanocobalamin  50  mcg ; sodium chloride 0.9%  1000  ml ; lidocaine 1%  1  ml ; heparin (hemodialysis)  1000  unit ; heparin (hemodialysis)  500  unit ; ferric gluconate  125  mg ; 
anemia in chronic kidney disease diverticulosis of colon (without mention of hemorrhage) kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure polycystic kidney, unspecified type chronic glomerulonephritis with unspecified pathological lesion in kidney hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease complications of transplanted kidney personal history of other malignant neoplasm of skin end stage renal disease disorders of phosphorus metabolism renal dialysis status attention to colostomy other complications due to renal dialysis device, implant, and graft surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids unspecified occupant of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident end stage renal disease accidental puncture or laceration during a procedure, not elsewhere classified peritoneal adhesions (postoperative) (postinfection) perforation of intestine other fluid overload complications of transplanted kidney surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acidosis acute kidney failure, unspecified other iatrogenic hypotension polycystic kidney, unspecified type acute venous embolism and thrombosis of internal jugular veins unspecified protein-calorie malnutrition intestinal bypass or anastomosis status unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident precipitous drop in hematocrit long-term (current) use of steroids surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation toxic encephalopathy postoperative shock, not elsewhere classified other ascites mechanical complication of other vascular device, implant, and graft peritonitis (acute) generalized diverticulosis of colon (without mention of hemorrhage) surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute respiratory failure
white m 63 $nan$hematology blood hematocrit  43.3  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  101  k ul; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  8.5  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  73  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  74  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; calcitriol  0.5  mcg ; calcium acetate  667  mg ; nephrocaps  1  cap ; sodium bicarbonate  975  mg ; oxycodone (immediate release)   5  mg ; hydromorphone (dilaudid)  0.5-1.0  mg ; docusate sodium  100  mg ; senna  8.6  mg ; folic acid  1  mg ; cyanocobalamin  50  mcg ; lidocaine 1%  1  ml ; acetaminophen  650  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; 
anemia in chronic kidney disease diverticulosis of colon (without mention of hemorrhage) kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure polycystic kidney, unspecified type chronic glomerulonephritis with unspecified pathological lesion in kidney hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease complications of transplanted kidney personal history of other malignant neoplasm of skin end stage renal disease disorders of phosphorus metabolism renal dialysis status attention to colostomy other complications due to renal dialysis device, implant, and graft surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids unspecified occupant of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident end stage renal disease accidental puncture or laceration during a procedure, not elsewhere classified peritoneal adhesions (postoperative) (postinfection) perforation of intestine other fluid overload complications of transplanted kidney surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acidosis acute kidney failure, unspecified other iatrogenic hypotension polycystic kidney, unspecified type acute venous embolism and thrombosis of internal jugular veins unspecified protein-calorie malnutrition intestinal bypass or anastomosis status unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident precipitous drop in hematocrit long-term (current) use of steroids surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation toxic encephalopathy postoperative shock, not elsewhere classified other ascites mechanical complication of other vascular device, implant, and graft peritonitis (acute) generalized diverticulosis of colon (without mention of hemorrhage) surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute respiratory failure
white m 63 $nan$hematology blood hematocrit  39.8  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  127  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  5.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  124  mg dl$aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; calcitriol  0.5  mcg ; calcium acetate  667  mg ; nephrocaps  1  cap ; sodium bicarbonate  975  mg ; oxycodone (immediate release)   5  mg ; hydromorphone (dilaudid)  0.5-1.0  mg ; docusate sodium  100  mg ; senna  8.6  mg ; folic acid  1  mg ; cyanocobalamin  50  mcg ; acetaminophen  650  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; 
anemia in chronic kidney disease diverticulosis of colon (without mention of hemorrhage) kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure polycystic kidney, unspecified type chronic glomerulonephritis with unspecified pathological lesion in kidney hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease complications of transplanted kidney personal history of other malignant neoplasm of skin end stage renal disease disorders of phosphorus metabolism renal dialysis status attention to colostomy other complications due to renal dialysis device, implant, and graft surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids unspecified occupant of pick-up truck or van injured in collision with railway train or railway vehicle in nontraffic accident end stage renal disease accidental puncture or laceration during a procedure, not elsewhere classified peritoneal adhesions (postoperative) (postinfection) perforation of intestine other fluid overload complications of transplanted kidney surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acidosis acute kidney failure, unspecified other iatrogenic hypotension polycystic kidney, unspecified type acute venous embolism and thrombosis of internal jugular veins unspecified protein-calorie malnutrition intestinal bypass or anastomosis status unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident precipitous drop in hematocrit long-term (current) use of steroids surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation toxic encephalopathy postoperative shock, not elsewhere classified other ascites mechanical complication of other vascular device, implant, and graft peritonitis (acute) generalized diverticulosis of colon (without mention of hemorrhage) surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute respiratory failure
white f 31 $nan$nan$heparin  5000  unit ; pregabalin  75  mg ; acetaminophen  1000  mg ; 
unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause crossing vessel and stricture of ureter without hydronephrosis other specified noninflammatory disorders of cervix uteri patient room in hospital as the place of occurrence of the external cause personal history of irradiation anemia in neoplastic disease nausea personal history of antineoplastic chemotherapy postprocedural intestinal obstruction radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure malignant neoplasm of cervix uteri, unspecified decreased white blood cell count, unspecified hypotension, unspecified removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
white f 31 $nan$nan$heparin  5000  unit ; pregabalin  75  mg ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; acetaminophen  500-1000  mg ; 
unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause crossing vessel and stricture of ureter without hydronephrosis other specified noninflammatory disorders of cervix uteri patient room in hospital as the place of occurrence of the external cause personal history of irradiation anemia in neoplastic disease nausea personal history of antineoplastic chemotherapy postprocedural intestinal obstruction radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure malignant neoplasm of cervix uteri, unspecified decreased white blood cell count, unspecified hypotension, unspecified removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
white f 31 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  91  mg dl$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; acetaminophen  500-1000  mg ; ketorolac  30  mg ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; metoclopramide  10  mg ; silver nitrate applicator  1  stck ; oxycodone (immediate release)  5-10  mg ; 
unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause crossing vessel and stricture of ureter without hydronephrosis other specified noninflammatory disorders of cervix uteri patient room in hospital as the place of occurrence of the external cause personal history of irradiation anemia in neoplastic disease nausea personal history of antineoplastic chemotherapy postprocedural intestinal obstruction radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure malignant neoplasm of cervix uteri, unspecified decreased white blood cell count, unspecified hypotension, unspecified removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
white f 31 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ketorolac  30  mg ; bag  2  bag ; magnesium sulfate  4  gm ; metoclopramide  10  mg ; silver nitrate applicator  1  stck ; oxycodone (immediate release)  5-10  mg ; 
unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause crossing vessel and stricture of ureter without hydronephrosis other specified noninflammatory disorders of cervix uteri patient room in hospital as the place of occurrence of the external cause personal history of irradiation anemia in neoplastic disease nausea personal history of antineoplastic chemotherapy postprocedural intestinal obstruction radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure malignant neoplasm of cervix uteri, unspecified decreased white blood cell count, unspecified hypotension, unspecified removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
black african american f 69 $nan$nan$levothyroxine sodium  100  mcg ; metoprolol succinate xl  100  mg ; hydrochlorothiazide  25  mg ; 
 
black african american f 69 $nan$nan$levothyroxine sodium  100  mcg ; metoprolol succinate xl  100  mg ; hydrochlorothiazide  25  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  1  g ; isotonic sodium chloride  50  ml ; gentamicin  80  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; bag  50  ml ; magnesium sulfate  2  gm ; ondansetron  4  mg ; promethazine  6.25  mg ; metoclopramide  10  mg ; docusate sodium  100  mg ; phenazopyridine  100  mg ; omeprazole  20  mg ; calcium carbonate  500  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
 
black african american f 69 $nan$nan$levothyroxine sodium  100  mcg ; metoprolol succinate xl  100  mg ; hydrochlorothiazide  25  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  1  g ; isotonic sodium chloride  50  ml ; gentamicin  80  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; bag  50  ml ; magnesium sulfate  2  gm ; ondansetron  4  mg ; promethazine  6.25  mg ; metoclopramide  10  mg ; docusate sodium  100  mg ; phenazopyridine  100  mg ; omeprazole  20  mg ; calcium carbonate  500  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; polyethylene glycol  17  g ; bisacodyl  10  mg ; 
 
black african american f 69 $nan$nan$levothyroxine sodium  100  mcg ; metoprolol succinate xl  100  mg ; hydrochlorothiazide  25  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  1  g ; isotonic sodium chloride  50  ml ; gentamicin  80  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5  mg ; ondansetron  4  mg ; promethazine  6.25  mg ; metoclopramide  10  mg ; docusate sodium  100  mg ; phenazopyridine  100  mg ; calcium carbonate  500  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; polyethylene glycol  17  g ; bisacodyl  10  mg ; 
 
hispanic latino m 71 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  366  mg dl; chemistry blood lactate dehydrogenase (ld)  554  iu l; blood gas blood potassium, whole blood  4.7  meq l; chemistry blood % hemoglobin a1c  8.5  %$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol inhaler  1-2  puff ; ipratropium-albuterol neb  1  neb ; guaifenesin  5-10  ml ; trazodone  25  mg ; albuterol 0.083% neb soln  1  neb ; lidocaine 1%  2.5  ml ; 
 
hispanic latino m 71 $nan$hematology blood hematocrit  34.2  %; hematology blood hematocrit  41.9  %; hematology blood hematocrit  36.2  %; hematology blood hemoglobin  11.1  g dl; hematology blood hemoglobin  13.4  g dl; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  231  k ul; hematology blood platelet count  363  k ul; hematology blood platelet count  309  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  19  meq l; chemistry blood anion gap  23  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  5.1  meq l; chemistry blood potassium  5.6  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  124  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry urine creatinine, urine  84  mg dl; chemistry urine urea nitrogen, urine  616  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  235  mg dl; chemistry blood glucose  265  mg dl; chemistry blood glucose  264  mg dl; chemistry blood glucose  212  mg dl; chemistry blood lactate dehydrogenase (ld)  676  iu l; chemistry blood lactate dehydrogenase (ld)  705  iu l; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.01  mmol l; blood gas blood lactate  3.4  mmol l; blood gas blood lactate  3.1  mmol l; blood gas blood lactate  4.2  mmol l; blood gas blood lactate  4.2  mmol l; blood gas blood lactate  4.0  mmol l; blood gas blood chloride, whole blood  106  meq l; blood gas blood glucose  211  mg dl; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood sodium, whole blood  132  meq l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; ipratropium-albuterol neb  1  neb ; guaifenesin  5-10  ml ; trazodone  25  mg ; albuterol 0.083% neb soln  1  neb ; lidocaine 1%  2.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  1000  ml ; insulin  0  unit ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; insulin  25  unit ; aspirin  325  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; docusate sodium  100  mg ; senna  8.6  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  1500  mg ; soln.  200  ml ; mannitol 20 %  40  g ; propofol  1000  mg ; lorazepam  6  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; allopurinol  300  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  81  mg ; levetiracetam  750  mg ; acetaminophen iv  1000  mg ; ipratropium bromide mdi  2  puff ; albuterol inhaler  2  puff ; dexamethasone  10  mg ; dexamethasone  6  mg ; 
 
hispanic latino m 71 $nan$hematology blood hematocrit  35.9  %; hematology blood hematocrit  31.8  %; hematology blood hemoglobin  11.3  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  208  k ul; hematology blood platelet count  190  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  252  mg dl; chemistry blood glucose  281  mg dl; chemistry blood lactate dehydrogenase (ld)  564  iu l; chemistry blood albumin  1.9  g dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; guaifenesin  5-10  ml ; trazodone  25  mg ; lidocaine 1%  2.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  1000  ml ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; aspirin  325  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; docusate sodium  100  mg ; senna  8.6  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  1500  mg ; propofol  1000  mg ; lorazepam  6  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; allopurinol  300  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  81  mg ; acetaminophen iv  1000  mg ; ipratropium bromide mdi  2  puff ; albuterol inhaler  2  puff ; dexamethasone  10  mg ; atorvastatin  80  mg ; mannitol  80  g ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; soln.  400  ml ; mannitol 20 %  80  g ; sodium chloride 0.9%  flush  10-20  ml ; 
 
hispanic latino m 71 $nan$hematology blood hematocrit  33.5  %; hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  238  k ul; hematology blood platelet count  263  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  20  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood creatinine  3.5  mg dl; chemistry blood creatinine  4.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood urea nitrogen  52  mg dl; chemistry blood urea nitrogen  55  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  295  mg dl; chemistry blood glucose  241  mg dl; chemistry blood glucose  279  mg dl; chemistry blood lactate dehydrogenase (ld)  755  iu l; chemistry blood albumin  2.1  g dl; blood gas blood lactate  2.5  mmol l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lidocaine 1%  2.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; docusate sodium  100  mg ; senna  8.6  mg ; propofol  1000  mg ; allopurinol  300  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; aspirin  81  mg ; ipratropium bromide mdi  2  puff ; albuterol inhaler  2  puff ; atorvastatin  80  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; sodium chloride 0.9%  flush  10-20  ml ; dextrose 5%  150  ml ; levofloxacin  750  mg ; allopurinol  100  mg ; 
 
hispanic latino m 71 $nan$nan$sodium chloride 0.9%  flush  3  ml ; glucose gel  15  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  10-20  ml ; lorazepam  0.5-2  mg ; 
 
black african american f 88 $temp  98.1  heartrate  93.0  resprate  16.0  o2sat  97.0  sbp  133.0  dbp  78.0  rhythm    pain  3  $hematology blood hematocrit  24.6  %; hematology blood hemoglobin  6.2  g dl; hematology blood platelet count  1039  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  3.0  ; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  128  mg dl$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.25  mg ; ondansetron  4  mg ; clopidogrel  75  mg ; aspirin  325  mg ; metoprolol succinate xl  200  mg ; metoprolol tartrate  100  mg ; omeprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  2  puff ; insulin  0  unit ; sodium chloride 0.9%  1000  ml ; hydromorphone (dilaudid)  0.5  mg ; pravastatin  40  mg ; diltiazem extended-release  120  mg ; torsemide  20  mg ; aspirin ec  325  mg ; 5% dextrose  50  ml ; phytonadione  5  mg ; hydromorphone (dilaudid)  20  mg ; metoprolol tartrate  5  mg ; acetaminophen iv  1000  mg ; 
chronic diastolic heart failure other and unspecified hyperlipidemia essential thrombocythemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peripheral vascular disease, unspecified unspecified essential hypertension congestive heart failure, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of anticoagulants percutaneous transluminal coronary angioplasty status atrial fibrillation old myocardial infarction other and unspecified hyperlipidemia unspecified essential hypertension gout, unspecified arterial embolism and thrombosis of lower extremity long-term (current) use of anticoagulants atrial fibrillation surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other complications due to other vascular device, implant, and graft coronary atherosclerosis of native coronary artery old myocardial infarction long-term (current) use of aspirin congestive heart failure, unspecified home accidents peripheral vascular disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled angiodysplasia of stomach and duodenum with hemorrhage atrial fibrillation chronic kidney disease, stage iii (moderate) other acute and subacute forms of ischemic heart disease, other other and unspecified hyperlipidemia abnormal coagulation profile cellulitis and abscess of upper arm and forearm diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled peripheral vascular disease, unspecified congestive heart failure, unspecified acute posthemorrhagic anemia anticoagulants causing adverse effects in therapeutic use acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified infection and inflammatory reaction due to other vascular device, implant, and graft coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants old myocardial infarction unspecified essential hypertension pneumonia, organism unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled
black african american f 88 $nan$hematology blood hematocrit  27.6  %; hematology blood hematocrit  28.0  %; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  806  k ul; hematology blood platelet count  856  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.9  ; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  132  mg dl$senna  8.6  mg ; torsemide  20  mg ; aspirin ec  325  mg ; hydromorphone (dilaudid)  20  mg ; metoprolol tartrate  5  mg ; acetaminophen iv  1000  mg ; heparin  5000  unit ; oxycodone (immediate release)   2.5  mg ; morphine sulfate  1-2  mg ; hydromorphone (dilaudid)  0.5-1.0  mg ; oxycodone (immediate release)   2.5-5  mg ; docusate sodium  100  mg ; alprazolam  0.5  mg ; warfarin  5  mg ; warfarin  1  dose ; 
chronic diastolic heart failure other and unspecified hyperlipidemia essential thrombocythemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peripheral vascular disease, unspecified unspecified essential hypertension congestive heart failure, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of anticoagulants percutaneous transluminal coronary angioplasty status atrial fibrillation old myocardial infarction other and unspecified hyperlipidemia unspecified essential hypertension gout, unspecified arterial embolism and thrombosis of lower extremity long-term (current) use of anticoagulants atrial fibrillation surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other complications due to other vascular device, implant, and graft coronary atherosclerosis of native coronary artery old myocardial infarction long-term (current) use of aspirin congestive heart failure, unspecified home accidents peripheral vascular disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled angiodysplasia of stomach and duodenum with hemorrhage atrial fibrillation chronic kidney disease, stage iii (moderate) other acute and subacute forms of ischemic heart disease, other other and unspecified hyperlipidemia abnormal coagulation profile cellulitis and abscess of upper arm and forearm diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled peripheral vascular disease, unspecified congestive heart failure, unspecified acute posthemorrhagic anemia anticoagulants causing adverse effects in therapeutic use acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified infection and inflammatory reaction due to other vascular device, implant, and graft coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants old myocardial infarction unspecified essential hypertension pneumonia, organism unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled
black african american f 88 $nan$hematology blood inr(pt)  1.5  $senna  8.6  mg ; torsemide  20  mg ; hydromorphone (dilaudid)  0.5-1.0  mg ; oxycodone (immediate release)   2.5-5  mg ; docusate sodium  100  mg ; alprazolam  0.5  mg ; warfarin  5  mg ; warfarin  1  dose ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; oxycodone (immediate release)   5-10  mg ; warfarin  3  mg ; 
chronic diastolic heart failure other and unspecified hyperlipidemia essential thrombocythemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peripheral vascular disease, unspecified unspecified essential hypertension congestive heart failure, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of anticoagulants percutaneous transluminal coronary angioplasty status atrial fibrillation old myocardial infarction other and unspecified hyperlipidemia unspecified essential hypertension gout, unspecified arterial embolism and thrombosis of lower extremity long-term (current) use of anticoagulants atrial fibrillation surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other complications due to other vascular device, implant, and graft coronary atherosclerosis of native coronary artery old myocardial infarction long-term (current) use of aspirin congestive heart failure, unspecified home accidents peripheral vascular disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled angiodysplasia of stomach and duodenum with hemorrhage atrial fibrillation chronic kidney disease, stage iii (moderate) other acute and subacute forms of ischemic heart disease, other other and unspecified hyperlipidemia abnormal coagulation profile cellulitis and abscess of upper arm and forearm diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled peripheral vascular disease, unspecified congestive heart failure, unspecified acute posthemorrhagic anemia anticoagulants causing adverse effects in therapeutic use acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified infection and inflammatory reaction due to other vascular device, implant, and graft coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants old myocardial infarction unspecified essential hypertension pneumonia, organism unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled
black african american f 88 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  928  k ul; hematology blood inr(pt)  1.7  $senna  8.6  mg ; torsemide  20  mg ; docusate sodium  100  mg ; alprazolam  0.5  mg ; warfarin  1  dose ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; oxycodone (immediate release)   5-10  mg ; warfarin  3  mg ; oxycodone (immediate release)   10-15  mg ; lidocaine 5% patch  1  ptch ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.45% sodium chloride  1000  ml ; 
chronic diastolic heart failure other and unspecified hyperlipidemia essential thrombocythemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peripheral vascular disease, unspecified unspecified essential hypertension congestive heart failure, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of anticoagulants percutaneous transluminal coronary angioplasty status atrial fibrillation old myocardial infarction other and unspecified hyperlipidemia unspecified essential hypertension gout, unspecified arterial embolism and thrombosis of lower extremity long-term (current) use of anticoagulants atrial fibrillation surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other complications due to other vascular device, implant, and graft coronary atherosclerosis of native coronary artery old myocardial infarction long-term (current) use of aspirin congestive heart failure, unspecified home accidents peripheral vascular disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled angiodysplasia of stomach and duodenum with hemorrhage atrial fibrillation chronic kidney disease, stage iii (moderate) other acute and subacute forms of ischemic heart disease, other other and unspecified hyperlipidemia abnormal coagulation profile cellulitis and abscess of upper arm and forearm diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled peripheral vascular disease, unspecified congestive heart failure, unspecified acute posthemorrhagic anemia anticoagulants causing adverse effects in therapeutic use acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified infection and inflammatory reaction due to other vascular device, implant, and graft coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants old myocardial infarction unspecified essential hypertension pneumonia, organism unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled
black african american f 88 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  825  k ul; hematology blood inr(pt)  2.1  ; hematology urine wbc  64  # hpf; hematology urine glucose  150  mg dl$senna  8.6  mg ; torsemide  20  mg ; docusate sodium  100  mg ; alprazolam  0.5  mg ; warfarin  1  dose ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; lidocaine 5% patch  1  ptch ; 0.45% sodium chloride  1000  ml ; insulin  4  unit ; 
chronic diastolic heart failure other and unspecified hyperlipidemia essential thrombocythemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peripheral vascular disease, unspecified unspecified essential hypertension congestive heart failure, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of anticoagulants percutaneous transluminal coronary angioplasty status atrial fibrillation old myocardial infarction other and unspecified hyperlipidemia unspecified essential hypertension gout, unspecified arterial embolism and thrombosis of lower extremity long-term (current) use of anticoagulants atrial fibrillation surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other complications due to other vascular device, implant, and graft coronary atherosclerosis of native coronary artery old myocardial infarction long-term (current) use of aspirin congestive heart failure, unspecified home accidents peripheral vascular disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled angiodysplasia of stomach and duodenum with hemorrhage atrial fibrillation chronic kidney disease, stage iii (moderate) other acute and subacute forms of ischemic heart disease, other other and unspecified hyperlipidemia abnormal coagulation profile cellulitis and abscess of upper arm and forearm diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled peripheral vascular disease, unspecified congestive heart failure, unspecified acute posthemorrhagic anemia anticoagulants causing adverse effects in therapeutic use acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified infection and inflammatory reaction due to other vascular device, implant, and graft coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants old myocardial infarction unspecified essential hypertension pneumonia, organism unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled
black african american f 88 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  858  k ul; hematology blood inr(pt)  2.5  $senna  8.6  mg ; torsemide  20  mg ; docusate sodium  100  mg ; alprazolam  0.5  mg ; warfarin  1  dose ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; lidocaine 5% patch  1  ptch ; 0.45% sodium chloride  1000  ml ; insulin  4  unit ; 
chronic diastolic heart failure other and unspecified hyperlipidemia essential thrombocythemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peripheral vascular disease, unspecified unspecified essential hypertension congestive heart failure, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of anticoagulants percutaneous transluminal coronary angioplasty status atrial fibrillation old myocardial infarction other and unspecified hyperlipidemia unspecified essential hypertension gout, unspecified arterial embolism and thrombosis of lower extremity long-term (current) use of anticoagulants atrial fibrillation surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other complications due to other vascular device, implant, and graft coronary atherosclerosis of native coronary artery old myocardial infarction long-term (current) use of aspirin congestive heart failure, unspecified home accidents peripheral vascular disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled angiodysplasia of stomach and duodenum with hemorrhage atrial fibrillation chronic kidney disease, stage iii (moderate) other acute and subacute forms of ischemic heart disease, other other and unspecified hyperlipidemia abnormal coagulation profile cellulitis and abscess of upper arm and forearm diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled peripheral vascular disease, unspecified congestive heart failure, unspecified acute posthemorrhagic anemia anticoagulants causing adverse effects in therapeutic use acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified infection and inflammatory reaction due to other vascular device, implant, and graft coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants old myocardial infarction unspecified essential hypertension pneumonia, organism unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled
black african american f 88 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  831  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  2.6  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  103  mg dl$senna  8.6  mg ; torsemide  20  mg ; docusate sodium  100  mg ; alprazolam  0.5  mg ; warfarin  1  dose ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; lidocaine 5% patch  1  ptch ; 0.45% sodium chloride  1000  ml ; miconazole powder 2%  1  appl ; amoxicillin-clavulanic acid  875  mg ; 
chronic diastolic heart failure other and unspecified hyperlipidemia essential thrombocythemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peripheral vascular disease, unspecified unspecified essential hypertension congestive heart failure, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of anticoagulants percutaneous transluminal coronary angioplasty status atrial fibrillation old myocardial infarction other and unspecified hyperlipidemia unspecified essential hypertension gout, unspecified arterial embolism and thrombosis of lower extremity long-term (current) use of anticoagulants atrial fibrillation surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other complications due to other vascular device, implant, and graft coronary atherosclerosis of native coronary artery old myocardial infarction long-term (current) use of aspirin congestive heart failure, unspecified home accidents peripheral vascular disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled angiodysplasia of stomach and duodenum with hemorrhage atrial fibrillation chronic kidney disease, stage iii (moderate) other acute and subacute forms of ischemic heart disease, other other and unspecified hyperlipidemia abnormal coagulation profile cellulitis and abscess of upper arm and forearm diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled peripheral vascular disease, unspecified congestive heart failure, unspecified acute posthemorrhagic anemia anticoagulants causing adverse effects in therapeutic use acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified infection and inflammatory reaction due to other vascular device, implant, and graft coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants old myocardial infarction unspecified essential hypertension pneumonia, organism unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled
black african american f 88 $nan$nan$senna  8.6  mg ; torsemide  20  mg ; docusate sodium  100  mg ; alprazolam  0.5  mg ; warfarin  1  dose ; lidocaine 5% patch  1  ptch ; miconazole powder 2%  1  appl ; amoxicillin-clavulanic acid  875  mg ; aspirin  81  mg ; 
chronic diastolic heart failure other and unspecified hyperlipidemia essential thrombocythemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peripheral vascular disease, unspecified unspecified essential hypertension congestive heart failure, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of anticoagulants percutaneous transluminal coronary angioplasty status atrial fibrillation old myocardial infarction other and unspecified hyperlipidemia unspecified essential hypertension gout, unspecified arterial embolism and thrombosis of lower extremity long-term (current) use of anticoagulants atrial fibrillation surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other complications due to other vascular device, implant, and graft coronary atherosclerosis of native coronary artery old myocardial infarction long-term (current) use of aspirin congestive heart failure, unspecified home accidents peripheral vascular disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled angiodysplasia of stomach and duodenum with hemorrhage atrial fibrillation chronic kidney disease, stage iii (moderate) other acute and subacute forms of ischemic heart disease, other other and unspecified hyperlipidemia abnormal coagulation profile cellulitis and abscess of upper arm and forearm diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled peripheral vascular disease, unspecified congestive heart failure, unspecified acute posthemorrhagic anemia anticoagulants causing adverse effects in therapeutic use acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified infection and inflammatory reaction due to other vascular device, implant, and graft coronary atherosclerosis of native coronary artery long-term (current) use of anticoagulants old myocardial infarction unspecified essential hypertension pneumonia, organism unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled
white f 73 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  324  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  109  mg dl$nan
 
white f 73 $nan$hematology blood hematocrit  29.7  %; hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  245  k ul; hematology blood platelet count  260  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.1  ; chemistry urine chloride, urine  33  meq l; chemistry urine creatinine, urine  50  mg dl; chemistry urine potassium, urine  29  meq l; chemistry urine sodium, urine  32  meq l; chemistry urine urea nitrogen, urine  226  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  109  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; heparin  1400-2800  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; 0.9% sodium chloride  1000  ml ; vitamin d  400  unit ; lansoprazole oral disintegrating tab  30  mg ; folic acid  5  mg ; diltiazem extended-release  240  mg ; doxazosin  2  mg ; losartan potassium  50  mg ; 
 
white f 91 $temp    heartrate  67.0  resprate  20.0  o2sat  96.0  sbp  156.0  dbp  73.0  rhythm  sinus rhythm  pain  0  ; temp  98.3  heartrate  62.0  resprate  22.0  o2sat  96.0  sbp  126.0  dbp  49.0  rhythm    pain  `0  ; temp    heartrate  62.0  resprate  18.0  o2sat  96.0  sbp  126.0  dbp  49.0  rhythm    pain  sleeping  ; temp    heartrate  61.0  resprate  20.0  o2sat  95.0  sbp  117.0  dbp  56.0  rhythm    pain  sleeping  ; temp    heartrate  67.0  resprate  18.0  o2sat  96.0  sbp  124.0  dbp  83.0  rhythm    pain  0  ; temp    heartrate  59.0  resprate  18.0  o2sat  94.0  sbp  139.0  dbp  64.0  rhythm    pain  sleep  ; temp  98.3  heartrate  54.0  resprate  18.0  o2sat  98.0  sbp  142.0  dbp  61.0  rhythm    pain  0  $nan$sodium chloride 0.9%  flush  3  ml ; warfarin  2  mg ; propranolol  80  mg ; simvastatin  20  mg ; omeprazole  20  mg ; aspirin  81  mg ; torsemide  5  mg ; 
need for prophylactic vaccination and inoculation against influenza cyst of kidney, acquired esophageal reflux other and unspecified hyperlipidemia primary hypercoagulable state other and unspecified escherichia coli [e. coli] metabolic syndrome home accidents fall resulting in striking against other object personal history of venous thrombosis and embolism chronic kidney disease, unspecified anticoagulants causing adverse effects in therapeutic use gross hematuria personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits urinary tract infection, site not specified long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified 
white f 91 $nan$nan$sodium chloride 0.9%  flush  3  ml ; warfarin  2  mg ; propranolol  80  mg ; simvastatin  20  mg ; omeprazole  20  mg ; aspirin  81  mg ; torsemide  5  mg ; 
need for prophylactic vaccination and inoculation against influenza cyst of kidney, acquired esophageal reflux other and unspecified hyperlipidemia primary hypercoagulable state other and unspecified escherichia coli [e. coli] metabolic syndrome home accidents fall resulting in striking against other object personal history of venous thrombosis and embolism chronic kidney disease, unspecified anticoagulants causing adverse effects in therapeutic use gross hematuria personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits urinary tract infection, site not specified long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified 
white f 29 $nan$nan$labetalol  100  mg ; labetalol  200  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxytocin  20  unit ; sodium citrate  30  ml ; lr  1000  ml ; ranitidine  75  mg ; 
 
white f 29 $nan$nan$ibuprofen  600  mg ; influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
white f 29 $nan$nan$ibuprofen  600  mg ; influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
white m 67 $nan$nan$insulin  50  unit ; aspirin  325  mg ; furosemide  40  mg ; lisinopril  10  mg ; simvastatin  40  mg ; clopidogrel  75  mg ; warfarin  5  mg ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  34.8  %; hematology blood hematocrit  33.2  %; hematology blood hemoglobin  11.3  g dl; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  424  k ul; hematology blood platelet count  428  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  2.2  ; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  163  mg dl; chemistry blood glucose  250  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  sm  mg dl$insulin  50  unit ; aspirin  325  mg ; furosemide  40  mg ; lisinopril  10  mg ; simvastatin  40  mg ; clopidogrel  75  mg ; warfarin  5  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; oxycodone-acetaminophen  1  tab ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lorazepam  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; insulin  0  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; bag  50  ml ; magnesium sulfate  2  gm ; ciprofloxacin hcl  500  mg ; oxycodone (immediate release)   5  mg ; acetaminophen  500-1000  mg ; 0.9% sodium chloride  1000  ml ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  506  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  105  mg dl$insulin  50  unit ; aspirin  325  mg ; furosemide  40  mg ; lisinopril  10  mg ; simvastatin  40  mg ; clopidogrel  75  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lorazepam  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; insulin  0  unit ; ciprofloxacin hcl  500  mg ; oxycodone (immediate release)   5  mg ; acetaminophen  500-1000  mg ; 0.9% sodium chloride  1000  ml ; warfarin  4  mg ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  548  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  135  mg dl$aspirin  325  mg ; furosemide  40  mg ; lisinopril  10  mg ; simvastatin  40  mg ; clopidogrel  75  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lorazepam  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; oxycodone (immediate release)   5  mg ; acetaminophen  500-1000  mg ; warfarin  4  mg ; oxycodone (immediate release)   7.5-10  mg ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$chemistry blood chloride  98  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  132  meq l$aspirin  325  mg ; furosemide  40  mg ; lisinopril  10  mg ; simvastatin  40  mg ; clopidogrel  75  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lorazepam  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  500-1000  mg ; warfarin  4  mg ; oxycodone (immediate release)   7.5-10  mg ; insulin  40  unit ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  563  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  184  mg dl$aspirin  325  mg ; furosemide  40  mg ; lisinopril  10  mg ; simvastatin  40  mg ; clopidogrel  75  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lorazepam  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  500-1000  mg ; warfarin  4  mg ; oxycodone (immediate release)   7.5-10  mg ; insulin  40  unit ; 5% dextrose  250  ml ; vancomycin  1250  mg ; oxycodone sr (oxycontin)  20  mg ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  559  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  202  mg dl; chemistry blood % hemoglobin a1c  10.6  %$aspirin  325  mg ; furosemide  40  mg ; lisinopril  10  mg ; simvastatin  40  mg ; clopidogrel  75  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lorazepam  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  500-1000  mg ; insulin  40  unit ; 5% dextrose  250  ml ; vancomycin  1250  mg ; oxycodone sr (oxycontin)  20  mg ; warfarin  1  mg ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  561  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood glucose  116  mg dl$aspirin  325  mg ; furosemide  40  mg ; lisinopril  10  mg ; simvastatin  40  mg ; clopidogrel  75  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lorazepam  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  500-1000  mg ; 5% dextrose  250  ml ; vancomycin  1250  mg ; oxycodone sr (oxycontin)  20  mg ; warfarin  1  mg ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  489  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  135  mg dl$aspirin  325  mg ; furosemide  40  mg ; lisinopril  10  mg ; simvastatin  40  mg ; clopidogrel  75  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lorazepam  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  500-1000  mg ; 5% dextrose  250  ml ; vancomycin  1250  mg ; oxycodone sr (oxycontin)  20  mg ; lr  1000  ml ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  24.1  %; hematology blood hematocrit  25.9  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  496  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  157  mg dl; chemistry blood glucose  152  mg dl$aspirin  325  mg ; simvastatin  40  mg ; clopidogrel  75  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lorazepam  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  500-1000  mg ; 5% dextrose  250  ml ; vancomycin  1250  mg ; oxycodone sr (oxycontin)  20  mg ; lr  1000  ml ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  26.6  %; hematology blood hematocrit  21.9  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  460  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  125  mg dl$aspirin  325  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lorazepam  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  500-1000  mg ; oxycodone sr (oxycontin)  20  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  435  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  99  mg dl$aspirin  325  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lorazepam  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  500-1000  mg ; oxycodone sr (oxycontin)  20  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; furosemide  20  mg ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  25.6  %; hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  391  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  141  mg dl$aspirin  325  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lorazepam  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  500-1000  mg ; oxycodone sr (oxycontin)  20  mg ; 1 2 ns  1000  ml ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  411  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  102  mg dl$aspirin  325  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lorazepam  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  500-1000  mg ; oxycodone sr (oxycontin)  20  mg ; 1 2 ns  1000  ml ; insulin  8  unit ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  392  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  131  mg dl$aspirin  325  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lorazepam  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  500-1000  mg ; oxycodone sr (oxycontin)  20  mg ; insulin  8  unit ; d5 1 2ns  1000  ml ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  399  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  128  mg dl$aspirin  325  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lorazepam  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  500-1000  mg ; oxycodone sr (oxycontin)  20  mg ; vancomycin  750  mg ; insulin  32  unit ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  373  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  163  mg dl$aspirin  325  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lorazepam  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  500-1000  mg ; oxycodone sr (oxycontin)  20  mg ; vancomycin  750  mg ; insulin  34  unit ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  28.5  %; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood glucose  128  mg dl$aspirin  325  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lorazepam  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  500-1000  mg ; oxycodone sr (oxycontin)  20  mg ; vancomycin  750  mg ; insulin  34  unit ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  333  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  151  mg dl$aspirin  325  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lorazepam  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  500-1000  mg ; oxycodone sr (oxycontin)  20  mg ; vancomycin  750  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  318  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  123  mg dl$aspirin  325  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lorazepam  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  500-1000  mg ; oxycodone sr (oxycontin)  20  mg ; vancomycin  750  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; heparin flush (10 units ml)  2  ml ; oxycodone-acetaminophen  1-2  tab ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  285  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  118  mg dl$aspirin  325  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lorazepam  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  500-1000  mg ; oxycodone sr (oxycontin)  20  mg ; vancomycin  750  mg ; heparin flush (10 units ml)  2  ml ; oxycodone-acetaminophen  1-2  tab ; calcium carbonate  1000  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-15  mg ; hydromorphone (dilaudid)  0.25  mg ; lidocaine 5% patch  2  ptch ; morphine sulfate  2-4  mg ; morphine sulfate  50  mg ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$nan$aspirin  325  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lorazepam  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; ciprofloxacin hcl  500  mg ; vancomycin  750  mg ; heparin flush (10 units ml)  2  ml ; calcium carbonate  1000  mg ; lidocaine 5% patch  2  ptch ; morphine sulfate  50  mg ; metformin (glucophage)  500  mg ; acetaminophen  650  mg ; gabapentin  800  mg ; hydromorphone (dilaudid)  12.5  mg ; hydromorphone (dilaudid)  1-2  mg ; gabapentin  300  mg ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  293  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  83  mg dl; chemistry blood glucose  122  mg dl$aspirin  325  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; ciprofloxacin hcl  500  mg ; vancomycin  750  mg ; heparin flush (10 units ml)  2  ml ; metformin (glucophage)  500  mg ; acetaminophen  650  mg ; gabapentin  800  mg ; hydromorphone (dilaudid)  12.5  mg ; hydromorphone (dilaudid)  1-2  mg ; gabapentin  300  mg ; warfarin  6  mg ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  26.6  %; hematology blood hematocrit  27.7  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  218  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  226  mg dl$aspirin  325  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; ciprofloxacin hcl  500  mg ; vancomycin  750  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  650  mg ; gabapentin  300  mg ; warfarin  6  mg ; insulin  30  unit ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  27.0  %; hematology blood inr(pt)  1.4  $aspirin  325  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; ciprofloxacin hcl  500  mg ; vancomycin  750  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  650  mg ; gabapentin  300  mg ; warfarin  6  mg ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$nan$aspirin  325  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; ciprofloxacin hcl  500  mg ; vancomycin  750  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  650  mg ; gabapentin  300  mg ; warfarin  6  mg ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
white m 67 $nan$hematology blood hematocrit  26.8  %; hematology blood inr(pt)  1.5  $aspirin  325  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  25  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; metronidazole (flagyl)  500  mg ; methadone  40  mg ; ciprofloxacin hcl  500  mg ; vancomycin  750  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  650  mg ; gabapentin  300  mg ; warfarin  6  mg ; 
atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site obesity, unspecified cocaine abuse, episodic tobacco use disorder other and unspecified alcohol dependence, continuous long-term (current) use of insulin pure hypercholesterolemia ulcer of heel and midfoot atrial fibrillation
other f 42 $nan$nan$heparin  5000  unit ; levothyroxine sodium  25  mcg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; metoclopramide  10  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; acetaminophen iv  1000  mg ; bupropion (sustained release)  150  mg ; 
 
other f 42 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  274  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  110  mg dl$heparin  5000  unit ; levothyroxine sodium  25  mcg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; metoclopramide  10  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; acetaminophen iv  1000  mg ; bupropion (sustained release)  150  mg ; bag  1  bag ; magnesium sulfate  2  gm ; tramadol  50-100  mg ; 
 
other f 42 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  82  mg dl$levothyroxine sodium  25  mcg ; sodium chloride 0.9%  flush  3-10  ml ; metoclopramide  10  mg ; acetaminophen iv  1000  mg ; bupropion (sustained release)  150  mg ; tramadol  50-100  mg ; acetaminophen  650  mg ; potassium chloride  40  meq ; 
 
other m 18 $nan$chemistry blood bilirubin, total  0.4  mg dl; chemistry blood % hemoglobin a1c  4.9  %$influenza vaccine quadrivalent  0.5  ml ; acetaminophen  650  mg ; lorazepam  0.5  mg ; ramelteon  8  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
other specified anxiety disorders suicidal ideations patient's other noncompliance with medication regimen unspecified mood [affective] disorder
other m 18 $nan$nan$acetaminophen  650  mg ; lorazepam  0.5  mg ; ramelteon  8  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
other specified anxiety disorders suicidal ideations patient's other noncompliance with medication regimen unspecified mood [affective] disorder
other m 18 $nan$nan$acetaminophen  650  mg ; ramelteon  8  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
other specified anxiety disorders suicidal ideations patient's other noncompliance with medication regimen unspecified mood [affective] disorder
other m 18 $nan$nan$acetaminophen  650  mg ; ramelteon  8  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
other specified anxiety disorders suicidal ideations patient's other noncompliance with medication regimen unspecified mood [affective] disorder
other m 18 $nan$nan$acetaminophen  650  mg ; ramelteon  8  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
other specified anxiety disorders suicidal ideations patient's other noncompliance with medication regimen unspecified mood [affective] disorder
other m 18 $nan$nan$acetaminophen  650  mg ; ramelteon  8  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
other specified anxiety disorders suicidal ideations patient's other noncompliance with medication regimen unspecified mood [affective] disorder
other m 18 $nan$nan$acetaminophen  650  mg ; ramelteon  8  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
other specified anxiety disorders suicidal ideations patient's other noncompliance with medication regimen unspecified mood [affective] disorder
other m 18 $nan$nan$acetaminophen  650  mg ; ramelteon  8  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
other specified anxiety disorders suicidal ideations patient's other noncompliance with medication regimen unspecified mood [affective] disorder
other m 18 $nan$nan$acetaminophen  650  mg ; ramelteon  8  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
other specified anxiety disorders suicidal ideations patient's other noncompliance with medication regimen unspecified mood [affective] disorder
other m 18 $nan$nan$acetaminophen  650  mg ; ramelteon  8  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
other specified anxiety disorders suicidal ideations patient's other noncompliance with medication regimen unspecified mood [affective] disorder
other m 18 $nan$nan$acetaminophen  650  mg ; ramelteon  8  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
other specified anxiety disorders suicidal ideations patient's other noncompliance with medication regimen unspecified mood [affective] disorder
other m 18 $nan$nan$acetaminophen  650  mg ; ramelteon  8  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; hydroxyzine  25  mg ; 
other specified anxiety disorders suicidal ideations patient's other noncompliance with medication regimen unspecified mood [affective] disorder
other m 18 $nan$nan$acetaminophen  650  mg ; ramelteon  8  mg ; hydroxyzine  25  mg ; fluoxetine  10  mg ; 
other specified anxiety disorders suicidal ideations patient's other noncompliance with medication regimen unspecified mood [affective] disorder
other m 18 $nan$nan$acetaminophen  650  mg ; ramelteon  8  mg ; fluoxetine  10  mg ; 
other specified anxiety disorders suicidal ideations patient's other noncompliance with medication regimen unspecified mood [affective] disorder
other m 18 $nan$nan$acetaminophen  650  mg ; ramelteon  8  mg ; fluoxetine  10  mg ; 
other specified anxiety disorders suicidal ideations patient's other noncompliance with medication regimen unspecified mood [affective] disorder
white f 40 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  222  k ul$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
outcome of delivery, single liveborn motorcycle driver injured in collision with fixed or stationary object in nontraffic accident elderly primigravida, delivered, with or without mention of antepartum condition 
white f 40 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; measles, mumps & rubella vac  0.5  ml ; 
outcome of delivery, single liveborn motorcycle driver injured in collision with fixed or stationary object in nontraffic accident elderly primigravida, delivered, with or without mention of antepartum condition 
white f 40 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; measles, mumps & rubella vac  0.5  ml ; 
outcome of delivery, single liveborn motorcycle driver injured in collision with fixed or stationary object in nontraffic accident elderly primigravida, delivered, with or without mention of antepartum condition 
white f 54 $nan$hematology blood hematocrit  34.4  %; hematology blood hematocrit  34.1  %; hematology blood hematocrit  32.1  %; hematology blood hemoglobin  11.8  g dl; hematology blood hemoglobin  12.1  g dl; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  231  k ul; hematology blood platelet count  193  k ul; hematology blood platelet count  185  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  111  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  93  mg dl; chemistry blood lactate dehydrogenase (ld)  180  iu l; chemistry blood albumin  3.5  g dl; hematology blood bands  1  %; hematology blood bands  29  %; hematology blood bands  19  %; blood gas blood lactate  2.8  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  1.0  mmol l$ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  0.5  mg ; ondansetron  4  mg ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; hydromorphone (dilaudid)  0.25-0.5  mg ; neutra-phos  2  pkt ; heparin  5000  unit ; docusate sodium  100  mg ; 5% dextrose  50  ml ; clindamycin  900  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; 0.9% sodium chloride  1000  ml ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride  500  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; clindamycin  600  mg ; d5w  300  ml ; linezolid  600  mg ; levothyroxine sodium  100  mcg ; neutra-phos  1  pkt ; ondansetron  8  mg ; promethazine  6.25  mg ; 
 
white f 54 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  174  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  101  mg dl; blood gas blood lactate  1.4  mmol l$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; hydromorphone (dilaudid)  0.25-0.5  mg ; heparin  5000  unit ; docusate sodium  100  mg ; 0.9% sodium chloride  1000  ml ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 0.9% sodium chloride  500  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; clindamycin  600  mg ; d5w  300  ml ; linezolid  600  mg ; levothyroxine sodium  100  mcg ; neutra-phos  1  pkt ; ondansetron  8  mg ; promethazine  6.25  mg ; 
 
white f 54 $nan$hematology blood hematocrit  37.7  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  233  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; hydromorphone (dilaudid)  0.25-0.5  mg ; heparin  5000  unit ; docusate sodium  100  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; d5w  300  ml ; linezolid  600  mg ; levothyroxine sodium  100  mcg ; ondansetron  8  mg ; promethazine  6.25  mg ; ketorolac  15  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; vial  1  vial ; pantoprazole  40  mg ; d5lr  1000  ml ; acetaminophen iv  1000  mg ; phosphorus  500  mg ; potassium chloride  20  meq ; lorazepam  0.5  mg ; 
 
white f 54 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  147  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; levothyroxine sodium  100  mcg ; ketorolac  15  mg ; vial  1  vial ; pantoprazole  40  mg ; d5lr  1000  ml ; acetaminophen iv  1000  mg ; phosphorus  500  mg ; potassium chloride  20  meq ; lorazepam  0.5  mg ; 5% dextrose  100  ml ; penicillin g potassium  4  million units ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; metoclopramide  10  mg ; potassium phosphate  30  mmol ; 
 
white f 54 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  252  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  101  mg dl; hematology blood bands  1  %$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; levothyroxine sodium  100  mcg ; ketorolac  15  mg ; vial  1  vial ; pantoprazole  40  mg ; acetaminophen iv  1000  mg ; lorazepam  0.5  mg ; 5% dextrose  100  ml ; penicillin g potassium  4  million units ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; metoclopramide  10  mg ; potassium phosphate  30  mmol ; bicitra  30  ml ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; potassium chloride  40  meq ; 
 
white f 54 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  275  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  96  mg dl; hematology blood bands  1  %$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; levothyroxine sodium  100  mcg ; 5% dextrose  100  ml ; penicillin g potassium  4  million units ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; bicitra  30  ml ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; potassium chloride  40  meq ; 
 
white f 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; levothyroxine sodium  100  mcg ; 5% dextrose  100  ml ; penicillin g potassium  4  million units ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; 
 
white f 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; levothyroxine sodium  100  mcg ; 5% dextrose  100  ml ; penicillin g potassium  4  million units ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; 
 
white f 89 $temp    heartrate  82.0  resprate  20.0  o2sat  96.0  sbp  112.0  dbp  96.0  rhythm    pain  6  ; temp    heartrate  92.0  resprate  22.0  o2sat  95.0  sbp  175.0  dbp  97.0  rhythm    pain  5  $hematology blood hematocrit  36.3  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  262  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  130  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; trazodone  25  mg ; labetalol  200  mg ; carvedilol  25  mg ; timolol maleate 0.5%  1  drop ; vitamin b complex  1  cap ; vitamin d  1000  unit ; heparin  1200-2400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; magnesium oxide  400  mg ; potassium chloride  40  meq ; hydralazine  10  mg ; 
other speech disturbance closed fracture of two ribs injury to other specified intrathoracic organs without mention of open wound into cavity unspecified fall hip joint replacement unspecified essential hypertension other specified metabolic disorders long-term (current) use of anticoagulants unspecified transient cerebral ischemia other and unspecified hyperlipidemia osteoarthrosis, unspecified whether generalized or localized, site unspecified abnormality of gait personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits spinal stenosis in cervical region car passenger injured in collision with van in traffic accident home accidents atrial fibrillation knee joint replacement knee joint replacement orthostatic hypotension atrial fibrillation subarachnoid hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness other specified metabolic disorders other and unspecified hyperlipidemia unspecified external cause status unspecified fall home accidents unspecified essential hypertension car passenger injured in collision with van in traffic accident hip joint replacement osteoarthrosis, unspecified whether generalized or localized, site unspecified contusion of shoulder region long-term (current) use of anticoagulants dehydration subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness 
white f 89 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  243  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  116  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; trazodone  25  mg ; labetalol  200  mg ; carvedilol  25  mg ; timolol maleate 0.5%  1  drop ; vitamin b complex  1  cap ; vitamin d  1000  unit ; heparin  1200-2400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; magnesium oxide  400  mg ; potassium chloride  40  meq ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; bag  1  bag ; magnesium sulfate  2  gm ; 
other speech disturbance closed fracture of two ribs injury to other specified intrathoracic organs without mention of open wound into cavity unspecified fall hip joint replacement unspecified essential hypertension other specified metabolic disorders long-term (current) use of anticoagulants unspecified transient cerebral ischemia other and unspecified hyperlipidemia osteoarthrosis, unspecified whether generalized or localized, site unspecified abnormality of gait personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits spinal stenosis in cervical region car passenger injured in collision with van in traffic accident home accidents atrial fibrillation knee joint replacement knee joint replacement orthostatic hypotension atrial fibrillation subarachnoid hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness other specified metabolic disorders other and unspecified hyperlipidemia unspecified external cause status unspecified fall home accidents unspecified essential hypertension car passenger injured in collision with van in traffic accident hip joint replacement osteoarthrosis, unspecified whether generalized or localized, site unspecified contusion of shoulder region long-term (current) use of anticoagulants dehydration subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness 
white f 89 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  123  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; trazodone  25  mg ; carvedilol  25  mg ; timolol maleate 0.5%  1  drop ; vitamin b complex  1  cap ; vitamin d  1000  unit ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; bag  1  bag ; magnesium sulfate  2  gm ; furosemide  10  mg ; nifedipine  10  mg ; lactated ringers  1000  ml ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; glucagon  1  mg ; 
other speech disturbance closed fracture of two ribs injury to other specified intrathoracic organs without mention of open wound into cavity unspecified fall hip joint replacement unspecified essential hypertension other specified metabolic disorders long-term (current) use of anticoagulants unspecified transient cerebral ischemia other and unspecified hyperlipidemia osteoarthrosis, unspecified whether generalized or localized, site unspecified abnormality of gait personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits spinal stenosis in cervical region car passenger injured in collision with van in traffic accident home accidents atrial fibrillation knee joint replacement knee joint replacement orthostatic hypotension atrial fibrillation subarachnoid hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness other specified metabolic disorders other and unspecified hyperlipidemia unspecified external cause status unspecified fall home accidents unspecified essential hypertension car passenger injured in collision with van in traffic accident hip joint replacement osteoarthrosis, unspecified whether generalized or localized, site unspecified contusion of shoulder region long-term (current) use of anticoagulants dehydration subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness 
white f 89 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  254  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  103  mg dl; chemistry blood lactate dehydrogenase (ld)  230  iu l$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; trazodone  25  mg ; timolol maleate 0.5%  1  drop ; vitamin b complex  1  cap ; vitamin d  1000  unit ; atorvastatin  80  mg ; lamotrigine  25  mg ; apixaban  2.5  mg ; 
other speech disturbance closed fracture of two ribs injury to other specified intrathoracic organs without mention of open wound into cavity unspecified fall hip joint replacement unspecified essential hypertension other specified metabolic disorders long-term (current) use of anticoagulants unspecified transient cerebral ischemia other and unspecified hyperlipidemia osteoarthrosis, unspecified whether generalized or localized, site unspecified abnormality of gait personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits spinal stenosis in cervical region car passenger injured in collision with van in traffic accident home accidents atrial fibrillation knee joint replacement knee joint replacement orthostatic hypotension atrial fibrillation subarachnoid hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness other specified metabolic disorders other and unspecified hyperlipidemia unspecified external cause status unspecified fall home accidents unspecified essential hypertension car passenger injured in collision with van in traffic accident hip joint replacement osteoarthrosis, unspecified whether generalized or localized, site unspecified contusion of shoulder region long-term (current) use of anticoagulants dehydration subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness 
white f 89 $nan$hematology blood hematocrit  37.1  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  98  mg dl; chemistry blood albumin  3.1  g dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; trazodone  25  mg ; timolol maleate 0.5%  1  drop ; vitamin b complex  1  cap ; vitamin d  1000  unit ; apixaban  2.5  mg ; atorvastatin  40  mg ; lamotrigine  50  mg ; 
other speech disturbance closed fracture of two ribs injury to other specified intrathoracic organs without mention of open wound into cavity unspecified fall hip joint replacement unspecified essential hypertension other specified metabolic disorders long-term (current) use of anticoagulants unspecified transient cerebral ischemia other and unspecified hyperlipidemia osteoarthrosis, unspecified whether generalized or localized, site unspecified abnormality of gait personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits spinal stenosis in cervical region car passenger injured in collision with van in traffic accident home accidents atrial fibrillation knee joint replacement knee joint replacement orthostatic hypotension atrial fibrillation subarachnoid hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness other specified metabolic disorders other and unspecified hyperlipidemia unspecified external cause status unspecified fall home accidents unspecified essential hypertension car passenger injured in collision with van in traffic accident hip joint replacement osteoarthrosis, unspecified whether generalized or localized, site unspecified contusion of shoulder region long-term (current) use of anticoagulants dehydration subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness 
white f 74 $temp  98.7  heartrate  80.0  resprate  16.0  o2sat  96.0  sbp  141.0  dbp  64.0  rhythm    pain  6  ; temp  98.1  heartrate  81.0  resprate  15.0  o2sat  96.0  sbp  162.0  dbp  72.0  rhythm    pain  6  ; temp    heartrate  78.0  resprate  16.0  o2sat  95.0  sbp  130.0  dbp  61.0  rhythm    pain  sleep  ; temp    heartrate  76.0  resprate  16.0  o2sat  95.0  sbp  146.0  dbp  65.0  rhythm    pain  6  ; temp    heartrate  68.0  resprate  16.0  o2sat  96.0  sbp  132.0  dbp  62.0  rhythm    pain    ; temp  98.2  heartrate  73.0  resprate  14.0  o2sat  95.0  sbp  122.0  dbp  73.0  rhythm    pain  6  $hematology blood hematocrit  41.4  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  74  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; lorazepam  0.5  mg ; morphine sr (ms contin)  30  mg ; omeprazole  20  mg ; vitamin d  2000  unit ; hydrocodone-acetaminophen (5mg-500mg)  2  tab ; prednisone  8  mg ; pantoprazole  40  mg ; hydromorphone (dilaudid)  0.125  mg ; acetaminophen  650  mg ; dexamethasone  4  mg ; heparin  5000  unit ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  122  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; lorazepam  0.5  mg ; pantoprazole  40  mg ; hydromorphone (dilaudid)  0.125  mg ; acetaminophen  650  mg ; dexamethasone  4  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; tramadol (ultram)  50  mg ; hydromorphone (dilaudid)  0.25  mg ; bisacodyl  10  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  38.6  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  125  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; dexamethasone  4  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; hydromorphone (dilaudid)  0.25  mg ; bisacodyl  10  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; polyethylene glycol  17  g ; guaifenesin  5-10  ml ; ondansetron  4  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; ondansetron  8  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  38.4  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  72  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; polyethylene glycol  17  g ; guaifenesin  5-10  ml ; ondansetron  4  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; ondansetron  8  mg ; ipratropium bromide neb  1  neb ; fentanyl patch  12  mcg h ; prednisone  3  mg ; prednisone  5  mg ; hydromorphone (dilaudid)  1-2  mg ; hydromorphone (dilaudid)  1  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  40.4  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  77  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; polyethylene glycol  17  g ; guaifenesin  5-10  ml ; ondansetron  4  mg ; ipratropium bromide neb  1  neb ; fentanyl patch  12  mcg h ; prednisone  3  mg ; prednisone  5  mg ; hydromorphone (dilaudid)  2-3  mg ; trazodone  25  mg ; fentanyl patch  25  mcg h ; hydromorphone (dilaudid)  2-4  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  40.0  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  185  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  81  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; polyethylene glycol  17  g ; guaifenesin  5-10  ml ; ondansetron  4  mg ; ipratropium bromide neb  1  neb ; prednisone  3  mg ; prednisone  5  mg ; trazodone  25  mg ; fentanyl patch  25  mcg h ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.75  mg ; citalopram  20  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; fentanyl patch  50  mcg h ; methocarbamol  500  mg ; hydromorphone (dilaudid)  2  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  40.0  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  78  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; guaifenesin  5-10  ml ; ondansetron  4  mg ; ipratropium bromide neb  1  neb ; prednisone  3  mg ; prednisone  5  mg ; trazodone  25  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.75  mg ; citalopram  20  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; fentanyl patch  50  mcg h ; methocarbamol  500  mg ; hydromorphone (dilaudid)  2  mg ; 0.9% sodium chloride  500  ml ; cepastat (phenol) lozenge  1  loz ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  42.6  %; hematology blood hematocrit  42.6  %; hematology blood hemoglobin  14.2  g dl; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  208  k ul; hematology blood platelet count  217  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  91  mg dl; chemistry blood glucose  78  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; guaifenesin  5-10  ml ; ondansetron  4  mg ; ipratropium bromide neb  1  neb ; prednisone  3  mg ; prednisone  5  mg ; trazodone  25  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.75  mg ; citalopram  20  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; fentanyl patch  50  mcg h ; methocarbamol  500  mg ; 0.9% sodium chloride  500  ml ; cepastat (phenol) lozenge  1  loz ; milk of magnesia  30  ml ; aspirin  325  mg ; nitroglycerin sl  0.4  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  39.3  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  73  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; prednisone  3  mg ; prednisone  5  mg ; trazodone  25  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.75  mg ; citalopram  20  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; fentanyl patch  50  mcg h ; cepastat (phenol) lozenge  1  loz ; nitroglycerin sl  0.4  mg ; hydromorphone (dilaudid)  0.5  mg ; benzonatate  100  mg ; simethicone  40-80  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  94  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; guaifenesin  5-10  ml ; ipratropium bromide neb  1  neb ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.75  mg ; citalopram  20  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; fentanyl patch  50  mcg h ; cepastat (phenol) lozenge  1  loz ; benzonatate  100  mg ; simethicone  40-80  mg ; guaifenesin-codeine phosphate  5-10  ml ; hydromorphone (dilaudid)  4  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  85  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; ipratropium bromide neb  1  neb ; hydromorphone (dilaudid)  0.75  mg ; citalopram  20  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; fentanyl patch  50  mcg h ; cepastat (phenol) lozenge  1  loz ; benzonatate  100  mg ; simethicone  40-80  mg ; guaifenesin-codeine phosphate  5-10  ml ; hydromorphone (dilaudid)  4  mg ; gabapentin  100  mg ; hydromorphone (dilaudid)  2-6  mg ; fentanyl patch  75  mcg h ; gabapentin  300  mg ; guaifenesin-codeine phosphate  5-15  ml ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  39.4  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  64  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; ipratropium bromide neb  1  neb ; hydromorphone (dilaudid)  0.75  mg ; citalopram  20  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; cepastat (phenol) lozenge  1  loz ; simethicone  40-80  mg ; hydromorphone (dilaudid)  2-6  mg ; fentanyl patch  75  mcg h ; gabapentin  300  mg ; guaifenesin-codeine phosphate  5-15  ml ; benzonatate  200  mg ; sodium chloride nasal  1-2  spry ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$nan$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; citalopram  20  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; cepastat (phenol) lozenge  1  loz ; simethicone  40-80  mg ; hydromorphone (dilaudid)  2-6  mg ; fentanyl patch  75  mcg h ; gabapentin  300  mg ; guaifenesin-codeine phosphate  5-15  ml ; benzonatate  200  mg ; sodium chloride nasal  1-2  spry ; hydromorphone (dilaudid)  8  mg ; lidocaine 5% patch  1  ptch ; gabapentin  400  mg ; fentanyl patch  100  mcg h ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  37.1  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  218  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  23  mg dl; hematology urine wbc  5  # hpf; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  87  mg dl; chemistry blood albumin  3.8  g dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; acetaminophen  650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; citalopram  20  mg ; cepastat (phenol) lozenge  1  loz ; simethicone  40-80  mg ; hydromorphone (dilaudid)  2-6  mg ; guaifenesin-codeine phosphate  5-15  ml ; benzonatate  200  mg ; sodium chloride nasal  1-2  spry ; hydromorphone (dilaudid)  8  mg ; lidocaine 5% patch  1  ptch ; fentanyl patch  100  mcg h ; fluticasone propionate nasal  1  spry ; gabapentin  600  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; dextrose 5%  150  ml ; levofloxacin  750  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood glucose  86  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; acetaminophen  650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; citalopram  20  mg ; cepastat (phenol) lozenge  1  loz ; simethicone  40-80  mg ; hydromorphone (dilaudid)  2-6  mg ; guaifenesin-codeine phosphate  5-15  ml ; benzonatate  200  mg ; sodium chloride nasal  1-2  spry ; hydromorphone (dilaudid)  8  mg ; lidocaine 5% patch  1  ptch ; fentanyl patch  100  mcg h ; fluticasone propionate nasal  1  spry ; gabapentin  600  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; dextrose 5%  150  ml ; levofloxacin  750  mg ; hydromorphone (dilaudid)  2-8  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  211  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  78  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; acetaminophen  650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; citalopram  20  mg ; cepastat (phenol) lozenge  1  loz ; simethicone  40-80  mg ; guaifenesin-codeine phosphate  5-15  ml ; benzonatate  200  mg ; sodium chloride nasal  1-2  spry ; hydromorphone (dilaudid)  8  mg ; lidocaine 5% patch  1  ptch ; fentanyl patch  100  mcg h ; fluticasone propionate nasal  1  spry ; gabapentin  600  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; dextrose 5%  150  ml ; levofloxacin  750  mg ; hydromorphone (dilaudid)  2-8  mg ; hydromorphone (dilaudid)  0.5-1  mg ; lactated ringers  1000  ml ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  37.0  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  202  k ul$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; acetaminophen  650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; citalopram  20  mg ; cepastat (phenol) lozenge  1  loz ; simethicone  40-80  mg ; guaifenesin-codeine phosphate  5-15  ml ; benzonatate  200  mg ; sodium chloride nasal  1-2  spry ; hydromorphone (dilaudid)  8  mg ; lidocaine 5% patch  1  ptch ; fentanyl patch  100  mcg h ; fluticasone propionate nasal  1  spry ; gabapentin  600  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; dextrose 5%  150  ml ; levofloxacin  750  mg ; hydromorphone (dilaudid)  2-8  mg ; hydromorphone (dilaudid)  0.5-1  mg ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  20  mg ; hydromorphone (dilaudid)  8-12  mg ; hydromorphone (dilaudid)  0.5-1.5  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$nan$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; acetaminophen  650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; citalopram  20  mg ; cepastat (phenol) lozenge  1  loz ; simethicone  40-80  mg ; guaifenesin-codeine phosphate  5-15  ml ; benzonatate  200  mg ; sodium chloride nasal  1-2  spry ; lidocaine 5% patch  1  ptch ; fentanyl patch  100  mcg h ; fluticasone propionate nasal  1  spry ; gabapentin  600  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; dextrose 5%  150  ml ; levofloxacin  750  mg ; hydromorphone (dilaudid)  8-12  mg ; hydromorphone (dilaudid)  0.5-1.5  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  223  k ul; chemistry blood creatinine  1.3  mg dl; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.0  $influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; acetaminophen  650  mg ; heparin  5000  unit ; senna  1  tab ; docusate sodium  100  mg ; citalopram  20  mg ; cepastat (phenol) lozenge  1  loz ; simethicone  40-80  mg ; guaifenesin-codeine phosphate  5-15  ml ; benzonatate  200  mg ; sodium chloride nasal  1-2  spry ; lidocaine 5% patch  1  ptch ; fentanyl patch  100  mcg h ; fluticasone propionate nasal  1  spry ; gabapentin  600  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; dextrose 5%  150  ml ; levofloxacin  750  mg ; hydromorphone (dilaudid)  8-12  mg ; hydromorphone (dilaudid)  0.5-1.5  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  2  # hpf; chemistry blood glucose  78  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; acetaminophen  650  mg ; senna  1  tab ; docusate sodium  100  mg ; citalopram  20  mg ; cepastat (phenol) lozenge  1  loz ; simethicone  40-80  mg ; guaifenesin-codeine phosphate  5-15  ml ; benzonatate  200  mg ; sodium chloride nasal  1-2  spry ; lidocaine 5% patch  1  ptch ; fentanyl patch  100  mcg h ; fluticasone propionate nasal  1  spry ; gabapentin  600  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; dextrose 5%  150  ml ; levofloxacin  750  mg ; hydromorphone (dilaudid)  8-12  mg ; hydromorphone (dilaudid)  0.5-1.5  mg ; bupivacaine 0.05%  250  ml ; hydromorphone p.f.  5000  mcg ; hydromorphone (dilaudid)  4-8  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$nan$yellow cadd cassette  1  cadd ; influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; acetaminophen  650  mg ; senna  1  tab ; docusate sodium  100  mg ; citalopram  20  mg ; cepastat (phenol) lozenge  1  loz ; simethicone  40-80  mg ; guaifenesin-codeine phosphate  5-15  ml ; benzonatate  200  mg ; sodium chloride nasal  1-2  spry ; lidocaine 5% patch  1  ptch ; fluticasone propionate nasal  1  spry ; gabapentin  600  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; dextrose 5%  150  ml ; levofloxacin  750  mg ; bupivacaine 0.05%  250  ml ; hydromorphone p.f.  5000  mcg ; hydromorphone (dilaudid)  4-8  mg ; hydromorphone (dilaudid)  6-10  mg ; cephalexin  500  mg ; baclofen  5  mg ; hydromorphone (dilaudid)  6-12  mg ; hydromorphone p.f.  10,000  mcg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$nan$yellow cadd cassette  1  cadd ; influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; acetaminophen  650  mg ; senna  1  tab ; docusate sodium  100  mg ; citalopram  20  mg ; cepastat (phenol) lozenge  1  loz ; simethicone  40-80  mg ; guaifenesin-codeine phosphate  5-15  ml ; benzonatate  200  mg ; sodium chloride nasal  1-2  spry ; lidocaine 5% patch  1  ptch ; fluticasone propionate nasal  1  spry ; gabapentin  600  mg ; cephalexin  500  mg ; baclofen  5  mg ; hydromorphone (dilaudid)  6-12  mg ; hydromorphone p.f.  10,000  mcg ; naloxone  0.4  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  25  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; acetaminophen  650  mg ; senna  1  tab ; docusate sodium  100  mg ; citalopram  20  mg ; cepastat (phenol) lozenge  1  loz ; simethicone  40-80  mg ; guaifenesin-codeine phosphate  5-15  ml ; benzonatate  200  mg ; sodium chloride nasal  1-2  spry ; lidocaine 5% patch  1  ptch ; fluticasone propionate nasal  1  spry ; gabapentin  600  mg ; cephalexin  500  mg ; baclofen  5  mg ; naloxone  0.4  mg ; d5 1 2ns  1000  ml ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  179  k ul$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; acetaminophen  650  mg ; senna  1  tab ; docusate sodium  100  mg ; citalopram  20  mg ; cepastat (phenol) lozenge  1  loz ; simethicone  40-80  mg ; guaifenesin-codeine phosphate  5-15  ml ; benzonatate  200  mg ; sodium chloride nasal  1-2  spry ; lidocaine 5% patch  1  ptch ; fluticasone propionate nasal  1  spry ; gabapentin  600  mg ; cephalexin  500  mg ; baclofen  5  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  85  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; acetaminophen  650  mg ; senna  1  tab ; docusate sodium  100  mg ; citalopram  20  mg ; cepastat (phenol) lozenge  1  loz ; simethicone  40-80  mg ; guaifenesin-codeine phosphate  5-15  ml ; benzonatate  200  mg ; sodium chloride nasal  1-2  spry ; lidocaine 5% patch  1  ptch ; fluticasone propionate nasal  1  spry ; gabapentin  600  mg ; baclofen  5  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  39.9  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  186  k ul; hematology blood inr(pt)  1.0  ; hematology urine wbc  0  # hpf$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; acetaminophen  650  mg ; senna  1  tab ; docusate sodium  100  mg ; citalopram  20  mg ; cepastat (phenol) lozenge  1  loz ; simethicone  40-80  mg ; guaifenesin-codeine phosphate  5-15  ml ; benzonatate  200  mg ; sodium chloride nasal  1-2  spry ; lidocaine 5% patch  1  ptch ; fluticasone propionate nasal  1  spry ; gabapentin  600  mg ; baclofen  5  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; acetaminophen iv  1000  mg ; cefazolin  1  g ; dexamethasone  2  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  157  mg dl; blood gas blood lactate  4.0  mmol l; blood gas blood lactate  2.7  mmol l; blood gas blood lactate  4.3  mmol l$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; amlodipine  10  mg ; fluticasone propionate 110mcg  2  puff ; loratadine  10  mg ; acetaminophen  650  mg ; senna  1  tab ; docusate sodium  100  mg ; citalopram  20  mg ; cepastat (phenol) lozenge  1  loz ; simethicone  40-80  mg ; guaifenesin-codeine phosphate  5-15  ml ; benzonatate  200  mg ; sodium chloride nasal  1-2  spry ; lidocaine 5% patch  1  ptch ; fluticasone propionate nasal  1  spry ; gabapentin  600  mg ; baclofen  5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; acetaminophen iv  1000  mg ; cefazolin  1  g ; dexamethasone  2  mg ; albuterol 0.083% neb soln  1  neb ; propofol  1000  mg ; fentanyl citrate  25-100  mcg ; cefepime  2  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; vial  1  vial ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; hydromorphone (dilaudid)  0.5-2  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  130  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  70  mg dl$albuterol 0.083% neb soln  1  neb ; propofol  1000  mg ; fentanyl citrate  25-100  mcg ; cefepime  2  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; vial  1  vial ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  145  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  90  mg dl$albuterol 0.083% neb soln  1  neb ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; vial  1  vial ; acetaminophen w codeine elixir  12.5-25  ml ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$nan$albuterol 0.083% neb soln  1  neb ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; acetaminophen w codeine elixir  12.5-25  ml ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$nan$albuterol 0.083% neb soln  1  neb ; acetaminophen w codeine elixir  12.5-25  ml ; baclofen  10  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  154  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood glucose  88  mg dl$albuterol 0.083% neb soln  1  neb ; acetaminophen w codeine elixir  12.5-25  ml ; baclofen  10  mg ; soln  100  ml ; ampicillin sodium  2  g ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  99  mg dl$albuterol 0.083% neb soln  1  neb ; acetaminophen w codeine elixir  12.5-25  ml ; baclofen  10  mg ; soln  100  ml ; ceftriaxone  2  gm ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  39.2  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  142  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  118  mg dl$albuterol 0.083% neb soln  1  neb ; baclofen  10  mg ; soln  100  ml ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  95  mg dl$albuterol 0.083% neb soln  1  neb ; baclofen  10  mg ; soln  100  ml ; vancomycin  750  mg ; scopolamine patch  1  ptch ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  131  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  84  mg dl$albuterol 0.083% neb soln  1  neb ; baclofen  10  mg ; soln  100  ml ; vancomycin  750  mg ; scopolamine patch  1  ptch ; lorazepam  1  mg ; methadone  5  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  132  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  83  mg dl$albuterol 0.083% neb soln  1  neb ; baclofen  10  mg ; soln  100  ml ; lorazepam  1  mg ; methadone  5  mg ; 5% dextrose  150  ml ; vancomycin  500  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  80  mg dl$albuterol 0.083% neb soln  1  neb ; baclofen  10  mg ; soln  100  ml ; methadone  5  mg ; 5% dextrose  150  ml ; vancomycin  500  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  165  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  78  mg dl$5% dextrose  250  ml ; albuterol 0.083% neb soln  1  neb ; baclofen  10  mg ; soln  100  ml ; methadone  5  mg ; lidocaine 1%  1  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$hematology urine wbc  8  # hpf$5% dextrose  250  ml ; albuterol 0.083% neb soln  1  neb ; baclofen  10  mg ; soln  100  ml ; methadone  5  mg ; lidocaine 1%  1  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10  ml ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$nan$5% dextrose  250  ml ; albuterol 0.083% neb soln  1  neb ; baclofen  10  mg ; soln  100  ml ; methadone  5  mg ; sodium chloride 0.9%  flush  10  ml ; hydromorphone (dilaudid)  6  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white f 74 $nan$nan$albuterol 0.083% neb soln  1  neb ; baclofen  10  mg ; soln  100  ml ; methadone  5  mg ; sodium chloride 0.9%  flush  10  ml ; hydromorphone (dilaudid)  6  mg ; 
malignant neoplasm of kidney, except pelvis chest pain, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use secondary malignant neoplasm of lung
white m 65 $nan$hematology blood hematocrit  42.6  %; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  279  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  98  mg dl; chemistry blood albumin  4.4  g dl$0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  250  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; hydroxyzine  50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; sw  150  ml ; sw  200  ml ; heparin flush (10 units ml)  1  ml ; 5% dextrose  50  ml ; aldesleukin  54  million units ; ranitidine  150  mg ; cephalexin  500  mg ; 
asthma, unspecified type, unspecified pure hypercholesterolemia unspecified sinusitis (chronic) other specified pruritic conditions hyposmolality and/or hyponatremia hypovolemia malignant neoplasm of kidney, except pelvis diarrhea acidosis encounter for antineoplastic immunotherapy acute kidney failure, unspecified secondary malignant neoplasm of other specified sites hallucinations secondary malignant neoplasm of lung antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use toxic encephalopathy unspecified hemorrhoids without mention of complication other shock without mention of trauma dermatitis due to drugs and medicines taken internally delirium due to conditions classified elsewhere nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acidosis pure hypercholesterolemia malignant neoplasm of kidney, except pelvis other specified anemias acquired absence of kidney secondary malignant neoplasm of lung encounter for antineoplastic immunotherapy acute kidney failure, unspecified unspecified essential hypertension toxic encephalopathy hypocalcemia secondary malignant neoplasm of other specified sites asthma, unspecified type, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use thrombocytopenia, unspecified unspecified essential hypertension asthma, unspecified type, unspecified secondary malignant neoplasm of lung secondary malignant neoplasm of other specified sites secondary malignant neoplasm of other urinary organs malignant neoplasm of kidney, except pelvis acute kidney failure, unspecified other and unspecified hyperlipidemia personal history of tobacco use 
white m 65 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  101  mg dl; chemistry blood lactate dehydrogenase (ld)  191  iu l; chemistry blood albumin  3.0  g dl$0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  250  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; hydroxyzine  50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; sw  150  ml ; sw  200  ml ; heparin flush (10 units ml)  1  ml ; 5% dextrose  50  ml ; aldesleukin  54  million units ; ranitidine  150  mg ; cephalexin  500  mg ; oxycodone (immediate release)   5-10  mg ; 
asthma, unspecified type, unspecified pure hypercholesterolemia unspecified sinusitis (chronic) other specified pruritic conditions hyposmolality and/or hyponatremia hypovolemia malignant neoplasm of kidney, except pelvis diarrhea acidosis encounter for antineoplastic immunotherapy acute kidney failure, unspecified secondary malignant neoplasm of other specified sites hallucinations secondary malignant neoplasm of lung antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use toxic encephalopathy unspecified hemorrhoids without mention of complication other shock without mention of trauma dermatitis due to drugs and medicines taken internally delirium due to conditions classified elsewhere nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acidosis pure hypercholesterolemia malignant neoplasm of kidney, except pelvis other specified anemias acquired absence of kidney secondary malignant neoplasm of lung encounter for antineoplastic immunotherapy acute kidney failure, unspecified unspecified essential hypertension toxic encephalopathy hypocalcemia secondary malignant neoplasm of other specified sites asthma, unspecified type, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use thrombocytopenia, unspecified unspecified essential hypertension asthma, unspecified type, unspecified secondary malignant neoplasm of lung secondary malignant neoplasm of other specified sites secondary malignant neoplasm of other urinary organs malignant neoplasm of kidney, except pelvis acute kidney failure, unspecified other and unspecified hyperlipidemia personal history of tobacco use 
white m 65 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  103  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  102  mg dl; chemistry blood albumin  2.8  g dl$0.9% sodium chloride  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; hydroxyzine  50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; sw  150  ml ; sw  200  ml ; heparin flush (10 units ml)  1  ml ; 5% dextrose  50  ml ; aldesleukin  54  million units ; ranitidine  150  mg ; cephalexin  500  mg ; oxycodone (immediate release)   5-10  mg ; 
asthma, unspecified type, unspecified pure hypercholesterolemia unspecified sinusitis (chronic) other specified pruritic conditions hyposmolality and/or hyponatremia hypovolemia malignant neoplasm of kidney, except pelvis diarrhea acidosis encounter for antineoplastic immunotherapy acute kidney failure, unspecified secondary malignant neoplasm of other specified sites hallucinations secondary malignant neoplasm of lung antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use toxic encephalopathy unspecified hemorrhoids without mention of complication other shock without mention of trauma dermatitis due to drugs and medicines taken internally delirium due to conditions classified elsewhere nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acidosis pure hypercholesterolemia malignant neoplasm of kidney, except pelvis other specified anemias acquired absence of kidney secondary malignant neoplasm of lung encounter for antineoplastic immunotherapy acute kidney failure, unspecified unspecified essential hypertension toxic encephalopathy hypocalcemia secondary malignant neoplasm of other specified sites asthma, unspecified type, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use thrombocytopenia, unspecified unspecified essential hypertension asthma, unspecified type, unspecified secondary malignant neoplasm of lung secondary malignant neoplasm of other specified sites secondary malignant neoplasm of other urinary organs malignant neoplasm of kidney, except pelvis acute kidney failure, unspecified other and unspecified hyperlipidemia personal history of tobacco use 
white m 65 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  89  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  100  mg dl; chemistry blood albumin  2.5  g dl$0.9% sodium chloride  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; hydroxyzine  50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; sw  150  ml ; sw  200  ml ; heparin flush (10 units ml)  1  ml ; 5% dextrose  50  ml ; aldesleukin  54  million units ; ranitidine  150  mg ; cephalexin  500  mg ; oxycodone (immediate release)   5-10  mg ; 
asthma, unspecified type, unspecified pure hypercholesterolemia unspecified sinusitis (chronic) other specified pruritic conditions hyposmolality and/or hyponatremia hypovolemia malignant neoplasm of kidney, except pelvis diarrhea acidosis encounter for antineoplastic immunotherapy acute kidney failure, unspecified secondary malignant neoplasm of other specified sites hallucinations secondary malignant neoplasm of lung antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use toxic encephalopathy unspecified hemorrhoids without mention of complication other shock without mention of trauma dermatitis due to drugs and medicines taken internally delirium due to conditions classified elsewhere nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acidosis pure hypercholesterolemia malignant neoplasm of kidney, except pelvis other specified anemias acquired absence of kidney secondary malignant neoplasm of lung encounter for antineoplastic immunotherapy acute kidney failure, unspecified unspecified essential hypertension toxic encephalopathy hypocalcemia secondary malignant neoplasm of other specified sites asthma, unspecified type, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use thrombocytopenia, unspecified unspecified essential hypertension asthma, unspecified type, unspecified secondary malignant neoplasm of lung secondary malignant neoplasm of other specified sites secondary malignant neoplasm of other urinary organs malignant neoplasm of kidney, except pelvis acute kidney failure, unspecified other and unspecified hyperlipidemia personal history of tobacco use 
white m 65 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  96  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  104  mg dl; chemistry blood albumin  2.7  g dl$0.9% sodium chloride  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; hydroxyzine  50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; sw  150  ml ; sw  200  ml ; heparin flush (10 units ml)  1  ml ; 5% dextrose  50  ml ; aldesleukin  54  million units ; ranitidine  150  mg ; cephalexin  500  mg ; oxycodone (immediate release)   5-10  mg ; 
asthma, unspecified type, unspecified pure hypercholesterolemia unspecified sinusitis (chronic) other specified pruritic conditions hyposmolality and/or hyponatremia hypovolemia malignant neoplasm of kidney, except pelvis diarrhea acidosis encounter for antineoplastic immunotherapy acute kidney failure, unspecified secondary malignant neoplasm of other specified sites hallucinations secondary malignant neoplasm of lung antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use toxic encephalopathy unspecified hemorrhoids without mention of complication other shock without mention of trauma dermatitis due to drugs and medicines taken internally delirium due to conditions classified elsewhere nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acidosis pure hypercholesterolemia malignant neoplasm of kidney, except pelvis other specified anemias acquired absence of kidney secondary malignant neoplasm of lung encounter for antineoplastic immunotherapy acute kidney failure, unspecified unspecified essential hypertension toxic encephalopathy hypocalcemia secondary malignant neoplasm of other specified sites asthma, unspecified type, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use thrombocytopenia, unspecified unspecified essential hypertension asthma, unspecified type, unspecified secondary malignant neoplasm of lung secondary malignant neoplasm of other specified sites secondary malignant neoplasm of other urinary organs malignant neoplasm of kidney, except pelvis acute kidney failure, unspecified other and unspecified hyperlipidemia personal history of tobacco use 
white m 65 $nan$nan$sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; hydroxyzine  50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; sw  150  ml ; sw  200  ml ; heparin flush (10 units ml)  1  ml ; 5% dextrose  50  ml ; aldesleukin  54  million units ; ranitidine  150  mg ; cephalexin  500  mg ; oxycodone (immediate release)   5-10  mg ; 
asthma, unspecified type, unspecified pure hypercholesterolemia unspecified sinusitis (chronic) other specified pruritic conditions hyposmolality and/or hyponatremia hypovolemia malignant neoplasm of kidney, except pelvis diarrhea acidosis encounter for antineoplastic immunotherapy acute kidney failure, unspecified secondary malignant neoplasm of other specified sites hallucinations secondary malignant neoplasm of lung antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use toxic encephalopathy unspecified hemorrhoids without mention of complication other shock without mention of trauma dermatitis due to drugs and medicines taken internally delirium due to conditions classified elsewhere nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acidosis pure hypercholesterolemia malignant neoplasm of kidney, except pelvis other specified anemias acquired absence of kidney secondary malignant neoplasm of lung encounter for antineoplastic immunotherapy acute kidney failure, unspecified unspecified essential hypertension toxic encephalopathy hypocalcemia secondary malignant neoplasm of other specified sites asthma, unspecified type, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use thrombocytopenia, unspecified unspecified essential hypertension asthma, unspecified type, unspecified secondary malignant neoplasm of lung secondary malignant neoplasm of other specified sites secondary malignant neoplasm of other urinary organs malignant neoplasm of kidney, except pelvis acute kidney failure, unspecified other and unspecified hyperlipidemia personal history of tobacco use 
white m 48 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; lorazepam  1-2  mg ; ibuprofen  600  mg ; 
 
white f 91 $temp    heartrate  67.0  resprate  18.0  o2sat  94.0  sbp  144.0  dbp  75.0  rhythm    pain  0  $hematology blood hematocrit  26.9  %; hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  458  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  86  mg dl$acetaminophen  1000  mg ; acetaminophen  975  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; senna  1  tab ; oxycodone (immediate release)   2.5-5  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; labetalol  200  mg ; valsartan  160  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; pravastatin  10  mg ; vitamin d  800  unit ; psyllium  1  pkt ; 
do not resuscitate status coronary atherosclerosis of native coronary artery infectious diarrhea history of fall unspecified essential hypertension hypovolemia intestinal infection due to other organism, not elsewhere classified unspecified psychosis hyposmolality and/or hyponatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other and unspecified hyperlipidemia anemia, unspecified
white f 91 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  438  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood calcium, total  8.2  mg dl$acetaminophen  1000  mg ; acetaminophen  975  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; oxycodone (immediate release)   2.5-5  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; labetalol  200  mg ; valsartan  160  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; pravastatin  10  mg ; vitamin d  800  unit ; psyllium  1  pkt ; 
do not resuscitate status coronary atherosclerosis of native coronary artery infectious diarrhea history of fall unspecified essential hypertension hypovolemia intestinal infection due to other organism, not elsewhere classified unspecified psychosis hyposmolality and/or hyponatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other and unspecified hyperlipidemia anemia, unspecified
white f 91 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  502  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood calcium, total  8.3  mg dl$acetaminophen  1000  mg ; acetaminophen  975  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; oxycodone (immediate release)   2.5-5  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; labetalol  200  mg ; valsartan  160  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; pravastatin  10  mg ; vitamin d  800  unit ; psyllium  1  pkt ; 
do not resuscitate status coronary atherosclerosis of native coronary artery infectious diarrhea history of fall unspecified essential hypertension hypovolemia intestinal infection due to other organism, not elsewhere classified unspecified psychosis hyposmolality and/or hyponatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other and unspecified hyperlipidemia anemia, unspecified
white f 91 $nan$nan$acetaminophen  1000  mg ; acetaminophen  975  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; oxycodone (immediate release)   2.5-5  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; labetalol  200  mg ; valsartan  160  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; pravastatin  10  mg ; vitamin d  800  unit ; psyllium  1  pkt ; 
do not resuscitate status coronary atherosclerosis of native coronary artery infectious diarrhea history of fall unspecified essential hypertension hypovolemia intestinal infection due to other organism, not elsewhere classified unspecified psychosis hyposmolality and/or hyponatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other and unspecified hyperlipidemia anemia, unspecified
white m 64 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  236  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  147  mg dl$insulin pump (self administering medication)     ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; heparin  5000  unit ; atenolol  25  mg ; atorvastatin  40  mg ; losartan potassium  25  mg ; trazodone  25  mg ; metformin (glucophage)  1000  mg ; metronidazole  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; 
acquired absence of right great toe acquired absence of other right toe(s) essential (primary) hypertension peripheral vascular disease, unspecified cellulitis of left lower limb presence of insulin pump (external) (internal) long term (current) use of insulin type 1 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of left foot with unspecified severity type 1 diabetes mellitus with hyperglycemia type 1 diabetes mellitus with diabetic neuropathy, unspecified long-term (current) use of antiplatelet/antithrombotic peripheral vascular disease, unspecified long-term (current) use of aspirin hyperpotassemia knee joint replacement other toe(s) amputation status great toe amputation status cellulitis and abscess of toe, unspecified diabetes with unspecified complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia long-term (current) use of insulin unspecified essential hypertension long-term (current) use of insulin cellulitis and abscess of toe, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified peripheral vascular diseases other toe(s) amputation status polyneuropathy in diabetes unspecified essential hypertension blister of foot and toe(s), infected diabetes with neurological manifestations, type i [juvenile type], uncontrolled insulin pump status diabetes with peripheral circulatory disorders, type i [juvenile type], uncontrolled unspecified accident pure hypercholesterolemia peripheral vascular disease, unspecified other toe(s) amputation status knee joint replacement 
white m 64 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  109  mg dl$insulin pump (self administering medication)     ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; heparin  5000  unit ; atenolol  25  mg ; atorvastatin  40  mg ; losartan potassium  25  mg ; trazodone  25  mg ; metformin (glucophage)  1000  mg ; metronidazole  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; 
acquired absence of right great toe acquired absence of other right toe(s) essential (primary) hypertension peripheral vascular disease, unspecified cellulitis of left lower limb presence of insulin pump (external) (internal) long term (current) use of insulin type 1 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of left foot with unspecified severity type 1 diabetes mellitus with hyperglycemia type 1 diabetes mellitus with diabetic neuropathy, unspecified long-term (current) use of antiplatelet/antithrombotic peripheral vascular disease, unspecified long-term (current) use of aspirin hyperpotassemia knee joint replacement other toe(s) amputation status great toe amputation status cellulitis and abscess of toe, unspecified diabetes with unspecified complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia long-term (current) use of insulin unspecified essential hypertension long-term (current) use of insulin cellulitis and abscess of toe, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified peripheral vascular diseases other toe(s) amputation status polyneuropathy in diabetes unspecified essential hypertension blister of foot and toe(s), infected diabetes with neurological manifestations, type i [juvenile type], uncontrolled insulin pump status diabetes with peripheral circulatory disorders, type i [juvenile type], uncontrolled unspecified accident pure hypercholesterolemia peripheral vascular disease, unspecified other toe(s) amputation status knee joint replacement 
white m 64 $nan$hematology blood hematocrit  37.3  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  143  mg dl$insulin pump (self administering medication)     ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; heparin  5000  unit ; atenolol  25  mg ; atorvastatin  40  mg ; losartan potassium  25  mg ; trazodone  25  mg ; metformin (glucophage)  1000  mg ; metronidazole  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; magnesium oxide  400  mg ; 
acquired absence of right great toe acquired absence of other right toe(s) essential (primary) hypertension peripheral vascular disease, unspecified cellulitis of left lower limb presence of insulin pump (external) (internal) long term (current) use of insulin type 1 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of left foot with unspecified severity type 1 diabetes mellitus with hyperglycemia type 1 diabetes mellitus with diabetic neuropathy, unspecified long-term (current) use of antiplatelet/antithrombotic peripheral vascular disease, unspecified long-term (current) use of aspirin hyperpotassemia knee joint replacement other toe(s) amputation status great toe amputation status cellulitis and abscess of toe, unspecified diabetes with unspecified complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia long-term (current) use of insulin unspecified essential hypertension long-term (current) use of insulin cellulitis and abscess of toe, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified peripheral vascular diseases other toe(s) amputation status polyneuropathy in diabetes unspecified essential hypertension blister of foot and toe(s), infected diabetes with neurological manifestations, type i [juvenile type], uncontrolled insulin pump status diabetes with peripheral circulatory disorders, type i [juvenile type], uncontrolled unspecified accident pure hypercholesterolemia peripheral vascular disease, unspecified other toe(s) amputation status knee joint replacement 
white m 64 $nan$hematology blood hematocrit  37.7  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  280  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  118  mg dl$insulin pump (self administering medication)     ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; heparin  5000  unit ; atenolol  25  mg ; atorvastatin  40  mg ; losartan potassium  25  mg ; trazodone  25  mg ; metformin (glucophage)  1000  mg ; metronidazole  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; magnesium oxide  400  mg ; bag  1  bag ; magnesium sulfate  4  gm ; 
acquired absence of right great toe acquired absence of other right toe(s) essential (primary) hypertension peripheral vascular disease, unspecified cellulitis of left lower limb presence of insulin pump (external) (internal) long term (current) use of insulin type 1 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of left foot with unspecified severity type 1 diabetes mellitus with hyperglycemia type 1 diabetes mellitus with diabetic neuropathy, unspecified long-term (current) use of antiplatelet/antithrombotic peripheral vascular disease, unspecified long-term (current) use of aspirin hyperpotassemia knee joint replacement other toe(s) amputation status great toe amputation status cellulitis and abscess of toe, unspecified diabetes with unspecified complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia long-term (current) use of insulin unspecified essential hypertension long-term (current) use of insulin cellulitis and abscess of toe, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified peripheral vascular diseases other toe(s) amputation status polyneuropathy in diabetes unspecified essential hypertension blister of foot and toe(s), infected diabetes with neurological manifestations, type i [juvenile type], uncontrolled insulin pump status diabetes with peripheral circulatory disorders, type i [juvenile type], uncontrolled unspecified accident pure hypercholesterolemia peripheral vascular disease, unspecified other toe(s) amputation status knee joint replacement 
white m 64 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  271  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  100  mg dl$insulin pump (self administering medication)     ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; heparin  5000  unit ; atenolol  25  mg ; atorvastatin  40  mg ; losartan potassium  25  mg ; trazodone  25  mg ; metformin (glucophage)  1000  mg ; metronidazole  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; bag  1  bag ; magnesium sulfate  4  gm ; 
acquired absence of right great toe acquired absence of other right toe(s) essential (primary) hypertension peripheral vascular disease, unspecified cellulitis of left lower limb presence of insulin pump (external) (internal) long term (current) use of insulin type 1 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of left foot with unspecified severity type 1 diabetes mellitus with hyperglycemia type 1 diabetes mellitus with diabetic neuropathy, unspecified long-term (current) use of antiplatelet/antithrombotic peripheral vascular disease, unspecified long-term (current) use of aspirin hyperpotassemia knee joint replacement other toe(s) amputation status great toe amputation status cellulitis and abscess of toe, unspecified diabetes with unspecified complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia long-term (current) use of insulin unspecified essential hypertension long-term (current) use of insulin cellulitis and abscess of toe, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified peripheral vascular diseases other toe(s) amputation status polyneuropathy in diabetes unspecified essential hypertension blister of foot and toe(s), infected diabetes with neurological manifestations, type i [juvenile type], uncontrolled insulin pump status diabetes with peripheral circulatory disorders, type i [juvenile type], uncontrolled unspecified accident pure hypercholesterolemia peripheral vascular disease, unspecified other toe(s) amputation status knee joint replacement 
white m 64 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  285  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  245  mg dl$insulin pump (self administering medication)     ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; heparin  5000  unit ; atenolol  25  mg ; atorvastatin  40  mg ; losartan potassium  25  mg ; trazodone  25  mg ; metformin (glucophage)  1000  mg ; metronidazole  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; 
acquired absence of right great toe acquired absence of other right toe(s) essential (primary) hypertension peripheral vascular disease, unspecified cellulitis of left lower limb presence of insulin pump (external) (internal) long term (current) use of insulin type 1 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of left foot with unspecified severity type 1 diabetes mellitus with hyperglycemia type 1 diabetes mellitus with diabetic neuropathy, unspecified long-term (current) use of antiplatelet/antithrombotic peripheral vascular disease, unspecified long-term (current) use of aspirin hyperpotassemia knee joint replacement other toe(s) amputation status great toe amputation status cellulitis and abscess of toe, unspecified diabetes with unspecified complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia long-term (current) use of insulin unspecified essential hypertension long-term (current) use of insulin cellulitis and abscess of toe, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified peripheral vascular diseases other toe(s) amputation status polyneuropathy in diabetes unspecified essential hypertension blister of foot and toe(s), infected diabetes with neurological manifestations, type i [juvenile type], uncontrolled insulin pump status diabetes with peripheral circulatory disorders, type i [juvenile type], uncontrolled unspecified accident pure hypercholesterolemia peripheral vascular disease, unspecified other toe(s) amputation status knee joint replacement 
white m 64 $nan$hematology blood hematocrit  37.3  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  288  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  59  mg dl$insulin pump (self administering medication)     ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; heparin  5000  unit ; atenolol  25  mg ; atorvastatin  40  mg ; losartan potassium  25  mg ; trazodone  25  mg ; metformin (glucophage)  1000  mg ; metronidazole  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; 
acquired absence of right great toe acquired absence of other right toe(s) essential (primary) hypertension peripheral vascular disease, unspecified cellulitis of left lower limb presence of insulin pump (external) (internal) long term (current) use of insulin type 1 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of left foot with unspecified severity type 1 diabetes mellitus with hyperglycemia type 1 diabetes mellitus with diabetic neuropathy, unspecified long-term (current) use of antiplatelet/antithrombotic peripheral vascular disease, unspecified long-term (current) use of aspirin hyperpotassemia knee joint replacement other toe(s) amputation status great toe amputation status cellulitis and abscess of toe, unspecified diabetes with unspecified complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia long-term (current) use of insulin unspecified essential hypertension long-term (current) use of insulin cellulitis and abscess of toe, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified peripheral vascular diseases other toe(s) amputation status polyneuropathy in diabetes unspecified essential hypertension blister of foot and toe(s), infected diabetes with neurological manifestations, type i [juvenile type], uncontrolled insulin pump status diabetes with peripheral circulatory disorders, type i [juvenile type], uncontrolled unspecified accident pure hypercholesterolemia peripheral vascular disease, unspecified other toe(s) amputation status knee joint replacement 
white m 64 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  263  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  224  mg dl$insulin pump (self administering medication)     ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; heparin  5000  unit ; atenolol  25  mg ; atorvastatin  40  mg ; losartan potassium  25  mg ; trazodone  25  mg ; metformin (glucophage)  1000  mg ; metronidazole  500  mg ; ciprofloxacin hcl  500  mg ; 
acquired absence of right great toe acquired absence of other right toe(s) essential (primary) hypertension peripheral vascular disease, unspecified cellulitis of left lower limb presence of insulin pump (external) (internal) long term (current) use of insulin type 1 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of left foot with unspecified severity type 1 diabetes mellitus with hyperglycemia type 1 diabetes mellitus with diabetic neuropathy, unspecified long-term (current) use of antiplatelet/antithrombotic peripheral vascular disease, unspecified long-term (current) use of aspirin hyperpotassemia knee joint replacement other toe(s) amputation status great toe amputation status cellulitis and abscess of toe, unspecified diabetes with unspecified complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia long-term (current) use of insulin unspecified essential hypertension long-term (current) use of insulin cellulitis and abscess of toe, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified peripheral vascular diseases other toe(s) amputation status polyneuropathy in diabetes unspecified essential hypertension blister of foot and toe(s), infected diabetes with neurological manifestations, type i [juvenile type], uncontrolled insulin pump status diabetes with peripheral circulatory disorders, type i [juvenile type], uncontrolled unspecified accident pure hypercholesterolemia peripheral vascular disease, unspecified other toe(s) amputation status knee joint replacement 
white m 64 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  140  mg dl$insulin pump (self administering medication)     ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; heparin  5000  unit ; atenolol  25  mg ; atorvastatin  40  mg ; losartan potassium  25  mg ; trazodone  25  mg ; metformin (glucophage)  1000  mg ; metronidazole  500  mg ; ciprofloxacin hcl  500  mg ; 
acquired absence of right great toe acquired absence of other right toe(s) essential (primary) hypertension peripheral vascular disease, unspecified cellulitis of left lower limb presence of insulin pump (external) (internal) long term (current) use of insulin type 1 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of left foot with unspecified severity type 1 diabetes mellitus with hyperglycemia type 1 diabetes mellitus with diabetic neuropathy, unspecified long-term (current) use of antiplatelet/antithrombotic peripheral vascular disease, unspecified long-term (current) use of aspirin hyperpotassemia knee joint replacement other toe(s) amputation status great toe amputation status cellulitis and abscess of toe, unspecified diabetes with unspecified complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia long-term (current) use of insulin unspecified essential hypertension long-term (current) use of insulin cellulitis and abscess of toe, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified peripheral vascular diseases other toe(s) amputation status polyneuropathy in diabetes unspecified essential hypertension blister of foot and toe(s), infected diabetes with neurological manifestations, type i [juvenile type], uncontrolled insulin pump status diabetes with peripheral circulatory disorders, type i [juvenile type], uncontrolled unspecified accident pure hypercholesterolemia peripheral vascular disease, unspecified other toe(s) amputation status knee joint replacement 
white m 48 $nan$nan$duloxetine  90  mg ; lamotrigine  400  mg ; 
 
white m 48 $nan$nan$duloxetine  90  mg ; lamotrigine  400  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; clonazepam  1  mg ; hydromorphone (dilaudid)  0.5  mg ; acetaminophen  1000  mg ; bisacodyl  10  mg ; senna  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; docusate sodium  100  mg ; quetiapine extended-release  400  mg ; quetiapine fumarate  50  mg ; omeprazole  20  mg ; ranitidine  75  mg ; simvastatin  10  mg ; 
 
white m 48 $nan$nan$duloxetine  90  mg ; lamotrigine  400  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; clonazepam  1  mg ; hydromorphone (dilaudid)  0.5  mg ; acetaminophen  1000  mg ; bisacodyl  10  mg ; senna  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; docusate sodium  100  mg ; omeprazole  20  mg ; ranitidine  75  mg ; simvastatin  10  mg ; oxycodone-acetaminophen  1  tab ; diphenhydramine  25  mg ; quetiapine fumarate  400  mg ; 
 
white m 48 $nan$nan$duloxetine  90  mg ; lamotrigine  400  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; clonazepam  1  mg ; acetaminophen  1000  mg ; bisacodyl  10  mg ; senna  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; docusate sodium  100  mg ; omeprazole  20  mg ; ranitidine  75  mg ; simvastatin  10  mg ; oxycodone-acetaminophen  1  tab ; diphenhydramine  25  mg ; quetiapine fumarate  400  mg ; 
 
white m 47 $nan$nan$divalproex (extended release)  1000  mg ; divalproex (extended release)  250  mg ; omeprazole  20  mg ; oxcarbazepine  600  mg ; 
tobacco use disorder atrial flutter herpes simplex with other specified complications unspecified episodic mood disorder localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy retention of urine, unspecified atrial fibrillation 
white m 47 $nan$hematology blood hematocrit  39.5  %; hematology blood hematocrit  38.9  %; hematology blood hematocrit  38.7  %; hematology blood hemoglobin  13.2  g dl; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  175  k ul; hematology blood platelet count  186  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  122  mg dl; chemistry blood glucose  114  mg dl; blood gas blood free calcium  1.12  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood chloride, whole blood  96  meq l; blood gas blood glucose  118  mg dl; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood sodium, whole blood  132  meq l$iso-osmotic dextrose  50  ml ; cefazolin  1  g ; divalproex (extended release)  1000  mg ; divalproex (extended release)  250  mg ; omeprazole  20  mg ; oxcarbazepine  600  mg ; sodium chloride 0.9%  flush  3  ml ; clonazepam  1  mg ; divalproex (extended release)  1500  mg ; lorazepam  0.5-1  mg ; oxycodone (immediate release)   5  mg ; lorazepam  1-2  mg ; metoprolol tartrate  10  mg ; 0.9% sodium chloride  1000  ml ; diazepam  5  mg ; 0.9% sodium chloride  500  ml ; metoprolol tartrate  12.5  mg ; furosemide  10  mg ; diltiazem  30  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; cosyntropin  250  mcg ; acetaminophen  325-650  mg ; heparin  5000  unit ; furosemide  20  mg ; albuterol inhaler  2  puff ; lorazepam  1  mg ; lorazepam  4  mg ; haloperidol  10  mg ; 
tobacco use disorder atrial flutter herpes simplex with other specified complications unspecified episodic mood disorder localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy retention of urine, unspecified atrial fibrillation 
white m 47 $nan$hematology blood hematocrit  38.4  %; hematology blood hematocrit  40.2  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  96  mg dl$iso-osmotic dextrose  50  ml ; cefazolin  1  g ; divalproex (extended release)  1000  mg ; divalproex (extended release)  250  mg ; omeprazole  20  mg ; oxcarbazepine  600  mg ; clonazepam  1  mg ; divalproex (extended release)  1500  mg ; lorazepam  0.5-1  mg ; oxycodone (immediate release)   5  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; acetaminophen  325-650  mg ; furosemide  20  mg ; albuterol inhaler  2  puff ; lorazepam  4  mg ; haloperidol  10  mg ; metoprolol tartrate  5  mg ; valproate sodium  1250  mg ; haloperidol  5  mg ; potassium chloride (powder)  40  meq ; bag  100  ml ; magnesium sulfate  4  gm ; 
tobacco use disorder atrial flutter herpes simplex with other specified complications unspecified episodic mood disorder localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy retention of urine, unspecified atrial fibrillation 
white m 47 $nan$hematology blood hematocrit  39.3  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  79  mg dl$divalproex (extended release)  1000  mg ; omeprazole  20  mg ; oxcarbazepine  600  mg ; clonazepam  1  mg ; divalproex (extended release)  1500  mg ; lorazepam  0.5-1  mg ; oxycodone (immediate release)   5  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; acetaminophen  325-650  mg ; albuterol inhaler  2  puff ; metoprolol tartrate  5  mg ; valproate sodium  1250  mg ; haloperidol  5  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; metoprolol tartrate  25  mg ; diazepam  5-10  mg ; 
tobacco use disorder atrial flutter herpes simplex with other specified complications unspecified episodic mood disorder localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy retention of urine, unspecified atrial fibrillation 
white m 47 $nan$hematology blood hematocrit  42.9  %; hematology blood hemoglobin  15.1  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  78  mg dl; chemistry blood lactate dehydrogenase (ld)  284  iu l$divalproex (extended release)  1000  mg ; omeprazole  20  mg ; oxcarbazepine  600  mg ; clonazepam  1  mg ; divalproex (extended release)  1500  mg ; lorazepam  0.5-1  mg ; oxycodone (immediate release)   5  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; acetaminophen  325-650  mg ; albuterol inhaler  2  puff ; valproate sodium  1250  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; diazepam  5-10  mg ; metoprolol tartrate  37.5  mg ; nicotine patch  14  mg ; metoprolol tartrate  50  mg ; 
tobacco use disorder atrial flutter herpes simplex with other specified complications unspecified episodic mood disorder localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy retention of urine, unspecified atrial fibrillation 
white m 47 $nan$hematology blood hematocrit  38.3  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  110  mg dl$divalproex (extended release)  1000  mg ; omeprazole  20  mg ; oxcarbazepine  600  mg ; divalproex (extended release)  1500  mg ; lorazepam  0.5-1  mg ; oxycodone (immediate release)   5  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; acetaminophen  325-650  mg ; albuterol inhaler  2  puff ; nicotine patch  14  mg ; metoprolol tartrate  50  mg ; heparin  1000-2000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; 0.9% sodium chloride  100  ml ; 
tobacco use disorder atrial flutter herpes simplex with other specified complications unspecified episodic mood disorder localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy retention of urine, unspecified atrial fibrillation 
white m 47 $nan$hematology blood hematocrit  37.7  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  10.7  mg dl; chemistry blood glucose  187  mg dl$omeprazole  20  mg ; oxcarbazepine  600  mg ; divalproex (extended release)  1500  mg ; lorazepam  0.5-1  mg ; oxycodone (immediate release)   5  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; acetaminophen  325-650  mg ; albuterol inhaler  2  puff ; nicotine patch  14  mg ; metoprolol tartrate  50  mg ; heparin  1000-2000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; potassium chloride  20  meq ; bag  50  ml ; magnesium sulfate  2  gm ; 
tobacco use disorder atrial flutter herpes simplex with other specified complications unspecified episodic mood disorder localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy retention of urine, unspecified atrial fibrillation 
white m 47 $nan$hematology blood hematocrit  38.3  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  98  mg dl$omeprazole  20  mg ; oxcarbazepine  600  mg ; divalproex (extended release)  1500  mg ; lorazepam  0.5-1  mg ; oxycodone (immediate release)   5  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; acetaminophen  325-650  mg ; albuterol inhaler  2  puff ; nicotine patch  14  mg ; heparin  1000-2000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; diltiazem  10  mg ; diltiazem  15  mg ; 5% dextrose  100  ml ; diltiazem  125  mg ; 
tobacco use disorder atrial flutter herpes simplex with other specified complications unspecified episodic mood disorder localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy retention of urine, unspecified atrial fibrillation 
white m 47 $nan$hematology blood hematocrit  40.3  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  94  mg dl$omeprazole  20  mg ; oxcarbazepine  600  mg ; divalproex (extended release)  1500  mg ; lorazepam  0.5-1  mg ; oxycodone (immediate release)   5  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; acetaminophen  325-650  mg ; albuterol inhaler  2  puff ; nicotine patch  14  mg ; heparin  1000-2000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; diltiazem  10  mg ; diltiazem  15  mg ; 5% dextrose  100  ml ; diltiazem  125  mg ; 
tobacco use disorder atrial flutter herpes simplex with other specified complications unspecified episodic mood disorder localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy retention of urine, unspecified atrial fibrillation 
white m 47 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  236  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  105  mg dl$omeprazole  20  mg ; oxcarbazepine  600  mg ; lorazepam  0.5-1  mg ; oxycodone (immediate release)   5  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; acetaminophen  325-650  mg ; albuterol inhaler  2  puff ; nicotine patch  14  mg ; heparin  1000-2000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; diltiazem extended-release  120  mg ; warfarin  5  mg ; senna  1  tab ; docusate sodium  100  mg ; polyethylene glycol  17  g ; 
tobacco use disorder atrial flutter herpes simplex with other specified complications unspecified episodic mood disorder localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy retention of urine, unspecified atrial fibrillation 
white m 47 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  109  mg dl$omeprazole  20  mg ; oxcarbazepine  600  mg ; lorazepam  0.5-1  mg ; oxycodone (immediate release)   5  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; acetaminophen  325-650  mg ; albuterol inhaler  2  puff ; nicotine patch  14  mg ; heparin  1000-2000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; diltiazem extended-release  120  mg ; warfarin  5  mg ; senna  1  tab ; docusate sodium  100  mg ; polyethylene glycol  17  g ; zolpidem tartrate  5  mg ; warfarin  2.5  mg ; enoxaparin sodium  100  mg ; 
tobacco use disorder atrial flutter herpes simplex with other specified complications unspecified episodic mood disorder localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy retention of urine, unspecified atrial fibrillation 
white m 47 $nan$nan$omeprazole  20  mg ; oxcarbazepine  600  mg ; lorazepam  0.5-1  mg ; oxycodone (immediate release)   5  mg ; multivitamins  1  tab ; thiamine  100  mg ; folic acid  1  mg ; acetaminophen  325-650  mg ; albuterol inhaler  2  puff ; nicotine patch  14  mg ; diltiazem extended-release  120  mg ; senna  1  tab ; docusate sodium  100  mg ; polyethylene glycol  17  g ; zolpidem tartrate  5  mg ; warfarin  2.5  mg ; enoxaparin sodium  100  mg ; 
tobacco use disorder atrial flutter herpes simplex with other specified complications unspecified episodic mood disorder localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy retention of urine, unspecified atrial fibrillation 
other f 55 $temp  98.0  heartrate  71.0  resprate  16.0  o2sat  92.0  sbp  178.0  dbp  90.0  rhythm  sinus rhythm  pain    ; temp    heartrate  69.0  resprate  20.0  o2sat  92.0  sbp  166.0  dbp  88.0  rhythm  sinus rhythm  pain  0  ; temp  98.1  heartrate  62.0  resprate  17.0  o2sat  92.0  sbp  185.0  dbp  93.0  rhythm  sinus rhythm  pain  10  $nan$methadone  60  mg ; 
 
other f 55 $temp  97.4  heartrate  64.0  resprate  15.0  o2sat  99.0  sbp  182.0  dbp  87.0  rhythm  sinus rhythm  pain  2  $hematology blood hematocrit  38.7  %; hematology blood hematocrit  41.6  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  43  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  104  mg dl$methadone  60  mg ; dapsone  100  mg ; emtricitabine-tenofovir (truvada)  1  tab ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; vial  1  vial ; pantoprazole  40  mg ; 0.9% sodium chloride  100  ml ; octreotide acetate  600  mcg ; hydromorphone (dilaudid)  1  mg ; hydromorphone (dilaudid)  0.5  mg ; azithromycin  1200  mg ; alprazolam  1  mg ; albuterol inhaler  2  puff ; methadone  50  mg ; darunavir  600  mg ; etravirine  200  mg ; ritonavir  100  mg ; raltegravir  400  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.5-1  mg ; 
 
other f 55 $nan$hematology blood hematocrit  42.2  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  34  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  3.6  mg dl; chemistry blood glucose  87  mg dl; chemistry blood albumin  3.1  g dl$methadone  60  mg ; dapsone  100  mg ; emtricitabine-tenofovir (truvada)  1  tab ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; azithromycin  1200  mg ; alprazolam  1  mg ; albuterol inhaler  2  puff ; darunavir  600  mg ; etravirine  200  mg ; ritonavir  100  mg ; raltegravir  400  mg ; sodium chloride 0.9%  flush  3  ml ; spironolactone  50  mg ; diazepam  10  mg ; hydromorphone (dilaudid)  2-4  mg ; anastrozole  1  mg ; spironolactone  100  mg ; furosemide  40  mg ; nadolol  20  mg ; hydromorphone (dilaudid)  2  mg ; lactulose  15-30  ml ; methadone  40  mg ; neutra-phos  2  pkt ; bag  50  ml ; magnesium sulfate  2  gm ; 
 
other f 55 $nan$hematology blood hematocrit  41.1  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  32  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.6  ; hematology urine wbc  4  # hpf; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  4.2  mg dl; chemistry blood glucose  93  mg dl; chemistry blood albumin  3.2  g dl$dapsone  100  mg ; emtricitabine-tenofovir (truvada)  1  tab ; azithromycin  1200  mg ; albuterol inhaler  2  puff ; darunavir  600  mg ; etravirine  200  mg ; ritonavir  100  mg ; raltegravir  400  mg ; sodium chloride 0.9%  flush  3  ml ; diazepam  10  mg ; anastrozole  1  mg ; spironolactone  100  mg ; furosemide  40  mg ; nadolol  20  mg ; hydromorphone (dilaudid)  2  mg ; lactulose  15-30  ml ; methadone  40  mg ; neutra-phos  2  pkt ; bag  50  ml ; magnesium sulfate  2  gm ; lidocaine 5% patch  2  ptch ; nadolol  40  mg ; 
 
other f 55 $nan$hematology blood hematocrit  38.5  %; hematology blood hematocrit  32.2  %; hematology blood hematocrit  34.2  %; hematology blood hemoglobin  12.8  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  23  k ul; hematology blood platelet count  25  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  2.0  ; hematology urine wbc  4  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  3.0  mg dl; chemistry blood glucose  65  mg dl; chemistry blood lactate dehydrogenase (ld)  349  iu l; chemistry blood albumin  3.8  g dl$dapsone  100  mg ; emtricitabine-tenofovir (truvada)  1  tab ; azithromycin  1200  mg ; albuterol inhaler  2  puff ; darunavir  600  mg ; etravirine  200  mg ; ritonavir  100  mg ; raltegravir  400  mg ; sodium chloride 0.9%  flush  3  ml ; diazepam  10  mg ; anastrozole  1  mg ; spironolactone  100  mg ; furosemide  40  mg ; lactulose  15-30  ml ; methadone  40  mg ; lidocaine 5% patch  2  ptch ; nadolol  40  mg ; potassium chloride  40  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; methadone  30  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; albumin 25% (12.5g   50ml)  25  g ; albumin 25% (12.5g   50ml)  75  g ; acetaminophen iv  500  mg ; lactulose enema  1000  ml ; 
 
other f 55 $nan$hematology blood hematocrit  33.8  %; hematology blood hematocrit  31.7  %; hematology blood hematocrit  31.3  %; hematology blood hematocrit  31.0  %; hematology blood hemoglobin  11.1  g dl; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  21  k ul; hematology blood platelet count  19  k ul; hematology blood platelet count  16  k ul; hematology blood platelet count  18  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  2.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  3.3  mg dl; chemistry blood glucose  90  mg dl$dapsone  100  mg ; emtricitabine-tenofovir (truvada)  1  tab ; azithromycin  1200  mg ; albuterol inhaler  2  puff ; darunavir  600  mg ; etravirine  200  mg ; ritonavir  100  mg ; raltegravir  400  mg ; sodium chloride 0.9%  flush  3  ml ; diazepam  10  mg ; anastrozole  1  mg ; lactulose  15-30  ml ; lidocaine 5% patch  2  ptch ; potassium chloride  40  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; methadone  30  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; albumin 25% (12.5g   50ml)  75  g ; acetaminophen iv  500  mg ; lactulose enema  1000  ml ; potassium chloride  20  meq ; alprazolam  0.5  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; albumin 25% (12.5g   50ml)  50  g ; lactulose  30  ml ; methadone  20  mg ; 
 
other f 55 $nan$hematology blood hematocrit  30.5  %; hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  30  k ul; hematology blood platelet count  39  k ul; hematology blood platelet count  36  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  4.1  mg dl; chemistry blood glucose  140  mg dl; chemistry blood lactate dehydrogenase (ld)  297  iu l$dapsone  100  mg ; emtricitabine-tenofovir (truvada)  1  tab ; azithromycin  1200  mg ; albuterol inhaler  2  puff ; darunavir  600  mg ; etravirine  200  mg ; ritonavir  100  mg ; raltegravir  400  mg ; sodium chloride 0.9%  flush  3  ml ; diazepam  10  mg ; anastrozole  1  mg ; lidocaine 5% patch  2  ptch ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; alprazolam  0.5  mg ; albumin 25% (12.5g   50ml)  50  g ; lactulose  30  ml ; methadone  20  mg ; 
 
other f 55 $nan$hematology blood hematocrit  31.7  %; hematology blood hematocrit  30.5  %; hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  26  k ul; hematology blood platelet count  32  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, indirect  2.9  mg dl; chemistry blood bilirubin, total  3.6  mg dl; chemistry blood bilirubin, total  4.3  mg dl; chemistry blood glucose  140  mg dl; chemistry blood glucose  89  mg dl; chemistry blood lactate dehydrogenase (ld)  271  iu l; chemistry blood albumin  3.6  g dl; hematology blood bands  0  %; chemistry blood bilirubin, direct  1.4  mg dl$dapsone  100  mg ; emtricitabine-tenofovir (truvada)  1  tab ; azithromycin  1200  mg ; albuterol inhaler  2  puff ; darunavir  600  mg ; etravirine  200  mg ; ritonavir  100  mg ; raltegravir  400  mg ; sodium chloride 0.9%  flush  3  ml ; diazepam  10  mg ; anastrozole  1  mg ; lidocaine 5% patch  2  ptch ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; alprazolam  0.5  mg ; lactulose  30  ml ; methadone  20  mg ; multivitamins  1  tab ; folic acid  1  mg ; lactulose  45  ml ; rifaximin  550  mg ; 0.9% sodium chloride  250  ml ; thiamine  500  mg ; methadone  10  mg ; lorazepam  0.5  mg ; 
 
other f 55 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  34  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  3.5  mg dl; chemistry blood glucose  76  mg dl; chemistry blood lactate dehydrogenase (ld)  257  iu l$dapsone  100  mg ; emtricitabine-tenofovir (truvada)  1  tab ; azithromycin  1200  mg ; albuterol inhaler  2  puff ; darunavir  600  mg ; etravirine  200  mg ; ritonavir  100  mg ; raltegravir  400  mg ; sodium chloride 0.9%  flush  3  ml ; anastrozole  1  mg ; lidocaine 5% patch  2  ptch ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; multivitamins  1  tab ; folic acid  1  mg ; lactulose  45  ml ; rifaximin  550  mg ; 0.9% sodium chloride  250  ml ; thiamine  500  mg ; methadone  10  mg ; lorazepam  0.5  mg ; 
 
other f 55 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  44  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  3.7  mg dl; chemistry blood glucose  90  mg dl; chemistry blood lactate dehydrogenase (ld)  245  iu l$dapsone  100  mg ; emtricitabine-tenofovir (truvada)  1  tab ; azithromycin  1200  mg ; albuterol inhaler  2  puff ; darunavir  600  mg ; etravirine  200  mg ; ritonavir  100  mg ; raltegravir  400  mg ; sodium chloride 0.9%  flush  3  ml ; anastrozole  1  mg ; lidocaine 5% patch  2  ptch ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; multivitamins  1  tab ; folic acid  1  mg ; lactulose  45  ml ; rifaximin  550  mg ; 0.9% sodium chloride  250  ml ; thiamine  500  mg ; methadone  10  mg ; lorazepam  0.5  mg ; neutra-phos  1  pkt ; 
 
other f 55 $nan$nan$dapsone  100  mg ; emtricitabine-tenofovir (truvada)  1  tab ; azithromycin  1200  mg ; albuterol inhaler  2  puff ; darunavir  600  mg ; etravirine  200  mg ; ritonavir  100  mg ; raltegravir  400  mg ; sodium chloride 0.9%  flush  3  ml ; anastrozole  1  mg ; lidocaine 5% patch  2  ptch ; multivitamins  1  tab ; folic acid  1  mg ; lactulose  45  ml ; rifaximin  550  mg ; 0.9% sodium chloride  250  ml ; thiamine  500  mg ; methadone  10  mg ; lorazepam  0.5  mg ; 
 
white f 92 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  329  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; docusate sodium  100  mg ; senna  1  tab ; pantoprazole  40  mg ; acetaminophen  1000  mg ; ns  1000  ml ; heparin  5000  unit ; pangestyme-ec  2  cap ; carvedilol  25  mg ; fluticasone propionate nasal  1  spry ; fexofenadine  60  mg ; magnesium sulfate  2  gm ; valsartan  160  mg ; lidocaine 5% patch  1  ptch ; triamterene-hydrochlorothiazide  1  cap ; cyanocobalamin  100  mcg ; lidocaine 5% patch  2  ptch ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other constipation chronic kidney disease, stage iii (moderate) bronchiectasis with acute exacerbation other vitamin b12 deficiency anemia personal history of malignant neoplasm of large intestine chronic pancreatitis congestive heart failure, unspecified anemia, unspecified benign essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of malignant neoplasm of large intestine chronic pancreatitis other malaise and fatigue edema bronchiectasis without acute exacerbation other b-complex deficiencies acute upper respiratory infections of unspecified site hypovolemia 
white f 92 $nan$nan$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; docusate sodium  100  mg ; senna  1  tab ; pantoprazole  40  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; pangestyme-ec  2  cap ; carvedilol  25  mg ; fluticasone propionate nasal  1  spry ; fexofenadine  60  mg ; magnesium sulfate  2  gm ; valsartan  160  mg ; triamterene-hydrochlorothiazide  1  cap ; cyanocobalamin  100  mcg ; lidocaine 5% patch  2  ptch ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other constipation chronic kidney disease, stage iii (moderate) bronchiectasis with acute exacerbation other vitamin b12 deficiency anemia personal history of malignant neoplasm of large intestine chronic pancreatitis congestive heart failure, unspecified anemia, unspecified benign essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of malignant neoplasm of large intestine chronic pancreatitis other malaise and fatigue edema bronchiectasis without acute exacerbation other b-complex deficiencies acute upper respiratory infections of unspecified site hypovolemia 
white f 92 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  337  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  97  mg dl$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; docusate sodium  100  mg ; senna  1  tab ; pantoprazole  40  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; pangestyme-ec  2  cap ; carvedilol  25  mg ; fluticasone propionate nasal  1  spry ; fexofenadine  60  mg ; valsartan  160  mg ; triamterene-hydrochlorothiazide  1  cap ; cyanocobalamin  100  mcg ; lidocaine 5% patch  2  ptch ; ibuprofen  400  mg ; acetaminophen  650  mg ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other constipation chronic kidney disease, stage iii (moderate) bronchiectasis with acute exacerbation other vitamin b12 deficiency anemia personal history of malignant neoplasm of large intestine chronic pancreatitis congestive heart failure, unspecified anemia, unspecified benign essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of malignant neoplasm of large intestine chronic pancreatitis other malaise and fatigue edema bronchiectasis without acute exacerbation other b-complex deficiencies acute upper respiratory infections of unspecified site hypovolemia 
white f 92 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  294  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  110  mg dl$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; docusate sodium  100  mg ; senna  1  tab ; pantoprazole  40  mg ; heparin  5000  unit ; pangestyme-ec  2  cap ; carvedilol  25  mg ; fluticasone propionate nasal  1  spry ; fexofenadine  60  mg ; valsartan  160  mg ; cyanocobalamin  100  mcg ; lidocaine 5% patch  2  ptch ; ibuprofen  400  mg ; acetaminophen  650  mg ; morphine sulfate  0.5-1  mg ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other constipation chronic kidney disease, stage iii (moderate) bronchiectasis with acute exacerbation other vitamin b12 deficiency anemia personal history of malignant neoplasm of large intestine chronic pancreatitis congestive heart failure, unspecified anemia, unspecified benign essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of malignant neoplasm of large intestine chronic pancreatitis other malaise and fatigue edema bronchiectasis without acute exacerbation other b-complex deficiencies acute upper respiratory infections of unspecified site hypovolemia 
white f 92 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  325  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry urine chloride, urine  78  meq l; chemistry urine creatinine, urine  26  mg dl; chemistry urine potassium, urine  22  meq l; chemistry urine sodium, urine  81  meq l; chemistry urine urea nitrogen, urine  330  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  96  mg dl; chemistry blood albumin  3.2  g dl$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; docusate sodium  100  mg ; senna  1  tab ; pantoprazole  40  mg ; heparin  5000  unit ; pangestyme-ec  2  cap ; carvedilol  25  mg ; fluticasone propionate nasal  1  spry ; fexofenadine  60  mg ; valsartan  160  mg ; cyanocobalamin  100  mcg ; lidocaine 5% patch  2  ptch ; acetaminophen  650  mg ; morphine sulfate  0.5-1  mg ; bisacodyl  10  mg ; sodium polystyrene sulfonate  30  gm ; morphine sulfate  0.5  mg ; oxycodone (immediate release)   2.5-5  mg ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other constipation chronic kidney disease, stage iii (moderate) bronchiectasis with acute exacerbation other vitamin b12 deficiency anemia personal history of malignant neoplasm of large intestine chronic pancreatitis congestive heart failure, unspecified anemia, unspecified benign essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of malignant neoplasm of large intestine chronic pancreatitis other malaise and fatigue edema bronchiectasis without acute exacerbation other b-complex deficiencies acute upper respiratory infections of unspecified site hypovolemia 
white f 92 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  313  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  98  mg dl; chemistry blood albumin  3.2  g dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; heparin  5000  unit ; pangestyme-ec  2  cap ; carvedilol  25  mg ; fluticasone propionate nasal  1  spry ; fexofenadine  60  mg ; valsartan  160  mg ; cyanocobalamin  100  mcg ; lidocaine 5% patch  2  ptch ; acetaminophen  650  mg ; bisacodyl  10  mg ; sodium polystyrene sulfonate  30  gm ; morphine sulfate  0.5  mg ; oxycodone (immediate release)   2.5-5  mg ; clonidine patch 0.3 mg 24 hr  1  ptch ; tramadol (ultram)  25  mg ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other constipation chronic kidney disease, stage iii (moderate) bronchiectasis with acute exacerbation other vitamin b12 deficiency anemia personal history of malignant neoplasm of large intestine chronic pancreatitis congestive heart failure, unspecified anemia, unspecified benign essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of malignant neoplasm of large intestine chronic pancreatitis other malaise and fatigue edema bronchiectasis without acute exacerbation other b-complex deficiencies acute upper respiratory infections of unspecified site hypovolemia 
white f 92 $nan$nan$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; heparin  5000  unit ; pangestyme-ec  2  cap ; carvedilol  25  mg ; fexofenadine  60  mg ; valsartan  160  mg ; cyanocobalamin  100  mcg ; lidocaine 5% patch  2  ptch ; acetaminophen  650  mg ; morphine sulfate  0.5  mg ; oxycodone (immediate release)   2.5-5  mg ; clonidine patch 0.3 mg 24 hr  1  ptch ; tramadol (ultram)  25  mg ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other constipation chronic kidney disease, stage iii (moderate) bronchiectasis with acute exacerbation other vitamin b12 deficiency anemia personal history of malignant neoplasm of large intestine chronic pancreatitis congestive heart failure, unspecified anemia, unspecified benign essential hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of malignant neoplasm of large intestine chronic pancreatitis other malaise and fatigue edema bronchiectasis without acute exacerbation other b-complex deficiencies acute upper respiratory infections of unspecified site hypovolemia 
white f 39 $temp  97.9  heartrate  96.0  resprate  18.0  o2sat  99.0  sbp  130.0  dbp  87.0  rhythm    pain  10  ; temp  98.0  heartrate  81.0  resprate  18.0  o2sat  100.0  sbp  111.0  dbp  75.0  rhythm    pain    ; temp  98.3  heartrate  79.0  resprate  18.0  o2sat  100.0  sbp  129.0  dbp  71.0  rhythm    pain  10  ; temp    heartrate  80.0  resprate  18.0  o2sat  100.0  sbp  136.0  dbp  78.0  rhythm    pain  7  $hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  264  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood glucose  100  mg dl$nan
need for prophylactic vaccination and inoculation against influenza esophageal reflux anemia, unspecified abdominal pain, right upper quadrant bariatric surgery status 
white f 39 $temp  98.4  heartrate  82.0  resprate  17.0  o2sat  99.0  sbp  128.0  dbp  82.0  rhythm    pain  4-5  ; temp    heartrate  88.0  resprate  16.0  o2sat  99.0  sbp  141.0  dbp  89.0  rhythm    pain  8  ; temp  98.4  heartrate  73.0  resprate  18.0  o2sat  99.0  sbp  98.0  dbp  68.0  rhythm    pain  6  ; temp  97.9  heartrate  80.0  resprate  18.0  o2sat  99.0  sbp  109.0  dbp  76.0  rhythm    pain  5  $nan$influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; prenatal vitamins  1  tab ; bisacodyl  10  mg ; oxycodone (immediate release)   5  mg ; pyridoxine  25  mg ; ranitidine  150  mg ; ondansetron  4  mg ; albuterol inhaler  2  puff ; gabapentin  300  mg ; oxycodone (immediate release)   5-10  mg ; 
need for prophylactic vaccination and inoculation against influenza esophageal reflux anemia, unspecified abdominal pain, right upper quadrant bariatric surgery status 
white f 39 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; pyridoxine  25  mg ; ranitidine  150  mg ; ondansetron  4  mg ; albuterol inhaler  2  puff ; gabapentin  300  mg ; oxycodone (immediate release)   5-10  mg ; vitamin d  2000  unit ; cyanocobalamin  1000  mcg ; prenatal vitamins  2  tab ; lidocaine 5% patch  1  ptch ; 
need for prophylactic vaccination and inoculation against influenza esophageal reflux anemia, unspecified abdominal pain, right upper quadrant bariatric surgery status 
white f 39 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; pyridoxine  25  mg ; ranitidine  150  mg ; ondansetron  4  mg ; albuterol inhaler  2  puff ; vitamin d  2000  unit ; cyanocobalamin  1000  mcg ; prenatal vitamins  2  tab ; 
need for prophylactic vaccination and inoculation against influenza esophageal reflux anemia, unspecified abdominal pain, right upper quadrant bariatric surgery status 
white m 45 $nan$hematology blood hematocrit  46.3  %; hematology blood hematocrit  39.8  %; hematology blood hemoglobin  15.5  g dl; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  309  k ul; hematology blood platelet count  279  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  101  mg dl; chemistry blood glucose  106  mg dl; blood gas blood lactate  1.9  mmol l$sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; acetaminophen  1000  mg ; hydromorphone (dilaudid)  2-4  mg ; pantoprazole  40  mg ; multivitamins w minerals chewable  1  tab ; senna  8.6  mg ; polyethylene glycol  17  g ; bag  1  bag ; magnesium sulfate  2  gm ; oxycodone (immediate release)  5  mg ; oxycodone (immediate release)  2.5-5  mg ; 
constipation, unspecified hyperosmolality and hypernatremia hypokalemia adult hypertrophic pyloric stenosis personal history of peptic ulcer disease fall on stairs or ladders in water transport injuring unspecified person other disorders of phosphorus metabolism elevated white blood cell count, unspecified unspecified severe protein-calorie malnutrition dehydration hypomagnesemia other fall from one level to another in water transport injuring occupant of other watercraft -- crew body mass index (bmi) 19.9 or less, adult acute kidney failure, unspecified long term (current) use of anticoagulants unspecified place or not applicable surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure cachexia body mass index (bmi) 19.9 or less, adult anemia in other chronic diseases classified elsewhere adult hypertrophic pyloric stenosis iron deficiency anemia, unspecified other mechanical complication of other specified internal prosthetic devices, implants and grafts, initial encounter personal history of peptic ulcer disease nicotine dependence, cigarettes, uncomplicated personal history of other venous thrombosis and embolism other postprocedural complications and disorders of digestive system chronic or unspecified gastrojejunal ulcer with hemorrhage postprocedural intestinal obstruction unspecified severe protein-calorie malnutrition
white m 45 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; pantoprazole  40  mg ; multivitamins w minerals chewable  1  tab ; senna  8.6  mg ; polyethylene glycol  17  g ; oxycodone (immediate release)  2.5-5  mg ; 
constipation, unspecified hyperosmolality and hypernatremia hypokalemia adult hypertrophic pyloric stenosis personal history of peptic ulcer disease fall on stairs or ladders in water transport injuring unspecified person other disorders of phosphorus metabolism elevated white blood cell count, unspecified unspecified severe protein-calorie malnutrition dehydration hypomagnesemia other fall from one level to another in water transport injuring occupant of other watercraft -- crew body mass index (bmi) 19.9 or less, adult acute kidney failure, unspecified long term (current) use of anticoagulants unspecified place or not applicable surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure cachexia body mass index (bmi) 19.9 or less, adult anemia in other chronic diseases classified elsewhere adult hypertrophic pyloric stenosis iron deficiency anemia, unspecified other mechanical complication of other specified internal prosthetic devices, implants and grafts, initial encounter personal history of peptic ulcer disease nicotine dependence, cigarettes, uncomplicated personal history of other venous thrombosis and embolism other postprocedural complications and disorders of digestive system chronic or unspecified gastrojejunal ulcer with hemorrhage postprocedural intestinal obstruction unspecified severe protein-calorie malnutrition
white m 48 $nan$nan$prednisone  40  mg ; nicotine patch  21  mg ; 
 
white m 48 $nan$nan$prednisone  40  mg ; nicotine patch  21  mg ; 1 2 ns  1000  ml ; pantoprazole  40  mg ; levofloxacin  500  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; insulin  0  unit ; azithromycin  500  mg ; heparin  5000  unit ; metformin (glucophage)  500  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; oseltamivir phosphate  75  mg ; dextromethorphan-guaifenesin (sugar free)  5  ml ; glipizide  10  mg ; albuterol inhaler  2  puff ; dextromethorphan-guaifenesin (sugar free)  5-10  ml ; ipratropium bromide mdi  2  puff ; 
 
white m 48 $nan$nan$prednisone  40  mg ; nicotine patch  21  mg ; pantoprazole  40  mg ; insulin  0  unit ; azithromycin  500  mg ; heparin  5000  unit ; metformin (glucophage)  500  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; glipizide  10  mg ; albuterol inhaler  2  puff ; dextromethorphan-guaifenesin (sugar free)  5-10  ml ; ipratropium bromide mdi  2  puff ; 
 
white m 48 $nan$nan$prednisone  40  mg ; nicotine patch  21  mg ; pantoprazole  40  mg ; azithromycin  500  mg ; heparin  5000  unit ; metformin (glucophage)  500  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; glipizide  10  mg ; albuterol inhaler  2  puff ; dextromethorphan-guaifenesin (sugar free)  5-10  ml ; ipratropium bromide mdi  2  puff ; 
 
white m 78 $temp  98.2  heartrate  65.0  resprate  20.0  o2sat  96.0  sbp  109.0  dbp  54.0  rhythm  sinus rhythm  pain  0  $hematology blood hematocrit  41.4  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  22  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  40  mg ; fluticasone propionate nasal  2  spry ; metoprolol succinate xl  50  mg ; losartan potassium  25  mg ; nitroglycerin sl  0.4  mg ; quetiapine fumarate  25  mg ; tiotropium bromide  1  cap ; acetaminophen  650  mg ; 
insomnia, unspecified automatic implantable cardiac defibrillator in situ unspecified essential hypertension paralytic ileus percutaneous transluminal coronary angioplasty status paroxysmal ventricular tachycardia other specified forms of chronic ischemic heart disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other and unspecified hyperlipidemia obstructive sleep apnea (adult)(pediatric) osteoarthrosis, localized, not specified whether primary or secondary, lower leg coronary atherosclerosis of native coronary artery coronary atherosclerosis of native coronary artery dehydration old myocardial infarction intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) pure hypercholesterolemia percutaneous transluminal coronary angioplasty status
white m 78 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  40  mg ; fluticasone propionate nasal  2  spry ; metoprolol succinate xl  50  mg ; losartan potassium  25  mg ; nitroglycerin sl  0.4  mg ; quetiapine fumarate  25  mg ; tiotropium bromide  1  cap ; acetaminophen  650  mg ; 
insomnia, unspecified automatic implantable cardiac defibrillator in situ unspecified essential hypertension paralytic ileus percutaneous transluminal coronary angioplasty status paroxysmal ventricular tachycardia other specified forms of chronic ischemic heart disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other and unspecified hyperlipidemia obstructive sleep apnea (adult)(pediatric) osteoarthrosis, localized, not specified whether primary or secondary, lower leg coronary atherosclerosis of native coronary artery coronary atherosclerosis of native coronary artery dehydration old myocardial infarction intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) pure hypercholesterolemia percutaneous transluminal coronary angioplasty status
white m 91 $nan$nan$donepezil  10  mg ; lisinopril  2.5  mg ; aspirin  81  mg ; vitamin d  800  unit ; cyanocobalamin  50  mcg ; multivitamins w minerals  1  tab ; 
fall from other slipping, tripping, or stumbling contusion of hip other specified retention of urine other alteration of consciousness unspecified essential hypertension alzheimer's disease acute posthemorrhagic anemia dementia in conditions classified elsewhere without behavioral disturbance
white m 91 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  233  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood glucose  107  mg dl$donepezil  10  mg ; lisinopril  2.5  mg ; aspirin  81  mg ; vitamin d  800  unit ; cyanocobalamin  50  mcg ; multivitamins w minerals  1  tab ; 1 2 ns  1000  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  500  mg ; acetaminophen  325-650  mg ; 0.9% sodium chloride  1000  ml ; senna  1  tab ; fish oil (omega 3)  1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; benzonatate  100  mg ; guaifenesin  5-10  ml ; ranitidine  150  mg ; 
fall from other slipping, tripping, or stumbling contusion of hip other specified retention of urine other alteration of consciousness unspecified essential hypertension alzheimer's disease acute posthemorrhagic anemia dementia in conditions classified elsewhere without behavioral disturbance
white m 91 $nan$nan$donepezil  10  mg ; lisinopril  2.5  mg ; aspirin  81  mg ; vitamin d  800  unit ; cyanocobalamin  50  mcg ; multivitamins w minerals  1  tab ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  500  mg ; acetaminophen  325-650  mg ; senna  1  tab ; fish oil (omega 3)  1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; benzonatate  100  mg ; guaifenesin  5-10  ml ; ranitidine  150  mg ; 
fall from other slipping, tripping, or stumbling contusion of hip other specified retention of urine other alteration of consciousness unspecified essential hypertension alzheimer's disease acute posthemorrhagic anemia dementia in conditions classified elsewhere without behavioral disturbance
white m 64 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  134  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  40  mg dl; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  1.4  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  4.5  mg dl; chemistry blood bilirubin, total  4.6  mg dl; chemistry blood bilirubin, total  4.6  mg dl; chemistry blood glucose  217  mg dl; chemistry blood glucose  338  mg dl; chemistry blood glucose  322  mg dl; chemistry blood lactate dehydrogenase (ld)  444  iu l; chemistry blood lactate dehydrogenase (ld)  500  iu l; chemistry blood lactate dehydrogenase (ld)  703  iu l; chemistry blood albumin  3.2  g dl; blood gas blood lactate  1.6  mmol l; chemistry blood bilirubin, direct  3.9  mg dl$bag  1  bag ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; bupropion (sustained release)  200  mg ; sertraline  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; furosemide  40  mg ; heparin  4000  unit ; heparin  1300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; aspirin  81  mg ; furosemide  80  mg ; metoprolol tartrate  6.25  mg ; acetaminophen  325  mg ; docusate sodium  100  mg ; senna  8.6  mg ; 
obstructive sleep apnea (adult) (pediatric) essential (primary) hypertension type 2 diabetes mellitus without complications major depressive disorder, single episode, unspecified hyperlipidemia, unspecified cellulitis of right lower limb
white m 64 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  1.4  ; chemistry urine creatinine, urine  43  mg dl; chemistry urine sodium, urine  27  meq l; chemistry urine urea nitrogen, urine  542  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  4.4  mg dl; chemistry blood glucose  307  mg dl; chemistry blood glucose  402  mg dl; chemistry blood lactate dehydrogenase (ld)  681  iu l$bag  1  bag ; sodium chloride 0.9%  flush  3-10  ml ; bupropion (sustained release)  200  mg ; sertraline  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; furosemide  40  mg ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; aspirin  81  mg ; furosemide  80  mg ; metoprolol tartrate  6.25  mg ; acetaminophen  325  mg ; docusate sodium  100  mg ; senna  8.6  mg ; insulin  9  unit ; insulin  12  unit ; cepacol (sore throat lozenge)  1  loz ; insulin  6  unit ; albuterol 0.083% neb soln  1  neb ; 5% dextrose  50  ml ; furosemide  250  mg ; acetaminophen  650  mg ; sodium chloride nasal  1-2  spry ; 
obstructive sleep apnea (adult) (pediatric) essential (primary) hypertension type 2 diabetes mellitus without complications major depressive disorder, single episode, unspecified hyperlipidemia, unspecified cellulitis of right lower limb
white m 64 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  252  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  3.4  mg dl; chemistry blood glucose  418  mg dl; chemistry blood glucose  411  mg dl$sodium chloride 0.9%  flush  3-10  ml ; bupropion (sustained release)  200  mg ; sertraline  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; metoprolol tartrate  6.25  mg ; docusate sodium  100  mg ; senna  8.6  mg ; cepacol (sore throat lozenge)  1  loz ; albuterol 0.083% neb soln  1  neb ; 5% dextrose  50  ml ; furosemide  250  mg ; acetaminophen  650  mg ; sodium chloride nasal  1-2  spry ; insulin  11  unit ; potassium chloride  40  meq ; neutra-phos  2  pkt ; insulin  2  unit ; insulin  10  unit ; potassium chloride  20  meq ; magnesium oxide  800  mg ; furosemide  20  mg ; furosemide  100  mg ; 
obstructive sleep apnea (adult) (pediatric) essential (primary) hypertension type 2 diabetes mellitus without complications major depressive disorder, single episode, unspecified hyperlipidemia, unspecified cellulitis of right lower limb
white m 64 $nan$hematology blood hematocrit  35.9  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  318  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  2.6  mg dl; chemistry blood glucose  402  mg dl; chemistry blood glucose  419  mg dl$sodium chloride 0.9%  flush  3-10  ml ; bupropion (sustained release)  200  mg ; sertraline  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; metoprolol tartrate  6.25  mg ; docusate sodium  100  mg ; senna  8.6  mg ; cepacol (sore throat lozenge)  1  loz ; albuterol 0.083% neb soln  1  neb ; acetaminophen  650  mg ; sodium chloride nasal  1-2  spry ; insulin  2  unit ; insulin  14  unit ; insulin  5  unit ; insulin  8  unit ; insulin  7  unit ; magnesium oxide  400  mg ; 
obstructive sleep apnea (adult) (pediatric) essential (primary) hypertension type 2 diabetes mellitus without complications major depressive disorder, single episode, unspecified hyperlipidemia, unspecified cellulitis of right lower limb
white m 64 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  350  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  90  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  2.0  mg dl; chemistry blood glucose  332  mg dl; chemistry blood glucose  420  mg dl; chemistry blood lactate dehydrogenase (ld)  410  iu l$sodium chloride 0.9%  flush  3-10  ml ; bupropion (sustained release)  200  mg ; sertraline  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; metoprolol tartrate  6.25  mg ; docusate sodium  100  mg ; senna  8.6  mg ; cepacol (sore throat lozenge)  1  loz ; albuterol 0.083% neb soln  1  neb ; acetaminophen  650  mg ; sodium chloride nasal  1-2  spry ; insulin  8  unit ; insulin  7  unit ; magnesium oxide  400  mg ; insulin  20  unit ; captopril  3.15  mg ; 
obstructive sleep apnea (adult) (pediatric) essential (primary) hypertension type 2 diabetes mellitus without complications major depressive disorder, single episode, unspecified hyperlipidemia, unspecified cellulitis of right lower limb
white m 64 $nan$hematology blood hematocrit  39.1  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  379  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  88  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  1.9  mg dl; chemistry blood glucose  257  mg dl; chemistry blood glucose  296  mg dl; chemistry blood lactate dehydrogenase (ld)  362  iu l$sodium chloride 0.9%  flush  3-10  ml ; bupropion (sustained release)  200  mg ; sertraline  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; metoprolol tartrate  6.25  mg ; docusate sodium  100  mg ; senna  8.6  mg ; cepacol (sore throat lozenge)  1  loz ; albuterol 0.083% neb soln  1  neb ; acetaminophen  650  mg ; sodium chloride nasal  1-2  spry ; insulin  8  unit ; captopril  3.15  mg ; insulin  25  unit ; 
obstructive sleep apnea (adult) (pediatric) essential (primary) hypertension type 2 diabetes mellitus without complications major depressive disorder, single episode, unspecified hyperlipidemia, unspecified cellulitis of right lower limb
white m 64 $nan$hematology blood hematocrit  42.0  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  413  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  86  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood glucose  201  mg dl; chemistry blood glucose  256  mg dl; chemistry blood lactate dehydrogenase (ld)  380  iu l; chemistry blood % hemoglobin a1c  8.2  %$sodium chloride 0.9%  flush  3-10  ml ; bupropion (sustained release)  200  mg ; sertraline  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; metoprolol tartrate  6.25  mg ; docusate sodium  100  mg ; senna  8.6  mg ; cepacol (sore throat lozenge)  1  loz ; albuterol 0.083% neb soln  1  neb ; acetaminophen  650  mg ; sodium chloride nasal  1-2  spry ; captopril  3.15  mg ; insulin  28  unit ; insulin  17  unit ; 
obstructive sleep apnea (adult) (pediatric) essential (primary) hypertension type 2 diabetes mellitus without complications major depressive disorder, single episode, unspecified hyperlipidemia, unspecified cellulitis of right lower limb
white m 64 $nan$hematology blood hematocrit  42.1  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  391  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  85  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  1.7  mg dl; chemistry blood glucose  199  mg dl; chemistry blood glucose  258  mg dl; chemistry blood lactate dehydrogenase (ld)  330  iu l$sodium chloride 0.9%  flush  3-10  ml ; bupropion (sustained release)  200  mg ; sertraline  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; docusate sodium  100  mg ; senna  8.6  mg ; cepacol (sore throat lozenge)  1  loz ; albuterol 0.083% neb soln  1  neb ; acetaminophen  650  mg ; sodium chloride nasal  1-2  spry ; insulin  17  unit ; insulin  30  unit ; lisinopril  2.5  mg ; metoprolol succinate xl  25  mg ; insulin  18  unit ; calcium carbonate  500  mg ; 
obstructive sleep apnea (adult) (pediatric) essential (primary) hypertension type 2 diabetes mellitus without complications major depressive disorder, single episode, unspecified hyperlipidemia, unspecified cellulitis of right lower limb
white m 64 $nan$hematology blood hematocrit  41.4  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  363  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  151  mg dl; chemistry blood lactate dehydrogenase (ld)  290  iu l$sodium chloride 0.9%  flush  3-10  ml ; bupropion (sustained release)  200  mg ; sertraline  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; docusate sodium  100  mg ; senna  8.6  mg ; cepacol (sore throat lozenge)  1  loz ; albuterol 0.083% neb soln  1  neb ; acetaminophen  650  mg ; sodium chloride nasal  1-2  spry ; lisinopril  2.5  mg ; metoprolol succinate xl  25  mg ; insulin  18  unit ; calcium carbonate  500  mg ; ibuprofen  600  mg ; 
obstructive sleep apnea (adult) (pediatric) essential (primary) hypertension type 2 diabetes mellitus without complications major depressive disorder, single episode, unspecified hyperlipidemia, unspecified cellulitis of right lower limb
white m 64 $nan$hematology blood hematocrit  41.3  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  342  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  119  mg dl$sodium chloride 0.9%  flush  3-10  ml ; bupropion (sustained release)  200  mg ; sertraline  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; docusate sodium  100  mg ; senna  8.6  mg ; cepacol (sore throat lozenge)  1  loz ; albuterol 0.083% neb soln  1  neb ; acetaminophen  650  mg ; sodium chloride nasal  1-2  spry ; insulin  18  unit ; calcium carbonate  500  mg ; ibuprofen  600  mg ; 
obstructive sleep apnea (adult) (pediatric) essential (primary) hypertension type 2 diabetes mellitus without complications major depressive disorder, single episode, unspecified hyperlipidemia, unspecified cellulitis of right lower limb
white m 64 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; bupropion (sustained release)  200  mg ; sertraline  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; docusate sodium  100  mg ; senna  8.6  mg ; cepacol (sore throat lozenge)  1  loz ; albuterol 0.083% neb soln  1  neb ; acetaminophen  650  mg ; sodium chloride nasal  1-2  spry ; insulin  18  unit ; calcium carbonate  500  mg ; metoprolol succinate xl  12.5  mg ; 
obstructive sleep apnea (adult) (pediatric) essential (primary) hypertension type 2 diabetes mellitus without complications major depressive disorder, single episode, unspecified hyperlipidemia, unspecified cellulitis of right lower limb
other f 67 $nan$hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl; chemistry blood % hemoglobin a1c  5.8  %; chemistry blood % hemoglobin a1c  5.4  %$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  2  spry ; acetaminophen  650  mg ; hydralazine  10  mg ; ranitidine  75  mg ; simvastatin  20  mg ; aspirin  325  mg ; heparin  5000  unit ; betamethasone valerate 0.1% cream  1  appl ; senna  1  tab ; docusate sodium  100  mg ; 
 
other f 67 $nan$nan$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; fluticasone propionate nasal  2  spry ; acetaminophen  650  mg ; hydralazine  10  mg ; ranitidine  75  mg ; simvastatin  20  mg ; aspirin  325  mg ; heparin  5000  unit ; betamethasone valerate 0.1% cream  1  appl ; senna  1  tab ; docusate sodium  100  mg ; 
 
white m 69 $nan$hematology blood hematocrit  41.0  %; hematology blood hematocrit  30.0  %; hematology blood hematocrit  32.7  %; hematology blood hemoglobin  13.3  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  188  k ul; hematology blood platelet count  123  k ul; hematology blood platelet count  121  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.2  ; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  122  mg dl; chemistry blood lactate dehydrogenase (ld)  174  iu l; chemistry blood albumin  4.5  g dl; blood gas blood free calcium  1.23  mmol l; blood gas blood free calcium  1.16  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.33  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood chloride, whole blood  107  meq l; blood gas blood chloride, whole blood  109  meq l; blood gas blood glucose  100  mg dl; blood gas blood glucose  133  mg dl; blood gas blood glucose  164  mg dl; blood gas blood glucose  165  mg dl; blood gas blood glucose  121  mg dl; blood gas blood hematocrit, calculated  38  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  31  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hemoglobin  12.8  g dl; blood gas blood hemoglobin  10.6  g dl; blood gas blood hemoglobin  10.4  g dl; blood gas blood hemoglobin  10.5  g dl; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  3.4  meq l; blood gas blood sodium, whole blood  138  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood sodium, whole blood  138  meq l; chemistry blood % hemoglobin a1c  5.0  %$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  325-650  mg ; mupirocin ointment 2%  1  appl ; atorvastatin  40  mg ; aspirin  81  mg ; metoprolol tartrate  12.5  mg ; sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; 0.9 % sodium chloride  25  ml ; phenylephrine  6  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; insulin human regular  100  unit ; glucagon  1  mg ; glucose gel  15  g ; fentanyl citrate  12.5-50  mcg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; acetaminophen iv  1000  mg ; acetaminophen  1000  mg ; 
 
white m 69 $nan$hematology blood hematocrit  34.8  %; hematology blood hematocrit  32.8  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  132  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  104  mg dl; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood glucose  102  mg dl; blood gas blood glucose  110  mg dl; blood gas blood glucose  107  mg dl; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  4.2  meq l$sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; dextrose 5%  1000  ml ; propofol  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; 0.9 % sodium chloride  25  ml ; phenylephrine  6  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; insulin human regular  100  unit ; glucagon  1  mg ; glucose gel  15  g ; fentanyl citrate  12.5-50  mcg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; acetaminophen iv  1000  mg ; acetaminophen  1000  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; dexmedetomidine  0.4  mg ; mouth care oral rinse  7-15  ml ; ranitidine  150  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; insulin glargine  (cvicu protocol)  0-50  unit ; insulin  0-10  unit ; insulin  0  unit ; aspirin ec  81  mg ; fenofibrate  145  mg ; furosemide  20  mg ; 
 
white m 69 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  79  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; dextrose 5%  1000  ml ; d5w  250  ml ; nitroglycerin  100  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; insulin human regular  100  unit ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; acetaminophen iv  1000  mg ; acetaminophen  1000  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; ranitidine  150  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; insulin  0  unit ; aspirin ec  81  mg ; fenofibrate  145  mg ; furosemide  20  mg ; senna  17.2  mg ; bisacodyl  10  mg ; 
 
white m 69 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  99  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  108  mg dl$polyethylene glycol  17  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; insulin  0  unit ; aspirin ec  81  mg ; fenofibrate  145  mg ; furosemide  20  mg ; senna  17.2  mg ; bisacodyl  10  mg ; ketorolac  15  mg ; bag  1  bag ; 
 
white m 69 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  143  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  92  mg dl$polyethylene glycol  17  g ; glucose gel  15  g ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; aspirin ec  81  mg ; fenofibrate  145  mg ; furosemide  20  mg ; senna  17.2  mg ; bisacodyl  10  mg ; artificial tears  1-2  drop ; ibuprofen  600  mg ; 
 
white m 69 $nan$nan$polyethylene glycol  17  g ; glucose gel  15  g ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; aspirin ec  81  mg ; fenofibrate  145  mg ; furosemide  20  mg ; senna  17.2  mg ; bisacodyl  10  mg ; artificial tears  1-2  drop ; ibuprofen  600  mg ; 
 
other m 44 $nan$hematology blood hematocrit  42.7  %; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  310  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  89  mg dl$sodium chloride 0.9%  flush  3-10  ml ; influenza vaccine quadrivalent  0.5  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; soln  100  ml ; acetaminophen iv  1000  mg ; ns  100  ml ; metronidazole  500  mg ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; ciprofloxacin hcl  500  mg ; cepacol (sore throat lozenge)  2  loz ; ciprofloxacin hcl  250  mg ; 
 
other m 44 $nan$hematology blood hematocrit  42.8  %; hematology blood hemoglobin  14.9  g dl; hematology blood platelet count  327  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; soln  100  ml ; acetaminophen iv  1000  mg ; ciprofloxacin hcl  500  mg ; cepacol (sore throat lozenge)  2  loz ; acetaminophen  1000  mg ; 
 
black african american m 69 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; amlodipine  5  mg ; aspirin  81  mg ; clobetasol propionate 0.05% ointment  1  appl ; hydrochlorothiazide  12.5  mg ; metoprolol succinate xl  25  mg ; nicotine patch  14  mg ; 
 
white f 35 $nan$nan$sodium chloride 0.9%  flush  3  ml ; syringe (chemo)  2.4  ml ; methotrexate sodium  60  mg ; 
 
white f 35 $nan$nan$sodium chloride 0.9%  flush  3  ml ; syringe (chemo)  2.4  ml ; methotrexate sodium  60  mg ; leucovorin calcium  5  mg ; 
 
white f 35 $nan$nan$sodium chloride 0.9%  flush  3  ml ; leucovorin calcium  5  mg ; 
 
white m 74 $nan$hematology blood hematocrit  38.5  %; hematology blood hematocrit  37.9  %; hematology blood hemoglobin  12.8  g dl; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  131  k ul; hematology blood platelet count  129  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; acetaminophen  650  mg ; ranitidine  150  mg ; prochlorperazine  10  mg ; oxycodone (immediate release)  5-10  mg ; nystatin oral suspension  10  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; ipratropium-albuterol neb  1  neb ; heparin  6200  unit ; heparin  1600-3100  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; albuterol 0.083% neb soln  1  neb ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; hydromorphone (dilaudid)  0.25  mg ; sodium chloride 0.9%  1000  ml ; docusate sodium  100  mg ; 
anorexia body mass index (bmi) 26.0-26.9, adult chronic obstructive pulmonary disease, unspecified unspecified place or not applicable fever, unspecified epigastric pain candidal stomatitis displacement of bile duct prosthesis, initial encounter personal history of nicotine dependence right upper quadrant pain malignant neoplasm of head of pancreas other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure portal hypertension malignant neoplasm of pancreas, part unspecified umbilical hernia without mention of obstruction or gangrene personal history of tobacco use chronic airway obstruction, not elsewhere classified hypoxemia cirrhosis of liver without mention of alcohol other ascites appendicitis, unqualified intestinal infection due to clostridium difficile hypocalcemia malignant neoplasm of head of pancreas fever presenting with conditions classified elsewhere acidosis other secondary thrombocytopenia systemic inflammatory response syndrome, unspecified chronic airway obstruction, not elsewhere classified other complications due to other vascular device, implant, and graft accidents occurring in residential institution neutropenia, unspecified hypotension, unspecified acute venous embolism and thrombosis of superficial veins of upper extremity disorders of phosphorus metabolism other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use antineoplastic chemotherapy induced anemia personal history of antineoplastic chemotherapy hypopotassemia personal history of tobacco use family history of malignant neoplasm of prostate other emphysema hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) malignant neoplasm of head of pancreas obstruction of bile duct other and unspecified hyperlipidemia esophageal reflux
white m 74 $nan$hematology blood hematocrit  39.1  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  132  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  99  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; acetaminophen  650  mg ; ranitidine  150  mg ; prochlorperazine  10  mg ; oxycodone (immediate release)  5-10  mg ; nystatin oral suspension  10  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; heparin  6200  unit ; heparin  1600-3100  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; albuterol 0.083% neb soln  1  neb ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; hydromorphone (dilaudid)  0.25  mg ; docusate sodium  100  mg ; enoxaparin sodium  60  mg ; multivitamins w minerals  1  tab ; 
anorexia body mass index (bmi) 26.0-26.9, adult chronic obstructive pulmonary disease, unspecified unspecified place or not applicable fever, unspecified epigastric pain candidal stomatitis displacement of bile duct prosthesis, initial encounter personal history of nicotine dependence right upper quadrant pain malignant neoplasm of head of pancreas other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure portal hypertension malignant neoplasm of pancreas, part unspecified umbilical hernia without mention of obstruction or gangrene personal history of tobacco use chronic airway obstruction, not elsewhere classified hypoxemia cirrhosis of liver without mention of alcohol other ascites appendicitis, unqualified intestinal infection due to clostridium difficile hypocalcemia malignant neoplasm of head of pancreas fever presenting with conditions classified elsewhere acidosis other secondary thrombocytopenia systemic inflammatory response syndrome, unspecified chronic airway obstruction, not elsewhere classified other complications due to other vascular device, implant, and graft accidents occurring in residential institution neutropenia, unspecified hypotension, unspecified acute venous embolism and thrombosis of superficial veins of upper extremity disorders of phosphorus metabolism other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use antineoplastic chemotherapy induced anemia personal history of antineoplastic chemotherapy hypopotassemia personal history of tobacco use family history of malignant neoplasm of prostate other emphysema hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) malignant neoplasm of head of pancreas obstruction of bile duct other and unspecified hyperlipidemia esophageal reflux
white m 74 $nan$nan$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; acetaminophen  650  mg ; ranitidine  150  mg ; prochlorperazine  10  mg ; oxycodone (immediate release)  5-10  mg ; nystatin oral suspension  10  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; albuterol 0.083% neb soln  1  neb ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; hydromorphone (dilaudid)  0.25  mg ; docusate sodium  100  mg ; enoxaparin sodium  60  mg ; multivitamins w minerals  1  tab ; 
anorexia body mass index (bmi) 26.0-26.9, adult chronic obstructive pulmonary disease, unspecified unspecified place or not applicable fever, unspecified epigastric pain candidal stomatitis displacement of bile duct prosthesis, initial encounter personal history of nicotine dependence right upper quadrant pain malignant neoplasm of head of pancreas other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure portal hypertension malignant neoplasm of pancreas, part unspecified umbilical hernia without mention of obstruction or gangrene personal history of tobacco use chronic airway obstruction, not elsewhere classified hypoxemia cirrhosis of liver without mention of alcohol other ascites appendicitis, unqualified intestinal infection due to clostridium difficile hypocalcemia malignant neoplasm of head of pancreas fever presenting with conditions classified elsewhere acidosis other secondary thrombocytopenia systemic inflammatory response syndrome, unspecified chronic airway obstruction, not elsewhere classified other complications due to other vascular device, implant, and graft accidents occurring in residential institution neutropenia, unspecified hypotension, unspecified acute venous embolism and thrombosis of superficial veins of upper extremity disorders of phosphorus metabolism other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use antineoplastic chemotherapy induced anemia personal history of antineoplastic chemotherapy hypopotassemia personal history of tobacco use family history of malignant neoplasm of prostate other emphysema hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) malignant neoplasm of head of pancreas obstruction of bile duct other and unspecified hyperlipidemia esophageal reflux
white m 69 $nan$hematology blood hematocrit  40.3  %; hematology blood platelet count  184  k ul; hematology blood platelet count  170  k ul; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.6  meq l; chemistry blood urea nitrogen  8  mg dl$sodium chloride 0.9%  1000  ml ; guaifenesin-dextromethorphan  5  ml ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; simethicone  40-80  mg ; acetaminophen  500-1000  mg ; nitroglycerin sl  0.3  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; metoprolol tartrate  25  mg ; pravastatin  40  mg ; cepacol (sore throat lozenge)  1  loz ; aspirin ec  81  mg ; clopidogrel  75  mg ; montelukast  10  mg ; tramadol  50  mg ; allopurinol  300  mg ; losartan potassium  25  mg ; 
 
white m 69 $nan$nan$guaifenesin-dextromethorphan  5  ml ; sodium chloride 0.9%  flush  3  ml ; simethicone  40-80  mg ; acetaminophen  500-1000  mg ; nitroglycerin sl  0.3  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; metoprolol tartrate  25  mg ; pravastatin  40  mg ; cepacol (sore throat lozenge)  1  loz ; aspirin ec  81  mg ; clopidogrel  75  mg ; montelukast  10  mg ; tramadol  50  mg ; allopurinol  300  mg ; losartan potassium  25  mg ; 
 
hispanic latino m 43 $nan$hematology blood hematocrit  33.5  %; hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  309  k ul; hematology blood platelet count  278  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  4.2  ; hematology blood inr(pt)  4.3  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  82  mg dl; chemistry blood glucose  91  mg dl; chemistry blood lactate dehydrogenase (ld)  244  iu l; chemistry blood lactate dehydrogenase (ld)  232  iu l; chemistry blood albumin  4.1  g dl; chemistry blood albumin  3.7  g dl; blood gas blood lactate  1.5  mmol l; blood gas blood chloride, whole blood  97  meq l; blood gas blood glucose  86  mg dl; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood sodium, whole blood  132  meq l; blood gas blood calculated bicarbonate, whole blood  24  meq l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; lorazepam  1  mg ; oxycodone (immediate release)   5  mg ; acetaminophen  650  mg ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride  20  meq ; sodium chloride 0.9%  1000  ml ; tramadol (ultram)  50  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; diphenhydramine  25  mg ; allopurinol  300  mg ; amiodarone  200  mg ; amlodipine  10  mg ; aspirin  325  mg ; famotidine  20  mg ; ferrous sulfate  325  mg ; levothyroxine sodium  150  mcg ; spironolactone  50  mg ; torsemide  40  mg ; entecavir  1  mg ; colchicine  0.6  mg ; digoxin  0.125  mg ; phosphorus  250  mg ; d5 1 2ns  1000  ml ; hydralazine  10  mg ; warfarin  1  dose ; micafungin  100  mg ; sodium chloride nasal  1-2  spry ; 
anxiety disorder, unspecified abnormal coagulation profile hemiplegia and hemiparesis following cerebral infarction affecting right dominant side presence of automatic (implantable) cardiac defibrillator gout, unspecified unspecified viral hepatitis b without hepatic coma body mass index (bmi) 37.0-37.9, adult iron deficiency obstructive sleep apnea (adult) (pediatric) dilated cardiomyopathy long term (current) use of anticoagulants chronic systolic (congestive) heart failure personal history of nicotine dependence rheumatic heart failure presence of prosthetic heart valve unspecified atrial flutter presence of heart assist device morbid (severe) obesity due to excess calories rheumatic heart disease, unspecified morbid obesity body mass index 40.0-44.9, adult constipation, unspecified iron deficiency anemia, unspecified congestive heart failure, unspecified other primary cardiomyopathies long-term (current) use of anticoagulants chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta gout, unspecified cirrhosis of liver without mention of alcohol other abnormal blood chemistry hyposmolality and/or hyponatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, unspecified personal history of sudden cardiac arrest obstructive sleep apnea (adult)(pediatric) other chronic pulmonary heart diseases other chronic pain anxiety state, unspecified heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified alcohol abuse, in remission atrial flutter unspecified acquired hypothyroidism automatic implantable cardiac defibrillator in situ acute kidney failure, unspecified acute on chronic systolic heart failure internal hemorrhoids without mention of complication
hispanic latino m 43 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  4.0  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  88  mg dl; chemistry blood lactate dehydrogenase (ld)  220  iu l$sodium chloride 0.9%  flush  3  ml ; lorazepam  1  mg ; oxycodone (immediate release)   5  mg ; tramadol (ultram)  50  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; diphenhydramine  25  mg ; allopurinol  300  mg ; amiodarone  200  mg ; amlodipine  10  mg ; famotidine  20  mg ; ferrous sulfate  325  mg ; levothyroxine sodium  150  mcg ; entecavir  1  mg ; colchicine  0.6  mg ; digoxin  0.125  mg ; phosphorus  250  mg ; d5 1 2ns  1000  ml ; hydralazine  10  mg ; sodium chloride nasal  1-2  spry ; aspirin  81  mg ; 
anxiety disorder, unspecified abnormal coagulation profile hemiplegia and hemiparesis following cerebral infarction affecting right dominant side presence of automatic (implantable) cardiac defibrillator gout, unspecified unspecified viral hepatitis b without hepatic coma body mass index (bmi) 37.0-37.9, adult iron deficiency obstructive sleep apnea (adult) (pediatric) dilated cardiomyopathy long term (current) use of anticoagulants chronic systolic (congestive) heart failure personal history of nicotine dependence rheumatic heart failure presence of prosthetic heart valve unspecified atrial flutter presence of heart assist device morbid (severe) obesity due to excess calories rheumatic heart disease, unspecified morbid obesity body mass index 40.0-44.9, adult constipation, unspecified iron deficiency anemia, unspecified congestive heart failure, unspecified other primary cardiomyopathies long-term (current) use of anticoagulants chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta gout, unspecified cirrhosis of liver without mention of alcohol other abnormal blood chemistry hyposmolality and/or hyponatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, unspecified personal history of sudden cardiac arrest obstructive sleep apnea (adult)(pediatric) other chronic pulmonary heart diseases other chronic pain anxiety state, unspecified heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified alcohol abuse, in remission atrial flutter unspecified acquired hypothyroidism automatic implantable cardiac defibrillator in situ acute kidney failure, unspecified acute on chronic systolic heart failure internal hemorrhoids without mention of complication
hispanic latino m 43 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  227  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  2.3  ; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  86  mg dl; chemistry blood lactate dehydrogenase (ld)  198  iu l$sodium chloride 0.9%  flush  3  ml ; lorazepam  1  mg ; oxycodone (immediate release)   5  mg ; tramadol (ultram)  50  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; diphenhydramine  25  mg ; allopurinol  300  mg ; amiodarone  200  mg ; amlodipine  10  mg ; famotidine  20  mg ; ferrous sulfate  325  mg ; levothyroxine sodium  150  mcg ; entecavir  1  mg ; colchicine  0.6  mg ; digoxin  0.125  mg ; phosphorus  250  mg ; hydralazine  10  mg ; sodium chloride nasal  1-2  spry ; aspirin  81  mg ; warfarin  3  mg ; torsemide  20  mg ; hydralazine  20  mg ; heparin  2200-4300  unit ; heparin sodium  25,000  unit ; 
anxiety disorder, unspecified abnormal coagulation profile hemiplegia and hemiparesis following cerebral infarction affecting right dominant side presence of automatic (implantable) cardiac defibrillator gout, unspecified unspecified viral hepatitis b without hepatic coma body mass index (bmi) 37.0-37.9, adult iron deficiency obstructive sleep apnea (adult) (pediatric) dilated cardiomyopathy long term (current) use of anticoagulants chronic systolic (congestive) heart failure personal history of nicotine dependence rheumatic heart failure presence of prosthetic heart valve unspecified atrial flutter presence of heart assist device morbid (severe) obesity due to excess calories rheumatic heart disease, unspecified morbid obesity body mass index 40.0-44.9, adult constipation, unspecified iron deficiency anemia, unspecified congestive heart failure, unspecified other primary cardiomyopathies long-term (current) use of anticoagulants chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta gout, unspecified cirrhosis of liver without mention of alcohol other abnormal blood chemistry hyposmolality and/or hyponatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, unspecified personal history of sudden cardiac arrest obstructive sleep apnea (adult)(pediatric) other chronic pulmonary heart diseases other chronic pain anxiety state, unspecified heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified alcohol abuse, in remission atrial flutter unspecified acquired hypothyroidism automatic implantable cardiac defibrillator in situ acute kidney failure, unspecified acute on chronic systolic heart failure internal hemorrhoids without mention of complication
hispanic latino m 43 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  243  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  194  iu l$5% dextrose  250  ml ; sodium chloride 0.9%  flush  3  ml ; lorazepam  1  mg ; oxycodone (immediate release)   5  mg ; tramadol (ultram)  50  mg ; diphenhydramine  25  mg ; allopurinol  300  mg ; amiodarone  200  mg ; amlodipine  10  mg ; famotidine  20  mg ; ferrous sulfate  325  mg ; levothyroxine sodium  150  mcg ; entecavir  1  mg ; colchicine  0.6  mg ; digoxin  0.125  mg ; phosphorus  250  mg ; sodium chloride nasal  1-2  spry ; warfarin  3  mg ; torsemide  20  mg ; hydralazine  20  mg ; heparin sodium  25,000  unit ; potassium chloride  40  meq ; torsemide  10  mg ; spironolactone  25  mg ; hydralazine  30  mg ; 
anxiety disorder, unspecified abnormal coagulation profile hemiplegia and hemiparesis following cerebral infarction affecting right dominant side presence of automatic (implantable) cardiac defibrillator gout, unspecified unspecified viral hepatitis b without hepatic coma body mass index (bmi) 37.0-37.9, adult iron deficiency obstructive sleep apnea (adult) (pediatric) dilated cardiomyopathy long term (current) use of anticoagulants chronic systolic (congestive) heart failure personal history of nicotine dependence rheumatic heart failure presence of prosthetic heart valve unspecified atrial flutter presence of heart assist device morbid (severe) obesity due to excess calories rheumatic heart disease, unspecified morbid obesity body mass index 40.0-44.9, adult constipation, unspecified iron deficiency anemia, unspecified congestive heart failure, unspecified other primary cardiomyopathies long-term (current) use of anticoagulants chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta gout, unspecified cirrhosis of liver without mention of alcohol other abnormal blood chemistry hyposmolality and/or hyponatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, unspecified personal history of sudden cardiac arrest obstructive sleep apnea (adult)(pediatric) other chronic pulmonary heart diseases other chronic pain anxiety state, unspecified heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified alcohol abuse, in remission atrial flutter unspecified acquired hypothyroidism automatic implantable cardiac defibrillator in situ acute kidney failure, unspecified acute on chronic systolic heart failure internal hemorrhoids without mention of complication
hispanic latino m 43 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  266  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  82  mg dl; chemistry blood lactate dehydrogenase (ld)  206  iu l$5% dextrose  250  ml ; sodium chloride 0.9%  flush  3  ml ; lorazepam  1  mg ; oxycodone (immediate release)   5  mg ; tramadol (ultram)  50  mg ; diphenhydramine  25  mg ; allopurinol  300  mg ; amiodarone  200  mg ; amlodipine  10  mg ; famotidine  20  mg ; ferrous sulfate  325  mg ; levothyroxine sodium  150  mcg ; entecavir  1  mg ; colchicine  0.6  mg ; digoxin  0.125  mg ; phosphorus  250  mg ; sodium chloride nasal  1-2  spry ; heparin sodium  25,000  unit ; potassium chloride  40  meq ; torsemide  10  mg ; spironolactone  25  mg ; hydralazine  30  mg ; docusate sodium  100  mg ; senna  8.6  mg ; warfarin  4  mg ; 
anxiety disorder, unspecified abnormal coagulation profile hemiplegia and hemiparesis following cerebral infarction affecting right dominant side presence of automatic (implantable) cardiac defibrillator gout, unspecified unspecified viral hepatitis b without hepatic coma body mass index (bmi) 37.0-37.9, adult iron deficiency obstructive sleep apnea (adult) (pediatric) dilated cardiomyopathy long term (current) use of anticoagulants chronic systolic (congestive) heart failure personal history of nicotine dependence rheumatic heart failure presence of prosthetic heart valve unspecified atrial flutter presence of heart assist device morbid (severe) obesity due to excess calories rheumatic heart disease, unspecified morbid obesity body mass index 40.0-44.9, adult constipation, unspecified iron deficiency anemia, unspecified congestive heart failure, unspecified other primary cardiomyopathies long-term (current) use of anticoagulants chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta gout, unspecified cirrhosis of liver without mention of alcohol other abnormal blood chemistry hyposmolality and/or hyponatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, unspecified personal history of sudden cardiac arrest obstructive sleep apnea (adult)(pediatric) other chronic pulmonary heart diseases other chronic pain anxiety state, unspecified heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified alcohol abuse, in remission atrial flutter unspecified acquired hypothyroidism automatic implantable cardiac defibrillator in situ acute kidney failure, unspecified acute on chronic systolic heart failure internal hemorrhoids without mention of complication
hispanic latino m 43 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  262  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  2.2  ; hematology blood inr(pt)  2.4  ; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  73  mg dl; chemistry blood lactate dehydrogenase (ld)  211  iu l$5% dextrose  250  ml ; sodium chloride 0.9%  flush  3  ml ; lorazepam  1  mg ; oxycodone (immediate release)   5  mg ; tramadol (ultram)  50  mg ; diphenhydramine  25  mg ; allopurinol  300  mg ; amiodarone  200  mg ; amlodipine  10  mg ; famotidine  20  mg ; ferrous sulfate  325  mg ; levothyroxine sodium  150  mcg ; entecavir  1  mg ; colchicine  0.6  mg ; digoxin  0.125  mg ; phosphorus  250  mg ; sodium chloride nasal  1-2  spry ; heparin sodium  25,000  unit ; hydralazine  30  mg ; docusate sodium  100  mg ; senna  8.6  mg ; warfarin  4  mg ; 
anxiety disorder, unspecified abnormal coagulation profile hemiplegia and hemiparesis following cerebral infarction affecting right dominant side presence of automatic (implantable) cardiac defibrillator gout, unspecified unspecified viral hepatitis b without hepatic coma body mass index (bmi) 37.0-37.9, adult iron deficiency obstructive sleep apnea (adult) (pediatric) dilated cardiomyopathy long term (current) use of anticoagulants chronic systolic (congestive) heart failure personal history of nicotine dependence rheumatic heart failure presence of prosthetic heart valve unspecified atrial flutter presence of heart assist device morbid (severe) obesity due to excess calories rheumatic heart disease, unspecified morbid obesity body mass index 40.0-44.9, adult constipation, unspecified iron deficiency anemia, unspecified congestive heart failure, unspecified other primary cardiomyopathies long-term (current) use of anticoagulants chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta gout, unspecified cirrhosis of liver without mention of alcohol other abnormal blood chemistry hyposmolality and/or hyponatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, unspecified personal history of sudden cardiac arrest obstructive sleep apnea (adult)(pediatric) other chronic pulmonary heart diseases other chronic pain anxiety state, unspecified heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified alcohol abuse, in remission atrial flutter unspecified acquired hypothyroidism automatic implantable cardiac defibrillator in situ acute kidney failure, unspecified acute on chronic systolic heart failure internal hemorrhoids without mention of complication
hispanic latino m 43 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  268  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  2.8  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  80  mg dl; chemistry blood lactate dehydrogenase (ld)  205  iu l$5% dextrose  250  ml ; sodium chloride 0.9%  flush  3  ml ; lorazepam  1  mg ; oxycodone (immediate release)   5  mg ; tramadol (ultram)  50  mg ; diphenhydramine  25  mg ; allopurinol  300  mg ; amiodarone  200  mg ; amlodipine  10  mg ; famotidine  20  mg ; ferrous sulfate  325  mg ; levothyroxine sodium  150  mcg ; entecavir  1  mg ; colchicine  0.6  mg ; digoxin  0.125  mg ; sodium chloride nasal  1-2  spry ; heparin sodium  25,000  unit ; hydralazine  30  mg ; docusate sodium  100  mg ; senna  8.6  mg ; bag  1.5  bag ; magnesium sulfate  3  gm ; 
anxiety disorder, unspecified abnormal coagulation profile hemiplegia and hemiparesis following cerebral infarction affecting right dominant side presence of automatic (implantable) cardiac defibrillator gout, unspecified unspecified viral hepatitis b without hepatic coma body mass index (bmi) 37.0-37.9, adult iron deficiency obstructive sleep apnea (adult) (pediatric) dilated cardiomyopathy long term (current) use of anticoagulants chronic systolic (congestive) heart failure personal history of nicotine dependence rheumatic heart failure presence of prosthetic heart valve unspecified atrial flutter presence of heart assist device morbid (severe) obesity due to excess calories rheumatic heart disease, unspecified morbid obesity body mass index 40.0-44.9, adult constipation, unspecified iron deficiency anemia, unspecified congestive heart failure, unspecified other primary cardiomyopathies long-term (current) use of anticoagulants chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta gout, unspecified cirrhosis of liver without mention of alcohol other abnormal blood chemistry hyposmolality and/or hyponatremia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, unspecified personal history of sudden cardiac arrest obstructive sleep apnea (adult)(pediatric) other chronic pulmonary heart diseases other chronic pain anxiety state, unspecified heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified alcohol abuse, in remission atrial flutter unspecified acquired hypothyroidism automatic implantable cardiac defibrillator in situ acute kidney failure, unspecified acute on chronic systolic heart failure internal hemorrhoids without mention of complication
white f 40 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; ketorolac  30  mg ; ondansetron  4  mg ; acetaminophen  325-650  mg ; 
 
white f 89 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  155  mg dl$cyanocobalamin  500  mcg ; metoprolol succinate xl  12.5  mg ; tramadol  50  mg ; vitamin d  1000  unit ; warfarin  6  mg ; metoprolol tartrate  12.5  mg ; potassium chloride  40  meq ; diltiazem  30  mg ; metoprolol tartrate  25  mg ; metoprolol succinate xl  25  mg ; heparin  5000  unit ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  98  mg dl$cyanocobalamin  500  mcg ; tramadol  50  mg ; vitamin d  1000  unit ; warfarin  6  mg ; metoprolol tartrate  25  mg ; heparin  5000  unit ; albuterol inhaler  1-2  puff ; metoprolol tartrate  37.5  mg ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  87  mg dl$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; warfarin  6  mg ; metoprolol tartrate  37.5  mg ; metoprolol tartrate  50  mg ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$nan$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; warfarin  6  mg ; metoprolol tartrate  50  mg ; hydrocortisone oint 1%  1  appl ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$hematology blood inr(pt)  3.3  $cyanocobalamin  500  mcg ; vitamin d  1000  unit ; warfarin  6  mg ; metoprolol tartrate  50  mg ; hydrocortisone oint 1%  1  appl ; warfarin  3  mg ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$hematology blood hematocrit  41.2  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  2.5  ; chemistry blood glucose  101  mg dl$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; warfarin  3  mg ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$nan$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; warfarin  3  mg ; guaifenesin-dextromethorphan  5  ml ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$hematology blood hematocrit  40.6  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  98  mg dl$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; warfarin  3  mg ; guaifenesin-dextromethorphan  5  ml ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$hematology blood inr(pt)  2.3  $cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; warfarin  3  mg ; guaifenesin-dextromethorphan  5  ml ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$nan$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; warfarin  3  mg ; guaifenesin-dextromethorphan  5  ml ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$hematology blood inr(pt)  2.4  $cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; warfarin  3  mg ; guaifenesin-dextromethorphan  5  ml ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$nan$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; warfarin  3  mg ; guaifenesin-dextromethorphan  5  ml ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$nan$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; warfarin  3  mg ; guaifenesin-dextromethorphan  5  ml ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$hematology blood inr(pt)  2.2  $cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; warfarin  3  mg ; guaifenesin-dextromethorphan  5  ml ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$nan$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; warfarin  3  mg ; guaifenesin-dextromethorphan  5  ml ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$nan$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; warfarin  3  mg ; guaifenesin-dextromethorphan  5  ml ; artificial tears  1-2  drop ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$hematology blood inr(pt)  2.5  $cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; warfarin  3  mg ; guaifenesin-dextromethorphan  5  ml ; artificial tears  1-2  drop ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$nan$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; warfarin  3  mg ; guaifenesin-dextromethorphan  5  ml ; artificial tears  1-2  drop ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$nan$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; warfarin  3  mg ; guaifenesin-dextromethorphan  5  ml ; artificial tears  1-2  drop ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$hematology blood inr(pt)  2.8  $cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; warfarin  3  mg ; guaifenesin-dextromethorphan  5  ml ; artificial tears  1-2  drop ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$nan$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; warfarin  3  mg ; guaifenesin-dextromethorphan  5  ml ; artificial tears  1-2  drop ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$nan$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; warfarin  3  mg ; guaifenesin-dextromethorphan  5  ml ; artificial tears  1-2  drop ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$nan$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; warfarin  3  mg ; guaifenesin-dextromethorphan  5  ml ; artificial tears  1-2  drop ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$hematology blood inr(pt)  2.7  $cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; warfarin  3  mg ; guaifenesin-dextromethorphan  5  ml ; artificial tears  1-2  drop ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$nan$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; warfarin  3  mg ; guaifenesin-dextromethorphan  5  ml ; artificial tears  1-2  drop ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$hematology blood hematocrit  41.6  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  3.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  101  mg dl$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; warfarin  3  mg ; guaifenesin-dextromethorphan  5  ml ; artificial tears  1-2  drop ; warfarin  2.5  mg ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$nan$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; guaifenesin-dextromethorphan  5  ml ; artificial tears  1-2  drop ; warfarin  2.5  mg ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$nan$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; hydrocortisone oint 1%  1  appl ; guaifenesin-dextromethorphan  5  ml ; artificial tears  1-2  drop ; warfarin  2.5  mg ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$hematology blood inr(pt)  2.5  $cyanocobalamin  500  mcg ; vitamin d  1000  unit ; guaifenesin-dextromethorphan  5  ml ; artificial tears  1-2  drop ; warfarin  2.5  mg ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$nan$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; guaifenesin-dextromethorphan  5  ml ; artificial tears  1-2  drop ; warfarin  2.5  mg ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$hematology blood hematocrit  43.3  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  213  k ul; hematology blood inr(pt)  2.6  $cyanocobalamin  500  mcg ; vitamin d  1000  unit ; guaifenesin-dextromethorphan  5  ml ; artificial tears  1-2  drop ; warfarin  2.5  mg ; ipratropium-albuterol neb  1  neb ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$nan$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; guaifenesin-dextromethorphan  5  ml ; artificial tears  1-2  drop ; warfarin  2.5  mg ; ipratropium-albuterol neb  1  neb ; mirtazapine  7.5  mg ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$nan$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; guaifenesin-dextromethorphan  5  ml ; artificial tears  1-2  drop ; warfarin  2.5  mg ; ipratropium-albuterol neb  1  neb ; mirtazapine  7.5  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
white f 89 $nan$hematology blood hematocrit  44.8  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  189  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  102  mg dl; chemistry blood albumin  2.9  g dl; hematology blood bands  0  %$cyanocobalamin  500  mcg ; vitamin d  1000  unit ; guaifenesin-dextromethorphan  5  ml ; artificial tears  1-2  drop ; warfarin  2.5  mg ; ipratropium-albuterol neb  1  neb ; mirtazapine  7.5  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; cefpodoxime proxetil  100  mg ; 
long term (current) use of antithrombotics/antiplatelets paroxysmal atrial fibrillation personal history of nicotine dependence extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue [malt-lymphoma] personal history of other venous thrombosis and embolism malignant neoplasm of thorax other fatigue family history of malignant neoplasm of trachea, bronchus and lung metabolic encephalopathy persistent atrial fibrillation unspecified severe protein-calorie malnutrition effusion, right knee dehydration chronic diastolic (congestive) heart failure personal history of urinary (tract) infections pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere urinary tract infection, site not specified dysphagia, unspecified rash and other nonspecific skin eruption nontoxic goiter, unspecified sepsis, unspecified organism deficiency of other specified b group vitamins acute kidney failure, unspecified body mass index (bmi) 24.0-24.9, adult unspecified dementia with behavioral disturbance enterococcus as the cause of diseases classified elsewhere severe sepsis with septic shock long term (current) use of anticoagulants abnormal coagulation profile other specified types of non-hodgkin lymphoma, extranodal and solid organ sites adult failure to thrive 
black african american f 37 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  231  k ul$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; hydroxychloroquine sulfate  400  mg ; 
 
black african american f 37 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; hydroxychloroquine sulfate  400  mg ; 
 
black african american f 37 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; hydroxychloroquine sulfate  400  mg ; 
 
black african american f 37 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; hydroxychloroquine sulfate  400  mg ; 
 
white m 68 $nan$hematology blood hematocrit  40.8  %; hematology blood hematocrit  39.6  %; hematology blood hemoglobin  14.2  g dl; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  447  k ul; hematology blood platelet count  430  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  99  mg dl; chemistry blood glucose  97  mg dl; chemistry blood glucose  98  mg dl; blood gas blood sodium, whole blood  129  meq l$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  650  mg ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; metoprolol tartrate  12.5  mg ; ranitidine  150  mg ; citalopram  10  mg ; folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; omeprazole  20  mg ; aspirin ec  81  mg ; nystatin oral suspension  5  ml ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; heparin  5000  unit ; 0.9% sodium chloride  1000  ml ; 
other and unspecified hyperlipidemia tobacco use disorder other specified cardiac dysrhythmias personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other late effects of cerebrovascular disease, facial weakness other and unspecified alcohol dependence, unspecified intracerebral hemorrhage unspecified essential hypertension
white m 68 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  413  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  94  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; citalopram  10  mg ; folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; aspirin ec  81  mg ; nystatin oral suspension  5  ml ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; heparin  5000  unit ; 0.9% sodium chloride  1000  ml ; sodium chloride  1  gm ; 
other and unspecified hyperlipidemia tobacco use disorder other specified cardiac dysrhythmias personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other late effects of cerebrovascular disease, facial weakness other and unspecified alcohol dependence, unspecified intracerebral hemorrhage unspecified essential hypertension
white m 68 $nan$hematology blood hematocrit  38.4  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  369  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry urine chloride, urine  78  meq l; chemistry urine creatinine, urine  191  mg dl; chemistry urine potassium, urine  81  meq l; chemistry urine sodium, urine  90  meq l; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  136  mg dl; chemistry blood glucose  141  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; citalopram  10  mg ; folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; aspirin ec  81  mg ; nystatin oral suspension  5  ml ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; heparin  5000  unit ; sodium chloride  1  gm ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
other and unspecified hyperlipidemia tobacco use disorder other specified cardiac dysrhythmias personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other late effects of cerebrovascular disease, facial weakness other and unspecified alcohol dependence, unspecified intracerebral hemorrhage unspecified essential hypertension
white m 68 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  358  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  96  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; citalopram  10  mg ; folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; aspirin ec  81  mg ; nystatin oral suspension  5  ml ; heparin  5000  unit ; sodium chloride  1  gm ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
other and unspecified hyperlipidemia tobacco use disorder other specified cardiac dysrhythmias personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other late effects of cerebrovascular disease, facial weakness other and unspecified alcohol dependence, unspecified intracerebral hemorrhage unspecified essential hypertension
white m 68 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  335  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  90  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; citalopram  10  mg ; folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; aspirin ec  81  mg ; nystatin oral suspension  5  ml ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; heparin flush (10 units ml)  2  ml ; 
other and unspecified hyperlipidemia tobacco use disorder other specified cardiac dysrhythmias personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other late effects of cerebrovascular disease, facial weakness other and unspecified alcohol dependence, unspecified intracerebral hemorrhage unspecified essential hypertension
white m 68 $nan$hematology blood hematocrit  41.2  %; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  369  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  90  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; aspirin ec  81  mg ; nystatin oral suspension  5  ml ; heparin  5000  unit ; heparin flush (10 units ml)  2  ml ; furosemide  20  mg ; lisinopril  20  mg ; sodium chloride 3% (hypertonic)  500  ml ; 
other and unspecified hyperlipidemia tobacco use disorder other specified cardiac dysrhythmias personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other late effects of cerebrovascular disease, facial weakness other and unspecified alcohol dependence, unspecified intracerebral hemorrhage unspecified essential hypertension
white m 68 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  278  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  95  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; aspirin ec  81  mg ; nystatin oral suspension  5  ml ; heparin  5000  unit ; heparin flush (10 units ml)  2  ml ; furosemide  20  mg ; lisinopril  20  mg ; sodium chloride 3% (hypertonic)  500  ml ; sodium chloride  2  gm ; pneumococcal vac polyvalent  0.5  ml ; 
other and unspecified hyperlipidemia tobacco use disorder other specified cardiac dysrhythmias personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other late effects of cerebrovascular disease, facial weakness other and unspecified alcohol dependence, unspecified intracerebral hemorrhage unspecified essential hypertension
white m 68 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  271  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; aspirin ec  81  mg ; heparin  5000  unit ; heparin flush (10 units ml)  2  ml ; furosemide  20  mg ; lisinopril  20  mg ; sodium chloride  2  gm ; pneumococcal vac polyvalent  0.5  ml ; 
other and unspecified hyperlipidemia tobacco use disorder other specified cardiac dysrhythmias personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits other late effects of cerebrovascular disease, facial weakness other and unspecified alcohol dependence, unspecified intracerebral hemorrhage unspecified essential hypertension
black african american f 65 $temp  97.9  heartrate  77.0  resprate  16.0  o2sat  99.0  sbp  140.0  dbp  90.0  rhythm    pain  3  ; temp  97.6  heartrate  66.0  resprate  16.0  o2sat  100.0  sbp  114.0  dbp  73.0  rhythm    pain  8  ; temp  98.0  heartrate  77.0  resprate  18.0  o2sat  100.0  sbp  108.0  dbp  65.0  rhythm    pain  0 10  $hematology blood hematocrit  39.3  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  144  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  89  mg dl$vitamin d  800  unit ; levothyroxine sodium  50  mcg ; abacavir sulfate  600  mg ; lamivudine  300  mg ; sodium chloride 0.9%  flush  3  ml ; diazepam  2.5-5  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  1000  mg ; ondansetron  4  mg ; senna  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; 
osteoporosis, unspecified other and unspecified hyperlipidemia constipation, unspecified anemia, unspecified tietze's disease asymptomatic human immunodeficiency virus [hiv] infection status leukocytopenia, unspecified other respiratory abnormalities
black african american f 65 $nan$hematology blood hematocrit  42.5  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  189  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  92  mg dl$vitamin d  800  unit ; levothyroxine sodium  50  mcg ; abacavir sulfate  600  mg ; lamivudine  300  mg ; sodium chloride 0.9%  flush  3  ml ; diazepam  2.5-5  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  1000  mg ; ondansetron  4  mg ; senna  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; calcium carbonate  500  mg ; nabumetone  500  mg ; raltegravir  400  mg ; sulfameth trimethoprim ds  2  tab ; docusate sodium  100  mg ; heparin  5000  unit ; gabapentin  600  mg ; gabapentin  300  mg ; amoxicillin-clavulanic acid  875  mg ; 
osteoporosis, unspecified other and unspecified hyperlipidemia constipation, unspecified anemia, unspecified tietze's disease asymptomatic human immunodeficiency virus [hiv] infection status leukocytopenia, unspecified other respiratory abnormalities
black african american f 65 $nan$nan$vitamin d  800  unit ; levothyroxine sodium  50  mcg ; abacavir sulfate  600  mg ; lamivudine  300  mg ; sodium chloride 0.9%  flush  3  ml ; diazepam  2.5-5  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  1000  mg ; ondansetron  4  mg ; senna  1  tab ; calcium carbonate  500  mg ; nabumetone  500  mg ; raltegravir  400  mg ; sulfameth trimethoprim ds  2  tab ; docusate sodium  100  mg ; heparin  5000  unit ; gabapentin  600  mg ; gabapentin  300  mg ; amoxicillin-clavulanic acid  875  mg ; 
osteoporosis, unspecified other and unspecified hyperlipidemia constipation, unspecified anemia, unspecified tietze's disease asymptomatic human immunodeficiency virus [hiv] infection status leukocytopenia, unspecified other respiratory abnormalities
white f 24 $temp  97.8  heartrate  82.0  resprate  16.0  o2sat  96.0  sbp  120.0  dbp  59.0  rhythm    pain  7  $hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  230  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  106  mg dl; chemistry blood albumin  3.9  g dl; hematology blood bands  0  %; blood gas blood lactate  2.1  mmol l$nan
other chronic pain acute lymphoid leukemia, without mention of having achieved remission tobacco use disorder nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] other respiratory abnormalities thrombocytopenia, unspecified anemia, unspecified long-term (current) use of anticoagulants backache, unspecified attention deficit disorder with hyperactivity depressive disorder, not elsewhere classified cough anxiety state, unspecified asthma, unspecified type, unspecified obesity, unspecified acute venous embolism and thrombosis of subclavian veins anxiety state, unspecified other complications due to other vascular device, implant, and graft other constipation acute sinusitis, unspecified personal history of antineoplastic chemotherapy asthma, unspecified type, unspecified acute lymphoid leukemia, without mention of having achieved remission unspecified otitis media depressive disorder, not elsewhere classified insomnia, unspecified acute lymphoid leukemia, without mention of having achieved remission other chest pain tobacco use disorder other respiratory abnormalities allergic urticaria antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use drug induced neutropenia person on outside of bus injured in collision with pedestrian or animal in traffic accident personal history of tobacco use depressive disorder, not elsewhere classified nausea with vomiting headache unspecified hereditary and idiopathic peripheral neuropathy asthma, unspecified type, unspecified thrombocytopenia, unspecified urinary frequency acute lymphoid leukemia, in remission examination of participant in clinical trial antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use attention deficit disorder with hyperactivity fever presenting with conditions classified elsewhere other specified cardiac dysrhythmias
white f 24 $temp  97.2  heartrate  86.0  resprate  16.0  o2sat  99.0  sbp  124.0  dbp  78.0  rhythm    pain    ; temp  98.7  heartrate  79.0  resprate  18.0  o2sat  99.0  sbp  116.0  dbp  75.0  rhythm    pain    $hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  135  mg dl; chemistry blood lactate dehydrogenase (ld)  352  iu l; chemistry blood albumin  3.8  g dl; hematology blood bands  1  %$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   10  mg ; acyclovir  400  mg ; albuterol inhaler  2  puff ; dapsone  100  mg ; folic acid  1  mg ; lidocaine viscous 2%  20  ml ; lorazepam  0.5-2  mg ; omeprazole  40  mg ; venlafaxine xr  37.5  mg ; venlafaxine xr  75  mg ; senna  1  tab ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; docusate sodium  100  mg ; hydrocortisone  25  mg ; methotrexate sodium p.f.  12  mg ; 0.9% sodium chloride p.f. (syringe)  6  ml ; cytarabine  40  mg ; hydrocortisone  50  mg ; oxycodone (immediate release)   5  mg ; zolpidem tartrate  5  mg ; ondansetron  4  mg ; 
other chronic pain acute lymphoid leukemia, without mention of having achieved remission tobacco use disorder nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] other respiratory abnormalities thrombocytopenia, unspecified anemia, unspecified long-term (current) use of anticoagulants backache, unspecified attention deficit disorder with hyperactivity depressive disorder, not elsewhere classified cough anxiety state, unspecified asthma, unspecified type, unspecified obesity, unspecified acute venous embolism and thrombosis of subclavian veins anxiety state, unspecified other complications due to other vascular device, implant, and graft other constipation acute sinusitis, unspecified personal history of antineoplastic chemotherapy asthma, unspecified type, unspecified acute lymphoid leukemia, without mention of having achieved remission unspecified otitis media depressive disorder, not elsewhere classified insomnia, unspecified acute lymphoid leukemia, without mention of having achieved remission other chest pain tobacco use disorder other respiratory abnormalities allergic urticaria antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use drug induced neutropenia person on outside of bus injured in collision with pedestrian or animal in traffic accident personal history of tobacco use depressive disorder, not elsewhere classified nausea with vomiting headache unspecified hereditary and idiopathic peripheral neuropathy asthma, unspecified type, unspecified thrombocytopenia, unspecified urinary frequency acute lymphoid leukemia, in remission examination of participant in clinical trial antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use attention deficit disorder with hyperactivity fever presenting with conditions classified elsewhere other specified cardiac dysrhythmias
white f 24 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  104  mg dl; chemistry blood lactate dehydrogenase (ld)  304  iu l; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   10  mg ; acyclovir  400  mg ; albuterol inhaler  2  puff ; dapsone  100  mg ; folic acid  1  mg ; lidocaine viscous 2%  20  ml ; lorazepam  0.5-2  mg ; omeprazole  40  mg ; venlafaxine xr  37.5  mg ; venlafaxine xr  75  mg ; senna  1  tab ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; docusate sodium  100  mg ; hydrocortisone  50  mg ; oxycodone (immediate release)   5  mg ; zolpidem tartrate  5  mg ; ondansetron  4  mg ; vitamin d  50,000  unit ; 
other chronic pain acute lymphoid leukemia, without mention of having achieved remission tobacco use disorder nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] other respiratory abnormalities thrombocytopenia, unspecified anemia, unspecified long-term (current) use of anticoagulants backache, unspecified attention deficit disorder with hyperactivity depressive disorder, not elsewhere classified cough anxiety state, unspecified asthma, unspecified type, unspecified obesity, unspecified acute venous embolism and thrombosis of subclavian veins anxiety state, unspecified other complications due to other vascular device, implant, and graft other constipation acute sinusitis, unspecified personal history of antineoplastic chemotherapy asthma, unspecified type, unspecified acute lymphoid leukemia, without mention of having achieved remission unspecified otitis media depressive disorder, not elsewhere classified insomnia, unspecified acute lymphoid leukemia, without mention of having achieved remission other chest pain tobacco use disorder other respiratory abnormalities allergic urticaria antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use drug induced neutropenia person on outside of bus injured in collision with pedestrian or animal in traffic accident personal history of tobacco use depressive disorder, not elsewhere classified nausea with vomiting headache unspecified hereditary and idiopathic peripheral neuropathy asthma, unspecified type, unspecified thrombocytopenia, unspecified urinary frequency acute lymphoid leukemia, in remission examination of participant in clinical trial antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use attention deficit disorder with hyperactivity fever presenting with conditions classified elsewhere other specified cardiac dysrhythmias
black african american m 78 $temp  97.5  heartrate  60.0  resprate  16.0  o2sat  99.0  sbp  184.0  dbp  97.0  rhythm    pain  6  ; temp    heartrate  77.0  resprate  18.0  o2sat  99.0  sbp  210.0  dbp  108.0  rhythm    pain  6  ; temp  98.3  heartrate  68.0  resprate  21.0  o2sat  99.0  sbp  189.0  dbp  96.0  rhythm    pain  5  ; temp  97.5  heartrate  64.0  resprate  28.0  o2sat  98.0  sbp  193.0  dbp  116.0  rhythm    pain  7  ; temp  97.4  heartrate  74.0  resprate  20.0  o2sat  95.0  sbp  191.0  dbp  117.0  rhythm    pain  5  ; temp  97.6  heartrate  65.0  resprate  16.0  o2sat  98.0  sbp  191.0  dbp  109.0  rhythm    pain  0  $hematology blood hematocrit  40.4  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  98  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  5.2  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  1  # hpf; chemistry blood glucose  130  mg dl; chemistry blood glucose  103  mg dl; blood gas blood lactate  1.6  mmol l$nan
thrombocytopenia, unspecified acute on chronic systolic heart failure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled old myocardial infarction pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident other acute and subacute forms of ischemic heart disease, other tobacco use disorder hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of surgery to heart and great vessels, presenting hazards to health hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia mitral valve disorders congestive heart failure, unspecified anxiety state, unspecified chronic kidney disease, unspecified long-term (current) use of aspirin tobacco use disorder hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) other and unspecified hyperlipidemia peripheral vascular disease, unspecified pain in limb acute on chronic systolic heart failure chronic kidney disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin congestive heart failure, unspecified subendocardial infarction, initial episode of care pain in joint, ankle and foot old myocardial infarction anemia, unspecified hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified thrombocytopenia, unspecified tobacco use disorder acute on chronic systolic heart failure hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) other acute and subacute forms of ischemic heart disease, other hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery acute kidney failure, unspecified personal history of noncompliance with medical treatment, presenting hazards to health diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of venous thrombosis and embolism chronic kidney disease, unspecified congestive heart failure, unspecified acute kidney failure, unspecified abdominal aneurysm, ruptured other acute and subacute forms of ischemic heart disease, other
black african american m 78 $temp    heartrate  67.0  resprate  14.0  o2sat  98.0  sbp  188.0  dbp  111.0  rhythm    pain  asleep  ; temp    heartrate  68.0  resprate  16.0  o2sat  98.0  sbp  192.0  dbp  106.0  rhythm    pain  asleep  ; temp  97.5  heartrate  66.0  resprate  20.0  o2sat  99.0  sbp  184.0  dbp  103.0  rhythm    pain  5  ; temp    heartrate  66.0  resprate  18.0  o2sat  100.0  sbp  178.0  dbp  99.0  rhythm    pain  4  ; temp  97.3  heartrate  59.0  resprate  18.0  o2sat  100.0  sbp  191.0  dbp  99.0  rhythm    pain  4  ; temp  97.7  heartrate  54.0  resprate  18.0  o2sat  100.0  sbp  163.0  dbp  105.0  rhythm    pain  0  $hematology blood hematocrit  39.4  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  105  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood urea nitrogen  50  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  119  mg dl; chemistry blood glucose  171  mg dl; chemistry blood albumin  3.7  g dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  40  mg ; bisacodyl  10  mg ; hydralazine  25  mg ; isosorbide mononitrate (extended release)  60  mg ; lisinopril  20  mg ; polyethylene glycol  17  g ; doxazosin  4  mg ; clonidine  0.2  mg ; d5w  250  ml ; nitroglycerin  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; isosorbide dinitrate  40  mg ; furosemide  80  mg ; furosemide  120  mg ; hydralazine  50  mg ; carvedilol  12.5  mg ; 
thrombocytopenia, unspecified acute on chronic systolic heart failure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled old myocardial infarction pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident other acute and subacute forms of ischemic heart disease, other tobacco use disorder hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of surgery to heart and great vessels, presenting hazards to health hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia mitral valve disorders congestive heart failure, unspecified anxiety state, unspecified chronic kidney disease, unspecified long-term (current) use of aspirin tobacco use disorder hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) other and unspecified hyperlipidemia peripheral vascular disease, unspecified pain in limb acute on chronic systolic heart failure chronic kidney disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin congestive heart failure, unspecified subendocardial infarction, initial episode of care pain in joint, ankle and foot old myocardial infarction anemia, unspecified hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified thrombocytopenia, unspecified tobacco use disorder acute on chronic systolic heart failure hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) other acute and subacute forms of ischemic heart disease, other hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery acute kidney failure, unspecified personal history of noncompliance with medical treatment, presenting hazards to health diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of venous thrombosis and embolism chronic kidney disease, unspecified congestive heart failure, unspecified acute kidney failure, unspecified abdominal aneurysm, ruptured other acute and subacute forms of ischemic heart disease, other
black african american m 78 $nan$hematology blood hematocrit  37.3  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  99  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood urea nitrogen  54  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  87  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  40  mg ; bisacodyl  10  mg ; lisinopril  20  mg ; polyethylene glycol  17  g ; doxazosin  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; furosemide  120  mg ; hydralazine  50  mg ; carvedilol  12.5  mg ; hydralazine  75  mg ; hydralazine  100  mg ; clonidine  0.1  mg ; 
thrombocytopenia, unspecified acute on chronic systolic heart failure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled old myocardial infarction pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident other acute and subacute forms of ischemic heart disease, other tobacco use disorder hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of surgery to heart and great vessels, presenting hazards to health hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia mitral valve disorders congestive heart failure, unspecified anxiety state, unspecified chronic kidney disease, unspecified long-term (current) use of aspirin tobacco use disorder hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) other and unspecified hyperlipidemia peripheral vascular disease, unspecified pain in limb acute on chronic systolic heart failure chronic kidney disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin congestive heart failure, unspecified subendocardial infarction, initial episode of care pain in joint, ankle and foot old myocardial infarction anemia, unspecified hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified thrombocytopenia, unspecified tobacco use disorder acute on chronic systolic heart failure hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) other acute and subacute forms of ischemic heart disease, other hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery acute kidney failure, unspecified personal history of noncompliance with medical treatment, presenting hazards to health diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of venous thrombosis and embolism chronic kidney disease, unspecified congestive heart failure, unspecified acute kidney failure, unspecified abdominal aneurysm, ruptured other acute and subacute forms of ischemic heart disease, other
black african american m 78 $nan$chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  52  mg dl; chemistry blood urea nitrogen  49  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  107  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  40  mg ; bisacodyl  10  mg ; lisinopril  20  mg ; polyethylene glycol  17  g ; doxazosin  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; carvedilol  12.5  mg ; hydralazine  100  mg ; clonidine  0.1  mg ; spironolactone  25  mg ; 
thrombocytopenia, unspecified acute on chronic systolic heart failure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled old myocardial infarction pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident other acute and subacute forms of ischemic heart disease, other tobacco use disorder hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of surgery to heart and great vessels, presenting hazards to health hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia mitral valve disorders congestive heart failure, unspecified anxiety state, unspecified chronic kidney disease, unspecified long-term (current) use of aspirin tobacco use disorder hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) other and unspecified hyperlipidemia peripheral vascular disease, unspecified pain in limb acute on chronic systolic heart failure chronic kidney disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin congestive heart failure, unspecified subendocardial infarction, initial episode of care pain in joint, ankle and foot old myocardial infarction anemia, unspecified hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified thrombocytopenia, unspecified tobacco use disorder acute on chronic systolic heart failure hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) other acute and subacute forms of ischemic heart disease, other hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery acute kidney failure, unspecified personal history of noncompliance with medical treatment, presenting hazards to health diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of venous thrombosis and embolism chronic kidney disease, unspecified congestive heart failure, unspecified acute kidney failure, unspecified abdominal aneurysm, ruptured other acute and subacute forms of ischemic heart disease, other
black african american m 78 $nan$chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  40  mg ; bisacodyl  10  mg ; lisinopril  20  mg ; polyethylene glycol  17  g ; doxazosin  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; carvedilol  12.5  mg ; hydralazine  100  mg ; spironolactone  25  mg ; potassium chloride  20  meq ; torsemide  80  mg ; hydralazine  150  mg ; torsemide  40  mg ; isosorbide dinitrate  60  mg ; 
thrombocytopenia, unspecified acute on chronic systolic heart failure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled old myocardial infarction pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident other acute and subacute forms of ischemic heart disease, other tobacco use disorder hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of surgery to heart and great vessels, presenting hazards to health hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia mitral valve disorders congestive heart failure, unspecified anxiety state, unspecified chronic kidney disease, unspecified long-term (current) use of aspirin tobacco use disorder hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) other and unspecified hyperlipidemia peripheral vascular disease, unspecified pain in limb acute on chronic systolic heart failure chronic kidney disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin congestive heart failure, unspecified subendocardial infarction, initial episode of care pain in joint, ankle and foot old myocardial infarction anemia, unspecified hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified thrombocytopenia, unspecified tobacco use disorder acute on chronic systolic heart failure hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) other acute and subacute forms of ischemic heart disease, other hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery acute kidney failure, unspecified personal history of noncompliance with medical treatment, presenting hazards to health diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of venous thrombosis and embolism chronic kidney disease, unspecified congestive heart failure, unspecified acute kidney failure, unspecified abdominal aneurysm, ruptured other acute and subacute forms of ischemic heart disease, other
black african american m 78 $nan$chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  56  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  97  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  40  mg ; bisacodyl  10  mg ; lisinopril  20  mg ; polyethylene glycol  17  g ; doxazosin  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; carvedilol  12.5  mg ; spironolactone  25  mg ; hydralazine  150  mg ; torsemide  40  mg ; isosorbide dinitrate  60  mg ; hydralazine  5  mg ; lisinopril  40  mg ; 
thrombocytopenia, unspecified acute on chronic systolic heart failure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled old myocardial infarction pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident other acute and subacute forms of ischemic heart disease, other tobacco use disorder hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of surgery to heart and great vessels, presenting hazards to health hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia mitral valve disorders congestive heart failure, unspecified anxiety state, unspecified chronic kidney disease, unspecified long-term (current) use of aspirin tobacco use disorder hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) other and unspecified hyperlipidemia peripheral vascular disease, unspecified pain in limb acute on chronic systolic heart failure chronic kidney disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin congestive heart failure, unspecified subendocardial infarction, initial episode of care pain in joint, ankle and foot old myocardial infarction anemia, unspecified hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified thrombocytopenia, unspecified tobacco use disorder acute on chronic systolic heart failure hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) other acute and subacute forms of ischemic heart disease, other hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery acute kidney failure, unspecified personal history of noncompliance with medical treatment, presenting hazards to health diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of venous thrombosis and embolism chronic kidney disease, unspecified congestive heart failure, unspecified acute kidney failure, unspecified abdominal aneurysm, ruptured other acute and subacute forms of ischemic heart disease, other
white f 98 $temp    heartrate  69.0  resprate  16.0  o2sat  97.0  sbp  129.0  dbp  98.0  rhythm    pain    ; temp  98.0  heartrate  69.0  resprate  16.0  o2sat  97.0  sbp  129.0  dbp  98.0  rhythm  normal sinus rhythm  pain  uta  $hematology blood hematocrit  36.5  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  126  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  95  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; bisacodyl  10  mg ; docusate sodium  100  mg ; ipratropium-albuterol neb  1  neb ; milk of magnesia  30  ml ; senna  17.2  mg ; metoprolol tartrate  12.5  mg ; heparin  5000  unit ; d5 1 2ns  1000  ml ; olanzapine (disintegrating tablet)  2.5  mg ; vitamin d  5000  unit ; levothyroxine sodium  75  mcg ; 
unqualified visual loss, both eyes chronic kidney disease, stage iv (severe) dementia, unspecified, without behavioral disturbance hyperosmolality and/or hypernatremia atrial fibrillation unspecified pleural effusion infection with microorganisms without mention of resistance to multiple drugs unspecified hearing loss pneumonia, organism unspecified unspecified glaucoma osteoporosis, unspecified toxic encephalopathy cephalosporin group causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified acquired hypothyroidism streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] dermatitis due to drugs and medicines taken internally hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acidosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iv (severe) esophageal reflux dementia, unspecified, without behavioral disturbance proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site diarrhea dermatitis due to drugs and medicines taken internally osteoporosis, unspecified do not resuscitate status unspecified acquired hypothyroidism urinary tract infection, site not specified acute kidney failure, unspecified cephalosporin group causing adverse effects in therapeutic use delirium due to conditions classified elsewhere other specified antibiotics causing adverse effects in therapeutic use personal history of colonic polyps dementia in conditions classified elsewhere without behavioral disturbance hyperosmolality and/or hypernatremia dermatitis due to drugs and medicines taken internally atrial fibrillation toxic erythema toxic encephalopathy do not resuscitate status acute kidney failure, unspecified unspecified glaucoma leukocytosis, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site chronic kidney disease, stage iv (severe) urinary tract infection, site not specified
white f 98 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  112  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  75  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; bisacodyl  10  mg ; docusate sodium  100  mg ; ipratropium-albuterol neb  1  neb ; milk of magnesia  30  ml ; senna  17.2  mg ; metoprolol tartrate  12.5  mg ; heparin  5000  unit ; olanzapine (disintegrating tablet)  2.5  mg ; vitamin d  5000  unit ; levothyroxine sodium  75  mcg ; 
unqualified visual loss, both eyes chronic kidney disease, stage iv (severe) dementia, unspecified, without behavioral disturbance hyperosmolality and/or hypernatremia atrial fibrillation unspecified pleural effusion infection with microorganisms without mention of resistance to multiple drugs unspecified hearing loss pneumonia, organism unspecified unspecified glaucoma osteoporosis, unspecified toxic encephalopathy cephalosporin group causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified acquired hypothyroidism streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] dermatitis due to drugs and medicines taken internally hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acidosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iv (severe) esophageal reflux dementia, unspecified, without behavioral disturbance proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site diarrhea dermatitis due to drugs and medicines taken internally osteoporosis, unspecified do not resuscitate status unspecified acquired hypothyroidism urinary tract infection, site not specified acute kidney failure, unspecified cephalosporin group causing adverse effects in therapeutic use delirium due to conditions classified elsewhere other specified antibiotics causing adverse effects in therapeutic use personal history of colonic polyps dementia in conditions classified elsewhere without behavioral disturbance hyperosmolality and/or hypernatremia dermatitis due to drugs and medicines taken internally atrial fibrillation toxic erythema toxic encephalopathy do not resuscitate status acute kidney failure, unspecified unspecified glaucoma leukocytosis, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site chronic kidney disease, stage iv (severe) urinary tract infection, site not specified
white f 98 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; bisacodyl  10  mg ; docusate sodium  100  mg ; ipratropium-albuterol neb  1  neb ; milk of magnesia  30  ml ; senna  17.2  mg ; metoprolol tartrate  12.5  mg ; heparin  5000  unit ; olanzapine (disintegrating tablet)  2.5  mg ; vitamin d  5000  unit ; levothyroxine sodium  75  mcg ; 
unqualified visual loss, both eyes chronic kidney disease, stage iv (severe) dementia, unspecified, without behavioral disturbance hyperosmolality and/or hypernatremia atrial fibrillation unspecified pleural effusion infection with microorganisms without mention of resistance to multiple drugs unspecified hearing loss pneumonia, organism unspecified unspecified glaucoma osteoporosis, unspecified toxic encephalopathy cephalosporin group causing adverse effects in therapeutic use urinary tract infection, site not specified unspecified acquired hypothyroidism streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] dermatitis due to drugs and medicines taken internally hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acidosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iv (severe) esophageal reflux dementia, unspecified, without behavioral disturbance proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site diarrhea dermatitis due to drugs and medicines taken internally osteoporosis, unspecified do not resuscitate status unspecified acquired hypothyroidism urinary tract infection, site not specified acute kidney failure, unspecified cephalosporin group causing adverse effects in therapeutic use delirium due to conditions classified elsewhere other specified antibiotics causing adverse effects in therapeutic use personal history of colonic polyps dementia in conditions classified elsewhere without behavioral disturbance hyperosmolality and/or hypernatremia dermatitis due to drugs and medicines taken internally atrial fibrillation toxic erythema toxic encephalopathy do not resuscitate status acute kidney failure, unspecified unspecified glaucoma leukocytosis, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site chronic kidney disease, stage iv (severe) urinary tract infection, site not specified
white f 92 $temp  98.5  heartrate  86.0  resprate  15.0  o2sat  96.0  sbp  155.0  dbp  79.0  rhythm    pain  0  $hematology blood hematocrit  34.0  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  235  mg dl; chemistry blood albumin  3.4  g dl; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  3.9  mmol l; blood gas blood lactate  3.2  mmol l$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; levothyroxine sodium  25  mcg ; lidocaine jelly 2%  1  appl ; lidocaine viscous 2%  15  ml ; metoprolol succinate xl  25  mg ; multivitamins  1  tab ; omeprazole  20  mg ; ondansetron  4  mg ; oxcarbazepine  75  mg ; sertraline  25  mg ; terazosin  1  mg ; morphine sulfate (oral soln.)  5  mg ; vitamin d  1000  unit ; carbamazepine  300  mg ; d5 1 2ns  1000  ml ; celecoxib  200  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  1000  ml ; potassium chloride  60  meq ; potassium chloride (powder)  60  meq ; oxcarbazepine  150  mg ; sw  400  ml ; potassium chloride  40  meq ; sw  200  ml ; potassium chloride  20  meq ; 
 
white f 92 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  105  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  176  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; levothyroxine sodium  25  mcg ; lidocaine jelly 2%  1  appl ; lidocaine viscous 2%  15  ml ; metoprolol succinate xl  25  mg ; multivitamins  1  tab ; omeprazole  20  mg ; ondansetron  4  mg ; sertraline  25  mg ; terazosin  1  mg ; vitamin d  1000  unit ; carbamazepine  300  mg ; celecoxib  200  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; potassium chloride (powder)  60  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  200  ml ; potassium chloride  20  meq ; 
 
white f 92 $nan$hematology blood hematocrit  29.9  %; hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  103  k ul; hematology blood platelet count  98  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  162  mg dl; chemistry blood % hemoglobin a1c  7.4  %$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; levothyroxine sodium  25  mcg ; lidocaine jelly 2%  1  appl ; lidocaine viscous 2%  15  ml ; metoprolol succinate xl  25  mg ; multivitamins  1  tab ; omeprazole  20  mg ; ondansetron  4  mg ; sertraline  25  mg ; terazosin  1  mg ; vitamin d  1000  unit ; carbamazepine  300  mg ; celecoxib  200  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
 
white f 92 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; levothyroxine sodium  25  mcg ; lidocaine jelly 2%  1  appl ; lidocaine viscous 2%  15  ml ; metoprolol succinate xl  25  mg ; multivitamins  1  tab ; omeprazole  20  mg ; ondansetron  4  mg ; sertraline  25  mg ; terazosin  1  mg ; vitamin d  1000  unit ; carbamazepine  300  mg ; celecoxib  200  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
 
hispanic latino f 29 $nan$hematology blood hematocrit  35.9  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  306  k ul$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ketorolac  15  mg ; ketorolac  30  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
failed medical or unspecified induction of labor, antepartum condition or complication post term pregnancy, antepartum condition or complication
hispanic latino f 29 $nan$hematology blood hematocrit  30.5  %$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ketorolac  15  mg ; ketorolac  30  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
failed medical or unspecified induction of labor, antepartum condition or complication post term pregnancy, antepartum condition or complication
hispanic latino f 29 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
failed medical or unspecified induction of labor, antepartum condition or complication post term pregnancy, antepartum condition or complication
hispanic latino f 29 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
failed medical or unspecified induction of labor, antepartum condition or complication post term pregnancy, antepartum condition or complication
hispanic latino f 29 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
failed medical or unspecified induction of labor, antepartum condition or complication post term pregnancy, antepartum condition or complication
white f 83 $nan$nan$insulin  20  unit ; furosemide  40  mg ; omeprazole  20  mg ; aspirin  81  mg ; folic acid  1  mg ; ferrous sulfate  325  mg ; citalopram hydrobromide  20  mg ; clopidogrel  75  mg ; atorvastatin  20  mg ; 
 
white f 83 $nan$hematology blood hematocrit  31.8  %; hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  216  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood glucose  167  mg dl$insulin  20  unit ; furosemide  40  mg ; omeprazole  20  mg ; aspirin  81  mg ; folic acid  1  mg ; ferrous sulfate  325  mg ; citalopram hydrobromide  20  mg ; clopidogrel  75  mg ; atorvastatin  20  mg ; metoprolol tartrate  50  mg ; docusate sodium  100  mg ; senna  1  tab ; heparin  5000  unit ; diclofenac sodium dr  50  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  325-650  mg ; insulin  0  unit ; insulin  13  unit ; cyanocobalamin  100  mcg ; 
 
unknown f 61 $nan$hematology blood hematocrit  25.3  %; hematology blood hematocrit  26.3  %; hematology blood hematocrit  25.3  %; hematology blood hemoglobin  8.5  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  31  k ul; hematology blood platelet count  32  k ul; hematology blood platelet count  27  k ul; hematology blood platelet count  46  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  20  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood bicarbonate  11  meq l; chemistry blood bicarbonate  11  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  3.3  mg dl; chemistry blood creatinine  3.6  mg dl; chemistry blood creatinine  3.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry blood urea nitrogen  50  mg dl; chemistry blood urea nitrogen  54  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  6.5  mg dl; chemistry blood calcium, total  6.6  mg dl; chemistry blood calcium, total  6.2  mg dl; chemistry blood bilirubin, total  2.0  mg dl; chemistry blood glucose  239  mg dl; chemistry blood glucose  200  mg dl; chemistry blood glucose  146  mg dl; chemistry blood lactate dehydrogenase (ld)  426  iu l; chemistry blood albumin  2.0  g dl; hematology blood bands  3  %; blood gas blood free calcium  1.02  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  1.6  mmol l$influenza vaccine quadrivalent  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; soln  50  ml ; fentanyl citrate  2.5  mg ; propofol  1000  mg ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; heparin  5000  unit ; phenylephrine  50  mg ; phenylephrine  200  mg ; vial  1  vial ; cefepime  1  g ; iso-osmotic sodium chloride  0  bag ; calcium gluconate  0  g ; iso-osmotic sodium chloride  1  bag ; calcium gluconate  2  g ; iso-osmotic sodium chloride  2  bag ; calcium gluconate  4  g ; vasopressin  40  unit ; sodium bicarbonate  1300  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  3-10  ml ; metoprolol tartrate  6.25  mg ; vancomycin  0  md to order daily dose ; vancomycin  1250  mg ; lactated ringers  1000  ml ; heparin flush (100 units ml)  5  ml ; insulin  0  unit ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; artificial tears  1-2  drop ; 
 
unknown f 61 $nan$hematology blood hematocrit  24.1  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  55  k ul; hematology blood platelet count  51  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  3.6  mg dl; chemistry blood creatinine  3.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  57  mg dl; chemistry blood urea nitrogen  61  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  6.4  mg dl; chemistry blood calcium, total  6.4  mg dl; chemistry blood bilirubin, total  1.7  mg dl; chemistry blood glucose  189  mg dl; chemistry blood glucose  240  mg dl; chemistry blood lactate dehydrogenase (ld)  470  iu l; chemistry blood albumin  1.7  g dl; hematology blood bands  5  %; blood gas blood lactate  1.3  mmol l$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; propofol  1000  mg ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; vial  1  vial ; cefepime  1  g ; iso-osmotic sodium chloride  0  bag ; calcium gluconate  0  g ; iso-osmotic sodium chloride  1  bag ; calcium gluconate  2  g ; iso-osmotic sodium chloride  2  bag ; calcium gluconate  4  g ; vasopressin  40  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  3-10  ml ; vancomycin  0  md to order daily dose ; vancomycin  1250  mg ; heparin flush (100 units ml)  5  ml ; insulin  0  unit ; artificial tears  1-2  drop ; sodium citrate 4%  1-2  ml ; heparin flush (1000 units ml)  2000-8000  unit ; famotidine  20  mg ; azithromycin  250  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; metoprolol tartrate  5  mg ; metoprolol tartrate  12.5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; amiodarone  150  mg ; 0.9% nacl (excel viaflo bag)  250  ml ; amiodarone  450  mg ; 
 
unknown f 61 $nan$hematology blood hematocrit  23.4  %; hematology blood hematocrit  23.6  %; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  53  k ul; hematology blood platelet count  53  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  11  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  3.4  mg dl; chemistry blood creatinine  3.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  60  mg dl; chemistry blood urea nitrogen  66  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  6.4  mg dl; chemistry blood calcium, total  6.5  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  268  mg dl; chemistry blood glucose  191  mg dl; chemistry blood albumin  1.7  g dl; hematology blood bands  2  %; blood gas blood free calcium  1.00  mmol l; blood gas blood lactate  1.1  mmol l$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; propofol  1000  mg ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; iso-osmotic sodium chloride  0  bag ; calcium gluconate  0  g ; iso-osmotic sodium chloride  1  bag ; calcium gluconate  2  g ; iso-osmotic sodium chloride  2  bag ; calcium gluconate  4  g ; vasopressin  40  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  3-10  ml ; vancomycin  0  md to order daily dose ; heparin flush (100 units ml)  5  ml ; insulin  0  unit ; artificial tears  1-2  drop ; heparin flush (1000 units ml)  2000-8000  unit ; famotidine  20  mg ; azithromycin  250  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; metoprolol tartrate  5  mg ; metoprolol tartrate  12.5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; amiodarone  150  mg ; amiodarone  200  mg ; furosemide  80  mg ; potassium chloride  20  meq ; mouth care oral rinse  7-15  ml ; 
 
unknown f 61 $nan$hematology blood hematocrit  26.4  %; hematology blood hematocrit  23.8  %; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  78  k ul; hematology blood platelet count  75  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  3.3  mg dl; chemistry blood creatinine  3.1  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  64  mg dl; chemistry blood urea nitrogen  66  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.0  mg dl; chemistry blood calcium, total  7.0  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  242  mg dl; chemistry blood glucose  298  mg dl; chemistry blood lactate dehydrogenase (ld)  741  iu l; chemistry blood albumin  1.4  g dl; blood gas blood free calcium  1.00  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood glucose  226  mg dl; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood potassium, whole blood  2.7  meq l$ceftriaxone  2  gm ; bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; propofol  1000  mg ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; iso-osmotic sodium chloride  0  bag ; calcium gluconate  0  g ; iso-osmotic sodium chloride  1  bag ; calcium gluconate  2  g ; iso-osmotic sodium chloride  2  bag ; calcium gluconate  4  g ; vasopressin  40  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  3-10  ml ; vancomycin  0  md to order daily dose ; heparin flush (100 units ml)  5  ml ; insulin  0  unit ; artificial tears  1-2  drop ; heparin flush (1000 units ml)  2000-8000  unit ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; amiodarone  200  mg ; furosemide  80  mg ; potassium chloride  20  meq ; mouth care oral rinse  7-15  ml ; dexmedetomidine  0.4  mg ; potassium chloride  40  meq ; metoprolol tartrate  25  mg ; acetaminophen (liquid)  650  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; insulin  12  unit ; nystatin ointment  1  appl ; heparin  1300-2600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; midazolam  100  mg ; dexmedetomidine  1  mg ; potassium chloride (powder)  20  meq ; 
 
unknown f 61 $nan$hematology blood hematocrit  22.1  %; hematology blood hematocrit  21.5  %; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  69  k ul; hematology blood platelet count  61  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  3.1  mg dl; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  65  mg dl; chemistry blood urea nitrogen  69  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.1  mg dl; chemistry blood calcium, total  6.7  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  227  mg dl; chemistry blood glucose  200  mg dl; chemistry blood albumin  2.1  g dl; blood gas blood free calcium  1.06  mmol l; blood gas blood free calcium  1.05  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood glucose  154  mg dl; blood gas blood glucose  223  mg dl; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood potassium, whole blood  2.7  meq l$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; iso-osmotic sodium chloride  0  bag ; calcium gluconate  0  g ; iso-osmotic sodium chloride  1  bag ; calcium gluconate  2  g ; iso-osmotic sodium chloride  2  bag ; calcium gluconate  4  g ; vasopressin  40  unit ; sodium chloride 0.9%  flush  3-10  ml ; vancomycin  0  md to order daily dose ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; heparin flush (1000 units ml)  2000-8000  unit ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; heparin  1300-2600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; midazolam  100  mg ; dexmedetomidine  1  mg ; potassium chloride (powder)  20  meq ; acetaminophen (liquid)  1000  mg ; potassium chloride (powder)  40  meq ; albumin 5% (12.5g   250ml)  25  g ; miconazole nitrate vag cream 2%  1  appl ; insulin  20  unit ; insulin  10  unit ; hydromorphone  20  mg ; 0.9% sodium chloride  50  ml ; desmopressin acetate  40  mcg ; 
 
unknown f 61 $nan$hematology blood hematocrit  20.3  %; hematology blood hematocrit  24.7  %; hematology blood hematocrit  24.8  %; hematology blood hemoglobin  6.7  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  57  k ul; hematology blood platelet count  65  k ul; hematology blood platelet count  70  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  67  mg dl; chemistry blood urea nitrogen  73  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  6.8  mg dl; chemistry blood calcium, total  7.0  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  206  mg dl; chemistry blood glucose  209  mg dl; chemistry blood lactate dehydrogenase (ld)  508  iu l; chemistry blood albumin  1.8  g dl; blood gas blood lactate  1.2  mmol l$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; iso-osmotic sodium chloride  0  bag ; calcium gluconate  0  g ; iso-osmotic sodium chloride  1  bag ; calcium gluconate  2  g ; iso-osmotic sodium chloride  2  bag ; calcium gluconate  4  g ; vancomycin  0  md to order daily dose ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; heparin flush (1000 units ml)  2000-8000  unit ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; midazolam  100  mg ; dexmedetomidine  1  mg ; acetaminophen (liquid)  1000  mg ; miconazole nitrate vag cream 2%  1  appl ; insulin  10  unit ; hydromorphone  20  mg ; 0.9% sodium chloride  50  ml ; desmopressin acetate  40  mcg ; insulin  30  unit ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; insulin  13  unit ; 
 
unknown f 61 $nan$hematology blood hematocrit  22.6  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  78  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  78  mg dl; chemistry blood urea nitrogen  80  mg dl; chemistry blood calcium, total  6.8  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood glucose  256  mg dl; chemistry blood glucose  276  mg dl; blood gas blood lactate  0.8  mmol l$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; iso-osmotic sodium chloride  0  bag ; calcium gluconate  0  g ; iso-osmotic sodium chloride  1  bag ; calcium gluconate  2  g ; iso-osmotic sodium chloride  2  bag ; calcium gluconate  4  g ; vancomycin  0  md to order daily dose ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; heparin flush (1000 units ml)  2000-8000  unit ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; midazolam  100  mg ; dexmedetomidine  1  mg ; acetaminophen (liquid)  1000  mg ; miconazole nitrate vag cream 2%  1  appl ; hydromorphone  20  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; insulin  13  unit ; quetiapine fumarate  12.5  mg ; midodrine  5  mg ; quetiapine fumarate  25  mg ; insulin  16  unit ; midodrine  10  mg ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; 
 
unknown f 61 $nan$hematology blood hematocrit  20.9  %; hematology blood hematocrit  24.4  %; hematology blood hemoglobin  6.8  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  104  k ul; hematology blood platelet count  100  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  83  mg dl; chemistry blood urea nitrogen  82  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  6.7  mg dl; chemistry blood calcium, total  6.9  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  134  mg dl; chemistry blood glucose  149  mg dl; chemistry blood lactate dehydrogenase (ld)  611  iu l; chemistry blood albumin  1.9  g dl; blood gas blood free calcium  1.05  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood glucose  118  mg dl; blood gas blood potassium, whole blood  2.9  meq l$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; iso-osmotic sodium chloride  0  bag ; calcium gluconate  0  g ; iso-osmotic sodium chloride  1  bag ; calcium gluconate  2  g ; iso-osmotic sodium chloride  2  bag ; calcium gluconate  4  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; heparin flush (1000 units ml)  2000-8000  unit ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; midazolam  100  mg ; dexmedetomidine  1  mg ; acetaminophen (liquid)  1000  mg ; miconazole nitrate vag cream 2%  1  appl ; hydromorphone  20  mg ; quetiapine fumarate  25  mg ; insulin  16  unit ; midodrine  10  mg ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; insulin  37  unit ; loperamide  2  mg ; insulin  8  unit ; midazolam  2  mg ; midodrine  20  mg ; 
 
unknown f 61 $nan$hematology blood hematocrit  24.7  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  80  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  6.8  mg dl; chemistry blood glucose  107  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; iso-osmotic sodium chloride  0  bag ; calcium gluconate  0  g ; iso-osmotic sodium chloride  1  bag ; calcium gluconate  2  g ; iso-osmotic sodium chloride  2  bag ; calcium gluconate  4  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; heparin flush (1000 units ml)  2000-8000  unit ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; miconazole nitrate vag cream 2%  1  appl ; hydromorphone  20  mg ; quetiapine fumarate  25  mg ; insulin  16  unit ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; insulin  37  unit ; loperamide  2  mg ; insulin  8  unit ; midazolam  2  mg ; midodrine  20  mg ; lidocaine jelly 2% (glydo)  1  appl ; ipratropium-albuterol neb  1  neb ; 
 
unknown f 61 $nan$hematology blood hematocrit  23.3  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  134  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  78  mg dl; chemistry blood urea nitrogen  82  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  231  mg dl; chemistry blood glucose  163  mg dl; chemistry blood lactate dehydrogenase (ld)  389  iu l; blood gas blood lactate  1.1  mmol l$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; iso-osmotic sodium chloride  0  bag ; calcium gluconate  0  g ; iso-osmotic sodium chloride  1  bag ; calcium gluconate  2  g ; iso-osmotic sodium chloride  2  bag ; calcium gluconate  4  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; heparin flush (1000 units ml)  2000-8000  unit ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; miconazole nitrate vag cream 2%  1  appl ; hydromorphone  20  mg ; quetiapine fumarate  25  mg ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; loperamide  2  mg ; lidocaine jelly 2% (glydo)  1  appl ; ipratropium-albuterol neb  1  neb ; 
 
unknown f 61 $nan$hematology blood hematocrit  23.8  %; hematology blood hematocrit  23.2  %; hematology blood hematocrit  21.4  %; hematology blood hemoglobin  7.4  g dl; hematology blood hemoglobin  7.2  g dl; hematology blood hemoglobin  6.6  g dl; hematology blood platelet count  176  k ul; hematology blood platelet count  182  k ul; hematology blood platelet count  169  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  78  mg dl; chemistry blood urea nitrogen  78  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  156  mg dl; chemistry blood glucose  143  mg dl; chemistry blood lactate dehydrogenase (ld)  404  iu l; chemistry blood albumin  2.3  g dl; hematology blood bands  1  %$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; iso-osmotic sodium chloride  0  bag ; calcium gluconate  0  g ; iso-osmotic sodium chloride  1  bag ; calcium gluconate  2  g ; iso-osmotic sodium chloride  2  bag ; calcium gluconate  4  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; heparin flush (1000 units ml)  2000-8000  unit ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; miconazole nitrate vag cream 2%  1  appl ; hydromorphone  20  mg ; quetiapine fumarate  25  mg ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; loperamide  2  mg ; 
 
unknown f 61 $nan$hematology blood hematocrit  27.0  %; hematology blood hematocrit  24.7  %; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  174  k ul; hematology blood platelet count  149  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  81  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  145  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; iso-osmotic sodium chloride  0  bag ; calcium gluconate  0  g ; iso-osmotic sodium chloride  1  bag ; calcium gluconate  2  g ; iso-osmotic sodium chloride  2  bag ; calcium gluconate  4  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; heparin flush (1000 units ml)  2000-8000  unit ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; miconazole nitrate vag cream 2%  1  appl ; hydromorphone  20  mg ; quetiapine fumarate  25  mg ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; loperamide  2  mg ; neutra-phos  1  pkt ; syringe (sw)  1  ml ; alteplase (catheter clearance)  1  mg ; 
 
unknown f 61 $nan$hematology blood hematocrit  24.8  %; hematology blood hematocrit  24.4  %; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  145  k ul; hematology blood platelet count  142  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  149  meq l; chemistry blood sodium  150  meq l; chemistry blood urea nitrogen  77  mg dl; chemistry blood urea nitrogen  69  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  159  mg dl; chemistry blood glucose  113  mg dl; blood gas blood lactate  0.8  mmol l$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; iso-osmotic sodium chloride  0  bag ; calcium gluconate  0  g ; iso-osmotic sodium chloride  1  bag ; calcium gluconate  2  g ; iso-osmotic sodium chloride  2  bag ; calcium gluconate  4  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; heparin flush (1000 units ml)  2000-8000  unit ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; quetiapine fumarate  25  mg ; loperamide  2  mg ; syringe (sw)  1  ml ; alteplase (catheter clearance)  1  mg ; acetylcysteine 20%  3-5  ml ; 
 
unknown f 61 $nan$hematology blood hematocrit  23.7  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  136  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  154  meq l; chemistry blood sodium  151  meq l; chemistry blood urea nitrogen  71  mg dl; chemistry blood urea nitrogen  68  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  164  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; heparin flush (1000 units ml)  2000-8000  unit ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; loperamide  2  mg ; acetylcysteine 20%  3-5  ml ; hydromorphone (dilaudid)  0.25  mg ; sterile water  50  ml ; 
 
unknown f 61 $nan$hematology blood hematocrit  23.8  %; hematology blood hematocrit  24.5  %; hematology blood hemoglobin  7.1  g dl; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  133  k ul; hematology blood platelet count  142  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  61  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  134  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; heparin flush (1000 units ml)  2000-8000  unit ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; loperamide  2  mg ; acetylcysteine 20%  3-5  ml ; sterile water  50  ml ; scopolamine patch  1  ptch ; 
 
unknown f 61 $nan$hematology blood hematocrit  22.6  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  121  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  92  mg dl; chemistry blood albumin  2.5  g dl$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; loperamide  2  mg ; acetylcysteine 20%  3-5  ml ; scopolamine patch  1  ptch ; 
 
unknown f 61 $nan$hematology blood hematocrit  23.3  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  122  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  115  mg dl; chemistry blood albumin  2.3  g dl$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; loperamide  2  mg ; acetylcysteine 20%  3-5  ml ; 
 
unknown f 61 $nan$hematology blood hematocrit  23.0  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  133  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  123  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; loperamide  2  mg ; acetylcysteine 20%  3-5  ml ; 
 
unknown f 61 $nan$hematology blood hematocrit  22.1  %; hematology blood hematocrit  26.0  %; hematology blood hemoglobin  6.6  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  140  k ul; hematology blood platelet count  156  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  127  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; loperamide  2  mg ; acetylcysteine 20%  3-5  ml ; guaifenesin  5-10  ml ; 
 
unknown f 61 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  101  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  125  mg dl; chemistry blood lactate dehydrogenase (ld)  434  iu l; hematology blood bands  4  %$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; loperamide  2  mg ; acetylcysteine 20%  3-5  ml ; guaifenesin  5-10  ml ; ciprofloxacin hcl  500  mg ; ceftazidime  1  g ; linezolid  600  mg ; 
 
unknown f 61 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  194  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  5.7  meq l; chemistry blood potassium  5.5  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  99  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  440  iu l; chemistry blood % hemoglobin a1c  6.7  %$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; acetylcysteine 20%  3-5  ml ; guaifenesin  5-10  ml ; ceftazidime  1  g ; linezolid  600  mg ; lorazepam  0.5  mg ; insulin (regular) for hyperkalemia  10  unit ; dextrose 50%  25  gm ; anastrozole  1  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; atorvastatin  40  mg ; 
 
unknown f 61 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  43  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  130  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; acetylcysteine 20%  3-5  ml ; guaifenesin  5-10  ml ; ceftazidime  1  g ; linezolid  600  mg ; lorazepam  0.5  mg ; anastrozole  1  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; atorvastatin  40  mg ; dakins 1 4 strength  1  appl ; 
 
unknown f 61 $nan$hematology blood hematocrit  24.8  %; hematology blood hematocrit  24.9  %; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  219  k ul; hematology blood platelet count  228  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  42  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  118  mg dl; blood gas blood lactate  1.1  mmol l$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; acetylcysteine 20%  3-5  ml ; guaifenesin  5-10  ml ; anastrozole  1  mg ; atorvastatin  40  mg ; dakins 1 4 strength  1  appl ; sodium chloride 0.9%  1000  ml ; insulin  32  unit ; oxycodone (immediate release)  5  mg ; lidocaine 1%  1  ml ; heparin  5200  unit ; 
 
unknown f 61 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  69  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; acetylcysteine 20%  3-5  ml ; guaifenesin  5-10  ml ; atorvastatin  40  mg ; dakins 1 4 strength  1  appl ; sodium chloride 0.9%  1000  ml ; oxycodone (immediate release)  5  mg ; lidocaine 1%  1  ml ; heparin  5200  unit ; ondansetron  4  mg ; 
 
unknown f 61 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  224  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood sodium  150  meq l; chemistry blood urea nitrogen  43  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  138  mg dl; chemistry blood lactate dehydrogenase (ld)  391  iu l$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; acetylcysteine 20%  3-5  ml ; guaifenesin  5-10  ml ; atorvastatin  40  mg ; dakins 1 4 strength  1  appl ; heparin  5200  unit ; ondansetron  4  mg ; 
 
unknown f 61 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  168  mg dl; chemistry blood lactate dehydrogenase (ld)  334  iu l$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; famotidine  20  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; acetylcysteine 20%  3-5  ml ; guaifenesin  5-10  ml ; atorvastatin  40  mg ; dakins 1 4 strength  1  appl ; heparin  5200  unit ; 
 
unknown f 61 $nan$hematology blood hematocrit  24.4  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  155  mg dl; chemistry blood albumin  2.8  g dl$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; acetylcysteine 20%  3-5  ml ; guaifenesin  5-10  ml ; atorvastatin  40  mg ; dakins 1 4 strength  1  appl ; heparin  5200  unit ; apixaban  5  mg ; metoprolol succinate xl  100  mg ; 
 
unknown f 61 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  194  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  119  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; acetylcysteine 20%  3-5  ml ; guaifenesin  5-10  ml ; atorvastatin  40  mg ; dakins 1 4 strength  1  appl ; metoprolol succinate xl  100  mg ; insulin  50  unit ; 
 
unknown f 61 $nan$nan$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; acetylcysteine 20%  3-5  ml ; guaifenesin  5-10  ml ; atorvastatin  40  mg ; metoprolol succinate xl  100  mg ; insulin  50  unit ; 
 
unknown f 61 $nan$nan$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; acetylcysteine 20%  3-5  ml ; guaifenesin  5-10  ml ; atorvastatin  40  mg ; metoprolol succinate xl  100  mg ; insulin  50  unit ; 
 
unknown f 61 $nan$nan$bisacodyl  10  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (100 units ml)  5  ml ; artificial tears  1-2  drop ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; acetaminophen (liquid)  1000  mg ; acetylcysteine 20%  3-5  ml ; guaifenesin  5-10  ml ; atorvastatin  40  mg ; metoprolol succinate xl  100  mg ; insulin  50  unit ; 
 
white f 76 $temp  98.5  heartrate  82.0  resprate  18.0  o2sat  97.0  sbp  109.0  dbp  68.0  rhythm    pain  0  $hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  156  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood glucose  138  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; tramadol  25  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lactated ringers  1000  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 
 
white f 76 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, indirect  0.4  mg dl; chemistry blood bilirubin, total  2.4  mg dl; chemistry blood glucose  98  mg dl; chemistry blood lactate dehydrogenase (ld)  211  iu l; chemistry blood bilirubin, direct  2.0  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; tramadol  25  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lactated ringers  1000  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 
 
white f 76 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  165  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, indirect  0.9  mg dl; chemistry blood bilirubin, total  4.0  mg dl; chemistry blood glucose  130  mg dl; chemistry blood bilirubin, direct  3.1  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; tramadol  25  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lactated ringers  1000  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; d5 1 2ns  1000  ml ; buspirone  5  mg ; bag  1  bag ; magnesium sulfate  2  gm ; ranitidine  150  mg ; 
 
white f 76 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood glucose  124  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; tramadol  25  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; buspirone  5  mg ; bag  1  bag ; magnesium sulfate  2  gm ; ranitidine  150  mg ; sertraline  150  mg ; omeprazole  20  mg ; 
 
white f 60 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  260  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  32  mg dl; hematology urine wbc  95  # hpf; chemistry blood glucose  103  mg dl; hematology blood bands  2  %; blood gas blood lactate  1.3  mmol l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl; hematology urine wbc clumps  rare  $nan
chronic kidney disease, unspecified congenital deficiency of other clotting factors other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation stricture or kinking of ureter hemorrhage complicating a procedure acute kidney failure with lesion of tubular necrosis kidney replaced by transplant hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history, urinary (tract) infection hydronephrosis urinary tract infection, site not specified stricture or kinking of ureter surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled complications of transplanted kidney unspecified essential hypertension acidosis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled primary hypercoagulable state edema gout, unspecified depressive disorder, not elsewhere classified unspecified essential hypertension surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified complications of transplanted kidney gout, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin anemia, unspecified urinary tract infection, site not specified kidney replaced by transplant hydronephrosis depressive disorder, not elsewhere classified acute kidney failure, unspecified unspecified essential hypertension car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident primary hypercoagulable state hyperpotassemia gout, unspecified congenital factor viii disorder kidney replaced by transplant hydronephrosis
white f 60 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  126  mg dl; hematology blood bands  1  %$meropenem  500  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; pantoprazole  40  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; tacrolimus  2  mg ; acetaminophen  325-650  mg ; myfortic  180  mg ; heparin  5000  unit ; gabapentin  300  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; glipizide  5  mg ; metoprolol succinate xl  100  mg ; sulfameth trimethoprim ss  1  tab ; aspirin  81  mg ; d5w  300  ml ; linezolid  600  mg ; warfarin  3  mg ; tacrolimus  3  mg ; hydrocodone-acetaminophen  1-2  tab ; 
chronic kidney disease, unspecified congenital deficiency of other clotting factors other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation stricture or kinking of ureter hemorrhage complicating a procedure acute kidney failure with lesion of tubular necrosis kidney replaced by transplant hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history, urinary (tract) infection hydronephrosis urinary tract infection, site not specified stricture or kinking of ureter surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled complications of transplanted kidney unspecified essential hypertension acidosis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled primary hypercoagulable state edema gout, unspecified depressive disorder, not elsewhere classified unspecified essential hypertension surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified complications of transplanted kidney gout, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin anemia, unspecified urinary tract infection, site not specified kidney replaced by transplant hydronephrosis depressive disorder, not elsewhere classified acute kidney failure, unspecified unspecified essential hypertension car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident primary hypercoagulable state hyperpotassemia gout, unspecified congenital factor viii disorder kidney replaced by transplant hydronephrosis
white f 60 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  165  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  100  mg dl; hematology blood bands  0  %$meropenem  500  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; pantoprazole  40  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; tacrolimus  2  mg ; myfortic  180  mg ; gabapentin  300  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; glipizide  5  mg ; metoprolol succinate xl  100  mg ; sulfameth trimethoprim ss  1  tab ; aspirin  81  mg ; d5w  300  ml ; linezolid  600  mg ; warfarin  3  mg ; tacrolimus  3  mg ; hydrocodone-acetaminophen  1-2  tab ; allopurinol  100  mg ; vial  1  vial ; filgrastim  480  mcg ; ondansetron  4  mg ; warfarin  2  mg ; ranitidine  150  mg ; diphenhydramine  50  mg ; vancomycin oral liquid  250  mg ; prednisone  40  mg ; 
chronic kidney disease, unspecified congenital deficiency of other clotting factors other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation stricture or kinking of ureter hemorrhage complicating a procedure acute kidney failure with lesion of tubular necrosis kidney replaced by transplant hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history, urinary (tract) infection hydronephrosis urinary tract infection, site not specified stricture or kinking of ureter surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled complications of transplanted kidney unspecified essential hypertension acidosis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled primary hypercoagulable state edema gout, unspecified depressive disorder, not elsewhere classified unspecified essential hypertension surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified complications of transplanted kidney gout, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin anemia, unspecified urinary tract infection, site not specified kidney replaced by transplant hydronephrosis depressive disorder, not elsewhere classified acute kidney failure, unspecified unspecified essential hypertension car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident primary hypercoagulable state hyperpotassemia gout, unspecified congenital factor viii disorder kidney replaced by transplant hydronephrosis
white f 60 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  5.7  meq l; chemistry blood potassium  5.2  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.8  ; hematology urine wbc  8  # hpf; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  191  mg dl; hematology blood bands  4  %; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$meropenem  500  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; pantoprazole  40  mg ; gabapentin  300  mg ; glipizide  5  mg ; metoprolol succinate xl  100  mg ; aspirin  81  mg ; d5w  300  ml ; linezolid  600  mg ; hydrocodone-acetaminophen  1-2  tab ; allopurinol  100  mg ; vial  1  vial ; filgrastim  480  mcg ; ondansetron  4  mg ; warfarin  2  mg ; ranitidine  150  mg ; diphenhydramine  50  mg ; vancomycin oral liquid  250  mg ; prednisone  40  mg ; furosemide  20  mg ; 0.9% sodium chloride  500  ml ; d5 1 2ns  1000  ml ; sodium chloride 0.9%  flush  10  ml ; warfarin  1  mg ; 
chronic kidney disease, unspecified congenital deficiency of other clotting factors other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation stricture or kinking of ureter hemorrhage complicating a procedure acute kidney failure with lesion of tubular necrosis kidney replaced by transplant hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history, urinary (tract) infection hydronephrosis urinary tract infection, site not specified stricture or kinking of ureter surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled complications of transplanted kidney unspecified essential hypertension acidosis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled primary hypercoagulable state edema gout, unspecified depressive disorder, not elsewhere classified unspecified essential hypertension surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified complications of transplanted kidney gout, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin anemia, unspecified urinary tract infection, site not specified kidney replaced by transplant hydronephrosis depressive disorder, not elsewhere classified acute kidney failure, unspecified unspecified essential hypertension car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident primary hypercoagulable state hyperpotassemia gout, unspecified congenital factor viii disorder kidney replaced by transplant hydronephrosis
white f 60 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  126  mg dl$meropenem  500  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; pantoprazole  40  mg ; gabapentin  300  mg ; glipizide  5  mg ; metoprolol succinate xl  100  mg ; aspirin  81  mg ; hydrocodone-acetaminophen  1-2  tab ; allopurinol  100  mg ; vancomycin oral liquid  250  mg ; furosemide  20  mg ; 0.9% sodium chloride  500  ml ; sodium chloride 0.9%  flush  10  ml ; warfarin  1  mg ; acetaminophen  650  mg ; fluconazole  400  mg ; 
chronic kidney disease, unspecified congenital deficiency of other clotting factors other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation stricture or kinking of ureter hemorrhage complicating a procedure acute kidney failure with lesion of tubular necrosis kidney replaced by transplant hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history, urinary (tract) infection hydronephrosis urinary tract infection, site not specified stricture or kinking of ureter surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled complications of transplanted kidney unspecified essential hypertension acidosis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled primary hypercoagulable state edema gout, unspecified depressive disorder, not elsewhere classified unspecified essential hypertension surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified complications of transplanted kidney gout, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin anemia, unspecified urinary tract infection, site not specified kidney replaced by transplant hydronephrosis depressive disorder, not elsewhere classified acute kidney failure, unspecified unspecified essential hypertension car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident primary hypercoagulable state hyperpotassemia gout, unspecified congenital factor viii disorder kidney replaced by transplant hydronephrosis
white f 60 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  163  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood glucose  83  mg dl; hematology blood bands  3  %$meropenem  500  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; pantoprazole  40  mg ; gabapentin  300  mg ; glipizide  5  mg ; metoprolol succinate xl  100  mg ; aspirin  81  mg ; hydrocodone-acetaminophen  1-2  tab ; allopurinol  100  mg ; vancomycin oral liquid  250  mg ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  650  mg ; fluconazole  400  mg ; fluconazole  200  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; filgrastim  300  mcg ; tacrolimus  1  mg ; docusate sodium  100  mg ; senna  1  tab ; 
chronic kidney disease, unspecified congenital deficiency of other clotting factors other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation stricture or kinking of ureter hemorrhage complicating a procedure acute kidney failure with lesion of tubular necrosis kidney replaced by transplant hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history, urinary (tract) infection hydronephrosis urinary tract infection, site not specified stricture or kinking of ureter surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled complications of transplanted kidney unspecified essential hypertension acidosis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled primary hypercoagulable state edema gout, unspecified depressive disorder, not elsewhere classified unspecified essential hypertension surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified complications of transplanted kidney gout, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin anemia, unspecified urinary tract infection, site not specified kidney replaced by transplant hydronephrosis depressive disorder, not elsewhere classified acute kidney failure, unspecified unspecified essential hypertension car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident primary hypercoagulable state hyperpotassemia gout, unspecified congenital factor viii disorder kidney replaced by transplant hydronephrosis
white f 60 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  2.6  ; chemistry blood calcium, total  10.1  mg dl; chemistry blood glucose  136  mg dl$meropenem  500  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; pantoprazole  40  mg ; gabapentin  300  mg ; glipizide  5  mg ; metoprolol succinate xl  100  mg ; aspirin  81  mg ; hydrocodone-acetaminophen  1-2  tab ; allopurinol  100  mg ; vancomycin oral liquid  250  mg ; sodium chloride 0.9%  flush  10  ml ; fluconazole  200  mg ; filgrastim  300  mcg ; tacrolimus  1  mg ; docusate sodium  100  mg ; senna  1  tab ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  50  ml ; imipenem-cilastatin  250  mg ; 
chronic kidney disease, unspecified congenital deficiency of other clotting factors other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation stricture or kinking of ureter hemorrhage complicating a procedure acute kidney failure with lesion of tubular necrosis kidney replaced by transplant hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history, urinary (tract) infection hydronephrosis urinary tract infection, site not specified stricture or kinking of ureter surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled complications of transplanted kidney unspecified essential hypertension acidosis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled primary hypercoagulable state edema gout, unspecified depressive disorder, not elsewhere classified unspecified essential hypertension surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified complications of transplanted kidney gout, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin anemia, unspecified urinary tract infection, site not specified kidney replaced by transplant hydronephrosis depressive disorder, not elsewhere classified acute kidney failure, unspecified unspecified essential hypertension car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident primary hypercoagulable state hyperpotassemia gout, unspecified congenital factor viii disorder kidney replaced by transplant hydronephrosis
white f 60 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  3.4  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  118  mg dl; hematology blood bands  1  %$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; pantoprazole  40  mg ; gabapentin  300  mg ; glipizide  5  mg ; metoprolol succinate xl  100  mg ; aspirin  81  mg ; hydrocodone-acetaminophen  1-2  tab ; allopurinol  100  mg ; vancomycin oral liquid  250  mg ; sodium chloride 0.9%  flush  10  ml ; fluconazole  200  mg ; docusate sodium  100  mg ; senna  1  tab ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  50  ml ; imipenem-cilastatin  250  mg ; 
chronic kidney disease, unspecified congenital deficiency of other clotting factors other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation stricture or kinking of ureter hemorrhage complicating a procedure acute kidney failure with lesion of tubular necrosis kidney replaced by transplant hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history, urinary (tract) infection hydronephrosis urinary tract infection, site not specified stricture or kinking of ureter surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled complications of transplanted kidney unspecified essential hypertension acidosis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled primary hypercoagulable state edema gout, unspecified depressive disorder, not elsewhere classified unspecified essential hypertension surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified complications of transplanted kidney gout, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin anemia, unspecified urinary tract infection, site not specified kidney replaced by transplant hydronephrosis depressive disorder, not elsewhere classified acute kidney failure, unspecified unspecified essential hypertension car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident primary hypercoagulable state hyperpotassemia gout, unspecified congenital factor viii disorder kidney replaced by transplant hydronephrosis
white f 60 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  3.9  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  65  mg dl; hematology blood bands  11  %$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; pantoprazole  40  mg ; gabapentin  300  mg ; glipizide  5  mg ; metoprolol succinate xl  100  mg ; aspirin  81  mg ; hydrocodone-acetaminophen  1-2  tab ; allopurinol  100  mg ; sodium chloride 0.9%  flush  10  ml ; fluconazole  200  mg ; docusate sodium  100  mg ; senna  1  tab ; warfarin  0  mg ; tacrolimus  0.5  mg ; 
chronic kidney disease, unspecified congenital deficiency of other clotting factors other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation stricture or kinking of ureter hemorrhage complicating a procedure acute kidney failure with lesion of tubular necrosis kidney replaced by transplant hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history, urinary (tract) infection hydronephrosis urinary tract infection, site not specified stricture or kinking of ureter surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled complications of transplanted kidney unspecified essential hypertension acidosis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled primary hypercoagulable state edema gout, unspecified depressive disorder, not elsewhere classified unspecified essential hypertension surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified complications of transplanted kidney gout, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin anemia, unspecified urinary tract infection, site not specified kidney replaced by transplant hydronephrosis depressive disorder, not elsewhere classified acute kidney failure, unspecified unspecified essential hypertension car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident primary hypercoagulable state hyperpotassemia gout, unspecified congenital factor viii disorder kidney replaced by transplant hydronephrosis
white f 60 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  167  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  3.0  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  64  mg dl; hematology blood bands  13  %$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; pantoprazole  40  mg ; gabapentin  300  mg ; glipizide  5  mg ; metoprolol succinate xl  100  mg ; aspirin  81  mg ; hydrocodone-acetaminophen  1-2  tab ; allopurinol  100  mg ; sodium chloride 0.9%  flush  10  ml ; fluconazole  200  mg ; docusate sodium  100  mg ; senna  1  tab ; warfarin  0  mg ; tacrolimus  0.5  mg ; 
chronic kidney disease, unspecified congenital deficiency of other clotting factors other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation stricture or kinking of ureter hemorrhage complicating a procedure acute kidney failure with lesion of tubular necrosis kidney replaced by transplant hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified gout, unspecified car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history, urinary (tract) infection hydronephrosis urinary tract infection, site not specified stricture or kinking of ureter surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled complications of transplanted kidney unspecified essential hypertension acidosis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled primary hypercoagulable state edema gout, unspecified depressive disorder, not elsewhere classified unspecified essential hypertension surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation venous (peripheral) insufficiency, unspecified acute kidney failure, unspecified complications of transplanted kidney gout, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of aspirin anemia, unspecified urinary tract infection, site not specified kidney replaced by transplant hydronephrosis depressive disorder, not elsewhere classified acute kidney failure, unspecified unspecified essential hypertension car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident primary hypercoagulable state hyperpotassemia gout, unspecified congenital factor viii disorder kidney replaced by transplant hydronephrosis
white m 80 $nan$nan$iso-osmotic dextrose  50  ml ; cefazolin  2  g ; influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1  floor stock bag ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; ondansetron  4-8  mg ; lidocaine jelly 2% (urojet)  1  appl ; morphine sulfate  2-4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; atenolol  25  mg ; hydrochlorothiazide  25  mg ; omeprazole  40  mg ; moexipril  15  mg ; 
 
white m 80 $nan$nan$iso-osmotic dextrose  50  ml ; cefazolin  2  g ; influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1  floor stock bag ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; ondansetron  4-8  mg ; lidocaine jelly 2% (urojet)  1  appl ; morphine sulfate  2-4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; atenolol  25  mg ; hydrochlorothiazide  25  mg ; omeprazole  40  mg ; moexipril  15  mg ; bisacodyl  10  mg ; fleet enema  1  enema ; tamsulosin  0.4  mg ; 
 
white m 80 $nan$nan$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; ondansetron  4-8  mg ; morphine sulfate  2-4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; atenolol  25  mg ; hydrochlorothiazide  25  mg ; omeprazole  40  mg ; moexipril  15  mg ; fleet enema  1  enema ; tamsulosin  0.4  mg ; 
 
white m 80 $nan$nan$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; ondansetron  4-8  mg ; morphine sulfate  2-4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; atenolol  25  mg ; hydrochlorothiazide  25  mg ; omeprazole  40  mg ; moexipril  15  mg ; fleet enema  1  enema ; tamsulosin  0.4  mg ; 
 
white m 69 $nan$nan$metoprolol succinate xl  150  mg ; aspirin  325  mg ; niacin sr  500  mg ; simvastatin  40  mg ; multivitamins  1  tab ; thiamine  100  mg ; ascorbic acid  500  mg ; vitamin e  400  unit ; vitamin d  400  unit ; amiodarone  200  mg ; 
congestive heart failure, unspecified atherosclerosis of native arteries of the extremities, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified automatic implantable cardiac defibrillator in situ acute on chronic systolic heart failure other and unspecified hyperlipidemia acute kidney failure, unspecified other primary cardiomyopathies chronic kidney disease, unspecified automatic implantable cardiac defibrillator in situ acute on chronic combined systolic and diastolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other primary cardiomyopathies chronic kidney disease, stage iii (moderate) peripheral vascular disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified tobacco use disorder automatic implantable cardiac defibrillator in situ other diseases of lung, not elsewhere classified congestive heart failure, unspecified chronic kidney disease, stage iii (moderate) peripheral vascular disease, unspecified acute on chronic systolic heart failure chest pain, unspecified other and unspecified hyperlipidemia unspecified essential hypertension other primary cardiomyopathies acute kidney failure, unspecified acute on chronic systolic heart failure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled automatic implantable cardiac defibrillator in situ coronary atherosclerosis of native coronary artery congestive heart failure, unspecified other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities, unspecified enlargement of lymph nodes chronic total occlusion of artery of the extremities other primary cardiomyopathies acute on chronic systolic heart failure automatic implantable cardiac defibrillator in situ other specified anemias congestive heart failure, unspecified acute kidney failure, unspecified
white m 69 $nan$hematology blood hematocrit  39.8  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  179  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  130  mg dl$metoprolol succinate xl  150  mg ; aspirin  325  mg ; niacin sr  500  mg ; simvastatin  40  mg ; multivitamins  1  tab ; thiamine  100  mg ; ascorbic acid  500  mg ; vitamin e  400  unit ; vitamin d  400  unit ; amiodarone  200  mg ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; furosemide  40  mg ; calcium carbonate  500  mg ; perphenazine  6  mg ; imipramine  125  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; insulin  0  unit ; docusate sodium  100  mg ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; heparin  5000  unit ; lisinopril  2.5  mg ; milk of magnesia  30  ml ; simethicone  40-80  mg ; 
congestive heart failure, unspecified atherosclerosis of native arteries of the extremities, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified automatic implantable cardiac defibrillator in situ acute on chronic systolic heart failure other and unspecified hyperlipidemia acute kidney failure, unspecified other primary cardiomyopathies chronic kidney disease, unspecified automatic implantable cardiac defibrillator in situ acute on chronic combined systolic and diastolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other primary cardiomyopathies chronic kidney disease, stage iii (moderate) peripheral vascular disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified tobacco use disorder automatic implantable cardiac defibrillator in situ other diseases of lung, not elsewhere classified congestive heart failure, unspecified chronic kidney disease, stage iii (moderate) peripheral vascular disease, unspecified acute on chronic systolic heart failure chest pain, unspecified other and unspecified hyperlipidemia unspecified essential hypertension other primary cardiomyopathies acute kidney failure, unspecified acute on chronic systolic heart failure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled automatic implantable cardiac defibrillator in situ coronary atherosclerosis of native coronary artery congestive heart failure, unspecified other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities, unspecified enlargement of lymph nodes chronic total occlusion of artery of the extremities other primary cardiomyopathies acute on chronic systolic heart failure automatic implantable cardiac defibrillator in situ other specified anemias congestive heart failure, unspecified acute kidney failure, unspecified
white m 69 $nan$nan$metoprolol succinate xl  150  mg ; aspirin  325  mg ; niacin sr  500  mg ; simvastatin  40  mg ; multivitamins  1  tab ; thiamine  100  mg ; ascorbic acid  500  mg ; vitamin e  400  unit ; vitamin d  400  unit ; amiodarone  200  mg ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; calcium carbonate  500  mg ; perphenazine  6  mg ; imipramine  125  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; heparin  5000  unit ; lisinopril  2.5  mg ; milk of magnesia  30  ml ; simethicone  40-80  mg ; 
congestive heart failure, unspecified atherosclerosis of native arteries of the extremities, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified automatic implantable cardiac defibrillator in situ acute on chronic systolic heart failure other and unspecified hyperlipidemia acute kidney failure, unspecified other primary cardiomyopathies chronic kidney disease, unspecified automatic implantable cardiac defibrillator in situ acute on chronic combined systolic and diastolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other primary cardiomyopathies chronic kidney disease, stage iii (moderate) peripheral vascular disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified tobacco use disorder automatic implantable cardiac defibrillator in situ other diseases of lung, not elsewhere classified congestive heart failure, unspecified chronic kidney disease, stage iii (moderate) peripheral vascular disease, unspecified acute on chronic systolic heart failure chest pain, unspecified other and unspecified hyperlipidemia unspecified essential hypertension other primary cardiomyopathies acute kidney failure, unspecified acute on chronic systolic heart failure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled automatic implantable cardiac defibrillator in situ coronary atherosclerosis of native coronary artery congestive heart failure, unspecified other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities, unspecified enlargement of lymph nodes chronic total occlusion of artery of the extremities other primary cardiomyopathies acute on chronic systolic heart failure automatic implantable cardiac defibrillator in situ other specified anemias congestive heart failure, unspecified acute kidney failure, unspecified
white m 90 $nan$hematology blood hematocrit  29.9  %; hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  288  k ul; hematology blood platelet count  305  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry urine creatinine, urine  26  mg dl; chemistry urine sodium, urine  73  meq l; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  118  mg dl$morphine sulfate  2  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; 0.9% sodium chloride  1000  ml ; heparin  5000  unit ; isosorbide mononitrate (extended release)  30  mg ; levothyroxine sodium  75  mcg ; atorvastatin  80  mg ; metoprolol succinate xl  25  mg ; ranitidine  75  mg ; digoxin  0.125  mg ; folic acid  1  mg ; clopidogrel  75  mg ; aspirin  325  mg ; moexipril  7.5  mg ; aspirin  81  mg ; oxycodone-acetaminophen  1-2  tab ; morphine sulfate  1-2  mg ; cyclobenzaprine  5  mg ; acetaminophen  500  mg ; morphine sulfate  1-4  mg ; metoprolol tartrate  5  mg ; 
congestive heart failure, unspecified unspecified acquired hypothyroidism other specified forms of chronic ischemic heart disease coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified chronic systolic heart failure aortocoronary bypass status other left bundle branch block esophageal reflux hyposmolality and/or hyponatremia atrial fibrillation acute posthemorrhagic anemia coronary atherosclerosis of native coronary artery aortic valve disorders other left bundle branch block atrial fibrillation unspecified acquired hypothyroidism esophageal reflux other specified forms of chronic ischemic heart disease depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified long-term (current) use of anticoagulants chronic systolic heart failure other diseases of lung, not elsewhere classified iron deficiency anemia, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits intermediate coronary syndrome other and unspecified angina pectoris coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism atrial fibrillation chronic systolic heart failure pulmonary collapse long-term (current) use of anticoagulants aortic valve disorders esophageal reflux depressive disorder, not elsewhere classified congestive heart failure, unspecified 
white m 90 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  299  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  3.3  ; hematology blood inr(pt)  3.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  118  mg dl$morphine sulfate  2  mg ; sodium chloride 0.9%  flush  3  ml ; isosorbide mononitrate (extended release)  30  mg ; levothyroxine sodium  75  mcg ; atorvastatin  80  mg ; metoprolol succinate xl  25  mg ; ranitidine  75  mg ; digoxin  0.125  mg ; folic acid  1  mg ; clopidogrel  75  mg ; moexipril  7.5  mg ; aspirin  81  mg ; oxycodone-acetaminophen  1-2  tab ; cyclobenzaprine  5  mg ; acetaminophen  500  mg ; morphine sulfate  1-4  mg ; metoprolol tartrate  5  mg ; diltiazem  15  mg ; diltiazem  30  mg ; ibuprofen  800  mg ; morphine sulfate (oral soln.)  5-10  mg ; lidocaine 5% patch  1  ptch ; senna  1  tab ; docusate sodium  100  mg ; acetaminophen  650  mg ; 
congestive heart failure, unspecified unspecified acquired hypothyroidism other specified forms of chronic ischemic heart disease coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified chronic systolic heart failure aortocoronary bypass status other left bundle branch block esophageal reflux hyposmolality and/or hyponatremia atrial fibrillation acute posthemorrhagic anemia coronary atherosclerosis of native coronary artery aortic valve disorders other left bundle branch block atrial fibrillation unspecified acquired hypothyroidism esophageal reflux other specified forms of chronic ischemic heart disease depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified long-term (current) use of anticoagulants chronic systolic heart failure other diseases of lung, not elsewhere classified iron deficiency anemia, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits intermediate coronary syndrome other and unspecified angina pectoris coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism atrial fibrillation chronic systolic heart failure pulmonary collapse long-term (current) use of anticoagulants aortic valve disorders esophageal reflux depressive disorder, not elsewhere classified congestive heart failure, unspecified 
white m 90 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  272  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  2.9  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; isosorbide mononitrate (extended release)  30  mg ; levothyroxine sodium  75  mcg ; atorvastatin  80  mg ; metoprolol succinate xl  25  mg ; ranitidine  75  mg ; digoxin  0.125  mg ; folic acid  1  mg ; clopidogrel  75  mg ; moexipril  7.5  mg ; aspirin  81  mg ; morphine sulfate  1-4  mg ; ibuprofen  800  mg ; lidocaine 5% patch  1  ptch ; senna  1  tab ; docusate sodium  100  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; furosemide  20  mg ; docusate sodium  200  mg ; 
congestive heart failure, unspecified unspecified acquired hypothyroidism other specified forms of chronic ischemic heart disease coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified chronic systolic heart failure aortocoronary bypass status other left bundle branch block esophageal reflux hyposmolality and/or hyponatremia atrial fibrillation acute posthemorrhagic anemia coronary atherosclerosis of native coronary artery aortic valve disorders other left bundle branch block atrial fibrillation unspecified acquired hypothyroidism esophageal reflux other specified forms of chronic ischemic heart disease depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status congestive heart failure, unspecified long-term (current) use of anticoagulants chronic systolic heart failure other diseases of lung, not elsewhere classified iron deficiency anemia, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits intermediate coronary syndrome other and unspecified angina pectoris coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism atrial fibrillation chronic systolic heart failure pulmonary collapse long-term (current) use of anticoagulants aortic valve disorders esophageal reflux depressive disorder, not elsewhere classified congestive heart failure, unspecified 
unknown m 67 $nan$hematology blood hematocrit  30.2  %; hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.8  g dl; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  387  k ul; hematology blood platelet count  362  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  error  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  119  mg dl; chemistry blood glucose  116  mg dl; hematology blood bands  0  %; blood gas blood free calcium  1.09  mmol l$iso-osmotic dextrose  200  ml ; d5 1 2ns  1000  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fentanyl citrate  25-100  mcg ; propofol  1000  mg ; propofol  200  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; vancomycin  1000  mg ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; sw  600  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1000  ml ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; aspirin  300  mg ; aspirin  325  mg ; metoprolol tartrate  5  mg ; hydralazine  10-20  mg ; enalaprilat  0.625  mg ; metoprolol tartrate  7.5  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen iv  1000  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 
 
unknown m 67 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  401  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  112  mg dl$iso-osmotic dextrose  200  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; fentanyl citrate  25-100  mcg ; vancomycin  1000  mg ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; sw  600  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1000  ml ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; aspirin  325  mg ; metoprolol tartrate  5  mg ; hydralazine  10-20  mg ; enalaprilat  0.625  mg ; metoprolol tartrate  7.5  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen iv  1000  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; ondansetron  4  mg ; metoclopramide  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10  ml ; 
 
unknown m 67 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  443  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  125  mg dl$iso-osmotic dextrose  200  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; hydralazine  10-20  mg ; enalaprilat  0.625  mg ; metoprolol tartrate  7.5  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; metoclopramide  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  flush  10  ml ; sterile water  100  ml ; d5w  250  ml ; nitroglycerin  100  mg ; 
 
unknown m 67 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  458  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  138  mg dl$iso-osmotic dextrose  200  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; enalaprilat  0.625  mg ; metoprolol tartrate  7.5  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  flush  10  ml ; sterile water  100  ml ; 5% dextrose (excel bag)  250  ml ; nitroglycerin  200  mg ; 5% dextrose  50  ml ; atorvastatin  80  mg ; labetalol  200  mg ; 
 
unknown m 67 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  439  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  120  mg dl; chemistry blood % hemoglobin a1c  5.8  %$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose (excel bag)  250  ml ; nitroglycerin  200  mg ; 5% dextrose  50  ml ; 
 
unknown m 67 $nan$chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  121  mg dl; chemistry blood glucose  120  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose (excel bag)  250  ml ; nitroglycerin  200  mg ; 5% dextrose  50  ml ; metoprolol tartrate  10  mg ; furosemide  20  mg ; 
 
unknown m 67 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  457  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  122  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose (excel bag)  250  ml ; nitroglycerin  200  mg ; 5% dextrose  50  ml ; metoprolol tartrate  10  mg ; metoprolol tartrate  15  mg ; heparin  5000  unit ; 
 
unknown m 67 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  424  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  156  mg dl; chemistry blood albumin  2.5  g dl; blood gas blood free calcium  1.08  mmol l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  50  ml ; metoprolol tartrate  15  mg ; heparin  5000  unit ; senna  8.6  mg ; polyethylene glycol  17  g ; nystatin cream  1  appl ; docusate sodium  100  mg ; 
 
unknown m 67 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  405  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  133  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; senna  8.6  mg ; polyethylene glycol  17  g ; nystatin cream  1  appl ; docusate sodium  100  mg ; bisacodyl  10  mg ; 
 
unknown m 67 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  401  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  155  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; senna  8.6  mg ; polyethylene glycol  17  g ; nystatin cream  1  appl ; docusate sodium  100  mg ; 
 
unknown m 67 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; senna  8.6  mg ; polyethylene glycol  17  g ; nystatin cream  1  appl ; docusate sodium  100  mg ; 
 
white f 52 $temp  98.5  heartrate  83.0  resprate  18.0  o2sat  100.0  sbp  129.0  dbp  86.0  rhythm    pain    $nan$atorvastatin  40  mg ; lisinopril  10  mg ; omeprazole  20  mg ; 
 
white f 52 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  108  mg dl$atorvastatin  40  mg ; lisinopril  10  mg ; omeprazole  20  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  650  mg ; benzonatate  100  mg ; azithromycin  250  mg ; ondansetron  4  mg ; levofloxacin  750  mg ; lorazepam  0.5  mg ; 
 
white f 52 $nan$nan$atorvastatin  40  mg ; lisinopril  10  mg ; omeprazole  20  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  650  mg ; benzonatate  100  mg ; ondansetron  4  mg ; levofloxacin  750  mg ; lorazepam  0.5  mg ; 
 
white m 89 $temp  98.2  heartrate  96.0  resprate  18.0  o2sat  97.0  sbp  148.0  dbp  85.0  rhythm    pain  0  ; temp  97.7  heartrate  92.0  resprate  16.0  o2sat  93.0  sbp  106.0  dbp  70.0  rhythm    pain    ; temp  98.0  heartrate  81.0  resprate  15.0  o2sat  98.0  sbp  113.0  dbp  59.0  rhythm    pain  0  ; temp    heartrate  51.0  resprate  16.0  o2sat  100.0  sbp  125.0  dbp  66.0  rhythm    pain  0  ; temp    heartrate  85.0  resprate  16.0  o2sat  100.0  sbp  125.0  dbp  72.0  rhythm    pain  0  $hematology blood hematocrit  26.0  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  320  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  5.5  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood urea nitrogen  32  mg dl; chemistry blood glucose  174  mg dl; chemistry blood glucose  149  mg dl$nan
 
white m 89 $temp  99.0  heartrate  74.0  resprate  16.0  o2sat  96.0  sbp  110.0  dbp  64.0  rhythm    pain  0  $hematology blood hematocrit  25.9  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  332  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  117  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  81  mg ; furosemide  40  mg ; gabapentin  100  mg ; multivitamins  1  tab ; omeprazole  20  mg ; simvastatin  20  mg ; tamsulosin  0.4  mg ; sodium chloride 0.9%  1000  ml ; ondansetron  4  mg ; 
 
white m 89 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  357  k ul; chemistry blood anion gap  25  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  109  mg dl; blood gas blood lactate  1.8  mmol l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  81  mg ; gabapentin  100  mg ; multivitamins  1  tab ; omeprazole  20  mg ; simvastatin  20  mg ; tamsulosin  0.4  mg ; ondansetron  4  mg ; d5lr  1000  ml ; 
 
white m 89 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  441  k ul; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  51  mg dl; hematology blood inr(pt)  1.2  ; chemistry urine creatinine, urine  85  mg dl; chemistry urine sodium, urine  40  meq l; hematology urine wbc  19  # hpf; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  152  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  81  mg ; gabapentin  100  mg ; multivitamins  1  tab ; omeprazole  20  mg ; simvastatin  20  mg ; tamsulosin  0.4  mg ; ondansetron  4  mg ; d5lr  1000  ml ; bisacodyl  10  mg ; maalox diphenhydramine lidocaine  15  ml ; lorazepam  0.25  mg ; docusate sodium  100  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  1.5  g ; prochlorperazine  10  mg ; lidocaine jelly 2% (urojet)  1  appl ; ampicillin-sulbactam  3  g ; lactated ringers  1000  ml ; morphine sulfate  4  mg ; 
 
white m 89 $nan$nan$sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; prochlorperazine  10  mg ; lidocaine jelly 2% (urojet)  1  appl ; morphine sulfate  4  mg ; lorazepam  0.5  mg ; glycopyrrolate  0.2  mg ; morphine sulfate  2-4  mg ; 
 
white m 91 $temp  98.5  heartrate  87.0  resprate  17.0  o2sat  98.0  sbp  134.0  dbp  87.0  rhythm    pain  unable  ; temp  98.5  heartrate  87.0  resprate  17.0  o2sat  98.0  sbp  134.0  dbp  87.0  rhythm    pain  unable  $hematology blood hematocrit  45.7  %; hematology blood hemoglobin  15.4  g dl; hematology blood platelet count  147  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  84  mg dl; chemistry blood albumin  3.6  g dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; memantine  10  mg ; digoxin  0.1  mg ; ondansetron  4  mg ; d5 1 2ns  1000  ml ; metoprolol tartrate  50  mg ; 
 
white m 91 $nan$hematology blood hematocrit  45.2  %; hematology blood hemoglobin  14.9  g dl; hematology blood platelet count  152  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  120  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; memantine  10  mg ; digoxin  0.1  mg ; ondansetron  4  mg ; d5 1 2ns  1000  ml ; metoprolol tartrate  50  mg ; docusate sodium  100  mg ; senna  8.6  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; oxycodone (immediate release)   5  mg ; hydromorphone (dilaudid)  0.25  mg ; digoxin  0.125  mg ; exelon  9.5  mg ; acetaminophen  650  mg ; 
 
white m 91 $nan$nan$memantine  10  mg ; ondansetron  4  mg ; metoprolol tartrate  50  mg ; docusate sodium  100  mg ; senna  8.6  mg ; oxycodone (immediate release)   5  mg ; hydromorphone (dilaudid)  0.25  mg ; digoxin  0.125  mg ; exelon  9.5  mg ; acetaminophen  650  mg ; quetiapine fumarate  12.5  mg ; 
 
white m 91 $nan$nan$memantine  10  mg ; ondansetron  4  mg ; metoprolol tartrate  50  mg ; docusate sodium  100  mg ; senna  8.6  mg ; oxycodone (immediate release)   5  mg ; hydromorphone (dilaudid)  0.25  mg ; digoxin  0.125  mg ; exelon  9.5  mg ; acetaminophen  650  mg ; quetiapine fumarate  12.5  mg ; aspirin  325  mg ; 
 
white m 91 $nan$nan$memantine  10  mg ; ondansetron  4  mg ; metoprolol tartrate  50  mg ; docusate sodium  100  mg ; senna  8.6  mg ; oxycodone (immediate release)   5  mg ; hydromorphone (dilaudid)  0.25  mg ; digoxin  0.125  mg ; exelon  9.5  mg ; acetaminophen  650  mg ; aspirin  325  mg ; 
 
white m 62 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  82  mg dl; chemistry blood lactate dehydrogenase (ld)  314  iu l; chemistry blood albumin  4.2  g dl; hematology blood bands  1  %; blood gas blood lactate  1.4  mmol l; blood gas blood glucose  87  mg dl$nan
chronic hepatitis c without mention of hepatic coma cirrhosis of liver without mention of alcohol other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation infection and inflammatory reaction due to other vascular device, implant, and graft congestive heart failure, unspecified end stage renal disease chronic systolic heart failure unspecified acquired hypothyroidism bacteremia hyperpotassemia epilepsy, unspecified, without mention of intractable epilepsy pulmonary collapse gastroesophageal laceration-hemorrhage syndrome unspecified viral hepatitis c without hepatic coma other and unspecified infection due to central venous catheter kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease bacteremia congestive heart failure, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus other specified cardiac dysrhythmias complications of transplanted kidney acute on chronic combined systolic and diastolic heart failure accidents occurring in other specified places epilepsy, unspecified, without mention of intractable epilepsy surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation end stage renal disease atherosclerosis of native arteries of the extremities, unspecified chronic hepatitis c without mention of hepatic coma noncompliance with renal dialysis other specified cardiac dysrhythmias chronic combined systolic and diastolic heart failure hypertensive chronic kidney disease, malignant, with chronic kidney disease stage v or end stage renal disease congestive heart failure, unspecified pneumonia, organism unspecified end stage renal disease unspecified acquired hypothyroidism cirrhosis of liver without mention of alcohol epilepsy, unspecified, without mention of intractable epilepsy awaiting organ transplant status hyperpotassemia end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy congestive heart failure, unspecified acidosis combined systolic and diastolic heart failure, unspecified hypertensive chronic kidney disease, malignant, with chronic kidney disease stage v or end stage renal disease personal history of methicillin resistant staphylococcus aureus
white m 62 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  5.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  83  mg dl; chemistry blood albumin  3.7  g dl$sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; cinacalcet  90  mg ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; clopidogrel  75  mg ; lisinopril  40  mg ; lisinopril  20  mg ; heparin  5000  unit ; rifaximin  200  mg ; nifedipine cr  60  mg ; phenytoin  200  mg ; lamotrigine  250  mg ; clonidine  0.1  mg ; levetiracetam  375  mg ; metoprolol tartrate  50  mg ; 
chronic hepatitis c without mention of hepatic coma cirrhosis of liver without mention of alcohol other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation infection and inflammatory reaction due to other vascular device, implant, and graft congestive heart failure, unspecified end stage renal disease chronic systolic heart failure unspecified acquired hypothyroidism bacteremia hyperpotassemia epilepsy, unspecified, without mention of intractable epilepsy pulmonary collapse gastroesophageal laceration-hemorrhage syndrome unspecified viral hepatitis c without hepatic coma other and unspecified infection due to central venous catheter kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease bacteremia congestive heart failure, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus other specified cardiac dysrhythmias complications of transplanted kidney acute on chronic combined systolic and diastolic heart failure accidents occurring in other specified places epilepsy, unspecified, without mention of intractable epilepsy surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation end stage renal disease atherosclerosis of native arteries of the extremities, unspecified chronic hepatitis c without mention of hepatic coma noncompliance with renal dialysis other specified cardiac dysrhythmias chronic combined systolic and diastolic heart failure hypertensive chronic kidney disease, malignant, with chronic kidney disease stage v or end stage renal disease congestive heart failure, unspecified pneumonia, organism unspecified end stage renal disease unspecified acquired hypothyroidism cirrhosis of liver without mention of alcohol epilepsy, unspecified, without mention of intractable epilepsy awaiting organ transplant status hyperpotassemia end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy congestive heart failure, unspecified acidosis combined systolic and diastolic heart failure, unspecified hypertensive chronic kidney disease, malignant, with chronic kidney disease stage v or end stage renal disease personal history of methicillin resistant staphylococcus aureus
white m 62 $nan$nan$sodium chloride 0.9%  flush  3  ml ; cinacalcet  90  mg ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; heparin  5000  unit ; rifaximin  200  mg ; nifedipine cr  60  mg ; phenytoin  200  mg ; lamotrigine  250  mg ; clonidine  0.1  mg ; levetiracetam  375  mg ; levetiracetam  250  mg ; 
chronic hepatitis c without mention of hepatic coma cirrhosis of liver without mention of alcohol other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation infection and inflammatory reaction due to other vascular device, implant, and graft congestive heart failure, unspecified end stage renal disease chronic systolic heart failure unspecified acquired hypothyroidism bacteremia hyperpotassemia epilepsy, unspecified, without mention of intractable epilepsy pulmonary collapse gastroesophageal laceration-hemorrhage syndrome unspecified viral hepatitis c without hepatic coma other and unspecified infection due to central venous catheter kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease bacteremia congestive heart failure, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus other specified cardiac dysrhythmias complications of transplanted kidney acute on chronic combined systolic and diastolic heart failure accidents occurring in other specified places epilepsy, unspecified, without mention of intractable epilepsy surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation end stage renal disease atherosclerosis of native arteries of the extremities, unspecified chronic hepatitis c without mention of hepatic coma noncompliance with renal dialysis other specified cardiac dysrhythmias chronic combined systolic and diastolic heart failure hypertensive chronic kidney disease, malignant, with chronic kidney disease stage v or end stage renal disease congestive heart failure, unspecified pneumonia, organism unspecified end stage renal disease unspecified acquired hypothyroidism cirrhosis of liver without mention of alcohol epilepsy, unspecified, without mention of intractable epilepsy awaiting organ transplant status hyperpotassemia end stage renal disease epilepsy, unspecified, without mention of intractable epilepsy congestive heart failure, unspecified acidosis combined systolic and diastolic heart failure, unspecified hypertensive chronic kidney disease, malignant, with chronic kidney disease stage v or end stage renal disease personal history of methicillin resistant staphylococcus aureus
white f 76 $nan$nan$multivitamins  1  cap ; sertraline  50  mg ; simvastatin  20  mg ; valsartan  80  mg ; docusate sodium  100  mg ; senna  1  tab ; clonazepam  0.5  mg ; metoprolol tartrate  50  mg ; 
 
white f 76 $nan$nan$multivitamins  1  cap ; sertraline  50  mg ; simvastatin  20  mg ; valsartan  80  mg ; docusate sodium  100  mg ; senna  1  tab ; clonazepam  0.5  mg ; metoprolol tartrate  50  mg ; acetaminophen  650  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; oxycodone (immediate release)   5  mg ; lorazepam  1  mg ; aspirin  81  mg ; hydrocodone-acetaminophen  1-2  tab ; metoprolol succinate xl  100  mg ; metoprolol succinate xl  50  mg ; 
 
white f 76 $nan$nan$multivitamins  1  cap ; sertraline  50  mg ; simvastatin  20  mg ; valsartan  80  mg ; docusate sodium  100  mg ; senna  1  tab ; clonazepam  0.5  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; aspirin  81  mg ; hydrocodone-acetaminophen  1-2  tab ; metoprolol succinate xl  100  mg ; metoprolol succinate xl  50  mg ; enoxaparin sodium  40  mg ; 
 
white f 76 $nan$nan$multivitamins  1  cap ; sertraline  50  mg ; simvastatin  20  mg ; valsartan  80  mg ; docusate sodium  100  mg ; senna  1  tab ; clonazepam  0.5  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; aspirin  81  mg ; hydrocodone-acetaminophen  1-2  tab ; metoprolol succinate xl  100  mg ; metoprolol succinate xl  50  mg ; enoxaparin sodium  40  mg ; 
 
white f 76 $nan$nan$multivitamins  1  cap ; sertraline  50  mg ; simvastatin  20  mg ; valsartan  80  mg ; docusate sodium  100  mg ; senna  1  tab ; clonazepam  0.5  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; aspirin  81  mg ; hydrocodone-acetaminophen  1-2  tab ; metoprolol succinate xl  100  mg ; metoprolol succinate xl  50  mg ; enoxaparin sodium  40  mg ; diphenhydramine  25  mg ; valsartan  40  mg ; triamterene-hydrochlorothiazide  1  cap ; sertraline  75  mg ; 
 
white f 76 $nan$nan$multivitamins  1  cap ; simvastatin  20  mg ; docusate sodium  100  mg ; senna  1  tab ; pantoprazole  40  mg ; bisacodyl  10  mg ; aspirin  81  mg ; hydrocodone-acetaminophen  1-2  tab ; metoprolol succinate xl  100  mg ; metoprolol succinate xl  50  mg ; enoxaparin sodium  40  mg ; diphenhydramine  25  mg ; valsartan  40  mg ; triamterene-hydrochlorothiazide  1  cap ; sertraline  75  mg ; 
 
white f 76 $nan$nan$multivitamins  1  cap ; simvastatin  20  mg ; docusate sodium  100  mg ; senna  1  tab ; pantoprazole  40  mg ; bisacodyl  10  mg ; aspirin  81  mg ; hydrocodone-acetaminophen  1-2  tab ; metoprolol succinate xl  100  mg ; metoprolol succinate xl  50  mg ; enoxaparin sodium  40  mg ; valsartan  40  mg ; triamterene-hydrochlorothiazide  1  cap ; sertraline  75  mg ; 
 
white f 64 $nan$nan$aspirin  81  mg ; ascorbic acid  1000  mg ; vitamin d  800  unit ; multivitamins  1  tab ; fish oil (omega 3)  1000  mg ; vitamin e  400  unit ; 
malignant neoplasm of peritoneum, unspecified encounter for antineoplastic chemotherapy need for desensitization to allergens antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use dehydration other specified intestinal obstruction tachycardia, unspecified other ascites other iatrogenic hypotension secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes acute posthemorrhagic anemia malignant neoplasm of specified parts of peritoneum
white f 64 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  524  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  95  mg dl$aspirin  81  mg ; ascorbic acid  1000  mg ; vitamin d  800  unit ; multivitamins  1  tab ; fish oil (omega 3)  1000  mg ; vitamin e  400  unit ; heparin  5000  unit ; calcium carbonate  500  mg ; sodium chloride 0.9%  flush  3  ml ; diphenhydramine  25  mg ; epinephrine 1:1000  0.3  mg ; acetaminophen  325-650  mg ; albuterol inhaler  2  puff ; prochlorperazine  5  mg ; lorazepam  0.5-1  mg ; ondansetron  4  mg ; bisacodyl  5-10  mg ; docusate sodium  100  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; 
malignant neoplasm of peritoneum, unspecified encounter for antineoplastic chemotherapy need for desensitization to allergens antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use dehydration other specified intestinal obstruction tachycardia, unspecified other ascites other iatrogenic hypotension secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes acute posthemorrhagic anemia malignant neoplasm of specified parts of peritoneum
white f 43 $nan$hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$nan
 
white f 43 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3  ml ; ns  1000  ml ; ondansetron  4  mg ; meclizine  12.5  mg ; diazepam  2  mg ; 
 
hispanic latino m 81 $temp  97.4  heartrate  76.0  resprate  20.0  o2sat  94.0  sbp  132.0  dbp  65.0  rhythm    pain  0  $nan$insulin  38  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  1  tab ; aripiprazole  5  mg ; aspirin  81  mg ; escitalopram oxalate  10  mg ; ferrous sulfate  325  mg ; simvastatin  40  mg ; divalproex (delayed release)  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; albuterol 0.083% neb soln  1  neb ; insulin  0  unit ; isoso  30  mg ; furosemide  40  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)   5  mg ; enoxaparin sodium  100  mg ; warfarin  5  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; insulin  18  unit ; heparin  2000-4100  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; pantoprazole  40  mg ; mirtazapine  15  mg ; 
diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of toe, unspecified peripheral angiopathy in diseases classified elsewhere polyneuropathy in diabetes diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident coronary atherosclerosis of native coronary artery ulcer of other part of foot diarrhea cervical spondylosis without myelopathy other dependence on machines, supplemental oxygen old myocardial infarction obesity, unspecified pure hypercholesterolemia bipolar disorder, unspecified chronic obstructive asthma with (acute) exacerbation personal history of venous thrombosis and embolism long-term (current) use of anticoagulants benign essential hypertension obstructive sleep apnea (adult)(pediatric) other persistent mental disorders due to conditions classified elsewhere chronic obstructive asthma, unspecified cellulitis and abscess of foot, except toes old myocardial infarction other chronic pulmonary heart diseases personal history of venous thrombosis and embolism disruption of external operation (surgical) wound bipolar i disorder, most recent episode (or current) depressed, unspecified chronic kidney disease, stage ii (mild) pure hypercholesterolemia other bone involvement in diseases classified elsewhere abnormal coagulation profile diabetes with other specified manifestations, type ii or unspecified type, uncontrolled obstructive sleep apnea (adult)(pediatric) anemia in chronic kidney disease esophageal reflux other persistent mental disorders due to conditions classified elsewhere cellulitis and abscess of toe, unspecified anticoagulants causing adverse effects in therapeutic use acute osteomyelitis, ankle and foot cellulitis and abscess of foot, except toes other and unspecified hyperlipidemia congestive heart failure, unspecified methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site benign essential hypertension bipolar i disorder, most recent episode (or current) depressed, unspecified obstructive sleep apnea (adult)(pediatric) old myocardial infarction
hispanic latino m 81 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  282  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  117  mg dl$insulin  38  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  1  tab ; aripiprazole  5  mg ; aspirin  81  mg ; escitalopram oxalate  10  mg ; ferrous sulfate  325  mg ; simvastatin  40  mg ; divalproex (delayed release)  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; albuterol 0.083% neb soln  1  neb ; insulin  0  unit ; isoso  30  mg ; furosemide  40  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)   5  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; insulin  18  unit ; heparin  2000-4100  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; pantoprazole  40  mg ; mirtazapine  15  mg ; 
diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of toe, unspecified peripheral angiopathy in diseases classified elsewhere polyneuropathy in diabetes diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident coronary atherosclerosis of native coronary artery ulcer of other part of foot diarrhea cervical spondylosis without myelopathy other dependence on machines, supplemental oxygen old myocardial infarction obesity, unspecified pure hypercholesterolemia bipolar disorder, unspecified chronic obstructive asthma with (acute) exacerbation personal history of venous thrombosis and embolism long-term (current) use of anticoagulants benign essential hypertension obstructive sleep apnea (adult)(pediatric) other persistent mental disorders due to conditions classified elsewhere chronic obstructive asthma, unspecified cellulitis and abscess of foot, except toes old myocardial infarction other chronic pulmonary heart diseases personal history of venous thrombosis and embolism disruption of external operation (surgical) wound bipolar i disorder, most recent episode (or current) depressed, unspecified chronic kidney disease, stage ii (mild) pure hypercholesterolemia other bone involvement in diseases classified elsewhere abnormal coagulation profile diabetes with other specified manifestations, type ii or unspecified type, uncontrolled obstructive sleep apnea (adult)(pediatric) anemia in chronic kidney disease esophageal reflux other persistent mental disorders due to conditions classified elsewhere cellulitis and abscess of toe, unspecified anticoagulants causing adverse effects in therapeutic use acute osteomyelitis, ankle and foot cellulitis and abscess of foot, except toes other and unspecified hyperlipidemia congestive heart failure, unspecified methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site benign essential hypertension bipolar i disorder, most recent episode (or current) depressed, unspecified obstructive sleep apnea (adult)(pediatric) old myocardial infarction
hispanic latino m 81 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  321  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  5.2  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  163  mg dl; chemistry blood glucose  143  mg dl$insulin  38  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  1  tab ; aripiprazole  5  mg ; aspirin  81  mg ; escitalopram oxalate  10  mg ; ferrous sulfate  325  mg ; simvastatin  40  mg ; divalproex (delayed release)  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; albuterol 0.083% neb soln  1  neb ; insulin  0  unit ; isoso  30  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)   5  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; insulin  18  unit ; heparin  2000-4100  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; pantoprazole  40  mg ; mirtazapine  15  mg ; vancomycin  1250  mg ; d5 1 2ns  1000  ml ; warfarin  1  dose ; 
diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of toe, unspecified peripheral angiopathy in diseases classified elsewhere polyneuropathy in diabetes diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident coronary atherosclerosis of native coronary artery ulcer of other part of foot diarrhea cervical spondylosis without myelopathy other dependence on machines, supplemental oxygen old myocardial infarction obesity, unspecified pure hypercholesterolemia bipolar disorder, unspecified chronic obstructive asthma with (acute) exacerbation personal history of venous thrombosis and embolism long-term (current) use of anticoagulants benign essential hypertension obstructive sleep apnea (adult)(pediatric) other persistent mental disorders due to conditions classified elsewhere chronic obstructive asthma, unspecified cellulitis and abscess of foot, except toes old myocardial infarction other chronic pulmonary heart diseases personal history of venous thrombosis and embolism disruption of external operation (surgical) wound bipolar i disorder, most recent episode (or current) depressed, unspecified chronic kidney disease, stage ii (mild) pure hypercholesterolemia other bone involvement in diseases classified elsewhere abnormal coagulation profile diabetes with other specified manifestations, type ii or unspecified type, uncontrolled obstructive sleep apnea (adult)(pediatric) anemia in chronic kidney disease esophageal reflux other persistent mental disorders due to conditions classified elsewhere cellulitis and abscess of toe, unspecified anticoagulants causing adverse effects in therapeutic use acute osteomyelitis, ankle and foot cellulitis and abscess of foot, except toes other and unspecified hyperlipidemia congestive heart failure, unspecified methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site benign essential hypertension bipolar i disorder, most recent episode (or current) depressed, unspecified obstructive sleep apnea (adult)(pediatric) old myocardial infarction
hispanic latino m 81 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  311  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  163  mg dl$insulin  38  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  1  tab ; aripiprazole  5  mg ; aspirin  81  mg ; escitalopram oxalate  10  mg ; ferrous sulfate  325  mg ; simvastatin  40  mg ; divalproex (delayed release)  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; albuterol 0.083% neb soln  1  neb ; insulin  0  unit ; isoso  30  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)   5  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; insulin  18  unit ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; pantoprazole  40  mg ; mirtazapine  15  mg ; vancomycin  1250  mg ; d5 1 2ns  1000  ml ; warfarin  1  dose ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; 
diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of toe, unspecified peripheral angiopathy in diseases classified elsewhere polyneuropathy in diabetes diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident coronary atherosclerosis of native coronary artery ulcer of other part of foot diarrhea cervical spondylosis without myelopathy other dependence on machines, supplemental oxygen old myocardial infarction obesity, unspecified pure hypercholesterolemia bipolar disorder, unspecified chronic obstructive asthma with (acute) exacerbation personal history of venous thrombosis and embolism long-term (current) use of anticoagulants benign essential hypertension obstructive sleep apnea (adult)(pediatric) other persistent mental disorders due to conditions classified elsewhere chronic obstructive asthma, unspecified cellulitis and abscess of foot, except toes old myocardial infarction other chronic pulmonary heart diseases personal history of venous thrombosis and embolism disruption of external operation (surgical) wound bipolar i disorder, most recent episode (or current) depressed, unspecified chronic kidney disease, stage ii (mild) pure hypercholesterolemia other bone involvement in diseases classified elsewhere abnormal coagulation profile diabetes with other specified manifestations, type ii or unspecified type, uncontrolled obstructive sleep apnea (adult)(pediatric) anemia in chronic kidney disease esophageal reflux other persistent mental disorders due to conditions classified elsewhere cellulitis and abscess of toe, unspecified anticoagulants causing adverse effects in therapeutic use acute osteomyelitis, ankle and foot cellulitis and abscess of foot, except toes other and unspecified hyperlipidemia congestive heart failure, unspecified methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site benign essential hypertension bipolar i disorder, most recent episode (or current) depressed, unspecified obstructive sleep apnea (adult)(pediatric) old myocardial infarction
hispanic latino m 81 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  298  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  153  mg dl$insulin  38  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  1  tab ; aripiprazole  5  mg ; aspirin  81  mg ; escitalopram oxalate  10  mg ; ferrous sulfate  325  mg ; simvastatin  40  mg ; divalproex (delayed release)  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; albuterol 0.083% neb soln  1  neb ; insulin  0  unit ; isoso  30  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)   5  mg ; insulin  18  unit ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; pantoprazole  40  mg ; mirtazapine  15  mg ; d5 1 2ns  1000  ml ; warfarin  1  dose ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; 
diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of toe, unspecified peripheral angiopathy in diseases classified elsewhere polyneuropathy in diabetes diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident coronary atherosclerosis of native coronary artery ulcer of other part of foot diarrhea cervical spondylosis without myelopathy other dependence on machines, supplemental oxygen old myocardial infarction obesity, unspecified pure hypercholesterolemia bipolar disorder, unspecified chronic obstructive asthma with (acute) exacerbation personal history of venous thrombosis and embolism long-term (current) use of anticoagulants benign essential hypertension obstructive sleep apnea (adult)(pediatric) other persistent mental disorders due to conditions classified elsewhere chronic obstructive asthma, unspecified cellulitis and abscess of foot, except toes old myocardial infarction other chronic pulmonary heart diseases personal history of venous thrombosis and embolism disruption of external operation (surgical) wound bipolar i disorder, most recent episode (or current) depressed, unspecified chronic kidney disease, stage ii (mild) pure hypercholesterolemia other bone involvement in diseases classified elsewhere abnormal coagulation profile diabetes with other specified manifestations, type ii or unspecified type, uncontrolled obstructive sleep apnea (adult)(pediatric) anemia in chronic kidney disease esophageal reflux other persistent mental disorders due to conditions classified elsewhere cellulitis and abscess of toe, unspecified anticoagulants causing adverse effects in therapeutic use acute osteomyelitis, ankle and foot cellulitis and abscess of foot, except toes other and unspecified hyperlipidemia congestive heart failure, unspecified methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site benign essential hypertension bipolar i disorder, most recent episode (or current) depressed, unspecified obstructive sleep apnea (adult)(pediatric) old myocardial infarction
hispanic latino m 81 $nan$hematology blood hematocrit  35.9  %; hematology blood hematocrit  34.6  %; hematology blood hemoglobin  11.9  g dl; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  309  k ul; hematology blood platelet count  299  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  5.2  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  169  mg dl; chemistry blood glucose  160  mg dl$insulin  38  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  1  tab ; aripiprazole  5  mg ; aspirin  81  mg ; escitalopram oxalate  10  mg ; ferrous sulfate  325  mg ; simvastatin  40  mg ; divalproex (delayed release)  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; albuterol 0.083% neb soln  1  neb ; insulin  0  unit ; isoso  30  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)   5  mg ; insulin  18  unit ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; pantoprazole  40  mg ; mirtazapine  15  mg ; d5 1 2ns  1000  ml ; warfarin  1  dose ; heparin flush (10 units ml)  2  ml ; warfarin  7.5  mg ; 
diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of toe, unspecified peripheral angiopathy in diseases classified elsewhere polyneuropathy in diabetes diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident coronary atherosclerosis of native coronary artery ulcer of other part of foot diarrhea cervical spondylosis without myelopathy other dependence on machines, supplemental oxygen old myocardial infarction obesity, unspecified pure hypercholesterolemia bipolar disorder, unspecified chronic obstructive asthma with (acute) exacerbation personal history of venous thrombosis and embolism long-term (current) use of anticoagulants benign essential hypertension obstructive sleep apnea (adult)(pediatric) other persistent mental disorders due to conditions classified elsewhere chronic obstructive asthma, unspecified cellulitis and abscess of foot, except toes old myocardial infarction other chronic pulmonary heart diseases personal history of venous thrombosis and embolism disruption of external operation (surgical) wound bipolar i disorder, most recent episode (or current) depressed, unspecified chronic kidney disease, stage ii (mild) pure hypercholesterolemia other bone involvement in diseases classified elsewhere abnormal coagulation profile diabetes with other specified manifestations, type ii or unspecified type, uncontrolled obstructive sleep apnea (adult)(pediatric) anemia in chronic kidney disease esophageal reflux other persistent mental disorders due to conditions classified elsewhere cellulitis and abscess of toe, unspecified anticoagulants causing adverse effects in therapeutic use acute osteomyelitis, ankle and foot cellulitis and abscess of foot, except toes other and unspecified hyperlipidemia congestive heart failure, unspecified methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site benign essential hypertension bipolar i disorder, most recent episode (or current) depressed, unspecified obstructive sleep apnea (adult)(pediatric) old myocardial infarction
hispanic latino m 81 $nan$nan$insulin  38  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  1  tab ; aripiprazole  5  mg ; aspirin  81  mg ; escitalopram oxalate  10  mg ; ferrous sulfate  325  mg ; simvastatin  40  mg ; divalproex (delayed release)  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; albuterol 0.083% neb soln  1  neb ; insulin  0  unit ; isoso  30  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)   5  mg ; insulin  18  unit ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; pantoprazole  40  mg ; mirtazapine  15  mg ; d5 1 2ns  1000  ml ; warfarin  1  dose ; heparin flush (10 units ml)  2  ml ; warfarin  7.5  mg ; 
diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled cellulitis and abscess of toe, unspecified peripheral angiopathy in diseases classified elsewhere polyneuropathy in diabetes diabetes with peripheral circulatory disorders, type ii or unspecified type, not stated as uncontrolled person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident coronary atherosclerosis of native coronary artery ulcer of other part of foot diarrhea cervical spondylosis without myelopathy other dependence on machines, supplemental oxygen old myocardial infarction obesity, unspecified pure hypercholesterolemia bipolar disorder, unspecified chronic obstructive asthma with (acute) exacerbation personal history of venous thrombosis and embolism long-term (current) use of anticoagulants benign essential hypertension obstructive sleep apnea (adult)(pediatric) other persistent mental disorders due to conditions classified elsewhere chronic obstructive asthma, unspecified cellulitis and abscess of foot, except toes old myocardial infarction other chronic pulmonary heart diseases personal history of venous thrombosis and embolism disruption of external operation (surgical) wound bipolar i disorder, most recent episode (or current) depressed, unspecified chronic kidney disease, stage ii (mild) pure hypercholesterolemia other bone involvement in diseases classified elsewhere abnormal coagulation profile diabetes with other specified manifestations, type ii or unspecified type, uncontrolled obstructive sleep apnea (adult)(pediatric) anemia in chronic kidney disease esophageal reflux other persistent mental disorders due to conditions classified elsewhere cellulitis and abscess of toe, unspecified anticoagulants causing adverse effects in therapeutic use acute osteomyelitis, ankle and foot cellulitis and abscess of foot, except toes other and unspecified hyperlipidemia congestive heart failure, unspecified methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site benign essential hypertension bipolar i disorder, most recent episode (or current) depressed, unspecified obstructive sleep apnea (adult)(pediatric) old myocardial infarction
white f 54 $temp  98.5  heartrate  88.0  resprate  18.0  o2sat  99.0  sbp  107.0  dbp  54.0  rhythm    pain  0  $hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  138  iu l; blood gas blood lactate  1.6  mmol l$sodium chloride 0.9%  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; sodium bicarbonate  650  mg ; simethicone  80  mg ; senna  8.6  mg ; docusate sodium  100  mg ; cyclosporine (neoral) modified  100  mg ; cyclosporine (neoral) modified  25  mg ; bisacodyl  10  mg ; sulfameth trimethoprim ss  1  tab ; rosuvastatin calcium  5  mg ; prednisone  5  mg ; omeprazole  40  mg ; mycophenolate mofetil  500  mg ; citalopram  60  mg ; bupropion (sustained release)  150  mg ; aspirin  81  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; lorazepam  0.25  mg ; lactulose  30  ml ; fleet enema (mineral oil)  1  enema ; moviprep  1  l ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$hematology blood hematocrit  38.4  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  225  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  101  mg dl; blood gas blood lactate  1.1  mmol l$sodium chloride 0.9%  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; sodium bicarbonate  650  mg ; simethicone  80  mg ; docusate sodium  100  mg ; cyclosporine (neoral) modified  100  mg ; cyclosporine (neoral) modified  25  mg ; sulfameth trimethoprim ss  1  tab ; rosuvastatin calcium  5  mg ; prednisone  5  mg ; omeprazole  40  mg ; mycophenolate mofetil  500  mg ; citalopram  60  mg ; bupropion (sustained release)  150  mg ; aspirin  81  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; lorazepam  0.25  mg ; lactulose  30  ml ; fleet enema (mineral oil)  1  enema ; tramadol  25  mg ; lorazepam  2-4  mg ; polyethylene glycol  17  g ; labetalol  200  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$hematology blood hematocrit  32.9  %; hematology blood hematocrit  35.8  %; hematology blood hemoglobin  10.9  g dl; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  187  k ul; hematology blood platelet count  185  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; sodium bicarbonate  650  mg ; simethicone  80  mg ; docusate sodium  100  mg ; cyclosporine (neoral) modified  100  mg ; cyclosporine (neoral) modified  25  mg ; sulfameth trimethoprim ss  1  tab ; rosuvastatin calcium  5  mg ; prednisone  5  mg ; omeprazole  40  mg ; mycophenolate mofetil  500  mg ; aspirin  81  mg ; acetaminophen  1000  mg ; lactulose  30  ml ; polyethylene glycol  17  g ; labetalol  200  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  107  mg dl; chemistry blood lactate dehydrogenase (ld)  144  iu l; chemistry blood albumin  3.4  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; sodium bicarbonate  650  mg ; simethicone  80  mg ; docusate sodium  100  mg ; cyclosporine (neoral) modified  100  mg ; cyclosporine (neoral) modified  25  mg ; sulfameth trimethoprim ss  1  tab ; rosuvastatin calcium  5  mg ; prednisone  5  mg ; omeprazole  40  mg ; mycophenolate mofetil  500  mg ; aspirin  81  mg ; acetaminophen  1000  mg ; lactulose  30  ml ; polyethylene glycol  17  g ; lorazepam  0.5  mg ; prochlorperazine  5  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  137  iu l; chemistry blood albumin  3.5  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; sodium bicarbonate  650  mg ; simethicone  80  mg ; docusate sodium  100  mg ; cyclosporine (neoral) modified  100  mg ; cyclosporine (neoral) modified  25  mg ; sulfameth trimethoprim ss  1  tab ; rosuvastatin calcium  5  mg ; prednisone  5  mg ; omeprazole  40  mg ; mycophenolate mofetil  500  mg ; aspirin  81  mg ; acetaminophen  1000  mg ; lactulose  30  ml ; polyethylene glycol  17  g ; lorazepam  0.5  mg ; prochlorperazine  5  mg ; citalopram  40  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$hematology blood hematocrit  35.5  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  99  mg dl; chemistry blood lactate dehydrogenase (ld)  168  iu l$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; sodium bicarbonate  650  mg ; simethicone  80  mg ; cyclosporine (neoral) modified  100  mg ; cyclosporine (neoral) modified  25  mg ; sulfameth trimethoprim ss  1  tab ; rosuvastatin calcium  5  mg ; prednisone  5  mg ; omeprazole  40  mg ; mycophenolate mofetil  500  mg ; aspirin  81  mg ; acetaminophen  1000  mg ; polyethylene glycol  17  g ; prochlorperazine  5  mg ; citalopram  40  mg ; tamsulosin  0.4  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; sodium bicarbonate  650  mg ; simethicone  80  mg ; cyclosporine (neoral) modified  100  mg ; cyclosporine (neoral) modified  25  mg ; sulfameth trimethoprim ss  1  tab ; rosuvastatin calcium  5  mg ; prednisone  5  mg ; omeprazole  40  mg ; mycophenolate mofetil  500  mg ; aspirin  81  mg ; acetaminophen  1000  mg ; polyethylene glycol  17  g ; citalopram  40  mg ; tamsulosin  0.4  mg ; acetaminophen iv  1000  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; sodium bicarbonate  650  mg ; simethicone  80  mg ; cyclosporine (neoral) modified  100  mg ; cyclosporine (neoral) modified  25  mg ; sulfameth trimethoprim ss  1  tab ; rosuvastatin calcium  5  mg ; prednisone  5  mg ; omeprazole  40  mg ; mycophenolate mofetil  500  mg ; aspirin  81  mg ; acetaminophen  1000  mg ; citalopram  40  mg ; tamsulosin  0.4  mg ; acetaminophen iv  1000  mg ; sumatriptan succinate  25  mg ; mycophenolate sodium dr  360  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; sodium bicarbonate  650  mg ; simethicone  80  mg ; sulfameth trimethoprim ss  1  tab ; rosuvastatin calcium  5  mg ; prednisone  5  mg ; omeprazole  40  mg ; aspirin  81  mg ; acetaminophen  1000  mg ; citalopram  40  mg ; tamsulosin  0.4  mg ; mycophenolate sodium dr  360  mg ; cyclosporine (neoral) modified  75  mg ; nortriptyline  10  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; sodium bicarbonate  650  mg ; simethicone  80  mg ; sulfameth trimethoprim ss  1  tab ; rosuvastatin calcium  5  mg ; prednisone  5  mg ; omeprazole  40  mg ; aspirin  81  mg ; acetaminophen  1000  mg ; citalopram  40  mg ; mycophenolate sodium dr  360  mg ; cyclosporine (neoral) modified  75  mg ; nortriptyline  10  mg ; captopril  6.25  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry urine creatinine, urine  104  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  91  mg dl; chemistry urine protein creatinine ratio  0.6  mg mg$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; sodium bicarbonate  650  mg ; simethicone  80  mg ; sulfameth trimethoprim ss  1  tab ; rosuvastatin calcium  5  mg ; prednisone  5  mg ; omeprazole  40  mg ; aspirin  81  mg ; acetaminophen  1000  mg ; citalopram  40  mg ; mycophenolate sodium dr  360  mg ; nortriptyline  10  mg ; captopril  6.25  mg ; metoclopramide  5  mg ; fludrocortisone acetate  0.1  mg ; sirolimus  2  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; sodium bicarbonate  650  mg ; simethicone  80  mg ; sulfameth trimethoprim ss  1  tab ; rosuvastatin calcium  5  mg ; prednisone  5  mg ; omeprazole  40  mg ; aspirin  81  mg ; acetaminophen  1000  mg ; citalopram  40  mg ; mycophenolate sodium dr  360  mg ; nortriptyline  10  mg ; captopril  6.25  mg ; fludrocortisone acetate  0.1  mg ; sirolimus  2  mg ; oxycodone (immediate release)  5  mg ; cyclosporine (neoral) modified  50  mg ; topiramate (topamax)  25  mg ; 0.9% sodium chloride  50  ml ; valproate sodium  500  mg ; lactated ringers  1000  ml ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$hematology blood hematocrit  38.6  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood glucose  99  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; sodium bicarbonate  650  mg ; simethicone  80  mg ; sulfameth trimethoprim ss  1  tab ; rosuvastatin calcium  5  mg ; prednisone  5  mg ; omeprazole  40  mg ; aspirin  81  mg ; acetaminophen  1000  mg ; citalopram  40  mg ; mycophenolate sodium dr  360  mg ; nortriptyline  10  mg ; captopril  6.25  mg ; fludrocortisone acetate  0.1  mg ; sirolimus  2  mg ; cyclosporine (neoral) modified  50  mg ; 0.9% sodium chloride  50  ml ; valproate sodium  500  mg ; lactated ringers  1000  ml ; midodrine  5  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; sodium bicarbonate  650  mg ; simethicone  80  mg ; sulfameth trimethoprim ss  1  tab ; prednisone  5  mg ; omeprazole  40  mg ; aspirin  81  mg ; acetaminophen  1000  mg ; citalopram  40  mg ; mycophenolate sodium dr  360  mg ; nortriptyline  10  mg ; fludrocortisone acetate  0.1  mg ; sirolimus  2  mg ; cyclosporine (neoral) modified  50  mg ; midodrine  5  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$chemistry urine creatinine, urine  65  mg dl; chemistry urine sodium, urine  75  meq l; chemistry urine protein creatinine ratio  0.4  mg mg$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; sodium bicarbonate  650  mg ; simethicone  80  mg ; sulfameth trimethoprim ss  1  tab ; prednisone  5  mg ; omeprazole  40  mg ; aspirin  81  mg ; acetaminophen  1000  mg ; citalopram  40  mg ; mycophenolate sodium dr  360  mg ; nortriptyline  10  mg ; fludrocortisone acetate  0.1  mg ; sirolimus  2  mg ; midodrine  5  mg ; cyclobenzaprine  5  mg ; meclizine  12.5  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$hematology blood hematocrit  38.3  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  13  mg dl; hematology urine wbc  7  # hpf; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  110  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; sodium bicarbonate  650  mg ; simethicone  80  mg ; sulfameth trimethoprim ss  1  tab ; prednisone  5  mg ; omeprazole  40  mg ; aspirin  81  mg ; acetaminophen  1000  mg ; citalopram  40  mg ; mycophenolate sodium dr  360  mg ; nortriptyline  10  mg ; fludrocortisone acetate  0.1  mg ; sirolimus  2  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$hematology blood hematocrit  39.0  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry urine sodium, urine  43  meq l; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  96  mg dl; chemistry blood lactate dehydrogenase (ld)  192  iu l; chemistry blood albumin  4.0  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; sodium bicarbonate  650  mg ; simethicone  80  mg ; sulfameth trimethoprim ss  1  tab ; prednisone  5  mg ; omeprazole  40  mg ; aspirin  81  mg ; acetaminophen  1000  mg ; citalopram  40  mg ; mycophenolate sodium dr  360  mg ; nortriptyline  10  mg ; fludrocortisone acetate  0.1  mg ; sirolimus  2  mg ; ondansetron odt  4  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$hematology blood hematocrit  38.2  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine sodium, urine  33  meq l; chemistry blood calcium, total  10.0  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  171  mg dl; chemistry blood glucose  137  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; sodium bicarbonate  650  mg ; simethicone  80  mg ; sulfameth trimethoprim ss  1  tab ; prednisone  5  mg ; omeprazole  40  mg ; aspirin  81  mg ; acetaminophen  1000  mg ; citalopram  40  mg ; mycophenolate sodium dr  360  mg ; fludrocortisone acetate  0.1  mg ; sirolimus  2  mg ; ondansetron odt  4  mg ; ramelteon  8  mg ; lidocaine 1%  1  ml ; 0.9% sodium chloride  100  ml ; acyclovir  650  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$hematology blood hematocrit  36.7  %; hematology blood hematocrit  35.6  %; hematology blood hematocrit  34.1  %; hematology blood hemoglobin  12.6  g dl; hematology blood hemoglobin  12.3  g dl; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  236  k ul; hematology blood platelet count  234  k ul; hematology blood platelet count  209  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  0.9  ; hematology blood inr(pt)  0.9  ; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  127  mg dl; chemistry blood glucose  138  mg dl; chemistry blood glucose  147  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; sodium bicarbonate  650  mg ; prednisone  5  mg ; omeprazole  40  mg ; aspirin  81  mg ; acetaminophen  1000  mg ; mycophenolate sodium dr  360  mg ; sirolimus  2  mg ; ramelteon  8  mg ; lidocaine 1%  1  ml ; 0.9% sodium chloride  100  ml ; acyclovir  650  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; soln.  350  ml ; mannitol 20 %  70  g ; dexamethasone  4  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; dexmedetomidine  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  136  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sodium bicarbonate  650  mg ; omeprazole  40  mg ; aspirin  81  mg ; mycophenolate sodium dr  360  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; dexamethasone  4  mg ; heparin flush (10 units ml)  2  ml ; dexmedetomidine  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lidocaine 1%  5  ml ; fentanyl citrate  25-50  mcg ; sodium chloride 0.9%  flush  10-20  ml ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  124  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sodium bicarbonate  650  mg ; omeprazole  40  mg ; aspirin  81  mg ; mycophenolate sodium dr  360  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; dexamethasone  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10-20  ml ; clonidine  0.1  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  185  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  136  mg dl$sodium bicarbonate  650  mg ; omeprazole  40  mg ; aspirin  81  mg ; mycophenolate sodium dr  360  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; dexamethasone  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10-20  ml ; clonidine  0.1  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  118  mg dl$sodium bicarbonate  650  mg ; omeprazole  40  mg ; aspirin  81  mg ; mycophenolate sodium dr  360  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10-20  ml ; clonidine  0.1  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  153  mg dl$sodium bicarbonate  650  mg ; omeprazole  40  mg ; aspirin  81  mg ; mycophenolate sodium dr  360  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10-20  ml ; clonidine  0.1  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  111  mg dl$sodium bicarbonate  650  mg ; omeprazole  40  mg ; aspirin  81  mg ; mycophenolate sodium dr  360  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10-20  ml ; clonidine  0.1  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry urine creatinine, urine  16  mg dl; chemistry urine potassium, urine  16  meq l; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  103  mg dl; chemistry urine protein creatinine ratio  0.7  mg mg$sodium bicarbonate  650  mg ; omeprazole  40  mg ; aspirin  81  mg ; mycophenolate sodium dr  360  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10-20  ml ; clonidine  0.1  mg ; neutra-phos  2  pkt ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  169  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry urine sodium, urine  150  meq l; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  115  mg dl$sodium bicarbonate  650  mg ; omeprazole  40  mg ; aspirin  81  mg ; mycophenolate sodium dr  360  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10-20  ml ; clonidine  0.1  mg ; neutra-phos  2  pkt ; amoxicillin  500  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  179  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  111  mg dl$sodium bicarbonate  650  mg ; omeprazole  40  mg ; aspirin  81  mg ; mycophenolate sodium dr  360  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10-20  ml ; amoxicillin  500  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  108  mg dl$sodium bicarbonate  650  mg ; omeprazole  40  mg ; aspirin  81  mg ; mycophenolate sodium dr  360  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10-20  ml ; amoxicillin  500  mg ; ampicillin sodium  500  mg ; multivitamins w minerals  1  tab ; sirolimus  3  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
white f 54 $nan$nan$sodium bicarbonate  650  mg ; omeprazole  40  mg ; aspirin  81  mg ; mycophenolate sodium dr  360  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10-20  ml ; ampicillin sodium  500  mg ; multivitamins w minerals  1  tab ; sirolimus  3  mg ; 
constipation, unspecified essential (primary) hypertension neuromuscular dysfunction of bladder, unspecified personal history of other malignant neoplasm of skin pancreas transplant status pleurodynia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status anxiety disorder, unspecified other cholelithiasis without obstruction dyskinesia of esophagus presence of aortocoronary bypass graft major depressive disorder, single episode, unspecified hypoxemia hematemesis pneumonitis due to inhalation of food and vomit presence of aortocoronary bypass graft essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris pneumonia, unspecified organism kidney transplant status pancreas transplant status hemoptysis other secondary thrombocytopenia gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of systemic steroids cytomegaloviral disease, unspecified pancreas transplant status other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris kidney transplant status acute kidney failure, unspecified other complication of kidney transplant hyperlipidemia, unspecified acidosis dyskinesia of esophagus presence of aortocoronary bypass graft unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure neuromuscular dysfunction of bladder, unspecified essential (primary) hypertension decreased white blood cell count, unspecified long qt syndrome type 1 diabetes mellitus with diabetic neuropathic arthropathy hypo-osmolality and hyponatremia other postprocedural cardiac functional disturbances following other surgery type 1 diabetes mellitus with diabetic neuropathy, unspecified
asian f 28 $nan$hematology blood hematocrit  31.6  %$lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; codeine sulfate  30-60  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
asian f 28 $nan$nan$lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; codeine sulfate  30-60  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
asian f 28 $nan$nan$lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; codeine sulfate  30-60  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
asian f 28 $nan$nan$lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; codeine sulfate  30-60  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
white m 82 $nan$hematology blood hematocrit  41.5  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  302  k ul$lactated ringers  1000  ml ; pneumococcal vac polyvalent  0.5  ml ; 0.9% sodium chloride  1000  ml ; heparin  5000  unit ; lisinopril  5  mg ; omeprazole  20  mg ; pyridoxine  100  mg ; 
 
white m 91 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  174  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  500-1000  mg ; tramadol (ultram)  25  mg ; morphine sulfate  2-4  mg ; pantoprazole  40  mg ; enoxaparin sodium  40  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; allopurinol  300  mg ; nadolol  40  mg ; simvastatin  40  mg ; spironolactone  25  mg ; hydrochlorothiazide  25  mg ; acetaminophen  1000  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; hydralazine  10  mg ; 
 
white m 91 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  131  k ul$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  500-1000  mg ; tramadol (ultram)  25  mg ; morphine sulfate  2-4  mg ; pantoprazole  40  mg ; enoxaparin sodium  40  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; allopurinol  300  mg ; nadolol  40  mg ; simvastatin  40  mg ; spironolactone  25  mg ; hydrochlorothiazide  25  mg ; acetaminophen  1000  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; hydralazine  10  mg ; senna  8.6  mg ; 
 
white m 91 $nan$hematology blood hematocrit  23.3  %$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  500-1000  mg ; tramadol (ultram)  25  mg ; morphine sulfate  2-4  mg ; pantoprazole  40  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; allopurinol  300  mg ; nadolol  40  mg ; simvastatin  40  mg ; spironolactone  25  mg ; hydrochlorothiazide  25  mg ; hydralazine  10  mg ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; enoxaparin sodium  30  mg ; 
 
white m 91 $nan$hematology blood hematocrit  21.6  %$acetaminophen  500-1000  mg ; tramadol (ultram)  25  mg ; morphine sulfate  2-4  mg ; pantoprazole  40  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; allopurinol  300  mg ; nadolol  40  mg ; simvastatin  40  mg ; spironolactone  25  mg ; hydrochlorothiazide  25  mg ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; tamsulosin  0.4  mg ; 
 
white m 91 $nan$hematology blood hematocrit  30.4  %$tramadol (ultram)  25  mg ; morphine sulfate  2-4  mg ; pantoprazole  40  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; allopurinol  300  mg ; nadolol  40  mg ; simvastatin  40  mg ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; tamsulosin  0.4  mg ; acetaminophen  650  mg ; 
 
white m 91 $nan$hematology blood hematocrit  29.6  %$tramadol (ultram)  25  mg ; morphine sulfate  2-4  mg ; pantoprazole  40  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; allopurinol  300  mg ; nadolol  40  mg ; simvastatin  40  mg ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; tamsulosin  0.4  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; 
 
white m 91 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  187  k ul$tramadol (ultram)  25  mg ; morphine sulfate  2-4  mg ; pantoprazole  40  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; allopurinol  300  mg ; nadolol  40  mg ; simvastatin  40  mg ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; tamsulosin  0.4  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; acetaminophen iv  1000  mg ; 
 
white m 91 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  203  mg dl; chemistry blood % hemoglobin a1c  6.1  %$tramadol (ultram)  25  mg ; morphine sulfate  2-4  mg ; pantoprazole  40  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; allopurinol  300  mg ; nadolol  40  mg ; simvastatin  40  mg ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; tamsulosin  0.4  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aspirin  325  mg ; 
 
white m 91 $nan$hematology blood hematocrit  29.4  %$tramadol (ultram)  25  mg ; morphine sulfate  2-4  mg ; pantoprazole  40  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; allopurinol  300  mg ; nadolol  40  mg ; simvastatin  40  mg ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; tamsulosin  0.4  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aspirin  325  mg ; 
 
white m 91 $nan$nan$tramadol (ultram)  25  mg ; morphine sulfate  2-4  mg ; pantoprazole  40  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; allopurinol  300  mg ; nadolol  40  mg ; simvastatin  40  mg ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; tamsulosin  0.4  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aspirin  325  mg ; simvastatin  20  mg ; 
 
white m 91 $nan$nan$tramadol (ultram)  25  mg ; morphine sulfate  2-4  mg ; pantoprazole  40  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; allopurinol  300  mg ; nadolol  40  mg ; simvastatin  40  mg ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; tamsulosin  0.4  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aspirin  325  mg ; simvastatin  20  mg ; 
 
white m 91 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  165  mg dl$tramadol (ultram)  25  mg ; morphine sulfate  2-4  mg ; pantoprazole  40  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; allopurinol  300  mg ; nadolol  40  mg ; simvastatin  40  mg ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; tamsulosin  0.4  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aspirin  325  mg ; simvastatin  20  mg ; d5 1 2ns  1000  ml ; 
 
white m 91 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  252  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  133  mg dl$tramadol (ultram)  25  mg ; morphine sulfate  2-4  mg ; pantoprazole  40  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; allopurinol  300  mg ; nadolol  40  mg ; simvastatin  40  mg ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; tamsulosin  0.4  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aspirin  325  mg ; simvastatin  20  mg ; d5 1 2ns  1000  ml ; 
 
white m 91 $nan$nan$tramadol (ultram)  25  mg ; morphine sulfate  2-4  mg ; pantoprazole  40  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; allopurinol  300  mg ; nadolol  40  mg ; simvastatin  40  mg ; senna  8.6  mg ; docusate sodium (liquid)  100  mg ; tamsulosin  0.4  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aspirin  325  mg ; 
 
white f 71 $nan$nan$metoprolol succinate xl  50  mg ; triamterene-hydrochlorothiazide  1  cap ; valsartan  320  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; 
 
white f 71 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  90  mg dl$metoprolol succinate xl  50  mg ; triamterene-hydrochlorothiazide  1  cap ; valsartan  320  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; hydromorphone (dilaudid)  0.25  mg ; oxycodone-acetaminophen  1-2  tab ; ondansetron  4  mg ; lorazepam  1  mg ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  500  ml ; docusate sodium  100  mg ; levetiracetam  500  mg ; senna  1  tab ; potassium chl 20 meq   1000 ml ns  1000  ml ; metoclopramide  10  mg ; lorazepam  0.5  mg ; 
 
white f 71 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  90  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$metoprolol succinate xl  50  mg ; triamterene-hydrochlorothiazide  1  cap ; valsartan  320  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; levetiracetam  500  mg ; senna  1  tab ; potassium chl 20 meq   1000 ml ns  1000  ml ; metoclopramide  10  mg ; prochlorperazine  10  mg ; pantoprazole  40  mg ; acetaminophen-caff-butalbital  1-2  tab ; levetiracetam  1000  mg ; hydromorphone (dilaudid)  2-4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; dexamethasone  4  mg ; hydralazine  10-20  mg ; 
 
white f 71 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  127  mg dl$metoprolol succinate xl  50  mg ; triamterene-hydrochlorothiazide  1  cap ; valsartan  320  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; metoclopramide  10  mg ; prochlorperazine  10  mg ; pantoprazole  40  mg ; acetaminophen-caff-butalbital  1-2  tab ; levetiracetam  1000  mg ; hydromorphone (dilaudid)  2-4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; dexamethasone  4  mg ; hydralazine  10-20  mg ; metoprolol tartrate  5  mg ; sodium chloride nasal  1-2  spry ; 
 
white f 71 $nan$nan$metoprolol succinate xl  50  mg ; triamterene-hydrochlorothiazide  1  cap ; valsartan  320  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; metoclopramide  10  mg ; prochlorperazine  10  mg ; pantoprazole  40  mg ; acetaminophen-caff-butalbital  1-2  tab ; hydromorphone (dilaudid)  2-4  mg ; dexamethasone  4  mg ; hydralazine  10-20  mg ; sodium chloride nasal  1-2  spry ; 
 
white f 71 $nan$nan$metoprolol succinate xl  50  mg ; triamterene-hydrochlorothiazide  1  cap ; valsartan  320  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; metoclopramide  10  mg ; prochlorperazine  10  mg ; pantoprazole  40  mg ; acetaminophen-caff-butalbital  1-2  tab ; hydromorphone (dilaudid)  2-4  mg ; dexamethasone  4  mg ; hydralazine  10-20  mg ; sodium chloride nasal  1-2  spry ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 
 
white f 71 $nan$nan$metoprolol succinate xl  50  mg ; triamterene-hydrochlorothiazide  1  cap ; valsartan  320  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; metoclopramide  10  mg ; prochlorperazine  10  mg ; pantoprazole  40  mg ; acetaminophen-caff-butalbital  1-2  tab ; hydromorphone (dilaudid)  2-4  mg ; dexamethasone  4  mg ; hydralazine  10-20  mg ; sodium chloride nasal  1-2  spry ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 
 
white f 37 $nan$nan$bisacodyl  10  mg ; levothyroxine sodium  50  mcg ; atorvastatin  40  mg ; 
other specified complications of procedures not elsewhere classified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation postprocedural fever unspecified acquired hypothyroidism displacement of lumbar intervertebral disc without myelopathy other and unspecified hyperlipidemia asthma, unspecified type, unspecified 
white f 37 $nan$nan$bisacodyl  10  mg ; levothyroxine sodium  50  mcg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  12.5  mg ; gabapentin  600  mg ; diazepam  5  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; cepacol (menthol)  1  loz ; docusate sodium  100  mg ; 
other specified complications of procedures not elsewhere classified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation postprocedural fever unspecified acquired hypothyroidism displacement of lumbar intervertebral disc without myelopathy other and unspecified hyperlipidemia asthma, unspecified type, unspecified 
white f 37 $nan$hematology blood hematocrit  31.1  %; hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  289  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  124  mg dl; blood gas blood hematocrit, calculated  32  %; blood gas blood hemoglobin  10.5  g dl$bisacodyl  10  mg ; levothyroxine sodium  50  mcg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  325-650  mg ; gabapentin  600  mg ; diazepam  5  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; cepacol (menthol)  1  loz ; docusate sodium  100  mg ; bupivacaine 0.1%  250  ml ; epidural bag  1  bag ; hydromorphone p.f.  2500  mcg ; droperidol  0.625  mg ; diphenhydramine  12.5-25  mg ; oxycodone-acetaminophen  1-2  tab ; oxycodone (immediate release)   5-10  mg ; 
other specified complications of procedures not elsewhere classified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation postprocedural fever unspecified acquired hypothyroidism displacement of lumbar intervertebral disc without myelopathy other and unspecified hyperlipidemia asthma, unspecified type, unspecified 
white f 37 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  302  k ul; hematology urine wbc  0-2  # hpf; hematology urine glucose  neg  mg dl; hematology urine bilirubin  sm  mg dl$bisacodyl  10  mg ; levothyroxine sodium  50  mcg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  325-650  mg ; gabapentin  600  mg ; diazepam  5  mg ; cepacol (menthol)  1  loz ; docusate sodium  100  mg ; droperidol  0.625  mg ; diphenhydramine  12.5-25  mg ; oxycodone (immediate release)   5-10  mg ; morphine sr (ms contin)  30  mg ; 
other specified complications of procedures not elsewhere classified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation postprocedural fever unspecified acquired hypothyroidism displacement of lumbar intervertebral disc without myelopathy other and unspecified hyperlipidemia asthma, unspecified type, unspecified 
white f 37 $nan$nan$bisacodyl  10  mg ; levothyroxine sodium  50  mcg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  325-650  mg ; gabapentin  600  mg ; diazepam  5  mg ; cepacol (menthol)  1  loz ; docusate sodium  100  mg ; droperidol  0.625  mg ; diphenhydramine  12.5-25  mg ; oxycodone (immediate release)   5-10  mg ; morphine sr (ms contin)  30  mg ; sarna lotion  1  appl ; magnesium citrate  300  ml ; 
other specified complications of procedures not elsewhere classified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation postprocedural fever unspecified acquired hypothyroidism displacement of lumbar intervertebral disc without myelopathy other and unspecified hyperlipidemia asthma, unspecified type, unspecified 
white f 37 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  341  k ul; hematology urine wbc  3-5  # hpf; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$bisacodyl  10  mg ; levothyroxine sodium  50  mcg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  325-650  mg ; gabapentin  600  mg ; diazepam  5  mg ; cepacol (menthol)  1  loz ; docusate sodium  100  mg ; droperidol  0.625  mg ; diphenhydramine  12.5-25  mg ; oxycodone (immediate release)   5-10  mg ; morphine sr (ms contin)  30  mg ; sarna lotion  1  appl ; magnesium citrate  300  ml ; calcium carbonate  500  mg ; ciprofloxacin hcl  500  mg ; 
other specified complications of procedures not elsewhere classified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation postprocedural fever unspecified acquired hypothyroidism displacement of lumbar intervertebral disc without myelopathy other and unspecified hyperlipidemia asthma, unspecified type, unspecified 
white f 37 $nan$nan$bisacodyl  10  mg ; levothyroxine sodium  50  mcg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  325-650  mg ; diazepam  5  mg ; cepacol (menthol)  1  loz ; docusate sodium  100  mg ; oxycodone (immediate release)   5-10  mg ; sarna lotion  1  appl ; calcium carbonate  500  mg ; ciprofloxacin hcl  500  mg ; gabapentin  300  mg ; morphine sr (ms contin)  15  mg ; acetaminophen  325  mg ; 
other specified complications of procedures not elsewhere classified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation postprocedural fever unspecified acquired hypothyroidism displacement of lumbar intervertebral disc without myelopathy other and unspecified hyperlipidemia asthma, unspecified type, unspecified 
white f 37 $nan$nan$bisacodyl  10  mg ; levothyroxine sodium  50  mcg ; atorvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  325-650  mg ; diazepam  5  mg ; cepacol (menthol)  1  loz ; docusate sodium  100  mg ; oxycodone (immediate release)   5-10  mg ; sarna lotion  1  appl ; calcium carbonate  500  mg ; ciprofloxacin hcl  500  mg ; gabapentin  300  mg ; morphine sr (ms contin)  15  mg ; acetaminophen  325  mg ; 
other specified complications of procedures not elsewhere classified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation postprocedural fever unspecified acquired hypothyroidism displacement of lumbar intervertebral disc without myelopathy other and unspecified hyperlipidemia asthma, unspecified type, unspecified 
white m 82 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  7  meq l; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  82  mg dl; chemistry blood glucose  121  mg dl; chemistry blood % hemoglobin a1c  6.0  %$sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; aspirin  81  mg ; tamsulosin  0.4  mg ; vitamin d  1000  unit ; polyethylene glycol  17  g ; bisacodyl  10  mg ; lactulose  15  ml ; metoprolol succinate xl  100  mg ; isosorbide mononitrate (extended release)  30  mg ; loratadine  10  mg ; ranitidine  150  mg ; finasteride  5  mg ; clopidogrel  75  mg ; oxybutynin  5  mg ; acyclovir  400  mg ; atovaquone suspension  750  mg ; 
hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery with unstable angina pectoris hyperlipidemia, unspecified chronic kidney disease, unspecified presence of coronary angioplasty implant and graft long term (current) use of antithrombotics/antiplatelets multiple myeloma not having achieved remission atherosclerotic heart disease of native coronary artery with other forms of angina pectoris long term (current) use of antithrombotics/antiplatelets unspecified place or not applicable hyperlipidemia, unspecified presence of coronary angioplasty implant and graft other chest pain benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease anemia in neoplastic disease multiple myeloma not having achieved remission chronic kidney disease, stage 3 (moderate) adverse effect of antineoplastic and immunosuppressive drugs, initial encounter old myocardial infarction hyperlipidemia, unspecified anemia in neoplastic disease chronic lymphocytic leukemia of b-cell type not having achieved remission personal history of malignant neoplasm of testis miscellaneous cardiovascular devices associated with adverse incidents, not elsewhere classified multiple myeloma not having achieved remission pure hypercholesterolemia, unspecified chronic kidney disease, stage 3 (moderate) stenosis of coronary artery stent, initial encounter benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris non-st elevation (nstemi) myocardial infarction anuria and oliguria multiple myeloma not having achieved remission hypo-osmolality and hyponatremia benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hyperlipidemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft acidosis anemia in neoplastic disease overactive bladder acute kidney failure with tubular necrosis chronic lymphocytic leukemia of b-cell type in remission thrombocytopenia, unspecified
white m 82 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  191  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; tamsulosin  0.4  mg ; vitamin d  1000  unit ; polyethylene glycol  17  g ; bisacodyl  10  mg ; lactulose  15  ml ; metoprolol succinate xl  100  mg ; isosorbide mononitrate (extended release)  30  mg ; loratadine  10  mg ; ranitidine  150  mg ; finasteride  5  mg ; clopidogrel  75  mg ; oxybutynin  5  mg ; atovaquone suspension  1500  mg ; 
hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery with unstable angina pectoris hyperlipidemia, unspecified chronic kidney disease, unspecified presence of coronary angioplasty implant and graft long term (current) use of antithrombotics/antiplatelets multiple myeloma not having achieved remission atherosclerotic heart disease of native coronary artery with other forms of angina pectoris long term (current) use of antithrombotics/antiplatelets unspecified place or not applicable hyperlipidemia, unspecified presence of coronary angioplasty implant and graft other chest pain benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease anemia in neoplastic disease multiple myeloma not having achieved remission chronic kidney disease, stage 3 (moderate) adverse effect of antineoplastic and immunosuppressive drugs, initial encounter old myocardial infarction hyperlipidemia, unspecified anemia in neoplastic disease chronic lymphocytic leukemia of b-cell type not having achieved remission personal history of malignant neoplasm of testis miscellaneous cardiovascular devices associated with adverse incidents, not elsewhere classified multiple myeloma not having achieved remission pure hypercholesterolemia, unspecified chronic kidney disease, stage 3 (moderate) stenosis of coronary artery stent, initial encounter benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris non-st elevation (nstemi) myocardial infarction anuria and oliguria multiple myeloma not having achieved remission hypo-osmolality and hyponatremia benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hyperlipidemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft acidosis anemia in neoplastic disease overactive bladder acute kidney failure with tubular necrosis chronic lymphocytic leukemia of b-cell type in remission thrombocytopenia, unspecified
white m 82 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; tamsulosin  0.4  mg ; vitamin d  1000  unit ; polyethylene glycol  17  g ; bisacodyl  10  mg ; lactulose  15  ml ; metoprolol succinate xl  100  mg ; isosorbide mononitrate (extended release)  30  mg ; loratadine  10  mg ; ranitidine  150  mg ; finasteride  5  mg ; clopidogrel  75  mg ; oxybutynin  5  mg ; atovaquone suspension  1500  mg ; 
hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery with unstable angina pectoris hyperlipidemia, unspecified chronic kidney disease, unspecified presence of coronary angioplasty implant and graft long term (current) use of antithrombotics/antiplatelets multiple myeloma not having achieved remission atherosclerotic heart disease of native coronary artery with other forms of angina pectoris long term (current) use of antithrombotics/antiplatelets unspecified place or not applicable hyperlipidemia, unspecified presence of coronary angioplasty implant and graft other chest pain benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease anemia in neoplastic disease multiple myeloma not having achieved remission chronic kidney disease, stage 3 (moderate) adverse effect of antineoplastic and immunosuppressive drugs, initial encounter old myocardial infarction hyperlipidemia, unspecified anemia in neoplastic disease chronic lymphocytic leukemia of b-cell type not having achieved remission personal history of malignant neoplasm of testis miscellaneous cardiovascular devices associated with adverse incidents, not elsewhere classified multiple myeloma not having achieved remission pure hypercholesterolemia, unspecified chronic kidney disease, stage 3 (moderate) stenosis of coronary artery stent, initial encounter benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris non-st elevation (nstemi) myocardial infarction anuria and oliguria multiple myeloma not having achieved remission hypo-osmolality and hyponatremia benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hyperlipidemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft acidosis anemia in neoplastic disease overactive bladder acute kidney failure with tubular necrosis chronic lymphocytic leukemia of b-cell type in remission thrombocytopenia, unspecified
white m 82 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  13  mg dl; hematology urine wbc  0  # hpf; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; tamsulosin  0.4  mg ; vitamin d  1000  unit ; polyethylene glycol  17  g ; bisacodyl  10  mg ; lactulose  15  ml ; metoprolol succinate xl  100  mg ; isosorbide mononitrate (extended release)  30  mg ; loratadine  10  mg ; ranitidine  150  mg ; finasteride  5  mg ; clopidogrel  75  mg ; oxybutynin  5  mg ; atovaquone suspension  1500  mg ; 
hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery with unstable angina pectoris hyperlipidemia, unspecified chronic kidney disease, unspecified presence of coronary angioplasty implant and graft long term (current) use of antithrombotics/antiplatelets multiple myeloma not having achieved remission atherosclerotic heart disease of native coronary artery with other forms of angina pectoris long term (current) use of antithrombotics/antiplatelets unspecified place or not applicable hyperlipidemia, unspecified presence of coronary angioplasty implant and graft other chest pain benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease anemia in neoplastic disease multiple myeloma not having achieved remission chronic kidney disease, stage 3 (moderate) adverse effect of antineoplastic and immunosuppressive drugs, initial encounter old myocardial infarction hyperlipidemia, unspecified anemia in neoplastic disease chronic lymphocytic leukemia of b-cell type not having achieved remission personal history of malignant neoplasm of testis miscellaneous cardiovascular devices associated with adverse incidents, not elsewhere classified multiple myeloma not having achieved remission pure hypercholesterolemia, unspecified chronic kidney disease, stage 3 (moderate) stenosis of coronary artery stent, initial encounter benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris non-st elevation (nstemi) myocardial infarction anuria and oliguria multiple myeloma not having achieved remission hypo-osmolality and hyponatremia benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hyperlipidemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft acidosis anemia in neoplastic disease overactive bladder acute kidney failure with tubular necrosis chronic lymphocytic leukemia of b-cell type in remission thrombocytopenia, unspecified
white m 82 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; tamsulosin  0.4  mg ; vitamin d  1000  unit ; polyethylene glycol  17  g ; bisacodyl  10  mg ; lactulose  15  ml ; metoprolol succinate xl  100  mg ; isosorbide mononitrate (extended release)  30  mg ; loratadine  10  mg ; ranitidine  150  mg ; finasteride  5  mg ; clopidogrel  75  mg ; oxybutynin  5  mg ; atovaquone suspension  1500  mg ; furosemide  20  mg ; pantoprazole  40  mg ; 
hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery with unstable angina pectoris hyperlipidemia, unspecified chronic kidney disease, unspecified presence of coronary angioplasty implant and graft long term (current) use of antithrombotics/antiplatelets multiple myeloma not having achieved remission atherosclerotic heart disease of native coronary artery with other forms of angina pectoris long term (current) use of antithrombotics/antiplatelets unspecified place or not applicable hyperlipidemia, unspecified presence of coronary angioplasty implant and graft other chest pain benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease anemia in neoplastic disease multiple myeloma not having achieved remission chronic kidney disease, stage 3 (moderate) adverse effect of antineoplastic and immunosuppressive drugs, initial encounter old myocardial infarction hyperlipidemia, unspecified anemia in neoplastic disease chronic lymphocytic leukemia of b-cell type not having achieved remission personal history of malignant neoplasm of testis miscellaneous cardiovascular devices associated with adverse incidents, not elsewhere classified multiple myeloma not having achieved remission pure hypercholesterolemia, unspecified chronic kidney disease, stage 3 (moderate) stenosis of coronary artery stent, initial encounter benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris non-st elevation (nstemi) myocardial infarction anuria and oliguria multiple myeloma not having achieved remission hypo-osmolality and hyponatremia benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hyperlipidemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft acidosis anemia in neoplastic disease overactive bladder acute kidney failure with tubular necrosis chronic lymphocytic leukemia of b-cell type in remission thrombocytopenia, unspecified
white m 82 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  83  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; tamsulosin  0.4  mg ; vitamin d  1000  unit ; polyethylene glycol  17  g ; bisacodyl  10  mg ; lactulose  15  ml ; metoprolol succinate xl  100  mg ; isosorbide mononitrate (extended release)  30  mg ; loratadine  10  mg ; ranitidine  150  mg ; finasteride  5  mg ; clopidogrel  75  mg ; oxybutynin  5  mg ; atovaquone suspension  1500  mg ; furosemide  20  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; 
hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery with unstable angina pectoris hyperlipidemia, unspecified chronic kidney disease, unspecified presence of coronary angioplasty implant and graft long term (current) use of antithrombotics/antiplatelets multiple myeloma not having achieved remission atherosclerotic heart disease of native coronary artery with other forms of angina pectoris long term (current) use of antithrombotics/antiplatelets unspecified place or not applicable hyperlipidemia, unspecified presence of coronary angioplasty implant and graft other chest pain benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease anemia in neoplastic disease multiple myeloma not having achieved remission chronic kidney disease, stage 3 (moderate) adverse effect of antineoplastic and immunosuppressive drugs, initial encounter old myocardial infarction hyperlipidemia, unspecified anemia in neoplastic disease chronic lymphocytic leukemia of b-cell type not having achieved remission personal history of malignant neoplasm of testis miscellaneous cardiovascular devices associated with adverse incidents, not elsewhere classified multiple myeloma not having achieved remission pure hypercholesterolemia, unspecified chronic kidney disease, stage 3 (moderate) stenosis of coronary artery stent, initial encounter benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris non-st elevation (nstemi) myocardial infarction anuria and oliguria multiple myeloma not having achieved remission hypo-osmolality and hyponatremia benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hyperlipidemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft acidosis anemia in neoplastic disease overactive bladder acute kidney failure with tubular necrosis chronic lymphocytic leukemia of b-cell type in remission thrombocytopenia, unspecified
white m 82 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  89  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; tamsulosin  0.4  mg ; vitamin d  1000  unit ; polyethylene glycol  17  g ; bisacodyl  10  mg ; lactulose  15  ml ; metoprolol succinate xl  100  mg ; isosorbide mononitrate (extended release)  30  mg ; loratadine  10  mg ; ranitidine  150  mg ; finasteride  5  mg ; clopidogrel  75  mg ; oxybutynin  5  mg ; atovaquone suspension  1500  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; 
hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery with unstable angina pectoris hyperlipidemia, unspecified chronic kidney disease, unspecified presence of coronary angioplasty implant and graft long term (current) use of antithrombotics/antiplatelets multiple myeloma not having achieved remission atherosclerotic heart disease of native coronary artery with other forms of angina pectoris long term (current) use of antithrombotics/antiplatelets unspecified place or not applicable hyperlipidemia, unspecified presence of coronary angioplasty implant and graft other chest pain benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease anemia in neoplastic disease multiple myeloma not having achieved remission chronic kidney disease, stage 3 (moderate) adverse effect of antineoplastic and immunosuppressive drugs, initial encounter old myocardial infarction hyperlipidemia, unspecified anemia in neoplastic disease chronic lymphocytic leukemia of b-cell type not having achieved remission personal history of malignant neoplasm of testis miscellaneous cardiovascular devices associated with adverse incidents, not elsewhere classified multiple myeloma not having achieved remission pure hypercholesterolemia, unspecified chronic kidney disease, stage 3 (moderate) stenosis of coronary artery stent, initial encounter benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris non-st elevation (nstemi) myocardial infarction anuria and oliguria multiple myeloma not having achieved remission hypo-osmolality and hyponatremia benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hyperlipidemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft acidosis anemia in neoplastic disease overactive bladder acute kidney failure with tubular necrosis chronic lymphocytic leukemia of b-cell type in remission thrombocytopenia, unspecified
white m 82 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  155  k ul; hematology blood inr(pt)  1.2  $sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; tamsulosin  0.4  mg ; vitamin d  1000  unit ; polyethylene glycol  17  g ; bisacodyl  10  mg ; lactulose  15  ml ; metoprolol succinate xl  100  mg ; isosorbide mononitrate (extended release)  30  mg ; loratadine  10  mg ; ranitidine  150  mg ; finasteride  5  mg ; clopidogrel  75  mg ; oxybutynin  5  mg ; atovaquone suspension  1500  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; 
hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery with unstable angina pectoris hyperlipidemia, unspecified chronic kidney disease, unspecified presence of coronary angioplasty implant and graft long term (current) use of antithrombotics/antiplatelets multiple myeloma not having achieved remission atherosclerotic heart disease of native coronary artery with other forms of angina pectoris long term (current) use of antithrombotics/antiplatelets unspecified place or not applicable hyperlipidemia, unspecified presence of coronary angioplasty implant and graft other chest pain benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease anemia in neoplastic disease multiple myeloma not having achieved remission chronic kidney disease, stage 3 (moderate) adverse effect of antineoplastic and immunosuppressive drugs, initial encounter old myocardial infarction hyperlipidemia, unspecified anemia in neoplastic disease chronic lymphocytic leukemia of b-cell type not having achieved remission personal history of malignant neoplasm of testis miscellaneous cardiovascular devices associated with adverse incidents, not elsewhere classified multiple myeloma not having achieved remission pure hypercholesterolemia, unspecified chronic kidney disease, stage 3 (moderate) stenosis of coronary artery stent, initial encounter benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris non-st elevation (nstemi) myocardial infarction anuria and oliguria multiple myeloma not having achieved remission hypo-osmolality and hyponatremia benign prostatic hyperplasia without lower urinary tract symptoms hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hyperlipidemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft acidosis anemia in neoplastic disease overactive bladder acute kidney failure with tubular necrosis chronic lymphocytic leukemia of b-cell type in remission thrombocytopenia, unspecified
white m 79 $nan$nan$aspirin  325  mg ; atorvastatin  40  mg ; amiodarone  200  mg ; 
 
white m 79 $nan$hematology blood hematocrit  23.1  %; hematology blood hematocrit  30.6  %; hematology blood hematocrit  20.4  %; hematology blood hemoglobin  5.4  g dl; hematology blood platelet count  254  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.9  ; hematology blood inr(pt)  6.0  ; hematology blood inr(pt)  5.9  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  159  iu l$aspirin  325  mg ; atorvastatin  40  mg ; amiodarone  200  mg ; 1 2 ns  1000  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; diltiazem  60  mg ; donepezil  10  mg ; phytonadione  10  mg ; aspirin  81  mg ; ferrous sulfate  325  mg ; bisacodyl  10  mg ; 
 
white m 79 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  89  mg dl$atorvastatin  40  mg ; amiodarone  200  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; diltiazem  60  mg ; donepezil  10  mg ; phytonadione  10  mg ; ferrous sulfate  325  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; olanzapine  2.5  mg ; cyanocobalamin  50  mcg ; folic acid  1  mg ; multivitamins  1  cap ; ns  100  ml ; ferric gluconate  125  mg ; pantoprazole  40  mg ; heparin  5000  unit ; 
 
white m 79 $nan$hematology blood hematocrit  29.2  %; hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  233  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  82  mg dl; chemistry blood lactate dehydrogenase (ld)  202  iu l; chemistry blood albumin  3.7  g dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$atorvastatin  40  mg ; amiodarone  200  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; diltiazem  60  mg ; donepezil  10  mg ; ferrous sulfate  325  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; olanzapine  2.5  mg ; cyanocobalamin  50  mcg ; folic acid  1  mg ; multivitamins  1  cap ; ns  100  ml ; ferric gluconate  125  mg ; pantoprazole  40  mg ; heparin  5000  unit ; haloperidol  5  mg ; d5 1 2ns  1000  ml ; 
 
white m 79 $nan$hematology blood hematocrit  26.2  %; hematology blood hematocrit  30.0  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  252  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  83  mg dl$atorvastatin  40  mg ; amiodarone  200  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; diltiazem  60  mg ; donepezil  10  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; cyanocobalamin  50  mcg ; folic acid  1  mg ; multivitamins  1  cap ; heparin  5000  unit ; haloperidol  5  mg ; d5 1 2ns  1000  ml ; 
 
white m 79 $nan$nan$atorvastatin  40  mg ; amiodarone  200  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; diltiazem  60  mg ; donepezil  10  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; cyanocobalamin  50  mcg ; folic acid  1  mg ; multivitamins  1  cap ; heparin  5000  unit ; 
 
white m 73 $temp  99.2  heartrate  85.0  resprate  18.0  o2sat  96.0  sbp  168.0  dbp  93.0  rhythm    pain  1  ; temp    heartrate  86.0  resprate  18.0  o2sat  97.0  sbp  155.0  dbp  74.0  rhythm    pain  4  ; temp    heartrate  67.0  resprate  18.0  o2sat  95.0  sbp  131.0  dbp  69.0  rhythm    pain  2  ; temp    heartrate  58.0  resprate  18.0  o2sat  97.0  sbp  126.0  dbp  72.0  rhythm    pain  0  $hematology blood hematocrit  41.4  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  219  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  95  mg dl; chemistry blood albumin  4.1  g dl$nan
 
white m 35 $nan$nan$atorvastatin  10  mg ; 
 
white m 35 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  102  mg dl$atorvastatin  10  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; hydromorphone (dilaudid)  1-2  mg ; labetalol  200  mg ; hydromorphone (dilaudid)  0.5-1  mg ; docusate sodium  100  mg ; amlodipine  10  mg ; 
 
white m 35 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  261  k ul$atorvastatin  10  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; labetalol  200  mg ; hydromorphone (dilaudid)  0.5-1  mg ; docusate sodium  100  mg ; amlodipine  10  mg ; acetaminophen  650  mg ; 
 
white m 35 $nan$nan$atorvastatin  10  mg ; sodium chloride 0.9%  flush  3  ml ; labetalol  200  mg ; hydromorphone (dilaudid)  0.5-1  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; 
 
white m 80 $nan$hematology blood hematocrit  30.1  %; hematology blood hematocrit  25.5  %; hematology blood hematocrit  20.6  %; hematology blood hematocrit  25.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  9.1  g dl; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  252  k ul; hematology blood platelet count  248  k ul; hematology blood platelet count  172  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  144  mg dl; chemistry blood glucose  154  mg dl; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  2.2  mmol l$multivitamins  1  cap ; vitamin d  400  unit ; acetaminophen  1000  mg ; pregabalin  75  mg ; tramadol (ultram)  25  mg ; albumin 5% (12.5g   250ml)  12.5  g ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; oxycodone (immediate release)   2.5  mg ; pantoprazole  40  mg ; amlodipine  5  mg ; aspirin  81  mg ; atorvastatin  20  mg ; lisinopril  40  mg ; timolol maleate 0.25%  1  drop ; 5% dextrose  250  ml ; phenylephrine  60  mg ; docusate sodium  100  mg ; senna  8.6  mg ; calcium carbonate  500  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  800  ml ; potassium chloride  80  meq ; hydromorphone (dilaudid)  0.25-0.5  mg ; 
personal history of malignant neoplasm of large intestine pure hypercholesterolemia calculus of gallbladder without mention of cholecystitis, without mention of obstruction unspecified essential hypertension unspecified hearing loss unspecified essential hypertension person on outside of bus injured in collision with pedestrian or animal in traffic accident disorder of bone and cartilage, unspecified urgency of urination other specified causes of urethral stricture other specified disorders of bladder osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) other specified disorders of arteries and arterioles elevated prostate specific antigen [psa] examination of participant in clinical trial personal history of malignant neoplasm of large intestine pure hypercholesterolemia personal history of other malignant neoplasm of skin acute pharyngitis
white m 80 $nan$hematology blood hematocrit  25.6  %; hematology blood hematocrit  24.6  %; hematology blood hematocrit  27.3  %; hematology blood hematocrit  26.5  %; hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  154  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  109  mg dl$multivitamins  1  cap ; vitamin d  400  unit ; albumin 5% (12.5g   250ml)  12.5  g ; sodium chloride 0.9%  flush  3  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; oxycodone (immediate release)   2.5  mg ; pantoprazole  40  mg ; aspirin  81  mg ; atorvastatin  20  mg ; timolol maleate 0.25%  1  drop ; 5% dextrose  250  ml ; phenylephrine  60  mg ; docusate sodium  100  mg ; senna  8.6  mg ; calcium carbonate  500  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  800  ml ; potassium chloride  80  meq ; hydromorphone (dilaudid)  0.25-0.5  mg ; tramadol (ultram)  50  mg ; enoxaparin sodium  40  mg ; oxycodone (immediate release)   5  mg ; 
personal history of malignant neoplasm of large intestine pure hypercholesterolemia calculus of gallbladder without mention of cholecystitis, without mention of obstruction unspecified essential hypertension unspecified hearing loss unspecified essential hypertension person on outside of bus injured in collision with pedestrian or animal in traffic accident disorder of bone and cartilage, unspecified urgency of urination other specified causes of urethral stricture other specified disorders of bladder osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) other specified disorders of arteries and arterioles elevated prostate specific antigen [psa] examination of participant in clinical trial personal history of malignant neoplasm of large intestine pure hypercholesterolemia personal history of other malignant neoplasm of skin acute pharyngitis
white m 80 $nan$hematology blood hematocrit  25.1  %; hematology blood hematocrit  22.0  %; hematology blood hematocrit  24.6  %; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  155  k ul; hematology blood platelet count  158  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry urine chloride, urine  119  meq l; chemistry urine creatinine, urine  135  mg dl; chemistry urine potassium, urine  86  meq l; chemistry urine sodium, urine  59  meq l; chemistry urine urea nitrogen, urine  900  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  108  mg dl$multivitamins  1  cap ; vitamin d  400  unit ; sodium chloride 0.9%  flush  3  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; pantoprazole  40  mg ; aspirin  81  mg ; atorvastatin  20  mg ; timolol maleate 0.25%  1  drop ; 5% dextrose  250  ml ; phenylephrine  60  mg ; docusate sodium  100  mg ; senna  8.6  mg ; calcium carbonate  500  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  800  ml ; potassium chloride  80  meq ; hydromorphone (dilaudid)  0.25-0.5  mg ; oxycodone (immediate release)   5  mg ; neutra-phos  2  pkt ; enoxaparin sodium  30  mg ; sodium chloride 0.9%  1000  ml ; 
personal history of malignant neoplasm of large intestine pure hypercholesterolemia calculus of gallbladder without mention of cholecystitis, without mention of obstruction unspecified essential hypertension unspecified hearing loss unspecified essential hypertension person on outside of bus injured in collision with pedestrian or animal in traffic accident disorder of bone and cartilage, unspecified urgency of urination other specified causes of urethral stricture other specified disorders of bladder osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) other specified disorders of arteries and arterioles elevated prostate specific antigen [psa] examination of participant in clinical trial personal history of malignant neoplasm of large intestine pure hypercholesterolemia personal history of other malignant neoplasm of skin acute pharyngitis
white m 80 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  124  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  83  mg dl$multivitamins  1  cap ; vitamin d  400  unit ; sodium chloride 0.9%  flush  3  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; pantoprazole  40  mg ; aspirin  81  mg ; atorvastatin  20  mg ; timolol maleate 0.25%  1  drop ; docusate sodium  100  mg ; senna  8.6  mg ; calcium carbonate  500  mg ; neutra-phos  2  pkt ; 0.9% sodium chloride  500  ml ; chlorpromazine  25  mg ; 
personal history of malignant neoplasm of large intestine pure hypercholesterolemia calculus of gallbladder without mention of cholecystitis, without mention of obstruction unspecified essential hypertension unspecified hearing loss unspecified essential hypertension person on outside of bus injured in collision with pedestrian or animal in traffic accident disorder of bone and cartilage, unspecified urgency of urination other specified causes of urethral stricture other specified disorders of bladder osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) other specified disorders of arteries and arterioles elevated prostate specific antigen [psa] examination of participant in clinical trial personal history of malignant neoplasm of large intestine pure hypercholesterolemia personal history of other malignant neoplasm of skin acute pharyngitis
white m 80 $nan$hematology blood hematocrit  23.5  %; hematology blood hematocrit  24.5  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  215  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  89  mg dl$multivitamins  1  cap ; vitamin d  400  unit ; sodium chloride 0.9%  flush  3  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; pantoprazole  40  mg ; atorvastatin  20  mg ; timolol maleate 0.25%  1  drop ; docusate sodium  100  mg ; senna  8.6  mg ; calcium carbonate  500  mg ; aspirin  325  mg ; 
personal history of malignant neoplasm of large intestine pure hypercholesterolemia calculus of gallbladder without mention of cholecystitis, without mention of obstruction unspecified essential hypertension unspecified hearing loss unspecified essential hypertension person on outside of bus injured in collision with pedestrian or animal in traffic accident disorder of bone and cartilage, unspecified urgency of urination other specified causes of urethral stricture other specified disorders of bladder osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) other specified disorders of arteries and arterioles elevated prostate specific antigen [psa] examination of participant in clinical trial personal history of malignant neoplasm of large intestine pure hypercholesterolemia personal history of other malignant neoplasm of skin acute pharyngitis
white m 80 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  300  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood glucose  112  mg dl$multivitamins  1  cap ; vitamin d  400  unit ; sodium chloride 0.9%  flush  3  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; pantoprazole  40  mg ; atorvastatin  20  mg ; timolol maleate 0.25%  1  drop ; docusate sodium  100  mg ; senna  8.6  mg ; calcium carbonate  500  mg ; aspirin  325  mg ; ferrous sulfate  325  mg ; 
personal history of malignant neoplasm of large intestine pure hypercholesterolemia calculus of gallbladder without mention of cholecystitis, without mention of obstruction unspecified essential hypertension unspecified hearing loss unspecified essential hypertension person on outside of bus injured in collision with pedestrian or animal in traffic accident disorder of bone and cartilage, unspecified urgency of urination other specified causes of urethral stricture other specified disorders of bladder osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) other specified disorders of arteries and arterioles elevated prostate specific antigen [psa] examination of participant in clinical trial personal history of malignant neoplasm of large intestine pure hypercholesterolemia personal history of other malignant neoplasm of skin acute pharyngitis
white f 30 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  236  k ul; hematology blood inr(pt)  0.9  $docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
outcome of delivery, single liveborn motorcycle driver injured in collision with fixed or stationary object in nontraffic accident retained placenta without hemorrhage, delivered, with mention of postpartum complication first-degree perineal laceration, delivered, with or without mention of antepartum condition
white f 30 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  218  k ul$docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
outcome of delivery, single liveborn motorcycle driver injured in collision with fixed or stationary object in nontraffic accident retained placenta without hemorrhage, delivered, with mention of postpartum complication first-degree perineal laceration, delivered, with or without mention of antepartum condition
other f 39 $nan$nan$iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; hydromorphone (dilaudid)  0.25  mg ; ondansetron  4-8  mg ; oxycodone liquid  5  mg ; lorazepam  0.25  mg ; acetaminophen iv  1000  mg ; ketorolac  15  mg ; 

other f 39 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; hydromorphone (dilaudid)  0.25  mg ; ondansetron  4-8  mg ; oxycodone liquid  5  mg ; lorazepam  0.25  mg ; acetaminophen iv  1000  mg ; ketorolac  30  mg ; loratadine  10  mg ; lansoprazole oral disintegrating tab  30  mg ; ranitidine (liquid)  150  mg ; acetaminophen  1000  mg ; ranitidine  150  mg ; oxycodone (immediate release)  5  mg ; docusate sodium  100  mg ; bag  1  bag ; magnesium sulfate  4  gm ; 

white m 64 $nan$nan$pantoprazole  40  mg ; insulin  36  unit ; gabapentin  200  mg ; iron polysaccharides complex  150  mg ; aspirin  81  mg ; citalopram hydrobromide  30  mg ; simvastatin  80  mg ; digoxin  0.125  mg ; 
nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere venous (peripheral) insufficiency, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia aortocoronary bypass status cellulitis and abscess of hand, except fingers and thumb atrial fibrillation coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of anticoagulants morbid obesity obstructive sleep apnea (adult)(pediatric) chronic airway obstruction, not elsewhere classified chronic kidney disease, unspecified peripheral vascular disease, unspecified systolic heart failure, unspecified congestive heart failure, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified anemia in chronic kidney disease 
white m 64 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  272  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  2.6  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  183  mg dl$pantoprazole  40  mg ; insulin  36  unit ; gabapentin  200  mg ; iron polysaccharides complex  150  mg ; aspirin  81  mg ; citalopram hydrobromide  30  mg ; simvastatin  80  mg ; digoxin  0.125  mg ; amoxicillin-clavulanic acid  500  mg ; amoxicillin-clavulanic acid  875  mg ; bisacodyl  10  mg ; senna  2  tab ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; oxycodone-acetaminophen  1-2  tab ; sodium chloride 0.9%  flush  3  ml ; metolazone  2.5  mg ; insulin  0  unit ; sulfameth trimethoprim ds  1  tab ; metoprolol tartrate  50  mg ; heparin  5000  unit ; divalproex sodium  125  mg ; docusate sodium  100  mg ; fluticasone-salmeterol (250 50)   1  inh ; bumetanide  4  mg ; risperidone  0.5  mg ; trazodone  50  mg ; insulin  30  unit ; 
nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere venous (peripheral) insufficiency, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia aortocoronary bypass status cellulitis and abscess of hand, except fingers and thumb atrial fibrillation coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of anticoagulants morbid obesity obstructive sleep apnea (adult)(pediatric) chronic airway obstruction, not elsewhere classified chronic kidney disease, unspecified peripheral vascular disease, unspecified systolic heart failure, unspecified congestive heart failure, unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled depressive disorder, not elsewhere classified anemia in chronic kidney disease 
black african american f 26 $temp    heartrate  89.0  resprate  16.0  o2sat  100.0  sbp  73.0  dbp  47.0  rhythm    pain  0  ; temp    heartrate  89.0  resprate  16.0  o2sat  100.0  sbp  59.0  dbp  43.0  rhythm    pain    $hematology blood hematocrit  57.1  %; hematology blood hemoglobin  18.6  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  25  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  9.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  109  mg dl; chemistry blood albumin  4.6  g dl; blood gas blood lactate  3.3  mmol l$nan
 
black african american f 26 $temp    heartrate  88.0  resprate  16.0  o2sat  100.0  sbp  76.0  dbp  57.0  rhythm    pain  0  ; temp    heartrate  91.0  resprate  16.0  o2sat  100.0  sbp  99.0  dbp  80.0  rhythm    pain  0  ; temp    heartrate  88.0  resprate  14.0  o2sat  100.0  sbp  74.0  dbp  49.0  rhythm    pain  0  $hematology blood hematocrit  42.8  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  9.4  mg dl; chemistry blood creatinine  7.1  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.0  mg dl; chemistry blood calcium, total  4.8  mg dl; chemistry blood glucose  133  mg dl; chemistry blood glucose  82  mg dl; blood gas blood free calcium  0.67  mmol l; blood gas blood lactate  1.6  mmol l$influenza virus vaccine  0.5  ml ; senna  1  tab ; acetaminophen  325-650  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 0.9% sodium chloride  500  ml ; heparin  5000  unit ; docusate sodium  100  mg ; calcium acetate  1334  mg ; calcitriol  2  mcg ; bag  50  ml ; magnesium sulfate  2  gm ; sodium chloride 0.9%  flush  3  ml ; 
 
black african american f 26 $nan$hematology blood hematocrit  45.9  %; hematology blood hemoglobin  15.2  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  10.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood calcium, total  6.5  mg dl; chemistry blood glucose  94  mg dl; blood gas blood free calcium  1.02  mmol l$influenza virus vaccine  0.5  ml ; senna  1  tab ; acetaminophen  325-650  mg ; heparin  5000  unit ; docusate sodium  100  mg ; calcium acetate  1334  mg ; calcitriol  2  mcg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  250  ml ; diphenhydramine  50  mg ; calcium carbonate  1500  mg ; 
 
black african american f 26 $nan$nan$influenza virus vaccine  0.5  ml ; senna  1  tab ; acetaminophen  325-650  mg ; heparin  5000  unit ; docusate sodium  100  mg ; calcitriol  2  mcg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  250  ml ; calcium carbonate  1500  mg ; 
 
white m 24 $nan$hematology blood hematocrit  43.0  %; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  8  # hpf; chemistry blood calcium, total  9.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  91  mg dl; chemistry blood lactate dehydrogenase (ld)  293  iu l; chemistry blood albumin  4.6  g dl$levetiracetam  1000  mg ; olanzapine (disintegrating tablet)  5  mg ; sodium chloride 0.9%  flush  3  ml ; lorazepam  1-2  mg ; acetaminophen  325-650  mg ; senna  1  tab ; heparin  5000  unit ; sarna lotion  1  appl ; divalproex (delayed release)  500  mg ; topiramate (topamax)  25  mg ; docusate sodium  100  mg ; rufinamide  200  mg ; levetiracetam  1500  mg ; 
other autosomal deletions unspecified intellectual disabilities generalized nonconvulsive epilepsy, with intractable epilepsy 
white m 24 $nan$nan$levetiracetam  1000  mg ; sodium chloride 0.9%  flush  3  ml ; lorazepam  1-2  mg ; acetaminophen  325-650  mg ; senna  1  tab ; heparin  5000  unit ; sarna lotion  1  appl ; divalproex (delayed release)  500  mg ; topiramate (topamax)  25  mg ; docusate sodium  100  mg ; rufinamide  200  mg ; levetiracetam  1500  mg ; olanzapine  2.5  mg ; 
other autosomal deletions unspecified intellectual disabilities generalized nonconvulsive epilepsy, with intractable epilepsy 
white m 24 $nan$nan$levetiracetam  1000  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; heparin  5000  unit ; sarna lotion  1  appl ; divalproex (delayed release)  500  mg ; topiramate (topamax)  25  mg ; docusate sodium  100  mg ; rufinamide  200  mg ; levetiracetam  1500  mg ; olanzapine  2.5  mg ; levetiracetam  500  mg ; rufinamide  100  mg ; 
other autosomal deletions unspecified intellectual disabilities generalized nonconvulsive epilepsy, with intractable epilepsy 
white m 24 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; heparin  5000  unit ; sarna lotion  1  appl ; divalproex (delayed release)  500  mg ; topiramate (topamax)  25  mg ; docusate sodium  100  mg ; levetiracetam  500  mg ; rufinamide  100  mg ; levetiracetam  2000  mg ; 
other autosomal deletions unspecified intellectual disabilities generalized nonconvulsive epilepsy, with intractable epilepsy 
white m 24 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; heparin  5000  unit ; sarna lotion  1  appl ; divalproex (delayed release)  500  mg ; topiramate (topamax)  25  mg ; docusate sodium  100  mg ; levetiracetam  2000  mg ; topiramate (topamax)  75  mg ; 
other autosomal deletions unspecified intellectual disabilities generalized nonconvulsive epilepsy, with intractable epilepsy 
white m 24 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; heparin  5000  unit ; sarna lotion  1  appl ; divalproex (delayed release)  500  mg ; docusate sodium  100  mg ; levetiracetam  2000  mg ; topiramate (topamax)  75  mg ; artificial tears  1-2  drop ; 
other autosomal deletions unspecified intellectual disabilities generalized nonconvulsive epilepsy, with intractable epilepsy 
white m 24 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; heparin  5000  unit ; sarna lotion  1  appl ; divalproex (delayed release)  500  mg ; docusate sodium  100  mg ; levetiracetam  2000  mg ; topiramate (topamax)  75  mg ; artificial tears  1-2  drop ; topiramate (topamax)  50  mg ; 
other autosomal deletions unspecified intellectual disabilities generalized nonconvulsive epilepsy, with intractable epilepsy 
white m 24 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; heparin  5000  unit ; sarna lotion  1  appl ; divalproex (delayed release)  500  mg ; docusate sodium  100  mg ; levetiracetam  2000  mg ; artificial tears  1-2  drop ; topiramate (topamax)  50  mg ; quetiapine fumarate  12.5  mg ; 
other autosomal deletions unspecified intellectual disabilities generalized nonconvulsive epilepsy, with intractable epilepsy 
white m 24 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; heparin  5000  unit ; sarna lotion  1  appl ; divalproex (delayed release)  500  mg ; docusate sodium  100  mg ; levetiracetam  2000  mg ; artificial tears  1-2  drop ; topiramate (topamax)  50  mg ; quetiapine fumarate  12.5  mg ; 
other autosomal deletions unspecified intellectual disabilities generalized nonconvulsive epilepsy, with intractable epilepsy 
white f 40 $nan$nan$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; ketorolac  15  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; docusate sodium  100  mg ; 
 
white f 40 $nan$nan$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; ketorolac  15  mg ; docusate sodium  100  mg ; 
 
unknown m 87 $temp    heartrate  77.0  resprate  17.0  o2sat  95.0  sbp  128.0  dbp  62.0  rhythm    pain    ; temp    heartrate  74.0  resprate  19.0  o2sat  98.0  sbp    dbp    rhythm    pain    ; temp    heartrate  84.0  resprate  15.0  o2sat  96.0  sbp  106.0  dbp  67.0  rhythm    pain  0  ; temp    heartrate  66.0  resprate  18.0  o2sat  97.0  sbp  87.0  dbp  63.0  rhythm    pain    ; temp    heartrate    resprate    o2sat    sbp  107.0  dbp  68.0  rhythm    pain    $hematology blood hematocrit  27.4  %; hematology blood hematocrit  25.9  %; hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  159  k ul; hematology blood platelet count  149  k ul; hematology blood platelet count  193  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  9  meq l; chemistry blood anion gap  10  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.0  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  1.8  ; chemistry urine creatinine, urine  79  mg dl; chemistry urine sodium, urine  48  meq l; chemistry urine urea nitrogen, urine  656  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  160  mg dl; chemistry blood glucose  145  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  194  iu l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood potassium, whole blood  4.0  meq l$influenza vaccine quadrivalent  0.5  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; erythromycin 0.5% ophth oint  0.5  in ; atorvastatin  80  mg ; azithromycin  500  mg ; cefepime  2  g ; metronidazole  500  mg ; bag  1  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; syringe  1  ml ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; heparin  4800  unit ; heparin  1200-2400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; lactated ringers  1000  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; vitamin d  1000  unit ; vial  1  vial ; ceftriaxone  2  gm ; azithromycin  250  mg ; cefepime  1  g ; ceftriaxone  1  gm ; inv-thiamine  100  mg\ 0 mg ; inv-ascorbic acid  1  mg\ 0 mg ; inv-hydrocortisone  50  mg\ 0 mg ; 
 
unknown m 87 $nan$hematology blood hematocrit  24.1  %; hematology blood hematocrit  24.8  %; hematology blood hematocrit  23.9  %; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  126  k ul; hematology blood platelet count  146  k ul; hematology blood platelet count  155  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  114  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  126  mg dl; chemistry blood lactate dehydrogenase (ld)  172  iu l; blood gas blood lactate  1.0  mmol l$influenza vaccine quadrivalent  0.5  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; cefepime  2  g ; bag  1  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; calcium gluconate  4  g ; syringe  1  ml ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; vitamin d  1000  unit ; azithromycin  250  mg ; ceftriaxone  1  gm ; pravastatin  80  mg ; metoprolol tartrate  37.5  mg ; sodium chloride 0.9%  flush  3-10  ml ; inv-thiamine  100  mg\ 0 mg ; inv-ascorbic acid  1  mg\ 0 mg ; inv-hydrocortisone  50  mg\ 0 mg ; 
 
unknown m 87 $nan$hematology blood hematocrit  24.5  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  169  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  116  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  87  mg dl$influenza vaccine quadrivalent  0.5  ml ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; vitamin d  1000  unit ; azithromycin  250  mg ; ceftriaxone  1  gm ; pravastatin  80  mg ; metoprolol tartrate  37.5  mg ; sodium chloride 0.9%  flush  3-10  ml ; apixaban  5  mg ; d5 1 2ns  1000  ml ; 
 
unknown m 87 $nan$hematology blood hematocrit  23.8  %; hematology blood hematocrit  24.4  %; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  165  k ul; hematology blood platelet count  175  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  117  mg dl; blood gas blood lactate  1.1  mmol l$influenza vaccine quadrivalent  0.5  ml ; vitamin d  1000  unit ; azithromycin  250  mg ; ceftriaxone  1  gm ; pravastatin  80  mg ; metoprolol tartrate  37.5  mg ; sodium chloride 0.9%  flush  3-10  ml ; apixaban  5  mg ; d5 1 2ns  1000  ml ; ramelteon  8  mg ; 
 
unknown m 87 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  98  mg dl$influenza vaccine quadrivalent  0.5  ml ; vitamin d  1000  unit ; azithromycin  250  mg ; pravastatin  80  mg ; metoprolol tartrate  37.5  mg ; sodium chloride 0.9%  flush  3-10  ml ; apixaban  5  mg ; d5 1 2ns  1000  ml ; ramelteon  8  mg ; loperamide  2  mg ; 
 
unknown m 87 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  101  mg dl$influenza vaccine quadrivalent  0.5  ml ; vitamin d  1000  unit ; pravastatin  80  mg ; metoprolol tartrate  37.5  mg ; sodium chloride 0.9%  flush  3-10  ml ; apixaban  5  mg ; ramelteon  8  mg ; loperamide  2  mg ; 
 
unknown m 87 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; vitamin d  1000  unit ; pravastatin  80  mg ; metoprolol tartrate  37.5  mg ; sodium chloride 0.9%  flush  3-10  ml ; apixaban  5  mg ; ramelteon  8  mg ; loperamide  2  mg ; 
 
unknown m 87 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; vitamin d  1000  unit ; pravastatin  80  mg ; metoprolol tartrate  37.5  mg ; sodium chloride 0.9%  flush  3-10  ml ; apixaban  5  mg ; ramelteon  8  mg ; loperamide  2  mg ; 
 
white m 34 $nan$hematology blood hematocrit  45.4  %; hematology blood hematocrit  39.6  %; hematology blood hemoglobin  15.8  g dl; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  304  k ul; hematology blood platelet count  191  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  173  mg dl; hematology blood bands  43  %; blood gas blood free calcium  1.18  mmol l; blood gas blood lactate  3.0  mmol l; blood gas blood chloride, whole blood  104  meq l; blood gas blood glucose  127  mg dl; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood sodium, whole blood  133  meq l$hydromorphone (dilaudid)  0.5  mg ; lorazepam  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  20  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ketorolac  30  mg ; acetaminophen iv  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; vial  1  vial ; pantoprazole  40  mg ; meperidine  12.5  mg ; haloperidol  0.25-0.5  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.2-0.6  mg ; bag  50  ml ; magnesium sulfate  2  gm ; heparin  5000  unit ; albumin 5% (25g   500ml)  50  g ; 
body mass index 35.0-35.9, adult unspecified essential hypertension morbid obesity family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident diverticulitis of colon (without mention of hemorrhage)
white m 34 $nan$hematology blood hematocrit  48.9  %; hematology blood hematocrit  43.4  %; hematology blood hematocrit  44.9  %; hematology blood hematocrit  45.2  %; hematology blood hematocrit  40.6  %; hematology blood hemoglobin  16.7  g dl; hematology blood hemoglobin  14.7  g dl; hematology blood hemoglobin  15.5  g dl; hematology blood hemoglobin  14.9  g dl; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  290  k ul; hematology blood platelet count  214  k ul; hematology blood platelet count  281  k ul; hematology blood platelet count  254  k ul; hematology blood platelet count  252  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  10  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.4  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  6.5  mg dl; chemistry blood glucose  114  mg dl; chemistry blood glucose  144  mg dl; chemistry blood glucose  122  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  154  mg dl; hematology blood bands  56  %; blood gas blood free calcium  1.24  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood free calcium  1.27  mmol l; blood gas blood free calcium  1.24  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  2.9  mmol l; blood gas blood lactate  3.4  mmol l; blood gas blood lactate  3.5  mmol l; blood gas blood lactate  3.0  mmol l; blood gas blood lactate  2.7  mmol l; blood gas blood lactate  2.6  mmol l; blood gas blood lactate  2.9  mmol l; blood gas blood lactate  3.2  mmol l; blood gas blood lactate  2.8  mmol l; blood gas blood chloride, whole blood  99  meq l; blood gas blood glucose  125  mg dl; blood gas blood glucose  98  mg dl; blood gas blood glucose  125  mg dl; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood sodium, whole blood  132  meq l; blood gas blood calculated bicarbonate, whole blood  23  meq l$albumin 5% (25g   500ml)  50  g ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; norepinephrine  8  mg ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; propofol  1000  mg ; fentanyl citrate  2.5  mg ; insulin  0  unit ; norepinephrine  16  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; midazolam  2-4  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; 
body mass index 35.0-35.9, adult unspecified essential hypertension morbid obesity family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident diverticulitis of colon (without mention of hemorrhage)
white m 34 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  9  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.0  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  6.9  mg dl; chemistry blood calcium, total  6.7  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  89  mg dl; chemistry blood glucose  128  mg dl; chemistry blood glucose  121  mg dl; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  3.5  mmol l; blood gas blood lactate  3.3  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  4.7  mmol l; blood gas blood chloride, whole blood  104  meq l; blood gas blood glucose  106  mg dl; blood gas blood glucose  113  mg dl; blood gas blood glucose  96  mg dl; blood gas blood hematocrit, calculated  38  %; blood gas blood hemoglobin  12.7  g dl; blood gas blood potassium, whole blood  3.3  meq l; blood gas blood sodium, whole blood  130  meq l$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; fentanyl citrate  2.5  mg ; insulin  0  unit ; norepinephrine  16  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; neutra-phos  2  pkt ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; sodium phosphate  15  mmol ; sodium phosphate  30  mmol ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; artificial tear ointment  1  appl ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 5% dextrose  150  ml ; vancomycin  500  mg ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; 
body mass index 35.0-35.9, adult unspecified essential hypertension morbid obesity family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident diverticulitis of colon (without mention of hemorrhage)
white m 34 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  6.8  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  2.5  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  101  mg dl; chemistry blood glucose  89  mg dl; chemistry blood albumin  1.7  g dl; blood gas blood free calcium  1.19  mmol l; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood glucose  107  mg dl; blood gas blood glucose  88  mg dl$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; fentanyl citrate  2.5  mg ; insulin  0  unit ; norepinephrine  16  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; artificial tear ointment  1  appl ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; 5% dextrose  500  ml ; vancomycin  1500  mg ; 0.9% sodium chloride  250  ml ; albumin 5% (12.5g   250ml)  12.5  g ; furosemide  20  mg ; 5% dextrose  40  ml ; furosemide  40  mg ; 
body mass index 35.0-35.9, adult unspecified essential hypertension morbid obesity family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident diverticulitis of colon (without mention of hemorrhage)
white m 34 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  4.7  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  89  mg dl; chemistry blood albumin  1.7  g dl; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood free calcium  1.02  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood potassium, whole blood  3.2  meq l$soln  100  ml ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; fentanyl citrate  2.5  mg ; insulin  0  unit ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; artificial tear ointment  1  appl ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; 5% dextrose  40  ml ; furosemide  40  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; 
body mass index 35.0-35.9, adult unspecified essential hypertension morbid obesity family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident diverticulitis of colon (without mention of hemorrhage)
white m 34 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  98  mg dl; chemistry blood glucose  78  mg dl; chemistry blood glucose  88  mg dl; blood gas blood free calcium  1.01  mmol l; blood gas blood free calcium  1.03  mmol l; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.06  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood potassium, whole blood  3.4  meq l$soln  100  ml ; sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; fentanyl citrate  2.5  mg ; insulin  0  unit ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; artificial tear ointment  1  appl ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; ns  100  ml ; metronidazole (flagyl)  500  mg ; metolazone  5  mg ; 
body mass index 35.0-35.9, adult unspecified essential hypertension morbid obesity family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident diverticulitis of colon (without mention of hemorrhage)
white m 34 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  218  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  3.0  meq l; chemistry blood potassium  2.8  meq l; chemistry blood potassium  2.7  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  130  mg dl; chemistry blood glucose  129  mg dl; chemistry blood glucose  118  mg dl; chemistry blood glucose  120  mg dl; chemistry blood albumin  1.9  g dl; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.04  mmol l$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; fentanyl citrate  2.5  mg ; insulin  0  unit ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; artificial tear ointment  1  appl ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; metolazone  5  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; psyllium wafer  1  waf ; psyllium  1  pkt ; iso-osmotic sodium chloride  200  ml ; fluconazole  400  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  650  mg ; 
body mass index 35.0-35.9, adult unspecified essential hypertension morbid obesity family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident diverticulitis of colon (without mention of hemorrhage)
white m 34 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  267  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  39  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  119  mg dl; chemistry blood glucose  118  mg dl; chemistry blood glucose  127  mg dl; chemistry blood glucose  117  mg dl; blood gas blood free calcium  1.05  mmol l$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; fentanyl citrate  2.5  mg ; insulin  0  unit ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; artificial tear ointment  1  appl ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; iso-osmotic sodium chloride  200  ml ; fluconazole  400  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  650  mg ; 5% dextrose  25  ml ; acetazolamide sodium  250  mg ; potassium chloride  80  meq ; 
body mass index 35.0-35.9, adult unspecified essential hypertension morbid obesity family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident diverticulitis of colon (without mention of hemorrhage)
white m 34 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  329  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  8  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  111  mg dl; chemistry blood glucose  113  mg dl; chemistry blood glucose  114  mg dl; chemistry blood glucose  118  mg dl$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; artificial tear ointment  1  appl ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; iso-osmotic sodium chloride  200  ml ; fluconazole  400  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  650  mg ; 5% dextrose  25  ml ; acetazolamide sodium  250  mg ; potassium chloride  80  meq ; chlorpromazine  25  mg ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; 
body mass index 35.0-35.9, adult unspecified essential hypertension morbid obesity family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident diverticulitis of colon (without mention of hemorrhage)
white m 34 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  373  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  9  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology urine wbc  5  # hpf; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  147  mg dl; chemistry blood glucose  109  mg dl; blood gas blood free calcium  1.03  mmol l$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; artificial tear ointment  1  appl ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; iso-osmotic sodium chloride  200  ml ; fluconazole  400  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  650  mg ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; fentanyl citrate  25-50  mcg ; 
body mass index 35.0-35.9, adult unspecified essential hypertension morbid obesity family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident diverticulitis of colon (without mention of hemorrhage)
white m 34 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  518  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  108  mg dl$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; artificial tear ointment  1  appl ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; iso-osmotic sodium chloride  200  ml ; fluconazole  400  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  650  mg ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; fentanyl citrate  25-50  mcg ; lorazepam  1  mg ; 
body mass index 35.0-35.9, adult unspecified essential hypertension morbid obesity family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident diverticulitis of colon (without mention of hemorrhage)
white m 34 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  627  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  101  mg dl; chemistry blood glucose  107  mg dl$sodium chloride 0.9%  flush  10  ml ; artificial tear ointment  1  appl ; iso-osmotic sodium chloride  200  ml ; fluconazole  400  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  650  mg ; potassium chloride (powder)  20  meq ; 
body mass index 35.0-35.9, adult unspecified essential hypertension morbid obesity family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident diverticulitis of colon (without mention of hemorrhage)
white m 34 $nan$nan$artificial tear ointment  1  appl ; iso-osmotic sodium chloride  200  ml ; fluconazole  400  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  650  mg ; potassium chloride (powder)  20  meq ; loperamide  4  mg ; amoxicillin-clavulanic acid  875  mg ; 
body mass index 35.0-35.9, adult unspecified essential hypertension morbid obesity family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident diverticulitis of colon (without mention of hemorrhage)
white m 34 $nan$nan$artificial tear ointment  1  appl ; acetaminophen  650  mg ; amoxicillin-clavulanic acid  875  mg ; loperamide  2  mg ; 
body mass index 35.0-35.9, adult unspecified essential hypertension morbid obesity family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident diverticulitis of colon (without mention of hemorrhage)
white m 34 $nan$nan$artificial tear ointment  1  appl ; acetaminophen  650  mg ; amoxicillin-clavulanic acid  875  mg ; loperamide  2  mg ; trazodone  25  mg ; diphenhydramine  50  mg ; 
body mass index 35.0-35.9, adult unspecified essential hypertension morbid obesity family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident diverticulitis of colon (without mention of hemorrhage)
white m 34 $nan$nan$artificial tear ointment  1  appl ; acetaminophen  650  mg ; amoxicillin-clavulanic acid  875  mg ; loperamide  2  mg ; trazodone  25  mg ; diphenhydramine  50  mg ; hydromorphone (dilaudid)  0.25  mg ; 
body mass index 35.0-35.9, adult unspecified essential hypertension morbid obesity family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident diverticulitis of colon (without mention of hemorrhage)
white f 68 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  275  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  131  mg dl$nan
essential and other specified forms of tremor personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits
white f 68 $nan$hematology blood hematocrit  27.6  %; hematology blood hematocrit  25.8  %; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  256  k ul; hematology blood platelet count  228  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  166  mg dl; chemistry blood albumin  4.0  g dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; acetaminophen  325-650  mg ; oxycodone-acetaminophen  1  tab ; ondansetron  4  mg ; bisacodyl  10  mg ; topiramate (topamax)  100  mg ; clonazepam  0.5  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; vitamin d  400  unit ; multivitamins w minerals  1  tab ; hydralazine  10-20  mg ; phenytoin  100  mg ; 0.9% sodium chloride  100  ml ; phenytoin sodium  100  mg ; 
essential and other specified forms of tremor personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits
white f 68 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  114  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; acetaminophen  325-650  mg ; oxycodone-acetaminophen  1  tab ; ondansetron  4  mg ; bisacodyl  10  mg ; topiramate (topamax)  100  mg ; clonazepam  0.5  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; vitamin d  400  unit ; multivitamins w minerals  1  tab ; 0.9% sodium chloride  100  ml ; phenytoin sodium  100  mg ; cefazolin  2  g ; heparin  5000  unit ; metoclopramide  10  mg ; scopolamine patch  1  ptch ; 
essential and other specified forms of tremor personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits
white f 68 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  218  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  125  mg dl$pneumococcal vac polyvalent  0.5  ml ; acetaminophen  325-650  mg ; oxycodone-acetaminophen  1  tab ; bisacodyl  10  mg ; topiramate (topamax)  100  mg ; clonazepam  0.5  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; vitamin d  400  unit ; multivitamins w minerals  1  tab ; 0.9% sodium chloride  100  ml ; phenytoin sodium  100  mg ; heparin  5000  unit ; metoclopramide  10  mg ; scopolamine patch  1  ptch ; 
essential and other specified forms of tremor personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits
white f 68 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; acetaminophen  325-650  mg ; oxycodone-acetaminophen  1  tab ; bisacodyl  10  mg ; topiramate (topamax)  100  mg ; clonazepam  0.5  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; vitamin d  400  unit ; multivitamins w minerals  1  tab ; 0.9% sodium chloride  100  ml ; phenytoin sodium  100  mg ; heparin  5000  unit ; metoclopramide  10  mg ; scopolamine patch  1  ptch ; 
essential and other specified forms of tremor personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits
white f 68 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; acetaminophen  325-650  mg ; oxycodone-acetaminophen  1  tab ; bisacodyl  10  mg ; topiramate (topamax)  100  mg ; clonazepam  0.5  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; vitamin d  400  unit ; multivitamins w minerals  1  tab ; heparin  5000  unit ; metoclopramide  10  mg ; scopolamine patch  1  ptch ; 
essential and other specified forms of tremor personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits
white m 64 $temp  101.1  heartrate  102.0  resprate  18.0  o2sat  97.0  sbp  157.0  dbp  88.0  rhythm    pain  4  $hematology urine wbc  125  # hpf$nan
 
black african american m 37 $nan$nan$morphine sr (ms contin)  30  mg ; folic acid  1  mg ; 
plasma cell leukemia, without mention of having achieved remission unspecified essential hypertension other secondary thrombocytopenia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted bone marrow graft-versus-host disease, unspecified acute kidney failure, unspecified diarrhea hypopotassemia acute pharyngitis defibrination syndrome thrombotic microangiopathy acute on chronic graft-versus-host disease antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other and unspecified noninfectious gastroenteritis and colitis unspecified essential hypertension acute venous embolism and thrombosis of superficial veins of upper extremity complications of other specified transplanted organ other specified cardiac dysrhythmias surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation methicillin resistant pneumonia due to staphylococcus aureus bacteremia polyneuropathy due to drugs plasma cell leukemia, in relapse dysuria other complications due to other vascular device, implant, and graft other specified viral infection fever presenting with conditions classified elsewhere plasma cell leukemia, without mention of having achieved remission other secondary thrombocytopenia acute graft-versus-host disease candidiasis of mouth complications of transplanted bone marrow diarrhea personal history of venous thrombosis and embolism other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation plasma cell leukemia, in relapse peripheral stem cells replaced by transplant acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified other complications due to other vascular device, implant, and graft thrombocytopenia, unspecified cephalosporin group causing adverse effects in therapeutic use mechanical complication due to graft of other tissue, not elsewhere classified plasma cell leukemia, in relapse dermatitis due to drugs and medicines taken internally chronic graft-versus-host disease surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
black african american m 37 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  37  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  87  mg dl; chemistry blood lactate dehydrogenase (ld)  204  iu l; hematology blood bands  5  %$morphine sr (ms contin)  30  mg ; folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acyclovir  400  mg ; lorazepam  1  mg ; ondansetron  8  mg ; budesonide  3  mg ; metoprolol tartrate  25  mg ; mycophenolate mofetil  500  mg ; voriconazole  200  mg ; vancomycin oral liquid  125  mg ; acetaminophen  650  mg ; 5% dextrose  250  ml ; potassium chloride  20  meq ; bag  50  ml ; magnesium sulfate  2  gm ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; acetaminophen  1000  mg ; nystatin oral suspension  5  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; 
plasma cell leukemia, without mention of having achieved remission unspecified essential hypertension other secondary thrombocytopenia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted bone marrow graft-versus-host disease, unspecified acute kidney failure, unspecified diarrhea hypopotassemia acute pharyngitis defibrination syndrome thrombotic microangiopathy acute on chronic graft-versus-host disease antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other and unspecified noninfectious gastroenteritis and colitis unspecified essential hypertension acute venous embolism and thrombosis of superficial veins of upper extremity complications of other specified transplanted organ other specified cardiac dysrhythmias surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation methicillin resistant pneumonia due to staphylococcus aureus bacteremia polyneuropathy due to drugs plasma cell leukemia, in relapse dysuria other complications due to other vascular device, implant, and graft other specified viral infection fever presenting with conditions classified elsewhere plasma cell leukemia, without mention of having achieved remission other secondary thrombocytopenia acute graft-versus-host disease candidiasis of mouth complications of transplanted bone marrow diarrhea personal history of venous thrombosis and embolism other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation plasma cell leukemia, in relapse peripheral stem cells replaced by transplant acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified other complications due to other vascular device, implant, and graft thrombocytopenia, unspecified cephalosporin group causing adverse effects in therapeutic use mechanical complication due to graft of other tissue, not elsewhere classified plasma cell leukemia, in relapse dermatitis due to drugs and medicines taken internally chronic graft-versus-host disease surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
black african american m 37 $nan$hematology blood hematocrit  21.1  %; hematology blood hemoglobin  6.7  g dl; hematology blood platelet count  19  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  2.0  ; chemistry urine chloride, urine  107  meq l; chemistry urine creatinine, urine  16  mg dl; chemistry urine potassium, urine  9  meq l; chemistry urine sodium, urine  113  meq l; chemistry urine urea nitrogen, urine  59  mg dl; hematology urine wbc  3  # hpf; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  119  mg dl; chemistry blood lactate dehydrogenase (ld)  178  iu l; hematology blood bands  1  %$morphine sr (ms contin)  30  mg ; folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; acyclovir  400  mg ; lorazepam  1  mg ; ondansetron  8  mg ; budesonide  3  mg ; mycophenolate mofetil  500  mg ; voriconazole  200  mg ; vancomycin oral liquid  125  mg ; acetaminophen  650  mg ; 5% dextrose  250  ml ; potassium chloride  20  meq ; bag  50  ml ; magnesium sulfate  2  gm ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; acetaminophen  1000  mg ; nystatin oral suspension  5  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; lorazepam  0.5  mg ; 5% dextrose  100  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; 5% dextrose  50  ml ; clindamycin  600  mg ; oxymetazoline  1  spry ; metoprolol tartrate  5  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; potassium chloride  60  meq ; phytonadione  1  mg ; phytonadione  5  mg ; morphine sulfate  1  mg ; 
plasma cell leukemia, without mention of having achieved remission unspecified essential hypertension other secondary thrombocytopenia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted bone marrow graft-versus-host disease, unspecified acute kidney failure, unspecified diarrhea hypopotassemia acute pharyngitis defibrination syndrome thrombotic microangiopathy acute on chronic graft-versus-host disease antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other and unspecified noninfectious gastroenteritis and colitis unspecified essential hypertension acute venous embolism and thrombosis of superficial veins of upper extremity complications of other specified transplanted organ other specified cardiac dysrhythmias surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation methicillin resistant pneumonia due to staphylococcus aureus bacteremia polyneuropathy due to drugs plasma cell leukemia, in relapse dysuria other complications due to other vascular device, implant, and graft other specified viral infection fever presenting with conditions classified elsewhere plasma cell leukemia, without mention of having achieved remission other secondary thrombocytopenia acute graft-versus-host disease candidiasis of mouth complications of transplanted bone marrow diarrhea personal history of venous thrombosis and embolism other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation plasma cell leukemia, in relapse peripheral stem cells replaced by transplant acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified other complications due to other vascular device, implant, and graft thrombocytopenia, unspecified cephalosporin group causing adverse effects in therapeutic use mechanical complication due to graft of other tissue, not elsewhere classified plasma cell leukemia, in relapse dermatitis due to drugs and medicines taken internally chronic graft-versus-host disease surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
black african american m 37 $nan$hematology blood hematocrit  23.5  %; hematology blood hematocrit  21.2  %; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  10  k ul; hematology blood platelet count  97  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  73  mg dl; chemistry blood glucose  87  mg dl; chemistry blood lactate dehydrogenase (ld)  158  iu l; hematology blood bands  0  %$morphine sr (ms contin)  30  mg ; folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; budesonide  3  mg ; mycophenolate mofetil  500  mg ; vancomycin oral liquid  125  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; nystatin oral suspension  5  ml ; lorazepam  0.5  mg ; 5% dextrose  100  ml ; 5% dextrose  50  ml ; clindamycin  600  mg ; oxymetazoline  1  spry ; metoprolol tartrate  5  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; potassium chloride  60  meq ; phytonadione  1  mg ; phytonadione  5  mg ; morphine sulfate  1  mg ; potassium chloride (powder)  60  meq ; morphine sulfate  2  mg ; magnesium sulfate  4  gm ; morphine sulfate  3  mg ; 
plasma cell leukemia, without mention of having achieved remission unspecified essential hypertension other secondary thrombocytopenia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted bone marrow graft-versus-host disease, unspecified acute kidney failure, unspecified diarrhea hypopotassemia acute pharyngitis defibrination syndrome thrombotic microangiopathy acute on chronic graft-versus-host disease antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other and unspecified noninfectious gastroenteritis and colitis unspecified essential hypertension acute venous embolism and thrombosis of superficial veins of upper extremity complications of other specified transplanted organ other specified cardiac dysrhythmias surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation methicillin resistant pneumonia due to staphylococcus aureus bacteremia polyneuropathy due to drugs plasma cell leukemia, in relapse dysuria other complications due to other vascular device, implant, and graft other specified viral infection fever presenting with conditions classified elsewhere plasma cell leukemia, without mention of having achieved remission other secondary thrombocytopenia acute graft-versus-host disease candidiasis of mouth complications of transplanted bone marrow diarrhea personal history of venous thrombosis and embolism other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation plasma cell leukemia, in relapse peripheral stem cells replaced by transplant acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified other complications due to other vascular device, implant, and graft thrombocytopenia, unspecified cephalosporin group causing adverse effects in therapeutic use mechanical complication due to graft of other tissue, not elsewhere classified plasma cell leukemia, in relapse dermatitis due to drugs and medicines taken internally chronic graft-versus-host disease surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
black african american m 37 $nan$hematology blood hematocrit  25.1  %; hematology blood hematocrit  23.8  %; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  71  k ul; hematology blood platelet count  69  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  80  mg dl; chemistry blood glucose  78  mg dl; chemistry blood lactate dehydrogenase (ld)  206  iu l; chemistry blood lactate dehydrogenase (ld)  152  iu l; hematology blood bands  0  %; hematology blood bands  0  %$folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; budesonide  3  mg ; mycophenolate mofetil  500  mg ; vancomycin oral liquid  125  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; nystatin oral suspension  5  ml ; lorazepam  0.5  mg ; 5% dextrose  100  ml ; 5% dextrose  50  ml ; clindamycin  600  mg ; oxymetazoline  1  spry ; metoprolol tartrate  5  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; potassium chloride (powder)  60  meq ; morphine sulfate  2  mg ; magnesium sulfate  4  gm ; morphine sulfate  3  mg ; lr  1000  ml ; potassium chl 40 meq   1000 ml ns  1000  ml ; 300 mcg vial  1  vial ; filgrastim  300  mcg ; 
plasma cell leukemia, without mention of having achieved remission unspecified essential hypertension other secondary thrombocytopenia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted bone marrow graft-versus-host disease, unspecified acute kidney failure, unspecified diarrhea hypopotassemia acute pharyngitis defibrination syndrome thrombotic microangiopathy acute on chronic graft-versus-host disease antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other and unspecified noninfectious gastroenteritis and colitis unspecified essential hypertension acute venous embolism and thrombosis of superficial veins of upper extremity complications of other specified transplanted organ other specified cardiac dysrhythmias surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation methicillin resistant pneumonia due to staphylococcus aureus bacteremia polyneuropathy due to drugs plasma cell leukemia, in relapse dysuria other complications due to other vascular device, implant, and graft other specified viral infection fever presenting with conditions classified elsewhere plasma cell leukemia, without mention of having achieved remission other secondary thrombocytopenia acute graft-versus-host disease candidiasis of mouth complications of transplanted bone marrow diarrhea personal history of venous thrombosis and embolism other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation plasma cell leukemia, in relapse peripheral stem cells replaced by transplant acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified other complications due to other vascular device, implant, and graft thrombocytopenia, unspecified cephalosporin group causing adverse effects in therapeutic use mechanical complication due to graft of other tissue, not elsewhere classified plasma cell leukemia, in relapse dermatitis due to drugs and medicines taken internally chronic graft-versus-host disease surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
black african american m 37 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  47  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  69  mg dl; chemistry blood lactate dehydrogenase (ld)  194  iu l; chemistry blood albumin  2.3  g dl; hematology blood bands  0  %$folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; budesonide  3  mg ; mycophenolate mofetil  500  mg ; vancomycin oral liquid  125  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; nystatin oral suspension  5  ml ; lorazepam  0.5  mg ; 5% dextrose  100  ml ; oxymetazoline  1  spry ; metoprolol tartrate  5  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; lr  1000  ml ; 300 mcg vial  1  vial ; filgrastim  300  mcg ; bag  100  ml ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; calcium replacement (oncology)  1  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  3  g ; 
plasma cell leukemia, without mention of having achieved remission unspecified essential hypertension other secondary thrombocytopenia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted bone marrow graft-versus-host disease, unspecified acute kidney failure, unspecified diarrhea hypopotassemia acute pharyngitis defibrination syndrome thrombotic microangiopathy acute on chronic graft-versus-host disease antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other and unspecified noninfectious gastroenteritis and colitis unspecified essential hypertension acute venous embolism and thrombosis of superficial veins of upper extremity complications of other specified transplanted organ other specified cardiac dysrhythmias surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation methicillin resistant pneumonia due to staphylococcus aureus bacteremia polyneuropathy due to drugs plasma cell leukemia, in relapse dysuria other complications due to other vascular device, implant, and graft other specified viral infection fever presenting with conditions classified elsewhere plasma cell leukemia, without mention of having achieved remission other secondary thrombocytopenia acute graft-versus-host disease candidiasis of mouth complications of transplanted bone marrow diarrhea personal history of venous thrombosis and embolism other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation plasma cell leukemia, in relapse peripheral stem cells replaced by transplant acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified other complications due to other vascular device, implant, and graft thrombocytopenia, unspecified cephalosporin group causing adverse effects in therapeutic use mechanical complication due to graft of other tissue, not elsewhere classified plasma cell leukemia, in relapse dermatitis due to drugs and medicines taken internally chronic graft-versus-host disease surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
black african american m 37 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  37  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  65  mg dl; chemistry blood lactate dehydrogenase (ld)  162  iu l; chemistry blood albumin  2.0  g dl; hematology blood bands  0  %$folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; budesonide  3  mg ; mycophenolate mofetil  500  mg ; vancomycin oral liquid  125  mg ; nystatin oral suspension  5  ml ; lorazepam  0.5  mg ; 300 mcg vial  1  vial ; filgrastim  300  mcg ; bag  100  ml ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; calcium replacement (oncology)  1  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  3  g ; bag  250  ml ; gammagard liquid  25  g ; diphenhydramine  25  mg ; hydrocortisone na succ.  100  mg ; epinephrine 1:1000  0.3  mg ; diphenhydramine  50  mg ; 
plasma cell leukemia, without mention of having achieved remission unspecified essential hypertension other secondary thrombocytopenia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted bone marrow graft-versus-host disease, unspecified acute kidney failure, unspecified diarrhea hypopotassemia acute pharyngitis defibrination syndrome thrombotic microangiopathy acute on chronic graft-versus-host disease antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other and unspecified noninfectious gastroenteritis and colitis unspecified essential hypertension acute venous embolism and thrombosis of superficial veins of upper extremity complications of other specified transplanted organ other specified cardiac dysrhythmias surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation methicillin resistant pneumonia due to staphylococcus aureus bacteremia polyneuropathy due to drugs plasma cell leukemia, in relapse dysuria other complications due to other vascular device, implant, and graft other specified viral infection fever presenting with conditions classified elsewhere plasma cell leukemia, without mention of having achieved remission other secondary thrombocytopenia acute graft-versus-host disease candidiasis of mouth complications of transplanted bone marrow diarrhea personal history of venous thrombosis and embolism other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation plasma cell leukemia, in relapse peripheral stem cells replaced by transplant acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified other complications due to other vascular device, implant, and graft thrombocytopenia, unspecified cephalosporin group causing adverse effects in therapeutic use mechanical complication due to graft of other tissue, not elsewhere classified plasma cell leukemia, in relapse dermatitis due to drugs and medicines taken internally chronic graft-versus-host disease surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
black african american m 37 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  23  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  70  mg dl; chemistry blood lactate dehydrogenase (ld)  112  iu l; hematology blood bands  0  %$folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; budesonide  3  mg ; mycophenolate mofetil  500  mg ; nystatin oral suspension  5  ml ; lorazepam  0.5  mg ; 300 mcg vial  1  vial ; filgrastim  300  mcg ; bag  100  ml ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; calcium replacement (oncology)  1  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  3  g ; bag  250  ml ; gammagard liquid  25  g ; diphenhydramine  25  mg ; hydrocortisone na succ.  100  mg ; epinephrine 1:1000  0.3  mg ; diphenhydramine  50  mg ; vancomycin oral liquid  500  mg ; 
plasma cell leukemia, without mention of having achieved remission unspecified essential hypertension other secondary thrombocytopenia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted bone marrow graft-versus-host disease, unspecified acute kidney failure, unspecified diarrhea hypopotassemia acute pharyngitis defibrination syndrome thrombotic microangiopathy acute on chronic graft-versus-host disease antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other and unspecified noninfectious gastroenteritis and colitis unspecified essential hypertension acute venous embolism and thrombosis of superficial veins of upper extremity complications of other specified transplanted organ other specified cardiac dysrhythmias surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation methicillin resistant pneumonia due to staphylococcus aureus bacteremia polyneuropathy due to drugs plasma cell leukemia, in relapse dysuria other complications due to other vascular device, implant, and graft other specified viral infection fever presenting with conditions classified elsewhere plasma cell leukemia, without mention of having achieved remission other secondary thrombocytopenia acute graft-versus-host disease candidiasis of mouth complications of transplanted bone marrow diarrhea personal history of venous thrombosis and embolism other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation plasma cell leukemia, in relapse peripheral stem cells replaced by transplant acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified other complications due to other vascular device, implant, and graft thrombocytopenia, unspecified cephalosporin group causing adverse effects in therapeutic use mechanical complication due to graft of other tissue, not elsewhere classified plasma cell leukemia, in relapse dermatitis due to drugs and medicines taken internally chronic graft-versus-host disease surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
black african american m 37 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  19  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  81  mg dl; chemistry blood lactate dehydrogenase (ld)  125  iu l; chemistry blood albumin  2.2  g dl; hematology blood bands  0  %$folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; budesonide  3  mg ; mycophenolate mofetil  500  mg ; nystatin oral suspension  5  ml ; lorazepam  0.5  mg ; 300 mcg vial  1  vial ; filgrastim  300  mcg ; bag  100  ml ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; calcium replacement (oncology)  1  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  3  g ; hydrocortisone na succ.  100  mg ; epinephrine 1:1000  0.3  mg ; diphenhydramine  50  mg ; vancomycin oral liquid  500  mg ; 
plasma cell leukemia, without mention of having achieved remission unspecified essential hypertension other secondary thrombocytopenia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted bone marrow graft-versus-host disease, unspecified acute kidney failure, unspecified diarrhea hypopotassemia acute pharyngitis defibrination syndrome thrombotic microangiopathy acute on chronic graft-versus-host disease antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other and unspecified noninfectious gastroenteritis and colitis unspecified essential hypertension acute venous embolism and thrombosis of superficial veins of upper extremity complications of other specified transplanted organ other specified cardiac dysrhythmias surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation methicillin resistant pneumonia due to staphylococcus aureus bacteremia polyneuropathy due to drugs plasma cell leukemia, in relapse dysuria other complications due to other vascular device, implant, and graft other specified viral infection fever presenting with conditions classified elsewhere plasma cell leukemia, without mention of having achieved remission other secondary thrombocytopenia acute graft-versus-host disease candidiasis of mouth complications of transplanted bone marrow diarrhea personal history of venous thrombosis and embolism other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation plasma cell leukemia, in relapse peripheral stem cells replaced by transplant acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified other complications due to other vascular device, implant, and graft thrombocytopenia, unspecified cephalosporin group causing adverse effects in therapeutic use mechanical complication due to graft of other tissue, not elsewhere classified plasma cell leukemia, in relapse dermatitis due to drugs and medicines taken internally chronic graft-versus-host disease surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
black african american m 37 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  29  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  67  mg dl; chemistry blood lactate dehydrogenase (ld)  208  iu l; hematology blood bands  0  %$folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; budesonide  3  mg ; nystatin oral suspension  5  ml ; lorazepam  0.5  mg ; 300 mcg vial  1  vial ; filgrastim  300  mcg ; bag  100  ml ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; calcium replacement (oncology)  1  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  3  g ; hydrocortisone na succ.  100  mg ; epinephrine 1:1000  0.3  mg ; diphenhydramine  50  mg ; vancomycin oral liquid  500  mg ; sodium chloride 0.9%  flush  10  ml ; sterile water  50  ml ; potassium chloride  40  meq ; potassium chloride  80  meq ; mycophenolate mofetil  250  mg ; 
plasma cell leukemia, without mention of having achieved remission unspecified essential hypertension other secondary thrombocytopenia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted bone marrow graft-versus-host disease, unspecified acute kidney failure, unspecified diarrhea hypopotassemia acute pharyngitis defibrination syndrome thrombotic microangiopathy acute on chronic graft-versus-host disease antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other and unspecified noninfectious gastroenteritis and colitis unspecified essential hypertension acute venous embolism and thrombosis of superficial veins of upper extremity complications of other specified transplanted organ other specified cardiac dysrhythmias surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation methicillin resistant pneumonia due to staphylococcus aureus bacteremia polyneuropathy due to drugs plasma cell leukemia, in relapse dysuria other complications due to other vascular device, implant, and graft other specified viral infection fever presenting with conditions classified elsewhere plasma cell leukemia, without mention of having achieved remission other secondary thrombocytopenia acute graft-versus-host disease candidiasis of mouth complications of transplanted bone marrow diarrhea personal history of venous thrombosis and embolism other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation plasma cell leukemia, in relapse peripheral stem cells replaced by transplant acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified other complications due to other vascular device, implant, and graft thrombocytopenia, unspecified cephalosporin group causing adverse effects in therapeutic use mechanical complication due to graft of other tissue, not elsewhere classified plasma cell leukemia, in relapse dermatitis due to drugs and medicines taken internally chronic graft-versus-host disease surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
black african american m 37 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  22  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  70  mg dl; chemistry blood lactate dehydrogenase (ld)  204  iu l; hematology blood bands  0  %$folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; budesonide  3  mg ; nystatin oral suspension  5  ml ; lorazepam  0.5  mg ; 300 mcg vial  1  vial ; filgrastim  300  mcg ; bag  100  ml ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; calcium replacement (oncology)  1  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  3  g ; hydrocortisone na succ.  100  mg ; epinephrine 1:1000  0.3  mg ; diphenhydramine  50  mg ; vancomycin oral liquid  500  mg ; sodium chloride 0.9%  flush  10  ml ; sterile water  50  ml ; potassium chloride  40  meq ; potassium chloride  80  meq ; mycophenolate mofetil  250  mg ; revlimid  10  mg ; 
plasma cell leukemia, without mention of having achieved remission unspecified essential hypertension other secondary thrombocytopenia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted bone marrow graft-versus-host disease, unspecified acute kidney failure, unspecified diarrhea hypopotassemia acute pharyngitis defibrination syndrome thrombotic microangiopathy acute on chronic graft-versus-host disease antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other and unspecified noninfectious gastroenteritis and colitis unspecified essential hypertension acute venous embolism and thrombosis of superficial veins of upper extremity complications of other specified transplanted organ other specified cardiac dysrhythmias surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation methicillin resistant pneumonia due to staphylococcus aureus bacteremia polyneuropathy due to drugs plasma cell leukemia, in relapse dysuria other complications due to other vascular device, implant, and graft other specified viral infection fever presenting with conditions classified elsewhere plasma cell leukemia, without mention of having achieved remission other secondary thrombocytopenia acute graft-versus-host disease candidiasis of mouth complications of transplanted bone marrow diarrhea personal history of venous thrombosis and embolism other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation plasma cell leukemia, in relapse peripheral stem cells replaced by transplant acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified other complications due to other vascular device, implant, and graft thrombocytopenia, unspecified cephalosporin group causing adverse effects in therapeutic use mechanical complication due to graft of other tissue, not elsewhere classified plasma cell leukemia, in relapse dermatitis due to drugs and medicines taken internally chronic graft-versus-host disease surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
black african american m 37 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  18  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  77  mg dl; chemistry blood lactate dehydrogenase (ld)  171  iu l; hematology blood bands  0  %$folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; budesonide  3  mg ; nystatin oral suspension  5  ml ; 300 mcg vial  1  vial ; filgrastim  300  mcg ; bag  100  ml ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; calcium replacement (oncology)  1  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  3  g ; hydrocortisone na succ.  100  mg ; epinephrine 1:1000  0.3  mg ; diphenhydramine  50  mg ; vancomycin oral liquid  500  mg ; sodium chloride 0.9%  flush  10  ml ; sterile water  50  ml ; potassium chloride  40  meq ; potassium chloride  80  meq ; mycophenolate mofetil  250  mg ; revlimid  10  mg ; revlimid  20  mg ; dexamethasone  20  mg ; morphine sr (ms contin)  15  mg ; 
plasma cell leukemia, without mention of having achieved remission unspecified essential hypertension other secondary thrombocytopenia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted bone marrow graft-versus-host disease, unspecified acute kidney failure, unspecified diarrhea hypopotassemia acute pharyngitis defibrination syndrome thrombotic microangiopathy acute on chronic graft-versus-host disease antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other and unspecified noninfectious gastroenteritis and colitis unspecified essential hypertension acute venous embolism and thrombosis of superficial veins of upper extremity complications of other specified transplanted organ other specified cardiac dysrhythmias surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation methicillin resistant pneumonia due to staphylococcus aureus bacteremia polyneuropathy due to drugs plasma cell leukemia, in relapse dysuria other complications due to other vascular device, implant, and graft other specified viral infection fever presenting with conditions classified elsewhere plasma cell leukemia, without mention of having achieved remission other secondary thrombocytopenia acute graft-versus-host disease candidiasis of mouth complications of transplanted bone marrow diarrhea personal history of venous thrombosis and embolism other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation plasma cell leukemia, in relapse peripheral stem cells replaced by transplant acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified other complications due to other vascular device, implant, and graft thrombocytopenia, unspecified cephalosporin group causing adverse effects in therapeutic use mechanical complication due to graft of other tissue, not elsewhere classified plasma cell leukemia, in relapse dermatitis due to drugs and medicines taken internally chronic graft-versus-host disease surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
black african american m 37 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  72  k ul; hematology blood platelet count  55  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  98  mg dl; chemistry blood lactate dehydrogenase (ld)  203  iu l; hematology blood bands  2  %$folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; budesonide  3  mg ; nystatin oral suspension  5  ml ; 300 mcg vial  1  vial ; filgrastim  300  mcg ; bag  100  ml ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; calcium replacement (oncology)  1  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  3  g ; hydrocortisone na succ.  100  mg ; epinephrine 1:1000  0.3  mg ; diphenhydramine  50  mg ; vancomycin oral liquid  500  mg ; sodium chloride 0.9%  flush  10  ml ; sterile water  50  ml ; potassium chloride  40  meq ; potassium chloride  80  meq ; revlimid  20  mg ; dexamethasone  20  mg ; morphine sr (ms contin)  15  mg ; 
plasma cell leukemia, without mention of having achieved remission unspecified essential hypertension other secondary thrombocytopenia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted bone marrow graft-versus-host disease, unspecified acute kidney failure, unspecified diarrhea hypopotassemia acute pharyngitis defibrination syndrome thrombotic microangiopathy acute on chronic graft-versus-host disease antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other and unspecified noninfectious gastroenteritis and colitis unspecified essential hypertension acute venous embolism and thrombosis of superficial veins of upper extremity complications of other specified transplanted organ other specified cardiac dysrhythmias surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation methicillin resistant pneumonia due to staphylococcus aureus bacteremia polyneuropathy due to drugs plasma cell leukemia, in relapse dysuria other complications due to other vascular device, implant, and graft other specified viral infection fever presenting with conditions classified elsewhere plasma cell leukemia, without mention of having achieved remission other secondary thrombocytopenia acute graft-versus-host disease candidiasis of mouth complications of transplanted bone marrow diarrhea personal history of venous thrombosis and embolism other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation plasma cell leukemia, in relapse peripheral stem cells replaced by transplant acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified other complications due to other vascular device, implant, and graft thrombocytopenia, unspecified cephalosporin group causing adverse effects in therapeutic use mechanical complication due to graft of other tissue, not elsewhere classified plasma cell leukemia, in relapse dermatitis due to drugs and medicines taken internally chronic graft-versus-host disease surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
black african american m 37 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  36  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  152  mg dl; chemistry blood lactate dehydrogenase (ld)  195  iu l; chemistry blood albumin  2.4  g dl; hematology blood bands  3  %$folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; budesonide  3  mg ; nystatin oral suspension  5  ml ; 300 mcg vial  1  vial ; filgrastim  300  mcg ; bag  100  ml ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; calcium replacement (oncology)  1  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  3  g ; hydrocortisone na succ.  100  mg ; epinephrine 1:1000  0.3  mg ; diphenhydramine  50  mg ; vancomycin oral liquid  500  mg ; sodium chloride 0.9%  flush  10  ml ; sterile water  50  ml ; potassium chloride  40  meq ; potassium chloride  80  meq ; revlimid  20  mg ; dexamethasone  20  mg ; morphine sr (ms contin)  15  mg ; captopril  6.25  mg ; nifedipine cr  30  mg ; 
plasma cell leukemia, without mention of having achieved remission unspecified essential hypertension other secondary thrombocytopenia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted bone marrow graft-versus-host disease, unspecified acute kidney failure, unspecified diarrhea hypopotassemia acute pharyngitis defibrination syndrome thrombotic microangiopathy acute on chronic graft-versus-host disease antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other and unspecified noninfectious gastroenteritis and colitis unspecified essential hypertension acute venous embolism and thrombosis of superficial veins of upper extremity complications of other specified transplanted organ other specified cardiac dysrhythmias surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation methicillin resistant pneumonia due to staphylococcus aureus bacteremia polyneuropathy due to drugs plasma cell leukemia, in relapse dysuria other complications due to other vascular device, implant, and graft other specified viral infection fever presenting with conditions classified elsewhere plasma cell leukemia, without mention of having achieved remission other secondary thrombocytopenia acute graft-versus-host disease candidiasis of mouth complications of transplanted bone marrow diarrhea personal history of venous thrombosis and embolism other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation plasma cell leukemia, in relapse peripheral stem cells replaced by transplant acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified other complications due to other vascular device, implant, and graft thrombocytopenia, unspecified cephalosporin group causing adverse effects in therapeutic use mechanical complication due to graft of other tissue, not elsewhere classified plasma cell leukemia, in relapse dermatitis due to drugs and medicines taken internally chronic graft-versus-host disease surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
black african american m 37 $nan$hematology blood hematocrit  24.3  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  21  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  148  mg dl; chemistry blood lactate dehydrogenase (ld)  207  iu l; hematology blood bands  1  %$folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; budesonide  3  mg ; nystatin oral suspension  5  ml ; bag  100  ml ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; calcium replacement (oncology)  1  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  3  g ; hydrocortisone na succ.  100  mg ; epinephrine 1:1000  0.3  mg ; diphenhydramine  50  mg ; vancomycin oral liquid  500  mg ; sodium chloride 0.9%  flush  10  ml ; sterile water  50  ml ; potassium chloride  40  meq ; potassium chloride  80  meq ; revlimid  20  mg ; dexamethasone  20  mg ; morphine sr (ms contin)  15  mg ; nifedipine cr  30  mg ; 
plasma cell leukemia, without mention of having achieved remission unspecified essential hypertension other secondary thrombocytopenia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted bone marrow graft-versus-host disease, unspecified acute kidney failure, unspecified diarrhea hypopotassemia acute pharyngitis defibrination syndrome thrombotic microangiopathy acute on chronic graft-versus-host disease antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other and unspecified noninfectious gastroenteritis and colitis unspecified essential hypertension acute venous embolism and thrombosis of superficial veins of upper extremity complications of other specified transplanted organ other specified cardiac dysrhythmias surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation methicillin resistant pneumonia due to staphylococcus aureus bacteremia polyneuropathy due to drugs plasma cell leukemia, in relapse dysuria other complications due to other vascular device, implant, and graft other specified viral infection fever presenting with conditions classified elsewhere plasma cell leukemia, without mention of having achieved remission other secondary thrombocytopenia acute graft-versus-host disease candidiasis of mouth complications of transplanted bone marrow diarrhea personal history of venous thrombosis and embolism other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation plasma cell leukemia, in relapse peripheral stem cells replaced by transplant acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified other complications due to other vascular device, implant, and graft thrombocytopenia, unspecified cephalosporin group causing adverse effects in therapeutic use mechanical complication due to graft of other tissue, not elsewhere classified plasma cell leukemia, in relapse dermatitis due to drugs and medicines taken internally chronic graft-versus-host disease surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
black african american m 37 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  12  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  112  mg dl; chemistry blood lactate dehydrogenase (ld)  295  iu l$folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; budesonide  3  mg ; nystatin oral suspension  5  ml ; bag  100  ml ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; calcium replacement (oncology)  1  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  3  g ; hydrocortisone na succ.  100  mg ; epinephrine 1:1000  0.3  mg ; diphenhydramine  50  mg ; sodium chloride 0.9%  flush  10  ml ; sterile water  50  ml ; potassium chloride  40  meq ; potassium chloride  80  meq ; revlimid  20  mg ; morphine sr (ms contin)  15  mg ; nifedipine cr  30  mg ; 
plasma cell leukemia, without mention of having achieved remission unspecified essential hypertension other secondary thrombocytopenia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted bone marrow graft-versus-host disease, unspecified acute kidney failure, unspecified diarrhea hypopotassemia acute pharyngitis defibrination syndrome thrombotic microangiopathy acute on chronic graft-versus-host disease antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other and unspecified noninfectious gastroenteritis and colitis unspecified essential hypertension acute venous embolism and thrombosis of superficial veins of upper extremity complications of other specified transplanted organ other specified cardiac dysrhythmias surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation methicillin resistant pneumonia due to staphylococcus aureus bacteremia polyneuropathy due to drugs plasma cell leukemia, in relapse dysuria other complications due to other vascular device, implant, and graft other specified viral infection fever presenting with conditions classified elsewhere plasma cell leukemia, without mention of having achieved remission other secondary thrombocytopenia acute graft-versus-host disease candidiasis of mouth complications of transplanted bone marrow diarrhea personal history of venous thrombosis and embolism other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation plasma cell leukemia, in relapse peripheral stem cells replaced by transplant acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified other complications due to other vascular device, implant, and graft thrombocytopenia, unspecified cephalosporin group causing adverse effects in therapeutic use mechanical complication due to graft of other tissue, not elsewhere classified plasma cell leukemia, in relapse dermatitis due to drugs and medicines taken internally chronic graft-versus-host disease surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
black african american m 37 $nan$hematology blood hematocrit  23.4  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  8  k ul; hematology blood platelet count  84  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  78  mg dl; chemistry blood lactate dehydrogenase (ld)  224  iu l; hematology blood bands  0  %$folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; budesonide  3  mg ; nystatin oral suspension  5  ml ; bag  100  ml ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; calcium replacement (oncology)  1  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  3  g ; hydrocortisone na succ.  100  mg ; epinephrine 1:1000  0.3  mg ; diphenhydramine  50  mg ; sodium chloride 0.9%  flush  10  ml ; sterile water  50  ml ; potassium chloride  40  meq ; potassium chloride  80  meq ; revlimid  20  mg ; morphine sr (ms contin)  15  mg ; nifedipine cr  30  mg ; 
plasma cell leukemia, without mention of having achieved remission unspecified essential hypertension other secondary thrombocytopenia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted bone marrow graft-versus-host disease, unspecified acute kidney failure, unspecified diarrhea hypopotassemia acute pharyngitis defibrination syndrome thrombotic microangiopathy acute on chronic graft-versus-host disease antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other and unspecified noninfectious gastroenteritis and colitis unspecified essential hypertension acute venous embolism and thrombosis of superficial veins of upper extremity complications of other specified transplanted organ other specified cardiac dysrhythmias surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation methicillin resistant pneumonia due to staphylococcus aureus bacteremia polyneuropathy due to drugs plasma cell leukemia, in relapse dysuria other complications due to other vascular device, implant, and graft other specified viral infection fever presenting with conditions classified elsewhere plasma cell leukemia, without mention of having achieved remission other secondary thrombocytopenia acute graft-versus-host disease candidiasis of mouth complications of transplanted bone marrow diarrhea personal history of venous thrombosis and embolism other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation plasma cell leukemia, in relapse peripheral stem cells replaced by transplant acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified other complications due to other vascular device, implant, and graft thrombocytopenia, unspecified cephalosporin group causing adverse effects in therapeutic use mechanical complication due to graft of other tissue, not elsewhere classified plasma cell leukemia, in relapse dermatitis due to drugs and medicines taken internally chronic graft-versus-host disease surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
black african american m 37 $nan$hematology blood hematocrit  22.6  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  37  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  89  mg dl; chemistry blood lactate dehydrogenase (ld)  156  iu l; hematology blood bands  0  %$folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; budesonide  3  mg ; nystatin oral suspension  5  ml ; bag  100  ml ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; calcium replacement (oncology)  1  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  3  g ; hydrocortisone na succ.  100  mg ; epinephrine 1:1000  0.3  mg ; diphenhydramine  50  mg ; sodium chloride 0.9%  flush  10  ml ; sterile water  50  ml ; potassium chloride  40  meq ; potassium chloride  80  meq ; revlimid  20  mg ; morphine sr (ms contin)  15  mg ; nifedipine cr  30  mg ; albuterol inhaler  2  puff ; syringe (sterile water)  6  ml ; pentamidine-inhalation  300  mg ; 
plasma cell leukemia, without mention of having achieved remission unspecified essential hypertension other secondary thrombocytopenia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted bone marrow graft-versus-host disease, unspecified acute kidney failure, unspecified diarrhea hypopotassemia acute pharyngitis defibrination syndrome thrombotic microangiopathy acute on chronic graft-versus-host disease antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other and unspecified noninfectious gastroenteritis and colitis unspecified essential hypertension acute venous embolism and thrombosis of superficial veins of upper extremity complications of other specified transplanted organ other specified cardiac dysrhythmias surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation methicillin resistant pneumonia due to staphylococcus aureus bacteremia polyneuropathy due to drugs plasma cell leukemia, in relapse dysuria other complications due to other vascular device, implant, and graft other specified viral infection fever presenting with conditions classified elsewhere plasma cell leukemia, without mention of having achieved remission other secondary thrombocytopenia acute graft-versus-host disease candidiasis of mouth complications of transplanted bone marrow diarrhea personal history of venous thrombosis and embolism other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation plasma cell leukemia, in relapse peripheral stem cells replaced by transplant acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified other complications due to other vascular device, implant, and graft thrombocytopenia, unspecified cephalosporin group causing adverse effects in therapeutic use mechanical complication due to graft of other tissue, not elsewhere classified plasma cell leukemia, in relapse dermatitis due to drugs and medicines taken internally chronic graft-versus-host disease surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
black african american m 37 $nan$nan$folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; budesonide  3  mg ; nystatin oral suspension  5  ml ; bag  100  ml ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; calcium replacement (oncology)  1  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  3  g ; hydrocortisone na succ.  100  mg ; epinephrine 1:1000  0.3  mg ; diphenhydramine  50  mg ; sodium chloride 0.9%  flush  10  ml ; sterile water  50  ml ; potassium chloride  40  meq ; potassium chloride  80  meq ; revlimid  20  mg ; morphine sr (ms contin)  15  mg ; nifedipine cr  30  mg ; albuterol inhaler  2  puff ; syringe (sterile water)  6  ml ; pentamidine-inhalation  300  mg ; 
plasma cell leukemia, without mention of having achieved remission unspecified essential hypertension other secondary thrombocytopenia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted bone marrow graft-versus-host disease, unspecified acute kidney failure, unspecified diarrhea hypopotassemia acute pharyngitis defibrination syndrome thrombotic microangiopathy acute on chronic graft-versus-host disease antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other and unspecified noninfectious gastroenteritis and colitis unspecified essential hypertension acute venous embolism and thrombosis of superficial veins of upper extremity complications of other specified transplanted organ other specified cardiac dysrhythmias surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation methicillin resistant pneumonia due to staphylococcus aureus bacteremia polyneuropathy due to drugs plasma cell leukemia, in relapse dysuria other complications due to other vascular device, implant, and graft other specified viral infection fever presenting with conditions classified elsewhere plasma cell leukemia, without mention of having achieved remission other secondary thrombocytopenia acute graft-versus-host disease candidiasis of mouth complications of transplanted bone marrow diarrhea personal history of venous thrombosis and embolism other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation plasma cell leukemia, in relapse peripheral stem cells replaced by transplant acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified other complications due to other vascular device, implant, and graft thrombocytopenia, unspecified cephalosporin group causing adverse effects in therapeutic use mechanical complication due to graft of other tissue, not elsewhere classified plasma cell leukemia, in relapse dermatitis due to drugs and medicines taken internally chronic graft-versus-host disease surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
white m 74 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  178  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood glucose  79  mg dl$atorvastatin  10  mg ; aspirin  325  mg ; atacand  8  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; furosemide  10  mg ; heparin  5000  unit ; furosemide  20  mg ; metoprolol tartrate  25  mg ; terazosin  10  mg ; 
 
white m 74 $nan$hematology blood hematocrit  33.4  %; hematology blood hematocrit  33.2  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood glucose  100  mg dl$atorvastatin  10  mg ; aspirin  325  mg ; atacand  8  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; furosemide  10  mg ; heparin  5000  unit ; furosemide  20  mg ; metoprolol tartrate  25  mg ; terazosin  10  mg ; senna  1  tab ; ferrous sulfate  325  mg ; atacand  16  mg ; docusate sodium  100  mg ; 
 
white m 74 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  194  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood glucose  87  mg dl$atorvastatin  10  mg ; aspirin  325  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin  5000  unit ; metoprolol tartrate  25  mg ; terazosin  10  mg ; senna  1  tab ; ferrous sulfate  325  mg ; atacand  16  mg ; docusate sodium  100  mg ; furosemide  40  mg ; guaifenesin  5-10  ml ; fluticasone propionate nasal  1  spry ; oxymetazoline  1  spry ; potassium chloride  40  meq ; 
 
white m 74 $nan$nan$atorvastatin  10  mg ; aspirin  325  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin  5000  unit ; metoprolol tartrate  25  mg ; terazosin  10  mg ; senna  1  tab ; ferrous sulfate  325  mg ; atacand  16  mg ; docusate sodium  100  mg ; furosemide  40  mg ; guaifenesin  5-10  ml ; fluticasone propionate nasal  1  spry ; oxymetazoline  1  spry ; potassium chloride  40  meq ; 
 
white f 63 $nan$hematology blood hematocrit  32.2  %; hematology blood hematocrit  33.2  %; hematology blood hemoglobin  11.0  g dl; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  165  k ul; hematology blood platelet count  146  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.6  meq l; chemistry blood potassium  5.6  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  263  mg dl; chemistry blood glucose  193  mg dl$multivitamins  1  cap ; vitamin d  400  unit ; ferrous sulfate  325  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; warfarin  5  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  20  mg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; ketorolac  15  mg ; albuterol inhaler  1-2  puff ; clonazepam  1  mg ; alprazolam  0.5-1  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  1  spry ; levothyroxine sodium  100  mcg ; lisinopril  5  mg ; polyethylene glycol  17  g ; psyllium  1  pkt ; omeprazole  20  mg ; lorazepam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin pump (self administering medication)     ; docusate sodium  100  mg ; senna  8.6  mg ; calcium carbonate  500  mg ; aspirin  325  mg ; insulin lispro  0  unit ; 
 
white f 63 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  137  k ul; hematology blood inr(pt)  1.6  $multivitamins  1  cap ; vitamin d  400  unit ; ferrous sulfate  325  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; warfarin  5  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  20  mg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; ketorolac  15  mg ; albuterol inhaler  1-2  puff ; clonazepam  1  mg ; alprazolam  0.5-1  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  1  spry ; levothyroxine sodium  100  mcg ; lisinopril  5  mg ; polyethylene glycol  17  g ; psyllium  1  pkt ; omeprazole  20  mg ; lorazepam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin pump (self administering medication)     ; docusate sodium  100  mg ; senna  8.6  mg ; calcium carbonate  500  mg ; aspirin  325  mg ; insulin lispro  0  unit ; progesterone micronized  100  mg ; evamist estradiol 1.53mg  spray  1  spry ; oxycodone (immediate release)   5-10  mg ; 
 
white f 63 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  133  k ul; chemistry blood chloride  100  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  135  meq l; hematology blood inr(pt)  1.6  $multivitamins  1  cap ; vitamin d  400  unit ; ferrous sulfate  325  mg ; warfarin  5  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; ketorolac  15  mg ; albuterol inhaler  1-2  puff ; clonazepam  1  mg ; alprazolam  0.5-1  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  1  spry ; levothyroxine sodium  100  mcg ; lisinopril  5  mg ; polyethylene glycol  17  g ; psyllium  1  pkt ; omeprazole  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin pump (self administering medication)     ; docusate sodium  100  mg ; senna  8.6  mg ; calcium carbonate  500  mg ; aspirin  325  mg ; insulin lispro  0  unit ; progesterone micronized  100  mg ; evamist estradiol 1.53mg  spray  1  spry ; oxycodone (immediate release)   5-10  mg ; oxybutynin  5  mg ; docusate sodium  200  mg ; senna  17.2  mg ; sodium chloride nasal  1-2  spry ; 
 
white f 63 $nan$nan$multivitamins  1  cap ; vitamin d  400  unit ; ferrous sulfate  325  mg ; warfarin  5  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; albuterol inhaler  1-2  puff ; clonazepam  1  mg ; alprazolam  0.5-1  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  1  spry ; levothyroxine sodium  100  mcg ; lisinopril  5  mg ; polyethylene glycol  17  g ; psyllium  1  pkt ; omeprazole  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin pump (self administering medication)     ; calcium carbonate  500  mg ; aspirin  325  mg ; insulin lispro  0  unit ; progesterone micronized  100  mg ; evamist estradiol 1.53mg  spray  1  spry ; oxycodone (immediate release)   5-10  mg ; oxybutynin  5  mg ; docusate sodium  200  mg ; senna  17.2  mg ; sodium chloride nasal  1-2  spry ; 
 
black african american m 49 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  76  mg dl$insulin  15  unit ; insulin  10  unit ; insulin  5  unit ; aspirin  81  mg ; citalopram  20  mg ; folic acid  1  mg ; lisinopril  20  mg ; multivitamins  1  tab ; omeprazole  20  mg ; nicotine patch  14  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chloride  20  meq ; diazepam  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; oxycodone (immediate release)   5  mg ; gabapentin  300  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; acetaminophen  500  mg ; trazodone  25  mg ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; docusate sodium  100  mg ; senna  1  tab ; 
alkalosis tobacco use disorder other and unspecified hyperlipidemia benign essential hypertension depressive disorder, not elsewhere classified anemia, unspecified hypercalcemia acute kidney failure, unspecified hyposmolality and/or hyponatremia anxiety state, unspecified alcohol abuse, unspecified personal history of noncompliance with medical treatment, presenting hazards to health diabetes with ketoacidosis, type ii or unspecified type, uncontrolled long-term (current) use of insulin unspecified essential hypertension personal history of tobacco use alcohol withdrawal other and unspecified alcohol dependence, continuous acute kidney failure, unspecified long-term (current) use of insulin mononeuritis of unspecified site diabetes with ketoacidosis, type ii or unspecified type, uncontrolled anxiety state, unspecified other and unspecified hyperlipidemia dysphagia, unspecified alcohol withdrawal unspecified essential hypertension chronic pancreatitis personal history of tobacco use other and unspecified alcohol dependence, episodic acute kidney failure, unspecified alcoholic liver damage, unspecified diabetes with ketoacidosis, type ii or unspecified type, uncontrolled anxiety state, unspecified unspecified hereditary and idiopathic peripheral neuropathy acute pancreatitis pure hyperglyceridemia other and unspecified hyperlipidemia acidosis diabetes with ketoacidosis, type ii or unspecified type, uncontrolled tobacco use disorder other and unspecified alcohol dependence, continuous hyposmolality and/or hyponatremia alcohol withdrawal anemia, unspecified unspecified essential hypertension chronic pancreatitis acute pancreatitis
black african american m 49 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  323  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  129  mg dl; chemistry blood albumin  3.2  g dl$aspirin  81  mg ; citalopram  20  mg ; folic acid  1  mg ; lisinopril  20  mg ; multivitamins  1  tab ; omeprazole  20  mg ; nicotine patch  14  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chloride  20  meq ; diazepam  10  mg ; oxycodone (immediate release)   5  mg ; gabapentin  300  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; heparin  5000  unit ; acetaminophen  500  mg ; trazodone  25  mg ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; calcium carbonate  500  mg ; docusate sodium  100  mg ; senna  1  tab ; 
alkalosis tobacco use disorder other and unspecified hyperlipidemia benign essential hypertension depressive disorder, not elsewhere classified anemia, unspecified hypercalcemia acute kidney failure, unspecified hyposmolality and/or hyponatremia anxiety state, unspecified alcohol abuse, unspecified personal history of noncompliance with medical treatment, presenting hazards to health diabetes with ketoacidosis, type ii or unspecified type, uncontrolled long-term (current) use of insulin unspecified essential hypertension personal history of tobacco use alcohol withdrawal other and unspecified alcohol dependence, continuous acute kidney failure, unspecified long-term (current) use of insulin mononeuritis of unspecified site diabetes with ketoacidosis, type ii or unspecified type, uncontrolled anxiety state, unspecified other and unspecified hyperlipidemia dysphagia, unspecified alcohol withdrawal unspecified essential hypertension chronic pancreatitis personal history of tobacco use other and unspecified alcohol dependence, episodic acute kidney failure, unspecified alcoholic liver damage, unspecified diabetes with ketoacidosis, type ii or unspecified type, uncontrolled anxiety state, unspecified unspecified hereditary and idiopathic peripheral neuropathy acute pancreatitis pure hyperglyceridemia other and unspecified hyperlipidemia acidosis diabetes with ketoacidosis, type ii or unspecified type, uncontrolled tobacco use disorder other and unspecified alcohol dependence, continuous hyposmolality and/or hyponatremia alcohol withdrawal anemia, unspecified unspecified essential hypertension chronic pancreatitis acute pancreatitis
white f 69 $temp    heartrate  79.0  resprate  17.0  o2sat  100.0  sbp  165.0  dbp  74.0  rhythm    pain  4  $nan$omeprazole  20  mg ; 
contracture of joint, forearm esophageal reflux osteoporosis, unspecified pain in joint, forearm dysthymic disorder other complications due to other internal orthopedic device, implant, and graft stiffness of joint, not elsewhere classified, forearm disorder of bone and cartilage, unspecified surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation stiffness of joint, not elsewhere classified, hand other disorders of plasma-protein metabolism, not elsewhere classified subdural hemorrhage following injury without mention of open intracranial wound, with brief [less than one hour] loss of consciousness dysthymic disorder closed fracture of middle or proximal phalanx or phalanges of hand closed fracture of lower end of radius with ulna accidental fall on or from other stairs or steps syncope and collapse bronchiectasis without acute exacerbation open wound of scalp, without mention of complication 
white f 69 $temp  98.3  heartrate  83.0  resprate  28.0  o2sat  97.0  sbp  156.0  dbp  74.0  rhythm    pain  4  $hematology blood hematocrit  37.7  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  91  mg dl$omeprazole  20  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; polyethylene glycol  17  g ; heparin  5000  unit ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; 
contracture of joint, forearm esophageal reflux osteoporosis, unspecified pain in joint, forearm dysthymic disorder other complications due to other internal orthopedic device, implant, and graft stiffness of joint, not elsewhere classified, forearm disorder of bone and cartilage, unspecified surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation stiffness of joint, not elsewhere classified, hand other disorders of plasma-protein metabolism, not elsewhere classified subdural hemorrhage following injury without mention of open intracranial wound, with brief [less than one hour] loss of consciousness dysthymic disorder closed fracture of middle or proximal phalanx or phalanges of hand closed fracture of lower end of radius with ulna accidental fall on or from other stairs or steps syncope and collapse bronchiectasis without acute exacerbation open wound of scalp, without mention of complication 
white f 69 $nan$nan$omeprazole  20  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; polyethylene glycol  17  g ; heparin  5000  unit ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; 
contracture of joint, forearm esophageal reflux osteoporosis, unspecified pain in joint, forearm dysthymic disorder other complications due to other internal orthopedic device, implant, and graft stiffness of joint, not elsewhere classified, forearm disorder of bone and cartilage, unspecified surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation stiffness of joint, not elsewhere classified, hand other disorders of plasma-protein metabolism, not elsewhere classified subdural hemorrhage following injury without mention of open intracranial wound, with brief [less than one hour] loss of consciousness dysthymic disorder closed fracture of middle or proximal phalanx or phalanges of hand closed fracture of lower end of radius with ulna accidental fall on or from other stairs or steps syncope and collapse bronchiectasis without acute exacerbation open wound of scalp, without mention of complication 
white f 91 $nan$hematology blood hematocrit  41.3  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood glucose  131  mg dl$acetaminophen  325-650  mg ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  1  tab ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; docusate sodium  100  mg ; heparin  5000  unit ; metoprolol tartrate  50  mg ; insulin  0  unit ; pneumococcal vac polyvalent  0.5  ml ; 
 
white f 91 $nan$hematology blood hematocrit  40.5  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  231  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  19  mg dl; hematology urine wbc  3  # hpf; chemistry blood glucose  96  mg dl$acetaminophen  325-650  mg ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  1  tab ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; docusate sodium  100  mg ; heparin  5000  unit ; metoprolol tartrate  50  mg ; insulin  0  unit ; pneumococcal vac polyvalent  0.5  ml ; levothyroxine sodium  50  mcg ; atenolol  50  mg ; acetaminophen  650  mg ; 
 
white f 91 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl$acetaminophen  325-650  mg ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  1  tab ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; docusate sodium  100  mg ; heparin  5000  unit ; insulin  0  unit ; pneumococcal vac polyvalent  0.5  ml ; levothyroxine sodium  50  mcg ; atenolol  50  mg ; acetaminophen  650  mg ; 
 
white f 91 $nan$hematology blood hematocrit  39.1  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  273  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  23  mg dl$acetaminophen  325-650  mg ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; senna  1  tab ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; docusate sodium  100  mg ; heparin  5000  unit ; insulin  0  unit ; pneumococcal vac polyvalent  0.5  ml ; levothyroxine sodium  50  mcg ; atenolol  50  mg ; acetaminophen  650  mg ; cephalexin  250  mg ; clotrimazole cream  1  appl ; 
 
asian f 79 $nan$hematology blood inr(pt)  1.3  $pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; metoprolol tartrate  50  mg ; 
 
asian f 79 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  83  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  8.8  mg dl; chemistry blood glucose  75  mg dl$glucagon  1  mg ; glucose gel  15  g ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; metoprolol tartrate  50  mg ; atorvastatin  40  mg ; lisinopril  2.5  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; acetaminophen iv  1000  mg ; morphine sulfate  1-2  mg ; ciprofloxacin hcl  500  mg ; d5 1 2ns  1000  ml ; morphine sulfate  2-4  mg ; 
 
asian f 79 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  83  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  7.7  mg dl; chemistry blood glucose  107  mg dl$glucagon  1  mg ; glucose gel  15  g ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; metoprolol tartrate  50  mg ; atorvastatin  40  mg ; lisinopril  2.5  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; acetaminophen iv  1000  mg ; ciprofloxacin hcl  500  mg ; morphine sulfate  2-4  mg ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; furosemide  20  mg ; potassium chloride  40  meq ; 
 
asian f 79 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  103  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  8.7  mg dl; chemistry blood glucose  64  mg dl$glucagon  1  mg ; glucose gel  15  g ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; metoprolol tartrate  50  mg ; atorvastatin  40  mg ; lisinopril  2.5  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; ciprofloxacin hcl  500  mg ; morphine sulfate  2-4  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; furosemide  20  mg ; bag  2  bag ; magnesium sulfate  4  gm ; sodium chloride 0.9%  1000  ml ; 
 
asian f 79 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  106  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  8.0  mg dl; chemistry blood glucose  85  mg dl$glucagon  1  mg ; glucose gel  15  g ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; metoprolol tartrate  50  mg ; atorvastatin  40  mg ; lisinopril  2.5  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; ciprofloxacin hcl  500  mg ; morphine sulfate  2-4  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; bag  2  bag ; magnesium sulfate  4  gm ; sodium chloride 0.9%  1000  ml ; 
 
asian f 79 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  128  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  7.7  mg dl; chemistry blood glucose  67  mg dl$glucagon  1  mg ; glucose gel  15  g ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; metoprolol tartrate  50  mg ; atorvastatin  40  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; ciprofloxacin hcl  500  mg ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; aspirin  81  mg ; ursodiol  300  mg ; 
 
asian f 79 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  130  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood bilirubin, total  7.3  mg dl; chemistry blood glucose  101  mg dl; chemistry blood albumin  1.9  g dl$glucagon  1  mg ; glucose gel  15  g ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; metoprolol tartrate  50  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; ciprofloxacin hcl  500  mg ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; aspirin  81  mg ; ursodiol  300  mg ; lidocaine 1%  1  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; ipratropium bromide neb  1  neb ; guaifenesin er  1200  mg ; sodium chloride 0.9%  flush  10  ml ; 
 
asian f 79 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  90  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  7.8  mg dl; chemistry blood glucose  96  mg dl$glucagon  1  mg ; glucose gel  15  g ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; metoprolol tartrate  50  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; aspirin  81  mg ; ursodiol  300  mg ; lidocaine 1%  1  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; ipratropium bromide neb  1  neb ; guaifenesin er  1200  mg ; sodium chloride 0.9%  flush  10  ml ; guaifenesin  5-10  ml ; phytonadione  5  mg ; 
 
asian f 79 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  64  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  41  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood bilirubin, indirect  1.6  mg dl; chemistry blood bilirubin, total  7.3  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  317  iu l; chemistry blood albumin  1.8  g dl; chemistry blood bilirubin, direct  5.7  mg dl$glucagon  1  mg ; glucose gel  15  g ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; metoprolol tartrate  50  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; ursodiol  300  mg ; lidocaine 1%  1  ml ; sodium chloride 0.9%  flush  20  ml ; ipratropium bromide neb  1  neb ; sodium chloride 0.9%  flush  10  ml ; guaifenesin  5-10  ml ; phytonadione  5  mg ; 
 
asian f 79 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  67  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  43  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood bilirubin, total  7.8  mg dl; chemistry blood glucose  150  mg dl; chemistry blood lactate dehydrogenase (ld)  319  iu l$glucagon  1  mg ; glucose gel  15  g ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  50  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; ursodiol  300  mg ; lidocaine 1%  1  ml ; sodium chloride 0.9%  flush  20  ml ; ipratropium bromide neb  1  neb ; sodium chloride 0.9%  flush  10  ml ; guaifenesin  5-10  ml ; prednisone  30  mg ; trazodone  50  mg ; 
 
asian f 79 $nan$hematology blood hematocrit  23.6  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  83  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  49  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood bilirubin, total  7.2  mg dl; chemistry blood glucose  204  mg dl; chemistry blood lactate dehydrogenase (ld)  442  iu l$glucagon  1  mg ; glucose gel  15  g ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  50  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; ursodiol  300  mg ; lidocaine 1%  1  ml ; ipratropium bromide neb  1  neb ; sodium chloride 0.9%  flush  10  ml ; guaifenesin  5-10  ml ; prednisone  30  mg ; trazodone  50  mg ; pantoprazole  40  mg ; 
 
asian f 79 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  165  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  55  mg dl; chemistry blood bilirubin, total  5.8  mg dl; chemistry blood glucose  213  mg dl; chemistry blood lactate dehydrogenase (ld)  513  iu l$glucagon  1  mg ; glucose gel  15  g ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; insulin  0  unit ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; ursodiol  300  mg ; lidocaine 1%  1  ml ; ipratropium bromide neb  1  neb ; sodium chloride 0.9%  flush  10  ml ; guaifenesin  5-10  ml ; prednisone  30  mg ; trazodone  50  mg ; pantoprazole  40  mg ; metoprolol succinate xl  100  mg ; 
 
asian f 79 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  62  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood bilirubin, total  5.5  mg dl; chemistry blood glucose  89  mg dl; chemistry blood lactate dehydrogenase (ld)  587  iu l$glucagon  1  mg ; glucose gel  15  g ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; insulin  0  unit ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; ursodiol  300  mg ; lidocaine 1%  1  ml ; ipratropium bromide neb  1  neb ; sodium chloride 0.9%  flush  10  ml ; guaifenesin  5-10  ml ; prednisone  30  mg ; pantoprazole  40  mg ; metoprolol succinate xl  100  mg ; lorazepam  0.5  mg ; docusate sodium  100  mg ; senna  8.6  mg ; 
 
asian f 79 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  65  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood bilirubin, total  4.5  mg dl; chemistry blood glucose  119  mg dl; chemistry blood albumin  2.1  g dl$glucagon  1  mg ; glucose gel  15  g ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; insulin  0  unit ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; ursodiol  300  mg ; lidocaine 1%  1  ml ; ipratropium bromide neb  1  neb ; sodium chloride 0.9%  flush  10  ml ; guaifenesin  5-10  ml ; prednisone  30  mg ; pantoprazole  40  mg ; metoprolol succinate xl  100  mg ; lorazepam  0.5  mg ; docusate sodium  100  mg ; senna  8.6  mg ; 
 
asian f 79 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  225  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  64  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  3.9  mg dl; chemistry blood glucose  83  mg dl$glucagon  1  mg ; glucose gel  15  g ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; insulin  0  unit ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; ursodiol  300  mg ; lidocaine 1%  1  ml ; ipratropium bromide neb  1  neb ; sodium chloride 0.9%  flush  10  ml ; guaifenesin  5-10  ml ; prednisone  30  mg ; pantoprazole  40  mg ; metoprolol succinate xl  100  mg ; lorazepam  0.5  mg ; docusate sodium  100  mg ; senna  8.6  mg ; calcium carbonate  500  mg ; sulfameth trimethoprim ss  1  tab ; 
 
asian f 79 $nan$nan$glucagon  1  mg ; glucose gel  15  g ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; insulin  0  unit ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; ursodiol  300  mg ; lidocaine 1%  1  ml ; ipratropium bromide neb  1  neb ; sodium chloride 0.9%  flush  10  ml ; guaifenesin  5-10  ml ; prednisone  30  mg ; pantoprazole  40  mg ; metoprolol succinate xl  100  mg ; lorazepam  0.5  mg ; docusate sodium  100  mg ; senna  8.6  mg ; calcium carbonate  500  mg ; sulfameth trimethoprim ss  1  tab ; vitamin d  1000  unit ; 
 
asian f 79 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  239  k ul; chemistry blood bilirubin, total  3.6  mg dl$glucagon  1  mg ; glucose gel  15  g ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; insulin  0  unit ; ursodiol  300  mg ; sodium chloride 0.9%  flush  10  ml ; prednisone  30  mg ; pantoprazole  40  mg ; metoprolol succinate xl  100  mg ; lorazepam  0.5  mg ; docusate sodium  100  mg ; senna  8.6  mg ; calcium carbonate  500  mg ; vitamin d  1000  unit ; acetaminophen  650  mg ; sulfameth trimethoprim ds  1  tab ; 
 
other m 84 $temp  98.9  heartrate  74.0  resprate  16.0  o2sat  100.0  sbp  128.0  dbp  68.0  rhythm    pain  4  $hematology blood hematocrit  22.1  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  108  k ul; chemistry blood anion gap  5  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  177  mg dl$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   2.5-5  mg ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; folic acid  1  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; docusate sodium  100  mg ; cyanocobalamin  1000  mcg ; brimonidine tartrate 0.15% ophth.  1  drop ; senna  8.6  mg ; tamsulosin  0.4  mg ; acyclovir  400  mg ; morphine sulfate  2-4  mg ; enoxaparin sodium  30  mg ; d5 1 2ns  1000  ml ; ondansetron  8  mg ; hydrocortisone na succ.  25  mg ; 
anemia, unspecified unspecified glaucoma fever, unspecified constipation, unspecified conjunctivitis, unspecified backache, unspecified candidiasis of mouth do not resuscitate status cough pain in limb long-term (current) use of aspirin retention of urine, unspecified pain in joint, shoulder region other chronic pain systemic inflammatory response syndrome due to noninfectious process without acute organ dysfunction diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled pain in joint, lower leg acute kidney failure, unspecified other drugs and medicinal substances causing adverse effects in therapeutic use osteoporosis, unspecified hypercalcemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) acute kidney failure, unspecified unspecified glaucoma arthropathy, unspecified, site unspecified long-term (current) use of aspirin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) do not resuscitate status multiple myeloma, without mention of having achieved remission chronic kidney disease, unspecified anemia of other chronic disease hypercalcemia osteoporosis, unspecified hyposmolality and/or hyponatremia anemia in chronic kidney disease multiple myeloma, without mention of having achieved remission hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of tobacco use anemia, unspecified chest pain, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anemia in neoplastic disease multiple myeloma, without mention of having achieved remission acute kidney failure, unspecified 
other m 84 $nan$hematology blood hematocrit  23.0  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  111  k ul; chemistry blood anion gap  6  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.2  mg dl; chemistry blood glucose  76  mg dl; chemistry blood albumin  2.0  g dl$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   2.5-5  mg ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; folic acid  1  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; docusate sodium  100  mg ; cyanocobalamin  1000  mcg ; brimonidine tartrate 0.15% ophth.  1  drop ; senna  8.6  mg ; tamsulosin  0.4  mg ; acyclovir  400  mg ; morphine sulfate  2-4  mg ; enoxaparin sodium  30  mg ; ondansetron  8  mg ; hydrocortisone na succ.  25  mg ; morphine sr (ms contin)  15  mg ; acetaminophen  650  mg ; hydrocortisone na succ.  100  mg ; 
anemia, unspecified unspecified glaucoma fever, unspecified constipation, unspecified conjunctivitis, unspecified backache, unspecified candidiasis of mouth do not resuscitate status cough pain in limb long-term (current) use of aspirin retention of urine, unspecified pain in joint, shoulder region other chronic pain systemic inflammatory response syndrome due to noninfectious process without acute organ dysfunction diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled pain in joint, lower leg acute kidney failure, unspecified other drugs and medicinal substances causing adverse effects in therapeutic use osteoporosis, unspecified hypercalcemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) acute kidney failure, unspecified unspecified glaucoma arthropathy, unspecified, site unspecified long-term (current) use of aspirin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) do not resuscitate status multiple myeloma, without mention of having achieved remission chronic kidney disease, unspecified anemia of other chronic disease hypercalcemia osteoporosis, unspecified hyposmolality and/or hyponatremia anemia in chronic kidney disease multiple myeloma, without mention of having achieved remission hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of tobacco use anemia, unspecified chest pain, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anemia in neoplastic disease multiple myeloma, without mention of having achieved remission acute kidney failure, unspecified 
other m 84 $nan$hematology blood hematocrit  23.0  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  118  k ul; chemistry blood anion gap  5  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  76  mg dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   2.5-5  mg ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; folic acid  1  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; docusate sodium  100  mg ; cyanocobalamin  1000  mcg ; brimonidine tartrate 0.15% ophth.  1  drop ; senna  8.6  mg ; tamsulosin  0.4  mg ; acyclovir  400  mg ; enoxaparin sodium  30  mg ; ondansetron  8  mg ; morphine sr (ms contin)  15  mg ; acetaminophen  650  mg ; morphine sulfate ir  7.5  mg ; 
anemia, unspecified unspecified glaucoma fever, unspecified constipation, unspecified conjunctivitis, unspecified backache, unspecified candidiasis of mouth do not resuscitate status cough pain in limb long-term (current) use of aspirin retention of urine, unspecified pain in joint, shoulder region other chronic pain systemic inflammatory response syndrome due to noninfectious process without acute organ dysfunction diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled pain in joint, lower leg acute kidney failure, unspecified other drugs and medicinal substances causing adverse effects in therapeutic use osteoporosis, unspecified hypercalcemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) acute kidney failure, unspecified unspecified glaucoma arthropathy, unspecified, site unspecified long-term (current) use of aspirin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) do not resuscitate status multiple myeloma, without mention of having achieved remission chronic kidney disease, unspecified anemia of other chronic disease hypercalcemia osteoporosis, unspecified hyposmolality and/or hyponatremia anemia in chronic kidney disease multiple myeloma, without mention of having achieved remission hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of tobacco use anemia, unspecified chest pain, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anemia in neoplastic disease multiple myeloma, without mention of having achieved remission acute kidney failure, unspecified 
other m 84 $nan$hematology blood hematocrit  23.1  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  93  k ul; chemistry blood anion gap  3  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  82  mg dl; chemistry blood albumin  2.0  g dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; folic acid  1  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; docusate sodium  100  mg ; cyanocobalamin  1000  mcg ; brimonidine tartrate 0.15% ophth.  1  drop ; senna  8.6  mg ; tamsulosin  0.4  mg ; acyclovir  400  mg ; ondansetron  8  mg ; morphine sr (ms contin)  15  mg ; acetaminophen  650  mg ; morphine sulfate ir  7.5  mg ; enoxaparin sodium  40  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; 
anemia, unspecified unspecified glaucoma fever, unspecified constipation, unspecified conjunctivitis, unspecified backache, unspecified candidiasis of mouth do not resuscitate status cough pain in limb long-term (current) use of aspirin retention of urine, unspecified pain in joint, shoulder region other chronic pain systemic inflammatory response syndrome due to noninfectious process without acute organ dysfunction diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled pain in joint, lower leg acute kidney failure, unspecified other drugs and medicinal substances causing adverse effects in therapeutic use osteoporosis, unspecified hypercalcemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) acute kidney failure, unspecified unspecified glaucoma arthropathy, unspecified, site unspecified long-term (current) use of aspirin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) do not resuscitate status multiple myeloma, without mention of having achieved remission chronic kidney disease, unspecified anemia of other chronic disease hypercalcemia osteoporosis, unspecified hyposmolality and/or hyponatremia anemia in chronic kidney disease multiple myeloma, without mention of having achieved remission hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of tobacco use anemia, unspecified chest pain, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anemia in neoplastic disease multiple myeloma, without mention of having achieved remission acute kidney failure, unspecified 
other m 84 $nan$hematology blood hematocrit  22.6  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  110  k ul; chemistry blood anion gap  6  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  76  mg dl$sodium chloride 0.9%  flush  3  ml ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; folic acid  1  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; docusate sodium  100  mg ; cyanocobalamin  1000  mcg ; brimonidine tartrate 0.15% ophth.  1  drop ; senna  8.6  mg ; tamsulosin  0.4  mg ; acyclovir  400  mg ; ondansetron  8  mg ; morphine sr (ms contin)  15  mg ; acetaminophen  650  mg ; morphine sulfate ir  7.5  mg ; enoxaparin sodium  40  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; magnesium citrate  300  ml ; 
anemia, unspecified unspecified glaucoma fever, unspecified constipation, unspecified conjunctivitis, unspecified backache, unspecified candidiasis of mouth do not resuscitate status cough pain in limb long-term (current) use of aspirin retention of urine, unspecified pain in joint, shoulder region other chronic pain systemic inflammatory response syndrome due to noninfectious process without acute organ dysfunction diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled pain in joint, lower leg acute kidney failure, unspecified other drugs and medicinal substances causing adverse effects in therapeutic use osteoporosis, unspecified hypercalcemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) acute kidney failure, unspecified unspecified glaucoma arthropathy, unspecified, site unspecified long-term (current) use of aspirin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) do not resuscitate status multiple myeloma, without mention of having achieved remission chronic kidney disease, unspecified anemia of other chronic disease hypercalcemia osteoporosis, unspecified hyposmolality and/or hyponatremia anemia in chronic kidney disease multiple myeloma, without mention of having achieved remission hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of tobacco use anemia, unspecified chest pain, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anemia in neoplastic disease multiple myeloma, without mention of having achieved remission acute kidney failure, unspecified 
other m 84 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  114  k ul; chemistry blood anion gap  3  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  75  mg dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; folic acid  1  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; docusate sodium  100  mg ; cyanocobalamin  1000  mcg ; brimonidine tartrate 0.15% ophth.  1  drop ; senna  8.6  mg ; tamsulosin  0.4  mg ; acyclovir  400  mg ; ondansetron  8  mg ; morphine sr (ms contin)  15  mg ; acetaminophen  650  mg ; morphine sulfate ir  7.5  mg ; enoxaparin sodium  40  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; magnesium citrate  300  ml ; aspirin  81  mg ; 
anemia, unspecified unspecified glaucoma fever, unspecified constipation, unspecified conjunctivitis, unspecified backache, unspecified candidiasis of mouth do not resuscitate status cough pain in limb long-term (current) use of aspirin retention of urine, unspecified pain in joint, shoulder region other chronic pain systemic inflammatory response syndrome due to noninfectious process without acute organ dysfunction diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled pain in joint, lower leg acute kidney failure, unspecified other drugs and medicinal substances causing adverse effects in therapeutic use osteoporosis, unspecified hypercalcemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) acute kidney failure, unspecified unspecified glaucoma arthropathy, unspecified, site unspecified long-term (current) use of aspirin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) do not resuscitate status multiple myeloma, without mention of having achieved remission chronic kidney disease, unspecified anemia of other chronic disease hypercalcemia osteoporosis, unspecified hyposmolality and/or hyponatremia anemia in chronic kidney disease multiple myeloma, without mention of having achieved remission hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of tobacco use anemia, unspecified chest pain, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anemia in neoplastic disease multiple myeloma, without mention of having achieved remission acute kidney failure, unspecified 
other m 84 $nan$hematology blood hematocrit  23.6  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  103  k ul; chemistry blood anion gap  4  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  76  mg dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; folic acid  1  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; docusate sodium  100  mg ; cyanocobalamin  1000  mcg ; brimonidine tartrate 0.15% ophth.  1  drop ; senna  8.6  mg ; tamsulosin  0.4  mg ; acyclovir  400  mg ; ondansetron  8  mg ; morphine sr (ms contin)  15  mg ; acetaminophen  650  mg ; morphine sulfate ir  7.5  mg ; enoxaparin sodium  40  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; aspirin  81  mg ; morphine sulfate ir  7.5-15  mg ; sodium chloride 0.9%  1000  ml ; 
anemia, unspecified unspecified glaucoma fever, unspecified constipation, unspecified conjunctivitis, unspecified backache, unspecified candidiasis of mouth do not resuscitate status cough pain in limb long-term (current) use of aspirin retention of urine, unspecified pain in joint, shoulder region other chronic pain systemic inflammatory response syndrome due to noninfectious process without acute organ dysfunction diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled pain in joint, lower leg acute kidney failure, unspecified other drugs and medicinal substances causing adverse effects in therapeutic use osteoporosis, unspecified hypercalcemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) acute kidney failure, unspecified unspecified glaucoma arthropathy, unspecified, site unspecified long-term (current) use of aspirin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) do not resuscitate status multiple myeloma, without mention of having achieved remission chronic kidney disease, unspecified anemia of other chronic disease hypercalcemia osteoporosis, unspecified hyposmolality and/or hyponatremia anemia in chronic kidney disease multiple myeloma, without mention of having achieved remission hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of tobacco use anemia, unspecified chest pain, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anemia in neoplastic disease multiple myeloma, without mention of having achieved remission acute kidney failure, unspecified 
other m 84 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  116  k ul; chemistry blood anion gap  5  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  185  mg dl$sodium chloride 0.9%  flush  3  ml ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; folic acid  1  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; docusate sodium  100  mg ; cyanocobalamin  1000  mcg ; brimonidine tartrate 0.15% ophth.  1  drop ; senna  8.6  mg ; tamsulosin  0.4  mg ; acyclovir  400  mg ; ondansetron  8  mg ; morphine sr (ms contin)  15  mg ; acetaminophen  650  mg ; enoxaparin sodium  40  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; aspirin  81  mg ; morphine sulfate ir  7.5-15  mg ; sodium chloride 0.9%  1000  ml ; dexamethasone  40  mg ; syringe  0.96  ml ; bortezomib  2.4  mg ; syringe  0.88  ml ; bortezomib  2.2  mg ; 
anemia, unspecified unspecified glaucoma fever, unspecified constipation, unspecified conjunctivitis, unspecified backache, unspecified candidiasis of mouth do not resuscitate status cough pain in limb long-term (current) use of aspirin retention of urine, unspecified pain in joint, shoulder region other chronic pain systemic inflammatory response syndrome due to noninfectious process without acute organ dysfunction diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled pain in joint, lower leg acute kidney failure, unspecified other drugs and medicinal substances causing adverse effects in therapeutic use osteoporosis, unspecified hypercalcemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) acute kidney failure, unspecified unspecified glaucoma arthropathy, unspecified, site unspecified long-term (current) use of aspirin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) do not resuscitate status multiple myeloma, without mention of having achieved remission chronic kidney disease, unspecified anemia of other chronic disease hypercalcemia osteoporosis, unspecified hyposmolality and/or hyponatremia anemia in chronic kidney disease multiple myeloma, without mention of having achieved remission hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of tobacco use anemia, unspecified chest pain, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anemia in neoplastic disease multiple myeloma, without mention of having achieved remission acute kidney failure, unspecified 
other m 84 $nan$nan$sodium chloride 0.9%  flush  3  ml ; multivitamins w minerals  1  tab ; latanoprost 0.005% ophth. soln.  1  drop ; folic acid  1  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; docusate sodium  100  mg ; cyanocobalamin  1000  mcg ; brimonidine tartrate 0.15% ophth.  1  drop ; senna  8.6  mg ; tamsulosin  0.4  mg ; acyclovir  400  mg ; ondansetron  8  mg ; morphine sr (ms contin)  15  mg ; acetaminophen  650  mg ; enoxaparin sodium  40  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; aspirin  81  mg ; morphine sulfate ir  7.5-15  mg ; syringe  0.88  ml ; bortezomib  2.2  mg ; 
anemia, unspecified unspecified glaucoma fever, unspecified constipation, unspecified conjunctivitis, unspecified backache, unspecified candidiasis of mouth do not resuscitate status cough pain in limb long-term (current) use of aspirin retention of urine, unspecified pain in joint, shoulder region other chronic pain systemic inflammatory response syndrome due to noninfectious process without acute organ dysfunction diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled pain in joint, lower leg acute kidney failure, unspecified other drugs and medicinal substances causing adverse effects in therapeutic use osteoporosis, unspecified hypercalcemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) acute kidney failure, unspecified unspecified glaucoma arthropathy, unspecified, site unspecified long-term (current) use of aspirin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) do not resuscitate status multiple myeloma, without mention of having achieved remission chronic kidney disease, unspecified anemia of other chronic disease hypercalcemia osteoporosis, unspecified hyposmolality and/or hyponatremia anemia in chronic kidney disease multiple myeloma, without mention of having achieved remission hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of tobacco use anemia, unspecified chest pain, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anemia in neoplastic disease multiple myeloma, without mention of having achieved remission acute kidney failure, unspecified 
white f 64 $temp    heartrate  87.0  resprate  17.0  o2sat  95.0  sbp  148.0  dbp  66.0  rhythm    pain  3  ; temp    heartrate  94.0  resprate  16.0  o2sat  95.0  sbp  174.0  dbp  80.0  rhythm    pain  3  ; temp    heartrate    resprate    o2sat    sbp  147.0  dbp  89.0  rhythm    pain    ; temp  99.5  heartrate  93.0  resprate  16.0  o2sat  94.0  sbp  160.0  dbp  76.0  rhythm    pain  3  $hematology blood hematocrit  39.5  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  61  k ul; hematology blood inr(pt)  1.1  ; blood gas blood lactate  1.2  mmol l$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  1  mg ; oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; argatroban  50  mg ; sodium chloride 0.9%  1000  ml ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; acetaminophen  1000  mg ; hydromorphone (dilaudid)  0.5  mg ; 
pulmonary collapse personal history of antineoplastic chemotherapy other specified cardiac dysrhythmias personal history of venous thrombosis and embolism unspecified septicemia personal history of tobacco use pneumonia, organism unspecified unspecified pleural effusion other diseases of lung, not elsewhere classified malignant neoplasm of bronchus and lung, unspecified other and unspecified hyperlipidemia empyema without mention of fistula person on outside of bus injured in collision with pedestrian or animal in traffic accident long-term (current) use of anticoagulants examination of participant in clinical trial disorder of bone and cartilage, unspecified sepsis pneumonia, organism unspecified other and unspecified hyperlipidemia personal history of tobacco use malignant neoplasm of upper lobe, bronchus or lung secondary and unspecified malignant neoplasm of intrathoracic lymph nodes contact dermatitis and other eczema, unspecified cause neutropenia, unspecified fever presenting with conditions classified elsewhere esophageal reflux asthma, unspecified type, unspecified 
white f 64 $nan$hematology blood hematocrit  38.2  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  58  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  86  mg dl; chemistry blood lactate dehydrogenase (ld)  433  iu l; chemistry blood albumin  3.7  g dl$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  1  mg ; oxycodone (immediate release)  5-10  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; acetaminophen  1000  mg ; hydromorphone (dilaudid)  0.5  mg ; vial  1  vial ; heparin sodium  800-1600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; morphine sulfate  2-4  mg ; oxycodone sr (oxycontin)  10  mg ; ranitidine  150  mg ; 
pulmonary collapse personal history of antineoplastic chemotherapy other specified cardiac dysrhythmias personal history of venous thrombosis and embolism unspecified septicemia personal history of tobacco use pneumonia, organism unspecified unspecified pleural effusion other diseases of lung, not elsewhere classified malignant neoplasm of bronchus and lung, unspecified other and unspecified hyperlipidemia empyema without mention of fistula person on outside of bus injured in collision with pedestrian or animal in traffic accident long-term (current) use of anticoagulants examination of participant in clinical trial disorder of bone and cartilage, unspecified sepsis pneumonia, organism unspecified other and unspecified hyperlipidemia personal history of tobacco use malignant neoplasm of upper lobe, bronchus or lung secondary and unspecified malignant neoplasm of intrathoracic lymph nodes contact dermatitis and other eczema, unspecified cause neutropenia, unspecified fever presenting with conditions classified elsewhere esophageal reflux asthma, unspecified type, unspecified 
white f 64 $nan$hematology blood hematocrit  37.1  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  81  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  104  mg dl; chemistry blood lactate dehydrogenase (ld)  393  iu l$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5-10  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; acetaminophen  1000  mg ; vial  1  vial ; heparin sodium  800-1600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; morphine sulfate  2-4  mg ; oxycodone sr (oxycontin)  10  mg ; ranitidine  150  mg ; polyethylene glycol  17  g ; oxycodone (immediate release)  5  mg ; docusate sodium  100  mg ; senna  17.2  mg ; 
pulmonary collapse personal history of antineoplastic chemotherapy other specified cardiac dysrhythmias personal history of venous thrombosis and embolism unspecified septicemia personal history of tobacco use pneumonia, organism unspecified unspecified pleural effusion other diseases of lung, not elsewhere classified malignant neoplasm of bronchus and lung, unspecified other and unspecified hyperlipidemia empyema without mention of fistula person on outside of bus injured in collision with pedestrian or animal in traffic accident long-term (current) use of anticoagulants examination of participant in clinical trial disorder of bone and cartilage, unspecified sepsis pneumonia, organism unspecified other and unspecified hyperlipidemia personal history of tobacco use malignant neoplasm of upper lobe, bronchus or lung secondary and unspecified malignant neoplasm of intrathoracic lymph nodes contact dermatitis and other eczema, unspecified cause neutropenia, unspecified fever presenting with conditions classified elsewhere esophageal reflux asthma, unspecified type, unspecified 
white f 64 $nan$hematology blood hematocrit  37.6  %; hematology blood hematocrit  35.1  %; hematology blood hemoglobin  12.2  g dl; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  133  k ul; hematology blood platelet count  128  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  67  mg dl; chemistry blood lactate dehydrogenase (ld)  355  iu l$sodium chloride 0.9%  flush  3  ml ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; acetaminophen  1000  mg ; oxycodone sr (oxycontin)  10  mg ; ranitidine  150  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; senna  17.2  mg ; enoxaparin sodium  100  mg ; 
pulmonary collapse personal history of antineoplastic chemotherapy other specified cardiac dysrhythmias personal history of venous thrombosis and embolism unspecified septicemia personal history of tobacco use pneumonia, organism unspecified unspecified pleural effusion other diseases of lung, not elsewhere classified malignant neoplasm of bronchus and lung, unspecified other and unspecified hyperlipidemia empyema without mention of fistula person on outside of bus injured in collision with pedestrian or animal in traffic accident long-term (current) use of anticoagulants examination of participant in clinical trial disorder of bone and cartilage, unspecified sepsis pneumonia, organism unspecified other and unspecified hyperlipidemia personal history of tobacco use malignant neoplasm of upper lobe, bronchus or lung secondary and unspecified malignant neoplasm of intrathoracic lymph nodes contact dermatitis and other eczema, unspecified cause neutropenia, unspecified fever presenting with conditions classified elsewhere esophageal reflux asthma, unspecified type, unspecified 
white f 64 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; acetaminophen  1000  mg ; oxycodone sr (oxycontin)  10  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; senna  17.2  mg ; enoxaparin sodium  100  mg ; morphine sulfate  4  mg ; bisacodyl  10  mg ; 
pulmonary collapse personal history of antineoplastic chemotherapy other specified cardiac dysrhythmias personal history of venous thrombosis and embolism unspecified septicemia personal history of tobacco use pneumonia, organism unspecified unspecified pleural effusion other diseases of lung, not elsewhere classified malignant neoplasm of bronchus and lung, unspecified other and unspecified hyperlipidemia empyema without mention of fistula person on outside of bus injured in collision with pedestrian or animal in traffic accident long-term (current) use of anticoagulants examination of participant in clinical trial disorder of bone and cartilage, unspecified sepsis pneumonia, organism unspecified other and unspecified hyperlipidemia personal history of tobacco use malignant neoplasm of upper lobe, bronchus or lung secondary and unspecified malignant neoplasm of intrathoracic lymph nodes contact dermatitis and other eczema, unspecified cause neutropenia, unspecified fever presenting with conditions classified elsewhere esophageal reflux asthma, unspecified type, unspecified 
white m 74 $nan$nan$atenolol  12.5  mg ; lisinopril  10  mg ; rosuvastatin calcium  10  mg ; venlafaxine xr  75  mg ; 
cholangitis unspecified essential hypertension depressive disorder, not elsewhere classified bacteremia personal history of peptic ulcer disease other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery pancytopenia escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site encephalopathy, unspecified personal history of venous thrombosis and embolism personal history of venous thrombosis and embolism aortic valve disorders inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) personal history of peptic ulcer disease paralytic ileus personal history of venous thrombosis and embolism other and unspecified hyperlipidemia other specified intestinal obstruction other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of native coronary artery digestive system complications, not elsewhere classified long-term (current) use of anticoagulants coronary atherosclerosis of native coronary artery other pulmonary embolism and infarction inguinal hernia, without mention of obstruction or gangrene, bilateral (not specified as recurrent) other and unspecified hyperlipidemia delirium due to conditions classified elsewhere
white m 74 $nan$hematology blood hematocrit  33.2  %; hematology blood hematocrit  32.0  %; hematology blood hemoglobin  11.0  g dl; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  241  k ul; hematology blood platelet count  225  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  128  mg dl$atenolol  12.5  mg ; lisinopril  10  mg ; rosuvastatin calcium  10  mg ; venlafaxine xr  75  mg ; sodium chloride 0.9%  flush  3  ml ; d5ns  1000  ml ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; ondansetron  4  mg ; zolpidem tartrate  10  mg ; 
cholangitis unspecified essential hypertension depressive disorder, not elsewhere classified bacteremia personal history of peptic ulcer disease other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery pancytopenia escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site encephalopathy, unspecified personal history of venous thrombosis and embolism personal history of venous thrombosis and embolism aortic valve disorders inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) personal history of peptic ulcer disease paralytic ileus personal history of venous thrombosis and embolism other and unspecified hyperlipidemia other specified intestinal obstruction other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of native coronary artery digestive system complications, not elsewhere classified long-term (current) use of anticoagulants coronary atherosclerosis of native coronary artery other pulmonary embolism and infarction inguinal hernia, without mention of obstruction or gangrene, bilateral (not specified as recurrent) other and unspecified hyperlipidemia delirium due to conditions classified elsewhere
white m 74 $nan$nan$atenolol  12.5  mg ; lisinopril  10  mg ; rosuvastatin calcium  10  mg ; venlafaxine xr  75  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; ondansetron  4  mg ; zolpidem tartrate  10  mg ; 
cholangitis unspecified essential hypertension depressive disorder, not elsewhere classified bacteremia personal history of peptic ulcer disease other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery pancytopenia escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site encephalopathy, unspecified personal history of venous thrombosis and embolism personal history of venous thrombosis and embolism aortic valve disorders inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) personal history of peptic ulcer disease paralytic ileus personal history of venous thrombosis and embolism other and unspecified hyperlipidemia other specified intestinal obstruction other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation coronary atherosclerosis of native coronary artery digestive system complications, not elsewhere classified long-term (current) use of anticoagulants coronary atherosclerosis of native coronary artery other pulmonary embolism and infarction inguinal hernia, without mention of obstruction or gangrene, bilateral (not specified as recurrent) other and unspecified hyperlipidemia delirium due to conditions classified elsewhere
white m 67 $temp  98.7  heartrate  107.0  resprate  18.0  o2sat  96.0  sbp  89.0  dbp  64.0  rhythm    pain  0  ; temp  98.7  heartrate  107.0  resprate  16.0  o2sat  96.0  sbp  117.0  dbp  63.0  rhythm    pain  0  $hematology blood hematocrit  36.9  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood glucose  95  mg dl; hematology blood wbc count  5.8  k ul$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; azithromycin  250  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; pantoprazole  40  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; heparin  5000  unit ; bupropion (sustained release)  100  mg ; metoprolol tartrate  50  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 5% dextrose  250  ml ; azithromycin   250  mg ; aspirin  81  mg ; atorvastatin  40  mg ; vitamin d  1000  unit ; allopurinol  200  mg ; venlafaxine xr  150  mg ; abacavir sulfate  600  mg ; carbamazepine chewable tabs  100  mg ; zidovudine  200  mg ; lamivudine  150  mg ; allopurinol  150  mg ; furosemide  20  mg ; furosemide  60  mg ; lamivudine  300  mg ; 0.9% sodium chloride  1000  ml ; cefepime  2  g ; metoprolol tartrate  100  mg ; warfarin  3.5  mg ; warfarin  2.5  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; 
 
white m 67 $nan$hematology blood hematocrit  43.2  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  3.0  ; chemistry urine chloride, urine  68  meq l; chemistry urine creatinine, urine  63  mg dl; chemistry urine potassium, urine  40  meq l; chemistry urine sodium, urine  48  meq l; chemistry urine urea nitrogen, urine  476  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  85  mg dl; chemistry blood lactate dehydrogenase (ld)  226  iu l$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; pantoprazole  40  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; heparin  5000  unit ; bupropion (sustained release)  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 5% dextrose  250  ml ; azithromycin   250  mg ; aspirin  81  mg ; atorvastatin  40  mg ; vitamin d  1000  unit ; venlafaxine xr  150  mg ; abacavir sulfate  600  mg ; carbamazepine chewable tabs  100  mg ; zidovudine  200  mg ; allopurinol  150  mg ; furosemide  60  mg ; lamivudine  300  mg ; cefepime  2  g ; warfarin  2.5  mg ; diltiazem  30  mg ; 
 
white m 67 $nan$hematology blood hematocrit  39.3  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  274  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  3.4  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  81  mg dl; chemistry blood glucose  115  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; pantoprazole  40  mg ; heparin  5000  unit ; bupropion (sustained release)  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 5% dextrose  250  ml ; azithromycin   250  mg ; aspirin  81  mg ; atorvastatin  40  mg ; vitamin d  1000  unit ; venlafaxine xr  150  mg ; abacavir sulfate  600  mg ; carbamazepine chewable tabs  100  mg ; zidovudine  200  mg ; allopurinol  150  mg ; furosemide  60  mg ; lamivudine  300  mg ; cefepime  2  g ; diltiazem  30  mg ; 
 
white m 67 $nan$hematology blood hematocrit  40.3  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  43  mg dl; hematology blood inr(pt)  3.0  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  103  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; pantoprazole  40  mg ; heparin  5000  unit ; bupropion (sustained release)  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; aspirin  81  mg ; atorvastatin  40  mg ; vitamin d  1000  unit ; venlafaxine xr  150  mg ; abacavir sulfate  600  mg ; carbamazepine chewable tabs  100  mg ; zidovudine  200  mg ; allopurinol  150  mg ; lamivudine  300  mg ; diltiazem  30  mg ; iso-osmotic dextrose  100  ml ; nafcillin  2  g ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; 
 
white m 67 $nan$hematology blood hematocrit  41.0  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  85  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; pantoprazole  40  mg ; heparin  5000  unit ; bupropion (sustained release)  100  mg ; aspirin  81  mg ; atorvastatin  40  mg ; vitamin d  1000  unit ; venlafaxine xr  150  mg ; abacavir sulfate  600  mg ; carbamazepine chewable tabs  100  mg ; zidovudine  200  mg ; allopurinol  150  mg ; lamivudine  300  mg ; diltiazem  30  mg ; iso-osmotic dextrose  100  ml ; nafcillin  2  g ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10  ml ; lisinopril  5  mg ; nystatin  1  appl ; magnesium oxide  400  mg ; warfarin  1.5  mg ; 
 
white m 67 $nan$hematology blood hematocrit  39.1  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  268  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  2.8  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  93  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; pantoprazole  40  mg ; bupropion (sustained release)  100  mg ; aspirin  81  mg ; atorvastatin  40  mg ; vitamin d  1000  unit ; venlafaxine xr  150  mg ; abacavir sulfate  600  mg ; carbamazepine chewable tabs  100  mg ; zidovudine  200  mg ; allopurinol  150  mg ; lamivudine  300  mg ; iso-osmotic dextrose  100  ml ; nafcillin  2  g ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10  ml ; lisinopril  5  mg ; nystatin  1  appl ; magnesium oxide  400  mg ; warfarin  1.5  mg ; isosorbide mononitrate (extended release)  30  mg ; tramadol (ultram)  50  mg ; 
 
black african american f 45 $nan$nan$enalapril maleate  20  mg ; 
morbid obesity acute pyelonephritis without lesion of renal medullary necrosis unspecified essential hypertension proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site iron deficiency anemia, unspecified calculus of kidney sickle-cell trait other postprocedural status unspecified essential hypertension obesity, unspecified sickle-cell trait urinary tract infection, site not specified urinary incontinence, unspecified proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site calculus of kidney morbid obesity abdominal pain, right lower quadrant urinary tract infection, site not specified constipation, unspecified unspecified essential hypertension sickle-cell trait iron deficiency anemia, unspecified accidents occurring in residential institution personal history of urinary calculi carrier or suspected carrier of other specified bacterial diseases morbid obesity tobacco use disorder calculus of kidney sickle-cell trait unspecified essential hypertension passenger in heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident surgical or other procedure not carried out because of contraindication performance of wrong operation (procedure) on correct patient escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site other abnormal glucose iron deficiency anemia, unspecified calculus of kidney morbid obesity constipation, unspecified sickle-cell trait acute pyelonephritis without lesion of renal medullary necrosis esophageal reflux unspecified essential hypertension tobacco use disorder sickle-cell trait calculus of kidney unspecified essential hypertension proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site
black african american f 45 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  381  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  85  mg dl$enalapril maleate  20  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; ns (mini bag plus)  100  ml ; meropenem  500  mg ; tramadol (ultram)  50  mg ; heparin  5000  unit ; ferrous sulfate  325  mg ; morphine sulfate  2  mg ; 0.9% sodium chloride  500  ml ; sw  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  100  ml ; ferric gluconate  125  mg ; senna  1  tab ; 
morbid obesity acute pyelonephritis without lesion of renal medullary necrosis unspecified essential hypertension proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site iron deficiency anemia, unspecified calculus of kidney sickle-cell trait other postprocedural status unspecified essential hypertension obesity, unspecified sickle-cell trait urinary tract infection, site not specified urinary incontinence, unspecified proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site calculus of kidney morbid obesity abdominal pain, right lower quadrant urinary tract infection, site not specified constipation, unspecified unspecified essential hypertension sickle-cell trait iron deficiency anemia, unspecified accidents occurring in residential institution personal history of urinary calculi carrier or suspected carrier of other specified bacterial diseases morbid obesity tobacco use disorder calculus of kidney sickle-cell trait unspecified essential hypertension passenger in heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident surgical or other procedure not carried out because of contraindication performance of wrong operation (procedure) on correct patient escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site other abnormal glucose iron deficiency anemia, unspecified calculus of kidney morbid obesity constipation, unspecified sickle-cell trait acute pyelonephritis without lesion of renal medullary necrosis esophageal reflux unspecified essential hypertension tobacco use disorder sickle-cell trait calculus of kidney unspecified essential hypertension proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site
black african american f 45 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  323  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  85  mg dl$enalapril maleate  20  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; ns (mini bag plus)  100  ml ; meropenem  500  mg ; tramadol (ultram)  50  mg ; heparin  5000  unit ; morphine sulfate  2  mg ; sw  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  100  ml ; ferric gluconate  125  mg ; senna  1  tab ; docusate sodium  100  mg ; oxycodone (immediate release)   5-10  mg ; bisacodyl  10  mg ; 
morbid obesity acute pyelonephritis without lesion of renal medullary necrosis unspecified essential hypertension proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site iron deficiency anemia, unspecified calculus of kidney sickle-cell trait other postprocedural status unspecified essential hypertension obesity, unspecified sickle-cell trait urinary tract infection, site not specified urinary incontinence, unspecified proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site calculus of kidney morbid obesity abdominal pain, right lower quadrant urinary tract infection, site not specified constipation, unspecified unspecified essential hypertension sickle-cell trait iron deficiency anemia, unspecified accidents occurring in residential institution personal history of urinary calculi carrier or suspected carrier of other specified bacterial diseases morbid obesity tobacco use disorder calculus of kidney sickle-cell trait unspecified essential hypertension passenger in heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident surgical or other procedure not carried out because of contraindication performance of wrong operation (procedure) on correct patient escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site other abnormal glucose iron deficiency anemia, unspecified calculus of kidney morbid obesity constipation, unspecified sickle-cell trait acute pyelonephritis without lesion of renal medullary necrosis esophageal reflux unspecified essential hypertension tobacco use disorder sickle-cell trait calculus of kidney unspecified essential hypertension proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site
black african american f 45 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  335  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; hematology urine wbc  430  # hpf; chemistry blood glucose  70  mg dl$enalapril maleate  20  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; ns (mini bag plus)  100  ml ; meropenem  500  mg ; tramadol (ultram)  50  mg ; heparin  5000  unit ; 0.9% sodium chloride  100  ml ; ferric gluconate  125  mg ; docusate sodium  100  mg ; oxycodone (immediate release)   5-10  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; 
morbid obesity acute pyelonephritis without lesion of renal medullary necrosis unspecified essential hypertension proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site iron deficiency anemia, unspecified calculus of kidney sickle-cell trait other postprocedural status unspecified essential hypertension obesity, unspecified sickle-cell trait urinary tract infection, site not specified urinary incontinence, unspecified proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site calculus of kidney morbid obesity abdominal pain, right lower quadrant urinary tract infection, site not specified constipation, unspecified unspecified essential hypertension sickle-cell trait iron deficiency anemia, unspecified accidents occurring in residential institution personal history of urinary calculi carrier or suspected carrier of other specified bacterial diseases morbid obesity tobacco use disorder calculus of kidney sickle-cell trait unspecified essential hypertension passenger in heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident surgical or other procedure not carried out because of contraindication performance of wrong operation (procedure) on correct patient escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site other abnormal glucose iron deficiency anemia, unspecified calculus of kidney morbid obesity constipation, unspecified sickle-cell trait acute pyelonephritis without lesion of renal medullary necrosis esophageal reflux unspecified essential hypertension tobacco use disorder sickle-cell trait calculus of kidney unspecified essential hypertension proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site
black african american f 45 $nan$nan$enalapril maleate  20  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; ns (mini bag plus)  100  ml ; meropenem  500  mg ; tramadol (ultram)  50  mg ; heparin  5000  unit ; 0.9% sodium chloride  100  ml ; ferric gluconate  125  mg ; docusate sodium  100  mg ; oxycodone (immediate release)   5-10  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; 
morbid obesity acute pyelonephritis without lesion of renal medullary necrosis unspecified essential hypertension proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site iron deficiency anemia, unspecified calculus of kidney sickle-cell trait other postprocedural status unspecified essential hypertension obesity, unspecified sickle-cell trait urinary tract infection, site not specified urinary incontinence, unspecified proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site calculus of kidney morbid obesity abdominal pain, right lower quadrant urinary tract infection, site not specified constipation, unspecified unspecified essential hypertension sickle-cell trait iron deficiency anemia, unspecified accidents occurring in residential institution personal history of urinary calculi carrier or suspected carrier of other specified bacterial diseases morbid obesity tobacco use disorder calculus of kidney sickle-cell trait unspecified essential hypertension passenger in heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident surgical or other procedure not carried out because of contraindication performance of wrong operation (procedure) on correct patient escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site other abnormal glucose iron deficiency anemia, unspecified calculus of kidney morbid obesity constipation, unspecified sickle-cell trait acute pyelonephritis without lesion of renal medullary necrosis esophageal reflux unspecified essential hypertension tobacco use disorder sickle-cell trait calculus of kidney unspecified essential hypertension proteus (mirabilis) (morganii) infection in conditions classified elsewhere and of unspecified site
asian f 57 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  79  k ul$sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; morphine sulfate  2-4  mg ; promethazine  12.5  mg ; zolpidem tartrate  5  mg ; cepacol (menthol)  1  loz ; pantoprazole  40  mg ; ciprofloxacin hcl  500  mg ; 
nontoxic multinodular goiter unspecified essential hypertension other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction esophageal reflux unspecified viral hepatitis c without hepatic coma
asian f 57 $nan$nan$sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; promethazine  12.5  mg ; zolpidem tartrate  5  mg ; cepacol (menthol)  1  loz ; pantoprazole  40  mg ; ciprofloxacin hcl  500  mg ; 
nontoxic multinodular goiter unspecified essential hypertension other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction esophageal reflux unspecified viral hepatitis c without hepatic coma
white m 66 $temp  98.5  heartrate  74.0  resprate  21.0  o2sat  96.0  sbp  136.0  dbp  67.0  rhythm    pain    $nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)  5  mg ; hydromorphone (dilaudid)  0.5  mg ; heparin  5000  unit ; lidocaine 5% patch  1  ptch ; lidocaine 2% epi 1:100,000  2  ml ; ketorolac  15  mg ; senna  8.6  mg ; docusate sodium  100  mg ; 
 
white m 66 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; oxycodone (immediate release)  5  mg ; hydromorphone (dilaudid)  0.5  mg ; heparin  5000  unit ; lidocaine 5% patch  1  ptch ; ketorolac  15  mg ; senna  8.6  mg ; docusate sodium  100  mg ; 
 
white m 66 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; oxycodone (immediate release)  5  mg ; heparin  5000  unit ; lidocaine 5% patch  1  ptch ; senna  8.6  mg ; docusate sodium  100  mg ; 
 
white m 38 $temp  98.6  heartrate  89.0  resprate  18.0  o2sat  99.0  sbp  103.0  dbp  68.0  rhythm    pain  0 10  $hematology blood hematocrit  44.9  %; hematology blood hemoglobin  15.0  g dl; hematology blood platelet count  236  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  82  mg dl; chemistry blood albumin  4.6  g dl$nan
 
white m 64 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  132  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  8.6  mg ; hydralazine  10  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5  mg ; insulin  0  unit ; 0.9% sodium chloride  100  ml ; levetiracetam  500  mg ; metformin (glucophage)  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; labetalol  5-10  mg ; hydralazine  10-20  mg ; clevidipine  25  mg ; 
 
white m 64 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  212  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  196  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  8.6  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5  mg ; insulin  0  unit ; 0.9% sodium chloride  100  ml ; levetiracetam  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; labetalol  5-10  mg ; hydralazine  10-20  mg ; clevidipine  25  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; heparin  5000  unit ; 
 
white m 64 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  155  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  8.6  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; 
 
white m 64 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  8.6  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; 
 
white m 83 $nan$nan$amlodipine  20  mg ; citalopram  20  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; 
nausea with vomiting abdominal pain, unspecified site obstructive sleep apnea (adult)(pediatric) other acute postoperative pain barrett's esophagus unspecified essential hypertension hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) coronary atherosclerosis of unspecified type of vessel, native or graft peripheral vascular disease, unspecified aortocoronary bypass status esophageal reflux 
white m 83 $nan$nan$amlodipine  20  mg ; citalopram  20  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   2.5-5  mg ; ondansetron  4  mg ; lisinopril  20  mg ; aspirin  162  mg ; metoprolol succinate xl  50  mg ; 
nausea with vomiting abdominal pain, unspecified site obstructive sleep apnea (adult)(pediatric) other acute postoperative pain barrett's esophagus unspecified essential hypertension hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) coronary atherosclerosis of unspecified type of vessel, native or graft peripheral vascular disease, unspecified aortocoronary bypass status esophageal reflux 
white m 58 $temp    heartrate  127.0  resprate  16.0  o2sat  95.0  sbp  117.0  dbp  95.0  rhythm    pain    $hematology blood hematocrit  39.6  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  81  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  139  mg dl; chemistry blood glucose  108  mg dl; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  0.91  mmol l; blood gas blood lactate  4.0  mmol l; blood gas blood lactate  1.5  mmol l$sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; 5% dextrose  100  ml ; diltiazem  125  mg ; heparin  5000  unit ; phenobarbital - icu alcohol withdrawal (initial load   rescue dose)  760  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; meclizine  25  mg ; oxycodone (immediate release)  10  mg ; pantoprazole  40  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; acetaminophen  650  mg ; sertraline  25  mg ; 0.9% sodium chloride  250  ml ; thiamine  500  mg ; folic acid  1  mg ; multivitamins  1  tab ; phenobarbital alcohol withdrawal dose taper (days 2-7)  44  mg ; neutra-phos  2  pkt ; metoprolol tartrate  50  mg ; diltiazem  60  mg ; 0.9% sodium chloride  50  ml ; thiamine  200  mg ; amitriptyline  10  mg ; 
other chronic pain alcoholic hepatitis without ascites bedroom in apartment as the place of occurrence of the external cause hypokalemia unspecified atrial fibrillation major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis body mass index (bmi) 35.0-35.9, adult contusion of eyeball and orbital tissues, right eye, initial encounter obesity, unspecified history of falling other and unspecified fall in water transport injuring occupant of small boat, powered hypocalcemia vitamin d deficiency, unspecified cervicalgia benign paroxysmal vertigo, unspecified ear alcohol dependence with withdrawal, unspecified low back pain thrombocytopenia, unspecified alcohol abuse with intoxication, unspecified dorsalgia, unspecified unspecified atrial fibrillation other chronic pain history of falling fracture of one rib, unspecified side, subsequent encounter for fracture with delayed healing cervicalgia polyneuropathy, unspecified rheumatoid arthritis, unspecified unspecified fall, subsequent encounter history of falling fall on same level, unspecified, initial encounter unspecified atrial fibrillation major depressive disorder, single episode, unspecified fracture of one rib, right side, initial encounter for closed fracture unspecified place or not applicable alcohol dependence with intoxication, unspecified unspecified injury of head, initial encounter essential (primary) hypertension paroxysmal atrial fibrillation migraine, unspecified, not intractable, without status migrainosus other chronic pain esophagitis, unspecified alcohol abuse, uncomplicated essential (primary) hypertension gastrointestinal hemorrhage, unspecified major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis polyneuropathy, unspecified
white m 58 $nan$hematology blood hematocrit  37.3  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  48  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood urea nitrogen  3  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  103  mg dl; chemistry blood glucose  89  mg dl; chemistry blood lactate dehydrogenase (ld)  205  iu l$sodium chloride 0.9%  flush  3  ml ; 5% dextrose  100  ml ; diltiazem  125  mg ; heparin  5000  unit ; phenobarbital - icu alcohol withdrawal (initial load   rescue dose)  760  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; meclizine  25  mg ; oxycodone (immediate release)  10  mg ; pantoprazole  40  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; acetaminophen  650  mg ; sertraline  25  mg ; folic acid  1  mg ; multivitamins  1  tab ; phenobarbital alcohol withdrawal dose taper (days 2-7)  44  mg ; neutra-phos  2  pkt ; metoprolol tartrate  50  mg ; diltiazem  60  mg ; 0.9% sodium chloride  50  ml ; thiamine  200  mg ; amitriptyline  10  mg ; potassium chloride  80  meq ; 
other chronic pain alcoholic hepatitis without ascites bedroom in apartment as the place of occurrence of the external cause hypokalemia unspecified atrial fibrillation major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis body mass index (bmi) 35.0-35.9, adult contusion of eyeball and orbital tissues, right eye, initial encounter obesity, unspecified history of falling other and unspecified fall in water transport injuring occupant of small boat, powered hypocalcemia vitamin d deficiency, unspecified cervicalgia benign paroxysmal vertigo, unspecified ear alcohol dependence with withdrawal, unspecified low back pain thrombocytopenia, unspecified alcohol abuse with intoxication, unspecified dorsalgia, unspecified unspecified atrial fibrillation other chronic pain history of falling fracture of one rib, unspecified side, subsequent encounter for fracture with delayed healing cervicalgia polyneuropathy, unspecified rheumatoid arthritis, unspecified unspecified fall, subsequent encounter history of falling fall on same level, unspecified, initial encounter unspecified atrial fibrillation major depressive disorder, single episode, unspecified fracture of one rib, right side, initial encounter for closed fracture unspecified place or not applicable alcohol dependence with intoxication, unspecified unspecified injury of head, initial encounter essential (primary) hypertension paroxysmal atrial fibrillation migraine, unspecified, not intractable, without status migrainosus other chronic pain esophagitis, unspecified alcohol abuse, uncomplicated essential (primary) hypertension gastrointestinal hemorrhage, unspecified major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis polyneuropathy, unspecified
white m 58 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  41  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  3  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  101  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; meclizine  25  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; sertraline  25  mg ; folic acid  1  mg ; phenobarbital alcohol withdrawal dose taper (days 2-7)  44  mg ; metoprolol tartrate  50  mg ; diltiazem  60  mg ; 0.9% sodium chloride  50  ml ; thiamine  200  mg ; amitriptyline  10  mg ; potassium chloride  80  meq ; phenobarbital alcohol withdrawal dose taper (days 2-7)  22  mg ; vitamin d  50,000  unit ; multivitamins w minerals  1  tab ; potassium chloride  60  meq ; 
other chronic pain alcoholic hepatitis without ascites bedroom in apartment as the place of occurrence of the external cause hypokalemia unspecified atrial fibrillation major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis body mass index (bmi) 35.0-35.9, adult contusion of eyeball and orbital tissues, right eye, initial encounter obesity, unspecified history of falling other and unspecified fall in water transport injuring occupant of small boat, powered hypocalcemia vitamin d deficiency, unspecified cervicalgia benign paroxysmal vertigo, unspecified ear alcohol dependence with withdrawal, unspecified low back pain thrombocytopenia, unspecified alcohol abuse with intoxication, unspecified dorsalgia, unspecified unspecified atrial fibrillation other chronic pain history of falling fracture of one rib, unspecified side, subsequent encounter for fracture with delayed healing cervicalgia polyneuropathy, unspecified rheumatoid arthritis, unspecified unspecified fall, subsequent encounter history of falling fall on same level, unspecified, initial encounter unspecified atrial fibrillation major depressive disorder, single episode, unspecified fracture of one rib, right side, initial encounter for closed fracture unspecified place or not applicable alcohol dependence with intoxication, unspecified unspecified injury of head, initial encounter essential (primary) hypertension paroxysmal atrial fibrillation migraine, unspecified, not intractable, without status migrainosus other chronic pain esophagitis, unspecified alcohol abuse, uncomplicated essential (primary) hypertension gastrointestinal hemorrhage, unspecified major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis polyneuropathy, unspecified
white m 58 $nan$hematology blood hematocrit  37.7  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  50  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; meclizine  25  mg ; pantoprazole  40  mg ; acetaminophen  650  mg ; sertraline  25  mg ; folic acid  1  mg ; amitriptyline  10  mg ; phenobarbital alcohol withdrawal dose taper (days 2-7)  22  mg ; vitamin d  50,000  unit ; multivitamins w minerals  1  tab ; potassium chloride  60  meq ; metoprolol succinate xl  200  mg ; diltiazem extended-release  240  mg ; thiamine  100  mg ; 
other chronic pain alcoholic hepatitis without ascites bedroom in apartment as the place of occurrence of the external cause hypokalemia unspecified atrial fibrillation major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis body mass index (bmi) 35.0-35.9, adult contusion of eyeball and orbital tissues, right eye, initial encounter obesity, unspecified history of falling other and unspecified fall in water transport injuring occupant of small boat, powered hypocalcemia vitamin d deficiency, unspecified cervicalgia benign paroxysmal vertigo, unspecified ear alcohol dependence with withdrawal, unspecified low back pain thrombocytopenia, unspecified alcohol abuse with intoxication, unspecified dorsalgia, unspecified unspecified atrial fibrillation other chronic pain history of falling fracture of one rib, unspecified side, subsequent encounter for fracture with delayed healing cervicalgia polyneuropathy, unspecified rheumatoid arthritis, unspecified unspecified fall, subsequent encounter history of falling fall on same level, unspecified, initial encounter unspecified atrial fibrillation major depressive disorder, single episode, unspecified fracture of one rib, right side, initial encounter for closed fracture unspecified place or not applicable alcohol dependence with intoxication, unspecified unspecified injury of head, initial encounter essential (primary) hypertension paroxysmal atrial fibrillation migraine, unspecified, not intractable, without status migrainosus other chronic pain esophagitis, unspecified alcohol abuse, uncomplicated essential (primary) hypertension gastrointestinal hemorrhage, unspecified major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis polyneuropathy, unspecified
white f 54 $nan$nan$insulin  10  unit ; folic acid  1  mg ; amlodipine  2.5  mg ; sulfameth trimethoprim ss  1  tab ; prednisone  10  mg ; 
other specified noninflammatory disorders of vagina other ascites herpetic gingivostomatitis hepatorenal syndrome iron deficiency anemia secondary to blood loss (chronic) chronic hepatitis c with hepatic coma toxic encephalopathy infection with microorganisms without mention of resistance to multiple drugs other and unspecified alcohol dependence, in remission hyposmolality and/or hyponatremia acute respiratory failure portal hypertension unspecified septicemia urinary tract infection, site not specified asthma, unspecified type, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, staphylococcus, unspecified other and unspecified escherichia coli [e. coli] other digestive system complications acute kidney failure, unspecified disorders of phosphorus metabolism attention deficit disorder with hyperactivity other specified disorders of biliary tract drug-induced delirium thrombocytopenia, unspecified bloodstream infection due to central venous catheter severe sepsis alcoholic cirrhosis of liver other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure septic shock acute posthemorrhagic anemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other sequelae of chronic liver disease end stage renal disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] depressive disorder, not elsewhere classified mixed acid-base balance disorder obstruction of bile duct ventilator associated pneumonia acquired coagulation factor deficiency acute kidney failure, unspecified other ascites disorders of phosphorus metabolism alcoholic cirrhosis of liver hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease asthma, unspecified type, unspecified end stage renal disease hepatorenal syndrome hypercalcemia
white f 54 $nan$hematology blood hematocrit  27.9  %; hematology blood hematocrit  29.1  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  258  k ul; hematology blood platelet count  280  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; chemistry urine chloride, urine  94  meq l; chemistry urine creatinine, urine  12  mg dl; chemistry urine potassium, urine  4  meq l; chemistry urine sodium, urine  118  meq l; chemistry urine urea nitrogen, urine  104  mg dl; hematology urine wbc  0  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood bilirubin, total  2.6  mg dl; chemistry blood glucose  74  mg dl; chemistry blood glucose  166  mg dl; chemistry blood albumin  3.1  g dl$insulin  10  unit ; folic acid  1  mg ; amlodipine  2.5  mg ; sulfameth trimethoprim ss  1  tab ; prednisone  10  mg ; sodium chloride 0.9%  flush  3  ml ; tacrolimus  0  mg ; heparin flush (10 units ml)  2  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; fluconazole  400  mg ; hydromorphone (dilaudid)  2  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; bupropion  150  mg ; ursodiol  300  mg ; docusate sodium  100  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; lactulose  15  ml ; lorazepam  0.5  mg ; ondansetron  4  mg ; senna  1  tab ; mycophenolate mofetil  1000  mg ; valganciclovir  900  mg ; bupropion  100  mg ; 0.9% sodium chloride  50  ml ; daptomycin  400  mg ; salmeterol xinafoate diskus (50 mcg)  1  inh ; furosemide  40  mg ; pantoprazole  40  mg ; hydromorphone (dilaudid)  2-4  mg ; bag  100  ml ; magnesium sulfate  4  gm ; transplant self medication program  1  bag ; 
other specified noninflammatory disorders of vagina other ascites herpetic gingivostomatitis hepatorenal syndrome iron deficiency anemia secondary to blood loss (chronic) chronic hepatitis c with hepatic coma toxic encephalopathy infection with microorganisms without mention of resistance to multiple drugs other and unspecified alcohol dependence, in remission hyposmolality and/or hyponatremia acute respiratory failure portal hypertension unspecified septicemia urinary tract infection, site not specified asthma, unspecified type, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, staphylococcus, unspecified other and unspecified escherichia coli [e. coli] other digestive system complications acute kidney failure, unspecified disorders of phosphorus metabolism attention deficit disorder with hyperactivity other specified disorders of biliary tract drug-induced delirium thrombocytopenia, unspecified bloodstream infection due to central venous catheter severe sepsis alcoholic cirrhosis of liver other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure septic shock acute posthemorrhagic anemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other sequelae of chronic liver disease end stage renal disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] depressive disorder, not elsewhere classified mixed acid-base balance disorder obstruction of bile duct ventilator associated pneumonia acquired coagulation factor deficiency acute kidney failure, unspecified other ascites disorders of phosphorus metabolism alcoholic cirrhosis of liver hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease asthma, unspecified type, unspecified end stage renal disease hepatorenal syndrome hypercalcemia
white f 54 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  2.4  mg dl; chemistry blood glucose  80  mg dl$insulin  10  unit ; folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  2  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; ursodiol  300  mg ; docusate sodium  100  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; lorazepam  0.5  mg ; ondansetron  4  mg ; senna  1  tab ; 0.9% sodium chloride  50  ml ; daptomycin  400  mg ; salmeterol xinafoate diskus (50 mcg)  1  inh ; furosemide  40  mg ; hydromorphone (dilaudid)  2-4  mg ; bag  100  ml ; magnesium sulfate  4  gm ; transplant self medication program  1  bag ; ampicillin-sulbactam  1.5  g ; potassium chloride  40  meq ; bupropion (sustained release)  150  mg ; metoprolol tartrate  12.5  mg ; prednisone  7.5  mg ; 
other specified noninflammatory disorders of vagina other ascites herpetic gingivostomatitis hepatorenal syndrome iron deficiency anemia secondary to blood loss (chronic) chronic hepatitis c with hepatic coma toxic encephalopathy infection with microorganisms without mention of resistance to multiple drugs other and unspecified alcohol dependence, in remission hyposmolality and/or hyponatremia acute respiratory failure portal hypertension unspecified septicemia urinary tract infection, site not specified asthma, unspecified type, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, staphylococcus, unspecified other and unspecified escherichia coli [e. coli] other digestive system complications acute kidney failure, unspecified disorders of phosphorus metabolism attention deficit disorder with hyperactivity other specified disorders of biliary tract drug-induced delirium thrombocytopenia, unspecified bloodstream infection due to central venous catheter severe sepsis alcoholic cirrhosis of liver other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure septic shock acute posthemorrhagic anemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other sequelae of chronic liver disease end stage renal disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] depressive disorder, not elsewhere classified mixed acid-base balance disorder obstruction of bile duct ventilator associated pneumonia acquired coagulation factor deficiency acute kidney failure, unspecified other ascites disorders of phosphorus metabolism alcoholic cirrhosis of liver hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease asthma, unspecified type, unspecified end stage renal disease hepatorenal syndrome hypercalcemia
white f 54 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  13  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood glucose  142  mg dl$insulin  10  unit ; folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  2  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; ursodiol  300  mg ; docusate sodium  100  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; lorazepam  0.5  mg ; ondansetron  4  mg ; senna  1  tab ; 0.9% sodium chloride  50  ml ; daptomycin  400  mg ; salmeterol xinafoate diskus (50 mcg)  1  inh ; hydromorphone (dilaudid)  2-4  mg ; transplant self medication program  1  bag ; ampicillin-sulbactam  1.5  g ; potassium chloride  40  meq ; bupropion (sustained release)  150  mg ; metoprolol tartrate  12.5  mg ; prednisone  7.5  mg ; tacrolimus  2  mg ; 
other specified noninflammatory disorders of vagina other ascites herpetic gingivostomatitis hepatorenal syndrome iron deficiency anemia secondary to blood loss (chronic) chronic hepatitis c with hepatic coma toxic encephalopathy infection with microorganisms without mention of resistance to multiple drugs other and unspecified alcohol dependence, in remission hyposmolality and/or hyponatremia acute respiratory failure portal hypertension unspecified septicemia urinary tract infection, site not specified asthma, unspecified type, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, staphylococcus, unspecified other and unspecified escherichia coli [e. coli] other digestive system complications acute kidney failure, unspecified disorders of phosphorus metabolism attention deficit disorder with hyperactivity other specified disorders of biliary tract drug-induced delirium thrombocytopenia, unspecified bloodstream infection due to central venous catheter severe sepsis alcoholic cirrhosis of liver other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure septic shock acute posthemorrhagic anemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other sequelae of chronic liver disease end stage renal disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] depressive disorder, not elsewhere classified mixed acid-base balance disorder obstruction of bile duct ventilator associated pneumonia acquired coagulation factor deficiency acute kidney failure, unspecified other ascites disorders of phosphorus metabolism alcoholic cirrhosis of liver hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease asthma, unspecified type, unspecified end stage renal disease hepatorenal syndrome hypercalcemia
white f 54 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood bilirubin, total  2.8  mg dl; chemistry blood glucose  114  mg dl$insulin  10  unit ; folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  2  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; ursodiol  300  mg ; docusate sodium  100  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; lorazepam  0.5  mg ; ondansetron  4  mg ; senna  1  tab ; 0.9% sodium chloride  50  ml ; daptomycin  400  mg ; salmeterol xinafoate diskus (50 mcg)  1  inh ; hydromorphone (dilaudid)  2-4  mg ; transplant self medication program  1  bag ; ampicillin-sulbactam  1.5  g ; bupropion (sustained release)  150  mg ; metoprolol tartrate  12.5  mg ; prednisone  7.5  mg ; tacrolimus  2  mg ; 
other specified noninflammatory disorders of vagina other ascites herpetic gingivostomatitis hepatorenal syndrome iron deficiency anemia secondary to blood loss (chronic) chronic hepatitis c with hepatic coma toxic encephalopathy infection with microorganisms without mention of resistance to multiple drugs other and unspecified alcohol dependence, in remission hyposmolality and/or hyponatremia acute respiratory failure portal hypertension unspecified septicemia urinary tract infection, site not specified asthma, unspecified type, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, staphylococcus, unspecified other and unspecified escherichia coli [e. coli] other digestive system complications acute kidney failure, unspecified disorders of phosphorus metabolism attention deficit disorder with hyperactivity other specified disorders of biliary tract drug-induced delirium thrombocytopenia, unspecified bloodstream infection due to central venous catheter severe sepsis alcoholic cirrhosis of liver other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure septic shock acute posthemorrhagic anemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other sequelae of chronic liver disease end stage renal disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] depressive disorder, not elsewhere classified mixed acid-base balance disorder obstruction of bile duct ventilator associated pneumonia acquired coagulation factor deficiency acute kidney failure, unspecified other ascites disorders of phosphorus metabolism alcoholic cirrhosis of liver hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease asthma, unspecified type, unspecified end stage renal disease hepatorenal syndrome hypercalcemia
white f 54 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  279  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  2.8  mg dl; chemistry blood glucose  145  mg dl$insulin  10  unit ; folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  2  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; ursodiol  300  mg ; docusate sodium  100  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; lorazepam  0.5  mg ; ondansetron  4  mg ; senna  1  tab ; 0.9% sodium chloride  50  ml ; daptomycin  400  mg ; salmeterol xinafoate diskus (50 mcg)  1  inh ; hydromorphone (dilaudid)  2-4  mg ; transplant self medication program  1  bag ; ampicillin-sulbactam  1.5  g ; bupropion (sustained release)  150  mg ; metoprolol tartrate  12.5  mg ; prednisone  7.5  mg ; tacrolimus  1.5  mg ; 5% dextrose  100  ml ; tigecycline  100  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; 
other specified noninflammatory disorders of vagina other ascites herpetic gingivostomatitis hepatorenal syndrome iron deficiency anemia secondary to blood loss (chronic) chronic hepatitis c with hepatic coma toxic encephalopathy infection with microorganisms without mention of resistance to multiple drugs other and unspecified alcohol dependence, in remission hyposmolality and/or hyponatremia acute respiratory failure portal hypertension unspecified septicemia urinary tract infection, site not specified asthma, unspecified type, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, staphylococcus, unspecified other and unspecified escherichia coli [e. coli] other digestive system complications acute kidney failure, unspecified disorders of phosphorus metabolism attention deficit disorder with hyperactivity other specified disorders of biliary tract drug-induced delirium thrombocytopenia, unspecified bloodstream infection due to central venous catheter severe sepsis alcoholic cirrhosis of liver other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure septic shock acute posthemorrhagic anemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other sequelae of chronic liver disease end stage renal disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] depressive disorder, not elsewhere classified mixed acid-base balance disorder obstruction of bile duct ventilator associated pneumonia acquired coagulation factor deficiency acute kidney failure, unspecified other ascites disorders of phosphorus metabolism alcoholic cirrhosis of liver hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease asthma, unspecified type, unspecified end stage renal disease hepatorenal syndrome hypercalcemia
white f 54 $nan$nan$insulin  10  unit ; folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  2  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; ursodiol  300  mg ; docusate sodium  100  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; lorazepam  0.5  mg ; ondansetron  4  mg ; senna  1  tab ; 0.9% sodium chloride  50  ml ; daptomycin  400  mg ; salmeterol xinafoate diskus (50 mcg)  1  inh ; hydromorphone (dilaudid)  2-4  mg ; transplant self medication program  1  bag ; bupropion (sustained release)  150  mg ; metoprolol tartrate  12.5  mg ; prednisone  7.5  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; tacrolimus  1  mg ; magnesium oxide  800  mg ; bag  50  ml ; magnesium sulfate  2  gm ; 
other specified noninflammatory disorders of vagina other ascites herpetic gingivostomatitis hepatorenal syndrome iron deficiency anemia secondary to blood loss (chronic) chronic hepatitis c with hepatic coma toxic encephalopathy infection with microorganisms without mention of resistance to multiple drugs other and unspecified alcohol dependence, in remission hyposmolality and/or hyponatremia acute respiratory failure portal hypertension unspecified septicemia urinary tract infection, site not specified asthma, unspecified type, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, staphylococcus, unspecified other and unspecified escherichia coli [e. coli] other digestive system complications acute kidney failure, unspecified disorders of phosphorus metabolism attention deficit disorder with hyperactivity other specified disorders of biliary tract drug-induced delirium thrombocytopenia, unspecified bloodstream infection due to central venous catheter severe sepsis alcoholic cirrhosis of liver other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure septic shock acute posthemorrhagic anemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other sequelae of chronic liver disease end stage renal disease streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] depressive disorder, not elsewhere classified mixed acid-base balance disorder obstruction of bile duct ventilator associated pneumonia acquired coagulation factor deficiency acute kidney failure, unspecified other ascites disorders of phosphorus metabolism alcoholic cirrhosis of liver hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease asthma, unspecified type, unspecified end stage renal disease hepatorenal syndrome hypercalcemia
black african american m 66 $temp  97.8  heartrate  100.0  resprate  16.0  o2sat  97.0  sbp  116.0  dbp  78.0  rhythm    pain    $nan$sodium chloride 0.9%  flush  3-10  ml ; lidocaine jelly 2% (glydo)  1  appl ; oxycodone (immediate release)  5  mg ; acetaminophen  500  mg ; nystatin oral suspension  5  ml ; tiotropium bromide  1  cap ; sucralfate  1  gm ; prochlorperazine  10  mg ; pantoprazole  40  mg ; metoprolol succinate xl  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; guaifenesin er  600  mg ; dexamethasone  4  mg ; atorvastatin  40  mg ; aspirin  81  mg ; albuterol 0.083% neb soln  1  neb ; acetylcysteine 20%  6-10  ml ; insulin  0  unit ; sodium chloride 0.9%  1000  ml ; senna  8.6  mg ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; adenosine  6  mg ; insulin  15  unit ; 
 
black african american m 66 $nan$hematology blood hematocrit  31.7  %; hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.5  g dl; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  254  k ul; hematology blood platelet count  257  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  310  mg dl; chemistry blood albumin  2.4  g dl$sodium chloride 0.9%  flush  3-10  ml ; lidocaine jelly 2% (glydo)  1  appl ; oxycodone (immediate release)  5  mg ; acetaminophen  500  mg ; nystatin oral suspension  5  ml ; tiotropium bromide  1  cap ; sucralfate  1  gm ; prochlorperazine  10  mg ; pantoprazole  40  mg ; metoprolol succinate xl  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; guaifenesin er  600  mg ; dexamethasone  4  mg ; atorvastatin  40  mg ; aspirin  81  mg ; albuterol 0.083% neb soln  1  neb ; acetylcysteine 20%  6-10  ml ; insulin  0  unit ; sodium chloride 0.9%  1000  ml ; senna  8.6  mg ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; adenosine  6  mg ; insulin  15  unit ; 
 
black african american m 66 $nan$hematology blood hematocrit  27.8  %; hematology blood hematocrit  23.5  %; hematology blood hematocrit  25.6  %; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  224  k ul; hematology blood platelet count  122  k ul; hematology blood platelet count  132  k ul; chemistry blood anion gap  6  meq l; chemistry blood anion gap  8  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.0  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  311  mg dl; chemistry blood glucose  293  mg dl; chemistry blood glucose  299  mg dl; chemistry blood albumin  2.3  g dl; blood gas blood free calcium  1.04  mmol l; blood gas blood free calcium  1.06  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood chloride, whole blood  106  meq l; blood gas blood glucose  245  mg dl; blood gas blood hematocrit, calculated  23  %; blood gas blood hematocrit, calculated  27  %; blood gas blood hemoglobin  7.7  g dl; blood gas blood hemoglobin  9.1  g dl; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood sodium, whole blood  132  meq l$sodium chloride 0.9%  flush  3-10  ml ; oxycodone (immediate release)  5  mg ; acetaminophen  500  mg ; nystatin oral suspension  5  ml ; tiotropium bromide  1  cap ; sucralfate  1  gm ; prochlorperazine  10  mg ; pantoprazole  40  mg ; metoprolol succinate xl  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; guaifenesin er  600  mg ; dexamethasone  4  mg ; atorvastatin  40  mg ; albuterol 0.083% neb soln  1  neb ; acetylcysteine 20%  6-10  ml ; insulin  0  unit ; senna  8.6  mg ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; insulin  15  unit ; thiamine  100  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; 0.9% sodium chloride  500  ml ; sodium phosphate  30  mmol ; 
 
black african american m 66 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  103  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  2.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood glucose  72  mg dl; blood gas blood lactate  1.6  mmol l; blood gas blood hematocrit, calculated  32  %; blood gas blood hemoglobin  10.5  g dl$sodium chloride 0.9%  flush  3-10  ml ; oxycodone (immediate release)  5  mg ; acetaminophen  500  mg ; nystatin oral suspension  5  ml ; tiotropium bromide  1  cap ; sucralfate  1  gm ; prochlorperazine  10  mg ; pantoprazole  40  mg ; metoprolol succinate xl  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; guaifenesin er  600  mg ; dexamethasone  4  mg ; atorvastatin  40  mg ; albuterol 0.083% neb soln  1  neb ; acetylcysteine 20%  6-10  ml ; insulin  0  unit ; senna  8.6  mg ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; insulin  15  unit ; thiamine  100  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; 0.9% sodium chloride  500  ml ; sodium phosphate  30  mmol ; 0.9% sodium chloride  100  ml ; dexmedetomidine  0.4  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; metoprolol tartrate  5  mg ; yellow cadd cassette  1  cadd ; bupivacaine 0.1%  250  ml ; ondansetron  4  mg ; calcium gluconate sliding scale (critical care-ionized calcium)  0  g ; calcium gluconate  2  g ; calcium gluconate  4  g ; fentanyl citrate  25-100  mcg ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1000  ml ; 
 
black african american m 66 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500  mg ; nystatin oral suspension  5  ml ; tiotropium bromide  1  cap ; sucralfate  1  gm ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; guaifenesin er  600  mg ; atorvastatin  40  mg ; albuterol 0.083% neb soln  1  neb ; acetylcysteine 20%  6-10  ml ; insulin  0  unit ; senna  8.6  mg ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; insulin  15  unit ; thiamine  100  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; metoprolol tartrate  5  mg ; yellow cadd cassette  1  cadd ; bupivacaine 0.1%  250  ml ; ondansetron  4  mg ; calcium gluconate sliding scale (critical care-ionized calcium)  0  g ; calcium gluconate  2  g ; calcium gluconate  4  g ; fentanyl citrate  25-100  mcg ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1000  ml ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; heparin  5000  unit ; ipratropium-albuterol neb  1  neb ; 
 
black african american m 66 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500  mg ; nystatin oral suspension  5  ml ; tiotropium bromide  1  cap ; sucralfate  1  gm ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; guaifenesin er  600  mg ; atorvastatin  40  mg ; albuterol 0.083% neb soln  1  neb ; acetylcysteine 20%  6-10  ml ; insulin  0  unit ; senna  8.6  mg ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; insulin  15  unit ; thiamine  100  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; metoprolol tartrate  5  mg ; ondansetron  4  mg ; heparin  5000  unit ; ipratropium-albuterol neb  1  neb ; gabapentin  300  mg ; morphine sulfate  1-2  mg ; 
 
black african american m 66 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500  mg ; nystatin oral suspension  5  ml ; tiotropium bromide  1  cap ; sucralfate  1  gm ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; guaifenesin er  600  mg ; albuterol 0.083% neb soln  1  neb ; acetylcysteine 20%  6-10  ml ; insulin  0  unit ; senna  8.6  mg ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; insulin  15  unit ; polyethylene glycol  17  g ; ondansetron  4  mg ; ipratropium-albuterol neb  1  neb ; gabapentin  300  mg ; morphine sulfate  1-2  mg ; 
 
black african american m 66 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500  mg ; nystatin oral suspension  5  ml ; tiotropium bromide  1  cap ; sucralfate  1  gm ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; guaifenesin er  600  mg ; albuterol 0.083% neb soln  1  neb ; acetylcysteine 20%  6-10  ml ; insulin  0  unit ; senna  8.6  mg ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; insulin  15  unit ; polyethylene glycol  17  g ; ondansetron  4  mg ; ipratropium-albuterol neb  1  neb ; gabapentin  300  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; 
 
black african american m 66 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500  mg ; nystatin oral suspension  5  ml ; tiotropium bromide  1  cap ; sucralfate  1  gm ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; guaifenesin er  600  mg ; albuterol 0.083% neb soln  1  neb ; acetylcysteine 20%  6-10  ml ; insulin  0  unit ; senna  8.6  mg ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; insulin  15  unit ; polyethylene glycol  17  g ; ipratropium-albuterol neb  1  neb ; gabapentin  300  mg ; oxycodone (immediate release)  5-10  mg ; 
 
black african american m 66 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500  mg ; nystatin oral suspension  5  ml ; tiotropium bromide  1  cap ; sucralfate  1  gm ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; guaifenesin er  600  mg ; albuterol 0.083% neb soln  1  neb ; acetylcysteine 20%  6-10  ml ; insulin  0  unit ; senna  8.6  mg ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; insulin  15  unit ; polyethylene glycol  17  g ; ipratropium-albuterol neb  1  neb ; gabapentin  300  mg ; oxycodone (immediate release)  5-10  mg ; 
 
black african american m 66 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500  mg ; tiotropium bromide  1  cap ; sucralfate  1  gm ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; guaifenesin er  600  mg ; albuterol 0.083% neb soln  1  neb ; acetylcysteine 20%  6-10  ml ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; ipratropium-albuterol neb  1  neb ; gabapentin  300  mg ; oxycodone (immediate release)  5-10  mg ; insulin  10  unit ; 
 
white f 47 $nan$nan$fluoxetine  40  mg ; omeprazole  20  mg ; clopidogrel  75  mg ; aspirin  81  mg ; 
atherosclerosis of aorta anxiety state, unspecified routine general medical examination at a health care facility driver of bus injured in collision with pedestrian or animal in nontraffic accident malignant essential hypertension depressive disorder, not elsewhere classified tobacco use disorder dissection of aorta, thoracoabdominal regional enteritis of unspecified site other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of native arteries of the extremities with intermittent claudication vascular complications of other vessels hematoma complicating a procedure regional enteritis of small intestine with large intestine unspecified essential hypertension thrombocytopenia, unspecified esophageal reflux reaction to spinal or lumbar puncture tobacco use disorder insomnia, unspecified other acquired absence of organ anemia of other chronic disease anxiety state, unspecified dissection of aorta, thoracic person on outside of bus injured in collision with pedestrian or animal in traffic accident depressive disorder, not elsewhere classified examination of participant in clinical trial other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
white f 47 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  92  mg dl$fluoxetine  40  mg ; omeprazole  20  mg ; clopidogrel  75  mg ; aspirin  81  mg ; labetalol  100  mg ; mesalamine  800  mg ; sodium chloride 0.9%  flush  3  ml ; alprazolam  0.5  mg ; trazodone  25  mg ; 0.45% sodium chloride  1000  ml ; mercaptopurine  50  mg ; acetaminophen  500-1000  mg ; 
atherosclerosis of aorta anxiety state, unspecified routine general medical examination at a health care facility driver of bus injured in collision with pedestrian or animal in nontraffic accident malignant essential hypertension depressive disorder, not elsewhere classified tobacco use disorder dissection of aorta, thoracoabdominal regional enteritis of unspecified site other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of native arteries of the extremities with intermittent claudication vascular complications of other vessels hematoma complicating a procedure regional enteritis of small intestine with large intestine unspecified essential hypertension thrombocytopenia, unspecified esophageal reflux reaction to spinal or lumbar puncture tobacco use disorder insomnia, unspecified other acquired absence of organ anemia of other chronic disease anxiety state, unspecified dissection of aorta, thoracic person on outside of bus injured in collision with pedestrian or animal in traffic accident depressive disorder, not elsewhere classified examination of participant in clinical trial other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation
white f 33 $temp  98.3  heartrate  88.0  resprate  18.0  o2sat  99.0  sbp  107.0  dbp  88.0  rhythm    pain  0  $hematology blood hematocrit  42.3  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  264  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; hematology urine wbc  36  # hpf; chemistry blood glucose  93  mg dl$nan
 
white m 81 $temp  98.1  heartrate  78.0  resprate  14.0  o2sat  99.0  sbp  177.0  dbp  78.0  rhythm    pain  7  $hematology blood hematocrit  37.3  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  1000  ml ; lidocaine 5% patch  1  ptch ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; acetaminophen  650  mg ; lisinopril  40  mg ; labetalol  400  mg ; isosorbide mononitrate (extended release)  120  mg ; apixaban  2.5  mg ; labetalol  200  mg ; lisinopril  20  mg ; furosemide  40  mg ; acetaminophen  1000  mg ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; simvastatin  40  mg ; gabapentin  100  mg ; 
chronic kidney disease, stage 3 (moderate) personal history of nicotine dependence patient's other noncompliance with medication regimen anxiety disorder, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hyperlipidemia, unspecified acute on chronic diastolic (congestive) heart failure unspecified atrial flutter other acute pain malignant neoplasm of prostate displacement of lumbar intervertebral disc without myelopathy unspecified essential hypertension
white m 87 $nan$hematology blood hematocrit  27.2  %; hematology blood hematocrit  28.1  %; hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.6  g dl; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  144  k ul; hematology blood platelet count  120  k ul; hematology blood platelet count  135  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.5  ; chemistry blood glucose  97  mg dl; blood gas blood free calcium  1.16  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  2.7  mmol l; blood gas blood chloride, whole blood  101  meq l; blood gas blood chloride, whole blood  104  meq l; blood gas blood glucose  114  mg dl; blood gas blood glucose  158  mg dl; blood gas blood glucose  136  mg dl; blood gas blood glucose  132  mg dl; blood gas blood glucose  126  mg dl; blood gas blood glucose  138  mg dl; blood gas blood glucose  108  mg dl; blood gas blood hematocrit, calculated  35  %; blood gas blood hematocrit, calculated  25  %; blood gas blood hematocrit, calculated  23  %; blood gas blood hematocrit, calculated  25  %; blood gas blood hemoglobin  11.6  g dl; blood gas blood hemoglobin  8.3  g dl; blood gas blood hemoglobin  7.8  g dl; blood gas blood hemoglobin  8.3  g dl; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  5.8  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  5.1  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  6.1  meq l; blood gas blood sodium, whole blood  137  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood sodium, whole blood  136  meq l$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; 5% dextrose  250  ml ; propofol  1000  mg ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sw  50  ml ; potassium chloride  20  meq ; calcium gluconate  2  g ; magnesium sulfate  2  gm ; meperidine  12.5  mg ; morphine sulfate  0.5-5.0  mg ; metoclopramide  10  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  650  mg ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; milk of magnesia  30  ml ; hydromorphone (dilaudid)  0.5  mg ; amiodarone  150  mg ; d5w (excel bag)  250  ml ; amiodarone  600  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ranitidine  150  mg ; docusate sodium  100  mg ; docusate sodium (liquid)  100  mg ; simvastatin  20  mg ; tramadol (ultram)  50  mg ; 
 
white m 87 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  101  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood glucose  127  mg dl$sodium chloride 0.9%  flush  3  ml ; 5% dextrose  250  ml ; propofol  1000  mg ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sw  50  ml ; potassium chloride  20  meq ; calcium gluconate  2  g ; magnesium sulfate  2  gm ; meperidine  12.5  mg ; morphine sulfate  0.5-5.0  mg ; metoclopramide  10  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  650  mg ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; milk of magnesia  30  ml ; hydromorphone (dilaudid)  0.5  mg ; amiodarone  150  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ranitidine  150  mg ; docusate sodium  100  mg ; docusate sodium (liquid)  100  mg ; simvastatin  20  mg ; tramadol (ultram)  50  mg ; metoprolol tartrate  25  mg ; fentanyl citrate  25-50  mcg ; aspirin ec  81  mg ; aspirin  81  mg ; ketorolac  15  mg ; metoprolol tartrate  2.5  mg ; sw  100  ml ; magnesium sulfate  4  gm ; 
 
white m 87 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  111  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  34  mg dl; hematology urine wbc  0-2  # hpf; chemistry blood glucose  162  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  3  ml ; 5% dextrose  250  ml ; sw  50  ml ; potassium chloride  20  meq ; calcium gluconate  2  g ; magnesium sulfate  2  gm ; metoclopramide  10  mg ; acetaminophen  650  mg ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; milk of magnesia  30  ml ; ranitidine  150  mg ; docusate sodium  100  mg ; simvastatin  20  mg ; metoprolol tartrate  25  mg ; aspirin ec  81  mg ; metoprolol tartrate  2.5  mg ; furosemide  20  mg ; mirapex  0.25  mg ; bisacodyl  10  mg ; insulin  0  unit ; 
 
white m 87 $nan$hematology blood hematocrit  25.9  %; hematology blood hematocrit  25.0  %; chemistry blood creatinine  1.1  mg dl; chemistry blood urea nitrogen  33  mg dl$mirapex  0.25  mg ; bisacodyl  10  mg ; insulin  0  unit ; insulin  10  unit ; 
 
white m 87 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood glucose  123  mg dl$mirapex  0.25  mg ; bisacodyl  10  mg ; insulin  0  unit ; insulin  10  unit ; furosemide  40  mg ; metoprolol tartrate  37.5  mg ; 
 
white m 87 $nan$nan$mirapex  0.25  mg ; bisacodyl  10  mg ; insulin  0  unit ; furosemide  40  mg ; metoprolol tartrate  37.5  mg ; metoprolol tartrate  50  mg ; 
 
white m 87 $nan$nan$mirapex  0.25  mg ; bisacodyl  10  mg ; insulin  0  unit ; metoprolol tartrate  50  mg ; ibuprofen  400  mg ; lisinopril  2.5  mg ; metoprolol tartrate  75  mg ; 
 
white f 53 $nan$hematology blood hematocrit  40.0  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  422  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  92  mg dl$nan
 
white f 53 $nan$nan$ns (mini bag plus)  100  ml ; ampicillin-sulbactam  3  gm ; lr  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; hydromorphone (dilaudid)  2-4  mg ; heparin  5000  unit ; docusate sodium  100  mg ; 
 
hispanic latino f 67 $nan$nan$insulin  30  unit ; 
nausea with vomiting obesity, unspecified long-term (current) use of insulin cellulitis and abscess of trunk leiomyoma of uterus, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic diastolic heart failure removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) asthma, unspecified type, unspecified congestive heart failure, unspecified arthropathy, unspecified, site unspecified esophageal reflux diarrhea other postoperative infection methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site unspecified essential hypertension asthma, unspecified type, unspecified removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation esophageal reflux congestive heart failure, unspecified chronic diastolic heart failure cellulitis and abscess of trunk coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b personal history of methicillin resistant staphylococcus aureus other postoperative infection obesity, unspecified chest pain, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
hispanic latino f 67 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  211  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  161  mg dl$insulin  30  unit ; valsartan  320  mg ; aspirin  81  mg ; diltiazem extended-release  120  mg ; d5 1 2ns  1000  ml ; 1 2 ns  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; albuterol inhaler  2  puff ; insulin  0  unit ; senna  1  tab ; morphine sulfate  2-4  mg ; heparin  5000  unit ; acetylcysteine 20%  1200  mg ; metoprolol tartrate  50  mg ; docusate sodium  100  mg ; lorazepam  0.5-1  mg ; 
nausea with vomiting obesity, unspecified long-term (current) use of insulin cellulitis and abscess of trunk leiomyoma of uterus, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic diastolic heart failure removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) asthma, unspecified type, unspecified congestive heart failure, unspecified arthropathy, unspecified, site unspecified esophageal reflux diarrhea other postoperative infection methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site unspecified essential hypertension asthma, unspecified type, unspecified removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation esophageal reflux congestive heart failure, unspecified chronic diastolic heart failure cellulitis and abscess of trunk coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b personal history of methicillin resistant staphylococcus aureus other postoperative infection obesity, unspecified chest pain, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
hispanic latino f 67 $nan$hematology blood inr(pt)  1.0  $insulin  30  unit ; aspirin  81  mg ; diltiazem extended-release  120  mg ; 1 2 ns  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; albuterol inhaler  2  puff ; insulin  0  unit ; senna  1  tab ; morphine sulfate  2-4  mg ; heparin  5000  unit ; acetylcysteine 20%  1200  mg ; metoprolol tartrate  50  mg ; docusate sodium  100  mg ; lorazepam  0.5-1  mg ; acetaminophen  1000  mg ; 
nausea with vomiting obesity, unspecified long-term (current) use of insulin cellulitis and abscess of trunk leiomyoma of uterus, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic diastolic heart failure removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) asthma, unspecified type, unspecified congestive heart failure, unspecified arthropathy, unspecified, site unspecified esophageal reflux diarrhea other postoperative infection methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site unspecified essential hypertension asthma, unspecified type, unspecified removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation esophageal reflux congestive heart failure, unspecified chronic diastolic heart failure cellulitis and abscess of trunk coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b personal history of methicillin resistant staphylococcus aureus other postoperative infection obesity, unspecified chest pain, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
hispanic latino f 67 $nan$hematology blood hematocrit  30.0  %; hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  231  k ul; hematology blood platelet count  223  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  192  mg dl; chemistry blood glucose  181  mg dl$insulin  30  unit ; aspirin  81  mg ; diltiazem extended-release  120  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; albuterol inhaler  2  puff ; insulin  0  unit ; senna  1  tab ; morphine sulfate  2-4  mg ; heparin  5000  unit ; metoprolol tartrate  50  mg ; docusate sodium  100  mg ; acetaminophen  1000  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ondansetron  4  mg ; insulin  64  unit ; 
nausea with vomiting obesity, unspecified long-term (current) use of insulin cellulitis and abscess of trunk leiomyoma of uterus, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic diastolic heart failure removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) asthma, unspecified type, unspecified congestive heart failure, unspecified arthropathy, unspecified, site unspecified esophageal reflux diarrhea other postoperative infection methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site unspecified essential hypertension asthma, unspecified type, unspecified removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation esophageal reflux congestive heart failure, unspecified chronic diastolic heart failure cellulitis and abscess of trunk coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b personal history of methicillin resistant staphylococcus aureus other postoperative infection obesity, unspecified chest pain, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
hispanic latino f 67 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  122  mg dl$insulin  30  unit ; aspirin  81  mg ; diltiazem extended-release  120  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; albuterol inhaler  2  puff ; insulin  0  unit ; senna  1  tab ; morphine sulfate  2-4  mg ; heparin  5000  unit ; metoprolol tartrate  50  mg ; docusate sodium  100  mg ; acetaminophen  1000  mg ; ondansetron  4  mg ; insulin  64  unit ; 
nausea with vomiting obesity, unspecified long-term (current) use of insulin cellulitis and abscess of trunk leiomyoma of uterus, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic diastolic heart failure removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) asthma, unspecified type, unspecified congestive heart failure, unspecified arthropathy, unspecified, site unspecified esophageal reflux diarrhea other postoperative infection methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site unspecified essential hypertension asthma, unspecified type, unspecified removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation esophageal reflux congestive heart failure, unspecified chronic diastolic heart failure cellulitis and abscess of trunk coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b personal history of methicillin resistant staphylococcus aureus other postoperative infection obesity, unspecified chest pain, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
hispanic latino f 67 $nan$nan$aspirin  81  mg ; diltiazem extended-release  120  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; albuterol inhaler  2  puff ; morphine sulfate  2-4  mg ; heparin  5000  unit ; metoprolol tartrate  50  mg ; acetaminophen  1000  mg ; ondansetron  4  mg ; insulin  64  unit ; 
nausea with vomiting obesity, unspecified long-term (current) use of insulin cellulitis and abscess of trunk leiomyoma of uterus, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic diastolic heart failure removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) asthma, unspecified type, unspecified congestive heart failure, unspecified arthropathy, unspecified, site unspecified esophageal reflux diarrhea other postoperative infection methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site unspecified essential hypertension asthma, unspecified type, unspecified removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation esophageal reflux congestive heart failure, unspecified chronic diastolic heart failure cellulitis and abscess of trunk coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b personal history of methicillin resistant staphylococcus aureus other postoperative infection obesity, unspecified chest pain, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white f 86 $nan$nan$0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; atorvastatin  10  mg ; diltiazem extended-release  120  mg ; isosorbide mononitrate (extended release)  30  mg ; levothyroxine sodium  75  mcg ; polyethylene glycol  17  g ; aspirin  81  mg ; multivitamins  1  tab ; senna  1  tab ; 
other constipation old myocardial infarction coronary atherosclerosis of native coronary artery hyposmolality and/or hyponatremia epilepsy, unspecified, without mention of intractable epilepsy diabetes mellitus without mention of complication, type i [juvenile type], not stated as uncontrolled osteoporosis, unspecified unspecified acquired hypothyroidism
white f 86 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  154  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  32  mg dl$0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; atorvastatin  10  mg ; diltiazem extended-release  120  mg ; isosorbide mononitrate (extended release)  30  mg ; levothyroxine sodium  75  mcg ; polyethylene glycol  17  g ; aspirin  81  mg ; multivitamins  1  tab ; senna  1  tab ; omeprazole  20  mg ; calcium carbonate  500  mg ; heparin  5000  unit ; 0.45% sodium chloride  1000  ml ; insulin  7  unit ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; trazodone  25  mg ; 
other constipation old myocardial infarction coronary atherosclerosis of native coronary artery hyposmolality and/or hyponatremia epilepsy, unspecified, without mention of intractable epilepsy diabetes mellitus without mention of complication, type i [juvenile type], not stated as uncontrolled osteoporosis, unspecified unspecified acquired hypothyroidism
hispanic latino f 61 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  96  mg dl$senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; levofloxacin  500  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; atenolol  25  mg ; hydrochlorothiazide  12.5  mg ; nifedipine cr  60  mg ; 
congestive heart failure, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site chronic osteomyelitis, lower leg ulcer of ankle late effect of injury due to war operations malignant hypertensive heart disease with heart failure chronic diastolic heart failure acute osteomyelitis, lower leg late effect of unspecified injury 
hispanic latino f 61 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  97  mg dl$senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; levofloxacin  500  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; atenolol  25  mg ; hydrochlorothiazide  12.5  mg ; nifedipine cr  60  mg ; potassium chloride  40  meq ; captopril  6.25  mg ; captopril  12.5  mg ; 
congestive heart failure, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site chronic osteomyelitis, lower leg ulcer of ankle late effect of injury due to war operations malignant hypertensive heart disease with heart failure chronic diastolic heart failure acute osteomyelitis, lower leg late effect of unspecified injury 
hispanic latino f 61 $nan$nan$senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; levofloxacin  500  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; atenolol  25  mg ; hydrochlorothiazide  12.5  mg ; potassium chloride  40  meq ; captopril  12.5  mg ; amoxicillin  500  mg ; lisinopril  10  mg ; 
congestive heart failure, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site chronic osteomyelitis, lower leg ulcer of ankle late effect of injury due to war operations malignant hypertensive heart disease with heart failure chronic diastolic heart failure acute osteomyelitis, lower leg late effect of unspecified injury 
white f 78 $nan$nan$clopidogrel  75  mg ; acetaminophen  650  mg ; 
unspecified essential hypertension chronic systolic heart failure tobacco use disorder old myocardial infarction personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other restorative surgery causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other and unspecified hyperlipidemia subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery other complications due to other cardiac device, implant, and graft congestive heart failure, unspecified paroxysmal ventricular tachycardia atrial fibrillation
white f 78 $nan$hematology blood hematocrit  33.3  %; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl$clopidogrel  75  mg ; acetaminophen  650  mg ; influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  1000  ml ; warfarin  2  mg ; heparin  5000  unit ; amlodipine  5  mg ; fluoxetine  60  mg ; metoprolol tartrate  12.5  mg ; pravastatin  20  mg ; 
unspecified essential hypertension chronic systolic heart failure tobacco use disorder old myocardial infarction personal history of malignant neoplasm of breast person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other restorative surgery causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other and unspecified hyperlipidemia subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery other complications due to other cardiac device, implant, and graft congestive heart failure, unspecified paroxysmal ventricular tachycardia atrial fibrillation
white m 53 $nan$nan$sodium chloride 0.9%  flush  3  ml ; atenolol  50  mg ; gabapentin  300  mg ; tramadol (ultram)  50  mg ; acetaminophen  500  mg ; enoxaparin sodium  100  mg ; allopurinol  150  mg ; hydrochlorothiazide  25  mg ; omeprazole  20  mg ; valsartan  40  mg ; cyanocobalamin  1000  mcg ; 
other and unspecified nonspecific immunological findings other b-complex deficiencies sickle-cell trait migraine, unspecified, without mention of intractable migraine without mention of status migrainosus chronic kidney disease, stage iii (moderate) calculus of kidney acute kidney failure, unspecified idiopathic pulmonary hemosiderosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified asthma, unspecified type, unspecified thrombocytopenia, unspecified disorders of iron metabolism other specified urticaria temporomandibular joint disorders, unspecified acute venous embolism and thrombosis of deep vessels of proximal lower extremity long-term (current) use of anticoagulants
white f 34 $nan$hematology blood hematocrit  37.7  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  290  k ul$influenza vaccine quadrivalent  0.5  ml ; lactated ringers  1000  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; 
post-term pregnancy abnormality in fetal heart rate and rhythm complicating labor and delivery single live birth 40 weeks gestation of pregnancy streptococcus b carrier state complicating childbirth full-term premature rupture of membranes, unspecified as to length of time between rupture and onset of labor
white f 34 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; lactated ringers  1000  ml ; dermoplast spray  1  spry ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; 
post-term pregnancy abnormality in fetal heart rate and rhythm complicating labor and delivery single live birth 40 weeks gestation of pregnancy streptococcus b carrier state complicating childbirth full-term premature rupture of membranes, unspecified as to length of time between rupture and onset of labor
white f 34 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; lactated ringers  1000  ml ; dermoplast spray  1  spry ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; 
post-term pregnancy abnormality in fetal heart rate and rhythm complicating labor and delivery single live birth 40 weeks gestation of pregnancy streptococcus b carrier state complicating childbirth full-term premature rupture of membranes, unspecified as to length of time between rupture and onset of labor
white f 34 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; lactated ringers  1000  ml ; dermoplast spray  1  spry ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; 
post-term pregnancy abnormality in fetal heart rate and rhythm complicating labor and delivery single live birth 40 weeks gestation of pregnancy streptococcus b carrier state complicating childbirth full-term premature rupture of membranes, unspecified as to length of time between rupture and onset of labor
white f 70 $nan$nan$prednisone  5  mg ; 
escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of venous thrombosis and embolism urinary tract infection, site not specified personal history of malignant neoplasm of other gastrointestinal tract regional enteritis of unspecified site candidiasis of other urogenital sites coronary atherosclerosis of unspecified type of vessel, native or graft gross hematuria personal history of malignant neoplasm of bronchus and lung aortocoronary bypass status postsurgical hypoinsulinemia regional enteritis of unspecified site other pulmonary embolism and infarction personal history of malignant neoplasm of other gastrointestinal tract osteoporosis, unspecified secondary malignant neoplasm of lung syncope and collapse diverticulosis of colon (without mention of hemorrhage) pathologic fracture of vertebrae percutaneous transluminal coronary angioplasty status urinary tract infection, site not specified insulins and antidiabetic agents causing adverse effects in therapeutic use anemia, unspecified regional enteritis of unspecified site personal history of malignant neoplasm of other gastrointestinal tract diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery diaphragmatic hernia without mention of obstruction or gangrene anemia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other pulmonary embolism and infarction empyema without mention of fistula other specified bacterial infections in conditions classified elsewhere and of unspecified site, other specified bacteria hematuria, unspecified secondary malignant neoplasm of lung personal history of malignant neoplasm of other gastrointestinal tract streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute cystitis regional enteritis of unspecified site coronary atherosclerosis of native coronary artery constipation, unspecified tobacco use disorder other malignant neoplasm without specification of site regional enteritis of unspecified site long-term (current) use of steroids diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 70 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  328  k ul$prednisone  5  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; mesalamine dr  800  mg ; bupropion  75  mg ; creon 10  2  cap ; acetaminophen  650  mg ; ondansetron  4  mg ; insulin  0  unit ; insulin  9  unit ; 
escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of venous thrombosis and embolism urinary tract infection, site not specified personal history of malignant neoplasm of other gastrointestinal tract regional enteritis of unspecified site candidiasis of other urogenital sites coronary atherosclerosis of unspecified type of vessel, native or graft gross hematuria personal history of malignant neoplasm of bronchus and lung aortocoronary bypass status postsurgical hypoinsulinemia regional enteritis of unspecified site other pulmonary embolism and infarction personal history of malignant neoplasm of other gastrointestinal tract osteoporosis, unspecified secondary malignant neoplasm of lung syncope and collapse diverticulosis of colon (without mention of hemorrhage) pathologic fracture of vertebrae percutaneous transluminal coronary angioplasty status urinary tract infection, site not specified insulins and antidiabetic agents causing adverse effects in therapeutic use anemia, unspecified regional enteritis of unspecified site personal history of malignant neoplasm of other gastrointestinal tract diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery diaphragmatic hernia without mention of obstruction or gangrene anemia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other pulmonary embolism and infarction empyema without mention of fistula other specified bacterial infections in conditions classified elsewhere and of unspecified site, other specified bacteria hematuria, unspecified secondary malignant neoplasm of lung personal history of malignant neoplasm of other gastrointestinal tract streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute cystitis regional enteritis of unspecified site coronary atherosclerosis of native coronary artery constipation, unspecified tobacco use disorder other malignant neoplasm without specification of site regional enteritis of unspecified site long-term (current) use of steroids diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 70 $nan$nan$prednisone  5  mg ; sodium chloride 0.9%  flush  3  ml ; mesalamine dr  800  mg ; bupropion  75  mg ; creon 10  2  cap ; acetaminophen  650  mg ; ondansetron  4  mg ; insulin  0  unit ; insulin  9  unit ; 
escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of venous thrombosis and embolism urinary tract infection, site not specified personal history of malignant neoplasm of other gastrointestinal tract regional enteritis of unspecified site candidiasis of other urogenital sites coronary atherosclerosis of unspecified type of vessel, native or graft gross hematuria personal history of malignant neoplasm of bronchus and lung aortocoronary bypass status postsurgical hypoinsulinemia regional enteritis of unspecified site other pulmonary embolism and infarction personal history of malignant neoplasm of other gastrointestinal tract osteoporosis, unspecified secondary malignant neoplasm of lung syncope and collapse diverticulosis of colon (without mention of hemorrhage) pathologic fracture of vertebrae percutaneous transluminal coronary angioplasty status urinary tract infection, site not specified insulins and antidiabetic agents causing adverse effects in therapeutic use anemia, unspecified regional enteritis of unspecified site personal history of malignant neoplasm of other gastrointestinal tract diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery diaphragmatic hernia without mention of obstruction or gangrene anemia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other pulmonary embolism and infarction empyema without mention of fistula other specified bacterial infections in conditions classified elsewhere and of unspecified site, other specified bacteria hematuria, unspecified secondary malignant neoplasm of lung personal history of malignant neoplasm of other gastrointestinal tract streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] acute cystitis regional enteritis of unspecified site coronary atherosclerosis of native coronary artery constipation, unspecified tobacco use disorder other malignant neoplasm without specification of site regional enteritis of unspecified site long-term (current) use of steroids diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 77 $temp    heartrate  78.0  resprate  17.0  o2sat  95.0  sbp  107.0  dbp  38.0  rhythm    pain  asleep  $nan$enoxaparin sodium  40  mg ; influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; morphine sulfate  1  mg ; oxycodone (immediate release)   5  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; amlodipine  5  mg ; atenolol  25  mg ; fluticasone propionate 110mcg  4  puff ; furosemide  20  mg ; gabapentin  100  mg ; lorazepam  0.5  mg ; omeprazole  40  mg ; pravastatin  20  mg ; morphine sulfate  5  mg ; morphine sulfate  1-2  mg ; sodium chloride 0.9%  1000  ml ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; docusate sodium  100  mg ; senna  8.6  mg ; hydromorphone (dilaudid)  0.12  mg ; albuterol 0.083% neb soln  1  neb ; 
 
white f 77 $nan$hematology blood hematocrit  30.1  %; hematology blood hematocrit  26.6  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  119  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  93  mg dl$enoxaparin sodium  40  mg ; influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; bisacodyl  10  mg ; amlodipine  5  mg ; atenolol  25  mg ; fluticasone propionate 110mcg  4  puff ; furosemide  20  mg ; lorazepam  0.5  mg ; omeprazole  40  mg ; pravastatin  20  mg ; morphine sulfate  1-2  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; albuterol 0.083% neb soln  1  neb ; gabapentin  300  mg ; 
 
white f 77 $nan$nan$enoxaparin sodium  40  mg ; influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; bisacodyl  10  mg ; amlodipine  5  mg ; atenolol  25  mg ; fluticasone propionate 110mcg  4  puff ; furosemide  20  mg ; lorazepam  0.5  mg ; omeprazole  40  mg ; pravastatin  20  mg ; morphine sulfate  1-2  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; albuterol 0.083% neb soln  1  neb ; gabapentin  300  mg ; timolol maleate 0.5%  1  drop ; 
 
white f 77 $nan$hematology blood hematocrit  25.8  %$enoxaparin sodium  40  mg ; influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; bisacodyl  10  mg ; amlodipine  5  mg ; atenolol  25  mg ; fluticasone propionate 110mcg  4  puff ; furosemide  20  mg ; lorazepam  0.5  mg ; omeprazole  40  mg ; pravastatin  20  mg ; morphine sulfate  1-2  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  8.6  mg ; albuterol 0.083% neb soln  1  neb ; gabapentin  300  mg ; 
 
white f 72 $nan$chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  145  mg dl$bupropion (sustained release)  300  mg ; amlodipine  2.5  mg ; aripiprazole  30  mg ; clonazepam  1  mg ; omeprazole  20  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; hydrocortisone na succ.  100  mg ; albuterol 0.083% neb soln  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; artificial tears  1-2  drop ; atenolol  100  mg ; duloxetine  30  mg ; gabapentin  600  mg ; glipizide  5  mg ; metformin (glucophage)  1000  mg ; metoclopramide  10  mg ; prednisone  10  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; ropinirole  4  mg ; insulin  40  unit ; 
other specified metabolic disorders home accidents closed fracture of orbital floor (blow-out) unspecified fall ulcerative colitis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin bipolar disorder, unspecified pure hypercholesterolemia unspecified viral infection cervical spondylosis without myelopathy anxiety state, unspecified chronic airway obstruction, not elsewhere classified tobacco use disorder unspecified essential hypertension lumbosacral spondylosis without myelopathy headache 
white f 72 $nan$nan$bupropion (sustained release)  300  mg ; amlodipine  2.5  mg ; aripiprazole  30  mg ; clonazepam  1  mg ; omeprazole  20  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; hydrocortisone na succ.  100  mg ; albuterol 0.083% neb soln  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; artificial tears  1-2  drop ; atenolol  100  mg ; duloxetine  30  mg ; gabapentin  600  mg ; glipizide  5  mg ; metformin (glucophage)  1000  mg ; metoclopramide  10  mg ; prednisone  10  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; ropinirole  4  mg ; insulin  40  unit ; acetaminophen  650  mg ; oxycodone (immediate release)   5  mg ; enalapril maleate  20  mg ; 
other specified metabolic disorders home accidents closed fracture of orbital floor (blow-out) unspecified fall ulcerative colitis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin bipolar disorder, unspecified pure hypercholesterolemia unspecified viral infection cervical spondylosis without myelopathy anxiety state, unspecified chronic airway obstruction, not elsewhere classified tobacco use disorder unspecified essential hypertension lumbosacral spondylosis without myelopathy headache 
white f 72 $nan$nan$bupropion (sustained release)  300  mg ; amlodipine  2.5  mg ; aripiprazole  30  mg ; clonazepam  1  mg ; omeprazole  20  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; artificial tears  1-2  drop ; atenolol  100  mg ; duloxetine  30  mg ; gabapentin  600  mg ; glipizide  5  mg ; metformin (glucophage)  1000  mg ; metoclopramide  10  mg ; prednisone  10  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; ropinirole  4  mg ; insulin  40  unit ; acetaminophen  650  mg ; oxycodone (immediate release)   5  mg ; enalapril maleate  20  mg ; erythromycin 0.5% ophth oint  0.5  in ; insulin  56  unit ; hydralazine  10  mg ; 
other specified metabolic disorders home accidents closed fracture of orbital floor (blow-out) unspecified fall ulcerative colitis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin bipolar disorder, unspecified pure hypercholesterolemia unspecified viral infection cervical spondylosis without myelopathy anxiety state, unspecified chronic airway obstruction, not elsewhere classified tobacco use disorder unspecified essential hypertension lumbosacral spondylosis without myelopathy headache 
white f 72 $nan$nan$bupropion (sustained release)  300  mg ; amlodipine  2.5  mg ; aripiprazole  30  mg ; clonazepam  1  mg ; omeprazole  20  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; artificial tears  1-2  drop ; atenolol  100  mg ; duloxetine  30  mg ; gabapentin  600  mg ; glipizide  5  mg ; metformin (glucophage)  1000  mg ; metoclopramide  10  mg ; prednisone  10  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; ropinirole  4  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5  mg ; enalapril maleate  20  mg ; erythromycin 0.5% ophth oint  0.5  in ; insulin  56  unit ; hydralazine  10  mg ; clindamycin  450  mg ; 
other specified metabolic disorders home accidents closed fracture of orbital floor (blow-out) unspecified fall ulcerative colitis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin bipolar disorder, unspecified pure hypercholesterolemia unspecified viral infection cervical spondylosis without myelopathy anxiety state, unspecified chronic airway obstruction, not elsewhere classified tobacco use disorder unspecified essential hypertension lumbosacral spondylosis without myelopathy headache 
white f 64 $nan$nan$ranitidine  150  mg ; docusate sodium  100  mg ; 
 
white f 64 $nan$nan$ranitidine  150  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; oxycodone (immediate release)  5-10  mg ; artificial tears  1-2  drop ; lorazepam  0.5  mg ; lactated ringers  1000  ml ; hydralazine  25  mg ; clonidine  0.1  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; 
 
white f 78 $nan$nan$divalproex sod. sprinkles  125  mg ; modafinil  200  mg ; levofloxacin  750  mg ; digoxin  0.125  mg ; amantadine syrup  50  mg ; bisacodyl  10  mg ; citalopram hydrobromide  20  mg ; multivitamins  1  cap ; warfarin  4  mg ; 
 
white f 78 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  71  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  2.0  ; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  86  mg dl; chemistry blood glucose  90  mg dl$divalproex sod. sprinkles  125  mg ; modafinil  200  mg ; levofloxacin  750  mg ; digoxin  0.125  mg ; amantadine syrup  50  mg ; bisacodyl  10  mg ; citalopram hydrobromide  20  mg ; multivitamins  1  cap ; warfarin  4  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ns  1000  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; metronidazole (flagyl)  500  mg ; lorazepam  0.25  mg ; metoprolol  12.5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; metoprolol  5  mg ; famotidine  20  mg ; insulin  0  unit ; cholestyramine  2  gm ; divalproex sod. sprinkles  500  mg ; levalbuterol hcl  0.63  mg ; clindamycin  300  mg ; diltiazem  10  mg ; divalproex sod. sprinkles  250  mg ; heparin flush picc (100 units ml)  2  ml ; furosemide  10  mg ; metoprolol  25  mg ; 
 
white f 78 $nan$hematology blood hematocrit  26.5  %; hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  55  k ul; hematology blood platelet count  58  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  2.9  ; hematology blood inr(pt)  3.3  ; hematology urine wbc  2  # hpf; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  90  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  128  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$modafinil  200  mg ; levofloxacin  750  mg ; digoxin  0.125  mg ; amantadine syrup  50  mg ; bisacodyl  10  mg ; citalopram hydrobromide  20  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; lorazepam  0.25  mg ; metoprolol  5  mg ; famotidine  20  mg ; insulin  0  unit ; cholestyramine  2  gm ; divalproex sod. sprinkles  500  mg ; clindamycin  300  mg ; diltiazem  10  mg ; heparin flush picc (100 units ml)  2  ml ; furosemide  10  mg ; metoprolol  25  mg ; metoprolol  37.5  mg ; sw  100  ml ; potassium chloride  40  meq ; trazodone  25  mg ; sw  50  ml ; magnesium sulfate  2  gm ; metoprolol  50  mg ; acetaminophen (liquid)  650  mg ; digoxin  0.25  mg ; ns  250  ml ; sodium phosphate  15  mmol ; 
 
white f 78 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  51  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  154  mg dl$modafinil  200  mg ; levofloxacin  750  mg ; amantadine syrup  50  mg ; bisacodyl  10  mg ; citalopram hydrobromide  20  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; famotidine  20  mg ; insulin  0  unit ; cholestyramine  2  gm ; divalproex sod. sprinkles  500  mg ; clindamycin  300  mg ; sw  100  ml ; potassium chloride  40  meq ; trazodone  25  mg ; sw  50  ml ; magnesium sulfate  2  gm ; metoprolol  50  mg ; acetaminophen (liquid)  650  mg ; digoxin  0.25  mg ; ns  250  ml ; sodium phosphate  15  mmol ; phytonadione  5  mg ; iso-osmotic dextrose  50  ml ; ceftazidime  1  gm ; 
 
white f 78 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  64  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  108  mg dl$modafinil  200  mg ; amantadine syrup  50  mg ; bisacodyl  10  mg ; citalopram hydrobromide  20  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; famotidine  20  mg ; insulin  0  unit ; cholestyramine  2  gm ; divalproex sod. sprinkles  500  mg ; acetaminophen (liquid)  650  mg ; digoxin  0.25  mg ; phytonadione  5  mg ; iso-osmotic dextrose  50  ml ; ceftazidime  1  gm ; neutra-phos  2  pkt ; potassium chloride  20  meq ; 
 
white f 78 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  64  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  104  mg dl$modafinil  200  mg ; amantadine syrup  50  mg ; bisacodyl  10  mg ; citalopram hydrobromide  20  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; famotidine  20  mg ; insulin  0  unit ; cholestyramine  2  gm ; divalproex sod. sprinkles  500  mg ; acetaminophen (liquid)  650  mg ; digoxin  0.25  mg ; iso-osmotic dextrose  50  ml ; ceftazidime  1  gm ; neutra-phos  2  pkt ; potassium chloride  20  meq ; 
 
white f 78 $nan$nan$modafinil  200  mg ; amantadine syrup  50  mg ; bisacodyl  10  mg ; citalopram hydrobromide  20  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; famotidine  20  mg ; insulin  0  unit ; cholestyramine  2  gm ; divalproex sod. sprinkles  500  mg ; acetaminophen (liquid)  650  mg ; digoxin  0.25  mg ; iso-osmotic dextrose  50  ml ; ceftazidime  1  gm ; sulfameth trimethoprim ds  1  tab ; 
 
white f 78 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood glucose  90  mg dl$modafinil  200  mg ; amantadine syrup  50  mg ; bisacodyl  10  mg ; citalopram hydrobromide  20  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; famotidine  20  mg ; insulin  0  unit ; cholestyramine  2  gm ; divalproex sod. sprinkles  500  mg ; acetaminophen (liquid)  650  mg ; digoxin  0.25  mg ; iso-osmotic dextrose  50  ml ; ceftazidime  1  gm ; sulfameth trimethoprim ds  1  tab ; 
 
white f 78 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  121  mg dl$modafinil  200  mg ; amantadine syrup  50  mg ; bisacodyl  10  mg ; citalopram hydrobromide  20  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; famotidine  20  mg ; insulin  0  unit ; cholestyramine  2  gm ; divalproex sod. sprinkles  500  mg ; acetaminophen (liquid)  650  mg ; digoxin  0.25  mg ; iso-osmotic dextrose  50  ml ; ceftazidime  1  gm ; sulfameth trimethoprim ds  1  tab ; ciprofloxacin hcl  500  mg ; cholestyramine  4  gm ; heparin flush (100 units ml)  2  ml ; 
 
white f 78 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood glucose  88  mg dl$modafinil  200  mg ; amantadine syrup  50  mg ; bisacodyl  10  mg ; citalopram hydrobromide  20  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; famotidine  20  mg ; insulin  0  unit ; divalproex sod. sprinkles  500  mg ; acetaminophen (liquid)  650  mg ; digoxin  0.25  mg ; iso-osmotic dextrose  50  ml ; ceftazidime  1  gm ; sulfameth trimethoprim ds  1  tab ; ciprofloxacin hcl  500  mg ; cholestyramine  4  gm ; heparin flush (100 units ml)  2  ml ; heparin  5000  unit ; ibuprofen  400  mg ; ns  500  ml ; 
 
white f 78 $nan$nan$modafinil  200  mg ; amantadine syrup  50  mg ; bisacodyl  10  mg ; citalopram hydrobromide  20  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; famotidine  20  mg ; insulin  0  unit ; divalproex sod. sprinkles  500  mg ; acetaminophen (liquid)  650  mg ; digoxin  0.25  mg ; iso-osmotic dextrose  50  ml ; ceftazidime  1  gm ; sulfameth trimethoprim ds  1  tab ; ciprofloxacin hcl  500  mg ; cholestyramine  4  gm ; heparin flush (100 units ml)  2  ml ; heparin  5000  unit ; ibuprofen  400  mg ; 
 
white f 78 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  285  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  97  mg dl$modafinil  200  mg ; amantadine syrup  50  mg ; bisacodyl  10  mg ; citalopram hydrobromide  20  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; famotidine  20  mg ; insulin  0  unit ; divalproex sod. sprinkles  500  mg ; acetaminophen (liquid)  650  mg ; digoxin  0.25  mg ; iso-osmotic dextrose  50  ml ; ceftazidime  1  gm ; sulfameth trimethoprim ds  1  tab ; ciprofloxacin hcl  500  mg ; cholestyramine  4  gm ; heparin flush (100 units ml)  2  ml ; heparin  5000  unit ; 
 
white f 78 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  120  mg dl$modafinil  200  mg ; amantadine syrup  50  mg ; bisacodyl  10  mg ; citalopram hydrobromide  20  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; famotidine  20  mg ; insulin  0  unit ; divalproex sod. sprinkles  500  mg ; acetaminophen (liquid)  650  mg ; digoxin  0.25  mg ; iso-osmotic dextrose  50  ml ; ceftazidime  1  gm ; sulfameth trimethoprim ds  1  tab ; ciprofloxacin hcl  500  mg ; cholestyramine  4  gm ; heparin flush (100 units ml)  2  ml ; heparin  5000  unit ; 
 
white f 78 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  109  mg dl; chemistry blood lactate dehydrogenase (ld)  197  iu l$modafinil  200  mg ; amantadine syrup  50  mg ; bisacodyl  10  mg ; citalopram hydrobromide  20  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; famotidine  20  mg ; insulin  0  unit ; divalproex sod. sprinkles  500  mg ; acetaminophen (liquid)  650  mg ; digoxin  0.25  mg ; iso-osmotic dextrose  50  ml ; ceftazidime  1  gm ; sulfameth trimethoprim ds  1  tab ; ciprofloxacin hcl  500  mg ; cholestyramine  4  gm ; heparin flush (100 units ml)  2  ml ; heparin  5000  unit ; 
 
white f 78 $nan$nan$modafinil  200  mg ; amantadine syrup  50  mg ; bisacodyl  10  mg ; citalopram hydrobromide  20  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; famotidine  20  mg ; insulin  0  unit ; divalproex sod. sprinkles  500  mg ; acetaminophen (liquid)  650  mg ; digoxin  0.25  mg ; iso-osmotic dextrose  50  ml ; ceftazidime  1  gm ; sulfameth trimethoprim ds  1  tab ; ciprofloxacin hcl  500  mg ; cholestyramine  4  gm ; heparin flush (100 units ml)  2  ml ; heparin  5000  unit ; 
 
white f 78 $nan$nan$modafinil  200  mg ; amantadine syrup  50  mg ; bisacodyl  10  mg ; citalopram hydrobromide  20  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; famotidine  20  mg ; insulin  0  unit ; divalproex sod. sprinkles  500  mg ; acetaminophen (liquid)  650  mg ; digoxin  0.25  mg ; cholestyramine  4  gm ; heparin flush (100 units ml)  2  ml ; heparin  5000  unit ; 
 
white f 31 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; prenatal vitamins  1  tab ; syringe  2  ml ; betamethasone na. phos acet  12  mg ; indomethacin  50  mg ; indomethacin  25  mg ; 
 
white f 31 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; prenatal vitamins  1  tab ; syringe  2  ml ; betamethasone na. phos acet  12  mg ; indomethacin  50  mg ; indomethacin  25  mg ; metronidazole  500  mg ; 
 
white f 31 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; prenatal vitamins  1  tab ; metronidazole  500  mg ; 
 
white f 31 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  288  k ul$influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; prenatal vitamins  1  tab ; metronidazole  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; 0.9% sodium chloride  100  ml ; erythromycin  250  mg ; lactated ringers  1000  ml ; 
 
white f 31 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  317  k ul; hematology blood inr(pt)  1.0  $docusate sodium  100  mg ; acetaminophen  650  mg ; prenatal vitamins  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; 0.9% sodium chloride  100  ml ; erythromycin  250  mg ; lactated ringers  1000  ml ; acyclovir  400  mg ; calcium carbonate  500  mg ; sodium chloride 0.9%  flush  3  ml ; 
 
white f 31 $nan$hematology urine wbc  8  # hpf$docusate sodium  100  mg ; acetaminophen  650  mg ; prenatal vitamins  1  tab ; acyclovir  400  mg ; calcium carbonate  500  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; oxazepam  15-30  mg ; lidocaine jelly 2% (urojet)  1  appl ; 
 
white f 31 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  314  k ul$lidocaine jelly 2% (urojet)  1  appl ; amoxicillin  500  mg ; 
 
white f 31 $nan$nan$amoxicillin  500  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; dermoplast spray  1  spry ; methylergonovine maleate  0.2  mg ; 
 
white f 31 $nan$nan$ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; dermoplast spray  1  spry ; methylergonovine maleate  0.2  mg ; 
 
white f 31 $nan$nan$ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; dermoplast spray  1  spry ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
white m 50 $nan$hematology blood hematocrit  36.5  %; hematology blood hematocrit  33.9  %; hematology blood hematocrit  34.9  %; hematology blood hemoglobin  12.2  g dl; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  252  k ul; hematology blood platelet count  260  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  113  mg dl$sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; acetaminophen  650  mg ; diphenhydramine  25  mg ; hydromorphone (dilaudid)  0.25  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; oxycodone-acetaminophen  1-2  tab ; atenolol  50  mg ; simvastatin  20  mg ; hydralazine  10  mg ; phenazopyridine hcl  100  mg ; oxybutynin  5  mg ; zolpidem tartrate  5  mg ; 
other and unspecified hyperlipidemia dyspepsia and other specified disorders of function of stomach unspecified essential hypertension malignant neoplasm of kidney, except pelvis gout, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts)
white m 50 $nan$hematology blood hematocrit  32.3  %; hematology blood hematocrit  32.9  %; hematology blood hemoglobin  11.3  g dl; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  224  k ul; hematology blood platelet count  231  k ul$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; diphenhydramine  25  mg ; hydromorphone (dilaudid)  0.25  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; oxycodone-acetaminophen  1-2  tab ; atenolol  50  mg ; simvastatin  20  mg ; hydralazine  10  mg ; phenazopyridine hcl  100  mg ; oxybutynin  5  mg ; zolpidem tartrate  5  mg ; 
other and unspecified hyperlipidemia dyspepsia and other specified disorders of function of stomach unspecified essential hypertension malignant neoplasm of kidney, except pelvis gout, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts)
white m 50 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  232  k ul$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; diphenhydramine  25  mg ; hydromorphone (dilaudid)  0.25  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; oxycodone-acetaminophen  1-2  tab ; atenolol  50  mg ; simvastatin  20  mg ; hydralazine  10  mg ; phenazopyridine hcl  100  mg ; oxybutynin  5  mg ; zolpidem tartrate  5  mg ; docusate sodium  100  mg ; 
other and unspecified hyperlipidemia dyspepsia and other specified disorders of function of stomach unspecified essential hypertension malignant neoplasm of kidney, except pelvis gout, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts)
white m 50 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  249  k ul$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; diphenhydramine  25  mg ; hydromorphone (dilaudid)  0.25  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; oxycodone-acetaminophen  1-2  tab ; atenolol  50  mg ; simvastatin  20  mg ; hydralazine  10  mg ; phenazopyridine hcl  100  mg ; oxybutynin  5  mg ; zolpidem tartrate  5  mg ; docusate sodium  100  mg ; 
other and unspecified hyperlipidemia dyspepsia and other specified disorders of function of stomach unspecified essential hypertension malignant neoplasm of kidney, except pelvis gout, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts)
white m 50 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; diphenhydramine  25  mg ; hydromorphone (dilaudid)  0.25  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; oxycodone-acetaminophen  1-2  tab ; atenolol  50  mg ; simvastatin  20  mg ; hydralazine  10  mg ; oxybutynin  5  mg ; zolpidem tartrate  5  mg ; docusate sodium  100  mg ; 
other and unspecified hyperlipidemia dyspepsia and other specified disorders of function of stomach unspecified essential hypertension malignant neoplasm of kidney, except pelvis gout, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts)
black african american f 80 $temp  98.0  heartrate  76.0  resprate  22.0  o2sat  100.0  sbp  191.0  dbp  87.0  rhythm    pain  0  ; temp  98.5  heartrate  66.0  resprate  20.0  o2sat  96.0  sbp  179.0  dbp  60.0  rhythm    pain    ; temp    heartrate  68.0  resprate  20.0  o2sat  96.0  sbp  165.0  dbp  71.0  rhythm  sinus rhythm  pain  0  ; temp  99.1  heartrate  69.0  resprate  22.0  o2sat  94.0  sbp  161.0  dbp  59.0  rhythm    pain    ; temp  98.5  heartrate  76.0  resprate  24.0  o2sat  96.0  sbp  185.0  dbp  70.0  rhythm    pain  0  ; temp    heartrate  72.0  resprate  22.0  o2sat  100.0  sbp  158.0  dbp  66.0  rhythm  sinus rhythm  pain  0  ; temp    heartrate  73.0  resprate  19.0  o2sat  96.0  sbp  162.0  dbp  57.0  rhythm    pain    ; temp    heartrate  69.0  resprate  21.0  o2sat  94.0  sbp  170.0  dbp  67.0  rhythm    pain    ; temp    heartrate  65.0  resprate  19.0  o2sat  95.0  sbp  169.0  dbp  62.0  rhythm    pain    ; temp    heartrate  66.0  resprate  19.0  o2sat  95.0  sbp  185.0  dbp  75.0  rhythm    pain    $hematology blood hematocrit  39.4  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  6.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  46  mg dl; hematology urine wbc  7  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  114  mg dl; blood gas blood lactate  1.6  mmol l; blood gas blood potassium, whole blood  5.2  meq l$nan
tobacco use disorder other specified anemias acidosis chronic diastolic heart failure osteoporosis, unspecified hypocalcemia surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted kidney chronic kidney disease, unspecified other chronic pulmonary heart diseases chronic kidney disease, stage iv (severe) pain in limb acute respiratory failure diarrhea hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney volume depletion, unspecified disorders of phosphorus metabolism esophageal reflux acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution other anaphylactic reaction urinary tract infection, site not specified other specified antibiotics causing adverse effects in therapeutic use other specified hypotension anemia in chronic kidney disease depressive disorder, not elsewhere classified cephalosporin group causing adverse effects in therapeutic use dissection of aorta, thoracic chronic airway obstruction, not elsewhere classified other nonspecific abnormal serum enzyme levels coronary atherosclerosis of native coronary artery other nonspecific findings on examination of urine acquired absence of both cervix and uterus tobacco use disorder long-term (current) use of aspirin anemia, unspecified dissection of aorta, abdominal pulmonary collapse unspecified protein-calorie malnutrition acute kidney failure with lesion of tubular necrosis influenza with pneumonia congestive heart failure, unspecified complications of transplanted kidney anxiety state, unspecified chronic kidney disease, stage v obstructive chronic bronchitis with (acute) exacerbation
black african american f 80 $temp    heartrate  88.0  resprate  28.0  o2sat  94.0  sbp  198.0  dbp  83.0  rhythm    pain    ; temp    heartrate  74.0  resprate  24.0  o2sat  98.0  sbp  124.0  dbp  72.0  rhythm    pain    ; temp    heartrate  74.0  resprate  21.0  o2sat  98.0  sbp  132.0  dbp  63.0  rhythm    pain    ; temp    heartrate  76.0  resprate  20.0  o2sat  97.0  sbp  137.0  dbp  66.0  rhythm    pain    ; temp    heartrate  76.0  resprate  21.0  o2sat  96.0  sbp  130.0  dbp  63.0  rhythm    pain    ; temp    heartrate  74.0  resprate  21.0  o2sat  95.0  sbp  140.0  dbp  59.0  rhythm    pain    ; temp    heartrate  75.0  resprate  22.0  o2sat  96.0  sbp  136.0  dbp  62.0  rhythm    pain    ; temp    heartrate  71.0  resprate  18.0  o2sat  98.0  sbp  140.0  dbp  62.0  rhythm    pain    ; temp    heartrate  69.0  resprate  18.0  o2sat  97.0  sbp  137.0  dbp  55.0  rhythm    pain    ; temp    heartrate  72.0  resprate  20.0  o2sat  97.0  sbp  133.0  dbp  66.0  rhythm    pain  0  ; temp    heartrate  67.0  resprate  17.0  o2sat  96.0  sbp  136.0  dbp  61.0  rhythm    pain    ; temp    heartrate  68.0  resprate  18.0  o2sat  95.0  sbp  153.0  dbp  63.0  rhythm    pain    ; temp    heartrate  71.0  resprate  19.0  o2sat  96.0  sbp  164.0  dbp  65.0  rhythm    pain    ; temp  98.2  heartrate  68.0  resprate  19.0  o2sat  99.0  sbp  147.0  dbp  68.0  rhythm    pain  0  $hematology blood hematocrit  35.5  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  5.2  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood urea nitrogen  57  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  157  mg dl; chemistry blood glucose  243  mg dl; chemistry blood lactate dehydrogenase (ld)  196  iu l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; acetaminophen  500  mg ; ascorbic acid  500  mg ; aspirin  81  mg ; calcitriol  0.5  mcg ; cinacalcet  60  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; omeprazole  20  mg ; sodium chloride nasal  1-2  spry ; tiotropium bromide  18  mcg ; ipratropium-albuterol neb  1  neb ; azathioprine  50  mg ; tacrolimus  2  mg ; citalopram  20  mg ; hydralazine  20  mg ; isosorbide mononitrate (extended release)  60  mg ; nicotine patch  7  mg ; lidocaine 5% ointment  1  appl ; azithromycin  250  mg ; carvedilol  25  mg ; furosemide  80  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; furosemide  160  mg ; 
tobacco use disorder other specified anemias acidosis chronic diastolic heart failure osteoporosis, unspecified hypocalcemia surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted kidney chronic kidney disease, unspecified other chronic pulmonary heart diseases chronic kidney disease, stage iv (severe) pain in limb acute respiratory failure diarrhea hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney volume depletion, unspecified disorders of phosphorus metabolism esophageal reflux acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution other anaphylactic reaction urinary tract infection, site not specified other specified antibiotics causing adverse effects in therapeutic use other specified hypotension anemia in chronic kidney disease depressive disorder, not elsewhere classified cephalosporin group causing adverse effects in therapeutic use dissection of aorta, thoracic chronic airway obstruction, not elsewhere classified other nonspecific abnormal serum enzyme levels coronary atherosclerosis of native coronary artery other nonspecific findings on examination of urine acquired absence of both cervix and uterus tobacco use disorder long-term (current) use of aspirin anemia, unspecified dissection of aorta, abdominal pulmonary collapse unspecified protein-calorie malnutrition acute kidney failure with lesion of tubular necrosis influenza with pneumonia congestive heart failure, unspecified complications of transplanted kidney anxiety state, unspecified chronic kidney disease, stage v obstructive chronic bronchitis with (acute) exacerbation
black african american f 80 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  156  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  5.5  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  60  mg dl; chemistry blood urea nitrogen  65  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  186  mg dl; chemistry blood glucose  105  mg dl; chemistry blood lactate dehydrogenase (ld)  195  iu l; chemistry blood albumin  3.8  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; acetaminophen  500  mg ; ascorbic acid  500  mg ; aspirin  81  mg ; calcitriol  0.5  mcg ; cinacalcet  60  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; omeprazole  20  mg ; sodium chloride nasal  1-2  spry ; tiotropium bromide  18  mcg ; ipratropium-albuterol neb  1  neb ; azathioprine  50  mg ; tacrolimus  2  mg ; citalopram  20  mg ; hydralazine  20  mg ; isosorbide mononitrate (extended release)  60  mg ; nicotine patch  7  mg ; lidocaine 5% ointment  1  appl ; azithromycin  250  mg ; carvedilol  25  mg ; furosemide  80  mg ; furosemide  160  mg ; prednisone  60  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; albuterol 0.083% neb soln  1  neb ; cepacol (sore throat lozenge)  2  loz ; 
tobacco use disorder other specified anemias acidosis chronic diastolic heart failure osteoporosis, unspecified hypocalcemia surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted kidney chronic kidney disease, unspecified other chronic pulmonary heart diseases chronic kidney disease, stage iv (severe) pain in limb acute respiratory failure diarrhea hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney volume depletion, unspecified disorders of phosphorus metabolism esophageal reflux acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution other anaphylactic reaction urinary tract infection, site not specified other specified antibiotics causing adverse effects in therapeutic use other specified hypotension anemia in chronic kidney disease depressive disorder, not elsewhere classified cephalosporin group causing adverse effects in therapeutic use dissection of aorta, thoracic chronic airway obstruction, not elsewhere classified other nonspecific abnormal serum enzyme levels coronary atherosclerosis of native coronary artery other nonspecific findings on examination of urine acquired absence of both cervix and uterus tobacco use disorder long-term (current) use of aspirin anemia, unspecified dissection of aorta, abdominal pulmonary collapse unspecified protein-calorie malnutrition acute kidney failure with lesion of tubular necrosis influenza with pneumonia congestive heart failure, unspecified complications of transplanted kidney anxiety state, unspecified chronic kidney disease, stage v obstructive chronic bronchitis with (acute) exacerbation
black african american f 80 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  166  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  70  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  171  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; acetaminophen  500  mg ; ascorbic acid  500  mg ; aspirin  81  mg ; calcitriol  0.5  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; omeprazole  20  mg ; sodium chloride nasal  1-2  spry ; tiotropium bromide  18  mcg ; azathioprine  50  mg ; tacrolimus  2  mg ; citalopram  20  mg ; isosorbide mononitrate (extended release)  60  mg ; nicotine patch  7  mg ; lidocaine 5% ointment  1  appl ; azithromycin  250  mg ; carvedilol  25  mg ; prednisone  60  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; albuterol 0.083% neb soln  1  neb ; cepacol (sore throat lozenge)  2  loz ; 
tobacco use disorder other specified anemias acidosis chronic diastolic heart failure osteoporosis, unspecified hypocalcemia surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted kidney chronic kidney disease, unspecified other chronic pulmonary heart diseases chronic kidney disease, stage iv (severe) pain in limb acute respiratory failure diarrhea hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney volume depletion, unspecified disorders of phosphorus metabolism esophageal reflux acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution other anaphylactic reaction urinary tract infection, site not specified other specified antibiotics causing adverse effects in therapeutic use other specified hypotension anemia in chronic kidney disease depressive disorder, not elsewhere classified cephalosporin group causing adverse effects in therapeutic use dissection of aorta, thoracic chronic airway obstruction, not elsewhere classified other nonspecific abnormal serum enzyme levels coronary atherosclerosis of native coronary artery other nonspecific findings on examination of urine acquired absence of both cervix and uterus tobacco use disorder long-term (current) use of aspirin anemia, unspecified dissection of aorta, abdominal pulmonary collapse unspecified protein-calorie malnutrition acute kidney failure with lesion of tubular necrosis influenza with pneumonia congestive heart failure, unspecified complications of transplanted kidney anxiety state, unspecified chronic kidney disease, stage v obstructive chronic bronchitis with (acute) exacerbation
black african american f 80 $nan$chemistry blood anion gap  24  meq l; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  73  mg dl; chemistry blood urea nitrogen  84  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  372  mg dl; chemistry blood glucose  132  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; acetaminophen  500  mg ; ascorbic acid  500  mg ; aspirin  81  mg ; calcitriol  0.5  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; omeprazole  20  mg ; sodium chloride nasal  1-2  spry ; tiotropium bromide  18  mcg ; azathioprine  50  mg ; tacrolimus  2  mg ; citalopram  20  mg ; isosorbide mononitrate (extended release)  60  mg ; nicotine patch  7  mg ; lidocaine 5% ointment  1  appl ; azithromycin  250  mg ; carvedilol  25  mg ; prednisone  60  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; albuterol 0.083% neb soln  1  neb ; cepacol (sore throat lozenge)  2  loz ; hydralazine  10  mg ; hydralazine  30  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
tobacco use disorder other specified anemias acidosis chronic diastolic heart failure osteoporosis, unspecified hypocalcemia surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted kidney chronic kidney disease, unspecified other chronic pulmonary heart diseases chronic kidney disease, stage iv (severe) pain in limb acute respiratory failure diarrhea hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney volume depletion, unspecified disorders of phosphorus metabolism esophageal reflux acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution other anaphylactic reaction urinary tract infection, site not specified other specified antibiotics causing adverse effects in therapeutic use other specified hypotension anemia in chronic kidney disease depressive disorder, not elsewhere classified cephalosporin group causing adverse effects in therapeutic use dissection of aorta, thoracic chronic airway obstruction, not elsewhere classified other nonspecific abnormal serum enzyme levels coronary atherosclerosis of native coronary artery other nonspecific findings on examination of urine acquired absence of both cervix and uterus tobacco use disorder long-term (current) use of aspirin anemia, unspecified dissection of aorta, abdominal pulmonary collapse unspecified protein-calorie malnutrition acute kidney failure with lesion of tubular necrosis influenza with pneumonia congestive heart failure, unspecified complications of transplanted kidney anxiety state, unspecified chronic kidney disease, stage v obstructive chronic bronchitis with (acute) exacerbation
black african american f 80 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  86  mg dl; chemistry blood urea nitrogen  87  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  165  mg dl; chemistry blood glucose  162  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; acetaminophen  500  mg ; ascorbic acid  500  mg ; aspirin  81  mg ; calcitriol  0.5  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; omeprazole  20  mg ; tiotropium bromide  18  mcg ; azathioprine  50  mg ; tacrolimus  2  mg ; citalopram  20  mg ; isosorbide mononitrate (extended release)  60  mg ; lidocaine 5% ointment  1  appl ; azithromycin  250  mg ; carvedilol  25  mg ; prednisone  60  mg ; albuterol 0.083% neb soln  1  neb ; cepacol (sore throat lozenge)  2  loz ; hydralazine  30  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; torsemide  20  mg ; benzonatate  100  mg ; nystatin oral suspension  10  ml ; 
tobacco use disorder other specified anemias acidosis chronic diastolic heart failure osteoporosis, unspecified hypocalcemia surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted kidney chronic kidney disease, unspecified other chronic pulmonary heart diseases chronic kidney disease, stage iv (severe) pain in limb acute respiratory failure diarrhea hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney volume depletion, unspecified disorders of phosphorus metabolism esophageal reflux acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution other anaphylactic reaction urinary tract infection, site not specified other specified antibiotics causing adverse effects in therapeutic use other specified hypotension anemia in chronic kidney disease depressive disorder, not elsewhere classified cephalosporin group causing adverse effects in therapeutic use dissection of aorta, thoracic chronic airway obstruction, not elsewhere classified other nonspecific abnormal serum enzyme levels coronary atherosclerosis of native coronary artery other nonspecific findings on examination of urine acquired absence of both cervix and uterus tobacco use disorder long-term (current) use of aspirin anemia, unspecified dissection of aorta, abdominal pulmonary collapse unspecified protein-calorie malnutrition acute kidney failure with lesion of tubular necrosis influenza with pneumonia congestive heart failure, unspecified complications of transplanted kidney anxiety state, unspecified chronic kidney disease, stage v obstructive chronic bronchitis with (acute) exacerbation
black african american f 80 $nan$hematology blood hematocrit  39.9  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  84  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  122  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; acetaminophen  500  mg ; ascorbic acid  500  mg ; aspirin  81  mg ; calcitriol  0.5  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; omeprazole  20  mg ; tiotropium bromide  18  mcg ; azathioprine  50  mg ; tacrolimus  2  mg ; citalopram  20  mg ; isosorbide mononitrate (extended release)  60  mg ; lidocaine 5% ointment  1  appl ; carvedilol  25  mg ; albuterol 0.083% neb soln  1  neb ; cepacol (sore throat lozenge)  2  loz ; hydralazine  30  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; benzonatate  100  mg ; nystatin oral suspension  10  ml ; nystatin oral suspension  5  ml ; tacrolimus  0.5  mg ; tacrolimus  1  mg ; miconazole powder 2%  1  appl ; 
tobacco use disorder other specified anemias acidosis chronic diastolic heart failure osteoporosis, unspecified hypocalcemia surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted kidney chronic kidney disease, unspecified other chronic pulmonary heart diseases chronic kidney disease, stage iv (severe) pain in limb acute respiratory failure diarrhea hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney volume depletion, unspecified disorders of phosphorus metabolism esophageal reflux acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution other anaphylactic reaction urinary tract infection, site not specified other specified antibiotics causing adverse effects in therapeutic use other specified hypotension anemia in chronic kidney disease depressive disorder, not elsewhere classified cephalosporin group causing adverse effects in therapeutic use dissection of aorta, thoracic chronic airway obstruction, not elsewhere classified other nonspecific abnormal serum enzyme levels coronary atherosclerosis of native coronary artery other nonspecific findings on examination of urine acquired absence of both cervix and uterus tobacco use disorder long-term (current) use of aspirin anemia, unspecified dissection of aorta, abdominal pulmonary collapse unspecified protein-calorie malnutrition acute kidney failure with lesion of tubular necrosis influenza with pneumonia congestive heart failure, unspecified complications of transplanted kidney anxiety state, unspecified chronic kidney disease, stage v obstructive chronic bronchitis with (acute) exacerbation
black african american f 80 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  5.3  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  89  mg dl; chemistry blood urea nitrogen  90  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  208  mg dl; chemistry blood glucose  172  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; acetaminophen  500  mg ; ascorbic acid  500  mg ; aspirin  81  mg ; calcitriol  0.5  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; omeprazole  20  mg ; tiotropium bromide  18  mcg ; azathioprine  50  mg ; citalopram  20  mg ; isosorbide mononitrate (extended release)  60  mg ; lidocaine 5% ointment  1  appl ; carvedilol  25  mg ; albuterol 0.083% neb soln  1  neb ; cepacol (sore throat lozenge)  2  loz ; hydralazine  30  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; benzonatate  100  mg ; nystatin oral suspension  5  ml ; tacrolimus  0.5  mg ; tacrolimus  1  mg ; miconazole powder 2%  1  appl ; prednisone  40  mg ; torsemide  40  mg ; sevelamer carbonate  800  mg ; 
tobacco use disorder other specified anemias acidosis chronic diastolic heart failure osteoporosis, unspecified hypocalcemia surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted kidney chronic kidney disease, unspecified other chronic pulmonary heart diseases chronic kidney disease, stage iv (severe) pain in limb acute respiratory failure diarrhea hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney volume depletion, unspecified disorders of phosphorus metabolism esophageal reflux acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution other anaphylactic reaction urinary tract infection, site not specified other specified antibiotics causing adverse effects in therapeutic use other specified hypotension anemia in chronic kidney disease depressive disorder, not elsewhere classified cephalosporin group causing adverse effects in therapeutic use dissection of aorta, thoracic chronic airway obstruction, not elsewhere classified other nonspecific abnormal serum enzyme levels coronary atherosclerosis of native coronary artery other nonspecific findings on examination of urine acquired absence of both cervix and uterus tobacco use disorder long-term (current) use of aspirin anemia, unspecified dissection of aorta, abdominal pulmonary collapse unspecified protein-calorie malnutrition acute kidney failure with lesion of tubular necrosis influenza with pneumonia congestive heart failure, unspecified complications of transplanted kidney anxiety state, unspecified chronic kidney disease, stage v obstructive chronic bronchitis with (acute) exacerbation
black african american f 80 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  98  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  174  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; acetaminophen  500  mg ; ascorbic acid  500  mg ; aspirin  81  mg ; calcitriol  0.5  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; omeprazole  20  mg ; tiotropium bromide  18  mcg ; azathioprine  50  mg ; citalopram  20  mg ; isosorbide mononitrate (extended release)  60  mg ; lidocaine 5% ointment  1  appl ; carvedilol  25  mg ; albuterol 0.083% neb soln  1  neb ; cepacol (sore throat lozenge)  2  loz ; hydralazine  30  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; benzonatate  100  mg ; tacrolimus  0.5  mg ; tacrolimus  1  mg ; miconazole powder 2%  1  appl ; prednisone  40  mg ; torsemide  40  mg ; sevelamer carbonate  800  mg ; guaifenesin  5  ml ; 
tobacco use disorder other specified anemias acidosis chronic diastolic heart failure osteoporosis, unspecified hypocalcemia surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted kidney chronic kidney disease, unspecified other chronic pulmonary heart diseases chronic kidney disease, stage iv (severe) pain in limb acute respiratory failure diarrhea hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney volume depletion, unspecified disorders of phosphorus metabolism esophageal reflux acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution other anaphylactic reaction urinary tract infection, site not specified other specified antibiotics causing adverse effects in therapeutic use other specified hypotension anemia in chronic kidney disease depressive disorder, not elsewhere classified cephalosporin group causing adverse effects in therapeutic use dissection of aorta, thoracic chronic airway obstruction, not elsewhere classified other nonspecific abnormal serum enzyme levels coronary atherosclerosis of native coronary artery other nonspecific findings on examination of urine acquired absence of both cervix and uterus tobacco use disorder long-term (current) use of aspirin anemia, unspecified dissection of aorta, abdominal pulmonary collapse unspecified protein-calorie malnutrition acute kidney failure with lesion of tubular necrosis influenza with pneumonia congestive heart failure, unspecified complications of transplanted kidney anxiety state, unspecified chronic kidney disease, stage v obstructive chronic bronchitis with (acute) exacerbation
black african american f 80 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  104  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  97  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; acetaminophen  500  mg ; aspirin  81  mg ; calcitriol  0.5  mcg ; fluticasone-salmeterol diskus (500 50)   1  inh ; omeprazole  20  mg ; tiotropium bromide  18  mcg ; azathioprine  50  mg ; citalopram  20  mg ; isosorbide mononitrate (extended release)  60  mg ; lidocaine 5% ointment  1  appl ; carvedilol  25  mg ; albuterol 0.083% neb soln  1  neb ; cepacol (sore throat lozenge)  2  loz ; hydralazine  30  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; benzonatate  100  mg ; miconazole powder 2%  1  appl ; prednisone  40  mg ; sevelamer carbonate  800  mg ; guaifenesin  5  ml ; 
tobacco use disorder other specified anemias acidosis chronic diastolic heart failure osteoporosis, unspecified hypocalcemia surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation complications of transplanted kidney chronic kidney disease, unspecified other chronic pulmonary heart diseases chronic kidney disease, stage iv (severe) pain in limb acute respiratory failure diarrhea hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney volume depletion, unspecified disorders of phosphorus metabolism esophageal reflux acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution other anaphylactic reaction urinary tract infection, site not specified other specified antibiotics causing adverse effects in therapeutic use other specified hypotension anemia in chronic kidney disease depressive disorder, not elsewhere classified cephalosporin group causing adverse effects in therapeutic use dissection of aorta, thoracic chronic airway obstruction, not elsewhere classified other nonspecific abnormal serum enzyme levels coronary atherosclerosis of native coronary artery other nonspecific findings on examination of urine acquired absence of both cervix and uterus tobacco use disorder long-term (current) use of aspirin anemia, unspecified dissection of aorta, abdominal pulmonary collapse unspecified protein-calorie malnutrition acute kidney failure with lesion of tubular necrosis influenza with pneumonia congestive heart failure, unspecified complications of transplanted kidney anxiety state, unspecified chronic kidney disease, stage v obstructive chronic bronchitis with (acute) exacerbation
white m 66 $nan$nan$aspirin ec  325  mg ; benicar  20  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  12.5  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; senna  1  tab ; ondansetron  4  mg ; ketorolac  15  mg ; docusate sodium  100  mg ; timolol maleate 0.25%  1  drop ; 
 
white m 66 $nan$nan$aspirin ec  325  mg ; benicar  20  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; senna  1  tab ; ondansetron  4  mg ; ketorolac  15  mg ; docusate sodium  100  mg ; timolol maleate 0.25%  1  drop ; 
 
white f 78 $nan$nan$aspirin  81  mg ; 
 
white f 78 $nan$hematology blood hematocrit  30.9  %; hematology blood hematocrit  34.2  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  206  k ul; hematology blood platelet count  227  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  113  mg dl$aspirin  81  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  1000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; atorvastatin  80  mg ; donepezil  10  mg ; amlodipine  10  mg ; lisinopril  60  mg ; metoprolol tartrate  12.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; senna  8.6  mg ; insulin  0  unit ; magnesium oxide  400  mg ; aspirin  325  mg ; 
 
white f 78 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  13  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  136  mg dl; chemistry blood albumin  3.8  g dl; chemistry blood % hemoglobin a1c  7.1  %$aspirin  81  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  1000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; atorvastatin  80  mg ; donepezil  10  mg ; amlodipine  10  mg ; lisinopril  60  mg ; metoprolol tartrate  12.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; senna  8.6  mg ; insulin  0  unit ; magnesium oxide  400  mg ; aspirin  325  mg ; hydralazine  25  mg ; 
 
white f 78 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  136  mg dl$aspirin  81  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  1000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; atorvastatin  80  mg ; donepezil  10  mg ; metoprolol tartrate  12.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; senna  8.6  mg ; insulin  0  unit ; hydralazine  25  mg ; mupirocin ointment 2%  1  appl ; 0.9% sodium chloride  100  ml ; ferric gluconate  125  mg ; epoetin alfa  3000  unit ; epoetin alfa  4000  unit ; 
 
white f 78 $nan$hematology blood hematocrit  34.2  %; hematology blood hematocrit  24.0  %; hematology blood hemoglobin  11.0  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  240  k ul; hematology blood platelet count  136  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  159  mg dl; blood gas blood free calcium  1.53  mmol l; blood gas blood lactate  3.4  mmol l; blood gas blood chloride, whole blood  111  meq l; blood gas blood glucose  203  mg dl; blood gas blood glucose  173  mg dl; blood gas blood glucose  152  mg dl; blood gas blood glucose  135  mg dl; blood gas blood hematocrit, calculated  24  %; blood gas blood hematocrit, calculated  26  %; blood gas blood hematocrit, calculated  26  %; blood gas blood hematocrit, calculated  25  %; blood gas blood hemoglobin  8.1  g dl; blood gas blood hemoglobin  8.8  g dl; blood gas blood hemoglobin  8.6  g dl; blood gas blood hemoglobin  8.3  g dl; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  3.4  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  3.4  meq l; blood gas blood sodium, whole blood  140  meq l$aspirin  81  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  1000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; atorvastatin  80  mg ; donepezil  10  mg ; metoprolol tartrate  12.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; senna  8.6  mg ; insulin  0  unit ; hydralazine  25  mg ; mupirocin ointment 2%  1  appl ; 0.9% sodium chloride  100  ml ; ferric gluconate  125  mg ; epoetin alfa  3000  unit ; epoetin alfa  4000  unit ; sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; 0.9 % sodium chloride  25  ml ; phenylephrine  6  mg ; bag  1  ml ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; sterile water  50  ml ; potassium chloride  20  meq ; insulin human regular  100  unit ; oxycodone (immediate release)  5-10  mg ; fentanyl citrate  12.5-50  mcg ; ondansetron  4  mg ; acetaminophen  1000  mg ; acetaminophen iv  1000  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; 
 
white f 78 $nan$hematology blood hematocrit  27.3  %; hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  154  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  99  mg dl; blood gas blood free calcium  1.29  mmol l; blood gas blood lactate  2.0  mmol l$sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; 0.9 % sodium chloride  25  ml ; phenylephrine  6  mg ; bag  1  ml ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; sterile water  50  ml ; potassium chloride  20  meq ; insulin human regular  100  unit ; oxycodone (immediate release)  5-10  mg ; fentanyl citrate  12.5-50  mcg ; ondansetron  4  mg ; acetaminophen  1000  mg ; acetaminophen iv  1000  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; mouth care oral rinse  15  ml ; ranitidine  150  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; insulin glargine  (cvicu protocol)  0-50  unit ; insulin  0-10  unit ; aspirin ec  81  mg ; isosorbide mononitrate (extended release)  30  mg ; metoprolol tartrate  25  mg ; insulin  20  unit ; furosemide  20  mg ; tramadol  50  mg ; 
 
white f 78 $nan$hematology blood hematocrit  24.8  %; hematology blood hematocrit  22.0  %; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  130  k ul; hematology blood platelet count  129  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  138  mg dl; chemistry blood glucose  129  mg dl; blood gas blood free calcium  1.22  mmol l$sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; dextrose 5%  1000  ml ; propofol  1000  mg ; propofol  200  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; bag  1  ml ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; sterile water  50  ml ; potassium chloride  20  meq ; insulin human regular  100  unit ; ondansetron  4  mg ; acetaminophen  1000  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; ranitidine  150  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; insulin glargine  (cvicu protocol)  0-50  unit ; insulin  0-10  unit ; aspirin ec  81  mg ; isosorbide mononitrate (extended release)  30  mg ; insulin  20  unit ; tramadol  50  mg ; furosemide  40  mg ; 
 
white f 78 $nan$hematology blood hematocrit  23.4  %; hematology blood hematocrit  23.0  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  150  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  34  mg dl; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  4  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  101  mg dl; blood gas blood free calcium  1.16  mmol l$sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; dextrose 5%  1000  ml ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; bag  1  ml ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; sterile water  50  ml ; potassium chloride  20  meq ; ondansetron  4  mg ; acetaminophen  1000  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; aspirin ec  81  mg ; isosorbide mononitrate (extended release)  30  mg ; insulin  20  unit ; tramadol  50  mg ; furosemide  40  mg ; metoprolol tartrate  2.5  mg ; sodium chloride 0.9%  1000  ml ; isosorbide dinitrate  5  mg ; 
 
white f 78 $nan$hematology blood hematocrit  21.0  %; hematology blood hemoglobin  6.7  g dl; hematology blood platelet count  169  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  78  mg dl; chemistry blood glucose  82  mg dl$sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; dextrose 5%  1000  ml ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; bag  1  ml ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; sterile water  50  ml ; potassium chloride  20  meq ; ondansetron  4  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; aspirin ec  81  mg ; insulin  20  unit ; metoprolol tartrate  2.5  mg ; sodium chloride 0.9%  1000  ml ; isosorbide dinitrate  5  mg ; 
 
white f 78 $nan$hematology blood hematocrit  22.8  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood glucose  72  mg dl$sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; dextrose 5%  1000  ml ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; bag  1  ml ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; sterile water  50  ml ; potassium chloride  20  meq ; ondansetron  4  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; aspirin ec  81  mg ; insulin  20  unit ; isosorbide dinitrate  5  mg ; bisacodyl  10  mg ; senna  17.2  mg ; ferrous sulfate  325  mg ; ascorbic acid  500  mg ; multivitamins  1  tab ; amlodipine  5  mg ; potassium chloride  40  meq ; 
 
white f 78 $nan$hematology blood hematocrit  22.3  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood glucose  77  mg dl$polyethylene glycol  17  g ; ondansetron  4  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; aspirin ec  81  mg ; insulin  20  unit ; isosorbide dinitrate  5  mg ; bisacodyl  10  mg ; senna  17.2  mg ; ferrous sulfate  325  mg ; ascorbic acid  500  mg ; multivitamins  1  tab ; amlodipine  5  mg ; potassium chloride  40  meq ; 
 
white f 78 $nan$nan$polyethylene glycol  17  g ; ondansetron  4  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; aspirin ec  81  mg ; insulin  20  unit ; isosorbide dinitrate  5  mg ; bisacodyl  10  mg ; senna  17.2  mg ; ferrous sulfate  325  mg ; ascorbic acid  500  mg ; multivitamins  1  tab ; amlodipine  5  mg ; potassium chloride  40  meq ; 
 
white f 57 $nan$nan$senna  1  tab ; bisacodyl  10  mg ; citalopram  40  mg ; simvastatin  20  mg ; omeprazole  20  mg ; multivitamins  1  tab ; 
delirium due to conditions classified elsewhere chronic systolic heart failure depressive disorder, not elsewhere classified mitral valve disorders other late effects of cerebrovascular disease other postprocedural status congestive heart failure, unspecified muscle weakness (generalized) epilepsy, unspecified, without mention of intractable epilepsy 
white f 57 $nan$nan$senna  1  tab ; bisacodyl  10  mg ; citalopram  40  mg ; simvastatin  20  mg ; omeprazole  20  mg ; multivitamins  1  tab ; docusate sodium  100  mg ; gabapentin  300  mg ; lamotrigine  200  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; acetaminophen  325-650  mg ; oxycodone-acetaminophen  1-2  tab ; ondansetron  4  mg ; hydralazine  25  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; isotonic sodium chloride  50  ml ; gentamicin  80  mg ; heparin flush (10 units ml)  2  ml ; 
delirium due to conditions classified elsewhere chronic systolic heart failure depressive disorder, not elsewhere classified mitral valve disorders other late effects of cerebrovascular disease other postprocedural status congestive heart failure, unspecified muscle weakness (generalized) epilepsy, unspecified, without mention of intractable epilepsy 
white f 57 $nan$nan$senna  1  tab ; bisacodyl  10  mg ; citalopram  40  mg ; simvastatin  20  mg ; omeprazole  20  mg ; multivitamins  1  tab ; docusate sodium  100  mg ; gabapentin  300  mg ; lamotrigine  200  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; acetaminophen  325-650  mg ; oxycodone-acetaminophen  1-2  tab ; ondansetron  4  mg ; hydralazine  25  mg ; isotonic sodium chloride  50  ml ; gentamicin  80  mg ; heparin flush (10 units ml)  2  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; diphenhydramine  25  mg ; 
delirium due to conditions classified elsewhere chronic systolic heart failure depressive disorder, not elsewhere classified mitral valve disorders other late effects of cerebrovascular disease other postprocedural status congestive heart failure, unspecified muscle weakness (generalized) epilepsy, unspecified, without mention of intractable epilepsy 
white f 57 $nan$nan$senna  1  tab ; bisacodyl  10  mg ; citalopram  40  mg ; simvastatin  20  mg ; omeprazole  20  mg ; multivitamins  1  tab ; docusate sodium  100  mg ; gabapentin  300  mg ; lamotrigine  200  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; acetaminophen  325-650  mg ; oxycodone-acetaminophen  1-2  tab ; ondansetron  4  mg ; hydralazine  25  mg ; heparin flush (10 units ml)  2  ml ; diphenhydramine  25  mg ; 
delirium due to conditions classified elsewhere chronic systolic heart failure depressive disorder, not elsewhere classified mitral valve disorders other late effects of cerebrovascular disease other postprocedural status congestive heart failure, unspecified muscle weakness (generalized) epilepsy, unspecified, without mention of intractable epilepsy 
white f 48 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  262  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  90  mg dl; hematology blood bands  0  %; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$nan
bronchiectasis without acute exacerbation cocaine abuse, unspecified personal history of tuberculosis acute posthemorrhagic anemia abdominal pain, left upper quadrant personal history of tuberculosis hemoptysis bacterial pneumonia, unspecified tobacco use disorder bronchiectasis without acute exacerbation anxiety state, unspecified 
white f 48 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  89  mg dl$sodium chloride 0.9%  flush  3  ml ; ns  1000  ml ; pantoprazole  40  mg ; acetaminophen  500-1000  mg ; ketorolac  30  mg ; senna  1  tab ; docusate sodium  100  mg ; lactulose  30  ml ; heparin  5000  unit ; lorazepam  0.5  mg ; bisacodyl  10  mg ; trazodone  25  mg ; ziprasidone  40  mg ; 
bronchiectasis without acute exacerbation cocaine abuse, unspecified personal history of tuberculosis acute posthemorrhagic anemia abdominal pain, left upper quadrant personal history of tuberculosis hemoptysis bacterial pneumonia, unspecified tobacco use disorder bronchiectasis without acute exacerbation anxiety state, unspecified 
white f 48 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  246  k ul$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; acetaminophen  500-1000  mg ; ketorolac  30  mg ; senna  1  tab ; docusate sodium  100  mg ; lactulose  30  ml ; heparin  5000  unit ; lorazepam  0.5  mg ; bisacodyl  10  mg ; trazodone  25  mg ; ziprasidone  40  mg ; 
bronchiectasis without acute exacerbation cocaine abuse, unspecified personal history of tuberculosis acute posthemorrhagic anemia abdominal pain, left upper quadrant personal history of tuberculosis hemoptysis bacterial pneumonia, unspecified tobacco use disorder bronchiectasis without acute exacerbation anxiety state, unspecified 
black african american f 59 $nan$hematology blood hematocrit  43.1  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  10.2  mg dl; chemistry blood glucose  174  mg dl; blood gas blood potassium, whole blood  5.2  meq l; blood gas blood sodium, whole blood  134  meq l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325  mg ; amlodipine  5  mg ; aspirin  81  mg ; montelukast  10  mg ; nicotine patch  14  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; tramadol (ultram)  100  mg ; vitamin d  1000  unit ; albuterol 0.083% neb soln  1  neb ; clotrimazole  1  troc ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (500 50)   1  inh ; gabapentin  300  mg ; atorvastatin  40  mg ; atovaquone suspension  750  mg ; ipratropium-albuterol neb  1  neb ; albuterol inhaler  4  puff ; azithromycin  500  mg ; ipratropium bromide mdi  6  puff ; methylprednisolone sodium succ  80  mg ; fexofenadine  60  mg ; benzonatate  100  mg ; guaifenesin  5-10  ml ; cepastat (phenol) lozenge  1  loz ; prednisone  60  mg ; 
obesity, unspecified chronic obstructive asthma with (acute) exacerbation other chronic pulmonary heart diseases acute respiratory failure esophageal reflux obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified essential hypertension other dependence on machines, supplemental oxygen acidosis tobacco use disorder personal history of venous thrombosis and embolism coronary atherosclerosis of native coronary artery tobacco use disorder percutaneous transluminal coronary angioplasty status esophageal reflux allergic rhinitis, cause unspecified other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen long-term (current) use of steroids obstructive sleep apnea (adult)(pediatric) long-term (current) use of aspirin unspecified essential hypertension old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident personal history of pulmonary embolism other dependence on machines, supplemental oxygen long-term (current) use of aspirin obstructive sleep apnea (adult)(pediatric) allergic rhinitis, cause unspecified tobacco use disorder percutaneous transluminal coronary angioplasty status unspecified essential hypertension coronary atherosclerosis of native coronary artery esophageal reflux other chronic pulmonary heart diseases chronic obstructive asthma with (acute) exacerbation spinal stenosis, lumbar region, without neurogenic claudication person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident old myocardial infarction person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident tobacco use disorder other chronic pulmonary heart diseases family history of malignant neoplasm of gastrointestinal tract obstructive chronic bronchitis with (acute) exacerbation chronic obstructive asthma, unspecified
black african american f 59 $nan$hematology blood hematocrit  42.4  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  153  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.8  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood calcium, total  10.5  mg dl; chemistry blood glucose  199  mg dl; blood gas blood free calcium  1.27  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood potassium, whole blood  5.1  meq l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325  mg ; amlodipine  5  mg ; aspirin  81  mg ; montelukast  10  mg ; nicotine patch  14  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; tramadol (ultram)  100  mg ; vitamin d  1000  unit ; albuterol 0.083% neb soln  1  neb ; clotrimazole  1  troc ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (500 50)   1  inh ; gabapentin  300  mg ; atorvastatin  40  mg ; atovaquone suspension  750  mg ; ipratropium-albuterol neb  1  neb ; albuterol inhaler  4  puff ; azithromycin  500  mg ; ipratropium bromide mdi  6  puff ; fexofenadine  60  mg ; benzonatate  100  mg ; guaifenesin  5-10  ml ; cepastat (phenol) lozenge  1  loz ; tiotropium bromide  1  cap ; albuterol   1  neb ; insulin (regular) for hyperkalemia  10  unit ; dextrose 50%  25  gm ; 
obesity, unspecified chronic obstructive asthma with (acute) exacerbation other chronic pulmonary heart diseases acute respiratory failure esophageal reflux obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified essential hypertension other dependence on machines, supplemental oxygen acidosis tobacco use disorder personal history of venous thrombosis and embolism coronary atherosclerosis of native coronary artery tobacco use disorder percutaneous transluminal coronary angioplasty status esophageal reflux allergic rhinitis, cause unspecified other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen long-term (current) use of steroids obstructive sleep apnea (adult)(pediatric) long-term (current) use of aspirin unspecified essential hypertension old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident personal history of pulmonary embolism other dependence on machines, supplemental oxygen long-term (current) use of aspirin obstructive sleep apnea (adult)(pediatric) allergic rhinitis, cause unspecified tobacco use disorder percutaneous transluminal coronary angioplasty status unspecified essential hypertension coronary atherosclerosis of native coronary artery esophageal reflux other chronic pulmonary heart diseases chronic obstructive asthma with (acute) exacerbation spinal stenosis, lumbar region, without neurogenic claudication person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident old myocardial infarction person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident tobacco use disorder other chronic pulmonary heart diseases family history of malignant neoplasm of gastrointestinal tract obstructive chronic bronchitis with (acute) exacerbation chronic obstructive asthma, unspecified
black african american f 59 $nan$hematology blood hematocrit  40.5  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  10.6  mg dl; chemistry blood glucose  173  mg dl; chemistry blood lactate dehydrogenase (ld)  429  iu l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325  mg ; amlodipine  5  mg ; aspirin  81  mg ; montelukast  10  mg ; nicotine patch  14  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; tramadol (ultram)  100  mg ; vitamin d  1000  unit ; albuterol 0.083% neb soln  1  neb ; clotrimazole  1  troc ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (500 50)   1  inh ; gabapentin  300  mg ; atorvastatin  40  mg ; atovaquone suspension  750  mg ; ipratropium-albuterol neb  1  neb ; albuterol inhaler  4  puff ; fexofenadine  60  mg ; benzonatate  100  mg ; guaifenesin  5-10  ml ; cepastat (phenol) lozenge  1  loz ; tiotropium bromide  1  cap ; albuterol   1  neb ; insulin (regular) for hyperkalemia  10  unit ; dextrose 50%  25  gm ; morphine sulfate  2  mg ; hydrochlorothiazide  25  mg ; albuterol 0.5%  1.5  ml ; 
obesity, unspecified chronic obstructive asthma with (acute) exacerbation other chronic pulmonary heart diseases acute respiratory failure esophageal reflux obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified essential hypertension other dependence on machines, supplemental oxygen acidosis tobacco use disorder personal history of venous thrombosis and embolism coronary atherosclerosis of native coronary artery tobacco use disorder percutaneous transluminal coronary angioplasty status esophageal reflux allergic rhinitis, cause unspecified other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen long-term (current) use of steroids obstructive sleep apnea (adult)(pediatric) long-term (current) use of aspirin unspecified essential hypertension old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident personal history of pulmonary embolism other dependence on machines, supplemental oxygen long-term (current) use of aspirin obstructive sleep apnea (adult)(pediatric) allergic rhinitis, cause unspecified tobacco use disorder percutaneous transluminal coronary angioplasty status unspecified essential hypertension coronary atherosclerosis of native coronary artery esophageal reflux other chronic pulmonary heart diseases chronic obstructive asthma with (acute) exacerbation spinal stenosis, lumbar region, without neurogenic claudication person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident old myocardial infarction person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident tobacco use disorder other chronic pulmonary heart diseases family history of malignant neoplasm of gastrointestinal tract obstructive chronic bronchitis with (acute) exacerbation chronic obstructive asthma, unspecified
black african american f 59 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325  mg ; amlodipine  5  mg ; aspirin  81  mg ; montelukast  10  mg ; nicotine patch  14  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; vitamin d  1000  unit ; albuterol 0.083% neb soln  1  neb ; clotrimazole  1  troc ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (500 50)   1  inh ; gabapentin  300  mg ; atorvastatin  40  mg ; atovaquone suspension  750  mg ; fexofenadine  60  mg ; benzonatate  100  mg ; guaifenesin  5-10  ml ; cepastat (phenol) lozenge  1  loz ; tiotropium bromide  1  cap ; morphine sulfate  2  mg ; hydrochlorothiazide  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
obesity, unspecified chronic obstructive asthma with (acute) exacerbation other chronic pulmonary heart diseases acute respiratory failure esophageal reflux obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified essential hypertension other dependence on machines, supplemental oxygen acidosis tobacco use disorder personal history of venous thrombosis and embolism coronary atherosclerosis of native coronary artery tobacco use disorder percutaneous transluminal coronary angioplasty status esophageal reflux allergic rhinitis, cause unspecified other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen long-term (current) use of steroids obstructive sleep apnea (adult)(pediatric) long-term (current) use of aspirin unspecified essential hypertension old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident personal history of pulmonary embolism other dependence on machines, supplemental oxygen long-term (current) use of aspirin obstructive sleep apnea (adult)(pediatric) allergic rhinitis, cause unspecified tobacco use disorder percutaneous transluminal coronary angioplasty status unspecified essential hypertension coronary atherosclerosis of native coronary artery esophageal reflux other chronic pulmonary heart diseases chronic obstructive asthma with (acute) exacerbation spinal stenosis, lumbar region, without neurogenic claudication person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident old myocardial infarction person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident tobacco use disorder other chronic pulmonary heart diseases family history of malignant neoplasm of gastrointestinal tract obstructive chronic bronchitis with (acute) exacerbation chronic obstructive asthma, unspecified
black african american f 59 $nan$hematology blood hematocrit  41.7  %; hematology blood hemoglobin  14.5  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  49  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  11.1  mg dl; chemistry blood glucose  200  mg dl; chemistry blood lactate dehydrogenase (ld)  426  iu l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325  mg ; amlodipine  5  mg ; aspirin  81  mg ; montelukast  10  mg ; nicotine patch  14  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; vitamin d  1000  unit ; albuterol 0.083% neb soln  1  neb ; clotrimazole  1  troc ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (500 50)   1  inh ; gabapentin  300  mg ; atorvastatin  40  mg ; atovaquone suspension  750  mg ; fexofenadine  60  mg ; benzonatate  100  mg ; guaifenesin  5-10  ml ; cepastat (phenol) lozenge  1  loz ; tiotropium bromide  1  cap ; morphine sulfate  2  mg ; hydrochlorothiazide  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; furosemide  40  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; miconazole powder 2%  1  appl ; 
obesity, unspecified chronic obstructive asthma with (acute) exacerbation other chronic pulmonary heart diseases acute respiratory failure esophageal reflux obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified essential hypertension other dependence on machines, supplemental oxygen acidosis tobacco use disorder personal history of venous thrombosis and embolism coronary atherosclerosis of native coronary artery tobacco use disorder percutaneous transluminal coronary angioplasty status esophageal reflux allergic rhinitis, cause unspecified other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen long-term (current) use of steroids obstructive sleep apnea (adult)(pediatric) long-term (current) use of aspirin unspecified essential hypertension old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident personal history of pulmonary embolism other dependence on machines, supplemental oxygen long-term (current) use of aspirin obstructive sleep apnea (adult)(pediatric) allergic rhinitis, cause unspecified tobacco use disorder percutaneous transluminal coronary angioplasty status unspecified essential hypertension coronary atherosclerosis of native coronary artery esophageal reflux other chronic pulmonary heart diseases chronic obstructive asthma with (acute) exacerbation spinal stenosis, lumbar region, without neurogenic claudication person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident old myocardial infarction person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident tobacco use disorder other chronic pulmonary heart diseases family history of malignant neoplasm of gastrointestinal tract obstructive chronic bronchitis with (acute) exacerbation chronic obstructive asthma, unspecified
black african american f 59 $nan$hematology blood hematocrit  42.7  %; hematology blood hematocrit  39.6  %; hematology blood hemoglobin  14.6  g dl; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  232  k ul; hematology blood platelet count  202  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  10.9  mg dl; chemistry blood calcium, total  10.2  mg dl; chemistry blood glucose  133  mg dl; chemistry blood glucose  148  mg dl; hematology blood bands  0  %; blood gas blood free calcium  1.29  mmol l; blood gas blood lactate  0.9  mmol l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325  mg ; amlodipine  5  mg ; aspirin  81  mg ; montelukast  10  mg ; nicotine patch  14  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; vitamin d  1000  unit ; albuterol 0.083% neb soln  1  neb ; clotrimazole  1  troc ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (500 50)   1  inh ; gabapentin  300  mg ; atorvastatin  40  mg ; atovaquone suspension  750  mg ; fexofenadine  60  mg ; benzonatate  100  mg ; guaifenesin  5-10  ml ; cepastat (phenol) lozenge  1  loz ; tiotropium bromide  1  cap ; morphine sulfate  2  mg ; hydrochlorothiazide  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; furosemide  40  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  1000  ml ; sodium chloride 0.9%  flush  10-20  ml ; albuterol 0.5%  2  ml ; 
obesity, unspecified chronic obstructive asthma with (acute) exacerbation other chronic pulmonary heart diseases acute respiratory failure esophageal reflux obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified essential hypertension other dependence on machines, supplemental oxygen acidosis tobacco use disorder personal history of venous thrombosis and embolism coronary atherosclerosis of native coronary artery tobacco use disorder percutaneous transluminal coronary angioplasty status esophageal reflux allergic rhinitis, cause unspecified other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen long-term (current) use of steroids obstructive sleep apnea (adult)(pediatric) long-term (current) use of aspirin unspecified essential hypertension old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident personal history of pulmonary embolism other dependence on machines, supplemental oxygen long-term (current) use of aspirin obstructive sleep apnea (adult)(pediatric) allergic rhinitis, cause unspecified tobacco use disorder percutaneous transluminal coronary angioplasty status unspecified essential hypertension coronary atherosclerosis of native coronary artery esophageal reflux other chronic pulmonary heart diseases chronic obstructive asthma with (acute) exacerbation spinal stenosis, lumbar region, without neurogenic claudication person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident old myocardial infarction person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident tobacco use disorder other chronic pulmonary heart diseases family history of malignant neoplasm of gastrointestinal tract obstructive chronic bronchitis with (acute) exacerbation chronic obstructive asthma, unspecified
black african american f 59 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  10.6  mg dl; chemistry blood glucose  121  mg dl; blood gas blood free calcium  1.33  mmol l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325  mg ; amlodipine  5  mg ; aspirin  81  mg ; montelukast  10  mg ; nicotine patch  14  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; vitamin d  1000  unit ; albuterol 0.083% neb soln  1  neb ; clotrimazole  1  troc ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (500 50)   1  inh ; gabapentin  300  mg ; atorvastatin  40  mg ; atovaquone suspension  750  mg ; fexofenadine  60  mg ; benzonatate  100  mg ; guaifenesin  5-10  ml ; cepastat (phenol) lozenge  1  loz ; tiotropium bromide  1  cap ; morphine sulfate  2  mg ; hydrochlorothiazide  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10-20  ml ; albuterol 0.5%  2  ml ; senna  8.6  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; 
obesity, unspecified chronic obstructive asthma with (acute) exacerbation other chronic pulmonary heart diseases acute respiratory failure esophageal reflux obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified essential hypertension other dependence on machines, supplemental oxygen acidosis tobacco use disorder personal history of venous thrombosis and embolism coronary atherosclerosis of native coronary artery tobacco use disorder percutaneous transluminal coronary angioplasty status esophageal reflux allergic rhinitis, cause unspecified other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen long-term (current) use of steroids obstructive sleep apnea (adult)(pediatric) long-term (current) use of aspirin unspecified essential hypertension old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident personal history of pulmonary embolism other dependence on machines, supplemental oxygen long-term (current) use of aspirin obstructive sleep apnea (adult)(pediatric) allergic rhinitis, cause unspecified tobacco use disorder percutaneous transluminal coronary angioplasty status unspecified essential hypertension coronary atherosclerosis of native coronary artery esophageal reflux other chronic pulmonary heart diseases chronic obstructive asthma with (acute) exacerbation spinal stenosis, lumbar region, without neurogenic claudication person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident old myocardial infarction person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident tobacco use disorder other chronic pulmonary heart diseases family history of malignant neoplasm of gastrointestinal tract obstructive chronic bronchitis with (acute) exacerbation chronic obstructive asthma, unspecified
black african american f 59 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  10.6  mg dl; chemistry blood glucose  125  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325  mg ; amlodipine  5  mg ; aspirin  81  mg ; montelukast  10  mg ; nicotine patch  14  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; vitamin d  1000  unit ; albuterol 0.083% neb soln  1  neb ; clotrimazole  1  troc ; fluticasone propionate nasal  2  spry ; fluticasone-salmeterol diskus (500 50)   1  inh ; gabapentin  300  mg ; atorvastatin  40  mg ; atovaquone suspension  750  mg ; fexofenadine  60  mg ; benzonatate  100  mg ; guaifenesin  5-10  ml ; cepastat (phenol) lozenge  1  loz ; tiotropium bromide  1  cap ; morphine sulfate  2  mg ; hydrochlorothiazide  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10-20  ml ; albuterol 0.5%  2  ml ; senna  8.6  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; 
obesity, unspecified chronic obstructive asthma with (acute) exacerbation other chronic pulmonary heart diseases acute respiratory failure esophageal reflux obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified essential hypertension other dependence on machines, supplemental oxygen acidosis tobacco use disorder personal history of venous thrombosis and embolism coronary atherosclerosis of native coronary artery tobacco use disorder percutaneous transluminal coronary angioplasty status esophageal reflux allergic rhinitis, cause unspecified other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen long-term (current) use of steroids obstructive sleep apnea (adult)(pediatric) long-term (current) use of aspirin unspecified essential hypertension old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident personal history of pulmonary embolism other dependence on machines, supplemental oxygen long-term (current) use of aspirin obstructive sleep apnea (adult)(pediatric) allergic rhinitis, cause unspecified tobacco use disorder percutaneous transluminal coronary angioplasty status unspecified essential hypertension coronary atherosclerosis of native coronary artery esophageal reflux other chronic pulmonary heart diseases chronic obstructive asthma with (acute) exacerbation spinal stenosis, lumbar region, without neurogenic claudication person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident old myocardial infarction person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident tobacco use disorder other chronic pulmonary heart diseases family history of malignant neoplasm of gastrointestinal tract obstructive chronic bronchitis with (acute) exacerbation chronic obstructive asthma, unspecified
black african american f 59 $nan$hematology blood hematocrit  30.5  %; hematology blood hematocrit  35.5  %; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  151  k ul; hematology blood platelet count  185  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  10.5  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  111  mg dl$heparin  5000  unit ; acetaminophen  325  mg ; amlodipine  5  mg ; aspirin  81  mg ; montelukast  10  mg ; nicotine patch  14  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; vitamin d  1000  unit ; albuterol 0.083% neb soln  1  neb ; fluticasone-salmeterol diskus (500 50)   1  inh ; gabapentin  300  mg ; atorvastatin  40  mg ; atovaquone suspension  750  mg ; fexofenadine  60  mg ; benzonatate  100  mg ; guaifenesin  5-10  ml ; cepastat (phenol) lozenge  1  loz ; tiotropium bromide  1  cap ; morphine sulfate  2  mg ; hydrochlorothiazide  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10-20  ml ; senna  8.6  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; prednisone  50  mg ; 
obesity, unspecified chronic obstructive asthma with (acute) exacerbation other chronic pulmonary heart diseases acute respiratory failure esophageal reflux obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified essential hypertension other dependence on machines, supplemental oxygen acidosis tobacco use disorder personal history of venous thrombosis and embolism coronary atherosclerosis of native coronary artery tobacco use disorder percutaneous transluminal coronary angioplasty status esophageal reflux allergic rhinitis, cause unspecified other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen long-term (current) use of steroids obstructive sleep apnea (adult)(pediatric) long-term (current) use of aspirin unspecified essential hypertension old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident personal history of pulmonary embolism other dependence on machines, supplemental oxygen long-term (current) use of aspirin obstructive sleep apnea (adult)(pediatric) allergic rhinitis, cause unspecified tobacco use disorder percutaneous transluminal coronary angioplasty status unspecified essential hypertension coronary atherosclerosis of native coronary artery esophageal reflux other chronic pulmonary heart diseases chronic obstructive asthma with (acute) exacerbation spinal stenosis, lumbar region, without neurogenic claudication person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident old myocardial infarction person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident tobacco use disorder other chronic pulmonary heart diseases family history of malignant neoplasm of gastrointestinal tract obstructive chronic bronchitis with (acute) exacerbation chronic obstructive asthma, unspecified
black african american f 59 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  10.2  mg dl; chemistry blood glucose  135  mg dl$heparin  5000  unit ; acetaminophen  325  mg ; amlodipine  5  mg ; aspirin  81  mg ; montelukast  10  mg ; nicotine patch  14  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; vitamin d  1000  unit ; albuterol 0.083% neb soln  1  neb ; fluticasone-salmeterol diskus (500 50)   1  inh ; gabapentin  300  mg ; atorvastatin  40  mg ; atovaquone suspension  750  mg ; fexofenadine  60  mg ; benzonatate  100  mg ; guaifenesin  5-10  ml ; cepastat (phenol) lozenge  1  loz ; tiotropium bromide  1  cap ; morphine sulfate  2  mg ; hydrochlorothiazide  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10-20  ml ; senna  8.6  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; prednisone  50  mg ; acetaminophen  1000  mg ; gabapentin  600  mg ; phosphorus  500  mg ; 
obesity, unspecified chronic obstructive asthma with (acute) exacerbation other chronic pulmonary heart diseases acute respiratory failure esophageal reflux obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified essential hypertension other dependence on machines, supplemental oxygen acidosis tobacco use disorder personal history of venous thrombosis and embolism coronary atherosclerosis of native coronary artery tobacco use disorder percutaneous transluminal coronary angioplasty status esophageal reflux allergic rhinitis, cause unspecified other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen long-term (current) use of steroids obstructive sleep apnea (adult)(pediatric) long-term (current) use of aspirin unspecified essential hypertension old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident personal history of pulmonary embolism other dependence on machines, supplemental oxygen long-term (current) use of aspirin obstructive sleep apnea (adult)(pediatric) allergic rhinitis, cause unspecified tobacco use disorder percutaneous transluminal coronary angioplasty status unspecified essential hypertension coronary atherosclerosis of native coronary artery esophageal reflux other chronic pulmonary heart diseases chronic obstructive asthma with (acute) exacerbation spinal stenosis, lumbar region, without neurogenic claudication person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident old myocardial infarction person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident tobacco use disorder other chronic pulmonary heart diseases family history of malignant neoplasm of gastrointestinal tract obstructive chronic bronchitis with (acute) exacerbation chronic obstructive asthma, unspecified
black african american f 59 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  108  mg dl$heparin  5000  unit ; amlodipine  5  mg ; aspirin  81  mg ; montelukast  10  mg ; nicotine patch  14  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; vitamin d  1000  unit ; albuterol 0.083% neb soln  1  neb ; fluticasone-salmeterol diskus (500 50)   1  inh ; atorvastatin  40  mg ; atovaquone suspension  750  mg ; fexofenadine  60  mg ; benzonatate  100  mg ; guaifenesin  5-10  ml ; cepastat (phenol) lozenge  1  loz ; tiotropium bromide  1  cap ; morphine sulfate  2  mg ; hydrochlorothiazide  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10-20  ml ; senna  8.6  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; prednisone  50  mg ; acetaminophen  1000  mg ; gabapentin  600  mg ; phosphorus  500  mg ; morphine sr (ms contin)  15  mg ; prednisone  40  mg ; 
obesity, unspecified chronic obstructive asthma with (acute) exacerbation other chronic pulmonary heart diseases acute respiratory failure esophageal reflux obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified essential hypertension other dependence on machines, supplemental oxygen acidosis tobacco use disorder personal history of venous thrombosis and embolism coronary atherosclerosis of native coronary artery tobacco use disorder percutaneous transluminal coronary angioplasty status esophageal reflux allergic rhinitis, cause unspecified other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen long-term (current) use of steroids obstructive sleep apnea (adult)(pediatric) long-term (current) use of aspirin unspecified essential hypertension old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident personal history of pulmonary embolism other dependence on machines, supplemental oxygen long-term (current) use of aspirin obstructive sleep apnea (adult)(pediatric) allergic rhinitis, cause unspecified tobacco use disorder percutaneous transluminal coronary angioplasty status unspecified essential hypertension coronary atherosclerosis of native coronary artery esophageal reflux other chronic pulmonary heart diseases chronic obstructive asthma with (acute) exacerbation spinal stenosis, lumbar region, without neurogenic claudication person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident old myocardial infarction person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident tobacco use disorder other chronic pulmonary heart diseases family history of malignant neoplasm of gastrointestinal tract obstructive chronic bronchitis with (acute) exacerbation chronic obstructive asthma, unspecified
black african american f 59 $nan$nan$heparin  5000  unit ; amlodipine  5  mg ; aspirin  81  mg ; montelukast  10  mg ; nicotine patch  14  mg ; pantoprazole  40  mg ; ranitidine  150  mg ; vitamin d  1000  unit ; albuterol 0.083% neb soln  1  neb ; fluticasone-salmeterol diskus (500 50)   1  inh ; atorvastatin  40  mg ; atovaquone suspension  750  mg ; fexofenadine  60  mg ; benzonatate  100  mg ; guaifenesin  5-10  ml ; cepastat (phenol) lozenge  1  loz ; tiotropium bromide  1  cap ; hydrochlorothiazide  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10-20  ml ; senna  8.6  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; acetaminophen  1000  mg ; gabapentin  600  mg ; morphine sr (ms contin)  15  mg ; atovaquone suspension  1500  mg ; 
obesity, unspecified chronic obstructive asthma with (acute) exacerbation other chronic pulmonary heart diseases acute respiratory failure esophageal reflux obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified essential hypertension other dependence on machines, supplemental oxygen acidosis tobacco use disorder personal history of venous thrombosis and embolism coronary atherosclerosis of native coronary artery tobacco use disorder percutaneous transluminal coronary angioplasty status esophageal reflux allergic rhinitis, cause unspecified other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen long-term (current) use of steroids obstructive sleep apnea (adult)(pediatric) long-term (current) use of aspirin unspecified essential hypertension old myocardial infarction person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident personal history of pulmonary embolism other dependence on machines, supplemental oxygen long-term (current) use of aspirin obstructive sleep apnea (adult)(pediatric) allergic rhinitis, cause unspecified tobacco use disorder percutaneous transluminal coronary angioplasty status unspecified essential hypertension coronary atherosclerosis of native coronary artery esophageal reflux other chronic pulmonary heart diseases chronic obstructive asthma with (acute) exacerbation spinal stenosis, lumbar region, without neurogenic claudication person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident old myocardial infarction person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident tobacco use disorder other chronic pulmonary heart diseases family history of malignant neoplasm of gastrointestinal tract obstructive chronic bronchitis with (acute) exacerbation chronic obstructive asthma, unspecified
white f 76 $temp  98.2  heartrate  76.0  resprate  15.0  o2sat  99.0  sbp  104.0  dbp  45.0  rhythm    pain  4  $hematology blood hematocrit  40.3  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  337  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  83  mg dl; chemistry blood albumin  3.5  g dl$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; heparin  5000  unit ; acetaminophen  650  mg ; fluticasone propionate nasal  1  spry ; vitamin d  1000  unit ; albuterol 0.083% neb soln  1  neb ; prempro  1  tab ; nicotine patch  21  mg ; bag  1  bag ; magnesium sulfate  2  gm ; 
family history of asthma and other chronic lower respiratory diseases unspecified macular degeneration infectious gastroenteritis and colitis, unspecified chronic obstructive pulmonary disease, unspecified orthostatic hypotension sleep apnea, unspecified polyneuropathy, unspecified family history of ischemic heart disease and other diseases of the circulatory system family history of diabetes mellitus dehydration hypokalemia gastro-esophageal reflux disease without esophagitis major depressive disorder, recurrent, unspecified spinal stenosis, site unspecified other specified noninfective gastroenteritis and colitis nicotine dependence, unspecified, uncomplicated hypo-osmolality and hyponatremia 
white f 76 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  307  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood urea nitrogen  3  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  82  mg dl; chemistry blood glucose  86  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; fluticasone propionate nasal  1  spry ; vitamin d  1000  unit ; albuterol 0.083% neb soln  1  neb ; prempro  1  tab ; nicotine patch  21  mg ; bag  1  bag ; magnesium sulfate  2  gm ; lorazepam  1  mg ; budesonide  9  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; loperamide  4  mg ; neutra-phos  1  pkt ; 
family history of asthma and other chronic lower respiratory diseases unspecified macular degeneration infectious gastroenteritis and colitis, unspecified chronic obstructive pulmonary disease, unspecified orthostatic hypotension sleep apnea, unspecified polyneuropathy, unspecified family history of ischemic heart disease and other diseases of the circulatory system family history of diabetes mellitus dehydration hypokalemia gastro-esophageal reflux disease without esophagitis major depressive disorder, recurrent, unspecified spinal stenosis, site unspecified other specified noninfective gastroenteritis and colitis nicotine dependence, unspecified, uncomplicated hypo-osmolality and hyponatremia 
white f 76 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  306  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  89  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; fluticasone propionate nasal  1  spry ; vitamin d  1000  unit ; albuterol 0.083% neb soln  1  neb ; prempro  1  tab ; nicotine patch  21  mg ; lorazepam  1  mg ; budesonide  9  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; loperamide  4  mg ; neutra-phos  1  pkt ; potassium chloride  20  meq ; neutra-phos  2  pkt ; 
family history of asthma and other chronic lower respiratory diseases unspecified macular degeneration infectious gastroenteritis and colitis, unspecified chronic obstructive pulmonary disease, unspecified orthostatic hypotension sleep apnea, unspecified polyneuropathy, unspecified family history of ischemic heart disease and other diseases of the circulatory system family history of diabetes mellitus dehydration hypokalemia gastro-esophageal reflux disease without esophagitis major depressive disorder, recurrent, unspecified spinal stenosis, site unspecified other specified noninfective gastroenteritis and colitis nicotine dependence, unspecified, uncomplicated hypo-osmolality and hyponatremia 
white f 32 $nan$nan$influenza virus vaccine  0.5  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; simethicone  80  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
white f 32 $nan$nan$influenza virus vaccine  0.5  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; simethicone  80  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
white f 32 $nan$nan$influenza virus vaccine  0.5  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; simethicone  80  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
white m 57 $temp  97.0  heartrate  72.0  resprate  16.0  o2sat  97.0  sbp  120.0  dbp  82.0  rhythm    pain  6  $hematology blood hematocrit  46.2  %; hematology blood hemoglobin  15.1  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  174  mg dl; chemistry blood albumin  4.3  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; senna  8.6  mg ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  10  mg ; simvastatin  20  mg ; finasteride  5  mg ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; insulin  0  unit ; alfuzosin er  10  mg ; 
 
white m 57 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; senna  8.6  mg ; acetaminophen  650  mg ; hydralazine  10  mg ; finasteride  5  mg ; alfuzosin er  10  mg ; simvastatin  40  mg ; 
 
white m 69 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  257  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  3.1  ; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  170  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; heparin  5000  unit ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; warfarin  1  dose ; omeprazole  20  mg ; atorvastatin  40  mg ; clopidogrel  75  mg ; gabapentin  300  mg ; isosorbide mononitrate (extended release)  30  mg ; metformin (glucophage)  1000  mg ; metoprolol tartrate  25  mg ; ns  100  ml ; metronidazole  500  mg ; insulin  0  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; potassium chloride  20  meq ; magnesium oxide  400  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; oxycodone (immediate release)  5  mg ; multivitamins  1  tab ; docusate sodium  100  mg ; polyethylene glycol  17  g ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; ciprofloxacin hcl  500  mg ; 
type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right foot with unspecified severity long term (current) use of anticoagulants acute posthemorrhagic anemia essential (primary) hypertension hyperlipidemia, unspecified presence of prosthetic heart valve essential (primary) hypertension type 2 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of right foot with unspecified severity 
white m 69 $nan$chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  86  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; warfarin  1  dose ; omeprazole  20  mg ; atorvastatin  40  mg ; clopidogrel  75  mg ; gabapentin  300  mg ; isosorbide mononitrate (extended release)  30  mg ; metformin (glucophage)  1000  mg ; metoprolol tartrate  25  mg ; insulin  0  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; potassium chloride  20  meq ; magnesium oxide  400  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; oxycodone (immediate release)  5  mg ; multivitamins  1  tab ; docusate sodium  100  mg ; polyethylene glycol  17  g ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; ciprofloxacin hcl  500  mg ; calcium carbonate  500  mg ; lactated ringers  1000  ml ; 0.45% sodium chloride  1000  ml ; bag  1  bag ; magnesium sulfate  2  gm ; 
type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right foot with unspecified severity long term (current) use of anticoagulants acute posthemorrhagic anemia essential (primary) hypertension hyperlipidemia, unspecified presence of prosthetic heart valve essential (primary) hypertension type 2 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of right foot with unspecified severity 
white m 69 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  116  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; warfarin  1  dose ; omeprazole  20  mg ; atorvastatin  40  mg ; clopidogrel  75  mg ; gabapentin  300  mg ; isosorbide mononitrate (extended release)  30  mg ; metformin (glucophage)  1000  mg ; metoprolol tartrate  25  mg ; insulin  0  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; oxycodone (immediate release)  5  mg ; multivitamins  1  tab ; docusate sodium  100  mg ; polyethylene glycol  17  g ; ciprofloxacin hcl  500  mg ; calcium carbonate  500  mg ; lactated ringers  1000  ml ; bag  1  bag ; magnesium sulfate  2  gm ; hydromorphone (dilaudid)  0.25  mg ; 
type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right foot with unspecified severity long term (current) use of anticoagulants acute posthemorrhagic anemia essential (primary) hypertension hyperlipidemia, unspecified presence of prosthetic heart valve essential (primary) hypertension type 2 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of right foot with unspecified severity 
white m 69 $nan$hematology blood hematocrit  35.8  %; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; warfarin  1  dose ; omeprazole  20  mg ; atorvastatin  40  mg ; clopidogrel  75  mg ; gabapentin  300  mg ; isosorbide mononitrate (extended release)  30  mg ; metformin (glucophage)  1000  mg ; metoprolol tartrate  25  mg ; insulin  0  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; oxycodone (immediate release)  5  mg ; multivitamins  1  tab ; docusate sodium  100  mg ; polyethylene glycol  17  g ; ciprofloxacin hcl  500  mg ; calcium carbonate  500  mg ; hydromorphone (dilaudid)  0.25  mg ; sodium chloride 0.9%  1000  ml ; oxycodone (immediate release)  5-10  mg ; diphenhydramine  12.5  mg ; 
type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right foot with unspecified severity long term (current) use of anticoagulants acute posthemorrhagic anemia essential (primary) hypertension hyperlipidemia, unspecified presence of prosthetic heart valve essential (primary) hypertension type 2 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of right foot with unspecified severity 
white m 69 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; warfarin  1  dose ; omeprazole  20  mg ; atorvastatin  40  mg ; clopidogrel  75  mg ; gabapentin  300  mg ; isosorbide mononitrate (extended release)  30  mg ; metoprolol tartrate  25  mg ; insulin  0  unit ; multivitamins  1  tab ; docusate sodium  100  mg ; polyethylene glycol  17  g ; ciprofloxacin hcl  500  mg ; calcium carbonate  500  mg ; hydromorphone (dilaudid)  0.25  mg ; oxycodone (immediate release)  5-10  mg ; insulin  8  unit ; sarna lotion  1  appl ; 
type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right foot with unspecified severity long term (current) use of anticoagulants acute posthemorrhagic anemia essential (primary) hypertension hyperlipidemia, unspecified presence of prosthetic heart valve essential (primary) hypertension type 2 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of right foot with unspecified severity 
white m 69 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  238  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  139  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; warfarin  1  dose ; omeprazole  20  mg ; atorvastatin  40  mg ; clopidogrel  75  mg ; gabapentin  300  mg ; isosorbide mononitrate (extended release)  30  mg ; metoprolol tartrate  25  mg ; insulin  0  unit ; multivitamins  1  tab ; docusate sodium  100  mg ; polyethylene glycol  17  g ; ciprofloxacin hcl  500  mg ; calcium carbonate  500  mg ; hydromorphone (dilaudid)  0.25  mg ; oxycodone (immediate release)  5-10  mg ; sarna lotion  1  appl ; gabapentin  200  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; 
type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right foot with unspecified severity long term (current) use of anticoagulants acute posthemorrhagic anemia essential (primary) hypertension hyperlipidemia, unspecified presence of prosthetic heart valve essential (primary) hypertension type 2 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of right foot with unspecified severity 
white m 69 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  294  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  229  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; warfarin  1  dose ; omeprazole  20  mg ; atorvastatin  40  mg ; clopidogrel  75  mg ; gabapentin  300  mg ; isosorbide mononitrate (extended release)  30  mg ; metoprolol tartrate  25  mg ; insulin  0  unit ; multivitamins  1  tab ; docusate sodium  100  mg ; polyethylene glycol  17  g ; ciprofloxacin hcl  500  mg ; calcium carbonate  500  mg ; hydromorphone (dilaudid)  0.25  mg ; oxycodone (immediate release)  5-10  mg ; sarna lotion  1  appl ; gabapentin  200  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; warfarin  8  mg ; fexofenadine  180  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ondansetron  4  mg ; acetaminophen  650  mg ; lorazepam  0.5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; labetalol  5-10  mg ; metformin (glucophage)  500  mg ; metoprolol succinate xl  25  mg ; 
type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right foot with unspecified severity long term (current) use of anticoagulants acute posthemorrhagic anemia essential (primary) hypertension hyperlipidemia, unspecified presence of prosthetic heart valve essential (primary) hypertension type 2 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of right foot with unspecified severity 
white m 69 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  298  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood glucose  186  mg dl$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; gabapentin  200  mg ; fexofenadine  180  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ondansetron  4  mg ; acetaminophen  650  mg ; lorazepam  0.5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; labetalol  5-10  mg ; metformin (glucophage)  500  mg ; metoprolol succinate xl  25  mg ; sodium chloride nasal  1-2  spry ; lidocaine jelly 2% (urojet)  1  appl ; bisacodyl  10  mg ; 
type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right foot with unspecified severity long term (current) use of anticoagulants acute posthemorrhagic anemia essential (primary) hypertension hyperlipidemia, unspecified presence of prosthetic heart valve essential (primary) hypertension type 2 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of right foot with unspecified severity 
white m 69 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  180  mg dl$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; gabapentin  200  mg ; fexofenadine  180  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ondansetron  4  mg ; acetaminophen  650  mg ; lorazepam  0.5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; labetalol  5-10  mg ; metformin (glucophage)  500  mg ; metoprolol succinate xl  25  mg ; sodium chloride nasal  1-2  spry ; lidocaine jelly 2% (urojet)  1  appl ; bisacodyl  10  mg ; tamsulosin  0.4  mg ; 
type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right foot with unspecified severity long term (current) use of anticoagulants acute posthemorrhagic anemia essential (primary) hypertension hyperlipidemia, unspecified presence of prosthetic heart valve essential (primary) hypertension type 2 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of right foot with unspecified severity 
white m 69 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  302  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  179  mg dl$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; gabapentin  200  mg ; fexofenadine  180  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ondansetron  4  mg ; acetaminophen  650  mg ; lorazepam  0.5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; labetalol  5-10  mg ; metformin (glucophage)  500  mg ; metoprolol succinate xl  25  mg ; sodium chloride nasal  1-2  spry ; bisacodyl  10  mg ; tamsulosin  0.4  mg ; 
type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right foot with unspecified severity long term (current) use of anticoagulants acute posthemorrhagic anemia essential (primary) hypertension hyperlipidemia, unspecified presence of prosthetic heart valve essential (primary) hypertension type 2 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of right foot with unspecified severity 
white m 69 $nan$nan$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; gabapentin  200  mg ; fexofenadine  180  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ondansetron  4  mg ; acetaminophen  650  mg ; lorazepam  0.5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; labetalol  5-10  mg ; metformin (glucophage)  500  mg ; metoprolol succinate xl  25  mg ; sodium chloride nasal  1-2  spry ; bisacodyl  10  mg ; tamsulosin  0.4  mg ; enoxaparin sodium  80  mg ; 
type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene non-pressure chronic ulcer of other part of right foot with unspecified severity long term (current) use of anticoagulants acute posthemorrhagic anemia essential (primary) hypertension hyperlipidemia, unspecified presence of prosthetic heart valve essential (primary) hypertension type 2 diabetes mellitus with foot ulcer non-pressure chronic ulcer of other part of right foot with unspecified severity 
white f 43 $temp  98.3  heartrate  77.0  resprate  16.0  o2sat  97.0  sbp  111.0  dbp  61.0  rhythm    pain  6  $hematology blood hematocrit  29.4  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  202  k ul$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; 5% dextrose  50  ml ; clindamycin  600  mg ; 5% dextrose  500  ml ; vancomycin  1500  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; ketorolac  15  mg ; 
 
white f 43 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  223  k ul$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; 5% dextrose  500  ml ; vancomycin  1500  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; ketorolac  15  mg ; levothyroxine sodium  264  mcg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; 
 
white f 43 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  228  k ul; hematology blood bands  1  %$ibuprofen  600  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; oxycodone (immediate release)   5  mg ; lorazepam  0.5  mg ; 
 
white f 43 $nan$nan$ibuprofen  600  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; oxycodone (immediate release)   5  mg ; lorazepam  0.5  mg ; amoxicillin-clavulanic acid  875  mg ; sulfameth trimethoprim ds  1  tab ; amoxicillin  1000  mg ; 
 
white m 53 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5  mg ; pantoprazole  40  mg ; acetaminophen  500-1000  mg ; aspirin  325  mg ; 
 
other f 27 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; dermoplast spray  1  spry ; 
abnormality in fetal heart rate or rhythm, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn first-degree perineal laceration, delivered, with or without mention of antepartum condition hypertonic, incoordinate, or prolonged uterine contractions, delivered, with or without mention of antepartum condition cord around neck, with compression, complicating labor and delivery, delivered, with or without mention of antepartum condition carrier or suspected carrier of group b streptococcus
other f 27 $nan$hematology blood hematocrit  33.4  %$sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; dermoplast spray  1  spry ; 
abnormality in fetal heart rate or rhythm, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn first-degree perineal laceration, delivered, with or without mention of antepartum condition hypertonic, incoordinate, or prolonged uterine contractions, delivered, with or without mention of antepartum condition cord around neck, with compression, complicating labor and delivery, delivered, with or without mention of antepartum condition carrier or suspected carrier of group b streptococcus
other f 27 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; dermoplast spray  1  spry ; 
abnormality in fetal heart rate or rhythm, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn first-degree perineal laceration, delivered, with or without mention of antepartum condition hypertonic, incoordinate, or prolonged uterine contractions, delivered, with or without mention of antepartum condition cord around neck, with compression, complicating labor and delivery, delivered, with or without mention of antepartum condition carrier or suspected carrier of group b streptococcus
unknown f 86 $nan$nan$sodium chloride 0.9%  flush  3  ml ; citalopram  10  mg ; donepezil  5  mg ; doxycycline hyclate  100  mg ; vial  1  vial ; pantoprazole  40  mg ; atenolol  50  mg ; dicyclomine  20  mg ; multivitamins  1  tab ; 

unknown f 86 $nan$nan$sodium chloride 0.9%  flush  3  ml ; citalopram  10  mg ; donepezil  5  mg ; vial  1  vial ; pantoprazole  40  mg ; atenolol  50  mg ; dicyclomine  20  mg ; multivitamins  1  tab ; bag  1  bag ; magnesium sulfate  2  gm ; 

unknown f 86 $nan$nan$sodium chloride 0.9%  flush  3  ml ; citalopram  10  mg ; donepezil  5  mg ; vial  1  vial ; pantoprazole  40  mg ; atenolol  50  mg ; dicyclomine  20  mg ; multivitamins  1  tab ; bag  1  bag ; magnesium sulfate  2  gm ; sarna lotion  1  appl ; sodium chloride 0.9%  1000  ml ; moviprep  1  l ; 

unknown f 86 $nan$nan$sodium chloride 0.9%  flush  3  ml ; citalopram  10  mg ; donepezil  5  mg ; vial  1  vial ; pantoprazole  40  mg ; atenolol  50  mg ; dicyclomine  20  mg ; multivitamins  1  tab ; sarna lotion  1  appl ; sodium chloride 0.9%  1000  ml ; moviprep  1  l ; magnesium citrate  300  ml ; 

unknown f 86 $nan$nan$sodium chloride 0.9%  flush  3  ml ; citalopram  10  mg ; donepezil  5  mg ; vial  1  vial ; pantoprazole  40  mg ; atenolol  50  mg ; multivitamins  1  tab ; sarna lotion  1  appl ; potassium chloride  40  meq ; 

white f 18 $nan$hematology blood hematocrit  39.0  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  323  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology urine wbc  3-5  # hpf; chemistry blood calcium, total  10.1  mg dl; chemistry blood glucose  104  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$nan
 
black african american f 24 $nan$nan$prenatal vitamins  1  tab ; docusate sodium  100  mg ; acetaminophen  650  mg ; albuterol inhaler  1-2  puff ; famotidine  20  mg ; montelukast  10  mg ; tiotropium bromide  1  cap ; loratadine  10  mg ; pantoprazole  40  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; 
asthma, unspecified type, with (acute) exacerbation obesity complicating pregnancy, childbirth, or the puerperium, antepartum condition or complication pedal cycle passenger injured in collision with fixed or stationary object in traffic accident pedal cycle driver injured in noncollision transport accident in nontraffic accident body mass index 50.0-59.9, adult other current conditions classifiable elsewhere of mother, antepartum condition or complication esophageal reflux family history of diabetes mellitus family history of asthma morbid obesity benign essential hypertension complicating pregnancy, childbirth, and the puerperium, antepartum condition or complication obesity complicating pregnancy, childbirth, or the puerperium, antepartum condition or complication leukocytosis, unspecified morbid obesity extrinsic asthma with (acute) exacerbation other diseases of vocal cords esophageal reflux adrenal cortical steroids causing adverse effects in therapeutic use other current conditions classifiable elsewhere of mother, antepartum condition or complication body mass index 50.0-59.9, adult abnormal glucose tolerance of mother, antepartum condition or complication other current conditions classifiable elsewhere of mother, antepartum condition or complication asthma, unspecified type, with (acute) exacerbation unspecified hypertension complicating pregnancy, childbirth, or the puerperium, antepartum condition or complication pulmonary eosinophilia obesity complicating pregnancy, childbirth, or the puerperium, antepartum condition or complication body mass index 50.0-59.9, adult mental disorders of mother, antepartum condition or complication abnormal glucose tolerance of mother, antepartum condition or complication morbid obesity adrenal cortical steroids causing adverse effects in therapeutic use asthma, unspecified type, with (acute) exacerbation other current conditions classifiable elsewhere of mother, antepartum condition or complication chest pain, unspecified depressive disorder, not elsewhere classified other current conditions classifiable elsewhere of mother, antepartum condition or complication other cardiovascular diseases of mother, antepartum condition or complication body mass index 50.0-59.9, adult dysuria depressive disorder, not elsewhere classified acute kidney failure, unspecified morbid obesity acidosis acute respiratory failure obesity complicating pregnancy, childbirth, or the puerperium, antepartum condition or complication anxiety state, unspecified other specified cardiac dysrhythmias unspecified renal disease in pregnancy, without mention of hypertension, antepartum condition or complication
other m 38 $temp  97.3  heartrate  87.0  resprate  18.0  o2sat  99.0  sbp  134.0  dbp  94.0  rhythm    pain  8  ; temp  97.7  heartrate  78.0  resprate  15.0  o2sat  97.0  sbp  125.0  dbp  70.0  rhythm    pain    ; temp  97.4  heartrate  87.0  resprate    o2sat  98.0  sbp  147.0  dbp  59.0  rhythm    pain    $hematology blood hematocrit  40.3  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  292  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  102  mg dl; chemistry blood albumin  4.2  g dl$nan
obesity, unspecified body mass index (bmi) 34.0-34.9, adult incisional hernia without obstruction or gangrene bariatric surgery status
white m 77 $nan$nan$insulin  35  unit ; nephrocaps  1  cap ; clopidogrel  75  mg ; allopurinol  100  mg ; metoprolol succinate xl  50  mg ; simvastatin  40  mg ; 
other toe(s) amputation status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease aortocoronary bypass status end stage renal disease congestive heart failure, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft atherosclerosis of native arteries of the extremities with ulceration polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled ulcer of other part of foot personal history of other malignant neoplasm of skin 
white m 77 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  8.6  mg dl; chemistry blood potassium  6.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  74  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  124  mg dl$insulin  35  unit ; nephrocaps  1  cap ; clopidogrel  75  mg ; allopurinol  100  mg ; metoprolol succinate xl  50  mg ; simvastatin  40  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; sevelamer carbonate  800  mg ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; sodium polystyrene sulfonate  30  gm ; zolpidem tartrate  5  mg ; 
other toe(s) amputation status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease aortocoronary bypass status end stage renal disease congestive heart failure, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft atherosclerosis of native arteries of the extremities with ulceration polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled ulcer of other part of foot personal history of other malignant neoplasm of skin 
white m 77 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  280  k ul$insulin  35  unit ; nephrocaps  1  cap ; clopidogrel  75  mg ; allopurinol  100  mg ; metoprolol succinate xl  50  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; sevelamer carbonate  800  mg ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; 
other toe(s) amputation status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease aortocoronary bypass status end stage renal disease congestive heart failure, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft atherosclerosis of native arteries of the extremities with ulceration polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled ulcer of other part of foot personal history of other malignant neoplasm of skin 
white m 77 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  258  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  7.9  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  63  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  111  mg dl$insulin  35  unit ; nephrocaps  1  cap ; clopidogrel  75  mg ; allopurinol  100  mg ; metoprolol succinate xl  50  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; sevelamer carbonate  800  mg ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; 
other toe(s) amputation status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease aortocoronary bypass status end stage renal disease congestive heart failure, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft atherosclerosis of native arteries of the extremities with ulceration polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled ulcer of other part of foot personal history of other malignant neoplasm of skin 
white m 77 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  9.0  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  80  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  166  mg dl$nephrocaps  1  cap ; clopidogrel  75  mg ; allopurinol  100  mg ; metoprolol succinate xl  50  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; sevelamer carbonate  800  mg ; metronidazole (flagyl)  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; 
other toe(s) amputation status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease aortocoronary bypass status end stage renal disease congestive heart failure, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft atherosclerosis of native arteries of the extremities with ulceration polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled ulcer of other part of foot personal history of other malignant neoplasm of skin 
white m 77 $nan$nan$nephrocaps  1  cap ; clopidogrel  75  mg ; allopurinol  100  mg ; metoprolol succinate xl  50  mg ; simvastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; sevelamer carbonate  800  mg ; metronidazole (flagyl)  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; 
other toe(s) amputation status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease aortocoronary bypass status end stage renal disease congestive heart failure, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft atherosclerosis of native arteries of the extremities with ulceration polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled ulcer of other part of foot personal history of other malignant neoplasm of skin 
white f 88 $temp  97.2  heartrate  71.0  resprate  20.0  o2sat  97.0  sbp  183.0  dbp  86.0  rhythm    pain  0  ; temp    heartrate  82.0  resprate  21.0  o2sat  98.0  sbp  171.0  dbp  90.0  rhythm    pain    ; temp    heartrate  78.0  resprate  18.0  o2sat  94.0  sbp  194.0  dbp  79.0  rhythm    pain  0  ; temp    heartrate  76.0  resprate  22.0  o2sat  97.0  sbp  151.0  dbp  62.0  rhythm    pain  0  ; temp    heartrate  74.0  resprate  18.0  o2sat  98.0  sbp  124.0  dbp  73.0  rhythm    pain  0  ; temp    heartrate  68.0  resprate  18.0  o2sat  95.0  sbp  155.0  dbp  62.0  rhythm    pain    ; temp  98.2  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    $hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  108  mg dl; chemistry blood albumin  3.9  g dl; blood gas blood lactate  1.9  mmol l$nan
pain in right knee hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease epilepsy, unspecified, not intractable, without status epilepticus hypothyroidism, unspecified do not resuscitate herpesviral encephalitis encounter for immunization chronic kidney disease, unspecified syndrome of inappropriate secretion of antidiuretic hormone physical restraint status personal history of nicotine dependence personal history of other malignant neoplasm of skin other chronic pain body mass index (bmi) 37.0-37.9, adult obesity, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of other malignant neoplasm of kidney diverticulosis of intestine, part unspecified, without perforation or abscess without bleeding other specified disorders of veins hypothyroidism, unspecified unspecified place or not applicable irritable bowel syndrome without diarrhea exposure to other specified factors, initial encounter personal history of pneumonia (recurrent) pneumonia, unspecified organism chronic kidney disease, stage 3 (moderate) constipation, unspecified other foreign object in bronchus causing other injury, initial encounter personal history of nicotine dependence unspecified essential hypertension calculus of bile duct without mention of cholecystitis, without mention of obstruction personal history of tobacco use personal history of malignant neoplasm of kidney other specified cardiac dysrhythmias acquired absence of kidney obesity, unspecified anemia, unspecified irritable bowel syndrome
white f 88 $temp  98.3  heartrate  67.0  resprate  16.0  o2sat  97.0  sbp  162.0  dbp  61.0  rhythm    pain  1  ; temp  98.1  heartrate  64.0  resprate  18.0  o2sat  98.0  sbp  121.0  dbp  52.0  rhythm    pain  0  $hematology blood hematocrit  35.5  %; hematology blood hematocrit  30.7  %; hematology blood hemoglobin  12.0  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  161  k ul; hematology blood platelet count  144  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  10.1  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; vitamin d  1000  unit ; sertraline  25  mg ; sertraline  50  mg ; triamcinolone acetonide 0.1% cream  1  appl ; lacosamide  200  mg ; levetiracetam  1500  mg ; multivitamins  1  tab ; ipratropium-albuterol neb  1  neb ; labetalol  100  mg ; labetalol  200  mg ; levothyroxine sodium  100  mcg ; heparin  5000  unit ; lorazepam  1-2  mg ; vial  1  vial ; ceftriaxone  1  gm ; levetiracetam  1000  mg ; ramelteon  8  mg ; 
pain in right knee hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease epilepsy, unspecified, not intractable, without status epilepticus hypothyroidism, unspecified do not resuscitate herpesviral encephalitis encounter for immunization chronic kidney disease, unspecified syndrome of inappropriate secretion of antidiuretic hormone physical restraint status personal history of nicotine dependence personal history of other malignant neoplasm of skin other chronic pain body mass index (bmi) 37.0-37.9, adult obesity, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of other malignant neoplasm of kidney diverticulosis of intestine, part unspecified, without perforation or abscess without bleeding other specified disorders of veins hypothyroidism, unspecified unspecified place or not applicable irritable bowel syndrome without diarrhea exposure to other specified factors, initial encounter personal history of pneumonia (recurrent) pneumonia, unspecified organism chronic kidney disease, stage 3 (moderate) constipation, unspecified other foreign object in bronchus causing other injury, initial encounter personal history of nicotine dependence unspecified essential hypertension calculus of bile duct without mention of cholecystitis, without mention of obstruction personal history of tobacco use personal history of malignant neoplasm of kidney other specified cardiac dysrhythmias acquired absence of kidney obesity, unspecified anemia, unspecified irritable bowel syndrome
white f 88 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; vitamin d  1000  unit ; sertraline  25  mg ; sertraline  50  mg ; triamcinolone acetonide 0.1% cream  1  appl ; lacosamide  200  mg ; multivitamins  1  tab ; ipratropium-albuterol neb  1  neb ; labetalol  100  mg ; labetalol  200  mg ; levothyroxine sodium  100  mcg ; heparin  5000  unit ; lorazepam  1-2  mg ; vial  1  vial ; ceftriaxone  1  gm ; levetiracetam  1000  mg ; ramelteon  8  mg ; levetiracetam - stat dose  1500  mg ; lacosamide  50  mg ; 
pain in right knee hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease epilepsy, unspecified, not intractable, without status epilepticus hypothyroidism, unspecified do not resuscitate herpesviral encephalitis encounter for immunization chronic kidney disease, unspecified syndrome of inappropriate secretion of antidiuretic hormone physical restraint status personal history of nicotine dependence personal history of other malignant neoplasm of skin other chronic pain body mass index (bmi) 37.0-37.9, adult obesity, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of other malignant neoplasm of kidney diverticulosis of intestine, part unspecified, without perforation or abscess without bleeding other specified disorders of veins hypothyroidism, unspecified unspecified place or not applicable irritable bowel syndrome without diarrhea exposure to other specified factors, initial encounter personal history of pneumonia (recurrent) pneumonia, unspecified organism chronic kidney disease, stage 3 (moderate) constipation, unspecified other foreign object in bronchus causing other injury, initial encounter personal history of nicotine dependence unspecified essential hypertension calculus of bile duct without mention of cholecystitis, without mention of obstruction personal history of tobacco use personal history of malignant neoplasm of kidney other specified cardiac dysrhythmias acquired absence of kidney obesity, unspecified anemia, unspecified irritable bowel syndrome
white f 88 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  123  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  97  mg dl; chemistry blood glucose  99  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; vitamin d  1000  unit ; sertraline  25  mg ; sertraline  50  mg ; triamcinolone acetonide 0.1% cream  1  appl ; multivitamins  1  tab ; ipratropium-albuterol neb  1  neb ; levothyroxine sodium  100  mcg ; heparin  5000  unit ; lorazepam  1-2  mg ; vial  1  vial ; ceftriaxone  1  gm ; ramelteon  8  mg ; levetiracetam - stat dose  1500  mg ; lacosamide  50  mg ; bag  1  bag ; magnesium sulfate  2  gm ; artificial tears  1-2  drop ; 
pain in right knee hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease epilepsy, unspecified, not intractable, without status epilepticus hypothyroidism, unspecified do not resuscitate herpesviral encephalitis encounter for immunization chronic kidney disease, unspecified syndrome of inappropriate secretion of antidiuretic hormone physical restraint status personal history of nicotine dependence personal history of other malignant neoplasm of skin other chronic pain body mass index (bmi) 37.0-37.9, adult obesity, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of other malignant neoplasm of kidney diverticulosis of intestine, part unspecified, without perforation or abscess without bleeding other specified disorders of veins hypothyroidism, unspecified unspecified place or not applicable irritable bowel syndrome without diarrhea exposure to other specified factors, initial encounter personal history of pneumonia (recurrent) pneumonia, unspecified organism chronic kidney disease, stage 3 (moderate) constipation, unspecified other foreign object in bronchus causing other injury, initial encounter personal history of nicotine dependence unspecified essential hypertension calculus of bile duct without mention of cholecystitis, without mention of obstruction personal history of tobacco use personal history of malignant neoplasm of kidney other specified cardiac dysrhythmias acquired absence of kidney obesity, unspecified anemia, unspecified irritable bowel syndrome
white f 88 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; vitamin d  1000  unit ; sertraline  25  mg ; sertraline  50  mg ; triamcinolone acetonide 0.1% cream  1  appl ; multivitamins  1  tab ; ipratropium-albuterol neb  1  neb ; levothyroxine sodium  100  mcg ; heparin  5000  unit ; lorazepam  1-2  mg ; vial  1  vial ; ceftriaxone  1  gm ; ramelteon  8  mg ; artificial tears  1-2  drop ; 
pain in right knee hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease epilepsy, unspecified, not intractable, without status epilepticus hypothyroidism, unspecified do not resuscitate herpesviral encephalitis encounter for immunization chronic kidney disease, unspecified syndrome of inappropriate secretion of antidiuretic hormone physical restraint status personal history of nicotine dependence personal history of other malignant neoplasm of skin other chronic pain body mass index (bmi) 37.0-37.9, adult obesity, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of other malignant neoplasm of kidney diverticulosis of intestine, part unspecified, without perforation or abscess without bleeding other specified disorders of veins hypothyroidism, unspecified unspecified place or not applicable irritable bowel syndrome without diarrhea exposure to other specified factors, initial encounter personal history of pneumonia (recurrent) pneumonia, unspecified organism chronic kidney disease, stage 3 (moderate) constipation, unspecified other foreign object in bronchus causing other injury, initial encounter personal history of nicotine dependence unspecified essential hypertension calculus of bile duct without mention of cholecystitis, without mention of obstruction personal history of tobacco use personal history of malignant neoplasm of kidney other specified cardiac dysrhythmias acquired absence of kidney obesity, unspecified anemia, unspecified irritable bowel syndrome
white f 88 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; vitamin d  1000  unit ; sertraline  25  mg ; sertraline  50  mg ; triamcinolone acetonide 0.1% cream  1  appl ; multivitamins  1  tab ; ipratropium-albuterol neb  1  neb ; levothyroxine sodium  100  mcg ; heparin  5000  unit ; lorazepam  1-2  mg ; vial  1  vial ; ceftriaxone  1  gm ; ramelteon  8  mg ; artificial tears  1-2  drop ; 
pain in right knee hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease epilepsy, unspecified, not intractable, without status epilepticus hypothyroidism, unspecified do not resuscitate herpesviral encephalitis encounter for immunization chronic kidney disease, unspecified syndrome of inappropriate secretion of antidiuretic hormone physical restraint status personal history of nicotine dependence personal history of other malignant neoplasm of skin other chronic pain body mass index (bmi) 37.0-37.9, adult obesity, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of other malignant neoplasm of kidney diverticulosis of intestine, part unspecified, without perforation or abscess without bleeding other specified disorders of veins hypothyroidism, unspecified unspecified place or not applicable irritable bowel syndrome without diarrhea exposure to other specified factors, initial encounter personal history of pneumonia (recurrent) pneumonia, unspecified organism chronic kidney disease, stage 3 (moderate) constipation, unspecified other foreign object in bronchus causing other injury, initial encounter personal history of nicotine dependence unspecified essential hypertension calculus of bile duct without mention of cholecystitis, without mention of obstruction personal history of tobacco use personal history of malignant neoplasm of kidney other specified cardiac dysrhythmias acquired absence of kidney obesity, unspecified anemia, unspecified irritable bowel syndrome
other m 62 $nan$hematology blood hematocrit  39.8  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  368  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  119  mg dl$dexamethasone  4  mg ; rivaroxaban  15  mg ; acetaminophen  650  mg ; oxycodone (immediate release)  5  mg ; ondansetron odt  4  mg ; ondansetron  4  mg ; vitamin d  1000  unit ; sodium chloride 0.9%  flush  3-10  ml ; tamsulosin  0.4  mg ; lidocaine 5% patch  1  ptch ; amlodipine  5  mg ; tiotropium bromide  1  cap ; bisacodyl  10  mg ; 
 
other m 62 $nan$nan$cyanocobalamin  200  mcg ; cyanocobalamin  1000  mcg ; 
 
other m 62 $nan$nan$ranitidine  150  mg ; 
 
other m 62 $nan$hematology blood hematocrit  37.0  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  373  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl$ranitidine  150  mg ; hydralazine  25  mg ; amlodipine  10  mg ; 
 
other m 62 $nan$nan$ranitidine  150  mg ; amlodipine  10  mg ; 
 
white f 36 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  276  k ul$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
white f 36 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; ibuprofen  600  mg ; 
 
white f 36 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; ibuprofen  600  mg ; 
 
white f 36 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; ibuprofen  600  mg ; 
 
white f 36 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; ibuprofen  600  mg ; 
 
white m 71 $temp  97.6  heartrate  84.0  resprate  18.0  o2sat  98.0  sbp  134.0  dbp  58.0  rhythm    pain    $nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; acetaminophen  325-650  mg ; morphine sulfate  2-4  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; omeprazole  20  mg ; simvastatin  20  mg ; hydrocodone-acetaminophen (5mg-500mg  1-2  tab ; 
 
white m 68 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.6  g dl; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  129  mg dl; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.21  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  0.8  mmol l; blood gas blood chloride, whole blood  105  meq l; blood gas blood glucose  102  mg dl; blood gas blood glucose  111  mg dl; blood gas blood glucose  127  mg dl; blood gas blood glucose  126  mg dl; blood gas blood glucose  120  mg dl; blood gas blood hematocrit, calculated  41  %; blood gas blood hematocrit, calculated  33  %; blood gas blood hematocrit, calculated  33  %; blood gas blood hemoglobin  13.7  g dl; blood gas blood hemoglobin  10.9  g dl; blood gas blood hemoglobin  11.0  g dl; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  4.9  meq l; blood gas blood potassium, whole blood  4.9  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood sodium, whole blood  137  meq l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; omeprazole  20  mg ; acetaminophen  325-650  mg ; mupirocin ointment 2%  1  appl ; acetaminophen  1000  mg ; acetaminophen  325  mg ; metoprolol tartrate  12.5  mg ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; propofol  200  mg ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; syringe (iso-osmotic dextrose)  50  ml ; phenylephrine  12  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; fentanyl citrate  12.5-50  mcg ; ondansetron  4  mg ; oxycodone (immediate release)  5-10  mg ; 
 
white m 68 $nan$hematology blood hematocrit  31.9  %; hematology blood hematocrit  28.3  %; hematology blood hemoglobin  11.1  g dl; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  210  k ul; hematology blood platelet count  167  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  118  mg dl; chemistry blood glucose  169  mg dl; blood gas blood free calcium  1.20  mmol l; blood gas blood free calcium  1.05  mmol l; blood gas blood free calcium  1.06  mmol l; blood gas blood glucose  188  mg dl; blood gas blood glucose  155  mg dl; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  3.9  meq l$sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; propofol  200  mg ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; syringe (iso-osmotic dextrose)  50  ml ; phenylephrine  12  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; fentanyl citrate  12.5-50  mcg ; ondansetron  4  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen iv  1000  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; albumin 5% (25g   500ml)  25  g ; ketorolac  15  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium  100  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; insulin glargine  (cvicu protocol)  0-50  unit ; insulin  0-10  unit ; metoprolol tartrate  25  mg ; hydromorphone (dilaudid)  2-4  mg ; aspirin ec  81  mg ; milk of magnesia  30  ml ; furosemide  20  mg ; insulin  20  unit ; 
 
white m 68 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  138  mg dl$acetaminophen  650  mg ; ondansetron  4  mg ; acetaminophen iv  1000  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ketorolac  15  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; metoprolol tartrate  25  mg ; hydromorphone (dilaudid)  2-4  mg ; aspirin ec  81  mg ; milk of magnesia  30  ml ; furosemide  20  mg ; insulin  20  unit ; bisacodyl  10  mg ; insulin  0  unit ; bag  1  bag ; 
 
white m 68 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood glucose  105  mg dl$acetaminophen  650  mg ; ondansetron  4  mg ; acetaminophen iv  1000  mg ; ketorolac  15  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; metoprolol tartrate  25  mg ; hydromorphone (dilaudid)  2-4  mg ; aspirin ec  81  mg ; milk of magnesia  30  ml ; furosemide  20  mg ; insulin  20  unit ; bisacodyl  10  mg ; insulin  0  unit ; bag  1  bag ; 
 
white m 68 $nan$hematology blood hematocrit  30.9  %; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood glucose  101  mg dl$acetaminophen  650  mg ; ondansetron  4  mg ; acetaminophen iv  1000  mg ; ketorolac  15  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; hydromorphone (dilaudid)  2-4  mg ; aspirin ec  81  mg ; milk of magnesia  30  ml ; furosemide  20  mg ; insulin  20  unit ; bisacodyl  10  mg ; insulin  0  unit ; 
 
white m 68 $nan$nan$acetaminophen  650  mg ; ondansetron  4  mg ; acetaminophen iv  1000  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; hydromorphone (dilaudid)  2-4  mg ; aspirin ec  81  mg ; milk of magnesia  30  ml ; furosemide  20  mg ; bisacodyl  10  mg ; 
 
white f 71 $temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  0  $hematology blood hematocrit  33.9  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  153  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  6  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  2.5  mg dl; chemistry blood glucose  131  mg dl$iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; lactated ringers  1000  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; atorvastatin  40  mg ; magnesium oxide  400  mg ; metoprolol succinate xl  50  mg ; d5 1 2ns  1000  ml ; tramadol  25  mg ; 
 
white f 71 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  152  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  88  mg dl; chemistry blood albumin  3.5  g dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; atorvastatin  40  mg ; magnesium oxide  400  mg ; metoprolol succinate xl  50  mg ; tramadol  25  mg ; fleet enema (saline)  1  enema ; 
 
white f 71 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  163  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  82  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; atorvastatin  40  mg ; magnesium oxide  400  mg ; metoprolol succinate xl  50  mg ; tramadol  25  mg ; senna  8.6  mg ; 
 
white f 71 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; atorvastatin  40  mg ; magnesium oxide  400  mg ; tramadol  25  mg ; senna  8.6  mg ; 
 
white m 65 $nan$hematology blood hematocrit  40.1  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  103  mg dl$heparin  300  unit ; heparin  1000  unit ; d5w  250  ml ; heparin sodium  25,000  unit ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; acetaminophen  500-1000  mg ; senna  1  tab ; omeprazole  40  mg ; docusate sodium  100  mg ; atenolol  12.5  mg ; valsartan  320  mg ; hydrochlorothiazide  25  mg ; simvastatin  20  mg ; aspirin  81  mg ; multivitamins  1  tab ; warfarin  5  mg ; 
 
white m 65 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; acetaminophen  500-1000  mg ; senna  1  tab ; omeprazole  40  mg ; docusate sodium  100  mg ; atenolol  12.5  mg ; valsartan  320  mg ; hydrochlorothiazide  25  mg ; simvastatin  20  mg ; aspirin  81  mg ; multivitamins  1  tab ; warfarin  5  mg ; 
 
white m 68 $nan$hematology blood hematocrit  41.4  %; hematology blood hemoglobin  14.5  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  104  mg dl; chemistry blood lactate dehydrogenase (ld)  168  iu l; chemistry blood albumin  4.2  g dl; blood gas blood lactate  1.3  mmol l$nan
personal history of contact with and (suspected) exposure to asbestos orthostatic hypotension unspecified pleural effusion abdominal pain, right upper quadrant other diseases of lung, not elsewhere classified unspecified cataract other and unspecified alcohol dependence, in remission unspecified viral hepatitis c without hepatic coma eosinophilia acute kidney failure, unspecified pneumonia, organism unspecified scoliosis [and kyphoscoliosis], idiopathic hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified sinusitis (chronic) loss of weight unspecified essential hypertension nonspecific reaction to tuberculin skin test without active tuberculosis fall from other slipping, tripping, or stumbling chronic airway obstruction, not elsewhere classified constipation, unspecified candidal esophagitis cyst of kidney, acquired tobacco use disorder transient alteration of awareness fever, unspecified unspecified viral hepatitis c without hepatic coma hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) benign essential hypertension pneumonia, organism unspecified abdominal pain, generalized tobacco use disorder constipation, unspecified chronic airway obstruction, not elsewhere classified dysthymic disorder dehydration neoplasm of unspecified nature of bone, soft tissue, and skin other and unspecified hyperlipidemia acute kidney failure with lesion of tubular necrosis other diseases of lung, not elsewhere classified esophageal reflux cystic kidney disease, unspecified unspecified sinusitis (chronic) hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics chronic airway obstruction, not elsewhere classified poisoning by salicylates poisoning by other and unspecified anticonvulsants
white m 68 $nan$hematology blood hematocrit  37.9  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  137  mg dl$0.45% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin  5000  unit ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  1  spry ; atorvastatin  80  mg ; montelukast sodium  10  mg ; tiotropium bromide  1  cap ; doxazosin  4  mg ; 
personal history of contact with and (suspected) exposure to asbestos orthostatic hypotension unspecified pleural effusion abdominal pain, right upper quadrant other diseases of lung, not elsewhere classified unspecified cataract other and unspecified alcohol dependence, in remission unspecified viral hepatitis c without hepatic coma eosinophilia acute kidney failure, unspecified pneumonia, organism unspecified scoliosis [and kyphoscoliosis], idiopathic hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified sinusitis (chronic) loss of weight unspecified essential hypertension nonspecific reaction to tuberculin skin test without active tuberculosis fall from other slipping, tripping, or stumbling chronic airway obstruction, not elsewhere classified constipation, unspecified candidal esophagitis cyst of kidney, acquired tobacco use disorder transient alteration of awareness fever, unspecified unspecified viral hepatitis c without hepatic coma hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) benign essential hypertension pneumonia, organism unspecified abdominal pain, generalized tobacco use disorder constipation, unspecified chronic airway obstruction, not elsewhere classified dysthymic disorder dehydration neoplasm of unspecified nature of bone, soft tissue, and skin other and unspecified hyperlipidemia acute kidney failure with lesion of tubular necrosis other diseases of lung, not elsewhere classified esophageal reflux cystic kidney disease, unspecified unspecified sinusitis (chronic) hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics chronic airway obstruction, not elsewhere classified poisoning by salicylates poisoning by other and unspecified anticonvulsants
white m 80 $temp    heartrate  60.0  resprate  22.0  o2sat  98.0  sbp  131.0  dbp  56.0  rhythm  sinus rhythm  pain  8  ; temp    heartrate  67.0  resprate  20.0  o2sat  99.0  sbp  143.0  dbp  74.0  rhythm  sinus rhythm  pain  0  $nan$aspirin  81  mg ; finasteride  5  mg ; folic acid  1  mg ; isosorbide mononitrate (extended release)  30  mg ; lisinopril  5  mg ; omeprazole  20  mg ; sertraline  125  mg ; atorvastatin  80  mg ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction long-term (current) use of insulin anemia, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled constipation, unspecified other chronic nonalcoholic liver disease esophageal reflux percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status impotence of organic origin abdominal pain, unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled nonspecific abnormal results of function study of liver unspecified essential hypertension hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension acute posthemorrhagic anemia constipation, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia other specified disorders of bladder tobacco use disorder urinary tract infection, site not specified gross hematuria long-term (current) use of aspirin esophageal reflux unspecified hereditary and idiopathic peripheral neuropathy incomplete bladder emptying diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled old myocardial infarction streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension other chest pain other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 80 $temp  98.0  heartrate  60.0  resprate  20.0  o2sat  97.0  sbp  135.0  dbp  71.0  rhythm  sinus rhythm  pain  0  $hematology blood hematocrit  36.8  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  163  mg dl$aspirin  81  mg ; finasteride  5  mg ; folic acid  1  mg ; isosorbide mononitrate (extended release)  30  mg ; lisinopril  5  mg ; omeprazole  20  mg ; sertraline  125  mg ; atorvastatin  80  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; glucagon  1  mg ; docusate sodium  100  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; senna  2  tab ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction long-term (current) use of insulin anemia, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled constipation, unspecified other chronic nonalcoholic liver disease esophageal reflux percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status impotence of organic origin abdominal pain, unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled nonspecific abnormal results of function study of liver unspecified essential hypertension hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension acute posthemorrhagic anemia constipation, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia other specified disorders of bladder tobacco use disorder urinary tract infection, site not specified gross hematuria long-term (current) use of aspirin esophageal reflux unspecified hereditary and idiopathic peripheral neuropathy incomplete bladder emptying diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled old myocardial infarction streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension other chest pain other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 80 $nan$hematology blood hematocrit  37.8  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  135  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  1.9  mg dl; chemistry blood glucose  263  mg dl; chemistry blood lactate dehydrogenase (ld)  159  iu l; chemistry blood albumin  4.3  g dl$aspirin  81  mg ; finasteride  5  mg ; folic acid  1  mg ; isosorbide mononitrate (extended release)  30  mg ; lisinopril  5  mg ; omeprazole  20  mg ; sertraline  125  mg ; atorvastatin  80  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; glucagon  1  mg ; docusate sodium  100  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; senna  2  tab ; bag  50  ml ; magnesium sulfate  2  gm ; atropine sulfate  0.5  mg ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction long-term (current) use of insulin anemia, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled constipation, unspecified other chronic nonalcoholic liver disease esophageal reflux percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status impotence of organic origin abdominal pain, unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled nonspecific abnormal results of function study of liver unspecified essential hypertension hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension acute posthemorrhagic anemia constipation, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia other specified disorders of bladder tobacco use disorder urinary tract infection, site not specified gross hematuria long-term (current) use of aspirin esophageal reflux unspecified hereditary and idiopathic peripheral neuropathy incomplete bladder emptying diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled old myocardial infarction streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension other chest pain other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 80 $nan$hematology blood hematocrit  40.0  %; hematology blood hematocrit  29.1  %; hematology blood hemoglobin  14.3  g dl; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  139  k ul; hematology blood platelet count  108  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.2  ; hematology urine wbc  1  # hpf; chemistry blood glucose  220  mg dl; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.36  mmol l; blood gas blood free calcium  1.27  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  3.9  mmol l; blood gas blood lactate  6.0  mmol l; blood gas blood lactate  6.4  mmol l; blood gas blood lactate  5.4  mmol l; blood gas blood lactate  5.4  mmol l; blood gas blood chloride, whole blood  101  meq l; blood gas blood chloride, whole blood  106  meq l; blood gas blood glucose  225  mg dl; blood gas blood glucose  206  mg dl; blood gas blood glucose  198  mg dl; blood gas blood glucose  187  mg dl; blood gas blood glucose  159  mg dl; blood gas blood glucose  138  mg dl; blood gas blood hematocrit, calculated  38  %; blood gas blood hematocrit, calculated  28  %; blood gas blood hematocrit, calculated  27  %; blood gas blood hematocrit, calculated  26  %; blood gas blood hematocrit, calculated  27  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hemoglobin  12.5  g dl; blood gas blood hemoglobin  9.3  g dl; blood gas blood hemoglobin  9.0  g dl; blood gas blood hemoglobin  8.8  g dl; blood gas blood hemoglobin  9.1  g dl; blood gas blood hemoglobin  10.5  g dl; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood potassium, whole blood  4.8  meq l; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  6.6  meq l; blood gas blood sodium, whole blood  132  meq l; blood gas blood sodium, whole blood  131  meq l; blood gas blood sodium, whole blood  131  meq l; hematology urine glucose  1000  mg dl; chemistry blood % hemoglobin a1c  6.7  %$aspirin  81  mg ; finasteride  5  mg ; folic acid  1  mg ; isosorbide mononitrate (extended release)  30  mg ; lisinopril  5  mg ; omeprazole  20  mg ; sertraline  125  mg ; atorvastatin  80  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; glucagon  1  mg ; docusate sodium  100  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; senna  2  tab ; bag  50  ml ; magnesium sulfate  2  gm ; atropine sulfate  0.5  mg ; mupirocin nasal ointment 2%  1  appl ; milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10  ml ; lactated ringers  1000  ml ; 5% dextrose  250  ml ; propofol  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction long-term (current) use of insulin anemia, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled constipation, unspecified other chronic nonalcoholic liver disease esophageal reflux percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status impotence of organic origin abdominal pain, unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled nonspecific abnormal results of function study of liver unspecified essential hypertension hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension acute posthemorrhagic anemia constipation, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia other specified disorders of bladder tobacco use disorder urinary tract infection, site not specified gross hematuria long-term (current) use of aspirin esophageal reflux unspecified hereditary and idiopathic peripheral neuropathy incomplete bladder emptying diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled old myocardial infarction streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension other chest pain other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 80 $nan$hematology blood hematocrit  30.2  %; hematology blood hematocrit  23.8  %; hematology blood hematocrit  22.5  %; hematology blood hematocrit  29.1  %; hematology blood hematocrit  27.5  %; hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.8  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  156  k ul; hematology blood platelet count  106  k ul; hematology blood platelet count  135  k ul; hematology blood platelet count  136  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  245  mg dl; blood gas blood free calcium  1.19  mmol l; blood gas blood free calcium  1.04  mmol l; blood gas blood free calcium  1.19  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.21  mmol l; blood gas blood free calcium  0.97  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  4.1  mmol l; blood gas blood chloride, whole blood  105  meq l; blood gas blood glucose  143  mg dl; blood gas blood glucose  143  mg dl; blood gas blood glucose  159  mg dl; blood gas blood glucose  178  mg dl; blood gas blood hematocrit, calculated  23  %; blood gas blood hemoglobin  7.7  g dl; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood potassium, whole blood  3.3  meq l; blood gas blood sodium, whole blood  131  meq l; blood gas blood sodium, whole blood  134  meq l$milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; propofol  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; albumin 5% (25g   500ml)  25  g ; norepinephrine  8  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; aspirin ec  81  mg ; metoprolol tartrate  2.5  mg ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction long-term (current) use of insulin anemia, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled constipation, unspecified other chronic nonalcoholic liver disease esophageal reflux percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status impotence of organic origin abdominal pain, unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled nonspecific abnormal results of function study of liver unspecified essential hypertension hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension acute posthemorrhagic anemia constipation, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia other specified disorders of bladder tobacco use disorder urinary tract infection, site not specified gross hematuria long-term (current) use of aspirin esophageal reflux unspecified hereditary and idiopathic peripheral neuropathy incomplete bladder emptying diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled old myocardial infarction streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension other chest pain other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 80 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  144  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  5.4  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  198  mg dl; chemistry blood glucose  184  mg dl; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood glucose  190  mg dl; blood gas blood potassium, whole blood  4.9  meq l$milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; albumin 5% (25g   500ml)  25  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; aspirin ec  81  mg ; metoprolol tartrate  2.5  mg ; metoprolol tartrate  5  mg ; artificial tears  1-2  drop ; furosemide  20  mg ; metoprolol tartrate  12.5  mg ; insulin  10  unit ; bisacodyl  10  mg ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction long-term (current) use of insulin anemia, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled constipation, unspecified other chronic nonalcoholic liver disease esophageal reflux percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status impotence of organic origin abdominal pain, unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled nonspecific abnormal results of function study of liver unspecified essential hypertension hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension acute posthemorrhagic anemia constipation, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia other specified disorders of bladder tobacco use disorder urinary tract infection, site not specified gross hematuria long-term (current) use of aspirin esophageal reflux unspecified hereditary and idiopathic peripheral neuropathy incomplete bladder emptying diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled old myocardial infarction streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension other chest pain other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 80 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  138  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood glucose  170  mg dl$bisacodyl  10  mg ; metformin (glucophage)  500  mg ; cepacol (menthol)  1  loz ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction long-term (current) use of insulin anemia, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled constipation, unspecified other chronic nonalcoholic liver disease esophageal reflux percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status impotence of organic origin abdominal pain, unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled nonspecific abnormal results of function study of liver unspecified essential hypertension hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension acute posthemorrhagic anemia constipation, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia other specified disorders of bladder tobacco use disorder urinary tract infection, site not specified gross hematuria long-term (current) use of aspirin esophageal reflux unspecified hereditary and idiopathic peripheral neuropathy incomplete bladder emptying diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled old myocardial infarction streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension other chest pain other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 80 $nan$nan$bisacodyl  10  mg ; metformin (glucophage)  500  mg ; cepacol (menthol)  1  loz ; tramadol (ultram)  50  mg ; metoprolol tartrate  37.5  mg ; furosemide  40  mg ; glipizide xl  15  mg ; lactulose  15  ml ; insulin  12  unit ; metoprolol tartrate  50  mg ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction long-term (current) use of insulin anemia, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled constipation, unspecified other chronic nonalcoholic liver disease esophageal reflux percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status impotence of organic origin abdominal pain, unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled nonspecific abnormal results of function study of liver unspecified essential hypertension hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension acute posthemorrhagic anemia constipation, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia other specified disorders of bladder tobacco use disorder urinary tract infection, site not specified gross hematuria long-term (current) use of aspirin esophageal reflux unspecified hereditary and idiopathic peripheral neuropathy incomplete bladder emptying diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled old myocardial infarction streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension other chest pain other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 80 $nan$hematology blood hematocrit  30.6  %; hematology blood hematocrit  30.4  %; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  190  k ul; hematology blood platelet count  195  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  163  mg dl; chemistry blood glucose  227  mg dl; chemistry blood lactate dehydrogenase (ld)  257  iu l$bisacodyl  10  mg ; cepacol (menthol)  1  loz ; tramadol (ultram)  50  mg ; furosemide  40  mg ; glipizide xl  15  mg ; lactulose  15  ml ; insulin  12  unit ; metoprolol tartrate  50  mg ; ondansetron  4  mg ; metformin (glucophage)  850  mg ; ipratropium bromide neb  1  neb ; insulin  15  unit ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction long-term (current) use of insulin anemia, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled constipation, unspecified other chronic nonalcoholic liver disease esophageal reflux percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status impotence of organic origin abdominal pain, unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled nonspecific abnormal results of function study of liver unspecified essential hypertension hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension acute posthemorrhagic anemia constipation, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia other specified disorders of bladder tobacco use disorder urinary tract infection, site not specified gross hematuria long-term (current) use of aspirin esophageal reflux unspecified hereditary and idiopathic peripheral neuropathy incomplete bladder emptying diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled old myocardial infarction streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension other chest pain other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 80 $nan$chemistry blood chloride  95  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  6.2  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood bilirubin, total  1.6  mg dl; chemistry blood albumin  3.5  g dl$bisacodyl  10  mg ; cepacol (menthol)  1  loz ; tramadol (ultram)  50  mg ; furosemide  40  mg ; glipizide xl  15  mg ; lactulose  15  ml ; metoprolol tartrate  50  mg ; ondansetron  4  mg ; metformin (glucophage)  850  mg ; ipratropium bromide neb  1  neb ; insulin  15  unit ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction long-term (current) use of insulin anemia, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled constipation, unspecified other chronic nonalcoholic liver disease esophageal reflux percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status impotence of organic origin abdominal pain, unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled nonspecific abnormal results of function study of liver unspecified essential hypertension hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension acute posthemorrhagic anemia constipation, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia other specified disorders of bladder tobacco use disorder urinary tract infection, site not specified gross hematuria long-term (current) use of aspirin esophageal reflux unspecified hereditary and idiopathic peripheral neuropathy incomplete bladder emptying diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled old myocardial infarction streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension other chest pain other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 80 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  255  k ul; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  30  mg dl$bisacodyl  10  mg ; cepacol (menthol)  1  loz ; tramadol (ultram)  50  mg ; furosemide  40  mg ; glipizide xl  15  mg ; lactulose  15  ml ; metoprolol tartrate  50  mg ; ondansetron  4  mg ; metformin (glucophage)  850  mg ; ipratropium bromide neb  1  neb ; lidocaine viscous 2%  20  ml ; acetaminophen iv  1000  mg ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction long-term (current) use of insulin anemia, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled constipation, unspecified other chronic nonalcoholic liver disease esophageal reflux percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status impotence of organic origin abdominal pain, unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled nonspecific abnormal results of function study of liver unspecified essential hypertension hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension acute posthemorrhagic anemia constipation, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia other specified disorders of bladder tobacco use disorder urinary tract infection, site not specified gross hematuria long-term (current) use of aspirin esophageal reflux unspecified hereditary and idiopathic peripheral neuropathy incomplete bladder emptying diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled old myocardial infarction streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension other chest pain other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 80 $nan$nan$bisacodyl  10  mg ; cepacol (menthol)  1  loz ; tramadol (ultram)  50  mg ; glipizide xl  15  mg ; lactulose  15  ml ; metoprolol tartrate  50  mg ; ondansetron  4  mg ; metformin (glucophage)  850  mg ; ipratropium bromide neb  1  neb ; lidocaine viscous 2%  20  ml ; acetaminophen iv  1000  mg ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction long-term (current) use of insulin anemia, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled constipation, unspecified other chronic nonalcoholic liver disease esophageal reflux percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status impotence of organic origin abdominal pain, unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled nonspecific abnormal results of function study of liver unspecified essential hypertension hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension acute posthemorrhagic anemia constipation, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia other specified disorders of bladder tobacco use disorder urinary tract infection, site not specified gross hematuria long-term (current) use of aspirin esophageal reflux unspecified hereditary and idiopathic peripheral neuropathy incomplete bladder emptying diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled old myocardial infarction streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension other chest pain other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 80 $nan$nan$bisacodyl  10  mg ; cepacol (menthol)  1  loz ; tramadol (ultram)  50  mg ; glipizide xl  15  mg ; lactulose  15  ml ; metoprolol tartrate  50  mg ; ondansetron  4  mg ; metformin (glucophage)  850  mg ; ipratropium bromide neb  1  neb ; lidocaine viscous 2%  20  ml ; 
calculus of bile duct without mention of cholecystitis, without mention of obstruction long-term (current) use of insulin anemia, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled constipation, unspecified other chronic nonalcoholic liver disease esophageal reflux percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status impotence of organic origin abdominal pain, unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled nonspecific abnormal results of function study of liver unspecified essential hypertension hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) unspecified essential hypertension acute posthemorrhagic anemia constipation, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia other specified disorders of bladder tobacco use disorder urinary tract infection, site not specified gross hematuria long-term (current) use of aspirin esophageal reflux unspecified hereditary and idiopathic peripheral neuropathy incomplete bladder emptying diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled old myocardial infarction streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension other chest pain other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
black african american f 69 $nan$hematology blood hematocrit  23.6  %; hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  161  k ul; hematology blood platelet count  146  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  188  mg dl$glipizide  10  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; aspirin  81  mg ; amlodipine  5  mg ; furosemide  40  mg ; lisinopril  40  mg ; ferrous sulfate  325  mg ; 
 
black african american f 69 $nan$chemistry urine creatinine, urine  98  mg dl; chemistry urine sodium, urine  32  meq l; chemistry urine urea nitrogen, urine  651  mg dl$glipizide  10  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; aspirin  81  mg ; amlodipine  5  mg ; lisinopril  40  mg ; ferrous sulfate  325  mg ; 
 
white m 22 $temp  98.4  heartrate  65.0  resprate  16.0  o2sat  98.0  sbp  130.0  dbp  60.0  rhythm    pain  9  $nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  400  mg ; cyclobenzaprine  10  mg ; docusate sodium  100  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; 
 
white m 22 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ibuprofen  400  mg ; cyclobenzaprine  10  mg ; docusate sodium  100  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; 
 
white f 72 $nan$hematology blood hematocrit  38.0  %; hematology blood hematocrit  35.0  %; hematology blood hematocrit  32.2  %; hematology blood hemoglobin  12.6  g dl; hematology blood hemoglobin  12.1  g dl; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  623  k ul; hematology blood platelet count  430  k ul; hematology blood platelet count  380  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.4  meq l; chemistry blood potassium  6.8  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.2  ; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  418  mg dl; chemistry blood glucose  182  mg dl; chemistry blood glucose  146  mg dl; chemistry blood lactate dehydrogenase (ld)  255  iu l; chemistry blood lactate dehydrogenase (ld)  186  iu l; chemistry blood albumin  3.6  g dl; chemistry blood albumin  3.3  g dl; hematology blood bands  0  %; blood gas blood lactate  3.4  mmol l; blood gas blood lactate  3.5  mmol l; blood gas blood lactate  1.9  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood hematocrit, calculated  42  %; blood gas blood hemoglobin  14.0  g dl; blood gas blood potassium, whole blood  4.9  meq l; hematology urine glucose  1000  mg dl; hematology urine bilirubin  neg  mg dl$1 2 ns  1000  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  10  ml ; fentanyl citrate  25-100  mcg ; bisacodyl  10  mg ; senna  1  tab ; ns  100  ml ; midazolam  100  mg ; d5w  250  ml ; norepinephrine  8  mg ; aspirin  325  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; insulin  0  unit ; cortrosyn  250  mcg ; heparin  5000  unit ; ns  50  ml ; sodium polystyrene sulfonate  30  gm ; calcium gluconate  2  gm ; insulin  10  unit ; dextrose 50%  40  gm ; furosemide  20  mg ; insulin human regular  100  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium (liquid)  100  mg ; sw  100  ml ; magnesium sulfate  4  gm ; hydrocortisone  1  dose ; 
 
white f 72 $nan$hematology blood hematocrit  28.4  %; hematology blood hematocrit  27.1  %; hematology blood hematocrit  26.4  %; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  324  k ul; hematology blood platelet count  314  k ul; hematology blood platelet count  313  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  160  mg dl; chemistry blood glucose  140  mg dl; blood gas blood lactate  0.8  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood glucose  127  mg dl; blood gas blood hematocrit, calculated  35  %; blood gas blood hematocrit, calculated  35  %; blood gas blood hematocrit, calculated  28  %; blood gas blood hemoglobin  11.7  g dl; blood gas blood hemoglobin  11.6  g dl; blood gas blood hemoglobin  9.2  g dl; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood carboxyhemoglobin  1  %; blood gas blood carboxyhemoglobin  0  %; blood gas blood methemoglobin  0  %; blood gas blood methemoglobin  0  %$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  10  ml ; fentanyl citrate  25-100  mcg ; bisacodyl  10  mg ; senna  1  tab ; ns  100  ml ; midazolam  100  mg ; d5w  250  ml ; norepinephrine  8  mg ; aspirin  325  mg ; heparin  5000  unit ; insulin human regular  100  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium (liquid)  100  mg ; sw  100  ml ; magnesium sulfate  4  gm ; lansoprazole oral disintegrating tab  30  mg ; potassium chloride  20  meq ; atorvastatin  80  mg ; clopidogrel  75  mg ; midazolam  0.5-2  mg ; atropine sulfate  0.5  mg ; eptifibatide  75  mg ; furosemide  40  mg ; potassium chloride  40  meq ; 
 
white f 72 $nan$hematology blood hematocrit  26.2  %; hematology blood hematocrit  25.8  %; hematology blood hematocrit  26.5  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  308  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; hematology urine wbc  21-50  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  143  mg dl; blood gas blood lactate  0.8  mmol l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; senna  1  tab ; d5w  250  ml ; norepinephrine  8  mg ; aspirin  325  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium (liquid)  100  mg ; lansoprazole oral disintegrating tab  30  mg ; potassium chloride  20  meq ; atorvastatin  80  mg ; clopidogrel  75  mg ; midazolam  0.5-2  mg ; atropine sulfate  0.5  mg ; furosemide  40  mg ; potassium chloride  40  meq ; magnesium sulfate  2  gm ; nitroglycerin  100  mg ; pantoprazole  40  mg ; trazodone  25  mg ; acetaminophen  325-650  mg ; hydrocortisone  100  mg ; 
 
white f 72 $nan$hematology blood hematocrit  26.7  %; hematology blood hematocrit  25.4  %; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  300  k ul; hematology blood platelet count  324  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  230  mg dl; chemistry blood glucose  161  mg dl$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; senna  1  tab ; aspirin  325  mg ; heparin  5000  unit ; atorvastatin  80  mg ; clopidogrel  75  mg ; atropine sulfate  0.5  mg ; magnesium sulfate  2  gm ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; captopril  6.25  mg ; insulin  26  unit ; trazodone  50  mg ; 
 
white f 72 $nan$hematology blood hematocrit  28.0  %; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  295  mg dl$sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; senna  1  tab ; aspirin  325  mg ; heparin  5000  unit ; atorvastatin  80  mg ; clopidogrel  75  mg ; atropine sulfate  0.5  mg ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; captopril  6.25  mg ; insulin  26  unit ; trazodone  50  mg ; ferrous sulfate  325  mg ; sodium chloride 0.9%  flush  3  ml ; captopril  12.5  mg ; guaifenesin-dextromethorphan  5-10  ml ; 
 
white f 72 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  399  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  185  mg dl; chemistry blood glucose  254  mg dl$bisacodyl  10  mg ; senna  1  tab ; aspirin  325  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; atropine sulfate  0.5  mg ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; insulin  26  unit ; ferrous sulfate  325  mg ; sodium chloride 0.9%  flush  3  ml ; guaifenesin-dextromethorphan  5-10  ml ; metoprolol tartrate  25  mg ; lisinopril  5  mg ; glyburide  7.5  mg ; lisinopril  10  mg ; insulin  28  unit ; glyburide  5  mg ; 
 
white f 72 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  417  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  150  mg dl$bisacodyl  10  mg ; senna  1  tab ; aspirin  325  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; atropine sulfate  0.5  mg ; pantoprazole  40  mg ; acetaminophen  325-650  mg ; ferrous sulfate  325  mg ; sodium chloride 0.9%  flush  3  ml ; guaifenesin-dextromethorphan  5-10  ml ; lisinopril  5  mg ; glyburide  7.5  mg ; glyburide  5  mg ; metformin (glucophage)  500  mg ; metoprolol succinate xl  25  mg ; 
 
asian m 49 $temp  98.0  heartrate  57.0  resprate  18.0  o2sat  98.0  sbp  103.0  dbp  52.0  rhythm    pain  0  $hematology blood hematocrit  44.9  %; hematology blood hemoglobin  14.9  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  6.1  mg dl; chemistry blood glucose  96  mg dl$d5 1 2ns  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; ondansetron  4  mg ; acetaminophen  500-1000  mg ; ramelteon  8  mg ; senna  8.6  mg ; heparin  5000  unit ; 
 
asian m 49 $nan$hematology blood hematocrit  44.2  %; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood bilirubin, total  2.0  mg dl; chemistry blood glucose  83  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; acetaminophen  500-1000  mg ; ramelteon  8  mg ; senna  8.6  mg ; 
 
asian m 49 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; acetaminophen  500-1000  mg ; ramelteon  8  mg ; senna  8.6  mg ; 
 
white f 49 $nan$nan$nicotine patch  21  mg ; tenofovir disoproxil (viread)  300  mg ; sulfameth trimethoprim ss  1  tab ; fluoxetine  80  mg ; provigil  200  mg ; fluticasone propionate nasal  1  spry ; 
 
white f 49 $nan$hematology blood hematocrit  32.7  %; hematology blood hematocrit  31.4  %; hematology blood hemoglobin  11.9  g dl; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  149  k ul; hematology blood platelet count  120  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  96  mg dl; chemistry blood lactate dehydrogenase (ld)  175  iu l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$nicotine patch  21  mg ; tenofovir disoproxil (viread)  300  mg ; sulfameth trimethoprim ss  1  tab ; fluoxetine  80  mg ; provigil  200  mg ; fluticasone propionate nasal  1  spry ; sodium chloride 0.9%  flush  3  ml ; acyclovir ointment 5%  1  appl ; lidocaine 5% ointment  1  appl ; ondansetron odt  8  mg ; pantoprazole  40  mg ; trazodone  50  mg ; triamcinolone acetonide 0.1% ointment  1  appl ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; senna  1  tab ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; etravirine  200  mg ; fexofenadine  60  mg ; lamivudine-zidovudine (combivir)  1  tab ; raltegravir  400  mg ; heparin  5000  unit ; docusate sodium  100  mg ; albuterol inhaler  2  puff ; fluconazole  100  mg ; oxycodone (immediate release)   5  mg ; oxycodone sr (oxycontin)  100  mg ; valtrex  500  mg ; 0.9% sodium chloride  1000  ml ; oxycodone (immediate release)   5-10  mg ; trazodone  100  mg ; morphine sulfate  2-4  mg ; acetaminophen  325-650  mg ; 
 
white f 49 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  111  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  98  mg dl$nicotine patch  21  mg ; tenofovir disoproxil (viread)  300  mg ; sulfameth trimethoprim ss  1  tab ; fluoxetine  80  mg ; provigil  200  mg ; fluticasone propionate nasal  1  spry ; sodium chloride 0.9%  flush  3  ml ; acyclovir ointment 5%  1  appl ; lidocaine 5% ointment  1  appl ; ondansetron odt  8  mg ; pantoprazole  40  mg ; triamcinolone acetonide 0.1% ointment  1  appl ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; senna  1  tab ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; etravirine  200  mg ; fexofenadine  60  mg ; lamivudine-zidovudine (combivir)  1  tab ; raltegravir  400  mg ; heparin  5000  unit ; docusate sodium  100  mg ; albuterol inhaler  2  puff ; fluconazole  100  mg ; oxycodone sr (oxycontin)  100  mg ; valtrex  500  mg ; oxycodone (immediate release)   5-10  mg ; trazodone  100  mg ; morphine sulfate  2-4  mg ; acetaminophen  325-650  mg ; magnesium sulfate  2  gm ; oxycodone (immediate release)   10  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  4-6  mg ; 
 
white f 49 $nan$nan$nicotine patch  21  mg ; tenofovir disoproxil (viread)  300  mg ; sulfameth trimethoprim ss  1  tab ; fluoxetine  80  mg ; provigil  200  mg ; fluticasone propionate nasal  1  spry ; sodium chloride 0.9%  flush  3  ml ; acyclovir ointment 5%  1  appl ; lidocaine 5% ointment  1  appl ; ondansetron odt  8  mg ; pantoprazole  40  mg ; triamcinolone acetonide 0.1% ointment  1  appl ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; senna  1  tab ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; etravirine  200  mg ; fexofenadine  60  mg ; lamivudine-zidovudine (combivir)  1  tab ; raltegravir  400  mg ; heparin  5000  unit ; docusate sodium  100  mg ; albuterol inhaler  2  puff ; fluconazole  100  mg ; oxycodone sr (oxycontin)  100  mg ; valtrex  500  mg ; trazodone  100  mg ; oxycodone (immediate release)   10  mg ; hydromorphone (dilaudid)  4-6  mg ; 
 
white m 38 $temp  97.8  heartrate  100.0  resprate  16.0  o2sat  100.0  sbp  138.0  dbp  88.0  rhythm    pain  0  $hematology blood hematocrit  37.6  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  113  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  91  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; acetaminophen  650  mg ; 5% dextrose  250  ml ; thiamine  500  mg ; diazepam  10  mg ; nicotine polacrilex  2  mg ; trazodone  25  mg ; multivitamins  1  tab ; folic acid  1  mg ; polyethylene glycol  17  g ; zolpidem tartrate  5  mg ; 
other specified metabolic disorders head injury, unspecified cervicalgia acute alcoholic intoxication in alcoholism, continuous unspecified fall alcohol withdrawal asthma, unspecified type, unspecified headache dizziness and giddiness accidents occurring in unspecified place depressive disorder, not elsewhere classified suicidal ideation alcohol withdrawal asthma, unspecified type, unspecified depressive disorder, not elsewhere classified other and unspecified alcohol dependence, continuous tobacco use disorder other and unspecified alcohol dependence, continuous hyperosmolality and/or hypernatremia alcohol withdrawal asthma, unspecified type, unspecified tobacco use disorder other specified counseling asthma, unspecified type, unspecified other and unspecified alcohol dependence, continuous alcohol withdrawal
white m 38 $nan$nan$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; nicotine polacrilex  2  mg ; trazodone  25  mg ; multivitamins  1  tab ; folic acid  1  mg ; polyethylene glycol  17  g ; diphenhydramine  25  mg ; diazepam  15  mg ; thiamine  100  mg ; 
other specified metabolic disorders head injury, unspecified cervicalgia acute alcoholic intoxication in alcoholism, continuous unspecified fall alcohol withdrawal asthma, unspecified type, unspecified headache dizziness and giddiness accidents occurring in unspecified place depressive disorder, not elsewhere classified suicidal ideation alcohol withdrawal asthma, unspecified type, unspecified depressive disorder, not elsewhere classified other and unspecified alcohol dependence, continuous tobacco use disorder other and unspecified alcohol dependence, continuous hyperosmolality and/or hypernatremia alcohol withdrawal asthma, unspecified type, unspecified tobacco use disorder other specified counseling asthma, unspecified type, unspecified other and unspecified alcohol dependence, continuous alcohol withdrawal
white m 38 $nan$nan$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; nicotine polacrilex  2  mg ; multivitamins  1  tab ; folic acid  1  mg ; polyethylene glycol  17  g ; thiamine  100  mg ; diazepam  5  mg ; trazodone  50  mg ; 
other specified metabolic disorders head injury, unspecified cervicalgia acute alcoholic intoxication in alcoholism, continuous unspecified fall alcohol withdrawal asthma, unspecified type, unspecified headache dizziness and giddiness accidents occurring in unspecified place depressive disorder, not elsewhere classified suicidal ideation alcohol withdrawal asthma, unspecified type, unspecified depressive disorder, not elsewhere classified other and unspecified alcohol dependence, continuous tobacco use disorder other and unspecified alcohol dependence, continuous hyperosmolality and/or hypernatremia alcohol withdrawal asthma, unspecified type, unspecified tobacco use disorder other specified counseling asthma, unspecified type, unspecified other and unspecified alcohol dependence, continuous alcohol withdrawal
white m 38 $nan$nan$sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; nicotine polacrilex  2  mg ; multivitamins  1  tab ; folic acid  1  mg ; polyethylene glycol  17  g ; thiamine  100  mg ; trazodone  50  mg ; 
other specified metabolic disorders head injury, unspecified cervicalgia acute alcoholic intoxication in alcoholism, continuous unspecified fall alcohol withdrawal asthma, unspecified type, unspecified headache dizziness and giddiness accidents occurring in unspecified place depressive disorder, not elsewhere classified suicidal ideation alcohol withdrawal asthma, unspecified type, unspecified depressive disorder, not elsewhere classified other and unspecified alcohol dependence, continuous tobacco use disorder other and unspecified alcohol dependence, continuous hyperosmolality and/or hypernatremia alcohol withdrawal asthma, unspecified type, unspecified tobacco use disorder other specified counseling asthma, unspecified type, unspecified other and unspecified alcohol dependence, continuous alcohol withdrawal
hispanic latino m 65 $temp    heartrate  124.0  resprate  20.0  o2sat  96.0  sbp  90.0  dbp  56.0  rhythm    pain  0  ; temp    heartrate  127.0  resprate  19.0  o2sat  97.0  sbp  95.0  dbp  58.0  rhythm    pain  0  ; temp    heartrate  130.0  resprate  26.0  o2sat  96.0  sbp  105.0  dbp  88.0  rhythm    pain  0  ; temp    heartrate  123.0  resprate  20.0  o2sat  96.0  sbp  90.0  dbp  53.0  rhythm    pain  0  ; temp    heartrate  120.0  resprate  25.0  o2sat  99.0  sbp  94.0  dbp  58.0  rhythm    pain  0  ; temp  98.6  heartrate  123.0  resprate  24.0  o2sat  96.0  sbp  108.0  dbp  68.0  rhythm    pain  0  ; temp    heartrate  120.0  resprate  23.0  o2sat  95.0  sbp  94.0  dbp  57.0  rhythm    pain  0  ; temp    heartrate  117.0  resprate  21.0  o2sat  95.0  sbp  85.0  dbp  57.0  rhythm    pain  0  ; temp    heartrate  117.0  resprate  24.0  o2sat  95.0  sbp  112.0  dbp  78.0  rhythm    pain  0  ; temp    heartrate  115.0  resprate  17.0  o2sat  96.0  sbp  100.0  dbp  57.0  rhythm    pain  0  $hematology blood hematocrit  36.9  %; hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.9  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  138  k ul; hematology blood platelet count  135  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  113  mg dl; chemistry blood glucose  92  mg dl; chemistry blood lactate dehydrogenase (ld)  228  iu l; chemistry blood lactate dehydrogenase (ld)  215  iu l; chemistry blood albumin  2.9  g dl; hematology blood bands  0  %; blood gas blood lactate  1.9  mmol l$0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; ns  100  ml ; metronidazole  500  mg ; omeprazole  40  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; prochlorperazine  10  mg ; lactated ringers  1000  ml ; morphine sulfate ir  30  mg ; tiotropium bromide  1  cap ; senna  8.6  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; docusate sodium  100  mg ; calcium carbonate  500  mg ; atorvastatin  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; heparin  5000  unit ; fluticasone-salmeterol diskus (500 50)   1  inh ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  10  ml ; folic acid  1  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; aspirin ec  81  mg ; methylprednisolone sodium succ  60  mg ; 
candidal stomatitis old myocardial infarction constipation, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter secondary malignant neoplasm of other specified sites presence of coronary angioplasty implant and graft adverse effect of antiasthmatics, initial encounter malignant neoplasm of upper lobe, right bronchus or lung pleurisy fever presenting with conditions classified elsewhere unspecified place or not applicable atherosclerotic heart disease of native coronary artery without angina pectoris gastro-esophageal reflux disease without esophagitis pleural effusion, not elsewhere classified emphysema, unspecified personal history of nicotine dependence long qt syndrome dizziness and giddiness old myocardial infarction long-term (current) use of aspirin peritoneal adhesions (postoperative) (postinfection) acute appendicitis without mention of peritonitis esophageal reflux nausea alone osteoarthrosis, unspecified whether generalized or localized, site unspecified other emphysema coronary atherosclerosis of unspecified type of vessel, native or graft personal history of tobacco use percutaneous transluminal coronary angioplasty status malignant neoplasm of bronchus and lung, unspecified chronic airway obstruction, not elsewhere classified percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified malignant neoplasm of upper lobe, bronchus or lung personal history of tobacco use old myocardial infarction esophageal reflux other emphysema hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) pneumonia, organism unspecified solitary pulmonary nodule retention of urine, unspecified tachycardia, unspecified constipation, unspecified coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status depressive disorder, not elsewhere classified
hispanic latino m 65 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  113  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  163  mg dl$0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; omeprazole  40  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; prochlorperazine  10  mg ; morphine sulfate ir  30  mg ; tiotropium bromide  1  cap ; senna  8.6  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; docusate sodium  100  mg ; calcium carbonate  500  mg ; atorvastatin  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; heparin  5000  unit ; fluticasone-salmeterol diskus (500 50)   1  inh ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  10  ml ; folic acid  1  mg ; aspirin ec  81  mg ; methylprednisolone sodium succ  60  mg ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  1000  ml ; 
candidal stomatitis old myocardial infarction constipation, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter secondary malignant neoplasm of other specified sites presence of coronary angioplasty implant and graft adverse effect of antiasthmatics, initial encounter malignant neoplasm of upper lobe, right bronchus or lung pleurisy fever presenting with conditions classified elsewhere unspecified place or not applicable atherosclerotic heart disease of native coronary artery without angina pectoris gastro-esophageal reflux disease without esophagitis pleural effusion, not elsewhere classified emphysema, unspecified personal history of nicotine dependence long qt syndrome dizziness and giddiness old myocardial infarction long-term (current) use of aspirin peritoneal adhesions (postoperative) (postinfection) acute appendicitis without mention of peritonitis esophageal reflux nausea alone osteoarthrosis, unspecified whether generalized or localized, site unspecified other emphysema coronary atherosclerosis of unspecified type of vessel, native or graft personal history of tobacco use percutaneous transluminal coronary angioplasty status malignant neoplasm of bronchus and lung, unspecified chronic airway obstruction, not elsewhere classified percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified malignant neoplasm of upper lobe, bronchus or lung personal history of tobacco use old myocardial infarction esophageal reflux other emphysema hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) pneumonia, organism unspecified solitary pulmonary nodule retention of urine, unspecified tachycardia, unspecified constipation, unspecified coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status depressive disorder, not elsewhere classified
hispanic latino m 65 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  117  mg dl; chemistry blood lactate dehydrogenase (ld)  188  iu l; chemistry blood albumin  2.5  g dl$0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; omeprazole  40  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; prochlorperazine  10  mg ; morphine sulfate ir  30  mg ; tiotropium bromide  1  cap ; senna  8.6  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; docusate sodium  100  mg ; calcium carbonate  500  mg ; atorvastatin  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; heparin  5000  unit ; fluticasone-salmeterol diskus (500 50)   1  inh ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  10  ml ; folic acid  1  mg ; aspirin ec  81  mg ; methylprednisolone sodium succ  60  mg ; nystatin oral suspension  5  ml ; heparin flush (10 units ml)  1  ml ; ipratropium bromide neb  1  neb ; sodium chloride 0.9%  flush  3  ml ; 
candidal stomatitis old myocardial infarction constipation, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter secondary malignant neoplasm of other specified sites presence of coronary angioplasty implant and graft adverse effect of antiasthmatics, initial encounter malignant neoplasm of upper lobe, right bronchus or lung pleurisy fever presenting with conditions classified elsewhere unspecified place or not applicable atherosclerotic heart disease of native coronary artery without angina pectoris gastro-esophageal reflux disease without esophagitis pleural effusion, not elsewhere classified emphysema, unspecified personal history of nicotine dependence long qt syndrome dizziness and giddiness old myocardial infarction long-term (current) use of aspirin peritoneal adhesions (postoperative) (postinfection) acute appendicitis without mention of peritonitis esophageal reflux nausea alone osteoarthrosis, unspecified whether generalized or localized, site unspecified other emphysema coronary atherosclerosis of unspecified type of vessel, native or graft personal history of tobacco use percutaneous transluminal coronary angioplasty status malignant neoplasm of bronchus and lung, unspecified chronic airway obstruction, not elsewhere classified percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified malignant neoplasm of upper lobe, bronchus or lung personal history of tobacco use old myocardial infarction esophageal reflux other emphysema hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) pneumonia, organism unspecified solitary pulmonary nodule retention of urine, unspecified tachycardia, unspecified constipation, unspecified coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status depressive disorder, not elsewhere classified
hispanic latino m 65 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  128  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  84  mg dl$0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; omeprazole  40  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; prochlorperazine  10  mg ; morphine sulfate ir  30  mg ; tiotropium bromide  1  cap ; senna  8.6  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; docusate sodium  100  mg ; calcium carbonate  500  mg ; atorvastatin  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; fluticasone-salmeterol diskus (500 50)   1  inh ; acetaminophen  650  mg ; folic acid  1  mg ; aspirin ec  81  mg ; methylprednisolone sodium succ  60  mg ; nystatin oral suspension  5  ml ; heparin flush (10 units ml)  1  ml ; ipratropium bromide neb  1  neb ; sodium chloride 0.9%  flush  3  ml ; maalox diphenhydramine lidocaine  15-30  ml ; 
candidal stomatitis old myocardial infarction constipation, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter secondary malignant neoplasm of other specified sites presence of coronary angioplasty implant and graft adverse effect of antiasthmatics, initial encounter malignant neoplasm of upper lobe, right bronchus or lung pleurisy fever presenting with conditions classified elsewhere unspecified place or not applicable atherosclerotic heart disease of native coronary artery without angina pectoris gastro-esophageal reflux disease without esophagitis pleural effusion, not elsewhere classified emphysema, unspecified personal history of nicotine dependence long qt syndrome dizziness and giddiness old myocardial infarction long-term (current) use of aspirin peritoneal adhesions (postoperative) (postinfection) acute appendicitis without mention of peritonitis esophageal reflux nausea alone osteoarthrosis, unspecified whether generalized or localized, site unspecified other emphysema coronary atherosclerosis of unspecified type of vessel, native or graft personal history of tobacco use percutaneous transluminal coronary angioplasty status malignant neoplasm of bronchus and lung, unspecified chronic airway obstruction, not elsewhere classified percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified malignant neoplasm of upper lobe, bronchus or lung personal history of tobacco use old myocardial infarction esophageal reflux other emphysema hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) pneumonia, organism unspecified solitary pulmonary nodule retention of urine, unspecified tachycardia, unspecified constipation, unspecified coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status depressive disorder, not elsewhere classified
hispanic latino m 65 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  83  mg dl$0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; prochlorperazine  10  mg ; morphine sulfate ir  30  mg ; tiotropium bromide  1  cap ; senna  8.6  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; docusate sodium  100  mg ; calcium carbonate  500  mg ; atorvastatin  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; fluticasone-salmeterol diskus (500 50)   1  inh ; acetaminophen  650  mg ; folic acid  1  mg ; aspirin ec  81  mg ; nystatin oral suspension  5  ml ; heparin flush (10 units ml)  1  ml ; ipratropium bromide neb  1  neb ; sodium chloride 0.9%  flush  3  ml ; maalox diphenhydramine lidocaine  15-30  ml ; lidocaine viscous 2%  15  ml ; nystatin oral suspension  10  ml ; 
candidal stomatitis old myocardial infarction constipation, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter secondary malignant neoplasm of other specified sites presence of coronary angioplasty implant and graft adverse effect of antiasthmatics, initial encounter malignant neoplasm of upper lobe, right bronchus or lung pleurisy fever presenting with conditions classified elsewhere unspecified place or not applicable atherosclerotic heart disease of native coronary artery without angina pectoris gastro-esophageal reflux disease without esophagitis pleural effusion, not elsewhere classified emphysema, unspecified personal history of nicotine dependence long qt syndrome dizziness and giddiness old myocardial infarction long-term (current) use of aspirin peritoneal adhesions (postoperative) (postinfection) acute appendicitis without mention of peritonitis esophageal reflux nausea alone osteoarthrosis, unspecified whether generalized or localized, site unspecified other emphysema coronary atherosclerosis of unspecified type of vessel, native or graft personal history of tobacco use percutaneous transluminal coronary angioplasty status malignant neoplasm of bronchus and lung, unspecified chronic airway obstruction, not elsewhere classified percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified malignant neoplasm of upper lobe, bronchus or lung personal history of tobacco use old myocardial infarction esophageal reflux other emphysema hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) pneumonia, organism unspecified solitary pulmonary nodule retention of urine, unspecified tachycardia, unspecified constipation, unspecified coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status depressive disorder, not elsewhere classified
hispanic latino m 65 $nan$hematology blood hematocrit  35.5  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  99  mg dl$albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; prochlorperazine  10  mg ; morphine sulfate ir  30  mg ; tiotropium bromide  1  cap ; senna  8.6  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; docusate sodium  100  mg ; calcium carbonate  500  mg ; atorvastatin  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; fluticasone-salmeterol diskus (500 50)   1  inh ; acetaminophen  650  mg ; folic acid  1  mg ; aspirin ec  81  mg ; heparin flush (10 units ml)  1  ml ; ipratropium bromide neb  1  neb ; sodium chloride 0.9%  flush  3  ml ; maalox diphenhydramine lidocaine  15-30  ml ; lidocaine viscous 2%  15  ml ; nystatin oral suspension  10  ml ; 
candidal stomatitis old myocardial infarction constipation, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter secondary malignant neoplasm of other specified sites presence of coronary angioplasty implant and graft adverse effect of antiasthmatics, initial encounter malignant neoplasm of upper lobe, right bronchus or lung pleurisy fever presenting with conditions classified elsewhere unspecified place or not applicable atherosclerotic heart disease of native coronary artery without angina pectoris gastro-esophageal reflux disease without esophagitis pleural effusion, not elsewhere classified emphysema, unspecified personal history of nicotine dependence long qt syndrome dizziness and giddiness old myocardial infarction long-term (current) use of aspirin peritoneal adhesions (postoperative) (postinfection) acute appendicitis without mention of peritonitis esophageal reflux nausea alone osteoarthrosis, unspecified whether generalized or localized, site unspecified other emphysema coronary atherosclerosis of unspecified type of vessel, native or graft personal history of tobacco use percutaneous transluminal coronary angioplasty status malignant neoplasm of bronchus and lung, unspecified chronic airway obstruction, not elsewhere classified percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified malignant neoplasm of upper lobe, bronchus or lung personal history of tobacco use old myocardial infarction esophageal reflux other emphysema hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) pneumonia, organism unspecified solitary pulmonary nodule retention of urine, unspecified tachycardia, unspecified constipation, unspecified coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status depressive disorder, not elsewhere classified
hispanic latino m 65 $nan$hematology blood hematocrit  38.3  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  288  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.4  mg dl$albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; prochlorperazine  10  mg ; morphine sulfate ir  30  mg ; tiotropium bromide  1  cap ; senna  8.6  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; docusate sodium  100  mg ; calcium carbonate  500  mg ; atorvastatin  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; fluticasone-salmeterol diskus (500 50)   1  inh ; acetaminophen  650  mg ; folic acid  1  mg ; aspirin ec  81  mg ; ipratropium bromide neb  1  neb ; maalox diphenhydramine lidocaine  15-30  ml ; lidocaine viscous 2%  15  ml ; nystatin oral suspension  10  ml ; morphine sulfate  2  mg ; acyclovir  200  mg ; caphosol  30  ml ; nystatin oral suspension  15  ml ; 
candidal stomatitis old myocardial infarction constipation, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter secondary malignant neoplasm of other specified sites presence of coronary angioplasty implant and graft adverse effect of antiasthmatics, initial encounter malignant neoplasm of upper lobe, right bronchus or lung pleurisy fever presenting with conditions classified elsewhere unspecified place or not applicable atherosclerotic heart disease of native coronary artery without angina pectoris gastro-esophageal reflux disease without esophagitis pleural effusion, not elsewhere classified emphysema, unspecified personal history of nicotine dependence long qt syndrome dizziness and giddiness old myocardial infarction long-term (current) use of aspirin peritoneal adhesions (postoperative) (postinfection) acute appendicitis without mention of peritonitis esophageal reflux nausea alone osteoarthrosis, unspecified whether generalized or localized, site unspecified other emphysema coronary atherosclerosis of unspecified type of vessel, native or graft personal history of tobacco use percutaneous transluminal coronary angioplasty status malignant neoplasm of bronchus and lung, unspecified chronic airway obstruction, not elsewhere classified percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified malignant neoplasm of upper lobe, bronchus or lung personal history of tobacco use old myocardial infarction esophageal reflux other emphysema hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) pneumonia, organism unspecified solitary pulmonary nodule retention of urine, unspecified tachycardia, unspecified constipation, unspecified coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status depressive disorder, not elsewhere classified
hispanic latino m 65 $nan$hematology blood hematocrit  43.9  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  377  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  10.0  mg dl; hematology blood bands  2  %$albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; prochlorperazine  10  mg ; morphine sulfate ir  30  mg ; tiotropium bromide  1  cap ; senna  8.6  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; docusate sodium  100  mg ; calcium carbonate  500  mg ; atorvastatin  20  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; acetaminophen  650  mg ; folic acid  1  mg ; aspirin ec  81  mg ; ipratropium bromide neb  1  neb ; maalox diphenhydramine lidocaine  15-30  ml ; lidocaine viscous 2%  15  ml ; morphine sulfate  2  mg ; acyclovir  200  mg ; caphosol  30  ml ; nystatin oral suspension  15  ml ; oxycodone liquid  5-10  mg ; 
candidal stomatitis old myocardial infarction constipation, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter secondary malignant neoplasm of other specified sites presence of coronary angioplasty implant and graft adverse effect of antiasthmatics, initial encounter malignant neoplasm of upper lobe, right bronchus or lung pleurisy fever presenting with conditions classified elsewhere unspecified place or not applicable atherosclerotic heart disease of native coronary artery without angina pectoris gastro-esophageal reflux disease without esophagitis pleural effusion, not elsewhere classified emphysema, unspecified personal history of nicotine dependence long qt syndrome dizziness and giddiness old myocardial infarction long-term (current) use of aspirin peritoneal adhesions (postoperative) (postinfection) acute appendicitis without mention of peritonitis esophageal reflux nausea alone osteoarthrosis, unspecified whether generalized or localized, site unspecified other emphysema coronary atherosclerosis of unspecified type of vessel, native or graft personal history of tobacco use percutaneous transluminal coronary angioplasty status malignant neoplasm of bronchus and lung, unspecified chronic airway obstruction, not elsewhere classified percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified malignant neoplasm of upper lobe, bronchus or lung personal history of tobacco use old myocardial infarction esophageal reflux other emphysema hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) pneumonia, organism unspecified solitary pulmonary nodule retention of urine, unspecified tachycardia, unspecified constipation, unspecified coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status depressive disorder, not elsewhere classified
hispanic latino m 65 $nan$nan$albuterol 0.083% neb soln  1  neb ; ondansetron  4  mg ; prochlorperazine  10  mg ; morphine sulfate ir  30  mg ; tiotropium bromide  1  cap ; senna  8.6  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; docusate sodium  100  mg ; calcium carbonate  500  mg ; atorvastatin  20  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; acetaminophen  650  mg ; folic acid  1  mg ; aspirin ec  81  mg ; maalox diphenhydramine lidocaine  15-30  ml ; lidocaine viscous 2%  15  ml ; acyclovir  200  mg ; caphosol  30  ml ; nystatin oral suspension  15  ml ; oxycodone liquid  5-10  mg ; 
candidal stomatitis old myocardial infarction constipation, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter secondary malignant neoplasm of other specified sites presence of coronary angioplasty implant and graft adverse effect of antiasthmatics, initial encounter malignant neoplasm of upper lobe, right bronchus or lung pleurisy fever presenting with conditions classified elsewhere unspecified place or not applicable atherosclerotic heart disease of native coronary artery without angina pectoris gastro-esophageal reflux disease without esophagitis pleural effusion, not elsewhere classified emphysema, unspecified personal history of nicotine dependence long qt syndrome dizziness and giddiness old myocardial infarction long-term (current) use of aspirin peritoneal adhesions (postoperative) (postinfection) acute appendicitis without mention of peritonitis esophageal reflux nausea alone osteoarthrosis, unspecified whether generalized or localized, site unspecified other emphysema coronary atherosclerosis of unspecified type of vessel, native or graft personal history of tobacco use percutaneous transluminal coronary angioplasty status malignant neoplasm of bronchus and lung, unspecified chronic airway obstruction, not elsewhere classified percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified malignant neoplasm of upper lobe, bronchus or lung personal history of tobacco use old myocardial infarction esophageal reflux other emphysema hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) pneumonia, organism unspecified solitary pulmonary nodule retention of urine, unspecified tachycardia, unspecified constipation, unspecified coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status depressive disorder, not elsewhere classified
hispanic latino m 56 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  158  iu l$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; tacrolimus  0.5  mg ; tacrolimus  2  mg ; insulin  0  unit ; docusate sodium  100  mg ; heparin  5000  unit ; glyburide  5  mg ; metoprolol tartrate  50  mg ; mycophenolate mofetil  250  mg ; citalopram hydrobromide  10  mg ; lisinopril  20  mg ; omeprazole  20  mg ; simvastatin  5  mg ; oxycodone-acetaminophen  1  tab ; ribavirin  400  mg ; 
 
hispanic latino m 56 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  170  k ul$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; tacrolimus  0.5  mg ; tacrolimus  2  mg ; insulin  0  unit ; docusate sodium  100  mg ; heparin  5000  unit ; glyburide  5  mg ; metoprolol tartrate  50  mg ; mycophenolate mofetil  250  mg ; citalopram hydrobromide  10  mg ; lisinopril  20  mg ; omeprazole  20  mg ; simvastatin  5  mg ; oxycodone-acetaminophen  1  tab ; ribavirin  400  mg ; 
 
black african american m 46 $temp    heartrate  70.0  resprate  17.0  o2sat  94.0  sbp  126.0  dbp  78.0  rhythm    pain    ; temp  97.9  heartrate  64.0  resprate  19.0  o2sat  96.0  sbp  126.0  dbp  68.0  rhythm    pain  8  $hematology blood hematocrit  38.6  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  189  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  261  mg dl; chemistry blood % hemoglobin a1c  8.1  %$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; atorvastatin  40  mg ; rosuvastatin calcium  20  mg ; insulin  25  unit ; 
 
white m 75 $temp    heartrate  76.0  resprate  19.0  o2sat  97.0  sbp  111.0  dbp  41.0  rhythm    pain  0  $hematology blood hematocrit  24.6  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  310  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  156  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; albuterol inhaler  3  puff ; aspirin  81  mg ; calcium carbonate  500  mg ; cyanocobalamin  1000  mcg ; docusate sodium  100  mg ; ferrous sulfate  325  mg ; furosemide  40  mg ; ipratropium bromide mdi  2  puff ; metoprolol tartrate  6.25  mg ; mirtazapine  15  mg ; mirtazapine  7.5  mg ; multivitamins  1  tab ; nitroglycerin sl  0.4  mg ; pantoprazole  40  mg ; psyllium  1  pkt ; senna  8.6  mg ; tamsulosin  0.4  mg ; tramadol (ultram)  50  mg ; trazodone  25  mg ; vitamin d  2000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  1000  ml ; insulin  4  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; 
chronic systolic heart failure postinflammatory pulmonary fibrosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic airway obstruction, not elsewhere classified unspecified disorder of kidney and ureter personal history of tobacco use other psoriasis chest pain, unspecified chronic kidney disease, unspecified old myocardial infarction other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft percutaneous transluminal coronary angioplasty status hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) peripheral vascular disease, unspecified congestive heart failure, unspecified other specified disorders of biliary tract aortocoronary bypass status other dependence on machines, supplemental oxygen person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cardiogenic shock other specified vaccinations against streptococcus pneumoniae [pneumococcus] other ascites subendocardial infarction, initial episode of care chronic kidney disease, stage iii (moderate) acute kidney failure with lesion of tubular necrosis other and unspecified coagulation defects acute respiratory failure physical restraints status ventilator associated pneumonia other suppurative peritonitis postinflammatory pulmonary fibrosis unspecified protein-calorie malnutrition malignant neoplasm of biliary tract, part unspecified site hyperpotassemia paroxysmal ventricular tachycardia congestive heart failure, unspecified diabetes with unspecified complication, type ii or unspecified type, uncontrolled other septicemia due to gram-negative organisms obstruction of bile duct hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) severe sepsis other specified gastritis, with hemorrhage coronary atherosclerosis of unspecified type of vessel, native or graft chronic airway obstruction, not elsewhere classified acidosis other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure
white m 75 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  345  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  167  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol inhaler  3  puff ; aspirin  81  mg ; calcium carbonate  500  mg ; cyanocobalamin  1000  mcg ; docusate sodium  100  mg ; ferrous sulfate  325  mg ; ipratropium bromide mdi  2  puff ; metoprolol tartrate  6.25  mg ; mirtazapine  15  mg ; mirtazapine  7.5  mg ; multivitamins  1  tab ; nitroglycerin sl  0.4  mg ; pantoprazole  40  mg ; psyllium  1  pkt ; senna  8.6  mg ; tamsulosin  0.4  mg ; tramadol (ultram)  50  mg ; trazodone  25  mg ; vitamin d  2000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  4  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; 
chronic systolic heart failure postinflammatory pulmonary fibrosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic airway obstruction, not elsewhere classified unspecified disorder of kidney and ureter personal history of tobacco use other psoriasis chest pain, unspecified chronic kidney disease, unspecified old myocardial infarction other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft percutaneous transluminal coronary angioplasty status hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) peripheral vascular disease, unspecified congestive heart failure, unspecified other specified disorders of biliary tract aortocoronary bypass status other dependence on machines, supplemental oxygen person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cardiogenic shock other specified vaccinations against streptococcus pneumoniae [pneumococcus] other ascites subendocardial infarction, initial episode of care chronic kidney disease, stage iii (moderate) acute kidney failure with lesion of tubular necrosis other and unspecified coagulation defects acute respiratory failure physical restraints status ventilator associated pneumonia other suppurative peritonitis postinflammatory pulmonary fibrosis unspecified protein-calorie malnutrition malignant neoplasm of biliary tract, part unspecified site hyperpotassemia paroxysmal ventricular tachycardia congestive heart failure, unspecified diabetes with unspecified complication, type ii or unspecified type, uncontrolled other septicemia due to gram-negative organisms obstruction of bile duct hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) severe sepsis other specified gastritis, with hemorrhage coronary atherosclerosis of unspecified type of vessel, native or graft chronic airway obstruction, not elsewhere classified acidosis other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure
white m 75 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol inhaler  3  puff ; aspirin  81  mg ; calcium carbonate  500  mg ; cyanocobalamin  1000  mcg ; docusate sodium  100  mg ; ferrous sulfate  325  mg ; ipratropium bromide mdi  2  puff ; metoprolol tartrate  6.25  mg ; mirtazapine  15  mg ; mirtazapine  7.5  mg ; multivitamins  1  tab ; nitroglycerin sl  0.4  mg ; pantoprazole  40  mg ; psyllium  1  pkt ; senna  8.6  mg ; tamsulosin  0.4  mg ; tramadol (ultram)  50  mg ; trazodone  25  mg ; vitamin d  2000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  4  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 
chronic systolic heart failure postinflammatory pulmonary fibrosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic airway obstruction, not elsewhere classified unspecified disorder of kidney and ureter personal history of tobacco use other psoriasis chest pain, unspecified chronic kidney disease, unspecified old myocardial infarction other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft percutaneous transluminal coronary angioplasty status hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) peripheral vascular disease, unspecified congestive heart failure, unspecified other specified disorders of biliary tract aortocoronary bypass status other dependence on machines, supplemental oxygen person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cardiogenic shock other specified vaccinations against streptococcus pneumoniae [pneumococcus] other ascites subendocardial infarction, initial episode of care chronic kidney disease, stage iii (moderate) acute kidney failure with lesion of tubular necrosis other and unspecified coagulation defects acute respiratory failure physical restraints status ventilator associated pneumonia other suppurative peritonitis postinflammatory pulmonary fibrosis unspecified protein-calorie malnutrition malignant neoplasm of biliary tract, part unspecified site hyperpotassemia paroxysmal ventricular tachycardia congestive heart failure, unspecified diabetes with unspecified complication, type ii or unspecified type, uncontrolled other septicemia due to gram-negative organisms obstruction of bile duct hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) severe sepsis other specified gastritis, with hemorrhage coronary atherosclerosis of unspecified type of vessel, native or graft chronic airway obstruction, not elsewhere classified acidosis other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure
white m 53 $nan$nan$thiamine  100  mg ; folic acid  1  mg ; multivitamins  1  tab ; 
 
white m 53 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  168  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  158  mg dl$thiamine  100  mg ; folic acid  1  mg ; multivitamins  1  tab ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; senna  1  tab ; docusate sodium  100  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; diazepam  10  mg ; neutra-phos  2  pkt ; ibuprofen  400  mg ; potassium chloride  40  meq ; ondansetron odt  4  mg ; tuberculin protein  0.1  ml ; 
 
white m 53 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  147  mg dl$thiamine  100  mg ; folic acid  1  mg ; multivitamins  1  tab ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; diazepam  10  mg ; neutra-phos  2  pkt ; ibuprofen  400  mg ; potassium chloride  40  meq ; ondansetron odt  4  mg ; tuberculin protein  0.1  ml ; 
 
white m 53 $nan$nan$thiamine  100  mg ; folic acid  1  mg ; multivitamins  1  tab ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; diazepam  10  mg ; ibuprofen  400  mg ; ondansetron odt  4  mg ; 
 
white f 74 $nan$nan$insulin  30  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; furosemide  80  mg ; omeprazole  40  mg ; losartan potassium  25  mg ; aspirin  81  mg ; 
 
white f 74 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  210  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  243  mg dl$insulin  30  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; furosemide  80  mg ; omeprazole  40  mg ; losartan potassium  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; 0.45% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; alprazolam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; gabapentin  800  mg ; atorvastatin  20  mg ; prednisone  10  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; insulin  0  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; metoprolol tartrate  50  mg ; bag  50  ml ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; gabapentin  600  mg ; potassium chloride  40  meq ; loperamide  2  mg ; 
 
white f 74 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  119  mg dl$insulin  30  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; furosemide  80  mg ; omeprazole  40  mg ; losartan potassium  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; 0.45% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; alprazolam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; atorvastatin  20  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; insulin  0  unit ; metoprolol tartrate  50  mg ; bag  50  ml ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; gabapentin  600  mg ; potassium chloride  40  meq ; loperamide  2  mg ; gabapentin  1200  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; furosemide  40  mg ; 
 
white f 74 $nan$nan$insulin  30  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; omeprazole  40  mg ; losartan potassium  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; alprazolam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; atorvastatin  20  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; insulin  0  unit ; metoprolol tartrate  50  mg ; heparin flush (10 units ml)  2  ml ; gabapentin  600  mg ; loperamide  2  mg ; gabapentin  1200  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; furosemide  40  mg ; trazodone  25  mg ; clopidogrel  300  mg ; morphine sr (ms contin)  15  mg ; oxycodone-acetaminophen  1-2  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; 
 
white f 74 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  150  mg dl$insulin  30  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; omeprazole  40  mg ; losartan potassium  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; alprazolam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; atorvastatin  20  mg ; insulin  0  unit ; metoprolol tartrate  50  mg ; heparin flush (10 units ml)  2  ml ; gabapentin  600  mg ; loperamide  2  mg ; gabapentin  1200  mg ; furosemide  40  mg ; trazodone  25  mg ; clopidogrel  300  mg ; morphine sr (ms contin)  15  mg ; oxycodone-acetaminophen  1-2  tab ; acetylcysteine 20%  600  mg ; nitrofurantoin monohyd (macrobid)  100  mg ; clopidogrel  75  mg ; metoprolol tartrate  25  mg ; 
 
white f 74 $nan$nan$insulin  30  unit ; omeprazole  40  mg ; losartan potassium  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; alprazolam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; atorvastatin  20  mg ; insulin  0  unit ; metoprolol tartrate  50  mg ; heparin flush (10 units ml)  2  ml ; gabapentin  600  mg ; loperamide  2  mg ; gabapentin  1200  mg ; furosemide  40  mg ; morphine sr (ms contin)  15  mg ; oxycodone-acetaminophen  1-2  tab ; nitrofurantoin monohyd (macrobid)  100  mg ; clopidogrel  75  mg ; metoprolol tartrate  25  mg ; hydromorphone (dilaudid)  0.25  mg ; hydromorphone (dilaudid)  0.5-1  mg ; 
 
white f 74 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  64  mg dl$insulin  30  unit ; omeprazole  40  mg ; losartan potassium  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; alprazolam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; atorvastatin  20  mg ; insulin  0  unit ; heparin flush (10 units ml)  2  ml ; gabapentin  600  mg ; loperamide  2  mg ; gabapentin  1200  mg ; furosemide  40  mg ; morphine sr (ms contin)  15  mg ; oxycodone-acetaminophen  1-2  tab ; nitrofurantoin monohyd (macrobid)  100  mg ; clopidogrel  75  mg ; metoprolol tartrate  25  mg ; hydromorphone (dilaudid)  0.5-1  mg ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.125  mg ; 
 
white f 74 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  116  mg dl$insulin  30  unit ; omeprazole  40  mg ; losartan potassium  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; alprazolam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; atorvastatin  20  mg ; insulin  0  unit ; heparin flush (10 units ml)  2  ml ; gabapentin  600  mg ; loperamide  2  mg ; gabapentin  1200  mg ; furosemide  40  mg ; nitrofurantoin monohyd (macrobid)  100  mg ; clopidogrel  75  mg ; metoprolol tartrate  25  mg ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.125  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; haloperidol  0.5-1  mg ; 
 
white f 74 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  253  k ul; hematology urine wbc  23  # hpf$insulin  30  unit ; omeprazole  40  mg ; losartan potassium  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; alprazolam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; atorvastatin  20  mg ; insulin  0  unit ; heparin flush (10 units ml)  2  ml ; gabapentin  600  mg ; loperamide  2  mg ; gabapentin  1200  mg ; furosemide  40  mg ; nitrofurantoin monohyd (macrobid)  100  mg ; clopidogrel  75  mg ; metoprolol tartrate  25  mg ; oxycodone (immediate release)   5-10  mg ; haloperidol  0.5-1  mg ; 
 
white f 74 $nan$nan$insulin  30  unit ; omeprazole  40  mg ; losartan potassium  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; alprazolam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; atorvastatin  20  mg ; insulin  0  unit ; heparin flush (10 units ml)  2  ml ; gabapentin  600  mg ; loperamide  2  mg ; gabapentin  1200  mg ; furosemide  40  mg ; nitrofurantoin monohyd (macrobid)  100  mg ; clopidogrel  75  mg ; metoprolol tartrate  25  mg ; oxycodone (immediate release)   5-10  mg ; haloperidol  0.5-1  mg ; miconazole powder 2%  1  appl ; 
 
white f 74 $nan$nan$insulin  30  unit ; omeprazole  40  mg ; losartan potassium  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; alprazolam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; atorvastatin  20  mg ; insulin  0  unit ; heparin flush (10 units ml)  2  ml ; gabapentin  600  mg ; loperamide  2  mg ; gabapentin  1200  mg ; furosemide  40  mg ; nitrofurantoin monohyd (macrobid)  100  mg ; clopidogrel  75  mg ; metoprolol tartrate  25  mg ; oxycodone (immediate release)   5-10  mg ; haloperidol  0.5-1  mg ; miconazole powder 2%  1  appl ; 
 
white f 74 $nan$nan$insulin  30  unit ; omeprazole  40  mg ; losartan potassium  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; alprazolam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; atorvastatin  20  mg ; insulin  0  unit ; heparin flush (10 units ml)  2  ml ; gabapentin  600  mg ; loperamide  2  mg ; gabapentin  1200  mg ; furosemide  40  mg ; clopidogrel  75  mg ; metoprolol tartrate  25  mg ; oxycodone (immediate release)   5-10  mg ; haloperidol  0.5-1  mg ; miconazole powder 2%  1  appl ; 
 
white f 74 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  419  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology urine wbc  3  # hpf; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  175  mg dl$insulin  30  unit ; omeprazole  40  mg ; losartan potassium  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; alprazolam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; atorvastatin  20  mg ; insulin  0  unit ; heparin flush (10 units ml)  2  ml ; gabapentin  600  mg ; loperamide  2  mg ; gabapentin  1200  mg ; furosemide  40  mg ; clopidogrel  75  mg ; metoprolol tartrate  25  mg ; oxycodone (immediate release)   5-10  mg ; haloperidol  0.5-1  mg ; miconazole powder 2%  1  appl ; morphine sulfate  2  mg ; ciprofloxacin hcl  250  mg ; ciprofloxacin hcl  500  mg ; potassium chloride  20  meq ; senna  1  tab ; 
 
white f 74 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  366  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  150  mg dl$insulin  30  unit ; omeprazole  40  mg ; losartan potassium  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; alprazolam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; atorvastatin  20  mg ; insulin  0  unit ; heparin flush (10 units ml)  2  ml ; gabapentin  600  mg ; loperamide  2  mg ; gabapentin  1200  mg ; furosemide  40  mg ; clopidogrel  75  mg ; metoprolol tartrate  25  mg ; oxycodone (immediate release)   5-10  mg ; haloperidol  0.5-1  mg ; miconazole powder 2%  1  appl ; morphine sulfate  2  mg ; ciprofloxacin hcl  250  mg ; ciprofloxacin hcl  500  mg ; potassium chloride  20  meq ; senna  1  tab ; docusate sodium  100  mg ; 5% dextrose  250  ml ; vancomycin  750  mg ; hydromorphone (dilaudid)  2-4  mg ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; 
 
white f 74 $nan$blood gas blood free calcium  1.22  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood chloride, whole blood  103  meq l; blood gas blood glucose  77  mg dl; blood gas blood glucose  99  mg dl; blood gas blood hematocrit, calculated  30  %; blood gas blood hematocrit, calculated  30  %; blood gas blood hemoglobin  10.0  g dl; blood gas blood hemoglobin  9.9  g dl; blood gas blood potassium, whole blood  3.3  meq l; blood gas blood sodium, whole blood  138  meq l$insulin  30  unit ; omeprazole  40  mg ; losartan potassium  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; alprazolam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; atorvastatin  20  mg ; insulin  0  unit ; gabapentin  600  mg ; loperamide  2  mg ; gabapentin  1200  mg ; furosemide  40  mg ; clopidogrel  75  mg ; metoprolol tartrate  25  mg ; haloperidol  0.5-1  mg ; miconazole powder 2%  1  appl ; ciprofloxacin hcl  250  mg ; ciprofloxacin hcl  500  mg ; senna  1  tab ; docusate sodium  100  mg ; 5% dextrose  250  ml ; vancomycin  750  mg ; hydromorphone (dilaudid)  2-4  mg ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; haloperidol  0.5  mg ; 0.9% sodium chloride  1000  ml ; 
 
white f 74 $nan$hematology blood hematocrit  28.9  %; hematology blood hematocrit  27.9  %; hematology blood hemoglobin  9.5  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  457  k ul; hematology blood platelet count  454  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  223  mg dl; chemistry blood glucose  255  mg dl$insulin  30  unit ; omeprazole  40  mg ; losartan potassium  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; alprazolam  0.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; atorvastatin  20  mg ; insulin  0  unit ; gabapentin  600  mg ; loperamide  2  mg ; gabapentin  1200  mg ; furosemide  40  mg ; clopidogrel  75  mg ; metoprolol tartrate  25  mg ; haloperidol  0.5-1  mg ; miconazole powder 2%  1  appl ; ciprofloxacin hcl  250  mg ; ciprofloxacin hcl  500  mg ; senna  1  tab ; docusate sodium  100  mg ; 5% dextrose  250  ml ; vancomycin  750  mg ; hydromorphone (dilaudid)  2-4  mg ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; haloperidol  0.5  mg ; 0.9% sodium chloride  1000  ml ; pneumococcal vac polyvalent  0.5  ml ; d5w  250  ml ; nitroglycerin  100  mg ; bag  100  ml ; magnesium sulfate  4  gm ; sterile water  50  ml ; heparin flush (10 units ml)  1  ml ; furosemide  20  mg ; 
 
white f 74 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  10.2  g dl; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  260  mg dl$insulin  30  unit ; omeprazole  40  mg ; losartan potassium  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; atorvastatin  20  mg ; insulin  0  unit ; gabapentin  600  mg ; gabapentin  1200  mg ; clopidogrel  75  mg ; metoprolol tartrate  25  mg ; haloperidol  0.5-1  mg ; miconazole powder 2%  1  appl ; ciprofloxacin hcl  250  mg ; ciprofloxacin hcl  500  mg ; senna  1  tab ; docusate sodium  100  mg ; 5% dextrose  250  ml ; vancomycin  750  mg ; hydromorphone (dilaudid)  2-4  mg ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; pneumococcal vac polyvalent  0.5  ml ; d5w  250  ml ; nitroglycerin  100  mg ; heparin flush (10 units ml)  1  ml ; furosemide  20  mg ; metoprolol tartrate  5  mg ; sterile water  100  ml ; hydromorphone (dilaudid)  0.5  mg ; 
 
white f 74 $nan$chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  130  mg dl; chemistry blood glucose  182  mg dl$insulin  30  unit ; omeprazole  40  mg ; losartan potassium  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; atorvastatin  20  mg ; insulin  0  unit ; gabapentin  600  mg ; gabapentin  1200  mg ; clopidogrel  75  mg ; metoprolol tartrate  25  mg ; haloperidol  0.5-1  mg ; miconazole powder 2%  1  appl ; ciprofloxacin hcl  250  mg ; ciprofloxacin hcl  500  mg ; senna  1  tab ; docusate sodium  100  mg ; 5% dextrose  250  ml ; vancomycin  750  mg ; hydromorphone (dilaudid)  2-4  mg ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; pneumococcal vac polyvalent  0.5  ml ; d5w  250  ml ; nitroglycerin  100  mg ; heparin flush (10 units ml)  1  ml ; metoprolol tartrate  5  mg ; sterile water  100  ml ; hydromorphone (dilaudid)  0.5  mg ; neutra-phos  1  pkt ; 
 
white f 74 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  123  mg dl$insulin  30  unit ; omeprazole  40  mg ; losartan potassium  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; atorvastatin  20  mg ; insulin  0  unit ; gabapentin  600  mg ; gabapentin  1200  mg ; clopidogrel  75  mg ; metoprolol tartrate  25  mg ; haloperidol  0.5-1  mg ; miconazole powder 2%  1  appl ; ciprofloxacin hcl  250  mg ; ciprofloxacin hcl  500  mg ; senna  1  tab ; docusate sodium  100  mg ; 5% dextrose  250  ml ; vancomycin  750  mg ; hydromorphone (dilaudid)  2-4  mg ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; pneumococcal vac polyvalent  0.5  ml ; d5w  250  ml ; nitroglycerin  100  mg ; heparin flush (10 units ml)  1  ml ; neutra-phos  1  pkt ; 0.9% sodium chloride  500  ml ; alprazolam  0.25  mg ; 0.9% sodium chloride  100  ml ; 
 
white f 74 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  154  mg dl$insulin  30  unit ; omeprazole  40  mg ; losartan potassium  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; atorvastatin  20  mg ; insulin  0  unit ; gabapentin  600  mg ; gabapentin  1200  mg ; clopidogrel  75  mg ; metoprolol tartrate  25  mg ; haloperidol  0.5-1  mg ; miconazole powder 2%  1  appl ; ciprofloxacin hcl  250  mg ; ciprofloxacin hcl  500  mg ; senna  1  tab ; docusate sodium  100  mg ; 5% dextrose  250  ml ; vancomycin  750  mg ; hydromorphone (dilaudid)  2-4  mg ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; pneumococcal vac polyvalent  0.5  ml ; d5w  250  ml ; nitroglycerin  100  mg ; heparin flush (10 units ml)  1  ml ; alprazolam  0.25  mg ; 
 
white f 74 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  460  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  179  mg dl$insulin  30  unit ; omeprazole  40  mg ; losartan potassium  25  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prochlorperazine  10  mg ; ondansetron  4  mg ; atorvastatin  20  mg ; insulin  0  unit ; gabapentin  600  mg ; gabapentin  1200  mg ; clopidogrel  75  mg ; metoprolol tartrate  25  mg ; haloperidol  0.5-1  mg ; miconazole powder 2%  1  appl ; ciprofloxacin hcl  250  mg ; ciprofloxacin hcl  500  mg ; senna  1  tab ; docusate sodium  100  mg ; 5% dextrose  250  ml ; vancomycin  750  mg ; hydromorphone (dilaudid)  2-4  mg ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; pneumococcal vac polyvalent  0.5  ml ; d5w  250  ml ; nitroglycerin  100  mg ; heparin flush (10 units ml)  1  ml ; alprazolam  0.25  mg ; magnesium oxide  400  mg ; 
 
white f 66 $temp  97.6  heartrate  72.0  resprate  16.0  o2sat  93.0  sbp  116.0  dbp  55.0  rhythm    pain  2  ; temp  98.0  heartrate  92.0  resprate  18.0  o2sat  95.0  sbp  142.0  dbp  62.0  rhythm    pain    ; temp  99.0  heartrate  71.0  resprate  18.0  o2sat  95.0  sbp  137.0  dbp  64.0  rhythm    pain    ; temp  98.1  heartrate  72.0  resprate  16.0  o2sat  95.0  sbp  144.0  dbp  73.0  rhythm    pain    $hematology blood hematocrit  34.7  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  335  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  106  mg dl$nan
 
white f 66 $temp  98.2  heartrate  70.0  resprate  16.0  o2sat  96.0  sbp  131.0  dbp  59.0  rhythm    pain  6  $hematology blood hematocrit  31.9  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  348  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  141  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; d5 1 2ns  1000  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; gabapentin  600  mg ; levetiracetam  500  mg ; omeprazole  40  mg ; nortriptyline  25  mg ; propranolol  30  mg ; sertraline  100  mg ; levothyroxine sodium  88  mcg ; hydrocodone-acetaminophen (5mg-325mg)  1  tab ; 
 
white f 66 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; gabapentin  600  mg ; levetiracetam  500  mg ; omeprazole  40  mg ; nortriptyline  25  mg ; propranolol  30  mg ; sertraline  100  mg ; levothyroxine sodium  88  mcg ; hydrocodone-acetaminophen (5mg-325mg)  1  tab ; 
 
asian f 79 $temp  100.0  heartrate  65.0  resprate  18.0  o2sat  98.0  sbp  174.0  dbp  77.0  rhythm    pain  0  $hematology blood hematocrit  36.1  %; hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.8  g dl; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  180  k ul; hematology blood platelet count  197  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  3.0  mg dl; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  46  mg dl; chemistry urine chloride, urine  109  meq l; chemistry urine creatinine, urine  34  mg dl; chemistry urine potassium, urine  39  meq l; chemistry urine sodium, urine  86  meq l; chemistry urine urea nitrogen, urine  274  mg dl; hematology urine wbc  0  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  339  mg dl; chemistry blood glucose  269  mg dl; chemistry blood glucose  282  mg dl; blood gas blood lactate  2.3  mmol l; hematology urine glucose  100  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  3  ml ; levofloxacin  750  mg ; albuterol 0.083% neb soln  1  neb ; guaifenesin-dextromethorphan  5-10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; furosemide  40  mg ; ondansetron  8  mg ; acetaminophen iv  650  mg ; acetaminophen iv  1000  mg ; heparin  5000  unit ; ipratropium bromide neb  1  neb ; soln  100  ml ; amlodipine  10  mg ; aspirin  81  mg ; atenolol  50  mg ; atorvastatin  20  mg ; clopidogrel  75  mg ; hydrochlorothiazide  25  mg ; nitroglycerin ointment  2%  1  in ; furosemide  80  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; levofloxacin  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; acetaminophen  325-650  mg ; insulin  15  unit ; 
congestive heart failure, unspecified atherosclerosis of renal artery coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ long-term (current) use of insulin personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, unspecified acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status esophageal reflux other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia peripheral vascular disease, unspecified chronic kidney disease, unspecified sinoatrial node dysfunction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified cardiac pacemaker in situ aortocoronary bypass status chronic diastolic heart failure acute kidney failure, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits aortocoronary bypass status anemia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified other and unspecified hyperlipidemia pneumonia, organism unspecified acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hyposmolality and/or hyponatremia 
asian f 79 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  3.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  122  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; insulin  0  unit ; heparin  5000  unit ; ipratropium bromide neb  1  neb ; aspirin  81  mg ; atorvastatin  20  mg ; clopidogrel  75  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; acetaminophen  325-650  mg ; insulin  15  unit ; dextrose 5%  100  ml ; cepastat (phenol) lozenge  1-2  loz ; 
congestive heart failure, unspecified atherosclerosis of renal artery coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ long-term (current) use of insulin personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, unspecified acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status esophageal reflux other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia peripheral vascular disease, unspecified chronic kidney disease, unspecified sinoatrial node dysfunction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified cardiac pacemaker in situ aortocoronary bypass status chronic diastolic heart failure acute kidney failure, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits aortocoronary bypass status anemia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified other and unspecified hyperlipidemia pneumonia, organism unspecified acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hyposmolality and/or hyponatremia 
asian f 79 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  3.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  215  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; insulin  0  unit ; heparin  5000  unit ; ipratropium bromide neb  1  neb ; aspirin  81  mg ; atorvastatin  20  mg ; clopidogrel  75  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetaminophen  325-650  mg ; insulin  15  unit ; dextrose 5%  100  ml ; cepastat (phenol) lozenge  1-2  loz ; multivitamins  1  tab ; vitamin d  2000  unit ; guaifenesin  5-10  ml ; docusate sodium  100  mg ; ranitidine  150  mg ; senna  1  tab ; 
congestive heart failure, unspecified atherosclerosis of renal artery coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ long-term (current) use of insulin personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, unspecified acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status esophageal reflux other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia peripheral vascular disease, unspecified chronic kidney disease, unspecified sinoatrial node dysfunction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified cardiac pacemaker in situ aortocoronary bypass status chronic diastolic heart failure acute kidney failure, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits aortocoronary bypass status anemia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified other and unspecified hyperlipidemia pneumonia, organism unspecified acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hyposmolality and/or hyponatremia 
asian f 79 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  90  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  3.5  mg dl; chemistry blood creatinine  3.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry urine chloride, urine  12  meq l; chemistry urine creatinine, urine  100  mg dl; chemistry urine potassium, urine  41  meq l; chemistry urine sodium, urine  20  meq l; chemistry urine urea nitrogen, urine  500  mg dl; hematology urine wbc  3  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  222  mg dl; chemistry blood glucose  99  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; insulin  0  unit ; heparin  5000  unit ; ipratropium bromide neb  1  neb ; aspirin  81  mg ; atorvastatin  20  mg ; clopidogrel  75  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetaminophen  325-650  mg ; insulin  15  unit ; cepastat (phenol) lozenge  1-2  loz ; multivitamins  1  tab ; vitamin d  2000  unit ; guaifenesin  5-10  ml ; docusate sodium  100  mg ; ranitidine  150  mg ; senna  1  tab ; hydralazine  25  mg ; 0.9% sodium chloride  500  ml ; polyethylene glycol  17  g ; isosorbide dinitrate er  40  mg ; 
congestive heart failure, unspecified atherosclerosis of renal artery coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ long-term (current) use of insulin personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, unspecified acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status esophageal reflux other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia peripheral vascular disease, unspecified chronic kidney disease, unspecified sinoatrial node dysfunction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified cardiac pacemaker in situ aortocoronary bypass status chronic diastolic heart failure acute kidney failure, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits aortocoronary bypass status anemia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified other and unspecified hyperlipidemia pneumonia, organism unspecified acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hyposmolality and/or hyponatremia 
asian f 79 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  211  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  3.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  60  mg dl; chemistry blood glucose  126  mg dl$sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; heparin  5000  unit ; ipratropium bromide neb  1  neb ; aspirin  81  mg ; atorvastatin  20  mg ; clopidogrel  75  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetaminophen  325-650  mg ; insulin  15  unit ; cepastat (phenol) lozenge  1-2  loz ; multivitamins  1  tab ; vitamin d  2000  unit ; guaifenesin  5-10  ml ; docusate sodium  100  mg ; ranitidine  150  mg ; senna  1  tab ; polyethylene glycol  17  g ; isosorbide dinitrate er  40  mg ; 
congestive heart failure, unspecified atherosclerosis of renal artery coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ long-term (current) use of insulin personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, unspecified acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status esophageal reflux other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia peripheral vascular disease, unspecified chronic kidney disease, unspecified sinoatrial node dysfunction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified cardiac pacemaker in situ aortocoronary bypass status chronic diastolic heart failure acute kidney failure, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits aortocoronary bypass status anemia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified other and unspecified hyperlipidemia pneumonia, organism unspecified acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hyposmolality and/or hyponatremia 
asian f 79 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  224  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  3.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  57  mg dl; chemistry urine creatinine, urine  68  mg dl; chemistry urine creatinine, urine  77  mg dl; chemistry urine potassium, urine  20  meq l; chemistry urine sodium, urine  16  meq l; chemistry urine urea nitrogen, urine  472  mg dl; hematology urine wbc  8  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  181  mg dl; chemistry blood albumin  3.0  g dl; chemistry urine protein creatinine ratio  3.3  mg mg; chemistry urine protein creatinine ratio  3.5  mg mg; hematology urine glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; heparin  5000  unit ; ipratropium bromide neb  1  neb ; aspirin  81  mg ; atorvastatin  20  mg ; clopidogrel  75  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetaminophen  325-650  mg ; insulin  15  unit ; cepastat (phenol) lozenge  1-2  loz ; multivitamins  1  tab ; vitamin d  2000  unit ; guaifenesin  5-10  ml ; docusate sodium  100  mg ; ranitidine  150  mg ; senna  1  tab ; polyethylene glycol  17  g ; isosorbide dinitrate er  40  mg ; 
congestive heart failure, unspecified atherosclerosis of renal artery coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ long-term (current) use of insulin personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, unspecified acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status esophageal reflux other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia peripheral vascular disease, unspecified chronic kidney disease, unspecified sinoatrial node dysfunction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified cardiac pacemaker in situ aortocoronary bypass status chronic diastolic heart failure acute kidney failure, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits aortocoronary bypass status anemia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified other and unspecified hyperlipidemia pneumonia, organism unspecified acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hyposmolality and/or hyponatremia 
asian f 79 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  227  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  55  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  146  mg dl; chemistry blood % hemoglobin a1c  8.4  %$sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; heparin  5000  unit ; ipratropium bromide neb  1  neb ; aspirin  81  mg ; atorvastatin  20  mg ; clopidogrel  75  mg ; acetaminophen  325-650  mg ; insulin  15  unit ; cepastat (phenol) lozenge  1-2  loz ; multivitamins  1  tab ; vitamin d  2000  unit ; guaifenesin  5-10  ml ; docusate sodium  100  mg ; ranitidine  150  mg ; senna  1  tab ; polyethylene glycol  17  g ; isosorbide dinitrate er  40  mg ; ondansetron  4-8  mg ; 
congestive heart failure, unspecified atherosclerosis of renal artery coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ long-term (current) use of insulin personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, unspecified acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status esophageal reflux other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia peripheral vascular disease, unspecified chronic kidney disease, unspecified sinoatrial node dysfunction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified cardiac pacemaker in situ aortocoronary bypass status chronic diastolic heart failure acute kidney failure, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits aortocoronary bypass status anemia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified other and unspecified hyperlipidemia pneumonia, organism unspecified acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hyposmolality and/or hyponatremia 
asian f 79 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; heparin  5000  unit ; ipratropium bromide neb  1  neb ; aspirin  81  mg ; atorvastatin  20  mg ; clopidogrel  75  mg ; acetaminophen  325-650  mg ; insulin  15  unit ; cepastat (phenol) lozenge  1-2  loz ; multivitamins  1  tab ; vitamin d  2000  unit ; guaifenesin  5-10  ml ; docusate sodium  100  mg ; ranitidine  150  mg ; senna  1  tab ; polyethylene glycol  17  g ; isosorbide dinitrate er  40  mg ; ondansetron  4-8  mg ; 
congestive heart failure, unspecified atherosclerosis of renal artery coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ long-term (current) use of insulin personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, unspecified acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status esophageal reflux other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia peripheral vascular disease, unspecified chronic kidney disease, unspecified sinoatrial node dysfunction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified cardiac pacemaker in situ aortocoronary bypass status chronic diastolic heart failure acute kidney failure, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits aortocoronary bypass status anemia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified other and unspecified hyperlipidemia pneumonia, organism unspecified acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hyposmolality and/or hyponatremia 
asian f 79 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  56  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  142  mg dl$sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  20  mg ; clopidogrel  75  mg ; acetaminophen  325-650  mg ; insulin  15  unit ; cepastat (phenol) lozenge  1-2  loz ; multivitamins  1  tab ; vitamin d  2000  unit ; guaifenesin  5-10  ml ; docusate sodium  100  mg ; ranitidine  150  mg ; senna  1  tab ; polyethylene glycol  17  g ; isosorbide dinitrate er  40  mg ; ondansetron  4-8  mg ; 
congestive heart failure, unspecified atherosclerosis of renal artery coronary atherosclerosis of unspecified type of vessel, native or graft cardiac pacemaker in situ long-term (current) use of insulin personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, unspecified acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status esophageal reflux other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia peripheral vascular disease, unspecified chronic kidney disease, unspecified sinoatrial node dysfunction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified cardiac pacemaker in situ aortocoronary bypass status chronic diastolic heart failure acute kidney failure, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits aortocoronary bypass status anemia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified other and unspecified hyperlipidemia pneumonia, organism unspecified acute on chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hyposmolality and/or hyponatremia 
white m 82 $nan$hematology blood hematocrit  43.1  %; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  128  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  133  mg dl$nan

white m 82 $nan$chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  116  mg dl$nan

black african american m 37 $temp  97.6  heartrate  100.0  resprate  18.0  o2sat  98.0  sbp  136.0  dbp  89.0  rhythm    pain  0  ; temp  97.5  heartrate  60.0  resprate  16.0  o2sat  95.0  sbp  147.0  dbp  82.0  rhythm    pain  3  $hematology urine wbc  1  # hpf$nan
suicidal ideations altered mental status, unspecified homelessness cocaine use, unspecified, uncomplicated personal history of traumatic brain injury post-traumatic stress disorder, unspecified major depressive disorder, single episode, unspecified opioid dependence, uncomplicated alcohol dependence, uncomplicated anxiety disorder, unspecified personal history of self-harm unspecified mood [affective] disorder anxiety disorder, unspecified personal history of self-harm cannabis abuse, uncomplicated adjustment disorder with depressed mood suicidal ideations post-traumatic stress disorder, unspecified unspecified asthma, uncomplicated other symptoms and signs involving cognitive functions and awareness cocaine abuse, uncomplicated acute bronchitis due to other specified organisms personal history of traumatic brain injury homelessness alcohol abuse, uncomplicated cocaine abuse, uncomplicated alcohol abuse with intoxication, unspecified anemia, unspecified alcohol dependence with withdrawal, unspecified pneumonia, unspecified organism personal history of other specified conditions tobacco use acidosis major depressive disorder, single episode, unspecified hemoptysis restlessness and agitation alcohol abuse with intoxication, unspecified altered mental status, unspecified nicotine dependence, unspecified, uncomplicated alcohol dependence, uncomplicated major depressive disorder, single episode, unspecified chest pain, unspecified other psychoactive substance abuse, uncomplicated unspecified mental disorder due to known physiological condition
black african american m 69 $temp  98.1  heartrate  82.0  resprate  18.0  o2sat  99.0  sbp  109.0  dbp  78.0  rhythm  nsr  pain  2  $nan$sodium chloride 0.9%  flush  3  ml ; 0.45% sodium chloride  1000  ml ; tramadol (ultram)  50  mg ; senna  1  tab ; docusate sodium  100  mg ; vial  1  vial ; pantoprazole  40  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; multivitamins  1  tab ; thiamine  100  mg ; diazepam  5  mg ; 
other specified disorders of stomach and duodenum abdominal pain, generalized chronic hepatitis c without mention of hepatic coma hemorrhage of gastrointestinal tract, unspecified unspecified essential hypertension alcoholic cirrhosis of liver alcohol abuse, unspecified unspecified viral hepatitis c without hepatic coma esophageal reflux acute alcoholic intoxication in alcoholism, unspecified unspecified essential hypertension alcoholic gastritis, with hemorrhage personal history of tobacco use alcoholic cirrhosis of liver esophageal varices in diseases classified elsewhere, without mention of bleeding esophageal varices in diseases classified elsewhere, without mention of bleeding acidosis alcohol abuse, unspecified anemia, unspecified chronic hepatitis c without mention of hepatic coma alcoholic cirrhosis of liver unspecified essential hypertension hemorrhage of gastrointestinal tract, unspecified personal history of tobacco use unspecified essential hypertension hemorrhage of gastrointestinal tract, unspecified chronic hepatitis c without mention of hepatic coma personal history of tobacco use esophageal varices in diseases classified elsewhere, without mention of bleeding alcohol abuse, unspecified esophageal reflux cirrhosis of liver without mention of alcohol personal history of noncompliance with medical treatment, presenting hazards to health hematemesis other and unspecified alcohol dependence, unspecified hemorrhage of rectum and anus other specified anemias alcoholic cirrhosis of liver unspecified essential hypertension esophageal varices without mention of bleeding other specified cardiac dysrhythmias esophageal varices in diseases classified elsewhere, with bleeding alcoholic cirrhosis of liver acute alcoholic intoxication in alcoholism, unspecified anemia, unspecified other chest pain portal hypertension unspecified essential hypertension
white m 83 $nan$nan$isosorbide mononitrate (extended release)  30  mg ; omeprazole  20  mg ; aspirin  81  mg ; pregabalin  25  mg ; prednisone  10  mg ; 
end stage renal disease polyneuropathy in diabetes aortocoronary bypass status other complications due to renal dialysis device, implant, and graft personal history of malignant neoplasm of large intestine other toe(s) amputation status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other postoperative infection cellulitis and abscess of leg, except foot diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled atherosclerosis of native arteries of the extremities, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft gout, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease acute kidney failure, unspecified gout, unspecified other toe(s) amputation status coronary atherosclerosis of native coronary artery diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status anemia in chronic kidney disease end stage renal disease hyperpotassemia 
white m 83 $nan$hematology blood hematocrit  31.3  %; hematology blood hematocrit  28.7  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  329  k ul; hematology blood platelet count  296  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  4.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  64  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood glucose  118  mg dl; chemistry blood albumin  2.3  g dl$isosorbide mononitrate (extended release)  30  mg ; omeprazole  20  mg ; aspirin  81  mg ; pregabalin  25  mg ; prednisone  10  mg ; 1 2 ns  1000  ml ; sevelamer hydrochloride  400  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  500  ml ; docusate sodium  100  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  500  mg ; morphine sulfate  2-4  mg ; insulin  0  unit ; heparin  5000  unit ; atorvastatin  20  mg ; valsartan  160  mg ; prednisone  20  mg ; 
end stage renal disease polyneuropathy in diabetes aortocoronary bypass status other complications due to renal dialysis device, implant, and graft personal history of malignant neoplasm of large intestine other toe(s) amputation status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other postoperative infection cellulitis and abscess of leg, except foot diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled atherosclerosis of native arteries of the extremities, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft gout, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease acute kidney failure, unspecified gout, unspecified other toe(s) amputation status coronary atherosclerosis of native coronary artery diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status anemia in chronic kidney disease end stage renal disease hyperpotassemia 
white m 83 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  266  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  3.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  115  mg dl; chemistry blood lactate dehydrogenase (ld)  187  iu l; chemistry blood albumin  2.4  g dl$isosorbide mononitrate (extended release)  30  mg ; omeprazole  20  mg ; aspirin  81  mg ; pregabalin  25  mg ; prednisone  10  mg ; 1 2 ns  1000  ml ; sevelamer hydrochloride  400  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  500  ml ; docusate sodium  100  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  500  mg ; morphine sulfate  2-4  mg ; insulin  0  unit ; heparin  5000  unit ; atorvastatin  20  mg ; valsartan  160  mg ; prednisone  20  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; simethicone  40-80  mg ; sw  50  ml ; magnesium sulfate  2  gm ; valsartan  80  mg ; glipizide xl  5  mg ; 
end stage renal disease polyneuropathy in diabetes aortocoronary bypass status other complications due to renal dialysis device, implant, and graft personal history of malignant neoplasm of large intestine other toe(s) amputation status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other postoperative infection cellulitis and abscess of leg, except foot diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled atherosclerosis of native arteries of the extremities, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft gout, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease acute kidney failure, unspecified gout, unspecified other toe(s) amputation status coronary atherosclerosis of native coronary artery diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status anemia in chronic kidney disease end stage renal disease hyperpotassemia 
white m 83 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  317  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  4.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  50  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  114  mg dl; chemistry blood albumin  2.6  g dl$isosorbide mononitrate (extended release)  30  mg ; omeprazole  20  mg ; aspirin  81  mg ; pregabalin  25  mg ; 1 2 ns  1000  ml ; sevelamer hydrochloride  400  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  500  mg ; morphine sulfate  2-4  mg ; insulin  0  unit ; heparin  5000  unit ; atorvastatin  20  mg ; prednisone  20  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; simethicone  40-80  mg ; sw  50  ml ; magnesium sulfate  2  gm ; valsartan  80  mg ; glipizide xl  5  mg ; insulin  12  unit ; 
end stage renal disease polyneuropathy in diabetes aortocoronary bypass status other complications due to renal dialysis device, implant, and graft personal history of malignant neoplasm of large intestine other toe(s) amputation status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other postoperative infection cellulitis and abscess of leg, except foot diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled atherosclerosis of native arteries of the extremities, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft gout, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease acute kidney failure, unspecified gout, unspecified other toe(s) amputation status coronary atherosclerosis of native coronary artery diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status anemia in chronic kidney disease end stage renal disease hyperpotassemia 
white m 83 $nan$nan$isosorbide mononitrate (extended release)  30  mg ; omeprazole  20  mg ; aspirin  81  mg ; pregabalin  25  mg ; sevelamer hydrochloride  400  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  500  mg ; morphine sulfate  2-4  mg ; insulin  0  unit ; heparin  5000  unit ; atorvastatin  20  mg ; prednisone  20  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; simethicone  40-80  mg ; valsartan  80  mg ; glipizide xl  5  mg ; insulin  12  unit ; 0.9% sodium chloride  250  ml ; 
end stage renal disease polyneuropathy in diabetes aortocoronary bypass status other complications due to renal dialysis device, implant, and graft personal history of malignant neoplasm of large intestine other toe(s) amputation status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other postoperative infection cellulitis and abscess of leg, except foot diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled atherosclerosis of native arteries of the extremities, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft gout, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease acute kidney failure, unspecified gout, unspecified other toe(s) amputation status coronary atherosclerosis of native coronary artery diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled percutaneous transluminal coronary angioplasty status anemia in chronic kidney disease end stage renal disease hyperpotassemia 
black african american f 52 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  478  mg dl$nan
other and unspecified hyperlipidemia other and unspecified angina pectoris long-term (current) use of insulin obesity, unspecified unspecified episodic mood disorder personal history of noncompliance with medical treatment, presenting hazards to health unspecified psychosis proteinuria sciatica long-term (current) use of aspirin anemia, unspecified diabetes with unspecified complication, type ii or unspecified type, uncontrolled chronic hepatitis c without mention of hepatic coma suicidal ideation posttraumatic stress disorder swelling of limb other and unspecified ovarian cyst other chest pain obesity, unspecified diabetes with renal manifestations, type ii or unspecified type, uncontrolled bipolar disorder, unspecified esophageal reflux tachycardia, unspecified other and unspecified hyperlipidemia posttraumatic stress disorder chronic hepatitis c without mention of hepatic coma nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere shortness of breath cirrhosis of liver without mention of alcohol anemia, unspecified long-term (current) use of insulin spasm of muscle other and unspecified angina pectoris long-term (current) use of insulin chronic hepatitis c without mention of hepatic coma other and unspecified hyperlipidemia diabetes with unspecified complication, type ii or unspecified type, uncontrolled unspecified hereditary and idiopathic peripheral neuropathy anemia, unspecified obesity, unspecified esophageal reflux other chest pain pain in joint, lower leg bipolar disorder, unspecified other specified disorders of stomach and duodenum posttraumatic stress disorder suicidal ideation depressive disorder, not elsewhere classified
white m 46 $nan$hematology blood hematocrit  40.2  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  384  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  88  mg dl; chemistry blood albumin  4.6  g dl; blood gas blood lactate  1.5  mmol l$nan
concussion with loss of consciousness of unspecified duration traumatic pneumothorax without mention of open wound into thorax essential and other specified forms of tremor other disorders of plasma-protein metabolism, not elsewhere classified alcohol abuse, unspecified dysthymic disorder closed fracture of eight or more ribs unspecified essential hypertension accidental fall on or from other stairs or steps 
white m 46 $nan$hematology blood hematocrit  28.1  %; hematology blood hematocrit  27.8  %; hematology blood hematocrit  26.8  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  372  k ul; hematology blood platelet count  335  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  95  mg dl$syringe  1  ml ; heparin sodium  5000  unit ; hydromorphone (dilaudid)  12.5  mg ; senna  1  tab ; acetaminophen  650  mg ; ondansetron  4  mg ; lr  1000  ml ; d5 1 2ns  1000  ml ; docusate sodium (liquid)  100  mg ; docusate sodium  100  mg ; 
concussion with loss of consciousness of unspecified duration traumatic pneumothorax without mention of open wound into thorax essential and other specified forms of tremor other disorders of plasma-protein metabolism, not elsewhere classified alcohol abuse, unspecified dysthymic disorder closed fracture of eight or more ribs unspecified essential hypertension accidental fall on or from other stairs or steps 
white m 46 $nan$hematology blood hematocrit  29.0  %; hematology blood hematocrit  27.7  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  448  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  100  mg dl$senna  1  tab ; acetaminophen  650  mg ; ondansetron  4  mg ; d5 1 2ns  1000  ml ; docusate sodium  100  mg ; thiamine  100  mg ; folic acid  1  mg ; multivitamins  1  tab ; diazepam  5  mg ; lorazepam  0.5-2  mg ; sodium chloride 0.9%  flush  3  ml ; 
concussion with loss of consciousness of unspecified duration traumatic pneumothorax without mention of open wound into thorax essential and other specified forms of tremor other disorders of plasma-protein metabolism, not elsewhere classified alcohol abuse, unspecified dysthymic disorder closed fracture of eight or more ribs unspecified essential hypertension accidental fall on or from other stairs or steps 
white m 46 $nan$hematology blood hematocrit  26.8  %; hematology blood hematocrit  25.5  %; hematology blood hematocrit  25.2  %; hematology blood hematocrit  24.6  %; hematology blood hemoglobin  9.5  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  349  k ul; hematology blood platelet count  341  k ul; hematology blood platelet count  362  k ul; hematology blood platelet count  365  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  110  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  113  mg dl; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.01  mmol l; blood gas blood lactate  0.8  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood chloride, whole blood  101  meq l; blood gas blood chloride, whole blood  101  meq l; blood gas blood glucose  94  mg dl; blood gas blood glucose  110  mg dl; blood gas blood hematocrit, calculated  27  %; blood gas blood hematocrit, calculated  30  %; blood gas blood hematocrit, calculated  25  %; blood gas blood hemoglobin  9.0  g dl; blood gas blood hemoglobin  9.9  g dl; blood gas blood hemoglobin  8.3  g dl; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood sodium, whole blood  134  meq l; blood gas blood sodium, whole blood  133  meq l$senna  1  tab ; acetaminophen  650  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; thiamine  100  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; albuterol 0.083% neb soln  1  neb ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; heparin  5000  unit ; vial  1  vial ; pantoprazole sodium  40  mg ; lorazepam  0.5  mg ; insulin  0  unit ; hydromorphone (dilaudid)  0.25  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lorazepam  0.5-1  mg ; metoprolol tartrate  5  mg ; propofol  1000  mg ; propofol  200  mg ; fentanyl citrate  25-100  mcg ; albuterol-ipratropium  6-8  puff ; 
concussion with loss of consciousness of unspecified duration traumatic pneumothorax without mention of open wound into thorax essential and other specified forms of tremor other disorders of plasma-protein metabolism, not elsewhere classified alcohol abuse, unspecified dysthymic disorder closed fracture of eight or more ribs unspecified essential hypertension accidental fall on or from other stairs or steps 
white m 46 $nan$hematology blood hematocrit  24.0  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  477  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  115  mg dl$ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; heparin  5000  unit ; vial  1  vial ; pantoprazole sodium  40  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lorazepam  0.5-1  mg ; metoprolol tartrate  5  mg ; propofol  1000  mg ; propofol  200  mg ; fentanyl citrate  25-100  mcg ; albuterol-ipratropium  6-8  puff ; hydromorphone (dilaudid)  0.12  mg ; 
concussion with loss of consciousness of unspecified duration traumatic pneumothorax without mention of open wound into thorax essential and other specified forms of tremor other disorders of plasma-protein metabolism, not elsewhere classified alcohol abuse, unspecified dysthymic disorder closed fracture of eight or more ribs unspecified essential hypertension accidental fall on or from other stairs or steps 
white m 46 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  496  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  97  mg dl$ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; heparin  5000  unit ; vial  1  vial ; pantoprazole sodium  40  mg ; lorazepam  0.5-1  mg ; metoprolol tartrate  12.5  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5  mg ; paroxetine  20  mg ; pantoprazole  40  mg ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  2-4  mg ; ibuprofen  600  mg ; 
concussion with loss of consciousness of unspecified duration traumatic pneumothorax without mention of open wound into thorax essential and other specified forms of tremor other disorders of plasma-protein metabolism, not elsewhere classified alcohol abuse, unspecified dysthymic disorder closed fracture of eight or more ribs unspecified essential hypertension accidental fall on or from other stairs or steps 
white m 46 $nan$nan$sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  12.5  mg ; acetaminophen  325-650  mg ; paroxetine  20  mg ; pantoprazole  40  mg ; hydromorphone (dilaudid)  2-4  mg ; ibuprofen  600  mg ; zolpidem tartrate  5  mg ; 
concussion with loss of consciousness of unspecified duration traumatic pneumothorax without mention of open wound into thorax essential and other specified forms of tremor other disorders of plasma-protein metabolism, not elsewhere classified alcohol abuse, unspecified dysthymic disorder closed fracture of eight or more ribs unspecified essential hypertension accidental fall on or from other stairs or steps 
white m 46 $nan$nan$sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  12.5  mg ; acetaminophen  325-650  mg ; paroxetine  20  mg ; pantoprazole  40  mg ; hydromorphone (dilaudid)  2-4  mg ; ibuprofen  600  mg ; zolpidem tartrate  5  mg ; 
concussion with loss of consciousness of unspecified duration traumatic pneumothorax without mention of open wound into thorax essential and other specified forms of tremor other disorders of plasma-protein metabolism, not elsewhere classified alcohol abuse, unspecified dysthymic disorder closed fracture of eight or more ribs unspecified essential hypertension accidental fall on or from other stairs or steps 
white m 27 $nan$hematology blood hematocrit  23.4  %; hematology blood hematocrit  21.5  %; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  334  k ul; hematology blood platelet count  344  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  213  mg dl; chemistry blood glucose  123  mg dl; chemistry blood lactate dehydrogenase (ld)  119  iu l; blood gas blood free calcium  1.06  mmol l$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ondansetron  4  mg ; methylprednisolone sodium succ  20  mg ; sodium chloride 0.9%  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10-20  ml ; lorazepam  0.5  mg ; bag  1  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; 5% dextrose  50  ml ; phytonadione  10  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 
 
white m 27 $nan$hematology blood hematocrit  22.3  %; hematology blood hematocrit  20.8  %; hematology blood hemoglobin  6.8  g dl; hematology blood platelet count  262  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  318  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ondansetron  4  mg ; methylprednisolone sodium succ  20  mg ; sodium chloride 0.9%  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10-20  ml ; lorazepam  0.5  mg ; bag  1  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; 5% dextrose  50  ml ; phytonadione  10  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; lidocaine jelly 2% (glydo)  1  appl ; lactated ringers  1000  ml ; hydromorphone  20  mg ; acetaminophen  1000  mg ; ketorolac  15  mg ; metoclopramide  10  mg ; magnesium sulfate  2  gm ; morphine sulfate  2  mg ; methylprednisolone sodium succ  10  mg ; 
 
white m 27 $nan$hematology blood hematocrit  19.9  %; hematology blood hemoglobin  6.5  g dl; hematology blood platelet count  300  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  320  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10-20  ml ; lorazepam  0.5  mg ; lidocaine jelly 2% (glydo)  1  appl ; hydromorphone  20  mg ; acetaminophen  1000  mg ; ketorolac  15  mg ; metoclopramide  10  mg ; magnesium sulfate  2  gm ; morphine sulfate  2  mg ; methylprednisolone sodium succ  10  mg ; oxycodone (immediate release)  5  mg ; methylprednisolone sodium succ  5  mg ; neutra-phos  1  pkt ; 
 
white m 27 $nan$hematology blood hematocrit  18.5  %; hematology blood hemoglobin  6.0  g dl; hematology blood platelet count  295  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  309  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sodium chloride 0.9%  flush  10-20  ml ; lorazepam  0.5  mg ; acetaminophen  1000  mg ; ketorolac  15  mg ; oxycodone (immediate release)  5  mg ; methylprednisolone sodium succ  5  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; ferric gluconate  125  mg ; 
 
white m 27 $nan$hematology blood hematocrit  19.9  %; hematology blood hematocrit  20.5  %; hematology blood hemoglobin  6.4  g dl; hematology blood hemoglobin  6.5  g dl; hematology blood platelet count  344  k ul; hematology blood platelet count  383  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  0.5  mg ; acetaminophen  1000  mg ; ketorolac  15  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; prednisone  5  mg ; methylprednisolone sodium succ  8  mg ; acetaminophen iv  1000  mg ; 
 
white m 27 $nan$hematology blood hematocrit  21.4  %; hematology blood hematocrit  21.0  %; hematology blood hemoglobin  7.0  g dl; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  273  k ul; hematology blood platelet count  326  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  283  mg dl; chemistry blood glucose  299  mg dl; hematology blood bands  0  %; blood gas blood free calcium  1.06  mmol l; hematology urine glucose  1000  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  0.5  mg ; oxycodone (immediate release)  5-10  mg ; methylprednisolone sodium succ  8  mg ; acetaminophen iv  1000  mg ; chloraseptic throat spray  1  spry ; cepacol (sore throat lozenge)  2  loz ; vial  1  vial ; pantoprazole  40  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; ns  100  ml ; metronidazole  500  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; 
 
white m 27 $nan$hematology blood hematocrit  21.0  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  297  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  127  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  0.5  mg ; chloraseptic throat spray  1  spry ; cepacol (sore throat lozenge)  2  loz ; vial  1  vial ; pantoprazole  40  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; ns  100  ml ; metronidazole  500  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; 0.45% sodium chloride  1000  ml ; 
 
white m 27 $nan$hematology blood hematocrit  22.5  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  289  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  112  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  0.5  mg ; chloraseptic throat spray  1  spry ; cepacol (sore throat lozenge)  2  loz ; vial  1  vial ; pantoprazole  40  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; ns  100  ml ; metronidazole  500  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; 0.45% sodium chloride  1000  ml ; ramelteon  8  mg ; sterile water  100  ml ; potassium chloride  40  meq ; phytonadione  2.5  mg ; 
 
white m 27 $nan$hematology blood hematocrit  20.4  %; hematology blood hematocrit  24.3  %; hematology blood hemoglobin  6.6  g dl; hematology blood platelet count  276  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  7.0  mg dl; chemistry blood glucose  134  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  0.5  mg ; chloraseptic throat spray  1  spry ; cepacol (sore throat lozenge)  2  loz ; vial  1  vial ; pantoprazole  40  mg ; ns  100  ml ; metronidazole  500  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; 0.45% sodium chloride  1000  ml ; ramelteon  8  mg ; phytonadione  2.5  mg ; ciprofloxacin hcl  500  mg ; calcium gluconate  4  g ; 
 
white m 27 $nan$hematology blood hematocrit  20.6  %; hematology blood hemoglobin  6.5  g dl; hematology blood platelet count  289  k ul; chemistry blood anion gap  6  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  83  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  0.5  mg ; chloraseptic throat spray  1  spry ; cepacol (sore throat lozenge)  2  loz ; vial  1  vial ; pantoprazole  40  mg ; ramelteon  8  mg ; ciprofloxacin hcl  500  mg ; calcium gluconate  4  g ; 
 
white m 27 $nan$hematology blood hematocrit  19.9  %; hematology blood hematocrit  20.8  %; hematology blood hemoglobin  6.2  g dl; hematology blood hemoglobin  6.5  g dl; hematology blood platelet count  332  k ul; hematology blood platelet count  343  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  84  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  0.5  mg ; chloraseptic throat spray  1  spry ; cepacol (sore throat lozenge)  2  loz ; vial  1  vial ; pantoprazole  40  mg ; ramelteon  8  mg ; ciprofloxacin hcl  500  mg ; calcium carbonate suspension  1250  mg ; gastroview (diatrizoate meglumine & sodium)  30  ml ; 
 
white m 27 $nan$hematology blood hematocrit  20.3  %; hematology blood hemoglobin  6.2  g dl; hematology blood platelet count  346  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  108  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  0.5  mg ; chloraseptic throat spray  1  spry ; cepacol (sore throat lozenge)  2  loz ; ramelteon  8  mg ; ciprofloxacin hcl  500  mg ; cyclobenzaprine  5  mg ; cyclobenzaprine  5-10  mg ; 
 
white m 27 $nan$hematology blood hematocrit  20.3  %; hematology blood hemoglobin  6.3  g dl; hematology blood platelet count  427  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  95  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  0.5  mg ; chloraseptic throat spray  1  spry ; cepacol (sore throat lozenge)  2  loz ; ramelteon  8  mg ; ciprofloxacin hcl  500  mg ; cyclobenzaprine  5-10  mg ; cyclobenzaprine  10  mg ; lidocaine 5% patch  1  ptch ; 
 
white m 27 $nan$hematology blood hematocrit  19.3  %; hematology blood hematocrit  24.6  %; hematology blood hematocrit  23.6  %; hematology blood hemoglobin  6.1  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  170  k ul; hematology blood platelet count  485  k ul; hematology blood platelet count  486  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  0.5  mg ; chloraseptic throat spray  1  spry ; cepacol (sore throat lozenge)  2  loz ; ramelteon  8  mg ; ciprofloxacin hcl  500  mg ; cyclobenzaprine  5-10  mg ; lidocaine 5% patch  1  ptch ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; 
 
white m 27 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  542  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  0.5  mg ; chloraseptic throat spray  1  spry ; cepacol (sore throat lozenge)  2  loz ; ramelteon  8  mg ; ciprofloxacin hcl  500  mg ; cyclobenzaprine  5-10  mg ; lidocaine 5% patch  1  ptch ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; gabapentin  300  mg ; lidocaine 5% patch  2  ptch ; 
 
white m 27 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  0.5  mg ; chloraseptic throat spray  1  spry ; cepacol (sore throat lozenge)  2  loz ; ramelteon  8  mg ; ciprofloxacin hcl  500  mg ; cyclobenzaprine  5-10  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; gabapentin  300  mg ; lidocaine 5% patch  2  ptch ; 
 
black african american f 62 $nan$chemistry blood anion gap  11  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  115  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  6.2  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  245  mg dl; chemistry blood glucose  164  mg dl$lisinopril  40  mg ; hydrochlorothiazide  25  mg ; metoprolol succinate xl  25  mg ; aspirin  81  mg ; docusate sodium  100  mg ; collagenase ointment  1  appl ; felodipine  10  mg ; heparin  5000  unit ; atorvastatin  40  mg ; gabapentin  1200  mg ; bag  1  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; nortriptyline  10  mg ; influenza vaccine quadrivalent  0.5  ml ; acetaminophen  650  mg ; amoxicillin-clavulanic acid  875  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; triamcinolone acetonide 0.1% cream  1  appl ; senna  8.6  mg ; insulin  0  unit ; polyethylene glycol  17  g ; hydralazine  10  mg ; d5 1 2ns  1000  ml ; 
diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled person on outside of bus injured in collision with pedestrian or animal in traffic accident long-term (current) use of anticoagulants ulcer of other part of foot examination of participant in clinical trial long-term (current) use of aspirin long-term (current) use of insulin occlusion and stenosis of carotid artery without mention of cerebral infarction atherosclerosis of native arteries of the extremities with ulceration long-term (current) use of other medications unspecified viral hepatitis c without hepatic coma unspecified essential hypertension personal history of tobacco use pure hypercholesterolemia acute posthemorrhagic anemia long-term (current) use of antiplatelet/antithrombotic diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension chronic hepatitis c without mention of hepatic coma atherosclerosis of native arteries of the extremities with intermittent claudication pure hypercholesterolemia unspecified essential hypertension polyneuropathy in diabetes chronic hepatitis c without mention of hepatic coma atherosclerosis of native arteries of the extremities with ulceration pure hypercholesterolemia diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled ulcer of other part of foot ulcer of other part of foot cellulitis and abscess of foot, except toes unspecified essential hypertension polyneuropathy in diabetes other hammer toe (acquired) diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic hepatitis c without mention of hepatic coma peripheral vascular disease, unspecified
black african american f 62 $nan$hematology blood hematocrit  22.0  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  186  k ul; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  268  mg dl; chemistry blood % hemoglobin a1c  7.7  %$lisinopril  40  mg ; hydrochlorothiazide  25  mg ; metoprolol succinate xl  25  mg ; aspirin  81  mg ; docusate sodium  100  mg ; collagenase ointment  1  appl ; felodipine  10  mg ; heparin  5000  unit ; atorvastatin  40  mg ; gabapentin  1200  mg ; bag  1  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; nortriptyline  10  mg ; influenza vaccine quadrivalent  0.5  ml ; acetaminophen  650  mg ; amoxicillin-clavulanic acid  875  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; triamcinolone acetonide 0.1% cream  1  appl ; senna  8.6  mg ; insulin  0  unit ; polyethylene glycol  17  g ; hydralazine  10  mg ; d5 1 2ns  1000  ml ; ondansetron  4  mg ; clopidogrel  75  mg ; gabapentin  600  mg ; insulin  28  unit ; 
diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled person on outside of bus injured in collision with pedestrian or animal in traffic accident long-term (current) use of anticoagulants ulcer of other part of foot examination of participant in clinical trial long-term (current) use of aspirin long-term (current) use of insulin occlusion and stenosis of carotid artery without mention of cerebral infarction atherosclerosis of native arteries of the extremities with ulceration long-term (current) use of other medications unspecified viral hepatitis c without hepatic coma unspecified essential hypertension personal history of tobacco use pure hypercholesterolemia acute posthemorrhagic anemia long-term (current) use of antiplatelet/antithrombotic diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension chronic hepatitis c without mention of hepatic coma atherosclerosis of native arteries of the extremities with intermittent claudication pure hypercholesterolemia unspecified essential hypertension polyneuropathy in diabetes chronic hepatitis c without mention of hepatic coma atherosclerosis of native arteries of the extremities with ulceration pure hypercholesterolemia diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled ulcer of other part of foot ulcer of other part of foot cellulitis and abscess of foot, except toes unspecified essential hypertension polyneuropathy in diabetes other hammer toe (acquired) diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic hepatitis c without mention of hepatic coma peripheral vascular disease, unspecified
black african american f 62 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  266  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  47  mg dl$lisinopril  40  mg ; hydrochlorothiazide  25  mg ; metoprolol succinate xl  25  mg ; aspirin  81  mg ; docusate sodium  100  mg ; collagenase ointment  1  appl ; felodipine  10  mg ; heparin  5000  unit ; atorvastatin  40  mg ; nortriptyline  10  mg ; influenza vaccine quadrivalent  0.5  ml ; acetaminophen  650  mg ; amoxicillin-clavulanic acid  875  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; triamcinolone acetonide 0.1% cream  1  appl ; senna  8.6  mg ; polyethylene glycol  17  g ; hydralazine  10  mg ; ondansetron  4  mg ; clopidogrel  75  mg ; gabapentin  600  mg ; insulin  28  unit ; 
diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled person on outside of bus injured in collision with pedestrian or animal in traffic accident long-term (current) use of anticoagulants ulcer of other part of foot examination of participant in clinical trial long-term (current) use of aspirin long-term (current) use of insulin occlusion and stenosis of carotid artery without mention of cerebral infarction atherosclerosis of native arteries of the extremities with ulceration long-term (current) use of other medications unspecified viral hepatitis c without hepatic coma unspecified essential hypertension personal history of tobacco use pure hypercholesterolemia acute posthemorrhagic anemia long-term (current) use of antiplatelet/antithrombotic diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension chronic hepatitis c without mention of hepatic coma atherosclerosis of native arteries of the extremities with intermittent claudication pure hypercholesterolemia unspecified essential hypertension polyneuropathy in diabetes chronic hepatitis c without mention of hepatic coma atherosclerosis of native arteries of the extremities with ulceration pure hypercholesterolemia diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled ulcer of other part of foot ulcer of other part of foot cellulitis and abscess of foot, except toes unspecified essential hypertension polyneuropathy in diabetes other hammer toe (acquired) diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic hepatitis c without mention of hepatic coma peripheral vascular disease, unspecified
black african american f 62 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  173  mg dl$lisinopril  40  mg ; hydrochlorothiazide  25  mg ; metoprolol succinate xl  25  mg ; aspirin  81  mg ; docusate sodium  100  mg ; collagenase ointment  1  appl ; felodipine  10  mg ; heparin  5000  unit ; atorvastatin  40  mg ; nortriptyline  10  mg ; influenza vaccine quadrivalent  0.5  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; triamcinolone acetonide 0.1% cream  1  appl ; senna  8.6  mg ; polyethylene glycol  17  g ; hydralazine  10  mg ; ondansetron  4  mg ; clopidogrel  75  mg ; gabapentin  600  mg ; zolpidem tartrate  5  mg ; sulfameth trimethoprim ss  1  tab ; 
diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled person on outside of bus injured in collision with pedestrian or animal in traffic accident long-term (current) use of anticoagulants ulcer of other part of foot examination of participant in clinical trial long-term (current) use of aspirin long-term (current) use of insulin occlusion and stenosis of carotid artery without mention of cerebral infarction atherosclerosis of native arteries of the extremities with ulceration long-term (current) use of other medications unspecified viral hepatitis c without hepatic coma unspecified essential hypertension personal history of tobacco use pure hypercholesterolemia acute posthemorrhagic anemia long-term (current) use of antiplatelet/antithrombotic diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension chronic hepatitis c without mention of hepatic coma atherosclerosis of native arteries of the extremities with intermittent claudication pure hypercholesterolemia unspecified essential hypertension polyneuropathy in diabetes chronic hepatitis c without mention of hepatic coma atherosclerosis of native arteries of the extremities with ulceration pure hypercholesterolemia diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled ulcer of other part of foot ulcer of other part of foot cellulitis and abscess of foot, except toes unspecified essential hypertension polyneuropathy in diabetes other hammer toe (acquired) diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled chronic hepatitis c without mention of hepatic coma peripheral vascular disease, unspecified
white m 67 $nan$hematology blood hematocrit  42.8  %; hematology blood hemoglobin  15.1  g dl; hematology blood platelet count  273  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  109  mg dl$nan
 
white f 32 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  167  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry urine chloride, urine  66  meq l; chemistry urine creatinine, urine  58  mg dl; chemistry urine potassium, urine  23  meq l; chemistry urine sodium, urine  71  meq l; chemistry urine urea nitrogen, urine  304  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  78  mg dl; blood gas blood potassium, whole blood  4.9  meq l$influenza vaccine quadrivalent  0.5  ml ; sodium polystyrene sulfonate  30  gm ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; heparin  5000  unit ; amitriptyline  10  mg ; atorvastatin  10  mg ; fluoxetine  20  mg ; omeprazole  20  mg ; baclofen  10  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; magnesium oxide  400  mg ; 
chronic glomerulonephritis with lesion of membranous glomerulonephritis hyperpotassemia hypovolemia other specified paralytic syndrome chronic kidney disease, unspecified other causes of myelitis
white f 32 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; amitriptyline  10  mg ; atorvastatin  10  mg ; fluoxetine  20  mg ; omeprazole  20  mg ; baclofen  10  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; magnesium oxide  400  mg ; 
chronic glomerulonephritis with lesion of membranous glomerulonephritis hyperpotassemia hypovolemia other specified paralytic syndrome chronic kidney disease, unspecified other causes of myelitis
white m 85 $temp    heartrate  41.0  resprate  16.0  o2sat  100.0  sbp  206.0  dbp  68.0  rhythm    pain  0  ; temp    heartrate  40.0  resprate  15.0  o2sat  98.0  sbp  198.0  dbp  79.0  rhythm    pain  0  ; temp    heartrate  39.0  resprate  18.0  o2sat  96.0  sbp  172.0  dbp  75.0  rhythm  ? complete heart block  pain  0  ; temp  98.2  heartrate  50.0  resprate  18.0  o2sat  99.0  sbp  151.0  dbp  51.0  rhythm  complete heart block  pain  0  ; temp  97.9  heartrate  57.0  resprate  16.0  o2sat  100.0  sbp  130.0  dbp  66.0  rhythm  complete heart block  pain  0  ; temp    heartrate  40.0  resprate  18.0  o2sat  98.0  sbp  145.0  dbp  64.0  rhythm  complete heart block  pain  0  ; temp  97.6  heartrate  43.0  resprate  18.0  o2sat  98.0  sbp  127.0  dbp  37.0  rhythm  complete heart block  pain  0  $nan$allopurinol  300  mg ; aspirin  325  mg ; atenolol  25  mg ; ferrous sulfate  325  mg ; hydrochlorothiazide  25  mg ; isosorbide mononitrate (extended release)  60  mg ; omeprazole  20  mg ; pravastatin  80  mg ; ranitidine  150  mg ; vitamin e  400  unit ; fish oil (omega 3)  1000  mg ; 
 
white m 85 $temp  97.7  heartrate  39.0  resprate  18.0  o2sat    sbp  143.0  dbp  55.0  rhythm  complete heart block  pain  0  $hematology blood hematocrit  44.4  %; hematology blood hemoglobin  15.7  g dl; hematology blood platelet count  110  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  194  mg dl$allopurinol  300  mg ; aspirin  325  mg ; atenolol  25  mg ; ferrous sulfate  325  mg ; hydrochlorothiazide  25  mg ; isosorbide mononitrate (extended release)  60  mg ; omeprazole  20  mg ; pravastatin  80  mg ; ranitidine  150  mg ; vitamin e  400  unit ; fish oil (omega 3)  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; nitroglycerin sl  0.3  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; oxycodone (immediate release)   2.5  mg ; acetaminophen  650  mg ; 
 
white m 85 $nan$hematology blood hematocrit  43.5  %; hematology blood hemoglobin  15.1  g dl; hematology blood platelet count  81  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood glucose  210  mg dl$allopurinol  300  mg ; aspirin  325  mg ; atenolol  25  mg ; ferrous sulfate  325  mg ; hydrochlorothiazide  25  mg ; omeprazole  20  mg ; pravastatin  80  mg ; ranitidine  150  mg ; vitamin e  400  unit ; fish oil (omega 3)  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; nitroglycerin sl  0.3  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; oxycodone (immediate release)   2.5  mg ; acetaminophen  650  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
 
white m 85 $nan$nan$allopurinol  300  mg ; aspirin  325  mg ; atenolol  25  mg ; ferrous sulfate  325  mg ; hydrochlorothiazide  25  mg ; omeprazole  20  mg ; pravastatin  80  mg ; ranitidine  150  mg ; vitamin e  400  unit ; fish oil (omega 3)  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; nitroglycerin sl  0.3  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; oxycodone (immediate release)   2.5  mg ; acetaminophen  650  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
 
white f 78 $temp  98.7  heartrate  80.0  resprate  26.0  o2sat  97.0  sbp  139.0  dbp  97.0  rhythm    pain  9  ; temp  98.4  heartrate  88.0  resprate  22.0  o2sat  95.0  sbp  143.0  dbp  58.0  rhythm    pain  4  ; temp  99.1  heartrate  94.0  resprate  18.0  o2sat  92.0  sbp  138.0  dbp  59.0  rhythm    pain  6  ; temp    heartrate  91.0  resprate  18.0  o2sat  93.0  sbp  140.0  dbp  73.0  rhythm    pain  6  ; temp  98.3  heartrate  81.0  resprate  18.0  o2sat  94.0  sbp  121.0  dbp  54.0  rhythm    pain  3  ; temp    heartrate  72.0  resprate  15.0  o2sat  94.0  sbp  109.0  dbp  53.0  rhythm    pain  0  $hematology blood hematocrit  38.1  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  291  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  0  # hpf; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  115  mg dl; chemistry blood albumin  4.2  g dl$nan
hypoxemia personal history of nicotine dependence polyneuropathy, unspecified unspecified asthma with (acute) exacerbation spinal stenosis, cervical region personal history of malignant neoplasm of breast personal history of pulmonary embolism pneumonia, unspecified organism restless legs syndrome long term (current) use of anticoagulants other specified disorders of veins gastro-esophageal reflux disease without esophagitis age-related osteoporosis without current pathological fracture anxiety disorder, unspecified hypo-osmolality and hyponatremia unspecified asthma with (acute) exacerbation pleural plaque with presence of asbestos acquired absence of left breast and nipple acute upper respiratory infection, unspecified other chorea other ill-defined heart diseases long term (current) use of antithrombotics/antiplatelets polyneuropathy, unspecified personal history of nicotine dependence herpesviral infection of urogenital system, unspecified contact with and (suspected) exposure to asbestos other disorders of lung spinal stenosis, lumbar region major depressive disorder, single episode, unspecified pulmonary fibrosis, unspecified personal history of pulmonary embolism personal history of malignant neoplasm of breast restless legs syndrome gastro-esophageal reflux disease without esophagitis acquired coagulation factor deficiency hypoxemia other cervical disc displacement, unspecified cervical region spinal stenosis, lumbar region other specified fracture of right acetabulum, initial encounter for closed fracture personal history of malignant neoplasm of breast gastro-esophageal reflux disease without esophagitis restless legs syndrome unspecified asthma with (acute) exacerbation long term (current) use of anticoagulants exposure to other specified factors, initial encounter personal history of pulmonary embolism mesothelioma of pleura acute bronchitis due to other specified organisms
white f 78 $temp  98.0  heartrate  70.0  resprate  15.0  o2sat  93.0  sbp  110.0  dbp  55.0  rhythm    pain  0  $hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  278  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  102  mg dl; chemistry blood albumin  3.6  g dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; albuterol 0.083% neb soln  1  neb ; furosemide  40  mg ; ipratropium-albuterol neb  1  neb ; multivitamins  1  tab ; omeprazole  20  mg ; senna  8.6  mg ; ranitidine  150  mg ; rivaroxaban  10  mg ; venlafaxine xr  75  mg ; loratadine  10  mg ; oxycodone (immediate release)  2.5  mg ; pramipexole  1  mg ; benzonatate  200  mg ; clonazepam  0.5  mg ; docusate sodium  100  mg ; lidocaine 5% patch  1  ptch ; 
hypoxemia personal history of nicotine dependence polyneuropathy, unspecified unspecified asthma with (acute) exacerbation spinal stenosis, cervical region personal history of malignant neoplasm of breast personal history of pulmonary embolism pneumonia, unspecified organism restless legs syndrome long term (current) use of anticoagulants other specified disorders of veins gastro-esophageal reflux disease without esophagitis age-related osteoporosis without current pathological fracture anxiety disorder, unspecified hypo-osmolality and hyponatremia unspecified asthma with (acute) exacerbation pleural plaque with presence of asbestos acquired absence of left breast and nipple acute upper respiratory infection, unspecified other chorea other ill-defined heart diseases long term (current) use of antithrombotics/antiplatelets polyneuropathy, unspecified personal history of nicotine dependence herpesviral infection of urogenital system, unspecified contact with and (suspected) exposure to asbestos other disorders of lung spinal stenosis, lumbar region major depressive disorder, single episode, unspecified pulmonary fibrosis, unspecified personal history of pulmonary embolism personal history of malignant neoplasm of breast restless legs syndrome gastro-esophageal reflux disease without esophagitis acquired coagulation factor deficiency hypoxemia other cervical disc displacement, unspecified cervical region spinal stenosis, lumbar region other specified fracture of right acetabulum, initial encounter for closed fracture personal history of malignant neoplasm of breast gastro-esophageal reflux disease without esophagitis restless legs syndrome unspecified asthma with (acute) exacerbation long term (current) use of anticoagulants exposure to other specified factors, initial encounter personal history of pulmonary embolism mesothelioma of pleura acute bronchitis due to other specified organisms
white f 78 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  289  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  110  mg dl; chemistry blood lactate dehydrogenase (ld)  148  iu l; chemistry blood albumin  3.7  g dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium-albuterol neb  1  neb ; multivitamins  1  tab ; omeprazole  20  mg ; senna  8.6  mg ; ranitidine  150  mg ; rivaroxaban  10  mg ; venlafaxine xr  75  mg ; loratadine  10  mg ; oxycodone (immediate release)  2.5  mg ; pramipexole  1  mg ; benzonatate  200  mg ; clonazepam  0.5  mg ; docusate sodium  100  mg ; lidocaine 5% patch  1  ptch ; 
hypoxemia personal history of nicotine dependence polyneuropathy, unspecified unspecified asthma with (acute) exacerbation spinal stenosis, cervical region personal history of malignant neoplasm of breast personal history of pulmonary embolism pneumonia, unspecified organism restless legs syndrome long term (current) use of anticoagulants other specified disorders of veins gastro-esophageal reflux disease without esophagitis age-related osteoporosis without current pathological fracture anxiety disorder, unspecified hypo-osmolality and hyponatremia unspecified asthma with (acute) exacerbation pleural plaque with presence of asbestos acquired absence of left breast and nipple acute upper respiratory infection, unspecified other chorea other ill-defined heart diseases long term (current) use of antithrombotics/antiplatelets polyneuropathy, unspecified personal history of nicotine dependence herpesviral infection of urogenital system, unspecified contact with and (suspected) exposure to asbestos other disorders of lung spinal stenosis, lumbar region major depressive disorder, single episode, unspecified pulmonary fibrosis, unspecified personal history of pulmonary embolism personal history of malignant neoplasm of breast restless legs syndrome gastro-esophageal reflux disease without esophagitis acquired coagulation factor deficiency hypoxemia other cervical disc displacement, unspecified cervical region spinal stenosis, lumbar region other specified fracture of right acetabulum, initial encounter for closed fracture personal history of malignant neoplasm of breast gastro-esophageal reflux disease without esophagitis restless legs syndrome unspecified asthma with (acute) exacerbation long term (current) use of anticoagulants exposure to other specified factors, initial encounter personal history of pulmonary embolism mesothelioma of pleura acute bronchitis due to other specified organisms
white f 78 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  321  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  86  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium-albuterol neb  1  neb ; multivitamins  1  tab ; omeprazole  20  mg ; senna  8.6  mg ; ranitidine  150  mg ; rivaroxaban  10  mg ; venlafaxine xr  75  mg ; loratadine  10  mg ; oxycodone (immediate release)  2.5  mg ; pramipexole  1  mg ; benzonatate  200  mg ; clonazepam  0.5  mg ; docusate sodium  100  mg ; lidocaine 5% patch  1  ptch ; prednisone  50  mg ; 
hypoxemia personal history of nicotine dependence polyneuropathy, unspecified unspecified asthma with (acute) exacerbation spinal stenosis, cervical region personal history of malignant neoplasm of breast personal history of pulmonary embolism pneumonia, unspecified organism restless legs syndrome long term (current) use of anticoagulants other specified disorders of veins gastro-esophageal reflux disease without esophagitis age-related osteoporosis without current pathological fracture anxiety disorder, unspecified hypo-osmolality and hyponatremia unspecified asthma with (acute) exacerbation pleural plaque with presence of asbestos acquired absence of left breast and nipple acute upper respiratory infection, unspecified other chorea other ill-defined heart diseases long term (current) use of antithrombotics/antiplatelets polyneuropathy, unspecified personal history of nicotine dependence herpesviral infection of urogenital system, unspecified contact with and (suspected) exposure to asbestos other disorders of lung spinal stenosis, lumbar region major depressive disorder, single episode, unspecified pulmonary fibrosis, unspecified personal history of pulmonary embolism personal history of malignant neoplasm of breast restless legs syndrome gastro-esophageal reflux disease without esophagitis acquired coagulation factor deficiency hypoxemia other cervical disc displacement, unspecified cervical region spinal stenosis, lumbar region other specified fracture of right acetabulum, initial encounter for closed fracture personal history of malignant neoplasm of breast gastro-esophageal reflux disease without esophagitis restless legs syndrome unspecified asthma with (acute) exacerbation long term (current) use of anticoagulants exposure to other specified factors, initial encounter personal history of pulmonary embolism mesothelioma of pleura acute bronchitis due to other specified organisms
white f 85 $nan$nan$aspirin  325  mg ; risperidone  1  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified intestinal infection due to other organism, not elsewhere classified personal history of malignant neoplasm of large intestine esophageal reflux personal history of tobacco use other psoriasis unspecified essential hypertension cataract extraction status schizophreniform disorder, unspecified
white f 85 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  339  mg dl; chemistry blood lactate dehydrogenase (ld)  133  iu l; chemistry blood albumin  3.7  g dl$aspirin  325  mg ; risperidone  1  mg ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; mupirocin cream 2%  1  appl ; ranitidine  150  mg ; fluticasone propionate 110mcg  2  puff ; bisacodyl  10  mg ; senna  1  tab ; acetaminophen  325-650  mg ; salmeterol xinafoate diskus (50 mcg)  1  inh ; lactic acid 12% lotion  1  appl ; verapamil  60  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; betamethasone dipro 0.05% cream  1  appl ; methylprednisolone sodium succ  125  mg ; insulin  0  unit ; risperidone  2  mg ; azithromycin  250  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; prednisone  60  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified intestinal infection due to other organism, not elsewhere classified personal history of malignant neoplasm of large intestine esophageal reflux personal history of tobacco use other psoriasis unspecified essential hypertension cataract extraction status schizophreniform disorder, unspecified
white f 85 $nan$hematology blood hematocrit  41.1  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  263  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  281  mg dl$aspirin  325  mg ; risperidone  1  mg ; heparin  5000  unit ; mupirocin cream 2%  1  appl ; ranitidine  150  mg ; fluticasone propionate 110mcg  2  puff ; bisacodyl  10  mg ; senna  1  tab ; acetaminophen  325-650  mg ; salmeterol xinafoate diskus (50 mcg)  1  inh ; lactic acid 12% lotion  1  appl ; verapamil  60  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; betamethasone dipro 0.05% cream  1  appl ; risperidone  2  mg ; azithromycin  250  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; prednisone  60  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; prochlorperazine  5  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified intestinal infection due to other organism, not elsewhere classified personal history of malignant neoplasm of large intestine esophageal reflux personal history of tobacco use other psoriasis unspecified essential hypertension cataract extraction status schizophreniform disorder, unspecified
white f 85 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  233  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  138  mg dl$aspirin  325  mg ; risperidone  1  mg ; heparin  5000  unit ; mupirocin cream 2%  1  appl ; ranitidine  150  mg ; fluticasone propionate 110mcg  2  puff ; bisacodyl  10  mg ; senna  1  tab ; acetaminophen  325-650  mg ; salmeterol xinafoate diskus (50 mcg)  1  inh ; lactic acid 12% lotion  1  appl ; verapamil  60  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; betamethasone dipro 0.05% cream  1  appl ; risperidone  2  mg ; azithromycin  250  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; prednisone  60  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; prochlorperazine  5  mg ; neutra-phos  2  pkt ; ns  1000  ml ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified intestinal infection due to other organism, not elsewhere classified personal history of malignant neoplasm of large intestine esophageal reflux personal history of tobacco use other psoriasis unspecified essential hypertension cataract extraction status schizophreniform disorder, unspecified
white f 85 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  233  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  150  mg dl$aspirin  325  mg ; risperidone  1  mg ; heparin  5000  unit ; mupirocin cream 2%  1  appl ; ranitidine  150  mg ; fluticasone propionate 110mcg  2  puff ; bisacodyl  10  mg ; senna  1  tab ; acetaminophen  325-650  mg ; salmeterol xinafoate diskus (50 mcg)  1  inh ; lactic acid 12% lotion  1  appl ; verapamil  60  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; betamethasone dipro 0.05% cream  1  appl ; risperidone  2  mg ; azithromycin  250  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; prednisone  60  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; prochlorperazine  5  mg ; neutra-phos  2  pkt ; prednisone  50  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified intestinal infection due to other organism, not elsewhere classified personal history of malignant neoplasm of large intestine esophageal reflux personal history of tobacco use other psoriasis unspecified essential hypertension cataract extraction status schizophreniform disorder, unspecified
white f 85 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  155  mg dl$aspirin  325  mg ; risperidone  1  mg ; heparin  5000  unit ; mupirocin cream 2%  1  appl ; ranitidine  150  mg ; fluticasone propionate 110mcg  2  puff ; bisacodyl  10  mg ; senna  1  tab ; acetaminophen  325-650  mg ; salmeterol xinafoate diskus (50 mcg)  1  inh ; lactic acid 12% lotion  1  appl ; verapamil  60  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; betamethasone dipro 0.05% cream  1  appl ; risperidone  2  mg ; azithromycin  250  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; prochlorperazine  5  mg ; prednisone  50  mg ; glyburide  5  mg ; levofloxacin  250  mg ; levofloxacin  500  mg ; verapamil sr  180  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified intestinal infection due to other organism, not elsewhere classified personal history of malignant neoplasm of large intestine esophageal reflux personal history of tobacco use other psoriasis unspecified essential hypertension cataract extraction status schizophreniform disorder, unspecified
white f 85 $nan$nan$aspirin  325  mg ; risperidone  1  mg ; heparin  5000  unit ; mupirocin cream 2%  1  appl ; ranitidine  150  mg ; fluticasone propionate 110mcg  2  puff ; bisacodyl  10  mg ; senna  1  tab ; acetaminophen  325-650  mg ; salmeterol xinafoate diskus (50 mcg)  1  inh ; lactic acid 12% lotion  1  appl ; betamethasone dipro 0.05% cream  1  appl ; risperidone  2  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; prednisone  50  mg ; glyburide  5  mg ; levofloxacin  250  mg ; levofloxacin  500  mg ; verapamil sr  180  mg ; prednisone  40  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified intestinal infection due to other organism, not elsewhere classified personal history of malignant neoplasm of large intestine esophageal reflux personal history of tobacco use other psoriasis unspecified essential hypertension cataract extraction status schizophreniform disorder, unspecified
white f 85 $nan$nan$aspirin  325  mg ; risperidone  1  mg ; heparin  5000  unit ; mupirocin cream 2%  1  appl ; ranitidine  150  mg ; fluticasone propionate 110mcg  2  puff ; bisacodyl  10  mg ; senna  1  tab ; acetaminophen  325-650  mg ; salmeterol xinafoate diskus (50 mcg)  1  inh ; lactic acid 12% lotion  1  appl ; betamethasone dipro 0.05% cream  1  appl ; risperidone  2  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; glyburide  5  mg ; levofloxacin  250  mg ; levofloxacin  500  mg ; verapamil sr  180  mg ; prednisone  40  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified intestinal infection due to other organism, not elsewhere classified personal history of malignant neoplasm of large intestine esophageal reflux personal history of tobacco use other psoriasis unspecified essential hypertension cataract extraction status schizophreniform disorder, unspecified
white m 41 $temp  98.1  heartrate  80.0  resprate  18.0  o2sat  96.0  sbp  140.0  dbp  91.0  rhythm    pain  4  $nan$sodium chloride 0.9%  flush  3  ml ; ibuprofen  600  mg ; omeprazole  20  mg ; oxycodone (immediate release)   5-10  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; gabapentin  200  mg ; pregabalin  75  mg ; gabapentin  300  mg ; ondansetron  4  mg ; gabapentin  600  mg ; 
other specified sports and athletic area as the place of occurrence of the external cause personal history of (healed) traumatic fracture arthrodesis status striking against other object with subsequent fall, initial encounter pain in right hand unspecified fracture of navicular [scaphoid] bone of right wrist, initial encounter for closed fracture postprocedural hemorrhage of a musculoskeletal structure following a musculoskeletal system procedure surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
white m 41 $nan$nan$sodium chloride 0.9%  flush  3  ml ; omeprazole  20  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; pregabalin  75  mg ; ketorolac  30  mg ; lorazepam  0.5-1  mg ; hydromorphone (dilaudid)  2-4  mg ; 
other specified sports and athletic area as the place of occurrence of the external cause personal history of (healed) traumatic fracture arthrodesis status striking against other object with subsequent fall, initial encounter pain in right hand unspecified fracture of navicular [scaphoid] bone of right wrist, initial encounter for closed fracture postprocedural hemorrhage of a musculoskeletal structure following a musculoskeletal system procedure surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
white m 41 $nan$nan$sodium chloride 0.9%  flush  3  ml ; omeprazole  20  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; lorazepam  0.5-1  mg ; hydromorphone (dilaudid)  2-4  mg ; ibuprofen  800  mg ; hydromorphone (dilaudid)  0.5  mg ; lorazepam  1  mg ; 
other specified sports and athletic area as the place of occurrence of the external cause personal history of (healed) traumatic fracture arthrodesis status striking against other object with subsequent fall, initial encounter pain in right hand unspecified fracture of navicular [scaphoid] bone of right wrist, initial encounter for closed fracture postprocedural hemorrhage of a musculoskeletal structure following a musculoskeletal system procedure surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
white m 41 $nan$nan$sodium chloride 0.9%  flush  3  ml ; omeprazole  20  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; lorazepam  0.5-1  mg ; hydromorphone (dilaudid)  2-4  mg ; ibuprofen  800  mg ; lorazepam  1  mg ; diphenhydramine  12.5  mg ; lidocaine 5% ointment  1  appl ; 
other specified sports and athletic area as the place of occurrence of the external cause personal history of (healed) traumatic fracture arthrodesis status striking against other object with subsequent fall, initial encounter pain in right hand unspecified fracture of navicular [scaphoid] bone of right wrist, initial encounter for closed fracture postprocedural hemorrhage of a musculoskeletal structure following a musculoskeletal system procedure surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
white m 76 $temp  98.6  heartrate  67.0  resprate  16.0  o2sat  97.0  sbp  132.0  dbp  57.0  rhythm    pain  0  $hematology blood hematocrit  31.3  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  86  mg dl$ascorbic acid  1000  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; atorvastatin  20  mg ; budesonide  3  mg ; fish oil (omega 3)  1000  mg ; metoprolol tartrate  12.5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; calcium carbonate  500  mg ; finasteride  5  mg ; folic acid  0.5  mg ; furosemide  20  mg ; lisinopril  40  mg ; vial  1  vial ; ceftriaxone  2  gm ; potassium chloride  60  meq ; 
presence of aortocoronary bypass graft chronic lymphocytic leukemia of b-cell type not having achieved remission essential (primary) hypertension personal history of other malignant neoplasm of skin personal history of sudden cardiac arrest other decreased white blood cell count toxic encephalopathy other specified sepsis atherosclerotic heart disease of native coronary artery without angina pectoris hypovolemia irritable bowel syndrome without diarrhea benign prostatic hyperplasia without lower urinary tract symptoms acute maxillary sinusitis, unspecified personal history of malignant melanoma of skin influenza due to other identified influenza virus with other respiratory manifestations severe sepsis without septic shock presence of automatic (implantable) cardiac defibrillator nonfamilial hypogammaglobulinemia personal history of other malignant neoplasm of skin nonfamilial hypogammaglobulinemia unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere atherosclerotic heart disease of native coronary artery without angina pectoris chronic lymphocytic leukemia of b-cell type not having achieved remission personal history of sudden cardiac arrest urinary tract infection, site not specified hyperosmolality and hypernatremia other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure benign prostatic hyperplasia without lower urinary tract symptoms hypokalemia acute kidney failure, unspecified presence of automatic (implantable) cardiac defibrillator bacteremia anemia, unspecified infection following a procedure, initial encounter dehydration noninfective gastroenteritis and colitis, unspecified unspecified place in hospital as the place of occurrence of the external cause personal history of malignant melanoma of skin personal history of malignant neoplasm of other organs and systems local infection of the skin and subcutaneous tissue, unspecified presence of aortocoronary bypass graft heart failure, unspecified hypertensive heart disease with heart failure presence of automatic (implantable) cardiac defibrillator unilateral primary osteoarthritis, left hip personal history of malignant melanoma of skin presence of aortocoronary bypass graft old myocardial infarction
white m 76 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  93  mg dl$ascorbic acid  1000  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; atorvastatin  20  mg ; budesonide  3  mg ; fish oil (omega 3)  1000  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; calcium carbonate  500  mg ; finasteride  5  mg ; folic acid  0.5  mg ; vial  1  vial ; ceftriaxone  2  gm ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3-10  ml ; potassium chloride  40  meq ; bag  1  bag ; magnesium sulfate  2  gm ; hemorrhoidal suppository  1  supp ; aspirin  325  mg ; 
presence of aortocoronary bypass graft chronic lymphocytic leukemia of b-cell type not having achieved remission essential (primary) hypertension personal history of other malignant neoplasm of skin personal history of sudden cardiac arrest other decreased white blood cell count toxic encephalopathy other specified sepsis atherosclerotic heart disease of native coronary artery without angina pectoris hypovolemia irritable bowel syndrome without diarrhea benign prostatic hyperplasia without lower urinary tract symptoms acute maxillary sinusitis, unspecified personal history of malignant melanoma of skin influenza due to other identified influenza virus with other respiratory manifestations severe sepsis without septic shock presence of automatic (implantable) cardiac defibrillator nonfamilial hypogammaglobulinemia personal history of other malignant neoplasm of skin nonfamilial hypogammaglobulinemia unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere atherosclerotic heart disease of native coronary artery without angina pectoris chronic lymphocytic leukemia of b-cell type not having achieved remission personal history of sudden cardiac arrest urinary tract infection, site not specified hyperosmolality and hypernatremia other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure benign prostatic hyperplasia without lower urinary tract symptoms hypokalemia acute kidney failure, unspecified presence of automatic (implantable) cardiac defibrillator bacteremia anemia, unspecified infection following a procedure, initial encounter dehydration noninfective gastroenteritis and colitis, unspecified unspecified place in hospital as the place of occurrence of the external cause personal history of malignant melanoma of skin personal history of malignant neoplasm of other organs and systems local infection of the skin and subcutaneous tissue, unspecified presence of aortocoronary bypass graft heart failure, unspecified hypertensive heart disease with heart failure presence of automatic (implantable) cardiac defibrillator unilateral primary osteoarthritis, left hip personal history of malignant melanoma of skin presence of aortocoronary bypass graft old myocardial infarction
white m 76 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  100  mg dl$ascorbic acid  1000  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; atorvastatin  20  mg ; budesonide  3  mg ; fish oil (omega 3)  1000  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; calcium carbonate  500  mg ; finasteride  5  mg ; folic acid  0.5  mg ; vial  1  vial ; ceftriaxone  2  gm ; sodium chloride 0.9%  flush  3-10  ml ; potassium chloride  40  meq ; bag  1  bag ; magnesium sulfate  2  gm ; hemorrhoidal suppository  1  supp ; aspirin  325  mg ; heparin  5000  unit ; ramelteon  8  mg ; aspirin  162  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 
presence of aortocoronary bypass graft chronic lymphocytic leukemia of b-cell type not having achieved remission essential (primary) hypertension personal history of other malignant neoplasm of skin personal history of sudden cardiac arrest other decreased white blood cell count toxic encephalopathy other specified sepsis atherosclerotic heart disease of native coronary artery without angina pectoris hypovolemia irritable bowel syndrome without diarrhea benign prostatic hyperplasia without lower urinary tract symptoms acute maxillary sinusitis, unspecified personal history of malignant melanoma of skin influenza due to other identified influenza virus with other respiratory manifestations severe sepsis without septic shock presence of automatic (implantable) cardiac defibrillator nonfamilial hypogammaglobulinemia personal history of other malignant neoplasm of skin nonfamilial hypogammaglobulinemia unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere atherosclerotic heart disease of native coronary artery without angina pectoris chronic lymphocytic leukemia of b-cell type not having achieved remission personal history of sudden cardiac arrest urinary tract infection, site not specified hyperosmolality and hypernatremia other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure benign prostatic hyperplasia without lower urinary tract symptoms hypokalemia acute kidney failure, unspecified presence of automatic (implantable) cardiac defibrillator bacteremia anemia, unspecified infection following a procedure, initial encounter dehydration noninfective gastroenteritis and colitis, unspecified unspecified place in hospital as the place of occurrence of the external cause personal history of malignant melanoma of skin personal history of malignant neoplasm of other organs and systems local infection of the skin and subcutaneous tissue, unspecified presence of aortocoronary bypass graft heart failure, unspecified hypertensive heart disease with heart failure presence of automatic (implantable) cardiac defibrillator unilateral primary osteoarthritis, left hip personal history of malignant melanoma of skin presence of aortocoronary bypass graft old myocardial infarction
white m 76 $nan$nan$ascorbic acid  1000  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; atorvastatin  20  mg ; budesonide  3  mg ; fish oil (omega 3)  1000  mg ; calcium carbonate  500  mg ; finasteride  5  mg ; folic acid  0.5  mg ; vial  1  vial ; ceftriaxone  2  gm ; sodium chloride 0.9%  flush  3-10  ml ; hemorrhoidal suppository  1  supp ; heparin  5000  unit ; ramelteon  8  mg ; aspirin  162  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10  ml ; potassium chloride  20  meq ; 
presence of aortocoronary bypass graft chronic lymphocytic leukemia of b-cell type not having achieved remission essential (primary) hypertension personal history of other malignant neoplasm of skin personal history of sudden cardiac arrest other decreased white blood cell count toxic encephalopathy other specified sepsis atherosclerotic heart disease of native coronary artery without angina pectoris hypovolemia irritable bowel syndrome without diarrhea benign prostatic hyperplasia without lower urinary tract symptoms acute maxillary sinusitis, unspecified personal history of malignant melanoma of skin influenza due to other identified influenza virus with other respiratory manifestations severe sepsis without septic shock presence of automatic (implantable) cardiac defibrillator nonfamilial hypogammaglobulinemia personal history of other malignant neoplasm of skin nonfamilial hypogammaglobulinemia unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere atherosclerotic heart disease of native coronary artery without angina pectoris chronic lymphocytic leukemia of b-cell type not having achieved remission personal history of sudden cardiac arrest urinary tract infection, site not specified hyperosmolality and hypernatremia other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure benign prostatic hyperplasia without lower urinary tract symptoms hypokalemia acute kidney failure, unspecified presence of automatic (implantable) cardiac defibrillator bacteremia anemia, unspecified infection following a procedure, initial encounter dehydration noninfective gastroenteritis and colitis, unspecified unspecified place in hospital as the place of occurrence of the external cause personal history of malignant melanoma of skin personal history of malignant neoplasm of other organs and systems local infection of the skin and subcutaneous tissue, unspecified presence of aortocoronary bypass graft heart failure, unspecified hypertensive heart disease with heart failure presence of automatic (implantable) cardiac defibrillator unilateral primary osteoarthritis, left hip personal history of malignant melanoma of skin presence of aortocoronary bypass graft old myocardial infarction
white m 29 $temp  97.5  heartrate  92.0  resprate  17.0  o2sat  100.0  sbp  134.0  dbp  80.0  rhythm    pain  0  ; temp  97.7  heartrate  96.0  resprate  16.0  o2sat  99.0  sbp  127.0  dbp  85.0  rhythm    pain    ; temp    heartrate  112.0  resprate  19.0  o2sat  98.0  sbp  114.0  dbp  83.0  rhythm    pain  0  ; temp    heartrate  94.0  resprate  19.0  o2sat  96.0  sbp  115.0  dbp  82.0  rhythm    pain  asleep  ; temp  98.9  heartrate  106.0  resprate  23.0  o2sat  96.0  sbp  119.0  dbp  74.0  rhythm    pain  0  ; temp    heartrate  98.0  resprate  19.0  o2sat  96.0  sbp  121.0  dbp  76.0  rhythm    pain  0  ; temp    heartrate  92.0  resprate  15.0  o2sat  96.0  sbp  120.0  dbp  80.0  rhythm    pain  asleep  ; temp    heartrate  95.0  resprate  15.0  o2sat  97.0  sbp  122.0  dbp  87.0  rhythm    pain  0  ; temp    heartrate  100.0  resprate  21.0  o2sat  96.0  sbp  133.0  dbp  90.0  rhythm    pain  0  ; temp    heartrate  97.0  resprate  15.0  o2sat  96.0  sbp  130.0  dbp  86.0  rhythm    pain  asleep  ; temp  98.7  heartrate  92.0  resprate  15.0  o2sat  97.0  sbp  137.0  dbp  81.0  rhythm    pain  0  $hematology urine wbc  2  # hpf$nan
esophagitis, unspecified portal hypertension other specified diseases of esophagus hematemesis other diseases of stomach and duodenum major depressive disorder, single episode, unspecified psoriasis, unspecified other chronic pain alcohol abuse with intoxication, unspecified enterococcus as the cause of diseases classified elsewhere chronic viral hepatitis c chronic prostatitis urinary tract infection, site not specified alcoholic cirrhosis of liver without ascites myalgia acquired coagulation factor deficiency mixed disorder of acid-base balance fall on stairs or ladders in water transport injuring unspecified person long qt syndrome alcoholic cirrhosis of liver with ascites other specified diseases of esophagus other disorders of phosphorus metabolism hypocalcemia other and unspecified fall in water transport injuring occupant of small boat, powered esophagitis, unspecified body mass index (bmi) 21.0-21.9, adult acute posthemorrhagic anemia other pancytopenia other diseases of stomach and duodenum hypokalemia alcoholic hepatitis without ascites alcohol dependence with withdrawal, unspecified bipolar disorder, unspecified portal hypertension unspecified protein-calorie malnutrition psoriasis, unspecified other diseases of stomach and duodenum long qt syndrome body mass index (bmi) 25.0-25.9, adult alcoholic hepatitis without ascites chronic viral hepatitis c portal hypertension hypo-osmolality and hyponatremia other secondary pulmonary hypertension diarrhea, unspecified other fall from one level to another in water transport injuring occupant of other watercraft -- crew unspecified cirrhosis of liver esophagitis, unspecified
white m 29 $nan$hematology blood hematocrit  27.5  %; hematology blood hematocrit  27.7  %; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  129  k ul; hematology blood platelet count  102  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood urea nitrogen  3  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  87  mg dl; chemistry blood glucose  145  mg dl; chemistry blood lactate dehydrogenase (ld)  284  iu l; chemistry blood albumin  4.5  g dl; blood gas blood lactate  1.4  mmol l$5% dextrose  250  ml ; thiamine  400  mg ; thiamine  500  mg ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  800  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 5% dextrose  100  ml ; phenobarbital  700  mg ; heparin  5000  unit ; acetaminophen  325  mg ; pantoprazole  40  mg ; ciprofloxacin hcl  500  mg ; hydroxyzine  50  mg ; multivitamins  1  tab ; phenobarbital alcohol withdrawal dose taper (days 2-7)  40  mg ; clobetasol propionate 0.05% cream  1  appl ; tramadol  50  mg ; neutra-phos  1  pkt ; trazodone  25  mg ; 
esophagitis, unspecified portal hypertension other specified diseases of esophagus hematemesis other diseases of stomach and duodenum major depressive disorder, single episode, unspecified psoriasis, unspecified other chronic pain alcohol abuse with intoxication, unspecified enterococcus as the cause of diseases classified elsewhere chronic viral hepatitis c chronic prostatitis urinary tract infection, site not specified alcoholic cirrhosis of liver without ascites myalgia acquired coagulation factor deficiency mixed disorder of acid-base balance fall on stairs or ladders in water transport injuring unspecified person long qt syndrome alcoholic cirrhosis of liver with ascites other specified diseases of esophagus other disorders of phosphorus metabolism hypocalcemia other and unspecified fall in water transport injuring occupant of small boat, powered esophagitis, unspecified body mass index (bmi) 21.0-21.9, adult acute posthemorrhagic anemia other pancytopenia other diseases of stomach and duodenum hypokalemia alcoholic hepatitis without ascites alcohol dependence with withdrawal, unspecified bipolar disorder, unspecified portal hypertension unspecified protein-calorie malnutrition psoriasis, unspecified other diseases of stomach and duodenum long qt syndrome body mass index (bmi) 25.0-25.9, adult alcoholic hepatitis without ascites chronic viral hepatitis c portal hypertension hypo-osmolality and hyponatremia other secondary pulmonary hypertension diarrhea, unspecified other fall from one level to another in water transport injuring occupant of other watercraft -- crew unspecified cirrhosis of liver esophagitis, unspecified
white m 29 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  102  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  110  mg dl$thiamine  500  mg ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  800  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 5% dextrose  100  ml ; phenobarbital  700  mg ; heparin  5000  unit ; acetaminophen  325  mg ; pantoprazole  40  mg ; ciprofloxacin hcl  500  mg ; hydroxyzine  50  mg ; multivitamins  1  tab ; clobetasol propionate 0.05% cream  1  appl ; tramadol  50  mg ; neutra-phos  1  pkt ; trazodone  25  mg ; sodium chloride 0.9%  flush  3  ml ; folic acid  1  mg ; phosphorus  500  mg ; thiamine  100  mg ; trazodone  50  mg ; baclofen  10  mg ; trazodone  100  mg ; magnesium oxide  800  mg ; 
esophagitis, unspecified portal hypertension other specified diseases of esophagus hematemesis other diseases of stomach and duodenum major depressive disorder, single episode, unspecified psoriasis, unspecified other chronic pain alcohol abuse with intoxication, unspecified enterococcus as the cause of diseases classified elsewhere chronic viral hepatitis c chronic prostatitis urinary tract infection, site not specified alcoholic cirrhosis of liver without ascites myalgia acquired coagulation factor deficiency mixed disorder of acid-base balance fall on stairs or ladders in water transport injuring unspecified person long qt syndrome alcoholic cirrhosis of liver with ascites other specified diseases of esophagus other disorders of phosphorus metabolism hypocalcemia other and unspecified fall in water transport injuring occupant of small boat, powered esophagitis, unspecified body mass index (bmi) 21.0-21.9, adult acute posthemorrhagic anemia other pancytopenia other diseases of stomach and duodenum hypokalemia alcoholic hepatitis without ascites alcohol dependence with withdrawal, unspecified bipolar disorder, unspecified portal hypertension unspecified protein-calorie malnutrition psoriasis, unspecified other diseases of stomach and duodenum long qt syndrome body mass index (bmi) 25.0-25.9, adult alcoholic hepatitis without ascites chronic viral hepatitis c portal hypertension hypo-osmolality and hyponatremia other secondary pulmonary hypertension diarrhea, unspecified other fall from one level to another in water transport injuring occupant of other watercraft -- crew unspecified cirrhosis of liver esophagitis, unspecified
white m 29 $nan$nan$heparin  5000  unit ; acetaminophen  325  mg ; pantoprazole  40  mg ; ciprofloxacin hcl  500  mg ; hydroxyzine  50  mg ; multivitamins  1  tab ; clobetasol propionate 0.05% cream  1  appl ; tramadol  50  mg ; sodium chloride 0.9%  flush  3  ml ; folic acid  1  mg ; phosphorus  500  mg ; thiamine  100  mg ; baclofen  10  mg ; trazodone  100  mg ; magnesium oxide  800  mg ; 
esophagitis, unspecified portal hypertension other specified diseases of esophagus hematemesis other diseases of stomach and duodenum major depressive disorder, single episode, unspecified psoriasis, unspecified other chronic pain alcohol abuse with intoxication, unspecified enterococcus as the cause of diseases classified elsewhere chronic viral hepatitis c chronic prostatitis urinary tract infection, site not specified alcoholic cirrhosis of liver without ascites myalgia acquired coagulation factor deficiency mixed disorder of acid-base balance fall on stairs or ladders in water transport injuring unspecified person long qt syndrome alcoholic cirrhosis of liver with ascites other specified diseases of esophagus other disorders of phosphorus metabolism hypocalcemia other and unspecified fall in water transport injuring occupant of small boat, powered esophagitis, unspecified body mass index (bmi) 21.0-21.9, adult acute posthemorrhagic anemia other pancytopenia other diseases of stomach and duodenum hypokalemia alcoholic hepatitis without ascites alcohol dependence with withdrawal, unspecified bipolar disorder, unspecified portal hypertension unspecified protein-calorie malnutrition psoriasis, unspecified other diseases of stomach and duodenum long qt syndrome body mass index (bmi) 25.0-25.9, adult alcoholic hepatitis without ascites chronic viral hepatitis c portal hypertension hypo-osmolality and hyponatremia other secondary pulmonary hypertension diarrhea, unspecified other fall from one level to another in water transport injuring occupant of other watercraft -- crew unspecified cirrhosis of liver esophagitis, unspecified
white f 76 $temp  97.8  heartrate  101.0  resprate  16.0  o2sat  99.0  sbp  126.0  dbp  99.0  rhythm    pain  0  $hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  2.0  ; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  176  mg dl; chemistry blood lactate dehydrogenase (ld)  2091  iu l; chemistry blood albumin  3.4  g dl$bisacodyl  10  mg ; senna  8.6  mg ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; metoprolol tartrate  6.25  mg ; metoprolol tartrate  12.5  mg ; mirtazapine  15  mg ; aspirin  81  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; calcium carbonate  500  mg ; ondansetron  4  mg ; dexamethasone  4  mg ; levetiracetam  500  mg ; atorvastatin  80  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; tagrisso (osimertinib)  80  mg ; 
acute respiratory failure with hypoxia other constipation hemiplegia, unspecified affecting right dominant side malignant neoplasm of unspecified part of right bronchus or lung adverse effect of other opioids, initial encounter patient room in hospital as the place of occurrence of the external cause anemia in neoplastic disease unspecified asthma, uncomplicated supraventricular tachycardia long term (current) use of aspirin generalized skin eruption due to drugs and medicaments taken internally do not resuscitate secondary malignant neoplasm of bone secondary malignant neoplasm of left adrenal gland secondary malignant neoplasm of brain atrial septal defect other pulmonary embolism without acute cor pulmonale acidosis cerebral infarction due to embolism of unspecified precerebral artery pathological fracture in neoplastic disease, other specified site, initial encounter for fracture unspecified atrial fibrillation non-st elevation (nstemi) myocardial infarction neoplasm related pain (acute) (chronic) 
white f 76 $nan$hematology blood hematocrit  32.2  %; hematology blood hematocrit  34.4  %; hematology blood hemoglobin  10.6  g dl; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  204  k ul; hematology blood platelet count  207  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  96  mg dl; chemistry blood lactate dehydrogenase (ld)  2230  iu l$5% dextrose  250  ml ; heparin sodium  25,000  unit ; mirtazapine  15  mg ; aspirin  81  mg ; metoprolol tartrate  25  mg ; simethicone  40-80  mg ; calcium carbonate  500  mg ; ondansetron  4  mg ; dexamethasone  4  mg ; levetiracetam  500  mg ; atorvastatin  80  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; tagrisso (osimertinib)  80  mg ; 
acute respiratory failure with hypoxia other constipation hemiplegia, unspecified affecting right dominant side malignant neoplasm of unspecified part of right bronchus or lung adverse effect of other opioids, initial encounter patient room in hospital as the place of occurrence of the external cause anemia in neoplastic disease unspecified asthma, uncomplicated supraventricular tachycardia long term (current) use of aspirin generalized skin eruption due to drugs and medicaments taken internally do not resuscitate secondary malignant neoplasm of bone secondary malignant neoplasm of left adrenal gland secondary malignant neoplasm of brain atrial septal defect other pulmonary embolism without acute cor pulmonale acidosis cerebral infarction due to embolism of unspecified precerebral artery pathological fracture in neoplastic disease, other specified site, initial encounter for fracture unspecified atrial fibrillation non-st elevation (nstemi) myocardial infarction neoplasm related pain (acute) (chronic) 
white f 76 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  42  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  144  mg dl; chemistry blood lactate dehydrogenase (ld)  3240  iu l$mirtazapine  15  mg ; aspirin  81  mg ; simethicone  40-80  mg ; calcium carbonate  500  mg ; ondansetron  4  mg ; dexamethasone  4  mg ; levetiracetam  500  mg ; atorvastatin  80  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; tagrisso (osimertinib)  80  mg ; metoprolol succinate xl  100  mg ; 
acute respiratory failure with hypoxia other constipation hemiplegia, unspecified affecting right dominant side malignant neoplasm of unspecified part of right bronchus or lung adverse effect of other opioids, initial encounter patient room in hospital as the place of occurrence of the external cause anemia in neoplastic disease unspecified asthma, uncomplicated supraventricular tachycardia long term (current) use of aspirin generalized skin eruption due to drugs and medicaments taken internally do not resuscitate secondary malignant neoplasm of bone secondary malignant neoplasm of left adrenal gland secondary malignant neoplasm of brain atrial septal defect other pulmonary embolism without acute cor pulmonale acidosis cerebral infarction due to embolism of unspecified precerebral artery pathological fracture in neoplastic disease, other specified site, initial encounter for fracture unspecified atrial fibrillation non-st elevation (nstemi) myocardial infarction neoplasm related pain (acute) (chronic) 
white f 76 $nan$nan$mirtazapine  15  mg ; aspirin  81  mg ; simethicone  40-80  mg ; calcium carbonate  500  mg ; ondansetron  4  mg ; dexamethasone  4  mg ; levetiracetam  500  mg ; atorvastatin  80  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; tagrisso (osimertinib)  80  mg ; metoprolol succinate xl  100  mg ; rivaroxaban  20  mg ; 
acute respiratory failure with hypoxia other constipation hemiplegia, unspecified affecting right dominant side malignant neoplasm of unspecified part of right bronchus or lung adverse effect of other opioids, initial encounter patient room in hospital as the place of occurrence of the external cause anemia in neoplastic disease unspecified asthma, uncomplicated supraventricular tachycardia long term (current) use of aspirin generalized skin eruption due to drugs and medicaments taken internally do not resuscitate secondary malignant neoplasm of bone secondary malignant neoplasm of left adrenal gland secondary malignant neoplasm of brain atrial septal defect other pulmonary embolism without acute cor pulmonale acidosis cerebral infarction due to embolism of unspecified precerebral artery pathological fracture in neoplastic disease, other specified site, initial encounter for fracture unspecified atrial fibrillation non-st elevation (nstemi) myocardial infarction neoplasm related pain (acute) (chronic) 
white f 53 $temp  98.1  heartrate  99.0  resprate  18.0  o2sat  100.0  sbp  129.0  dbp  74.0  rhythm    pain  10  ; temp  98.8  heartrate  63.0  resprate  16.0  o2sat  98.0  sbp  109.0  dbp  67.0  rhythm    pain    ; temp  98.1  heartrate  61.0  resprate  16.0  o2sat  98.0  sbp  109.0  dbp  60.0  rhythm  normal sinus rhythm  pain  0  $hematology blood hematocrit  37.3  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  318  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  131  mg dl$nan
bradycardia, unspecified hypothyroidism, unspecified epilepsy, unspecified, not intractable, without status epilepticus type 2 diabetes mellitus with hypoglycemia without coma personal history of traumatic brain injury apraxia bariatric surgery status obesity, unspecified epilepsy, unspecified, not intractable, without status epilepticus essential (primary) hypertension takotsubo syndrome other forms of acute ischemic heart disease bariatric surgery status type 2 diabetes mellitus without complications hypothyroidism, unspecified personal history of traumatic brain injury body mass index (bmi) 36.0-36.9, adult major depressive disorder, single episode, unspecified personal history of nicotine dependence major depressive disorder, single episode, unspecified other chronic pain headache type 2 diabetes mellitus without complications hypovolemia pneumonia, unspecified organism bariatric surgery status epilepsy, unspecified, not intractable, without status epilepticus hypothyroidism, unspecified sepsis, unspecified organism arthrodesis status dorsalgia, unspecified accidents occurring in industrial places and premises long-term (current) use of insulin other convulsions unspecified essential hypertension benign neoplasm of cerebral meninges morbid obesity closed fracture of vault of skull with subarachnoid, subdural, and extradural hemorrhage, with loss of consciousness of unspecified duration fall resulting in striking against other object metabolic syndrome diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white f 53 $temp    heartrate  56.0  resprate  14.0  o2sat  100.0  sbp  119.0  dbp  54.0  rhythm  sinus bradycardia  pain  0  ; temp    heartrate  65.0  resprate  18.0  o2sat  98.0  sbp  123.0  dbp  56.0  rhythm    pain  0  ; temp    heartrate  69.0  resprate  18.0  o2sat  100.0  sbp  157.0  dbp  74.0  rhythm    pain    ; temp  98.5  heartrate  72.0  resprate  18.0  o2sat  100.0  sbp  151.0  dbp  57.0  rhythm    pain  0  $hematology urine wbc  0  # hpf$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ondansetron  4  mg ; morphine sulfate  4  mg ; trazodone  50  mg ; glucose gel  15  g ; glucagon  1  mg ; dextrose 50%  12.5  gm ; fleet enema  1  enema ; insulin  0  unit ; 
bradycardia, unspecified hypothyroidism, unspecified epilepsy, unspecified, not intractable, without status epilepticus type 2 diabetes mellitus with hypoglycemia without coma personal history of traumatic brain injury apraxia bariatric surgery status obesity, unspecified epilepsy, unspecified, not intractable, without status epilepticus essential (primary) hypertension takotsubo syndrome other forms of acute ischemic heart disease bariatric surgery status type 2 diabetes mellitus without complications hypothyroidism, unspecified personal history of traumatic brain injury body mass index (bmi) 36.0-36.9, adult major depressive disorder, single episode, unspecified personal history of nicotine dependence major depressive disorder, single episode, unspecified other chronic pain headache type 2 diabetes mellitus without complications hypovolemia pneumonia, unspecified organism bariatric surgery status epilepsy, unspecified, not intractable, without status epilepticus hypothyroidism, unspecified sepsis, unspecified organism arthrodesis status dorsalgia, unspecified accidents occurring in industrial places and premises long-term (current) use of insulin other convulsions unspecified essential hypertension benign neoplasm of cerebral meninges morbid obesity closed fracture of vault of skull with subarachnoid, subdural, and extradural hemorrhage, with loss of consciousness of unspecified duration fall resulting in striking against other object metabolic syndrome diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white f 53 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  120  mg dl$d5 1 2ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ondansetron  4  mg ; morphine sulfate  4  mg ; trazodone  50  mg ; glucose gel  15  g ; glucagon  1  mg ; dextrose 50%  12.5  gm ; fleet enema  1  enema ; insulin  0  unit ; venlafaxine xr  150  mg ; levetiracetam  500  mg ; gabapentin  300  mg ; levothyroxine sodium  200  mcg ; topiramate (topamax)  150  mg ; ondansetron odt  4  mg ; acetaminophen  650  mg ; sucralfate  1  gm ; acetaminophen w codeine  1-2  tab ; levetiracetam  1000  mg ; atorvastatin  80  mg ; 
bradycardia, unspecified hypothyroidism, unspecified epilepsy, unspecified, not intractable, without status epilepticus type 2 diabetes mellitus with hypoglycemia without coma personal history of traumatic brain injury apraxia bariatric surgery status obesity, unspecified epilepsy, unspecified, not intractable, without status epilepticus essential (primary) hypertension takotsubo syndrome other forms of acute ischemic heart disease bariatric surgery status type 2 diabetes mellitus without complications hypothyroidism, unspecified personal history of traumatic brain injury body mass index (bmi) 36.0-36.9, adult major depressive disorder, single episode, unspecified personal history of nicotine dependence major depressive disorder, single episode, unspecified other chronic pain headache type 2 diabetes mellitus without complications hypovolemia pneumonia, unspecified organism bariatric surgery status epilepsy, unspecified, not intractable, without status epilepticus hypothyroidism, unspecified sepsis, unspecified organism arthrodesis status dorsalgia, unspecified accidents occurring in industrial places and premises long-term (current) use of insulin other convulsions unspecified essential hypertension benign neoplasm of cerebral meninges morbid obesity closed fracture of vault of skull with subarachnoid, subdural, and extradural hemorrhage, with loss of consciousness of unspecified duration fall resulting in striking against other object metabolic syndrome diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white f 53 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  138  mg dl$d5 1 2ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; trazodone  50  mg ; glucose gel  15  g ; glucagon  1  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; venlafaxine xr  150  mg ; gabapentin  300  mg ; levothyroxine sodium  200  mcg ; topiramate (topamax)  150  mg ; ondansetron odt  4  mg ; sucralfate  1  gm ; acetaminophen w codeine  1-2  tab ; levetiracetam  1000  mg ; atorvastatin  80  mg ; metoprolol succinate xl  25  mg ; aspirin  81  mg ; omeprazole  20  mg ; multivitamin iv  10  ml ; thiamine  100  mg ; 0.9% sodium chloride  1000  ml ; folic acid  1  mg ; vial  1  vial ; pantoprazole  40  mg ; 
bradycardia, unspecified hypothyroidism, unspecified epilepsy, unspecified, not intractable, without status epilepticus type 2 diabetes mellitus with hypoglycemia without coma personal history of traumatic brain injury apraxia bariatric surgery status obesity, unspecified epilepsy, unspecified, not intractable, without status epilepticus essential (primary) hypertension takotsubo syndrome other forms of acute ischemic heart disease bariatric surgery status type 2 diabetes mellitus without complications hypothyroidism, unspecified personal history of traumatic brain injury body mass index (bmi) 36.0-36.9, adult major depressive disorder, single episode, unspecified personal history of nicotine dependence major depressive disorder, single episode, unspecified other chronic pain headache type 2 diabetes mellitus without complications hypovolemia pneumonia, unspecified organism bariatric surgery status epilepsy, unspecified, not intractable, without status epilepticus hypothyroidism, unspecified sepsis, unspecified organism arthrodesis status dorsalgia, unspecified accidents occurring in industrial places and premises long-term (current) use of insulin other convulsions unspecified essential hypertension benign neoplasm of cerebral meninges morbid obesity closed fracture of vault of skull with subarachnoid, subdural, and extradural hemorrhage, with loss of consciousness of unspecified duration fall resulting in striking against other object metabolic syndrome diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white f 53 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  93  mg dl$d5 1 2ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; trazodone  50  mg ; glucose gel  15  g ; glucagon  1  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; venlafaxine xr  150  mg ; gabapentin  300  mg ; levothyroxine sodium  200  mcg ; topiramate (topamax)  150  mg ; ondansetron odt  4  mg ; acetaminophen w codeine  1-2  tab ; levetiracetam  1000  mg ; atorvastatin  80  mg ; metoprolol succinate xl  25  mg ; aspirin  81  mg ; vial  1  vial ; pantoprazole  40  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 
bradycardia, unspecified hypothyroidism, unspecified epilepsy, unspecified, not intractable, without status epilepticus type 2 diabetes mellitus with hypoglycemia without coma personal history of traumatic brain injury apraxia bariatric surgery status obesity, unspecified epilepsy, unspecified, not intractable, without status epilepticus essential (primary) hypertension takotsubo syndrome other forms of acute ischemic heart disease bariatric surgery status type 2 diabetes mellitus without complications hypothyroidism, unspecified personal history of traumatic brain injury body mass index (bmi) 36.0-36.9, adult major depressive disorder, single episode, unspecified personal history of nicotine dependence major depressive disorder, single episode, unspecified other chronic pain headache type 2 diabetes mellitus without complications hypovolemia pneumonia, unspecified organism bariatric surgery status epilepsy, unspecified, not intractable, without status epilepticus hypothyroidism, unspecified sepsis, unspecified organism arthrodesis status dorsalgia, unspecified accidents occurring in industrial places and premises long-term (current) use of insulin other convulsions unspecified essential hypertension benign neoplasm of cerebral meninges morbid obesity closed fracture of vault of skull with subarachnoid, subdural, and extradural hemorrhage, with loss of consciousness of unspecified duration fall resulting in striking against other object metabolic syndrome diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white f 53 $nan$nan$d5 1 2ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; trazodone  50  mg ; glucose gel  15  g ; glucagon  1  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; venlafaxine xr  150  mg ; gabapentin  300  mg ; levothyroxine sodium  200  mcg ; topiramate (topamax)  150  mg ; ondansetron odt  4  mg ; acetaminophen w codeine  1-2  tab ; levetiracetam  1000  mg ; atorvastatin  80  mg ; metoprolol succinate xl  25  mg ; aspirin  81  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 
bradycardia, unspecified hypothyroidism, unspecified epilepsy, unspecified, not intractable, without status epilepticus type 2 diabetes mellitus with hypoglycemia without coma personal history of traumatic brain injury apraxia bariatric surgery status obesity, unspecified epilepsy, unspecified, not intractable, without status epilepticus essential (primary) hypertension takotsubo syndrome other forms of acute ischemic heart disease bariatric surgery status type 2 diabetes mellitus without complications hypothyroidism, unspecified personal history of traumatic brain injury body mass index (bmi) 36.0-36.9, adult major depressive disorder, single episode, unspecified personal history of nicotine dependence major depressive disorder, single episode, unspecified other chronic pain headache type 2 diabetes mellitus without complications hypovolemia pneumonia, unspecified organism bariatric surgery status epilepsy, unspecified, not intractable, without status epilepticus hypothyroidism, unspecified sepsis, unspecified organism arthrodesis status dorsalgia, unspecified accidents occurring in industrial places and premises long-term (current) use of insulin other convulsions unspecified essential hypertension benign neoplasm of cerebral meninges morbid obesity closed fracture of vault of skull with subarachnoid, subdural, and extradural hemorrhage, with loss of consciousness of unspecified duration fall resulting in striking against other object metabolic syndrome diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
asian m 76 $nan$nan$omeprazole  20  mg ; spironolactone  25  mg ; fluticasone propionate nasal  2  spry ; adefovir  10  mg ; 
chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta thrombocytopenia, unspecified anemia, unspecified sepsis other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hypopotassemia unspecified essential hypertension other and unspecified infection due to central venous catheter diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled late effects of cerebrovascular disease, hemiplegia affecting unspecified side unspecified septicemia acute kidney failure, unspecified myelodysplastic syndrome, unspecified acute kidney failure, unspecified late effects of cerebrovascular disease, hemiplegia affecting nondominant side hypopotassemia chronic kidney disease, unspecified postinflammatory pulmonary fibrosis streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group a chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other secondary thrombocytopenia myelodysplastic syndrome, unspecified other specified anemias cellulitis and abscess of neck hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified late effects of cerebrovascular disease, hemiplegia affecting nondominant side anemia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled fever, unspecified myelodysplastic syndrome, unspecified acute kidney failure, unspecified chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta unspecified viral infection benign essential hypertension cirrhosis of liver without mention of alcohol thrombocytopenia, unspecified myelodysplastic syndrome, unspecified vestibular neuronitis antiviral drugs causing adverse effects in therapeutic use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta calculus of gallbladder without mention of cholecystitis, without mention of obstruction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other late effects of cerebrovascular disease other chest pain unspecified essential hypertension
asian m 76 $nan$hematology blood hematocrit  24.8  %; hematology blood hematocrit  23.1  %; hematology blood hematocrit  29.0  %; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  61  k ul; hematology blood platelet count  53  k ul; hematology blood platelet count  44  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  2.9  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, indirect  0.5  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  101  mg dl; chemistry blood glucose  129  mg dl; chemistry blood lactate dehydrogenase (ld)  1384  iu l; chemistry blood lactate dehydrogenase (ld)  1313  iu l; chemistry blood lactate dehydrogenase (ld)  1339  iu l; chemistry blood albumin  4.3  g dl; hematology blood bands  3  %; hematology blood bands  4  %; chemistry blood bilirubin, direct  0.2  mg dl; hematology urine glucose  300  mg dl$omeprazole  20  mg ; spironolactone  25  mg ; fluticasone propionate nasal  2  spry ; adefovir  10  mg ; 0.9% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; potassium chloride  60  meq ; senna  1  tab ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; 
chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta thrombocytopenia, unspecified anemia, unspecified sepsis other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hypopotassemia unspecified essential hypertension other and unspecified infection due to central venous catheter diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled late effects of cerebrovascular disease, hemiplegia affecting unspecified side unspecified septicemia acute kidney failure, unspecified myelodysplastic syndrome, unspecified acute kidney failure, unspecified late effects of cerebrovascular disease, hemiplegia affecting nondominant side hypopotassemia chronic kidney disease, unspecified postinflammatory pulmonary fibrosis streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group a chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other secondary thrombocytopenia myelodysplastic syndrome, unspecified other specified anemias cellulitis and abscess of neck hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified late effects of cerebrovascular disease, hemiplegia affecting nondominant side anemia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled fever, unspecified myelodysplastic syndrome, unspecified acute kidney failure, unspecified chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta unspecified viral infection benign essential hypertension cirrhosis of liver without mention of alcohol thrombocytopenia, unspecified myelodysplastic syndrome, unspecified vestibular neuronitis antiviral drugs causing adverse effects in therapeutic use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta calculus of gallbladder without mention of cholecystitis, without mention of obstruction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other late effects of cerebrovascular disease other chest pain unspecified essential hypertension
asian m 76 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  49  k ul; chemistry blood lactate dehydrogenase (ld)  1481  iu l; hematology blood bands  6  %$omeprazole  20  mg ; spironolactone  25  mg ; fluticasone propionate nasal  2  spry ; adefovir  10  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; potassium chloride  60  meq ; senna  1  tab ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; oxycodone (immediate release)   2.5  mg ; 
chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta thrombocytopenia, unspecified anemia, unspecified sepsis other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hypopotassemia unspecified essential hypertension other and unspecified infection due to central venous catheter diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled late effects of cerebrovascular disease, hemiplegia affecting unspecified side unspecified septicemia acute kidney failure, unspecified myelodysplastic syndrome, unspecified acute kidney failure, unspecified late effects of cerebrovascular disease, hemiplegia affecting nondominant side hypopotassemia chronic kidney disease, unspecified postinflammatory pulmonary fibrosis streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group a chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other secondary thrombocytopenia myelodysplastic syndrome, unspecified other specified anemias cellulitis and abscess of neck hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified late effects of cerebrovascular disease, hemiplegia affecting nondominant side anemia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled fever, unspecified myelodysplastic syndrome, unspecified acute kidney failure, unspecified chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta unspecified viral infection benign essential hypertension cirrhosis of liver without mention of alcohol thrombocytopenia, unspecified myelodysplastic syndrome, unspecified vestibular neuronitis antiviral drugs causing adverse effects in therapeutic use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta calculus of gallbladder without mention of cholecystitis, without mention of obstruction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other late effects of cerebrovascular disease other chest pain unspecified essential hypertension
asian m 76 $nan$nan$omeprazole  20  mg ; spironolactone  25  mg ; fluticasone propionate nasal  2  spry ; adefovir  10  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; senna  1  tab ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; oxycodone (immediate release)   2.5  mg ; 
chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta thrombocytopenia, unspecified anemia, unspecified sepsis other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure hypopotassemia unspecified essential hypertension other and unspecified infection due to central venous catheter diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled late effects of cerebrovascular disease, hemiplegia affecting unspecified side unspecified septicemia acute kidney failure, unspecified myelodysplastic syndrome, unspecified acute kidney failure, unspecified late effects of cerebrovascular disease, hemiplegia affecting nondominant side hypopotassemia chronic kidney disease, unspecified postinflammatory pulmonary fibrosis streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group a chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other secondary thrombocytopenia myelodysplastic syndrome, unspecified other specified anemias cellulitis and abscess of neck hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified late effects of cerebrovascular disease, hemiplegia affecting nondominant side anemia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled fever, unspecified myelodysplastic syndrome, unspecified acute kidney failure, unspecified chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta unspecified viral infection benign essential hypertension cirrhosis of liver without mention of alcohol thrombocytopenia, unspecified myelodysplastic syndrome, unspecified vestibular neuronitis antiviral drugs causing adverse effects in therapeutic use diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta calculus of gallbladder without mention of cholecystitis, without mention of obstruction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other late effects of cerebrovascular disease other chest pain unspecified essential hypertension
white f 22 $nan$nan$heparin  5000  unit ; 
other constipation 
white f 22 $nan$hematology blood hematocrit  30.5  %; hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  191  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  8  mg dl; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  81  mg dl; chemistry blood lactate dehydrogenase (ld)  158  iu l; chemistry blood albumin  4.0  g dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$heparin  5000  unit ; hydromorphone (dilaudid)  1  mg ; ondansetron  4  mg ; ns (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; lr  1000  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; metoclopramide  10  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  12.5  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; magnesium sulfate  2  gm ; 
other constipation 
white f 22 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  100  mg dl$vial  1  vial ; pantoprazole sodium  40  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  12.5  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; magnesium sulfate  2  gm ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; ketorolac  15-30  mg ; promethazine  6.25  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; syringe (ns)  50  ml ; ketamine  100  mg ; lorazepam  0.5  mg ; prochlorperazine  10  mg ; 
other constipation 
white f 22 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  95  mg dl$vial  1  vial ; pantoprazole sodium  40  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  12.5  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; promethazine  6.25  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; syringe (ns)  50  ml ; ketamine  100  mg ; lorazepam  0.5  mg ; prochlorperazine  10  mg ; prochlorperazine  5  mg ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; sw  50  ml ; 
other constipation 
white f 22 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  85  mg dl$vial  1  vial ; pantoprazole sodium  40  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  12.5  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; syringe (ns)  50  ml ; ketamine  100  mg ; lorazepam  0.5  mg ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; sw  50  ml ; insulin  0  unit ; 
other constipation 
white f 22 $nan$hematology blood hematocrit  23.0  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  185  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  123  mg dl$vial  1  vial ; pantoprazole sodium  40  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  325-650  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; lorazepam  0.5  mg ; insulin  0  unit ; sw  100  ml ; potassium chloride  40  meq ; 
other constipation 
white f 22 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  114  mg dl$vial  1  vial ; pantoprazole sodium  40  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  325-650  mg ; lorazepam  0.5  mg ; insulin  0  unit ; sw  100  ml ; potassium chloride  40  meq ; chloraseptic throat spray  1  spry ; 
other constipation 
white f 22 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  107  mg dl$vial  1  vial ; pantoprazole sodium  40  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  325-650  mg ; lorazepam  0.5  mg ; insulin  0  unit ; chloraseptic throat spray  1  spry ; hydromorphone (dilaudid)  0.5  mg ; 
other constipation 
white f 22 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  235  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  126  mg dl$vial  1  vial ; pantoprazole sodium  40  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  325-650  mg ; lorazepam  0.5  mg ; insulin  0  unit ; chloraseptic throat spray  1  spry ; hydromorphone (dilaudid)  0.5  mg ; cepacol (menthol)  1  loz ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; morphine sulfate  2  mg ; hydromorphone (dilaudid)  2-6  mg ; hydromorphone (dilaudid)  0.25  mg ; 
other constipation 
white f 22 $nan$nan$vial  1  vial ; pantoprazole sodium  40  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  325-650  mg ; lorazepam  0.5  mg ; insulin  0  unit ; chloraseptic throat spray  1  spry ; cepacol (menthol)  1  loz ; morphine sulfate  2  mg ; hydromorphone (dilaudid)  0.25  mg ; morphine sulfate  2-4  mg ; 
other constipation 
white f 22 $nan$nan$vial  1  vial ; pantoprazole sodium  40  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen  325-650  mg ; lorazepam  0.5  mg ; insulin  0  unit ; chloraseptic throat spray  1  spry ; cepacol (menthol)  1  loz ; pantoprazole  40  mg ; docusate sodium  100  mg ; senna  1  tab ; hydromorphone (dilaudid)  4-8  mg ; 
other constipation 
white f 22 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  136  mg dl; chemistry blood albumin  3.6  g dl$heparin flush (10 units ml)  2  ml ; acetaminophen  325-650  mg ; insulin  0  unit ; chloraseptic throat spray  1  spry ; cepacol (menthol)  1  loz ; pantoprazole  40  mg ; docusate sodium  100  mg ; senna  1  tab ; hydromorphone (dilaudid)  4-8  mg ; bisacodyl  10  mg ; ondansetron odt  4  mg ; 
other constipation 
white m 29 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  258  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  104  mg dl; blood gas blood lactate  0.8  mmol l; blood gas blood potassium, whole blood  4.0  meq l$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; diazepam  1  mg ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; enoxaparin sodium  40  mg ; multivitamins  1  cap ; vitamin d  400  unit ; folic acid  1  mg ; thiamine  100  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; senna  1  tab ; lorazepam  0.5  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; diazepam  5-10  mg ; hydromorphone (dilaudid)  12.5  mg ; magnesium sulfate  2  gm ; 
 
white m 29 $nan$hematology blood hematocrit  37.1  %; hematology blood hematocrit  37.9  %; hematology blood hemoglobin  12.8  g dl; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  223  k ul; hematology blood platelet count  244  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  124  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; multivitamins  1  cap ; vitamin d  400  unit ; folic acid  1  mg ; thiamine  100  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; senna  1  tab ; lorazepam  0.5  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; diazepam  5-10  mg ; hydromorphone (dilaudid)  12.5  mg ; magnesium sulfate  2  gm ; 
 
white m 29 $nan$hematology blood hematocrit  38.4  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  237  k ul$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; multivitamins  1  cap ; vitamin d  400  unit ; folic acid  1  mg ; thiamine  100  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; senna  1  tab ; calcium carbonate  500  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; diazepam  5-10  mg ; hydromorphone (dilaudid)  12.5  mg ; hydromorphone (dilaudid)  2-6  mg ; senna  2  tab ; 
 
white m 29 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; multivitamins  1  cap ; vitamin d  400  unit ; folic acid  1  mg ; thiamine  100  mg ; acetaminophen  650  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  gm ; diazepam  5-10  mg ; hydromorphone (dilaudid)  2-6  mg ; senna  2  tab ; 
 
white m 65 $temp  98.5  heartrate  90.0  resprate  20.0  o2sat  95.0  sbp  159.0  dbp  94.0  rhythm    pain  8  $hematology blood hematocrit  40.7  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  223  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  119  mg dl; chemistry blood lactate dehydrogenase (ld)  174  iu l; chemistry blood albumin  3.5  g dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  17.2  mg ; docusate sodium  200  mg ; polyethylene glycol  17  g ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; ipratropium-albuterol neb  1  neb ; citalopram  10  mg ; clonazepam  1-2  mg ; clonidine  0.1  mg ; gabapentin  600  mg ; lisinopril  20  mg ; oxycodone (immediate release)   10  mg ; efavirenz  600  mg ; lamivudine-zidovudine (combivir)  1  tab ; tamsulosin  0.4  mg ; tenofovir disoproxil (viread)  300  mg ; guaifenesin  5-10  ml ; oxycodone sr (oxycontin)  80  mg ; prednisone  40  mg ; lorazepam  0.5  mg ; methylprednisolone  32  mg ; potassium chloride  40  meq ; bag  1  bag ; magnesium sulfate  2  gm ; 
personal history of nicotine dependence benign prostatic hyperplasia without lower urinary tract symptoms personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chest pain, unspecified major depressive disorder, single episode, unspecified unspecified osteoarthritis, unspecified site unspecified mononeuropathy of right lower limb chronic obstructive pulmonary disease with (acute) exacerbation chronic systolic (congestive) heart failure spinal stenosis, site unspecified asymptomatic human immunodeficiency virus [hiv] infection status unspecified mononeuropathy of left lower limb other chronic pain radiculopathy, cervical region personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified hereditary and idiopathic peripheral neuropathy chronic hepatitis c without mention of hepatic coma do not resuscitate status nonspecific abnormal results of pulmonary function study spinal stenosis, unspecified region chronic systolic heart failure anxiety state, unspecified other chronic pain chronic obstructive asthma with (acute) exacerbation depressive disorder, not elsewhere classified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) benign neoplasm of adrenal gland personal history of tobacco use asymptomatic human immunodeficiency virus [hiv] infection status scrotal varices osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified cataract chronic systolic heart failure opioid type dependence, unspecified human immunodeficiency virus [hiv] disease hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) other chronic pain congestive heart failure, unspecified depressive disorder, not elsewhere classified chronic obstructive asthma with (acute) exacerbation brachial neuritis or radiculitis nos benign neoplasm of adrenal gland pleurisy without mention of effusion or current tuberculosis spinal stenosis, unspecified region other, mixed, or unspecified drug abuse, in remission personal history of tobacco use unspecified viral hepatitis c without hepatic coma
white m 65 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  17.2  mg ; docusate sodium  200  mg ; polyethylene glycol  17  g ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; ipratropium-albuterol neb  1  neb ; citalopram  10  mg ; clonazepam  1-2  mg ; clonidine  0.1  mg ; gabapentin  600  mg ; lisinopril  20  mg ; oxycodone (immediate release)   10  mg ; efavirenz  600  mg ; lamivudine-zidovudine (combivir)  1  tab ; tamsulosin  0.4  mg ; tenofovir disoproxil (viread)  300  mg ; guaifenesin  5-10  ml ; oxycodone sr (oxycontin)  80  mg ; lorazepam  0.5  mg ; potassium chloride  40  meq ; bag  1  bag ; magnesium sulfate  2  gm ; azithromycin  250  mg ; ondansetron  4  mg ; 
personal history of nicotine dependence benign prostatic hyperplasia without lower urinary tract symptoms personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chest pain, unspecified major depressive disorder, single episode, unspecified unspecified osteoarthritis, unspecified site unspecified mononeuropathy of right lower limb chronic obstructive pulmonary disease with (acute) exacerbation chronic systolic (congestive) heart failure spinal stenosis, site unspecified asymptomatic human immunodeficiency virus [hiv] infection status unspecified mononeuropathy of left lower limb other chronic pain radiculopathy, cervical region personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified hereditary and idiopathic peripheral neuropathy chronic hepatitis c without mention of hepatic coma do not resuscitate status nonspecific abnormal results of pulmonary function study spinal stenosis, unspecified region chronic systolic heart failure anxiety state, unspecified other chronic pain chronic obstructive asthma with (acute) exacerbation depressive disorder, not elsewhere classified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) benign neoplasm of adrenal gland personal history of tobacco use asymptomatic human immunodeficiency virus [hiv] infection status scrotal varices osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified cataract chronic systolic heart failure opioid type dependence, unspecified human immunodeficiency virus [hiv] disease hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) other chronic pain congestive heart failure, unspecified depressive disorder, not elsewhere classified chronic obstructive asthma with (acute) exacerbation brachial neuritis or radiculitis nos benign neoplasm of adrenal gland pleurisy without mention of effusion or current tuberculosis spinal stenosis, unspecified region other, mixed, or unspecified drug abuse, in remission personal history of tobacco use unspecified viral hepatitis c without hepatic coma
white m 78 $nan$nan$polyethylene glycol  17  g ; thiamine  100  mg ; omeprazole  20  mg ; paroxetine  30  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; carbidopa-levodopa (25-100)  0.5  tab ; 
drug-induced psychotic disorder with hallucinations encephalopathy, unspecified history of fall osteoarthrosis, unspecified whether generalized or localized, lower leg other constipation physical restraints status dementia with lewy bodies personal history of malignant neoplasm of prostate accidental fall from commode depressive disorder, not elsewhere classified osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh paralysis agitans other symptoms referable to back anti-parkinsonism drugs causing adverse effects in therapeutic use cervical spondylosis with myelopathy dementia in conditions classified elsewhere without behavioral disturbance infection and inflammatory reaction due to indwelling urinary catheter other specified causes of urethral stricture personal history of malignant neoplasm of prostate depressive disorder, not elsewhere classified urinary tract infection, site not specified influenza with pneumonia dehydration escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site anemia, unspecified retention of urine, unspecified esophageal reflux 
white m 78 $nan$hematology blood hematocrit  42.9  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  428  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  118  mg dl; chemistry blood lactate dehydrogenase (ld)  321  iu l; chemistry blood albumin  4.0  g dl$senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; thiamine  100  mg ; omeprazole  20  mg ; paroxetine  30  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; carbidopa-levodopa (25-100)  0.5  tab ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  75  mg ; donepezil  5  mg ; ibuprofen  400  mg ; 0.9% sodium chloride  1000  ml ; 
drug-induced psychotic disorder with hallucinations encephalopathy, unspecified history of fall osteoarthrosis, unspecified whether generalized or localized, lower leg other constipation physical restraints status dementia with lewy bodies personal history of malignant neoplasm of prostate accidental fall from commode depressive disorder, not elsewhere classified osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh paralysis agitans other symptoms referable to back anti-parkinsonism drugs causing adverse effects in therapeutic use cervical spondylosis with myelopathy dementia in conditions classified elsewhere without behavioral disturbance infection and inflammatory reaction due to indwelling urinary catheter other specified causes of urethral stricture personal history of malignant neoplasm of prostate depressive disorder, not elsewhere classified urinary tract infection, site not specified influenza with pneumonia dehydration escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site anemia, unspecified retention of urine, unspecified esophageal reflux 
white m 78 $nan$hematology blood hematocrit  40.4  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  402  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  107  mg dl$senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; thiamine  100  mg ; omeprazole  20  mg ; paroxetine  30  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3  ml ; ibuprofen  400  mg ; trazodone  100  mg ; trazodone  25  mg ; 
drug-induced psychotic disorder with hallucinations encephalopathy, unspecified history of fall osteoarthrosis, unspecified whether generalized or localized, lower leg other constipation physical restraints status dementia with lewy bodies personal history of malignant neoplasm of prostate accidental fall from commode depressive disorder, not elsewhere classified osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh paralysis agitans other symptoms referable to back anti-parkinsonism drugs causing adverse effects in therapeutic use cervical spondylosis with myelopathy dementia in conditions classified elsewhere without behavioral disturbance infection and inflammatory reaction due to indwelling urinary catheter other specified causes of urethral stricture personal history of malignant neoplasm of prostate depressive disorder, not elsewhere classified urinary tract infection, site not specified influenza with pneumonia dehydration escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site anemia, unspecified retention of urine, unspecified esophageal reflux 
white m 78 $nan$hematology blood hematocrit  39.2  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  407  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  105  mg dl$senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; thiamine  100  mg ; omeprazole  20  mg ; paroxetine  30  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3  ml ; ibuprofen  400  mg ; trazodone  100  mg ; trazodone  25  mg ; donepezil  10  mg ; quetiapine fumarate  6.25  mg ; 
drug-induced psychotic disorder with hallucinations encephalopathy, unspecified history of fall osteoarthrosis, unspecified whether generalized or localized, lower leg other constipation physical restraints status dementia with lewy bodies personal history of malignant neoplasm of prostate accidental fall from commode depressive disorder, not elsewhere classified osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh paralysis agitans other symptoms referable to back anti-parkinsonism drugs causing adverse effects in therapeutic use cervical spondylosis with myelopathy dementia in conditions classified elsewhere without behavioral disturbance infection and inflammatory reaction due to indwelling urinary catheter other specified causes of urethral stricture personal history of malignant neoplasm of prostate depressive disorder, not elsewhere classified urinary tract infection, site not specified influenza with pneumonia dehydration escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site anemia, unspecified retention of urine, unspecified esophageal reflux 
white m 78 $nan$nan$senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; thiamine  100  mg ; omeprazole  20  mg ; paroxetine  30  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3  ml ; ibuprofen  400  mg ; trazodone  100  mg ; trazodone  25  mg ; donepezil  10  mg ; quetiapine fumarate  6.25  mg ; paroxetine  25  mg ; bismuth subsalicylate  15  ml ; 
drug-induced psychotic disorder with hallucinations encephalopathy, unspecified history of fall osteoarthrosis, unspecified whether generalized or localized, lower leg other constipation physical restraints status dementia with lewy bodies personal history of malignant neoplasm of prostate accidental fall from commode depressive disorder, not elsewhere classified osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh paralysis agitans other symptoms referable to back anti-parkinsonism drugs causing adverse effects in therapeutic use cervical spondylosis with myelopathy dementia in conditions classified elsewhere without behavioral disturbance infection and inflammatory reaction due to indwelling urinary catheter other specified causes of urethral stricture personal history of malignant neoplasm of prostate depressive disorder, not elsewhere classified urinary tract infection, site not specified influenza with pneumonia dehydration escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site anemia, unspecified retention of urine, unspecified esophageal reflux 
white m 78 $nan$nan$senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; thiamine  100  mg ; omeprazole  20  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3  ml ; ibuprofen  400  mg ; trazodone  100  mg ; trazodone  25  mg ; donepezil  10  mg ; paroxetine  25  mg ; bismuth subsalicylate  15  ml ; mirtazapine  15  mg ; 
drug-induced psychotic disorder with hallucinations encephalopathy, unspecified history of fall osteoarthrosis, unspecified whether generalized or localized, lower leg other constipation physical restraints status dementia with lewy bodies personal history of malignant neoplasm of prostate accidental fall from commode depressive disorder, not elsewhere classified osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh paralysis agitans other symptoms referable to back anti-parkinsonism drugs causing adverse effects in therapeutic use cervical spondylosis with myelopathy dementia in conditions classified elsewhere without behavioral disturbance infection and inflammatory reaction due to indwelling urinary catheter other specified causes of urethral stricture personal history of malignant neoplasm of prostate depressive disorder, not elsewhere classified urinary tract infection, site not specified influenza with pneumonia dehydration escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site anemia, unspecified retention of urine, unspecified esophageal reflux 
white m 78 $nan$nan$senna  1  tab ; bisacodyl  10  mg ; polyethylene glycol  17  g ; thiamine  100  mg ; omeprazole  20  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3  ml ; ibuprofen  400  mg ; trazodone  100  mg ; trazodone  25  mg ; donepezil  10  mg ; paroxetine  25  mg ; bismuth subsalicylate  15  ml ; mirtazapine  15  mg ; 
drug-induced psychotic disorder with hallucinations encephalopathy, unspecified history of fall osteoarthrosis, unspecified whether generalized or localized, lower leg other constipation physical restraints status dementia with lewy bodies personal history of malignant neoplasm of prostate accidental fall from commode depressive disorder, not elsewhere classified osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh paralysis agitans other symptoms referable to back anti-parkinsonism drugs causing adverse effects in therapeutic use cervical spondylosis with myelopathy dementia in conditions classified elsewhere without behavioral disturbance infection and inflammatory reaction due to indwelling urinary catheter other specified causes of urethral stricture personal history of malignant neoplasm of prostate depressive disorder, not elsewhere classified urinary tract infection, site not specified influenza with pneumonia dehydration escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site anemia, unspecified retention of urine, unspecified esophageal reflux 
other m 71 $temp  98.0  heartrate  97.0  resprate  16.0  o2sat  99.0  sbp  156.0  dbp  85.0  rhythm    pain  0  $hematology blood hematocrit  39.5  %; hematology blood hematocrit  39.6  %; hematology blood hemoglobin  13.4  g dl; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  120  k ul; hematology blood platelet count  127  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  2.1  mg dl; chemistry blood glucose  90  mg dl; blood gas blood lactate  1.3  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; heparin  5000  unit ; clobetasol propionate 0.05% ointment  1  appl ; fluocinonide 0.05% ointment  1  appl ; lidocaine 5% patch  1  ptch ; multivitamins  1  tab ; tamsulosin  0.4  mg ; polyethylene glycol  17  g ; potassium chloride  60  meq ; bag  2  bag ; magnesium sulfate  4  gm ; ciprofloxacin hcl  250  mg ; lidocaine 5% ointment  1  appl ; 
alcohol dependence with intoxication, unspecified benign prostatic hyperplasia without lower urinary tract symptoms essential (primary) hypertension heart failure, unspecified hyperlipidemia, unspecified pain in right knee atherosclerotic heart disease of native coronary artery without angina pectoris other chest pain unspecified essential hypertension hypopotassemia other primary cardiomyopathies jaundice, unspecified, not of newborn other and unspecified alcohol dependence, continuous unspecified essential hypertension edema person boarding or alighting a car injured in collision with railway train or railway vehicle personal history of other infectious and parasitic diseases depressive disorder, not elsewhere classified arthrodesis status lumbago nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] calculus of gallbladder without mention of cholecystitis, without mention of obstruction other sequelae of chronic liver disease family history of other cardiovascular diseases acute alcoholic hepatitis personal history of noncompliance with medical treatment, presenting hazards to health
other m 71 $nan$hematology blood hematocrit  40.5  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  112  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood bilirubin, total  2.1  mg dl; chemistry blood glucose  89  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; heparin  5000  unit ; clobetasol propionate 0.05% ointment  1  appl ; fluocinonide 0.05% ointment  1  appl ; lidocaine 5% patch  1  ptch ; multivitamins  1  tab ; tamsulosin  0.4  mg ; polyethylene glycol  17  g ; potassium chloride  60  meq ; bag  2  bag ; magnesium sulfate  4  gm ; lidocaine 5% ointment  1  appl ; hydrochlorothiazide  25  mg ; lisinopril  40  mg ; 
alcohol dependence with intoxication, unspecified benign prostatic hyperplasia without lower urinary tract symptoms essential (primary) hypertension heart failure, unspecified hyperlipidemia, unspecified pain in right knee atherosclerotic heart disease of native coronary artery without angina pectoris other chest pain unspecified essential hypertension hypopotassemia other primary cardiomyopathies jaundice, unspecified, not of newborn other and unspecified alcohol dependence, continuous unspecified essential hypertension edema person boarding or alighting a car injured in collision with railway train or railway vehicle personal history of other infectious and parasitic diseases depressive disorder, not elsewhere classified arthrodesis status lumbago nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] calculus of gallbladder without mention of cholecystitis, without mention of obstruction other sequelae of chronic liver disease family history of other cardiovascular diseases acute alcoholic hepatitis personal history of noncompliance with medical treatment, presenting hazards to health
other m 71 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; heparin  5000  unit ; clobetasol propionate 0.05% ointment  1  appl ; fluocinonide 0.05% ointment  1  appl ; lidocaine 5% patch  1  ptch ; multivitamins  1  tab ; tamsulosin  0.4  mg ; polyethylene glycol  17  g ; lidocaine 5% ointment  1  appl ; hydrochlorothiazide  25  mg ; lisinopril  40  mg ; 
alcohol dependence with intoxication, unspecified benign prostatic hyperplasia without lower urinary tract symptoms essential (primary) hypertension heart failure, unspecified hyperlipidemia, unspecified pain in right knee atherosclerotic heart disease of native coronary artery without angina pectoris other chest pain unspecified essential hypertension hypopotassemia other primary cardiomyopathies jaundice, unspecified, not of newborn other and unspecified alcohol dependence, continuous unspecified essential hypertension edema person boarding or alighting a car injured in collision with railway train or railway vehicle personal history of other infectious and parasitic diseases depressive disorder, not elsewhere classified arthrodesis status lumbago nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] calculus of gallbladder without mention of cholecystitis, without mention of obstruction other sequelae of chronic liver disease family history of other cardiovascular diseases acute alcoholic hepatitis personal history of noncompliance with medical treatment, presenting hazards to health
white f 43 $temp  98.1  heartrate  73.0  resprate  18.0  o2sat  100.0  sbp  132.0  dbp  95.0  rhythm    pain  6  ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  7  ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  2  ; temp  97.5  heartrate  68.0  resprate  14.0  o2sat  98.0  sbp  140.0  dbp  77.0  rhythm    pain    $hematology blood hematocrit  35.5  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology urine wbc  3  # hpf; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  106  mg dl; chemistry blood albumin  4.3  g dl; blood gas blood lactate  1.6  mmol l$nan
adult failure to thrive unspecified place or not applicable surgical operation with formation of external stoma as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other complications of enterostomy dehydration acquired absence of other specified parts of digestive tract disorder of the skin and subcutaneous tissue, unspecified acute posthemorrhagic anemia parastomal hernia with gangrene cutaneous abscess of abdominal wall ileostomy status ulcerative colitis, unspecified, without complications ileus, unspecified nicotine dependence, cigarettes, uncomplicated contusion of abdominal wall ulcerative colitis, unspecified anticoagulants causing adverse effects in therapeutic use counseling on substance use and abuse vaccination not carried out because of patient refusal unspecified vitamin d deficiency adrenal cortical steroids causing adverse effects in therapeutic use other abnormal glucose pseudopolyposis of colon iron deficiency anemia secondary to blood loss (chronic) body mass index 34.0-34.9, adult obesity, unspecified tobacco use disorder unspecified pruritic disorder
white f 43 $nan$nan$lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; d5 1 2ns  1000  ml ; heparin  5000  unit ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; 
adult failure to thrive unspecified place or not applicable surgical operation with formation of external stoma as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other complications of enterostomy dehydration acquired absence of other specified parts of digestive tract disorder of the skin and subcutaneous tissue, unspecified acute posthemorrhagic anemia parastomal hernia with gangrene cutaneous abscess of abdominal wall ileostomy status ulcerative colitis, unspecified, without complications ileus, unspecified nicotine dependence, cigarettes, uncomplicated contusion of abdominal wall ulcerative colitis, unspecified anticoagulants causing adverse effects in therapeutic use counseling on substance use and abuse vaccination not carried out because of patient refusal unspecified vitamin d deficiency adrenal cortical steroids causing adverse effects in therapeutic use other abnormal glucose pseudopolyposis of colon iron deficiency anemia secondary to blood loss (chronic) body mass index 34.0-34.9, adult obesity, unspecified tobacco use disorder unspecified pruritic disorder
white f 43 $nan$hematology blood hematocrit  31.6  %; hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  173  k ul; hematology blood platelet count  190  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  94  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3-10  ml ; d5 1 2ns  1000  ml ; heparin  5000  unit ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; phosphorus  500  mg ; pseudoephedrine  30  mg ; acetaminophen  1000  mg ; enoxaparin sodium  40  mg ; sodium chloride 0.9%  1000  ml ; 
adult failure to thrive unspecified place or not applicable surgical operation with formation of external stoma as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other complications of enterostomy dehydration acquired absence of other specified parts of digestive tract disorder of the skin and subcutaneous tissue, unspecified acute posthemorrhagic anemia parastomal hernia with gangrene cutaneous abscess of abdominal wall ileostomy status ulcerative colitis, unspecified, without complications ileus, unspecified nicotine dependence, cigarettes, uncomplicated contusion of abdominal wall ulcerative colitis, unspecified anticoagulants causing adverse effects in therapeutic use counseling on substance use and abuse vaccination not carried out because of patient refusal unspecified vitamin d deficiency adrenal cortical steroids causing adverse effects in therapeutic use other abnormal glucose pseudopolyposis of colon iron deficiency anemia secondary to blood loss (chronic) body mass index 34.0-34.9, adult obesity, unspecified tobacco use disorder unspecified pruritic disorder
white f 43 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3-10  ml ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; phosphorus  500  mg ; pseudoephedrine  30  mg ; acetaminophen  1000  mg ; enoxaparin sodium  40  mg ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride  40  meq ; psyllium wafer  1  waf ; loperamide  2  mg ; 
adult failure to thrive unspecified place or not applicable surgical operation with formation of external stoma as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other complications of enterostomy dehydration acquired absence of other specified parts of digestive tract disorder of the skin and subcutaneous tissue, unspecified acute posthemorrhagic anemia parastomal hernia with gangrene cutaneous abscess of abdominal wall ileostomy status ulcerative colitis, unspecified, without complications ileus, unspecified nicotine dependence, cigarettes, uncomplicated contusion of abdominal wall ulcerative colitis, unspecified anticoagulants causing adverse effects in therapeutic use counseling on substance use and abuse vaccination not carried out because of patient refusal unspecified vitamin d deficiency adrenal cortical steroids causing adverse effects in therapeutic use other abnormal glucose pseudopolyposis of colon iron deficiency anemia secondary to blood loss (chronic) body mass index 34.0-34.9, adult obesity, unspecified tobacco use disorder unspecified pruritic disorder
white f 43 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; enoxaparin sodium  40  mg ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride  40  meq ; psyllium wafer  1  waf ; loperamide  2  mg ; 
adult failure to thrive unspecified place or not applicable surgical operation with formation of external stoma as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure other complications of enterostomy dehydration acquired absence of other specified parts of digestive tract disorder of the skin and subcutaneous tissue, unspecified acute posthemorrhagic anemia parastomal hernia with gangrene cutaneous abscess of abdominal wall ileostomy status ulcerative colitis, unspecified, without complications ileus, unspecified nicotine dependence, cigarettes, uncomplicated contusion of abdominal wall ulcerative colitis, unspecified anticoagulants causing adverse effects in therapeutic use counseling on substance use and abuse vaccination not carried out because of patient refusal unspecified vitamin d deficiency adrenal cortical steroids causing adverse effects in therapeutic use other abnormal glucose pseudopolyposis of colon iron deficiency anemia secondary to blood loss (chronic) body mass index 34.0-34.9, adult obesity, unspecified tobacco use disorder unspecified pruritic disorder
white f 91 $nan$nan$lisinopril  20  mg ; prednisone  2  mg ; atenolol  50  mg ; 
 
white f 91 $nan$chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.3  $lisinopril  20  mg ; prednisone  2  mg ; atenolol  50  mg ; oxycodone-acetaminophen  1-2  tab ; cephalexin  500  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; warfarin  4  mg ; warfarin  5  mg ; 
 
white f 91 $nan$nan$lisinopril  20  mg ; prednisone  2  mg ; atenolol  50  mg ; oxycodone-acetaminophen  1-2  tab ; cephalexin  500  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; warfarin  5  mg ; 
 
white f 91 $nan$nan$simvastatin  40  mg ; warfarin  5  mg ; multivitamins  1  cap ; 
 
white f 91 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  260  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  120  mg dl; chemistry blood lactate dehydrogenase (ld)  251  iu l; chemistry blood albumin  3.6  g dl; chemistry blood % hemoglobin a1c  6.0  %$simvastatin  40  mg ; warfarin  5  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ns  1000  ml ; acetaminophen  325-650  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; enalaprilat  0.625  mg ; d5w  250  ml ; heparin sodium  25,000  unit ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; senna  1  tab ; docusate sodium  100  mg ; heparin  900-1800  unit ; metoprolol  12.5  mg ; vitamin d  400  unit ; haloperidol  2.5  mg ; ns  500  ml ; metoprolol  5  mg ; sw  50  ml ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; calcium gluconate  2  gm ; ns  250  ml ; calcium gluconate  2-4  gm ; calcium gluconate  4  gm ; potassium chloride  40  meq ; potassium chloride  80  meq ; magnesium oxide  400  mg ; alendronate sodium  70  mg ; warfarin  2  mg ; 
 
white f 91 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  88  mg dl$simvastatin  40  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; enalaprilat  0.625  mg ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; senna  1  tab ; docusate sodium  100  mg ; metoprolol  12.5  mg ; vitamin d  400  unit ; haloperidol  2.5  mg ; ns  500  ml ; metoprolol  5  mg ; potassium chloride  40  meq ; potassium chloride  80  meq ; magnesium oxide  400  mg ; alendronate sodium  70  mg ; warfarin  2  mg ; warfarin  4  mg ; 
 
white f 91 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  303  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  2.0  ; hematology urine wbc  11-20  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  99  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$simvastatin  40  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; enalaprilat  0.625  mg ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; senna  1  tab ; docusate sodium  100  mg ; metoprolol  12.5  mg ; vitamin d  400  unit ; alendronate sodium  70  mg ; warfarin  4  mg ; calcium carbonate  500  mg ; neutra-phos  1  pkt ; metoprolol  25  mg ; sulfameth trimethoprim ds  1  tab ; metoprolol  37.5  mg ; diltiazem  10  mg ; diltiazem  30  mg ; 
 
white f 91 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  276  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  4.3  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  97  mg dl$simvastatin  40  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; enalaprilat  0.625  mg ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; senna  1  tab ; docusate sodium  100  mg ; vitamin d  400  unit ; alendronate sodium  70  mg ; warfarin  4  mg ; calcium carbonate  500  mg ; neutra-phos  1  pkt ; metoprolol  25  mg ; sulfameth trimethoprim ds  1  tab ; diltiazem  10  mg ; diltiazem  30  mg ; diltiazem  60  mg ; 
 
white f 91 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  6.3  ; chemistry blood glucose  82  mg dl$simvastatin  40  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; enalaprilat  0.625  mg ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; senna  1  tab ; docusate sodium  100  mg ; vitamin d  400  unit ; alendronate sodium  70  mg ; calcium carbonate  500  mg ; sulfameth trimethoprim ds  1  tab ; diltiazem  60  mg ; sodium chloride nasal  1-2  spry ; warfarin  2.5  mg ; 
 
white f 91 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  275  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  6.5  ; hematology urine wbc  10  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  128  mg dl$simvastatin  40  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; enalaprilat  0.625  mg ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; senna  1  tab ; docusate sodium  100  mg ; vitamin d  400  unit ; alendronate sodium  70  mg ; calcium carbonate  500  mg ; sulfameth trimethoprim ds  1  tab ; sodium chloride nasal  1-2  spry ; acetaminophen  325  mg ; ciprofloxacin hcl  500  mg ; 
 
white f 91 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  243  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  94  mg dl$simvastatin  40  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; enalaprilat  0.625  mg ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; senna  1  tab ; docusate sodium  100  mg ; vitamin d  400  unit ; alendronate sodium  70  mg ; calcium carbonate  500  mg ; sodium chloride nasal  1-2  spry ; acetaminophen  325  mg ; ciprofloxacin hcl  500  mg ; phytonadione  5  mg ; pneumococcal vac polyvalent  0.5  ml ; zolpidem tartrate  5  mg ; 
 
white f 91 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  287  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  104  mg dl$simvastatin  40  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; enalaprilat  0.625  mg ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; senna  1  tab ; docusate sodium  100  mg ; vitamin d  400  unit ; alendronate sodium  70  mg ; calcium carbonate  500  mg ; sodium chloride nasal  1-2  spry ; ciprofloxacin hcl  500  mg ; pneumococcal vac polyvalent  0.5  ml ; zolpidem tartrate  5  mg ; phenazopyridine hcl  100  mg ; 
 
white f 91 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  369  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  112  mg dl$simvastatin  40  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; enalaprilat  0.625  mg ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; senna  1  tab ; docusate sodium  100  mg ; vitamin d  400  unit ; alendronate sodium  70  mg ; calcium carbonate  500  mg ; sodium chloride nasal  1-2  spry ; ciprofloxacin hcl  500  mg ; pneumococcal vac polyvalent  0.5  ml ; zolpidem tartrate  5  mg ; diltiazem  90  mg ; 
 
white f 91 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  388  k ul; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  2.1  $simvastatin  40  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; enalaprilat  0.625  mg ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; senna  1  tab ; docusate sodium  100  mg ; vitamin d  400  unit ; alendronate sodium  70  mg ; calcium carbonate  500  mg ; sodium chloride nasal  1-2  spry ; ciprofloxacin hcl  500  mg ; pneumococcal vac polyvalent  0.5  ml ; zolpidem tartrate  5  mg ; diltiazem  90  mg ; lactulose  30  ml ; bisacodyl  10  mg ; diltiazem  120  mg ; 
 
white f 91 $nan$nan$simvastatin  40  mg ; multivitamins  1  cap ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; enalaprilat  0.625  mg ; insulin  0  unit ; fluticasone propionate 110mcg  2  puff ; senna  1  tab ; docusate sodium  100  mg ; vitamin d  400  unit ; alendronate sodium  70  mg ; calcium carbonate  500  mg ; sodium chloride nasal  1-2  spry ; ciprofloxacin hcl  500  mg ; pneumococcal vac polyvalent  0.5  ml ; zolpidem tartrate  5  mg ; bisacodyl  10  mg ; diltiazem  120  mg ; 
 
hispanic latino f 43 $nan$nan$lisinopril  10  mg ; 
 
hispanic latino f 43 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  64  mg dl$lisinopril  10  mg ; lactated ringers  1000  ml ; influenza virus vaccine  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; norgestimate-ethinyl estradiol  1  tab ; bag  50  ml ; magnesium sulfate  2  gm ; senna  1  tab ; 
 
hispanic latino f 43 $nan$nan$lisinopril  10  mg ; influenza virus vaccine  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; norgestimate-ethinyl estradiol  1  tab ; bag  50  ml ; magnesium sulfate  2  gm ; senna  1  tab ; docusate sodium  100  mg ; 
 
white m 63 $nan$nan$ondansetron  8  mg ; lorazepam  0.5-1  mg ; sodium chloride 0.9%  1000  ml ; 
unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hordeolum externum left lower eyelid anxiety disorder, unspecified multiple myeloma not having achieved remission migraine, unspecified, not intractable, without status migrainosus meibomian gland dysfunction of left eye, unspecified eyelid unspecified blepharitis right eye, upper and lower eyelids gastro-esophageal reflux disease without esophagitis unspecified blepharitis left eye, upper and lower eyelids hordeolum externum right lower eyelid hordeolum externum right upper eyelid hyperlipidemia, unspecified essential (primary) hypertension meibomian gland dysfunction of right eye, unspecified eyelid adverse effect of antineoplastic and immunosuppressive drugs, initial encounter periorbital cellulitis major depressive disorder, single episode, unspecified hordeolum externum left upper eyelid tourette's disorder other hyperlipidemia gastro-esophageal reflux disease without esophagitis calculus of gallbladder without cholecystitis without obstruction nausea with vomiting, unspecified major depressive disorder, single episode, unspecified anxiety disorder, unspecified epigastric pain migraine, unspecified, not intractable, without status migrainosus tourette's disorder fatty (change of) liver, not elsewhere classified multiple myeloma not having achieved remission nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] 
white m 63 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  165  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  120  mg dl; chemistry blood lactate dehydrogenase (ld)  148  iu l$ondansetron  8  mg ; lorazepam  0.5-1  mg ; sodium chloride 0.9%  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; fosaprepitant  150  mg ; 0.9% sodium chloride  150  ml ; dexamethasone sod phosphate  12  mg ; 0.9% sodium chloride  50  ml ; mesna  1350  mg ; 0.9% sodium chloride  250  ml ; cyclophosphamide  2240  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; acyclovir  400  mg ; amitriptyline  25  mg ; atorvastatin  20  mg ; atovaquone suspension  1500  mg ; diazepam  10  mg ; losartan potassium  25  mg ; pantoprazole  40  mg ; paroxetine  20  mg ; sumatriptan succinate  25  mg ; topiramate (topamax)  50  mg ; oxycodone (immediate release)  5  mg ; artificial tears preserv. free  1-2  drop ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; enoxaparin sodium  100  mg ; dexamethasone  8  mg ; 
unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hordeolum externum left lower eyelid anxiety disorder, unspecified multiple myeloma not having achieved remission migraine, unspecified, not intractable, without status migrainosus meibomian gland dysfunction of left eye, unspecified eyelid unspecified blepharitis right eye, upper and lower eyelids gastro-esophageal reflux disease without esophagitis unspecified blepharitis left eye, upper and lower eyelids hordeolum externum right lower eyelid hordeolum externum right upper eyelid hyperlipidemia, unspecified essential (primary) hypertension meibomian gland dysfunction of right eye, unspecified eyelid adverse effect of antineoplastic and immunosuppressive drugs, initial encounter periorbital cellulitis major depressive disorder, single episode, unspecified hordeolum externum left upper eyelid tourette's disorder other hyperlipidemia gastro-esophageal reflux disease without esophagitis calculus of gallbladder without cholecystitis without obstruction nausea with vomiting, unspecified major depressive disorder, single episode, unspecified anxiety disorder, unspecified epigastric pain migraine, unspecified, not intractable, without status migrainosus tourette's disorder fatty (change of) liver, not elsewhere classified multiple myeloma not having achieved remission nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] 
white m 63 $nan$nan$ondansetron  8  mg ; lorazepam  0.5-1  mg ; sodium chloride 0.9%  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; fosaprepitant  150  mg ; 0.9% sodium chloride  150  ml ; dexamethasone sod phosphate  12  mg ; 0.9% sodium chloride  50  ml ; mesna  1350  mg ; 0.9% sodium chloride  250  ml ; cyclophosphamide  2240  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; acyclovir  400  mg ; amitriptyline  25  mg ; atorvastatin  20  mg ; atovaquone suspension  1500  mg ; diazepam  10  mg ; losartan potassium  25  mg ; pantoprazole  40  mg ; paroxetine  20  mg ; sumatriptan succinate  25  mg ; topiramate (topamax)  50  mg ; oxycodone (immediate release)  5  mg ; artificial tears preserv. free  1-2  drop ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; enoxaparin sodium  100  mg ; dexamethasone  8  mg ; 
unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause hordeolum externum left lower eyelid anxiety disorder, unspecified multiple myeloma not having achieved remission migraine, unspecified, not intractable, without status migrainosus meibomian gland dysfunction of left eye, unspecified eyelid unspecified blepharitis right eye, upper and lower eyelids gastro-esophageal reflux disease without esophagitis unspecified blepharitis left eye, upper and lower eyelids hordeolum externum right lower eyelid hordeolum externum right upper eyelid hyperlipidemia, unspecified essential (primary) hypertension meibomian gland dysfunction of right eye, unspecified eyelid adverse effect of antineoplastic and immunosuppressive drugs, initial encounter periorbital cellulitis major depressive disorder, single episode, unspecified hordeolum externum left upper eyelid tourette's disorder other hyperlipidemia gastro-esophageal reflux disease without esophagitis calculus of gallbladder without cholecystitis without obstruction nausea with vomiting, unspecified major depressive disorder, single episode, unspecified anxiety disorder, unspecified epigastric pain migraine, unspecified, not intractable, without status migrainosus tourette's disorder fatty (change of) liver, not elsewhere classified multiple myeloma not having achieved remission nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] 
white f 81 $nan$nan$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; multivitamins  1  cap ; vitamin d  400  unit ; ferrous sulfate  325  mg ; atorvastatin  40  mg ; fluticasone propionate nasal  2  spry ; tiotropium bromide  1  cap ; potassium chloride  20  meq ; 
atrial fibrillation osteoporosis, unspecified long-term (current) use of anticoagulants peripheral vascular disease, unspecified other and unspecified hyperlipidemia iron deficiency anemia, unspecified esophageal reflux chronic diastolic heart failure unspecified essential hypertension bacterial pneumonia, unspecified obstructive chronic bronchitis with (acute) exacerbation congestive heart failure, unspecified long-term (current) use of steroids pulmonary eosinophilia osteoarthrosis, unspecified whether generalized or localized, site unspecified congestive heart failure, unspecified hypotension, unspecified chronic airway obstruction, not elsewhere classified atrial fibrillation unspecified essential hypertension pneumonia, organism unspecified hypovolemia long-term (current) use of anticoagulants chronic pulmonary embolism iron deficiency anemia, unspecified chronic diastolic heart failure pulmonary eosinophilia atherosclerosis of native arteries of the extremities, unspecified other disorders of plasma protein metabolism chronic airway obstruction, not elsewhere classified diastolic heart failure, unspecified personal history of venous thrombosis and embolism long-term (current) use of anticoagulants pneumonia, organism unspecified atrial fibrillation congestive heart failure, unspecified orthostatic hypotension congestive heart failure, unspecified obstructive chronic bronchitis with acute bronchitis chronic diastolic heart failure personal history of tobacco use esophageal reflux unspecified essential hypertension other cataract long-term (current) use of anticoagulants unspecified viral infection chronic pulmonary embolism atrial fibrillation
white f 81 $nan$hematology blood hematocrit  26.5  %; hematology blood hematocrit  31.6  %; hematology blood hemoglobin  8.7  g dl; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  268  k ul; hematology blood platelet count  193  k ul; hematology blood platelet count  194  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  126  mg dl; chemistry blood glucose  87  mg dl; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  1.5  mmol l$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; multivitamins  1  cap ; vitamin d  400  unit ; ferrous sulfate  325  mg ; atorvastatin  40  mg ; fluticasone propionate nasal  2  spry ; tiotropium bromide  1  cap ; potassium chloride  20  meq ; warfarin  4  mg ; naproxen  500  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; metoprolol tartrate  12.5  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; lr  1000  ml ; morphine sulfate  50  mg ; oxycodone (immediate release)   5  mg ; acetaminophen  650  mg ; famotidine  20  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; senna  1  tab ; trazodone  50  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; benzonatate  200  mg ; gabapentin  100  mg ; enoxaparin sodium  40  mg ; 
atrial fibrillation osteoporosis, unspecified long-term (current) use of anticoagulants peripheral vascular disease, unspecified other and unspecified hyperlipidemia iron deficiency anemia, unspecified esophageal reflux chronic diastolic heart failure unspecified essential hypertension bacterial pneumonia, unspecified obstructive chronic bronchitis with (acute) exacerbation congestive heart failure, unspecified long-term (current) use of steroids pulmonary eosinophilia osteoarthrosis, unspecified whether generalized or localized, site unspecified congestive heart failure, unspecified hypotension, unspecified chronic airway obstruction, not elsewhere classified atrial fibrillation unspecified essential hypertension pneumonia, organism unspecified hypovolemia long-term (current) use of anticoagulants chronic pulmonary embolism iron deficiency anemia, unspecified chronic diastolic heart failure pulmonary eosinophilia atherosclerosis of native arteries of the extremities, unspecified other disorders of plasma protein metabolism chronic airway obstruction, not elsewhere classified diastolic heart failure, unspecified personal history of venous thrombosis and embolism long-term (current) use of anticoagulants pneumonia, organism unspecified atrial fibrillation congestive heart failure, unspecified orthostatic hypotension congestive heart failure, unspecified obstructive chronic bronchitis with acute bronchitis chronic diastolic heart failure personal history of tobacco use esophageal reflux unspecified essential hypertension other cataract long-term (current) use of anticoagulants unspecified viral infection chronic pulmonary embolism atrial fibrillation
white f 81 $nan$hematology blood hematocrit  28.7  %; hematology blood hematocrit  25.8  %; hematology blood hemoglobin  9.5  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  170  k ul; hematology blood platelet count  145  k ul; hematology blood inr(pt)  1.4  $multivitamins  1  cap ; vitamin d  400  unit ; ferrous sulfate  325  mg ; atorvastatin  40  mg ; fluticasone propionate nasal  2  spry ; tiotropium bromide  1  cap ; naproxen  500  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; metoprolol tartrate  12.5  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; lr  1000  ml ; morphine sulfate  50  mg ; oxycodone (immediate release)   5  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; senna  1  tab ; trazodone  50  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; benzonatate  200  mg ; gabapentin  100  mg ; enoxaparin sodium  40  mg ; vial  1  vial ; pantoprazole  40  mg ; warfarin  1  mg ; furosemide  20  mg ; 0.9% sodium chloride  500  ml ; 
atrial fibrillation osteoporosis, unspecified long-term (current) use of anticoagulants peripheral vascular disease, unspecified other and unspecified hyperlipidemia iron deficiency anemia, unspecified esophageal reflux chronic diastolic heart failure unspecified essential hypertension bacterial pneumonia, unspecified obstructive chronic bronchitis with (acute) exacerbation congestive heart failure, unspecified long-term (current) use of steroids pulmonary eosinophilia osteoarthrosis, unspecified whether generalized or localized, site unspecified congestive heart failure, unspecified hypotension, unspecified chronic airway obstruction, not elsewhere classified atrial fibrillation unspecified essential hypertension pneumonia, organism unspecified hypovolemia long-term (current) use of anticoagulants chronic pulmonary embolism iron deficiency anemia, unspecified chronic diastolic heart failure pulmonary eosinophilia atherosclerosis of native arteries of the extremities, unspecified other disorders of plasma protein metabolism chronic airway obstruction, not elsewhere classified diastolic heart failure, unspecified personal history of venous thrombosis and embolism long-term (current) use of anticoagulants pneumonia, organism unspecified atrial fibrillation congestive heart failure, unspecified orthostatic hypotension congestive heart failure, unspecified obstructive chronic bronchitis with acute bronchitis chronic diastolic heart failure personal history of tobacco use esophageal reflux unspecified essential hypertension other cataract long-term (current) use of anticoagulants unspecified viral infection chronic pulmonary embolism atrial fibrillation
white f 81 $nan$hematology blood hematocrit  27.1  %; hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  143  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood glucose  102  mg dl$multivitamins  1  cap ; vitamin d  400  unit ; ferrous sulfate  325  mg ; atorvastatin  40  mg ; fluticasone propionate nasal  2  spry ; tiotropium bromide  1  cap ; naproxen  500  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; metoprolol tartrate  12.5  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; oxycodone (immediate release)   5  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; senna  1  tab ; trazodone  50  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; benzonatate  200  mg ; gabapentin  100  mg ; enoxaparin sodium  40  mg ; vial  1  vial ; pantoprazole  40  mg ; warfarin  1  mg ; 0.9% sodium chloride  500  ml ; prednisone  5  mg ; 
atrial fibrillation osteoporosis, unspecified long-term (current) use of anticoagulants peripheral vascular disease, unspecified other and unspecified hyperlipidemia iron deficiency anemia, unspecified esophageal reflux chronic diastolic heart failure unspecified essential hypertension bacterial pneumonia, unspecified obstructive chronic bronchitis with (acute) exacerbation congestive heart failure, unspecified long-term (current) use of steroids pulmonary eosinophilia osteoarthrosis, unspecified whether generalized or localized, site unspecified congestive heart failure, unspecified hypotension, unspecified chronic airway obstruction, not elsewhere classified atrial fibrillation unspecified essential hypertension pneumonia, organism unspecified hypovolemia long-term (current) use of anticoagulants chronic pulmonary embolism iron deficiency anemia, unspecified chronic diastolic heart failure pulmonary eosinophilia atherosclerosis of native arteries of the extremities, unspecified other disorders of plasma protein metabolism chronic airway obstruction, not elsewhere classified diastolic heart failure, unspecified personal history of venous thrombosis and embolism long-term (current) use of anticoagulants pneumonia, organism unspecified atrial fibrillation congestive heart failure, unspecified orthostatic hypotension congestive heart failure, unspecified obstructive chronic bronchitis with acute bronchitis chronic diastolic heart failure personal history of tobacco use esophageal reflux unspecified essential hypertension other cataract long-term (current) use of anticoagulants unspecified viral infection chronic pulmonary embolism atrial fibrillation
white f 81 $nan$hematology blood hematocrit  31.1  %; hematology blood hematocrit  27.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  80  mg dl$multivitamins  1  cap ; vitamin d  400  unit ; ferrous sulfate  325  mg ; atorvastatin  40  mg ; fluticasone propionate nasal  2  spry ; tiotropium bromide  1  cap ; docusate sodium  100  mg ; calcium carbonate  500  mg ; metoprolol tartrate  12.5  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; oxycodone (immediate release)   5  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; senna  1  tab ; trazodone  50  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; benzonatate  200  mg ; gabapentin  100  mg ; enoxaparin sodium  40  mg ; vial  1  vial ; pantoprazole  40  mg ; warfarin  1  mg ; prednisone  5  mg ; sodium chloride 0.9%  flush  3  ml ; 
atrial fibrillation osteoporosis, unspecified long-term (current) use of anticoagulants peripheral vascular disease, unspecified other and unspecified hyperlipidemia iron deficiency anemia, unspecified esophageal reflux chronic diastolic heart failure unspecified essential hypertension bacterial pneumonia, unspecified obstructive chronic bronchitis with (acute) exacerbation congestive heart failure, unspecified long-term (current) use of steroids pulmonary eosinophilia osteoarthrosis, unspecified whether generalized or localized, site unspecified congestive heart failure, unspecified hypotension, unspecified chronic airway obstruction, not elsewhere classified atrial fibrillation unspecified essential hypertension pneumonia, organism unspecified hypovolemia long-term (current) use of anticoagulants chronic pulmonary embolism iron deficiency anemia, unspecified chronic diastolic heart failure pulmonary eosinophilia atherosclerosis of native arteries of the extremities, unspecified other disorders of plasma protein metabolism chronic airway obstruction, not elsewhere classified diastolic heart failure, unspecified personal history of venous thrombosis and embolism long-term (current) use of anticoagulants pneumonia, organism unspecified atrial fibrillation congestive heart failure, unspecified orthostatic hypotension congestive heart failure, unspecified obstructive chronic bronchitis with acute bronchitis chronic diastolic heart failure personal history of tobacco use esophageal reflux unspecified essential hypertension other cataract long-term (current) use of anticoagulants unspecified viral infection chronic pulmonary embolism atrial fibrillation
white f 81 $nan$hematology blood hematocrit  29.5  %; hematology blood hematocrit  29.9  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  203  k ul$multivitamins  1  cap ; vitamin d  400  unit ; ferrous sulfate  325  mg ; atorvastatin  40  mg ; fluticasone propionate nasal  2  spry ; tiotropium bromide  1  cap ; docusate sodium  100  mg ; calcium carbonate  500  mg ; metoprolol tartrate  12.5  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; oxycodone (immediate release)   5  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; senna  1  tab ; trazodone  50  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; benzonatate  200  mg ; gabapentin  100  mg ; enoxaparin sodium  40  mg ; vial  1  vial ; pantoprazole  40  mg ; warfarin  1  mg ; prednisone  5  mg ; sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; 
atrial fibrillation osteoporosis, unspecified long-term (current) use of anticoagulants peripheral vascular disease, unspecified other and unspecified hyperlipidemia iron deficiency anemia, unspecified esophageal reflux chronic diastolic heart failure unspecified essential hypertension bacterial pneumonia, unspecified obstructive chronic bronchitis with (acute) exacerbation congestive heart failure, unspecified long-term (current) use of steroids pulmonary eosinophilia osteoarthrosis, unspecified whether generalized or localized, site unspecified congestive heart failure, unspecified hypotension, unspecified chronic airway obstruction, not elsewhere classified atrial fibrillation unspecified essential hypertension pneumonia, organism unspecified hypovolemia long-term (current) use of anticoagulants chronic pulmonary embolism iron deficiency anemia, unspecified chronic diastolic heart failure pulmonary eosinophilia atherosclerosis of native arteries of the extremities, unspecified other disorders of plasma protein metabolism chronic airway obstruction, not elsewhere classified diastolic heart failure, unspecified personal history of venous thrombosis and embolism long-term (current) use of anticoagulants pneumonia, organism unspecified atrial fibrillation congestive heart failure, unspecified orthostatic hypotension congestive heart failure, unspecified obstructive chronic bronchitis with acute bronchitis chronic diastolic heart failure personal history of tobacco use esophageal reflux unspecified essential hypertension other cataract long-term (current) use of anticoagulants unspecified viral infection chronic pulmonary embolism atrial fibrillation
white f 81 $nan$nan$multivitamins  1  cap ; vitamin d  400  unit ; ferrous sulfate  325  mg ; atorvastatin  40  mg ; fluticasone propionate nasal  2  spry ; tiotropium bromide  1  cap ; docusate sodium  100  mg ; calcium carbonate  500  mg ; metoprolol tartrate  12.5  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; oxycodone (immediate release)   5  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; senna  1  tab ; trazodone  50  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; benzonatate  200  mg ; gabapentin  100  mg ; enoxaparin sodium  40  mg ; vial  1  vial ; pantoprazole  40  mg ; warfarin  1  mg ; prednisone  5  mg ; sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; 
atrial fibrillation osteoporosis, unspecified long-term (current) use of anticoagulants peripheral vascular disease, unspecified other and unspecified hyperlipidemia iron deficiency anemia, unspecified esophageal reflux chronic diastolic heart failure unspecified essential hypertension bacterial pneumonia, unspecified obstructive chronic bronchitis with (acute) exacerbation congestive heart failure, unspecified long-term (current) use of steroids pulmonary eosinophilia osteoarthrosis, unspecified whether generalized or localized, site unspecified congestive heart failure, unspecified hypotension, unspecified chronic airway obstruction, not elsewhere classified atrial fibrillation unspecified essential hypertension pneumonia, organism unspecified hypovolemia long-term (current) use of anticoagulants chronic pulmonary embolism iron deficiency anemia, unspecified chronic diastolic heart failure pulmonary eosinophilia atherosclerosis of native arteries of the extremities, unspecified other disorders of plasma protein metabolism chronic airway obstruction, not elsewhere classified diastolic heart failure, unspecified personal history of venous thrombosis and embolism long-term (current) use of anticoagulants pneumonia, organism unspecified atrial fibrillation congestive heart failure, unspecified orthostatic hypotension congestive heart failure, unspecified obstructive chronic bronchitis with acute bronchitis chronic diastolic heart failure personal history of tobacco use esophageal reflux unspecified essential hypertension other cataract long-term (current) use of anticoagulants unspecified viral infection chronic pulmonary embolism atrial fibrillation
white m 62 $temp  98.1  heartrate  87.0  resprate  18.0  o2sat  92.0  sbp  93.0  dbp  63.0  rhythm    pain  0 10  $hematology blood hematocrit  38.5  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  145  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  3.9  mg dl; chemistry blood glucose  80  mg dl; chemistry blood albumin  2.5  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  81  mg ; diltiazem extended-release  120  mg ; ledipasvir sofosbuvir  1  tab ; omeprazole  40  mg ; ribavirin  600  mg ; ribavirin  400  mg ; 
person on outside of bus injured in collision with pedestrian or animal in traffic accident obstructive sleep apnea (adult)(pediatric) barrett's esophagus personal history of tobacco use other suppurative peritonitis tracheostomy status car driver injured in collision with heavy transport vehicle or bus in nontraffic accident thrombocytopenia, unspecified jaundice, unspecified, not of newborn alcoholic cirrhosis of liver chronic airway obstruction, not elsewhere classified esophageal reflux alcohol abuse, unspecified mitral valve disorders personal history of malignant neoplasm of larynx anemia, unspecified septicemia due to escherichia coli [e. coli] examination of participant in clinical trial diverticulitis of colon (without mention of hemorrhage) atrial fibrillation
white m 62 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  128  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood glucose  86  mg dl; chemistry blood glucose  82  mg dl; chemistry blood lactate dehydrogenase (ld)  210  iu l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  81  mg ; diltiazem extended-release  120  mg ; ledipasvir sofosbuvir  1  tab ; omeprazole  40  mg ; ribavirin  600  mg ; ribavirin  400  mg ; albumin 25% (12.5g   50ml)  25  g ; furosemide  40  mg ; bag  1  bag ; magnesium sulfate  2  gm ; lactulose  30  ml ; 
person on outside of bus injured in collision with pedestrian or animal in traffic accident obstructive sleep apnea (adult)(pediatric) barrett's esophagus personal history of tobacco use other suppurative peritonitis tracheostomy status car driver injured in collision with heavy transport vehicle or bus in nontraffic accident thrombocytopenia, unspecified jaundice, unspecified, not of newborn alcoholic cirrhosis of liver chronic airway obstruction, not elsewhere classified esophageal reflux alcohol abuse, unspecified mitral valve disorders personal history of malignant neoplasm of larynx anemia, unspecified septicemia due to escherichia coli [e. coli] examination of participant in clinical trial diverticulitis of colon (without mention of hemorrhage) atrial fibrillation
white m 62 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  123  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  2.5  mg dl; chemistry blood glucose  74  mg dl$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; diltiazem extended-release  120  mg ; ledipasvir sofosbuvir  1  tab ; omeprazole  40  mg ; ribavirin  600  mg ; ribavirin  400  mg ; furosemide  40  mg ; bag  1  bag ; magnesium sulfate  2  gm ; lactulose  30  ml ; spironolactone  100  mg ; potassium chloride  20  meq ; potassium chloride (powder)  20  meq ; 
person on outside of bus injured in collision with pedestrian or animal in traffic accident obstructive sleep apnea (adult)(pediatric) barrett's esophagus personal history of tobacco use other suppurative peritonitis tracheostomy status car driver injured in collision with heavy transport vehicle or bus in nontraffic accident thrombocytopenia, unspecified jaundice, unspecified, not of newborn alcoholic cirrhosis of liver chronic airway obstruction, not elsewhere classified esophageal reflux alcohol abuse, unspecified mitral valve disorders personal history of malignant neoplasm of larynx anemia, unspecified septicemia due to escherichia coli [e. coli] examination of participant in clinical trial diverticulitis of colon (without mention of hemorrhage) atrial fibrillation
white m 62 $nan$nan$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; diltiazem extended-release  120  mg ; ledipasvir sofosbuvir  1  tab ; omeprazole  40  mg ; ribavirin  600  mg ; ribavirin  400  mg ; spironolactone  100  mg ; potassium chloride (powder)  20  meq ; 
person on outside of bus injured in collision with pedestrian or animal in traffic accident obstructive sleep apnea (adult)(pediatric) barrett's esophagus personal history of tobacco use other suppurative peritonitis tracheostomy status car driver injured in collision with heavy transport vehicle or bus in nontraffic accident thrombocytopenia, unspecified jaundice, unspecified, not of newborn alcoholic cirrhosis of liver chronic airway obstruction, not elsewhere classified esophageal reflux alcohol abuse, unspecified mitral valve disorders personal history of malignant neoplasm of larynx anemia, unspecified septicemia due to escherichia coli [e. coli] examination of participant in clinical trial diverticulitis of colon (without mention of hemorrhage) atrial fibrillation
other f 50 $temp  98.2  heartrate  88.0  resprate  16.0  o2sat  100.0  sbp  111.0  dbp  75.0  rhythm    pain  5  $hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  99  mg dl$0.45% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; quetiapine fumarate  50-100  mg ; bisacodyl  10  mg ; oxycodone (immediate release)   5-10  mg ; omeprazole  20  mg ; nicotine patch  21  mg ; multivitamins  1  tab ; senna  8.6  mg ; docusate sodium  100  mg ; amphetamine-dextroamphetamine  20  mg ; quetiapine fumarate  25  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; 
alcohol abuse, unspecified physical restraints status other and unspecified special symptoms or syndromes, not elsewhere classified depressive disorder, not elsewhere classified
other f 50 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  100  mg dl$0.45% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; oxycodone (immediate release)   5-10  mg ; omeprazole  20  mg ; nicotine patch  21  mg ; multivitamins  1  tab ; senna  8.6  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; lamotrigine  200  mg ; heparin  5000  unit ; polyethylene glycol  17  g ; amphetamine-dextroamphetamine xr  60  mg ; amphetamine-dextroamphetamine xr  20  mg ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.5  mg ; 
alcohol abuse, unspecified physical restraints status other and unspecified special symptoms or syndromes, not elsewhere classified depressive disorder, not elsewhere classified
other f 50 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  77  mg dl$0.45% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; oxycodone (immediate release)   5-10  mg ; omeprazole  20  mg ; nicotine patch  21  mg ; multivitamins  1  tab ; senna  8.6  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; lamotrigine  200  mg ; heparin  5000  unit ; polyethylene glycol  17  g ; amphetamine-dextroamphetamine xr  20  mg ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.5  mg ; acetaminophen  1000  mg ; 
alcohol abuse, unspecified physical restraints status other and unspecified special symptoms or syndromes, not elsewhere classified depressive disorder, not elsewhere classified
other f 50 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3  ml ; omeprazole  20  mg ; nicotine patch  21  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; lamotrigine  200  mg ; amphetamine-dextroamphetamine xr  20  mg ; acetaminophen  1000  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; hydromorphone (dilaudid)  0.125  mg ; 
alcohol abuse, unspecified physical restraints status other and unspecified special symptoms or syndromes, not elsewhere classified depressive disorder, not elsewhere classified
other f 50 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  343  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  240  iu l$sodium chloride 0.9%  flush  3  ml ; omeprazole  20  mg ; nicotine patch  21  mg ; lamotrigine  200  mg ; amphetamine-dextroamphetamine xr  20  mg ; acetaminophen  1000  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; hydromorphone (dilaudid)  0.125  mg ; ondansetron  4  mg ; potassium chloride  60  meq ; 
alcohol abuse, unspecified physical restraints status other and unspecified special symptoms or syndromes, not elsewhere classified depressive disorder, not elsewhere classified
other f 50 $nan$nan$sodium chloride 0.9%  flush  3  ml ; omeprazole  20  mg ; nicotine patch  21  mg ; lamotrigine  200  mg ; amphetamine-dextroamphetamine xr  20  mg ; acetaminophen  1000  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; ondansetron  4  mg ; gabapentin  300  mg ; lidocaine 5% patch  1  ptch ; 
alcohol abuse, unspecified physical restraints status other and unspecified special symptoms or syndromes, not elsewhere classified depressive disorder, not elsewhere classified
white m 57 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  435  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  116  mg dl$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.5  mg ; alprazolam  0.5  mg ; lactated ringers  1000  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; mirtazapine  15  mg ; lisinopril  20  mg ; heparin  5000  unit ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; ns  100  ml ; metronidazole (flagyl)  500  mg ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; 
 
white m 57 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  465  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  81  mg dl$docusate sodium  100  mg ; senna  8.6  mg ; mirtazapine  15  mg ; lisinopril  20  mg ; heparin  5000  unit ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; ns  100  ml ; metronidazole (flagyl)  500  mg ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; 
 
white m 57 $nan$nan$docusate sodium  100  mg ; senna  8.6  mg ; mirtazapine  15  mg ; lisinopril  20  mg ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; ampicillin-sulbactam  3  g ; 
 
white m 57 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  486  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  101  mg dl$docusate sodium  100  mg ; senna  8.6  mg ; mirtazapine  15  mg ; lisinopril  20  mg ; heparin  5000  unit ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; ampicillin-sulbactam  3  g ; amoxicillin-clavulanic acid  875  mg ; bag  1  bag ; magnesium sulfate  2  gm ; 
 
white m 57 $nan$nan$docusate sodium  100  mg ; senna  8.6  mg ; mirtazapine  15  mg ; lisinopril  20  mg ; heparin  5000  unit ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; amoxicillin-clavulanic acid  875  mg ; bag  1  bag ; magnesium sulfate  2  gm ; 
 
white m 90 $temp    heartrate    resprate  12.0  o2sat    sbp  102.0  dbp  62.0  rhythm    pain    ; temp  97.6  heartrate  89.0  resprate  14.0  o2sat  100.0  sbp  102.0  dbp  62.0  rhythm    pain  0  $hematology blood hematocrit  33.3  %; hematology blood hematocrit  37.3  %; hematology blood hemoglobin  11.6  g dl; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  168  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  6.1  mg dl; chemistry blood glucose  93  mg dl; blood gas blood free calcium  0.91  mmol l; blood gas blood lactate  2.5  mmol l; blood gas blood glucose  91  mg dl$vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; levothyroxine sodium  100  mcg ; rosuvastatin calcium  20  mg ; acetaminophen  1000  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; lactated ringers  1000  ml ; sodium chloride 0.9%  1000  ml ; metoprolol tartrate  12.5  mg ; furosemide  20  mg ; quetiapine fumarate  12.5  mg ; 
unspecified essential hypertension long-term (current) use of aspirin other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits ulcer of other part of foot unspecified acquired hypothyroidism unspecified glaucoma gangrene other iatrogenic hypotension pathologic fracture of vertebrae arterial embolism and thrombosis of lower extremity congestive heart failure, unspecified personal history of tobacco use percutaneous transluminal coronary angioplasty status do not resuscitate status atrial fibrillation arterial embolism and thrombosis of upper extremity atrial fibrillation percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism aortic valve disorders unspecified essential hypertension
white m 80 $nan$hematology blood hematocrit  30.6  %; hematology blood hematocrit  29.9  %; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  152  k ul; hematology blood platelet count  155  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  5.0  meq l; chemistry blood potassium  5.2  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  68  mg dl; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  1.4  ; chemistry urine chloride, urine  48  meq l; chemistry urine creatinine, urine  111  mg dl; chemistry urine potassium, urine  64  meq l; chemistry urine sodium, urine  32  meq l; chemistry urine urea nitrogen, urine  571  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  128  mg dl; chemistry blood glucose  171  mg dl$acetaminophen  650  mg ; calcium gluconate  2  g ; carvedilol  3.125  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; hydromorphone (dilaudid)  0.5-2  mg ; ondansetron  4  mg ; metoprolol tartrate  5  mg ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; 0.9% sodium chloride  250  ml ; meperidine  12.5  mg ; promethazine hcl  6.25-12.5  mg ; prochlorperazine  2.5-5  mg ; haloperidol  0.25-0.5  mg ; hydromorphone (dilaudid)  0.2-0.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; gabapentin  800  mg ; fluticasone propionate 110mcg  2  puff ; 
systolic heart failure, unspecified unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with ulceration atrial fibrillation below knee amputation status personal history of other malignant neoplasm of skin congestive heart failure, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) atrial fibrillation gout, unspecified acquired absence of kidney chronic systolic heart failure personal history of other malignant neoplasm of skin atherosclerosis of native arteries of the extremities with rest pain congestive heart failure, unspecified chronic airway obstruction, not elsewhere classified cardiac pacemaker in situ below knee amputation status aseptic necrosis of bone, other atherosclerosis of native arteries of the extremities with gangrene congestive heart failure, unspecified personal history of malignant neoplasm of kidney personal history of other malignant neoplasm of skin acute posthemorrhagic anemia chronic systolic heart failure other complications due to other vascular device, implant, and graft other complications due to other vascular device, implant, and graft personal history of other malignant neoplasm of skin congestive heart failure, unspecified chronic systolic heart failure atrial fibrillation cardiac pacemaker in situ ulcer of other part of foot unspecified essential hypertension atherosclerosis of native arteries of the extremities with ulceration 
white m 80 $nan$hematology blood hematocrit  27.0  %; hematology blood hematocrit  28.7  %; hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.7  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  167  k ul; hematology blood platelet count  185  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood creatinine  3.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  48  mg dl; hematology blood inr(pt)  1.4  ; chemistry urine chloride, urine  25  meq l; chemistry urine creatinine, urine  182  mg dl; chemistry urine potassium, urine  52  meq l; chemistry urine sodium, urine  19  meq l; chemistry urine urea nitrogen, urine  347  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  101  mg dl; chemistry blood glucose  124  mg dl; chemistry urine calcium, urine  1.5  mg dl$acetaminophen  650  mg ; calcium gluconate  2  g ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; hydromorphone (dilaudid)  0.5-2  mg ; ondansetron  4  mg ; metoprolol tartrate  5  mg ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; 0.9% sodium chloride  250  ml ; docusate sodium  100  mg ; heparin  5000  unit ; gabapentin  800  mg ; fluticasone propionate 110mcg  2  puff ; simvastatin  20  mg ; aspirin  81  mg ; lisinopril  40  mg ; warfarin  5  mg ; simvastatin  10  mg ; 0.9% sodium chloride  500  ml ; furosemide  20  mg ; gemfibrozil  600  mg ; 
systolic heart failure, unspecified unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with ulceration atrial fibrillation below knee amputation status personal history of other malignant neoplasm of skin congestive heart failure, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) atrial fibrillation gout, unspecified acquired absence of kidney chronic systolic heart failure personal history of other malignant neoplasm of skin atherosclerosis of native arteries of the extremities with rest pain congestive heart failure, unspecified chronic airway obstruction, not elsewhere classified cardiac pacemaker in situ below knee amputation status aseptic necrosis of bone, other atherosclerosis of native arteries of the extremities with gangrene congestive heart failure, unspecified personal history of malignant neoplasm of kidney personal history of other malignant neoplasm of skin acute posthemorrhagic anemia chronic systolic heart failure other complications due to other vascular device, implant, and graft other complications due to other vascular device, implant, and graft personal history of other malignant neoplasm of skin congestive heart failure, unspecified chronic systolic heart failure atrial fibrillation cardiac pacemaker in situ ulcer of other part of foot unspecified essential hypertension atherosclerosis of native arteries of the extremities with ulceration 
white m 80 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood creatinine  3.4  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood urea nitrogen  57  mg dl; hematology blood inr(pt)  2.18  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  144  mg dl; chemistry blood glucose  107  mg dl$sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; hydromorphone (dilaudid)  0.5-2  mg ; ondansetron  4  mg ; metoprolol tartrate  5  mg ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; gabapentin  800  mg ; fluticasone propionate 110mcg  2  puff ; aspirin  81  mg ; lisinopril  40  mg ; simvastatin  10  mg ; 0.9% sodium chloride  500  ml ; furosemide  20  mg ; gemfibrozil  600  mg ; 
systolic heart failure, unspecified unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with ulceration atrial fibrillation below knee amputation status personal history of other malignant neoplasm of skin congestive heart failure, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) atrial fibrillation gout, unspecified acquired absence of kidney chronic systolic heart failure personal history of other malignant neoplasm of skin atherosclerosis of native arteries of the extremities with rest pain congestive heart failure, unspecified chronic airway obstruction, not elsewhere classified cardiac pacemaker in situ below knee amputation status aseptic necrosis of bone, other atherosclerosis of native arteries of the extremities with gangrene congestive heart failure, unspecified personal history of malignant neoplasm of kidney personal history of other malignant neoplasm of skin acute posthemorrhagic anemia chronic systolic heart failure other complications due to other vascular device, implant, and graft other complications due to other vascular device, implant, and graft personal history of other malignant neoplasm of skin congestive heart failure, unspecified chronic systolic heart failure atrial fibrillation cardiac pacemaker in situ ulcer of other part of foot unspecified essential hypertension atherosclerosis of native arteries of the extremities with ulceration 
white m 80 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  60  mg dl; hematology blood inr(pt)  2.6  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  119  mg dl$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.5-2  mg ; ondansetron  4  mg ; metoprolol tartrate  5  mg ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; gabapentin  800  mg ; fluticasone propionate 110mcg  2  puff ; aspirin  81  mg ; lisinopril  40  mg ; simvastatin  10  mg ; gemfibrozil  600  mg ; bag  1  bag ; 
systolic heart failure, unspecified unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with ulceration atrial fibrillation below knee amputation status personal history of other malignant neoplasm of skin congestive heart failure, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) atrial fibrillation gout, unspecified acquired absence of kidney chronic systolic heart failure personal history of other malignant neoplasm of skin atherosclerosis of native arteries of the extremities with rest pain congestive heart failure, unspecified chronic airway obstruction, not elsewhere classified cardiac pacemaker in situ below knee amputation status aseptic necrosis of bone, other atherosclerosis of native arteries of the extremities with gangrene congestive heart failure, unspecified personal history of malignant neoplasm of kidney personal history of other malignant neoplasm of skin acute posthemorrhagic anemia chronic systolic heart failure other complications due to other vascular device, implant, and graft other complications due to other vascular device, implant, and graft personal history of other malignant neoplasm of skin congestive heart failure, unspecified chronic systolic heart failure atrial fibrillation cardiac pacemaker in situ ulcer of other part of foot unspecified essential hypertension atherosclerosis of native arteries of the extremities with ulceration 
white m 80 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  57  mg dl; hematology blood inr(pt)  2.8  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.5-2  mg ; ondansetron  4  mg ; metoprolol tartrate  5  mg ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; gabapentin  800  mg ; fluticasone propionate 110mcg  2  puff ; aspirin  81  mg ; lisinopril  40  mg ; simvastatin  10  mg ; gemfibrozil  600  mg ; bag  1  bag ; furosemide  40  mg ; warfarin  2  mg ; tramadol (ultram)  25  mg ; 
systolic heart failure, unspecified unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with ulceration atrial fibrillation below knee amputation status personal history of other malignant neoplasm of skin congestive heart failure, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) atrial fibrillation gout, unspecified acquired absence of kidney chronic systolic heart failure personal history of other malignant neoplasm of skin atherosclerosis of native arteries of the extremities with rest pain congestive heart failure, unspecified chronic airway obstruction, not elsewhere classified cardiac pacemaker in situ below knee amputation status aseptic necrosis of bone, other atherosclerosis of native arteries of the extremities with gangrene congestive heart failure, unspecified personal history of malignant neoplasm of kidney personal history of other malignant neoplasm of skin acute posthemorrhagic anemia chronic systolic heart failure other complications due to other vascular device, implant, and graft other complications due to other vascular device, implant, and graft personal history of other malignant neoplasm of skin congestive heart failure, unspecified chronic systolic heart failure atrial fibrillation cardiac pacemaker in situ ulcer of other part of foot unspecified essential hypertension atherosclerosis of native arteries of the extremities with ulceration 
white m 80 $nan$nan$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.5-2  mg ; ondansetron  4  mg ; metoprolol tartrate  5  mg ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; gabapentin  800  mg ; fluticasone propionate 110mcg  2  puff ; aspirin  81  mg ; lisinopril  40  mg ; simvastatin  10  mg ; gemfibrozil  600  mg ; warfarin  2  mg ; tramadol (ultram)  25  mg ; 
systolic heart failure, unspecified unspecified essential hypertension ulcer of other part of foot other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with ulceration atrial fibrillation below knee amputation status personal history of other malignant neoplasm of skin congestive heart failure, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) atrial fibrillation gout, unspecified acquired absence of kidney chronic systolic heart failure personal history of other malignant neoplasm of skin atherosclerosis of native arteries of the extremities with rest pain congestive heart failure, unspecified chronic airway obstruction, not elsewhere classified cardiac pacemaker in situ below knee amputation status aseptic necrosis of bone, other atherosclerosis of native arteries of the extremities with gangrene congestive heart failure, unspecified personal history of malignant neoplasm of kidney personal history of other malignant neoplasm of skin acute posthemorrhagic anemia chronic systolic heart failure other complications due to other vascular device, implant, and graft other complications due to other vascular device, implant, and graft personal history of other malignant neoplasm of skin congestive heart failure, unspecified chronic systolic heart failure atrial fibrillation cardiac pacemaker in situ ulcer of other part of foot unspecified essential hypertension atherosclerosis of native arteries of the extremities with ulceration 
black african american m 52 $temp    heartrate  97.0  resprate  40.0  o2sat  96.0  sbp  171.0  dbp  96.0  rhythm    pain  0  ; temp    heartrate  101.0  resprate  35.0  o2sat  93.0  sbp  155.0  dbp  93.0  rhythm    pain    ; temp    heartrate  101.0  resprate  24.0  o2sat  95.0  sbp  180.0  dbp  116.0  rhythm    pain    ; temp    heartrate  93.0  resprate  21.0  o2sat  99.0  sbp  166.0  dbp  112.0  rhythm    pain    ; temp    heartrate  95.0  resprate  22.0  o2sat  99.0  sbp  148.0  dbp  112.0  rhythm    pain    ; temp    heartrate  93.0  resprate  22.0  o2sat  99.0  sbp  135.0  dbp  96.0  rhythm    pain    ; temp    heartrate  96.0  resprate  14.0  o2sat  96.0  sbp  130.0  dbp  86.0  rhythm    pain    ; temp    heartrate  97.0  resprate  18.0  o2sat  98.0  sbp  118.0  dbp  73.0  rhythm    pain    ; temp    heartrate  98.0  resprate  18.0  o2sat  99.0  sbp  100.0  dbp  66.0  rhythm    pain    ; temp    heartrate  87.0  resprate  20.0  o2sat  100.0  sbp  123.0  dbp  74.0  rhythm    pain    ; temp    heartrate  90.0  resprate  20.0  o2sat  100.0  sbp  110.0  dbp  71.0  rhythm    pain    $hematology blood hematocrit  45.6  %; hematology blood hemoglobin  15.7  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  135  mg dl$sodium chloride 0.9%  flush  3  ml ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; soln  50  ml ; fentanyl citrate  2.5  mg ; propofol  1000  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; methylprednisolone sodium succ  60  mg ; 0.9% sodium chloride  100  ml ; dexmedetomidine  0.4  mg ; 5% dextrose  250  ml ; azithromycin   250  mg ; azithromycin  250  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; olanzapine  20  mg ; sodium chloride 0.9%  1000  ml ; neutra-phos  2  pkt ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; 
pulmonary congestion and hypostasis unspecified viral infection polycythemia vera asthma, unspecified type, unspecified unspecified schizophrenia, unspecified tobacco use disorder acute upper respiratory infections of unspecified site anxiety state, unspecified other and unspecified hyperlipidemia obesity, unspecified unspecified essential hypertension body mass index 36.0-36.9, adult
black african american m 52 $nan$hematology blood hematocrit  42.7  %; hematology blood hemoglobin  15.0  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  127  mg dl$sodium chloride 0.9%  flush  3  ml ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; soln  50  ml ; fentanyl citrate  2.5  mg ; propofol  1000  mg ; 0.9% sodium chloride  100  ml ; dexmedetomidine  0.4  mg ; azithromycin  250  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; olanzapine  20  mg ; sodium chloride 0.9%  1000  ml ; neutra-phos  2  pkt ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; 
pulmonary congestion and hypostasis unspecified viral infection polycythemia vera asthma, unspecified type, unspecified unspecified schizophrenia, unspecified tobacco use disorder acute upper respiratory infections of unspecified site anxiety state, unspecified other and unspecified hyperlipidemia obesity, unspecified unspecified essential hypertension body mass index 36.0-36.9, adult
black african american m 52 $nan$hematology blood hematocrit  45.7  %; hematology blood hemoglobin  15.9  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3  ml ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; azithromycin  250  mg ; heparin  5000  unit ; olanzapine  20  mg ; ondansetron  4  mg ; senna  17.2  mg ; polyethylene glycol  17  g ; simethicone  40-80  mg ; ciprofloxacin 0.3% ophth soln  1-2  drop ; acetaminophen  325-650  mg ; albuterol inhaler  2  puff ; fluticasone-salmeterol diskus (250 50)   1  inh ; 
pulmonary congestion and hypostasis unspecified viral infection polycythemia vera asthma, unspecified type, unspecified unspecified schizophrenia, unspecified tobacco use disorder acute upper respiratory infections of unspecified site anxiety state, unspecified other and unspecified hyperlipidemia obesity, unspecified unspecified essential hypertension body mass index 36.0-36.9, adult
white m 86 $nan$nan$d5w  100  ml ; 1 2 ns  1000  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  100  mg ; lorazepam  0.5-2  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; 
hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) coronary atherosclerosis of native coronary artery unspecified essential hypertension old myocardial infarction gross hematuria history of fall
white m 86 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-2  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; 
hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) coronary atherosclerosis of native coronary artery unspecified essential hypertension old myocardial infarction gross hematuria history of fall
white m 58 $nan$nan$fluoxetine  60  mg ; magnesium oxide  400  mg ; megestrol acetate  800  mg ; multivitamins  1  tab ; spironolactone  50  mg ; torsemide  20  mg ; 
cirrhosis of liver without mention of alcohol other chronic pulmonary heart diseases depressive disorder, not elsewhere classified body mass index 27.0-27.9, adult portal hypertension esophageal varices in diseases classified elsewhere, without mention of bleeding hepatopulmonary syndrome unspecified protein-calorie malnutrition chronic hepatitis c without mention of hepatic coma personal history of pathologic fracture chronic kidney disease, unspecified long-term (current) use of other medications other chronic pain awaiting organ transplant status thrombocytopenia, unspecified osteoporosis, unspecified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure severe sepsis other septicemia due to gram-negative organisms other specified disorders of stomach and duodenum unspecified essential hypertension acute kidney failure, unspecified hepatorenal syndrome thrombocytopenia, unspecified pneumonia, organism unspecified esophageal varices without mention of bleeding depressive disorder, not elsewhere classified cirrhosis of liver without mention of alcohol awaiting organ transplant status chronic hepatitis c without mention of hepatic coma septic shock portal hypertension other ascites bloodstream infection due to central venous catheter other pancytopenia anemia of other chronic disease portal hypertension esophageal varices without mention of bleeding chronic venous embolism and thrombosis of deep veins of upper extremity examination of participant in clinical trial depressive disorder, not elsewhere classified esophageal reflux unspecified drug dependence, in remission personal history of tobacco use acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma unspecified essential hypertension other chronic pulmonary heart diseases
white m 58 $temp  97.7  heartrate  78.0  resprate  16.0  o2sat  100.0  sbp  131.0  dbp  86.0  rhythm    pain  5  $hematology blood hematocrit  31.4  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  36  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  1.6  mg dl; chemistry blood glucose  98  mg dl; chemistry blood lactate dehydrogenase (ld)  173  iu l; chemistry blood albumin  3.1  g dl$fluoxetine  60  mg ; magnesium oxide  400  mg ; megestrol acetate  800  mg ; multivitamins  1  tab ; spironolactone  50  mg ; torsemide  20  mg ; ferrous sulfate  325  mg ; omeprazole  20  mg ; rifaximin  550  mg ; sildenafil  20  mg ; vitamin d  1000  unit ; mirtazapine  15  mg ; sodium chloride 0.9%  flush  3  ml ; ciprofloxacin hcl  500  mg ; gabapentin  1200  mg ; hydromorphone (dilaudid)  2-4  mg ; morphine sr (ms contin)  60  mg ; sarna lotion  1  appl ; testosterone 4 mg patch  1  ptch ; sterile diluent for flolan  100  ml ; treprostinil sodium  5  mg ; furosemide  20  mg ; 
cirrhosis of liver without mention of alcohol other chronic pulmonary heart diseases depressive disorder, not elsewhere classified body mass index 27.0-27.9, adult portal hypertension esophageal varices in diseases classified elsewhere, without mention of bleeding hepatopulmonary syndrome unspecified protein-calorie malnutrition chronic hepatitis c without mention of hepatic coma personal history of pathologic fracture chronic kidney disease, unspecified long-term (current) use of other medications other chronic pain awaiting organ transplant status thrombocytopenia, unspecified osteoporosis, unspecified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure severe sepsis other septicemia due to gram-negative organisms other specified disorders of stomach and duodenum unspecified essential hypertension acute kidney failure, unspecified hepatorenal syndrome thrombocytopenia, unspecified pneumonia, organism unspecified esophageal varices without mention of bleeding depressive disorder, not elsewhere classified cirrhosis of liver without mention of alcohol awaiting organ transplant status chronic hepatitis c without mention of hepatic coma septic shock portal hypertension other ascites bloodstream infection due to central venous catheter other pancytopenia anemia of other chronic disease portal hypertension esophageal varices without mention of bleeding chronic venous embolism and thrombosis of deep veins of upper extremity examination of participant in clinical trial depressive disorder, not elsewhere classified esophageal reflux unspecified drug dependence, in remission personal history of tobacco use acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma unspecified essential hypertension other chronic pulmonary heart diseases
white m 58 $nan$nan$fluoxetine  60  mg ; magnesium oxide  400  mg ; multivitamins  1  tab ; spironolactone  50  mg ; torsemide  20  mg ; ferrous sulfate  325  mg ; omeprazole  20  mg ; rifaximin  550  mg ; sildenafil  20  mg ; vitamin d  1000  unit ; mirtazapine  15  mg ; sodium chloride 0.9%  flush  3  ml ; ciprofloxacin hcl  500  mg ; gabapentin  1200  mg ; hydromorphone (dilaudid)  2-4  mg ; morphine sr (ms contin)  60  mg ; sarna lotion  1  appl ; testosterone 4 mg patch  1  ptch ; sterile diluent for flolan  100  ml ; treprostinil sodium  5  mg ; 
cirrhosis of liver without mention of alcohol other chronic pulmonary heart diseases depressive disorder, not elsewhere classified body mass index 27.0-27.9, adult portal hypertension esophageal varices in diseases classified elsewhere, without mention of bleeding hepatopulmonary syndrome unspecified protein-calorie malnutrition chronic hepatitis c without mention of hepatic coma personal history of pathologic fracture chronic kidney disease, unspecified long-term (current) use of other medications other chronic pain awaiting organ transplant status thrombocytopenia, unspecified osteoporosis, unspecified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure severe sepsis other septicemia due to gram-negative organisms other specified disorders of stomach and duodenum unspecified essential hypertension acute kidney failure, unspecified hepatorenal syndrome thrombocytopenia, unspecified pneumonia, organism unspecified esophageal varices without mention of bleeding depressive disorder, not elsewhere classified cirrhosis of liver without mention of alcohol awaiting organ transplant status chronic hepatitis c without mention of hepatic coma septic shock portal hypertension other ascites bloodstream infection due to central venous catheter other pancytopenia anemia of other chronic disease portal hypertension esophageal varices without mention of bleeding chronic venous embolism and thrombosis of deep veins of upper extremity examination of participant in clinical trial depressive disorder, not elsewhere classified esophageal reflux unspecified drug dependence, in remission personal history of tobacco use acute kidney failure, unspecified unspecified viral hepatitis c without hepatic coma unspecified essential hypertension other chronic pulmonary heart diseases
white m 56 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  367  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; morphine sulfate  2-4  mg ; heparin  5000  unit ; 
 
white m 56 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  399  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  86  mg dl$ciprofloxacin hcl  500  mg ; ibuprofen  400  mg ; 
 
white m 56 $nan$nan$ciprofloxacin hcl  500  mg ; ibuprofen  400  mg ; 
 
white m 70 $temp  98.0  heartrate  72.0  resprate  18.0  o2sat  95.0  sbp  157.0  dbp  85.0  rhythm    pain  0  $hematology blood hematocrit  34.6  %; hematology blood hematocrit  30.6  %; hematology blood hemoglobin  11.9  g dl; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  10  k ul; hematology blood platelet count  8  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  6.6  mg dl; chemistry blood glucose  94  mg dl; chemistry blood albumin  2.7  g dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; lactated ringers  1000  ml ; magnesium oxide  400  mg ; loratadine  10  mg ; multivitamins  1  tab ; propranolol la  120  mg ; simvastatin  20  mg ; vitamin d  2000  unit ; nicotine lozenge  2  mg ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; captopril  12.5  mg ; nicotine patch  21  mg ; 
 
white m 70 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  11  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, indirect  2.5  mg dl; chemistry blood bilirubin, total  7.2  mg dl; chemistry blood glucose  93  mg dl; chemistry blood lactate dehydrogenase (ld)  885  iu l; chemistry blood albumin  2.7  g dl; chemistry blood bilirubin, direct  4.7  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; senna  8.6  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; lactated ringers  1000  ml ; magnesium oxide  400  mg ; loratadine  10  mg ; multivitamins  1  tab ; propranolol la  120  mg ; simvastatin  20  mg ; vitamin d  2000  unit ; nicotine lozenge  2  mg ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; captopril  12.5  mg ; nicotine patch  21  mg ; captopril  25  mg ; phytonadione  2.5  mg ; 
 
white m 70 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  12  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, indirect  2.8  mg dl; chemistry blood bilirubin, total  5.9  mg dl; chemistry blood glucose  108  mg dl; chemistry blood lactate dehydrogenase (ld)  1128  iu l; chemistry blood bilirubin, direct  3.1  mg dl$senna  8.6  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; magnesium oxide  400  mg ; loratadine  10  mg ; multivitamins  1  tab ; propranolol la  120  mg ; vitamin d  2000  unit ; nicotine lozenge  2  mg ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; nicotine patch  21  mg ; captopril  25  mg ; phytonadione  2.5  mg ; phosphorus  500  mg ; captopril  37.5  mg ; sodium chloride 0.9%  flush  3  ml ; 
 
white m 70 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  22  k ul; hematology blood platelet count  14  k ul; hematology blood inr(pt)  1.1  ; chemistry blood bilirubin, total  5.7  mg dl$senna  8.6  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; magnesium oxide  400  mg ; loratadine  10  mg ; multivitamins  1  tab ; propranolol la  120  mg ; vitamin d  2000  unit ; nicotine lozenge  2  mg ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; nicotine patch  21  mg ; phosphorus  500  mg ; captopril  37.5  mg ; sodium chloride 0.9%  flush  3  ml ; captopril  50  mg ; 
 
white m 70 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  10  k ul; chemistry blood bilirubin, total  6.1  mg dl$senna  8.6  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; magnesium oxide  400  mg ; loratadine  10  mg ; multivitamins  1  tab ; propranolol la  120  mg ; vitamin d  2000  unit ; nicotine lozenge  2  mg ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; nicotine patch  21  mg ; phosphorus  500  mg ; sodium chloride 0.9%  flush  3  ml ; captopril  50  mg ; albuterol 0.083% neb soln  1  neb ; furosemide  10  mg ; hydrochlorothiazide  25  mg ; bag  400  ml ; gammagard liquid  40  g ; 
 
white m 70 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  14  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  5.2  mg dl; chemistry blood glucose  126  mg dl; chemistry blood glucose  104  mg dl$docusate sodium  100  mg ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; magnesium oxide  400  mg ; loratadine  10  mg ; multivitamins  1  tab ; propranolol la  120  mg ; vitamin d  2000  unit ; nicotine lozenge  2  mg ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; nicotine patch  21  mg ; sodium chloride 0.9%  flush  3  ml ; captopril  50  mg ; albuterol 0.083% neb soln  1  neb ; furosemide  10  mg ; hydrochlorothiazide  25  mg ; bag  400  ml ; gammagard liquid  40  g ; furosemide  20  mg ; polyethylene glycol  17  g ; 
 
white m 70 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  12  k ul; hematology blood platelet count  36  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  4.8  mg dl; chemistry blood glucose  115  mg dl$docusate sodium  100  mg ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; magnesium oxide  400  mg ; loratadine  10  mg ; multivitamins  1  tab ; propranolol la  120  mg ; vitamin d  2000  unit ; nicotine lozenge  2  mg ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; nicotine patch  21  mg ; sodium chloride 0.9%  flush  3  ml ; captopril  50  mg ; albuterol 0.083% neb soln  1  neb ; hydrochlorothiazide  25  mg ; bag  400  ml ; gammagard liquid  40  g ; furosemide  20  mg ; polyethylene glycol  17  g ; ipratropium bromide neb  1  neb ; atorvastatin  80  mg ; nitroglycerin ointment  2%  1  in ; nitroglycerin ointment  2%  0.5  in ; metoprolol tartrate  12.5  mg ; 
 
white m 70 $nan$hematology blood hematocrit  24.9  %; hematology blood hematocrit  24.1  %; hematology blood hematocrit  24.2  %; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  29  k ul; hematology blood platelet count  22  k ul; hematology blood platelet count  49  k ul; hematology blood platelet count  50  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.0  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  4.1  mg dl; chemistry blood bilirubin, total  4.3  mg dl; chemistry blood glucose  110  mg dl; chemistry blood glucose  122  mg dl; chemistry blood lactate dehydrogenase (ld)  1545  iu l; chemistry blood lactate dehydrogenase (ld)  1418  iu l; chemistry blood albumin  2.7  g dl; chemistry blood albumin  2.9  g dl; hematology blood bands  0  %$docusate sodium  100  mg ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; magnesium oxide  400  mg ; loratadine  10  mg ; multivitamins  1  tab ; vitamin d  2000  unit ; nicotine lozenge  2  mg ; acetaminophen  325-650  mg ; pantoprazole  40  mg ; nicotine patch  21  mg ; sodium chloride 0.9%  flush  3  ml ; captopril  50  mg ; albuterol 0.083% neb soln  1  neb ; hydrochlorothiazide  25  mg ; bag  400  ml ; gammagard liquid  40  g ; polyethylene glycol  17  g ; ipratropium bromide neb  1  neb ; atorvastatin  80  mg ; nitroglycerin ointment  2%  0.5  in ; metoprolol tartrate  12.5  mg ; heparin  1400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; d5w  250  ml ; nitroglycerin  100  mg ; nitroglycerin sl  0.3  mg ; aspirin  325  mg ; 
 
white m 70 $nan$hematology blood hematocrit  23.4  %; hematology blood hematocrit  22.3  %; hematology blood hematocrit  24.6  %; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  32  k ul; hematology blood platelet count  30  k ul; hematology blood platelet count  35  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  8.4  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  141  mg dl$heparin  1400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; nitroglycerin sl  0.3  mg ; potassium chloride  40  meq ; aspirin  81  mg ; bag  1  bag ; magnesium sulfate  2  gm ; 
 
white m 70 $nan$hematology blood platelet count  29  k ul; hematology blood platelet count  43  k ul; hematology blood platelet count  33  k ul$heparin  1400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; nitroglycerin sl  0.3  mg ; aspirin  81  mg ; potassium chloride  20  meq ; 
 
white m 70 $nan$hematology blood hematocrit  28.4  %; hematology blood hematocrit  27.4  %; hematology blood hematocrit  25.4  %; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  9.1  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  33  k ul; hematology blood platelet count  23  k ul; hematology blood platelet count  43  k ul; hematology blood platelet count  28  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  3.6  mg dl; chemistry blood bilirubin, total  3.7  mg dl; chemistry blood glucose  132  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  108  mg dl; chemistry blood lactate dehydrogenase (ld)  1232  iu l; chemistry blood albumin  2.9  g dl$heparin  1400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; nitroglycerin sl  0.3  mg ; aspirin  81  mg ; potassium chloride  20  meq ; atorvastatin  40  mg ; 
 
white m 70 $nan$hematology blood hematocrit  26.5  %; hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  22  k ul; hematology blood platelet count  19  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  103  mg dl; chemistry blood glucose  95  mg dl$nitroglycerin sl  0.3  mg ; aspirin  81  mg ; atorvastatin  40  mg ; furosemide  40  mg ; phosphorus  250  mg ; spironolactone  12.5  mg ; 
 
white m 70 $nan$hematology blood hematocrit  27.6  %; hematology blood hematocrit  25.9  %; hematology blood hemoglobin  9.1  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  34  k ul; hematology blood platelet count  19  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  4.5  mg dl; chemistry blood glucose  107  mg dl; chemistry blood glucose  105  mg dl$nitroglycerin sl  0.3  mg ; aspirin  81  mg ; atorvastatin  40  mg ; furosemide  40  mg ; phosphorus  250  mg ; spironolactone  12.5  mg ; metoprolol succinate xl  25  mg ; 
 
white m 70 $nan$hematology blood hematocrit  27.4  %; hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.7  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  24  k ul; hematology blood platelet count  18  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  4.5  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  124  mg dl$nitroglycerin sl  0.3  mg ; aspirin  81  mg ; phosphorus  250  mg ; spironolactone  12.5  mg ; metoprolol succinate xl  25  mg ; hydromorphone (dilaudid)  1  mg ; 
 
white m 70 $nan$hematology blood hematocrit  25.8  %; hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  31  k ul; hematology blood platelet count  13  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  126  mg dl; chemistry blood glucose  163  mg dl; hematology blood bands  0  %$nitroglycerin sl  0.3  mg ; aspirin  81  mg ; phosphorus  250  mg ; spironolactone  12.5  mg ; metoprolol succinate xl  25  mg ; hydromorphone (dilaudid)  1  mg ; trazodone  25  mg ; spironolactone  25  mg ; prednisone  60  mg ; 
 
white m 70 $nan$hematology blood hematocrit  25.9  %; hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  28  k ul; hematology blood platelet count  25  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood urea nitrogen  36  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  3.0  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  162  mg dl$nitroglycerin sl  0.3  mg ; aspirin  81  mg ; metoprolol succinate xl  25  mg ; trazodone  25  mg ; prednisone  60  mg ; prednisone  30  mg ; trazodone  50  mg ; metoprolol succinate xl  50  mg ; prednisone  40  mg ; prednisone  50  mg ; 
 
white m 70 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  24  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  41  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  91  mg dl$nitroglycerin sl  0.3  mg ; trazodone  50  mg ; metoprolol succinate xl  50  mg ; prednisone  40  mg ; prednisone  50  mg ; torsemide  40  mg ; 
 
white m 70 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  22  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.2  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  2.8  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  161  mg dl; chemistry blood lactate dehydrogenase (ld)  1157  iu l; chemistry blood albumin  2.9  g dl$nitroglycerin sl  0.3  mg ; trazodone  50  mg ; metoprolol succinate xl  50  mg ; prednisone  40  mg ; prednisone  50  mg ; potassium chloride  60  meq ; torsemide  20  mg ; 
 
white m 70 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  14  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  42  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  3.2  mg dl; chemistry blood glucose  93  mg dl; chemistry blood lactate dehydrogenase (ld)  1249  iu l; chemistry blood albumin  3.0  g dl; hematology blood bands  0  %$nitroglycerin sl  0.3  mg ; trazodone  50  mg ; metoprolol succinate xl  50  mg ; prednisone  40  mg ; prednisone  50  mg ; 
 
white m 70 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  25  k ul; hematology blood platelet count  12  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  152  mg dl$nitroglycerin sl  0.3  mg ; trazodone  50  mg ; metoprolol succinate xl  50  mg ; prednisone  40  mg ; prednisone  50  mg ; metoprolol tartrate  25  mg ; 
 
white m 70 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  15  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  41  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  3.2  mg dl; chemistry blood glucose  93  mg dl$nitroglycerin sl  0.3  mg ; trazodone  50  mg ; metoprolol succinate xl  50  mg ; prednisone  40  mg ; prednisone  50  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; dexamethasone  40  mg ; 
 
white m 70 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  13  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood bilirubin, total  3.4  mg dl; chemistry blood glucose  109  mg dl; chemistry blood albumin  2.9  g dl$nitroglycerin sl  0.3  mg ; trazodone  50  mg ; metoprolol succinate xl  50  mg ; prednisone  50  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; dexamethasone  40  mg ; 
 
white m 70 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  12  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  111  mg dl$nitroglycerin sl  0.3  mg ; trazodone  50  mg ; metoprolol succinate xl  50  mg ; prednisone  50  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; dexamethasone  40  mg ; morphine sulfate ir  7.5  mg ; morphine sulfate (oral soln.)  2.5-5  mg ; 
 
white m 70 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  17  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  2.5  mg dl; chemistry blood glucose  118  mg dl$nitroglycerin sl  0.3  mg ; trazodone  50  mg ; metoprolol succinate xl  50  mg ; prednisone  50  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; dexamethasone  40  mg ; morphine sulfate (oral soln.)  2.5-5  mg ; furosemide  60  mg ; acetaminophen  650  mg ; diphenhydramine  25  mg ; 0.9% sodium chloride  500  ml ; rituximab  750  mg ; lamivudine  50  mg ; 
 
white m 70 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  18  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  2.4  mg dl; chemistry blood glucose  153  mg dl$nitroglycerin sl  0.3  mg ; trazodone  50  mg ; metoprolol succinate xl  50  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; dexamethasone  40  mg ; morphine sulfate (oral soln.)  2.5-5  mg ; lamivudine  50  mg ; nystatin oral suspension  5  ml ; 
 
white m 70 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  10  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  3.5  mg dl; chemistry blood glucose  90  mg dl; hematology blood bands  3  %$nitroglycerin sl  0.3  mg ; trazodone  50  mg ; metoprolol succinate xl  50  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; morphine sulfate (oral soln.)  2.5-5  mg ; lamivudine  50  mg ; nystatin oral suspension  5  ml ; 
 
white m 70 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  29  k ul; hematology blood platelet count  13  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry blood urea nitrogen  49  mg dl; hematology blood inr(pt)  1.3  ; hematology urine wbc  7  # hpf; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  3.5  mg dl; chemistry blood glucose  126  mg dl; chemistry blood glucose  107  mg dl$nitroglycerin sl  0.3  mg ; trazodone  50  mg ; metoprolol succinate xl  50  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; morphine sulfate (oral soln.)  2.5-5  mg ; lamivudine  50  mg ; nystatin oral suspension  5  ml ; aminocaproic acid  2  gm ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; morphine sulfate   2.5  mg ; folic acid  1  mg ; 
 
white m 70 $nan$nan$metoprolol succinate xl  50  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; morphine sulfate (oral soln.)  2.5-5  mg ; lamivudine  50  mg ; nystatin oral suspension  5  ml ; aminocaproic acid  2  gm ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; morphine sulfate   2.5  mg ; folic acid  1  mg ; 
 
black african american m 71 $nan$nan$senna  8.6  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; hydromorphone (dilaudid)  0.125-0.25  mg ; ranitidine  150  mg ; trazodone  50  mg ; ondansetron  4  mg ; nitroglycerin sl  0.4  mg ; amlodipine  10  mg ; diazepam - ciwa protocol  10  mg ; atorvastatin  40  mg ; metoprolol tartrate  50  mg ; gabapentin  300  mg ; doxazosin  4  mg ; 
 
black african american m 71 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  146  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  13  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  148  mg dl$senna  8.6  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; hydromorphone (dilaudid)  0.125-0.25  mg ; ranitidine  150  mg ; trazodone  50  mg ; ondansetron  4  mg ; nitroglycerin sl  0.4  mg ; amlodipine  10  mg ; diazepam - ciwa protocol  10  mg ; atorvastatin  40  mg ; metoprolol tartrate  50  mg ; gabapentin  300  mg ; doxazosin  4  mg ; docusate sodium  200  mg ; furosemide  40  mg ; lisinopril  40  mg ; aspirin  325  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; pantoprazole  40  mg ; 
 
black african american m 71 $nan$hematology blood hematocrit  24.7  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  144  k ul; chemistry blood calcium, total  8.6  mg dl$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ranitidine  150  mg ; trazodone  50  mg ; ondansetron  4  mg ; nitroglycerin sl  0.4  mg ; diazepam - ciwa protocol  10  mg ; atorvastatin  40  mg ; gabapentin  300  mg ; doxazosin  4  mg ; docusate sodium  200  mg ; aspirin  325  mg ; pantoprazole  40  mg ; 
 
black african american m 71 $nan$hematology blood hematocrit  21.3  %; hematology blood hematocrit  24.5  %; hematology blood hemoglobin  7.0  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  132  k ul; hematology blood platelet count  148  k ul; hematology urine wbc  0  # hpf$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ranitidine  150  mg ; trazodone  50  mg ; ondansetron  4  mg ; nitroglycerin sl  0.4  mg ; diazepam - ciwa protocol  10  mg ; atorvastatin  40  mg ; gabapentin  300  mg ; doxazosin  4  mg ; docusate sodium  200  mg ; aspirin  325  mg ; pantoprazole  40  mg ; ibuprofen  600  mg ; 
 
black african american m 71 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  176  k ul$senna  8.6  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ranitidine  150  mg ; trazodone  50  mg ; ondansetron  4  mg ; nitroglycerin sl  0.4  mg ; diazepam - ciwa protocol  10  mg ; atorvastatin  40  mg ; gabapentin  300  mg ; doxazosin  4  mg ; docusate sodium  200  mg ; aspirin  325  mg ; pantoprazole  40  mg ; ibuprofen  600  mg ; 
 
white f 92 $temp    heartrate  113.0  resprate  20.0  o2sat  98.0  sbp  126.0  dbp  91.0  rhythm    pain    ; temp    heartrate  145.0  resprate  20.0  o2sat  97.0  sbp  117.0  dbp  65.0  rhythm    pain  0  ; temp  98.7  heartrate  95.0  resprate  20.0  o2sat  96.0  sbp  100.0  dbp  75.0  rhythm    pain  0  $hematology blood hematocrit  45.6  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  147  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  144  mg dl; chemistry blood glucose  157  mg dl; chemistry blood glucose  134  mg dl; chemistry blood glucose  146  mg dl; blood gas blood lactate  2.6  mmol l$heparin  5000  unit ; furosemide  60  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levothyroxine sodium  25  mcg ; insulin  0  unit ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; diltiazem  30  mg ; potassium chloride  20  meq ; furosemide  100  mg ; miconazole powder 2%  1  appl ; diltiazem  45  mg ; diltiazem  15  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; diltiazem  60  mg ; 
 
white f 92 $nan$hematology blood hematocrit  44.1  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  193  mg dl; chemistry blood glucose  133  mg dl$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levothyroxine sodium  25  mcg ; insulin  0  unit ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; furosemide  100  mg ; miconazole powder 2%  1  appl ; diltiazem  15  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; diltiazem  60  mg ; diltiazem  75  mg ; diltiazem  90  mg ; 
 
white f 92 $nan$hematology blood hematocrit  44.2  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  165  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  166  mg dl; chemistry blood glucose  162  mg dl$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levothyroxine sodium  25  mcg ; insulin  0  unit ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; miconazole powder 2%  1  appl ; diltiazem  90  mg ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  12.5  mg ; potassium chloride  60  meq ; 5% dextrose  50  ml ; furosemide  250  mg ; metoprolol tartrate  25  mg ; 
 
white f 92 $nan$hematology blood hematocrit  47.9  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  154  mg dl; chemistry blood glucose  166  mg dl; chemistry blood glucose  142  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levothyroxine sodium  25  mcg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  3  ml ; 5% dextrose  50  ml ; furosemide  250  mg ; metoprolol tartrate  25  mg ; apixaban  5  mg ; metoprolol tartrate  5  mg ; potassium chloride  50  meq ; 5% dextrose  100  ml ; diltiazem  125  mg ; 
 
white f 92 $nan$hematology blood hematocrit  46.0  %; hematology blood hematocrit  47.4  %; hematology blood hemoglobin  13.9  g dl; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  179  k ul; hematology blood platelet count  174  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  235  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levothyroxine sodium  25  mcg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  3  ml ; apixaban  5  mg ; metoprolol tartrate  5  mg ; potassium chloride  50  meq ; metoprolol tartrate  50  mg ; torsemide  40  mg ; 
 
white f 92 $nan$hematology blood hematocrit  47.7  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  155  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levothyroxine sodium  25  mcg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  3  ml ; apixaban  5  mg ; metoprolol tartrate  50  mg ; torsemide  40  mg ; amiodarone  150  mg ; 5% dextrose (excel bag)  500  ml ; amiodarone  600  mg ; 
 
white f 92 $nan$hematology blood hematocrit  44.8  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  174  k ul; chemistry blood anion gap  24  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood urea nitrogen  39  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  171  mg dl; chemistry blood glucose  189  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levothyroxine sodium  25  mcg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  3  ml ; apixaban  5  mg ; metoprolol tartrate  50  mg ; amiodarone  150  mg ; amiodarone  400  mg ; 
 
white f 92 $nan$hematology blood hematocrit  46.1  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  166  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levothyroxine sodium  25  mcg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  3  ml ; apixaban  5  mg ; metoprolol tartrate  50  mg ; amiodarone  400  mg ; diltiazem extended-release  240  mg ; metoprolol succinate xl  200  mg ; 
 
white f 37 $nan$chemistry urine creatinine, urine  89  mg dl; chemistry urine protein creatinine ratio  2.4  mg mg; chemistry urine 24 hr creatinine  1424  mg 24hr$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; prenatal vitamins  1  tab ; syringe  2  ml ; betamethasone na. phos acet  12  mg ; 
 
white f 37 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; prenatal vitamins  1  tab ; syringe  2  ml ; betamethasone na. phos acet  12  mg ; naloxone  40-80  mcg ; naloxone  0.4  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; oxycodone (immediate release)   5-10  mg ; 
 
white f 37 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; naloxone  40-80  mcg ; naloxone  0.4  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; oxycodone (immediate release)   5-10  mg ; 
 
white f 37 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; naloxone  40-80  mcg ; naloxone  0.4  mg ; ondansetron  4  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; oxycodone (immediate release)   5-10  mg ; 
 
white f 37 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; naloxone  40-80  mcg ; naloxone  0.4  mg ; ondansetron  4  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; oxycodone (immediate release)   5-10  mg ; 
 
white f 37 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; naloxone  40-80  mcg ; naloxone  0.4  mg ; ondansetron  4  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; oxycodone (immediate release)   5-10  mg ; 
 
white m 46 $temp  97.9  heartrate  119.0  resprate  22.0  o2sat  99.0  sbp  120.0  dbp  55.0  rhythm    pain  6  ; temp  99.1  heartrate  124.0  resprate  18.0  o2sat  95.0  sbp  116.0  dbp  62.0  rhythm    pain  6  ; temp  98.7  heartrate  112.0  resprate  18.0  o2sat  96.0  sbp  115.0  dbp  62.0  rhythm    pain    $hematology blood hematocrit  33.9  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  751  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood glucose  86  mg dl$nan
insomnia, unspecified gender identity disorder, unspecified major depressive disorder, single episode, unspecified malignant ascites secondary malignant neoplasm of large intestine and rectum gastro-esophageal reflux disease without esophagitis secondary malignant neoplasm of other specified sites hormone replacement therapy secondary malignant neoplasm of retroperitoneum and peritoneum secondary malignant neoplasm of genital organs rosacea, unspecified anxiety disorder, unspecified
white m 46 $temp  97.6  heartrate  110.0  resprate  23.0  o2sat  96.0  sbp  96.0  dbp  78.0  rhythm    pain  6  ; temp    heartrate    resprate    o2sat    sbp  114.0  dbp  82.0  rhythm  sinus tachycardia  pain    $hematology blood hematocrit  34.4  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  783  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  88  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; heparin  5000  unit ; duloxetine  60  mg ; cetirizine  10  mg ; trazodone  50  mg ; bupropion xl (once daily)  150  mg ; hydromorphone (dilaudid)  0.25  mg ; ketorolac  15  mg ; acetaminophen iv  1000  mg ; docusate sodium  100  mg ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.5  mg ; cyclobenzaprine  10  mg ; magnesium oxide  400  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
insomnia, unspecified gender identity disorder, unspecified major depressive disorder, single episode, unspecified malignant ascites secondary malignant neoplasm of large intestine and rectum gastro-esophageal reflux disease without esophagitis secondary malignant neoplasm of other specified sites hormone replacement therapy secondary malignant neoplasm of retroperitoneum and peritoneum secondary malignant neoplasm of genital organs rosacea, unspecified anxiety disorder, unspecified
white m 46 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  695  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  85  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; heparin  5000  unit ; duloxetine  60  mg ; cetirizine  10  mg ; trazodone  50  mg ; bupropion xl (once daily)  150  mg ; docusate sodium  100  mg ; hydromorphone (dilaudid)  0.5  mg ; magnesium oxide  400  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; clonazepam  0.5  mg ; polyethylene glycol  17  g ; lorazepam  0.5  mg ; tramadol  50  mg ; 
insomnia, unspecified gender identity disorder, unspecified major depressive disorder, single episode, unspecified malignant ascites secondary malignant neoplasm of large intestine and rectum gastro-esophageal reflux disease without esophagitis secondary malignant neoplasm of other specified sites hormone replacement therapy secondary malignant neoplasm of retroperitoneum and peritoneum secondary malignant neoplasm of genital organs rosacea, unspecified anxiety disorder, unspecified
white m 46 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  717  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  97  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; duloxetine  60  mg ; cetirizine  10  mg ; trazodone  50  mg ; bupropion xl (once daily)  150  mg ; docusate sodium  100  mg ; clonazepam  0.5  mg ; polyethylene glycol  17  g ; lorazepam  0.5  mg ; tramadol  50  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; lidocaine 1%  5  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; hydromorphone (dilaudid)  0.2-0.6  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; 
insomnia, unspecified gender identity disorder, unspecified major depressive disorder, single episode, unspecified malignant ascites secondary malignant neoplasm of large intestine and rectum gastro-esophageal reflux disease without esophagitis secondary malignant neoplasm of other specified sites hormone replacement therapy secondary malignant neoplasm of retroperitoneum and peritoneum secondary malignant neoplasm of genital organs rosacea, unspecified anxiety disorder, unspecified
white m 46 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  754  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  120  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; duloxetine  60  mg ; cetirizine  10  mg ; trazodone  50  mg ; bupropion xl (once daily)  150  mg ; docusate sodium  100  mg ; clonazepam  0.5  mg ; polyethylene glycol  17  g ; tramadol  50  mg ; ipratropium bromide neb  1  neb ; hydromorphone (dilaudid)  0.2-0.6  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.125  mg ; 
insomnia, unspecified gender identity disorder, unspecified major depressive disorder, single episode, unspecified malignant ascites secondary malignant neoplasm of large intestine and rectum gastro-esophageal reflux disease without esophagitis secondary malignant neoplasm of other specified sites hormone replacement therapy secondary malignant neoplasm of retroperitoneum and peritoneum secondary malignant neoplasm of genital organs rosacea, unspecified anxiety disorder, unspecified
white m 46 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  684  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  93  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; duloxetine  60  mg ; cetirizine  10  mg ; trazodone  50  mg ; bupropion xl (once daily)  150  mg ; docusate sodium  100  mg ; clonazepam  0.5  mg ; polyethylene glycol  17  g ; ipratropium bromide neb  1  neb ; hydromorphone (dilaudid)  0.2-0.6  mg ; oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.125  mg ; lidocaine 5% patch  1  ptch ; bag  1  bag ; magnesium sulfate  2  gm ; lidocaine 1%  20  ml ; 
insomnia, unspecified gender identity disorder, unspecified major depressive disorder, single episode, unspecified malignant ascites secondary malignant neoplasm of large intestine and rectum gastro-esophageal reflux disease without esophagitis secondary malignant neoplasm of other specified sites hormone replacement therapy secondary malignant neoplasm of retroperitoneum and peritoneum secondary malignant neoplasm of genital organs rosacea, unspecified anxiety disorder, unspecified
white m 46 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  692  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  93  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; duloxetine  60  mg ; cetirizine  10  mg ; trazodone  50  mg ; bupropion xl (once daily)  150  mg ; docusate sodium  100  mg ; clonazepam  0.5  mg ; polyethylene glycol  17  g ; oxycodone (immediate release)  5-10  mg ; lidocaine 5% patch  1  ptch ; bag  1  bag ; magnesium sulfate  2  gm ; lidocaine 1%  20  ml ; hydromorphone (dilaudid)  0.5-1  mg ; hydromorphone (dilaudid)  2-4  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 
insomnia, unspecified gender identity disorder, unspecified major depressive disorder, single episode, unspecified malignant ascites secondary malignant neoplasm of large intestine and rectum gastro-esophageal reflux disease without esophagitis secondary malignant neoplasm of other specified sites hormone replacement therapy secondary malignant neoplasm of retroperitoneum and peritoneum secondary malignant neoplasm of genital organs rosacea, unspecified anxiety disorder, unspecified
white m 46 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  692  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  89  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; duloxetine  60  mg ; cetirizine  10  mg ; trazodone  50  mg ; bupropion xl (once daily)  150  mg ; docusate sodium  100  mg ; clonazepam  0.5  mg ; polyethylene glycol  17  g ; hydromorphone (dilaudid)  0.5-1  mg ; hydromorphone (dilaudid)  2-4  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; multivitamins  1  tab ; sodium chloride 0.9%  flush  10-20  ml ; bisacodyl  10  mg ; senna  8.6  mg ; 
insomnia, unspecified gender identity disorder, unspecified major depressive disorder, single episode, unspecified malignant ascites secondary malignant neoplasm of large intestine and rectum gastro-esophageal reflux disease without esophagitis secondary malignant neoplasm of other specified sites hormone replacement therapy secondary malignant neoplasm of retroperitoneum and peritoneum secondary malignant neoplasm of genital organs rosacea, unspecified anxiety disorder, unspecified
white m 46 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  668  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  84  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; duloxetine  60  mg ; cetirizine  10  mg ; trazodone  50  mg ; bupropion xl (once daily)  150  mg ; clonazepam  0.5  mg ; hydromorphone (dilaudid)  2-4  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; multivitamins  1  tab ; sodium chloride 0.9%  flush  10-20  ml ; bisacodyl  10  mg ; senna  8.6  mg ; sodium chloride 0.9%  1000  ml ; prochlorperazine  10  mg ; 0.9% sodium chloride  250  ml ; gemcitabine  1672  mg ; 
insomnia, unspecified gender identity disorder, unspecified major depressive disorder, single episode, unspecified malignant ascites secondary malignant neoplasm of large intestine and rectum gastro-esophageal reflux disease without esophagitis secondary malignant neoplasm of other specified sites hormone replacement therapy secondary malignant neoplasm of retroperitoneum and peritoneum secondary malignant neoplasm of genital organs rosacea, unspecified anxiety disorder, unspecified
white m 46 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  650  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  97  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; duloxetine  60  mg ; cetirizine  10  mg ; trazodone  50  mg ; bupropion xl (once daily)  150  mg ; clonazepam  0.5  mg ; hydromorphone (dilaudid)  2-4  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; multivitamins  1  tab ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  1000  ml ; prochlorperazine  10  mg ; 0.9% sodium chloride  250  ml ; gemcitabine  1672  mg ; lorazepam  0.5-1  mg ; milk of magnesia  30  ml ; senna  17.2  mg ; 
insomnia, unspecified gender identity disorder, unspecified major depressive disorder, single episode, unspecified malignant ascites secondary malignant neoplasm of large intestine and rectum gastro-esophageal reflux disease without esophagitis secondary malignant neoplasm of other specified sites hormone replacement therapy secondary malignant neoplasm of retroperitoneum and peritoneum secondary malignant neoplasm of genital organs rosacea, unspecified anxiety disorder, unspecified
white m 46 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; duloxetine  60  mg ; cetirizine  10  mg ; trazodone  50  mg ; bupropion xl (once daily)  150  mg ; clonazepam  0.5  mg ; hydromorphone (dilaudid)  2-4  mg ; lidocaine 1% (for picc midline insertions)  5  ml ; multivitamins  1  tab ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  250  ml ; gemcitabine  1672  mg ; milk of magnesia  30  ml ; senna  17.2  mg ; 
insomnia, unspecified gender identity disorder, unspecified major depressive disorder, single episode, unspecified malignant ascites secondary malignant neoplasm of large intestine and rectum gastro-esophageal reflux disease without esophagitis secondary malignant neoplasm of other specified sites hormone replacement therapy secondary malignant neoplasm of retroperitoneum and peritoneum secondary malignant neoplasm of genital organs rosacea, unspecified anxiety disorder, unspecified
hispanic latino f 75 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  130  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; morphine sulfate  50  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; senna  1  tab ; milk of magnesia  30  ml ; ondansetron  4  mg ; verapamil  80  mg ; morphine sulfate  2-4  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; multivitamins  1  cap ; vitamin d  400  unit ; prednisone  5  mg ; levothyroxine sodium  100  mcg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; oxycodone (immediate release)   5-10  mg ; iso-osmotic dextrose  50  ml ; clindamycin  600  mg ; enoxaparin sodium  40  mg ; 
 
hispanic latino f 75 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  168  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  141  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; acetaminophen  650  mg ; bisacodyl  10  mg ; senna  1  tab ; milk of magnesia  30  ml ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; multivitamins  1  cap ; vitamin d  400  unit ; prednisone  5  mg ; levothyroxine sodium  100  mcg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; oxycodone (immediate release)   5-10  mg ; iso-osmotic dextrose  50  ml ; clindamycin  600  mg ; enoxaparin sodium  40  mg ; 
 
hispanic latino f 75 $nan$hematology blood hematocrit  25.4  %; hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  169  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood glucose  100  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; acetaminophen  650  mg ; bisacodyl  10  mg ; senna  1  tab ; milk of magnesia  30  ml ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; multivitamins  1  cap ; vitamin d  400  unit ; prednisone  5  mg ; levothyroxine sodium  100  mcg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; oxycodone (immediate release)   5-10  mg ; enoxaparin sodium  40  mg ; 
 
hispanic latino f 75 $nan$nan$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; acetaminophen  650  mg ; bisacodyl  10  mg ; senna  1  tab ; milk of magnesia  30  ml ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; multivitamins  1  cap ; vitamin d  400  unit ; prednisone  5  mg ; levothyroxine sodium  100  mcg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; oxycodone (immediate release)   5-10  mg ; enoxaparin sodium  40  mg ; 
 
white f 40 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  219  k ul; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  340  mg dl$atorvastatin  40  mg ; omeprazole  40  mg ; valsartan  40  mg ; venlafaxine xr  112.5  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; oxycodone-acetaminophen  1-2  tab ; morphine sr (ms contin)  15  mg ; ondansetron  4  mg ; scopolamine patch  1  ptch ; hydromorphone (dilaudid)  12.5  mg ; cepacol (menthol)  1  loz ; docusate sodium  100  mg ; hydromorphone (dilaudid)  0.5-1  mg ; 
 
white f 40 $nan$nan$atorvastatin  40  mg ; omeprazole  40  mg ; valsartan  40  mg ; venlafaxine xr  112.5  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; morphine sr (ms contin)  15  mg ; ondansetron  4  mg ; scopolamine patch  1  ptch ; cepacol (menthol)  1  loz ; docusate sodium  100  mg ; hydromorphone (dilaudid)  0.5-1  mg ; oxycodone-acetaminophen  1  tab ; prochlorperazine  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
 
white f 40 $nan$hematology blood hematocrit  24.4  %; hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  193  k ul; hematology blood platelet count  208  k ul; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  93  mg dl; chemistry blood glucose  108  mg dl$atorvastatin  40  mg ; omeprazole  40  mg ; valsartan  40  mg ; venlafaxine xr  112.5  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; morphine sr (ms contin)  15  mg ; ondansetron  4  mg ; cepacol (menthol)  1  loz ; docusate sodium  100  mg ; oxycodone-acetaminophen  1  tab ; prochlorperazine  10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; levofloxacin  750  mg ; furosemide  10  mg ; guaifenesin  5-10  ml ; albuterol 0.083% neb soln  1  neb ; 
 
white f 40 $nan$nan$atorvastatin  40  mg ; omeprazole  40  mg ; valsartan  40  mg ; venlafaxine xr  112.5  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; morphine sr (ms contin)  15  mg ; ondansetron  4  mg ; cepacol (menthol)  1  loz ; docusate sodium  100  mg ; oxycodone-acetaminophen  1  tab ; prochlorperazine  10  mg ; levofloxacin  750  mg ; furosemide  10  mg ; guaifenesin  5-10  ml ; albuterol 0.083% neb soln  1  neb ; acetaminophen  650  mg ; hydromorphone (dilaudid)  1-2  mg ; ibuprofen  600  mg ; 
 
white f 40 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  272  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood glucose  194  mg dl; blood gas blood hematocrit, calculated  27  %; blood gas blood hemoglobin  9.0  g dl$atorvastatin  40  mg ; omeprazole  40  mg ; valsartan  40  mg ; venlafaxine xr  112.5  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; morphine sr (ms contin)  15  mg ; ondansetron  4  mg ; cepacol (menthol)  1  loz ; docusate sodium  100  mg ; prochlorperazine  10  mg ; levofloxacin  750  mg ; guaifenesin  5-10  ml ; albuterol 0.083% neb soln  1  neb ; acetaminophen  650  mg ; hydromorphone (dilaudid)  1-2  mg ; ibuprofen  600  mg ; piperacillin-tazobactam na  2.25  g ; acetylcysteine 20%  600  mg ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride  250  ml ; vancomycin desensitization  1000  mg ; 
 
white f 40 $nan$hematology blood hematocrit  24.1  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  279  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  236  mg dl$atorvastatin  40  mg ; omeprazole  40  mg ; valsartan  40  mg ; venlafaxine xr  112.5  mg ; sodium chloride 0.9%  flush  3  ml ; morphine sr (ms contin)  15  mg ; ondansetron  4  mg ; cepacol (menthol)  1  loz ; docusate sodium  100  mg ; prochlorperazine  10  mg ; guaifenesin  5-10  ml ; albuterol 0.083% neb soln  1  neb ; acetaminophen  650  mg ; hydromorphone (dilaudid)  1-2  mg ; ibuprofen  600  mg ; piperacillin-tazobactam na  2.25  g ; acetylcysteine 20%  600  mg ; heparin  5000  unit ; 0.9% sodium chloride  250  ml ; vancomycin desensitization  1000  mg ; 
 
white f 40 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  289  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  130  mg dl$atorvastatin  40  mg ; omeprazole  40  mg ; valsartan  40  mg ; venlafaxine xr  112.5  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; cepacol (menthol)  1  loz ; docusate sodium  100  mg ; prochlorperazine  10  mg ; guaifenesin  5-10  ml ; albuterol 0.083% neb soln  1  neb ; acetaminophen  650  mg ; ibuprofen  600  mg ; heparin  5000  unit ; 0.9% sodium chloride  250  ml ; vancomycin desensitization  1000  mg ; 
 
white f 40 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  285  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  112  mg dl$atorvastatin  40  mg ; omeprazole  40  mg ; valsartan  40  mg ; venlafaxine xr  112.5  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; cepacol (menthol)  1  loz ; docusate sodium  100  mg ; prochlorperazine  10  mg ; guaifenesin  5-10  ml ; albuterol 0.083% neb soln  1  neb ; acetaminophen  650  mg ; heparin  5000  unit ; 
 
white f 40 $nan$nan$atorvastatin  40  mg ; omeprazole  40  mg ; valsartan  40  mg ; venlafaxine xr  112.5  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; cepacol (menthol)  1  loz ; docusate sodium  100  mg ; prochlorperazine  10  mg ; guaifenesin  5-10  ml ; albuterol 0.083% neb soln  1  neb ; acetaminophen  650  mg ; heparin  5000  unit ; ondansetron odt  4  mg ; 
 
white m 64 $nan$hematology blood hematocrit  39.5  %$citalopram hydrobromide  20  mg ; lorazepam  0.5-1  mg ; lisinopril  20  mg ; multivitamins  1  tab ; atorvastatin  80  mg ; androgel  2  pkt ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  12.5  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; zolpidem tartrate  5-10  mg ; pantoprazole  40  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; 
 
white m 64 $nan$nan$citalopram hydrobromide  20  mg ; lisinopril  20  mg ; multivitamins  1  tab ; atorvastatin  80  mg ; androgel  2  pkt ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  12.5  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; zolpidem tartrate  5-10  mg ; pantoprazole  40  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; hydromorphone (dilaudid)  2-4  mg ; heparin  5000  unit ; trazodone  25  mg ; fluticasone propionate nasal  1  spry ; 
 
white m 64 $nan$nan$citalopram hydrobromide  20  mg ; lisinopril  20  mg ; multivitamins  1  tab ; atorvastatin  80  mg ; androgel  2  pkt ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; pantoprazole  40  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; hydromorphone (dilaudid)  2-4  mg ; heparin  5000  unit ; trazodone  25  mg ; fluticasone propionate nasal  1  spry ; 
 
white m 20 $temp  98.14  heartrate  82.0  resprate  18.0  o2sat  98.0  sbp  141.0  dbp  74.0  rhythm    pain  3  $nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; ibuprofen  600  mg ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.5  mg ; heparin  5000  unit ; acetaminophen iv  1000  mg ; bacitracin ointment  1  appl ; 
 
white m 20 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ibuprofen  600  mg ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.5  mg ; heparin  5000  unit ; acetaminophen iv  1000  mg ; bacitracin ointment  1  appl ; 
 
white m 58 $temp  97.8  heartrate  81.0  resprate  17.0  o2sat  100.0  sbp  104.0  dbp  72.0  rhythm    pain  0  ; temp  97.8  heartrate  79.0  resprate  15.0  o2sat  95.0  sbp  96.0  dbp  63.0  rhythm    pain  0  $hematology blood hematocrit  27.7  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  495  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.3  ; hematology urine wbc  6  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  82  mg dl$oxycodone sr (oxycontin)  10  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; nystatin oral suspension  5  ml ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
obesity, unspecified long-term (current) use of insulin essential thrombocythemia body mass index 31.0-31.9, adult malignant neoplasm of cardia postsurgical hypoinsulinemia acute kidney failure with lesion of tubular necrosis personal history of antineoplastic chemotherapy leukocytosis, unspecified personal history of tobacco use hypopotassemia other secondary thrombocytopenia personal history of tobacco use antineoplastic chemotherapy induced anemia fever, unspecified diarrhea disorders of magnesium metabolism antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use
white m 58 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  545  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl$oxycodone sr (oxycontin)  10  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; nystatin oral suspension  5  ml ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
obesity, unspecified long-term (current) use of insulin essential thrombocythemia body mass index 31.0-31.9, adult malignant neoplasm of cardia postsurgical hypoinsulinemia acute kidney failure with lesion of tubular necrosis personal history of antineoplastic chemotherapy leukocytosis, unspecified personal history of tobacco use hypopotassemia other secondary thrombocytopenia personal history of tobacco use antineoplastic chemotherapy induced anemia fever, unspecified diarrhea disorders of magnesium metabolism antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use
white m 58 $nan$nan$oxycodone sr (oxycontin)  10  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; nystatin oral suspension  5  ml ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
obesity, unspecified long-term (current) use of insulin essential thrombocythemia body mass index 31.0-31.9, adult malignant neoplasm of cardia postsurgical hypoinsulinemia acute kidney failure with lesion of tubular necrosis personal history of antineoplastic chemotherapy leukocytosis, unspecified personal history of tobacco use hypopotassemia other secondary thrombocytopenia personal history of tobacco use antineoplastic chemotherapy induced anemia fever, unspecified diarrhea disorders of magnesium metabolism antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use
other f 73 $nan$hematology blood hematocrit  31.5  %; chemistry blood chloride  101  meq l; chemistry blood potassium  2.9  meq l; chemistry blood sodium  139  meq l$heparin  5000  unit ; sw  400  ml ; potassium chloride  40  meq ; acetaminophen  1000  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  20  mg ; ondansetron  4  mg ; metoclopramide  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
accidental puncture or laceration during a procedure, not elsewhere classified accidents occurring in residential institution acute posthemorrhagic anemia obstructive sleep apnea (adult)(pediatric) obesity, unspecified nausea alone unspecified essential hypertension accidental cut, puncture, perforation or hemorrhage during surgical operation gastroparesis postprocedural fever body mass index 32.0-32.9, adult infected postoperative seroma malignant neoplasm of corpus uteri, except isthmus dysuria diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled peritoneal abscess surgical operation with formation of external stoma causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation 
other f 73 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  137  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  127  mg dl$heparin  5000  unit ; sw  400  ml ; potassium chloride  40  meq ; acetaminophen  1000  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  20  mg ; ondansetron  4  mg ; metoclopramide  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; bag  1  bag ; magnesium sulfate  2  gm ; sw  200  ml ; potassium chloride  20  meq ; d5 1 2ns  1000  ml ; atenolol  50  mg ; aspirin  81  mg ; amlodipine  2.5  mg ; 
accidental puncture or laceration during a procedure, not elsewhere classified accidents occurring in residential institution acute posthemorrhagic anemia obstructive sleep apnea (adult)(pediatric) obesity, unspecified nausea alone unspecified essential hypertension accidental cut, puncture, perforation or hemorrhage during surgical operation gastroparesis postprocedural fever body mass index 32.0-32.9, adult infected postoperative seroma malignant neoplasm of corpus uteri, except isthmus dysuria diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled peritoneal abscess surgical operation with formation of external stoma causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation 
other f 73 $nan$nan$heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  20  mg ; metoclopramide  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; bag  1  bag ; magnesium sulfate  2  gm ; sw  200  ml ; potassium chloride  20  meq ; d5 1 2ns  1000  ml ; atenolol  50  mg ; aspirin  81  mg ; amlodipine  2.5  mg ; oxycodone (immediate release)   2.5  mg ; calcium carbonate  500  mg ; 
accidental puncture or laceration during a procedure, not elsewhere classified accidents occurring in residential institution acute posthemorrhagic anemia obstructive sleep apnea (adult)(pediatric) obesity, unspecified nausea alone unspecified essential hypertension accidental cut, puncture, perforation or hemorrhage during surgical operation gastroparesis postprocedural fever body mass index 32.0-32.9, adult infected postoperative seroma malignant neoplasm of corpus uteri, except isthmus dysuria diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled peritoneal abscess surgical operation with formation of external stoma causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation 
other f 73 $nan$nan$heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; metoclopramide  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atenolol  50  mg ; aspirin  81  mg ; amlodipine  2.5  mg ; oxycodone (immediate release)   2.5  mg ; calcium carbonate  500  mg ; valsartan  160  mg ; metformin (glucophage)  500  mg ; 
accidental puncture or laceration during a procedure, not elsewhere classified accidents occurring in residential institution acute posthemorrhagic anemia obstructive sleep apnea (adult)(pediatric) obesity, unspecified nausea alone unspecified essential hypertension accidental cut, puncture, perforation or hemorrhage during surgical operation gastroparesis postprocedural fever body mass index 32.0-32.9, adult infected postoperative seroma malignant neoplasm of corpus uteri, except isthmus dysuria diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled peritoneal abscess surgical operation with formation of external stoma causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation 
white m 51 $temp    heartrate  71.0  resprate  23.0  o2sat  78.0  sbp    dbp    rhythm    pain  unable  ; temp    heartrate  72.0  resprate  20.0  o2sat  100.0  sbp  157.0  dbp  96.0  rhythm    pain  unable  ; temp    heartrate  87.0  resprate  24.0  o2sat  87.0  sbp    dbp    rhythm  sinus rhythm  pain  0  ; temp    heartrate  91.0  resprate  28.0  o2sat  100.0  sbp    dbp    rhythm  sinus rhythm  pain  0  ; temp    heartrate  90.0  resprate  24.0  o2sat  99.0  sbp  159.0  dbp  109.0  rhythm  sinus rhythm  pain  0  ; temp    heartrate  56.0  resprate  24.0  o2sat  96.0  sbp  170.0  dbp  84.0  rhythm  sinus bradycardia  pain  0  ; temp    heartrate  62.0  resprate  16.0  o2sat  96.0  sbp  170.0  dbp  84.0  rhythm  sinus rhythm  pain  0  ; temp    heartrate  72.0  resprate  14.0  o2sat  97.0  sbp  143.0  dbp  69.0  rhythm  sinus rhythm  pain  0  ; temp  99.6  heartrate  68.0  resprate  20.0  o2sat  94.0  sbp  93.0  dbp  50.0  rhythm    pain  unable  ; temp    heartrate  67.0  resprate  20.0  o2sat  92.0  sbp  85.0  dbp  43.0  rhythm    pain  unable  ; temp    heartrate  63.0  resprate  20.0  o2sat  97.0  sbp  84.0  dbp  48.0  rhythm    pain  unable  ; temp    heartrate  61.0  resprate  16.0  o2sat  98.0  sbp  88.0  dbp  51.0  rhythm    pain  unable  ; temp    heartrate  63.0  resprate  20.0  o2sat  100.0  sbp  93.0  dbp  50.0  rhythm    pain  unable  ; temp    heartrate  66.0  resprate  20.0  o2sat  100.0  sbp  102.0  dbp  64.0  rhythm    pain  unable  ; temp    heartrate  61.0  resprate  16.0  o2sat  97.0  sbp  80.0  dbp  43.0  rhythm    pain  unable  ; temp    heartrate  60.0  resprate  20.0  o2sat  95.0  sbp  78.0  dbp  33.0  rhythm    pain  unable  ; temp    heartrate  63.0  resprate  13.0  o2sat  100.0  sbp  137.0  dbp  63.0  rhythm    pain  vent  $nan$aspirin  81  mg ; fluoxetine  40  mg ; simvastatin  20  mg ; omeprazole  40  mg ; 
lumbago diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified pain in joint, shoulder region acute on chronic diastolic heart failure morbid obesity other and unspecified hyperlipidemia dermatophytosis of groin and perianal area unspecified essential hypertension tobacco use disorder acute kidney failure, unspecified obstructive chronic bronchitis with (acute) exacerbation anxiety state, unspecified long-term (current) use of insulin venous (peripheral) insufficiency, unspecified personal history of noncompliance with medical treatment, presenting hazards to health gastroparesis body mass index 50.0-59.9, adult other diseases of lung, not elsewhere classified tobacco use disorder personal history of peptic ulcer disease panic disorder without agoraphobia history of fall long-term (current) use of insulin pneumonia, organism unspecified rhabdomyolysis diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled unspecified essential hypertension morbid obesity acute kidney failure, unspecified venous (peripheral) insufficiency, unspecified person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of alcoholism obesity hypoventilation syndrome congestive heart failure, unspecified swelling of limb diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension acute kidney failure, unspecified acute on chronic diastolic heart failure other and unspecified hyperlipidemia morbid obesity major depressive affective disorder, single episode, unspecified congestive heart failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled tobacco use disorder depressive disorder, not elsewhere classified
white m 51 $temp    heartrate  58.0  resprate  10.0  o2sat  100.0  sbp  114.0  dbp  57.0  rhythm    pain  vent  ; temp  98.4  heartrate  59.0  resprate  15.0  o2sat  99.0  sbp  105.0  dbp  52.0  rhythm    pain    ; temp    heartrate  59.0  resprate  18.0  o2sat  96.0  sbp  105.0  dbp  56.0  rhythm    pain    $hematology blood hematocrit  37.7  %; hematology blood hematocrit  39.9  %; hematology blood hemoglobin  11.9  g dl; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  250  k ul; hematology blood platelet count  241  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  89  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  54  mg dl; chemistry blood urea nitrogen  57  mg dl; chemistry blood urea nitrogen  52  mg dl; chemistry urine creatinine, urine  24  mg dl; chemistry urine potassium, urine  10  meq l; chemistry urine sodium, urine  13  meq l; chemistry urine urea nitrogen, urine  427  mg dl; hematology urine wbc  63  # hpf; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  133  mg dl; chemistry blood glucose  224  mg dl; chemistry blood glucose  98  mg dl; blood gas blood lactate  0.6  mmol l$aspirin  81  mg ; fluoxetine  40  mg ; simvastatin  20  mg ; omeprazole  40  mg ; heparin  5000  unit ; 5% dextrose  500  ml ; vancomycin  1500  mg ; lidocaine jelly 2% (urojet)  1  appl ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; miconazole powder 2%  1  appl ; albuterol inhaler  2-4  puff ; ipratropium bromide mdi  2  puff ; d10w  1000  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; methylprednisolone sodium succ  60  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; heparin flush (10 units ml)  2  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; nicotine patch  14  mg ; 
lumbago diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified pain in joint, shoulder region acute on chronic diastolic heart failure morbid obesity other and unspecified hyperlipidemia dermatophytosis of groin and perianal area unspecified essential hypertension tobacco use disorder acute kidney failure, unspecified obstructive chronic bronchitis with (acute) exacerbation anxiety state, unspecified long-term (current) use of insulin venous (peripheral) insufficiency, unspecified personal history of noncompliance with medical treatment, presenting hazards to health gastroparesis body mass index 50.0-59.9, adult other diseases of lung, not elsewhere classified tobacco use disorder personal history of peptic ulcer disease panic disorder without agoraphobia history of fall long-term (current) use of insulin pneumonia, organism unspecified rhabdomyolysis diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled unspecified essential hypertension morbid obesity acute kidney failure, unspecified venous (peripheral) insufficiency, unspecified person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of alcoholism obesity hypoventilation syndrome congestive heart failure, unspecified swelling of limb diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension acute kidney failure, unspecified acute on chronic diastolic heart failure other and unspecified hyperlipidemia morbid obesity major depressive affective disorder, single episode, unspecified congestive heart failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled tobacco use disorder depressive disorder, not elsewhere classified
white m 51 $nan$hematology blood hematocrit  37.3  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  52  mg dl; chemistry blood urea nitrogen  46  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  148  mg dl; chemistry blood glucose  203  mg dl$aspirin  81  mg ; fluoxetine  40  mg ; simvastatin  20  mg ; omeprazole  40  mg ; heparin  5000  unit ; 5% dextrose  500  ml ; vancomycin  1500  mg ; lidocaine jelly 2% (urojet)  1  appl ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; miconazole powder 2%  1  appl ; albuterol inhaler  2-4  puff ; ipratropium bromide mdi  2  puff ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; methylprednisolone sodium succ  60  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; heparin flush (10 units ml)  2  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; nicotine patch  14  mg ; furosemide  60  mg ; alteplase 1mg 1ml ( clearance ie. temp tlcl )  1  mg ; lorazepam  0.5  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; 
lumbago diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified pain in joint, shoulder region acute on chronic diastolic heart failure morbid obesity other and unspecified hyperlipidemia dermatophytosis of groin and perianal area unspecified essential hypertension tobacco use disorder acute kidney failure, unspecified obstructive chronic bronchitis with (acute) exacerbation anxiety state, unspecified long-term (current) use of insulin venous (peripheral) insufficiency, unspecified personal history of noncompliance with medical treatment, presenting hazards to health gastroparesis body mass index 50.0-59.9, adult other diseases of lung, not elsewhere classified tobacco use disorder personal history of peptic ulcer disease panic disorder without agoraphobia history of fall long-term (current) use of insulin pneumonia, organism unspecified rhabdomyolysis diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled unspecified essential hypertension morbid obesity acute kidney failure, unspecified venous (peripheral) insufficiency, unspecified person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of alcoholism obesity hypoventilation syndrome congestive heart failure, unspecified swelling of limb diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension acute kidney failure, unspecified acute on chronic diastolic heart failure other and unspecified hyperlipidemia morbid obesity major depressive affective disorder, single episode, unspecified congestive heart failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled tobacco use disorder depressive disorder, not elsewhere classified
white m 51 $nan$hematology blood hematocrit  42.8  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  43  mg dl; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  166  mg dl; hematology urine glucose  1000  mg dl$aspirin  81  mg ; fluoxetine  40  mg ; simvastatin  20  mg ; omeprazole  40  mg ; heparin  5000  unit ; 5% dextrose  500  ml ; vancomycin  1500  mg ; miconazole powder 2%  1  appl ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; methylprednisolone sodium succ  60  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; heparin flush (10 units ml)  2  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; nicotine patch  14  mg ; furosemide  60  mg ; alteplase 1mg 1ml ( clearance ie. temp tlcl )  1  mg ; lorazepam  0.5  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; metoprolol tartrate  25  mg ; methadone  20  mg ; prednisone  40  mg ; torsemide  80  mg ; sodium chloride 0.9%  flush  3  ml ; 
lumbago diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified pain in joint, shoulder region acute on chronic diastolic heart failure morbid obesity other and unspecified hyperlipidemia dermatophytosis of groin and perianal area unspecified essential hypertension tobacco use disorder acute kidney failure, unspecified obstructive chronic bronchitis with (acute) exacerbation anxiety state, unspecified long-term (current) use of insulin venous (peripheral) insufficiency, unspecified personal history of noncompliance with medical treatment, presenting hazards to health gastroparesis body mass index 50.0-59.9, adult other diseases of lung, not elsewhere classified tobacco use disorder personal history of peptic ulcer disease panic disorder without agoraphobia history of fall long-term (current) use of insulin pneumonia, organism unspecified rhabdomyolysis diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled unspecified essential hypertension morbid obesity acute kidney failure, unspecified venous (peripheral) insufficiency, unspecified person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of alcoholism obesity hypoventilation syndrome congestive heart failure, unspecified swelling of limb diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension acute kidney failure, unspecified acute on chronic diastolic heart failure other and unspecified hyperlipidemia morbid obesity major depressive affective disorder, single episode, unspecified congestive heart failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled tobacco use disorder depressive disorder, not elsewhere classified
white m 51 $nan$hematology blood hematocrit  42.9  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  239  mg dl$aspirin  81  mg ; fluoxetine  40  mg ; simvastatin  20  mg ; omeprazole  40  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (10 units ml)  2  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; nicotine patch  14  mg ; lorazepam  0.5  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; metoprolol tartrate  25  mg ; methadone  20  mg ; prednisone  40  mg ; torsemide  80  mg ; sodium chloride 0.9%  flush  3  ml ; fluticasone-salmeterol diskus (100 50)  1  inh ; acetaminophen  325-650  mg ; methadone  10  mg ; insulin  40  unit ; metoprolol succinate xl  125  mg ; vitamin d  1000  unit ; gabapentin  600  mg ; trazodone  50  mg ; 
lumbago diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified pain in joint, shoulder region acute on chronic diastolic heart failure morbid obesity other and unspecified hyperlipidemia dermatophytosis of groin and perianal area unspecified essential hypertension tobacco use disorder acute kidney failure, unspecified obstructive chronic bronchitis with (acute) exacerbation anxiety state, unspecified long-term (current) use of insulin venous (peripheral) insufficiency, unspecified personal history of noncompliance with medical treatment, presenting hazards to health gastroparesis body mass index 50.0-59.9, adult other diseases of lung, not elsewhere classified tobacco use disorder personal history of peptic ulcer disease panic disorder without agoraphobia history of fall long-term (current) use of insulin pneumonia, organism unspecified rhabdomyolysis diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled unspecified essential hypertension morbid obesity acute kidney failure, unspecified venous (peripheral) insufficiency, unspecified person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of alcoholism obesity hypoventilation syndrome congestive heart failure, unspecified swelling of limb diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension acute kidney failure, unspecified acute on chronic diastolic heart failure other and unspecified hyperlipidemia morbid obesity major depressive affective disorder, single episode, unspecified congestive heart failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled tobacco use disorder depressive disorder, not elsewhere classified
white m 51 $nan$hematology blood hematocrit  43.8  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  141  mg dl$aspirin  81  mg ; fluoxetine  40  mg ; simvastatin  20  mg ; omeprazole  40  mg ; heparin  5000  unit ; miconazole powder 2%  1  appl ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin flush (10 units ml)  2  ml ; nicotine patch  14  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; methadone  20  mg ; torsemide  80  mg ; sodium chloride 0.9%  flush  3  ml ; fluticasone-salmeterol diskus (100 50)  1  inh ; acetaminophen  325-650  mg ; methadone  10  mg ; insulin  40  unit ; metoprolol succinate xl  125  mg ; vitamin d  1000  unit ; gabapentin  600  mg ; trazodone  50  mg ; metformin (glucophage)  1000  mg ; prednisone  20  mg ; 
lumbago diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified pain in joint, shoulder region acute on chronic diastolic heart failure morbid obesity other and unspecified hyperlipidemia dermatophytosis of groin and perianal area unspecified essential hypertension tobacco use disorder acute kidney failure, unspecified obstructive chronic bronchitis with (acute) exacerbation anxiety state, unspecified long-term (current) use of insulin venous (peripheral) insufficiency, unspecified personal history of noncompliance with medical treatment, presenting hazards to health gastroparesis body mass index 50.0-59.9, adult other diseases of lung, not elsewhere classified tobacco use disorder personal history of peptic ulcer disease panic disorder without agoraphobia history of fall long-term (current) use of insulin pneumonia, organism unspecified rhabdomyolysis diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled unspecified essential hypertension morbid obesity acute kidney failure, unspecified venous (peripheral) insufficiency, unspecified person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of alcoholism obesity hypoventilation syndrome congestive heart failure, unspecified swelling of limb diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension acute kidney failure, unspecified acute on chronic diastolic heart failure other and unspecified hyperlipidemia morbid obesity major depressive affective disorder, single episode, unspecified congestive heart failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled tobacco use disorder depressive disorder, not elsewhere classified
white f 24 $nan$nan$acetaminophen  1000  mg ; gabapentin  300  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; ibuprofen  400  mg ; dicyclomine  20  mg ; hydroxyzine  50  mg ; venlafaxine  37.5  mg ; clonidine patch 0.1 mg 24 hr  1  ptch ; clonidine patch 0.1 mg 24 hr  2  ptch ; nicotine polacrilex  2  mg ; gabapentin  100  mg ; quetiapine fumarate  25  mg ; quetiapine fumarate  50  mg ; mirtazapine  15  mg ; mirtazapine  30  mg ; 
unspecified episodic mood disorder driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident other family disruption lack of housing opioid type dependence, unspecified 
white f 24 $nan$chemistry blood bilirubin, total  0.2  mg dl; chemistry blood albumin  4.1  g dl$acetaminophen  1000  mg ; gabapentin  300  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; ibuprofen  400  mg ; dicyclomine  20  mg ; hydroxyzine  50  mg ; venlafaxine  37.5  mg ; clonidine patch 0.1 mg 24 hr  2  ptch ; nicotine polacrilex  2  mg ; gabapentin  100  mg ; quetiapine fumarate  50  mg ; mirtazapine  30  mg ; quetiapine fumarate  100  mg ; naltrexone  50  mg ; 
unspecified episodic mood disorder driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident other family disruption lack of housing opioid type dependence, unspecified 
white f 24 $nan$nan$milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; ibuprofen  400  mg ; dicyclomine  20  mg ; hydroxyzine  50  mg ; venlafaxine  37.5  mg ; clonidine patch 0.1 mg 24 hr  2  ptch ; gabapentin  100  mg ; mirtazapine  30  mg ; quetiapine fumarate  100  mg ; naltrexone  50  mg ; 
unspecified episodic mood disorder driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident other family disruption lack of housing opioid type dependence, unspecified 
white f 24 $nan$nan$milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; ibuprofen  400  mg ; dicyclomine  20  mg ; hydroxyzine  50  mg ; clonidine patch 0.1 mg 24 hr  2  ptch ; mirtazapine  30  mg ; quetiapine fumarate  100  mg ; naltrexone  50  mg ; 
unspecified episodic mood disorder driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident other family disruption lack of housing opioid type dependence, unspecified 
white f 70 $temp  98.2  heartrate  63.0  resprate  18.0  o2sat  99.0  sbp  114.0  dbp  51.0  rhythm    pain  6  ; temp  98.2  heartrate  67.0  resprate  18.0  o2sat  100.0  sbp  116.0  dbp  62.0  rhythm    pain    ; temp    heartrate  67.0  resprate  15.0  o2sat  98.0  sbp  112.0  dbp  67.0  rhythm    pain    $nan$insulin  6  unit ; 
urinary tract infection, site not specified acute kidney failure, unspecified takotsubo syndrome diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anemia of other chronic disease other and unspecified hyperlipidemia volume depletion, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of insulin chronic kidney disease, stage iv (severe) insulins and antidiabetic agents causing adverse effects in therapeutic use lumbago abdominal pain, left lower quadrant spinal stenosis, unspecified region hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled other chronic pain thrombocytopenia, unspecified other and unspecified anti-infectives causing adverse effects in therapeutic use anemia, unspecified acute kidney failure, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site pyelonephritis, unspecified other postprocedural status chronic kidney disease, unspecified knee joint replacement constipation, unspecified other acute pain spinal stenosis, unspecified region escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site acute pyelonephritis without lesion of renal medullary necrosis sciatica bacteremia acute kidney failure, unspecified acidosis anemia, unspecified knee joint replacement pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled other chronic pain scoliosis [and kyphoscoliosis], idiopathic hyposmolality and/or hyponatremia unspecified essential hypertension 
white f 70 $temp  97.8  heartrate  66.0  resprate  16.0  o2sat    sbp  133.0  dbp  69.0  rhythm    pain    $hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  448  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  9  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.0  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  79  mg dl; chemistry blood urea nitrogen  68  mg dl; chemistry urine chloride, urine  36  meq l; chemistry urine creatinine, urine  41  mg dl; chemistry urine potassium, urine  18  meq l; chemistry urine sodium, urine  46  meq l; chemistry urine urea nitrogen, urine  487  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  76  mg dl; chemistry blood glucose  118  mg dl; chemistry urine protein creatinine ratio  0.5  ratio; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  0.9  mmol l; chemistry urine albumin, urine  8.2  mg dl; chemistry urine albumin creatinine, urine  200.0  mg g$insulin  6  unit ; docusate sodium  100  mg ; heparin  5000  unit ; metoprolol tartrate  12.5  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone (immediate release)   5  mg ; ondansetron  4-8  mg ; insulin  0  unit ; hydroxyzine  25  mg ; insulin  12  unit ; sarna lotion  1  appl ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; ranitidine  150  mg ; maalox lidocaine  15  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; ciprofloxacin hcl  250  mg ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; 
urinary tract infection, site not specified acute kidney failure, unspecified takotsubo syndrome diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anemia of other chronic disease other and unspecified hyperlipidemia volume depletion, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of insulin chronic kidney disease, stage iv (severe) insulins and antidiabetic agents causing adverse effects in therapeutic use lumbago abdominal pain, left lower quadrant spinal stenosis, unspecified region hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled other chronic pain thrombocytopenia, unspecified other and unspecified anti-infectives causing adverse effects in therapeutic use anemia, unspecified acute kidney failure, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site pyelonephritis, unspecified other postprocedural status chronic kidney disease, unspecified knee joint replacement constipation, unspecified other acute pain spinal stenosis, unspecified region escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site acute pyelonephritis without lesion of renal medullary necrosis sciatica bacteremia acute kidney failure, unspecified acidosis anemia, unspecified knee joint replacement pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled other chronic pain scoliosis [and kyphoscoliosis], idiopathic hyposmolality and/or hyponatremia unspecified essential hypertension 
white f 70 $nan$hematology blood hematocrit  26.6  %; hematology blood hematocrit  29.6  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  395  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  59  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  86  mg dl$insulin  6  unit ; docusate sodium  100  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone (immediate release)   5  mg ; ondansetron  4-8  mg ; insulin  0  unit ; insulin  12  unit ; sarna lotion  1  appl ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; ranitidine  150  mg ; maalox lidocaine  15  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; ciprofloxacin hcl  250  mg ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  20  meq ; polyethylene glycol  17  g ; 
urinary tract infection, site not specified acute kidney failure, unspecified takotsubo syndrome diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anemia of other chronic disease other and unspecified hyperlipidemia volume depletion, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of insulin chronic kidney disease, stage iv (severe) insulins and antidiabetic agents causing adverse effects in therapeutic use lumbago abdominal pain, left lower quadrant spinal stenosis, unspecified region hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled other chronic pain thrombocytopenia, unspecified other and unspecified anti-infectives causing adverse effects in therapeutic use anemia, unspecified acute kidney failure, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site pyelonephritis, unspecified other postprocedural status chronic kidney disease, unspecified knee joint replacement constipation, unspecified other acute pain spinal stenosis, unspecified region escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site acute pyelonephritis without lesion of renal medullary necrosis sciatica bacteremia acute kidney failure, unspecified acidosis anemia, unspecified knee joint replacement pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled other chronic pain scoliosis [and kyphoscoliosis], idiopathic hyposmolality and/or hyponatremia unspecified essential hypertension 
white f 70 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  420  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  79  mg dl$insulin  6  unit ; docusate sodium  100  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone (immediate release)   5  mg ; ondansetron  4-8  mg ; insulin  0  unit ; insulin  12  unit ; sarna lotion  1  appl ; ranitidine  150  mg ; ciprofloxacin hcl  250  mg ; potassium chloride  20  meq ; polyethylene glycol  17  g ; bisacodyl  10  mg ; 
urinary tract infection, site not specified acute kidney failure, unspecified takotsubo syndrome diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anemia of other chronic disease other and unspecified hyperlipidemia volume depletion, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of insulin chronic kidney disease, stage iv (severe) insulins and antidiabetic agents causing adverse effects in therapeutic use lumbago abdominal pain, left lower quadrant spinal stenosis, unspecified region hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled other chronic pain thrombocytopenia, unspecified other and unspecified anti-infectives causing adverse effects in therapeutic use anemia, unspecified acute kidney failure, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site pyelonephritis, unspecified other postprocedural status chronic kidney disease, unspecified knee joint replacement constipation, unspecified other acute pain spinal stenosis, unspecified region escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site acute pyelonephritis without lesion of renal medullary necrosis sciatica bacteremia acute kidney failure, unspecified acidosis anemia, unspecified knee joint replacement pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled other chronic pain scoliosis [and kyphoscoliosis], idiopathic hyposmolality and/or hyponatremia unspecified essential hypertension 
white f 70 $nan$nan$insulin  6  unit ; docusate sodium  100  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone (immediate release)   5  mg ; ondansetron  4-8  mg ; insulin  0  unit ; insulin  12  unit ; sarna lotion  1  appl ; ranitidine  150  mg ; ciprofloxacin hcl  250  mg ; bisacodyl  10  mg ; 
urinary tract infection, site not specified acute kidney failure, unspecified takotsubo syndrome diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anemia of other chronic disease other and unspecified hyperlipidemia volume depletion, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of insulin chronic kidney disease, stage iv (severe) insulins and antidiabetic agents causing adverse effects in therapeutic use lumbago abdominal pain, left lower quadrant spinal stenosis, unspecified region hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled other chronic pain thrombocytopenia, unspecified other and unspecified anti-infectives causing adverse effects in therapeutic use anemia, unspecified acute kidney failure, unspecified escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site pyelonephritis, unspecified other postprocedural status chronic kidney disease, unspecified knee joint replacement constipation, unspecified other acute pain spinal stenosis, unspecified region escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site acute pyelonephritis without lesion of renal medullary necrosis sciatica bacteremia acute kidney failure, unspecified acidosis anemia, unspecified knee joint replacement pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled other chronic pain scoliosis [and kyphoscoliosis], idiopathic hyposmolality and/or hyponatremia unspecified essential hypertension 
white m 80 $nan$nan$omeprazole  20  mg ; spironolactone  25  mg ; valsartan  320  mg ; aspirin  81  mg ; 
 
white m 80 $nan$nan$omeprazole  20  mg ; spironolactone  25  mg ; valsartan  320  mg ; aspirin  81  mg ; acetaminophen  650  mg ; nitroglycerin sl  0.3  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; cephalexin  500  mg ; metoprolol tartrate  25  mg ; atorvastatin  20  mg ; ibuprofen  600  mg ; 
 
white m 80 $nan$nan$omeprazole  20  mg ; spironolactone  25  mg ; valsartan  320  mg ; aspirin  81  mg ; acetaminophen  650  mg ; nitroglycerin sl  0.3  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; cephalexin  500  mg ; metoprolol tartrate  25  mg ; atorvastatin  20  mg ; ibuprofen  600  mg ; 
 
white m 50 $nan$nan$aripiprazole  10  mg ; psyllium  1  pkt ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure ventilator associated pneumonia hypoxemia gastrostomy status acute and chronic respiratory failure fever, unspecified unspecified essential hypertension late effect of spinal cord injury car driver injured in collision with heavy transport vehicle or bus in nontraffic accident tracheostomy status pressure ulcer, lower back bipolar disorder, unspecified personal history of venous thrombosis and embolism anxiety state, unspecified car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident pneumonia, organism unspecified dependence on respirator, status unspecified pleural effusion pressure ulcer, stage ii quadriplegia, unspecified late effects of motor vehicle accident car passenger injured in collision with van in traffic accident injury to other intra-abdominal organs without mention of open wound into cavity, peritoneum injury to liver without mention of open wound into cavity laceration, unspecified urinary tract infection, site not specified closed fracture of c1-c4 level with complete lesion of cord closed fracture of subtrochanteric section of neck of femur motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle iatrogenic pulmonary embolism and infarction hip joint replacement unspecified essential hypertension closed fracture of shaft of femur bipolar disorder, unspecified acute respiratory failure closed fracture of three ribs traumatic shock ventilator associated pneumonia acute venous embolism and thrombosis of deep vessels of proximal lower extremity
white m 50 $nan$hematology blood inr(pt)  2.2  $aripiprazole  10  mg ; psyllium  1  pkt ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; senna  1  tab ; famotidine  20  mg ; ondansetron  4  mg ; acetaminophen  500-1000  mg ; albuterol 0.083% neb soln  1  neb ; bisacodyl  5  mg ; miconazole powder 2%  1  appl ; tramadol (ultram)  50  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; lorazepam  1  mg ; calcium carbonate  500  mg ; theophylline (oral solution)  80  mg ; trazodone  200  mg ; baclofen  20  mg ; paroxetine  40  mg ; quetiapine fumarate  100  mg ; baclofen  15  mg ; alendronate sodium  70  mg ; methylphenidate (ritalin)  2.5  mg ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure ventilator associated pneumonia hypoxemia gastrostomy status acute and chronic respiratory failure fever, unspecified unspecified essential hypertension late effect of spinal cord injury car driver injured in collision with heavy transport vehicle or bus in nontraffic accident tracheostomy status pressure ulcer, lower back bipolar disorder, unspecified personal history of venous thrombosis and embolism anxiety state, unspecified car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident pneumonia, organism unspecified dependence on respirator, status unspecified pleural effusion pressure ulcer, stage ii quadriplegia, unspecified late effects of motor vehicle accident car passenger injured in collision with van in traffic accident injury to other intra-abdominal organs without mention of open wound into cavity, peritoneum injury to liver without mention of open wound into cavity laceration, unspecified urinary tract infection, site not specified closed fracture of c1-c4 level with complete lesion of cord closed fracture of subtrochanteric section of neck of femur motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle iatrogenic pulmonary embolism and infarction hip joint replacement unspecified essential hypertension closed fracture of shaft of femur bipolar disorder, unspecified acute respiratory failure closed fracture of three ribs traumatic shock ventilator associated pneumonia acute venous embolism and thrombosis of deep vessels of proximal lower extremity
white m 50 $nan$nan$aripiprazole  10  mg ; psyllium  1  pkt ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; senna  1  tab ; famotidine  20  mg ; ondansetron  4  mg ; acetaminophen  500-1000  mg ; albuterol 0.083% neb soln  1  neb ; bisacodyl  5  mg ; miconazole powder 2%  1  appl ; tramadol (ultram)  50  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; lorazepam  1  mg ; calcium carbonate  500  mg ; theophylline (oral solution)  80  mg ; trazodone  200  mg ; baclofen  20  mg ; paroxetine  40  mg ; quetiapine fumarate  100  mg ; baclofen  15  mg ; alendronate sodium  70  mg ; methylphenidate (ritalin)  2.5  mg ; 0.9% sodium chloride  500  ml ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure ventilator associated pneumonia hypoxemia gastrostomy status acute and chronic respiratory failure fever, unspecified unspecified essential hypertension late effect of spinal cord injury car driver injured in collision with heavy transport vehicle or bus in nontraffic accident tracheostomy status pressure ulcer, lower back bipolar disorder, unspecified personal history of venous thrombosis and embolism anxiety state, unspecified car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident pneumonia, organism unspecified dependence on respirator, status unspecified pleural effusion pressure ulcer, stage ii quadriplegia, unspecified late effects of motor vehicle accident car passenger injured in collision with van in traffic accident injury to other intra-abdominal organs without mention of open wound into cavity, peritoneum injury to liver without mention of open wound into cavity laceration, unspecified urinary tract infection, site not specified closed fracture of c1-c4 level with complete lesion of cord closed fracture of subtrochanteric section of neck of femur motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle iatrogenic pulmonary embolism and infarction hip joint replacement unspecified essential hypertension closed fracture of shaft of femur bipolar disorder, unspecified acute respiratory failure closed fracture of three ribs traumatic shock ventilator associated pneumonia acute venous embolism and thrombosis of deep vessels of proximal lower extremity
white m 50 $nan$hematology blood inr(pt)  1.4  $aripiprazole  10  mg ; psyllium  1  pkt ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; senna  1  tab ; famotidine  20  mg ; ondansetron  4  mg ; acetaminophen  500-1000  mg ; albuterol 0.083% neb soln  1  neb ; bisacodyl  5  mg ; miconazole powder 2%  1  appl ; tramadol (ultram)  50  mg ; lorazepam  1  mg ; calcium carbonate  500  mg ; theophylline (oral solution)  80  mg ; trazodone  200  mg ; baclofen  20  mg ; paroxetine  40  mg ; quetiapine fumarate  100  mg ; baclofen  15  mg ; alendronate sodium  70  mg ; methylphenidate (ritalin)  2.5  mg ; 0.9% sodium chloride  500  ml ; warfarin  0.5  mg ; warfarin  10  mg ; 
other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure ventilator associated pneumonia hypoxemia gastrostomy status acute and chronic respiratory failure fever, unspecified unspecified essential hypertension late effect of spinal cord injury car driver injured in collision with heavy transport vehicle or bus in nontraffic accident tracheostomy status pressure ulcer, lower back bipolar disorder, unspecified personal history of venous thrombosis and embolism anxiety state, unspecified car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident pneumonia, organism unspecified dependence on respirator, status unspecified pleural effusion pressure ulcer, stage ii quadriplegia, unspecified late effects of motor vehicle accident car passenger injured in collision with van in traffic accident injury to other intra-abdominal organs without mention of open wound into cavity, peritoneum injury to liver without mention of open wound into cavity laceration, unspecified urinary tract infection, site not specified closed fracture of c1-c4 level with complete lesion of cord closed fracture of subtrochanteric section of neck of femur motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle iatrogenic pulmonary embolism and infarction hip joint replacement unspecified essential hypertension closed fracture of shaft of femur bipolar disorder, unspecified acute respiratory failure closed fracture of three ribs traumatic shock ventilator associated pneumonia acute venous embolism and thrombosis of deep vessels of proximal lower extremity
white m 71 $temp  96.8  heartrate  94.0  resprate  16.0  o2sat  98.0  sbp  99.0  dbp  60.0  rhythm    pain  8  ; temp    heartrate  91.0  resprate  15.0  o2sat  98.0  sbp  100.0  dbp  58.0  rhythm    pain    ; temp    heartrate  85.0  resprate  15.0  o2sat  98.0  sbp  96.0  dbp  61.0  rhythm    pain  8  ; temp  97.9  heartrate  88.0  resprate  14.0  o2sat  93.0  sbp  113.0  dbp  67.0  rhythm    pain    ; temp    heartrate  85.0  resprate  14.0  o2sat  94.0  sbp  105.0  dbp  64.0  rhythm    pain  sleeping  ; temp    heartrate  89.0  resprate  15.0  o2sat  93.0  sbp  108.0  dbp  70.0  rhythm    pain  sleeping  ; temp    heartrate  94.0  resprate  17.0  o2sat  96.0  sbp  103.0  dbp  51.0  rhythm    pain  sleeping  ; temp  97.7  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    ; temp    heartrate  90.0  resprate  16.0  o2sat  93.0  sbp  99.0  dbp  64.0  rhythm    pain  sleeping  ; temp  97.3  heartrate  87.0  resprate  14.0  o2sat  96.0  sbp  107.0  dbp  65.0  rhythm    pain  0  ; temp    heartrate  83.0  resprate  14.0  o2sat  94.0  sbp  109.0  dbp  68.0  rhythm    pain  sleeping  $hematology blood hematocrit  21.7  %; hematology blood hemoglobin  6.7  g dl; hematology blood platelet count  414  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  144  mg dl; chemistry blood albumin  2.1  g dl; blood gas blood lactate  2.1  mmol l$nadolol  10  mg ; 
anemia in neoplastic disease essential (primary) hypertension secondary malignant neoplasm of right lung malignant ascites encounter for palliative care personal history of pulmonary embolism acute kidney failure, unspecified other retention of urine secondary malignant neoplasm of left lung gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia with lower urinary tract symptoms atherosclerotic heart disease of native coronary artery without angina pectoris personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified protein-calorie malnutrition family history of malignant neoplasm of kidney secondary malignant neoplasm of unspecified adrenal gland anxiety disorder, unspecified body mass index (bmi) 25.0-25.9, adult personal history of other malignant neoplasm of kidney secondary malignant neoplasm of retroperitoneum and peritoneum fall on stairs or ladders in water transport injuring unspecified person presence of coronary angioplasty implant and graft secondary malignant neoplasm of liver and intrahepatic bile duct neoplasm related pain (acute) (chronic) secondary malignant neoplasm of other digestive organs long term (current) use of antithrombotics/antiplatelets other disorders of phosphorus metabolism secondary malignant neoplasm of other specified sites personal history of pulmonary embolism essential (primary) hypertension unspecified protein-calorie malnutrition neoplasm related pain (acute) (chronic) benign prostatic hyperplasia with lower urinary tract symptoms secondary malignant neoplasm of other digestive organs constipation, unspecified presence of coronary angioplasty implant and graft secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris secondary malignant neoplasm of liver and intrahepatic bile duct personal history of other malignant neoplasm of kidney long term (current) use of anticoagulants secondary malignant neoplasm of bone hypercalcemia other ascites other retention of urine other and unspecified fall in water transport injuring occupant of other watercraft -- crew toxic encephalopathy gastro-esophageal reflux disease without esophagitis
white m 71 $nan$hematology blood hematocrit  27.2  %; hematology blood hematocrit  28.2  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  401  k ul; hematology blood platelet count  409  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  142  mg dl; chemistry blood lactate dehydrogenase (ld)  169  iu l$nadolol  10  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  500  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; ondansetron  4  mg ; vial  1  vial ; ceftriaxone  1  gm ; pantoprazole  40  mg ; atorvastatin  40  mg ; finasteride  5  mg ; lorazepam  1  mg ; meclizine  25  mg ; multivitamins w minerals  1  tab ; oxycodone (immediate release)  5  mg ; tamsulosin  0.8  mg ; prochlorperazine  10  mg ; bisacodyl  10  mg ; aspirin  81  mg ; 
anemia in neoplastic disease essential (primary) hypertension secondary malignant neoplasm of right lung malignant ascites encounter for palliative care personal history of pulmonary embolism acute kidney failure, unspecified other retention of urine secondary malignant neoplasm of left lung gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia with lower urinary tract symptoms atherosclerotic heart disease of native coronary artery without angina pectoris personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified protein-calorie malnutrition family history of malignant neoplasm of kidney secondary malignant neoplasm of unspecified adrenal gland anxiety disorder, unspecified body mass index (bmi) 25.0-25.9, adult personal history of other malignant neoplasm of kidney secondary malignant neoplasm of retroperitoneum and peritoneum fall on stairs or ladders in water transport injuring unspecified person presence of coronary angioplasty implant and graft secondary malignant neoplasm of liver and intrahepatic bile duct neoplasm related pain (acute) (chronic) secondary malignant neoplasm of other digestive organs long term (current) use of antithrombotics/antiplatelets other disorders of phosphorus metabolism secondary malignant neoplasm of other specified sites personal history of pulmonary embolism essential (primary) hypertension unspecified protein-calorie malnutrition neoplasm related pain (acute) (chronic) benign prostatic hyperplasia with lower urinary tract symptoms secondary malignant neoplasm of other digestive organs constipation, unspecified presence of coronary angioplasty implant and graft secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris secondary malignant neoplasm of liver and intrahepatic bile duct personal history of other malignant neoplasm of kidney long term (current) use of anticoagulants secondary malignant neoplasm of bone hypercalcemia other ascites other retention of urine other and unspecified fall in water transport injuring occupant of other watercraft -- crew toxic encephalopathy gastro-esophageal reflux disease without esophagitis
white m 71 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  406  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.1  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  147  mg dl; chemistry blood albumin  2.0  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  500  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; ondansetron  4  mg ; vial  1  vial ; ceftriaxone  1  gm ; pantoprazole  40  mg ; atorvastatin  40  mg ; finasteride  5  mg ; lorazepam  1  mg ; meclizine  25  mg ; multivitamins w minerals  1  tab ; oxycodone (immediate release)  5  mg ; tamsulosin  0.8  mg ; prochlorperazine  10  mg ; bisacodyl  10  mg ; aspirin  81  mg ; heparin  1500-3000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; 
anemia in neoplastic disease essential (primary) hypertension secondary malignant neoplasm of right lung malignant ascites encounter for palliative care personal history of pulmonary embolism acute kidney failure, unspecified other retention of urine secondary malignant neoplasm of left lung gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia with lower urinary tract symptoms atherosclerotic heart disease of native coronary artery without angina pectoris personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified protein-calorie malnutrition family history of malignant neoplasm of kidney secondary malignant neoplasm of unspecified adrenal gland anxiety disorder, unspecified body mass index (bmi) 25.0-25.9, adult personal history of other malignant neoplasm of kidney secondary malignant neoplasm of retroperitoneum and peritoneum fall on stairs or ladders in water transport injuring unspecified person presence of coronary angioplasty implant and graft secondary malignant neoplasm of liver and intrahepatic bile duct neoplasm related pain (acute) (chronic) secondary malignant neoplasm of other digestive organs long term (current) use of antithrombotics/antiplatelets other disorders of phosphorus metabolism secondary malignant neoplasm of other specified sites personal history of pulmonary embolism essential (primary) hypertension unspecified protein-calorie malnutrition neoplasm related pain (acute) (chronic) benign prostatic hyperplasia with lower urinary tract symptoms secondary malignant neoplasm of other digestive organs constipation, unspecified presence of coronary angioplasty implant and graft secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris secondary malignant neoplasm of liver and intrahepatic bile duct personal history of other malignant neoplasm of kidney long term (current) use of anticoagulants secondary malignant neoplasm of bone hypercalcemia other ascites other retention of urine other and unspecified fall in water transport injuring occupant of other watercraft -- crew toxic encephalopathy gastro-esophageal reflux disease without esophagitis
white m 71 $nan$hematology blood hematocrit  27.8  %; hematology blood hematocrit  26.1  %; hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  406  k ul; hematology blood platelet count  410  k ul; hematology blood platelet count  435  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  130  mg dl; chemistry blood albumin  2.0  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  500  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; ondansetron  4  mg ; vial  1  vial ; ceftriaxone  1  gm ; pantoprazole  40  mg ; atorvastatin  40  mg ; finasteride  5  mg ; lorazepam  1  mg ; meclizine  25  mg ; multivitamins w minerals  1  tab ; oxycodone (immediate release)  5  mg ; tamsulosin  0.8  mg ; prochlorperazine  10  mg ; bisacodyl  10  mg ; aspirin  81  mg ; heparin  1500-3000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; oxycodone sr (oxycontin)  10  mg ; furosemide  20  mg ; spironolactone  25  mg ; metoclopramide  10  mg ; 
anemia in neoplastic disease essential (primary) hypertension secondary malignant neoplasm of right lung malignant ascites encounter for palliative care personal history of pulmonary embolism acute kidney failure, unspecified other retention of urine secondary malignant neoplasm of left lung gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia with lower urinary tract symptoms atherosclerotic heart disease of native coronary artery without angina pectoris personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified protein-calorie malnutrition family history of malignant neoplasm of kidney secondary malignant neoplasm of unspecified adrenal gland anxiety disorder, unspecified body mass index (bmi) 25.0-25.9, adult personal history of other malignant neoplasm of kidney secondary malignant neoplasm of retroperitoneum and peritoneum fall on stairs or ladders in water transport injuring unspecified person presence of coronary angioplasty implant and graft secondary malignant neoplasm of liver and intrahepatic bile duct neoplasm related pain (acute) (chronic) secondary malignant neoplasm of other digestive organs long term (current) use of antithrombotics/antiplatelets other disorders of phosphorus metabolism secondary malignant neoplasm of other specified sites personal history of pulmonary embolism essential (primary) hypertension unspecified protein-calorie malnutrition neoplasm related pain (acute) (chronic) benign prostatic hyperplasia with lower urinary tract symptoms secondary malignant neoplasm of other digestive organs constipation, unspecified presence of coronary angioplasty implant and graft secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris secondary malignant neoplasm of liver and intrahepatic bile duct personal history of other malignant neoplasm of kidney long term (current) use of anticoagulants secondary malignant neoplasm of bone hypercalcemia other ascites other retention of urine other and unspecified fall in water transport injuring occupant of other watercraft -- crew toxic encephalopathy gastro-esophageal reflux disease without esophagitis
white m 71 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  443  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.1  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  145  mg dl; chemistry blood albumin  2.2  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  500  mg ; pantoprazole  40  mg ; atorvastatin  40  mg ; finasteride  5  mg ; lorazepam  1  mg ; meclizine  25  mg ; multivitamins w minerals  1  tab ; oxycodone (immediate release)  5  mg ; tamsulosin  0.8  mg ; bisacodyl  10  mg ; aspirin  81  mg ; heparin  1500-3000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; oxycodone sr (oxycontin)  10  mg ; furosemide  20  mg ; spironolactone  25  mg ; metoclopramide  10  mg ; ciprofloxacin hcl  500  mg ; 
anemia in neoplastic disease essential (primary) hypertension secondary malignant neoplasm of right lung malignant ascites encounter for palliative care personal history of pulmonary embolism acute kidney failure, unspecified other retention of urine secondary malignant neoplasm of left lung gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia with lower urinary tract symptoms atherosclerotic heart disease of native coronary artery without angina pectoris personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified protein-calorie malnutrition family history of malignant neoplasm of kidney secondary malignant neoplasm of unspecified adrenal gland anxiety disorder, unspecified body mass index (bmi) 25.0-25.9, adult personal history of other malignant neoplasm of kidney secondary malignant neoplasm of retroperitoneum and peritoneum fall on stairs or ladders in water transport injuring unspecified person presence of coronary angioplasty implant and graft secondary malignant neoplasm of liver and intrahepatic bile duct neoplasm related pain (acute) (chronic) secondary malignant neoplasm of other digestive organs long term (current) use of antithrombotics/antiplatelets other disorders of phosphorus metabolism secondary malignant neoplasm of other specified sites personal history of pulmonary embolism essential (primary) hypertension unspecified protein-calorie malnutrition neoplasm related pain (acute) (chronic) benign prostatic hyperplasia with lower urinary tract symptoms secondary malignant neoplasm of other digestive organs constipation, unspecified presence of coronary angioplasty implant and graft secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris secondary malignant neoplasm of liver and intrahepatic bile duct personal history of other malignant neoplasm of kidney long term (current) use of anticoagulants secondary malignant neoplasm of bone hypercalcemia other ascites other retention of urine other and unspecified fall in water transport injuring occupant of other watercraft -- crew toxic encephalopathy gastro-esophageal reflux disease without esophagitis
white m 71 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  466  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.6  ; chemistry urine potassium, urine  59  meq l; chemistry urine urea nitrogen, urine  605  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  191  mg dl; chemistry blood glucose  127  mg dl; chemistry blood albumin  2.1  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  500  mg ; pantoprazole  40  mg ; atorvastatin  40  mg ; finasteride  5  mg ; lorazepam  1  mg ; meclizine  25  mg ; multivitamins w minerals  1  tab ; oxycodone (immediate release)  5  mg ; tamsulosin  0.8  mg ; bisacodyl  10  mg ; aspirin  81  mg ; furosemide  20  mg ; spironolactone  25  mg ; metoclopramide  10  mg ; ciprofloxacin hcl  500  mg ; docusate sodium  100  mg ; simethicone  40-80  mg ; rivaroxaban  20  mg ; 
anemia in neoplastic disease essential (primary) hypertension secondary malignant neoplasm of right lung malignant ascites encounter for palliative care personal history of pulmonary embolism acute kidney failure, unspecified other retention of urine secondary malignant neoplasm of left lung gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia with lower urinary tract symptoms atherosclerotic heart disease of native coronary artery without angina pectoris personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified protein-calorie malnutrition family history of malignant neoplasm of kidney secondary malignant neoplasm of unspecified adrenal gland anxiety disorder, unspecified body mass index (bmi) 25.0-25.9, adult personal history of other malignant neoplasm of kidney secondary malignant neoplasm of retroperitoneum and peritoneum fall on stairs or ladders in water transport injuring unspecified person presence of coronary angioplasty implant and graft secondary malignant neoplasm of liver and intrahepatic bile duct neoplasm related pain (acute) (chronic) secondary malignant neoplasm of other digestive organs long term (current) use of antithrombotics/antiplatelets other disorders of phosphorus metabolism secondary malignant neoplasm of other specified sites personal history of pulmonary embolism essential (primary) hypertension unspecified protein-calorie malnutrition neoplasm related pain (acute) (chronic) benign prostatic hyperplasia with lower urinary tract symptoms secondary malignant neoplasm of other digestive organs constipation, unspecified presence of coronary angioplasty implant and graft secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris secondary malignant neoplasm of liver and intrahepatic bile duct personal history of other malignant neoplasm of kidney long term (current) use of anticoagulants secondary malignant neoplasm of bone hypercalcemia other ascites other retention of urine other and unspecified fall in water transport injuring occupant of other watercraft -- crew toxic encephalopathy gastro-esophageal reflux disease without esophagitis
white m 71 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  458  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.5  ; chemistry urine potassium, urine  21  meq l; chemistry urine urea nitrogen, urine  336  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  145  mg dl; chemistry blood glucose  180  mg dl; chemistry blood glucose  135  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  500  mg ; pantoprazole  40  mg ; atorvastatin  40  mg ; finasteride  5  mg ; lorazepam  1  mg ; meclizine  25  mg ; multivitamins w minerals  1  tab ; oxycodone (immediate release)  5  mg ; tamsulosin  0.8  mg ; bisacodyl  10  mg ; aspirin  81  mg ; metoclopramide  10  mg ; ciprofloxacin hcl  500  mg ; docusate sodium  100  mg ; simethicone  40-80  mg ; rivaroxaban  20  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; sodium chloride 0.9%  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; oxycodone (immediate release)  5-10  mg ; 
anemia in neoplastic disease essential (primary) hypertension secondary malignant neoplasm of right lung malignant ascites encounter for palliative care personal history of pulmonary embolism acute kidney failure, unspecified other retention of urine secondary malignant neoplasm of left lung gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia with lower urinary tract symptoms atherosclerotic heart disease of native coronary artery without angina pectoris personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified protein-calorie malnutrition family history of malignant neoplasm of kidney secondary malignant neoplasm of unspecified adrenal gland anxiety disorder, unspecified body mass index (bmi) 25.0-25.9, adult personal history of other malignant neoplasm of kidney secondary malignant neoplasm of retroperitoneum and peritoneum fall on stairs or ladders in water transport injuring unspecified person presence of coronary angioplasty implant and graft secondary malignant neoplasm of liver and intrahepatic bile duct neoplasm related pain (acute) (chronic) secondary malignant neoplasm of other digestive organs long term (current) use of antithrombotics/antiplatelets other disorders of phosphorus metabolism secondary malignant neoplasm of other specified sites personal history of pulmonary embolism essential (primary) hypertension unspecified protein-calorie malnutrition neoplasm related pain (acute) (chronic) benign prostatic hyperplasia with lower urinary tract symptoms secondary malignant neoplasm of other digestive organs constipation, unspecified presence of coronary angioplasty implant and graft secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris secondary malignant neoplasm of liver and intrahepatic bile duct personal history of other malignant neoplasm of kidney long term (current) use of anticoagulants secondary malignant neoplasm of bone hypercalcemia other ascites other retention of urine other and unspecified fall in water transport injuring occupant of other watercraft -- crew toxic encephalopathy gastro-esophageal reflux disease without esophagitis
white m 71 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  467  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  120  mg dl; chemistry blood albumin  2.1  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  500  mg ; pantoprazole  40  mg ; atorvastatin  40  mg ; finasteride  5  mg ; lorazepam  1  mg ; meclizine  25  mg ; multivitamins w minerals  1  tab ; tamsulosin  0.8  mg ; bisacodyl  10  mg ; aspirin  81  mg ; metoclopramide  10  mg ; ciprofloxacin hcl  500  mg ; docusate sodium  100  mg ; simethicone  40-80  mg ; rivaroxaban  20  mg ; sodium chloride 0.9%  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; oxycodone (immediate release)  5-10  mg ; senna  17.2  mg ; 
anemia in neoplastic disease essential (primary) hypertension secondary malignant neoplasm of right lung malignant ascites encounter for palliative care personal history of pulmonary embolism acute kidney failure, unspecified other retention of urine secondary malignant neoplasm of left lung gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia with lower urinary tract symptoms atherosclerotic heart disease of native coronary artery without angina pectoris personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified protein-calorie malnutrition family history of malignant neoplasm of kidney secondary malignant neoplasm of unspecified adrenal gland anxiety disorder, unspecified body mass index (bmi) 25.0-25.9, adult personal history of other malignant neoplasm of kidney secondary malignant neoplasm of retroperitoneum and peritoneum fall on stairs or ladders in water transport injuring unspecified person presence of coronary angioplasty implant and graft secondary malignant neoplasm of liver and intrahepatic bile duct neoplasm related pain (acute) (chronic) secondary malignant neoplasm of other digestive organs long term (current) use of antithrombotics/antiplatelets other disorders of phosphorus metabolism secondary malignant neoplasm of other specified sites personal history of pulmonary embolism essential (primary) hypertension unspecified protein-calorie malnutrition neoplasm related pain (acute) (chronic) benign prostatic hyperplasia with lower urinary tract symptoms secondary malignant neoplasm of other digestive organs constipation, unspecified presence of coronary angioplasty implant and graft secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris secondary malignant neoplasm of liver and intrahepatic bile duct personal history of other malignant neoplasm of kidney long term (current) use of anticoagulants secondary malignant neoplasm of bone hypercalcemia other ascites other retention of urine other and unspecified fall in water transport injuring occupant of other watercraft -- crew toxic encephalopathy gastro-esophageal reflux disease without esophagitis
white m 71 $nan$hematology blood hematocrit  24.8  %; hematology blood hematocrit  26.9  %; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  413  k ul; hematology blood platelet count  450  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  134  mg dl; chemistry blood glucose  139  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  500  mg ; pantoprazole  40  mg ; atorvastatin  40  mg ; finasteride  5  mg ; lorazepam  1  mg ; meclizine  25  mg ; multivitamins w minerals  1  tab ; tamsulosin  0.8  mg ; bisacodyl  10  mg ; aspirin  81  mg ; metoclopramide  10  mg ; docusate sodium  100  mg ; simethicone  40-80  mg ; rivaroxaban  20  mg ; senna  17.2  mg ; albumin 25% (12.5g   50ml)  12.5  g ; 
anemia in neoplastic disease essential (primary) hypertension secondary malignant neoplasm of right lung malignant ascites encounter for palliative care personal history of pulmonary embolism acute kidney failure, unspecified other retention of urine secondary malignant neoplasm of left lung gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia with lower urinary tract symptoms atherosclerotic heart disease of native coronary artery without angina pectoris personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified protein-calorie malnutrition family history of malignant neoplasm of kidney secondary malignant neoplasm of unspecified adrenal gland anxiety disorder, unspecified body mass index (bmi) 25.0-25.9, adult personal history of other malignant neoplasm of kidney secondary malignant neoplasm of retroperitoneum and peritoneum fall on stairs or ladders in water transport injuring unspecified person presence of coronary angioplasty implant and graft secondary malignant neoplasm of liver and intrahepatic bile duct neoplasm related pain (acute) (chronic) secondary malignant neoplasm of other digestive organs long term (current) use of antithrombotics/antiplatelets other disorders of phosphorus metabolism secondary malignant neoplasm of other specified sites personal history of pulmonary embolism essential (primary) hypertension unspecified protein-calorie malnutrition neoplasm related pain (acute) (chronic) benign prostatic hyperplasia with lower urinary tract symptoms secondary malignant neoplasm of other digestive organs constipation, unspecified presence of coronary angioplasty implant and graft secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris secondary malignant neoplasm of liver and intrahepatic bile duct personal history of other malignant neoplasm of kidney long term (current) use of anticoagulants secondary malignant neoplasm of bone hypercalcemia other ascites other retention of urine other and unspecified fall in water transport injuring occupant of other watercraft -- crew toxic encephalopathy gastro-esophageal reflux disease without esophagitis
white m 71 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  425  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  139  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  500  mg ; pantoprazole  40  mg ; atorvastatin  40  mg ; finasteride  5  mg ; lorazepam  1  mg ; meclizine  25  mg ; multivitamins w minerals  1  tab ; tamsulosin  0.8  mg ; bisacodyl  10  mg ; aspirin  81  mg ; metoclopramide  10  mg ; docusate sodium  100  mg ; simethicone  40-80  mg ; rivaroxaban  20  mg ; senna  17.2  mg ; albumin 25% (12.5g   50ml)  12.5  g ; 
anemia in neoplastic disease essential (primary) hypertension secondary malignant neoplasm of right lung malignant ascites encounter for palliative care personal history of pulmonary embolism acute kidney failure, unspecified other retention of urine secondary malignant neoplasm of left lung gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia with lower urinary tract symptoms atherosclerotic heart disease of native coronary artery without angina pectoris personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified protein-calorie malnutrition family history of malignant neoplasm of kidney secondary malignant neoplasm of unspecified adrenal gland anxiety disorder, unspecified body mass index (bmi) 25.0-25.9, adult personal history of other malignant neoplasm of kidney secondary malignant neoplasm of retroperitoneum and peritoneum fall on stairs or ladders in water transport injuring unspecified person presence of coronary angioplasty implant and graft secondary malignant neoplasm of liver and intrahepatic bile duct neoplasm related pain (acute) (chronic) secondary malignant neoplasm of other digestive organs long term (current) use of antithrombotics/antiplatelets other disorders of phosphorus metabolism secondary malignant neoplasm of other specified sites personal history of pulmonary embolism essential (primary) hypertension unspecified protein-calorie malnutrition neoplasm related pain (acute) (chronic) benign prostatic hyperplasia with lower urinary tract symptoms secondary malignant neoplasm of other digestive organs constipation, unspecified presence of coronary angioplasty implant and graft secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris secondary malignant neoplasm of liver and intrahepatic bile duct personal history of other malignant neoplasm of kidney long term (current) use of anticoagulants secondary malignant neoplasm of bone hypercalcemia other ascites other retention of urine other and unspecified fall in water transport injuring occupant of other watercraft -- crew toxic encephalopathy gastro-esophageal reflux disease without esophagitis
white m 71 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  425  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  131  mg dl$sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  500  mg ; pantoprazole  40  mg ; atorvastatin  40  mg ; finasteride  5  mg ; lorazepam  1  mg ; meclizine  25  mg ; multivitamins w minerals  1  tab ; tamsulosin  0.8  mg ; bisacodyl  10  mg ; aspirin  81  mg ; metoclopramide  10  mg ; docusate sodium  100  mg ; simethicone  40-80  mg ; rivaroxaban  20  mg ; senna  17.2  mg ; oxycodone (immediate release)  10  mg ; oxycodone sr (oxycontin)  20  mg ; 
anemia in neoplastic disease essential (primary) hypertension secondary malignant neoplasm of right lung malignant ascites encounter for palliative care personal history of pulmonary embolism acute kidney failure, unspecified other retention of urine secondary malignant neoplasm of left lung gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia with lower urinary tract symptoms atherosclerotic heart disease of native coronary artery without angina pectoris personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified protein-calorie malnutrition family history of malignant neoplasm of kidney secondary malignant neoplasm of unspecified adrenal gland anxiety disorder, unspecified body mass index (bmi) 25.0-25.9, adult personal history of other malignant neoplasm of kidney secondary malignant neoplasm of retroperitoneum and peritoneum fall on stairs or ladders in water transport injuring unspecified person presence of coronary angioplasty implant and graft secondary malignant neoplasm of liver and intrahepatic bile duct neoplasm related pain (acute) (chronic) secondary malignant neoplasm of other digestive organs long term (current) use of antithrombotics/antiplatelets other disorders of phosphorus metabolism secondary malignant neoplasm of other specified sites personal history of pulmonary embolism essential (primary) hypertension unspecified protein-calorie malnutrition neoplasm related pain (acute) (chronic) benign prostatic hyperplasia with lower urinary tract symptoms secondary malignant neoplasm of other digestive organs constipation, unspecified presence of coronary angioplasty implant and graft secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris secondary malignant neoplasm of liver and intrahepatic bile duct personal history of other malignant neoplasm of kidney long term (current) use of anticoagulants secondary malignant neoplasm of bone hypercalcemia other ascites other retention of urine other and unspecified fall in water transport injuring occupant of other watercraft -- crew toxic encephalopathy gastro-esophageal reflux disease without esophagitis
white m 71 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  500  mg ; pantoprazole  40  mg ; atorvastatin  40  mg ; finasteride  5  mg ; lorazepam  1  mg ; meclizine  25  mg ; multivitamins w minerals  1  tab ; tamsulosin  0.8  mg ; bisacodyl  10  mg ; aspirin  81  mg ; metoclopramide  10  mg ; docusate sodium  100  mg ; simethicone  40-80  mg ; rivaroxaban  20  mg ; senna  17.2  mg ; oxycodone (immediate release)  10  mg ; oxycodone sr (oxycontin)  20  mg ; trazodone  25  mg ; 
anemia in neoplastic disease essential (primary) hypertension secondary malignant neoplasm of right lung malignant ascites encounter for palliative care personal history of pulmonary embolism acute kidney failure, unspecified other retention of urine secondary malignant neoplasm of left lung gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia with lower urinary tract symptoms atherosclerotic heart disease of native coronary artery without angina pectoris personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified protein-calorie malnutrition family history of malignant neoplasm of kidney secondary malignant neoplasm of unspecified adrenal gland anxiety disorder, unspecified body mass index (bmi) 25.0-25.9, adult personal history of other malignant neoplasm of kidney secondary malignant neoplasm of retroperitoneum and peritoneum fall on stairs or ladders in water transport injuring unspecified person presence of coronary angioplasty implant and graft secondary malignant neoplasm of liver and intrahepatic bile duct neoplasm related pain (acute) (chronic) secondary malignant neoplasm of other digestive organs long term (current) use of antithrombotics/antiplatelets other disorders of phosphorus metabolism secondary malignant neoplasm of other specified sites personal history of pulmonary embolism essential (primary) hypertension unspecified protein-calorie malnutrition neoplasm related pain (acute) (chronic) benign prostatic hyperplasia with lower urinary tract symptoms secondary malignant neoplasm of other digestive organs constipation, unspecified presence of coronary angioplasty implant and graft secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris secondary malignant neoplasm of liver and intrahepatic bile duct personal history of other malignant neoplasm of kidney long term (current) use of anticoagulants secondary malignant neoplasm of bone hypercalcemia other ascites other retention of urine other and unspecified fall in water transport injuring occupant of other watercraft -- crew toxic encephalopathy gastro-esophageal reflux disease without esophagitis
white m 71 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  500  mg ; pantoprazole  40  mg ; atorvastatin  40  mg ; finasteride  5  mg ; lorazepam  1  mg ; meclizine  25  mg ; multivitamins w minerals  1  tab ; tamsulosin  0.8  mg ; bisacodyl  10  mg ; aspirin  81  mg ; metoclopramide  10  mg ; docusate sodium  100  mg ; simethicone  40-80  mg ; rivaroxaban  20  mg ; senna  17.2  mg ; oxycodone sr (oxycontin)  20  mg ; trazodone  25  mg ; 
anemia in neoplastic disease essential (primary) hypertension secondary malignant neoplasm of right lung malignant ascites encounter for palliative care personal history of pulmonary embolism acute kidney failure, unspecified other retention of urine secondary malignant neoplasm of left lung gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia with lower urinary tract symptoms atherosclerotic heart disease of native coronary artery without angina pectoris personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified protein-calorie malnutrition family history of malignant neoplasm of kidney secondary malignant neoplasm of unspecified adrenal gland anxiety disorder, unspecified body mass index (bmi) 25.0-25.9, adult personal history of other malignant neoplasm of kidney secondary malignant neoplasm of retroperitoneum and peritoneum fall on stairs or ladders in water transport injuring unspecified person presence of coronary angioplasty implant and graft secondary malignant neoplasm of liver and intrahepatic bile duct neoplasm related pain (acute) (chronic) secondary malignant neoplasm of other digestive organs long term (current) use of antithrombotics/antiplatelets other disorders of phosphorus metabolism secondary malignant neoplasm of other specified sites personal history of pulmonary embolism essential (primary) hypertension unspecified protein-calorie malnutrition neoplasm related pain (acute) (chronic) benign prostatic hyperplasia with lower urinary tract symptoms secondary malignant neoplasm of other digestive organs constipation, unspecified presence of coronary angioplasty implant and graft secondary malignant neoplasm of unspecified lung atherosclerotic heart disease of native coronary artery without angina pectoris secondary malignant neoplasm of liver and intrahepatic bile duct personal history of other malignant neoplasm of kidney long term (current) use of anticoagulants secondary malignant neoplasm of bone hypercalcemia other ascites other retention of urine other and unspecified fall in water transport injuring occupant of other watercraft -- crew toxic encephalopathy gastro-esophageal reflux disease without esophagitis
black african american f 53 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  115  mg dl; chemistry blood lactate dehydrogenase (ld)  208  iu l; chemistry blood albumin  3.8  g dl$1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; lorazepam  0.5-1  mg ; senna  1  tab ; acetaminophen  325-650  mg ; insulin  0  unit ; tizanidine  2  mg ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  81  mg ; simvastatin  20  mg ; citalopram hydrobromide  20  mg ; omeprazole  40  mg ; ondansetron odt  4  mg ; ondansetron  4  mg ; 
diarrhea migraine, unspecified, without mention of intractable migraine without mention of status migrainosus chronic diastolic heart failure other chest pain diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled other acquired absence of organ obstructive sleep apnea (adult)(pediatric) other chronic pulmonary heart diseases congestive heart failure, unspecified morbid obesity acquired absence of both cervix and uterus polyneuropathy in diabetes background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension acute kidney failure, unspecified unspecified essential hypertension abdominal pain, left lower quadrant polyneuropathy in diabetes diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other acquired absence of organ esophageal reflux background diabetic retinopathy nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled acquired absence of both cervix and uterus pure hypercholesterolemia benign intracranial hypertension unspecified sleep apnea migraine, unspecified, without mention of intractable migraine without mention of status migrainosus constipation, unspecified unspecified essential hypertension displacement of lumbar intervertebral disc without myelopathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified sleep apnea diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled migraine, unspecified, without mention of intractable migraine without mention of status migrainosus pure hypercholesterolemia esophageal reflux other chest pain unspecified essential hypertension acquired absence of both cervix and uterus malignant essential hypertension other acquired absence of organ unspecified sleep apnea
black african american f 53 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  163  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  116  mg dl$1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; lorazepam  0.5-1  mg ; senna  1  tab ; acetaminophen  325-650  mg ; insulin  0  unit ; tizanidine  2  mg ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  81  mg ; simvastatin  20  mg ; citalopram hydrobromide  20  mg ; omeprazole  40  mg ; ondansetron odt  4  mg ; ondansetron  4  mg ; ranitidine  150  mg ; metoclopramide  5  mg ; magnesium sulfate  2  gm ; neutra-phos  1  pkt ; pantoprazole  40  mg ; labetalol  200  mg ; 
diarrhea migraine, unspecified, without mention of intractable migraine without mention of status migrainosus chronic diastolic heart failure other chest pain diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled other acquired absence of organ obstructive sleep apnea (adult)(pediatric) other chronic pulmonary heart diseases congestive heart failure, unspecified morbid obesity acquired absence of both cervix and uterus polyneuropathy in diabetes background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension acute kidney failure, unspecified unspecified essential hypertension abdominal pain, left lower quadrant polyneuropathy in diabetes diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other acquired absence of organ esophageal reflux background diabetic retinopathy nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled acquired absence of both cervix and uterus pure hypercholesterolemia benign intracranial hypertension unspecified sleep apnea migraine, unspecified, without mention of intractable migraine without mention of status migrainosus constipation, unspecified unspecified essential hypertension displacement of lumbar intervertebral disc without myelopathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified sleep apnea diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled migraine, unspecified, without mention of intractable migraine without mention of status migrainosus pure hypercholesterolemia esophageal reflux other chest pain unspecified essential hypertension acquired absence of both cervix and uterus malignant essential hypertension other acquired absence of organ unspecified sleep apnea
black african american f 53 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  109  mg dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; lorazepam  0.5-1  mg ; senna  1  tab ; acetaminophen  325-650  mg ; insulin  0  unit ; tizanidine  2  mg ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  81  mg ; simvastatin  20  mg ; ondansetron  4  mg ; ranitidine  150  mg ; metoclopramide  5  mg ; magnesium sulfate  2  gm ; neutra-phos  1  pkt ; pantoprazole  40  mg ; labetalol  200  mg ; benzonatate  100-200  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; neutra-phos  2  pkt ; 
diarrhea migraine, unspecified, without mention of intractable migraine without mention of status migrainosus chronic diastolic heart failure other chest pain diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled other acquired absence of organ obstructive sleep apnea (adult)(pediatric) other chronic pulmonary heart diseases congestive heart failure, unspecified morbid obesity acquired absence of both cervix and uterus polyneuropathy in diabetes background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension acute kidney failure, unspecified unspecified essential hypertension abdominal pain, left lower quadrant polyneuropathy in diabetes diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other acquired absence of organ esophageal reflux background diabetic retinopathy nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled acquired absence of both cervix and uterus pure hypercholesterolemia benign intracranial hypertension unspecified sleep apnea migraine, unspecified, without mention of intractable migraine without mention of status migrainosus constipation, unspecified unspecified essential hypertension displacement of lumbar intervertebral disc without myelopathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified sleep apnea diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled migraine, unspecified, without mention of intractable migraine without mention of status migrainosus pure hypercholesterolemia esophageal reflux other chest pain unspecified essential hypertension acquired absence of both cervix and uterus malignant essential hypertension other acquired absence of organ unspecified sleep apnea
black african american f 53 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  142  mg dl; chemistry blood lactate dehydrogenase (ld)  193  iu l; chemistry blood albumin  4.2  g dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; lorazepam  0.5-1  mg ; senna  1  tab ; acetaminophen  325-650  mg ; insulin  0  unit ; tizanidine  2  mg ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  81  mg ; simvastatin  20  mg ; ondansetron  4  mg ; ranitidine  150  mg ; metoclopramide  5  mg ; pantoprazole  40  mg ; labetalol  200  mg ; benzonatate  100-200  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; neutra-phos  2  pkt ; trazodone  25  mg ; acetaminophen  500-1000  mg ; simethicone  40-80  mg ; albuterol 0.083% neb soln  1  neb ; lisinopril  40  mg ; sw  50  ml ; morphine sulfate  2-4  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; 
diarrhea migraine, unspecified, without mention of intractable migraine without mention of status migrainosus chronic diastolic heart failure other chest pain diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled other acquired absence of organ obstructive sleep apnea (adult)(pediatric) other chronic pulmonary heart diseases congestive heart failure, unspecified morbid obesity acquired absence of both cervix and uterus polyneuropathy in diabetes background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension acute kidney failure, unspecified unspecified essential hypertension abdominal pain, left lower quadrant polyneuropathy in diabetes diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other acquired absence of organ esophageal reflux background diabetic retinopathy nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled acquired absence of both cervix and uterus pure hypercholesterolemia benign intracranial hypertension unspecified sleep apnea migraine, unspecified, without mention of intractable migraine without mention of status migrainosus constipation, unspecified unspecified essential hypertension displacement of lumbar intervertebral disc without myelopathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified sleep apnea diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled migraine, unspecified, without mention of intractable migraine without mention of status migrainosus pure hypercholesterolemia esophageal reflux other chest pain unspecified essential hypertension acquired absence of both cervix and uterus malignant essential hypertension other acquired absence of organ unspecified sleep apnea
black african american f 53 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  105  mg dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; lorazepam  0.5-1  mg ; senna  1  tab ; insulin  0  unit ; tizanidine  2  mg ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  81  mg ; simvastatin  20  mg ; ondansetron  4  mg ; ranitidine  150  mg ; metoclopramide  5  mg ; pantoprazole  40  mg ; labetalol  200  mg ; benzonatate  100-200  mg ; acetaminophen  500-1000  mg ; albuterol 0.083% neb soln  1  neb ; lisinopril  40  mg ; sw  50  ml ; morphine sulfate  2-4  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; spironolactone  100  mg ; 
diarrhea migraine, unspecified, without mention of intractable migraine without mention of status migrainosus chronic diastolic heart failure other chest pain diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled other acquired absence of organ obstructive sleep apnea (adult)(pediatric) other chronic pulmonary heart diseases congestive heart failure, unspecified morbid obesity acquired absence of both cervix and uterus polyneuropathy in diabetes background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension acute kidney failure, unspecified unspecified essential hypertension abdominal pain, left lower quadrant polyneuropathy in diabetes diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other acquired absence of organ esophageal reflux background diabetic retinopathy nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled acquired absence of both cervix and uterus pure hypercholesterolemia benign intracranial hypertension unspecified sleep apnea migraine, unspecified, without mention of intractable migraine without mention of status migrainosus constipation, unspecified unspecified essential hypertension displacement of lumbar intervertebral disc without myelopathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified sleep apnea diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled migraine, unspecified, without mention of intractable migraine without mention of status migrainosus pure hypercholesterolemia esophageal reflux other chest pain unspecified essential hypertension acquired absence of both cervix and uterus malignant essential hypertension other acquired absence of organ unspecified sleep apnea
black african american f 53 $nan$nan$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; lorazepam  0.5-1  mg ; senna  1  tab ; insulin  0  unit ; tizanidine  2  mg ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  81  mg ; simvastatin  20  mg ; ondansetron  4  mg ; ranitidine  150  mg ; pantoprazole  40  mg ; labetalol  200  mg ; benzonatate  100-200  mg ; acetaminophen  500-1000  mg ; albuterol 0.083% neb soln  1  neb ; lisinopril  40  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; spironolactone  100  mg ; amlodipine  10  mg ; 
diarrhea migraine, unspecified, without mention of intractable migraine without mention of status migrainosus chronic diastolic heart failure other chest pain diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled other acquired absence of organ obstructive sleep apnea (adult)(pediatric) other chronic pulmonary heart diseases congestive heart failure, unspecified morbid obesity acquired absence of both cervix and uterus polyneuropathy in diabetes background diabetic retinopathy diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension acute kidney failure, unspecified unspecified essential hypertension abdominal pain, left lower quadrant polyneuropathy in diabetes diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled other acquired absence of organ esophageal reflux background diabetic retinopathy nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled acquired absence of both cervix and uterus pure hypercholesterolemia benign intracranial hypertension unspecified sleep apnea migraine, unspecified, without mention of intractable migraine without mention of status migrainosus constipation, unspecified unspecified essential hypertension displacement of lumbar intervertebral disc without myelopathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified sleep apnea diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled migraine, unspecified, without mention of intractable migraine without mention of status migrainosus pure hypercholesterolemia esophageal reflux other chest pain unspecified essential hypertension acquired absence of both cervix and uterus malignant essential hypertension other acquired absence of organ unspecified sleep apnea
white f 80 $nan$hematology blood hematocrit  38.2  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  194  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  105  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; levothyroxine sodium  112  mcg ; losartan potassium  50  mg ; dabigatran etexilate  150  mg ; furosemide  20  mg ; atenolol  12.5  mg ; potassium chloride  20  meq ; metoprolol tartrate  6.25  mg ; losartan potassium  25  mg ; hydralazine  10  mg ; 
 
white f 80 $nan$hematology blood hematocrit  42.3  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  170  mg dl$sodium chloride 0.9%  flush  3-10  ml ; levothyroxine sodium  112  mcg ; dabigatran etexilate  150  mg ; metoprolol tartrate  6.25  mg ; losartan potassium  25  mg ; hydralazine  10  mg ; hydralazine  5  mg ; metoprolol tartrate  2.5  mg ; diltiazem  20  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)  2.5  mg ; losartan potassium  75  mg ; diltiazem  60  mg ; 
 
white f 80 $nan$hematology blood hematocrit  40.1  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  189  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  128  mg dl$sodium chloride 0.9%  flush  3-10  ml ; levothyroxine sodium  112  mcg ; acetaminophen  1000  mg ; oxycodone (immediate release)  2.5  mg ; diltiazem  60  mg ; cephalexin  500  mg ; diltiazem  90  mg ; amiodarone  200  mg ; 
 
white f 80 $nan$hematology blood hematocrit  40.5  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  142  mg dl$sodium chloride 0.9%  flush  3-10  ml ; levothyroxine sodium  112  mcg ; acetaminophen  1000  mg ; oxycodone (immediate release)  2.5  mg ; cephalexin  500  mg ; amiodarone  200  mg ; metoprolol succinate xl  50  mg ; 
 
white m 52 $temp  101.6  heartrate  98.0  resprate  20.0  o2sat  97.0  sbp    dbp    rhythm    pain  0  $hematology blood hematocrit  32.7  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  67  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  100  mg dl; chemistry blood lactate dehydrogenase (ld)  254  iu l; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; lactated ringers  1000  ml ; alprazolam  0.25  mg ; aspirin  81  mg ; ondansetron  8  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; calcitriol  0.25  mcg ; darunavir  600  mg ; etravirine  200  mg ; pravastatin  20  mg ; raltegravir  400  mg ; ritonavir  100  mg ; 5% dextrose  150  ml ; acyclovir  800  mg ; sarna lotion  1  appl ; acetaminophen  650  mg ; opium tincture  10  drop ; emtricitabine-tenofovir (truvada)  1  tab ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; opium tincture  20  drop ; 
 
white m 52 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  86  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  137  mg dl; chemistry blood lactate dehydrogenase (ld)  276  iu l; chemistry blood albumin  4.0  g dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; alprazolam  0.25  mg ; aspirin  81  mg ; ondansetron  8  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; calcitriol  0.25  mcg ; darunavir  600  mg ; etravirine  200  mg ; pravastatin  20  mg ; raltegravir  400  mg ; ritonavir  100  mg ; 5% dextrose  150  ml ; acyclovir  800  mg ; sarna lotion  1  appl ; acetaminophen  650  mg ; emtricitabine-tenofovir (truvada)  1  tab ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; opium tincture  20  drop ; cephalexin  500  mg ; valacyclovir  1000  mg ; 
 
white m 52 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; alprazolam  0.25  mg ; aspirin  81  mg ; ondansetron  8  mg ; calcitriol  0.25  mcg ; darunavir  600  mg ; etravirine  200  mg ; pravastatin  20  mg ; raltegravir  400  mg ; ritonavir  100  mg ; sarna lotion  1  appl ; acetaminophen  650  mg ; emtricitabine-tenofovir (truvada)  1  tab ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; opium tincture  20  drop ; valacyclovir  1000  mg ; 
 
black african american f 63 $nan$nan$iso-osmotic dextrose  50  ml ; cefazolin  1  g ; acetaminophen  500-1000  mg ; famotidine  20  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  325-650  mg ; diazepam  2  mg ; gabapentin  600  mg ; sodium chloride 0.9%  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  17.2  mg ; insulin  0  unit ; hydralazine  10  mg ; 
type 2 diabetes mellitus without complications radiculopathy, lumbar region
black african american f 63 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  264  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  125  mg dl$iso-osmotic dextrose  50  ml ; cefazolin  1  g ; acetaminophen  500-1000  mg ; famotidine  20  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  325-650  mg ; diazepam  2  mg ; gabapentin  600  mg ; sodium chloride 0.9%  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  17.2  mg ; insulin  0  unit ; hydralazine  10  mg ; heparin  5000  unit ; 
type 2 diabetes mellitus without complications radiculopathy, lumbar region
hispanic latino m 72 $nan$nan$metoprolol succinate xl  50  mg ; 
long term (current) use of anticoagulants pulmonary hypertension, unspecified non-pressure chronic ulcer of other part of left foot with unspecified severity physical restraint status type 2 diabetes mellitus with diabetic neuropathy, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease benign prostatic hyperplasia without lower urinary tract symptoms personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene chronic kidney disease, stage 3 (moderate) acute kidney failure, unspecified personal history of nicotine dependence constipation, unspecified long term (current) use of insulin major depressive disorder, single episode, unspecified dorsalgia, unspecified hyperlipidemia, unspecified delirium due to known physiological condition type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema type 2 diabetes mellitus with diabetic chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris gangrene, not elsewhere classified toxic encephalopathy unspecified dementia without behavioral disturbance type 2 diabetes mellitus with hypoglycemia without coma other chronic pain type 2 diabetes mellitus with diabetic nephropathy encephalopathy, unspecified benign prostatic hyperplasia without lower urinary tract symptoms atherosclerosis of native arteries of extremities with gangrene, other extremity atherosclerotic heart disease of native coronary artery without angina pectoris embolism and thrombosis of unspecified parts of aorta type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene unspecified dementia without behavioral disturbance long term (current) use of insulin hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of anticoagulants major depressive disorder, single episode, unspecified acute kidney failure, unspecified personal history of nicotine dependence chronic kidney disease, stage 3 (moderate) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits non-pressure chronic ulcer of other part of left foot with unspecified severity benign prostatic hyperplasia without lower urinary tract symptoms non-pressure chronic ulcer of right ankle with unspecified severity hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
hispanic latino m 72 $nan$hematology blood hematocrit  31.2  %; hematology blood hematocrit  32.9  %; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  256  k ul; hematology blood platelet count  237  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  6.5  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  183  mg dl; chemistry blood glucose  123  mg dl$metoprolol succinate xl  50  mg ; atorvastatin  80  mg ; gabapentin  300  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactated ringers  1000  ml ; insulin  0  unit ; tamsulosin  0.4  mg ; insulin (regular) for hyperkalemia  10  unit ; dextrose 50%  25  gm ; aspirin  81  mg ; bupropion xl (once daily)  300  mg ; clopidogrel  75  mg ; sodium polystyrene sulfonate  30  gm ; 
long term (current) use of anticoagulants pulmonary hypertension, unspecified non-pressure chronic ulcer of other part of left foot with unspecified severity physical restraint status type 2 diabetes mellitus with diabetic neuropathy, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease benign prostatic hyperplasia without lower urinary tract symptoms personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene chronic kidney disease, stage 3 (moderate) acute kidney failure, unspecified personal history of nicotine dependence constipation, unspecified long term (current) use of insulin major depressive disorder, single episode, unspecified dorsalgia, unspecified hyperlipidemia, unspecified delirium due to known physiological condition type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema type 2 diabetes mellitus with diabetic chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris gangrene, not elsewhere classified toxic encephalopathy unspecified dementia without behavioral disturbance type 2 diabetes mellitus with hypoglycemia without coma other chronic pain type 2 diabetes mellitus with diabetic nephropathy encephalopathy, unspecified benign prostatic hyperplasia without lower urinary tract symptoms atherosclerosis of native arteries of extremities with gangrene, other extremity atherosclerotic heart disease of native coronary artery without angina pectoris embolism and thrombosis of unspecified parts of aorta type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene unspecified dementia without behavioral disturbance long term (current) use of insulin hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of anticoagulants major depressive disorder, single episode, unspecified acute kidney failure, unspecified personal history of nicotine dependence chronic kidney disease, stage 3 (moderate) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits non-pressure chronic ulcer of other part of left foot with unspecified severity benign prostatic hyperplasia without lower urinary tract symptoms non-pressure chronic ulcer of right ankle with unspecified severity hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
hispanic latino m 72 $nan$hematology blood hematocrit  34.2  %; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l$metoprolol succinate xl  50  mg ; atorvastatin  80  mg ; gabapentin  300  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactated ringers  1000  ml ; insulin  0  unit ; tamsulosin  0.4  mg ; dextrose 50%  25  gm ; aspirin  81  mg ; bupropion xl (once daily)  300  mg ; sodium polystyrene sulfonate  30  gm ; sodium chloride 0.9%  1000  ml ; haloperidol  2.5  mg ; hydralazine  10  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; chlorthalidone  25  mg ; acetaminophen  500-1000  mg ; 
long term (current) use of anticoagulants pulmonary hypertension, unspecified non-pressure chronic ulcer of other part of left foot with unspecified severity physical restraint status type 2 diabetes mellitus with diabetic neuropathy, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease benign prostatic hyperplasia without lower urinary tract symptoms personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene chronic kidney disease, stage 3 (moderate) acute kidney failure, unspecified personal history of nicotine dependence constipation, unspecified long term (current) use of insulin major depressive disorder, single episode, unspecified dorsalgia, unspecified hyperlipidemia, unspecified delirium due to known physiological condition type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema type 2 diabetes mellitus with diabetic chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris gangrene, not elsewhere classified toxic encephalopathy unspecified dementia without behavioral disturbance type 2 diabetes mellitus with hypoglycemia without coma other chronic pain type 2 diabetes mellitus with diabetic nephropathy encephalopathy, unspecified benign prostatic hyperplasia without lower urinary tract symptoms atherosclerosis of native arteries of extremities with gangrene, other extremity atherosclerotic heart disease of native coronary artery without angina pectoris embolism and thrombosis of unspecified parts of aorta type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene unspecified dementia without behavioral disturbance long term (current) use of insulin hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of anticoagulants major depressive disorder, single episode, unspecified acute kidney failure, unspecified personal history of nicotine dependence chronic kidney disease, stage 3 (moderate) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits non-pressure chronic ulcer of other part of left foot with unspecified severity benign prostatic hyperplasia without lower urinary tract symptoms non-pressure chronic ulcer of right ankle with unspecified severity hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
hispanic latino m 72 $nan$nan$sodium chloride 0.9%  1000  ml ; haloperidol  2.5  mg ; hydralazine  10  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; chlorthalidone  25  mg ; acetaminophen  500-1000  mg ; divalproex sod. sprinkles  125  mg ; 
long term (current) use of anticoagulants pulmonary hypertension, unspecified non-pressure chronic ulcer of other part of left foot with unspecified severity physical restraint status type 2 diabetes mellitus with diabetic neuropathy, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease benign prostatic hyperplasia without lower urinary tract symptoms personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene chronic kidney disease, stage 3 (moderate) acute kidney failure, unspecified personal history of nicotine dependence constipation, unspecified long term (current) use of insulin major depressive disorder, single episode, unspecified dorsalgia, unspecified hyperlipidemia, unspecified delirium due to known physiological condition type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema type 2 diabetes mellitus with diabetic chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris gangrene, not elsewhere classified toxic encephalopathy unspecified dementia without behavioral disturbance type 2 diabetes mellitus with hypoglycemia without coma other chronic pain type 2 diabetes mellitus with diabetic nephropathy encephalopathy, unspecified benign prostatic hyperplasia without lower urinary tract symptoms atherosclerosis of native arteries of extremities with gangrene, other extremity atherosclerotic heart disease of native coronary artery without angina pectoris embolism and thrombosis of unspecified parts of aorta type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene unspecified dementia without behavioral disturbance long term (current) use of insulin hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of anticoagulants major depressive disorder, single episode, unspecified acute kidney failure, unspecified personal history of nicotine dependence chronic kidney disease, stage 3 (moderate) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits non-pressure chronic ulcer of other part of left foot with unspecified severity benign prostatic hyperplasia without lower urinary tract symptoms non-pressure chronic ulcer of right ankle with unspecified severity hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
hispanic latino m 72 $nan$nan$sodium chloride 0.9%  1000  ml ; hydralazine  10  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; chlorthalidone  25  mg ; acetaminophen  500-1000  mg ; divalproex sod. sprinkles  125  mg ; ramelteon  8  mg ; 
long term (current) use of anticoagulants pulmonary hypertension, unspecified non-pressure chronic ulcer of other part of left foot with unspecified severity physical restraint status type 2 diabetes mellitus with diabetic neuropathy, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease benign prostatic hyperplasia without lower urinary tract symptoms personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene chronic kidney disease, stage 3 (moderate) acute kidney failure, unspecified personal history of nicotine dependence constipation, unspecified long term (current) use of insulin major depressive disorder, single episode, unspecified dorsalgia, unspecified hyperlipidemia, unspecified delirium due to known physiological condition type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema type 2 diabetes mellitus with diabetic chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris gangrene, not elsewhere classified toxic encephalopathy unspecified dementia without behavioral disturbance type 2 diabetes mellitus with hypoglycemia without coma other chronic pain type 2 diabetes mellitus with diabetic nephropathy encephalopathy, unspecified benign prostatic hyperplasia without lower urinary tract symptoms atherosclerosis of native arteries of extremities with gangrene, other extremity atherosclerotic heart disease of native coronary artery without angina pectoris embolism and thrombosis of unspecified parts of aorta type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene unspecified dementia without behavioral disturbance long term (current) use of insulin hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of anticoagulants major depressive disorder, single episode, unspecified acute kidney failure, unspecified personal history of nicotine dependence chronic kidney disease, stage 3 (moderate) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits non-pressure chronic ulcer of other part of left foot with unspecified severity benign prostatic hyperplasia without lower urinary tract symptoms non-pressure chronic ulcer of right ankle with unspecified severity hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
hispanic latino m 72 $nan$nan$sodium chloride 0.9%  1000  ml ; hydralazine  10  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; chlorthalidone  25  mg ; acetaminophen  500-1000  mg ; divalproex sod. sprinkles  125  mg ; quetiapine fumarate  12.5  mg ; quetiapine fumarate  25  mg ; insulin  10  unit ; insulin  30  unit ; 
long term (current) use of anticoagulants pulmonary hypertension, unspecified non-pressure chronic ulcer of other part of left foot with unspecified severity physical restraint status type 2 diabetes mellitus with diabetic neuropathy, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease benign prostatic hyperplasia without lower urinary tract symptoms personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene chronic kidney disease, stage 3 (moderate) acute kidney failure, unspecified personal history of nicotine dependence constipation, unspecified long term (current) use of insulin major depressive disorder, single episode, unspecified dorsalgia, unspecified hyperlipidemia, unspecified delirium due to known physiological condition type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema type 2 diabetes mellitus with diabetic chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris gangrene, not elsewhere classified toxic encephalopathy unspecified dementia without behavioral disturbance type 2 diabetes mellitus with hypoglycemia without coma other chronic pain type 2 diabetes mellitus with diabetic nephropathy encephalopathy, unspecified benign prostatic hyperplasia without lower urinary tract symptoms atherosclerosis of native arteries of extremities with gangrene, other extremity atherosclerotic heart disease of native coronary artery without angina pectoris embolism and thrombosis of unspecified parts of aorta type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene unspecified dementia without behavioral disturbance long term (current) use of insulin hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of anticoagulants major depressive disorder, single episode, unspecified acute kidney failure, unspecified personal history of nicotine dependence chronic kidney disease, stage 3 (moderate) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits non-pressure chronic ulcer of other part of left foot with unspecified severity benign prostatic hyperplasia without lower urinary tract symptoms non-pressure chronic ulcer of right ankle with unspecified severity hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
hispanic latino m 72 $nan$nan$sodium chloride 0.9%  1000  ml ; hydralazine  10  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; chlorthalidone  25  mg ; acetaminophen  500-1000  mg ; divalproex sod. sprinkles  125  mg ; quetiapine fumarate  12.5  mg ; quetiapine fumarate  25  mg ; insulin  10  unit ; insulin  30  unit ; 
long term (current) use of anticoagulants pulmonary hypertension, unspecified non-pressure chronic ulcer of other part of left foot with unspecified severity physical restraint status type 2 diabetes mellitus with diabetic neuropathy, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease benign prostatic hyperplasia without lower urinary tract symptoms personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene chronic kidney disease, stage 3 (moderate) acute kidney failure, unspecified personal history of nicotine dependence constipation, unspecified long term (current) use of insulin major depressive disorder, single episode, unspecified dorsalgia, unspecified hyperlipidemia, unspecified delirium due to known physiological condition type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema type 2 diabetes mellitus with diabetic chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris gangrene, not elsewhere classified toxic encephalopathy unspecified dementia without behavioral disturbance type 2 diabetes mellitus with hypoglycemia without coma other chronic pain type 2 diabetes mellitus with diabetic nephropathy encephalopathy, unspecified benign prostatic hyperplasia without lower urinary tract symptoms atherosclerosis of native arteries of extremities with gangrene, other extremity atherosclerotic heart disease of native coronary artery without angina pectoris embolism and thrombosis of unspecified parts of aorta type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene unspecified dementia without behavioral disturbance long term (current) use of insulin hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of anticoagulants major depressive disorder, single episode, unspecified acute kidney failure, unspecified personal history of nicotine dependence chronic kidney disease, stage 3 (moderate) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits non-pressure chronic ulcer of other part of left foot with unspecified severity benign prostatic hyperplasia without lower urinary tract symptoms non-pressure chronic ulcer of right ankle with unspecified severity hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
hispanic latino m 72 $nan$nan$sodium chloride 0.9%  1000  ml ; hydralazine  10  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; chlorthalidone  25  mg ; acetaminophen  500-1000  mg ; divalproex sod. sprinkles  125  mg ; quetiapine fumarate  12.5  mg ; insulin  30  unit ; 
long term (current) use of anticoagulants pulmonary hypertension, unspecified non-pressure chronic ulcer of other part of left foot with unspecified severity physical restraint status type 2 diabetes mellitus with diabetic neuropathy, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease benign prostatic hyperplasia without lower urinary tract symptoms personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene chronic kidney disease, stage 3 (moderate) acute kidney failure, unspecified personal history of nicotine dependence constipation, unspecified long term (current) use of insulin major depressive disorder, single episode, unspecified dorsalgia, unspecified hyperlipidemia, unspecified delirium due to known physiological condition type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema type 2 diabetes mellitus with diabetic chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris gangrene, not elsewhere classified toxic encephalopathy unspecified dementia without behavioral disturbance type 2 diabetes mellitus with hypoglycemia without coma other chronic pain type 2 diabetes mellitus with diabetic nephropathy encephalopathy, unspecified benign prostatic hyperplasia without lower urinary tract symptoms atherosclerosis of native arteries of extremities with gangrene, other extremity atherosclerotic heart disease of native coronary artery without angina pectoris embolism and thrombosis of unspecified parts of aorta type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene unspecified dementia without behavioral disturbance long term (current) use of insulin hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of anticoagulants major depressive disorder, single episode, unspecified acute kidney failure, unspecified personal history of nicotine dependence chronic kidney disease, stage 3 (moderate) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits non-pressure chronic ulcer of other part of left foot with unspecified severity benign prostatic hyperplasia without lower urinary tract symptoms non-pressure chronic ulcer of right ankle with unspecified severity hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
hispanic latino m 72 $nan$nan$hydralazine  10  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; chlorthalidone  25  mg ; acetaminophen  500-1000  mg ; divalproex sod. sprinkles  125  mg ; quetiapine fumarate  12.5  mg ; insulin  30  unit ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; 
long term (current) use of anticoagulants pulmonary hypertension, unspecified non-pressure chronic ulcer of other part of left foot with unspecified severity physical restraint status type 2 diabetes mellitus with diabetic neuropathy, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease benign prostatic hyperplasia without lower urinary tract symptoms personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene chronic kidney disease, stage 3 (moderate) acute kidney failure, unspecified personal history of nicotine dependence constipation, unspecified long term (current) use of insulin major depressive disorder, single episode, unspecified dorsalgia, unspecified hyperlipidemia, unspecified delirium due to known physiological condition type 2 diabetes mellitus with foot ulcer type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema type 2 diabetes mellitus with diabetic chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris gangrene, not elsewhere classified toxic encephalopathy unspecified dementia without behavioral disturbance type 2 diabetes mellitus with hypoglycemia without coma other chronic pain type 2 diabetes mellitus with diabetic nephropathy encephalopathy, unspecified benign prostatic hyperplasia without lower urinary tract symptoms atherosclerosis of native arteries of extremities with gangrene, other extremity atherosclerotic heart disease of native coronary artery without angina pectoris embolism and thrombosis of unspecified parts of aorta type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene unspecified dementia without behavioral disturbance long term (current) use of insulin hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of anticoagulants major depressive disorder, single episode, unspecified acute kidney failure, unspecified personal history of nicotine dependence chronic kidney disease, stage 3 (moderate) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits non-pressure chronic ulcer of other part of left foot with unspecified severity benign prostatic hyperplasia without lower urinary tract symptoms non-pressure chronic ulcer of right ankle with unspecified severity hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
white m 78 $nan$hematology blood hematocrit  38.4  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  282  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  159  mg dl$acetaminophen  325-650  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  325  mg ; lisinopril  20  mg ; simvastatin  20  mg ; hydrochlorothiazide  12.5  mg ; omeprazole  20  mg ; lisinopril  10  mg ; thiamine  100  mg ; multivitamins  1  tab ; diazepam  5  mg ; metoprolol tartrate  12.5  mg ; 
 
black african american f 79 $temp  98.1  heartrate  78.0  resprate  16.0  o2sat  97.0  sbp  134.0  dbp  91.0  rhythm    pain  0  $hematology blood hematocrit  45.7  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  230  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  146  mg dl$sodium chloride 0.9%  1000  ml ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; insulin  0  unit ; ondansetron  4  mg ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; d5 1 2ns  1000  ml ; 
morbid obesity knee joint replacement other postprocedural status congestive heart failure, unspecified chronic kidney disease, stage iii (moderate) long-term (current) use of anticoagulants gout, unspecified persistent postoperative fistula body mass index 50.0-59.9, adult diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits osteoarthrosis, unspecified whether generalized or localized, site unspecified chronic diastolic heart failure atrial fibrillation obstructive sleep apnea (adult)(pediatric) other digestive system complications congestive heart failure, unspecified morbid obesity oliguria and anuria long-term (current) use of anticoagulants removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iii (moderate) laparoscopic surgical procedure converted to open procedure knee joint replacement body mass index 50.0-59.9, adult acute pancreatitis chronic diastolic heart failure calculus of gallbladder without mention of cholecystitis, with obstruction paralytic ileus atrial fibrillation gout, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified morbid obesity knee joint replacement gout, unspecified chronic diastolic heart failure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) long-term (current) use of anticoagulants personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, stage iii (moderate)
black african american f 79 $nan$hematology blood hematocrit  42.7  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  121  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; insulin  0  unit ; ondansetron  4  mg ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; d5 1 2ns  1000  ml ; acetaminophen iv  1000  mg ; amlodipine  10  mg ; furosemide  40  mg ; atenolol  100  mg ; vial  1  vial ; pantoprazole  40  mg ; 
morbid obesity knee joint replacement other postprocedural status congestive heart failure, unspecified chronic kidney disease, stage iii (moderate) long-term (current) use of anticoagulants gout, unspecified persistent postoperative fistula body mass index 50.0-59.9, adult diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits osteoarthrosis, unspecified whether generalized or localized, site unspecified chronic diastolic heart failure atrial fibrillation obstructive sleep apnea (adult)(pediatric) other digestive system complications congestive heart failure, unspecified morbid obesity oliguria and anuria long-term (current) use of anticoagulants removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iii (moderate) laparoscopic surgical procedure converted to open procedure knee joint replacement body mass index 50.0-59.9, adult acute pancreatitis chronic diastolic heart failure calculus of gallbladder without mention of cholecystitis, with obstruction paralytic ileus atrial fibrillation gout, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified morbid obesity knee joint replacement gout, unspecified chronic diastolic heart failure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) long-term (current) use of anticoagulants personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, stage iii (moderate)
black african american f 79 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; ondansetron  4  mg ; d5 1 2ns  1000  ml ; acetaminophen iv  1000  mg ; amlodipine  10  mg ; furosemide  40  mg ; atenolol  100  mg ; vial  1  vial ; pantoprazole  40  mg ; heparin  2300-4600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; latanoprost 0.005% ophth. soln.  1  drop ; 
morbid obesity knee joint replacement other postprocedural status congestive heart failure, unspecified chronic kidney disease, stage iii (moderate) long-term (current) use of anticoagulants gout, unspecified persistent postoperative fistula body mass index 50.0-59.9, adult diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits osteoarthrosis, unspecified whether generalized or localized, site unspecified chronic diastolic heart failure atrial fibrillation obstructive sleep apnea (adult)(pediatric) other digestive system complications congestive heart failure, unspecified morbid obesity oliguria and anuria long-term (current) use of anticoagulants removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iii (moderate) laparoscopic surgical procedure converted to open procedure knee joint replacement body mass index 50.0-59.9, adult acute pancreatitis chronic diastolic heart failure calculus of gallbladder without mention of cholecystitis, with obstruction paralytic ileus atrial fibrillation gout, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified morbid obesity knee joint replacement gout, unspecified chronic diastolic heart failure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) long-term (current) use of anticoagulants personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, stage iii (moderate)
black african american f 79 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  9.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  97  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; ondansetron  4  mg ; amlodipine  10  mg ; furosemide  40  mg ; atenolol  100  mg ; vial  1  vial ; pantoprazole  40  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; latanoprost 0.005% ophth. soln.  1  drop ; enoxaparin sodium  130  mg ; warfarin  1  dose ; warfarin  2  mg ; warfarin  5  mg ; warfarin  6  mg ; acetaminophen  650  mg ; 
morbid obesity knee joint replacement other postprocedural status congestive heart failure, unspecified chronic kidney disease, stage iii (moderate) long-term (current) use of anticoagulants gout, unspecified persistent postoperative fistula body mass index 50.0-59.9, adult diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits osteoarthrosis, unspecified whether generalized or localized, site unspecified chronic diastolic heart failure atrial fibrillation obstructive sleep apnea (adult)(pediatric) other digestive system complications congestive heart failure, unspecified morbid obesity oliguria and anuria long-term (current) use of anticoagulants removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iii (moderate) laparoscopic surgical procedure converted to open procedure knee joint replacement body mass index 50.0-59.9, adult acute pancreatitis chronic diastolic heart failure calculus of gallbladder without mention of cholecystitis, with obstruction paralytic ileus atrial fibrillation gout, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified morbid obesity knee joint replacement gout, unspecified chronic diastolic heart failure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) long-term (current) use of anticoagulants personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, stage iii (moderate)
black african american f 79 $nan$chemistry blood chloride  104  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.5  $sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; ondansetron  4  mg ; amlodipine  10  mg ; furosemide  40  mg ; atenolol  100  mg ; vial  1  vial ; pantoprazole  40  mg ; latanoprost 0.005% ophth. soln.  1  drop ; enoxaparin sodium  130  mg ; warfarin  1  dose ; warfarin  6  mg ; acetaminophen  650  mg ; 
morbid obesity knee joint replacement other postprocedural status congestive heart failure, unspecified chronic kidney disease, stage iii (moderate) long-term (current) use of anticoagulants gout, unspecified persistent postoperative fistula body mass index 50.0-59.9, adult diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits osteoarthrosis, unspecified whether generalized or localized, site unspecified chronic diastolic heart failure atrial fibrillation obstructive sleep apnea (adult)(pediatric) other digestive system complications congestive heart failure, unspecified morbid obesity oliguria and anuria long-term (current) use of anticoagulants removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iii (moderate) laparoscopic surgical procedure converted to open procedure knee joint replacement body mass index 50.0-59.9, adult acute pancreatitis chronic diastolic heart failure calculus of gallbladder without mention of cholecystitis, with obstruction paralytic ileus atrial fibrillation gout, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified morbid obesity knee joint replacement gout, unspecified chronic diastolic heart failure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) long-term (current) use of anticoagulants personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, stage iii (moderate)
black african american f 79 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; ondansetron  4  mg ; amlodipine  10  mg ; furosemide  40  mg ; atenolol  100  mg ; vial  1  vial ; pantoprazole  40  mg ; latanoprost 0.005% ophth. soln.  1  drop ; acetaminophen  650  mg ; 
morbid obesity knee joint replacement other postprocedural status congestive heart failure, unspecified chronic kidney disease, stage iii (moderate) long-term (current) use of anticoagulants gout, unspecified persistent postoperative fistula body mass index 50.0-59.9, adult diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits osteoarthrosis, unspecified whether generalized or localized, site unspecified chronic diastolic heart failure atrial fibrillation obstructive sleep apnea (adult)(pediatric) other digestive system complications congestive heart failure, unspecified morbid obesity oliguria and anuria long-term (current) use of anticoagulants removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, stage iii (moderate) laparoscopic surgical procedure converted to open procedure knee joint replacement body mass index 50.0-59.9, adult acute pancreatitis chronic diastolic heart failure calculus of gallbladder without mention of cholecystitis, with obstruction paralytic ileus atrial fibrillation gout, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified morbid obesity knee joint replacement gout, unspecified chronic diastolic heart failure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled intestinal or peritoneal adhesions with obstruction (postoperative) (postinfection) long-term (current) use of anticoagulants personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, stage iii (moderate)
white f 54 $nan$nan$multivitamins  1  tab ; vitamin d  400  unit ; 
urinary tract infection, site not specified chronic pulmonary embolism wheelchair dependence methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site carrier or suspected carrier of methicillin resistant staphylococcus aureus nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hypothermia not associated with low environmental temperature other specified diseases of hair and hair follicles anemia, unspecified toxic encephalopathy abnormal coagulation profile multiple sclerosis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants
white f 54 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  119  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  86  meq l; chemistry blood chloride  85  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  118  meq l; chemistry blood sodium  117  meq l; chemistry blood sodium  121  meq l; chemistry blood sodium  119  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry urine chloride, urine  108  meq l; chemistry urine potassium, urine  78  meq l; chemistry urine sodium, urine  111  meq l; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  57  mg dl; chemistry blood glucose  79  mg dl; hematology blood bands  0  %; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood chloride, whole blood  85  meq l; blood gas blood glucose  105  mg dl; blood gas blood hematocrit, calculated  27  %; blood gas blood hemoglobin  8.9  g dl; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood sodium, whole blood  116  meq l$multivitamins  1  tab ; vitamin d  400  unit ; 0.45% sodium chloride  1000  ml ; warfarin  1  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; docusate sodium  100  mg ; senna  1  tab ; calcium carbonate  500  mg ; lorazepam  0.5  mg ; tolterodine  2  mg ; clotrimazole cream  1  appl ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; lorazepam  1  mg ; 0.9% sodium chloride  250  ml ; phenytoin sodium  1000  mg ; phenytoin (suspension)  300  mg ; 
urinary tract infection, site not specified chronic pulmonary embolism wheelchair dependence methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site carrier or suspected carrier of methicillin resistant staphylococcus aureus nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hypothermia not associated with low environmental temperature other specified diseases of hair and hair follicles anemia, unspecified toxic encephalopathy abnormal coagulation profile multiple sclerosis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants
white f 54 $nan$hematology blood hematocrit  25.2  %; hematology blood hematocrit  21.4  %; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  143  k ul; hematology blood platelet count  127  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  21  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  4.7  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  4.8  ; hematology blood inr(pt)  2.8  ; chemistry blood calcium, total  6.7  mg dl; chemistry blood calcium, total  6.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  60  mg dl; chemistry blood glucose  290  mg dl; chemistry blood glucose  116  mg dl; chemistry blood albumin  3.0  g dl; hematology blood bands  5  %; blood gas blood lactate  5.5  mmol l; blood gas blood lactate  6.0  mmol l$0.9% sodium chloride  1000  ml ; 5% dextrose  250  ml ; multivitamins  1  tab ; vitamin d  400  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; docusate sodium  100  mg ; senna  1  tab ; calcium carbonate  500  mg ; tolterodine  2  mg ; clotrimazole cream  1  appl ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; lorazepam  1  mg ; 0.9% sodium chloride  250  ml ; phenytoin sodium  1000  mg ; phenytoin (suspension)  300  mg ; warfarin  0.5  mg ; phenylephrine  60  mg ; phenytoin sodium  500  mg ; 5% dextrose  100  ml ; acyclovir  400  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; sodium phosphate  30  mmol ; heparin  5000  unit ; levetiracetam oral solution  1000  mg ; docusate sodium (liquid)  100  mg ; ceftriaxone  2  gm ; potassium chloride (powder)  40  meq ; 5% dextrose  500  ml ; potassium phosphate  30  mmol ; neutra-phos  2  pkt ; vial  1  vial ; pantoprazole  40  mg ; 5% dextrose  50  ml ; fosphenytoin  100  mg pe ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; dextrose 5%  100  ml ; levofloxacin  500  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; norepinephrine  8  mg ; norepinephrine  8  mg ; 0.9% sodium chloride  50  ml ; 
urinary tract infection, site not specified chronic pulmonary embolism wheelchair dependence methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site carrier or suspected carrier of methicillin resistant staphylococcus aureus nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hypothermia not associated with low environmental temperature other specified diseases of hair and hair follicles anemia, unspecified toxic encephalopathy abnormal coagulation profile multiple sclerosis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants
white f 54 $nan$hematology blood hematocrit  21.0  %; hematology blood hematocrit  20.6  %; hematology blood hematocrit  24.1  %; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  86  k ul; hematology blood platelet count  93  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  3.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  79  mg dl; blood gas blood free calcium  1.01  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.0  mmol l$0.9% sodium chloride  1000  ml ; phenytoin sodium  500  mg ; 5% dextrose  100  ml ; acyclovir  400  mg ; levetiracetam oral solution  1000  mg ; docusate sodium (liquid)  100  mg ; potassium chloride (powder)  40  meq ; 5% dextrose  500  ml ; potassium phosphate  30  mmol ; neutra-phos  2  pkt ; vial  1  vial ; pantoprazole  40  mg ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; dextrose 5%  150  ml ; levofloxacin  750  mg ; norepinephrine  8  mg ; 0.9% sodium chloride  50  ml ; 0.9% sodium chloride  100  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; phosphorus  500  mg ; sterile water  100  ml ; potassium chloride  40  meq ; miconazole powder 2%  1  appl ; 
urinary tract infection, site not specified chronic pulmonary embolism wheelchair dependence methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site carrier or suspected carrier of methicillin resistant staphylococcus aureus nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hypothermia not associated with low environmental temperature other specified diseases of hair and hair follicles anemia, unspecified toxic encephalopathy abnormal coagulation profile multiple sclerosis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants
white f 54 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  93  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  6.5  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  90  mg dl$5% dextrose  100  ml ; acyclovir  400  mg ; levetiracetam oral solution  1000  mg ; docusate sodium (liquid)  100  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; norepinephrine  8  mg ; 0.9% sodium chloride  50  ml ; 0.9% sodium chloride  100  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; phosphorus  500  mg ; miconazole powder 2%  1  appl ; levetiracetam  1500  mg ; potassium chloride (powder)  60  meq ; phytonadione  5  mg ; furosemide  20  mg ; 
urinary tract infection, site not specified chronic pulmonary embolism wheelchair dependence methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site carrier or suspected carrier of methicillin resistant staphylococcus aureus nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hypothermia not associated with low environmental temperature other specified diseases of hair and hair follicles anemia, unspecified toxic encephalopathy abnormal coagulation profile multiple sclerosis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants
white f 54 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  118  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  109  mg dl; chemistry blood albumin  2.7  g dl; blood gas blood lactate  1.0  mmol l$5% dextrose  100  ml ; acyclovir  400  mg ; docusate sodium (liquid)  100  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; norepinephrine  8  mg ; 0.9% sodium chloride  50  ml ; 0.9% sodium chloride  100  ml ; sodium chloride 0.9%  flush  10  ml ; miconazole powder 2%  1  appl ; levetiracetam  1500  mg ; potassium chloride (powder)  60  meq ; phytonadione  5  mg ; furosemide  20  mg ; 
urinary tract infection, site not specified chronic pulmonary embolism wheelchair dependence methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site carrier or suspected carrier of methicillin resistant staphylococcus aureus nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hypothermia not associated with low environmental temperature other specified diseases of hair and hair follicles anemia, unspecified toxic encephalopathy abnormal coagulation profile multiple sclerosis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants
white f 54 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  156  k ul; chemistry blood anion gap  6  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  2.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  93  mg dl$docusate sodium (liquid)  100  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.9% sodium chloride  50  ml ; 0.9% sodium chloride  100  ml ; sodium chloride 0.9%  flush  10  ml ; miconazole powder 2%  1  appl ; levetiracetam  1500  mg ; 5% dextrose  25  ml ; acetazolamide sodium  250  mg ; 
urinary tract infection, site not specified chronic pulmonary embolism wheelchair dependence methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site carrier or suspected carrier of methicillin resistant staphylococcus aureus nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hypothermia not associated with low environmental temperature other specified diseases of hair and hair follicles anemia, unspecified toxic encephalopathy abnormal coagulation profile multiple sclerosis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants
white f 54 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  93  mg dl; chemistry blood glucose  111  mg dl; blood gas blood free calcium  1.19  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  1.0  mmol l$docusate sodium (liquid)  100  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.9% sodium chloride  50  ml ; 0.9% sodium chloride  100  ml ; sodium chloride 0.9%  flush  10  ml ; miconazole powder 2%  1  appl ; levetiracetam  1500  mg ; 5% dextrose  25  ml ; acetazolamide sodium  250  mg ; lacosamide  50  mg ; lacosamide  200  mg ; enoxaparin sodium  50  mg ; 
urinary tract infection, site not specified chronic pulmonary embolism wheelchair dependence methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site carrier or suspected carrier of methicillin resistant staphylococcus aureus nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hypothermia not associated with low environmental temperature other specified diseases of hair and hair follicles anemia, unspecified toxic encephalopathy abnormal coagulation profile multiple sclerosis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants
white f 54 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  97  mg dl; blood gas blood free calcium  1.14  mmol l; blood gas blood lactate  1.2  mmol l$docusate sodium (liquid)  100  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.9% sodium chloride  50  ml ; 0.9% sodium chloride  100  ml ; sodium chloride 0.9%  flush  10  ml ; miconazole powder 2%  1  appl ; 5% dextrose  25  ml ; acetazolamide sodium  250  mg ; lacosamide  200  mg ; enoxaparin sodium  50  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; levetiracetam  2000  mg ; lacosamide  300  mg ; valproic acid  1250  mg ; valproic acid  250  mg ; 
urinary tract infection, site not specified chronic pulmonary embolism wheelchair dependence methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site carrier or suspected carrier of methicillin resistant staphylococcus aureus nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hypothermia not associated with low environmental temperature other specified diseases of hair and hair follicles anemia, unspecified toxic encephalopathy abnormal coagulation profile multiple sclerosis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants
white f 54 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  282  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  104  mg dl; chemistry blood albumin  2.6  g dl; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.18  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  1.1  mmol l$docusate sodium (liquid)  100  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.9% sodium chloride  50  ml ; 0.9% sodium chloride  100  ml ; sodium chloride 0.9%  flush  10  ml ; miconazole powder 2%  1  appl ; 5% dextrose  25  ml ; acetazolamide sodium  250  mg ; enoxaparin sodium  50  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; levetiracetam  2000  mg ; lacosamide  300  mg ; valproic acid  1250  mg ; valproic acid  250  mg ; valproic acid  500  mg ; miconazole 2% cream  1  appl ; 
urinary tract infection, site not specified chronic pulmonary embolism wheelchair dependence methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site carrier or suspected carrier of methicillin resistant staphylococcus aureus nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hypothermia not associated with low environmental temperature other specified diseases of hair and hair follicles anemia, unspecified toxic encephalopathy abnormal coagulation profile multiple sclerosis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants
white f 54 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  319  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  86  mg dl; blood gas blood free calcium  1.16  mmol l; blood gas blood lactate  1.6  mmol l$docusate sodium (liquid)  100  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.9% sodium chloride  50  ml ; sodium chloride 0.9%  flush  10  ml ; miconazole powder 2%  1  appl ; enoxaparin sodium  50  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; levetiracetam  2000  mg ; lacosamide  300  mg ; valproic acid  250  mg ; miconazole 2% cream  1  appl ; valproic acid  750  mg ; 
urinary tract infection, site not specified chronic pulmonary embolism wheelchair dependence methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site carrier or suspected carrier of methicillin resistant staphylococcus aureus nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hypothermia not associated with low environmental temperature other specified diseases of hair and hair follicles anemia, unspecified toxic encephalopathy abnormal coagulation profile multiple sclerosis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants
white f 54 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  315  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  90  mg dl; chemistry blood albumin  2.8  g dl; blood gas blood free calcium  1.14  mmol l; blood gas blood lactate  0.6  mmol l$docusate sodium (liquid)  100  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.9% sodium chloride  50  ml ; sodium chloride 0.9%  flush  10  ml ; miconazole powder 2%  1  appl ; enoxaparin sodium  50  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; levetiracetam  2000  mg ; lacosamide  300  mg ; miconazole 2% cream  1  appl ; propofol  1000  mg ; 
urinary tract infection, site not specified chronic pulmonary embolism wheelchair dependence methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site carrier or suspected carrier of methicillin resistant staphylococcus aureus nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hypothermia not associated with low environmental temperature other specified diseases of hair and hair follicles anemia, unspecified toxic encephalopathy abnormal coagulation profile multiple sclerosis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants
white f 54 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  392  k ul; chemistry blood anion gap  7  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  93  mg dl; chemistry blood glucose  111  mg dl; chemistry blood lactate dehydrogenase (ld)  222  iu l$docusate sodium (liquid)  100  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.9% sodium chloride  50  ml ; sodium chloride 0.9%  flush  10  ml ; enoxaparin sodium  50  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; levetiracetam  2000  mg ; lacosamide  300  mg ; propofol  1000  mg ; valproic acid  1000  mg ; fluocinonide 0.05% ointment  1  appl ; acetaminophen (liquid)  650  mg ; 
urinary tract infection, site not specified chronic pulmonary embolism wheelchair dependence methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site carrier or suspected carrier of methicillin resistant staphylococcus aureus nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hypothermia not associated with low environmental temperature other specified diseases of hair and hair follicles anemia, unspecified toxic encephalopathy abnormal coagulation profile multiple sclerosis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants
white f 54 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  426  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  310  mg dl; chemistry blood glucose  114  mg dl; chemistry blood lactate dehydrogenase (ld)  234  iu l; chemistry blood albumin  3.0  g dl; blood gas blood free calcium  1.18  mmol l; blood gas blood lactate  0.8  mmol l$docusate sodium (liquid)  100  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.9% sodium chloride  50  ml ; sodium chloride 0.9%  flush  10  ml ; enoxaparin sodium  50  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; levetiracetam  2000  mg ; lacosamide  300  mg ; valproic acid  1000  mg ; fluocinonide 0.05% ointment  1  appl ; acetaminophen (liquid)  650  mg ; midazolam  1.5  mg ; fentanyl citrate  50  mcg ; sterile water  50  ml ; potassium chloride  20  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; magnesium sulfate  2-4  gm ; potassium chloride  60  meq ; potassium chloride  80  meq ; morphine sulfate  1-2  mg ; 
urinary tract infection, site not specified chronic pulmonary embolism wheelchair dependence methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site carrier or suspected carrier of methicillin resistant staphylococcus aureus nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hypothermia not associated with low environmental temperature other specified diseases of hair and hair follicles anemia, unspecified toxic encephalopathy abnormal coagulation profile multiple sclerosis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants
white f 54 $nan$hematology blood hematocrit  23.6  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  470  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  106  mg dl; chemistry blood lactate dehydrogenase (ld)  184  iu l; chemistry blood albumin  2.8  g dl$docusate sodium (liquid)  100  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.9% sodium chloride  50  ml ; sodium chloride 0.9%  flush  10  ml ; enoxaparin sodium  50  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; levetiracetam  2000  mg ; lacosamide  300  mg ; fluocinonide 0.05% ointment  1  appl ; acetaminophen (liquid)  650  mg ; sterile water  50  ml ; potassium chloride  20  meq ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; magnesium sulfate  2-4  gm ; potassium chloride  60  meq ; potassium chloride  80  meq ; morphine sulfate  1-2  mg ; albuterol inhaler  1-2  puff ; ipratropium bromide mdi  2  puff ; 
urinary tract infection, site not specified chronic pulmonary embolism wheelchair dependence methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site carrier or suspected carrier of methicillin resistant staphylococcus aureus nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hypothermia not associated with low environmental temperature other specified diseases of hair and hair follicles anemia, unspecified toxic encephalopathy abnormal coagulation profile multiple sclerosis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants
white f 54 $nan$hematology blood hematocrit  23.2  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  453  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  111  mg dl$docusate sodium (liquid)  100  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.9% sodium chloride  50  ml ; sodium chloride 0.9%  flush  10  ml ; enoxaparin sodium  50  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; levetiracetam  2000  mg ; lacosamide  300  mg ; fluocinonide 0.05% ointment  1  appl ; acetaminophen (liquid)  650  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; magnesium sulfate  2-4  gm ; potassium chloride  60  meq ; potassium chloride  80  meq ; albuterol inhaler  1-2  puff ; ipratropium bromide mdi  2  puff ; morphine sulfate (oral soln.)  5-10  mg ; neutra-phos  1  pkt ; 
urinary tract infection, site not specified chronic pulmonary embolism wheelchair dependence methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site carrier or suspected carrier of methicillin resistant staphylococcus aureus nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hypothermia not associated with low environmental temperature other specified diseases of hair and hair follicles anemia, unspecified toxic encephalopathy abnormal coagulation profile multiple sclerosis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants
white f 54 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  497  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  3  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  121  mg dl$docusate sodium (liquid)  100  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.9% sodium chloride  50  ml ; sodium chloride 0.9%  flush  10  ml ; enoxaparin sodium  50  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; levetiracetam  2000  mg ; lacosamide  300  mg ; fluocinonide 0.05% ointment  1  appl ; acetaminophen (liquid)  650  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; magnesium sulfate  2-4  gm ; potassium chloride  60  meq ; potassium chloride  80  meq ; albuterol inhaler  1-2  puff ; ipratropium bromide mdi  2  puff ; morphine sulfate (oral soln.)  5-10  mg ; neutra-phos  1  pkt ; 
urinary tract infection, site not specified chronic pulmonary embolism wheelchair dependence methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site carrier or suspected carrier of methicillin resistant staphylococcus aureus nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hypothermia not associated with low environmental temperature other specified diseases of hair and hair follicles anemia, unspecified toxic encephalopathy abnormal coagulation profile multiple sclerosis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants
white f 54 $nan$hematology blood hematocrit  22.9  %; hematology blood hematocrit  19.6  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  454  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  109  mg dl$docusate sodium (liquid)  100  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.9% sodium chloride  50  ml ; sodium chloride 0.9%  flush  10  ml ; enoxaparin sodium  50  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; levetiracetam  2000  mg ; lacosamide  300  mg ; fluocinonide 0.05% ointment  1  appl ; acetaminophen (liquid)  650  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; magnesium sulfate  2-4  gm ; potassium chloride  60  meq ; potassium chloride  80  meq ; albuterol inhaler  1-2  puff ; ipratropium bromide mdi  2  puff ; morphine sulfate (oral soln.)  5-10  mg ; heparin flush (10 units ml)  2  ml ; 
urinary tract infection, site not specified chronic pulmonary embolism wheelchair dependence methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site carrier or suspected carrier of methicillin resistant staphylococcus aureus nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hypothermia not associated with low environmental temperature other specified diseases of hair and hair follicles anemia, unspecified toxic encephalopathy abnormal coagulation profile multiple sclerosis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants
white f 54 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  381  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  122  mg dl; chemistry blood lactate dehydrogenase (ld)  207  iu l$docusate sodium (liquid)  100  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; levetiracetam  2000  mg ; lacosamide  300  mg ; fluocinonide 0.05% ointment  1  appl ; acetaminophen (liquid)  650  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; magnesium sulfate  2-4  gm ; potassium chloride  60  meq ; potassium chloride  80  meq ; albuterol inhaler  1-2  puff ; ipratropium bromide mdi  2  puff ; morphine sulfate (oral soln.)  5-10  mg ; heparin flush (10 units ml)  2  ml ; fosphenytoin  500  mg pe ; fosphenytoin  125  mg pe ; valproate sodium  500  mg ; 
urinary tract infection, site not specified chronic pulmonary embolism wheelchair dependence methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site carrier or suspected carrier of methicillin resistant staphylococcus aureus nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hypothermia not associated with low environmental temperature other specified diseases of hair and hair follicles anemia, unspecified toxic encephalopathy abnormal coagulation profile multiple sclerosis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants
white f 54 $nan$hematology blood hematocrit  28.1  %; hematology blood hematocrit  26.5  %; hematology blood hemoglobin  9.8  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  404  k ul; hematology blood platelet count  407  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  104  mg dl$docusate sodium (liquid)  100  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; levetiracetam  2000  mg ; lacosamide  300  mg ; fluocinonide 0.05% ointment  1  appl ; acetaminophen (liquid)  650  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; magnesium sulfate  2-4  gm ; potassium chloride  60  meq ; potassium chloride  80  meq ; albuterol inhaler  1-2  puff ; ipratropium bromide mdi  2  puff ; morphine sulfate (oral soln.)  5-10  mg ; heparin flush (10 units ml)  2  ml ; fosphenytoin  125  mg pe ; valproate sodium  500  mg ; ibuprofen suspension  600  mg ; morphine sulfate  2-4  mg ; 
urinary tract infection, site not specified chronic pulmonary embolism wheelchair dependence methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site carrier or suspected carrier of methicillin resistant staphylococcus aureus nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hypothermia not associated with low environmental temperature other specified diseases of hair and hair follicles anemia, unspecified toxic encephalopathy abnormal coagulation profile multiple sclerosis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants
white f 54 $nan$nan$docusate sodium (liquid)  100  mg ; vial  1  vial ; pantoprazole  40  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; levetiracetam  2000  mg ; lacosamide  300  mg ; fluocinonide 0.05% ointment  1  appl ; acetaminophen (liquid)  650  mg ; albuterol inhaler  1-2  puff ; ipratropium bromide mdi  2  puff ; morphine sulfate (oral soln.)  5-10  mg ; heparin flush (10 units ml)  2  ml ; fosphenytoin  125  mg pe ; ibuprofen suspension  600  mg ; morphine sulfate  2-4  mg ; scopolamine patch  1  ptch ; 
urinary tract infection, site not specified chronic pulmonary embolism wheelchair dependence methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site carrier or suspected carrier of methicillin resistant staphylococcus aureus nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] hypothermia not associated with low environmental temperature other specified diseases of hair and hair follicles anemia, unspecified toxic encephalopathy abnormal coagulation profile multiple sclerosis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident long-term (current) use of anticoagulants
white m 84 $nan$hematology blood hematocrit  29.3  %; hematology blood hematocrit  25.8  %; hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  139  k ul; hematology blood platelet count  116  k ul; hematology blood platelet count  105  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  9  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  115  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.2  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood urea nitrogen  35  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  136  mg dl; chemistry blood glucose  101  mg dl; chemistry blood glucose  309  mg dl; blood gas blood free calcium  1.20  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  0.8  mmol l; blood gas blood lactate  0.6  mmol l; blood gas blood chloride, whole blood  117  meq l; blood gas blood glucose  261  mg dl; blood gas blood hematocrit, calculated  26  %; blood gas blood hemoglobin  8.8  g dl; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood sodium, whole blood  144  meq l$influenza vaccine quadrivalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; iso-osmotic dextrose  50  ml ; clindamycin  600  mg ; lidocaine jelly 2% (glydo)  1  appl ; glucose gel  15  g ; iso-osmotic sodium chloride  0  bag ; calcium gluconate  0  g ; iso-osmotic sodium chloride  1  bag ; calcium gluconate  2  g ; iso-osmotic sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; lactated ringers  1000  ml ; insulin  0  unit ; piperacillin-tazobactam  2.25  g ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; heparin  5000  unit ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; albumin 5% (12.5g   250ml)  12.5  g ; sw  100  ml ; potassium chloride  10  meq ; sw  200  ml ; sw  400  ml ; 0.9% sodium chloride  500  ml ; sw  600  ml ; 0.9% sodium chloride  1000  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; aspirin  81  mg ; simvastatin  40  mg ; tamsulosin  0.4  mg ; thiamine  100  mg ; famotidine  20  mg ; escitalopram oxalate  10  mg ; folic acid  1  mg ; multivitamins  1  tab ; psyllium powder  1  pkt ; milk of magnesia  30  ml ; bisacodyl  10  mg ; amantadine syrup  100  mg ; acetaminophen  650  mg ; 
hydrocephalus in diseases classified elsewhere methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere type 2 diabetes mellitus with other specified complication retention of urine, unspecified other sequelae following unspecified cerebrovascular disease essential (primary) hypertension type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene dependence on wheelchair personal history of nicotine dependence long term (current) use of insulin pressure ulcer of right heel, stage 2 unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere iron deficiency anemia secondary to blood loss (chronic) pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere pressure ulcer of left heel, stage 4 enterococcus as the cause of diseases classified elsewhere type 2 diabetes mellitus with diabetic polyneuropathy gangrene, not elsewhere classified memory deficit following unspecified cerebrovascular disease other osteomyelitis, ankle and foot
white m 84 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  132  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  124  mg dl$influenza vaccine quadrivalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; lidocaine jelly 2% (glydo)  1  appl ; glucose gel  15  g ; iso-osmotic sodium chloride  0  bag ; calcium gluconate  0  g ; iso-osmotic sodium chloride  1  bag ; calcium gluconate  2  g ; iso-osmotic sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; piperacillin-tazobactam  2.25  g ; hydromorphone (dilaudid)  0.25-0.5  mg ; heparin  5000  unit ; albumin 5% (12.5g   250ml)  12.5  g ; sw  200  ml ; sw  400  ml ; 0.9% sodium chloride  500  ml ; sw  600  ml ; 0.9% sodium chloride  1000  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; aspirin  81  mg ; simvastatin  40  mg ; tamsulosin  0.4  mg ; thiamine  100  mg ; famotidine  20  mg ; escitalopram oxalate  10  mg ; folic acid  1  mg ; multivitamins  1  tab ; psyllium powder  1  pkt ; milk of magnesia  30  ml ; bisacodyl  10  mg ; amantadine syrup  100  mg ; acetaminophen  650  mg ; oxycodone (immediate release)  2.5-5  mg ; sodium chloride 0.9%  flush  3-10  ml ; 
hydrocephalus in diseases classified elsewhere methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere type 2 diabetes mellitus with other specified complication retention of urine, unspecified other sequelae following unspecified cerebrovascular disease essential (primary) hypertension type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene dependence on wheelchair personal history of nicotine dependence long term (current) use of insulin pressure ulcer of right heel, stage 2 unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere iron deficiency anemia secondary to blood loss (chronic) pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere pressure ulcer of left heel, stage 4 enterococcus as the cause of diseases classified elsewhere type 2 diabetes mellitus with diabetic polyneuropathy gangrene, not elsewhere classified memory deficit following unspecified cerebrovascular disease other osteomyelitis, ankle and foot
white m 84 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  119  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  129  mg dl$influenza vaccine quadrivalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; piperacillin-tazobactam  2.25  g ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; aspirin  81  mg ; simvastatin  40  mg ; tamsulosin  0.4  mg ; thiamine  100  mg ; escitalopram oxalate  10  mg ; folic acid  1  mg ; multivitamins  1  tab ; psyllium powder  1  pkt ; milk of magnesia  30  ml ; bisacodyl  10  mg ; amantadine syrup  100  mg ; oxycodone (immediate release)  2.5-5  mg ; sodium chloride 0.9%  flush  3-10  ml ; magnesium sulfate  2  gm ; acetaminophen  1000  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; gabapentin  100  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 
hydrocephalus in diseases classified elsewhere methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere type 2 diabetes mellitus with other specified complication retention of urine, unspecified other sequelae following unspecified cerebrovascular disease essential (primary) hypertension type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene dependence on wheelchair personal history of nicotine dependence long term (current) use of insulin pressure ulcer of right heel, stage 2 unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere iron deficiency anemia secondary to blood loss (chronic) pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere pressure ulcer of left heel, stage 4 enterococcus as the cause of diseases classified elsewhere type 2 diabetes mellitus with diabetic polyneuropathy gangrene, not elsewhere classified memory deficit following unspecified cerebrovascular disease other osteomyelitis, ankle and foot
white m 84 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  126  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  164  mg dl$acetaminophen  1000  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; gabapentin  100  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; insulin  15  unit ; finasteride  5  mg ; 
hydrocephalus in diseases classified elsewhere methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere type 2 diabetes mellitus with other specified complication retention of urine, unspecified other sequelae following unspecified cerebrovascular disease essential (primary) hypertension type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene dependence on wheelchair personal history of nicotine dependence long term (current) use of insulin pressure ulcer of right heel, stage 2 unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere iron deficiency anemia secondary to blood loss (chronic) pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere pressure ulcer of left heel, stage 4 enterococcus as the cause of diseases classified elsewhere type 2 diabetes mellitus with diabetic polyneuropathy gangrene, not elsewhere classified memory deficit following unspecified cerebrovascular disease other osteomyelitis, ankle and foot
white m 84 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  128  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  70  mg dl$acetaminophen  1000  mg ; gabapentin  100  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; insulin  15  unit ; finasteride  5  mg ; neutra-phos  1  pkt ; 
hydrocephalus in diseases classified elsewhere methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere type 2 diabetes mellitus with other specified complication retention of urine, unspecified other sequelae following unspecified cerebrovascular disease essential (primary) hypertension type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene dependence on wheelchair personal history of nicotine dependence long term (current) use of insulin pressure ulcer of right heel, stage 2 unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere iron deficiency anemia secondary to blood loss (chronic) pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere pressure ulcer of left heel, stage 4 enterococcus as the cause of diseases classified elsewhere type 2 diabetes mellitus with diabetic polyneuropathy gangrene, not elsewhere classified memory deficit following unspecified cerebrovascular disease other osteomyelitis, ankle and foot
white m 84 $nan$nan$acetaminophen  1000  mg ; gabapentin  100  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; insulin  15  unit ; finasteride  5  mg ; neutra-phos  1  pkt ; loperamide  2  mg ; 
hydrocephalus in diseases classified elsewhere methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere type 2 diabetes mellitus with other specified complication retention of urine, unspecified other sequelae following unspecified cerebrovascular disease essential (primary) hypertension type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene dependence on wheelchair personal history of nicotine dependence long term (current) use of insulin pressure ulcer of right heel, stage 2 unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere iron deficiency anemia secondary to blood loss (chronic) pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere pressure ulcer of left heel, stage 4 enterococcus as the cause of diseases classified elsewhere type 2 diabetes mellitus with diabetic polyneuropathy gangrene, not elsewhere classified memory deficit following unspecified cerebrovascular disease other osteomyelitis, ankle and foot
white m 84 $nan$hematology blood hematocrit  26.5  %; hematology blood hematocrit  24.3  %; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  152  k ul; hematology blood platelet count  162  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  150  mg dl$acetaminophen  1000  mg ; gabapentin  100  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; insulin  15  unit ; finasteride  5  mg ; loperamide  2  mg ; 
hydrocephalus in diseases classified elsewhere methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere type 2 diabetes mellitus with other specified complication retention of urine, unspecified other sequelae following unspecified cerebrovascular disease essential (primary) hypertension type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene dependence on wheelchair personal history of nicotine dependence long term (current) use of insulin pressure ulcer of right heel, stage 2 unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere iron deficiency anemia secondary to blood loss (chronic) pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere pressure ulcer of left heel, stage 4 enterococcus as the cause of diseases classified elsewhere type 2 diabetes mellitus with diabetic polyneuropathy gangrene, not elsewhere classified memory deficit following unspecified cerebrovascular disease other osteomyelitis, ankle and foot
white m 84 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  121  mg dl$bag  1  bag ; acetaminophen  1000  mg ; gabapentin  100  mg ; insulin  15  unit ; finasteride  5  mg ; loperamide  2  mg ; neutra-phos  2  pkt ; 
hydrocephalus in diseases classified elsewhere methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere type 2 diabetes mellitus with other specified complication retention of urine, unspecified other sequelae following unspecified cerebrovascular disease essential (primary) hypertension type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene dependence on wheelchair personal history of nicotine dependence long term (current) use of insulin pressure ulcer of right heel, stage 2 unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere iron deficiency anemia secondary to blood loss (chronic) pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere pressure ulcer of left heel, stage 4 enterococcus as the cause of diseases classified elsewhere type 2 diabetes mellitus with diabetic polyneuropathy gangrene, not elsewhere classified memory deficit following unspecified cerebrovascular disease other osteomyelitis, ankle and foot
white m 84 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  104  mg dl$acetaminophen  1000  mg ; gabapentin  100  mg ; insulin  15  unit ; finasteride  5  mg ; loperamide  2  mg ; 
hydrocephalus in diseases classified elsewhere methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere type 2 diabetes mellitus with other specified complication retention of urine, unspecified other sequelae following unspecified cerebrovascular disease essential (primary) hypertension type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene dependence on wheelchair personal history of nicotine dependence long term (current) use of insulin pressure ulcer of right heel, stage 2 unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere iron deficiency anemia secondary to blood loss (chronic) pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere pressure ulcer of left heel, stage 4 enterococcus as the cause of diseases classified elsewhere type 2 diabetes mellitus with diabetic polyneuropathy gangrene, not elsewhere classified memory deficit following unspecified cerebrovascular disease other osteomyelitis, ankle and foot
white m 84 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  113  mg dl$acetaminophen  1000  mg ; gabapentin  100  mg ; insulin  15  unit ; finasteride  5  mg ; loperamide  2  mg ; 
hydrocephalus in diseases classified elsewhere methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere type 2 diabetes mellitus with other specified complication retention of urine, unspecified other sequelae following unspecified cerebrovascular disease essential (primary) hypertension type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene dependence on wheelchair personal history of nicotine dependence long term (current) use of insulin pressure ulcer of right heel, stage 2 unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere iron deficiency anemia secondary to blood loss (chronic) pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere pressure ulcer of left heel, stage 4 enterococcus as the cause of diseases classified elsewhere type 2 diabetes mellitus with diabetic polyneuropathy gangrene, not elsewhere classified memory deficit following unspecified cerebrovascular disease other osteomyelitis, ankle and foot
white m 84 $nan$nan$acetaminophen  1000  mg ; gabapentin  100  mg ; insulin  15  unit ; finasteride  5  mg ; loperamide  2  mg ; 
hydrocephalus in diseases classified elsewhere methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere type 2 diabetes mellitus with other specified complication retention of urine, unspecified other sequelae following unspecified cerebrovascular disease essential (primary) hypertension type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene dependence on wheelchair personal history of nicotine dependence long term (current) use of insulin pressure ulcer of right heel, stage 2 unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere iron deficiency anemia secondary to blood loss (chronic) pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere pressure ulcer of left heel, stage 4 enterococcus as the cause of diseases classified elsewhere type 2 diabetes mellitus with diabetic polyneuropathy gangrene, not elsewhere classified memory deficit following unspecified cerebrovascular disease other osteomyelitis, ankle and foot
white f 91 $temp  97.6  heartrate  107.0  resprate  18.0  o2sat  97.0  sbp  124.0  dbp  58.0  rhythm  atrial fibrillation  pain  0  ; temp  97.6  heartrate  108.0  resprate  16.0  o2sat  96.0  sbp  124.0  dbp  62.0  rhythm    pain  0  $chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  131  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; furosemide-heart failure  10  mg ; heparin  5000  unit ; aspirin  81  mg ; omeprazole  20  mg ; tramadol (ultram)  50  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; pilocarpine 4%  1  drop ; metoprolol tartrate  12.5  mg ; dipyridamole  150  mg ; metoprolol tartrate  25  mg ; heparin  900  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; heparin  1200-2400  unit ; furosemide  10  mg ; 
osteoarthrosis, unspecified whether generalized or localized, site unspecified osteoporosis, unspecified personal history of tobacco use other specified cardiac dysrhythmias anemia, unspecified unspecified essential hypertension unspecified glaucoma hypoxemia other chronic pulmonary heart diseases 
white f 91 $nan$hematology blood hematocrit  39.2  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  98  mg dl; chemistry blood glucose  124  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; furosemide-heart failure  10  mg ; aspirin  81  mg ; omeprazole  20  mg ; tramadol (ultram)  50  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; pilocarpine 4%  1  drop ; dipyridamole  150  mg ; heparin  1200-2400  unit ; furosemide  10  mg ; potassium chloride  60  meq ; acetaminophen  650  mg ; furosemide  20  mg ; metoprolol tartrate  50  mg ; 
osteoarthrosis, unspecified whether generalized or localized, site unspecified osteoporosis, unspecified personal history of tobacco use other specified cardiac dysrhythmias anemia, unspecified unspecified essential hypertension unspecified glaucoma hypoxemia other chronic pulmonary heart diseases 
white f 91 $nan$hematology blood hematocrit  38.6  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  10.1  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  121  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; aspirin  81  mg ; omeprazole  20  mg ; tramadol (ultram)  50  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; pilocarpine 4%  1  drop ; dipyridamole  150  mg ; heparin  1200-2400  unit ; acetaminophen  650  mg ; furosemide  20  mg ; metoprolol tartrate  50  mg ; trazodone  25  mg ; potassium chloride  20  meq ; metoprolol tartrate  75  mg ; 
osteoarthrosis, unspecified whether generalized or localized, site unspecified osteoporosis, unspecified personal history of tobacco use other specified cardiac dysrhythmias anemia, unspecified unspecified essential hypertension unspecified glaucoma hypoxemia other chronic pulmonary heart diseases 
white f 91 $nan$hematology blood hematocrit  40.8  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  100  mg dl; chemistry blood glucose  129  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; aspirin  81  mg ; omeprazole  20  mg ; tramadol (ultram)  50  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; pilocarpine 4%  1  drop ; dipyridamole  150  mg ; heparin  1200-2400  unit ; acetaminophen  650  mg ; furosemide  20  mg ; trazodone  25  mg ; potassium chloride  20  meq ; metoprolol tartrate  75  mg ; cepastat (phenol) lozenge  1  loz ; magnesium oxide  400  mg ; warfarin  5  mg ; warfarin  2.5  mg ; 
osteoarthrosis, unspecified whether generalized or localized, site unspecified osteoporosis, unspecified personal history of tobacco use other specified cardiac dysrhythmias anemia, unspecified unspecified essential hypertension unspecified glaucoma hypoxemia other chronic pulmonary heart diseases 
white f 91 $nan$hematology blood hematocrit  38.9  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  238  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  135  mg dl; chemistry blood glucose  141  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; aspirin  81  mg ; omeprazole  20  mg ; tramadol (ultram)  50  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; pilocarpine 4%  1  drop ; dipyridamole  150  mg ; heparin  1200-2400  unit ; acetaminophen  650  mg ; metoprolol tartrate  75  mg ; cepastat (phenol) lozenge  1  loz ; magnesium oxide  400  mg ; warfarin  5  mg ; furosemide  40  mg ; 
osteoarthrosis, unspecified whether generalized or localized, site unspecified osteoporosis, unspecified personal history of tobacco use other specified cardiac dysrhythmias anemia, unspecified unspecified essential hypertension unspecified glaucoma hypoxemia other chronic pulmonary heart diseases 
white f 91 $nan$hematology blood hematocrit  39.9  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  2.6  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  115  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; omeprazole  20  mg ; tramadol (ultram)  50  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; pilocarpine 4%  1  drop ; heparin  1200-2400  unit ; acetaminophen  650  mg ; cepastat (phenol) lozenge  1  loz ; furosemide  40  mg ; warfarin  2  mg ; 
osteoarthrosis, unspecified whether generalized or localized, site unspecified osteoporosis, unspecified personal history of tobacco use other specified cardiac dysrhythmias anemia, unspecified unspecified essential hypertension unspecified glaucoma hypoxemia other chronic pulmonary heart diseases 
white f 91 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  3.8  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; omeprazole  20  mg ; tramadol (ultram)  50  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; pilocarpine 4%  1  drop ; acetaminophen  650  mg ; cepastat (phenol) lozenge  1  loz ; furosemide  40  mg ; warfarin  2  mg ; metoprolol succinate xl  50  mg ; lidocaine 5% patch  1  ptch ; silver sulfadiazine 1% cream  1  appl ; 
osteoarthrosis, unspecified whether generalized or localized, site unspecified osteoporosis, unspecified personal history of tobacco use other specified cardiac dysrhythmias anemia, unspecified unspecified essential hypertension unspecified glaucoma hypoxemia other chronic pulmonary heart diseases 
white f 91 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; omeprazole  20  mg ; tramadol (ultram)  50  mg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; pilocarpine 4%  1  drop ; acetaminophen  650  mg ; cepastat (phenol) lozenge  1  loz ; metoprolol succinate xl  50  mg ; lidocaine 5% patch  1  ptch ; silver sulfadiazine 1% cream  1  appl ; 
osteoarthrosis, unspecified whether generalized or localized, site unspecified osteoporosis, unspecified personal history of tobacco use other specified cardiac dysrhythmias anemia, unspecified unspecified essential hypertension unspecified glaucoma hypoxemia other chronic pulmonary heart diseases 
white m 77 $nan$nan$atorvastatin  80  mg ; clopidogrel  75  mg ; aspirin  162  mg ; amlodipine  10  mg ; metoprolol succinate xl  12.5  mg ; 
 
white m 77 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  55  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  183  mg dl$sodium chloride 0.9%  flush  3  ml ; atorvastatin  80  mg ; clopidogrel  75  mg ; aspirin  162  mg ; amlodipine  10  mg ; metoprolol succinate xl  12.5  mg ; pneumococcal vac polyvalent  0.5  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; niacin sr  1000  mg ; allopurinol  200  mg ; metoprolol succinate xl  25  mg ; 
 
white m 77 $nan$hematology blood hematocrit  31.0  %; hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  167  mg dl$sodium chloride 0.9%  flush  3  ml ; atorvastatin  80  mg ; clopidogrel  75  mg ; aspirin  162  mg ; amlodipine  10  mg ; pneumococcal vac polyvalent  0.5  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; niacin sr  1000  mg ; allopurinol  200  mg ; metoprolol succinate xl  25  mg ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5  mg ; phenylephrine  60  mg ; d5w  250  ml ; nitroglycerin  100  mg ; bag  50  ml ; magnesium sulfate  2  gm ; acetaminophen  1000  mg ; 
 
white m 77 $nan$nan$sodium chloride 0.9%  flush  3  ml ; atorvastatin  80  mg ; amlodipine  10  mg ; niacin sr  1000  mg ; allopurinol  200  mg ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5  mg ; d5w  250  ml ; nitroglycerin  100  mg ; acetaminophen  1000  mg ; tamsulosin  0.4  mg ; 
 
white f 86 $nan$hematology blood hematocrit  40.5  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  48  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood glucose  94  mg dl; chemistry blood glucose  99  mg dl; blood gas blood lactate  1.0  mmol l$5% dextrose  250  ml ; bisacodyl  10  mg ; senna  8.6  mg ; cetirizine  10  mg ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (500 50)   1  inh ; ipratropium-albuterol neb  1  neb ; levothyroxine sodium  75  mcg ; magnesium oxide  400  mg ; montelukast  10  mg ; pantoprazole  40  mg ; pravastatin  80  mg ; warfarin  2.5  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; acetaminophen  650  mg ; furosemide  20  mg ; furosemide  40  mg ; isoproterenol  2  mg ; 
chronic obstructive pulmonary disease, unspecified cardiomyopathy, unspecified chronic diastolic (congestive) heart failure dependence on supplemental oxygen unspecified asthma, uncomplicated unspecified atrial fibrillation chronic kidney disease, stage 3 (moderate) acute kidney failure, unspecified gastro-esophageal reflux disease without esophagitis hypothyroidism, unspecified presence of xenogenic heart valve long term (current) use of anticoagulants atherosclerotic heart disease of native coronary artery without angina pectoris nonrheumatic mitral (valve) insufficiency hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease esophageal reflux other dependence on machines, supplemental oxygen hematoma complicating a procedure mitral valve insufficiency and aortic valve stenosis depressive disorder, not elsewhere classified heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident chronic obstructive asthma, unspecified coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia unspecified acquired hypothyroidism accidents occurring in unspecified place person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident atrial fibrillation unspecified procedure as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified essential hypertension other primary cardiomyopathies other complications due to other cardiac device, implant, and graft dementia, unspecified, without behavioral disturbance unspecified acquired hypothyroidism delirium due to conditions classified elsewhere congestive heart failure, unspecified family history of ischemic heart disease atrial fibrillation examination of participant in clinical trial chronic obstructive asthma, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other chronic pulmonary heart diseases coronary atherosclerosis of native coronary artery other primary cardiomyopathies other and unspecified hyperlipidemia mitral valve disorders long-term (current) use of aspirin
white f 86 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  110  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  49  mg dl; hematology blood inr(pt)  3.0  ; hematology urine wbc  56  # hpf; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  100  mg dl$bisacodyl  10  mg ; senna  8.6  mg ; cetirizine  10  mg ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (500 50)   1  inh ; ipratropium-albuterol neb  1  neb ; levothyroxine sodium  75  mcg ; magnesium oxide  400  mg ; montelukast  10  mg ; pantoprazole  40  mg ; pravastatin  80  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; acetaminophen  650  mg ; furosemide  20  mg ; furosemide  40  mg ; warfarin  5  mg ; warfarin  4  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; donepezil  10  mg ; 
chronic obstructive pulmonary disease, unspecified cardiomyopathy, unspecified chronic diastolic (congestive) heart failure dependence on supplemental oxygen unspecified asthma, uncomplicated unspecified atrial fibrillation chronic kidney disease, stage 3 (moderate) acute kidney failure, unspecified gastro-esophageal reflux disease without esophagitis hypothyroidism, unspecified presence of xenogenic heart valve long term (current) use of anticoagulants atherosclerotic heart disease of native coronary artery without angina pectoris nonrheumatic mitral (valve) insufficiency hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease esophageal reflux other dependence on machines, supplemental oxygen hematoma complicating a procedure mitral valve insufficiency and aortic valve stenosis depressive disorder, not elsewhere classified heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident chronic obstructive asthma, unspecified coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia unspecified acquired hypothyroidism accidents occurring in unspecified place person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident atrial fibrillation unspecified procedure as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified essential hypertension other primary cardiomyopathies other complications due to other cardiac device, implant, and graft dementia, unspecified, without behavioral disturbance unspecified acquired hypothyroidism delirium due to conditions classified elsewhere congestive heart failure, unspecified family history of ischemic heart disease atrial fibrillation examination of participant in clinical trial chronic obstructive asthma, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other chronic pulmonary heart diseases coronary atherosclerosis of native coronary artery other primary cardiomyopathies other and unspecified hyperlipidemia mitral valve disorders long-term (current) use of aspirin
white f 86 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  116  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  86  mg dl$cetirizine  10  mg ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (500 50)   1  inh ; ipratropium-albuterol neb  1  neb ; levothyroxine sodium  75  mcg ; magnesium oxide  400  mg ; montelukast  10  mg ; pantoprazole  40  mg ; pravastatin  80  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; acetaminophen  650  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; donepezil  10  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; torsemide  40  mg ; losartan potassium  50  mg ; ciprofloxacin hcl  250  mg ; 
chronic obstructive pulmonary disease, unspecified cardiomyopathy, unspecified chronic diastolic (congestive) heart failure dependence on supplemental oxygen unspecified asthma, uncomplicated unspecified atrial fibrillation chronic kidney disease, stage 3 (moderate) acute kidney failure, unspecified gastro-esophageal reflux disease without esophagitis hypothyroidism, unspecified presence of xenogenic heart valve long term (current) use of anticoagulants atherosclerotic heart disease of native coronary artery without angina pectoris nonrheumatic mitral (valve) insufficiency hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease esophageal reflux other dependence on machines, supplemental oxygen hematoma complicating a procedure mitral valve insufficiency and aortic valve stenosis depressive disorder, not elsewhere classified heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident chronic obstructive asthma, unspecified coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia unspecified acquired hypothyroidism accidents occurring in unspecified place person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident atrial fibrillation unspecified procedure as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified essential hypertension other primary cardiomyopathies other complications due to other cardiac device, implant, and graft dementia, unspecified, without behavioral disturbance unspecified acquired hypothyroidism delirium due to conditions classified elsewhere congestive heart failure, unspecified family history of ischemic heart disease atrial fibrillation examination of participant in clinical trial chronic obstructive asthma, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other chronic pulmonary heart diseases coronary atherosclerosis of native coronary artery other primary cardiomyopathies other and unspecified hyperlipidemia mitral valve disorders long-term (current) use of aspirin
white f 86 $nan$hematology blood inr(pt)  3.3  $cetirizine  10  mg ; fluticasone propionate nasal  1  spry ; fluticasone-salmeterol diskus (500 50)   1  inh ; ipratropium-albuterol neb  1  neb ; levothyroxine sodium  75  mcg ; magnesium oxide  400  mg ; montelukast  10  mg ; pantoprazole  40  mg ; pravastatin  80  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; acetaminophen  650  mg ; donepezil  10  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; torsemide  40  mg ; losartan potassium  50  mg ; warfarin  1  mg ; metoprolol succinate xl  25  mg ; 
chronic obstructive pulmonary disease, unspecified cardiomyopathy, unspecified chronic diastolic (congestive) heart failure dependence on supplemental oxygen unspecified asthma, uncomplicated unspecified atrial fibrillation chronic kidney disease, stage 3 (moderate) acute kidney failure, unspecified gastro-esophageal reflux disease without esophagitis hypothyroidism, unspecified presence of xenogenic heart valve long term (current) use of anticoagulants atherosclerotic heart disease of native coronary artery without angina pectoris nonrheumatic mitral (valve) insufficiency hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease esophageal reflux other dependence on machines, supplemental oxygen hematoma complicating a procedure mitral valve insufficiency and aortic valve stenosis depressive disorder, not elsewhere classified heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident chronic obstructive asthma, unspecified coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia unspecified acquired hypothyroidism accidents occurring in unspecified place person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident atrial fibrillation unspecified procedure as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified essential hypertension other primary cardiomyopathies other complications due to other cardiac device, implant, and graft dementia, unspecified, without behavioral disturbance unspecified acquired hypothyroidism delirium due to conditions classified elsewhere congestive heart failure, unspecified family history of ischemic heart disease atrial fibrillation examination of participant in clinical trial chronic obstructive asthma, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other chronic pulmonary heart diseases coronary atherosclerosis of native coronary artery other primary cardiomyopathies other and unspecified hyperlipidemia mitral valve disorders long-term (current) use of aspirin
white f 76 $nan$nan$vitamin d  400  unit ; vitamin e  400  unit ; pyridoxine  50  mg ; 
 
white f 76 $nan$hematology blood hematocrit  30.3  %; hematology blood hematocrit  27.4  %; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  305  k ul; hematology blood platelet count  277  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  138  mg dl; chemistry blood glucose  137  mg dl; chemistry blood lactate dehydrogenase (ld)  201  iu l; chemistry blood albumin  3.1  g dl$vitamin d  400  unit ; vitamin e  400  unit ; pyridoxine  50  mg ; pneumococcal vac polyvalent  0.5  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; senna  1  tab ; prochlorperazine  10  mg ; ondansetron  8  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; d5ns  1000  ml ; heparin  5000  unit ; docusate sodium  100  mg ; trazodone  25  mg ; dronabinol  2.5  mg ; 
 
white f 76 $nan$hematology blood hematocrit  26.0  %; hematology blood hematocrit  27.5  %; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  208  k ul; hematology blood platelet count  250  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  116  mg dl; chemistry blood albumin  2.5  g dl$vitamin d  400  unit ; vitamin e  400  unit ; pyridoxine  50  mg ; pneumococcal vac polyvalent  0.5  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; senna  1  tab ; prochlorperazine  10  mg ; ondansetron  8  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; heparin  5000  unit ; docusate sodium  100  mg ; trazodone  25  mg ; dronabinol  2.5  mg ; d5 1 2ns  1000  ml ; lorazepam  0.5-1  mg ; 
 
white f 76 $nan$nan$vitamin d  400  unit ; vitamin e  400  unit ; pyridoxine  50  mg ; pneumococcal vac polyvalent  0.5  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; senna  1  tab ; prochlorperazine  10  mg ; ondansetron  8  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; heparin  5000  unit ; docusate sodium  100  mg ; dronabinol  2.5  mg ; lorazepam  0.5-1  mg ; 
 
white f 76 $nan$nan$vitamin d  400  unit ; vitamin e  400  unit ; pyridoxine  50  mg ; pneumococcal vac polyvalent  0.5  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; senna  1  tab ; prochlorperazine  10  mg ; ondansetron  8  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; heparin  5000  unit ; docusate sodium  100  mg ; dronabinol  2.5  mg ; lorazepam  0.5-1  mg ; 
 
black african american f 27 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; calcium carbonate  500  mg ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
black african american f 27 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; calcium carbonate  500  mg ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; tucks hemorrhoidal oint 1%  1  appl ; 
 
black african american f 27 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; calcium carbonate  500  mg ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; tucks hemorrhoidal oint 1%  1  appl ; 
 
black african american f 27 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; calcium carbonate  500  mg ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; tucks hemorrhoidal oint 1%  1  appl ; 
 
hispanic latino f 75 $temp  96.7  heartrate  70.0  resprate  18.0  o2sat  98.0  sbp  145.0  dbp  98.0  rhythm    pain  8  $nan$pantoprazole  40  mg ; 
old myocardial infarction vestibular neuronitis, unspecified ear unspecified urinary incontinence unspecified asthma, uncomplicated abnormal coagulation profile obesity, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation long term (current) use of anticoagulants major depressive disorder, single episode, unspecified body mass index (bmi) 40.0-44.9, adult chronic kidney disease, stage 3 (moderate) type 2 diabetes mellitus with diabetic chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris unspecified osteoarthritis, unspecified site spinal stenosis, lumbar region hypothyroidism, unspecified thalassemia minor other specified disorders of bone density and structure, unspecified site pure hypercholesterolemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris old myocardial infarction chronic systolic (congestive) heart failure hemorrhage of anus and rectum obesity, unspecified unspecified urinary incontinence hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease major depressive disorder, single episode, unspecified long term (current) use of anticoagulants tachycardia, unspecified unspecified atrial fibrillation body mass index (bmi) 38.0-38.9, adult diverticulosis of large intestine without perforation or abscess without bleeding type 2 diabetes mellitus with diabetic chronic kidney disease abnormal levels of other serum enzymes thalassemia minor unspecified asthma, uncomplicated chronic kidney disease, stage 3 (moderate) hypothyroidism, unspecified other specified disorders of bone density and structure, unspecified site pure hypercholesterolemia, unspecified hydronephrosis unspecified essential hypertension long-term (current) use of anticoagulants calculus of ureter unspecified acquired hypothyroidism urinary tract infection, site not specified atrial fibrillation
hispanic latino f 75 $temp  98.2  heartrate  90.0  resprate  16.0  o2sat  96.0  sbp  113.0  dbp  68.0  rhythm    pain    $hematology blood hematocrit  37.8  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  147  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  2.0  ; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  86  mg dl$pantoprazole  40  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; ondansetron  4  mg ; acetaminophen  650  mg ; famotidine  40  mg ; levothyroxine sodium  50  mcg ; lidocaine 5% patch  1  ptch ; lisinopril  40  mg ; montelukast  10  mg ; oxybutynin  5  mg ; citalopram  20  mg ; metoprolol succinate xl  25  mg ; torsemide  20  mg ; 
old myocardial infarction vestibular neuronitis, unspecified ear unspecified urinary incontinence unspecified asthma, uncomplicated abnormal coagulation profile obesity, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation long term (current) use of anticoagulants major depressive disorder, single episode, unspecified body mass index (bmi) 40.0-44.9, adult chronic kidney disease, stage 3 (moderate) type 2 diabetes mellitus with diabetic chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris unspecified osteoarthritis, unspecified site spinal stenosis, lumbar region hypothyroidism, unspecified thalassemia minor other specified disorders of bone density and structure, unspecified site pure hypercholesterolemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris old myocardial infarction chronic systolic (congestive) heart failure hemorrhage of anus and rectum obesity, unspecified unspecified urinary incontinence hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease major depressive disorder, single episode, unspecified long term (current) use of anticoagulants tachycardia, unspecified unspecified atrial fibrillation body mass index (bmi) 38.0-38.9, adult diverticulosis of large intestine without perforation or abscess without bleeding type 2 diabetes mellitus with diabetic chronic kidney disease abnormal levels of other serum enzymes thalassemia minor unspecified asthma, uncomplicated chronic kidney disease, stage 3 (moderate) hypothyroidism, unspecified other specified disorders of bone density and structure, unspecified site pure hypercholesterolemia, unspecified hydronephrosis unspecified essential hypertension long-term (current) use of anticoagulants calculus of ureter unspecified acquired hypothyroidism urinary tract infection, site not specified atrial fibrillation
hispanic latino f 75 $nan$hematology blood hematocrit  43.2  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  108  mg dl$pantoprazole  40  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; ondansetron  4  mg ; acetaminophen  650  mg ; famotidine  40  mg ; levothyroxine sodium  50  mcg ; lidocaine 5% patch  1  ptch ; lisinopril  40  mg ; montelukast  10  mg ; oxybutynin  5  mg ; citalopram  20  mg ; metoprolol succinate xl  25  mg ; torsemide  20  mg ; lactated ringers  1000  ml ; 
old myocardial infarction vestibular neuronitis, unspecified ear unspecified urinary incontinence unspecified asthma, uncomplicated abnormal coagulation profile obesity, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation long term (current) use of anticoagulants major depressive disorder, single episode, unspecified body mass index (bmi) 40.0-44.9, adult chronic kidney disease, stage 3 (moderate) type 2 diabetes mellitus with diabetic chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris unspecified osteoarthritis, unspecified site spinal stenosis, lumbar region hypothyroidism, unspecified thalassemia minor other specified disorders of bone density and structure, unspecified site pure hypercholesterolemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris old myocardial infarction chronic systolic (congestive) heart failure hemorrhage of anus and rectum obesity, unspecified unspecified urinary incontinence hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease major depressive disorder, single episode, unspecified long term (current) use of anticoagulants tachycardia, unspecified unspecified atrial fibrillation body mass index (bmi) 38.0-38.9, adult diverticulosis of large intestine without perforation or abscess without bleeding type 2 diabetes mellitus with diabetic chronic kidney disease abnormal levels of other serum enzymes thalassemia minor unspecified asthma, uncomplicated chronic kidney disease, stage 3 (moderate) hypothyroidism, unspecified other specified disorders of bone density and structure, unspecified site pure hypercholesterolemia, unspecified hydronephrosis unspecified essential hypertension long-term (current) use of anticoagulants calculus of ureter unspecified acquired hypothyroidism urinary tract infection, site not specified atrial fibrillation
hispanic latino f 75 $nan$hematology blood hematocrit  43.2  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  99  mg dl$pantoprazole  40  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; ondansetron  4  mg ; acetaminophen  650  mg ; famotidine  40  mg ; levothyroxine sodium  50  mcg ; lidocaine 5% patch  1  ptch ; lisinopril  40  mg ; montelukast  10  mg ; oxybutynin  5  mg ; citalopram  20  mg ; metoprolol succinate xl  25  mg ; torsemide  20  mg ; 
old myocardial infarction vestibular neuronitis, unspecified ear unspecified urinary incontinence unspecified asthma, uncomplicated abnormal coagulation profile obesity, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation long term (current) use of anticoagulants major depressive disorder, single episode, unspecified body mass index (bmi) 40.0-44.9, adult chronic kidney disease, stage 3 (moderate) type 2 diabetes mellitus with diabetic chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris unspecified osteoarthritis, unspecified site spinal stenosis, lumbar region hypothyroidism, unspecified thalassemia minor other specified disorders of bone density and structure, unspecified site pure hypercholesterolemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris old myocardial infarction chronic systolic (congestive) heart failure hemorrhage of anus and rectum obesity, unspecified unspecified urinary incontinence hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease major depressive disorder, single episode, unspecified long term (current) use of anticoagulants tachycardia, unspecified unspecified atrial fibrillation body mass index (bmi) 38.0-38.9, adult diverticulosis of large intestine without perforation or abscess without bleeding type 2 diabetes mellitus with diabetic chronic kidney disease abnormal levels of other serum enzymes thalassemia minor unspecified asthma, uncomplicated chronic kidney disease, stage 3 (moderate) hypothyroidism, unspecified other specified disorders of bone density and structure, unspecified site pure hypercholesterolemia, unspecified hydronephrosis unspecified essential hypertension long-term (current) use of anticoagulants calculus of ureter unspecified acquired hypothyroidism urinary tract infection, site not specified atrial fibrillation
hispanic latino f 75 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  122  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  87  mg dl$pantoprazole  40  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ondansetron  4  mg ; acetaminophen  650  mg ; levothyroxine sodium  50  mcg ; lidocaine 5% patch  1  ptch ; lisinopril  40  mg ; montelukast  10  mg ; oxybutynin  5  mg ; citalopram  20  mg ; metoprolol succinate xl  25  mg ; torsemide  20  mg ; oxycodone (immediate release)  5  mg ; acetaminophen  1000  mg ; senna  8.6  mg ; warfarin  4  mg ; 
old myocardial infarction vestibular neuronitis, unspecified ear unspecified urinary incontinence unspecified asthma, uncomplicated abnormal coagulation profile obesity, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation long term (current) use of anticoagulants major depressive disorder, single episode, unspecified body mass index (bmi) 40.0-44.9, adult chronic kidney disease, stage 3 (moderate) type 2 diabetes mellitus with diabetic chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris unspecified osteoarthritis, unspecified site spinal stenosis, lumbar region hypothyroidism, unspecified thalassemia minor other specified disorders of bone density and structure, unspecified site pure hypercholesterolemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris old myocardial infarction chronic systolic (congestive) heart failure hemorrhage of anus and rectum obesity, unspecified unspecified urinary incontinence hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease major depressive disorder, single episode, unspecified long term (current) use of anticoagulants tachycardia, unspecified unspecified atrial fibrillation body mass index (bmi) 38.0-38.9, adult diverticulosis of large intestine without perforation or abscess without bleeding type 2 diabetes mellitus with diabetic chronic kidney disease abnormal levels of other serum enzymes thalassemia minor unspecified asthma, uncomplicated chronic kidney disease, stage 3 (moderate) hypothyroidism, unspecified other specified disorders of bone density and structure, unspecified site pure hypercholesterolemia, unspecified hydronephrosis unspecified essential hypertension long-term (current) use of anticoagulants calculus of ureter unspecified acquired hypothyroidism urinary tract infection, site not specified atrial fibrillation
hispanic latino f 75 $nan$nan$pantoprazole  40  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ondansetron  4  mg ; levothyroxine sodium  50  mcg ; lidocaine 5% patch  1  ptch ; lisinopril  40  mg ; montelukast  10  mg ; oxybutynin  5  mg ; citalopram  20  mg ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; 
old myocardial infarction vestibular neuronitis, unspecified ear unspecified urinary incontinence unspecified asthma, uncomplicated abnormal coagulation profile obesity, unspecified hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation long term (current) use of anticoagulants major depressive disorder, single episode, unspecified body mass index (bmi) 40.0-44.9, adult chronic kidney disease, stage 3 (moderate) type 2 diabetes mellitus with diabetic chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris unspecified osteoarthritis, unspecified site spinal stenosis, lumbar region hypothyroidism, unspecified thalassemia minor other specified disorders of bone density and structure, unspecified site pure hypercholesterolemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris old myocardial infarction chronic systolic (congestive) heart failure hemorrhage of anus and rectum obesity, unspecified unspecified urinary incontinence hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease major depressive disorder, single episode, unspecified long term (current) use of anticoagulants tachycardia, unspecified unspecified atrial fibrillation body mass index (bmi) 38.0-38.9, adult diverticulosis of large intestine without perforation or abscess without bleeding type 2 diabetes mellitus with diabetic chronic kidney disease abnormal levels of other serum enzymes thalassemia minor unspecified asthma, uncomplicated chronic kidney disease, stage 3 (moderate) hypothyroidism, unspecified other specified disorders of bone density and structure, unspecified site pure hypercholesterolemia, unspecified hydronephrosis unspecified essential hypertension long-term (current) use of anticoagulants calculus of ureter unspecified acquired hypothyroidism urinary tract infection, site not specified atrial fibrillation
white m 66 $temp  97.3  heartrate  96.0  resprate  16.0  o2sat  96.0  sbp  132.0  dbp  70.0  rhythm    pain  1  ; temp  100.0  heartrate  75.0  resprate  18.0  o2sat  97.0  sbp  123.0  dbp  55.0  rhythm    pain    ; temp  99.8  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    ; temp  98.9  heartrate  64.0  resprate  16.0  o2sat  98.0  sbp  119.0  dbp  63.0  rhythm    pain    ; temp  98.6  heartrate  72.0  resprate  18.0  o2sat  94.0  sbp  106.0  dbp  63.0  rhythm    pain  0  ; temp  98.2  heartrate  77.0  resprate  18.0  o2sat  97.0  sbp  130.0  dbp  82.0  rhythm    pain  0  ; temp  98.3  heartrate  65.0  resprate  16.0  o2sat  95.0  sbp  105.0  dbp  50.0  rhythm    pain    $hematology blood hematocrit  47.1  %; hematology blood hemoglobin  15.9  g dl; hematology blood platelet count  223  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  3.4  ; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  103  mg dl; chemistry blood albumin  4.2  g dl; blood gas blood lactate  1.3  mmol l$nan
crohn's disease, unspecified, without complications long term (current) use of anticoagulants sepsis, unspecified organism personal history of pulmonary embolism unspecified place in hospital as the place of occurrence of the external cause other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension anxiety disorder, unspecified other postprocedural complications and disorders of digestive system personal history of other venous thrombosis and embolism gastro-esophageal reflux disease without esophagitis cholangitis infection following a procedure, initial encounter obstruction of bile duct long term (current) use of anticoagulants anxiety disorder, unspecified obstruction of bile duct abnormal coagulation profile cholangitis personal history of pulmonary embolism crohn's disease, unspecified, without complications biliary cirrhosis, unspecified personal history of other venous thrombosis and embolism personal history of venous thrombosis and embolism personal history of pulmonary embolism unspecified essential hypertension acquired absence of intestine (large) (small) long-term (current) use of steroids esophageal reflux depressive disorder, not elsewhere classified anxiety state, unspecified long-term (current) use of anticoagulants cholangitis obstruction of bile duct regional enteritis of unspecified site unspecified essential hypertension cholangitis acquired absence of intestine (large) (small) other and unspecified escherichia coli [e. coli] personal history of venous thrombosis and embolism long-term (current) use of steroids unspecified septicemia intestinal infection due to clostridium difficile anxiety state, unspecified personal history of pulmonary embolism long-term (current) use of anticoagulants regional enteritis of unspecified site depressive disorder, not elsewhere classified
white m 66 $temp  98.3  heartrate  66.0  resprate  18.0  o2sat  94.0  sbp  126.0  dbp  76.0  rhythm    pain  0  ; temp  98.3  heartrate  68.0  resprate  16.0  o2sat  94.0  sbp  116.0  dbp  64.0  rhythm    pain  0  ; temp  97.9  heartrate  58.0  resprate  18.0  o2sat  99.0  sbp  107.0  dbp  75.0  rhythm    pain    ; temp  98.0  heartrate  60.0  resprate  18.0  o2sat  97.0  sbp  124.0  dbp  68.0  rhythm    pain  0  ; temp  98.5  heartrate  59.0  resprate  17.0  o2sat  98.0  sbp  122.0  dbp  65.0  rhythm    pain  0  $hematology blood hematocrit  43.8  %; hematology blood hemoglobin  14.6  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  3.2  ; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  90  mg dl$nan
crohn's disease, unspecified, without complications long term (current) use of anticoagulants sepsis, unspecified organism personal history of pulmonary embolism unspecified place in hospital as the place of occurrence of the external cause other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension anxiety disorder, unspecified other postprocedural complications and disorders of digestive system personal history of other venous thrombosis and embolism gastro-esophageal reflux disease without esophagitis cholangitis infection following a procedure, initial encounter obstruction of bile duct long term (current) use of anticoagulants anxiety disorder, unspecified obstruction of bile duct abnormal coagulation profile cholangitis personal history of pulmonary embolism crohn's disease, unspecified, without complications biliary cirrhosis, unspecified personal history of other venous thrombosis and embolism personal history of venous thrombosis and embolism personal history of pulmonary embolism unspecified essential hypertension acquired absence of intestine (large) (small) long-term (current) use of steroids esophageal reflux depressive disorder, not elsewhere classified anxiety state, unspecified long-term (current) use of anticoagulants cholangitis obstruction of bile duct regional enteritis of unspecified site unspecified essential hypertension cholangitis acquired absence of intestine (large) (small) other and unspecified escherichia coli [e. coli] personal history of venous thrombosis and embolism long-term (current) use of steroids unspecified septicemia intestinal infection due to clostridium difficile anxiety state, unspecified personal history of pulmonary embolism long-term (current) use of anticoagulants regional enteritis of unspecified site depressive disorder, not elsewhere classified
white m 66 $nan$hematology blood hematocrit  41.8  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  216  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  3.7  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  86  mg dl; chemistry blood albumin  3.5  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; ondansetron  4  mg ; ursodiol  900  mg ; lorazepam  0.5  mg ; acetaminophen  500  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; apriso  0.75  g ; warfarin  2  mg ; warfarin  1  dose ; 
crohn's disease, unspecified, without complications long term (current) use of anticoagulants sepsis, unspecified organism personal history of pulmonary embolism unspecified place in hospital as the place of occurrence of the external cause other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension anxiety disorder, unspecified other postprocedural complications and disorders of digestive system personal history of other venous thrombosis and embolism gastro-esophageal reflux disease without esophagitis cholangitis infection following a procedure, initial encounter obstruction of bile duct long term (current) use of anticoagulants anxiety disorder, unspecified obstruction of bile duct abnormal coagulation profile cholangitis personal history of pulmonary embolism crohn's disease, unspecified, without complications biliary cirrhosis, unspecified personal history of other venous thrombosis and embolism personal history of venous thrombosis and embolism personal history of pulmonary embolism unspecified essential hypertension acquired absence of intestine (large) (small) long-term (current) use of steroids esophageal reflux depressive disorder, not elsewhere classified anxiety state, unspecified long-term (current) use of anticoagulants cholangitis obstruction of bile duct regional enteritis of unspecified site unspecified essential hypertension cholangitis acquired absence of intestine (large) (small) other and unspecified escherichia coli [e. coli] personal history of venous thrombosis and embolism long-term (current) use of steroids unspecified septicemia intestinal infection due to clostridium difficile anxiety state, unspecified personal history of pulmonary embolism long-term (current) use of anticoagulants regional enteritis of unspecified site depressive disorder, not elsewhere classified
white m 66 $nan$hematology blood hematocrit  41.3  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  87  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; ursodiol  900  mg ; lorazepam  0.5  mg ; acetaminophen  500  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; apriso  0.75  g ; warfarin  2  mg ; 
crohn's disease, unspecified, without complications long term (current) use of anticoagulants sepsis, unspecified organism personal history of pulmonary embolism unspecified place in hospital as the place of occurrence of the external cause other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension anxiety disorder, unspecified other postprocedural complications and disorders of digestive system personal history of other venous thrombosis and embolism gastro-esophageal reflux disease without esophagitis cholangitis infection following a procedure, initial encounter obstruction of bile duct long term (current) use of anticoagulants anxiety disorder, unspecified obstruction of bile duct abnormal coagulation profile cholangitis personal history of pulmonary embolism crohn's disease, unspecified, without complications biliary cirrhosis, unspecified personal history of other venous thrombosis and embolism personal history of venous thrombosis and embolism personal history of pulmonary embolism unspecified essential hypertension acquired absence of intestine (large) (small) long-term (current) use of steroids esophageal reflux depressive disorder, not elsewhere classified anxiety state, unspecified long-term (current) use of anticoagulants cholangitis obstruction of bile duct regional enteritis of unspecified site unspecified essential hypertension cholangitis acquired absence of intestine (large) (small) other and unspecified escherichia coli [e. coli] personal history of venous thrombosis and embolism long-term (current) use of steroids unspecified septicemia intestinal infection due to clostridium difficile anxiety state, unspecified personal history of pulmonary embolism long-term (current) use of anticoagulants regional enteritis of unspecified site depressive disorder, not elsewhere classified
white m 66 $nan$hematology blood hematocrit  44.2  %; hematology blood hemoglobin  14.9  g dl; hematology blood platelet count  265  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  87  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; ursodiol  900  mg ; lorazepam  0.5  mg ; acetaminophen  500  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; apriso  0.75  g ; 
crohn's disease, unspecified, without complications long term (current) use of anticoagulants sepsis, unspecified organism personal history of pulmonary embolism unspecified place in hospital as the place of occurrence of the external cause other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension anxiety disorder, unspecified other postprocedural complications and disorders of digestive system personal history of other venous thrombosis and embolism gastro-esophageal reflux disease without esophagitis cholangitis infection following a procedure, initial encounter obstruction of bile duct long term (current) use of anticoagulants anxiety disorder, unspecified obstruction of bile duct abnormal coagulation profile cholangitis personal history of pulmonary embolism crohn's disease, unspecified, without complications biliary cirrhosis, unspecified personal history of other venous thrombosis and embolism personal history of venous thrombosis and embolism personal history of pulmonary embolism unspecified essential hypertension acquired absence of intestine (large) (small) long-term (current) use of steroids esophageal reflux depressive disorder, not elsewhere classified anxiety state, unspecified long-term (current) use of anticoagulants cholangitis obstruction of bile duct regional enteritis of unspecified site unspecified essential hypertension cholangitis acquired absence of intestine (large) (small) other and unspecified escherichia coli [e. coli] personal history of venous thrombosis and embolism long-term (current) use of steroids unspecified septicemia intestinal infection due to clostridium difficile anxiety state, unspecified personal history of pulmonary embolism long-term (current) use of anticoagulants regional enteritis of unspecified site depressive disorder, not elsewhere classified
white m 66 $nan$hematology blood hematocrit  42.1  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  275  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  91  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; ursodiol  900  mg ; lorazepam  0.5  mg ; acetaminophen  500  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; apriso  0.75  g ; enoxaparin sodium  90  mg ; 
crohn's disease, unspecified, without complications long term (current) use of anticoagulants sepsis, unspecified organism personal history of pulmonary embolism unspecified place in hospital as the place of occurrence of the external cause other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension anxiety disorder, unspecified other postprocedural complications and disorders of digestive system personal history of other venous thrombosis and embolism gastro-esophageal reflux disease without esophagitis cholangitis infection following a procedure, initial encounter obstruction of bile duct long term (current) use of anticoagulants anxiety disorder, unspecified obstruction of bile duct abnormal coagulation profile cholangitis personal history of pulmonary embolism crohn's disease, unspecified, without complications biliary cirrhosis, unspecified personal history of other venous thrombosis and embolism personal history of venous thrombosis and embolism personal history of pulmonary embolism unspecified essential hypertension acquired absence of intestine (large) (small) long-term (current) use of steroids esophageal reflux depressive disorder, not elsewhere classified anxiety state, unspecified long-term (current) use of anticoagulants cholangitis obstruction of bile duct regional enteritis of unspecified site unspecified essential hypertension cholangitis acquired absence of intestine (large) (small) other and unspecified escherichia coli [e. coli] personal history of venous thrombosis and embolism long-term (current) use of steroids unspecified septicemia intestinal infection due to clostridium difficile anxiety state, unspecified personal history of pulmonary embolism long-term (current) use of anticoagulants regional enteritis of unspecified site depressive disorder, not elsewhere classified
white m 66 $nan$hematology blood hematocrit  45.9  %; hematology blood hemoglobin  15.4  g dl; hematology blood platelet count  327  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  85  mg dl; chemistry blood lactate dehydrogenase (ld)  205  iu l; chemistry blood albumin  4.0  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; ursodiol  900  mg ; lorazepam  0.5  mg ; acetaminophen  500  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; apriso  0.75  g ; enoxaparin sodium  90  mg ; 
crohn's disease, unspecified, without complications long term (current) use of anticoagulants sepsis, unspecified organism personal history of pulmonary embolism unspecified place in hospital as the place of occurrence of the external cause other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension anxiety disorder, unspecified other postprocedural complications and disorders of digestive system personal history of other venous thrombosis and embolism gastro-esophageal reflux disease without esophagitis cholangitis infection following a procedure, initial encounter obstruction of bile duct long term (current) use of anticoagulants anxiety disorder, unspecified obstruction of bile duct abnormal coagulation profile cholangitis personal history of pulmonary embolism crohn's disease, unspecified, without complications biliary cirrhosis, unspecified personal history of other venous thrombosis and embolism personal history of venous thrombosis and embolism personal history of pulmonary embolism unspecified essential hypertension acquired absence of intestine (large) (small) long-term (current) use of steroids esophageal reflux depressive disorder, not elsewhere classified anxiety state, unspecified long-term (current) use of anticoagulants cholangitis obstruction of bile duct regional enteritis of unspecified site unspecified essential hypertension cholangitis acquired absence of intestine (large) (small) other and unspecified escherichia coli [e. coli] personal history of venous thrombosis and embolism long-term (current) use of steroids unspecified septicemia intestinal infection due to clostridium difficile anxiety state, unspecified personal history of pulmonary embolism long-term (current) use of anticoagulants regional enteritis of unspecified site depressive disorder, not elsewhere classified
white m 66 $nan$hematology blood hematocrit  42.2  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  308  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  93  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; ursodiol  900  mg ; lorazepam  0.5  mg ; acetaminophen  500  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; apriso  0.75  g ; lactated ringers  1000  ml ; warfarin  10  mg ; 
crohn's disease, unspecified, without complications long term (current) use of anticoagulants sepsis, unspecified organism personal history of pulmonary embolism unspecified place in hospital as the place of occurrence of the external cause other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension anxiety disorder, unspecified other postprocedural complications and disorders of digestive system personal history of other venous thrombosis and embolism gastro-esophageal reflux disease without esophagitis cholangitis infection following a procedure, initial encounter obstruction of bile duct long term (current) use of anticoagulants anxiety disorder, unspecified obstruction of bile duct abnormal coagulation profile cholangitis personal history of pulmonary embolism crohn's disease, unspecified, without complications biliary cirrhosis, unspecified personal history of other venous thrombosis and embolism personal history of venous thrombosis and embolism personal history of pulmonary embolism unspecified essential hypertension acquired absence of intestine (large) (small) long-term (current) use of steroids esophageal reflux depressive disorder, not elsewhere classified anxiety state, unspecified long-term (current) use of anticoagulants cholangitis obstruction of bile duct regional enteritis of unspecified site unspecified essential hypertension cholangitis acquired absence of intestine (large) (small) other and unspecified escherichia coli [e. coli] personal history of venous thrombosis and embolism long-term (current) use of steroids unspecified septicemia intestinal infection due to clostridium difficile anxiety state, unspecified personal history of pulmonary embolism long-term (current) use of anticoagulants regional enteritis of unspecified site depressive disorder, not elsewhere classified
white m 66 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; ursodiol  900  mg ; lorazepam  0.5  mg ; acetaminophen  500  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; apriso  0.75  g ; warfarin  10  mg ; 
crohn's disease, unspecified, without complications long term (current) use of anticoagulants sepsis, unspecified organism personal history of pulmonary embolism unspecified place in hospital as the place of occurrence of the external cause other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure essential (primary) hypertension anxiety disorder, unspecified other postprocedural complications and disorders of digestive system personal history of other venous thrombosis and embolism gastro-esophageal reflux disease without esophagitis cholangitis infection following a procedure, initial encounter obstruction of bile duct long term (current) use of anticoagulants anxiety disorder, unspecified obstruction of bile duct abnormal coagulation profile cholangitis personal history of pulmonary embolism crohn's disease, unspecified, without complications biliary cirrhosis, unspecified personal history of other venous thrombosis and embolism personal history of venous thrombosis and embolism personal history of pulmonary embolism unspecified essential hypertension acquired absence of intestine (large) (small) long-term (current) use of steroids esophageal reflux depressive disorder, not elsewhere classified anxiety state, unspecified long-term (current) use of anticoagulants cholangitis obstruction of bile duct regional enteritis of unspecified site unspecified essential hypertension cholangitis acquired absence of intestine (large) (small) other and unspecified escherichia coli [e. coli] personal history of venous thrombosis and embolism long-term (current) use of steroids unspecified septicemia intestinal infection due to clostridium difficile anxiety state, unspecified personal history of pulmonary embolism long-term (current) use of anticoagulants regional enteritis of unspecified site depressive disorder, not elsewhere classified
white f 83 $temp  97.9  heartrate  99.0  resprate  24.0  o2sat  99.0  sbp  159.0  dbp  74.0  rhythm    pain  0  ; temp  98.0  heartrate  98.0  resprate  16.0  o2sat  96.0  sbp  138.0  dbp  66.0  rhythm    pain  0  $hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  442  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  83  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry urine creatinine, urine  66  mg dl; chemistry urine urea nitrogen, urine  808  mg dl; chemistry blood glucose  265  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; azithromycin  250  mg ; amlodipine  5  mg ; aspirin  81  mg ; atorvastatin  40  mg ; levothyroxine sodium  88  mcg ; omeprazole  20  mg ; polyethylene glycol  17  g ; ranitidine  150  mg ; fluocinonide 0.05% cream  1  appl ; desonide 0.05% cream  1  appl ; cetirizine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; prednisone  40  mg ; potassium chloride  40  meq ; bisacodyl  10  mg ; metformin (glucophage)  500  mg ; 
esophageal reflux other and unspecified hyperlipidemia personal history of tobacco use cellulitis and abscess of upper arm and forearm unspecified acquired hypothyroidism unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled home accidents abnormality of gait unspecified fall bimalleolar fracture, closed other specified metabolic disorders nausea with vomiting unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified transient cerebral ischemia personal history of tobacco use streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other and unspecified hyperlipidemia urinary tract infection, site not specified unspecified essential hypertension 
white f 83 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  393  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  197  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; amlodipine  5  mg ; aspirin  81  mg ; atorvastatin  40  mg ; levothyroxine sodium  88  mcg ; omeprazole  20  mg ; polyethylene glycol  17  g ; ranitidine  150  mg ; fluocinonide 0.05% cream  1  appl ; desonide 0.05% cream  1  appl ; cetirizine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; prednisone  40  mg ; potassium chloride  40  meq ; bisacodyl  10  mg ; metformin (glucophage)  500  mg ; acetaminophen  650  mg ; neutra-phos  2  pkt ; 
esophageal reflux other and unspecified hyperlipidemia personal history of tobacco use cellulitis and abscess of upper arm and forearm unspecified acquired hypothyroidism unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled home accidents abnormality of gait unspecified fall bimalleolar fracture, closed other specified metabolic disorders nausea with vomiting unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified transient cerebral ischemia personal history of tobacco use streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other and unspecified hyperlipidemia urinary tract infection, site not specified unspecified essential hypertension 
white f 83 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  202  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; aspirin  81  mg ; atorvastatin  40  mg ; levothyroxine sodium  88  mcg ; omeprazole  20  mg ; polyethylene glycol  17  g ; ranitidine  150  mg ; fluocinonide 0.05% cream  1  appl ; desonide 0.05% cream  1  appl ; cetirizine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; bisacodyl  10  mg ; metformin (glucophage)  500  mg ; acetaminophen  650  mg ; neutra-phos  2  pkt ; amlodipine  10  mg ; tiotropium bromide  1  cap ; bag  2  bag ; magnesium sulfate  4  gm ; 
esophageal reflux other and unspecified hyperlipidemia personal history of tobacco use cellulitis and abscess of upper arm and forearm unspecified acquired hypothyroidism unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled home accidents abnormality of gait unspecified fall bimalleolar fracture, closed other specified metabolic disorders nausea with vomiting unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified transient cerebral ischemia personal history of tobacco use streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other and unspecified hyperlipidemia urinary tract infection, site not specified unspecified essential hypertension 
white m 33 $nan$nan$fluoxetine  40  mg ; buspirone  20  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; baclofen  10  mg ; divalproex (delayed release)  500  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  0.25  mg ; oxycodone (immediate release)   5  mg ; ondansetron  4  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; 
opioid abuse, uncomplicated nonrheumatic mitral (valve) insufficiency sepsis due to methicillin susceptible staphylococcus aureus aphasia following cerebral infarction facial weakness following cerebral infarction infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts, subsequent encounter compression of brain unspecified place or not applicable restlessness and agitation personal history of nicotine dependence unspecified convulsions hemiplegia and hemiparesis following cerebral infarction affecting right dominant side other bacterial meningitis mild cognitive impairment, so stated surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure anxiety disorder, unspecified other specified sepsis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure disruption of external operation (surgical) wound, not elsewhere classified, initial encounter nonrheumatic mitral (valve) insufficiency other acquired deformity of head personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified place or not applicable epilepsy, unspecified, not intractable, without status epilepticus nicotine dependence, cigarettes, uncomplicated opioid dependence, uncomplicated mitral valve disorders embolism and thrombosis of other specified artery opioid type dependence, continuous acute and subacute bacterial endocarditis anemia, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] candidiasis of mouth cerebral edema hemiplegia, unspecified, affecting unspecified side subdural hemorrhage aphasia hyperosmolality and/or hypernatremia epilepsy, unspecified, without mention of intractable epilepsy acute kidney failure with lesion of tubular necrosis septic arterial embolism cerebral embolism with cerebral infarction tobacco use disorder physical restraints status bacteremia compression of brain
white m 33 $nan$hematology blood hematocrit  37.1  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  102  mg dl$fluoxetine  40  mg ; buspirone  20  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; baclofen  10  mg ; divalproex (delayed release)  500  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  0.25  mg ; oxycodone (immediate release)   5  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; nicotine patch  14  mg ; morphine sulfate  2-4  mg ; heparin  5000  unit ; trazodone  50  mg ; 
opioid abuse, uncomplicated nonrheumatic mitral (valve) insufficiency sepsis due to methicillin susceptible staphylococcus aureus aphasia following cerebral infarction facial weakness following cerebral infarction infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts, subsequent encounter compression of brain unspecified place or not applicable restlessness and agitation personal history of nicotine dependence unspecified convulsions hemiplegia and hemiparesis following cerebral infarction affecting right dominant side other bacterial meningitis mild cognitive impairment, so stated surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure anxiety disorder, unspecified other specified sepsis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure disruption of external operation (surgical) wound, not elsewhere classified, initial encounter nonrheumatic mitral (valve) insufficiency other acquired deformity of head personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified place or not applicable epilepsy, unspecified, not intractable, without status epilepticus nicotine dependence, cigarettes, uncomplicated opioid dependence, uncomplicated mitral valve disorders embolism and thrombosis of other specified artery opioid type dependence, continuous acute and subacute bacterial endocarditis anemia, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] candidiasis of mouth cerebral edema hemiplegia, unspecified, affecting unspecified side subdural hemorrhage aphasia hyperosmolality and/or hypernatremia epilepsy, unspecified, without mention of intractable epilepsy acute kidney failure with lesion of tubular necrosis septic arterial embolism cerebral embolism with cerebral infarction tobacco use disorder physical restraints status bacteremia compression of brain
white m 33 $nan$nan$fluoxetine  40  mg ; buspirone  20  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; baclofen  10  mg ; divalproex (delayed release)  500  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; nicotine patch  14  mg ; morphine sulfate  2-4  mg ; heparin  5000  unit ; trazodone  50  mg ; 
opioid abuse, uncomplicated nonrheumatic mitral (valve) insufficiency sepsis due to methicillin susceptible staphylococcus aureus aphasia following cerebral infarction facial weakness following cerebral infarction infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts, subsequent encounter compression of brain unspecified place or not applicable restlessness and agitation personal history of nicotine dependence unspecified convulsions hemiplegia and hemiparesis following cerebral infarction affecting right dominant side other bacterial meningitis mild cognitive impairment, so stated surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure anxiety disorder, unspecified other specified sepsis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure disruption of external operation (surgical) wound, not elsewhere classified, initial encounter nonrheumatic mitral (valve) insufficiency other acquired deformity of head personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified place or not applicable epilepsy, unspecified, not intractable, without status epilepticus nicotine dependence, cigarettes, uncomplicated opioid dependence, uncomplicated mitral valve disorders embolism and thrombosis of other specified artery opioid type dependence, continuous acute and subacute bacterial endocarditis anemia, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] candidiasis of mouth cerebral edema hemiplegia, unspecified, affecting unspecified side subdural hemorrhage aphasia hyperosmolality and/or hypernatremia epilepsy, unspecified, without mention of intractable epilepsy acute kidney failure with lesion of tubular necrosis septic arterial embolism cerebral embolism with cerebral infarction tobacco use disorder physical restraints status bacteremia compression of brain
white m 33 $nan$nan$fluoxetine  40  mg ; buspirone  20  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; baclofen  10  mg ; divalproex (delayed release)  500  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; nicotine patch  14  mg ; morphine sulfate  2-4  mg ; heparin  5000  unit ; trazodone  50  mg ; 
opioid abuse, uncomplicated nonrheumatic mitral (valve) insufficiency sepsis due to methicillin susceptible staphylococcus aureus aphasia following cerebral infarction facial weakness following cerebral infarction infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts, subsequent encounter compression of brain unspecified place or not applicable restlessness and agitation personal history of nicotine dependence unspecified convulsions hemiplegia and hemiparesis following cerebral infarction affecting right dominant side other bacterial meningitis mild cognitive impairment, so stated surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure anxiety disorder, unspecified other specified sepsis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure disruption of external operation (surgical) wound, not elsewhere classified, initial encounter nonrheumatic mitral (valve) insufficiency other acquired deformity of head personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified place or not applicable epilepsy, unspecified, not intractable, without status epilepticus nicotine dependence, cigarettes, uncomplicated opioid dependence, uncomplicated mitral valve disorders embolism and thrombosis of other specified artery opioid type dependence, continuous acute and subacute bacterial endocarditis anemia, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] candidiasis of mouth cerebral edema hemiplegia, unspecified, affecting unspecified side subdural hemorrhage aphasia hyperosmolality and/or hypernatremia epilepsy, unspecified, without mention of intractable epilepsy acute kidney failure with lesion of tubular necrosis septic arterial embolism cerebral embolism with cerebral infarction tobacco use disorder physical restraints status bacteremia compression of brain
white m 33 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  216  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  93  mg dl$fluoxetine  40  mg ; buspirone  20  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; baclofen  10  mg ; divalproex (delayed release)  500  mg ; sodium chloride 0.9%  1000  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; nicotine patch  14  mg ; heparin  5000  unit ; trazodone  50  mg ; morphine sulfate  1-2  mg ; 
opioid abuse, uncomplicated nonrheumatic mitral (valve) insufficiency sepsis due to methicillin susceptible staphylococcus aureus aphasia following cerebral infarction facial weakness following cerebral infarction infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts, subsequent encounter compression of brain unspecified place or not applicable restlessness and agitation personal history of nicotine dependence unspecified convulsions hemiplegia and hemiparesis following cerebral infarction affecting right dominant side other bacterial meningitis mild cognitive impairment, so stated surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure anxiety disorder, unspecified other specified sepsis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure disruption of external operation (surgical) wound, not elsewhere classified, initial encounter nonrheumatic mitral (valve) insufficiency other acquired deformity of head personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified place or not applicable epilepsy, unspecified, not intractable, without status epilepticus nicotine dependence, cigarettes, uncomplicated opioid dependence, uncomplicated mitral valve disorders embolism and thrombosis of other specified artery opioid type dependence, continuous acute and subacute bacterial endocarditis anemia, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] candidiasis of mouth cerebral edema hemiplegia, unspecified, affecting unspecified side subdural hemorrhage aphasia hyperosmolality and/or hypernatremia epilepsy, unspecified, without mention of intractable epilepsy acute kidney failure with lesion of tubular necrosis septic arterial embolism cerebral embolism with cerebral infarction tobacco use disorder physical restraints status bacteremia compression of brain
white m 33 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  92  mg dl$fluoxetine  40  mg ; buspirone  20  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; baclofen  10  mg ; divalproex (delayed release)  500  mg ; acetaminophen  325-650  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; nicotine patch  14  mg ; trazodone  50  mg ; morphine sulfate  1-2  mg ; bisacodyl  10  mg ; 
opioid abuse, uncomplicated nonrheumatic mitral (valve) insufficiency sepsis due to methicillin susceptible staphylococcus aureus aphasia following cerebral infarction facial weakness following cerebral infarction infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts, subsequent encounter compression of brain unspecified place or not applicable restlessness and agitation personal history of nicotine dependence unspecified convulsions hemiplegia and hemiparesis following cerebral infarction affecting right dominant side other bacterial meningitis mild cognitive impairment, so stated surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure anxiety disorder, unspecified other specified sepsis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure disruption of external operation (surgical) wound, not elsewhere classified, initial encounter nonrheumatic mitral (valve) insufficiency other acquired deformity of head personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified place or not applicable epilepsy, unspecified, not intractable, without status epilepticus nicotine dependence, cigarettes, uncomplicated opioid dependence, uncomplicated mitral valve disorders embolism and thrombosis of other specified artery opioid type dependence, continuous acute and subacute bacterial endocarditis anemia, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] candidiasis of mouth cerebral edema hemiplegia, unspecified, affecting unspecified side subdural hemorrhage aphasia hyperosmolality and/or hypernatremia epilepsy, unspecified, without mention of intractable epilepsy acute kidney failure with lesion of tubular necrosis septic arterial embolism cerebral embolism with cerebral infarction tobacco use disorder physical restraints status bacteremia compression of brain
white m 55 $nan$nan$diltiazem extended-release  240  mg ; ezetimibe  10  mg ; lisinopril  20  mg ; aspirin  325  mg ; atorvastatin  80  mg ; aspirin  81  mg ; prasugrel  10  mg ; 
 
white m 55 $nan$hematology blood hematocrit  40.0  %; hematology blood platelet count  101  k ul; hematology blood platelet count  98  k ul; chemistry blood chloride  102  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl$diltiazem extended-release  240  mg ; ezetimibe  10  mg ; lisinopril  20  mg ; aspirin  325  mg ; atorvastatin  80  mg ; aspirin  81  mg ; prasugrel  10  mg ; trazodone  50  mg ; nitroglycerin sl  0.3  mg ; acetaminophen  650  mg ; simethicone  40-80  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; docusate sodium  100  mg ; carvedilol  12.5  mg ; omeprazole  40  mg ; ranitidine  300  mg ; 
 
white m 55 $nan$nan$diltiazem extended-release  240  mg ; ezetimibe  10  mg ; lisinopril  20  mg ; atorvastatin  80  mg ; aspirin  81  mg ; prasugrel  10  mg ; trazodone  50  mg ; nitroglycerin sl  0.3  mg ; acetaminophen  650  mg ; simethicone  40-80  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; carvedilol  12.5  mg ; omeprazole  40  mg ; ranitidine  300  mg ; 
 
hispanic latino m 25 $temp  98.2  heartrate  80.0  resprate  18.0  o2sat  99.0  sbp  158.0  dbp  102.0  rhythm    pain  0  $nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; benztropine mesylate  1  mg ; clonidine  0.1  mg ; divalproex (delayed release)  750  mg ; olanzapine  30  mg ; perphenazine  16  mg ; simvastatin  20  mg ; trazodone  100  mg ; 
personal history of traumatic brain injury pure hypercholesterolemia schizoaffective disorder, unspecified unspecified intellectual disabilities dizziness and giddiness unspecified essential hypertension anemia, unspecified borderline personality disorder asthma, unspecified type, unspecified suicidal ideation unspecified essential hypertension bipolar disorder, unspecified unspecified schizophrenia, unspecified pure hypercholesterolemia unspecified delay in development unspecified essential hypertension asthma, unspecified type, unspecified bipolar disorder, unspecified unspecified schizophrenia, unspecified unspecified delay in development suicidal ideation schizoaffective disorder, chronic with acute exacerbation borderline personality disorder other and unspecified hyperlipidemia unspecified essential hypertension unspecified intellectual disabilities schizoaffective disorder, unspecified pain in joint, ankle and foot unspecified intellectual disabilities unspecified essential hypertension borderline personality disorder asthma, unspecified type, unspecified unspecified essential hypertension suicidal ideation homicidal ideation other and unspecified hyperlipidemia unspecified delay in development schizoaffective disorder, unspecified other specified metabolic disorders borderline personality disorder unspecified essential hypertension unspecified fall schizoaffective disorder, unspecified other and unspecified hyperlipidemia unspecified intellectual disabilities sprain of neck suicidal ideation unspecified intellectual disabilities
hispanic latino m 25 $nan$hematology blood hematocrit  43.3  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  105  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; benztropine mesylate  1  mg ; clonidine  0.1  mg ; divalproex (delayed release)  750  mg ; olanzapine  30  mg ; perphenazine  16  mg ; simvastatin  20  mg ; trazodone  100  mg ; 
personal history of traumatic brain injury pure hypercholesterolemia schizoaffective disorder, unspecified unspecified intellectual disabilities dizziness and giddiness unspecified essential hypertension anemia, unspecified borderline personality disorder asthma, unspecified type, unspecified suicidal ideation unspecified essential hypertension bipolar disorder, unspecified unspecified schizophrenia, unspecified pure hypercholesterolemia unspecified delay in development unspecified essential hypertension asthma, unspecified type, unspecified bipolar disorder, unspecified unspecified schizophrenia, unspecified unspecified delay in development suicidal ideation schizoaffective disorder, chronic with acute exacerbation borderline personality disorder other and unspecified hyperlipidemia unspecified essential hypertension unspecified intellectual disabilities schizoaffective disorder, unspecified pain in joint, ankle and foot unspecified intellectual disabilities unspecified essential hypertension borderline personality disorder asthma, unspecified type, unspecified unspecified essential hypertension suicidal ideation homicidal ideation other and unspecified hyperlipidemia unspecified delay in development schizoaffective disorder, unspecified other specified metabolic disorders borderline personality disorder unspecified essential hypertension unspecified fall schizoaffective disorder, unspecified other and unspecified hyperlipidemia unspecified intellectual disabilities sprain of neck suicidal ideation unspecified intellectual disabilities
hispanic latino m 25 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; benztropine mesylate  1  mg ; clonidine  0.1  mg ; divalproex (delayed release)  750  mg ; olanzapine  30  mg ; perphenazine  16  mg ; simvastatin  20  mg ; trazodone  100  mg ; 
personal history of traumatic brain injury pure hypercholesterolemia schizoaffective disorder, unspecified unspecified intellectual disabilities dizziness and giddiness unspecified essential hypertension anemia, unspecified borderline personality disorder asthma, unspecified type, unspecified suicidal ideation unspecified essential hypertension bipolar disorder, unspecified unspecified schizophrenia, unspecified pure hypercholesterolemia unspecified delay in development unspecified essential hypertension asthma, unspecified type, unspecified bipolar disorder, unspecified unspecified schizophrenia, unspecified unspecified delay in development suicidal ideation schizoaffective disorder, chronic with acute exacerbation borderline personality disorder other and unspecified hyperlipidemia unspecified essential hypertension unspecified intellectual disabilities schizoaffective disorder, unspecified pain in joint, ankle and foot unspecified intellectual disabilities unspecified essential hypertension borderline personality disorder asthma, unspecified type, unspecified unspecified essential hypertension suicidal ideation homicidal ideation other and unspecified hyperlipidemia unspecified delay in development schizoaffective disorder, unspecified other specified metabolic disorders borderline personality disorder unspecified essential hypertension unspecified fall schizoaffective disorder, unspecified other and unspecified hyperlipidemia unspecified intellectual disabilities sprain of neck suicidal ideation unspecified intellectual disabilities
hispanic latino m 25 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; benztropine mesylate  1  mg ; clonidine  0.1  mg ; divalproex (delayed release)  750  mg ; olanzapine  30  mg ; perphenazine  16  mg ; simvastatin  20  mg ; trazodone  100  mg ; 
personal history of traumatic brain injury pure hypercholesterolemia schizoaffective disorder, unspecified unspecified intellectual disabilities dizziness and giddiness unspecified essential hypertension anemia, unspecified borderline personality disorder asthma, unspecified type, unspecified suicidal ideation unspecified essential hypertension bipolar disorder, unspecified unspecified schizophrenia, unspecified pure hypercholesterolemia unspecified delay in development unspecified essential hypertension asthma, unspecified type, unspecified bipolar disorder, unspecified unspecified schizophrenia, unspecified unspecified delay in development suicidal ideation schizoaffective disorder, chronic with acute exacerbation borderline personality disorder other and unspecified hyperlipidemia unspecified essential hypertension unspecified intellectual disabilities schizoaffective disorder, unspecified pain in joint, ankle and foot unspecified intellectual disabilities unspecified essential hypertension borderline personality disorder asthma, unspecified type, unspecified unspecified essential hypertension suicidal ideation homicidal ideation other and unspecified hyperlipidemia unspecified delay in development schizoaffective disorder, unspecified other specified metabolic disorders borderline personality disorder unspecified essential hypertension unspecified fall schizoaffective disorder, unspecified other and unspecified hyperlipidemia unspecified intellectual disabilities sprain of neck suicidal ideation unspecified intellectual disabilities
hispanic latino m 25 $nan$nan$heparin  5000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; benztropine mesylate  1  mg ; clonidine  0.1  mg ; divalproex (delayed release)  750  mg ; olanzapine  30  mg ; perphenazine  16  mg ; simvastatin  20  mg ; trazodone  100  mg ; 
personal history of traumatic brain injury pure hypercholesterolemia schizoaffective disorder, unspecified unspecified intellectual disabilities dizziness and giddiness unspecified essential hypertension anemia, unspecified borderline personality disorder asthma, unspecified type, unspecified suicidal ideation unspecified essential hypertension bipolar disorder, unspecified unspecified schizophrenia, unspecified pure hypercholesterolemia unspecified delay in development unspecified essential hypertension asthma, unspecified type, unspecified bipolar disorder, unspecified unspecified schizophrenia, unspecified unspecified delay in development suicidal ideation schizoaffective disorder, chronic with acute exacerbation borderline personality disorder other and unspecified hyperlipidemia unspecified essential hypertension unspecified intellectual disabilities schizoaffective disorder, unspecified pain in joint, ankle and foot unspecified intellectual disabilities unspecified essential hypertension borderline personality disorder asthma, unspecified type, unspecified unspecified essential hypertension suicidal ideation homicidal ideation other and unspecified hyperlipidemia unspecified delay in development schizoaffective disorder, unspecified other specified metabolic disorders borderline personality disorder unspecified essential hypertension unspecified fall schizoaffective disorder, unspecified other and unspecified hyperlipidemia unspecified intellectual disabilities sprain of neck suicidal ideation unspecified intellectual disabilities
white f 21 $nan$hematology blood hematocrit  39.2  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  302  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood glucose  98  mg dl$1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; 0.9% sodium chloride  1000  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; diphenhydramine  25  mg ; cephalexin  500  mg ; 
 
white f 21 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; 0.9% sodium chloride  1000  ml ; diphenhydramine  25  mg ; cephalexin  500  mg ; sulfameth trimethoprim ds  2  tab ; 
 
white f 43 $nan$nan$bisacodyl  10  mg ; thiamine  100  mg ; 
 
white f 43 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  105  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  2.6  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  103  mg dl; chemistry blood glucose  147  mg dl$bisacodyl  10  mg ; thiamine  100  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  100  ml ; phenytoin sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; lorazepam  0.5  mg ; syringe  1  syr ; folic acid  1  mg ; multivitamins  10  ml ; senna  1  tab ; docusate sodium  100  mg ; famotidine  20  mg ; levetiracetam  1000  mg ; lorazepam  0.5-2  mg ; acetaminophen  325-650  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50-100  ml ; magnesium sulfate  2-4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  500  ml ; 
 
white f 43 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  116  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  105  mg dl$bisacodyl  10  mg ; thiamine  100  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; oxycodone-acetaminophen  1-2  tab ; syringe  1  syr ; folic acid  1  mg ; multivitamins  10  ml ; senna  1  tab ; famotidine  20  mg ; levetiracetam  1000  mg ; lorazepam  0.5-2  mg ; acetaminophen  325-650  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50-100  ml ; magnesium sulfate  2-4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  500  ml ; diazepam  10  mg ; nicotine patch  21  mg ; clonidine patch 0.1 mg 24 hr  1  ptch ; multivitamins  1  tab ; 
 
white f 43 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  77  mg dl$bisacodyl  10  mg ; thiamine  100  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone-acetaminophen  1-2  tab ; syringe  1  syr ; folic acid  1  mg ; senna  1  tab ; famotidine  20  mg ; levetiracetam  1000  mg ; lorazepam  0.5-2  mg ; acetaminophen  325-650  mg ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50-100  ml ; magnesium sulfate  2-4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; diazepam  10  mg ; nicotine patch  21  mg ; clonidine patch 0.1 mg 24 hr  1  ptch ; multivitamins  1  tab ; clonidine  0.1  mg ; levofloxacin  750  mg ; magnesium oxide  400  mg ; 
 
white f 43 $nan$chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  84  mg dl$bisacodyl  10  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone-acetaminophen  1-2  tab ; senna  1  tab ; famotidine  20  mg ; lorazepam  0.5-2  mg ; acetaminophen  325-650  mg ; diazepam  10  mg ; multivitamins  1  tab ; levofloxacin  750  mg ; magnesium oxide  400  mg ; cepacol (menthol)  1  loz ; 
 
white f 43 $nan$nan$bisacodyl  10  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone-acetaminophen  1-2  tab ; senna  1  tab ; famotidine  20  mg ; lorazepam  0.5-2  mg ; acetaminophen  325-650  mg ; diazepam  10  mg ; multivitamins  1  tab ; levofloxacin  750  mg ; cepacol (menthol)  1  loz ; oxycodone-acetaminophen  1  tab ; 
 
white f 51 $nan$nan$omeprazole  20  mg ; fluoxetine  40  mg ; 
personal history of other malignant neoplasm of skin chronic pulmonary embolism depressive disorder, not elsewhere classified long-term (current) use of anticoagulants esophageal reflux unspecified cataract personal history of tobacco use immune thrombocytopenic purpura long-term (current) use of anticoagulants other pulmonary embolism and infarction family history of unspecified malignant neoplasm unspecified pedal cyclist injured in collision with other nonmotor vehicle in traffic accident immune thrombocytopenic purpura family history of malignant neoplasm of gastrointestinal tract other acquired absence of organ pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident personal history of other malignant neoplasm of skin pain in limb thrombocytopenia, unspecified depressive disorder, not elsewhere classified esophageal reflux hemorrhage of gastrointestinal tract, unspecified chest pain, unspecified nausea alone disorder of bone and cartilage, unspecified spontaneous ecchymoses personal history of pulmonary embolism depressive disorder, not elsewhere classified immune thrombocytopenic purpura other chest pain long-term (current) use of anticoagulants other, mixed, or unspecified drug abuse, in remission esophageal reflux nonspecific abnormal electrocardiogram [ecg] [ekg] other pulmonary embolism and infarction basal cell carcinoma of skin of other and unspecified parts of face tobacco use disorder unspecified cataract tobacco use disorder other pulmonary embolism and infarction long-term (current) use of anticoagulants depressive disorder, not elsewhere classified other opiates and related narcotics causing adverse effects in therapeutic use intracerebral hemorrhage accidents occurring in residential institution cerebral embolism with cerebral infarction allergic urticaria personal history of pulmonary embolism
white f 51 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  722  k ul$omeprazole  20  mg ; fluoxetine  40  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen w codeine  1-2  tab ; ibuprofen  400  mg ; ondansetron  4  mg ; trazodone  50  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; scopolamine patch  1  ptch ; docusate sodium  100  mg ; prednisone  40  mg ; 
personal history of other malignant neoplasm of skin chronic pulmonary embolism depressive disorder, not elsewhere classified long-term (current) use of anticoagulants esophageal reflux unspecified cataract personal history of tobacco use immune thrombocytopenic purpura long-term (current) use of anticoagulants other pulmonary embolism and infarction family history of unspecified malignant neoplasm unspecified pedal cyclist injured in collision with other nonmotor vehicle in traffic accident immune thrombocytopenic purpura family history of malignant neoplasm of gastrointestinal tract other acquired absence of organ pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident personal history of other malignant neoplasm of skin pain in limb thrombocytopenia, unspecified depressive disorder, not elsewhere classified esophageal reflux hemorrhage of gastrointestinal tract, unspecified chest pain, unspecified nausea alone disorder of bone and cartilage, unspecified spontaneous ecchymoses personal history of pulmonary embolism depressive disorder, not elsewhere classified immune thrombocytopenic purpura other chest pain long-term (current) use of anticoagulants other, mixed, or unspecified drug abuse, in remission esophageal reflux nonspecific abnormal electrocardiogram [ecg] [ekg] other pulmonary embolism and infarction basal cell carcinoma of skin of other and unspecified parts of face tobacco use disorder unspecified cataract tobacco use disorder other pulmonary embolism and infarction long-term (current) use of anticoagulants depressive disorder, not elsewhere classified other opiates and related narcotics causing adverse effects in therapeutic use intracerebral hemorrhage accidents occurring in residential institution cerebral embolism with cerebral infarction allergic urticaria personal history of pulmonary embolism
white f 51 $nan$nan$omeprazole  20  mg ; fluoxetine  40  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen w codeine  1-2  tab ; ibuprofen  400  mg ; ondansetron  4  mg ; trazodone  50  mg ; scopolamine patch  1  ptch ; docusate sodium  100  mg ; prednisone  40  mg ; 
personal history of other malignant neoplasm of skin chronic pulmonary embolism depressive disorder, not elsewhere classified long-term (current) use of anticoagulants esophageal reflux unspecified cataract personal history of tobacco use immune thrombocytopenic purpura long-term (current) use of anticoagulants other pulmonary embolism and infarction family history of unspecified malignant neoplasm unspecified pedal cyclist injured in collision with other nonmotor vehicle in traffic accident immune thrombocytopenic purpura family history of malignant neoplasm of gastrointestinal tract other acquired absence of organ pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident personal history of other malignant neoplasm of skin pain in limb thrombocytopenia, unspecified depressive disorder, not elsewhere classified esophageal reflux hemorrhage of gastrointestinal tract, unspecified chest pain, unspecified nausea alone disorder of bone and cartilage, unspecified spontaneous ecchymoses personal history of pulmonary embolism depressive disorder, not elsewhere classified immune thrombocytopenic purpura other chest pain long-term (current) use of anticoagulants other, mixed, or unspecified drug abuse, in remission esophageal reflux nonspecific abnormal electrocardiogram [ecg] [ekg] other pulmonary embolism and infarction basal cell carcinoma of skin of other and unspecified parts of face tobacco use disorder unspecified cataract tobacco use disorder other pulmonary embolism and infarction long-term (current) use of anticoagulants depressive disorder, not elsewhere classified other opiates and related narcotics causing adverse effects in therapeutic use intracerebral hemorrhage accidents occurring in residential institution cerebral embolism with cerebral infarction allergic urticaria personal history of pulmonary embolism
white m 88 $temp  98.2  heartrate  55.0  resprate  16.0  o2sat  95.0  sbp  117.0  dbp  60.0  rhythm    pain  0  $hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  113  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  50  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  119  mg dl; chemistry blood glucose  99  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  10  mg ; finasteride  5  mg ; metoprolol succinate xl  12.5  mg ; tamsulosin  0.8  mg ; furosemide  20  mg ; senna  8.6  mg ; aspirin  325  mg ; heparin  4000  unit ; heparin  1400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; polyethylene glycol  17  g ; furosemide  40  mg ; bag  1  bag ; magnesium sulfate  2  gm ; guaifenesin-dextromethorphan  5  ml ; hydralazine  10  mg ; furosemide  80  mg ; atorvastatin  40  mg ; vial  1  vial ; ceftriaxone  1  gm ; 
presence of coronary angioplasty implant and graft long term (current) use of aspirin resistance to other single specified antibiotic benign prostatic hyperplasia with lower urinary tract symptoms urinary tract infection, site not specified old myocardial infarction chronic kidney disease, stage 3 (moderate) chronic obstructive pulmonary disease, unspecified cyst of kidney, acquired chronic systolic (congestive) heart failure obesity, unspecified hematuria, unspecified body mass index (bmi) 35.0-35.9, adult acute kidney failure, unspecified unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere ischemic cardiomyopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease sepsis due to escherichia coli [e. coli] atherosclerotic heart disease of native coronary artery without angina pectoris unspecified hearing loss, unspecified ear calculus of kidney other septicemia due to gram-negative organisms other specified forms of chronic ischemic heart disease other postprocedural status congestive heart failure, unspecified unspecified hearing loss chronic kidney disease, unspecified urinary tract infection, site not specified percutaneous transluminal coronary angioplasty status personal history of tobacco use pure hypercholesterolemia acute kidney failure, unspecified long-term (current) use of aspirin other and unspecified hyperlipidemia chronic systolic heart failure do not resuscitate status gross hematuria chronic airway obstruction, not elsewhere classified esophageal reflux hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) old myocardial infarction severe sepsis prostatitis, unspecified coronary atherosclerosis of native coronary artery flatulence, eructation, and gas pain
white m 88 $nan$hematology blood hematocrit  37.7  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  122  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood urea nitrogen  54  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  197  mg dl; chemistry blood glucose  117  mg dl$sodium chloride 0.9%  flush  3-10  ml ; finasteride  5  mg ; metoprolol succinate xl  12.5  mg ; tamsulosin  0.8  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; guaifenesin-dextromethorphan  5  ml ; hydralazine  10  mg ; atorvastatin  40  mg ; vial  1  vial ; ceftriaxone  1  gm ; furosemide  120  mg ; hydralazine  25  mg ; furosemide  100  mg ; potassium chloride  20  meq ; 
presence of coronary angioplasty implant and graft long term (current) use of aspirin resistance to other single specified antibiotic benign prostatic hyperplasia with lower urinary tract symptoms urinary tract infection, site not specified old myocardial infarction chronic kidney disease, stage 3 (moderate) chronic obstructive pulmonary disease, unspecified cyst of kidney, acquired chronic systolic (congestive) heart failure obesity, unspecified hematuria, unspecified body mass index (bmi) 35.0-35.9, adult acute kidney failure, unspecified unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere ischemic cardiomyopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease sepsis due to escherichia coli [e. coli] atherosclerotic heart disease of native coronary artery without angina pectoris unspecified hearing loss, unspecified ear calculus of kidney other septicemia due to gram-negative organisms other specified forms of chronic ischemic heart disease other postprocedural status congestive heart failure, unspecified unspecified hearing loss chronic kidney disease, unspecified urinary tract infection, site not specified percutaneous transluminal coronary angioplasty status personal history of tobacco use pure hypercholesterolemia acute kidney failure, unspecified long-term (current) use of aspirin other and unspecified hyperlipidemia chronic systolic heart failure do not resuscitate status gross hematuria chronic airway obstruction, not elsewhere classified esophageal reflux hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) old myocardial infarction severe sepsis prostatitis, unspecified coronary atherosclerosis of native coronary artery flatulence, eructation, and gas pain
white m 88 $nan$hematology blood hematocrit  42.3  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  147  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  55  mg dl; chemistry blood urea nitrogen  56  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  148  mg dl; chemistry blood glucose  119  mg dl$sodium chloride 0.9%  flush  3-10  ml ; finasteride  5  mg ; metoprolol succinate xl  12.5  mg ; tamsulosin  0.8  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; guaifenesin-dextromethorphan  5  ml ; atorvastatin  40  mg ; vial  1  vial ; ceftriaxone  1  gm ; hydralazine  25  mg ; furosemide  100  mg ; potassium chloride  20  meq ; torsemide  20  mg ; hydralazine  37.5  mg ; 
presence of coronary angioplasty implant and graft long term (current) use of aspirin resistance to other single specified antibiotic benign prostatic hyperplasia with lower urinary tract symptoms urinary tract infection, site not specified old myocardial infarction chronic kidney disease, stage 3 (moderate) chronic obstructive pulmonary disease, unspecified cyst of kidney, acquired chronic systolic (congestive) heart failure obesity, unspecified hematuria, unspecified body mass index (bmi) 35.0-35.9, adult acute kidney failure, unspecified unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere ischemic cardiomyopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease sepsis due to escherichia coli [e. coli] atherosclerotic heart disease of native coronary artery without angina pectoris unspecified hearing loss, unspecified ear calculus of kidney other septicemia due to gram-negative organisms other specified forms of chronic ischemic heart disease other postprocedural status congestive heart failure, unspecified unspecified hearing loss chronic kidney disease, unspecified urinary tract infection, site not specified percutaneous transluminal coronary angioplasty status personal history of tobacco use pure hypercholesterolemia acute kidney failure, unspecified long-term (current) use of aspirin other and unspecified hyperlipidemia chronic systolic heart failure do not resuscitate status gross hematuria chronic airway obstruction, not elsewhere classified esophageal reflux hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) old myocardial infarction severe sepsis prostatitis, unspecified coronary atherosclerosis of native coronary artery flatulence, eructation, and gas pain
white m 88 $nan$hematology blood hematocrit  39.7  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  154  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  59  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  112  mg dl$sodium chloride 0.9%  flush  3-10  ml ; finasteride  5  mg ; metoprolol succinate xl  12.5  mg ; tamsulosin  0.8  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; guaifenesin-dextromethorphan  5  ml ; atorvastatin  40  mg ; vial  1  vial ; ceftriaxone  1  gm ; torsemide  20  mg ; 
presence of coronary angioplasty implant and graft long term (current) use of aspirin resistance to other single specified antibiotic benign prostatic hyperplasia with lower urinary tract symptoms urinary tract infection, site not specified old myocardial infarction chronic kidney disease, stage 3 (moderate) chronic obstructive pulmonary disease, unspecified cyst of kidney, acquired chronic systolic (congestive) heart failure obesity, unspecified hematuria, unspecified body mass index (bmi) 35.0-35.9, adult acute kidney failure, unspecified unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere ischemic cardiomyopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease sepsis due to escherichia coli [e. coli] atherosclerotic heart disease of native coronary artery without angina pectoris unspecified hearing loss, unspecified ear calculus of kidney other septicemia due to gram-negative organisms other specified forms of chronic ischemic heart disease other postprocedural status congestive heart failure, unspecified unspecified hearing loss chronic kidney disease, unspecified urinary tract infection, site not specified percutaneous transluminal coronary angioplasty status personal history of tobacco use pure hypercholesterolemia acute kidney failure, unspecified long-term (current) use of aspirin other and unspecified hyperlipidemia chronic systolic heart failure do not resuscitate status gross hematuria chronic airway obstruction, not elsewhere classified esophageal reflux hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) old myocardial infarction severe sepsis prostatitis, unspecified coronary atherosclerosis of native coronary artery flatulence, eructation, and gas pain
white m 62 $nan$nan$captopril  6.25  mg ; 
 
white m 62 $nan$hematology blood hematocrit  41.7  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  224  k ul; hematology blood platelet count  209  k ul; hematology blood platelet count  180  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  119  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  120  mg dl$captopril  6.25  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; sw  100  ml ; eptifibatide  75  mg ; potassium chloride (powder)  40  meq ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  12.5  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; atorvastatin  80  mg ; metoprolol tartrate  6.25  mg ; furosemide  20  mg ; nitroglycerin sl  0.3  mg ; morphine sulfate  2-4  mg ; albuterol inhaler  2  puff ; fluticasone-salmeterol diskus (250 50)   1  inh ; warfarin  2.5  mg ; captopril  3.125  mg ; amiodarone  150  mg ; 5% dextrose (excel bag)  500  ml ; amiodarone  600  mg ; captopril  12.5  mg ; heparin  2100-4300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; aspirin ec  81  mg ; clopidogrel  75  mg ; 
 
white m 62 $nan$hematology blood hematocrit  40.8  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  112  mg dl$pantoprazole  40  mg ; ondansetron  4  mg ; potassium chloride (powder)  40  meq ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  12.5  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; atorvastatin  80  mg ; metoprolol tartrate  6.25  mg ; furosemide  20  mg ; nitroglycerin sl  0.3  mg ; morphine sulfate  2-4  mg ; albuterol inhaler  2  puff ; fluticasone-salmeterol diskus (250 50)   1  inh ; warfarin  2.5  mg ; captopril  3.125  mg ; amiodarone  150  mg ; captopril  12.5  mg ; heparin  2100-4300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; aspirin ec  81  mg ; clopidogrel  75  mg ; lisinopril  10  mg ; amiodarone  200  mg ; 
 
white m 62 $nan$hematology blood hematocrit  43.1  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  163  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  103  mg dl$pantoprazole  40  mg ; ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; atorvastatin  80  mg ; metoprolol tartrate  6.25  mg ; nitroglycerin sl  0.3  mg ; morphine sulfate  2-4  mg ; albuterol inhaler  2  puff ; fluticasone-salmeterol diskus (250 50)   1  inh ; heparin  2100-4300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; aspirin ec  81  mg ; clopidogrel  75  mg ; lisinopril  10  mg ; amiodarone  200  mg ; metoprolol succinate xl  25  mg ; lisinopril  20  mg ; spironolactone  25  mg ; 
 
white m 62 $nan$nan$pantoprazole  40  mg ; ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; atorvastatin  80  mg ; nitroglycerin sl  0.3  mg ; morphine sulfate  2-4  mg ; albuterol inhaler  2  puff ; fluticasone-salmeterol diskus (250 50)   1  inh ; heparin  2100-4300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; aspirin ec  81  mg ; clopidogrel  75  mg ; amiodarone  200  mg ; metoprolol succinate xl  25  mg ; lisinopril  20  mg ; spironolactone  25  mg ; lisinopril  40  mg ; warfarin  4  mg ; enoxaparin sodium  150  mg ; 
 
white m 59 $temp  98.4  heartrate  83.0  resprate  16.0  o2sat  93.0  sbp  143.0  dbp  61.0  rhythm    pain    $hematology blood hematocrit  32.0  %; hematology blood hematocrit  35.8  %; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  309  k ul; hematology blood platelet count  346  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  63  mg dl; chemistry blood urea nitrogen  63  mg dl; chemistry blood urea nitrogen  66  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  260  mg dl; chemistry blood glucose  269  mg dl; chemistry blood glucose  176  mg dl; chemistry blood lactate dehydrogenase (ld)  183  iu l; chemistry blood albumin  3.0  g dl$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; aspirin  81  mg ; dorzolamide 2% ophth. soln.  1  drop ; loratadine  10  mg ; lorazepam  0.5  mg ; simvastatin  20  mg ; furosemide  40  mg ; acetaminophen  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; atropine sulfate ophth 1%  1  % ; clotrimazole cream  1-0.05  % ; azithromycin  500  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; captopril  6.25  mg ; 
 
white m 59 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  375  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  69  mg dl; chemistry blood urea nitrogen  72  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  230  mg dl; chemistry blood glucose  258  mg dl; blood gas blood lactate  1.7  mmol l$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; aspirin  81  mg ; dorzolamide 2% ophth. soln.  1  drop ; loratadine  10  mg ; lorazepam  0.5  mg ; simvastatin  20  mg ; acetaminophen  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; atropine sulfate ophth 1%  1  % ; clotrimazole cream  1-0.05  % ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; metoprolol tartrate  5  mg ; adenosine  6  mg ; adenosine  12  mg ; timolol maleate 0.5%  1  drop ; azithromycin  250  mg ; trazodone  50  mg ; lidocaine jelly 2% (glydo)  1  appl ; 
 
white m 59 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  375  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  71  mg dl; chemistry blood urea nitrogen  71  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  332  mg dl; chemistry blood glucose  278  mg dl$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; aspirin  81  mg ; dorzolamide 2% ophth. soln.  1  drop ; loratadine  10  mg ; simvastatin  20  mg ; acetaminophen  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; atropine sulfate ophth 1%  1  % ; clotrimazole cream  1-0.05  % ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; timolol maleate 0.5%  1  drop ; azithromycin  250  mg ; trazodone  50  mg ; lidocaine jelly 2% (glydo)  1  appl ; furosemide  80  mg ; sodium chloride 0.9%  1000  ml ; heparin  8100  unit ; heparin  2000-4100  unit ; heparin sodium  25,000  unit ; 
 
white m 59 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  394  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  73  mg dl; chemistry blood urea nitrogen  76  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  224  mg dl; chemistry blood glucose  208  mg dl$influenza vaccine quadrivalent  0.5  ml ; aspirin  81  mg ; dorzolamide 2% ophth. soln.  1  drop ; loratadine  10  mg ; simvastatin  20  mg ; acetaminophen  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; atropine sulfate ophth 1%  1  % ; clotrimazole cream  1-0.05  % ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; timolol maleate 0.5%  1  drop ; azithromycin  250  mg ; trazodone  50  mg ; heparin  8100  unit ; heparin  2000-4100  unit ; heparin sodium  25,000  unit ; heparin  6000-8500  unit ; senna  8.6  mg ; bisacodyl  10  mg ; warfarin  5  mg ; 
 
white m 59 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  453  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  90  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  4.1  mg dl; chemistry blood creatinine  4.4  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  6.2  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  83  mg dl; chemistry blood urea nitrogen  89  mg dl; hematology blood inr(pt)  1.4  ; chemistry urine creatinine, urine  117  mg dl; chemistry urine sodium, urine  56  meq l; chemistry urine urea nitrogen, urine  194  mg dl; hematology urine wbc  42  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  192  mg dl; chemistry blood glucose  197  mg dl; blood gas blood lactate  1.3  mmol l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood sodium, whole blood  127  meq l$influenza vaccine quadrivalent  0.5  ml ; aspirin  81  mg ; loratadine  10  mg ; simvastatin  20  mg ; acetaminophen  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; atropine sulfate ophth 1%  1  % ; clotrimazole cream  1-0.05  % ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; timolol maleate 0.5%  1  drop ; azithromycin  250  mg ; trazodone  50  mg ; heparin  6000-8500  unit ; senna  8.6  mg ; bisacodyl  10  mg ; warfarin  5  mg ; furosemide  160  mg ; 5% dextrose  50  ml ; chlorothiazide sodium  500  mg ; furosemide  200  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; heparin  7500-9000  unit ; 
 
white m 59 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  475  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  90  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  4.3  mg dl; chemistry blood creatinine  3.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  89  mg dl; chemistry blood urea nitrogen  84  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  156  mg dl; chemistry blood glucose  216  mg dl; chemistry blood lactate dehydrogenase (ld)  240  iu l; chemistry blood albumin  2.9  g dl$influenza vaccine quadrivalent  0.5  ml ; aspirin  81  mg ; loratadine  10  mg ; simvastatin  20  mg ; acetaminophen  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; atropine sulfate ophth 1%  1  % ; clotrimazole cream  1-0.05  % ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; timolol maleate 0.5%  1  drop ; azithromycin  250  mg ; trazodone  50  mg ; senna  8.6  mg ; bisacodyl  10  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; heparin  7500-9000  unit ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  3-10  ml ; 
 
white m 59 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  505  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  73  mg dl; chemistry blood urea nitrogen  68  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  196  mg dl; chemistry blood glucose  257  mg dl$influenza vaccine quadrivalent  0.5  ml ; aspirin  81  mg ; loratadine  10  mg ; simvastatin  20  mg ; acetaminophen  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; atropine sulfate ophth 1%  1  % ; clotrimazole cream  1-0.05  % ; timolol maleate 0.5%  1  drop ; trazodone  50  mg ; senna  8.6  mg ; bisacodyl  10  mg ; heparin  7500-9000  unit ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  3-10  ml ; 
 
white m 59 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  567  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  222  mg dl; chemistry blood glucose  182  mg dl; hematology blood bands  1  %$5% dextrose  250  ml ; influenza vaccine quadrivalent  0.5  ml ; aspirin  81  mg ; loratadine  10  mg ; simvastatin  20  mg ; acetaminophen  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; atropine sulfate ophth 1%  1  % ; clotrimazole cream  1-0.05  % ; timolol maleate 0.5%  1  drop ; trazodone  50  mg ; senna  8.6  mg ; bisacodyl  10  mg ; heparin  7500-9000  unit ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; magnesium oxide  400  mg ; oxycodone (immediate release)  5  mg ; mirtazapine  15  mg ; trazodone  100  mg ; docusate sodium  100  mg ; 
 
white m 59 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  571  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  167  mg dl$5% dextrose  250  ml ; influenza vaccine quadrivalent  0.5  ml ; aspirin  81  mg ; loratadine  10  mg ; simvastatin  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; atropine sulfate ophth 1%  1  % ; clotrimazole cream  1-0.05  % ; timolol maleate 0.5%  1  drop ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; magnesium oxide  400  mg ; oxycodone (immediate release)  5  mg ; trazodone  100  mg ; docusate sodium  100  mg ; 
 
white m 59 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  535  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  154  mg dl$aspirin  81  mg ; loratadine  10  mg ; simvastatin  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; atropine sulfate ophth 1%  1  % ; clotrimazole cream  1-0.05  % ; timolol maleate 0.5%  1  drop ; senna  8.6  mg ; bisacodyl  10  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; oxycodone (immediate release)  5  mg ; trazodone  100  mg ; docusate sodium  100  mg ; polyethylene glycol  34  g ; tramadol  50  mg ; acetaminophen  1000  mg ; warfarin  4  mg ; 
 
white m 59 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  554  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood potassium  5.7  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  3.4  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  328  mg dl; chemistry blood glucose  159  mg dl$aspirin  81  mg ; loratadine  10  mg ; simvastatin  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; atropine sulfate ophth 1%  1  % ; clotrimazole cream  1-0.05  % ; timolol maleate 0.5%  1  drop ; senna  8.6  mg ; bisacodyl  10  mg ; sodium chloride 0.9%  flush  3-10  ml ; oxycodone (immediate release)  5  mg ; trazodone  100  mg ; docusate sodium  100  mg ; polyethylene glycol  34  g ; tramadol  50  mg ; acetaminophen  1000  mg ; warfarin  4  mg ; torsemide  20  mg ; prednisone  40  mg ; sodium polystyrene sulfonate  30  gm ; 
 
white m 59 $nan$hematology blood hematocrit  35.5  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  553  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  5.7  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood urea nitrogen  42  mg dl; hematology blood inr(pt)  3.4  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  244  mg dl; chemistry blood glucose  254  mg dl$aspirin  81  mg ; loratadine  10  mg ; simvastatin  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; atropine sulfate ophth 1%  1  % ; clotrimazole cream  1-0.05  % ; timolol maleate 0.5%  1  drop ; senna  8.6  mg ; bisacodyl  10  mg ; sodium chloride 0.9%  flush  3-10  ml ; oxycodone (immediate release)  5  mg ; trazodone  100  mg ; docusate sodium  100  mg ; polyethylene glycol  34  g ; acetaminophen  1000  mg ; torsemide  20  mg ; sodium polystyrene sulfonate  30  gm ; prednisolone acetate 1% ophth. susp.  1  drop ; warfarin  1  mg ; 
 
white m 59 $nan$nan$aspirin  81  mg ; loratadine  10  mg ; simvastatin  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; atropine sulfate ophth 1%  1  % ; clotrimazole cream  1-0.05  % ; timolol maleate 0.5%  1  drop ; senna  8.6  mg ; bisacodyl  10  mg ; sodium chloride 0.9%  flush  3-10  ml ; oxycodone (immediate release)  5  mg ; trazodone  100  mg ; docusate sodium  100  mg ; polyethylene glycol  34  g ; acetaminophen  1000  mg ; torsemide  20  mg ; sodium polystyrene sulfonate  30  gm ; prednisolone acetate 1% ophth. susp.  1  drop ; warfarin  1  mg ; 
 
white f 20 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  287  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  114  mg dl; blood gas blood lactate  1.2  mmol l$nan
 
white f 20 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ibuprofen  600  mg ; tramadol (ultram)  50  mg ; prochlorperazine  5-10  mg ; heparin  5000  unit ; tizanidine  2  mg ; 
 
white f 34 $nan$nan$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; tizanidine  8  mg ; alprazolam  0.5  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; tucks hemorrhoidal oint 1%  1  appl ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; heparin  5000  unit ; fluticasone-salmeterol diskus (100 50)  1  inh ; divalproex (extended release)  250  mg ; carbamazepine  400  mg ; gabapentin  900  mg ; fexofenadine  60  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; rifaximin  200  mg ; ranitidine  300  mg ; oxycodone (immediate release)   10  mg ; lorazepam  0.5  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; benzonatate  100  mg ; quetiapine fumarate  100  mg ; divalproex (extended release)  500  mg ; lamotrigine  25  mg ; guaifenesin-dextromethorphan  5  ml ; 
asthma, unspecified type, unspecified ulcer of heel and midfoot moderate dysplasia of cervix epilepsy, unspecified, without mention of intractable epilepsy opioid abuse, in remission history of physical abuse anorexia nervosa iron deficiency anemia, unspecified irritable bowel syndrome anxiety state, unspecified accidents caused by other specified cutting and piercing instruments or objects cellulitis and abscess of foot, except toes esophageal reflux 
white f 34 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  330  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  80  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; tizanidine  8  mg ; alprazolam  0.5  mg ; acetaminophen  1000  mg ; tucks hemorrhoidal oint 1%  1  appl ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; heparin  5000  unit ; fluticasone-salmeterol diskus (100 50)  1  inh ; divalproex (extended release)  250  mg ; carbamazepine  400  mg ; gabapentin  900  mg ; fexofenadine  60  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; rifaximin  200  mg ; ranitidine  300  mg ; oxycodone (immediate release)   10  mg ; lorazepam  0.5  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; benzonatate  100  mg ; quetiapine fumarate  100  mg ; divalproex (extended release)  500  mg ; lamotrigine  25  mg ; guaifenesin-dextromethorphan  5  ml ; ciprofloxacin hcl  750  mg ; doxycycline hyclate  100  mg ; oxycodone (immediate release)   5  mg ; 
asthma, unspecified type, unspecified ulcer of heel and midfoot moderate dysplasia of cervix epilepsy, unspecified, without mention of intractable epilepsy opioid abuse, in remission history of physical abuse anorexia nervosa iron deficiency anemia, unspecified irritable bowel syndrome anxiety state, unspecified accidents caused by other specified cutting and piercing instruments or objects cellulitis and abscess of foot, except toes esophageal reflux 
other m 27 $temp  97.6  heartrate  77.0  resprate  16.0  o2sat  100.0  sbp  134.0  dbp  79.0  rhythm    pain  6  ; temp  98.1  heartrate  78.0  resprate  16.0  o2sat    sbp  127.0  dbp  75.0  rhythm    pain    ; temp  98.0  heartrate  74.0  resprate  16.0  o2sat  100.0  sbp  131.0  dbp  73.0  rhythm    pain  0  ; temp  98.0  heartrate  72.0  resprate  16.0  o2sat  100.0  sbp  127.0  dbp  71.0  rhythm    pain  0  $nan$enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; acetaminophen iv  1000  mg ; 
 
other m 27 $nan$nan$enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; acetaminophen iv  1000  mg ; 
 
other m 27 $nan$nan$enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; 
 
other m 27 $nan$hematology blood hematocrit  41.1  %$enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; diphenhydramine  12.5  mg ; 
 
white f 84 $temp  98.1  heartrate  84.0  resprate  20.0  o2sat  99.0  sbp  162.0  dbp  47.0  rhythm    pain  5  $hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  283  mg dl; chemistry blood albumin  3.6  g dl$nan
old myocardial infarction other mechanical complication of other internal orthopedic device, implant, and graft occlusion and stenosis of carotid artery with cerebral infarction coronary atherosclerosis of unspecified type of vessel, native or graft accidents occurring in residential institution other late effects of cerebrovascular disease, facial weakness iatrogenic cerebrovascular infarction or hemorrhage diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation aortocoronary bypass status diverticulosis of colon (without mention of hemorrhage) nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy aphasia other and unspecified hyperlipidemia esophageal reflux monoplegia of upper limb affecting unspecified side other specified forms of chronic ischemic heart disease atrial fibrillation polyneuropathy in diabetes diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits esophageal reflux surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation friedländer's bacillus infection in conditions classified elsewhere and of unspecified site diverticulosis of colon with hemorrhage unspecified acquired hypothyroidism other fluid overload long-term (current) use of aspirin unspecified disorder of autonomic nervous system nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled urinary incontinence, unspecified osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh unspecified essential hypertension aortocoronary bypass status polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin other mechanical complication of other internal orthopedic device, implant, and graft other and unspecified hyperlipidemia urinary tract infection, site not specified personal history of tobacco use atrial fibrillation chronic kidney disease, stage iii (moderate) closed fracture of intertrochanteric section of neck of femur
white f 84 $temp  98.1  heartrate  78.0  resprate  16.0  o2sat  99.0  sbp  138.0  dbp  53.0  rhythm    pain  0  $hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  2.4  mg dl; chemistry blood glucose  146  mg dl; chemistry blood lactate dehydrogenase (ld)  625  iu l; chemistry blood albumin  3.6  g dl; hematology urine glucose  70  mg dl$sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydromorphone (dilaudid)  2  mg ; ascorbic acid  500  mg ; aspirin  325  mg ; desmopressin acetate  0.2  mg ; docusate sodium  100  mg ; levothyroxine sodium  75  mcg ; midodrine  2.5  mg ; multivitamins  1  tab ; omeprazole  20  mg ; ondansetron  4  mg ; polyethylene glycol  17  g ; rivaroxaban  20  mg ; senna  8.6  mg ; sodium chloride  1  gm ; insulin  0  unit ; magnesium sulfate  2  gm ; lidocaine 5% patch  1  ptch ; insulin  26  unit ; 
old myocardial infarction other mechanical complication of other internal orthopedic device, implant, and graft occlusion and stenosis of carotid artery with cerebral infarction coronary atherosclerosis of unspecified type of vessel, native or graft accidents occurring in residential institution other late effects of cerebrovascular disease, facial weakness iatrogenic cerebrovascular infarction or hemorrhage diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation aortocoronary bypass status diverticulosis of colon (without mention of hemorrhage) nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy aphasia other and unspecified hyperlipidemia esophageal reflux monoplegia of upper limb affecting unspecified side other specified forms of chronic ischemic heart disease atrial fibrillation polyneuropathy in diabetes diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits esophageal reflux surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation friedländer's bacillus infection in conditions classified elsewhere and of unspecified site diverticulosis of colon with hemorrhage unspecified acquired hypothyroidism other fluid overload long-term (current) use of aspirin unspecified disorder of autonomic nervous system nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled urinary incontinence, unspecified osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh unspecified essential hypertension aortocoronary bypass status polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin other mechanical complication of other internal orthopedic device, implant, and graft other and unspecified hyperlipidemia urinary tract infection, site not specified personal history of tobacco use atrial fibrillation chronic kidney disease, stage iii (moderate) closed fracture of intertrochanteric section of neck of femur
white f 84 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  165  mg dl$sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydromorphone (dilaudid)  2  mg ; ascorbic acid  500  mg ; aspirin  325  mg ; desmopressin acetate  0.2  mg ; docusate sodium  100  mg ; levothyroxine sodium  75  mcg ; midodrine  2.5  mg ; multivitamins  1  tab ; omeprazole  20  mg ; ondansetron  4  mg ; polyethylene glycol  17  g ; rivaroxaban  20  mg ; senna  8.6  mg ; sodium chloride  1  gm ; insulin  0  unit ; magnesium sulfate  2  gm ; lidocaine 5% patch  1  ptch ; insulin  26  unit ; sodium chloride 0.9%  1000  ml ; 
old myocardial infarction other mechanical complication of other internal orthopedic device, implant, and graft occlusion and stenosis of carotid artery with cerebral infarction coronary atherosclerosis of unspecified type of vessel, native or graft accidents occurring in residential institution other late effects of cerebrovascular disease, facial weakness iatrogenic cerebrovascular infarction or hemorrhage diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation aortocoronary bypass status diverticulosis of colon (without mention of hemorrhage) nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy aphasia other and unspecified hyperlipidemia esophageal reflux monoplegia of upper limb affecting unspecified side other specified forms of chronic ischemic heart disease atrial fibrillation polyneuropathy in diabetes diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits esophageal reflux surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation friedländer's bacillus infection in conditions classified elsewhere and of unspecified site diverticulosis of colon with hemorrhage unspecified acquired hypothyroidism other fluid overload long-term (current) use of aspirin unspecified disorder of autonomic nervous system nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled urinary incontinence, unspecified osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh unspecified essential hypertension aortocoronary bypass status polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin other mechanical complication of other internal orthopedic device, implant, and graft other and unspecified hyperlipidemia urinary tract infection, site not specified personal history of tobacco use atrial fibrillation chronic kidney disease, stage iii (moderate) closed fracture of intertrochanteric section of neck of femur
white f 84 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  148  mg dl$sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydromorphone (dilaudid)  2  mg ; ascorbic acid  500  mg ; aspirin  325  mg ; desmopressin acetate  0.2  mg ; docusate sodium  100  mg ; levothyroxine sodium  75  mcg ; midodrine  2.5  mg ; multivitamins  1  tab ; omeprazole  20  mg ; ondansetron  4  mg ; polyethylene glycol  17  g ; rivaroxaban  20  mg ; senna  8.6  mg ; sodium chloride  1  gm ; insulin  0  unit ; lidocaine 5% patch  1  ptch ; insulin  26  unit ; sodium chloride 0.9%  1000  ml ; atorvastatin  20  mg ; 
old myocardial infarction other mechanical complication of other internal orthopedic device, implant, and graft occlusion and stenosis of carotid artery with cerebral infarction coronary atherosclerosis of unspecified type of vessel, native or graft accidents occurring in residential institution other late effects of cerebrovascular disease, facial weakness iatrogenic cerebrovascular infarction or hemorrhage diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation aortocoronary bypass status diverticulosis of colon (without mention of hemorrhage) nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy aphasia other and unspecified hyperlipidemia esophageal reflux monoplegia of upper limb affecting unspecified side other specified forms of chronic ischemic heart disease atrial fibrillation polyneuropathy in diabetes diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits esophageal reflux surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation friedländer's bacillus infection in conditions classified elsewhere and of unspecified site diverticulosis of colon with hemorrhage unspecified acquired hypothyroidism other fluid overload long-term (current) use of aspirin unspecified disorder of autonomic nervous system nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled urinary incontinence, unspecified osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh unspecified essential hypertension aortocoronary bypass status polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin other mechanical complication of other internal orthopedic device, implant, and graft other and unspecified hyperlipidemia urinary tract infection, site not specified personal history of tobacco use atrial fibrillation chronic kidney disease, stage iii (moderate) closed fracture of intertrochanteric section of neck of femur
white f 84 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  185  mg dl$sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydromorphone (dilaudid)  2  mg ; ascorbic acid  500  mg ; aspirin  325  mg ; desmopressin acetate  0.2  mg ; docusate sodium  100  mg ; levothyroxine sodium  75  mcg ; midodrine  2.5  mg ; multivitamins  1  tab ; omeprazole  20  mg ; ondansetron  4  mg ; polyethylene glycol  17  g ; rivaroxaban  20  mg ; senna  8.6  mg ; sodium chloride  1  gm ; insulin  0  unit ; lidocaine 5% patch  1  ptch ; insulin  26  unit ; atorvastatin  40  mg ; 
old myocardial infarction other mechanical complication of other internal orthopedic device, implant, and graft occlusion and stenosis of carotid artery with cerebral infarction coronary atherosclerosis of unspecified type of vessel, native or graft accidents occurring in residential institution other late effects of cerebrovascular disease, facial weakness iatrogenic cerebrovascular infarction or hemorrhage diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled unspecified acquired hypothyroidism surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation aortocoronary bypass status diverticulosis of colon (without mention of hemorrhage) nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy aphasia other and unspecified hyperlipidemia esophageal reflux monoplegia of upper limb affecting unspecified side other specified forms of chronic ischemic heart disease atrial fibrillation polyneuropathy in diabetes diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits esophageal reflux surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation friedländer's bacillus infection in conditions classified elsewhere and of unspecified site diverticulosis of colon with hemorrhage unspecified acquired hypothyroidism other fluid overload long-term (current) use of aspirin unspecified disorder of autonomic nervous system nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled urinary incontinence, unspecified osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh unspecified essential hypertension aortocoronary bypass status polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin other mechanical complication of other internal orthopedic device, implant, and graft other and unspecified hyperlipidemia urinary tract infection, site not specified personal history of tobacco use atrial fibrillation chronic kidney disease, stage iii (moderate) closed fracture of intertrochanteric section of neck of femur
white m 51 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  170  iu l; chemistry blood albumin  3.7  g dl$docusate sodium  100  mg ; senna  8.6  mg ; mycophenolate mofetil  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  15-30  ml ; zolpidem tartrate  5  mg ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  20  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; amlodipine  10  mg ; doxycycline hyclate  100  mg ; lamivudine  100  mg ; metoprolol succinate xl  100  mg ; pravastatin  10  mg ; prednisone  5  mg ; rifaximin  550  mg ; sulfameth trimethoprim ss  1  tab ; ursodiol  600  mg ; insulin  0  unit ; insulin  20  unit ; tacrolimus  0.5  mg ; tacrolimus  1  mg ; enoxaparin sodium  40  mg ; 
cholangitis surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of insulin obstruction of bile duct kidney replaced by transplant tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health complications of transplanted liver diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of other medications unspecified essential hypertension car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident cytomegaloviral disease complications of transplanted liver other malaise and fatigue unspecified pruritic disorder generalized hyperhidrosis unspecified essential hypertension cytomegaloviral disease hepatitis b carrier cholangitis nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] other specified disorders of biliary tract surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids alcohol abuse, in remission bacteremia cholangitis other specified disorders of biliary tract kidney replaced by transplant liver replaced by transplant diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident abscess of liver diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident unspecified essential hypertension tobacco use disorder unspecified chronic liver disease without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled liver replaced by transplant bacteremia streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident cholangitis other specified disorders of biliary tract
white m 51 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  178  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  14  mg dl; hematology urine wbc  8  # hpf; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  135  mg dl; chemistry blood lactate dehydrogenase (ld)  129  iu l; chemistry blood albumin  3.7  g dl; hematology urine glucose  100  mg dl$docusate sodium  100  mg ; senna  8.6  mg ; mycophenolate mofetil  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  15-30  ml ; zolpidem tartrate  5  mg ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; doxycycline hyclate  100  mg ; lamivudine  100  mg ; pravastatin  10  mg ; prednisone  5  mg ; rifaximin  550  mg ; sulfameth trimethoprim ss  1  tab ; ursodiol  600  mg ; tacrolimus  1  mg ; enoxaparin sodium  40  mg ; gabapentin  300  mg ; oxycodone (immediate release)   5-15  mg ; morphine sulfate  4  mg ; oxycodone (immediate release)   15-25  mg ; hydromorphone (dilaudid)  0.5-2  mg ; 
cholangitis surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of insulin obstruction of bile duct kidney replaced by transplant tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health complications of transplanted liver diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of other medications unspecified essential hypertension car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident cytomegaloviral disease complications of transplanted liver other malaise and fatigue unspecified pruritic disorder generalized hyperhidrosis unspecified essential hypertension cytomegaloviral disease hepatitis b carrier cholangitis nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] other specified disorders of biliary tract surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids alcohol abuse, in remission bacteremia cholangitis other specified disorders of biliary tract kidney replaced by transplant liver replaced by transplant diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident abscess of liver diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident unspecified essential hypertension tobacco use disorder unspecified chronic liver disease without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled liver replaced by transplant bacteremia streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident cholangitis other specified disorders of biliary tract
white m 51 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, indirect  0.3  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  116  mg dl; chemistry blood lactate dehydrogenase (ld)  151  iu l; chemistry blood albumin  3.3  g dl; chemistry blood bilirubin, direct  0.2  mg dl$docusate sodium  100  mg ; senna  8.6  mg ; mycophenolate mofetil  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  15-30  ml ; zolpidem tartrate  5  mg ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; doxycycline hyclate  100  mg ; lamivudine  100  mg ; pravastatin  10  mg ; prednisone  5  mg ; rifaximin  550  mg ; sulfameth trimethoprim ss  1  tab ; ursodiol  600  mg ; tacrolimus  1  mg ; enoxaparin sodium  40  mg ; gabapentin  300  mg ; morphine sulfate  4  mg ; oxycodone (immediate release)   15-25  mg ; hydromorphone (dilaudid)  0.5-2  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; insulin  10  unit ; 
cholangitis surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of insulin obstruction of bile duct kidney replaced by transplant tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health complications of transplanted liver diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of other medications unspecified essential hypertension car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident cytomegaloviral disease complications of transplanted liver other malaise and fatigue unspecified pruritic disorder generalized hyperhidrosis unspecified essential hypertension cytomegaloviral disease hepatitis b carrier cholangitis nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] other specified disorders of biliary tract surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids alcohol abuse, in remission bacteremia cholangitis other specified disorders of biliary tract kidney replaced by transplant liver replaced by transplant diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident abscess of liver diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident unspecified essential hypertension tobacco use disorder unspecified chronic liver disease without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled liver replaced by transplant bacteremia streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident cholangitis other specified disorders of biliary tract
white m 51 $nan$nan$docusate sodium  100  mg ; senna  8.6  mg ; mycophenolate mofetil  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lactulose  15-30  ml ; zolpidem tartrate  5  mg ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; doxycycline hyclate  100  mg ; lamivudine  100  mg ; pravastatin  10  mg ; prednisone  5  mg ; rifaximin  550  mg ; sulfameth trimethoprim ss  1  tab ; ursodiol  600  mg ; tacrolimus  1  mg ; enoxaparin sodium  40  mg ; gabapentin  300  mg ; oxycodone (immediate release)   15-25  mg ; hydromorphone (dilaudid)  0.5-2  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; insulin  10  unit ; 
cholangitis surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of insulin obstruction of bile duct kidney replaced by transplant tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health complications of transplanted liver diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of other medications unspecified essential hypertension car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident cytomegaloviral disease complications of transplanted liver other malaise and fatigue unspecified pruritic disorder generalized hyperhidrosis unspecified essential hypertension cytomegaloviral disease hepatitis b carrier cholangitis nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] other specified disorders of biliary tract surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation long-term (current) use of steroids alcohol abuse, in remission bacteremia cholangitis other specified disorders of biliary tract kidney replaced by transplant liver replaced by transplant diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident abscess of liver diarrhea surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident unspecified essential hypertension tobacco use disorder unspecified chronic liver disease without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled liver replaced by transplant bacteremia streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident cholangitis other specified disorders of biliary tract
unknown m 87 $nan$hematology blood hematocrit  37.6  %; hematology blood hematocrit  35.4  %; hematology blood hemoglobin  12.6  g dl; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  294  k ul; hematology blood platelet count  300  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  3.7  mg dl; chemistry blood creatinine  3.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  71  mg dl; chemistry blood urea nitrogen  74  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry urine chloride, urine  112  meq l; chemistry urine creatinine, urine  29  mg dl; chemistry urine potassium, urine  23  meq l; chemistry urine sodium, urine  109  meq l; hematology urine wbc  5  # hpf; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  69  mg dl; chemistry blood glucose  76  mg dl; chemistry blood albumin  2.6  g dl; blood gas blood lactate  1.6  mmol l$sodium chloride 0.9%  flush  3  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; 0.9% sodium chloride  1000  ml ; heparin  5000  unit ; hydromorphone (dilaudid)  0.5  mg ; 
 
unknown m 87 $nan$hematology blood hematocrit  39.7  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  325  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  3.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  80  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  50  mg dl; chemistry blood lactate dehydrogenase (ld)  589  iu l$lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; lorazepam  0.5  mg ; 
 
unknown m 87 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  341  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  3.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  87  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  82  mg dl; hematology blood bands  1  %$lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; lorazepam  0.5  mg ; lidocaine jelly 2% (urojet)  1  appl ; 
 
unknown m 87 $nan$hematology blood hematocrit  36.1  %; hematology blood hematocrit  38.9  %; hematology blood hemoglobin  11.7  g dl; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  383  k ul; hematology blood platelet count  336  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  85  mg dl; hematology blood inr(pt)  1.3  ; hematology urine wbc  5  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  100  mg dl; hematology blood bands  0  %$lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; amlodipine  5  mg ; hydralazine  5  mg ; 
 
unknown m 87 $nan$hematology blood hematocrit  39.5  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  343  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  115  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  149  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  78  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  139  mg dl$sodium chloride 0.9%  flush  3  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; amlodipine  5  mg ; hydralazine  5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; d5 1 2ns  1000  ml ; lidocaine 5% patch  1  ptch ; 
 
unknown m 87 $nan$hematology blood hematocrit  39.0  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  362  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  117  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  149  meq l; chemistry blood sodium  151  meq l; chemistry blood urea nitrogen  69  mg dl; chemistry blood urea nitrogen  63  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  234  mg dl; chemistry blood glucose  232  mg dl$sodium chloride 0.9%  flush  3  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; amlodipine  5  mg ; d5 1 2ns  1000  ml ; lidocaine 5% patch  1  ptch ; hydromorphone (dilaudid)  1  mg ; 
 
unknown m 87 $nan$hematology blood hematocrit  39.9  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  327  k ul; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  118  meq l; chemistry blood chloride  119  meq l; chemistry blood chloride  120  meq l; chemistry blood chloride  120  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  154  meq l; chemistry blood urea nitrogen  56  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  228  mg dl$sodium chloride 0.9%  flush  3  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; amlodipine  5  mg ; lidocaine 5% patch  1  ptch ; hydromorphone (dilaudid)  1  mg ; 5% dextrose  1000  ml ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
 
unknown m 87 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  332  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  116  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  179  mg dl$sodium chloride 0.9%  flush  3  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; amlodipine  5  mg ; lidocaine 5% patch  1  ptch ; hydromorphone (dilaudid)  1  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
 
unknown m 87 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  350  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  291  mg dl; chemistry blood albumin  1.8  g dl$sodium chloride 0.9%  flush  3  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; amlodipine  5  mg ; lidocaine 5% patch  1  ptch ; hydromorphone (dilaudid)  1  mg ; miconazole powder 2%  1  appl ; 
 
unknown m 87 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  359  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  59  mg dl; chemistry blood glucose  201  mg dl$sodium chloride 0.9%  flush  3  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; amlodipine  5  mg ; hydromorphone (dilaudid)  1  mg ; miconazole powder 2%  1  appl ; 
 
unknown m 87 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  470  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  149  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  70  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  192  mg dl$sodium chloride 0.9%  flush  3  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; amlodipine  5  mg ; miconazole powder 2%  1  appl ; diphenhydramine  12.5  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; iso-osmotic sodium chloride  100  ml ; fluconazole  200  mg ; 
 
unknown m 87 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  475  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  62  mg dl; chemistry blood glucose  251  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; amlodipine  5  mg ; miconazole powder 2%  1  appl ; diphenhydramine  12.5  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; iso-osmotic sodium chloride  100  ml ; fluconazole  200  mg ; potassium chloride (powder)  40  meq ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; 
 
unknown m 87 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  474  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  56  mg dl; chemistry blood urea nitrogen  56  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  155  mg dl; chemistry blood glucose  160  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; amlodipine  5  mg ; miconazole powder 2%  1  appl ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; potassium chloride (powder)  40  meq ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; triamcinolone acetonide 0.025% cream  1  appl ; 
 
unknown m 87 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  544  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  59  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  161  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; amlodipine  5  mg ; miconazole powder 2%  1  appl ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; triamcinolone acetonide 0.025% cream  1  appl ; hydroxyzine  12.5  mg ; 
 
unknown m 87 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  577  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  116  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  61  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  158  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; amlodipine  5  mg ; miconazole powder 2%  1  appl ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; triamcinolone acetonide 0.025% cream  1  appl ; hydroxyzine  12.5  mg ; lansoprazole oral disintegrating tab  30  mg ; 
 
unknown m 87 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  569  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  120  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.8  meq l; chemistry blood sodium  150  meq l; chemistry blood urea nitrogen  63  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  162  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; amlodipine  5  mg ; miconazole powder 2%  1  appl ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; triamcinolone acetonide 0.025% cream  1  appl ; lansoprazole oral disintegrating tab  30  mg ; sodium polystyrene sulfonate  15  gm ; 
 
unknown m 87 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  564  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  119  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  149  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  65  mg dl; chemistry blood urea nitrogen  64  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  150  mg dl; chemistry blood glucose  166  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; amlodipine  5  mg ; miconazole powder 2%  1  appl ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; triamcinolone acetonide 0.025% cream  1  appl ; lansoprazole oral disintegrating tab  30  mg ; sodium polystyrene sulfonate  15  gm ; d10w  1000  ml ; senna  1  tab ; bisacodyl  10  mg ; fentanyl patch  50  mcg h ; hydromorphone (dilaudid)  0.5-1  mg ; 
 
unknown m 87 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  601  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  73  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  77  mg dl; blood gas blood free calcium  1.26  mmol l; blood gas blood lactate  0.7  mmol l; blood gas blood chloride, whole blood  118  meq l; blood gas blood glucose  77  mg dl; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood sodium, whole blood  144  meq l$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; amlodipine  5  mg ; miconazole powder 2%  1  appl ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; triamcinolone acetonide 0.025% cream  1  appl ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; bisacodyl  10  mg ; fentanyl patch  50  mcg h ; hydromorphone (dilaudid)  0.5-1  mg ; acetaminophen iv  1000  mg ; docusate sodium  100  mg ; docusate sodium (liquid)  100  mg ; furosemide  10  mg ; fentanyl patch  25  mcg h ; 
 
unknown m 87 $nan$hematology blood hematocrit  24.7  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  576  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  117  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  150  meq l; chemistry blood urea nitrogen  70  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  109  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; amlodipine  5  mg ; miconazole powder 2%  1  appl ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; triamcinolone acetonide 0.025% cream  1  appl ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; bisacodyl  10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; acetaminophen iv  1000  mg ; docusate sodium (liquid)  100  mg ; furosemide  10  mg ; fentanyl patch  25  mcg h ; haloperidol  0.25  mg ; 
 
unknown m 87 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  527  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  118  meq l; chemistry blood chloride  121  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  6.0  meq l; chemistry blood potassium  2.6  meq l; chemistry blood potassium  5.7  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  148  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  65  mg dl; chemistry blood urea nitrogen  67  mg dl; chemistry blood urea nitrogen  66  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  136  mg dl; chemistry blood glucose  122  mg dl; chemistry blood glucose  136  mg dl; chemistry blood albumin  1.9  g dl; chemistry blood albumin  2.1  g dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; amlodipine  5  mg ; miconazole powder 2%  1  appl ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; triamcinolone acetonide 0.025% cream  1  appl ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; bisacodyl  10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; docusate sodium (liquid)  100  mg ; fentanyl patch  25  mcg h ; hydralazine  10  mg ; ondansetron  4  mg ; sterile water  50  ml ; potassium chloride  20  meq ; potassium chloride  60  meq ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  3  mg ; 
 
unknown m 87 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  495  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  118  meq l; chemistry blood chloride  119  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  68  mg dl; chemistry blood glucose  136  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; miconazole powder 2%  1  appl ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; triamcinolone acetonide 0.025% cream  1  appl ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; bisacodyl  10  mg ; docusate sodium (liquid)  100  mg ; fentanyl patch  25  mcg h ; hydralazine  10  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  3  mg ; furosemide  40  mg ; naloxone  0.4  mg ; hydromorphone (dilaudid)  1-2  mg ; ipratropium bromide neb  1  neb ; 
 
unknown m 87 $nan$hematology blood hematocrit  22.0  %; hematology blood hemoglobin  6.7  g dl; hematology blood platelet count  500  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  118  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  125  meq l; chemistry blood urea nitrogen  61  mg dl; chemistry blood urea nitrogen  67  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  1932  mg dl; chemistry blood glucose  101  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; miconazole powder 2%  1  appl ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; triamcinolone acetonide 0.025% cream  1  appl ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; bisacodyl  10  mg ; docusate sodium (liquid)  100  mg ; fentanyl patch  25  mcg h ; ondansetron  4  mg ; furosemide  40  mg ; naloxone  0.4  mg ; ipratropium bromide neb  1  neb ; haloperidol  0.5  mg ; 
 
unknown m 87 $nan$hematology blood hematocrit  25.8  %; hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  540  k ul; hematology blood platelet count  556  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  120  meq l; chemistry blood chloride  119  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  152  meq l; chemistry blood sodium  152  meq l; chemistry blood urea nitrogen  67  mg dl; chemistry blood urea nitrogen  68  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  84  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; lidocaine jelly 2% (urojet)  1  appl ; miconazole powder 2%  1  appl ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; triamcinolone acetonide 0.025% cream  1  appl ; lansoprazole oral disintegrating tab  30  mg ; senna  1  tab ; bisacodyl  10  mg ; docusate sodium (liquid)  100  mg ; ondansetron  4  mg ; furosemide  40  mg ; ipratropium bromide neb  1  neb ; sterile water  100  ml ; potassium chloride  40  meq ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  20  mg ; scopolamine patch  1  ptch ; lorazepam  0.5-1  mg ; 
 
unknown m 87 $nan$nan$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  20  mg ; scopolamine patch  1  ptch ; lorazepam  0.5-1  mg ; glycopyrrolate  0.2  mg ; 
 
white f 92 $temp    heartrate  75.0  resprate  18.0  o2sat  98.0  sbp  149.0  dbp  84.0  rhythm    pain  unable  ; temp    heartrate  70.0  resprate  18.0  o2sat  98.0  sbp  99.0  dbp  53.0  rhythm    pain    ; temp  98.3  heartrate  75.0  resprate  18.0  o2sat  98.0  sbp  83.0  dbp  45.0  rhythm    pain    ; temp    heartrate  75.0  resprate  18.0  o2sat  98.0  sbp  99.0  dbp  50.0  rhythm    pain    ; temp    heartrate  74.0  resprate  14.0  o2sat  94.0  sbp  97.0  dbp  57.0  rhythm    pain  8  ; temp    heartrate  74.0  resprate  15.0  o2sat  93.0  sbp  112.0  dbp  60.0  rhythm    pain    ; temp    heartrate  73.0  resprate  15.0  o2sat  95.0  sbp  123.0  dbp  61.0  rhythm    pain    ; temp    heartrate  73.0  resprate  15.0  o2sat  95.0  sbp  125.0  dbp  61.0  rhythm    pain    ; temp    heartrate  73.0  resprate  14.0  o2sat  94.0  sbp  119.0  dbp  57.0  rhythm    pain    ; temp    heartrate  78.0  resprate  15.0  o2sat  94.0  sbp  108.0  dbp  55.0  rhythm    pain    ; temp    heartrate  77.0  resprate  14.0  o2sat  94.0  sbp  104.0  dbp  56.0  rhythm    pain    ; temp    heartrate  76.0  resprate  14.0  o2sat  94.0  sbp  105.0  dbp  55.0  rhythm    pain    ; temp    heartrate  78.0  resprate  15.0  o2sat  95.0  sbp  112.0  dbp  57.0  rhythm    pain    ; temp  98.0  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    ; temp  99.8  heartrate  79.0  resprate  16.0  o2sat  94.0  sbp  121.0  dbp  74.0  rhythm    pain  ua  ; temp  98.1  heartrate  70.0  resprate  24.0  o2sat  93.0  sbp  147.0  dbp  67.0  rhythm    pain  ua  ; temp    heartrate  59.0  resprate  18.0  o2sat  92.0  sbp  108.0  dbp  86.0  rhythm    pain    ; temp    heartrate  101.0  resprate  20.0  o2sat  98.0  sbp  120.0  dbp  84.0  rhythm    pain  0  ; temp  96.8  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    ; temp    heartrate    resprate    o2sat  95.0  sbp    dbp    rhythm    pain  0  $hematology blood hematocrit  38.2  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  278  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  109  mg dl; chemistry blood albumin  3.6  g dl$nan
radiculopathy, cervical region iron deficiency anemia, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits spondylosis, unspecified spinal stenosis, site unspecified major depressive disorder, single episode, unspecified collapsed vertebra, not elsewhere classified, thoracic region, initial encounter for fracture constipation, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension abdominal aortic aneurysm, without rupture gastro-esophageal reflux disease without esophagitis disorientation, unspecified dementia, unspecified, without behavioral disturbance other specified metabolic disorders unspecified essential hypertension coronary atherosclerosis of native coronary artery long-term (current) use of antiplatelet/antithrombotic unspecified fall accidents occurring in residential institution do not resuscitate status head injury, unspecified urinary tract infection, site not specified other opiates and related narcotics causing adverse effects in therapeutic use personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified fall toxic encephalopathy closed fracture of intertrochanteric section of neck of femur spinal stenosis in cervical region acute posthemorrhagic anemia depressive disorder, not elsewhere classified chronic kidney disease, stage iii (moderate) other and unspecified escherichia coli [e. coli] esophageal reflux urinary tract infection, site not specified other conditions of brain constipation, unspecified dementia, unspecified, without behavioral disturbance pressure ulcer, stage i other specified metabolic disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pressure ulcer, lower back accidents occurring in residential institution dehydration accidents occurring in unspecified place do not resuscitate status coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia
white f 92 $temp  97.6  heartrate  91.0  resprate  22.0  o2sat  97.0  sbp  130.0  dbp  73.0  rhythm    pain    $nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; docusate sodium  100  mg ; donepezil  10  mg ; isosorbide mononitrate (extended release)  30  mg ; lidocaine 5% patch  1  ptch ; multivitamins  1  tab ; paroxetine  20  mg ; senna  8.6  mg ; tramadol  50  mg ; vitamin d  1000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; pantoprazole  40  mg ; cefepime  1  g ; heparin  5000  unit ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; 
radiculopathy, cervical region iron deficiency anemia, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits spondylosis, unspecified spinal stenosis, site unspecified major depressive disorder, single episode, unspecified collapsed vertebra, not elsewhere classified, thoracic region, initial encounter for fracture constipation, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension abdominal aortic aneurysm, without rupture gastro-esophageal reflux disease without esophagitis disorientation, unspecified dementia, unspecified, without behavioral disturbance other specified metabolic disorders unspecified essential hypertension coronary atherosclerosis of native coronary artery long-term (current) use of antiplatelet/antithrombotic unspecified fall accidents occurring in residential institution do not resuscitate status head injury, unspecified urinary tract infection, site not specified other opiates and related narcotics causing adverse effects in therapeutic use personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified fall toxic encephalopathy closed fracture of intertrochanteric section of neck of femur spinal stenosis in cervical region acute posthemorrhagic anemia depressive disorder, not elsewhere classified chronic kidney disease, stage iii (moderate) other and unspecified escherichia coli [e. coli] esophageal reflux urinary tract infection, site not specified other conditions of brain constipation, unspecified dementia, unspecified, without behavioral disturbance pressure ulcer, stage i other specified metabolic disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pressure ulcer, lower back accidents occurring in residential institution dehydration accidents occurring in unspecified place do not resuscitate status coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia
white f 92 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  85  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; docusate sodium  100  mg ; donepezil  10  mg ; isosorbide mononitrate (extended release)  30  mg ; lidocaine 5% patch  1  ptch ; multivitamins  1  tab ; paroxetine  20  mg ; senna  8.6  mg ; tramadol  50  mg ; vitamin d  1000  unit ; pantoprazole  40  mg ; cefepime  1  g ; heparin  5000  unit ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; ondansetron  4  mg ; 
radiculopathy, cervical region iron deficiency anemia, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits spondylosis, unspecified spinal stenosis, site unspecified major depressive disorder, single episode, unspecified collapsed vertebra, not elsewhere classified, thoracic region, initial encounter for fracture constipation, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension abdominal aortic aneurysm, without rupture gastro-esophageal reflux disease without esophagitis disorientation, unspecified dementia, unspecified, without behavioral disturbance other specified metabolic disorders unspecified essential hypertension coronary atherosclerosis of native coronary artery long-term (current) use of antiplatelet/antithrombotic unspecified fall accidents occurring in residential institution do not resuscitate status head injury, unspecified urinary tract infection, site not specified other opiates and related narcotics causing adverse effects in therapeutic use personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified fall toxic encephalopathy closed fracture of intertrochanteric section of neck of femur spinal stenosis in cervical region acute posthemorrhagic anemia depressive disorder, not elsewhere classified chronic kidney disease, stage iii (moderate) other and unspecified escherichia coli [e. coli] esophageal reflux urinary tract infection, site not specified other conditions of brain constipation, unspecified dementia, unspecified, without behavioral disturbance pressure ulcer, stage i other specified metabolic disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pressure ulcer, lower back accidents occurring in residential institution dehydration accidents occurring in unspecified place do not resuscitate status coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia
white f 92 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  223  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  95  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; docusate sodium  100  mg ; donepezil  10  mg ; isosorbide mononitrate (extended release)  30  mg ; lidocaine 5% patch  1  ptch ; multivitamins  1  tab ; paroxetine  20  mg ; senna  8.6  mg ; tramadol  50  mg ; vitamin d  1000  unit ; pantoprazole  40  mg ; cefepime  1  g ; heparin  5000  unit ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; 
radiculopathy, cervical region iron deficiency anemia, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits spondylosis, unspecified spinal stenosis, site unspecified major depressive disorder, single episode, unspecified collapsed vertebra, not elsewhere classified, thoracic region, initial encounter for fracture constipation, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension abdominal aortic aneurysm, without rupture gastro-esophageal reflux disease without esophagitis disorientation, unspecified dementia, unspecified, without behavioral disturbance other specified metabolic disorders unspecified essential hypertension coronary atherosclerosis of native coronary artery long-term (current) use of antiplatelet/antithrombotic unspecified fall accidents occurring in residential institution do not resuscitate status head injury, unspecified urinary tract infection, site not specified other opiates and related narcotics causing adverse effects in therapeutic use personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified fall toxic encephalopathy closed fracture of intertrochanteric section of neck of femur spinal stenosis in cervical region acute posthemorrhagic anemia depressive disorder, not elsewhere classified chronic kidney disease, stage iii (moderate) other and unspecified escherichia coli [e. coli] esophageal reflux urinary tract infection, site not specified other conditions of brain constipation, unspecified dementia, unspecified, without behavioral disturbance pressure ulcer, stage i other specified metabolic disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pressure ulcer, lower back accidents occurring in residential institution dehydration accidents occurring in unspecified place do not resuscitate status coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia
white f 92 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  242  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  84  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; docusate sodium  100  mg ; donepezil  10  mg ; isosorbide mononitrate (extended release)  30  mg ; lidocaine 5% patch  1  ptch ; multivitamins  1  tab ; paroxetine  20  mg ; senna  8.6  mg ; tramadol  50  mg ; vitamin d  1000  unit ; pantoprazole  40  mg ; cefepime  1  g ; heparin  5000  unit ; bisacodyl  10  mg ; polyethylene glycol  17  g ; ciprofloxacin hcl  500  mg ; potassium chloride  40  meq ; 
radiculopathy, cervical region iron deficiency anemia, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits spondylosis, unspecified spinal stenosis, site unspecified major depressive disorder, single episode, unspecified collapsed vertebra, not elsewhere classified, thoracic region, initial encounter for fracture constipation, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris essential (primary) hypertension abdominal aortic aneurysm, without rupture gastro-esophageal reflux disease without esophagitis disorientation, unspecified dementia, unspecified, without behavioral disturbance other specified metabolic disorders unspecified essential hypertension coronary atherosclerosis of native coronary artery long-term (current) use of antiplatelet/antithrombotic unspecified fall accidents occurring in residential institution do not resuscitate status head injury, unspecified urinary tract infection, site not specified other opiates and related narcotics causing adverse effects in therapeutic use personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified fall toxic encephalopathy closed fracture of intertrochanteric section of neck of femur spinal stenosis in cervical region acute posthemorrhagic anemia depressive disorder, not elsewhere classified chronic kidney disease, stage iii (moderate) other and unspecified escherichia coli [e. coli] esophageal reflux urinary tract infection, site not specified other conditions of brain constipation, unspecified dementia, unspecified, without behavioral disturbance pressure ulcer, stage i other specified metabolic disorders hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pressure ulcer, lower back accidents occurring in residential institution dehydration accidents occurring in unspecified place do not resuscitate status coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia
white f 56 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  111  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  56  mg dl; chemistry blood albumin  3.1  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.5  mg ; acetaminophen  500-1000  mg ; ciprofloxacin hcl  500  mg ; insulin  0  unit ; insulin  40  unit ; omeprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  2  puff ; oxycodone (immediate release)  5  mg ; lamotrigine  200  mg ; lamotrigine  400  mg ; levetiracetam  1500  mg ; gemfibrozil  600  mg ; topiramate (topamax)  100  mg ; methadone  20  mg ; methadone  15  mg ; insulin  35  unit ; fluticasone-salmeterol diskus (250 50)   1  inh ; d5lr  1000  ml ; phytonadione  5  mg ; d10w  1000  ml ; 
acute pancreatitis other acquired absence of organ polyneuropathy in diabetes peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction background diabetic retinopathy diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled epilepsy, unspecified, without mention of intractable epilepsy diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled legal blindness, as defined in u.s.a. long-term (current) use of anticoagulants chronic pancreatitis other chronic nonalcoholic liver disease esophageal reflux
white f 56 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  109  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  101  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; ciprofloxacin hcl  500  mg ; omeprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  2  puff ; oxycodone (immediate release)  5  mg ; lamotrigine  200  mg ; lamotrigine  400  mg ; levetiracetam  1500  mg ; gemfibrozil  600  mg ; topiramate (topamax)  100  mg ; methadone  20  mg ; methadone  15  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; phytonadione  5  mg ; d10w  1000  ml ; hydromorphone (dilaudid)  1  mg ; oxycodone (immediate release)  10  mg ; docusate sodium  100  mg ; 
acute pancreatitis other acquired absence of organ polyneuropathy in diabetes peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction background diabetic retinopathy diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled epilepsy, unspecified, without mention of intractable epilepsy diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled legal blindness, as defined in u.s.a. long-term (current) use of anticoagulants chronic pancreatitis other chronic nonalcoholic liver disease esophageal reflux
white f 56 $nan$hematology blood hematocrit  35.5  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  106  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; ciprofloxacin hcl  500  mg ; omeprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  2  puff ; lamotrigine  200  mg ; lamotrigine  400  mg ; levetiracetam  1500  mg ; gemfibrozil  600  mg ; topiramate (topamax)  100  mg ; methadone  20  mg ; methadone  15  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; phytonadione  5  mg ; hydromorphone (dilaudid)  1  mg ; oxycodone (immediate release)  10  mg ; docusate sodium  100  mg ; senna  17.2  mg ; oxycodone (immediate release)  15  mg ; d5 1 2ns  1000  ml ; 
acute pancreatitis other acquired absence of organ polyneuropathy in diabetes peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction background diabetic retinopathy diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled epilepsy, unspecified, without mention of intractable epilepsy diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled legal blindness, as defined in u.s.a. long-term (current) use of anticoagulants chronic pancreatitis other chronic nonalcoholic liver disease esophageal reflux
white f 56 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  95  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood glucose  203  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; ciprofloxacin hcl  500  mg ; omeprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  2  puff ; lamotrigine  200  mg ; lamotrigine  400  mg ; levetiracetam  1500  mg ; gemfibrozil  600  mg ; topiramate (topamax)  100  mg ; methadone  20  mg ; methadone  15  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; docusate sodium  100  mg ; senna  17.2  mg ; oxycodone (immediate release)  15  mg ; d5 1 2ns  1000  ml ; 
acute pancreatitis other acquired absence of organ polyneuropathy in diabetes peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction background diabetic retinopathy diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled epilepsy, unspecified, without mention of intractable epilepsy diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled legal blindness, as defined in u.s.a. long-term (current) use of anticoagulants chronic pancreatitis other chronic nonalcoholic liver disease esophageal reflux
white f 56 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  134  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; ciprofloxacin hcl  500  mg ; omeprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  2  puff ; lamotrigine  200  mg ; lamotrigine  400  mg ; levetiracetam  1500  mg ; gemfibrozil  600  mg ; topiramate (topamax)  100  mg ; methadone  20  mg ; methadone  15  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; docusate sodium  100  mg ; senna  17.2  mg ; 
acute pancreatitis other acquired absence of organ polyneuropathy in diabetes peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction background diabetic retinopathy diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled epilepsy, unspecified, without mention of intractable epilepsy diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled legal blindness, as defined in u.s.a. long-term (current) use of anticoagulants chronic pancreatitis other chronic nonalcoholic liver disease esophageal reflux
white f 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; ciprofloxacin hcl  500  mg ; omeprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  2  puff ; lamotrigine  200  mg ; lamotrigine  400  mg ; levetiracetam  1500  mg ; gemfibrozil  600  mg ; topiramate (topamax)  100  mg ; methadone  20  mg ; methadone  15  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; docusate sodium  100  mg ; senna  17.2  mg ; 
acute pancreatitis other acquired absence of organ polyneuropathy in diabetes peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction background diabetic retinopathy diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled epilepsy, unspecified, without mention of intractable epilepsy diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled legal blindness, as defined in u.s.a. long-term (current) use of anticoagulants chronic pancreatitis other chronic nonalcoholic liver disease esophageal reflux
white f 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; omeprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  2  puff ; lamotrigine  200  mg ; lamotrigine  400  mg ; levetiracetam  1500  mg ; gemfibrozil  600  mg ; topiramate (topamax)  100  mg ; methadone  20  mg ; methadone  15  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; docusate sodium  100  mg ; senna  17.2  mg ; 
acute pancreatitis other acquired absence of organ polyneuropathy in diabetes peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction background diabetic retinopathy diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled epilepsy, unspecified, without mention of intractable epilepsy diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled legal blindness, as defined in u.s.a. long-term (current) use of anticoagulants chronic pancreatitis other chronic nonalcoholic liver disease esophageal reflux
white f 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; omeprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  2  puff ; lamotrigine  200  mg ; lamotrigine  400  mg ; levetiracetam  1500  mg ; gemfibrozil  600  mg ; topiramate (topamax)  100  mg ; methadone  20  mg ; methadone  15  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; docusate sodium  100  mg ; senna  17.2  mg ; 
acute pancreatitis other acquired absence of organ polyneuropathy in diabetes peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction background diabetic retinopathy diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled epilepsy, unspecified, without mention of intractable epilepsy diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled legal blindness, as defined in u.s.a. long-term (current) use of anticoagulants chronic pancreatitis other chronic nonalcoholic liver disease esophageal reflux
black african american m 43 $temp  97.7  heartrate  93.0  resprate  25.0  o2sat  95.0  sbp  143.0  dbp  92.0  rhythm    pain  0  $hematology blood hematocrit  44.9  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  117  mg dl; blood gas blood free calcium  1.15  mmol l; blood gas blood lactate  1.2  mmol l; chemistry blood % hemoglobin a1c  5.7  %$ns  100  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; hydralazine  10  mg ; bag  1  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; sodium chloride 0.9%  1000  ml ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; esmolol  2000  mg ; bag  500  ml ; sodium chloride 3% (hypertonic)  500  ml ; hydralazine  10-20  mg ; acetaminophen iv  1000  mg ; labetalol  10  mg ; senna  8.6  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; labetalol  100  mg ; acetaminophen  1000  mg ; labetalol  200  mg ; heparin  5000  unit ; 
 
black african american m 43 $nan$hematology blood hematocrit  46.0  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  254  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  127  mg dl$sodium chloride 0.9%  flush  3-10  ml ; bag  1  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; hydralazine  10-20  mg ; labetalol  10  mg ; senna  8.6  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  1000  mg ; labetalol  200  mg ; heparin  5000  unit ; labetalol  10-20  mg ; labetalol  300  mg ; sodium chloride 0.9%  flush  10  ml ; docusate sodium  100  mg ; captopril  6.25  mg ; labetalol  400  mg ; sodium chloride  1  gm ; 
 
black african american m 43 $nan$hematology blood hematocrit  44.1  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  116  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  149  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  101  mg dl; chemistry blood glucose  109  mg dl; blood gas blood free calcium  1.15  mmol l; blood gas blood lactate  1.1  mmol l$sodium chloride 0.9%  flush  3-10  ml ; bag  1  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; hydralazine  10-20  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  1000  mg ; heparin  5000  unit ; labetalol  10-20  mg ; sodium chloride 0.9%  flush  10  ml ; docusate sodium  100  mg ; captopril  6.25  mg ; labetalol  400  mg ; sodium chloride  1  gm ; captopril  12.5  mg ; captopril  25  mg ; oxycodone (immediate release)  5  mg ; 
 
black african american m 43 $nan$hematology blood hematocrit  45.7  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  149  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  148  meq l; chemistry blood sodium  148  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry urine creatinine, urine  54  mg dl; chemistry urine sodium, urine  219  meq l; hematology urine wbc  0  # hpf; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  112  mg dl; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  1.1  mmol l$sodium chloride 0.9%  flush  3-10  ml ; bag  1  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; hydralazine  10-20  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; labetalol  10-20  mg ; sodium chloride 0.9%  flush  10  ml ; docusate sodium  100  mg ; sodium chloride  1  gm ; captopril  25  mg ; oxycodone (immediate release)  5  mg ; captopril  37.5  mg ; captopril  50  mg ; 
 
black african american m 43 $nan$hematology blood hematocrit  43.0  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  236  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  120  mg dl$sodium chloride 0.9%  flush  3-10  ml ; bag  1  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; hydralazine  10-20  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; labetalol  10-20  mg ; sodium chloride 0.9%  flush  10  ml ; docusate sodium  100  mg ; oxycodone (immediate release)  5  mg ; captopril  50  mg ; trazodone  25  mg ; amlodipine  10  mg ; 
 
black african american m 43 $nan$hematology blood hematocrit  43.0  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3-10  ml ; bag  1  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; hydralazine  10-20  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; docusate sodium  100  mg ; captopril  50  mg ; trazodone  25  mg ; amlodipine  10  mg ; 
 
black african american m 43 $nan$hematology blood hematocrit  41.8  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  243  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3-10  ml ; hydralazine  10-20  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; docusate sodium  100  mg ; captopril  50  mg ; trazodone  25  mg ; amlodipine  10  mg ; 
 
black african american m 43 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; hydralazine  10-20  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; docusate sodium  100  mg ; trazodone  25  mg ; amlodipine  10  mg ; lisinopril  40  mg ; chlorthalidone  25  mg ; 
 
black african american m 43 $nan$chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  84  mg dl$sodium chloride 0.9%  flush  3-10  ml ; hydralazine  10-20  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; docusate sodium  100  mg ; trazodone  25  mg ; amlodipine  10  mg ; lisinopril  40  mg ; chlorthalidone  25  mg ; 
 
black african american m 43 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; hydralazine  10-20  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; docusate sodium  100  mg ; trazodone  25  mg ; amlodipine  10  mg ; lisinopril  40  mg ; chlorthalidone  25  mg ; 
 
hispanic latino m 81 $temp  99.1  heartrate  82.0  resprate  16.0  o2sat  97.0  sbp  100.0  dbp  65.0  rhythm    pain  0  $hematology blood hematocrit  36.7  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  117  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  115  mg dl; chemistry blood lactate dehydrogenase (ld)  137  iu l; chemistry blood albumin  3.2  g dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  1000  mg ; metoclopramide  10  mg ; ondansetron  8  mg ; pantoprazole  40  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; metronidazole (flagyl)  500  mg ; 
personal history of tobacco use accidents occurring in residential institution unspecified essential hypertension pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident other and unspecified hyperlipidemia family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in noncollision transport accident in nontraffic accident portal vein thrombosis esophageal reflux accidental cut, puncture, perforation or hemorrhage during surgical operation benign neoplasm of duodenum, jejunum, and ileum other alteration of consciousness family history of diabetes mellitus accidental puncture or laceration during a procedure, not elsewhere classified malignant neoplasm of pancreatic duct physical restraints status other and unspecified hyperlipidemia unspecified essential hypertension diarrhea obstruction of bile duct tabes dorsalis portal vein thrombosis cholangitis unspecified disease of pancreas other specified disorders of stomach and duodenum 
hispanic latino m 81 $nan$hematology blood hematocrit  35.9  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  122  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  102  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  1000  mg ; metoclopramide  10  mg ; ondansetron  8  mg ; pantoprazole  40  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; metronidazole (flagyl)  500  mg ; ampicillin-sulbactam  3  g ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ciprofloxacin hcl  250  mg ; ciprofloxacin hcl  500  mg ; 
personal history of tobacco use accidents occurring in residential institution unspecified essential hypertension pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident other and unspecified hyperlipidemia family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in noncollision transport accident in nontraffic accident portal vein thrombosis esophageal reflux accidental cut, puncture, perforation or hemorrhage during surgical operation benign neoplasm of duodenum, jejunum, and ileum other alteration of consciousness family history of diabetes mellitus accidental puncture or laceration during a procedure, not elsewhere classified malignant neoplasm of pancreatic duct physical restraints status other and unspecified hyperlipidemia unspecified essential hypertension diarrhea obstruction of bile duct tabes dorsalis portal vein thrombosis cholangitis unspecified disease of pancreas other specified disorders of stomach and duodenum 
hispanic latino m 81 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  146  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  114  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; metoclopramide  10  mg ; ondansetron  8  mg ; pantoprazole  40  mg ; ciprofloxacin hcl  250  mg ; ciprofloxacin hcl  500  mg ; 
personal history of tobacco use accidents occurring in residential institution unspecified essential hypertension pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident other and unspecified hyperlipidemia family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in noncollision transport accident in nontraffic accident portal vein thrombosis esophageal reflux accidental cut, puncture, perforation or hemorrhage during surgical operation benign neoplasm of duodenum, jejunum, and ileum other alteration of consciousness family history of diabetes mellitus accidental puncture or laceration during a procedure, not elsewhere classified malignant neoplasm of pancreatic duct physical restraints status other and unspecified hyperlipidemia unspecified essential hypertension diarrhea obstruction of bile duct tabes dorsalis portal vein thrombosis cholangitis unspecified disease of pancreas other specified disorders of stomach and duodenum 
hispanic latino m 81 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; metoclopramide  10  mg ; ondansetron  8  mg ; pantoprazole  40  mg ; ciprofloxacin hcl  250  mg ; ciprofloxacin hcl  500  mg ; docusate sodium  100  mg ; senna  8.6  mg ; 
personal history of tobacco use accidents occurring in residential institution unspecified essential hypertension pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident other and unspecified hyperlipidemia family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in noncollision transport accident in nontraffic accident portal vein thrombosis esophageal reflux accidental cut, puncture, perforation or hemorrhage during surgical operation benign neoplasm of duodenum, jejunum, and ileum other alteration of consciousness family history of diabetes mellitus accidental puncture or laceration during a procedure, not elsewhere classified malignant neoplasm of pancreatic duct physical restraints status other and unspecified hyperlipidemia unspecified essential hypertension diarrhea obstruction of bile duct tabes dorsalis portal vein thrombosis cholangitis unspecified disease of pancreas other specified disorders of stomach and duodenum 
white m 39 $nan$hematology blood hematocrit  40.4  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  105  mg dl$nan
unspecified episodic mood disorder acute alcoholic intoxication in alcoholism, unspecified
black african american f 47 $temp  101.0  heartrate  89.0  resprate  16.0  o2sat  99.0  sbp  114.0  dbp  74.0  rhythm    pain  2  $hematology blood hematocrit  19.8  %; hematology blood hemoglobin  6.7  g dl; hematology blood platelet count  127  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  2.1  mg dl; chemistry blood glucose  96  mg dl; chemistry blood lactate dehydrogenase (ld)  664  iu l$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; lactated ringers  1000  ml ; dicyclomine  10  mg ; folic acid  1  mg ; vitamin d  1000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; acetaminophen  325-650  mg ; 
 
black african american f 47 $nan$hematology blood hematocrit  19.7  %; hematology blood hemoglobin  6.6  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, indirect  1.8  mg dl; chemistry blood bilirubin, total  2.4  mg dl; chemistry blood glucose  97  mg dl; chemistry blood bilirubin, direct  0.6  mg dl$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; dicyclomine  10  mg ; folic acid  1  mg ; vitamin d  1000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; acetaminophen  325-650  mg ; zolpidem tartrate  5  mg ; 
 
black african american f 47 $nan$hematology blood hematocrit  18.4  %; hematology blood hemoglobin  6.3  g dl; hematology blood platelet count  148  k ul; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood lactate dehydrogenase (ld)  562  iu l; hematology blood bands  0  %$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; dicyclomine  10  mg ; vitamin d  1000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; acetaminophen  325-650  mg ; zolpidem tartrate  5  mg ; folic acid  2  mg ; 
 
black african american f 47 $nan$hematology blood hematocrit  21.4  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  214  k ul; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood lactate dehydrogenase (ld)  547  iu l$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; dicyclomine  10  mg ; vitamin d  1000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; acetaminophen  325-650  mg ; zolpidem tartrate  5  mg ; folic acid  2  mg ; 
 
black african american f 47 $nan$hematology blood hematocrit  20.1  %; hematology blood hemoglobin  6.6  g dl; hematology blood platelet count  203  k ul$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; dicyclomine  10  mg ; vitamin d  1000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; acetaminophen  325-650  mg ; zolpidem tartrate  5  mg ; folic acid  2  mg ; 
 
other f 70 $nan$nan$aspirin ec  325  mg ; clopidogrel  75  mg ; 
 
other f 70 $nan$hematology blood hematocrit  38.0  %; hematology blood platelet count  457  k ul; hematology blood platelet count  450  k ul; chemistry blood chloride  107  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  5.2  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  17  mg dl$aspirin ec  325  mg ; clopidogrel  75  mg ; d5 1 2ns  1000  ml ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; zolpidem tartrate  5  mg ; sodium chloride 0.9%  flush  3  ml ; prednisone  10  mg ; atorvastatin  20  mg ; atenolol  25  mg ; nitrofurantoin (macrodantin)  100  mg ; avapro  150  mg ; 
 
other f 70 $nan$nan$aspirin ec  325  mg ; clopidogrel  75  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; zolpidem tartrate  5  mg ; sodium chloride 0.9%  flush  3  ml ; prednisone  10  mg ; atorvastatin  20  mg ; atenolol  25  mg ; nitrofurantoin (macrodantin)  100  mg ; avapro  150  mg ; 
 
asian m 72 $nan$hematology blood hematocrit  31.3  %; hematology blood hematocrit  32.8  %; hematology blood hematocrit  33.9  %; hematology blood hematocrit  28.8  %; hematology blood hematocrit  23.8  %; hematology blood hemoglobin  10.8  g dl; hematology blood hemoglobin  11.4  g dl; hematology blood hemoglobin  11.6  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  60  k ul; hematology blood platelet count  75  k ul; hematology blood platelet count  49  k ul; hematology blood platelet count  38  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.9  meq l; chemistry blood potassium  6.3  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  2.8  ; hematology blood inr(pt)  1.9  ; hematology blood inr(pt)  1.2  ; chemistry blood glucose  121  mg dl; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.04  mmol l; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.37  mmol l; blood gas blood free calcium  1.30  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  2.5  mmol l; blood gas blood lactate  3.7  mmol l; blood gas blood lactate  3.3  mmol l; blood gas blood lactate  3.5  mmol l; blood gas blood lactate  5.8  mmol l; blood gas blood lactate  6.3  mmol l; blood gas blood lactate  4.2  mmol l; blood gas blood lactate  4.6  mmol l; blood gas blood lactate  4.3  mmol l; blood gas blood chloride, whole blood  104  meq l; blood gas blood chloride, whole blood  105  meq l; blood gas blood chloride, whole blood  112  meq l; blood gas blood chloride, whole blood  113  meq l; blood gas blood chloride, whole blood  114  meq l; blood gas blood glucose  104  mg dl; blood gas blood glucose  116  mg dl; blood gas blood glucose  164  mg dl; blood gas blood glucose  170  mg dl; blood gas blood glucose  148  mg dl; blood gas blood glucose  86  mg dl; blood gas blood glucose  120  mg dl; blood gas blood glucose  145  mg dl; blood gas blood glucose  112  mg dl; blood gas blood glucose  107  mg dl; blood gas blood glucose  106  mg dl; blood gas blood glucose  128  mg dl; blood gas blood hematocrit, calculated  38  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  33  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  29  %; blood gas blood hematocrit, calculated  29  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  29  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  33  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hemoglobin  12.8  g dl; blood gas blood hemoglobin  10.7  g dl; blood gas blood hemoglobin  10.9  g dl; blood gas blood hemoglobin  10.7  g dl; blood gas blood hemoglobin  9.6  g dl; blood gas blood hemoglobin  9.8  g dl; blood gas blood hemoglobin  10.5  g dl; blood gas blood hemoglobin  9.5  g dl; blood gas blood hemoglobin  10.6  g dl; blood gas blood hemoglobin  11.0  g dl; blood gas blood hemoglobin  10.8  g dl; blood gas blood potassium, whole blood  3.6  meq l; blood gas blood potassium, whole blood  5.9  meq l; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  5.9  meq l; blood gas blood potassium, whole blood  5.9  meq l; blood gas blood potassium, whole blood  5.6  meq l; blood gas blood potassium, whole blood  5.3  meq l; blood gas blood potassium, whole blood  6.7  meq l; blood gas blood potassium, whole blood  6.0  meq l; blood gas blood potassium, whole blood  6.2  meq l; blood gas blood potassium, whole blood  6.0  meq l; blood gas blood sodium, whole blood  140  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood sodium, whole blood  137  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood sodium, whole blood  137  meq l$sodium chloride 0.9%  flush  10  ml ; aspirin ec  81  mg ; aspirin  81  mg ; milk of magnesia  30  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; syringe  1  syr ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; glucagon  1  mg ; glucose gel  15  g ; norepinephrine  8  mg ; norepinephrine bitartrate  1600  mcg ; docusate sodium  100  mg ; ranitidine  150  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; albumin 5% (25g   500ml)  25  g ; 
 
asian m 72 $nan$hematology blood hematocrit  30.1  %; hematology blood hematocrit  27.9  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  66  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  157  mg dl; blood gas blood lactate  3.7  mmol l$sodium chloride 0.9%  flush  10  ml ; aspirin ec  81  mg ; aspirin  81  mg ; milk of magnesia  30  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; syringe  1  syr ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; glucagon  1  mg ; glucose gel  15  g ; norepinephrine  8  mg ; norepinephrine bitartrate  1600  mcg ; docusate sodium  100  mg ; ranitidine  150  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; albumin 5% (25g   500ml)  25  g ; furosemide  20  mg ; meperidine  12.5  mg ; hydralazine  10  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; furosemide  40  mg ; metoprolol tartrate  2.5  mg ; metoprolol tartrate  5  mg ; furosemide  60  mg ; amiodarone  150  mg ; 5% dextrose (excel bag)  500  ml ; amiodarone  600  mg ; ondansetron  4-8  mg ; promethazine  6.25  mg ; 
 
asian m 72 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  53  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  10  ml ; aspirin ec  81  mg ; milk of magnesia  30  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 5%  1000  ml ; d5w  250  ml ; nitroglycerin  100  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; syringe  1  syr ; phenylephrine  12  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; glucagon  1  mg ; glucose gel  15  g ; norepinephrine  8  mg ; norepinephrine bitartrate  1600  mcg ; hydralazine  10  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; furosemide  40  mg ; metoprolol tartrate  2.5  mg ; metoprolol tartrate  5  mg ; furosemide  60  mg ; amiodarone  150  mg ; ondansetron  4-8  mg ; promethazine  6.25  mg ; metoprolol tartrate  12.5  mg ; metoprolol tartrate  25  mg ; tramadol (ultram)  50  mg ; amiodarone  200  mg ; 
 
asian m 72 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  68  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  10  ml ; aspirin ec  81  mg ; milk of magnesia  30  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 5%  1000  ml ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  10  mg ; ondansetron  4-8  mg ; metoprolol tartrate  25  mg ; tramadol (ultram)  50  mg ; amiodarone  200  mg ; potassium chloride  40  meq ; amiodarone  400  mg ; bisacodyl  10  mg ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; 
 
asian m 72 $nan$hematology blood hematocrit  29.4  %; hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  77  k ul; hematology blood platelet count  99  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood glucose  123  mg dl; chemistry blood glucose  103  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; amiodarone  400  mg ; bisacodyl  10  mg ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; 
 
asian m 72 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; amiodarone  400  mg ; bisacodyl  10  mg ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; fleet enema  1  enema ; amlodipine  2.5  mg ; 
 
other f 54 $temp  97.9  heartrate  85.0  resprate  15.0  o2sat  100.0  sbp  90.0  dbp  55.0  rhythm    pain  0  ; temp  97.4  heartrate  68.0  resprate  16.0  o2sat  100.0  sbp  90.0  dbp  62.0  rhythm    pain    $hematology blood hematocrit  33.1  %; hematology blood hematocrit  36.0  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  144  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.2  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry urine chloride, urine  153  meq l; chemistry urine creatinine, urine  15  mg dl; chemistry urine sodium, urine  67  meq l; chemistry urine urea nitrogen, urine  577  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  72  mg dl; chemistry blood albumin  2.9  g dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; acetaminophen  650  mg ; fentanyl patch  25  mcg h ; hydrocodone-acetaminophen (5mg-500mg  1-2  tab ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; polyethylene glycol  17  g ; bisacodyl  10  mg ; docusate sodium  100  mg ; heparin  5000  unit ; baclofen  5  mg ; divalproex (extended release)  500  mg ; levetiracetam  750  mg ; senna  1  tab ; potassium chloride  40  meq ; 
unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident thrombocytopenia, unspecified pressure ulcer, stage iv delirium due to conditions classified elsewhere pressure ulcer, lower back other chronic pain epilepsy, unspecified, without mention of intractable epilepsy personal history, urinary (tract) infection candidiasis of other urogenital sites wheelchair dependence mononeuritis of lower limb, unspecified multiple sclerosis encephalopathy, unspecified acidosis streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] wheelchair dependence pressure ulcer, lower back other convulsions unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident pressure ulcer, heel urinary tract infection, site not specified delirium due to conditions classified elsewhere pressure ulcer, stage iv paraplegia depressive disorder, not elsewhere classified multiple sclerosis other chronic pain cardiac arrest
other f 54 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.2  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  5  mg dl; hematology urine wbc  57  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  68  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; acetaminophen  650  mg ; fentanyl patch  25  mcg h ; hydrocodone-acetaminophen (5mg-500mg  1-2  tab ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 0.9% sodium chloride  500  ml ; polyethylene glycol  17  g ; bisacodyl  10  mg ; docusate sodium  100  mg ; heparin  5000  unit ; divalproex (extended release)  500  mg ; levetiracetam  750  mg ; senna  1  tab ; potassium chloride  40  meq ; divalproex (extended release)  1000  mg ; doxepin hcl  50  mg ; lactulose  30  ml ; 
unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident thrombocytopenia, unspecified pressure ulcer, stage iv delirium due to conditions classified elsewhere pressure ulcer, lower back other chronic pain epilepsy, unspecified, without mention of intractable epilepsy personal history, urinary (tract) infection candidiasis of other urogenital sites wheelchair dependence mononeuritis of lower limb, unspecified multiple sclerosis encephalopathy, unspecified acidosis streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] wheelchair dependence pressure ulcer, lower back other convulsions unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident pressure ulcer, heel urinary tract infection, site not specified delirium due to conditions classified elsewhere pressure ulcer, stage iv paraplegia depressive disorder, not elsewhere classified multiple sclerosis other chronic pain cardiac arrest
other f 54 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.2  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  74  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; acetaminophen  650  mg ; fentanyl patch  25  mcg h ; hydrocodone-acetaminophen (5mg-500mg  1-2  tab ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; polyethylene glycol  17  g ; bisacodyl  10  mg ; docusate sodium  100  mg ; heparin  5000  unit ; divalproex (extended release)  500  mg ; levetiracetam  750  mg ; senna  1  tab ; divalproex (extended release)  1000  mg ; doxepin hcl  50  mg ; lactulose  30  ml ; trazodone  12.5  mg ; 
unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident thrombocytopenia, unspecified pressure ulcer, stage iv delirium due to conditions classified elsewhere pressure ulcer, lower back other chronic pain epilepsy, unspecified, without mention of intractable epilepsy personal history, urinary (tract) infection candidiasis of other urogenital sites wheelchair dependence mononeuritis of lower limb, unspecified multiple sclerosis encephalopathy, unspecified acidosis streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] wheelchair dependence pressure ulcer, lower back other convulsions unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident pressure ulcer, heel urinary tract infection, site not specified delirium due to conditions classified elsewhere pressure ulcer, stage iv paraplegia depressive disorder, not elsewhere classified multiple sclerosis other chronic pain cardiac arrest
other f 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; acetaminophen  650  mg ; fentanyl patch  25  mcg h ; hydrocodone-acetaminophen (5mg-500mg  1-2  tab ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; polyethylene glycol  17  g ; bisacodyl  10  mg ; docusate sodium  100  mg ; heparin  5000  unit ; divalproex (extended release)  500  mg ; levetiracetam  750  mg ; senna  1  tab ; divalproex (extended release)  1000  mg ; doxepin hcl  50  mg ; trazodone  12.5  mg ; 
unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident thrombocytopenia, unspecified pressure ulcer, stage iv delirium due to conditions classified elsewhere pressure ulcer, lower back other chronic pain epilepsy, unspecified, without mention of intractable epilepsy personal history, urinary (tract) infection candidiasis of other urogenital sites wheelchair dependence mononeuritis of lower limb, unspecified multiple sclerosis encephalopathy, unspecified acidosis streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] wheelchair dependence pressure ulcer, lower back other convulsions unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident pressure ulcer, heel urinary tract infection, site not specified delirium due to conditions classified elsewhere pressure ulcer, stage iv paraplegia depressive disorder, not elsewhere classified multiple sclerosis other chronic pain cardiac arrest
white m 60 $temp  97.7  heartrate  84.0  resprate  16.0  o2sat  100.0  sbp  109.0  dbp  74.0  rhythm    pain  0  $hematology blood hematocrit  26.7  %; hematology blood hematocrit  22.9  %; hematology blood hematocrit  22.3  %; hematology blood hematocrit  24.0  %; hematology blood hematocrit  22.7  %; hematology blood hematocrit  32.6  %; hematology blood hematocrit  32.3  %; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  7.6  g dl; hematology blood hemoglobin  7.4  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  11.1  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  211  k ul; hematology blood platelet count  126  k ul; hematology blood platelet count  133  k ul; hematology blood platelet count  95  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  6.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  113  mg dl; chemistry blood glucose  96  mg dl$0.45% sodium chloride  1000  ml ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; 0.9% sodium chloride  100  ml ; pantoprazole  80  mg ; trazodone  25  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
acquired spondylolisthesis unspecified essential hypertension other and unspecified hyperlipidemia mechanical complication due to other implant and internal device, not elsewhere classified personal history of malignant neoplasm of testis persistent vomiting personal history of malignant neoplasm of testis acquired spondylolisthesis digestive system complications, not elsewhere classified other specified diseases of pancreas adjustment disorder with mixed anxiety and depressed mood other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other ascites other and unspecified hyperlipidemia unspecified essential hypertension other orchitis, epididymitis, and epididymo-orchitis, without mention of abscess other and unspecified hyperlipidemia acute pancreatitis hyposmolality and/or hyponatremia personal history of malignant neoplasm of testis chronic cholecystitis cyst and pseudocyst of pancreas chronic pancreatitis other severe protein-calorie malnutrition unspecified essential hypertension acquired spondylolisthesis personal history of malignant neoplasm of testis other chronic pain cyst and pseudocyst of pancreas acute pancreatitis other and unspecified hyperlipidemia rash and other nonspecific skin eruption portal vein thrombosis acquired spondylolisthesis other diseases of spleen 
white m 60 $nan$hematology blood hematocrit  34.3  %; hematology blood hematocrit  33.0  %; hematology blood hemoglobin  11.9  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  137  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  115  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; trazodone  25  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
acquired spondylolisthesis unspecified essential hypertension other and unspecified hyperlipidemia mechanical complication due to other implant and internal device, not elsewhere classified personal history of malignant neoplasm of testis persistent vomiting personal history of malignant neoplasm of testis acquired spondylolisthesis digestive system complications, not elsewhere classified other specified diseases of pancreas adjustment disorder with mixed anxiety and depressed mood other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other ascites other and unspecified hyperlipidemia unspecified essential hypertension other orchitis, epididymitis, and epididymo-orchitis, without mention of abscess other and unspecified hyperlipidemia acute pancreatitis hyposmolality and/or hyponatremia personal history of malignant neoplasm of testis chronic cholecystitis cyst and pseudocyst of pancreas chronic pancreatitis other severe protein-calorie malnutrition unspecified essential hypertension acquired spondylolisthesis personal history of malignant neoplasm of testis other chronic pain cyst and pseudocyst of pancreas acute pancreatitis other and unspecified hyperlipidemia rash and other nonspecific skin eruption portal vein thrombosis acquired spondylolisthesis other diseases of spleen 
white m 60 $nan$hematology blood hematocrit  32.8  %; hematology blood hematocrit  33.0  %; hematology blood hemoglobin  11.2  g dl; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  171  k ul; hematology blood platelet count  144  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  132  mg dl$trazodone  25  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
acquired spondylolisthesis unspecified essential hypertension other and unspecified hyperlipidemia mechanical complication due to other implant and internal device, not elsewhere classified personal history of malignant neoplasm of testis persistent vomiting personal history of malignant neoplasm of testis acquired spondylolisthesis digestive system complications, not elsewhere classified other specified diseases of pancreas adjustment disorder with mixed anxiety and depressed mood other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other ascites other and unspecified hyperlipidemia unspecified essential hypertension other orchitis, epididymitis, and epididymo-orchitis, without mention of abscess other and unspecified hyperlipidemia acute pancreatitis hyposmolality and/or hyponatremia personal history of malignant neoplasm of testis chronic cholecystitis cyst and pseudocyst of pancreas chronic pancreatitis other severe protein-calorie malnutrition unspecified essential hypertension acquired spondylolisthesis personal history of malignant neoplasm of testis other chronic pain cyst and pseudocyst of pancreas acute pancreatitis other and unspecified hyperlipidemia rash and other nonspecific skin eruption portal vein thrombosis acquired spondylolisthesis other diseases of spleen 
white m 60 $nan$nan$trazodone  25  mg ; sodium chloride 0.9%  flush  10  ml ; 
acquired spondylolisthesis unspecified essential hypertension other and unspecified hyperlipidemia mechanical complication due to other implant and internal device, not elsewhere classified personal history of malignant neoplasm of testis persistent vomiting personal history of malignant neoplasm of testis acquired spondylolisthesis digestive system complications, not elsewhere classified other specified diseases of pancreas adjustment disorder with mixed anxiety and depressed mood other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other ascites other and unspecified hyperlipidemia unspecified essential hypertension other orchitis, epididymitis, and epididymo-orchitis, without mention of abscess other and unspecified hyperlipidemia acute pancreatitis hyposmolality and/or hyponatremia personal history of malignant neoplasm of testis chronic cholecystitis cyst and pseudocyst of pancreas chronic pancreatitis other severe protein-calorie malnutrition unspecified essential hypertension acquired spondylolisthesis personal history of malignant neoplasm of testis other chronic pain cyst and pseudocyst of pancreas acute pancreatitis other and unspecified hyperlipidemia rash and other nonspecific skin eruption portal vein thrombosis acquired spondylolisthesis other diseases of spleen 
white m 54 $temp    heartrate  58.0  resprate  16.0  o2sat  98.0  sbp  116.0  dbp  62.0  rhythm    pain    ; temp    heartrate  56.0  resprate  18.0  o2sat  100.0  sbp  117.0  dbp  73.0  rhythm    pain    ; temp    heartrate  62.0  resprate  16.0  o2sat  98.0  sbp  118.0  dbp  75.0  rhythm    pain    ; temp    heartrate  69.0  resprate  20.0  o2sat  98.0  sbp  122.0  dbp  75.0  rhythm    pain  9  ; temp    heartrate  57.0  resprate  9.0  o2sat  96.0  sbp  120.0  dbp  71.0  rhythm    pain    $hematology blood hematocrit  36.9  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  153  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  104  mg dl; chemistry blood lactate dehydrogenase (ld)  167  iu l; chemistry blood albumin  3.7  g dl$nan
cerebral edema constipation, unspecified prickly heat other staphylococcal septicemia unspecified essential hypertension intracerebral hemorrhage other disorders of neurohypophysis leukocytosis, unspecified lipoma of other specified sites personal history of tobacco use nonpyogenic thrombosis of intracranial venous sinus sepsis urinary tract infection, site not specified lumbago personal history, urinary (tract) infection candidiasis of mouth urinary tract infection, site not specified cerebral edema unspecified essential hypertension unspecified intracranial hemorrhage constipation, unspecified intracerebral hemorrhage other malaise and fatigue personal history of tobacco use retention of urine, unspecified other disorders of neurohypophysis nonpyogenic thrombosis of intracranial venous sinus atrial flutter hemiplegia, unspecified, affecting unspecified side leukocytosis, unspecified other staphylococcal septicemia lipoma of other specified sites hiccough prickly heat lumbago sepsis personal history, urinary (tract) infection candidiasis of mouth
white m 54 $temp  97.8  heartrate  60.0  resprate  16.0  o2sat  98.0  sbp  107.0  dbp  73.0  rhythm    pain    $hematology blood hematocrit  38.5  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  98  mg dl; chemistry blood lactate dehydrogenase (ld)  154  iu l; chemistry blood albumin  3.8  g dl$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; acetaminophen-caff-butalbital  1-2  tab ; chlorpromazine  25  mg ; tramadol (ultram)  50  mg ; acetaminophen  325-650  mg ; lactulose  30  ml ; pantoprazole  40  mg ; hydromorphone (dilaudid)  2  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; calcium carbonate  500  mg ; levetiracetam  500  mg ; aspirin  81  mg ; bisacodyl  10  mg ; lisinopril  10  mg ; multivitamins  1  tab ; fluoxetine  20  mg ; 0.9% sodium chloride  1000  ml ; tamsulosin  0.4  mg ; 
cerebral edema constipation, unspecified prickly heat other staphylococcal septicemia unspecified essential hypertension intracerebral hemorrhage other disorders of neurohypophysis leukocytosis, unspecified lipoma of other specified sites personal history of tobacco use nonpyogenic thrombosis of intracranial venous sinus sepsis urinary tract infection, site not specified lumbago personal history, urinary (tract) infection candidiasis of mouth urinary tract infection, site not specified cerebral edema unspecified essential hypertension unspecified intracranial hemorrhage constipation, unspecified intracerebral hemorrhage other malaise and fatigue personal history of tobacco use retention of urine, unspecified other disorders of neurohypophysis nonpyogenic thrombosis of intracranial venous sinus atrial flutter hemiplegia, unspecified, affecting unspecified side leukocytosis, unspecified other staphylococcal septicemia lipoma of other specified sites hiccough prickly heat lumbago sepsis personal history, urinary (tract) infection candidiasis of mouth
white m 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen-caff-butalbital  1-2  tab ; chlorpromazine  25  mg ; tramadol (ultram)  50  mg ; acetaminophen  325-650  mg ; lactulose  30  ml ; pantoprazole  40  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; calcium carbonate  500  mg ; levetiracetam  500  mg ; aspirin  81  mg ; bisacodyl  10  mg ; multivitamins  1  tab ; fluoxetine  20  mg ; 0.9% sodium chloride  1000  ml ; tamsulosin  0.4  mg ; 
cerebral edema constipation, unspecified prickly heat other staphylococcal septicemia unspecified essential hypertension intracerebral hemorrhage other disorders of neurohypophysis leukocytosis, unspecified lipoma of other specified sites personal history of tobacco use nonpyogenic thrombosis of intracranial venous sinus sepsis urinary tract infection, site not specified lumbago personal history, urinary (tract) infection candidiasis of mouth urinary tract infection, site not specified cerebral edema unspecified essential hypertension unspecified intracranial hemorrhage constipation, unspecified intracerebral hemorrhage other malaise and fatigue personal history of tobacco use retention of urine, unspecified other disorders of neurohypophysis nonpyogenic thrombosis of intracranial venous sinus atrial flutter hemiplegia, unspecified, affecting unspecified side leukocytosis, unspecified other staphylococcal septicemia lipoma of other specified sites hiccough prickly heat lumbago sepsis personal history, urinary (tract) infection candidiasis of mouth
white f 64 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  285  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood glucose  51  mg dl$iso-osmotic dextrose  100  ml ; cefazolin  2  g ; lactated ringers  1000  ml ; oxycodone (immediate release)  5-10  mg ; morphine sulfate  2-4  mg ; acetaminophen  1000  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; insulin  24  unit ; insulin  15  unit ; 
type 2 diabetes mellitus with diabetic polyneuropathy other infective (teno)synovitis, right hand acquired absence of right leg below knee methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere type 2 diabetes mellitus with hyperglycemia other acute osteomyelitis, right hand kitchen of single-family (private) house as the place of occurrence of the external cause contact with hot stove (kitchen), initial encounter hyperlipidemia, unspecified cellulitis of right finger burn of first degree of single right finger (nail) except thumb, initial encounter type 2 diabetes mellitus with other skin complications bariatric surgery status essential (primary) hypertension encounter for immunization long term (current) use of insulin intestinal bypass and anastomosis status type 2 diabetes mellitus with other specified complication
white f 64 $nan$nan$oxycodone (immediate release)  5-10  mg ; morphine sulfate  2-4  mg ; acetaminophen  1000  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; metformin (glucophage)  1000  mg ; duloxetine  60  mg ; tramadol  150  mg ; insulin  10  unit ; 
type 2 diabetes mellitus with diabetic polyneuropathy other infective (teno)synovitis, right hand acquired absence of right leg below knee methicillin resistant staphylococcus aureus infection as the cause of diseases classified elsewhere type 2 diabetes mellitus with hyperglycemia other acute osteomyelitis, right hand kitchen of single-family (private) house as the place of occurrence of the external cause contact with hot stove (kitchen), initial encounter hyperlipidemia, unspecified cellulitis of right finger burn of first degree of single right finger (nail) except thumb, initial encounter type 2 diabetes mellitus with other skin complications bariatric surgery status essential (primary) hypertension encounter for immunization long term (current) use of insulin intestinal bypass and anastomosis status type 2 diabetes mellitus with other specified complication
white f 75 $temp  97.7  heartrate  53.0  resprate  18.0  o2sat  100.0  sbp  126.0  dbp  61.0  rhythm    pain  i  $hematology blood hematocrit  34.4  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  165  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  139  mg dl; blood gas blood free calcium  1.05  mmol l; blood gas blood lactate  1.6  mmol l$sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; allopurinol  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; memantine  10  mg ; propofol  1000  mg ; propofol  200  mg ; hydralazine  10  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; vial  0  vial ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; hydralazine  10-20  mg ; insulin  0  unit ; 0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; lorazepam  1  mg ; dexmedetomidine  0.4  mg ; 
 
white f 75 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  156  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  190  mg dl$sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; allopurinol  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; memantine  10  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; vial  0  vial ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; hydralazine  10-20  mg ; insulin  0  unit ; 0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; lorazepam  1  mg ; labetalol  10-20  mg ; labetalol  100  mg ; quetiapine fumarate  12.5  mg ; quetiapine fumarate  25  mg ; oxycodone liquid  2.5  mg ; labetalol  200  mg ; fentanyl citrate  25-50  mcg ; fentanyl citrate  75  mcg ; 
 
white f 75 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  302  mg dl; chemistry blood % hemoglobin a1c  6.1  %$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; allopurinol  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; memantine  10  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; vial  0  vial ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; insulin  0  unit ; labetalol  10-20  mg ; quetiapine fumarate  25  mg ; oxycodone liquid  2.5  mg ; labetalol  200  mg ; fentanyl citrate  75  mcg ; labetalol  350  mg ; 
 
white f 75 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  190  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; allopurinol  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; memantine  10  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; vial  0  vial ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; insulin  0  unit ; labetalol  10-20  mg ; quetiapine fumarate  25  mg ; labetalol  350  mg ; heparin  5000  unit ; donepezil  10  mg ; baclofen  5  mg ; olmesartan  40  mg ; hydrochlorothiazide  50  mg ; 
 
white f 75 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  192  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; allopurinol  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; memantine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; vial  0  vial ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; insulin  0  unit ; labetalol  10-20  mg ; quetiapine fumarate  25  mg ; heparin  5000  unit ; donepezil  10  mg ; baclofen  5  mg ; tamsulosin  0.4  mg ; 
 
white f 75 $nan$hematology urine wbc  9  # hpf$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; allopurinol  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; memantine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; vial  0  vial ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; insulin  0  unit ; labetalol  10-20  mg ; quetiapine fumarate  25  mg ; heparin  5000  unit ; donepezil  10  mg ; baclofen  5  mg ; tamsulosin  0.4  mg ; atenolol  25  mg ; 
 
white f 75 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; allopurinol  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; memantine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; vial  0  vial ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; insulin  0  unit ; quetiapine fumarate  25  mg ; heparin  5000  unit ; donepezil  10  mg ; baclofen  5  mg ; tamsulosin  0.4  mg ; 
 
white f 75 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; allopurinol  100  mg ; latanoprost 0.005% ophth. soln.  1  drop ; memantine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; vial  0  vial ; calcium gluconate  0  g ; vial  2  vial ; calcium gluconate  2  g ; vial  4  vial ; calcium gluconate  4  g ; insulin  0  unit ; quetiapine fumarate  25  mg ; heparin  5000  unit ; donepezil  10  mg ; baclofen  5  mg ; tamsulosin  0.4  mg ; 
 
white f 60 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  282  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood glucose  107  mg dl$nan
 
white f 60 $nan$hematology blood hematocrit  35.5  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  237  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  125  mg dl$sodium chloride 0.9%  flush  3  ml ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; acetaminophen  650  mg ; heparin  5000  unit ; citalopram  20  mg ; d5 1 2ns  1000  ml ; 
 
white f 60 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  270  k ul$sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; acetaminophen  650  mg ; heparin  5000  unit ; citalopram  20  mg ; 
 
white f 83 $nan$hematology blood hematocrit  19.5  %; hematology blood hemoglobin  6.3  g dl; hematology blood platelet count  324  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  81  mg dl; chemistry blood lactate dehydrogenase (ld)  160  iu l; chemistry blood albumin  2.6  g dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; heparin  5000  unit ; fluticasone-salmeterol diskus (250 50)   1  inh ; diltiazem extended-release  180  mg ; omeprazole  20  mg ; montelukast sodium  10  mg ; multivitamins  1  tab ; ascorbic acid  1000  mg ; femara  2.5  mg ; pancrelipase 5000  1  cap ; golytely  4  l ; insulin  8  unit ; golytely  2  l ; 
esophageal reflux osteoporosis, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal acute posthemorrhagic anemia postsurgical hypoinsulinemia malignant neoplasm of duodenum chronic airway obstruction, not elsewhere classified personal history of malignant neoplasm of breast
white f 83 $nan$hematology blood hematocrit  28.1  %; hematology blood hematocrit  32.1  %; hematology blood hematocrit  30.1  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  296  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood glucose  107  mg dl; chemistry blood albumin  3.1  g dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; diltiazem extended-release  180  mg ; omeprazole  20  mg ; montelukast sodium  10  mg ; multivitamins  1  tab ; ascorbic acid  1000  mg ; femara  2.5  mg ; pancrelipase 5000  1  cap ; insulin  8  unit ; golytely  2  l ; 
esophageal reflux osteoporosis, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal acute posthemorrhagic anemia postsurgical hypoinsulinemia malignant neoplasm of duodenum chronic airway obstruction, not elsewhere classified personal history of malignant neoplasm of breast
white f 83 $nan$hematology blood hematocrit  28.9  %; hematology blood hematocrit  25.9  %; hematology blood hematocrit  29.2  %; hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  292  k ul$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; diltiazem extended-release  180  mg ; omeprazole  20  mg ; montelukast sodium  10  mg ; multivitamins  1  tab ; ascorbic acid  1000  mg ; femara  2.5  mg ; pancrelipase 5000  1  cap ; insulin  8  unit ; golytely  2  l ; 
esophageal reflux osteoporosis, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal acute posthemorrhagic anemia postsurgical hypoinsulinemia malignant neoplasm of duodenum chronic airway obstruction, not elsewhere classified personal history of malignant neoplasm of breast
white f 83 $nan$hematology blood hematocrit  25.1  %; hematology blood hematocrit  26.3  %; hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  310  k ul$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; diltiazem extended-release  180  mg ; omeprazole  20  mg ; montelukast sodium  10  mg ; multivitamins  1  tab ; ascorbic acid  1000  mg ; femara  2.5  mg ; pancrelipase 5000  1  cap ; insulin  8  unit ; golytely  2  l ; 
esophageal reflux osteoporosis, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal acute posthemorrhagic anemia postsurgical hypoinsulinemia malignant neoplasm of duodenum chronic airway obstruction, not elsewhere classified personal history of malignant neoplasm of breast
white f 83 $nan$hematology blood hematocrit  27.5  %$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; diltiazem extended-release  180  mg ; omeprazole  20  mg ; montelukast sodium  10  mg ; multivitamins  1  tab ; ascorbic acid  1000  mg ; femara  2.5  mg ; pancrelipase 5000  1  cap ; insulin  8  unit ; golytely  2  l ; 
esophageal reflux osteoporosis, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal acute posthemorrhagic anemia postsurgical hypoinsulinemia malignant neoplasm of duodenum chronic airway obstruction, not elsewhere classified personal history of malignant neoplasm of breast
white f 83 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  225  k ul; hematology blood inr(pt)  1.2  $influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; diltiazem extended-release  180  mg ; omeprazole  20  mg ; montelukast sodium  10  mg ; multivitamins  1  tab ; ascorbic acid  1000  mg ; femara  2.5  mg ; pancrelipase 5000  1  cap ; insulin  8  unit ; golytely  2  l ; nadolol  40  mg ; furosemide  20  mg ; 
esophageal reflux osteoporosis, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal acute posthemorrhagic anemia postsurgical hypoinsulinemia malignant neoplasm of duodenum chronic airway obstruction, not elsewhere classified personal history of malignant neoplasm of breast
white f 65 $temp  98.5  heartrate  120.0  resprate  28.0  o2sat    sbp  116.0  dbp  81.0  rhythm    pain  unable  ; temp  98.5  heartrate  82.0  resprate  28.0  o2sat  100.0  sbp  173.0  dbp  86.0  rhythm    pain  uta  ; temp    heartrate  94.0  resprate  24.0  o2sat  100.0  sbp  135.0  dbp  65.0  rhythm    pain  uta  $hematology blood hematocrit  31.2  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  287  k ul; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood glucose  177  mg dl; blood gas blood lactate  5.1  mmol l$nan
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $temp  98.0  heartrate  77.0  resprate  21.0  o2sat  97.0  sbp  146.0  dbp  79.0  rhythm    pain  uta  $hematology blood hematocrit  24.4  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  121  mg dl; chemistry blood glucose  160  mg dl; chemistry blood glucose  150  mg dl; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  1.0  mmol l$heparin  5000  unit ; lactated ringers  1000  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)  5  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; clonazepam  0.5  mg ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$nan$d5 1 2ns  1000  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; oxycodone (immediate release)  5  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; clonazepam  0.5  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; metformin (glucophage)  500  mg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$hematology blood hematocrit  23.2  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  99  mg dl$d5 1 2ns  1000  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; oxycodone (immediate release)  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; metformin (glucophage)  500  mg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; bisoprolol fumarate  2.5  mg ; sodium chloride 0.9%  1000  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; ketorolac  15  mg ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$hematology blood hematocrit  24.5  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood glucose  73  mg dl$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; bisoprolol fumarate  2.5  mg ; sodium chloride 0.9%  1000  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; ketorolac  15  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; quetiapine fumarate  25  mg ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$hematology blood hematocrit  21.4  %; hematology blood hemoglobin  6.6  g dl; hematology blood platelet count  208  k ul$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; bisoprolol fumarate  2.5  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; quetiapine fumarate  25  mg ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$hematology blood hematocrit  24.2  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood glucose  107  mg dl$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; bisoprolol fumarate  2.5  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$nan$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; bisoprolol fumarate  2.5  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$hematology blood hematocrit  24.3  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  274  k ul$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; bisoprolol fumarate  2.5  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; ciprofloxacin hcl  500  mg ; senna  8.6  mg ; bisacodyl  10  mg ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  292  k ul$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; bisoprolol fumarate  2.5  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; ciprofloxacin hcl  500  mg ; senna  8.6  mg ; bisacodyl  10  mg ; irbesartan  75  mg ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$nan$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; bisoprolol fumarate  2.5  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; ciprofloxacin hcl  500  mg ; senna  8.6  mg ; bisacodyl  10  mg ; irbesartan  75  mg ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$nan$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; ciprofloxacin hcl  500  mg ; senna  8.6  mg ; bisacodyl  10  mg ; irbesartan  75  mg ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  302  k ul$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; ciprofloxacin hcl  500  mg ; senna  8.6  mg ; bisacodyl  10  mg ; irbesartan  75  mg ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$nan$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; ciprofloxacin hcl  500  mg ; senna  8.6  mg ; bisacodyl  10  mg ; irbesartan  75  mg ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$nan$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; ciprofloxacin hcl  500  mg ; senna  8.6  mg ; bisacodyl  10  mg ; irbesartan  75  mg ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$nan$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; ciprofloxacin hcl  500  mg ; senna  8.6  mg ; bisacodyl  10  mg ; irbesartan  75  mg ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$nan$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; senna  8.6  mg ; bisacodyl  10  mg ; irbesartan  75  mg ; ipratropium-albuterol neb  1  neb ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$nan$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; senna  8.6  mg ; bisacodyl  10  mg ; irbesartan  75  mg ; ipratropium-albuterol neb  1  neb ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$nan$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; senna  8.6  mg ; bisacodyl  10  mg ; irbesartan  75  mg ; ipratropium-albuterol neb  1  neb ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$nan$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; senna  8.6  mg ; bisacodyl  10  mg ; irbesartan  75  mg ; ipratropium-albuterol neb  1  neb ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$nan$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; senna  8.6  mg ; bisacodyl  10  mg ; irbesartan  75  mg ; ipratropium-albuterol neb  1  neb ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$hematology urine wbc  1  # hpf$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; senna  8.6  mg ; bisacodyl  10  mg ; irbesartan  75  mg ; ipratropium-albuterol neb  1  neb ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$nan$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; senna  8.6  mg ; bisacodyl  10  mg ; irbesartan  75  mg ; ipratropium-albuterol neb  1  neb ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$nan$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; senna  8.6  mg ; bisacodyl  10  mg ; irbesartan  75  mg ; ipratropium-albuterol neb  1  neb ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$nan$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; senna  8.6  mg ; bisacodyl  10  mg ; irbesartan  75  mg ; ipratropium-albuterol neb  1  neb ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$nan$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; senna  8.6  mg ; bisacodyl  10  mg ; irbesartan  75  mg ; ipratropium-albuterol neb  1  neb ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$nan$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; senna  8.6  mg ; bisacodyl  10  mg ; irbesartan  75  mg ; ipratropium-albuterol neb  1  neb ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$nan$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; senna  8.6  mg ; bisacodyl  10  mg ; irbesartan  75  mg ; ipratropium-albuterol neb  1  neb ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$nan$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; erythromycin 0.5% ophth oint  0.5  in ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; nystatin ointment  1  appl ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; senna  8.6  mg ; bisacodyl  10  mg ; irbesartan  75  mg ; ipratropium-albuterol neb  1  neb ; fluticasone propionate nasal  1  spry ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$nan$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; senna  8.6  mg ; bisacodyl  10  mg ; irbesartan  75  mg ; ipratropium-albuterol neb  1  neb ; fluticasone propionate nasal  1  spry ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 65 $nan$nan$acetaminophen  1000  mg ; insulin  0  unit ; fluocinonide 0.05% cream  1  appl ; risperidone  3  mg ; ferrous gluconate  324  mg ; aspirin  81  mg ; atorvastatin  40  mg ; citalopram  20  mg ; ezetimibe  10  mg ; levothyroxine sodium  75  mcg ; omeprazole  20  mg ; triamcinolone acetonide 0.025% cream  1  appl ; ascorbic acid  500  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)  5-10  mg ; enoxaparin sodium  40  mg ; artificial tears  1-2  drop ; senna  8.6  mg ; bisacodyl  10  mg ; irbesartan  75  mg ; ipratropium-albuterol neb  1  neb ; fluticasone propionate nasal  1  spry ; 
morbid obesity unspecified acquired hypothyroidism diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled blood in stool helicobacter pylori [h. pylori] unspecified schizophrenia, unspecified acute posthemorrhagic anemia iron deficiency anemia, unspecified paroxysmal ventricular tachycardia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status unspecified acquired hypothyroidism hypovolemia fever acidosis unspecified schizophrenia, unspecified bipolar disorder, unspecified pure hypercholesterolemia
white f 56 $nan$hematology blood hematocrit  24.7  %; hematology blood hematocrit  22.6  %; hematology blood hematocrit  23.1  %; hematology blood hemoglobin  8.1  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  494  k ul; hematology blood platelet count  438  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.5  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  174  mg dl; chemistry blood glucose  184  mg dl; chemistry blood glucose  70  mg dl; chemistry blood lactate dehydrogenase (ld)  355  iu l; chemistry blood albumin  2.0  g dl; chemistry blood albumin  2.0  g dl; hematology blood bands  3  %; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  0.9  mmol l$influenza virus vaccine  0.5  ml ; insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; lr  1000  ml ; fentanyl citrate  25-100  mcg ; midazolam  1  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; 0.9% sodium chloride  250  ml ; fentanyl citrate  2.5  mg ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; albuterol inhaler  2-4  puff ; ns  100  ml ; fluconazole  200  mg ; ns (mini bag plus)  100  ml ; cefepime  2  g ; sw  50  ml ; potassium chloride  20  meq ; sw  100  ml ; potassium chloride  40  meq ; sw  150  ml ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; calcium gluconate  2  gm ; calcium gluconate  3  gm ; calcium gluconate  4  gm ; meropenem  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; heparin  5000  unit ; levothyroxine sodium  75  mcg ; d10w  1000  ml ; ipratropium bromide mdi  2  puff ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; midazolam  100  mg ; midazolam  10  mg ; hydromorphone (dilaudid)  1  mg ; furosemide  100  mg ; 
 
white f 56 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  528  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  115  mg dl; blood gas blood free calcium  1.02  mmol l; blood gas blood potassium, whole blood  3.4  meq l$vancomycin  1000  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; midazolam  1  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; 0.9% sodium chloride  250  ml ; fentanyl citrate  2.5  mg ; albuterol inhaler  2-4  puff ; ns  100  ml ; fluconazole  200  mg ; sw  50  ml ; potassium chloride  20  meq ; sw  100  ml ; potassium chloride  40  meq ; sw  150  ml ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; calcium gluconate  2  gm ; calcium gluconate  3  gm ; calcium gluconate  4  gm ; meropenem  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; heparin  5000  unit ; levothyroxine sodium  75  mcg ; ipratropium bromide mdi  2  puff ; midazolam  100  mg ; midazolam  10  mg ; hydromorphone (dilaudid)  1  mg ; furosemide  100  mg ; iso-osmotic dextrose  200  ml ; miconazole powder 2%  1  appl ; meropenem  500  mg ; 
 
white f 56 $nan$hematology blood hematocrit  24.0  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  533  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  149  mg dl; chemistry blood glucose  62  mg dl; chemistry blood lactate dehydrogenase (ld)  339  iu l; chemistry blood albumin  2.2  g dl; blood gas blood free calcium  1.10  mmol l$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; midazolam  1  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; albuterol inhaler  2-4  puff ; sw  50  ml ; potassium chloride  20  meq ; sw  100  ml ; potassium chloride  40  meq ; sw  150  ml ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; calcium gluconate  2  gm ; calcium gluconate  3  gm ; calcium gluconate  4  gm ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; heparin  5000  unit ; levothyroxine sodium  75  mcg ; ipratropium bromide mdi  2  puff ; furosemide  100  mg ; miconazole powder 2%  1  appl ; meropenem  500  mg ; 
 
white f 56 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  625  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  131  mg dl; chemistry blood lactate dehydrogenase (ld)  306  iu l; chemistry blood albumin  2.3  g dl; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.21  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood glucose  134  mg dl; blood gas blood potassium, whole blood  3.6  meq l; blood gas blood potassium, whole blood  3.8  meq l$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; albuterol inhaler  2-4  puff ; sw  50  ml ; potassium chloride  20  meq ; sw  100  ml ; potassium chloride  40  meq ; sw  150  ml ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; calcium gluconate  2  gm ; calcium gluconate  3  gm ; calcium gluconate  4  gm ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; heparin  5000  unit ; levothyroxine sodium  75  mcg ; ipratropium bromide mdi  2  puff ; miconazole powder 2%  1  appl ; meropenem  500  mg ; 5% dextrose  25  ml ; acetazolamide sodium  250  mg ; 
 
white f 56 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  708  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  140  mg dl; chemistry blood lactate dehydrogenase (ld)  291  iu l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood glucose  117  mg dl; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood potassium, whole blood  3.4  meq l$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; albuterol inhaler  2-4  puff ; sw  50  ml ; potassium chloride  20  meq ; sw  100  ml ; potassium chloride  40  meq ; sw  150  ml ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; calcium gluconate  2  gm ; calcium gluconate  3  gm ; calcium gluconate  4  gm ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; heparin  5000  unit ; levothyroxine sodium  75  mcg ; ipratropium bromide mdi  2  puff ; miconazole powder 2%  1  appl ; meropenem  500  mg ; 5% dextrose  25  ml ; acetazolamide sodium  250  mg ; lorazepam  1  mg ; lisinopril  20  mg ; 
 
white f 56 $nan$hematology blood hematocrit  23.8  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  713  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  87  mg dl; chemistry blood lactate dehydrogenase (ld)  268  iu l; chemistry blood albumin  2.6  g dl; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood glucose  205  mg dl; blood gas blood potassium, whole blood  3.6  meq l$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; sw  50  ml ; potassium chloride  20  meq ; sw  100  ml ; potassium chloride  40  meq ; sw  150  ml ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; calcium gluconate  2  gm ; calcium gluconate  3  gm ; calcium gluconate  4  gm ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; heparin  5000  unit ; levothyroxine sodium  75  mcg ; miconazole powder 2%  1  appl ; meropenem  500  mg ; lorazepam  1  mg ; lisinopril  20  mg ; insulin  15  unit ; levothyroxine sodium  150  mcg ; neutra-phos  2  pkt ; 
 
white f 56 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  659  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  151  mg dl; chemistry blood lactate dehydrogenase (ld)  254  iu l; chemistry blood albumin  2.8  g dl; blood gas blood free calcium  1.13  mmol l; blood gas blood potassium, whole blood  3.9  meq l$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; sw  50  ml ; potassium chloride  20  meq ; sw  100  ml ; potassium chloride  40  meq ; sw  150  ml ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; calcium gluconate  2  gm ; calcium gluconate  3  gm ; calcium gluconate  4  gm ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; heparin  5000  unit ; miconazole powder 2%  1  appl ; meropenem  500  mg ; lisinopril  20  mg ; levothyroxine sodium  150  mcg ; neutra-phos  2  pkt ; ondansetron  4  mg ; insulin  20  unit ; 
 
white f 56 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  604  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  124  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; sw  50  ml ; potassium chloride  20  meq ; sw  100  ml ; potassium chloride  40  meq ; sw  150  ml ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; calcium gluconate  2  gm ; calcium gluconate  3  gm ; calcium gluconate  4  gm ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; heparin  5000  unit ; miconazole powder 2%  1  appl ; meropenem  500  mg ; lisinopril  20  mg ; levothyroxine sodium  150  mcg ; ondansetron  4  mg ; insulin  20  unit ; insulin  30  unit ; heparin flush (10 units ml)  1  ml ; furosemide  40  mg ; 
 
white f 56 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  557  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  59  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; miconazole powder 2%  1  appl ; meropenem  500  mg ; lisinopril  20  mg ; levothyroxine sodium  150  mcg ; ondansetron  4  mg ; heparin flush (10 units ml)  1  ml ; furosemide  40  mg ; docusate sodium  100  mg ; 
 
white f 56 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  520  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  193  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; miconazole powder 2%  1  appl ; meropenem  500  mg ; lisinopril  20  mg ; levothyroxine sodium  150  mcg ; heparin flush (10 units ml)  1  ml ; docusate sodium  100  mg ; 
 
white f 56 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; miconazole powder 2%  1  appl ; meropenem  500  mg ; lisinopril  20  mg ; levothyroxine sodium  150  mcg ; heparin flush (10 units ml)  1  ml ; docusate sodium  100  mg ; 
 
white f 56 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; miconazole powder 2%  1  appl ; meropenem  500  mg ; lisinopril  20  mg ; levothyroxine sodium  150  mcg ; heparin flush (10 units ml)  1  ml ; docusate sodium  100  mg ; 
 
white f 56 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; miconazole powder 2%  1  appl ; meropenem  500  mg ; lisinopril  20  mg ; levothyroxine sodium  150  mcg ; heparin flush (10 units ml)  1  ml ; docusate sodium  100  mg ; 
 
white f 56 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; miconazole powder 2%  1  appl ; meropenem  500  mg ; lisinopril  20  mg ; levothyroxine sodium  150  mcg ; heparin flush (10 units ml)  1  ml ; docusate sodium  100  mg ; fluoxetine  20  mg ; 
 
white m 56 $temp  98.9  heartrate  96.0  resprate  16.0  o2sat  100.0  sbp  132.0  dbp  56.0  rhythm    pain    $nan$insulin  50  unit ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified osteomyelitis, ankle and foot unspecified disorders of arteries and arterioles atherosclerosis of native arteries of the extremities with ulceration chronic kidney disease, stage iii (moderate) other bone involvement in diseases classified elsewhere other amputation stump complication coronary atherosclerosis of native coronary artery other complications due to other vascular device, implant, and graft acute posthemorrhagic anemia hypocalcemia diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled venous (peripheral) insufficiency, unspecified personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified accidents occurring in residential institution ulcer of heel and midfoot morbid obesity diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled acute kidney failure with lesion of tubular necrosis pulmonary congestion and hypostasis removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation background diabetic retinopathy percutaneous transluminal coronary angioplasty status disorders of phosphorus metabolism body mass index 45.0-49.9, adult diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes gangrene edema personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified ulcer of other part of foot other specified forms of chronic ischemic heart disease other and unspecified hyperlipidemia obesity, unspecified background diabetic retinopathy peripheral vascular disease, unspecified chronic kidney disease, stage iii (moderate) polyneuropathy in diabetes long-term (current) use of aspirin other chronic pain diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled old myocardial infarction acute kidney failure, unspecified ulcer of heel and midfoot percutaneous transluminal coronary angioplasty status
white m 56 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  233  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  6.3  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  60  mg dl; hematology blood inr(pt)  3.0  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  106  mg dl$insulin  50  unit ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bisacodyl  10  mg ; senna  8.6  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; clopidogrel  75  mg ; furosemide  80  mg ; gabapentin  800  mg ; heparin  5000  unit ; docusate sodium  100  mg ; metolazone  2.5  mg ; sodium chloride 0.9%  1000  ml ; heparin dwell (1000 units ml)  2000-8000  unit ; neomycin-polymyxin-bacitracin  1  appl ; heparin (hemodialysis)  5000  unit ; epoetin alfa  4000  unit ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; sevelamer carbonate  1600  mg ; heparin flush (1000 units ml)  4000-11000  unit ; hydrocodone-acetaminophen (5mg-325mg)  1-2  tab ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified osteomyelitis, ankle and foot unspecified disorders of arteries and arterioles atherosclerosis of native arteries of the extremities with ulceration chronic kidney disease, stage iii (moderate) other bone involvement in diseases classified elsewhere other amputation stump complication coronary atherosclerosis of native coronary artery other complications due to other vascular device, implant, and graft acute posthemorrhagic anemia hypocalcemia diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled venous (peripheral) insufficiency, unspecified personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified accidents occurring in residential institution ulcer of heel and midfoot morbid obesity diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled acute kidney failure with lesion of tubular necrosis pulmonary congestion and hypostasis removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation background diabetic retinopathy percutaneous transluminal coronary angioplasty status disorders of phosphorus metabolism body mass index 45.0-49.9, adult diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes gangrene edema personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified ulcer of other part of foot other specified forms of chronic ischemic heart disease other and unspecified hyperlipidemia obesity, unspecified background diabetic retinopathy peripheral vascular disease, unspecified chronic kidney disease, stage iii (moderate) polyneuropathy in diabetes long-term (current) use of aspirin other chronic pain diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled old myocardial infarction acute kidney failure, unspecified ulcer of heel and midfoot percutaneous transluminal coronary angioplasty status
white m 56 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  4.6  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  2.5  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  165  mg dl$insulin  50  unit ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bisacodyl  10  mg ; senna  8.6  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; clopidogrel  75  mg ; heparin  5000  unit ; docusate sodium  100  mg ; metolazone  2.5  mg ; sevelamer carbonate  1600  mg ; heparin flush (1000 units ml)  4000-11000  unit ; hydrocodone-acetaminophen (5mg-325mg)  1-2  tab ; rosuvastatin calcium  20  mg ; sodium chloride 0.9%  flush  10  ml ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified osteomyelitis, ankle and foot unspecified disorders of arteries and arterioles atherosclerosis of native arteries of the extremities with ulceration chronic kidney disease, stage iii (moderate) other bone involvement in diseases classified elsewhere other amputation stump complication coronary atherosclerosis of native coronary artery other complications due to other vascular device, implant, and graft acute posthemorrhagic anemia hypocalcemia diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled venous (peripheral) insufficiency, unspecified personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified accidents occurring in residential institution ulcer of heel and midfoot morbid obesity diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled acute kidney failure with lesion of tubular necrosis pulmonary congestion and hypostasis removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation background diabetic retinopathy percutaneous transluminal coronary angioplasty status disorders of phosphorus metabolism body mass index 45.0-49.9, adult diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes gangrene edema personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified ulcer of other part of foot other specified forms of chronic ischemic heart disease other and unspecified hyperlipidemia obesity, unspecified background diabetic retinopathy peripheral vascular disease, unspecified chronic kidney disease, stage iii (moderate) polyneuropathy in diabetes long-term (current) use of aspirin other chronic pain diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled old myocardial infarction acute kidney failure, unspecified ulcer of heel and midfoot percutaneous transluminal coronary angioplasty status
white m 56 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  5.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  51  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  78  mg dl$insulin  50  unit ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bisacodyl  10  mg ; senna  8.6  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; clopidogrel  75  mg ; heparin  5000  unit ; docusate sodium  100  mg ; metolazone  2.5  mg ; sevelamer carbonate  1600  mg ; heparin flush (1000 units ml)  4000-11000  unit ; hydrocodone-acetaminophen (5mg-325mg)  1-2  tab ; rosuvastatin calcium  20  mg ; sodium chloride 0.9%  flush  10  ml ; heparin sodium  25,000  unit ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified osteomyelitis, ankle and foot unspecified disorders of arteries and arterioles atherosclerosis of native arteries of the extremities with ulceration chronic kidney disease, stage iii (moderate) other bone involvement in diseases classified elsewhere other amputation stump complication coronary atherosclerosis of native coronary artery other complications due to other vascular device, implant, and graft acute posthemorrhagic anemia hypocalcemia diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled venous (peripheral) insufficiency, unspecified personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified accidents occurring in residential institution ulcer of heel and midfoot morbid obesity diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled acute kidney failure with lesion of tubular necrosis pulmonary congestion and hypostasis removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation background diabetic retinopathy percutaneous transluminal coronary angioplasty status disorders of phosphorus metabolism body mass index 45.0-49.9, adult diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes gangrene edema personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified ulcer of other part of foot other specified forms of chronic ischemic heart disease other and unspecified hyperlipidemia obesity, unspecified background diabetic retinopathy peripheral vascular disease, unspecified chronic kidney disease, stage iii (moderate) polyneuropathy in diabetes long-term (current) use of aspirin other chronic pain diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled old myocardial infarction acute kidney failure, unspecified ulcer of heel and midfoot percutaneous transluminal coronary angioplasty status
white m 56 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  242  k ul; hematology blood inr(pt)  2.3  ; hematology blood inr(pt)  1.8  $insulin  50  unit ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bisacodyl  10  mg ; senna  8.6  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; clopidogrel  75  mg ; docusate sodium  100  mg ; metolazone  2.5  mg ; sevelamer carbonate  1600  mg ; heparin flush (1000 units ml)  4000-11000  unit ; hydrocodone-acetaminophen (5mg-325mg)  1-2  tab ; rosuvastatin calcium  20  mg ; sodium chloride 0.9%  flush  10  ml ; heparin sodium  25,000  unit ; heparin flush (10 units ml)  1  ml ; ciprofloxacin hcl  500  mg ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified osteomyelitis, ankle and foot unspecified disorders of arteries and arterioles atherosclerosis of native arteries of the extremities with ulceration chronic kidney disease, stage iii (moderate) other bone involvement in diseases classified elsewhere other amputation stump complication coronary atherosclerosis of native coronary artery other complications due to other vascular device, implant, and graft acute posthemorrhagic anemia hypocalcemia diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled venous (peripheral) insufficiency, unspecified personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified accidents occurring in residential institution ulcer of heel and midfoot morbid obesity diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled acute kidney failure with lesion of tubular necrosis pulmonary congestion and hypostasis removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation background diabetic retinopathy percutaneous transluminal coronary angioplasty status disorders of phosphorus metabolism body mass index 45.0-49.9, adult diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes gangrene edema personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified ulcer of other part of foot other specified forms of chronic ischemic heart disease other and unspecified hyperlipidemia obesity, unspecified background diabetic retinopathy peripheral vascular disease, unspecified chronic kidney disease, stage iii (moderate) polyneuropathy in diabetes long-term (current) use of aspirin other chronic pain diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled old myocardial infarction acute kidney failure, unspecified ulcer of heel and midfoot percutaneous transluminal coronary angioplasty status
white m 56 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  265  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  7.4  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  71  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  95  mg dl$5% dextrose  250  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bisacodyl  10  mg ; senna  8.6  mg ; clopidogrel  75  mg ; docusate sodium  100  mg ; metolazone  2.5  mg ; sevelamer carbonate  1600  mg ; heparin flush (1000 units ml)  4000-11000  unit ; hydrocodone-acetaminophen (5mg-325mg)  1-2  tab ; rosuvastatin calcium  20  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; ciprofloxacin hcl  500  mg ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified osteomyelitis, ankle and foot unspecified disorders of arteries and arterioles atherosclerosis of native arteries of the extremities with ulceration chronic kidney disease, stage iii (moderate) other bone involvement in diseases classified elsewhere other amputation stump complication coronary atherosclerosis of native coronary artery other complications due to other vascular device, implant, and graft acute posthemorrhagic anemia hypocalcemia diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled venous (peripheral) insufficiency, unspecified personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified accidents occurring in residential institution ulcer of heel and midfoot morbid obesity diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled acute kidney failure with lesion of tubular necrosis pulmonary congestion and hypostasis removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation background diabetic retinopathy percutaneous transluminal coronary angioplasty status disorders of phosphorus metabolism body mass index 45.0-49.9, adult diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes gangrene edema personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified ulcer of other part of foot other specified forms of chronic ischemic heart disease other and unspecified hyperlipidemia obesity, unspecified background diabetic retinopathy peripheral vascular disease, unspecified chronic kidney disease, stage iii (moderate) polyneuropathy in diabetes long-term (current) use of aspirin other chronic pain diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled old myocardial infarction acute kidney failure, unspecified ulcer of heel and midfoot percutaneous transluminal coronary angioplasty status
white m 56 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  243  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  5.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  172  mg dl$5% dextrose  250  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bisacodyl  10  mg ; senna  8.6  mg ; clopidogrel  75  mg ; docusate sodium  100  mg ; metolazone  2.5  mg ; sevelamer carbonate  1600  mg ; heparin flush (1000 units ml)  4000-11000  unit ; hydrocodone-acetaminophen (5mg-325mg)  1-2  tab ; rosuvastatin calcium  20  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; ciprofloxacin hcl  500  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified osteomyelitis, ankle and foot unspecified disorders of arteries and arterioles atherosclerosis of native arteries of the extremities with ulceration chronic kidney disease, stage iii (moderate) other bone involvement in diseases classified elsewhere other amputation stump complication coronary atherosclerosis of native coronary artery other complications due to other vascular device, implant, and graft acute posthemorrhagic anemia hypocalcemia diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled venous (peripheral) insufficiency, unspecified personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified accidents occurring in residential institution ulcer of heel and midfoot morbid obesity diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled acute kidney failure with lesion of tubular necrosis pulmonary congestion and hypostasis removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation background diabetic retinopathy percutaneous transluminal coronary angioplasty status disorders of phosphorus metabolism body mass index 45.0-49.9, adult diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes gangrene edema personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified ulcer of other part of foot other specified forms of chronic ischemic heart disease other and unspecified hyperlipidemia obesity, unspecified background diabetic retinopathy peripheral vascular disease, unspecified chronic kidney disease, stage iii (moderate) polyneuropathy in diabetes long-term (current) use of aspirin other chronic pain diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled old myocardial infarction acute kidney failure, unspecified ulcer of heel and midfoot percutaneous transluminal coronary angioplasty status
white m 56 $nan$hematology blood inr(pt)  2.1  ; hematology blood inr(pt)  2.3  $sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bisacodyl  10  mg ; senna  8.6  mg ; clopidogrel  75  mg ; docusate sodium  100  mg ; metolazone  2.5  mg ; sevelamer carbonate  1600  mg ; heparin flush (1000 units ml)  4000-11000  unit ; hydrocodone-acetaminophen (5mg-325mg)  1-2  tab ; rosuvastatin calcium  20  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; ciprofloxacin hcl  500  mg ; 
surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified osteomyelitis, ankle and foot unspecified disorders of arteries and arterioles atherosclerosis of native arteries of the extremities with ulceration chronic kidney disease, stage iii (moderate) other bone involvement in diseases classified elsewhere other amputation stump complication coronary atherosclerosis of native coronary artery other complications due to other vascular device, implant, and graft acute posthemorrhagic anemia hypocalcemia diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled venous (peripheral) insufficiency, unspecified personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified accidents occurring in residential institution ulcer of heel and midfoot morbid obesity diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled acute kidney failure with lesion of tubular necrosis pulmonary congestion and hypostasis removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation background diabetic retinopathy percutaneous transluminal coronary angioplasty status disorders of phosphorus metabolism body mass index 45.0-49.9, adult diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes gangrene edema personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified ulcer of other part of foot other specified forms of chronic ischemic heart disease other and unspecified hyperlipidemia obesity, unspecified background diabetic retinopathy peripheral vascular disease, unspecified chronic kidney disease, stage iii (moderate) polyneuropathy in diabetes long-term (current) use of aspirin other chronic pain diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled old myocardial infarction acute kidney failure, unspecified ulcer of heel and midfoot percutaneous transluminal coronary angioplasty status
white f 57 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  342  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  24  mg dl; hematology urine wbc  6-10  # hpf; chemistry blood glucose  170  mg dl; hematology blood bands  0  %; hematology urine glucose  tr  mg dl; hematology urine bilirubin  neg  mg dl$nan
esophageal reflux calculus of ureter diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity hematuria depressive disorder, not elsewhere classified other and unspecified hyperlipidemia hydronephrosis
white f 57 $nan$hematology blood hematocrit  32.7  %; hematology blood hematocrit  34.9  %; hematology blood hematocrit  36.0  %; hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  297  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  139  mg dl$lr  1000  ml ; sodium chloride 0.9%  flush  3  ml ; metronidazole (flagyl)  500  mg ; ciprofloxacin hcl  250  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  1000  mg ; sodium chloride nasal  1-2  spry ; insulin  0  unit ; tolterodine  2  mg ; paroxetine  10  mg ; paroxetine  20  mg ; levothyroxine sodium  50  mcg ; rosuvastatin calcium  40  mg ; omeprazole  20  mg ; multivitamins  1  tab ; omeprazole  40  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; 
esophageal reflux calculus of ureter diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity hematuria depressive disorder, not elsewhere classified other and unspecified hyperlipidemia hydronephrosis
white f 57 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  265  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  117  mg dl$lr  1000  ml ; sodium chloride 0.9%  flush  3  ml ; metronidazole (flagyl)  500  mg ; sodium chloride nasal  1-2  spry ; insulin  0  unit ; tolterodine  2  mg ; paroxetine  10  mg ; paroxetine  20  mg ; levothyroxine sodium  50  mcg ; rosuvastatin calcium  40  mg ; multivitamins  1  tab ; omeprazole  40  mg ; acetaminophen  650  mg ; prochlorperazine  10  mg ; golytely  4  l ; lorazepam  0.5  mg ; magnesium citrate  300  ml ; 
esophageal reflux calculus of ureter diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity hematuria depressive disorder, not elsewhere classified other and unspecified hyperlipidemia hydronephrosis
white f 57 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  276  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  154  mg dl$sodium chloride 0.9%  flush  3  ml ; metronidazole (flagyl)  500  mg ; sodium chloride nasal  1-2  spry ; insulin  0  unit ; tolterodine  2  mg ; paroxetine  10  mg ; paroxetine  20  mg ; levothyroxine sodium  50  mcg ; rosuvastatin calcium  40  mg ; multivitamins  1  tab ; omeprazole  40  mg ; golytely  4  l ; lorazepam  0.5  mg ; magnesium citrate  300  ml ; 
esophageal reflux calculus of ureter diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity hematuria depressive disorder, not elsewhere classified other and unspecified hyperlipidemia hydronephrosis
white f 57 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  312  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood glucose  111  mg dl$sodium chloride 0.9%  flush  3  ml ; metronidazole (flagyl)  500  mg ; sodium chloride nasal  1-2  spry ; insulin  0  unit ; tolterodine  2  mg ; paroxetine  10  mg ; paroxetine  20  mg ; levothyroxine sodium  50  mcg ; rosuvastatin calcium  40  mg ; multivitamins  1  tab ; omeprazole  40  mg ; potassium chloride  40  meq ; 
esophageal reflux calculus of ureter diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled morbid obesity hematuria depressive disorder, not elsewhere classified other and unspecified hyperlipidemia hydronephrosis
white m 44 $temp  98.0  heartrate  75.0  resprate  16.0  o2sat  97.0  sbp  114.0  dbp  67.0  rhythm    pain  0  ; temp  98.0  heartrate  77.0  resprate  18.0  o2sat  98.0  sbp  129.0  dbp  89.0  rhythm    pain    $nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; acetaminophen  650  mg ; heparin  5000  unit ; clonidine  0.2  mg ; loperamide  2  mg ; ondansetron  4  mg ; methocarbamol  1000  mg ; 
 
white m 44 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  210  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  101  mg dl; chemistry blood lactate dehydrogenase (ld)  144  iu l; chemistry blood albumin  4.2  g dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; acetaminophen  650  mg ; heparin  5000  unit ; clonidine  0.2  mg ; loperamide  2  mg ; ondansetron  4  mg ; methocarbamol  1000  mg ; dicyclomine  20  mg ; sodium chloride 0.9%  1000  ml ; hydroxyzine  50  mg ; methadone (oral solution)  2 mg 1 ml  2  mg ; methadone (oral solution)  2 mg 1 ml  70  mg ; 
 
white m 44 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; acetaminophen  650  mg ; heparin  5000  unit ; clonidine  0.2  mg ; loperamide  2  mg ; ondansetron  4  mg ; methocarbamol  1000  mg ; dicyclomine  20  mg ; hydroxyzine  50  mg ; methadone (oral solution)  2 mg 1 ml  2  mg ; methadone (oral solution)  2 mg 1 ml  70  mg ; 
 
other m 50 $nan$hematology blood hematocrit  37.0  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  187  iu l; chemistry blood albumin  4.2  g dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; albuterol 0.083% neb soln  1  neb ; acetaminophen  325-650  mg ; lorazepam  1-2  mg ; divalproex (extended release)  750  mg ; citalopram  40  mg ; buspirone  10  mg ; lisinopril  10  mg ; heparin  5000  unit ; nicotine patch  14  mg ; divalproex (extended release)  1000  mg ; meclizine  25  mg ; levetiracetam  500  mg ; divalproex (extended release)  500  mg ; 
 
other m 50 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; acetaminophen  325-650  mg ; lorazepam  1-2  mg ; lisinopril  10  mg ; heparin  5000  unit ; nicotine patch  14  mg ; divalproex (extended release)  1000  mg ; meclizine  25  mg ; levetiracetam  500  mg ; divalproex (extended release)  500  mg ; 
 
other m 50 $nan$nan$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; acetaminophen  325-650  mg ; lorazepam  1-2  mg ; lisinopril  10  mg ; heparin  5000  unit ; nicotine patch  14  mg ; divalproex (extended release)  1000  mg ; meclizine  25  mg ; hydrocortisone cream 1%  1  appl ; lorazepam  1  mg ; 
 
other m 50 $nan$nan$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; acetaminophen  325-650  mg ; lorazepam  1-2  mg ; lisinopril  10  mg ; heparin  5000  unit ; nicotine patch  14  mg ; divalproex (extended release)  1000  mg ; hydrocortisone cream 1%  1  appl ; lorazepam  1  mg ; 
 
white m 58 $nan$nan$insulin pump (self administering medication)     ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  5  mg ; aspirin  325  mg ; acetaminophen  650  mg ; heparin  5000  unit ; oxycodone (immediate release)   5-10  mg ; d5w  250  ml ; nitroglycerin  100  mg ; rosuvastatin calcium  20  mg ; 
pedal cycle driver injured in noncollision transport accident in nontraffic accident family history of ischemic heart disease diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled malignant essential hypertension cerebral artery occlusion, unspecified with cerebral infarction person boarding or alighting a pedal cycle injured in collision with fixed or stationary object family history of diabetes mellitus other and unspecified hyperlipidemia
white m 58 $nan$hematology blood hematocrit  35.6  %; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l$glucose gel  15  g ; insulin pump (self administering medication)     ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  5  mg ; aspirin  325  mg ; acetaminophen  650  mg ; heparin  5000  unit ; oxycodone (immediate release)   5-10  mg ; d5w  250  ml ; nitroglycerin  100  mg ; rosuvastatin calcium  20  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; 0.45% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; amlodipine  5  mg ; lisinopril  40  mg ; amlodipine  10  mg ; omeprazole  20  mg ; metoprolol tartrate  200  mg ; 
pedal cycle driver injured in noncollision transport accident in nontraffic accident family history of ischemic heart disease diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled malignant essential hypertension cerebral artery occlusion, unspecified with cerebral infarction person boarding or alighting a pedal cycle injured in collision with fixed or stationary object family history of diabetes mellitus other and unspecified hyperlipidemia
black african american m 43 $temp  98.5  heartrate  90.0  resprate  18.0  o2sat  97.0  sbp  103.0  dbp  62.0  rhythm    pain  2  $hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  536  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  93  mg dl$amoxicillin-clavulanic acid  875  mg ; linezolid  600  mg ; ondansetron  4  mg ; zolpidem tartrate  5  mg ; methadone  40  mg ; acetaminophen  650  mg ; 
other chronic pain leukocytosis, unspecified pressure ulcer, lower back unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident neurogenic bladder nos tobacco use disorder hypotension, unspecified car passenger injured in collision with heavy transport vehicle or bus in traffic accident pressure ulcer, unspecified stage other artificial opening of urinary tract status unspecified viral hepatitis c without hepatic coma ulcer of other part of lower limb infection (chronic) of amputation stump urinary tract infection, site not specified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits tachycardia, unspecified colostomy status paraplegia other chronic pain opioid abuse, continuous chronic osteomyelitis, site unspecified other nonspecific findings on examination of urine nausea with vomiting pressure ulcer, lower back tobacco use disorder esophageal reflux above knee amputation status colostomy status sickle-cell trait fever, unspecified other malaise and fatigue leukocytosis, unspecified pressure ulcer, unspecified stage unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident other chronic pain backache, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic hepatitis c without mention of hepatic coma pressure ulcer, other site paraplegia iron deficiency anemia, unspecified pressure ulcer, stage iii neurogenic bladder nos personal history, urinary (tract) infection other chronic pain other amputation stump complication amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits
black african american m 43 $nan$nan$ondansetron  4  mg ; zolpidem tartrate  5  mg ; methadone  40  mg ; acetaminophen  650  mg ; 
other chronic pain leukocytosis, unspecified pressure ulcer, lower back unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident neurogenic bladder nos tobacco use disorder hypotension, unspecified car passenger injured in collision with heavy transport vehicle or bus in traffic accident pressure ulcer, unspecified stage other artificial opening of urinary tract status unspecified viral hepatitis c without hepatic coma ulcer of other part of lower limb infection (chronic) of amputation stump urinary tract infection, site not specified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits tachycardia, unspecified colostomy status paraplegia other chronic pain opioid abuse, continuous chronic osteomyelitis, site unspecified other nonspecific findings on examination of urine nausea with vomiting pressure ulcer, lower back tobacco use disorder esophageal reflux above knee amputation status colostomy status sickle-cell trait fever, unspecified other malaise and fatigue leukocytosis, unspecified pressure ulcer, unspecified stage unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident other chronic pain backache, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic hepatitis c without mention of hepatic coma pressure ulcer, other site paraplegia iron deficiency anemia, unspecified pressure ulcer, stage iii neurogenic bladder nos personal history, urinary (tract) infection other chronic pain other amputation stump complication amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits
black african american m 43 $nan$nan$ondansetron  4  mg ; zolpidem tartrate  5  mg ; methadone  40  mg ; acetaminophen  650  mg ; 
other chronic pain leukocytosis, unspecified pressure ulcer, lower back unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident neurogenic bladder nos tobacco use disorder hypotension, unspecified car passenger injured in collision with heavy transport vehicle or bus in traffic accident pressure ulcer, unspecified stage other artificial opening of urinary tract status unspecified viral hepatitis c without hepatic coma ulcer of other part of lower limb infection (chronic) of amputation stump urinary tract infection, site not specified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits tachycardia, unspecified colostomy status paraplegia other chronic pain opioid abuse, continuous chronic osteomyelitis, site unspecified other nonspecific findings on examination of urine nausea with vomiting pressure ulcer, lower back tobacco use disorder esophageal reflux above knee amputation status colostomy status sickle-cell trait fever, unspecified other malaise and fatigue leukocytosis, unspecified pressure ulcer, unspecified stage unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident other chronic pain backache, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic hepatitis c without mention of hepatic coma pressure ulcer, other site paraplegia iron deficiency anemia, unspecified pressure ulcer, stage iii neurogenic bladder nos personal history, urinary (tract) infection other chronic pain other amputation stump complication amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits
black african american m 43 $nan$nan$ondansetron  4  mg ; zolpidem tartrate  5  mg ; methadone  40  mg ; acetaminophen  650  mg ; 
other chronic pain leukocytosis, unspecified pressure ulcer, lower back unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident neurogenic bladder nos tobacco use disorder hypotension, unspecified car passenger injured in collision with heavy transport vehicle or bus in traffic accident pressure ulcer, unspecified stage other artificial opening of urinary tract status unspecified viral hepatitis c without hepatic coma ulcer of other part of lower limb infection (chronic) of amputation stump urinary tract infection, site not specified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits tachycardia, unspecified colostomy status paraplegia other chronic pain opioid abuse, continuous chronic osteomyelitis, site unspecified other nonspecific findings on examination of urine nausea with vomiting pressure ulcer, lower back tobacco use disorder esophageal reflux above knee amputation status colostomy status sickle-cell trait fever, unspecified other malaise and fatigue leukocytosis, unspecified pressure ulcer, unspecified stage unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident other chronic pain backache, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic hepatitis c without mention of hepatic coma pressure ulcer, other site paraplegia iron deficiency anemia, unspecified pressure ulcer, stage iii neurogenic bladder nos personal history, urinary (tract) infection other chronic pain other amputation stump complication amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits
black african american m 43 $nan$nan$ondansetron  4  mg ; zolpidem tartrate  5  mg ; methadone  40  mg ; acetaminophen  650  mg ; 
other chronic pain leukocytosis, unspecified pressure ulcer, lower back unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident neurogenic bladder nos tobacco use disorder hypotension, unspecified car passenger injured in collision with heavy transport vehicle or bus in traffic accident pressure ulcer, unspecified stage other artificial opening of urinary tract status unspecified viral hepatitis c without hepatic coma ulcer of other part of lower limb infection (chronic) of amputation stump urinary tract infection, site not specified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits tachycardia, unspecified colostomy status paraplegia other chronic pain opioid abuse, continuous chronic osteomyelitis, site unspecified other nonspecific findings on examination of urine nausea with vomiting pressure ulcer, lower back tobacco use disorder esophageal reflux above knee amputation status colostomy status sickle-cell trait fever, unspecified other malaise and fatigue leukocytosis, unspecified pressure ulcer, unspecified stage unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident other chronic pain backache, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic hepatitis c without mention of hepatic coma pressure ulcer, other site paraplegia iron deficiency anemia, unspecified pressure ulcer, stage iii neurogenic bladder nos personal history, urinary (tract) infection other chronic pain other amputation stump complication amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits
black african american m 43 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  497  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  76  mg dl$ondansetron  4  mg ; zolpidem tartrate  5  mg ; methadone  40  mg ; acetaminophen  650  mg ; 
other chronic pain leukocytosis, unspecified pressure ulcer, lower back unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident neurogenic bladder nos tobacco use disorder hypotension, unspecified car passenger injured in collision with heavy transport vehicle or bus in traffic accident pressure ulcer, unspecified stage other artificial opening of urinary tract status unspecified viral hepatitis c without hepatic coma ulcer of other part of lower limb infection (chronic) of amputation stump urinary tract infection, site not specified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits tachycardia, unspecified colostomy status paraplegia other chronic pain opioid abuse, continuous chronic osteomyelitis, site unspecified other nonspecific findings on examination of urine nausea with vomiting pressure ulcer, lower back tobacco use disorder esophageal reflux above knee amputation status colostomy status sickle-cell trait fever, unspecified other malaise and fatigue leukocytosis, unspecified pressure ulcer, unspecified stage unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident other chronic pain backache, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic hepatitis c without mention of hepatic coma pressure ulcer, other site paraplegia iron deficiency anemia, unspecified pressure ulcer, stage iii neurogenic bladder nos personal history, urinary (tract) infection other chronic pain other amputation stump complication amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits
black african american m 43 $nan$nan$ondansetron  4  mg ; zolpidem tartrate  5  mg ; methadone  40  mg ; acetaminophen  650  mg ; 
other chronic pain leukocytosis, unspecified pressure ulcer, lower back unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident neurogenic bladder nos tobacco use disorder hypotension, unspecified car passenger injured in collision with heavy transport vehicle or bus in traffic accident pressure ulcer, unspecified stage other artificial opening of urinary tract status unspecified viral hepatitis c without hepatic coma ulcer of other part of lower limb infection (chronic) of amputation stump urinary tract infection, site not specified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits tachycardia, unspecified colostomy status paraplegia other chronic pain opioid abuse, continuous chronic osteomyelitis, site unspecified other nonspecific findings on examination of urine nausea with vomiting pressure ulcer, lower back tobacco use disorder esophageal reflux above knee amputation status colostomy status sickle-cell trait fever, unspecified other malaise and fatigue leukocytosis, unspecified pressure ulcer, unspecified stage unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident other chronic pain backache, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic hepatitis c without mention of hepatic coma pressure ulcer, other site paraplegia iron deficiency anemia, unspecified pressure ulcer, stage iii neurogenic bladder nos personal history, urinary (tract) infection other chronic pain other amputation stump complication amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits
black african american m 43 $nan$nan$ondansetron  4  mg ; zolpidem tartrate  5  mg ; methadone  40  mg ; acetaminophen  650  mg ; 
other chronic pain leukocytosis, unspecified pressure ulcer, lower back unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident neurogenic bladder nos tobacco use disorder hypotension, unspecified car passenger injured in collision with heavy transport vehicle or bus in traffic accident pressure ulcer, unspecified stage other artificial opening of urinary tract status unspecified viral hepatitis c without hepatic coma ulcer of other part of lower limb infection (chronic) of amputation stump urinary tract infection, site not specified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits tachycardia, unspecified colostomy status paraplegia other chronic pain opioid abuse, continuous chronic osteomyelitis, site unspecified other nonspecific findings on examination of urine nausea with vomiting pressure ulcer, lower back tobacco use disorder esophageal reflux above knee amputation status colostomy status sickle-cell trait fever, unspecified other malaise and fatigue leukocytosis, unspecified pressure ulcer, unspecified stage unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident other chronic pain backache, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic hepatitis c without mention of hepatic coma pressure ulcer, other site paraplegia iron deficiency anemia, unspecified pressure ulcer, stage iii neurogenic bladder nos personal history, urinary (tract) infection other chronic pain other amputation stump complication amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits
black african american m 43 $nan$nan$ondansetron  4  mg ; zolpidem tartrate  5  mg ; methadone  40  mg ; acetaminophen  650  mg ; 
other chronic pain leukocytosis, unspecified pressure ulcer, lower back unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident neurogenic bladder nos tobacco use disorder hypotension, unspecified car passenger injured in collision with heavy transport vehicle or bus in traffic accident pressure ulcer, unspecified stage other artificial opening of urinary tract status unspecified viral hepatitis c without hepatic coma ulcer of other part of lower limb infection (chronic) of amputation stump urinary tract infection, site not specified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits tachycardia, unspecified colostomy status paraplegia other chronic pain opioid abuse, continuous chronic osteomyelitis, site unspecified other nonspecific findings on examination of urine nausea with vomiting pressure ulcer, lower back tobacco use disorder esophageal reflux above knee amputation status colostomy status sickle-cell trait fever, unspecified other malaise and fatigue leukocytosis, unspecified pressure ulcer, unspecified stage unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident other chronic pain backache, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic hepatitis c without mention of hepatic coma pressure ulcer, other site paraplegia iron deficiency anemia, unspecified pressure ulcer, stage iii neurogenic bladder nos personal history, urinary (tract) infection other chronic pain other amputation stump complication amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits
black african american m 43 $nan$nan$ondansetron  4  mg ; zolpidem tartrate  5  mg ; methadone  40  mg ; acetaminophen  650  mg ; 
other chronic pain leukocytosis, unspecified pressure ulcer, lower back unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident neurogenic bladder nos tobacco use disorder hypotension, unspecified car passenger injured in collision with heavy transport vehicle or bus in traffic accident pressure ulcer, unspecified stage other artificial opening of urinary tract status unspecified viral hepatitis c without hepatic coma ulcer of other part of lower limb infection (chronic) of amputation stump urinary tract infection, site not specified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits tachycardia, unspecified colostomy status paraplegia other chronic pain opioid abuse, continuous chronic osteomyelitis, site unspecified other nonspecific findings on examination of urine nausea with vomiting pressure ulcer, lower back tobacco use disorder esophageal reflux above knee amputation status colostomy status sickle-cell trait fever, unspecified other malaise and fatigue leukocytosis, unspecified pressure ulcer, unspecified stage unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident other chronic pain backache, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic hepatitis c without mention of hepatic coma pressure ulcer, other site paraplegia iron deficiency anemia, unspecified pressure ulcer, stage iii neurogenic bladder nos personal history, urinary (tract) infection other chronic pain other amputation stump complication amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits
black african american m 43 $nan$nan$ondansetron  4  mg ; zolpidem tartrate  5  mg ; methadone  40  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  10  ml ; 
other chronic pain leukocytosis, unspecified pressure ulcer, lower back unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident neurogenic bladder nos tobacco use disorder hypotension, unspecified car passenger injured in collision with heavy transport vehicle or bus in traffic accident pressure ulcer, unspecified stage other artificial opening of urinary tract status unspecified viral hepatitis c without hepatic coma ulcer of other part of lower limb infection (chronic) of amputation stump urinary tract infection, site not specified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits tachycardia, unspecified colostomy status paraplegia other chronic pain opioid abuse, continuous chronic osteomyelitis, site unspecified other nonspecific findings on examination of urine nausea with vomiting pressure ulcer, lower back tobacco use disorder esophageal reflux above knee amputation status colostomy status sickle-cell trait fever, unspecified other malaise and fatigue leukocytosis, unspecified pressure ulcer, unspecified stage unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident other chronic pain backache, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic hepatitis c without mention of hepatic coma pressure ulcer, other site paraplegia iron deficiency anemia, unspecified pressure ulcer, stage iii neurogenic bladder nos personal history, urinary (tract) infection other chronic pain other amputation stump complication amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits
black african american m 43 $nan$nan$5% dextrose  250  ml ; ondansetron  4  mg ; zolpidem tartrate  5  mg ; methadone  40  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  10  ml ; ceftaroline  600  mg ; 
other chronic pain leukocytosis, unspecified pressure ulcer, lower back unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident neurogenic bladder nos tobacco use disorder hypotension, unspecified car passenger injured in collision with heavy transport vehicle or bus in traffic accident pressure ulcer, unspecified stage other artificial opening of urinary tract status unspecified viral hepatitis c without hepatic coma ulcer of other part of lower limb infection (chronic) of amputation stump urinary tract infection, site not specified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits tachycardia, unspecified colostomy status paraplegia other chronic pain opioid abuse, continuous chronic osteomyelitis, site unspecified other nonspecific findings on examination of urine nausea with vomiting pressure ulcer, lower back tobacco use disorder esophageal reflux above knee amputation status colostomy status sickle-cell trait fever, unspecified other malaise and fatigue leukocytosis, unspecified pressure ulcer, unspecified stage unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident other chronic pain backache, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic hepatitis c without mention of hepatic coma pressure ulcer, other site paraplegia iron deficiency anemia, unspecified pressure ulcer, stage iii neurogenic bladder nos personal history, urinary (tract) infection other chronic pain other amputation stump complication amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits
black african american m 43 $nan$nan$5% dextrose  250  ml ; ondansetron  4  mg ; zolpidem tartrate  5  mg ; methadone  40  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  10  ml ; ceftaroline  600  mg ; heparin flush (10 units ml)  2  ml ; 
other chronic pain leukocytosis, unspecified pressure ulcer, lower back unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident neurogenic bladder nos tobacco use disorder hypotension, unspecified car passenger injured in collision with heavy transport vehicle or bus in traffic accident pressure ulcer, unspecified stage other artificial opening of urinary tract status unspecified viral hepatitis c without hepatic coma ulcer of other part of lower limb infection (chronic) of amputation stump urinary tract infection, site not specified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits tachycardia, unspecified colostomy status paraplegia other chronic pain opioid abuse, continuous chronic osteomyelitis, site unspecified other nonspecific findings on examination of urine nausea with vomiting pressure ulcer, lower back tobacco use disorder esophageal reflux above knee amputation status colostomy status sickle-cell trait fever, unspecified other malaise and fatigue leukocytosis, unspecified pressure ulcer, unspecified stage unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident other chronic pain backache, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic hepatitis c without mention of hepatic coma pressure ulcer, other site paraplegia iron deficiency anemia, unspecified pressure ulcer, stage iii neurogenic bladder nos personal history, urinary (tract) infection other chronic pain other amputation stump complication amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits
black african american m 43 $nan$nan$5% dextrose  250  ml ; ondansetron  4  mg ; zolpidem tartrate  5  mg ; methadone  40  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  10  ml ; ceftaroline  600  mg ; heparin flush (10 units ml)  2  ml ; 
other chronic pain leukocytosis, unspecified pressure ulcer, lower back unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident neurogenic bladder nos tobacco use disorder hypotension, unspecified car passenger injured in collision with heavy transport vehicle or bus in traffic accident pressure ulcer, unspecified stage other artificial opening of urinary tract status unspecified viral hepatitis c without hepatic coma ulcer of other part of lower limb infection (chronic) of amputation stump urinary tract infection, site not specified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits tachycardia, unspecified colostomy status paraplegia other chronic pain opioid abuse, continuous chronic osteomyelitis, site unspecified other nonspecific findings on examination of urine nausea with vomiting pressure ulcer, lower back tobacco use disorder esophageal reflux above knee amputation status colostomy status sickle-cell trait fever, unspecified other malaise and fatigue leukocytosis, unspecified pressure ulcer, unspecified stage unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident other chronic pain backache, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic hepatitis c without mention of hepatic coma pressure ulcer, other site paraplegia iron deficiency anemia, unspecified pressure ulcer, stage iii neurogenic bladder nos personal history, urinary (tract) infection other chronic pain other amputation stump complication amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits
black african american m 43 $nan$nan$5% dextrose  250  ml ; ondansetron  4  mg ; zolpidem tartrate  5  mg ; methadone  40  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  10  ml ; ceftaroline  600  mg ; heparin flush (10 units ml)  2  ml ; 
other chronic pain leukocytosis, unspecified pressure ulcer, lower back unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident neurogenic bladder nos tobacco use disorder hypotension, unspecified car passenger injured in collision with heavy transport vehicle or bus in traffic accident pressure ulcer, unspecified stage other artificial opening of urinary tract status unspecified viral hepatitis c without hepatic coma ulcer of other part of lower limb infection (chronic) of amputation stump urinary tract infection, site not specified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits tachycardia, unspecified colostomy status paraplegia other chronic pain opioid abuse, continuous chronic osteomyelitis, site unspecified other nonspecific findings on examination of urine nausea with vomiting pressure ulcer, lower back tobacco use disorder esophageal reflux above knee amputation status colostomy status sickle-cell trait fever, unspecified other malaise and fatigue leukocytosis, unspecified pressure ulcer, unspecified stage unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident other chronic pain backache, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic hepatitis c without mention of hepatic coma pressure ulcer, other site paraplegia iron deficiency anemia, unspecified pressure ulcer, stage iii neurogenic bladder nos personal history, urinary (tract) infection other chronic pain other amputation stump complication amputation of limb(s) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits
black african american f 56 $nan$nan$insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; insulin  75  unit ; simvastatin  80  mg ; aspirin  325  mg ; cyanocobalamin  1000  mcg ; insulin  25  unit ; 
adult failure to thrive diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia major depressive affective disorder, single episode, severe, without mention of psychotic behavior
black african american f 56 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; simvastatin  80  mg ; aspirin  325  mg ; cyanocobalamin  1000  mcg ; insulin  25  unit ; mirtazapine  7.5  mg ; 
adult failure to thrive diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia major depressive affective disorder, single episode, severe, without mention of psychotic behavior
black african american f 56 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; simvastatin  80  mg ; aspirin  325  mg ; cyanocobalamin  1000  mcg ; insulin  25  unit ; mirtazapine  7.5  mg ; aripiprazole  5  mg ; mirtazapine  15  mg ; 
adult failure to thrive diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia major depressive affective disorder, single episode, severe, without mention of psychotic behavior
black african american f 56 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; simvastatin  80  mg ; aspirin  325  mg ; cyanocobalamin  1000  mcg ; insulin  25  unit ; aripiprazole  5  mg ; mirtazapine  15  mg ; 
adult failure to thrive diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia major depressive affective disorder, single episode, severe, without mention of psychotic behavior
black african american f 56 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; simvastatin  80  mg ; aspirin  325  mg ; cyanocobalamin  1000  mcg ; insulin  25  unit ; aripiprazole  5  mg ; mirtazapine  15  mg ; 
adult failure to thrive diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia major depressive affective disorder, single episode, severe, without mention of psychotic behavior
black african american f 56 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; simvastatin  80  mg ; aspirin  325  mg ; cyanocobalamin  1000  mcg ; insulin  25  unit ; aripiprazole  5  mg ; mirtazapine  15  mg ; 
adult failure to thrive diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia major depressive affective disorder, single episode, severe, without mention of psychotic behavior
black african american f 56 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; simvastatin  80  mg ; aspirin  325  mg ; cyanocobalamin  1000  mcg ; insulin  25  unit ; aripiprazole  5  mg ; mirtazapine  15  mg ; aripiprazole  7.5  mg ; 
adult failure to thrive diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia major depressive affective disorder, single episode, severe, without mention of psychotic behavior
black african american f 56 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; simvastatin  80  mg ; aspirin  325  mg ; cyanocobalamin  1000  mcg ; insulin  25  unit ; mirtazapine  15  mg ; aripiprazole  7.5  mg ; 
adult failure to thrive diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia major depressive affective disorder, single episode, severe, without mention of psychotic behavior
black african american f 56 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; simvastatin  80  mg ; aspirin  325  mg ; cyanocobalamin  1000  mcg ; insulin  25  unit ; mirtazapine  15  mg ; aripiprazole  7.5  mg ; 
adult failure to thrive diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia major depressive affective disorder, single episode, severe, without mention of psychotic behavior
black african american f 56 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; simvastatin  80  mg ; aspirin  325  mg ; cyanocobalamin  1000  mcg ; insulin  25  unit ; mirtazapine  15  mg ; aripiprazole  7.5  mg ; metformin (glucophage)  500  mg ; glyburide  5  mg ; 
adult failure to thrive diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia major depressive affective disorder, single episode, severe, without mention of psychotic behavior
black african american f 56 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; simvastatin  80  mg ; aspirin  325  mg ; cyanocobalamin  1000  mcg ; insulin  25  unit ; mirtazapine  15  mg ; aripiprazole  7.5  mg ; metformin (glucophage)  500  mg ; glyburide  5  mg ; metformin (glucophage)  1000  mg ; glyburide  10  mg ; 
adult failure to thrive diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia major depressive affective disorder, single episode, severe, without mention of psychotic behavior
white f 68 $nan$hematology blood hematocrit  35.2  %; hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  101  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.12  mg ; heparin  5000  unit ; ketorolac  15  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; metoclopramide  10  mg ; lactated ringers  1000  ml ; citalopram  10  mg ; bupropion (sustained release)  100  mg ; zolpidem tartrate  10  mg ; 
coronary atherosclerosis of native coronary artery personal history of tobacco use abscess of intestine diverticulitis of colon (without mention of hemorrhage) depressive disorder, not elsewhere classified unspecified pleural effusion
white f 68 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.12  mg ; heparin  5000  unit ; ketorolac  15  mg ; metoclopramide  10  mg ; lactated ringers  1000  ml ; citalopram  10  mg ; bupropion (sustained release)  100  mg ; zolpidem tartrate  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride  500  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; 
coronary atherosclerosis of native coronary artery personal history of tobacco use abscess of intestine diverticulitis of colon (without mention of hemorrhage) depressive disorder, not elsewhere classified unspecified pleural effusion
white f 68 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ketorolac  15  mg ; metoclopramide  10  mg ; citalopram  10  mg ; bupropion (sustained release)  100  mg ; zolpidem tartrate  10  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; simvastatin  10  mg ; 
coronary atherosclerosis of native coronary artery personal history of tobacco use abscess of intestine diverticulitis of colon (without mention of hemorrhage) depressive disorder, not elsewhere classified unspecified pleural effusion
white f 68 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ketorolac  15  mg ; citalopram  10  mg ; bupropion (sustained release)  100  mg ; zolpidem tartrate  10  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; simvastatin  10  mg ; 
coronary atherosclerosis of native coronary artery personal history of tobacco use abscess of intestine diverticulitis of colon (without mention of hemorrhage) depressive disorder, not elsewhere classified unspecified pleural effusion
white f 39 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  101  k ul$naloxone  40-80  mcg ; naloxone  0.4  mg ; ketorolac  15  mg ; ketorolac  30  mg ; oxycodone (immediate release)  5-10  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; calcium carbonate  500  mg ; simethicone  80  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; docusate sodium  100  mg ; levothyroxine sodium  50  mcg ; 
 
white f 39 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  92  k ul$naloxone  40-80  mcg ; naloxone  0.4  mg ; ketorolac  15  mg ; ketorolac  30  mg ; oxycodone (immediate release)  5-10  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; calcium carbonate  500  mg ; simethicone  80  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; docusate sodium  100  mg ; levothyroxine sodium  50  mcg ; 
 
white f 39 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; oxycodone (immediate release)  5-10  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; calcium carbonate  500  mg ; simethicone  80  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; docusate sodium  100  mg ; levothyroxine sodium  50  mcg ; ibuprofen  400  mg ; famotidine  20  mg ; senna  8.6  mg ; 
 
white f 39 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; oxycodone (immediate release)  5-10  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; calcium carbonate  500  mg ; simethicone  80  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; levothyroxine sodium  50  mcg ; ibuprofen  400  mg ; famotidine  20  mg ; senna  8.6  mg ; dermoplast spray  1  spry ; hydromorphone (dilaudid)  2-4  mg ; 
 
white f 39 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; calcium carbonate  500  mg ; simethicone  80  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; levothyroxine sodium  50  mcg ; famotidine  20  mg ; senna  8.6  mg ; dermoplast spray  1  spry ; hydromorphone (dilaudid)  2-4  mg ; 
 
white m 48 $temp  97.7  heartrate  65.0  resprate  17.0  o2sat  100.0  sbp  142.0  dbp  85.0  rhythm    pain  2  ; temp  98.0  heartrate  54.0  resprate  16.0  o2sat  97.0  sbp  135.0  dbp  86.0  rhythm    pain  0  ; temp  97.9  heartrate  54.0  resprate  16.0  o2sat  99.0  sbp  127.0  dbp  77.0  rhythm    pain  1  $hematology blood hematocrit  46.6  %; hematology blood hemoglobin  16.0  g dl; hematology blood platelet count  210  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood glucose  124  mg dl$nan
 
white m 48 $nan$chemistry blood creatinine  0.8  mg dl; chemistry blood urea nitrogen  17  mg dl; chemistry blood % hemoglobin a1c  5.2  %$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; omeprazole  20  mg ; aspirin  81  mg ; insulin  0  unit ; acetaminophen  500-1000  mg ; 
 
white m 48 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; insulin  0  unit ; acetaminophen  500-1000  mg ; atorvastatin  80  mg ; 
 
white m 60 $temp    heartrate  69.0  resprate  19.0  o2sat  96.0  sbp  136.0  dbp  75.0  rhythm  normal sinus rhythm  pain  0  $hematology blood hematocrit  36.7  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  93  mg dl; chemistry blood glucose  117  mg dl$d5w  250  ml ; nitroglycerin  100  mg ; sodium chloride 0.9%  flush  3  ml ; 5% dextrose  50  ml ; furosemide  250  mg ; furosemide-heart failure  20  mg ; heparin  5000  unit ; potassium chloride  20  meq ; hydralazine  10  mg ; isosorbide dinitrate  10  mg ; 
 
white m 60 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  80  mg dl; chemistry blood lactate dehydrogenase (ld)  212  iu l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; hydralazine  10  mg ; isosorbide dinitrate  10  mg ; aspirin  81  mg ; furosemide  40  mg ; 
 
white m 60 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  167  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; hydralazine  10  mg ; isosorbide dinitrate  10  mg ; aspirin  81  mg ; furosemide  40  mg ; furosemide  80  mg ; metoprolol tartrate  12.5  mg ; isosorbide mononitrate  20  mg ; atorvastatin  80  mg ; 
 
white m 60 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; hydralazine  10  mg ; aspirin  81  mg ; furosemide  80  mg ; metoprolol tartrate  12.5  mg ; isosorbide mononitrate  20  mg ; atorvastatin  80  mg ; potassium chloride  60  meq ; 
 
white m 67 $nan$chemistry blood anion gap  11  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  3.3  mg dl; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  80  mg dl; chemistry blood urea nitrogen  71  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  245  mg dl; chemistry blood glucose  109  mg dl$1 2 ns  1000  ml ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; 0.9% sodium chloride  1000  ml ; levofloxacin  250  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone sr (oxycontin)  10  mg ; lidocaine jelly 2% (urojet)  1  appl ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; brimonidine tartrate 0.15% ophth.  1  drop ; fluorometholone 0.1% ophth susp.  1  drop ; cyclopentolate 1%  1  drop ; gabapentin  100  mg ; insulin  30  unit ; oxycodone (immediate release)   5  mg ; simvastatin  10  mg ; levothyroxine sodium  25  mcg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; insulin  25  unit ; gabapentin  200  mg ; 
coronary atherosclerosis of native coronary artery chronic kidney disease, unspecified dermatophytosis of foot lack of coordination background diabetic retinopathy acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other constipation morbid obesity diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled dehydration peripheral vascular disease, unspecified long-term (current) use of insulin metabolic encephalopathy
white m 67 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  62  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  109  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; levofloxacin  250  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone sr (oxycontin)  10  mg ; lidocaine jelly 2% (urojet)  1  appl ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; brimonidine tartrate 0.15% ophth.  1  drop ; fluorometholone 0.1% ophth susp.  1  drop ; cyclopentolate 1%  1  drop ; insulin  30  unit ; oxycodone (immediate release)   5  mg ; simvastatin  10  mg ; levothyroxine sodium  25  mcg ; insulin  25  unit ; gabapentin  200  mg ; tamsulosin  0.4  mg ; gabapentin  600  mg ; 
coronary atherosclerosis of native coronary artery chronic kidney disease, unspecified dermatophytosis of foot lack of coordination background diabetic retinopathy acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other constipation morbid obesity diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled dehydration peripheral vascular disease, unspecified long-term (current) use of insulin metabolic encephalopathy
white f 77 $temp    heartrate  186.0  resprate    o2sat    sbp  123.0  dbp  90.0  rhythm    pain    ; temp    heartrate  171.0  resprate  36.0  o2sat    sbp  92.0  dbp  57.0  rhythm    pain  uta  ; temp  36.6  heartrate  172.0  resprate  36.0  o2sat    sbp  109.0  dbp  60.0  rhythm    pain  uta  ; temp  36.7  heartrate  128.0  resprate  36.0  o2sat    sbp  129.0  dbp  71.0  rhythm    pain  uta  ; temp  36.8  heartrate  110.0  resprate  36.0  o2sat  100.0  sbp  126.0  dbp  74.0  rhythm    pain  uta  ; temp  37.1  heartrate  110.0  resprate  36.0  o2sat  100.0  sbp  114.0  dbp  72.0  rhythm    pain  uta  ; temp  37.4  heartrate  113.0  resprate  36.0  o2sat  100.0  sbp  107.0  dbp  67.0  rhythm    pain  uta  ; temp  37.5  heartrate  114.0  resprate  36.0  o2sat  100.0  sbp  118.0  dbp  73.0  rhythm    pain  uta  ; temp  38.0  heartrate  119.0  resprate  36.0  o2sat  100.0  sbp  102.0  dbp  61.0  rhythm    pain    $hematology blood hematocrit  24.9  %; hematology blood hematocrit  22.8  %; hematology blood hematocrit  18.0  %; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  7.0  g dl; hematology blood hemoglobin  5.2  g dl; hematology blood platelet count  317  k ul; hematology blood platelet count  281  k ul; hematology blood platelet count  203  k ul; chemistry blood anion gap  38  meq l; chemistry blood anion gap  39  meq l; chemistry blood anion gap  35  meq l; chemistry blood anion gap  31  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  8  meq l; chemistry blood bicarbonate  8  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  3.3  mg dl; chemistry blood creatinine  3.8  mg dl; chemistry blood creatinine  3.2  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  5.3  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  148  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  151  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  2.1  ; hematology blood inr(pt)  3.3  ; hematology blood inr(pt)  4.0  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, indirect  0.5  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  26  mg dl; chemistry blood glucose  27  mg dl; chemistry blood glucose  122  mg dl; chemistry blood glucose  57  mg dl; chemistry blood lactate dehydrogenase (ld)  5560  iu l; chemistry blood lactate dehydrogenase (ld)  4900  iu l; chemistry blood lactate dehydrogenase (ld)  4800  iu l; chemistry blood albumin  3.4  g dl; blood gas blood free calcium  1.22  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  16  mmol l; blood gas blood lactate  23  mmol l; blood gas blood lactate  18.0  mmol l; blood gas blood lactate  23  mmol l; blood gas blood lactate  15  mmol l; chemistry blood bilirubin, direct  0.3  mg dl; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  5.2  meq l$influenza vaccine quadrivalent  0.5  ml ; heparin flush (1000 units ml)  1000-2200  unit ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; phenylephrine  50  mg ; 0.9% sodium chloride  100  ml ; vasopressin  40  unit ; soln  50  ml ; fentanyl citrate  2.5  mg ; heparin flush (100 units ml)  5  ml ; midazolam  100  mg ; calcium gluconate  4  g ; lactated ringers  1000  ml ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; vial  1  vial ; cefepime  1  g ; 0.9% sodium chloride  500  ml ; calcium gluconate  20  g ; bag  5000  ml ; prismasate (b32 k2)  5000  ml ; sodium chloride 0.9%  flush for crrt  100-200  ml ; sodium citrate 4%  1.2  ml ; sw  100  ml ; potassium chloride  10  meq ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; heparin (crrt machine priming)  5000  unit ; neomycin-polymyxin-bacitracin  1  appl ; bag  1  bag ; magnesium sulfate  2  gm ; potassium phosphate  15  mmol ; sodium bicarbonate  100  meq ; epinephrine  2  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; dextrose 50%  25  gm ; 
 
white f 77 $nan$nan$heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; midazolam  100  mg ; calcium gluconate  4  g ; soln  100  ml ; acetaminophen iv  1000  mg ; 0.9% sodium chloride  500  ml ; calcium gluconate  20  g ; bag  5000  ml ; prismasate (b32 k2)  5000  ml ; sw  100  ml ; potassium chloride  10  meq ; bag  1  bag ; magnesium sulfate  2  gm ; potassium phosphate  15  mmol ; sodium bicarbonate  100  meq ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; 
 
black african american m 62 $temp  98.1  heartrate  90.0  resprate  18.0  o2sat  99.0  sbp  180.0  dbp  100.0  rhythm    pain  0  $hematology blood hematocrit  30.8  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  97  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  51  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  140  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; bisacodyl  10  mg ; docusate sodium  100  mg ; omeprazole  20  mg ; senna  8.6  mg ; acetaminophen  650  mg ; methadone  10  mg ; mycophenolate mofetil  1000  mg ; metoprolol tartrate  25  mg ; doxycycline hyclate  100  mg ; tacrolimus  1  mg ; ondansetron  4  mg ; sulfameth trimethoprim ss  1  tab ; valganciclovir  450  mg ; lamivudine  25  mg ; ciprofloxacin hcl  500  mg ; prednisone  15  mg ; bag  1  bag ; magnesium sulfate  2  gm ; furosemide  20  mg ; 
personal history of nicotine dependence atherosclerotic heart disease of native coronary artery without angina pectoris chronic viral hepatitis c other long term (current) drug therapy urinary tract infection, site not specified unspecified staphylococcus as the cause of diseases classified elsewhere other complication of kidney transplant unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure old myocardial infarction essential (primary) hypertension fluid overload, unspecified hyperkalemia chronic viral hepatitis c adverse effect of glucocorticoids and synthetic analogues, initial encounter hyperglycemia, unspecified unspecified place in hospital as the place of occurrence of the external cause nicotine dependence, cigarettes, uncomplicated thrombocytopenia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris dorsalgia, unspecified end stage renal disease old myocardial infarction dependence on renal dialysis hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease chronic hepatitis c without mention of hepatic coma motor vehicle traffic accident involving collision with pedestrian injuring pedestrian subarachnoid hemorrhage following injury without mention of open intracranial wound, with brief [less than one hour] loss of consciousness end stage renal disease tobacco use disorder hyperpotassemia old myocardial infarction street and highway accidents awaiting organ transplant status coronary atherosclerosis of native coronary artery other pancytopenia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease 
black african american m 62 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; bisacodyl  10  mg ; docusate sodium  100  mg ; omeprazole  20  mg ; senna  8.6  mg ; acetaminophen  650  mg ; methadone  10  mg ; mycophenolate mofetil  1000  mg ; metoprolol tartrate  25  mg ; tacrolimus  1  mg ; ondansetron  4  mg ; sulfameth trimethoprim ss  1  tab ; valganciclovir  450  mg ; prednisone  15  mg ; lamivudine  50  mg ; 
personal history of nicotine dependence atherosclerotic heart disease of native coronary artery without angina pectoris chronic viral hepatitis c other long term (current) drug therapy urinary tract infection, site not specified unspecified staphylococcus as the cause of diseases classified elsewhere other complication of kidney transplant unspecified place or not applicable surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure old myocardial infarction essential (primary) hypertension fluid overload, unspecified hyperkalemia chronic viral hepatitis c adverse effect of glucocorticoids and synthetic analogues, initial encounter hyperglycemia, unspecified unspecified place in hospital as the place of occurrence of the external cause nicotine dependence, cigarettes, uncomplicated thrombocytopenia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris dorsalgia, unspecified end stage renal disease old myocardial infarction dependence on renal dialysis hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease chronic hepatitis c without mention of hepatic coma motor vehicle traffic accident involving collision with pedestrian injuring pedestrian subarachnoid hemorrhage following injury without mention of open intracranial wound, with brief [less than one hour] loss of consciousness end stage renal disease tobacco use disorder hyperpotassemia old myocardial infarction street and highway accidents awaiting organ transplant status coronary atherosclerosis of native coronary artery other pancytopenia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease 
white m 79 $nan$hematology blood hematocrit  32.9  %; hematology blood hematocrit  36.0  %; hematology blood hematocrit  33.6  %; hematology blood hematocrit  32.8  %; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  11.5  g dl; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  157  k ul; hematology blood platelet count  202  k ul; hematology blood platelet count  183  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  154  mg dl; chemistry blood glucose  186  mg dl; chemistry blood glucose  172  mg dl; hematology blood bands  3  %; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.15  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  3.0  mmol l; blood gas blood chloride, whole blood  105  meq l; blood gas blood chloride, whole blood  107  meq l; blood gas blood glucose  201  mg dl; blood gas blood glucose  128  mg dl; blood gas blood glucose  133  mg dl; blood gas blood glucose  158  mg dl; blood gas blood glucose  144  mg dl; blood gas blood glucose  127  mg dl; blood gas blood hematocrit, calculated  41  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  33  %; blood gas blood hemoglobin  13.8  g dl; blood gas blood hemoglobin  10.7  g dl; blood gas blood hemoglobin  11.0  g dl; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood sodium, whole blood  135  meq l$sodium chloride 0.9%  flush  10  ml ; montelukast  10  mg ; influenza vaccine quadrivalent  0.5  ml ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; syringe (iso-osmotic dextrose)  50  ml ; phenylephrine  12  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; meperidine  12.5  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; fentanyl citrate  12.5-50  mcg ; ondansetron  4  mg ; albumin 5% (25g   500ml)  25  g ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  2  mg ; albuterol inhaler  4  puff ; ipratropium bromide mdi  6  puff ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ranitidine  150  mg ; docusate sodium  100  mg ; carbidopa-levodopa (25-100)  1.5  tab ; trihexyphenidyl  1  mg ; simvastatin  40  mg ; metoprolol tartrate  5  mg ; metoprolol tartrate  25  mg ; tamsulosin  0.4  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension long-term (current) use of insulin other and unspecified hyperlipidemia paralysis agitans tachycardia, unspecified asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 79 $nan$chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  247  mg dl; blood gas blood potassium, whole blood  4.4  meq l$sodium chloride 0.9%  flush  10  ml ; montelukast  10  mg ; influenza vaccine quadrivalent  0.5  ml ; dextrose 5%  1000  ml ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; fentanyl citrate  12.5-50  mcg ; ondansetron  4  mg ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  2  mg ; albuterol inhaler  4  puff ; ipratropium bromide mdi  6  puff ; ranitidine  150  mg ; docusate sodium  100  mg ; carbidopa-levodopa (25-100)  1.5  tab ; trihexyphenidyl  1  mg ; simvastatin  40  mg ; metoprolol tartrate  5  mg ; metoprolol tartrate  25  mg ; tamsulosin  0.4  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; hydralazine  20  mg ; insulin glargine  (cvicu protocol)  0-50  unit ; insulin  0-10  unit ; metoprolol tartrate  12.5  mg ; furosemide  20  mg ; valsartan  80  mg ; insulin  0  unit ; aspirin ec  81  mg ; milk of magnesia  30  ml ; metoprolol tartrate  37.5  mg ; clopidogrel  75  mg ; insulin  26  unit ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; amiodarone  400  mg ; atorvastatin  40  mg ; tramadol  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; bisacodyl  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; furosemide  40  mg ; valsartan  160  mg ; insulin  28  unit ; metoprolol tartrate  50  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension long-term (current) use of insulin other and unspecified hyperlipidemia paralysis agitans tachycardia, unspecified asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 79 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  153  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood glucose  142  mg dl$carbidopa-levodopa (25-100)  1.5  tab ; metoprolol tartrate  50  mg ; cepacol (sore throat lozenge)  1  loz ; amlodipine  5  mg ; quetiapine fumarate  12.5  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension long-term (current) use of insulin other and unspecified hyperlipidemia paralysis agitans tachycardia, unspecified asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 79 $nan$hematology blood hematocrit  35.9  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood glucose  91  mg dl$carbidopa-levodopa (25-100)  1.5  tab ; cepacol (sore throat lozenge)  1  loz ; quetiapine fumarate  12.5  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension long-term (current) use of insulin other and unspecified hyperlipidemia paralysis agitans tachycardia, unspecified asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 79 $nan$hematology blood hematocrit  35.9  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  51  mg dl$carbidopa-levodopa (25-100)  1.5  tab ; cepacol (sore throat lozenge)  1  loz ; quetiapine fumarate  12.5  mg ; amiodarone  200  mg ; quetiapine fumarate  25  mg ; guaifenesin-dextromethorphan  10  ml ; insulin  20  unit ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension long-term (current) use of insulin other and unspecified hyperlipidemia paralysis agitans tachycardia, unspecified asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 79 $nan$chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood glucose  294  mg dl$carbidopa-levodopa (25-100)  1.5  tab ; cepacol (sore throat lozenge)  1  loz ; quetiapine fumarate  25  mg ; guaifenesin-dextromethorphan  10  ml ; insulin  20  unit ; insulin  10  unit ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension long-term (current) use of insulin other and unspecified hyperlipidemia paralysis agitans tachycardia, unspecified asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 79 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry blood glucose  227  mg dl$carbidopa-levodopa (25-100)  1.5  tab ; cepacol (sore throat lozenge)  1  loz ; guaifenesin-dextromethorphan  10  ml ; combivent respimat  1  puff ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension long-term (current) use of insulin other and unspecified hyperlipidemia paralysis agitans tachycardia, unspecified asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 79 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  5.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  42  mg dl; chemistry blood glucose  137  mg dl$carbidopa-levodopa (25-100)  1.5  tab ; cepacol (sore throat lozenge)  1  loz ; guaifenesin-dextromethorphan  10  ml ; combivent respimat  1  puff ; hydralazine  10  mg ; lidocaine jelly 2% (glydo)  1  appl ; haloperidol  1  mg ; lactulose  30  ml ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension long-term (current) use of insulin other and unspecified hyperlipidemia paralysis agitans tachycardia, unspecified asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 79 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  302  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood glucose  174  mg dl$carbidopa-levodopa (25-100)  1.5  tab ; cepacol (sore throat lozenge)  1  loz ; guaifenesin-dextromethorphan  10  ml ; combivent respimat  1  puff ; hydralazine  10  mg ; lidocaine jelly 2% (glydo)  1  appl ; haloperidol  1  mg ; lactulose  30  ml ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension long-term (current) use of insulin other and unspecified hyperlipidemia paralysis agitans tachycardia, unspecified asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 79 $nan$hematology blood hematocrit  36.0  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  321  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood urea nitrogen  53  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  226  mg dl; chemistry blood glucose  170  mg dl$carbidopa-levodopa (25-100)  1.5  tab ; cepacol (sore throat lozenge)  1  loz ; guaifenesin-dextromethorphan  10  ml ; combivent respimat  1  puff ; ciprofloxacin hcl  500  mg ; albumin 5% (12.5g   250ml)  12.5  g ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; insulin  8  unit ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension long-term (current) use of insulin other and unspecified hyperlipidemia paralysis agitans tachycardia, unspecified asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 79 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  303  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  214  mg dl$carbidopa-levodopa (25-100)  1.5  tab ; cepacol (sore throat lozenge)  1  loz ; guaifenesin-dextromethorphan  10  ml ; combivent respimat  1  puff ; ciprofloxacin hcl  500  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; insulin  15  unit ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension long-term (current) use of insulin other and unspecified hyperlipidemia paralysis agitans tachycardia, unspecified asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 79 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  353  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  56  mg dl; chemistry blood glucose  159  mg dl$carbidopa-levodopa (25-100)  1.5  tab ; cepacol (sore throat lozenge)  1  loz ; guaifenesin-dextromethorphan  10  ml ; combivent respimat  1  puff ; ciprofloxacin hcl  500  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; insulin  4  unit ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension long-term (current) use of insulin other and unspecified hyperlipidemia paralysis agitans tachycardia, unspecified asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 79 $nan$hematology blood hematocrit  33.9  %; hematology blood hematocrit  31.0  %; hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.6  g dl; hematology blood hemoglobin  9.6  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  378  k ul; hematology blood platelet count  332  k ul; hematology blood platelet count  350  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  60  mg dl; chemistry blood urea nitrogen  53  mg dl; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  90  mg dl; chemistry blood glucose  180  mg dl; chemistry blood glucose  158  mg dl; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood chloride, whole blood  107  meq l; blood gas blood glucose  198  mg dl; blood gas blood glucose  174  mg dl; blood gas blood glucose  179  mg dl; blood gas blood hematocrit, calculated  28  %; blood gas blood hemoglobin  9.3  g dl; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood sodium, whole blood  134  meq l; blood gas blood sodium, whole blood  133  meq l$carbidopa-levodopa (25-100)  1.5  tab ; cepacol (sore throat lozenge)  1  loz ; guaifenesin-dextromethorphan  10  ml ; combivent respimat  1  puff ; ciprofloxacin hcl  500  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; insulin  4  unit ; insulin  25  unit ; 5% dextrose  250  ml ; glycopyrrolate (cvicu reversal protocol)  1  mg ; neostigmine (cvicu reversal protocol)  5  mg ; bag  1  bag ; sw  200  ml ; iso-osmotic dextrose  100  ml ; d5w  250  ml ; nitroglycerin  100  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension long-term (current) use of insulin other and unspecified hyperlipidemia paralysis agitans tachycardia, unspecified asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 79 $nan$blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.05  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood potassium, whole blood  4.5  meq l$bag  1  bag ; sw  200  ml ; iso-osmotic dextrose  100  ml ; mometasone  2  puff ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension long-term (current) use of insulin other and unspecified hyperlipidemia paralysis agitans tachycardia, unspecified asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 79 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  348  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood glucose  154  mg dl$mometasone  2  puff ; acetaminophen  500-1000  mg ; magnesium oxide  400  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension long-term (current) use of insulin other and unspecified hyperlipidemia paralysis agitans tachycardia, unspecified asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 79 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  336  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood glucose  165  mg dl$mometasone  2  puff ; acetaminophen  500-1000  mg ; magnesium oxide  400  mg ; 
personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension long-term (current) use of insulin other and unspecified hyperlipidemia paralysis agitans tachycardia, unspecified asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
unknown f 73 $temp    heartrate  83.0  resprate  12.0  o2sat  99.0  sbp  120.0  dbp  67.0  rhythm    pain    $hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  223  k ul; chemistry blood creatinine  1.7  mg dl; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.1  ; blood gas blood free calcium  1.20  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood chloride, whole blood  101  meq l; blood gas blood glucose  159  mg dl; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood sodium, whole blood  142  meq l; blood gas blood calculated bicarbonate, whole blood  27  meq l$nan
 
unknown f 73 $nan$hematology blood hematocrit  30.0  %; hematology blood hematocrit  29.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  204  k ul; hematology blood platelet count  169  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  174  mg dl; chemistry blood glucose  143  mg dl$ondansetron  4  mg ; morphine sulfate  2-4  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; lactated ringers  1000  ml ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sw  200  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; insulin  0  unit ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 0.9% sodium chloride  100  ml ; levetiracetam  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  1.5  g ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)   5  mg ; amoxicillin-clavulanic acid  500  mg ; hydromorphone (dilaudid)  0.25-1  mg ; haloperidol  2.5  mg ; 
 
unknown f 73 $nan$chemistry urine chloride, urine  68  meq l; chemistry urine creatinine, urine  86  mg dl; chemistry urine potassium, urine  65  meq l; chemistry urine sodium, urine  53  meq l$ondansetron  4  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sw  200  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; insulin  0  unit ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 0.9% sodium chloride  100  ml ; levetiracetam  500  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)   5  mg ; amoxicillin-clavulanic acid  500  mg ; hydromorphone (dilaudid)  0.25-1  mg ; haloperidol  2.5  mg ; acetaminophen iv  1000  mg ; tamsulosin  0.4  mg ; heparin  5000  unit ; tramadol (ultram)  50  mg ; oxycodone (immediate release)   2.5  mg ; sodium chloride 0.9%  flush  3  ml ; 
 
unknown f 73 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  167  k ul; hematology urine wbc  11  # hpf$ondansetron  4  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 0.9% sodium chloride  100  ml ; levetiracetam  500  mg ; acetaminophen iv  1000  mg ; heparin  5000  unit ; oxycodone (immediate release)   2.5  mg ; sodium chloride 0.9%  flush  3  ml ; ciprofloxacin hcl  500  mg ; 
 
unknown f 73 $nan$nan$ondansetron  4  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 0.9% sodium chloride  100  ml ; levetiracetam  500  mg ; acetaminophen iv  1000  mg ; heparin  5000  unit ; oxycodone (immediate release)   2.5  mg ; sodium chloride 0.9%  flush  3  ml ; ciprofloxacin hcl  500  mg ; 
 
unknown f 73 $nan$nan$ondansetron  4  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 0.9% sodium chloride  100  ml ; levetiracetam  500  mg ; acetaminophen iv  1000  mg ; heparin  5000  unit ; oxycodone (immediate release)   2.5  mg ; sodium chloride 0.9%  flush  3  ml ; ciprofloxacin hcl  500  mg ; docusate sodium  100  mg ; senna  1  tab ; 
 
unknown f 73 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  82  mg dl$ondansetron  4  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen iv  1000  mg ; heparin  5000  unit ; oxycodone (immediate release)   2.5  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; magnesium oxide  400  mg ; 
 
unknown f 73 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood glucose  90  mg dl$ondansetron  4  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen iv  1000  mg ; heparin  5000  unit ; oxycodone (immediate release)   2.5  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; magnesium oxide  400  mg ; dronabinol  2.5  mg ; trazodone  50  mg ; 
 
unknown f 73 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  105  mg dl$ondansetron  4  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen iv  1000  mg ; heparin  5000  unit ; oxycodone (immediate release)   2.5  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; dronabinol  2.5  mg ; trazodone  50  mg ; dronabinol  5  mg ; 
 
unknown f 73 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  80  mg dl$ondansetron  4  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen iv  1000  mg ; heparin  5000  unit ; oxycodone (immediate release)   2.5  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; trazodone  50  mg ; dronabinol  5  mg ; 
 
white m 66 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; belladonna & opium (16.2 30mg)  1  supp ; lactated ringers  1000  ml ; bacitracin ointment  1  appl ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; phenazopyridine  200  mg ; 
 
white m 66 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; belladonna & opium (16.2 30mg)  1  supp ; lactated ringers  1000  ml ; bacitracin ointment  1  appl ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; phenazopyridine  200  mg ; milk of magnesia  30  ml ; 
 
white m 79 $nan$nan$lisinopril  20  mg ; heparin  5000  unit ; docusate sodium  100  mg ; influenza vaccine quadrivalent  0.5  ml ; lidocaine jelly 2% (glydo)  1  appl ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; terazosin  2  mg ; morphine sulfate  2-4  mg ; 
secondary malignant neoplasm of left lung gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence personal history of other malignant neoplasm of skin benign prostatic hyperplasia without lower urinary tract symptoms esophageal reflux personal history of tobacco use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) malignant neoplasm of connective and other soft tissue of upper limb, including shoulder atrial fibrillation
white m 79 $nan$hematology blood hematocrit  40.5  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  149  mg dl$lisinopril  20  mg ; docusate sodium  100  mg ; influenza vaccine quadrivalent  0.5  ml ; lidocaine jelly 2% (glydo)  1  appl ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; morphine sulfate  2-4  mg ; cepacol (sore throat lozenge)  1  loz ; calcium carbonate  500  mg ; ranitidine  150  mg ; 
secondary malignant neoplasm of left lung gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence personal history of other malignant neoplasm of skin benign prostatic hyperplasia without lower urinary tract symptoms esophageal reflux personal history of tobacco use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) malignant neoplasm of connective and other soft tissue of upper limb, including shoulder atrial fibrillation
white m 79 $nan$hematology blood hematocrit  37.8  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  108  mg dl$lisinopril  20  mg ; docusate sodium  100  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; morphine sulfate  2-4  mg ; cepacol (sore throat lozenge)  1  loz ; calcium carbonate  500  mg ; ranitidine  150  mg ; 
secondary malignant neoplasm of left lung gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence personal history of other malignant neoplasm of skin benign prostatic hyperplasia without lower urinary tract symptoms esophageal reflux personal history of tobacco use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) malignant neoplasm of connective and other soft tissue of upper limb, including shoulder atrial fibrillation
white m 79 $nan$hematology blood hematocrit  38.7  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  96  mg dl$lisinopril  20  mg ; docusate sodium  100  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; morphine sulfate  2-4  mg ; ranitidine  150  mg ; hydrochlorothiazide  12.5  mg ; hydrochlorothiazide  25  mg ; phosphorus  250  mg ; 
secondary malignant neoplasm of left lung gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence personal history of other malignant neoplasm of skin benign prostatic hyperplasia without lower urinary tract symptoms esophageal reflux personal history of tobacco use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) malignant neoplasm of connective and other soft tissue of upper limb, including shoulder atrial fibrillation
white m 79 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  115  mg dl$lisinopril  20  mg ; docusate sodium  100  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; morphine sulfate  2-4  mg ; ranitidine  150  mg ; hydrochlorothiazide  25  mg ; phosphorus  250  mg ; 
secondary malignant neoplasm of left lung gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence personal history of other malignant neoplasm of skin benign prostatic hyperplasia without lower urinary tract symptoms esophageal reflux personal history of tobacco use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) malignant neoplasm of connective and other soft tissue of upper limb, including shoulder atrial fibrillation
white m 79 $nan$nan$lisinopril  20  mg ; docusate sodium  100  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; morphine sulfate  2-4  mg ; ranitidine  150  mg ; hydrochlorothiazide  25  mg ; 
secondary malignant neoplasm of left lung gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence personal history of other malignant neoplasm of skin benign prostatic hyperplasia without lower urinary tract symptoms esophageal reflux personal history of tobacco use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) malignant neoplasm of connective and other soft tissue of upper limb, including shoulder atrial fibrillation
white f 68 $nan$nan$levothyroxine sodium  175  mcg ; folic acid  1  mg ; allopurinol  150  mg ; prednisone  10  mg ; 
chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism osteoarthrosis, unspecified whether generalized or localized, site unspecified malignant ascites chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism fever presenting with conditions classified elsewhere antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use abdominal pain, left lower quadrant leiomyoma of uterus, unspecified malignant ascites drug induced neutropenia malignant ascites hypotension, unspecified spontaneous bacterial peritonitis leiomyoma of uterus, unspecified unspecified acquired hypothyroidism personal history of tuberculosis chronic lymphoid leukemia, without mention of having achieved remission chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism other ascites pancytopenia fever presenting with conditions classified elsewhere hyposmolality and/or hyponatremia chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism candidiasis of mouth neutropenia, unspecified malignant ascites chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism myelodysplastic syndrome, unspecified spontaneous bacterial peritonitis chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism neutropenia, unspecified hypotension, unspecified fever presenting with conditions classified elsewhere spontaneous bacterial peritonitis anemia in neoplastic disease chronic lymphoid leukemia, without mention of having achieved remission anemia, unspecified drug induced neutropenia unspecified acquired hypothyroidism antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other ascites fever presenting with conditions classified elsewhere
white f 68 $nan$hematology blood hematocrit  21.8  %; hematology blood hematocrit  22.8  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  39  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  18  mg dl; hematology urine wbc  6  # hpf; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  89  mg dl; chemistry blood albumin  2.6  g dl$levothyroxine sodium  175  mcg ; folic acid  1  mg ; allopurinol  150  mg ; prednisone  10  mg ; magnesium oxide  400  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acyclovir  400  mg ; vial  1  vial ; filgrastim  300  mcg ; prochlorperazine  10  mg ; albumin 25% (12.5g   50ml)  75  g ; heparin flush (10 units ml)  1  ml ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50-100  ml ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; 
chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism osteoarthrosis, unspecified whether generalized or localized, site unspecified malignant ascites chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism fever presenting with conditions classified elsewhere antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use abdominal pain, left lower quadrant leiomyoma of uterus, unspecified malignant ascites drug induced neutropenia malignant ascites hypotension, unspecified spontaneous bacterial peritonitis leiomyoma of uterus, unspecified unspecified acquired hypothyroidism personal history of tuberculosis chronic lymphoid leukemia, without mention of having achieved remission chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism other ascites pancytopenia fever presenting with conditions classified elsewhere hyposmolality and/or hyponatremia chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism candidiasis of mouth neutropenia, unspecified malignant ascites chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism myelodysplastic syndrome, unspecified spontaneous bacterial peritonitis chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism neutropenia, unspecified hypotension, unspecified fever presenting with conditions classified elsewhere spontaneous bacterial peritonitis anemia in neoplastic disease chronic lymphoid leukemia, without mention of having achieved remission anemia, unspecified drug induced neutropenia unspecified acquired hypothyroidism antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other ascites fever presenting with conditions classified elsewhere
white f 68 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  39  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  94  mg dl; chemistry blood albumin  2.3  g dl; hematology blood bands  1  %$levothyroxine sodium  175  mcg ; folic acid  1  mg ; allopurinol  150  mg ; prednisone  10  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acyclovir  400  mg ; vial  1  vial ; filgrastim  300  mcg ; prochlorperazine  10  mg ; albumin 25% (12.5g   50ml)  75  g ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50-100  ml ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; midodrine  2.5  mg ; 
chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism osteoarthrosis, unspecified whether generalized or localized, site unspecified malignant ascites chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism fever presenting with conditions classified elsewhere antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use abdominal pain, left lower quadrant leiomyoma of uterus, unspecified malignant ascites drug induced neutropenia malignant ascites hypotension, unspecified spontaneous bacterial peritonitis leiomyoma of uterus, unspecified unspecified acquired hypothyroidism personal history of tuberculosis chronic lymphoid leukemia, without mention of having achieved remission chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism other ascites pancytopenia fever presenting with conditions classified elsewhere hyposmolality and/or hyponatremia chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism candidiasis of mouth neutropenia, unspecified malignant ascites chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism myelodysplastic syndrome, unspecified spontaneous bacterial peritonitis chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism neutropenia, unspecified hypotension, unspecified fever presenting with conditions classified elsewhere spontaneous bacterial peritonitis anemia in neoplastic disease chronic lymphoid leukemia, without mention of having achieved remission anemia, unspecified drug induced neutropenia unspecified acquired hypothyroidism antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other ascites fever presenting with conditions classified elsewhere
white f 68 $nan$nan$levothyroxine sodium  175  mcg ; folic acid  1  mg ; allopurinol  150  mg ; prednisone  10  mg ; sodium chloride 0.9%  flush  3  ml ; acyclovir  400  mg ; vial  1  vial ; filgrastim  300  mcg ; prochlorperazine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50-100  ml ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; midodrine  2.5  mg ; 
chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism osteoarthrosis, unspecified whether generalized or localized, site unspecified malignant ascites chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism fever presenting with conditions classified elsewhere antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use abdominal pain, left lower quadrant leiomyoma of uterus, unspecified malignant ascites drug induced neutropenia malignant ascites hypotension, unspecified spontaneous bacterial peritonitis leiomyoma of uterus, unspecified unspecified acquired hypothyroidism personal history of tuberculosis chronic lymphoid leukemia, without mention of having achieved remission chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism other ascites pancytopenia fever presenting with conditions classified elsewhere hyposmolality and/or hyponatremia chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism candidiasis of mouth neutropenia, unspecified malignant ascites chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism myelodysplastic syndrome, unspecified spontaneous bacterial peritonitis chronic lymphoid leukemia, without mention of having achieved remission unspecified acquired hypothyroidism neutropenia, unspecified hypotension, unspecified fever presenting with conditions classified elsewhere spontaneous bacterial peritonitis anemia in neoplastic disease chronic lymphoid leukemia, without mention of having achieved remission anemia, unspecified drug induced neutropenia unspecified acquired hypothyroidism antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use other ascites fever presenting with conditions classified elsewhere
black african american f 69 $nan$nan$heparin  5000  unit ; 
 
black african american f 69 $nan$nan$heparin  5000  unit ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; 0.9% sodium chloride  100  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; diphenhydramine  25  mg ; acetaminophen  650  mg ; oxycodone (immediate release)  5-10  mg ; 
 
black african american f 69 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  531  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl$heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetaminophen  650  mg ; oxycodone (immediate release)  5-10  mg ; ceftriaxone  2  gm ; iso-osmotic dextrose  100  ml ; vancomycin  500  mg ; sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; oxycodone (immediate release)  5  mg ; 
 
black african american f 69 $nan$nan$oxycodone (immediate release)  5  mg ; 
 
black african american f 69 $nan$nan$oxycodone (immediate release)  5  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; 
 
black african american f 69 $nan$nan$oxycodone (immediate release)  5  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; 
 
hispanic latino f 59 $temp    heartrate  105.0  resprate  24.0  o2sat    sbp  122.0  dbp  56.0  rhythm    pain    ; temp    heartrate  103.0  resprate  24.0  o2sat  99.0  sbp  123.0  dbp  63.0  rhythm    pain  0  $chemistry blood anion gap  14  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  119  meq l; chemistry blood chloride  119  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  192  mg dl; chemistry blood glucose  299  mg dl; chemistry blood lactate dehydrogenase (ld)  156  iu l; chemistry blood albumin  3.5  g dl; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.1  mmol l$sw  800  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; d5 1 2ns  1000  ml ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; phosphorus  250  mg ; oxycodone (immediate release)  5  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; ondansetron  4  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; insulin  0  unit ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; heparin  5000  unit ; insulin  24  unit ; insulin  10  unit ; insulin  20  unit ; insulin  8  unit ; lactated ringers  1000  ml ; 
tobacco use disorder wheelchair dependence unspecified essential hypertension tachycardia, unspecified other specified diseases of blood and blood-forming organs hyperosmolality and/or hypernatremia diabetes with ketoacidosis, type i [juvenile type], uncontrolled multiple sclerosis disturbance of salivary secretion pure hypercholesterolemia esophageal reflux acute pancreatitis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident 
hispanic latino f 59 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  134  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood glucose  201  mg dl; chemistry blood % hemoglobin a1c  15.2  %$sw  800  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; phosphorus  250  mg ; oxycodone (immediate release)  5  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; ondansetron  4  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; insulin  0  unit ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; heparin  5000  unit ; insulin  24  unit ; insulin  10  unit ; insulin  20  unit ; insulin  8  unit ; lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; aspirin  81  mg ; quetiapine fumarate  150  mg ; tizanidine  4  mg ; acetaminophen  500  mg ; lisinopril  5  mg ; insulin  18  unit ; insulin  7  unit ; 
tobacco use disorder wheelchair dependence unspecified essential hypertension tachycardia, unspecified other specified diseases of blood and blood-forming organs hyperosmolality and/or hypernatremia diabetes with ketoacidosis, type i [juvenile type], uncontrolled multiple sclerosis disturbance of salivary secretion pure hypercholesterolemia esophageal reflux acute pancreatitis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident 
hispanic latino f 59 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  249  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron  4  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; aspirin  81  mg ; quetiapine fumarate  150  mg ; tizanidine  4  mg ; acetaminophen  500  mg ; lisinopril  5  mg ; atorvastatin  40  mg ; 
tobacco use disorder wheelchair dependence unspecified essential hypertension tachycardia, unspecified other specified diseases of blood and blood-forming organs hyperosmolality and/or hypernatremia diabetes with ketoacidosis, type i [juvenile type], uncontrolled multiple sclerosis disturbance of salivary secretion pure hypercholesterolemia esophageal reflux acute pancreatitis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident 
hispanic latino f 59 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron  4  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; aspirin  81  mg ; quetiapine fumarate  150  mg ; tizanidine  4  mg ; acetaminophen  500  mg ; lisinopril  5  mg ; atorvastatin  40  mg ; insulin  12  unit ; 
tobacco use disorder wheelchair dependence unspecified essential hypertension tachycardia, unspecified other specified diseases of blood and blood-forming organs hyperosmolality and/or hypernatremia diabetes with ketoacidosis, type i [juvenile type], uncontrolled multiple sclerosis disturbance of salivary secretion pure hypercholesterolemia esophageal reflux acute pancreatitis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident 
hispanic latino f 59 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron  4  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; aspirin  81  mg ; quetiapine fumarate  150  mg ; tizanidine  4  mg ; acetaminophen  500  mg ; lisinopril  5  mg ; atorvastatin  40  mg ; insulin  12  unit ; insulin  16  unit ; 
tobacco use disorder wheelchair dependence unspecified essential hypertension tachycardia, unspecified other specified diseases of blood and blood-forming organs hyperosmolality and/or hypernatremia diabetes with ketoacidosis, type i [juvenile type], uncontrolled multiple sclerosis disturbance of salivary secretion pure hypercholesterolemia esophageal reflux acute pancreatitis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident 
hispanic latino f 59 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron  4  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; aspirin  81  mg ; quetiapine fumarate  150  mg ; tizanidine  4  mg ; acetaminophen  500  mg ; lisinopril  5  mg ; atorvastatin  40  mg ; insulin  14  unit ; 
tobacco use disorder wheelchair dependence unspecified essential hypertension tachycardia, unspecified other specified diseases of blood and blood-forming organs hyperosmolality and/or hypernatremia diabetes with ketoacidosis, type i [juvenile type], uncontrolled multiple sclerosis disturbance of salivary secretion pure hypercholesterolemia esophageal reflux acute pancreatitis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident 
hispanic latino f 59 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron  4  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; aspirin  81  mg ; quetiapine fumarate  150  mg ; tizanidine  4  mg ; acetaminophen  500  mg ; lisinopril  5  mg ; atorvastatin  40  mg ; 
tobacco use disorder wheelchair dependence unspecified essential hypertension tachycardia, unspecified other specified diseases of blood and blood-forming organs hyperosmolality and/or hypernatremia diabetes with ketoacidosis, type i [juvenile type], uncontrolled multiple sclerosis disturbance of salivary secretion pure hypercholesterolemia esophageal reflux acute pancreatitis unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident 
white f 96 $temp  98.2  heartrate  67.0  resprate  18.0  o2sat  97.0  sbp  174.0  dbp  85.0  rhythm    pain  0  ; temp  97.6  heartrate  64.0  resprate  16.0  o2sat  99.0  sbp  174.0  dbp  69.0  rhythm    pain  0  $nan$carvedilol  6.25  mg ; 
other fall from one level to another in water transport injuring occupant of other watercraft -- crew chronic kidney disease, stage 3 (moderate) hypomagnesemia left bundle-branch block, unspecified acute on chronic diastolic (congestive) heart failure hypokalemia hypo-osmolality and hyponatremia hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease major depressive disorder, single episode, unspecified toxic encephalopathy benign neoplasm of cerebral meninges insomnia, unspecified anemia, unspecified dysarthria and anarthria constipation, unspecified delusional disorders non-st elevation (nstemi) myocardial infarction urinary tract infection, site not specified suicidal ideations do not resuscitate acidosis personal history of malignant neoplasm of bladder hypokalemia hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease benign neoplasm of cerebral meninges fall on stairs or ladders in water transport injuring unspecified person hyperlipidemia, unspecified acute kidney failure, unspecified acidosis toxic encephalopathy other disorders resulting from impaired renal tubular function do not resuscitate localized edema personal history of malignant neoplasm of bladder other disorders of phosphorus metabolism paroxysmal atrial fibrillation diarrhea, unspecified chronic kidney disease, stage 3 (moderate) elevated white blood cell count, unspecified volume depletion, unspecified
white f 96 $temp  98.2  heartrate  69.0  resprate  20.0  o2sat  99.0  sbp  168.0  dbp  83.0  rhythm    pain    $hematology blood hematocrit  25.3  %; hematology blood hematocrit  25.7  %; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  269  k ul; hematology blood platelet count  238  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  71  meq l; chemistry blood chloride  75  meq l; chemistry blood chloride  80  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  2.5  meq l; chemistry blood sodium  112  meq l; chemistry blood sodium  116  meq l; chemistry blood sodium  108  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood urea nitrogen  44  mg dl; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine chloride, urine  45  meq l; chemistry urine chloride, urine  42  meq l; chemistry urine chloride, urine  40  meq l; chemistry urine chloride, urine  37  meq l; chemistry urine chloride, urine  30  meq l; chemistry urine potassium, urine  26  meq l; chemistry urine potassium, urine  29  meq l; chemistry urine potassium, urine  37  meq l; chemistry urine potassium, urine  41  meq l; chemistry urine potassium, urine  47  meq l; chemistry urine potassium, urine  32  meq l; chemistry urine sodium, urine  38  meq l; chemistry urine sodium, urine  34  meq l; chemistry urine sodium, urine  26  meq l; chemistry urine sodium, urine  21  meq l; hematology urine wbc  55  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  188  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  111  mg dl; blood gas blood chloride, whole blood  81  meq l; blood gas blood chloride, whole blood  82  meq l; blood gas blood chloride, whole blood  83  meq l; blood gas blood chloride, whole blood  85  meq l; blood gas blood chloride, whole blood  86  meq l; blood gas blood chloride, whole blood  75  meq l; blood gas blood chloride, whole blood  78  meq l; blood gas blood potassium, whole blood  3.3  meq l; blood gas blood potassium, whole blood  3.4  meq l; blood gas blood potassium, whole blood  3.6  meq l; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood potassium, whole blood  3.3  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood sodium, whole blood  117  meq l; blood gas blood sodium, whole blood  112  meq l; blood gas blood sodium, whole blood  113  meq l; blood gas blood sodium, whole blood  117  meq l; blood gas blood sodium, whole blood  110  meq l; blood gas blood sodium, whole blood  115  meq l; blood gas blood sodium, whole blood  110  meq l$carvedilol  6.25  mg ; potassium chloride  40  meq ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; sodium chloride  1  gm ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; acetaminophen  650  mg ; zolpidem tartrate  2.5  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; vial  1  vial ; pantoprazole  40  mg ; dextrose 5%  1000  ml ; aspirin  325  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 
other fall from one level to another in water transport injuring occupant of other watercraft -- crew chronic kidney disease, stage 3 (moderate) hypomagnesemia left bundle-branch block, unspecified acute on chronic diastolic (congestive) heart failure hypokalemia hypo-osmolality and hyponatremia hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease major depressive disorder, single episode, unspecified toxic encephalopathy benign neoplasm of cerebral meninges insomnia, unspecified anemia, unspecified dysarthria and anarthria constipation, unspecified delusional disorders non-st elevation (nstemi) myocardial infarction urinary tract infection, site not specified suicidal ideations do not resuscitate acidosis personal history of malignant neoplasm of bladder hypokalemia hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease benign neoplasm of cerebral meninges fall on stairs or ladders in water transport injuring unspecified person hyperlipidemia, unspecified acute kidney failure, unspecified acidosis toxic encephalopathy other disorders resulting from impaired renal tubular function do not resuscitate localized edema personal history of malignant neoplasm of bladder other disorders of phosphorus metabolism paroxysmal atrial fibrillation diarrhea, unspecified chronic kidney disease, stage 3 (moderate) elevated white blood cell count, unspecified volume depletion, unspecified
white f 96 $nan$hematology blood hematocrit  24.0  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  118  meq l; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine potassium, urine  47  meq l; chemistry urine potassium, urine  53  meq l; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  92  mg dl; blood gas blood chloride, whole blood  86  meq l; blood gas blood chloride, whole blood  88  meq l; blood gas blood chloride, whole blood  86  meq l; blood gas blood chloride, whole blood  88  meq l; blood gas blood chloride, whole blood  89  meq l; blood gas blood chloride, whole blood  90  meq l; blood gas blood chloride, whole blood  93  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  3.6  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  3.6  meq l; blood gas blood potassium, whole blood  3.6  meq l; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood sodium, whole blood  114  meq l; blood gas blood sodium, whole blood  117  meq l; blood gas blood sodium, whole blood  115  meq l; blood gas blood sodium, whole blood  113  meq l; blood gas blood sodium, whole blood  115  meq l; blood gas blood sodium, whole blood  121  meq l; blood gas blood sodium, whole blood  116  meq l$sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; acetaminophen  650  mg ; zolpidem tartrate  2.5  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; vial  1  vial ; pantoprazole  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; atorvastatin  20  mg ; 
other fall from one level to another in water transport injuring occupant of other watercraft -- crew chronic kidney disease, stage 3 (moderate) hypomagnesemia left bundle-branch block, unspecified acute on chronic diastolic (congestive) heart failure hypokalemia hypo-osmolality and hyponatremia hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease major depressive disorder, single episode, unspecified toxic encephalopathy benign neoplasm of cerebral meninges insomnia, unspecified anemia, unspecified dysarthria and anarthria constipation, unspecified delusional disorders non-st elevation (nstemi) myocardial infarction urinary tract infection, site not specified suicidal ideations do not resuscitate acidosis personal history of malignant neoplasm of bladder hypokalemia hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease benign neoplasm of cerebral meninges fall on stairs or ladders in water transport injuring unspecified person hyperlipidemia, unspecified acute kidney failure, unspecified acidosis toxic encephalopathy other disorders resulting from impaired renal tubular function do not resuscitate localized edema personal history of malignant neoplasm of bladder other disorders of phosphorus metabolism paroxysmal atrial fibrillation diarrhea, unspecified chronic kidney disease, stage 3 (moderate) elevated white blood cell count, unspecified volume depletion, unspecified
white f 96 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  50  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  84  mg dl; blood gas blood chloride, whole blood  92  meq l; blood gas blood chloride, whole blood  92  meq l; blood gas blood chloride, whole blood  94  meq l; blood gas blood chloride, whole blood  96  meq l; blood gas blood chloride, whole blood  98  meq l; blood gas blood potassium, whole blood  3.6  meq l; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood sodium, whole blood  125  meq l; blood gas blood sodium, whole blood  125  meq l; blood gas blood sodium, whole blood  127  meq l; blood gas blood sodium, whole blood  120  meq l; blood gas blood sodium, whole blood  124  meq l$sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; acetaminophen  650  mg ; zolpidem tartrate  2.5  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; vial  1  vial ; pantoprazole  40  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; atorvastatin  20  mg ; 0.9% sodium chloride  100  ml ; vancomycin  500  mg ; 
other fall from one level to another in water transport injuring occupant of other watercraft -- crew chronic kidney disease, stage 3 (moderate) hypomagnesemia left bundle-branch block, unspecified acute on chronic diastolic (congestive) heart failure hypokalemia hypo-osmolality and hyponatremia hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease major depressive disorder, single episode, unspecified toxic encephalopathy benign neoplasm of cerebral meninges insomnia, unspecified anemia, unspecified dysarthria and anarthria constipation, unspecified delusional disorders non-st elevation (nstemi) myocardial infarction urinary tract infection, site not specified suicidal ideations do not resuscitate acidosis personal history of malignant neoplasm of bladder hypokalemia hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease benign neoplasm of cerebral meninges fall on stairs or ladders in water transport injuring unspecified person hyperlipidemia, unspecified acute kidney failure, unspecified acidosis toxic encephalopathy other disorders resulting from impaired renal tubular function do not resuscitate localized edema personal history of malignant neoplasm of bladder other disorders of phosphorus metabolism paroxysmal atrial fibrillation diarrhea, unspecified chronic kidney disease, stage 3 (moderate) elevated white blood cell count, unspecified volume depletion, unspecified
white f 96 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  78  mg dl$sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; acetaminophen  650  mg ; zolpidem tartrate  2.5  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; atorvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; heparin flush (10 units ml)  2  ml ; 
other fall from one level to another in water transport injuring occupant of other watercraft -- crew chronic kidney disease, stage 3 (moderate) hypomagnesemia left bundle-branch block, unspecified acute on chronic diastolic (congestive) heart failure hypokalemia hypo-osmolality and hyponatremia hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease major depressive disorder, single episode, unspecified toxic encephalopathy benign neoplasm of cerebral meninges insomnia, unspecified anemia, unspecified dysarthria and anarthria constipation, unspecified delusional disorders non-st elevation (nstemi) myocardial infarction urinary tract infection, site not specified suicidal ideations do not resuscitate acidosis personal history of malignant neoplasm of bladder hypokalemia hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease benign neoplasm of cerebral meninges fall on stairs or ladders in water transport injuring unspecified person hyperlipidemia, unspecified acute kidney failure, unspecified acidosis toxic encephalopathy other disorders resulting from impaired renal tubular function do not resuscitate localized edema personal history of malignant neoplasm of bladder other disorders of phosphorus metabolism paroxysmal atrial fibrillation diarrhea, unspecified chronic kidney disease, stage 3 (moderate) elevated white blood cell count, unspecified volume depletion, unspecified
white f 96 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  224  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  44  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  114  mg dl; chemistry blood glucose  92  mg dl; blood gas blood sodium, whole blood  133  meq l$sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; brimonidine tartrate 0.15% ophth.  1  drop ; atorvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  2  ml ; senna  8.6  mg ; docusate sodium  100  mg ; mirtazapine  7.5  mg ; torsemide  20  mg ; 
other fall from one level to another in water transport injuring occupant of other watercraft -- crew chronic kidney disease, stage 3 (moderate) hypomagnesemia left bundle-branch block, unspecified acute on chronic diastolic (congestive) heart failure hypokalemia hypo-osmolality and hyponatremia hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease major depressive disorder, single episode, unspecified toxic encephalopathy benign neoplasm of cerebral meninges insomnia, unspecified anemia, unspecified dysarthria and anarthria constipation, unspecified delusional disorders non-st elevation (nstemi) myocardial infarction urinary tract infection, site not specified suicidal ideations do not resuscitate acidosis personal history of malignant neoplasm of bladder hypokalemia hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease benign neoplasm of cerebral meninges fall on stairs or ladders in water transport injuring unspecified person hyperlipidemia, unspecified acute kidney failure, unspecified acidosis toxic encephalopathy other disorders resulting from impaired renal tubular function do not resuscitate localized edema personal history of malignant neoplasm of bladder other disorders of phosphorus metabolism paroxysmal atrial fibrillation diarrhea, unspecified chronic kidney disease, stage 3 (moderate) elevated white blood cell count, unspecified volume depletion, unspecified
white f 96 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  254  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  110  mg dl$sodium chloride 0.9%  flush  10  ml ; brimonidine tartrate 0.15% ophth.  1  drop ; atorvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  2  ml ; senna  8.6  mg ; docusate sodium  100  mg ; torsemide  20  mg ; mirtazapine  15  mg ; polyethylene glycol  17  g ; cefpodoxime proxetil  400  mg ; 
other fall from one level to another in water transport injuring occupant of other watercraft -- crew chronic kidney disease, stage 3 (moderate) hypomagnesemia left bundle-branch block, unspecified acute on chronic diastolic (congestive) heart failure hypokalemia hypo-osmolality and hyponatremia hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease major depressive disorder, single episode, unspecified toxic encephalopathy benign neoplasm of cerebral meninges insomnia, unspecified anemia, unspecified dysarthria and anarthria constipation, unspecified delusional disorders non-st elevation (nstemi) myocardial infarction urinary tract infection, site not specified suicidal ideations do not resuscitate acidosis personal history of malignant neoplasm of bladder hypokalemia hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease benign neoplasm of cerebral meninges fall on stairs or ladders in water transport injuring unspecified person hyperlipidemia, unspecified acute kidney failure, unspecified acidosis toxic encephalopathy other disorders resulting from impaired renal tubular function do not resuscitate localized edema personal history of malignant neoplasm of bladder other disorders of phosphorus metabolism paroxysmal atrial fibrillation diarrhea, unspecified chronic kidney disease, stage 3 (moderate) elevated white blood cell count, unspecified volume depletion, unspecified
white f 96 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood urea nitrogen  47  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  94  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  10  ml ; brimonidine tartrate 0.15% ophth.  1  drop ; atorvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  2  ml ; senna  8.6  mg ; docusate sodium  100  mg ; torsemide  20  mg ; mirtazapine  15  mg ; polyethylene glycol  17  g ; cefpodoxime proxetil  400  mg ; sodium chloride 0.9%  1000  ml ; 
other fall from one level to another in water transport injuring occupant of other watercraft -- crew chronic kidney disease, stage 3 (moderate) hypomagnesemia left bundle-branch block, unspecified acute on chronic diastolic (congestive) heart failure hypokalemia hypo-osmolality and hyponatremia hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease major depressive disorder, single episode, unspecified toxic encephalopathy benign neoplasm of cerebral meninges insomnia, unspecified anemia, unspecified dysarthria and anarthria constipation, unspecified delusional disorders non-st elevation (nstemi) myocardial infarction urinary tract infection, site not specified suicidal ideations do not resuscitate acidosis personal history of malignant neoplasm of bladder hypokalemia hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease benign neoplasm of cerebral meninges fall on stairs or ladders in water transport injuring unspecified person hyperlipidemia, unspecified acute kidney failure, unspecified acidosis toxic encephalopathy other disorders resulting from impaired renal tubular function do not resuscitate localized edema personal history of malignant neoplasm of bladder other disorders of phosphorus metabolism paroxysmal atrial fibrillation diarrhea, unspecified chronic kidney disease, stage 3 (moderate) elevated white blood cell count, unspecified volume depletion, unspecified
white f 96 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  10  ml ; brimonidine tartrate 0.15% ophth.  1  drop ; atorvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  2  ml ; senna  8.6  mg ; docusate sodium  100  mg ; torsemide  20  mg ; mirtazapine  15  mg ; polyethylene glycol  17  g ; cefpodoxime proxetil  400  mg ; sodium chloride 0.9%  1000  ml ; acetaminophen  1000  mg ; sodium bicarbonate  1300  mg ; 
other fall from one level to another in water transport injuring occupant of other watercraft -- crew chronic kidney disease, stage 3 (moderate) hypomagnesemia left bundle-branch block, unspecified acute on chronic diastolic (congestive) heart failure hypokalemia hypo-osmolality and hyponatremia hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease major depressive disorder, single episode, unspecified toxic encephalopathy benign neoplasm of cerebral meninges insomnia, unspecified anemia, unspecified dysarthria and anarthria constipation, unspecified delusional disorders non-st elevation (nstemi) myocardial infarction urinary tract infection, site not specified suicidal ideations do not resuscitate acidosis personal history of malignant neoplasm of bladder hypokalemia hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease benign neoplasm of cerebral meninges fall on stairs or ladders in water transport injuring unspecified person hyperlipidemia, unspecified acute kidney failure, unspecified acidosis toxic encephalopathy other disorders resulting from impaired renal tubular function do not resuscitate localized edema personal history of malignant neoplasm of bladder other disorders of phosphorus metabolism paroxysmal atrial fibrillation diarrhea, unspecified chronic kidney disease, stage 3 (moderate) elevated white blood cell count, unspecified volume depletion, unspecified
white f 96 $nan$nan$sodium chloride 0.9%  flush  10  ml ; brimonidine tartrate 0.15% ophth.  1  drop ; atorvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  2  ml ; senna  8.6  mg ; docusate sodium  100  mg ; torsemide  20  mg ; mirtazapine  15  mg ; polyethylene glycol  17  g ; cefpodoxime proxetil  400  mg ; sodium chloride 0.9%  1000  ml ; acetaminophen  1000  mg ; sodium bicarbonate  1300  mg ; 
other fall from one level to another in water transport injuring occupant of other watercraft -- crew chronic kidney disease, stage 3 (moderate) hypomagnesemia left bundle-branch block, unspecified acute on chronic diastolic (congestive) heart failure hypokalemia hypo-osmolality and hyponatremia hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease major depressive disorder, single episode, unspecified toxic encephalopathy benign neoplasm of cerebral meninges insomnia, unspecified anemia, unspecified dysarthria and anarthria constipation, unspecified delusional disorders non-st elevation (nstemi) myocardial infarction urinary tract infection, site not specified suicidal ideations do not resuscitate acidosis personal history of malignant neoplasm of bladder hypokalemia hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease benign neoplasm of cerebral meninges fall on stairs or ladders in water transport injuring unspecified person hyperlipidemia, unspecified acute kidney failure, unspecified acidosis toxic encephalopathy other disorders resulting from impaired renal tubular function do not resuscitate localized edema personal history of malignant neoplasm of bladder other disorders of phosphorus metabolism paroxysmal atrial fibrillation diarrhea, unspecified chronic kidney disease, stage 3 (moderate) elevated white blood cell count, unspecified volume depletion, unspecified
white f 70 $nan$nan$amlodipine  10  mg ; duloxetine  60  mg ; enalapril maleate  5  mg ; hydrochlorothiazide  25  mg ; 
fall on same level from slipping, tripping and stumbling without subsequent striking against object, initial encounter gastro-esophageal reflux disease without esophagitis bipolar disorder, unspecified other fracture of shaft of right fibula, initial encounter for closed fracture other specified places as the place of occurrence of the external cause essential (primary) hypertension obstructive sleep apnea (adult) (pediatric) presence of right artificial knee joint displaced trimalleolar fracture of right lower leg, initial encounter for closed fracture 
white f 70 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  89  mg dl$amlodipine  10  mg ; duloxetine  60  mg ; enalapril maleate  5  mg ; hydrochlorothiazide  25  mg ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)  2.5-5  mg ; acetaminophen  650  mg ; morphine sulfate  1-2  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; omeprazole  20  mg ; trazodone  50  mg ; enoxaparin sodium  40  mg ; docusate sodium  100  mg ; senna  8.6  mg ; risperidone  2  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; oxycodone (immediate release)  5-7.5  mg ; potassium chloride  40  meq ; magnesium oxide  400  mg ; 
fall on same level from slipping, tripping and stumbling without subsequent striking against object, initial encounter gastro-esophageal reflux disease without esophagitis bipolar disorder, unspecified other fracture of shaft of right fibula, initial encounter for closed fracture other specified places as the place of occurrence of the external cause essential (primary) hypertension obstructive sleep apnea (adult) (pediatric) presence of right artificial knee joint displaced trimalleolar fracture of right lower leg, initial encounter for closed fracture 
white f 70 $nan$nan$amlodipine  10  mg ; duloxetine  60  mg ; enalapril maleate  5  mg ; hydrochlorothiazide  25  mg ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; acetaminophen  650  mg ; morphine sulfate  1-2  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; omeprazole  20  mg ; trazodone  50  mg ; enoxaparin sodium  40  mg ; docusate sodium  100  mg ; senna  8.6  mg ; risperidone  2  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; oxycodone (immediate release)  5-7.5  mg ; potassium chloride  40  meq ; magnesium oxide  400  mg ; 
fall on same level from slipping, tripping and stumbling without subsequent striking against object, initial encounter gastro-esophageal reflux disease without esophagitis bipolar disorder, unspecified other fracture of shaft of right fibula, initial encounter for closed fracture other specified places as the place of occurrence of the external cause essential (primary) hypertension obstructive sleep apnea (adult) (pediatric) presence of right artificial knee joint displaced trimalleolar fracture of right lower leg, initial encounter for closed fracture 
white m 78 $nan$nan$erythromycin  500  mg ; neomycin sulfate  500  mg ; 
 
white m 78 $nan$nan$erythromycin  500  mg ; neomycin sulfate  500  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; metoprolol  5  mg ; lidocaine viscous 2%  20  ml ; heparin flush cvl  (100 units ml)  1  ml ; morphine sulfate  2  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; lr  1000  ml ; 
 
white m 78 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol  5  mg ; lidocaine viscous 2%  20  ml ; heparin flush cvl  (100 units ml)  1  ml ; morphine sulfate  2  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; lr  1000  ml ; insulin  0  unit ; heparin  5000  unit ; magnesium sulfate  2  gm ; d5w  250  ml ; ciprofloxacin  400  mg ; 
 
white m 78 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lidocaine viscous 2%  20  ml ; heparin flush cvl  (100 units ml)  1  ml ; morphine sulfate  2  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; lr  1000  ml ; insulin  0  unit ; heparin  5000  unit ; magnesium sulfate  2  gm ; d5w  250  ml ; ciprofloxacin  400  mg ; metoprolol  10  mg ; valsartan  160  mg ; 
 
white m 78 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lidocaine viscous 2%  20  ml ; heparin flush cvl  (100 units ml)  1  ml ; morphine sulfate  2  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; lr  1000  ml ; insulin  0  unit ; heparin  5000  unit ; d5w  250  ml ; ciprofloxacin  400  mg ; metoprolol  10  mg ; valsartan  160  mg ; 
 
white m 78 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lidocaine viscous 2%  20  ml ; heparin flush cvl  (100 units ml)  1  ml ; morphine sulfate  2  mg ; vial  1  vial ; pantoprazole sodium  40  mg ; insulin  0  unit ; heparin  5000  unit ; d5w  250  ml ; ciprofloxacin  400  mg ; metoprolol  10  mg ; valsartan  160  mg ; metoprolol  25  mg ; tamsulosin  0.4  mg ; hydrocodone-acetaminophen  1-2  tab ; rosuvastatin calcium  40  mg ; valsartan  320  mg ; 
 
white m 78 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lidocaine viscous 2%  20  ml ; heparin flush cvl  (100 units ml)  1  ml ; insulin  0  unit ; heparin  5000  unit ; tamsulosin  0.4  mg ; hydrocodone-acetaminophen  1-2  tab ; rosuvastatin calcium  40  mg ; valsartan  320  mg ; sw  50  ml ; isosorbide mononitrate (extended release)  60  mg ; furosemide  5  mg ; metoclopramide  2.5  mg ; pneumococcal vac polyvalent  0.5  ml ; 
 
white m 78 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lidocaine viscous 2%  20  ml ; heparin flush cvl  (100 units ml)  1  ml ; heparin  5000  unit ; tamsulosin  0.4  mg ; hydrocodone-acetaminophen  1-2  tab ; rosuvastatin calcium  40  mg ; valsartan  320  mg ; isosorbide mononitrate (extended release)  60  mg ; metoclopramide  2.5  mg ; pneumococcal vac polyvalent  0.5  ml ; ferrous sulfate  325  mg ; 
 
white m 78 $nan$nan$heparin  5000  unit ; tamsulosin  0.4  mg ; hydrocodone-acetaminophen  1-2  tab ; rosuvastatin calcium  40  mg ; valsartan  320  mg ; isosorbide mononitrate (extended release)  60  mg ; metoclopramide  2.5  mg ; pneumococcal vac polyvalent  0.5  ml ; ferrous sulfate  325  mg ; 
 
white f 65 $temp  102.6  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    $nan$simvastatin  20  mg ; lanthanum  500  mg ; 
 
white f 65 $temp  102.0  heartrate  98.0  resprate  18.0  o2sat  96.0  sbp  144.0  dbp  68.0  rhythm    pain  2 10  $hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  5.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  92  mg dl; chemistry blood albumin  3.5  g dl$simvastatin  20  mg ; lanthanum  500  mg ; heparin  5000  unit ; docusate sodium  100  mg ; acetaminophen  650  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; lorazepam  1  mg ; acetaminophen  325-650  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride  50  ml ; cefepime  500  mg ; levothyroxine sodium  112  mcg ; omeprazole  40  mg ; amlodipine  2.5  mg ; 
 
white f 65 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  6.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  89  mg dl$amlodipine  2.5  mg ; metoprolol tartrate  25  mg ; lorazepam  0.5  mg ; iso-osmotic dextrose  100  ml ; nafcillin  2  g ; 
 
white f 65 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  7.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine creatinine, urine  41  mg dl; chemistry blood glucose  81  mg dl; chemistry urine 24 hr creatinine  513  mg 24hr$amlodipine  2.5  mg ; metoprolol tartrate  25  mg ; lorazepam  0.5  mg ; iso-osmotic dextrose  100  ml ; nafcillin  2  g ; 0.9% sodium chloride  250  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; heparin dwell (1000 units ml)  2000-8000  unit ; 
 
white f 65 $nan$nan$lorazepam  0.5  mg ; 0.9% sodium chloride  250  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; heparin dwell (1000 units ml)  2000-8000  unit ; 
 
black african american f 57 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  198  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  125  mg dl$albumin 5% (25g   500ml)  25  g ; yellow cadd cassette  1  cadd ; bupivacaine 0.1%  250  ml ; albuterol inhaler  2  puff ; amitriptyline  50  mg ; diazepam  5  mg ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; ondansetron  8  mg ; pregabalin  25  mg ; pregabalin  75  mg ; tiotropium bromide  1  cap ; tizanidine  2  mg ; torsemide  20  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  8.6  mg ; bisacodyl  10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; hydromorphone (dilaudid)  20  mg ; omeprazole  40  mg ; ranitidine  300  mg ; trazodone  200  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; sildenafil  60  mg ; sodium chloride nasal  1-2  spry ; oxycodone (immediate release)   5  mg ; 
congestive heart failure, unspecified chronic diastolic heart failure other dependence on machines, supplemental oxygen family history of ischemic heart disease other chronic pain person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident mononeuritis of lower limb, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other chronic pulmonary heart diseases chronic airway obstruction, not elsewhere classified tobacco use disorder cough osteoarthrosis, unspecified whether generalized or localized, site unspecified esophageal reflux esophageal reflux insomnia, unspecified chronic airway obstruction, not elsewhere classified other affections of shoulder region, not elsewhere classified other, mixed, or unspecified drug abuse, unspecified chronic pain syndrome other chest pain long-term (current) use of other medications chronic obstructive asthma, unspecified eosinophilia cocaine abuse, unspecified depressive disorder, not elsewhere classified rheumatoid arthritis acute on chronic diastolic heart failure other specified cardiac dysrhythmias unspecified essential hypertension mononeuritis of lower limb, unspecified alcoholic cirrhosis of liver other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen insomnia, unspecified other and unspecified alcohol dependence, unspecified backache, unspecified other chronic pain constipation, unspecified congestive heart failure, unspecified other diseases of lung, not elsewhere classified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other chest pain other chronic pulmonary heart diseases other secondary thrombocytopenia chronic diastolic heart failure chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction backache, unspecified
black african american f 57 $nan$hematology blood hematocrit  33.2  %; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood glucose  133  mg dl$albumin 5% (25g   500ml)  25  g ; yellow cadd cassette  1  cadd ; bupivacaine 0.1%  250  ml ; albuterol inhaler  2  puff ; amitriptyline  50  mg ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; pregabalin  25  mg ; pregabalin  75  mg ; tiotropium bromide  1  cap ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  8.6  mg ; bisacodyl  10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; hydromorphone (dilaudid)  20  mg ; omeprazole  40  mg ; ranitidine  300  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; sildenafil  60  mg ; sodium chloride nasal  1-2  spry ; oxycodone (immediate release)   5  mg ; ondansetron  4-8  mg ; oxycodone (immediate release)   5-10  mg ; morphine sulfate  2-6  mg ; hydromorphone (dilaudid)  1  mg ; sodium chloride 0.9%  1000  ml ; 
congestive heart failure, unspecified chronic diastolic heart failure other dependence on machines, supplemental oxygen family history of ischemic heart disease other chronic pain person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident mononeuritis of lower limb, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other chronic pulmonary heart diseases chronic airway obstruction, not elsewhere classified tobacco use disorder cough osteoarthrosis, unspecified whether generalized or localized, site unspecified esophageal reflux esophageal reflux insomnia, unspecified chronic airway obstruction, not elsewhere classified other affections of shoulder region, not elsewhere classified other, mixed, or unspecified drug abuse, unspecified chronic pain syndrome other chest pain long-term (current) use of other medications chronic obstructive asthma, unspecified eosinophilia cocaine abuse, unspecified depressive disorder, not elsewhere classified rheumatoid arthritis acute on chronic diastolic heart failure other specified cardiac dysrhythmias unspecified essential hypertension mononeuritis of lower limb, unspecified alcoholic cirrhosis of liver other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen insomnia, unspecified other and unspecified alcohol dependence, unspecified backache, unspecified other chronic pain constipation, unspecified congestive heart failure, unspecified other diseases of lung, not elsewhere classified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other chest pain other chronic pulmonary heart diseases other secondary thrombocytopenia chronic diastolic heart failure chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction backache, unspecified
black african american f 57 $nan$hematology blood hematocrit  29.8  %; hematology blood hematocrit  28.9  %; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  163  k ul; hematology blood platelet count  142  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry urine chloride, urine  95  meq l; chemistry urine creatinine, urine  17  mg dl; chemistry urine potassium, urine  20  meq l; chemistry urine sodium, urine  84  meq l; chemistry urine urea nitrogen, urine  116  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  98  mg dl; chemistry blood glucose  91  mg dl$albuterol inhaler  2  puff ; amitriptyline  50  mg ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; pregabalin  25  mg ; pregabalin  75  mg ; tiotropium bromide  1  cap ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  8.6  mg ; bisacodyl  10  mg ; omeprazole  40  mg ; ranitidine  300  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; sildenafil  60  mg ; sodium chloride nasal  1-2  spry ; ondansetron  4-8  mg ; oxycodone (immediate release)   5-10  mg ; morphine sulfate  2-6  mg ; hydromorphone (dilaudid)  1  mg ; sodium chloride 0.9%  1000  ml ; bag  1  bag ; magnesium sulfate  2  gm ; torsemide  40  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; 
congestive heart failure, unspecified chronic diastolic heart failure other dependence on machines, supplemental oxygen family history of ischemic heart disease other chronic pain person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident mononeuritis of lower limb, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other chronic pulmonary heart diseases chronic airway obstruction, not elsewhere classified tobacco use disorder cough osteoarthrosis, unspecified whether generalized or localized, site unspecified esophageal reflux esophageal reflux insomnia, unspecified chronic airway obstruction, not elsewhere classified other affections of shoulder region, not elsewhere classified other, mixed, or unspecified drug abuse, unspecified chronic pain syndrome other chest pain long-term (current) use of other medications chronic obstructive asthma, unspecified eosinophilia cocaine abuse, unspecified depressive disorder, not elsewhere classified rheumatoid arthritis acute on chronic diastolic heart failure other specified cardiac dysrhythmias unspecified essential hypertension mononeuritis of lower limb, unspecified alcoholic cirrhosis of liver other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen insomnia, unspecified other and unspecified alcohol dependence, unspecified backache, unspecified other chronic pain constipation, unspecified congestive heart failure, unspecified other diseases of lung, not elsewhere classified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other chest pain other chronic pulmonary heart diseases other secondary thrombocytopenia chronic diastolic heart failure chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction backache, unspecified
black african american f 57 $nan$hematology blood hematocrit  30.7  %; hematology blood hematocrit  25.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  157  k ul; hematology blood platelet count  176  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  74  mg dl$albuterol inhaler  2  puff ; amitriptyline  50  mg ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; pregabalin  25  mg ; pregabalin  75  mg ; tiotropium bromide  1  cap ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  8.6  mg ; bisacodyl  10  mg ; omeprazole  40  mg ; ranitidine  300  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; sildenafil  60  mg ; sodium chloride nasal  1-2  spry ; ondansetron  4-8  mg ; oxycodone (immediate release)   5-10  mg ; morphine sulfate  2-6  mg ; trazodone  100-200  mg ; 
congestive heart failure, unspecified chronic diastolic heart failure other dependence on machines, supplemental oxygen family history of ischemic heart disease other chronic pain person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident mononeuritis of lower limb, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other chronic pulmonary heart diseases chronic airway obstruction, not elsewhere classified tobacco use disorder cough osteoarthrosis, unspecified whether generalized or localized, site unspecified esophageal reflux esophageal reflux insomnia, unspecified chronic airway obstruction, not elsewhere classified other affections of shoulder region, not elsewhere classified other, mixed, or unspecified drug abuse, unspecified chronic pain syndrome other chest pain long-term (current) use of other medications chronic obstructive asthma, unspecified eosinophilia cocaine abuse, unspecified depressive disorder, not elsewhere classified rheumatoid arthritis acute on chronic diastolic heart failure other specified cardiac dysrhythmias unspecified essential hypertension mononeuritis of lower limb, unspecified alcoholic cirrhosis of liver other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen insomnia, unspecified other and unspecified alcohol dependence, unspecified backache, unspecified other chronic pain constipation, unspecified congestive heart failure, unspecified other diseases of lung, not elsewhere classified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other chest pain other chronic pulmonary heart diseases other secondary thrombocytopenia chronic diastolic heart failure chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction backache, unspecified
black african american f 57 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  113  mg dl$albuterol inhaler  2  puff ; amitriptyline  50  mg ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; pregabalin  25  mg ; pregabalin  75  mg ; tiotropium bromide  1  cap ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  8.6  mg ; bisacodyl  10  mg ; omeprazole  40  mg ; ranitidine  300  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; sodium chloride nasal  1-2  spry ; ondansetron  4-8  mg ; oxycodone (immediate release)   5-10  mg ; morphine sulfate  2-6  mg ; trazodone  100-200  mg ; sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)   5-15  mg ; 
congestive heart failure, unspecified chronic diastolic heart failure other dependence on machines, supplemental oxygen family history of ischemic heart disease other chronic pain person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident mononeuritis of lower limb, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other chronic pulmonary heart diseases chronic airway obstruction, not elsewhere classified tobacco use disorder cough osteoarthrosis, unspecified whether generalized or localized, site unspecified esophageal reflux esophageal reflux insomnia, unspecified chronic airway obstruction, not elsewhere classified other affections of shoulder region, not elsewhere classified other, mixed, or unspecified drug abuse, unspecified chronic pain syndrome other chest pain long-term (current) use of other medications chronic obstructive asthma, unspecified eosinophilia cocaine abuse, unspecified depressive disorder, not elsewhere classified rheumatoid arthritis acute on chronic diastolic heart failure other specified cardiac dysrhythmias unspecified essential hypertension mononeuritis of lower limb, unspecified alcoholic cirrhosis of liver other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen insomnia, unspecified other and unspecified alcohol dependence, unspecified backache, unspecified other chronic pain constipation, unspecified congestive heart failure, unspecified other diseases of lung, not elsewhere classified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other chest pain other chronic pulmonary heart diseases other secondary thrombocytopenia chronic diastolic heart failure chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction backache, unspecified
black african american f 57 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  86  mg dl$albuterol inhaler  2  puff ; amitriptyline  50  mg ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; pregabalin  25  mg ; pregabalin  75  mg ; tiotropium bromide  1  cap ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; senna  8.6  mg ; bisacodyl  10  mg ; omeprazole  40  mg ; ranitidine  300  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; sodium chloride nasal  1-2  spry ; ondansetron  4-8  mg ; morphine sulfate  2-6  mg ; trazodone  100-200  mg ; sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)   5-15  mg ; ferrous sulfate  325  mg ; 
congestive heart failure, unspecified chronic diastolic heart failure other dependence on machines, supplemental oxygen family history of ischemic heart disease other chronic pain person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident mononeuritis of lower limb, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other chronic pulmonary heart diseases chronic airway obstruction, not elsewhere classified tobacco use disorder cough osteoarthrosis, unspecified whether generalized or localized, site unspecified esophageal reflux esophageal reflux insomnia, unspecified chronic airway obstruction, not elsewhere classified other affections of shoulder region, not elsewhere classified other, mixed, or unspecified drug abuse, unspecified chronic pain syndrome other chest pain long-term (current) use of other medications chronic obstructive asthma, unspecified eosinophilia cocaine abuse, unspecified depressive disorder, not elsewhere classified rheumatoid arthritis acute on chronic diastolic heart failure other specified cardiac dysrhythmias unspecified essential hypertension mononeuritis of lower limb, unspecified alcoholic cirrhosis of liver other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen insomnia, unspecified other and unspecified alcohol dependence, unspecified backache, unspecified other chronic pain constipation, unspecified congestive heart failure, unspecified other diseases of lung, not elsewhere classified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other chest pain other chronic pulmonary heart diseases other secondary thrombocytopenia chronic diastolic heart failure chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction backache, unspecified
black african american f 57 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  218  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood glucose  106  mg dl$albuterol inhaler  2  puff ; amitriptyline  50  mg ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; pregabalin  25  mg ; pregabalin  75  mg ; tiotropium bromide  1  cap ; acetaminophen  650  mg ; senna  8.6  mg ; bisacodyl  10  mg ; omeprazole  40  mg ; ranitidine  300  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; sodium chloride nasal  1-2  spry ; ondansetron  4-8  mg ; morphine sulfate  2-6  mg ; trazodone  100-200  mg ; sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)   5-15  mg ; potassium chloride  40  meq ; 
congestive heart failure, unspecified chronic diastolic heart failure other dependence on machines, supplemental oxygen family history of ischemic heart disease other chronic pain person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident mononeuritis of lower limb, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other chronic pulmonary heart diseases chronic airway obstruction, not elsewhere classified tobacco use disorder cough osteoarthrosis, unspecified whether generalized or localized, site unspecified esophageal reflux esophageal reflux insomnia, unspecified chronic airway obstruction, not elsewhere classified other affections of shoulder region, not elsewhere classified other, mixed, or unspecified drug abuse, unspecified chronic pain syndrome other chest pain long-term (current) use of other medications chronic obstructive asthma, unspecified eosinophilia cocaine abuse, unspecified depressive disorder, not elsewhere classified rheumatoid arthritis acute on chronic diastolic heart failure other specified cardiac dysrhythmias unspecified essential hypertension mononeuritis of lower limb, unspecified alcoholic cirrhosis of liver other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen insomnia, unspecified other and unspecified alcohol dependence, unspecified backache, unspecified other chronic pain constipation, unspecified congestive heart failure, unspecified other diseases of lung, not elsewhere classified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other chest pain other chronic pulmonary heart diseases other secondary thrombocytopenia chronic diastolic heart failure chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction backache, unspecified
black african american f 57 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood glucose  106  mg dl$albuterol inhaler  2  puff ; amitriptyline  50  mg ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; pregabalin  25  mg ; pregabalin  75  mg ; tiotropium bromide  1  cap ; acetaminophen  650  mg ; senna  8.6  mg ; bisacodyl  10  mg ; omeprazole  40  mg ; ranitidine  300  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; sodium chloride nasal  1-2  spry ; ondansetron  4-8  mg ; morphine sulfate  2-6  mg ; trazodone  100-200  mg ; sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)   5-15  mg ; potassium chloride  40  meq ; 
congestive heart failure, unspecified chronic diastolic heart failure other dependence on machines, supplemental oxygen family history of ischemic heart disease other chronic pain person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident mononeuritis of lower limb, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other chronic pulmonary heart diseases chronic airway obstruction, not elsewhere classified tobacco use disorder cough osteoarthrosis, unspecified whether generalized or localized, site unspecified esophageal reflux esophageal reflux insomnia, unspecified chronic airway obstruction, not elsewhere classified other affections of shoulder region, not elsewhere classified other, mixed, or unspecified drug abuse, unspecified chronic pain syndrome other chest pain long-term (current) use of other medications chronic obstructive asthma, unspecified eosinophilia cocaine abuse, unspecified depressive disorder, not elsewhere classified rheumatoid arthritis acute on chronic diastolic heart failure other specified cardiac dysrhythmias unspecified essential hypertension mononeuritis of lower limb, unspecified alcoholic cirrhosis of liver other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen insomnia, unspecified other and unspecified alcohol dependence, unspecified backache, unspecified other chronic pain constipation, unspecified congestive heart failure, unspecified other diseases of lung, not elsewhere classified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other chest pain other chronic pulmonary heart diseases other secondary thrombocytopenia chronic diastolic heart failure chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction backache, unspecified
black african american f 57 $nan$nan$albuterol inhaler  2  puff ; amitriptyline  50  mg ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; pregabalin  25  mg ; pregabalin  75  mg ; tiotropium bromide  1  cap ; acetaminophen  650  mg ; senna  8.6  mg ; bisacodyl  10  mg ; omeprazole  40  mg ; ranitidine  300  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; sodium chloride nasal  1-2  spry ; ondansetron  4-8  mg ; morphine sulfate  2-6  mg ; trazodone  100-200  mg ; sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)   5-15  mg ; 
congestive heart failure, unspecified chronic diastolic heart failure other dependence on machines, supplemental oxygen family history of ischemic heart disease other chronic pain person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident mononeuritis of lower limb, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other chronic pulmonary heart diseases chronic airway obstruction, not elsewhere classified tobacco use disorder cough osteoarthrosis, unspecified whether generalized or localized, site unspecified esophageal reflux esophageal reflux insomnia, unspecified chronic airway obstruction, not elsewhere classified other affections of shoulder region, not elsewhere classified other, mixed, or unspecified drug abuse, unspecified chronic pain syndrome other chest pain long-term (current) use of other medications chronic obstructive asthma, unspecified eosinophilia cocaine abuse, unspecified depressive disorder, not elsewhere classified rheumatoid arthritis acute on chronic diastolic heart failure other specified cardiac dysrhythmias unspecified essential hypertension mononeuritis of lower limb, unspecified alcoholic cirrhosis of liver other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen insomnia, unspecified other and unspecified alcohol dependence, unspecified backache, unspecified other chronic pain constipation, unspecified congestive heart failure, unspecified other diseases of lung, not elsewhere classified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other chest pain other chronic pulmonary heart diseases other secondary thrombocytopenia chronic diastolic heart failure chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction backache, unspecified
black african american f 57 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  369  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  15  mg dl; hematology urine wbc  1  # hpf; chemistry blood glucose  101  mg dl$albuterol inhaler  2  puff ; amitriptyline  50  mg ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; pregabalin  25  mg ; pregabalin  75  mg ; tiotropium bromide  1  cap ; acetaminophen  650  mg ; senna  8.6  mg ; bisacodyl  10  mg ; omeprazole  40  mg ; ranitidine  300  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; sodium chloride nasal  1-2  spry ; ondansetron  4-8  mg ; morphine sulfate  2-6  mg ; trazodone  100-200  mg ; sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)   5-15  mg ; 
congestive heart failure, unspecified chronic diastolic heart failure other dependence on machines, supplemental oxygen family history of ischemic heart disease other chronic pain person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident mononeuritis of lower limb, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other chronic pulmonary heart diseases chronic airway obstruction, not elsewhere classified tobacco use disorder cough osteoarthrosis, unspecified whether generalized or localized, site unspecified esophageal reflux esophageal reflux insomnia, unspecified chronic airway obstruction, not elsewhere classified other affections of shoulder region, not elsewhere classified other, mixed, or unspecified drug abuse, unspecified chronic pain syndrome other chest pain long-term (current) use of other medications chronic obstructive asthma, unspecified eosinophilia cocaine abuse, unspecified depressive disorder, not elsewhere classified rheumatoid arthritis acute on chronic diastolic heart failure other specified cardiac dysrhythmias unspecified essential hypertension mononeuritis of lower limb, unspecified alcoholic cirrhosis of liver other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen insomnia, unspecified other and unspecified alcohol dependence, unspecified backache, unspecified other chronic pain constipation, unspecified congestive heart failure, unspecified other diseases of lung, not elsewhere classified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other chest pain other chronic pulmonary heart diseases other secondary thrombocytopenia chronic diastolic heart failure chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction backache, unspecified
black african american f 57 $nan$hematology blood hematocrit  30.3  %; hematology blood hematocrit  30.7  %; hematology blood hemoglobin  9.7  g dl; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  418  k ul; hematology blood platelet count  457  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  15  mg dl; chemistry blood glucose  121  mg dl; chemistry blood glucose  101  mg dl$albuterol inhaler  2  puff ; amitriptyline  50  mg ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; pregabalin  25  mg ; pregabalin  75  mg ; tiotropium bromide  1  cap ; acetaminophen  650  mg ; senna  8.6  mg ; bisacodyl  10  mg ; omeprazole  40  mg ; ranitidine  300  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; sodium chloride nasal  1-2  spry ; ondansetron  4-8  mg ; morphine sulfate  2-6  mg ; trazodone  100-200  mg ; sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)   5-15  mg ; 
congestive heart failure, unspecified chronic diastolic heart failure other dependence on machines, supplemental oxygen family history of ischemic heart disease other chronic pain person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident mononeuritis of lower limb, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other chronic pulmonary heart diseases chronic airway obstruction, not elsewhere classified tobacco use disorder cough osteoarthrosis, unspecified whether generalized or localized, site unspecified esophageal reflux esophageal reflux insomnia, unspecified chronic airway obstruction, not elsewhere classified other affections of shoulder region, not elsewhere classified other, mixed, or unspecified drug abuse, unspecified chronic pain syndrome other chest pain long-term (current) use of other medications chronic obstructive asthma, unspecified eosinophilia cocaine abuse, unspecified depressive disorder, not elsewhere classified rheumatoid arthritis acute on chronic diastolic heart failure other specified cardiac dysrhythmias unspecified essential hypertension mononeuritis of lower limb, unspecified alcoholic cirrhosis of liver other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen insomnia, unspecified other and unspecified alcohol dependence, unspecified backache, unspecified other chronic pain constipation, unspecified congestive heart failure, unspecified other diseases of lung, not elsewhere classified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other chest pain other chronic pulmonary heart diseases other secondary thrombocytopenia chronic diastolic heart failure chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction backache, unspecified
black african american f 57 $nan$nan$amitriptyline  50  mg ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; pregabalin  25  mg ; pregabalin  75  mg ; tiotropium bromide  1  cap ; acetaminophen  650  mg ; senna  8.6  mg ; bisacodyl  10  mg ; omeprazole  40  mg ; ranitidine  300  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; sodium chloride nasal  1-2  spry ; ondansetron  4-8  mg ; morphine sulfate  2-6  mg ; trazodone  100-200  mg ; sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)   5-15  mg ; 
congestive heart failure, unspecified chronic diastolic heart failure other dependence on machines, supplemental oxygen family history of ischemic heart disease other chronic pain person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident mononeuritis of lower limb, unspecified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other chronic pulmonary heart diseases chronic airway obstruction, not elsewhere classified tobacco use disorder cough osteoarthrosis, unspecified whether generalized or localized, site unspecified esophageal reflux esophageal reflux insomnia, unspecified chronic airway obstruction, not elsewhere classified other affections of shoulder region, not elsewhere classified other, mixed, or unspecified drug abuse, unspecified chronic pain syndrome other chest pain long-term (current) use of other medications chronic obstructive asthma, unspecified eosinophilia cocaine abuse, unspecified depressive disorder, not elsewhere classified rheumatoid arthritis acute on chronic diastolic heart failure other specified cardiac dysrhythmias unspecified essential hypertension mononeuritis of lower limb, unspecified alcoholic cirrhosis of liver other chronic pulmonary heart diseases other dependence on machines, supplemental oxygen insomnia, unspecified other and unspecified alcohol dependence, unspecified backache, unspecified other chronic pain constipation, unspecified congestive heart failure, unspecified other diseases of lung, not elsewhere classified person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other chest pain other chronic pulmonary heart diseases other secondary thrombocytopenia chronic diastolic heart failure chronic peptic ulcer of unspecified site without mention of hemorrhage or perforation, without mention of obstruction backache, unspecified
white f 83 $temp    heartrate  69.0  resprate    o2sat    sbp  114.0  dbp  52.0  rhythm    pain    ; temp  98.1  heartrate  69.0  resprate  17.0  o2sat  100.0  sbp  124.0  dbp  58.0  rhythm    pain    $nan$aspirin  81  mg ; multivitamins  1  tab ; simvastatin  40  mg ; venlafaxine xr  225  mg ; 
epilepsy, unspecified, without mention of intractable epilepsy atrial fibrillation other and unspecified hyperlipidemia person boarding or alighting a pedal cycle injured in collision with pedestrian or animal obstructive sleep apnea (adult)(pediatric) malignant neoplasm of bronchus and lung, unspecified osteoporosis, unspecified other iatrogenic hypotension anxiety state, unspecified esophageal reflux other ill-defined heart diseases hyperpotassemia disorders of pneumogastric [10th] nerve other isolated or specific phobias personal history of malignant neoplasm of breast personal history of tobacco use unspecified essential hypertension benign paroxysmal positional vertigo depressive disorder, not elsewhere classified coronary atherosclerosis of native coronary artery personal history of malignant neoplasm of bronchus and lung personal history of malignant neoplasm of breast unspecified essential hypertension palpitations chest pain, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal bacterial pneumonia, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal long-term (current) use of anticoagulants other emphysema benign essential hypertension person on outside of bus injured in collision with pedestrian or animal in traffic accident other ill-defined heart diseases contact dermatitis and other eczema, unspecified cause examination of participant in clinical trial personal history of malignant neoplasm of breast personal history of tobacco use malignant neoplasm of bronchus and lung, unspecified epilepsy, unspecified, without mention of intractable epilepsy person boarding or alighting a pedal cycle injured in collision with pedestrian or animal coronary atherosclerosis of native coronary artery malignant neoplasm of upper lobe, bronchus or lung epilepsy, unspecified, without mention of intractable epilepsy personal history of malignant neoplasm of bronchus and lung personal history of malignant neoplasm of breast personal history of tobacco use other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified essential hypertension
white f 83 $temp    heartrate  66.0  resprate  17.0  o2sat  100.0  sbp  123.0  dbp  57.0  rhythm    pain    ; temp  97.9  heartrate  69.0  resprate  16.0  o2sat  100.0  sbp  109.0  dbp  46.0  rhythm    pain  0  $hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  385  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  117  mg dl$aspirin  81  mg ; multivitamins  1  tab ; simvastatin  40  mg ; venlafaxine xr  225  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; lorazepam  0.5  mg ; quetiapine fumarate  25  mg ; warfarin  4  mg ; metoprolol tartrate  25  mg ; ondansetron  4  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; ipratropium bromide neb  1  neb ; meclizine  12.5  mg ; guaifenesin-codeine phosphate  5-10  ml ; sodium chloride nasal  1-2  spry ; benzonatate  100  mg ; phenytoin sodium extended  100  mg ; heparin  3800  unit ; heparin  900-1900  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; trazodone  25  mg ; metoprolol tartrate  12.5  mg ; metoprolol succinate xl  75  mg ; 
epilepsy, unspecified, without mention of intractable epilepsy atrial fibrillation other and unspecified hyperlipidemia person boarding or alighting a pedal cycle injured in collision with pedestrian or animal obstructive sleep apnea (adult)(pediatric) malignant neoplasm of bronchus and lung, unspecified osteoporosis, unspecified other iatrogenic hypotension anxiety state, unspecified esophageal reflux other ill-defined heart diseases hyperpotassemia disorders of pneumogastric [10th] nerve other isolated or specific phobias personal history of malignant neoplasm of breast personal history of tobacco use unspecified essential hypertension benign paroxysmal positional vertigo depressive disorder, not elsewhere classified coronary atherosclerosis of native coronary artery personal history of malignant neoplasm of bronchus and lung personal history of malignant neoplasm of breast unspecified essential hypertension palpitations chest pain, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal bacterial pneumonia, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal long-term (current) use of anticoagulants other emphysema benign essential hypertension person on outside of bus injured in collision with pedestrian or animal in traffic accident other ill-defined heart diseases contact dermatitis and other eczema, unspecified cause examination of participant in clinical trial personal history of malignant neoplasm of breast personal history of tobacco use malignant neoplasm of bronchus and lung, unspecified epilepsy, unspecified, without mention of intractable epilepsy person boarding or alighting a pedal cycle injured in collision with pedestrian or animal coronary atherosclerosis of native coronary artery malignant neoplasm of upper lobe, bronchus or lung epilepsy, unspecified, without mention of intractable epilepsy personal history of malignant neoplasm of bronchus and lung personal history of malignant neoplasm of breast personal history of tobacco use other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified essential hypertension
white f 83 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  394  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  6.1  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  104  mg dl$aspirin  81  mg ; multivitamins  1  tab ; simvastatin  40  mg ; venlafaxine xr  225  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; warfarin  4  mg ; ondansetron  4  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; ipratropium bromide neb  1  neb ; meclizine  12.5  mg ; guaifenesin-codeine phosphate  5-10  ml ; sodium chloride nasal  1-2  spry ; benzonatate  100  mg ; phenytoin sodium extended  100  mg ; trazodone  25  mg ; metoprolol succinate xl  75  mg ; warfarin  3  mg ; 
epilepsy, unspecified, without mention of intractable epilepsy atrial fibrillation other and unspecified hyperlipidemia person boarding or alighting a pedal cycle injured in collision with pedestrian or animal obstructive sleep apnea (adult)(pediatric) malignant neoplasm of bronchus and lung, unspecified osteoporosis, unspecified other iatrogenic hypotension anxiety state, unspecified esophageal reflux other ill-defined heart diseases hyperpotassemia disorders of pneumogastric [10th] nerve other isolated or specific phobias personal history of malignant neoplasm of breast personal history of tobacco use unspecified essential hypertension benign paroxysmal positional vertigo depressive disorder, not elsewhere classified coronary atherosclerosis of native coronary artery personal history of malignant neoplasm of bronchus and lung personal history of malignant neoplasm of breast unspecified essential hypertension palpitations chest pain, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal bacterial pneumonia, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal long-term (current) use of anticoagulants other emphysema benign essential hypertension person on outside of bus injured in collision with pedestrian or animal in traffic accident other ill-defined heart diseases contact dermatitis and other eczema, unspecified cause examination of participant in clinical trial personal history of malignant neoplasm of breast personal history of tobacco use malignant neoplasm of bronchus and lung, unspecified epilepsy, unspecified, without mention of intractable epilepsy person boarding or alighting a pedal cycle injured in collision with pedestrian or animal coronary atherosclerosis of native coronary artery malignant neoplasm of upper lobe, bronchus or lung epilepsy, unspecified, without mention of intractable epilepsy personal history of malignant neoplasm of bronchus and lung personal history of malignant neoplasm of breast personal history of tobacco use other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified essential hypertension
white f 83 $nan$nan$aspirin  81  mg ; multivitamins  1  tab ; simvastatin  40  mg ; venlafaxine xr  225  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; ipratropium bromide neb  1  neb ; meclizine  12.5  mg ; guaifenesin-codeine phosphate  5-10  ml ; sodium chloride nasal  1-2  spry ; benzonatate  100  mg ; phenytoin sodium extended  100  mg ; trazodone  25  mg ; warfarin  3  mg ; 
epilepsy, unspecified, without mention of intractable epilepsy atrial fibrillation other and unspecified hyperlipidemia person boarding or alighting a pedal cycle injured in collision with pedestrian or animal obstructive sleep apnea (adult)(pediatric) malignant neoplasm of bronchus and lung, unspecified osteoporosis, unspecified other iatrogenic hypotension anxiety state, unspecified esophageal reflux other ill-defined heart diseases hyperpotassemia disorders of pneumogastric [10th] nerve other isolated or specific phobias personal history of malignant neoplasm of breast personal history of tobacco use unspecified essential hypertension benign paroxysmal positional vertigo depressive disorder, not elsewhere classified coronary atherosclerosis of native coronary artery personal history of malignant neoplasm of bronchus and lung personal history of malignant neoplasm of breast unspecified essential hypertension palpitations chest pain, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal bacterial pneumonia, unspecified person boarding or alighting a pedal cycle injured in collision with pedestrian or animal long-term (current) use of anticoagulants other emphysema benign essential hypertension person on outside of bus injured in collision with pedestrian or animal in traffic accident other ill-defined heart diseases contact dermatitis and other eczema, unspecified cause examination of participant in clinical trial personal history of malignant neoplasm of breast personal history of tobacco use malignant neoplasm of bronchus and lung, unspecified epilepsy, unspecified, without mention of intractable epilepsy person boarding or alighting a pedal cycle injured in collision with pedestrian or animal coronary atherosclerosis of native coronary artery malignant neoplasm of upper lobe, bronchus or lung epilepsy, unspecified, without mention of intractable epilepsy personal history of malignant neoplasm of bronchus and lung personal history of malignant neoplasm of breast personal history of tobacco use other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified essential hypertension
white m 90 $nan$chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  117  mg dl$aspirin  81  mg ; amlodipine  5  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; 5% dextrose  250  ml ; phenylephrine  60  mg ; d5w  250  ml ; nitroglycerin  100  mg ; hydralazine  5-10  mg ; oxycodone (immediate release)  2.5-5  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; docusate sodium  100  mg ; simvastatin  40  mg ; losartan potassium  100  mg ; heparin  5000  unit ; donepezil  10  mg ; lidocaine jelly 2% (urojet)  1  appl ; 
mechanical complication of other vascular device, implant, and graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified obstructive sleep apnea (adult)(pediatric) other and unspecified hyperlipidemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular disease, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) chronic kidney disease, unspecified disorders of meninges, not elsewhere classified compression of brain anemia, unspecified gout, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits accidental puncture or laceration of dura during a procedure subdural hemorrhage external hemorrhoids with other complication pure hypercholesterolemia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation benign essential hypertension compression of brain personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia unspecified essential hypertension accidental fall from ladder subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness gout, unspecified 
white m 90 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  57  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood glucose  108  mg dl$aspirin  81  mg ; amlodipine  5  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; 5% dextrose  250  ml ; phenylephrine  60  mg ; d5w  250  ml ; nitroglycerin  100  mg ; hydralazine  5-10  mg ; oxycodone (immediate release)  2.5-5  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; docusate sodium  100  mg ; simvastatin  40  mg ; losartan potassium  100  mg ; heparin  5000  unit ; donepezil  10  mg ; lidocaine jelly 2% (urojet)  1  appl ; allopurinol  100  mg ; 
mechanical complication of other vascular device, implant, and graft hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified obstructive sleep apnea (adult)(pediatric) other and unspecified hyperlipidemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits peripheral vascular disease, unspecified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) chronic kidney disease, unspecified disorders of meninges, not elsewhere classified compression of brain anemia, unspecified gout, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits accidental puncture or laceration of dura during a procedure subdural hemorrhage external hemorrhoids with other complication pure hypercholesterolemia other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation benign essential hypertension compression of brain personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits pure hypercholesterolemia unspecified essential hypertension accidental fall from ladder subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness gout, unspecified 
hispanic latino f 33 $nan$nan$amlodipine  5  mg ; nephrocaps  1  cap ; fluticasone propionate nasal  1  spry ; furosemide  160  mg ; lisinopril  40  mg ; aspirin  325  mg ; atorvastatin  80  mg ; sevelamer carbonate  2400  mg ; 
diabetes with other specified manifestations, type i [juvenile type], uncontrolled renal dialysis status diabetes with renal manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease mitral valve disorders anemia in chronic kidney disease mechanical complication due to peritoneal dialysis catheter end stage renal disease obstructive sleep apnea (adult)(pediatric) dysthymic disorder other and unspecified hyperlipidemia keratoderma, acquired pulmonary collapse other constipation hyposmolality and/or hyponatremia acute posthemorrhagic anemia other and unspecified hyperlipidemia diabetes with neurological manifestations, type i [juvenile type], uncontrolled diabetes with other specified manifestations, type i [juvenile type], uncontrolled restless legs syndrome (rls) acromegaly and gigantism polyneuropathy in diabetes acidosis diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled background diabetic retinopathy other and unspecified anterior pituitary hyperfunction end stage renal disease dysthymic disorder excessive or frequent menstruation diabetes with renal manifestations, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease obstructive sleep apnea (adult)(pediatric) other and unspecified hyperlipidemia anemia in chronic kidney disease background diabetic retinopathy diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled end stage renal disease lipodystrophy infection following other infusion, injection, transfusion, or vaccination diabetes with renal manifestations, type i [juvenile type], uncontrolled intestinal infection due to other organism, not elsewhere classified diabetes with ketoacidosis, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease awaiting organ transplant status dysthymic disorder other suppurative peritonitis
hispanic latino f 33 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  215  k ul; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  13.1  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  80  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  171  mg dl; chemistry blood lactate dehydrogenase (ld)  356  iu l; chemistry blood albumin  2.3  g dl; blood gas blood glucose  68  mg dl$amlodipine  5  mg ; nephrocaps  1  cap ; fluticasone propionate nasal  1  spry ; furosemide  160  mg ; lisinopril  40  mg ; aspirin  325  mg ; atorvastatin  80  mg ; sevelamer carbonate  2400  mg ; bupropion (sustained release)  150  mg ; docusate sodium  100  mg ; labetalol  600  mg ; fexofenadine  60  mg ; nortriptyline  25  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; clonazepam  1  mg ; senna  1  tab ; gabapentin  300  mg ; pramipexole  0.125  mg ; trazodone  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; morphine sulfate  2-4  mg ; heparin  1100  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; nitroglycerin sl  0.3  mg ; insulin  0  unit ; tb syringe  0.05  ml ; insulin regular human (u-500)  25  unit ; tb syringe  0.12  ml ; insulin regular human (u-500)  60  unit ; insulin  25  unit ; tb syringe  0.1  ml ; insulin regular human (u-500)  50  unit ; furosemide  80  mg ; 
diabetes with other specified manifestations, type i [juvenile type], uncontrolled renal dialysis status diabetes with renal manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease mitral valve disorders anemia in chronic kidney disease mechanical complication due to peritoneal dialysis catheter end stage renal disease obstructive sleep apnea (adult)(pediatric) dysthymic disorder other and unspecified hyperlipidemia keratoderma, acquired pulmonary collapse other constipation hyposmolality and/or hyponatremia acute posthemorrhagic anemia other and unspecified hyperlipidemia diabetes with neurological manifestations, type i [juvenile type], uncontrolled diabetes with other specified manifestations, type i [juvenile type], uncontrolled restless legs syndrome (rls) acromegaly and gigantism polyneuropathy in diabetes acidosis diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled background diabetic retinopathy other and unspecified anterior pituitary hyperfunction end stage renal disease dysthymic disorder excessive or frequent menstruation diabetes with renal manifestations, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease obstructive sleep apnea (adult)(pediatric) other and unspecified hyperlipidemia anemia in chronic kidney disease background diabetic retinopathy diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled end stage renal disease lipodystrophy infection following other infusion, injection, transfusion, or vaccination diabetes with renal manifestations, type i [juvenile type], uncontrolled intestinal infection due to other organism, not elsewhere classified diabetes with ketoacidosis, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease awaiting organ transplant status dysthymic disorder other suppurative peritonitis
hispanic latino f 33 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  12.9  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  83  mg dl; chemistry urine chloride, urine  32  meq l; chemistry urine creatinine, urine  55  mg dl; chemistry urine potassium, urine  25  meq l; chemistry urine sodium, urine  52  meq l; chemistry urine urea nitrogen, urine  241  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood glucose  75  mg dl$amlodipine  5  mg ; nephrocaps  1  cap ; fluticasone propionate nasal  1  spry ; furosemide  160  mg ; lisinopril  40  mg ; aspirin  325  mg ; atorvastatin  80  mg ; sevelamer carbonate  2400  mg ; bupropion (sustained release)  150  mg ; docusate sodium  100  mg ; labetalol  600  mg ; fexofenadine  60  mg ; nortriptyline  25  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; clonazepam  1  mg ; senna  1  tab ; gabapentin  300  mg ; pramipexole  0.125  mg ; trazodone  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; morphine sulfate  2-4  mg ; heparin  1100  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; nitroglycerin sl  0.3  mg ; insulin  25  unit ; furosemide  80  mg ; acetaminophen  500-1000  mg ; 
diabetes with other specified manifestations, type i [juvenile type], uncontrolled renal dialysis status diabetes with renal manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease mitral valve disorders anemia in chronic kidney disease mechanical complication due to peritoneal dialysis catheter end stage renal disease obstructive sleep apnea (adult)(pediatric) dysthymic disorder other and unspecified hyperlipidemia keratoderma, acquired pulmonary collapse other constipation hyposmolality and/or hyponatremia acute posthemorrhagic anemia other and unspecified hyperlipidemia diabetes with neurological manifestations, type i [juvenile type], uncontrolled diabetes with other specified manifestations, type i [juvenile type], uncontrolled restless legs syndrome (rls) acromegaly and gigantism polyneuropathy in diabetes acidosis diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled background diabetic retinopathy other and unspecified anterior pituitary hyperfunction end stage renal disease dysthymic disorder excessive or frequent menstruation diabetes with renal manifestations, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease obstructive sleep apnea (adult)(pediatric) other and unspecified hyperlipidemia anemia in chronic kidney disease background diabetic retinopathy diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled end stage renal disease lipodystrophy infection following other infusion, injection, transfusion, or vaccination diabetes with renal manifestations, type i [juvenile type], uncontrolled intestinal infection due to other organism, not elsewhere classified diabetes with ketoacidosis, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease awaiting organ transplant status dysthymic disorder other suppurative peritonitis
hispanic latino f 33 $nan$nan$amlodipine  5  mg ; nephrocaps  1  cap ; fluticasone propionate nasal  1  spry ; furosemide  160  mg ; lisinopril  40  mg ; aspirin  325  mg ; atorvastatin  80  mg ; sevelamer carbonate  2400  mg ; bupropion (sustained release)  150  mg ; docusate sodium  100  mg ; labetalol  600  mg ; fexofenadine  60  mg ; nortriptyline  25  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; clonazepam  1  mg ; senna  1  tab ; gabapentin  300  mg ; pramipexole  0.125  mg ; trazodone  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; morphine sulfate  2-4  mg ; heparin  1100  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; nitroglycerin sl  0.3  mg ; insulin  25  unit ; acetaminophen  500-1000  mg ; 
diabetes with other specified manifestations, type i [juvenile type], uncontrolled renal dialysis status diabetes with renal manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease mitral valve disorders anemia in chronic kidney disease mechanical complication due to peritoneal dialysis catheter end stage renal disease obstructive sleep apnea (adult)(pediatric) dysthymic disorder other and unspecified hyperlipidemia keratoderma, acquired pulmonary collapse other constipation hyposmolality and/or hyponatremia acute posthemorrhagic anemia other and unspecified hyperlipidemia diabetes with neurological manifestations, type i [juvenile type], uncontrolled diabetes with other specified manifestations, type i [juvenile type], uncontrolled restless legs syndrome (rls) acromegaly and gigantism polyneuropathy in diabetes acidosis diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled background diabetic retinopathy other and unspecified anterior pituitary hyperfunction end stage renal disease dysthymic disorder excessive or frequent menstruation diabetes with renal manifestations, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease obstructive sleep apnea (adult)(pediatric) other and unspecified hyperlipidemia anemia in chronic kidney disease background diabetic retinopathy diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled end stage renal disease lipodystrophy infection following other infusion, injection, transfusion, or vaccination diabetes with renal manifestations, type i [juvenile type], uncontrolled intestinal infection due to other organism, not elsewhere classified diabetes with ketoacidosis, type i [juvenile type], uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease awaiting organ transplant status dysthymic disorder other suppurative peritonitis
white f 35 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; ibuprofen  600  mg ; ondansetron  4  mg ; albuterol inhaler  1-2  puff ; doxycycline hyclate  200  mg ; diphenhydramine  25  mg ; cepastat (phenol) lozenge  2  loz ; 
 
black african american f 49 $nan$hematology blood hematocrit  35.3  %; hematology blood hematocrit  35.7  %; hematology blood hemoglobin  11.3  g dl; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  258  k ul; hematology blood platelet count  257  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  83  mg dl$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  650  mg ; chloraseptic throat spray  1  spry ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
 
black african american f 49 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  272  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  97  mg dl$sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  650  mg ; chloraseptic throat spray  1  spry ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; bag  50  ml ; magnesium sulfate  2  gm ; 
 
black african american f 49 $nan$nan$sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; heparin  5000  unit ; chloraseptic throat spray  1  spry ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; bag  50  ml ; magnesium sulfate  2  gm ; 
 
white f 35 $nan$nan$levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
white f 35 $nan$nan$levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
white f 35 $nan$nan$levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
white f 52 $temp  97.5  heartrate  79.0  resprate  16.0  o2sat  98.0  sbp  112.0  dbp  62.0  rhythm    pain  0  $hematology blood hematocrit  36.7  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  276  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  95  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; atorvastatin  20  mg ; omeprazole  20  mg ; sertraline  100  mg ; calcium carbonate  500  mg ; vitamin d  800  unit ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; clobazam  20  mg ; clobazam  5  mg ; lamotrigine  400  mg ; lamotrigine  75  mg ; lorazepam  0.5-1  mg ; lamotrigine  100  mg ; lamotrigine  200  mg ; lamotrigine  50  mg ; 
late effects of motor vehicle accident chronic pain due to trauma generalized convulsive epilepsy, without mention of intractable epilepsy obstructive sleep apnea (adult)(pediatric) myalgia and myositis, unspecified insomnia, unspecified esophageal reflux major depressive affective disorder, single episode, unspecified personal history of tobacco use esophageal reflux acute posthemorrhagic anemia closed fracture of shaft of radius (alone) generalized convulsive epilepsy, without mention of intractable epilepsy obstructive sleep apnea (adult)(pediatric) myalgia and myositis, unspecified fracture of lateral malleolus, closed depressive disorder, not elsewhere classified closed fracture of three ribs tear of lateral cartilage or meniscus of knee, current motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle closed fracture of upper end of tibia alone 
white f 52 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; atorvastatin  20  mg ; omeprazole  20  mg ; sertraline  100  mg ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; clobazam  20  mg ; clobazam  5  mg ; lamotrigine  75  mg ; lorazepam  0.5-1  mg ; lamotrigine  100  mg ; lamotrigine  200  mg ; lamotrigine  50  mg ; vitamin d  50,000  unit ; 
late effects of motor vehicle accident chronic pain due to trauma generalized convulsive epilepsy, without mention of intractable epilepsy obstructive sleep apnea (adult)(pediatric) myalgia and myositis, unspecified insomnia, unspecified esophageal reflux major depressive affective disorder, single episode, unspecified personal history of tobacco use esophageal reflux acute posthemorrhagic anemia closed fracture of shaft of radius (alone) generalized convulsive epilepsy, without mention of intractable epilepsy obstructive sleep apnea (adult)(pediatric) myalgia and myositis, unspecified fracture of lateral malleolus, closed depressive disorder, not elsewhere classified closed fracture of three ribs tear of lateral cartilage or meniscus of knee, current motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle closed fracture of upper end of tibia alone 
white f 52 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; atorvastatin  20  mg ; omeprazole  20  mg ; sertraline  100  mg ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; clobazam  20  mg ; clobazam  5  mg ; lorazepam  0.5-1  mg ; vitamin d  50,000  unit ; hydroxyzine  50  mg ; 
late effects of motor vehicle accident chronic pain due to trauma generalized convulsive epilepsy, without mention of intractable epilepsy obstructive sleep apnea (adult)(pediatric) myalgia and myositis, unspecified insomnia, unspecified esophageal reflux major depressive affective disorder, single episode, unspecified personal history of tobacco use esophageal reflux acute posthemorrhagic anemia closed fracture of shaft of radius (alone) generalized convulsive epilepsy, without mention of intractable epilepsy obstructive sleep apnea (adult)(pediatric) myalgia and myositis, unspecified fracture of lateral malleolus, closed depressive disorder, not elsewhere classified closed fracture of three ribs tear of lateral cartilage or meniscus of knee, current motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle closed fracture of upper end of tibia alone 
white f 52 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; atorvastatin  20  mg ; omeprazole  20  mg ; sertraline  100  mg ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; clobazam  20  mg ; clobazam  5  mg ; lorazepam  0.5-1  mg ; vitamin d  50,000  unit ; hydroxyzine  50  mg ; acetaminophen  325-650  mg ; 0.9% sodium chloride  50  ml ; valproate sodium  1000  mg ; divalproex (extended release)  500  mg ; 
late effects of motor vehicle accident chronic pain due to trauma generalized convulsive epilepsy, without mention of intractable epilepsy obstructive sleep apnea (adult)(pediatric) myalgia and myositis, unspecified insomnia, unspecified esophageal reflux major depressive affective disorder, single episode, unspecified personal history of tobacco use esophageal reflux acute posthemorrhagic anemia closed fracture of shaft of radius (alone) generalized convulsive epilepsy, without mention of intractable epilepsy obstructive sleep apnea (adult)(pediatric) myalgia and myositis, unspecified fracture of lateral malleolus, closed depressive disorder, not elsewhere classified closed fracture of three ribs tear of lateral cartilage or meniscus of knee, current motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle closed fracture of upper end of tibia alone 
white f 52 $nan$hematology blood hematocrit  38.4  %; hematology blood hematocrit  39.4  %; hematology blood hemoglobin  12.6  g dl; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  275  k ul; hematology blood platelet count  293  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  68  mg dl; chemistry blood lactate dehydrogenase (ld)  156  iu l; chemistry blood lactate dehydrogenase (ld)  164  iu l; chemistry blood albumin  4.3  g dl; chemistry blood albumin  4.5  g dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; atorvastatin  20  mg ; omeprazole  20  mg ; sertraline  100  mg ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; clobazam  20  mg ; clobazam  5  mg ; lorazepam  0.5-1  mg ; vitamin d  50,000  unit ; acetaminophen  325-650  mg ; divalproex (extended release)  500  mg ; 
late effects of motor vehicle accident chronic pain due to trauma generalized convulsive epilepsy, without mention of intractable epilepsy obstructive sleep apnea (adult)(pediatric) myalgia and myositis, unspecified insomnia, unspecified esophageal reflux major depressive affective disorder, single episode, unspecified personal history of tobacco use esophageal reflux acute posthemorrhagic anemia closed fracture of shaft of radius (alone) generalized convulsive epilepsy, without mention of intractable epilepsy obstructive sleep apnea (adult)(pediatric) myalgia and myositis, unspecified fracture of lateral malleolus, closed depressive disorder, not elsewhere classified closed fracture of three ribs tear of lateral cartilage or meniscus of knee, current motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle closed fracture of upper end of tibia alone 
white f 52 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; atorvastatin  20  mg ; omeprazole  20  mg ; sertraline  100  mg ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; clobazam  20  mg ; clobazam  5  mg ; lorazepam  0.5-1  mg ; vitamin d  50,000  unit ; acetaminophen  325-650  mg ; 
late effects of motor vehicle accident chronic pain due to trauma generalized convulsive epilepsy, without mention of intractable epilepsy obstructive sleep apnea (adult)(pediatric) myalgia and myositis, unspecified insomnia, unspecified esophageal reflux major depressive affective disorder, single episode, unspecified personal history of tobacco use esophageal reflux acute posthemorrhagic anemia closed fracture of shaft of radius (alone) generalized convulsive epilepsy, without mention of intractable epilepsy obstructive sleep apnea (adult)(pediatric) myalgia and myositis, unspecified fracture of lateral malleolus, closed depressive disorder, not elsewhere classified closed fracture of three ribs tear of lateral cartilage or meniscus of knee, current motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle closed fracture of upper end of tibia alone 
white f 52 $nan$hematology blood hematocrit  38.9  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  102  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; atorvastatin  20  mg ; omeprazole  20  mg ; sertraline  100  mg ; heparin  5000  unit ; docusate sodium  100  mg ; senna  1  tab ; clobazam  20  mg ; clobazam  5  mg ; lorazepam  0.5-1  mg ; vitamin d  50,000  unit ; acetaminophen  325-650  mg ; 
late effects of motor vehicle accident chronic pain due to trauma generalized convulsive epilepsy, without mention of intractable epilepsy obstructive sleep apnea (adult)(pediatric) myalgia and myositis, unspecified insomnia, unspecified esophageal reflux major depressive affective disorder, single episode, unspecified personal history of tobacco use esophageal reflux acute posthemorrhagic anemia closed fracture of shaft of radius (alone) generalized convulsive epilepsy, without mention of intractable epilepsy obstructive sleep apnea (adult)(pediatric) myalgia and myositis, unspecified fracture of lateral malleolus, closed depressive disorder, not elsewhere classified closed fracture of three ribs tear of lateral cartilage or meniscus of knee, current motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle closed fracture of upper end of tibia alone 
white m 78 $temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  0  ; temp  98.5  heartrate  74.0  resprate  16.0  o2sat    sbp  132.0  dbp  79.0  rhythm    pain    ; temp  97.9  heartrate  72.0  resprate  12.0  o2sat    sbp  122.0  dbp  74.0  rhythm    pain    $nan$amiodarone  200  mg ; furosemide  20  mg ; gemfibrozil  600  mg ; lisinopril  20  mg ; metoprolol succinate xl  150  mg ; pravastatin  40  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified retention of urine benign neoplasm of cerebral meninges other primary cardiomyopathies other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified difficulty in walking chronic airway obstruction, not elsewhere classified personal history of antineoplastic chemotherapy long-term (current) use of anticoagulants chronic kidney disease, unspecified atrial fibrillation toxic encephalopathy hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) friedländer's bacillus infection in conditions classified elsewhere and of unspecified site congestive heart failure, unspecified gout, unspecified malignant neoplasm of lower lobe, bronchus or lung urinary tract infection, site not specified tobacco use disorder automatic implantable cardiac defibrillator in situ other primary cardiomyopathies personal history of tobacco use other and unspecified hyperlipidemia postoperative air leak chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atrial fibrillation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled emphysema (subcutaneous) (surgical) resulting from procedure chronic airway obstruction, not elsewhere classified personal history of other malignant neoplasm of skin long-term (current) use of anticoagulants incomplete bladder emptying other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) automatic implantable cardiac defibrillator in situ gout, unspecified malignant neoplasm of upper lobe, bronchus or lung injury to bladder and urethra, without mention of open wound into cavity nonspecific abnormal electrocardiogram [ecg] [ekg] gout, unspecified long-term (current) use of anticoagulants chronic airway obstruction, not elsewhere classified atrial fibrillation other specified causes of urethral stricture other and unspecified hyperlipidemia neoplasm of unspecified nature of respiratory system
white m 78 $temp  97.9  heartrate  72.0  resprate  12.0  o2sat  99.0  sbp  122.0  dbp  74.0  rhythm    pain  0  $hematology blood hematocrit  44.3  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  49  mg dl; hematology blood inr(pt)  2.6  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  125  mg dl$amiodarone  200  mg ; furosemide  20  mg ; gemfibrozil  600  mg ; lisinopril  20  mg ; metoprolol succinate xl  150  mg ; pravastatin  40  mg ; warfarin  2.5  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; senna  1  tab ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; ciprofloxacin hcl  250  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; cepacol (menthol)  1  loz ; heparin  5000  unit ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified retention of urine benign neoplasm of cerebral meninges other primary cardiomyopathies other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified difficulty in walking chronic airway obstruction, not elsewhere classified personal history of antineoplastic chemotherapy long-term (current) use of anticoagulants chronic kidney disease, unspecified atrial fibrillation toxic encephalopathy hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) friedländer's bacillus infection in conditions classified elsewhere and of unspecified site congestive heart failure, unspecified gout, unspecified malignant neoplasm of lower lobe, bronchus or lung urinary tract infection, site not specified tobacco use disorder automatic implantable cardiac defibrillator in situ other primary cardiomyopathies personal history of tobacco use other and unspecified hyperlipidemia postoperative air leak chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atrial fibrillation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled emphysema (subcutaneous) (surgical) resulting from procedure chronic airway obstruction, not elsewhere classified personal history of other malignant neoplasm of skin long-term (current) use of anticoagulants incomplete bladder emptying other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) automatic implantable cardiac defibrillator in situ gout, unspecified malignant neoplasm of upper lobe, bronchus or lung injury to bladder and urethra, without mention of open wound into cavity nonspecific abnormal electrocardiogram [ecg] [ekg] gout, unspecified long-term (current) use of anticoagulants chronic airway obstruction, not elsewhere classified atrial fibrillation other specified causes of urethral stricture other and unspecified hyperlipidemia neoplasm of unspecified nature of respiratory system
white m 78 $nan$hematology blood hematocrit  42.4  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood glucose  115  mg dl$amiodarone  200  mg ; gemfibrozil  600  mg ; pravastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; cepacol (menthol)  1  loz ; heparin  5000  unit ; ciprofloxacin hcl  500  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified retention of urine benign neoplasm of cerebral meninges other primary cardiomyopathies other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified difficulty in walking chronic airway obstruction, not elsewhere classified personal history of antineoplastic chemotherapy long-term (current) use of anticoagulants chronic kidney disease, unspecified atrial fibrillation toxic encephalopathy hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) friedländer's bacillus infection in conditions classified elsewhere and of unspecified site congestive heart failure, unspecified gout, unspecified malignant neoplasm of lower lobe, bronchus or lung urinary tract infection, site not specified tobacco use disorder automatic implantable cardiac defibrillator in situ other primary cardiomyopathies personal history of tobacco use other and unspecified hyperlipidemia postoperative air leak chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atrial fibrillation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled emphysema (subcutaneous) (surgical) resulting from procedure chronic airway obstruction, not elsewhere classified personal history of other malignant neoplasm of skin long-term (current) use of anticoagulants incomplete bladder emptying other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) automatic implantable cardiac defibrillator in situ gout, unspecified malignant neoplasm of upper lobe, bronchus or lung injury to bladder and urethra, without mention of open wound into cavity nonspecific abnormal electrocardiogram [ecg] [ekg] gout, unspecified long-term (current) use of anticoagulants chronic airway obstruction, not elsewhere classified atrial fibrillation other specified causes of urethral stricture other and unspecified hyperlipidemia neoplasm of unspecified nature of respiratory system
white m 78 $nan$hematology blood hematocrit  42.7  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood glucose  114  mg dl$amiodarone  200  mg ; gemfibrozil  600  mg ; pravastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; cepacol (menthol)  1  loz ; heparin  5000  unit ; ciprofloxacin hcl  500  mg ; ipratropium bromide neb  1  neb ; methylprednisolone sodium succ  40  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified retention of urine benign neoplasm of cerebral meninges other primary cardiomyopathies other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified difficulty in walking chronic airway obstruction, not elsewhere classified personal history of antineoplastic chemotherapy long-term (current) use of anticoagulants chronic kidney disease, unspecified atrial fibrillation toxic encephalopathy hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) friedländer's bacillus infection in conditions classified elsewhere and of unspecified site congestive heart failure, unspecified gout, unspecified malignant neoplasm of lower lobe, bronchus or lung urinary tract infection, site not specified tobacco use disorder automatic implantable cardiac defibrillator in situ other primary cardiomyopathies personal history of tobacco use other and unspecified hyperlipidemia postoperative air leak chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atrial fibrillation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled emphysema (subcutaneous) (surgical) resulting from procedure chronic airway obstruction, not elsewhere classified personal history of other malignant neoplasm of skin long-term (current) use of anticoagulants incomplete bladder emptying other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) automatic implantable cardiac defibrillator in situ gout, unspecified malignant neoplasm of upper lobe, bronchus or lung injury to bladder and urethra, without mention of open wound into cavity nonspecific abnormal electrocardiogram [ecg] [ekg] gout, unspecified long-term (current) use of anticoagulants chronic airway obstruction, not elsewhere classified atrial fibrillation other specified causes of urethral stricture other and unspecified hyperlipidemia neoplasm of unspecified nature of respiratory system
white m 78 $nan$hematology blood hematocrit  42.4  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  67  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood glucose  176  mg dl$amiodarone  200  mg ; gemfibrozil  600  mg ; pravastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; cepacol (menthol)  1  loz ; heparin  5000  unit ; ipratropium bromide neb  1  neb ; methylprednisolone sodium succ  40  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; heparin flush (10 units ml)  2  ml ; prednisone  20  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified retention of urine benign neoplasm of cerebral meninges other primary cardiomyopathies other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified difficulty in walking chronic airway obstruction, not elsewhere classified personal history of antineoplastic chemotherapy long-term (current) use of anticoagulants chronic kidney disease, unspecified atrial fibrillation toxic encephalopathy hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) friedländer's bacillus infection in conditions classified elsewhere and of unspecified site congestive heart failure, unspecified gout, unspecified malignant neoplasm of lower lobe, bronchus or lung urinary tract infection, site not specified tobacco use disorder automatic implantable cardiac defibrillator in situ other primary cardiomyopathies personal history of tobacco use other and unspecified hyperlipidemia postoperative air leak chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atrial fibrillation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled emphysema (subcutaneous) (surgical) resulting from procedure chronic airway obstruction, not elsewhere classified personal history of other malignant neoplasm of skin long-term (current) use of anticoagulants incomplete bladder emptying other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) automatic implantable cardiac defibrillator in situ gout, unspecified malignant neoplasm of upper lobe, bronchus or lung injury to bladder and urethra, without mention of open wound into cavity nonspecific abnormal electrocardiogram [ecg] [ekg] gout, unspecified long-term (current) use of anticoagulants chronic airway obstruction, not elsewhere classified atrial fibrillation other specified causes of urethral stricture other and unspecified hyperlipidemia neoplasm of unspecified nature of respiratory system
white m 78 $nan$hematology blood hematocrit  40.8  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  73  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood glucose  131  mg dl$amiodarone  200  mg ; gemfibrozil  600  mg ; pravastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; cepacol (menthol)  1  loz ; heparin  5000  unit ; ipratropium bromide neb  1  neb ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; heparin flush (10 units ml)  2  ml ; prednisone  20  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified retention of urine benign neoplasm of cerebral meninges other primary cardiomyopathies other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified difficulty in walking chronic airway obstruction, not elsewhere classified personal history of antineoplastic chemotherapy long-term (current) use of anticoagulants chronic kidney disease, unspecified atrial fibrillation toxic encephalopathy hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) friedländer's bacillus infection in conditions classified elsewhere and of unspecified site congestive heart failure, unspecified gout, unspecified malignant neoplasm of lower lobe, bronchus or lung urinary tract infection, site not specified tobacco use disorder automatic implantable cardiac defibrillator in situ other primary cardiomyopathies personal history of tobacco use other and unspecified hyperlipidemia postoperative air leak chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atrial fibrillation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled emphysema (subcutaneous) (surgical) resulting from procedure chronic airway obstruction, not elsewhere classified personal history of other malignant neoplasm of skin long-term (current) use of anticoagulants incomplete bladder emptying other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) automatic implantable cardiac defibrillator in situ gout, unspecified malignant neoplasm of upper lobe, bronchus or lung injury to bladder and urethra, without mention of open wound into cavity nonspecific abnormal electrocardiogram [ecg] [ekg] gout, unspecified long-term (current) use of anticoagulants chronic airway obstruction, not elsewhere classified atrial fibrillation other specified causes of urethral stricture other and unspecified hyperlipidemia neoplasm of unspecified nature of respiratory system
white m 78 $nan$nan$amiodarone  200  mg ; gemfibrozil  600  mg ; pravastatin  40  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; cepacol (menthol)  1  loz ; heparin  5000  unit ; ipratropium bromide neb  1  neb ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; heparin flush (10 units ml)  2  ml ; prednisone  20  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other specified retention of urine benign neoplasm of cerebral meninges other primary cardiomyopathies other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified difficulty in walking chronic airway obstruction, not elsewhere classified personal history of antineoplastic chemotherapy long-term (current) use of anticoagulants chronic kidney disease, unspecified atrial fibrillation toxic encephalopathy hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) friedländer's bacillus infection in conditions classified elsewhere and of unspecified site congestive heart failure, unspecified gout, unspecified malignant neoplasm of lower lobe, bronchus or lung urinary tract infection, site not specified tobacco use disorder automatic implantable cardiac defibrillator in situ other primary cardiomyopathies personal history of tobacco use other and unspecified hyperlipidemia postoperative air leak chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atrial fibrillation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled emphysema (subcutaneous) (surgical) resulting from procedure chronic airway obstruction, not elsewhere classified personal history of other malignant neoplasm of skin long-term (current) use of anticoagulants incomplete bladder emptying other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) automatic implantable cardiac defibrillator in situ gout, unspecified malignant neoplasm of upper lobe, bronchus or lung injury to bladder and urethra, without mention of open wound into cavity nonspecific abnormal electrocardiogram [ecg] [ekg] gout, unspecified long-term (current) use of anticoagulants chronic airway obstruction, not elsewhere classified atrial fibrillation other specified causes of urethral stricture other and unspecified hyperlipidemia neoplasm of unspecified nature of respiratory system
white f 66 $temp  97.6  heartrate  89.0  resprate  20.0  o2sat  100.0  sbp  124.0  dbp  54.0  rhythm    pain  8  ; temp  97.6  heartrate  84.0  resprate  20.0  o2sat  100.0  sbp  92.0  dbp  45.0  rhythm    pain  0  $hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  100  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  3.5  mg dl; chemistry blood creatinine  4.0  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  97  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  169  mg dl; chemistry blood albumin  3.1  g dl; blood gas blood chloride, whole blood  113  meq l; blood gas blood glucose  166  mg dl; blood gas blood potassium, whole blood  5.1  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood calculated bicarbonate, whole blood  11  meq l$nan
chronic kidney disease, unspecified obesity, unspecified acute kidney failure, unspecified acute posthemorrhagic anemia diverticulosis of colon (without mention of hemorrhage) hip joint replacement car passenger injured in collision with van in traffic accident unspecified acquired hypothyroidism blood in stool cirrhosis of liver without mention of alcohol depressive disorder, not elsewhere classified chronic hepatitis c without mention of hepatic coma knee joint replacement hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hyperpotassemia unspecified hereditary and idiopathic peripheral neuropathy personal history of tobacco use angiodysplasia of intestine (without mention of hemorrhage) esophageal reflux chronic hepatitis c without mention of hepatic coma hepatic encephalopathy hip joint replacement car passenger injured in collision with van in traffic accident poisoning by aromatic analgesics, not elsewhere classified esophageal varices in diseases classified elsewhere, without mention of bleeding hypercalcemia acute kidney failure, unspecified hyperosmolality and/or hypernatremia cirrhosis of liver without mention of alcohol unspecified hereditary and idiopathic peripheral neuropathy esophageal reflux unspecified essential hypertension hypopotassemia hepatitis, unspecified accidental poisoning by aromatic analgesics, not elsewhere classified 
white f 66 $temp  97.6  heartrate  86.0  resprate  20.0  o2sat  100.0  sbp  97.0  dbp  48.0  rhythm    pain  0  $hematology blood hematocrit  20.0  %; hematology blood hematocrit  22.0  %; hematology blood hemoglobin  6.4  g dl; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  67  k ul; hematology blood platelet count  84  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  94  mg dl; chemistry blood urea nitrogen  89  mg dl; hematology blood inr(pt)  1.3  ; chemistry urine chloride, urine  37  meq l; chemistry urine creatinine, urine  74  mg dl; chemistry urine potassium, urine  22  meq l; chemistry urine sodium, urine  54  meq l; chemistry urine urea nitrogen, urine  537  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  160  mg dl; chemistry blood glucose  108  mg dl; chemistry blood lactate dehydrogenase (ld)  85  iu l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin flush (10 units ml)  1  ml ; heparin  5000  unit ; oxycodone (immediate release)   5-10  mg ; duloxetine  60  mg ; lactulose  30  ml ; levothyroxine sodium  50  mcg ; rifaximin  550  mg ; trazodone  100  mg ; omeprazole  20  mg ; multivitamins  1  tab ; quetiapine fumarate  50  mg ; albumin 25% (12.5g   50ml)  100  g ; acetaminophen  650  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; insulin  10  unit ; dextrose 50%  25  gm ; sodium chloride 0.9%  flush  10  ml ; sodium polystyrene sulfonate  30  gm ; lidocaine viscous 2%  15  ml ; 
chronic kidney disease, unspecified obesity, unspecified acute kidney failure, unspecified acute posthemorrhagic anemia diverticulosis of colon (without mention of hemorrhage) hip joint replacement car passenger injured in collision with van in traffic accident unspecified acquired hypothyroidism blood in stool cirrhosis of liver without mention of alcohol depressive disorder, not elsewhere classified chronic hepatitis c without mention of hepatic coma knee joint replacement hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hyperpotassemia unspecified hereditary and idiopathic peripheral neuropathy personal history of tobacco use angiodysplasia of intestine (without mention of hemorrhage) esophageal reflux chronic hepatitis c without mention of hepatic coma hepatic encephalopathy hip joint replacement car passenger injured in collision with van in traffic accident poisoning by aromatic analgesics, not elsewhere classified esophageal varices in diseases classified elsewhere, without mention of bleeding hypercalcemia acute kidney failure, unspecified hyperosmolality and/or hypernatremia cirrhosis of liver without mention of alcohol unspecified hereditary and idiopathic peripheral neuropathy esophageal reflux unspecified essential hypertension hypopotassemia hepatitis, unspecified accidental poisoning by aromatic analgesics, not elsewhere classified 
white f 66 $nan$hematology blood hematocrit  23.5  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  66  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  117  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  70  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  91  mg dl$heparin flush (10 units ml)  1  ml ; heparin  5000  unit ; duloxetine  60  mg ; lactulose  30  ml ; levothyroxine sodium  50  mcg ; rifaximin  550  mg ; trazodone  100  mg ; omeprazole  20  mg ; multivitamins  1  tab ; quetiapine fumarate  50  mg ; acetaminophen  650  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; sodium chloride 0.9%  flush  10  ml ; sodium polystyrene sulfonate  30  gm ; lidocaine viscous 2%  15  ml ; 
chronic kidney disease, unspecified obesity, unspecified acute kidney failure, unspecified acute posthemorrhagic anemia diverticulosis of colon (without mention of hemorrhage) hip joint replacement car passenger injured in collision with van in traffic accident unspecified acquired hypothyroidism blood in stool cirrhosis of liver without mention of alcohol depressive disorder, not elsewhere classified chronic hepatitis c without mention of hepatic coma knee joint replacement hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hyperpotassemia unspecified hereditary and idiopathic peripheral neuropathy personal history of tobacco use angiodysplasia of intestine (without mention of hemorrhage) esophageal reflux chronic hepatitis c without mention of hepatic coma hepatic encephalopathy hip joint replacement car passenger injured in collision with van in traffic accident poisoning by aromatic analgesics, not elsewhere classified esophageal varices in diseases classified elsewhere, without mention of bleeding hypercalcemia acute kidney failure, unspecified hyperosmolality and/or hypernatremia cirrhosis of liver without mention of alcohol unspecified hereditary and idiopathic peripheral neuropathy esophageal reflux unspecified essential hypertension hypopotassemia hepatitis, unspecified accidental poisoning by aromatic analgesics, not elsewhere classified 
white f 66 $nan$hematology blood hematocrit  21.9  %; hematology blood hematocrit  24.2  %; hematology blood hemoglobin  7.0  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  61  k ul; hematology blood platelet count  58  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  91  mg dl; chemistry blood albumin  4.4  g dl$heparin flush (10 units ml)  1  ml ; duloxetine  60  mg ; lactulose  30  ml ; levothyroxine sodium  50  mcg ; rifaximin  550  mg ; trazodone  100  mg ; omeprazole  20  mg ; multivitamins  1  tab ; quetiapine fumarate  50  mg ; acetaminophen  650  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; sodium chloride 0.9%  flush  10  ml ; lidocaine viscous 2%  15  ml ; lorazepam  1  mg ; lidocaine jelly 2% (urojet)  1  appl ; moviprep  1  l ; 
chronic kidney disease, unspecified obesity, unspecified acute kidney failure, unspecified acute posthemorrhagic anemia diverticulosis of colon (without mention of hemorrhage) hip joint replacement car passenger injured in collision with van in traffic accident unspecified acquired hypothyroidism blood in stool cirrhosis of liver without mention of alcohol depressive disorder, not elsewhere classified chronic hepatitis c without mention of hepatic coma knee joint replacement hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hyperpotassemia unspecified hereditary and idiopathic peripheral neuropathy personal history of tobacco use angiodysplasia of intestine (without mention of hemorrhage) esophageal reflux chronic hepatitis c without mention of hepatic coma hepatic encephalopathy hip joint replacement car passenger injured in collision with van in traffic accident poisoning by aromatic analgesics, not elsewhere classified esophageal varices in diseases classified elsewhere, without mention of bleeding hypercalcemia acute kidney failure, unspecified hyperosmolality and/or hypernatremia cirrhosis of liver without mention of alcohol unspecified hereditary and idiopathic peripheral neuropathy esophageal reflux unspecified essential hypertension hypopotassemia hepatitis, unspecified accidental poisoning by aromatic analgesics, not elsewhere classified 
white f 66 $nan$hematology blood hematocrit  23.1  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  68  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  117  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  91  mg dl$heparin flush (10 units ml)  1  ml ; duloxetine  60  mg ; lactulose  30  ml ; levothyroxine sodium  50  mcg ; rifaximin  550  mg ; trazodone  100  mg ; omeprazole  20  mg ; multivitamins  1  tab ; quetiapine fumarate  50  mg ; acetaminophen  650  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; sodium chloride 0.9%  flush  10  ml ; lidocaine viscous 2%  15  ml ; lorazepam  1  mg ; lidocaine jelly 2% (urojet)  1  appl ; ciprofloxacin hcl  500  mg ; phosphorus  250  mg ; 
chronic kidney disease, unspecified obesity, unspecified acute kidney failure, unspecified acute posthemorrhagic anemia diverticulosis of colon (without mention of hemorrhage) hip joint replacement car passenger injured in collision with van in traffic accident unspecified acquired hypothyroidism blood in stool cirrhosis of liver without mention of alcohol depressive disorder, not elsewhere classified chronic hepatitis c without mention of hepatic coma knee joint replacement hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hyperpotassemia unspecified hereditary and idiopathic peripheral neuropathy personal history of tobacco use angiodysplasia of intestine (without mention of hemorrhage) esophageal reflux chronic hepatitis c without mention of hepatic coma hepatic encephalopathy hip joint replacement car passenger injured in collision with van in traffic accident poisoning by aromatic analgesics, not elsewhere classified esophageal varices in diseases classified elsewhere, without mention of bleeding hypercalcemia acute kidney failure, unspecified hyperosmolality and/or hypernatremia cirrhosis of liver without mention of alcohol unspecified hereditary and idiopathic peripheral neuropathy esophageal reflux unspecified essential hypertension hypopotassemia hepatitis, unspecified accidental poisoning by aromatic analgesics, not elsewhere classified 
white f 66 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  50  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  112  mg dl$heparin flush (10 units ml)  1  ml ; duloxetine  60  mg ; lactulose  30  ml ; levothyroxine sodium  50  mcg ; rifaximin  550  mg ; trazodone  100  mg ; omeprazole  20  mg ; multivitamins  1  tab ; quetiapine fumarate  50  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  10  ml ; lidocaine viscous 2%  15  ml ; ciprofloxacin hcl  500  mg ; phosphorus  250  mg ; bag  1  bag ; magnesium sulfate  2  gm ; phosphorus  500  mg ; cefpodoxime proxetil  200  mg ; furosemide  80  mg ; furosemide  40  mg ; 
chronic kidney disease, unspecified obesity, unspecified acute kidney failure, unspecified acute posthemorrhagic anemia diverticulosis of colon (without mention of hemorrhage) hip joint replacement car passenger injured in collision with van in traffic accident unspecified acquired hypothyroidism blood in stool cirrhosis of liver without mention of alcohol depressive disorder, not elsewhere classified chronic hepatitis c without mention of hepatic coma knee joint replacement hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hyperpotassemia unspecified hereditary and idiopathic peripheral neuropathy personal history of tobacco use angiodysplasia of intestine (without mention of hemorrhage) esophageal reflux chronic hepatitis c without mention of hepatic coma hepatic encephalopathy hip joint replacement car passenger injured in collision with van in traffic accident poisoning by aromatic analgesics, not elsewhere classified esophageal varices in diseases classified elsewhere, without mention of bleeding hypercalcemia acute kidney failure, unspecified hyperosmolality and/or hypernatremia cirrhosis of liver without mention of alcohol unspecified hereditary and idiopathic peripheral neuropathy esophageal reflux unspecified essential hypertension hypopotassemia hepatitis, unspecified accidental poisoning by aromatic analgesics, not elsewhere classified 
white f 66 $nan$nan$heparin flush (10 units ml)  1  ml ; duloxetine  60  mg ; lactulose  30  ml ; levothyroxine sodium  50  mcg ; rifaximin  550  mg ; trazodone  100  mg ; omeprazole  20  mg ; multivitamins  1  tab ; quetiapine fumarate  50  mg ; acetaminophen  650  mg ; sodium chloride 0.9%  flush  10  ml ; lidocaine viscous 2%  15  ml ; bag  1  bag ; magnesium sulfate  2  gm ; phosphorus  500  mg ; cefpodoxime proxetil  200  mg ; furosemide  80  mg ; furosemide  40  mg ; albuterol 0.083% neb soln  1  neb ; oxycodone (immediate release)   5  mg ; 
chronic kidney disease, unspecified obesity, unspecified acute kidney failure, unspecified acute posthemorrhagic anemia diverticulosis of colon (without mention of hemorrhage) hip joint replacement car passenger injured in collision with van in traffic accident unspecified acquired hypothyroidism blood in stool cirrhosis of liver without mention of alcohol depressive disorder, not elsewhere classified chronic hepatitis c without mention of hepatic coma knee joint replacement hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hyperpotassemia unspecified hereditary and idiopathic peripheral neuropathy personal history of tobacco use angiodysplasia of intestine (without mention of hemorrhage) esophageal reflux chronic hepatitis c without mention of hepatic coma hepatic encephalopathy hip joint replacement car passenger injured in collision with van in traffic accident poisoning by aromatic analgesics, not elsewhere classified esophageal varices in diseases classified elsewhere, without mention of bleeding hypercalcemia acute kidney failure, unspecified hyperosmolality and/or hypernatremia cirrhosis of liver without mention of alcohol unspecified hereditary and idiopathic peripheral neuropathy esophageal reflux unspecified essential hypertension hypopotassemia hepatitis, unspecified accidental poisoning by aromatic analgesics, not elsewhere classified 
other m 71 $nan$nan$gabapentin  300  mg ; aspirin  81  mg ; latanoprost 0.005% ophth. soln.  1  drop ; multivitamins  1  tab ; sulfameth trimethoprim ss  1  tab ; folic acid  1  mg ; allopurinol  100  mg ; 
person on outside of car injured in collision with two- or three-wheeled motor vehicle in nontraffic accident obesity, unspecified other malignant lymphomas, unspecified site, extranodal and solid organ sites coronary atherosclerosis of native coronary artery personal history of tobacco use unspecified acquired hypothyroidism other chronic nonalcoholic liver disease personal history of malignant neoplasm of kidney chronic kidney disease, unspecified heart valve replaced by transplant other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate other and unspecified angina pectoris coronary atherosclerosis of native coronary artery anemia, unspecified personal history of malignant neoplasm of prostate personal history of malignant neoplasm of kidney other and unspecified hyperlipidemia aortic valve disorders other malignant lymphomas, unspecified site, extranodal and solid organ sites obstructive sleep apnea (adult)(pediatric) chronic kidney disease, unspecified acquired absence of kidney personal history of malignant neoplasm of kidney coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate obstructive sleep apnea (adult)(pediatric) personal history of other lymphatic and hematopoietic neoplasms personal history of malignant neoplasm of other sites aortic valve disorders 
other m 71 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  152  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  181  mg dl; chemistry blood glucose  307  mg dl; chemistry blood lactate dehydrogenase (ld)  401  iu l; chemistry blood lactate dehydrogenase (ld)  434  iu l; chemistry blood albumin  3.5  g dl; hematology blood bands  0  %$sterile water  200  ml ; gabapentin  300  mg ; aspirin  81  mg ; latanoprost 0.005% ophth. soln.  1  drop ; multivitamins  1  tab ; sulfameth trimethoprim ss  1  tab ; folic acid  1  mg ; allopurinol  100  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; 0.9% sodium chloride  1000  ml ; 5% dextrose  50  ml ; ondansetron  16  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; clarithromycin  500  mg ; sw  400  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; potassium chloride  80  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; lorazepam  0.5-1  mg ; dexamethasone  10  mg ; valacyclovir  500  mg ; oxycodone (immediate release)   5  mg ; 0.9% sodium chloride  500  ml ; ifosfamide  2700  mg ; 0.9% sodium chloride  50  ml ; mesna  670  mg ; mitoxantrone  16  mg ; albuterol-ipratropium  1-2  puff ; etoposide  130  mg ; fluticasone propionate nasal  1  spry ; gabapentin  600  mg ; olanzapine  10  mg ; 
person on outside of car injured in collision with two- or three-wheeled motor vehicle in nontraffic accident obesity, unspecified other malignant lymphomas, unspecified site, extranodal and solid organ sites coronary atherosclerosis of native coronary artery personal history of tobacco use unspecified acquired hypothyroidism other chronic nonalcoholic liver disease personal history of malignant neoplasm of kidney chronic kidney disease, unspecified heart valve replaced by transplant other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate other and unspecified angina pectoris coronary atherosclerosis of native coronary artery anemia, unspecified personal history of malignant neoplasm of prostate personal history of malignant neoplasm of kidney other and unspecified hyperlipidemia aortic valve disorders other malignant lymphomas, unspecified site, extranodal and solid organ sites obstructive sleep apnea (adult)(pediatric) chronic kidney disease, unspecified acquired absence of kidney personal history of malignant neoplasm of kidney coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate obstructive sleep apnea (adult)(pediatric) personal history of other lymphatic and hematopoietic neoplasms personal history of malignant neoplasm of other sites aortic valve disorders 
other m 71 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  169  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  196  mg dl; chemistry blood lactate dehydrogenase (ld)  370  iu l; chemistry blood albumin  3.4  g dl; hematology blood bands  0  %$sterile water  200  ml ; gabapentin  300  mg ; aspirin  81  mg ; latanoprost 0.005% ophth. soln.  1  drop ; multivitamins  1  tab ; sulfameth trimethoprim ss  1  tab ; folic acid  1  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; 5% dextrose  50  ml ; ondansetron  16  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; clarithromycin  500  mg ; sw  400  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; potassium chloride  80  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; lorazepam  0.5-1  mg ; dexamethasone  10  mg ; valacyclovir  500  mg ; oxycodone (immediate release)   5  mg ; 0.9% sodium chloride  500  ml ; ifosfamide  2700  mg ; 0.9% sodium chloride  50  ml ; mesna  670  mg ; mitoxantrone  16  mg ; albuterol-ipratropium  1-2  puff ; etoposide  130  mg ; fluticasone propionate nasal  1  spry ; gabapentin  600  mg ; olanzapine  10  mg ; 
person on outside of car injured in collision with two- or three-wheeled motor vehicle in nontraffic accident obesity, unspecified other malignant lymphomas, unspecified site, extranodal and solid organ sites coronary atherosclerosis of native coronary artery personal history of tobacco use unspecified acquired hypothyroidism other chronic nonalcoholic liver disease personal history of malignant neoplasm of kidney chronic kidney disease, unspecified heart valve replaced by transplant other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate other and unspecified angina pectoris coronary atherosclerosis of native coronary artery anemia, unspecified personal history of malignant neoplasm of prostate personal history of malignant neoplasm of kidney other and unspecified hyperlipidemia aortic valve disorders other malignant lymphomas, unspecified site, extranodal and solid organ sites obstructive sleep apnea (adult)(pediatric) chronic kidney disease, unspecified acquired absence of kidney personal history of malignant neoplasm of kidney coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate obstructive sleep apnea (adult)(pediatric) personal history of other lymphatic and hematopoietic neoplasms personal history of malignant neoplasm of other sites aortic valve disorders 
other m 71 $nan$hematology blood hematocrit  31.1  %; hematology blood hematocrit  29.6  %; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  211  k ul; hematology blood platelet count  179  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  200  mg dl; chemistry blood glucose  335  mg dl; chemistry blood lactate dehydrogenase (ld)  480  iu l; chemistry blood albumin  3.7  g dl$sterile water  200  ml ; gabapentin  300  mg ; aspirin  81  mg ; latanoprost 0.005% ophth. soln.  1  drop ; multivitamins  1  tab ; sulfameth trimethoprim ss  1  tab ; folic acid  1  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; 5% dextrose  50  ml ; ondansetron  16  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; clarithromycin  500  mg ; sw  400  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; potassium chloride  80  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; lorazepam  0.5-1  mg ; dexamethasone  10  mg ; 0.9% sodium chloride  500  ml ; ifosfamide  2700  mg ; 0.9% sodium chloride  50  ml ; mesna  670  mg ; albuterol-ipratropium  1-2  puff ; etoposide  130  mg ; fluticasone propionate nasal  1  spry ; gabapentin  600  mg ; olanzapine  10  mg ; furosemide  20  mg ; furosemide  40  mg ; 
person on outside of car injured in collision with two- or three-wheeled motor vehicle in nontraffic accident obesity, unspecified other malignant lymphomas, unspecified site, extranodal and solid organ sites coronary atherosclerosis of native coronary artery personal history of tobacco use unspecified acquired hypothyroidism other chronic nonalcoholic liver disease personal history of malignant neoplasm of kidney chronic kidney disease, unspecified heart valve replaced by transplant other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate other and unspecified angina pectoris coronary atherosclerosis of native coronary artery anemia, unspecified personal history of malignant neoplasm of prostate personal history of malignant neoplasm of kidney other and unspecified hyperlipidemia aortic valve disorders other malignant lymphomas, unspecified site, extranodal and solid organ sites obstructive sleep apnea (adult)(pediatric) chronic kidney disease, unspecified acquired absence of kidney personal history of malignant neoplasm of kidney coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate obstructive sleep apnea (adult)(pediatric) personal history of other lymphatic and hematopoietic neoplasms personal history of malignant neoplasm of other sites aortic valve disorders 
other m 71 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  136  mg dl; chemistry blood lactate dehydrogenase (ld)  364  iu l; chemistry blood albumin  3.2  g dl$sterile water  200  ml ; gabapentin  300  mg ; aspirin  81  mg ; latanoprost 0.005% ophth. soln.  1  drop ; multivitamins  1  tab ; sulfameth trimethoprim ss  1  tab ; folic acid  1  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; 5% dextrose  50  ml ; ondansetron  16  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; clarithromycin  500  mg ; sw  400  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; potassium chloride  80  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; lorazepam  0.5-1  mg ; dexamethasone  10  mg ; 0.9% sodium chloride  500  ml ; ifosfamide  2700  mg ; 0.9% sodium chloride  50  ml ; mesna  670  mg ; albuterol-ipratropium  1-2  puff ; etoposide  130  mg ; fluticasone propionate nasal  1  spry ; gabapentin  600  mg ; olanzapine  10  mg ; furosemide  20  mg ; furosemide  40  mg ; vial  1  vial ; filgrastim  480  mcg ; 
person on outside of car injured in collision with two- or three-wheeled motor vehicle in nontraffic accident obesity, unspecified other malignant lymphomas, unspecified site, extranodal and solid organ sites coronary atherosclerosis of native coronary artery personal history of tobacco use unspecified acquired hypothyroidism other chronic nonalcoholic liver disease personal history of malignant neoplasm of kidney chronic kidney disease, unspecified heart valve replaced by transplant other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate other and unspecified angina pectoris coronary atherosclerosis of native coronary artery anemia, unspecified personal history of malignant neoplasm of prostate personal history of malignant neoplasm of kidney other and unspecified hyperlipidemia aortic valve disorders other malignant lymphomas, unspecified site, extranodal and solid organ sites obstructive sleep apnea (adult)(pediatric) chronic kidney disease, unspecified acquired absence of kidney personal history of malignant neoplasm of kidney coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate obstructive sleep apnea (adult)(pediatric) personal history of other lymphatic and hematopoietic neoplasms personal history of malignant neoplasm of other sites aortic valve disorders 
other m 71 $nan$nan$sterile water  200  ml ; gabapentin  300  mg ; aspirin  81  mg ; latanoprost 0.005% ophth. soln.  1  drop ; multivitamins  1  tab ; sulfameth trimethoprim ss  1  tab ; folic acid  1  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; clarithromycin  500  mg ; sw  400  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; potassium chloride  80  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; magnesium sulfate  4  gm ; lorazepam  0.5-1  mg ; albuterol-ipratropium  1-2  puff ; fluticasone propionate nasal  1  spry ; gabapentin  600  mg ; olanzapine  10  mg ; vial  1  vial ; filgrastim  480  mcg ; 
person on outside of car injured in collision with two- or three-wheeled motor vehicle in nontraffic accident obesity, unspecified other malignant lymphomas, unspecified site, extranodal and solid organ sites coronary atherosclerosis of native coronary artery personal history of tobacco use unspecified acquired hypothyroidism other chronic nonalcoholic liver disease personal history of malignant neoplasm of kidney chronic kidney disease, unspecified heart valve replaced by transplant other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate other and unspecified angina pectoris coronary atherosclerosis of native coronary artery anemia, unspecified personal history of malignant neoplasm of prostate personal history of malignant neoplasm of kidney other and unspecified hyperlipidemia aortic valve disorders other malignant lymphomas, unspecified site, extranodal and solid organ sites obstructive sleep apnea (adult)(pediatric) chronic kidney disease, unspecified acquired absence of kidney personal history of malignant neoplasm of kidney coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate obstructive sleep apnea (adult)(pediatric) personal history of other lymphatic and hematopoietic neoplasms personal history of malignant neoplasm of other sites aortic valve disorders 
white m 65 $nan$hematology blood hematocrit  37.1  %; hematology blood hematocrit  37.6  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  481  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood glucose  77  mg dl; chemistry blood albumin  3.6  g dl$1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; ns  1000  ml ; metoprolol succinate xl  25  mg ; fluconazole  100  mg ; nystatin  1,000,000  unit ; acetaminophen  650  mg ; guaifenesin  5-10  ml ; heparin  5000  unit ; 
 
white m 65 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  489  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  99  mg dl$1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol succinate xl  25  mg ; fluconazole  100  mg ; nystatin  1,000,000  unit ; acetaminophen  650  mg ; guaifenesin  5-10  ml ; heparin  5000  unit ; levofloxacin  750  mg ; metoprolol succinate xl  50  mg ; senna  1  tab ; bisacodyl  10  mg ; megestrol acetate  80  mg ; docusate sodium  100  mg ; megestrol acetate  400  mg ; 
 
white m 65 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  467  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry urine creatinine, urine  79  mg dl; chemistry urine sodium, urine  69  meq l; chemistry urine urea nitrogen, urine  325  mg dl; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  flush  3  ml ; fluconazole  100  mg ; nystatin  1,000,000  unit ; acetaminophen  650  mg ; guaifenesin  5-10  ml ; heparin  5000  unit ; levofloxacin  750  mg ; metoprolol succinate xl  50  mg ; senna  1  tab ; bisacodyl  10  mg ; docusate sodium  100  mg ; megestrol acetate  400  mg ; tamsulosin  0.4  mg ; d5ns  1000  ml ; 
 
white m 65 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  423  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  3  ml ; fluconazole  100  mg ; nystatin  1,000,000  unit ; acetaminophen  650  mg ; guaifenesin  5-10  ml ; heparin  5000  unit ; levofloxacin  750  mg ; senna  1  tab ; bisacodyl  10  mg ; docusate sodium  100  mg ; megestrol acetate  400  mg ; tamsulosin  0.4  mg ; guaifenesin-codeine phosphate  5-10  ml ; potassium chloride  40  meq ; sw  50  ml ; magnesium sulfate  2  gm ; 
 
white m 65 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  428  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3  ml ; fluconazole  100  mg ; nystatin  1,000,000  unit ; acetaminophen  650  mg ; heparin  5000  unit ; levofloxacin  750  mg ; senna  1  tab ; bisacodyl  10  mg ; docusate sodium  100  mg ; megestrol acetate  400  mg ; tamsulosin  0.4  mg ; guaifenesin-codeine phosphate  5-10  ml ; potassium chloride  40  meq ; sw  50  ml ; magnesium sulfate  2  gm ; pneumococcal vac polyvalent  0.5  ml ; 
 
white m 65 $nan$nan$sodium chloride 0.9%  flush  3  ml ; fluconazole  100  mg ; nystatin  1,000,000  unit ; acetaminophen  650  mg ; heparin  5000  unit ; levofloxacin  750  mg ; senna  1  tab ; bisacodyl  10  mg ; docusate sodium  100  mg ; megestrol acetate  400  mg ; tamsulosin  0.4  mg ; guaifenesin-codeine phosphate  5-10  ml ; pneumococcal vac polyvalent  0.5  ml ; 
 
white f 33 $nan$nan$aspirin  325  mg ; 
 
white f 33 $nan$hematology blood hematocrit  39.4  %; hematology blood hematocrit  36.1  %; hematology blood hemoglobin  13.3  g dl; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  358  k ul; hematology blood platelet count  277  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  81  mg dl; chemistry blood glucose  87  mg dl$aspirin  325  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; ns  1000  ml ; metoprolol tartrate  25  mg ; warfarin  5  mg ; metoprolol tartrate  10  mg ; heparin  5000  unit ; 
 
white f 33 $nan$nan$aspirin  325  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; warfarin  5  mg ; metoprolol tartrate  10  mg ; heparin  5000  unit ; 
 
white f 42 $temp  98.6  heartrate  74.0  resprate  16.0  o2sat  99.0  sbp  151.0  dbp  95.0  rhythm    pain  4  $hematology blood hematocrit  27.6  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  153  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine creatinine, urine  83  mg dl; chemistry urine sodium, urine  61  meq l; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  103  mg dl; chemistry urine protein creatinine ratio  0.1  mg mg$sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; cyanocobalamin  500  mcg ; famotidine  20  mg ; lamotrigine  200  mg ; levothyroxine sodium  200  mcg ; mycophenolate mofetil  1000  mg ; quetiapine fumarate  600  mg ; sulfameth trimethoprim ss  1  tab ; vitamin d  2000  unit ; acetaminophen  1000  mg ; oxycodone (immediate release)  5-10  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; maalox diphenhydramine lidocaine  15-30  ml ; hydromorphone (dilaudid)  0.25-0.5  mg ; tacrolimus  3  mg ; hydromorphone (dilaudid)  2  mg ; maalox diphenhydramine lidocaine  15  ml ; magnesium oxide  400  mg ; 5% dextrose  100  ml ; ganciclovir  260  mg ; 
essential (primary) hypertension major depressive disorder, single episode, unspecified other drug-induced agranulocytosis candidiasis of vulva and vagina candidal stomatitis fever presenting with conditions classified elsewhere adverse effect of antiviral drugs, initial encounter unspecified place in apartment as the place of occurrence of the external cause kidney transplant status chronic sinusitis, unspecified erythematous condition, unspecified pain in right leg kidney transplant status personal history of nicotine dependence major depressive disorder, single episode, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease acute kidney failure, unspecified pain in left leg effusion, right knee end stage renal disease other disturbances of skin sensation hypothyroidism, unspecified effusion, left knee candidiasis of vulva and vagina hyperkalemia chronic sinusitis, unspecified opioid abuse, in remission unspecified nephritic syndrome with unspecified morphologic changes constipation, unspecified anxiety disorder, unspecified hypothyroidism, unspecified major depressive disorder, single episode, unspecified personal history of other diseases of the nervous system and sense organs urgency of urination end stage renal disease acute posthemorrhagic anemia
white f 42 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  109  mg dl; chemistry blood lactate dehydrogenase (ld)  235  iu l$sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; cyanocobalamin  500  mcg ; famotidine  20  mg ; lamotrigine  200  mg ; levothyroxine sodium  200  mcg ; mycophenolate mofetil  1000  mg ; quetiapine fumarate  600  mg ; vitamin d  2000  unit ; acetaminophen  1000  mg ; oxycodone (immediate release)  5-10  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; maalox diphenhydramine lidocaine  15-30  ml ; hydromorphone (dilaudid)  0.25-0.5  mg ; tacrolimus  3  mg ; hydromorphone (dilaudid)  2  mg ; maalox diphenhydramine lidocaine  15  ml ; magnesium oxide  400  mg ; 5% dextrose  100  ml ; ganciclovir  260  mg ; allopurinol  100  mg ; dapsone  100  mg ; prednisone  5  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; lorazepam  0.5  mg ; sodium chloride 0.9%  flush  10-20  ml ; 
essential (primary) hypertension major depressive disorder, single episode, unspecified other drug-induced agranulocytosis candidiasis of vulva and vagina candidal stomatitis fever presenting with conditions classified elsewhere adverse effect of antiviral drugs, initial encounter unspecified place in apartment as the place of occurrence of the external cause kidney transplant status chronic sinusitis, unspecified erythematous condition, unspecified pain in right leg kidney transplant status personal history of nicotine dependence major depressive disorder, single episode, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease acute kidney failure, unspecified pain in left leg effusion, right knee end stage renal disease other disturbances of skin sensation hypothyroidism, unspecified effusion, left knee candidiasis of vulva and vagina hyperkalemia chronic sinusitis, unspecified opioid abuse, in remission unspecified nephritic syndrome with unspecified morphologic changes constipation, unspecified anxiety disorder, unspecified hypothyroidism, unspecified major depressive disorder, single episode, unspecified personal history of other diseases of the nervous system and sense organs urgency of urination end stage renal disease acute posthemorrhagic anemia
white f 42 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  174  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  160  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; cyanocobalamin  500  mcg ; famotidine  20  mg ; lamotrigine  200  mg ; levothyroxine sodium  200  mcg ; quetiapine fumarate  600  mg ; vitamin d  2000  unit ; acetaminophen  1000  mg ; oxycodone (immediate release)  5-10  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; maalox diphenhydramine lidocaine  15-30  ml ; tacrolimus  3  mg ; maalox diphenhydramine lidocaine  15  ml ; 5% dextrose  100  ml ; ganciclovir  260  mg ; allopurinol  100  mg ; dapsone  100  mg ; prednisone  5  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; lorazepam  0.5  mg ; sodium chloride 0.9%  flush  10-20  ml ; tacrolimus  4  mg ; 
essential (primary) hypertension major depressive disorder, single episode, unspecified other drug-induced agranulocytosis candidiasis of vulva and vagina candidal stomatitis fever presenting with conditions classified elsewhere adverse effect of antiviral drugs, initial encounter unspecified place in apartment as the place of occurrence of the external cause kidney transplant status chronic sinusitis, unspecified erythematous condition, unspecified pain in right leg kidney transplant status personal history of nicotine dependence major depressive disorder, single episode, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease acute kidney failure, unspecified pain in left leg effusion, right knee end stage renal disease other disturbances of skin sensation hypothyroidism, unspecified effusion, left knee candidiasis of vulva and vagina hyperkalemia chronic sinusitis, unspecified opioid abuse, in remission unspecified nephritic syndrome with unspecified morphologic changes constipation, unspecified anxiety disorder, unspecified hypothyroidism, unspecified major depressive disorder, single episode, unspecified personal history of other diseases of the nervous system and sense organs urgency of urination end stage renal disease acute posthemorrhagic anemia
white f 42 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; cyanocobalamin  500  mcg ; famotidine  20  mg ; lamotrigine  200  mg ; levothyroxine sodium  200  mcg ; quetiapine fumarate  600  mg ; vitamin d  2000  unit ; acetaminophen  1000  mg ; oxycodone (immediate release)  5-10  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; maalox diphenhydramine lidocaine  15-30  ml ; maalox diphenhydramine lidocaine  15  ml ; 5% dextrose  100  ml ; ganciclovir  260  mg ; allopurinol  100  mg ; dapsone  100  mg ; prednisone  5  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; lorazepam  0.5  mg ; sodium chloride 0.9%  flush  10-20  ml ; tacrolimus  4  mg ; 
essential (primary) hypertension major depressive disorder, single episode, unspecified other drug-induced agranulocytosis candidiasis of vulva and vagina candidal stomatitis fever presenting with conditions classified elsewhere adverse effect of antiviral drugs, initial encounter unspecified place in apartment as the place of occurrence of the external cause kidney transplant status chronic sinusitis, unspecified erythematous condition, unspecified pain in right leg kidney transplant status personal history of nicotine dependence major depressive disorder, single episode, unspecified hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease acute kidney failure, unspecified pain in left leg effusion, right knee end stage renal disease other disturbances of skin sensation hypothyroidism, unspecified effusion, left knee candidiasis of vulva and vagina hyperkalemia chronic sinusitis, unspecified opioid abuse, in remission unspecified nephritic syndrome with unspecified morphologic changes constipation, unspecified anxiety disorder, unspecified hypothyroidism, unspecified major depressive disorder, single episode, unspecified personal history of other diseases of the nervous system and sense organs urgency of urination end stage renal disease acute posthemorrhagic anemia
black african american f 51 $nan$hematology blood hematocrit  24.1  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  141  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  3.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  86  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ferrous sulfate  325  mg ; mycophenolate mofetil  750  mg ; sodium bicarbonate  2600  mg ; simethicone  40-80  mg ; acetaminophen  650  mg ; tacrolimus  3  mg ; heparin  5000  unit ; valacyclovir  500  mg ; 
other intraoperative complications of nervous system nicotine dependence, unspecified, uncomplicated iron deficiency anemia, unspecified other complication of kidney transplant patient's noncompliance with other medical treatment and regimen diarrhea, unspecified acute kidney failure, unspecified chronic kidney disease, stage 4 (severe) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure combined rheumatic disorders of mitral, aortic and tricuspid valves volume depletion, unspecified anoxic brain damage, not elsewhere classified systemic lupus erythematosus, unspecified herpesviral vulvovaginitis acidosis anemia in chronic kidney disease systemic lupus erythematosus, unspecified combined rheumatic disorders of mitral, aortic and tricuspid valves hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease anoxic brain damage, not elsewhere classified acute kidney failure, unspecified cough acidosis surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure herpesviral vulvovaginitis chronic kidney disease, stage 4 (severe) hypovolemia kidney transplant failure urinary tract infection, site not specified anemia in chronic kidney disease nicotine dependence, cigarettes, uncomplicated glomerular disease in systemic lupus erythematosus hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease pruritus, unspecified herpesviral vulvovaginitis pneumonia, unspecified organism nicotine dependence, cigarettes, uncomplicated kidney transplant status chronic kidney disease, stage 4 (severe) acidosis personal history of urinary (tract) infections anemia in chronic kidney disease unspecified place or not applicable tubulo-interstitial nephritis, not specified as acute or chronic hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fistula of vagina to large intestine surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
black african american f 51 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ferrous sulfate  325  mg ; mycophenolate mofetil  750  mg ; sodium bicarbonate  2600  mg ; simethicone  40-80  mg ; acetaminophen  650  mg ; tacrolimus  3  mg ; heparin  5000  unit ; valacyclovir  500  mg ; 
other intraoperative complications of nervous system nicotine dependence, unspecified, uncomplicated iron deficiency anemia, unspecified other complication of kidney transplant patient's noncompliance with other medical treatment and regimen diarrhea, unspecified acute kidney failure, unspecified chronic kidney disease, stage 4 (severe) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure combined rheumatic disorders of mitral, aortic and tricuspid valves volume depletion, unspecified anoxic brain damage, not elsewhere classified systemic lupus erythematosus, unspecified herpesviral vulvovaginitis acidosis anemia in chronic kidney disease systemic lupus erythematosus, unspecified combined rheumatic disorders of mitral, aortic and tricuspid valves hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease anoxic brain damage, not elsewhere classified acute kidney failure, unspecified cough acidosis surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure herpesviral vulvovaginitis chronic kidney disease, stage 4 (severe) hypovolemia kidney transplant failure urinary tract infection, site not specified anemia in chronic kidney disease nicotine dependence, cigarettes, uncomplicated glomerular disease in systemic lupus erythematosus hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease pruritus, unspecified herpesviral vulvovaginitis pneumonia, unspecified organism nicotine dependence, cigarettes, uncomplicated kidney transplant status chronic kidney disease, stage 4 (severe) acidosis personal history of urinary (tract) infections anemia in chronic kidney disease unspecified place or not applicable tubulo-interstitial nephritis, not specified as acute or chronic hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease fistula of vagina to large intestine surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
black african american f 35 $nan$hematology blood hematocrit  32.7  %$naloxone  40-80  mcg ; metoclopramide  10  mg ; ketorolac  15  mg ; ketorolac  30  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; hydrocortisone acetate ointment 1%  1  appl ; 
threatened premature labor, antepartum condition or complication previous cesarean delivery, antepartum condition or complication elderly multigravida, antepartum condition or complication other current conditions classifiable elsewhere of mother, antepartum condition or complication dehydration late vomiting of pregnancy, antepartum condition or complication headache other chronic pain abdominal pain, right lower quadrant other current conditions classifiable elsewhere of mother, antepartum condition or complication cervical shortening, antepartum condition or complication 
black african american f 35 $nan$nan$naloxone  40-80  mcg ; metoclopramide  10  mg ; ketorolac  15  mg ; ketorolac  30  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; hydrocortisone acetate ointment 1%  1  appl ; 
threatened premature labor, antepartum condition or complication previous cesarean delivery, antepartum condition or complication elderly multigravida, antepartum condition or complication other current conditions classifiable elsewhere of mother, antepartum condition or complication dehydration late vomiting of pregnancy, antepartum condition or complication headache other chronic pain abdominal pain, right lower quadrant other current conditions classifiable elsewhere of mother, antepartum condition or complication cervical shortening, antepartum condition or complication 
black african american f 35 $nan$nan$naloxone  40-80  mcg ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; hydrocortisone acetate ointment 1%  1  appl ; 
threatened premature labor, antepartum condition or complication previous cesarean delivery, antepartum condition or complication elderly multigravida, antepartum condition or complication other current conditions classifiable elsewhere of mother, antepartum condition or complication dehydration late vomiting of pregnancy, antepartum condition or complication headache other chronic pain abdominal pain, right lower quadrant other current conditions classifiable elsewhere of mother, antepartum condition or complication cervical shortening, antepartum condition or complication 
black african american f 35 $nan$nan$naloxone  40-80  mcg ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; hydrocortisone acetate ointment 1%  1  appl ; 
threatened premature labor, antepartum condition or complication previous cesarean delivery, antepartum condition or complication elderly multigravida, antepartum condition or complication other current conditions classifiable elsewhere of mother, antepartum condition or complication dehydration late vomiting of pregnancy, antepartum condition or complication headache other chronic pain abdominal pain, right lower quadrant other current conditions classifiable elsewhere of mother, antepartum condition or complication cervical shortening, antepartum condition or complication 
black african american f 35 $nan$nan$naloxone  40-80  mcg ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; hydrocortisone acetate ointment 1%  1  appl ; 
threatened premature labor, antepartum condition or complication previous cesarean delivery, antepartum condition or complication elderly multigravida, antepartum condition or complication other current conditions classifiable elsewhere of mother, antepartum condition or complication dehydration late vomiting of pregnancy, antepartum condition or complication headache other chronic pain abdominal pain, right lower quadrant other current conditions classifiable elsewhere of mother, antepartum condition or complication cervical shortening, antepartum condition or complication 
white m 63 $temp    heartrate  68.0  resprate  16.0  o2sat  99.0  sbp  127.0  dbp  82.0  rhythm    pain  0  $hematology blood hematocrit  37.4  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  167  mg dl$sodium chloride 0.9%  flush  3  ml ; diphenhydramine  25  mg ; loratadine  10  mg ; heparin  5000  unit ; prednisone  40  mg ; 
 
unknown m 66 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  174  mg dl; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  0.8  mmol l$sw  200  ml ; d5w  250  ml ; dopamine  400  mg ; sodium chloride 0.9%  1000  ml ; pantoprazole  40  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; clopidogrel  300  mg ; morphine sulfate  1-2  mg ; lorazepam  0.5-1  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; senna  8.6  mg ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; sw  600  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; clopidogrel  75  mg ; aspirin ec  81  mg ; docusate sodium  100  mg ; nicotine patch  14  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; atorvastatin  40  mg ; acetaminophen  650  mg ; lorazepam  1  mg ; ipratropium-albuterol neb  1  neb ; 
 
unknown m 66 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood urea nitrogen  49  mg dl; hematology blood inr(pt)  1.3  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  237  mg dl; chemistry blood glucose  278  mg dl; hematology urine glucose  300  mg dl$sw  200  ml ; pantoprazole  40  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; morphine sulfate  1-2  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; senna  8.6  mg ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; sw  600  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; clopidogrel  75  mg ; aspirin ec  81  mg ; docusate sodium  100  mg ; nicotine patch  14  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; atorvastatin  40  mg ; acetaminophen  650  mg ; ipratropium-albuterol neb  1  neb ; lisinopril  5  mg ; furosemide  20  mg ; simethicone  80  mg ; trazodone  50  mg ; 
 
unknown m 66 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  143  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  49  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  206  mg dl$sw  200  ml ; pantoprazole  40  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; morphine sulfate  1-2  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; senna  8.6  mg ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; sw  600  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; clopidogrel  75  mg ; aspirin ec  81  mg ; docusate sodium  100  mg ; nicotine patch  14  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; atorvastatin  40  mg ; acetaminophen  650  mg ; lisinopril  5  mg ; furosemide  20  mg ; simethicone  80  mg ; trazodone  50  mg ; atorvastatin  80  mg ; 
 
unknown m 66 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  194  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  235  mg dl; chemistry blood % hemoglobin a1c  10.3  %$sw  200  ml ; pantoprazole  40  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; morphine sulfate  1-2  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; senna  8.6  mg ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; sw  600  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; clopidogrel  75  mg ; aspirin ec  81  mg ; docusate sodium  100  mg ; nicotine patch  14  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  650  mg ; lisinopril  5  mg ; simethicone  80  mg ; trazodone  50  mg ; atorvastatin  80  mg ; quetiapine fumarate  12.5  mg ; quetiapine fumarate  25  mg ; 
 
unknown m 66 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  230  k ul; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  206  mg dl$pantoprazole  40  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; morphine sulfate  1-2  mg ; senna  8.6  mg ; clopidogrel  75  mg ; aspirin ec  81  mg ; docusate sodium  100  mg ; nicotine patch  14  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen  650  mg ; simethicone  80  mg ; trazodone  50  mg ; atorvastatin  80  mg ; 
 
hispanic latino m 58 $temp  98.2  heartrate  121.0  resprate  18.0  o2sat  97.0  sbp  85.0  dbp  63.0  rhythm    pain    ; temp    heartrate  113.0  resprate  18.0  o2sat  97.0  sbp  107.0  dbp  65.0  rhythm    pain  0  ; temp    heartrate  111.0  resprate  25.0  o2sat  100.0  sbp  102.0  dbp  61.0  rhythm    pain  0  ; temp    heartrate  105.0  resprate  24.0  o2sat  100.0  sbp  99.0  dbp  61.0  rhythm    pain  0  ; temp    heartrate  106.0  resprate  15.0  o2sat  98.0  sbp  98.0  dbp  66.0  rhythm    pain    ; temp    heartrate  111.0  resprate  24.0  o2sat  97.0  sbp  100.0  dbp  74.0  rhythm    pain    ; temp    heartrate  105.0  resprate  25.0  o2sat  97.0  sbp  95.0  dbp  81.0  rhythm    pain  0  ; temp    heartrate  109.0  resprate  23.0  o2sat  97.0  sbp  103.0  dbp  71.0  rhythm    pain  0  ; temp    heartrate  99.0  resprate  24.0  o2sat  96.0  sbp  112.0  dbp  71.0  rhythm    pain  0  ; temp    heartrate  101.0  resprate  20.0  o2sat  98.0  sbp  104.0  dbp  70.0  rhythm    pain  0  ; temp    heartrate  97.0  resprate  23.0  o2sat  97.0  sbp  111.0  dbp  69.0  rhythm    pain    ; temp    heartrate  99.0  resprate  28.0  o2sat  97.0  sbp  120.0  dbp  97.0  rhythm    pain    ; temp    heartrate  95.0  resprate  22.0  o2sat  97.0  sbp  148.0  dbp  89.0  rhythm    pain  0  ; temp    heartrate  95.0  resprate  25.0  o2sat  97.0  sbp  133.0  dbp  80.0  rhythm    pain    ; temp    heartrate  93.0  resprate  20.0  o2sat  93.0  sbp  103.0  dbp  51.0  rhythm    pain    ; temp    heartrate  92.0  resprate  20.0  o2sat  94.0  sbp  109.0  dbp  65.0  rhythm    pain    ; temp    heartrate  89.0  resprate  19.0  o2sat  95.0  sbp  102.0  dbp  63.0  rhythm    pain    ; temp    heartrate  82.0  resprate  18.0  o2sat  95.0  sbp  105.0  dbp  68.0  rhythm    pain    $hematology blood hematocrit  43.5  %; hematology blood hemoglobin  15.4  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  239  mg dl; chemistry blood albumin  4.1  g dl; blood gas blood lactate  3.9  mmol l$nan
chronic obstructive asthma with (acute) exacerbation pneumonia, organism unspecified other and unspecified hyperlipidemia obstructive sleep apnea (adult)(pediatric) hip joint replacement chronic kidney disease, unspecified other malignant lymphomas, unspecified site, extranodal and solid organ sites personal history of tobacco use esophageal reflux car passenger injured in collision with van in traffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of insulin depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use alcohol abuse, in remission other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of tobacco use other malignant lymphomas, unspecified site, extranodal and solid organ sites chronic obstructive asthma with (acute) exacerbation chronic kidney disease, stage iii (moderate) esophageal reflux diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled depressive disorder, not elsewhere classified obstructive sleep apnea (adult)(pediatric) hemorrhage of gastrointestinal tract, unspecified dysthymic disorder osteoarthrosis, unspecified whether generalized or localized, site unspecified nonspecific abnormal electrocardiogram [ecg] [ekg] abdominal pain, epigastric asthma, unspecified type, unspecified internal hemorrhoids without mention of complication constipation, unspecified unspecified essential hypertension other and unspecified alcohol dependence, in remission chronic obstructive asthma with (acute) exacerbation other iatrogenic hypotension long-term (current) use of steroids personal history of antineoplastic chemotherapy urinary tract infection, site not specified aseptic necrosis of head and neck of femur other acute postoperative pain other obstructive defects of renal pelvis and ureter volume depletion, unspecified obstructive sleep apnea (adult)(pediatric) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified large cell lymphoma, unspecified site, extranodal and solid organ sites
black african american f 64 $temp  98.6  heartrate  69.0  resprate  18.0  o2sat    sbp  124.0  dbp  65.0  rhythm    pain    $hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  102  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; lisinopril  40  mg ; omeprazole  40  mg ; citalopram  20  mg ; indomethacin  50  mg ; colchicine  0.6  mg ; acetaminophen  1000  mg ; potassium chloride  40  meq ; aspirin  650  mg ; 
mitral valve disorders abnormal involuntary movements obstructive sleep apnea (adult)(pediatric) insomnia, unspecified unspecified essential hypertension family history of ischemic heart disease bariatric surgery status iron deficiency anemia, unspecified other chest pain depressive disorder, not elsewhere classified person boarding or alighting a pedal cycle injured in collision with fixed or stationary object obstructive sleep apnea (adult)(pediatric) bicipital tenosynovitis unspecified essential hypertension bariatric surgery status osteoarthrosis, localized, not specified whether primary or secondary, shoulder region obstructive sleep apnea (adult)(pediatric) driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident unspecified essential hypertension lack of housing major depressive affective disorder, recurrent episode, unspecified unspecified sleep apnea bariatric surgery status depressive disorder, not elsewhere classified osteoarthrosis, unspecified whether generalized or localized, other specified sites other, mixed, or unspecified drug abuse, in remission osteoarthrosis, unspecified whether generalized or localized, lower leg suicidal ideation osteoarthrosis, unspecified whether generalized or localized, shoulder region unspecified essential hypertension personal history of tobacco use alcohol abuse, in remission other chest pain unspecified essential hypertension body mass index 39.0-39.9, adult osteoarthrosis, unspecified whether generalized or localized, site unspecified morbid obesity unspecified essential hypertension obstructive sleep apnea (adult)(pediatric) 
white m 36 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  257  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  3  ml ; oxycodone-acetaminophen  1-2  tab ; morphine sulfate  2  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin  5000  unit ; multivitamins  1  tab ; 
 
white m 36 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  274  k ul; chemistry blood creatinine  0.7  mg dl; chemistry blood urea nitrogen  10  mg dl$sodium chloride 0.9%  flush  3  ml ; oxycodone-acetaminophen  1-2  tab ; morphine sulfate  2  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin  5000  unit ; multivitamins  1  tab ; ondansetron  4  mg ; morphine sulfate ir  15-30  mg ; ondansetron  8  mg ; prochlorperazine  10  mg ; 
 
white m 36 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  259  k ul; chemistry blood creatinine  1.0  mg dl; chemistry blood urea nitrogen  10  mg dl$sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin  5000  unit ; multivitamins  1  tab ; morphine sulfate ir  15-30  mg ; ondansetron  8  mg ; prochlorperazine  10  mg ; sulfameth trimethoprim ds  1  tab ; 
 
white m 36 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  280  k ul; chemistry blood creatinine  1.0  mg dl; chemistry blood urea nitrogen  10  mg dl$sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin  5000  unit ; multivitamins  1  tab ; morphine sulfate ir  15-30  mg ; ondansetron  8  mg ; prochlorperazine  10  mg ; sulfameth trimethoprim ds  1  tab ; docusate sodium  100  mg ; 
 
white m 65 $nan$nan$diazepam  5  mg ; hydrochlorothiazide  25  mg ; moexipril  15  mg ; allopurinol  100  mg ; allopurinol  300  mg ; 
 
white m 65 $nan$nan$diazepam  5  mg ; hydrochlorothiazide  25  mg ; moexipril  15  mg ; allopurinol  100  mg ; allopurinol  300  mg ; pneumococcal vac polyvalent  0.5  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  325-650  mg ; morphine sulfate  1-3  mg ; bisacodyl  10  mg ; senna  1  tab ; verapamil sr  240  mg ; pantoprazole  40  mg ; oxycodone-acetaminophen  1-2  tab ; docusate sodium  100  mg ; 
 
white m 65 $nan$nan$diazepam  5  mg ; hydrochlorothiazide  25  mg ; moexipril  15  mg ; allopurinol  100  mg ; allopurinol  300  mg ; pneumococcal vac polyvalent  0.5  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  325-650  mg ; morphine sulfate  1-3  mg ; bisacodyl  10  mg ; senna  1  tab ; verapamil sr  240  mg ; pantoprazole  40  mg ; oxycodone-acetaminophen  1-2  tab ; docusate sodium  100  mg ; 
 
white f 82 $temp  97.7  heartrate  64.0  resprate  22.0  o2sat  96.0  sbp  139.0  dbp  54.0  rhythm    pain  0  ; temp  97.5  heartrate  53.0  resprate  18.0  o2sat  95.0  sbp  139.0  dbp  54.0  rhythm  sb  pain  0  ; temp    heartrate  59.0  resprate  18.0  o2sat  97.0  sbp  140.0  dbp  53.0  rhythm  sb  pain  0  ; temp  97.8  heartrate  59.0  resprate  18.0  o2sat  96.0  sbp  136.0  dbp  59.0  rhythm    pain    $nan$senna  8.6  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; heparin  5000  unit ; amlodipine  5  mg ; atenolol  25  mg ; tramadol (ultram)  25  mg ; docusate sodium  100  mg ; 
 
white f 82 $nan$hematology blood hematocrit  39.7  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood glucose  90  mg dl; chemistry blood % hemoglobin a1c  5.8  %$senna  8.6  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; heparin  5000  unit ; amlodipine  5  mg ; atenolol  25  mg ; tramadol (ultram)  25  mg ; docusate sodium  100  mg ; prednisone  40  mg ; azithromycin  250  mg ; furosemide  10  mg ; 
 
white f 82 $nan$chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  73  mg dl$senna  8.6  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; heparin  5000  unit ; amlodipine  5  mg ; atenolol  25  mg ; tramadol (ultram)  25  mg ; docusate sodium  100  mg ; prednisone  40  mg ; azithromycin  250  mg ; furosemide  10  mg ; tramadol (ultram)  50  mg ; 
 
white f 82 $nan$nan$senna  8.6  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; heparin  5000  unit ; amlodipine  5  mg ; atenolol  25  mg ; docusate sodium  100  mg ; prednisone  40  mg ; azithromycin  250  mg ; tramadol (ultram)  50  mg ; lidocaine 5% patch  1  ptch ; rivaroxaban  15  mg ; 
 
white f 82 $nan$nan$senna  8.6  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; amlodipine  5  mg ; atenolol  25  mg ; docusate sodium  100  mg ; prednisone  40  mg ; azithromycin  250  mg ; tramadol (ultram)  50  mg ; lidocaine 5% patch  1  ptch ; rivaroxaban  15  mg ; aspirin  81  mg ; atorvastatin  20  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; 
 
white f 82 $nan$hematology blood hematocrit  40.9  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  258  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood glucose  76  mg dl$senna  8.6  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; amlodipine  5  mg ; atenolol  25  mg ; docusate sodium  100  mg ; prednisone  40  mg ; azithromycin  250  mg ; tramadol (ultram)  50  mg ; lidocaine 5% patch  1  ptch ; aspirin  81  mg ; atorvastatin  20  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; 
 
white m 58 $nan$hematology blood hematocrit  40.5  %; hematology blood hematocrit  39.5  %; hematology blood hemoglobin  14.4  g dl; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  194  k ul; hematology blood platelet count  190  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  122  mg dl; chemistry blood glucose  141  mg dl$doxazosin  2  mg ; valsartan  160  mg ; multivitamins w minerals  1  tab ; magnesium oxide  140  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; oxycodone-acetaminophen  1-2  tab ; heparin  5000  unit ; diphenhydramine  50  mg ; fentanyl citrate  25-100  mcg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; pantoprazole  40  mg ; gabapentin  300  mg ; insulin  0  unit ; ropinirole  10  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; tolterodine  2  mg ; hydrocodone-acetaminophen  1-2  tab ; quinine sulfate  648  mg ; insulin  15  unit ; 
esophageal reflux impotence of organic origin polyneuropathy in diabetes surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled other mechanical complication of genitourinary device, implant, and graft background diabetic retinopathy accidents occurring in unspecified place 
white m 58 $nan$nan$doxazosin  2  mg ; valsartan  160  mg ; multivitamins w minerals  1  tab ; magnesium oxide  140  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; oxycodone-acetaminophen  1-2  tab ; heparin  5000  unit ; diphenhydramine  50  mg ; fentanyl citrate  25-100  mcg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; pantoprazole  40  mg ; gabapentin  300  mg ; insulin  0  unit ; ropinirole  10  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; tolterodine  2  mg ; hydrocodone-acetaminophen  1-2  tab ; quinine sulfate  648  mg ; insulin  15  unit ; cyclobenzaprine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; 
esophageal reflux impotence of organic origin polyneuropathy in diabetes surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled other mechanical complication of genitourinary device, implant, and graft background diabetic retinopathy accidents occurring in unspecified place 
white m 58 $nan$nan$doxazosin  2  mg ; valsartan  160  mg ; multivitamins w minerals  1  tab ; magnesium oxide  140  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; oxycodone-acetaminophen  1-2  tab ; heparin  5000  unit ; fentanyl citrate  25-100  mcg ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; pantoprazole  40  mg ; gabapentin  300  mg ; insulin  0  unit ; ropinirole  10  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; tolterodine  2  mg ; hydrocodone-acetaminophen  1-2  tab ; quinine sulfate  648  mg ; insulin  15  unit ; cyclobenzaprine  10  mg ; sw  100  ml ; magnesium sulfate  4  gm ; 
esophageal reflux impotence of organic origin polyneuropathy in diabetes surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled other mechanical complication of genitourinary device, implant, and graft background diabetic retinopathy accidents occurring in unspecified place 
white f 70 $nan$nan$insulin  40  unit ; 
 
white f 70 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  278  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  146  mg dl$insulin  40  unit ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  0.5  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; albuterol 0.083% neb soln  1  neb ; morphine sulfate  1-2  mg ; senna  8.6  mg ; 0.45% sodium chloride  1000  ml ; hydralazine  10  mg ; insulin  0  unit ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; pregabalin  25  mg ; pregabalin  75  mg ; morphine sr (ms contin)  30  mg ; insulin  20  unit ; quetiapine fumarate  50  mg ; trazodone  50  mg ; guaifenesin er  600  mg ; amlodipine  5  mg ; aspirin  81  mg ; ascorbic acid  500  mg ; furosemide  80  mg ; spironolactone  50  mg ; multivitamins  1  tab ; vitamin d  2000  unit ; duloxetine  60  mg ; metformin (glucophage)  500  mg ; 
 
white f 70 $nan$nan$insulin  40  unit ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  0.5  mg ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; morphine sulfate  1-2  mg ; senna  8.6  mg ; hydralazine  10  mg ; insulin  0  unit ; docusate sodium  100  mg ; fluticasone propionate 110mcg  2  puff ; pregabalin  25  mg ; pregabalin  75  mg ; morphine sr (ms contin)  30  mg ; insulin  20  unit ; quetiapine fumarate  50  mg ; trazodone  50  mg ; guaifenesin er  600  mg ; amlodipine  5  mg ; aspirin  81  mg ; ascorbic acid  500  mg ; furosemide  80  mg ; spironolactone  50  mg ; multivitamins  1  tab ; vitamin d  2000  unit ; duloxetine  60  mg ; metformin (glucophage)  500  mg ; 
 
white m 80 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  177  mg dl; chemistry blood albumin  4.1  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; carvedilol  37.5  mg ; simvastatin  10  mg ; ranolazine er  500  mg ; clopidogrel  75  mg ; folic acid  1  mg ; levothyroxine sodium  88  mcg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; acetaminophen  500-1000  mg ; 
aortic valve disorders pure hypercholesterolemia right bundle branch block and left anterior fascicular block chronic kidney disease, unspecified esophagitis, unspecified esophageal reflux diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction unspecified essential hypertension hypotension, unspecified acute posthemorrhagic anemia helicobacter pylori [h. pylori] coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified sprains and strains of other specified sites of shoulder and upper arm diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other bilateral bundle branch block aortic valve disorders coronary atherosclerosis of native coronary artery rotator cuff (capsule) sprain chronic kidney disease, unspecified other and unspecified hyperlipidemia fall from other slipping, tripping, or stumbling 
white m 80 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood glucose  167  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; simvastatin  10  mg ; ranolazine er  500  mg ; clopidogrel  75  mg ; folic acid  1  mg ; levothyroxine sodium  88  mcg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; acetaminophen  500-1000  mg ; aspirin  81  mg ; polyethylene glycol  17  g ; sucralfate  1  gm ; 
aortic valve disorders pure hypercholesterolemia right bundle branch block and left anterior fascicular block chronic kidney disease, unspecified esophagitis, unspecified esophageal reflux diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction unspecified essential hypertension hypotension, unspecified acute posthemorrhagic anemia helicobacter pylori [h. pylori] coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified sprains and strains of other specified sites of shoulder and upper arm diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other bilateral bundle branch block aortic valve disorders coronary atherosclerosis of native coronary artery rotator cuff (capsule) sprain chronic kidney disease, unspecified other and unspecified hyperlipidemia fall from other slipping, tripping, or stumbling 
white m 80 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  129  k ul; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  23  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; simvastatin  10  mg ; ranolazine er  500  mg ; clopidogrel  75  mg ; folic acid  1  mg ; levothyroxine sodium  88  mcg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  500-1000  mg ; aspirin  81  mg ; polyethylene glycol  17  g ; sucralfate  1  gm ; senna  8.6  mg ; bisacodyl  10  mg ; 
aortic valve disorders pure hypercholesterolemia right bundle branch block and left anterior fascicular block chronic kidney disease, unspecified esophagitis, unspecified esophageal reflux diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction unspecified essential hypertension hypotension, unspecified acute posthemorrhagic anemia helicobacter pylori [h. pylori] coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified sprains and strains of other specified sites of shoulder and upper arm diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other bilateral bundle branch block aortic valve disorders coronary atherosclerosis of native coronary artery rotator cuff (capsule) sprain chronic kidney disease, unspecified other and unspecified hyperlipidemia fall from other slipping, tripping, or stumbling 
white m 80 $nan$hematology blood hematocrit  26.3  %; hematology blood platelet count  135  k ul; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood urea nitrogen  19  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; simvastatin  10  mg ; ranolazine er  500  mg ; clopidogrel  75  mg ; folic acid  1  mg ; levothyroxine sodium  88  mcg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  500-1000  mg ; aspirin  81  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; bisacodyl  10  mg ; 
aortic valve disorders pure hypercholesterolemia right bundle branch block and left anterior fascicular block chronic kidney disease, unspecified esophagitis, unspecified esophageal reflux diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction unspecified essential hypertension hypotension, unspecified acute posthemorrhagic anemia helicobacter pylori [h. pylori] coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified sprains and strains of other specified sites of shoulder and upper arm diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other bilateral bundle branch block aortic valve disorders coronary atherosclerosis of native coronary artery rotator cuff (capsule) sprain chronic kidney disease, unspecified other and unspecified hyperlipidemia fall from other slipping, tripping, or stumbling 
white m 80 $nan$hematology blood hematocrit  27.4  %; hematology blood platelet count  148  k ul; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood urea nitrogen  20  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; simvastatin  10  mg ; ranolazine er  500  mg ; clopidogrel  75  mg ; folic acid  1  mg ; levothyroxine sodium  88  mcg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  500-1000  mg ; aspirin  81  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; 
aortic valve disorders pure hypercholesterolemia right bundle branch block and left anterior fascicular block chronic kidney disease, unspecified esophagitis, unspecified esophageal reflux diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction unspecified essential hypertension hypotension, unspecified acute posthemorrhagic anemia helicobacter pylori [h. pylori] coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified sprains and strains of other specified sites of shoulder and upper arm diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other bilateral bundle branch block aortic valve disorders coronary atherosclerosis of native coronary artery rotator cuff (capsule) sprain chronic kidney disease, unspecified other and unspecified hyperlipidemia fall from other slipping, tripping, or stumbling 
white m 80 $nan$hematology blood hematocrit  26.8  %; hematology blood platelet count  143  k ul$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; simvastatin  10  mg ; ranolazine er  500  mg ; clopidogrel  75  mg ; folic acid  1  mg ; levothyroxine sodium  88  mcg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  500-1000  mg ; aspirin  81  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; 
aortic valve disorders pure hypercholesterolemia right bundle branch block and left anterior fascicular block chronic kidney disease, unspecified esophagitis, unspecified esophageal reflux diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction unspecified essential hypertension hypotension, unspecified acute posthemorrhagic anemia helicobacter pylori [h. pylori] coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified sprains and strains of other specified sites of shoulder and upper arm diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other bilateral bundle branch block aortic valve disorders coronary atherosclerosis of native coronary artery rotator cuff (capsule) sprain chronic kidney disease, unspecified other and unspecified hyperlipidemia fall from other slipping, tripping, or stumbling 
white m 80 $nan$hematology blood hematocrit  26.2  %; hematology blood platelet count  154  k ul; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; simvastatin  10  mg ; ranolazine er  500  mg ; clopidogrel  75  mg ; folic acid  1  mg ; levothyroxine sodium  88  mcg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  500-1000  mg ; aspirin  81  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; lisinopril  40  mg ; metformin (glucophage)  750  mg ; 
aortic valve disorders pure hypercholesterolemia right bundle branch block and left anterior fascicular block chronic kidney disease, unspecified esophagitis, unspecified esophageal reflux diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled chronic or unspecified duodenal ulcer with hemorrhage, without mention of obstruction unspecified essential hypertension hypotension, unspecified acute posthemorrhagic anemia helicobacter pylori [h. pylori] coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified sprains and strains of other specified sites of shoulder and upper arm diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other bilateral bundle branch block aortic valve disorders coronary atherosclerosis of native coronary artery rotator cuff (capsule) sprain chronic kidney disease, unspecified other and unspecified hyperlipidemia fall from other slipping, tripping, or stumbling 
white m 67 $temp  98.8  heartrate  66.0  resprate  20.0  o2sat  97.0  sbp  113.0  dbp  70.0  rhythm    pain    ; temp  98.8  heartrate  66.0  resprate  20.0  o2sat  97.0  sbp  113.0  dbp  70.0  rhythm    pain    $hematology blood hematocrit  39.8  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  425  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; pantoprazole  40  mg ; tamsulosin  0.4  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; heparin  5000  unit ; sodium chloride 0.9%  1000  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; metoprolol succinate xl  25  mg ; d5 1 2ns  1000  ml ; 
accidents occurring in residential institution personal history of tobacco use atrial fibrillation benign carcinoid tumor of other sites other digestive system complications paralytic ileus removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of malignant neoplasm of prostate cardiac complications, not elsewhere classified mitral valve insufficiency and aortic valve insufficiency
white m 67 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  363  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  132  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; tamsulosin  0.4  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; heparin  5000  unit ; sodium chloride 0.9%  1000  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; metoprolol succinate xl  25  mg ; d5 1 2ns  1000  ml ; docusate sodium  100  mg ; senna  8.6  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; milk of magnesia  30  ml ; simethicone  40-80  mg ; rivaroxaban  20  mg ; bisacodyl  10  mg ; 
accidents occurring in residential institution personal history of tobacco use atrial fibrillation benign carcinoid tumor of other sites other digestive system complications paralytic ileus removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of malignant neoplasm of prostate cardiac complications, not elsewhere classified mitral valve insufficiency and aortic valve insufficiency
white m 67 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  409  k ul$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; tamsulosin  0.4  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; sodium chloride 0.9%  1000  ml ; metoprolol succinate xl  25  mg ; docusate sodium  100  mg ; senna  8.6  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; milk of magnesia  30  ml ; simethicone  40-80  mg ; rivaroxaban  20  mg ; bisacodyl  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; 
accidents occurring in residential institution personal history of tobacco use atrial fibrillation benign carcinoid tumor of other sites other digestive system complications paralytic ileus removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of malignant neoplasm of prostate cardiac complications, not elsewhere classified mitral valve insufficiency and aortic valve insufficiency
white m 78 $nan$nan$docusate sodium  100  mg ; valsartan  160  mg ; 
 
white m 78 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  360  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  98  mg dl$docusate sodium  100  mg ; valsartan  160  mg ; prochlorperazine  10  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; senna  1  tab ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; azithromycin  250  mg ; 0.9% sodium chloride  500  ml ; heparin  5000  unit ; 
 
white m 78 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  324  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  101  mg dl$docusate sodium  100  mg ; valsartan  160  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; senna  1  tab ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; azithromycin  250  mg ; heparin  5000  unit ; fluticasone-salmeterol diskus (250 50)   1  inh ; trazodone  25  mg ; prednisone  60  mg ; 
 
white m 78 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  392  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood glucose  210  mg dl$docusate sodium  100  mg ; valsartan  160  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; senna  1  tab ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; azithromycin  250  mg ; heparin  5000  unit ; fluticasone-salmeterol diskus (250 50)   1  inh ; trazodone  25  mg ; prednisone  60  mg ; acetaminophen  325-650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; cefpodoxime proxetil  200  mg ; 
 
white m 78 $nan$nan$docusate sodium  100  mg ; valsartan  160  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; senna  1  tab ; azithromycin  250  mg ; heparin  5000  unit ; fluticasone-salmeterol diskus (250 50)   1  inh ; prednisone  60  mg ; acetaminophen  325-650  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; cefpodoxime proxetil  200  mg ; 
 
white f 27 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood chloride  114  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  167  mg dl; chemistry blood glucose  211  mg dl; blood gas blood lactate  1.1  mmol l$influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; ondansetron  4  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; bag  50  ml ; magnesium sulfate  2  gm ; humalog  14  units ; lisinopril  10  mg ; insulin  10  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; magnesium oxide  400  mg ; levemir  27  units ; 
background diabetic retinopathy dehydration diabetes with ketoacidosis, type i [juvenile type], uncontrolled long-term (current) use of insulin diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled other and unspecified noninfectious gastroenteritis and colitis background diabetic retinopathy diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diabetes with ketoacidosis, type i [juvenile type], uncontrolled 
white f 76 $nan$hematology blood hematocrit  23.1  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  354  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  112  mg dl; chemistry blood lactate dehydrogenase (ld)  243  iu l; blood gas blood lactate  2.0  mmol l$nan
 
white f 76 $nan$hematology blood hematocrit  21.8  %; hematology blood hemoglobin  6.6  g dl; hematology blood platelet count  354  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  107  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; 0.9% sodium chloride  1000  ml ; docusate sodium  100  mg ; heparin  5000  unit ; hydrochlorothiazide  25  mg ; ferrous sulfate  325  mg ; aspirin ec  325  mg ; amlodipine  2.5  mg ; 
 
white f 76 $nan$hematology blood hematocrit  26.1  %; hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  319  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; hydrochlorothiazide  25  mg ; ferrous sulfate  325  mg ; amlodipine  2.5  mg ; 
 
white f 50 $temp  97.7  heartrate  76.0  resprate  18.0  o2sat  97.0  sbp  103.0  dbp  56.0  rhythm    pain  2  $hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  302  k ul$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; docusate sodium  100  mg ; heparin  5000  unit ; lansoprazole oral disintegrating tab  30  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetaminophen-caff-butalbital  1  tab ; d5 1 2ns  1000  ml ; ciprofloxacin hcl  500  mg ; lorazepam  0.5  mg ; zolpidem tartrate  2.5  mg ; 
acquired absence of bilateral breasts and nipples family history of malignant neoplasm of digestive organs other seasonal allergic rhinitis other specified places as the place of occurrence of the external cause family history of malignant neoplasm of breast other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure gastro-esophageal reflux disease without esophagitis genetic susceptibility to other disease postprocedural hematoma of a musculoskeletal structure following other procedure encounter for prophylactic removal of breast personal history of nicotine dependence genetic carrier of other disease family history of malignant neoplasm of breast gastro-esophageal reflux disease without esophagitis family history of malignant neoplasm of ovary 
white f 50 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  298  k ul$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; heparin  5000  unit ; lansoprazole oral disintegrating tab  30  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetaminophen-caff-butalbital  1  tab ; d5 1 2ns  1000  ml ; ciprofloxacin hcl  500  mg ; lorazepam  0.5  mg ; zolpidem tartrate  2.5  mg ; polyethylene glycol  17  g ; 
acquired absence of bilateral breasts and nipples family history of malignant neoplasm of digestive organs other seasonal allergic rhinitis other specified places as the place of occurrence of the external cause family history of malignant neoplasm of breast other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure gastro-esophageal reflux disease without esophagitis genetic susceptibility to other disease postprocedural hematoma of a musculoskeletal structure following other procedure encounter for prophylactic removal of breast personal history of nicotine dependence genetic carrier of other disease family history of malignant neoplasm of breast gastro-esophageal reflux disease without esophagitis family history of malignant neoplasm of ovary 
white f 50 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  302  k ul$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; heparin  5000  unit ; lansoprazole oral disintegrating tab  30  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetaminophen-caff-butalbital  1  tab ; d5 1 2ns  1000  ml ; ciprofloxacin hcl  500  mg ; lorazepam  0.5  mg ; zolpidem tartrate  2.5  mg ; polyethylene glycol  17  g ; sodium chloride nasal  1-2  spry ; sulfameth trimethoprim ds  2  tab ; 
acquired absence of bilateral breasts and nipples family history of malignant neoplasm of digestive organs other seasonal allergic rhinitis other specified places as the place of occurrence of the external cause family history of malignant neoplasm of breast other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure gastro-esophageal reflux disease without esophagitis genetic susceptibility to other disease postprocedural hematoma of a musculoskeletal structure following other procedure encounter for prophylactic removal of breast personal history of nicotine dependence genetic carrier of other disease family history of malignant neoplasm of breast gastro-esophageal reflux disease without esophagitis family history of malignant neoplasm of ovary 
white f 50 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  344  k ul$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; heparin  5000  unit ; lansoprazole oral disintegrating tab  30  mg ; acetaminophen-caff-butalbital  1  tab ; ciprofloxacin hcl  500  mg ; lorazepam  0.5  mg ; zolpidem tartrate  2.5  mg ; polyethylene glycol  17  g ; sodium chloride nasal  1-2  spry ; sulfameth trimethoprim ds  2  tab ; 
acquired absence of bilateral breasts and nipples family history of malignant neoplasm of digestive organs other seasonal allergic rhinitis other specified places as the place of occurrence of the external cause family history of malignant neoplasm of breast other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure gastro-esophageal reflux disease without esophagitis genetic susceptibility to other disease postprocedural hematoma of a musculoskeletal structure following other procedure encounter for prophylactic removal of breast personal history of nicotine dependence genetic carrier of other disease family history of malignant neoplasm of breast gastro-esophageal reflux disease without esophagitis family history of malignant neoplasm of ovary 
black african american f 95 $temp  98.1  heartrate  73.0  resprate  16.0  o2sat    sbp  125.0  dbp  63.0  rhythm    pain    $hematology blood hematocrit  28.8  %; hematology blood hemoglobin  8.9  g dl; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  52  mg dl; hematology urine wbc  16  # hpf; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  118  mg dl$0.45% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  5000  unit ; metoprolol tartrate  75  mg ; furosemide  80  mg ; losartan potassium  25  mg ; calcium carbonate  500  mg ; acetaminophen  500  mg ; oxycodone (immediate release)   2.5  mg ; lidocaine 5% ointment  1  appl ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  1000  mg ; calcitriol  0.25  mcg ; colchicine  0.6  mg ; ciprofloxacin hcl  250  mg ; guaifenesin  5  ml ; 
dehydration hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hypotension, unspecified anemia in chronic kidney disease nonspecific abnormal electrocardiogram [ecg] [ekg] rheumatoid arthritis cardiac pacemaker in situ osteoporosis, unspecified other respiratory abnormalities iron deficiency anemia, unspecified chronic kidney disease, unspecified dysuria embolism and thrombosis of thoracic aorta other respiratory abnormalities chronic kidney disease, stage iv (severe) thoracoabdominal aneurysm, without mention of rupture thrombocytopenia, unspecified chest pain, unspecified anemia in chronic kidney disease hyperosmolality and/or hypernatremia pulmonary collapse chronic airway obstruction, not elsewhere classified other diseases of lung, not elsewhere classified osteoporosis, unspecified chronic kidney disease, stage iii (moderate) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other respiratory abnormalities 
black african american f 95 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.1  g dl; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  105  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; metoprolol tartrate  75  mg ; furosemide  80  mg ; losartan potassium  25  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)   2.5  mg ; lidocaine 5% ointment  1  appl ; docusate sodium  100  mg ; senna  1  tab ; calcitriol  0.25  mcg ; colchicine  0.6  mg ; ciprofloxacin hcl  250  mg ; guaifenesin  5  ml ; oxycodone (immediate release)   2.5-5  mg ; potassium chloride (powder)  10  meq ; 
dehydration hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hypotension, unspecified anemia in chronic kidney disease nonspecific abnormal electrocardiogram [ecg] [ekg] rheumatoid arthritis cardiac pacemaker in situ osteoporosis, unspecified other respiratory abnormalities iron deficiency anemia, unspecified chronic kidney disease, unspecified dysuria embolism and thrombosis of thoracic aorta other respiratory abnormalities chronic kidney disease, stage iv (severe) thoracoabdominal aneurysm, without mention of rupture thrombocytopenia, unspecified chest pain, unspecified anemia in chronic kidney disease hyperosmolality and/or hypernatremia pulmonary collapse chronic airway obstruction, not elsewhere classified other diseases of lung, not elsewhere classified osteoporosis, unspecified chronic kidney disease, stage iii (moderate) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other respiratory abnormalities 
black african american f 95 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  219  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; metoprolol tartrate  75  mg ; furosemide  80  mg ; losartan potassium  25  mg ; calcium carbonate  500  mg ; lidocaine 5% ointment  1  appl ; docusate sodium  100  mg ; senna  1  tab ; calcitriol  0.25  mcg ; ciprofloxacin hcl  250  mg ; guaifenesin  5  ml ; oxycodone (immediate release)   2.5-5  mg ; potassium chloride (powder)  10  meq ; prednisone  20  mg ; 
dehydration hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hypotension, unspecified anemia in chronic kidney disease nonspecific abnormal electrocardiogram [ecg] [ekg] rheumatoid arthritis cardiac pacemaker in situ osteoporosis, unspecified other respiratory abnormalities iron deficiency anemia, unspecified chronic kidney disease, unspecified dysuria embolism and thrombosis of thoracic aorta other respiratory abnormalities chronic kidney disease, stage iv (severe) thoracoabdominal aneurysm, without mention of rupture thrombocytopenia, unspecified chest pain, unspecified anemia in chronic kidney disease hyperosmolality and/or hypernatremia pulmonary collapse chronic airway obstruction, not elsewhere classified other diseases of lung, not elsewhere classified osteoporosis, unspecified chronic kidney disease, stage iii (moderate) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other respiratory abnormalities 
black african american f 95 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  152  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; metoprolol tartrate  75  mg ; furosemide  80  mg ; losartan potassium  25  mg ; calcium carbonate  500  mg ; lidocaine 5% ointment  1  appl ; docusate sodium  100  mg ; senna  1  tab ; calcitriol  0.25  mcg ; ciprofloxacin hcl  250  mg ; guaifenesin  5  ml ; oxycodone (immediate release)   2.5-5  mg ; prednisone  20  mg ; sodium polystyrene sulfonate  30  gm ; polyethylene glycol  17  g ; 
dehydration hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hypotension, unspecified anemia in chronic kidney disease nonspecific abnormal electrocardiogram [ecg] [ekg] rheumatoid arthritis cardiac pacemaker in situ osteoporosis, unspecified other respiratory abnormalities iron deficiency anemia, unspecified chronic kidney disease, unspecified dysuria embolism and thrombosis of thoracic aorta other respiratory abnormalities chronic kidney disease, stage iv (severe) thoracoabdominal aneurysm, without mention of rupture thrombocytopenia, unspecified chest pain, unspecified anemia in chronic kidney disease hyperosmolality and/or hypernatremia pulmonary collapse chronic airway obstruction, not elsewhere classified other diseases of lung, not elsewhere classified osteoporosis, unspecified chronic kidney disease, stage iii (moderate) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other respiratory abnormalities 
black african american f 95 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  302  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  52  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  135  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; metoprolol tartrate  75  mg ; furosemide  80  mg ; losartan potassium  25  mg ; calcium carbonate  500  mg ; lidocaine 5% ointment  1  appl ; docusate sodium  100  mg ; senna  1  tab ; calcitriol  0.25  mcg ; guaifenesin  5  ml ; prednisone  20  mg ; polyethylene glycol  17  g ; prednisone  10  mg ; 
dehydration hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hypotension, unspecified anemia in chronic kidney disease nonspecific abnormal electrocardiogram [ecg] [ekg] rheumatoid arthritis cardiac pacemaker in situ osteoporosis, unspecified other respiratory abnormalities iron deficiency anemia, unspecified chronic kidney disease, unspecified dysuria embolism and thrombosis of thoracic aorta other respiratory abnormalities chronic kidney disease, stage iv (severe) thoracoabdominal aneurysm, without mention of rupture thrombocytopenia, unspecified chest pain, unspecified anemia in chronic kidney disease hyperosmolality and/or hypernatremia pulmonary collapse chronic airway obstruction, not elsewhere classified other diseases of lung, not elsewhere classified osteoporosis, unspecified chronic kidney disease, stage iii (moderate) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other respiratory abnormalities 
black african american m 96 $temp  98.3  heartrate  68.0  resprate  17.0  o2sat  100.0  sbp  109.0  dbp  57.0  rhythm    pain  0  $hematology blood hematocrit  29.9  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  311  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  3.6  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  183  mg dl$bisacodyl  10  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; warfarin  1  dose ; diltiazem extended-release  240  mg ; folic acid  2  mg ; hydrocortisone (rectal) 2.5% cream  1  appl ; mirtazapine  45  mg ; multivitamins w minerals  1  tab ; tamsulosin  0.4  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; warfarin  2.5  mg ; sodium chloride 0.9%  1000  ml ; oseltamivir  30  mg ; warfarin  1.5  mg ; azithromycin  500  mg ; 
unspecified atrial fibrillation presence of prosthetic heart valve residual hemorrhoidal skin tags unspecified protein-calorie malnutrition frequency of micturition chronic obstructive pulmonary disease, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris adult failure to thrive other mechanical complication of permanent sutures, initial encounter benign prostatic hyperplasia with lower urinary tract symptoms chronic kidney disease, stage 3 (moderate) long term (current) use of anticoagulants acute kidney failure, unspecified personal history of nicotine dependence other place in apartment as the place of occurrence of the external cause surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute posthemorrhagic anemia body mass index (bmi) 19.9 or less, adult bathroom in apartment as the place of occurrence of the external cause adverse effect of anticoagulants, initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other nonautoimmune hemolytic anemias hemorrhagic disorder due to extrinsic circulating anticoagulants major depressive disorder, single episode, unspecified other constipation weakness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atrial flutter other non-autoimmune hemolytic anemias infection and inflammatory reaction due to indwelling urinary catheter hypovolemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) anorexia insomnia, unspecified acute kidney failure, unspecified heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident driver of special construction vehicle injured in traffic accident urinary obstruction, not elsewhere classified personal history of tobacco use subendocardial infarction, initial episode of care body mass index less than 19, adult hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified coronary atherosclerosis of native coronary artery hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) acidosis retention of urine, unspecified other specified cardiac dysrhythmias
black african american m 96 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  282  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  4.4  ; chemistry urine creatinine, urine  78  mg dl; chemistry urine sodium, urine  60  meq l; chemistry urine urea nitrogen, urine  788  mg dl; hematology urine wbc  0  # hpf; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  146  mg dl; chemistry blood glucose  239  mg dl; hematology urine glucose  150  mg dl$bisacodyl  10  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; warfarin  1  dose ; diltiazem extended-release  240  mg ; folic acid  2  mg ; hydrocortisone (rectal) 2.5% cream  1  appl ; mirtazapine  45  mg ; multivitamins w minerals  1  tab ; tamsulosin  0.4  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; warfarin  2.5  mg ; oseltamivir  30  mg ; warfarin  1.5  mg ; azithromycin  500  mg ; prednisone  40  mg ; azithromycin  250  mg ; warfarin  0.5  mg ; 
unspecified atrial fibrillation presence of prosthetic heart valve residual hemorrhoidal skin tags unspecified protein-calorie malnutrition frequency of micturition chronic obstructive pulmonary disease, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris adult failure to thrive other mechanical complication of permanent sutures, initial encounter benign prostatic hyperplasia with lower urinary tract symptoms chronic kidney disease, stage 3 (moderate) long term (current) use of anticoagulants acute kidney failure, unspecified personal history of nicotine dependence other place in apartment as the place of occurrence of the external cause surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute posthemorrhagic anemia body mass index (bmi) 19.9 or less, adult bathroom in apartment as the place of occurrence of the external cause adverse effect of anticoagulants, initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other nonautoimmune hemolytic anemias hemorrhagic disorder due to extrinsic circulating anticoagulants major depressive disorder, single episode, unspecified other constipation weakness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atrial flutter other non-autoimmune hemolytic anemias infection and inflammatory reaction due to indwelling urinary catheter hypovolemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) anorexia insomnia, unspecified acute kidney failure, unspecified heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident driver of special construction vehicle injured in traffic accident urinary obstruction, not elsewhere classified personal history of tobacco use subendocardial infarction, initial episode of care body mass index less than 19, adult hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified coronary atherosclerosis of native coronary artery hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) acidosis retention of urine, unspecified other specified cardiac dysrhythmias
black african american m 96 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  286  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  3.1  ; chemistry blood glucose  90  mg dl$bisacodyl  10  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; warfarin  1  dose ; diltiazem extended-release  240  mg ; folic acid  2  mg ; hydrocortisone (rectal) 2.5% cream  1  appl ; mirtazapine  45  mg ; multivitamins w minerals  1  tab ; tamsulosin  0.4  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; oseltamivir  30  mg ; prednisone  40  mg ; azithromycin  250  mg ; warfarin  2  mg ; 
unspecified atrial fibrillation presence of prosthetic heart valve residual hemorrhoidal skin tags unspecified protein-calorie malnutrition frequency of micturition chronic obstructive pulmonary disease, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris adult failure to thrive other mechanical complication of permanent sutures, initial encounter benign prostatic hyperplasia with lower urinary tract symptoms chronic kidney disease, stage 3 (moderate) long term (current) use of anticoagulants acute kidney failure, unspecified personal history of nicotine dependence other place in apartment as the place of occurrence of the external cause surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute posthemorrhagic anemia body mass index (bmi) 19.9 or less, adult bathroom in apartment as the place of occurrence of the external cause adverse effect of anticoagulants, initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other nonautoimmune hemolytic anemias hemorrhagic disorder due to extrinsic circulating anticoagulants major depressive disorder, single episode, unspecified other constipation weakness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atrial flutter other non-autoimmune hemolytic anemias infection and inflammatory reaction due to indwelling urinary catheter hypovolemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) anorexia insomnia, unspecified acute kidney failure, unspecified heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident driver of special construction vehicle injured in traffic accident urinary obstruction, not elsewhere classified personal history of tobacco use subendocardial infarction, initial episode of care body mass index less than 19, adult hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified coronary atherosclerosis of native coronary artery hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) acidosis retention of urine, unspecified other specified cardiac dysrhythmias
black african american m 96 $nan$nan$bisacodyl  10  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; ipratropium-albuterol neb  1  neb ; albuterol 0.083% neb soln  1  neb ; warfarin  1  dose ; diltiazem extended-release  240  mg ; folic acid  2  mg ; hydrocortisone (rectal) 2.5% cream  1  appl ; mirtazapine  45  mg ; multivitamins w minerals  1  tab ; tamsulosin  0.4  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; oseltamivir  30  mg ; prednisone  40  mg ; azithromycin  250  mg ; warfarin  2  mg ; 
unspecified atrial fibrillation presence of prosthetic heart valve residual hemorrhoidal skin tags unspecified protein-calorie malnutrition frequency of micturition chronic obstructive pulmonary disease, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris adult failure to thrive other mechanical complication of permanent sutures, initial encounter benign prostatic hyperplasia with lower urinary tract symptoms chronic kidney disease, stage 3 (moderate) long term (current) use of anticoagulants acute kidney failure, unspecified personal history of nicotine dependence other place in apartment as the place of occurrence of the external cause surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute posthemorrhagic anemia body mass index (bmi) 19.9 or less, adult bathroom in apartment as the place of occurrence of the external cause adverse effect of anticoagulants, initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other nonautoimmune hemolytic anemias hemorrhagic disorder due to extrinsic circulating anticoagulants major depressive disorder, single episode, unspecified other constipation weakness personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits atrial flutter other non-autoimmune hemolytic anemias infection and inflammatory reaction due to indwelling urinary catheter hypovolemia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) anorexia insomnia, unspecified acute kidney failure, unspecified heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident driver of special construction vehicle injured in traffic accident urinary obstruction, not elsewhere classified personal history of tobacco use subendocardial infarction, initial episode of care body mass index less than 19, adult hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified coronary atherosclerosis of native coronary artery hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) acidosis retention of urine, unspecified other specified cardiac dysrhythmias
hispanic latino f 53 $nan$hematology blood hematocrit  37.3  %$iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; ondansetron  4  mg ; 
diverticulitis of colon (without mention of hemorrhage) celiac disease diverticulosis of colon (without mention of hemorrhage) esophageal reflux migraine, unspecified, without mention of intractable migraine without mention of status migrainosus pure hypercholesterolemia personal history of colonic polyps umbilical hernia without mention of obstruction or gangrene unspecified essential hypertension personal history of urinary calculi anemia, unspecified other disorders of menstruation and other abnormal bleeding from female genital tract removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified symptom associated with female genital organs unspecified essential hypertension chronic salpingitis and oophoritis obesity, unspecified endometriosis of uterus dysthymic disorder accidental puncture or laceration during a procedure, not elsewhere classified excessive or frequent menstruation accidents occurring in residential institution
hispanic latino f 53 $nan$hematology blood hematocrit  34.9  %$iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; heparin  5000  unit ; amlodipine  10  mg ; buspirone  7.5  mg ; gabapentin  300  mg ; levothyroxine sodium  50  mcg ; omeprazole  40  mg ; oxycodone liquid  5  mg ; acetaminophen (liquid)  650  mg ; metoprolol tartrate  25  mg ; hydralazine  10  mg ; oxycodone liquid  10  mg ; 
diverticulitis of colon (without mention of hemorrhage) celiac disease diverticulosis of colon (without mention of hemorrhage) esophageal reflux migraine, unspecified, without mention of intractable migraine without mention of status migrainosus pure hypercholesterolemia personal history of colonic polyps umbilical hernia without mention of obstruction or gangrene unspecified essential hypertension personal history of urinary calculi anemia, unspecified other disorders of menstruation and other abnormal bleeding from female genital tract removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified symptom associated with female genital organs unspecified essential hypertension chronic salpingitis and oophoritis obesity, unspecified endometriosis of uterus dysthymic disorder accidental puncture or laceration during a procedure, not elsewhere classified excessive or frequent menstruation accidents occurring in residential institution
hispanic latino f 53 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; heparin  5000  unit ; amlodipine  10  mg ; buspirone  7.5  mg ; gabapentin  300  mg ; levothyroxine sodium  50  mcg ; omeprazole  40  mg ; acetaminophen (liquid)  650  mg ; metoprolol tartrate  25  mg ; hydralazine  10  mg ; oxycodone liquid  10  mg ; 
diverticulitis of colon (without mention of hemorrhage) celiac disease diverticulosis of colon (without mention of hemorrhage) esophageal reflux migraine, unspecified, without mention of intractable migraine without mention of status migrainosus pure hypercholesterolemia personal history of colonic polyps umbilical hernia without mention of obstruction or gangrene unspecified essential hypertension personal history of urinary calculi anemia, unspecified other disorders of menstruation and other abnormal bleeding from female genital tract removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified symptom associated with female genital organs unspecified essential hypertension chronic salpingitis and oophoritis obesity, unspecified endometriosis of uterus dysthymic disorder accidental puncture or laceration during a procedure, not elsewhere classified excessive or frequent menstruation accidents occurring in residential institution
white f 33 $temp  99.4  heartrate  87.0  resprate  16.0  o2sat  96.0  sbp  124.0  dbp  64.0  rhythm    pain  6  $hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  443  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  96  mg dl; chemistry blood lactate dehydrogenase (ld)  229  iu l; chemistry blood albumin  2.9  g dl$sodium chloride 0.9%  flush  3-10  ml ; cyanocobalamin  2000  mcg ; folic acid  800  mcg ; lorazepam  0.5  mg ; hydromorphone (dilaudid)  0.5  mg ; gabapentin  800  mg ; oxcarbazepine  900  mg ; ketorolac  30  mg ; acetaminophen  650  mg ; diphenhydramine  50  mg ; hydromorphone (dilaudid)  2  mg ; pantoprazole  40  mg ; heparin  5000  unit ; folic acid  1  mg ; lactated ringers  1000  ml ; 
hordeolum internum left eye, unspecified eyelid body mass index (bmi) 45.0-49.9, adult morbid (severe) obesity due to excess calories epigastric pain peritoneal adhesions (postprocedural) (postinfection) fistula of stomach and duodenum personal history of traumatic brain injury personal history of traumatic brain injury personal history of other diseases of the digestive system diarrhea, unspecified anxiety disorder, unspecified major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified fistula of stomach and duodenum post-traumatic stress disorder, unspecified bariatric surgery status personal history of nicotine dependence other headache syndrome other chronic pain left upper quadrant pain left lower quadrant abdominal tenderness morbid (severe) obesity due to excess calories epigastric pain personal history of other venous thrombosis and embolism body mass index (bmi) 40.0-44.9, adult nausea with vomiting, unspecified epilepsy, unspecified, not intractable, without status epilepticus personal history of other venous thrombosis and embolism personal history of nicotine dependence unspecified abdominal pain bariatric surgery status body mass index (bmi) 40.0-44.9, adult obesity, unspecified anemia, unspecified unspecified convulsions personal history of traumatic brain injury long term (current) use of antithrombotics/antiplatelets other specified abnormal findings of blood chemistry personal history of other diseases of the digestive system headache anxiety disorder, unspecified personal history of other venous thrombosis and embolism urinary tract infection, site not specified long term (current) use of antithrombotics/antiplatelets unspecified fracture of fifth metacarpal bone, right hand, initial encounter for closed fracture hypokalemia laceration without foreign body of right upper arm, initial encounter
white f 33 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  402  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3-10  ml ; cyanocobalamin  2000  mcg ; folic acid  800  mcg ; lorazepam  0.5  mg ; gabapentin  800  mg ; oxcarbazepine  900  mg ; ketorolac  30  mg ; acetaminophen  650  mg ; diphenhydramine  50  mg ; hydromorphone (dilaudid)  2  mg ; pantoprazole  40  mg ; heparin  5000  unit ; folic acid  1  mg ; lactated ringers  1000  ml ; diphenhydramine  25  mg ; 
hordeolum internum left eye, unspecified eyelid body mass index (bmi) 45.0-49.9, adult morbid (severe) obesity due to excess calories epigastric pain peritoneal adhesions (postprocedural) (postinfection) fistula of stomach and duodenum personal history of traumatic brain injury personal history of traumatic brain injury personal history of other diseases of the digestive system diarrhea, unspecified anxiety disorder, unspecified major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified fistula of stomach and duodenum post-traumatic stress disorder, unspecified bariatric surgery status personal history of nicotine dependence other headache syndrome other chronic pain left upper quadrant pain left lower quadrant abdominal tenderness morbid (severe) obesity due to excess calories epigastric pain personal history of other venous thrombosis and embolism body mass index (bmi) 40.0-44.9, adult nausea with vomiting, unspecified epilepsy, unspecified, not intractable, without status epilepticus personal history of other venous thrombosis and embolism personal history of nicotine dependence unspecified abdominal pain bariatric surgery status body mass index (bmi) 40.0-44.9, adult obesity, unspecified anemia, unspecified unspecified convulsions personal history of traumatic brain injury long term (current) use of antithrombotics/antiplatelets other specified abnormal findings of blood chemistry personal history of other diseases of the digestive system headache anxiety disorder, unspecified personal history of other venous thrombosis and embolism urinary tract infection, site not specified long term (current) use of antithrombotics/antiplatelets unspecified fracture of fifth metacarpal bone, right hand, initial encounter for closed fracture hypokalemia laceration without foreign body of right upper arm, initial encounter
white f 33 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; cyanocobalamin  2000  mcg ; lorazepam  0.5  mg ; gabapentin  800  mg ; oxcarbazepine  900  mg ; ketorolac  30  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  2  mg ; pantoprazole  40  mg ; heparin  5000  unit ; folic acid  1  mg ; lactated ringers  1000  ml ; diphenhydramine  25  mg ; 
hordeolum internum left eye, unspecified eyelid body mass index (bmi) 45.0-49.9, adult morbid (severe) obesity due to excess calories epigastric pain peritoneal adhesions (postprocedural) (postinfection) fistula of stomach and duodenum personal history of traumatic brain injury personal history of traumatic brain injury personal history of other diseases of the digestive system diarrhea, unspecified anxiety disorder, unspecified major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified fistula of stomach and duodenum post-traumatic stress disorder, unspecified bariatric surgery status personal history of nicotine dependence other headache syndrome other chronic pain left upper quadrant pain left lower quadrant abdominal tenderness morbid (severe) obesity due to excess calories epigastric pain personal history of other venous thrombosis and embolism body mass index (bmi) 40.0-44.9, adult nausea with vomiting, unspecified epilepsy, unspecified, not intractable, without status epilepticus personal history of other venous thrombosis and embolism personal history of nicotine dependence unspecified abdominal pain bariatric surgery status body mass index (bmi) 40.0-44.9, adult obesity, unspecified anemia, unspecified unspecified convulsions personal history of traumatic brain injury long term (current) use of antithrombotics/antiplatelets other specified abnormal findings of blood chemistry personal history of other diseases of the digestive system headache anxiety disorder, unspecified personal history of other venous thrombosis and embolism urinary tract infection, site not specified long term (current) use of antithrombotics/antiplatelets unspecified fracture of fifth metacarpal bone, right hand, initial encounter for closed fracture hypokalemia laceration without foreign body of right upper arm, initial encounter
white f 62 $temp  98.0  heartrate  70.0  resprate  16.0  o2sat  97.0  sbp  140.0  dbp  54.0  rhythm    pain    $hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  95  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  60  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  84  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ondansetron  4  mg ; tacrolimus  0.5  mg ; tacrolimus  5  mg ; alprazolam  0.5  mg ; metoprolol succinate xl  25  mg ; sertraline  200  mg ; simvastatin  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sirolimus  3  mg ; atovaquone suspension  1500  mg ; lamivudine  50  mg ; prednisone  5  mg ; 
other complication of kidney transplant hyperlipidemia, unspecified diaphragmatic hernia without obstruction or gangrene esophageal obstruction adverse effect of other antiprotozoal drugs, initial encounter nausea with vomiting, unspecified acquired absence of both cervix and uterus adverse effect of other drugs, medicaments and biological substances, initial encounter enterocolitis due to clostridium difficile, not specified as recurrent adverse effect of electrolytic, caloric and water-balance agents, initial encounter secondary hyperparathyroidism of renal origin family history of disorders of kidney and ureter unspecified place in single-family (private) house as the place of occurrence of the external cause procedure and treatment not carried out for other reasons hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease hyperlipidemia, unspecified hyperglycemia, unspecified acquired absence of both cervix and uterus acidosis adverse effect of glucocorticoids and synthetic analogues, initial encounter polycystic kidney, adult type hypokalemia adverse effect of antineoplastic and immunosuppressive drugs, initial encounter drug or chemical induced diabetes mellitus without complications anemia in other chronic diseases classified elsewhere adverse effect of loop [high-ceiling] diuretics, initial encounter other drug-induced agranulocytosis patient room in hospital as the place of occurrence of the external cause end stage renal disease secondary hyperparathyroidism of renal origin unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent secondary hyperparathyroidism of renal origin polycystic kidney, unspecified procedure and treatment not carried out for other reasons hyperlipidemia, unspecified chronic kidney disease, stage 5 procedure and treatment not carried out for other reasons hyperlipidemia, unspecified polycystic kidney, unspecified secondary hyperparathyroidism of renal origin end stage renal disease polycystic kidney, unspecified hyperlipidemia, unspecified procedure and treatment not carried out for other reasons chronic kidney disease, stage 5 
white f 62 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  106  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  58  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  86  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ondansetron  4  mg ; tacrolimus  0.5  mg ; tacrolimus  5  mg ; alprazolam  0.5  mg ; metoprolol succinate xl  25  mg ; sertraline  200  mg ; simvastatin  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sirolimus  3  mg ; atovaquone suspension  1500  mg ; lamivudine  50  mg ; prednisone  5  mg ; potassium chloride  20  meq ; 
other complication of kidney transplant hyperlipidemia, unspecified diaphragmatic hernia without obstruction or gangrene esophageal obstruction adverse effect of other antiprotozoal drugs, initial encounter nausea with vomiting, unspecified acquired absence of both cervix and uterus adverse effect of other drugs, medicaments and biological substances, initial encounter enterocolitis due to clostridium difficile, not specified as recurrent adverse effect of electrolytic, caloric and water-balance agents, initial encounter secondary hyperparathyroidism of renal origin family history of disorders of kidney and ureter unspecified place in single-family (private) house as the place of occurrence of the external cause procedure and treatment not carried out for other reasons hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease hyperlipidemia, unspecified hyperglycemia, unspecified acquired absence of both cervix and uterus acidosis adverse effect of glucocorticoids and synthetic analogues, initial encounter polycystic kidney, adult type hypokalemia adverse effect of antineoplastic and immunosuppressive drugs, initial encounter drug or chemical induced diabetes mellitus without complications anemia in other chronic diseases classified elsewhere adverse effect of loop [high-ceiling] diuretics, initial encounter other drug-induced agranulocytosis patient room in hospital as the place of occurrence of the external cause end stage renal disease secondary hyperparathyroidism of renal origin unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent secondary hyperparathyroidism of renal origin polycystic kidney, unspecified procedure and treatment not carried out for other reasons hyperlipidemia, unspecified chronic kidney disease, stage 5 procedure and treatment not carried out for other reasons hyperlipidemia, unspecified polycystic kidney, unspecified secondary hyperparathyroidism of renal origin end stage renal disease polycystic kidney, unspecified hyperlipidemia, unspecified procedure and treatment not carried out for other reasons chronic kidney disease, stage 5 
white f 59 $nan$hematology blood hematocrit  25.2  %; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; telaprevir  750  mg ; ribavirin  200  mg ; 
 
white f 73 $nan$nan$fish oil (omega 3)  1000  mg ; multivitamins  1  tab ; timolol maleate 0.25%  1  drop ; vitamin e  1000  unit ; bisacodyl  10  mg ; ascorbic acid  500  mg ; docusate sodium  100  mg ; hydrocodone-acetaminophen (5mg-500mg)  1-2  tab ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; acetaminophen  325-650  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; ondansetron  4  mg ; bag  50  ml ; magnesium sulfate  2  gm ; potassium chloride  60  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 
 
white f 73 $nan$nan$fish oil (omega 3)  1000  mg ; multivitamins  1  tab ; timolol maleate 0.25%  1  drop ; vitamin e  1000  unit ; bisacodyl  10  mg ; ascorbic acid  500  mg ; docusate sodium  100  mg ; hydrocodone-acetaminophen (5mg-500mg)  1-2  tab ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; acetaminophen  325-650  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; ondansetron  4  mg ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 5% dextrose  100  ml ; naloxone  2  mg ; 
 
white f 73 $nan$nan$fish oil (omega 3)  1000  mg ; multivitamins  1  tab ; timolol maleate 0.25%  1  drop ; vitamin e  1000  unit ; bisacodyl  10  mg ; ascorbic acid  500  mg ; docusate sodium  100  mg ; hydrocodone-acetaminophen (5mg-500mg)  1-2  tab ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; acetaminophen  325-650  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; lorazepam  0.5-1  mg ; milk of magnesia  30  ml ; magnesium citrate  300  ml ; 
 
white f 73 $nan$nan$fish oil (omega 3)  1000  mg ; multivitamins  1  tab ; timolol maleate 0.25%  1  drop ; vitamin e  1000  unit ; bisacodyl  10  mg ; ascorbic acid  500  mg ; docusate sodium  100  mg ; hydrocodone-acetaminophen (5mg-500mg)  1-2  tab ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; ondansetron  4  mg ; lorazepam  0.5-1  mg ; milk of magnesia  30  ml ; magnesium citrate  300  ml ; 
 
white f 73 $nan$nan$fish oil (omega 3)  1000  mg ; multivitamins  1  tab ; timolol maleate 0.25%  1  drop ; vitamin e  1000  unit ; bisacodyl  10  mg ; ascorbic acid  500  mg ; docusate sodium  100  mg ; hydrocodone-acetaminophen (5mg-500mg)  1-2  tab ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; ondansetron  4  mg ; lorazepam  0.5-1  mg ; milk of magnesia  30  ml ; aspirin  81  mg ; 
 
white f 73 $nan$nan$fish oil (omega 3)  1000  mg ; multivitamins  1  tab ; timolol maleate 0.25%  1  drop ; vitamin e  1000  unit ; bisacodyl  10  mg ; ascorbic acid  500  mg ; docusate sodium  100  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; ondansetron  4  mg ; lorazepam  0.5-1  mg ; milk of magnesia  30  ml ; aspirin  81  mg ; 
 
black african american m 26 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sevelamer carbonate  800  mg ; metoprolol succinate xl  100  mg ; 
disturbance of skin sensation hyperpotassemia other fluid overload end stage renal disease other and unspecified hyperlipidemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hypoxemia shortness of breath renal dialysis status chest pain, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease atrial flutter anemia, unspecified end stage renal disease other specified pruritic conditions hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease acute kidney failure, unspecified chronic glomerulonephritis with lesion of membranous glomerulonephritis allergy, unspecified, not elsewhere classified end stage renal disease unspecified drug or medicinal substance causing adverse effects in therapeutic use 
white f 57 $temp  98.8  heartrate  77.0  resprate  17.0  o2sat  97.0  sbp  98.0  dbp  45.0  rhythm    pain  7  $hematology blood hematocrit  31.5  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  95  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  97  mg dl; chemistry blood % hemoglobin a1c  6.9  %$0.9% sodium chloride  1000  ml ; influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  1  mg ; cyclobenzaprine  10  mg ; diphenhydramine  50  mg ; nadolol  40  mg ; omeprazole  40  mg ; ondansetron  4  mg ; sucralfate  1  gm ; vitamin d  400  unit ; hydromorphone (dilaudid)  0.5-1  mg ; ondansetron  8  mg ; torsemide  10  mg ; ursodiol  300  mg ; heparin  5000  unit ; diazepam  2  mg ; magnesium oxide  800  mg ; levothyroxine sodium  50  mcg ; rifaximin  550  mg ; spironolactone  100  mg ; lactulose  100-120  ml ; d5 1 2ns  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lidocaine viscous 2%  20  ml ; insulin pump (self administering medication)     ; ursodiol  600  mg ; 
malignant neoplasm of liver, secondary diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cirrhosis of liver without mention of alcohol portal hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified anal fissure unspecified viral hepatitis without mention of hepatic coma external hemorrhoids without mention of complication other malignant lymphomas, unspecified site, extranodal and solid organ sites other malignant lymphomas, unspecified site, extranodal and solid organ sites portal hypertension calculus of gallbladder without mention of cholecystitis, without mention of obstruction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin laparoscopic surgical procedure converted to open procedure cirrhosis of liver without mention of alcohol other chronic nonalcoholic liver disease myalgia and myositis, unspecified peripheral stem cells replaced by transplant unspecified essential hypertension other ascites unspecified essential hypertension abdominal pain, right upper quadrant diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled cirrhosis of liver without mention of alcohol other malignant lymphomas, unspecified site, extranodal and solid organ sites peripheral stem cells replaced by transplant 
white f 57 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  83  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  78  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  1  mg ; cyclobenzaprine  10  mg ; diphenhydramine  50  mg ; nadolol  40  mg ; vitamin d  400  unit ; heparin  5000  unit ; diazepam  2  mg ; magnesium oxide  800  mg ; levothyroxine sodium  50  mcg ; rifaximin  550  mg ; lactulose  100-120  ml ; d5 1 2ns  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lidocaine viscous 2%  20  ml ; ursodiol  600  mg ; 
malignant neoplasm of liver, secondary diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cirrhosis of liver without mention of alcohol portal hypertension osteoarthrosis, unspecified whether generalized or localized, site unspecified anal fissure unspecified viral hepatitis without mention of hepatic coma external hemorrhoids without mention of complication other malignant lymphomas, unspecified site, extranodal and solid organ sites other malignant lymphomas, unspecified site, extranodal and solid organ sites portal hypertension calculus of gallbladder without mention of cholecystitis, without mention of obstruction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin laparoscopic surgical procedure converted to open procedure cirrhosis of liver without mention of alcohol other chronic nonalcoholic liver disease myalgia and myositis, unspecified peripheral stem cells replaced by transplant unspecified essential hypertension other ascites unspecified essential hypertension abdominal pain, right upper quadrant diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled cirrhosis of liver without mention of alcohol other malignant lymphomas, unspecified site, extranodal and solid organ sites peripheral stem cells replaced by transplant 
other f 37 $nan$hematology blood hematocrit  32.8  %; hematology blood hematocrit  31.9  %; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  322  k ul; hematology blood platelet count  339  k ul; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl$nan
unspecified pre-eclampsia, complicating childbirth post-term pregnancy gestational [pregnancy-induced] hypertension without significant proteinuria, complicating childbirth unspecified asthma, uncomplicated 40 weeks gestation of pregnancy obesity complicating childbirth diseases of the respiratory system complicating childbirth streptococcus b carrier state complicating childbirth labor and delivery complicated by meconium in amniotic fluid body mass index (bmi) 40.0-44.9, adult obesity, unspecified single live birth abnormality in fetal heart rate and rhythm complicating labor and delivery 
other f 37 $nan$nan$naloxone  40-80  mcg ; ketorolac  15-30  mg ; 0.9% sodium chloride  250  ml ; naloxone  0.4  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; diphenhydramine  25  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; enoxaparin sodium  40  mg ; hydromorphone (dilaudid)  2-4  mg ; sterile water  500  ml ; magnesium sulfate (ob)  20  gm ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; 
unspecified pre-eclampsia, complicating childbirth post-term pregnancy gestational [pregnancy-induced] hypertension without significant proteinuria, complicating childbirth unspecified asthma, uncomplicated 40 weeks gestation of pregnancy obesity complicating childbirth diseases of the respiratory system complicating childbirth streptococcus b carrier state complicating childbirth labor and delivery complicated by meconium in amniotic fluid body mass index (bmi) 40.0-44.9, adult obesity, unspecified single live birth abnormality in fetal heart rate and rhythm complicating labor and delivery 
other f 37 $nan$hematology blood hematocrit  29.9  %$naloxone  40-80  mcg ; ketorolac  15-30  mg ; 0.9% sodium chloride  250  ml ; naloxone  0.4  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; diphenhydramine  25  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; enoxaparin sodium  40  mg ; hydromorphone (dilaudid)  2-4  mg ; sterile water  500  ml ; magnesium sulfate (ob)  20  gm ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; 
unspecified pre-eclampsia, complicating childbirth post-term pregnancy gestational [pregnancy-induced] hypertension without significant proteinuria, complicating childbirth unspecified asthma, uncomplicated 40 weeks gestation of pregnancy obesity complicating childbirth diseases of the respiratory system complicating childbirth streptococcus b carrier state complicating childbirth labor and delivery complicated by meconium in amniotic fluid body mass index (bmi) 40.0-44.9, adult obesity, unspecified single live birth abnormality in fetal heart rate and rhythm complicating labor and delivery 
other f 37 $nan$nan$naloxone  40-80  mcg ; 0.9% sodium chloride  250  ml ; naloxone  0.4  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; diphenhydramine  25  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; enoxaparin sodium  40  mg ; hydromorphone (dilaudid)  2-4  mg ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; sarna lotion  1  appl ; 
unspecified pre-eclampsia, complicating childbirth post-term pregnancy gestational [pregnancy-induced] hypertension without significant proteinuria, complicating childbirth unspecified asthma, uncomplicated 40 weeks gestation of pregnancy obesity complicating childbirth diseases of the respiratory system complicating childbirth streptococcus b carrier state complicating childbirth labor and delivery complicated by meconium in amniotic fluid body mass index (bmi) 40.0-44.9, adult obesity, unspecified single live birth abnormality in fetal heart rate and rhythm complicating labor and delivery 
other f 37 $nan$nan$naloxone  40-80  mcg ; 0.9% sodium chloride  250  ml ; naloxone  0.4  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; diphenhydramine  25  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; enoxaparin sodium  40  mg ; hydromorphone (dilaudid)  2-4  mg ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; sarna lotion  1  appl ; 
unspecified pre-eclampsia, complicating childbirth post-term pregnancy gestational [pregnancy-induced] hypertension without significant proteinuria, complicating childbirth unspecified asthma, uncomplicated 40 weeks gestation of pregnancy obesity complicating childbirth diseases of the respiratory system complicating childbirth streptococcus b carrier state complicating childbirth labor and delivery complicated by meconium in amniotic fluid body mass index (bmi) 40.0-44.9, adult obesity, unspecified single live birth abnormality in fetal heart rate and rhythm complicating labor and delivery 
black african american m 62 $temp  97.6  heartrate  98.0  resprate  30.0  o2sat  98.0  sbp  116.0  dbp  62.0  rhythm    pain    $hematology blood hematocrit  32.0  %; hematology blood hematocrit  30.6  %; hematology blood hematocrit  35.0  %; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  9.7  g dl; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  120  k ul; hematology blood platelet count  101  k ul; hematology blood platelet count  110  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  22  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood creatinine  2.9  mg dl; chemistry blood creatinine  4.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.9  meq l; chemistry blood potassium  7.2  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  54  mg dl; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood bilirubin, total  3.5  mg dl; chemistry blood bilirubin, total  4.6  mg dl; chemistry blood glucose  128  mg dl; chemistry blood glucose  88  mg dl; chemistry blood glucose  117  mg dl; hematology blood bands  19  %; blood gas blood free calcium  1.01  mmol l; blood gas blood lactate  3.8  mmol l; blood gas blood lactate  4.2  mmol l; blood gas blood lactate  4.4  mmol l; blood gas blood lactate  4.6  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; bisacodyl  10  mg ; senna  8.6  mg ; propofol  1000  mg ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; norepinephrine  8  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; sulfameth trimethoprim ds  1  tab ; sodium chloride 0.9%  1000  ml ; cefepime  2  g ; lorazepam  2  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; propofol  200  mg ; soln  50  ml ; lansoprazole oral disintegrating tab  30  mg ; fosphenytoin  1600  mg pe ; levetiracetam  750  mg ; midazolam  2  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; phenylephrine  240  mg ; 
dissection of vertebral artery human immunodeficiency virus [hiv] disease personal history of irradiation ataxia following cerebral infarction retention of urine, unspecified obstructive hydrocephalus diffuse large b-cell lymphoma, extranodal and solid organ sites cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery cerebral edema compression of brain essential (primary) hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits tobacco use encounter for immunization personal history of antineoplastic chemotherapy hemiplegia, unspecified affecting right dominant side other abnormal glucose nonspecific reaction to tuberculin skin test without active tuberculosis tobacco use disorder unspecified essential hypertension meningoencephalitis due to toxoplasmosis other malignant lymphomas, lymph nodes of multiple sites person on outside of car injured in collision with railway train or railway vehicle in nontraffic accident human immunodeficiency virus [hiv] disease presence of cerebrospinal fluid drainage device meningitis due to unspecified bacterium anemia, unspecified nonspecific reaction to tuberculin skin test without active tuberculosis mechanical complication of nervous system device, implant, and graft other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other malignant lymphomas, unspecified site, extranodal and solid organ sites toxoplasmosis of other specified sites other specified disorders of skin esophagitis, unspecified human immunodeficiency virus [hiv] disease personal history of noncompliance with medical treatment, presenting hazards to health tracheoesophageal fistula, esophageal atresia and stenosis other convulsions benign essential hypertension pancytopenia human immunodeficiency virus [hiv] disease person on outside of car injured in collision with railway train or railway vehicle in nontraffic accident cerebral edema personal history of tobacco use nonspecific reaction to tuberculin skin test without active tuberculosis other malignant lymphomas, unspecified site, extranodal and solid organ sites presence of cerebrospinal fluid drainage device postconcussion syndrome
black african american m 62 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; bisacodyl  10  mg ; propofol  200  mg ; soln  50  ml ; lansoprazole oral disintegrating tab  30  mg ; levetiracetam  750  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; phenylephrine  240  mg ; furosemide  20  mg ; 
dissection of vertebral artery human immunodeficiency virus [hiv] disease personal history of irradiation ataxia following cerebral infarction retention of urine, unspecified obstructive hydrocephalus diffuse large b-cell lymphoma, extranodal and solid organ sites cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery cerebral edema compression of brain essential (primary) hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits tobacco use encounter for immunization personal history of antineoplastic chemotherapy hemiplegia, unspecified affecting right dominant side other abnormal glucose nonspecific reaction to tuberculin skin test without active tuberculosis tobacco use disorder unspecified essential hypertension meningoencephalitis due to toxoplasmosis other malignant lymphomas, lymph nodes of multiple sites person on outside of car injured in collision with railway train or railway vehicle in nontraffic accident human immunodeficiency virus [hiv] disease presence of cerebrospinal fluid drainage device meningitis due to unspecified bacterium anemia, unspecified nonspecific reaction to tuberculin skin test without active tuberculosis mechanical complication of nervous system device, implant, and graft other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other malignant lymphomas, unspecified site, extranodal and solid organ sites toxoplasmosis of other specified sites other specified disorders of skin esophagitis, unspecified human immunodeficiency virus [hiv] disease personal history of noncompliance with medical treatment, presenting hazards to health tracheoesophageal fistula, esophageal atresia and stenosis other convulsions benign essential hypertension pancytopenia human immunodeficiency virus [hiv] disease person on outside of car injured in collision with railway train or railway vehicle in nontraffic accident cerebral edema personal history of tobacco use nonspecific reaction to tuberculin skin test without active tuberculosis other malignant lymphomas, unspecified site, extranodal and solid organ sites presence of cerebrospinal fluid drainage device postconcussion syndrome
white m 25 $temp  100.1  heartrate  94.0  resprate  16.0  o2sat  99.0  sbp  105.0  dbp  54.0  rhythm    pain  2  $hematology blood hematocrit  39.4  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  93  mg dl; blood gas blood lactate  1.8  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; benzonatate  100  mg ; guaifenesin-codeine phosphate  5-10  ml ; acetaminophen  1000  mg ; acetaminophen  325-650  mg ; sodium chloride 0.9%  1000  ml ; acetaminophen  325  mg ; ibuprofen  400  mg ; ondansetron  4  mg ; 
 
white m 25 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; benzonatate  100  mg ; guaifenesin-codeine phosphate  5-10  ml ; acetaminophen  325-650  mg ; acetaminophen  325  mg ; ondansetron  4  mg ; 
 
other m 61 $temp  98.4  heartrate  98.0  resprate  18.0  o2sat  98.0  sbp  117.0  dbp  80.0  rhythm    pain  2  $hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  209  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)  5  mg ; amlodipine  5  mg ; heparin  5000  unit ; lorazepam  1  mg ; 
 
other m 61 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  223  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  93  mg dl$senna  8.6  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)  5  mg ; amlodipine  5  mg ; heparin  5000  unit ; lorazepam  1  mg ; docusate sodium  100  mg ; magnesium oxide  400  mg ; 
 
other m 61 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  94  mg dl$senna  8.6  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)  5  mg ; amlodipine  5  mg ; heparin  5000  unit ; lorazepam  1  mg ; docusate sodium  100  mg ; magnesium oxide  400  mg ; diazepam  5  mg ; diazepam  10  mg ; 0.9% sodium chloride  50  ml ; thiamine  100  mg ; 
 
other m 61 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  265  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  100  mg dl$senna  8.6  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)  5  mg ; amlodipine  5  mg ; heparin  5000  unit ; docusate sodium  100  mg ; diazepam  10  mg ; 0.9% sodium chloride  50  ml ; thiamine  100  mg ; haloperidol  0.5  mg ; diazepam - ciwa protocol  10  mg ; potassium chloride  40  meq ; 0.9% sodium chloride  250  ml ; thiamine  500  mg ; haloperidol  2  mg ; 
 
other m 61 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  84  mg dl$senna  8.6  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; oxycodone (immediate release)  5  mg ; amlodipine  5  mg ; heparin  5000  unit ; docusate sodium  100  mg ; 0.9% sodium chloride  250  ml ; thiamine  500  mg ; multivitamins  1  tab ; folic acid  1  mg ; 
 
white m 78 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5lr  1000  ml ; acetaminophen  650  mg ; trazodone  25  mg ; lidocaine jelly 2% (urojet)  1  appl ; lisinopril  20  mg ; metoprolol succinate xl  50  mg ; spironolactone  25  mg ; aspirin  81  mg ; torsemide  20  mg ; torsemide  10  mg ; phenazopyridine  200  mg ; 

white m 78 $nan$nan$sodium chloride 0.9%  flush  3  ml ; d5lr  1000  ml ; acetaminophen  650  mg ; trazodone  25  mg ; lidocaine jelly 2% (urojet)  1  appl ; spironolactone  25  mg ; aspirin  81  mg ; torsemide  20  mg ; phenazopyridine  200  mg ; 

hispanic latino m 52 $temp  98.0  heartrate  74.0  resprate  18.0  o2sat    sbp  120.0  dbp  73.0  rhythm    pain  3  $hematology blood hematocrit  41.5  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  211  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; gabapentin  800  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sulfameth trimethoprim ss  1  tab ; insulin  0  unit ; insulin  55  unit ; oxycodone (immediate release)   5  mg ; tacrolimus  1  mg ; bag  2  bag ; magnesium sulfate  4  gm ; gabapentin  1600  mg ; trazodone  25  mg ; trazodone  200  mg ; insulin  50  unit ; 
diabetes with ketoacidosis, type ii or unspecified type, uncontrolled hypovolemia urinary tract infection, site not specified long-term (current) use of insulin acute kidney failure, unspecified orthostatic hypotension person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident polyneuropathy in diabetes liver replaced by transplant diabetes with neurological manifestations, type ii or unspecified type, uncontrolled person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident hyperpotassemia acute kidney failure, unspecified anemia, unspecified hyposmolality and/or hyponatremia unspecified viral hepatitis c without hepatic coma pure hypercholesterolemia lymphocytosis (symptomatic) liver replaced by transplant leukocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident thrombocytopenia, unspecified headache anemia, unspecified pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled liver replaced by transplant unspecified viral hepatitis c without hepatic coma constipation, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes unspecified hemorrhoids with other complication diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled chronic hepatitis c without mention of hepatic coma
hispanic latino m 52 $nan$hematology blood hematocrit  39.6  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  463  mg dl; chemistry blood albumin  3.2  g dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; sulfameth trimethoprim ss  1  tab ; oxycodone (immediate release)   5  mg ; tacrolimus  1  mg ; bag  2  bag ; magnesium sulfate  4  gm ; gabapentin  1600  mg ; trazodone  200  mg ; insulin  50  unit ; insulin  12  unit ; vitamin d  1000  unit ; calcium carbonate  1250  mg ; sulfameth trimethoprim ds  2  tab ; insulin  60  unit ; 
diabetes with ketoacidosis, type ii or unspecified type, uncontrolled hypovolemia urinary tract infection, site not specified long-term (current) use of insulin acute kidney failure, unspecified orthostatic hypotension person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident polyneuropathy in diabetes liver replaced by transplant diabetes with neurological manifestations, type ii or unspecified type, uncontrolled person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident hyperpotassemia acute kidney failure, unspecified anemia, unspecified hyposmolality and/or hyponatremia unspecified viral hepatitis c without hepatic coma pure hypercholesterolemia lymphocytosis (symptomatic) liver replaced by transplant leukocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident thrombocytopenia, unspecified headache anemia, unspecified pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled liver replaced by transplant unspecified viral hepatitis c without hepatic coma constipation, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes unspecified hemorrhoids with other complication diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled chronic hepatitis c without mention of hepatic coma
hispanic latino m 52 $nan$hematology blood hematocrit  46.0  %; hematology blood hemoglobin  15.3  g dl; hematology blood platelet count  212  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  91  mg dl; chemistry blood albumin  3.6  g dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)   5  mg ; tacrolimus  1  mg ; gabapentin  1600  mg ; insulin  12  unit ; vitamin d  1000  unit ; calcium carbonate  1250  mg ; sulfameth trimethoprim ds  2  tab ; insulin  60  unit ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; cephalexin  500  mg ; 
diabetes with ketoacidosis, type ii or unspecified type, uncontrolled hypovolemia urinary tract infection, site not specified long-term (current) use of insulin acute kidney failure, unspecified orthostatic hypotension person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident polyneuropathy in diabetes liver replaced by transplant diabetes with neurological manifestations, type ii or unspecified type, uncontrolled person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident hyperpotassemia acute kidney failure, unspecified anemia, unspecified hyposmolality and/or hyponatremia unspecified viral hepatitis c without hepatic coma pure hypercholesterolemia lymphocytosis (symptomatic) liver replaced by transplant leukocytopenia, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident thrombocytopenia, unspecified headache anemia, unspecified pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled liver replaced by transplant unspecified viral hepatitis c without hepatic coma constipation, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes unspecified hemorrhoids with other complication diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled chronic hepatitis c without mention of hepatic coma
black african american m 71 $temp  97.1  heartrate  58.0  resprate  18.0  o2sat  99.0  sbp  210.0  dbp  98.0  rhythm    pain  0  ; temp    heartrate  57.0  resprate  12.0  o2sat  98.0  sbp  216.0  dbp  98.0  rhythm    pain    ; temp    heartrate  59.0  resprate  17.0  o2sat  99.0  sbp  180.0  dbp  90.0  rhythm    pain  0  ; temp    heartrate  37.0  resprate  16.0  o2sat  100.0  sbp  190.0  dbp  89.0  rhythm    pain  0  ; temp  98.1  heartrate  47.0  resprate  17.0  o2sat  96.0  sbp  156.0  dbp  97.0  rhythm    pain  0  ; temp    heartrate  60.0  resprate  18.0  o2sat  97.0  sbp  168.0  dbp  83.0  rhythm    pain  0  ; temp    heartrate  59.0  resprate  16.0  o2sat  96.0  sbp  175.0  dbp  61.0  rhythm    pain  0  ; temp    heartrate  60.0  resprate  16.0  o2sat  97.0  sbp  188.0  dbp  95.0  rhythm    pain  0  ; temp    heartrate  57.0  resprate  15.0  o2sat  96.0  sbp  178.0  dbp  94.0  rhythm    pain  0  $hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  1  # hpf; chemistry blood glucose  182  mg dl; hematology urine glucose  150  mg dl$nan
long term (current) use of insulin obesity, unspecified long term (current) use of antithrombotics/antiplatelets vitamin d deficiency, unspecified presence of aortocoronary bypass graft familial hypercholesterolemia aphasia following other cerebrovascular disease type 2 diabetes mellitus with hyperglycemia presence of coronary angioplasty implant and graft acute kidney failure, unspecified other spondylosis with myelopathy, site unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris chronic kidney disease, stage 4 (severe) chronic diastolic (congestive) heart failure type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema body mass index (bmi) 29.0-29.9, adult paresthesia of skin type 2 diabetes mellitus with diabetic chronic kidney disease family history of ischemic heart disease and other diseases of the circulatory system presence of aortocoronary bypass graft long term (current) use of antithrombotics/antiplatelets chronic diastolic (congestive) heart failure atherosclerotic heart disease of native coronary artery with unstable angina pectoris familial hypercholesterolemia aphasia following cerebral infarction chronic kidney disease, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of insulin hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease st elevation (stemi) myocardial infarction of unspecified site atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris other visual disturbances cough headache pain in left hip pain in right hip encounter for examination for normal comparison and control in clinical research program other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of aspirin chest pain, unspecified aortocoronary bypass status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled right bundle branch block need for prophylactic vaccination and inoculation against influenza diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status
black african american m 71 $temp    heartrate  46.0  resprate  16.0  o2sat  100.0  sbp  171.0  dbp  95.0  rhythm    pain  asleep  $hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  3.2  mg dl; chemistry blood creatinine  3.3  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood urea nitrogen  43  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  212  mg dl; chemistry blood glucose  110  mg dl$bag  1  bag ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; metoprolol tartrate  6.25  mg ; aspirin  81  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; latanoprost 0.005% ophth. soln.  1  drop ; vitamin d  2000  unit ; losartan potassium  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; rosuvastatin calcium  40  mg ; isosorbide dinitrate  30  mg ; losartan potassium  25  mg ; furosemide  80  mg ; magnesium sulfate  2  gm ; 
long term (current) use of insulin obesity, unspecified long term (current) use of antithrombotics/antiplatelets vitamin d deficiency, unspecified presence of aortocoronary bypass graft familial hypercholesterolemia aphasia following other cerebrovascular disease type 2 diabetes mellitus with hyperglycemia presence of coronary angioplasty implant and graft acute kidney failure, unspecified other spondylosis with myelopathy, site unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris chronic kidney disease, stage 4 (severe) chronic diastolic (congestive) heart failure type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema body mass index (bmi) 29.0-29.9, adult paresthesia of skin type 2 diabetes mellitus with diabetic chronic kidney disease family history of ischemic heart disease and other diseases of the circulatory system presence of aortocoronary bypass graft long term (current) use of antithrombotics/antiplatelets chronic diastolic (congestive) heart failure atherosclerotic heart disease of native coronary artery with unstable angina pectoris familial hypercholesterolemia aphasia following cerebral infarction chronic kidney disease, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of insulin hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease st elevation (stemi) myocardial infarction of unspecified site atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris other visual disturbances cough headache pain in left hip pain in right hip encounter for examination for normal comparison and control in clinical research program other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of aspirin chest pain, unspecified aortocoronary bypass status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled right bundle branch block need for prophylactic vaccination and inoculation against influenza diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status
black african american m 71 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  144  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  3.4  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  184  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; clopidogrel  75  mg ; latanoprost 0.005% ophth. soln.  1  drop ; vitamin d  2000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; rosuvastatin calcium  40  mg ; isosorbide dinitrate  30  mg ; losartan potassium  25  mg ; 
long term (current) use of insulin obesity, unspecified long term (current) use of antithrombotics/antiplatelets vitamin d deficiency, unspecified presence of aortocoronary bypass graft familial hypercholesterolemia aphasia following other cerebrovascular disease type 2 diabetes mellitus with hyperglycemia presence of coronary angioplasty implant and graft acute kidney failure, unspecified other spondylosis with myelopathy, site unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris chronic kidney disease, stage 4 (severe) chronic diastolic (congestive) heart failure type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema body mass index (bmi) 29.0-29.9, adult paresthesia of skin type 2 diabetes mellitus with diabetic chronic kidney disease family history of ischemic heart disease and other diseases of the circulatory system presence of aortocoronary bypass graft long term (current) use of antithrombotics/antiplatelets chronic diastolic (congestive) heart failure atherosclerotic heart disease of native coronary artery with unstable angina pectoris familial hypercholesterolemia aphasia following cerebral infarction chronic kidney disease, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of insulin hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease st elevation (stemi) myocardial infarction of unspecified site atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris other visual disturbances cough headache pain in left hip pain in right hip encounter for examination for normal comparison and control in clinical research program other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of aspirin chest pain, unspecified aortocoronary bypass status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled right bundle branch block need for prophylactic vaccination and inoculation against influenza diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status
black african american m 71 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  151  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  3.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  51  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  185  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; clopidogrel  75  mg ; latanoprost 0.005% ophth. soln.  1  drop ; vitamin d  2000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; rosuvastatin calcium  40  mg ; isosorbide dinitrate  30  mg ; losartan potassium  25  mg ; metoprolol succinate xl  12.5  mg ; losartan potassium  12.5  mg ; isosorbide dinitrate  10  mg ; 
long term (current) use of insulin obesity, unspecified long term (current) use of antithrombotics/antiplatelets vitamin d deficiency, unspecified presence of aortocoronary bypass graft familial hypercholesterolemia aphasia following other cerebrovascular disease type 2 diabetes mellitus with hyperglycemia presence of coronary angioplasty implant and graft acute kidney failure, unspecified other spondylosis with myelopathy, site unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris chronic kidney disease, stage 4 (severe) chronic diastolic (congestive) heart failure type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema body mass index (bmi) 29.0-29.9, adult paresthesia of skin type 2 diabetes mellitus with diabetic chronic kidney disease family history of ischemic heart disease and other diseases of the circulatory system presence of aortocoronary bypass graft long term (current) use of antithrombotics/antiplatelets chronic diastolic (congestive) heart failure atherosclerotic heart disease of native coronary artery with unstable angina pectoris familial hypercholesterolemia aphasia following cerebral infarction chronic kidney disease, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of insulin hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease st elevation (stemi) myocardial infarction of unspecified site atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris other visual disturbances cough headache pain in left hip pain in right hip encounter for examination for normal comparison and control in clinical research program other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of aspirin chest pain, unspecified aortocoronary bypass status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled right bundle branch block need for prophylactic vaccination and inoculation against influenza diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status
black african american m 71 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  3.2  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  50  mg dl; chemistry urine creatinine, urine  161  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  170  mg dl; chemistry urine protein creatinine ratio  4.4  mg mg$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; clopidogrel  75  mg ; latanoprost 0.005% ophth. soln.  1  drop ; vitamin d  2000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; rosuvastatin calcium  40  mg ; metoprolol succinate xl  12.5  mg ; losartan potassium  12.5  mg ; isosorbide dinitrate  10  mg ; polyethylene glycol  17  g ; 
long term (current) use of insulin obesity, unspecified long term (current) use of antithrombotics/antiplatelets vitamin d deficiency, unspecified presence of aortocoronary bypass graft familial hypercholesterolemia aphasia following other cerebrovascular disease type 2 diabetes mellitus with hyperglycemia presence of coronary angioplasty implant and graft acute kidney failure, unspecified other spondylosis with myelopathy, site unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris chronic kidney disease, stage 4 (severe) chronic diastolic (congestive) heart failure type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema body mass index (bmi) 29.0-29.9, adult paresthesia of skin type 2 diabetes mellitus with diabetic chronic kidney disease family history of ischemic heart disease and other diseases of the circulatory system presence of aortocoronary bypass graft long term (current) use of antithrombotics/antiplatelets chronic diastolic (congestive) heart failure atherosclerotic heart disease of native coronary artery with unstable angina pectoris familial hypercholesterolemia aphasia following cerebral infarction chronic kidney disease, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of insulin hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease st elevation (stemi) myocardial infarction of unspecified site atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris other visual disturbances cough headache pain in left hip pain in right hip encounter for examination for normal comparison and control in clinical research program other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of aspirin chest pain, unspecified aortocoronary bypass status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled right bundle branch block need for prophylactic vaccination and inoculation against influenza diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status
black african american m 71 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  209  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; clopidogrel  75  mg ; latanoprost 0.005% ophth. soln.  1  drop ; vitamin d  2000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; rosuvastatin calcium  40  mg ; isosorbide dinitrate  10  mg ; polyethylene glycol  17  g ; amlodipine  2.5  mg ; 
long term (current) use of insulin obesity, unspecified long term (current) use of antithrombotics/antiplatelets vitamin d deficiency, unspecified presence of aortocoronary bypass graft familial hypercholesterolemia aphasia following other cerebrovascular disease type 2 diabetes mellitus with hyperglycemia presence of coronary angioplasty implant and graft acute kidney failure, unspecified other spondylosis with myelopathy, site unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris chronic kidney disease, stage 4 (severe) chronic diastolic (congestive) heart failure type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema body mass index (bmi) 29.0-29.9, adult paresthesia of skin type 2 diabetes mellitus with diabetic chronic kidney disease family history of ischemic heart disease and other diseases of the circulatory system presence of aortocoronary bypass graft long term (current) use of antithrombotics/antiplatelets chronic diastolic (congestive) heart failure atherosclerotic heart disease of native coronary artery with unstable angina pectoris familial hypercholesterolemia aphasia following cerebral infarction chronic kidney disease, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of insulin hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease st elevation (stemi) myocardial infarction of unspecified site atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris other visual disturbances cough headache pain in left hip pain in right hip encounter for examination for normal comparison and control in clinical research program other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of aspirin chest pain, unspecified aortocoronary bypass status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled right bundle branch block need for prophylactic vaccination and inoculation against influenza diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status
black african american m 71 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  50  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  185  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; aspirin  81  mg ; clopidogrel  75  mg ; latanoprost 0.005% ophth. soln.  1  drop ; vitamin d  2000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; rosuvastatin calcium  40  mg ; polyethylene glycol  17  g ; amlodipine  2.5  mg ; 
long term (current) use of insulin obesity, unspecified long term (current) use of antithrombotics/antiplatelets vitamin d deficiency, unspecified presence of aortocoronary bypass graft familial hypercholesterolemia aphasia following other cerebrovascular disease type 2 diabetes mellitus with hyperglycemia presence of coronary angioplasty implant and graft acute kidney failure, unspecified other spondylosis with myelopathy, site unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris chronic kidney disease, stage 4 (severe) chronic diastolic (congestive) heart failure type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema body mass index (bmi) 29.0-29.9, adult paresthesia of skin type 2 diabetes mellitus with diabetic chronic kidney disease family history of ischemic heart disease and other diseases of the circulatory system presence of aortocoronary bypass graft long term (current) use of antithrombotics/antiplatelets chronic diastolic (congestive) heart failure atherosclerotic heart disease of native coronary artery with unstable angina pectoris familial hypercholesterolemia aphasia following cerebral infarction chronic kidney disease, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of insulin hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease st elevation (stemi) myocardial infarction of unspecified site atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris other visual disturbances cough headache pain in left hip pain in right hip encounter for examination for normal comparison and control in clinical research program other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft long-term (current) use of aspirin chest pain, unspecified aortocoronary bypass status diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled right bundle branch block need for prophylactic vaccination and inoculation against influenza diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status
asian m 22 $temp    heartrate  87.0  resprate  16.0  o2sat  97.0  sbp  116.0  dbp  79.0  rhythm    pain  0  $hematology blood hematocrit  43.6  %; hematology blood hematocrit  41.0  %; hematology blood hemoglobin  14.0  g dl; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  310  k ul; hematology blood platelet count  281  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  97  mg dl; chemistry blood glucose  95  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; lorazepam  2-4  mg ; apixaban  5  mg ; 
 
asian m 22 $nan$hematology blood hematocrit  45.9  %; hematology blood hemoglobin  14.9  g dl; hematology blood platelet count  325  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  86  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; lorazepam  2-4  mg ; apixaban  5  mg ; thiamine  100  mg ; acetazolamide  250  mg ; 
 
asian m 22 $nan$hematology blood hematocrit  49.1  %; hematology blood hemoglobin  16.3  g dl; hematology blood platelet count  312  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  98  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; lorazepam  2-4  mg ; apixaban  5  mg ; thiamine  100  mg ; acetazolamide  250  mg ; 
 
white f 76 $temp  97.8  heartrate  60.0  resprate  16.0  o2sat  100.0  sbp  148.0  dbp  60.0  rhythm    pain    ; temp    heartrate  59.0  resprate  18.0  o2sat  100.0  sbp  154.0  dbp  48.0  rhythm    pain  0  $hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  313  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine chloride, urine  63  meq l; chemistry urine creatinine, urine  58  mg dl; chemistry urine potassium, urine  19  meq l; chemistry urine sodium, urine  79  meq l; hematology urine wbc  2  # hpf; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  69  mg dl; blood gas blood lactate  1.3  mmol l$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  1000  ml ; aspirin  81  mg ; carvedilol  12.5  mg ; levothyroxine sodium  50  mcg ; mirtazapine  15  mg ; ondansetron  4  mg ; pantoprazole  40  mg ; polyethylene glycol  17  g ; vitamin d  2000  unit ; simvastatin  20  mg ; quetiapine fumarate  37.5  mg ; mirtazapine  7.5  mg ; 
aortocoronary bypass status urinary tract infection, site not specified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction chest pain, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ bipolar i disorder, most recent episode (or current) manic, severe, without mention of psychotic behavior unspecified acquired hypothyroidism other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery bipolar i disorder, most recent episode (or current) unspecified long-term (current) use of aspirin hypovolemia percutaneous transluminal coronary angioplasty status other and unspecified escherichia coli [e. coli] acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified urinary tract infection, site not specified personal history of tobacco use chronic kidney disease, stage iii (moderate) esophageal reflux coronary atherosclerosis of unspecified type of vessel, native or graft chronic kidney disease, stage iii (moderate) percutaneous transluminal coronary angioplasty status sinoatrial node dysfunction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other postablative hypothyroidism anemia of other chronic disease other and unspecified hyperlipidemia other and unspecified angina pectoris acute kidney failure, unspecified bipolar disorder, unspecified percutaneous transluminal coronary angioplasty status other diuretics causing adverse effects in therapeutic use coronary atherosclerosis of native coronary artery other pulmonary insufficiency, not elsewhere classified, following trauma and surgery acidosis other fluid overload anxiety state, unspecified ostium secundum type atrial septal defect other specified cardiac dysrhythmias
white f 76 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  310  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  85  mg dl$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  1000  ml ; aspirin  81  mg ; carvedilol  12.5  mg ; levothyroxine sodium  50  mcg ; ondansetron  4  mg ; pantoprazole  40  mg ; polyethylene glycol  17  g ; vitamin d  2000  unit ; simvastatin  20  mg ; quetiapine fumarate  37.5  mg ; nitroglycerin ointment  2%  0.5  in ; lorazepam  0.25  mg ; nitroglycerin ointment  2%  1  in ; sodium bicarbonate  650  mg ; amoxicillin-clavulanic acid  500  mg ; carvedilol  25  mg ; mirtazapine  30  mg ; 
aortocoronary bypass status urinary tract infection, site not specified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction chest pain, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ bipolar i disorder, most recent episode (or current) manic, severe, without mention of psychotic behavior unspecified acquired hypothyroidism other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery bipolar i disorder, most recent episode (or current) unspecified long-term (current) use of aspirin hypovolemia percutaneous transluminal coronary angioplasty status other and unspecified escherichia coli [e. coli] acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified urinary tract infection, site not specified personal history of tobacco use chronic kidney disease, stage iii (moderate) esophageal reflux coronary atherosclerosis of unspecified type of vessel, native or graft chronic kidney disease, stage iii (moderate) percutaneous transluminal coronary angioplasty status sinoatrial node dysfunction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other postablative hypothyroidism anemia of other chronic disease other and unspecified hyperlipidemia other and unspecified angina pectoris acute kidney failure, unspecified bipolar disorder, unspecified percutaneous transluminal coronary angioplasty status other diuretics causing adverse effects in therapeutic use coronary atherosclerosis of native coronary artery other pulmonary insufficiency, not elsewhere classified, following trauma and surgery acidosis other fluid overload anxiety state, unspecified ostium secundum type atrial septal defect other specified cardiac dysrhythmias
white f 76 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  311  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  94  mg dl$heparin  5000  unit ; aspirin  81  mg ; levothyroxine sodium  50  mcg ; ondansetron  4  mg ; pantoprazole  40  mg ; polyethylene glycol  17  g ; vitamin d  2000  unit ; simvastatin  20  mg ; quetiapine fumarate  37.5  mg ; sodium bicarbonate  650  mg ; amoxicillin-clavulanic acid  500  mg ; carvedilol  25  mg ; mirtazapine  30  mg ; sodium chloride 0.9%  flush  3  ml ; 
aortocoronary bypass status urinary tract infection, site not specified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction chest pain, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ bipolar i disorder, most recent episode (or current) manic, severe, without mention of psychotic behavior unspecified acquired hypothyroidism other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery bipolar i disorder, most recent episode (or current) unspecified long-term (current) use of aspirin hypovolemia percutaneous transluminal coronary angioplasty status other and unspecified escherichia coli [e. coli] acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified urinary tract infection, site not specified personal history of tobacco use chronic kidney disease, stage iii (moderate) esophageal reflux coronary atherosclerosis of unspecified type of vessel, native or graft chronic kidney disease, stage iii (moderate) percutaneous transluminal coronary angioplasty status sinoatrial node dysfunction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other postablative hypothyroidism anemia of other chronic disease other and unspecified hyperlipidemia other and unspecified angina pectoris acute kidney failure, unspecified bipolar disorder, unspecified percutaneous transluminal coronary angioplasty status other diuretics causing adverse effects in therapeutic use coronary atherosclerosis of native coronary artery other pulmonary insufficiency, not elsewhere classified, following trauma and surgery acidosis other fluid overload anxiety state, unspecified ostium secundum type atrial septal defect other specified cardiac dysrhythmias
white f 76 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  97  mg dl$heparin  5000  unit ; aspirin  81  mg ; levothyroxine sodium  50  mcg ; ondansetron  4  mg ; pantoprazole  40  mg ; polyethylene glycol  17  g ; vitamin d  2000  unit ; simvastatin  20  mg ; quetiapine fumarate  37.5  mg ; sodium bicarbonate  650  mg ; carvedilol  25  mg ; mirtazapine  30  mg ; sodium chloride 0.9%  flush  3  ml ; lactulose  30  ml ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; 
aortocoronary bypass status urinary tract infection, site not specified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction chest pain, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ bipolar i disorder, most recent episode (or current) manic, severe, without mention of psychotic behavior unspecified acquired hypothyroidism other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery bipolar i disorder, most recent episode (or current) unspecified long-term (current) use of aspirin hypovolemia percutaneous transluminal coronary angioplasty status other and unspecified escherichia coli [e. coli] acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified urinary tract infection, site not specified personal history of tobacco use chronic kidney disease, stage iii (moderate) esophageal reflux coronary atherosclerosis of unspecified type of vessel, native or graft chronic kidney disease, stage iii (moderate) percutaneous transluminal coronary angioplasty status sinoatrial node dysfunction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other postablative hypothyroidism anemia of other chronic disease other and unspecified hyperlipidemia other and unspecified angina pectoris acute kidney failure, unspecified bipolar disorder, unspecified percutaneous transluminal coronary angioplasty status other diuretics causing adverse effects in therapeutic use coronary atherosclerosis of native coronary artery other pulmonary insufficiency, not elsewhere classified, following trauma and surgery acidosis other fluid overload anxiety state, unspecified ostium secundum type atrial septal defect other specified cardiac dysrhythmias
white f 76 $nan$nan$heparin  5000  unit ; aspirin  81  mg ; levothyroxine sodium  50  mcg ; ondansetron  4  mg ; simvastatin  20  mg ; quetiapine fumarate  37.5  mg ; sodium bicarbonate  650  mg ; carvedilol  25  mg ; mirtazapine  30  mg ; sodium chloride 0.9%  flush  3  ml ; lactulose  30  ml ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; 
aortocoronary bypass status urinary tract infection, site not specified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction chest pain, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ bipolar i disorder, most recent episode (or current) manic, severe, without mention of psychotic behavior unspecified acquired hypothyroidism other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery bipolar i disorder, most recent episode (or current) unspecified long-term (current) use of aspirin hypovolemia percutaneous transluminal coronary angioplasty status other and unspecified escherichia coli [e. coli] acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified urinary tract infection, site not specified personal history of tobacco use chronic kidney disease, stage iii (moderate) esophageal reflux coronary atherosclerosis of unspecified type of vessel, native or graft chronic kidney disease, stage iii (moderate) percutaneous transluminal coronary angioplasty status sinoatrial node dysfunction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other postablative hypothyroidism anemia of other chronic disease other and unspecified hyperlipidemia other and unspecified angina pectoris acute kidney failure, unspecified bipolar disorder, unspecified percutaneous transluminal coronary angioplasty status other diuretics causing adverse effects in therapeutic use coronary atherosclerosis of native coronary artery other pulmonary insufficiency, not elsewhere classified, following trauma and surgery acidosis other fluid overload anxiety state, unspecified ostium secundum type atrial septal defect other specified cardiac dysrhythmias
white f 76 $nan$chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  104  mg dl$heparin  5000  unit ; aspirin  81  mg ; levothyroxine sodium  50  mcg ; ondansetron  4  mg ; simvastatin  20  mg ; quetiapine fumarate  37.5  mg ; sodium bicarbonate  650  mg ; carvedilol  25  mg ; mirtazapine  30  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; 
aortocoronary bypass status urinary tract infection, site not specified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction chest pain, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ bipolar i disorder, most recent episode (or current) manic, severe, without mention of psychotic behavior unspecified acquired hypothyroidism other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery bipolar i disorder, most recent episode (or current) unspecified long-term (current) use of aspirin hypovolemia percutaneous transluminal coronary angioplasty status other and unspecified escherichia coli [e. coli] acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified urinary tract infection, site not specified personal history of tobacco use chronic kidney disease, stage iii (moderate) esophageal reflux coronary atherosclerosis of unspecified type of vessel, native or graft chronic kidney disease, stage iii (moderate) percutaneous transluminal coronary angioplasty status sinoatrial node dysfunction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other postablative hypothyroidism anemia of other chronic disease other and unspecified hyperlipidemia other and unspecified angina pectoris acute kidney failure, unspecified bipolar disorder, unspecified percutaneous transluminal coronary angioplasty status other diuretics causing adverse effects in therapeutic use coronary atherosclerosis of native coronary artery other pulmonary insufficiency, not elsewhere classified, following trauma and surgery acidosis other fluid overload anxiety state, unspecified ostium secundum type atrial septal defect other specified cardiac dysrhythmias
white f 76 $nan$nan$heparin  5000  unit ; aspirin  81  mg ; levothyroxine sodium  50  mcg ; ondansetron  4  mg ; simvastatin  20  mg ; quetiapine fumarate  37.5  mg ; carvedilol  25  mg ; mirtazapine  30  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; olanzapine (disintegrating tablet)  2.5  mg ; lithium carbonate  150  mg ; 
aortocoronary bypass status urinary tract infection, site not specified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction chest pain, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ bipolar i disorder, most recent episode (or current) manic, severe, without mention of psychotic behavior unspecified acquired hypothyroidism other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery bipolar i disorder, most recent episode (or current) unspecified long-term (current) use of aspirin hypovolemia percutaneous transluminal coronary angioplasty status other and unspecified escherichia coli [e. coli] acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified urinary tract infection, site not specified personal history of tobacco use chronic kidney disease, stage iii (moderate) esophageal reflux coronary atherosclerosis of unspecified type of vessel, native or graft chronic kidney disease, stage iii (moderate) percutaneous transluminal coronary angioplasty status sinoatrial node dysfunction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other postablative hypothyroidism anemia of other chronic disease other and unspecified hyperlipidemia other and unspecified angina pectoris acute kidney failure, unspecified bipolar disorder, unspecified percutaneous transluminal coronary angioplasty status other diuretics causing adverse effects in therapeutic use coronary atherosclerosis of native coronary artery other pulmonary insufficiency, not elsewhere classified, following trauma and surgery acidosis other fluid overload anxiety state, unspecified ostium secundum type atrial septal defect other specified cardiac dysrhythmias
white f 76 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  44  mg dl$aspirin  81  mg ; levothyroxine sodium  50  mcg ; ondansetron  4  mg ; simvastatin  20  mg ; carvedilol  25  mg ; docusate sodium (liquid)  100  mg ; senna  8.6  mg ; olanzapine (disintegrating tablet)  2.5  mg ; lithium carbonate  150  mg ; 
aortocoronary bypass status urinary tract infection, site not specified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction chest pain, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ bipolar i disorder, most recent episode (or current) manic, severe, without mention of psychotic behavior unspecified acquired hypothyroidism other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery bipolar i disorder, most recent episode (or current) unspecified long-term (current) use of aspirin hypovolemia percutaneous transluminal coronary angioplasty status other and unspecified escherichia coli [e. coli] acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified urinary tract infection, site not specified personal history of tobacco use chronic kidney disease, stage iii (moderate) esophageal reflux coronary atherosclerosis of unspecified type of vessel, native or graft chronic kidney disease, stage iii (moderate) percutaneous transluminal coronary angioplasty status sinoatrial node dysfunction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other postablative hypothyroidism anemia of other chronic disease other and unspecified hyperlipidemia other and unspecified angina pectoris acute kidney failure, unspecified bipolar disorder, unspecified percutaneous transluminal coronary angioplasty status other diuretics causing adverse effects in therapeutic use coronary atherosclerosis of native coronary artery other pulmonary insufficiency, not elsewhere classified, following trauma and surgery acidosis other fluid overload anxiety state, unspecified ostium secundum type atrial septal defect other specified cardiac dysrhythmias
white f 76 $nan$chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry urine chloride, urine  49  meq l; chemistry urine potassium, urine  11  meq l; chemistry urine sodium, urine  61  meq l$aspirin  81  mg ; levothyroxine sodium  50  mcg ; ondansetron  4  mg ; simvastatin  20  mg ; carvedilol  25  mg ; senna  8.6  mg ; olanzapine (disintegrating tablet)  2.5  mg ; d5 1 2ns  1000  ml ; 
aortocoronary bypass status urinary tract infection, site not specified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction chest pain, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ bipolar i disorder, most recent episode (or current) manic, severe, without mention of psychotic behavior unspecified acquired hypothyroidism other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery bipolar i disorder, most recent episode (or current) unspecified long-term (current) use of aspirin hypovolemia percutaneous transluminal coronary angioplasty status other and unspecified escherichia coli [e. coli] acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified urinary tract infection, site not specified personal history of tobacco use chronic kidney disease, stage iii (moderate) esophageal reflux coronary atherosclerosis of unspecified type of vessel, native or graft chronic kidney disease, stage iii (moderate) percutaneous transluminal coronary angioplasty status sinoatrial node dysfunction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other postablative hypothyroidism anemia of other chronic disease other and unspecified hyperlipidemia other and unspecified angina pectoris acute kidney failure, unspecified bipolar disorder, unspecified percutaneous transluminal coronary angioplasty status other diuretics causing adverse effects in therapeutic use coronary atherosclerosis of native coronary artery other pulmonary insufficiency, not elsewhere classified, following trauma and surgery acidosis other fluid overload anxiety state, unspecified ostium secundum type atrial septal defect other specified cardiac dysrhythmias
white f 76 $nan$hematology blood hematocrit  28.2  %; hematology blood hematocrit  30.5  %; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  280  k ul; hematology blood platelet count  293  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  37  mg dl$aspirin  81  mg ; levothyroxine sodium  50  mcg ; ondansetron  4  mg ; simvastatin  20  mg ; carvedilol  25  mg ; senna  8.6  mg ; olanzapine (disintegrating tablet)  2.5  mg ; d5 1 2ns  1000  ml ; 
aortocoronary bypass status urinary tract infection, site not specified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction chest pain, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ bipolar i disorder, most recent episode (or current) manic, severe, without mention of psychotic behavior unspecified acquired hypothyroidism other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery bipolar i disorder, most recent episode (or current) unspecified long-term (current) use of aspirin hypovolemia percutaneous transluminal coronary angioplasty status other and unspecified escherichia coli [e. coli] acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified urinary tract infection, site not specified personal history of tobacco use chronic kidney disease, stage iii (moderate) esophageal reflux coronary atherosclerosis of unspecified type of vessel, native or graft chronic kidney disease, stage iii (moderate) percutaneous transluminal coronary angioplasty status sinoatrial node dysfunction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other postablative hypothyroidism anemia of other chronic disease other and unspecified hyperlipidemia other and unspecified angina pectoris acute kidney failure, unspecified bipolar disorder, unspecified percutaneous transluminal coronary angioplasty status other diuretics causing adverse effects in therapeutic use coronary atherosclerosis of native coronary artery other pulmonary insufficiency, not elsewhere classified, following trauma and surgery acidosis other fluid overload anxiety state, unspecified ostium secundum type atrial septal defect other specified cardiac dysrhythmias
white f 76 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  28  mg dl$aspirin  81  mg ; levothyroxine sodium  50  mcg ; ondansetron  4  mg ; simvastatin  20  mg ; carvedilol  25  mg ; senna  8.6  mg ; olanzapine (disintegrating tablet)  2.5  mg ; d5 1 2ns  1000  ml ; 
aortocoronary bypass status urinary tract infection, site not specified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction chest pain, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ bipolar i disorder, most recent episode (or current) manic, severe, without mention of psychotic behavior unspecified acquired hypothyroidism other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery bipolar i disorder, most recent episode (or current) unspecified long-term (current) use of aspirin hypovolemia percutaneous transluminal coronary angioplasty status other and unspecified escherichia coli [e. coli] acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified urinary tract infection, site not specified personal history of tobacco use chronic kidney disease, stage iii (moderate) esophageal reflux coronary atherosclerosis of unspecified type of vessel, native or graft chronic kidney disease, stage iii (moderate) percutaneous transluminal coronary angioplasty status sinoatrial node dysfunction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other postablative hypothyroidism anemia of other chronic disease other and unspecified hyperlipidemia other and unspecified angina pectoris acute kidney failure, unspecified bipolar disorder, unspecified percutaneous transluminal coronary angioplasty status other diuretics causing adverse effects in therapeutic use coronary atherosclerosis of native coronary artery other pulmonary insufficiency, not elsewhere classified, following trauma and surgery acidosis other fluid overload anxiety state, unspecified ostium secundum type atrial septal defect other specified cardiac dysrhythmias
white f 76 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.1  mg dl$aspirin  81  mg ; levothyroxine sodium  50  mcg ; ondansetron  4  mg ; simvastatin  20  mg ; carvedilol  25  mg ; senna  8.6  mg ; olanzapine (disintegrating tablet)  2.5  mg ; olanzapine  5  mg ; 
aortocoronary bypass status urinary tract infection, site not specified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction chest pain, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ bipolar i disorder, most recent episode (or current) manic, severe, without mention of psychotic behavior unspecified acquired hypothyroidism other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery bipolar i disorder, most recent episode (or current) unspecified long-term (current) use of aspirin hypovolemia percutaneous transluminal coronary angioplasty status other and unspecified escherichia coli [e. coli] acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified urinary tract infection, site not specified personal history of tobacco use chronic kidney disease, stage iii (moderate) esophageal reflux coronary atherosclerosis of unspecified type of vessel, native or graft chronic kidney disease, stage iii (moderate) percutaneous transluminal coronary angioplasty status sinoatrial node dysfunction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other postablative hypothyroidism anemia of other chronic disease other and unspecified hyperlipidemia other and unspecified angina pectoris acute kidney failure, unspecified bipolar disorder, unspecified percutaneous transluminal coronary angioplasty status other diuretics causing adverse effects in therapeutic use coronary atherosclerosis of native coronary artery other pulmonary insufficiency, not elsewhere classified, following trauma and surgery acidosis other fluid overload anxiety state, unspecified ostium secundum type atrial septal defect other specified cardiac dysrhythmias
white f 76 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  268  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  62  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood albumin  3.4  g dl$aspirin  81  mg ; levothyroxine sodium  50  mcg ; ondansetron  4  mg ; simvastatin  20  mg ; carvedilol  25  mg ; senna  8.6  mg ; olanzapine (disintegrating tablet)  2.5  mg ; olanzapine  5  mg ; olanzapine  2.5  mg ; ciprofloxacin hcl  250  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; 
aortocoronary bypass status urinary tract infection, site not specified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction chest pain, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ bipolar i disorder, most recent episode (or current) manic, severe, without mention of psychotic behavior unspecified acquired hypothyroidism other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery bipolar i disorder, most recent episode (or current) unspecified long-term (current) use of aspirin hypovolemia percutaneous transluminal coronary angioplasty status other and unspecified escherichia coli [e. coli] acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified urinary tract infection, site not specified personal history of tobacco use chronic kidney disease, stage iii (moderate) esophageal reflux coronary atherosclerosis of unspecified type of vessel, native or graft chronic kidney disease, stage iii (moderate) percutaneous transluminal coronary angioplasty status sinoatrial node dysfunction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other postablative hypothyroidism anemia of other chronic disease other and unspecified hyperlipidemia other and unspecified angina pectoris acute kidney failure, unspecified bipolar disorder, unspecified percutaneous transluminal coronary angioplasty status other diuretics causing adverse effects in therapeutic use coronary atherosclerosis of native coronary artery other pulmonary insufficiency, not elsewhere classified, following trauma and surgery acidosis other fluid overload anxiety state, unspecified ostium secundum type atrial septal defect other specified cardiac dysrhythmias
white f 76 $nan$nan$aspirin  81  mg ; levothyroxine sodium  50  mcg ; ondansetron  4  mg ; simvastatin  20  mg ; carvedilol  25  mg ; senna  8.6  mg ; olanzapine (disintegrating tablet)  2.5  mg ; olanzapine  5  mg ; olanzapine  2.5  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; 
aortocoronary bypass status urinary tract infection, site not specified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified old myocardial infarction chest pain, unspecified chronic kidney disease, unspecified cardiac pacemaker in situ bipolar i disorder, most recent episode (or current) manic, severe, without mention of psychotic behavior unspecified acquired hypothyroidism other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft other and unspecified hyperlipidemia unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery bipolar i disorder, most recent episode (or current) unspecified long-term (current) use of aspirin hypovolemia percutaneous transluminal coronary angioplasty status other and unspecified escherichia coli [e. coli] acute kidney failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified urinary tract infection, site not specified personal history of tobacco use chronic kidney disease, stage iii (moderate) esophageal reflux coronary atherosclerosis of unspecified type of vessel, native or graft chronic kidney disease, stage iii (moderate) percutaneous transluminal coronary angioplasty status sinoatrial node dysfunction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other postablative hypothyroidism anemia of other chronic disease other and unspecified hyperlipidemia other and unspecified angina pectoris acute kidney failure, unspecified bipolar disorder, unspecified percutaneous transluminal coronary angioplasty status other diuretics causing adverse effects in therapeutic use coronary atherosclerosis of native coronary artery other pulmonary insufficiency, not elsewhere classified, following trauma and surgery acidosis other fluid overload anxiety state, unspecified ostium secundum type atrial septal defect other specified cardiac dysrhythmias
black african american f 84 $nan$hematology blood hematocrit  28.8  %; hematology blood hematocrit  26.3  %; hematology blood hemoglobin  9.5  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  234  k ul; hematology blood platelet count  203  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  130  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$docusate sodium (liquid)  100  mg ; 1 2 ns  1000  ml ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; cephalexin  500  mg ; oxymetazoline  1-2  spry ; pantoprazole  40  mg ; metoprolol tartrate  5  mg ; hydralazine  10  mg ; nitroglycerin patch  0.1  mg hr ; ondansetron  4  mg ; acetaminophen  325-650  mg ; metoprolol tartrate  50  mg ; bupropion (sustained release)  100  mg ; lisinopril  30  mg ; nifedipine cr  90  mg ; cepacol (menthol)  1  loz ; 
 
black african american f 84 $nan$hematology blood hematocrit  24.0  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  212  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  112  mg dl$docusate sodium (liquid)  100  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; cephalexin  500  mg ; oxymetazoline  1-2  spry ; pantoprazole  40  mg ; nitroglycerin patch  0.1  mg hr ; ondansetron  4  mg ; acetaminophen  325-650  mg ; metoprolol tartrate  50  mg ; bupropion (sustained release)  100  mg ; lisinopril  30  mg ; cepacol (menthol)  1  loz ; sodium chloride 0.9%  flush  3  ml ; donepezil  5  mg ; ns  1000  ml ; 
 
black african american f 84 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  81  mg dl$docusate sodium (liquid)  100  mg ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; cephalexin  500  mg ; oxymetazoline  1-2  spry ; pantoprazole  40  mg ; nitroglycerin patch  0.1  mg hr ; ondansetron  4  mg ; acetaminophen  325-650  mg ; metoprolol tartrate  50  mg ; bupropion (sustained release)  100  mg ; lisinopril  30  mg ; cepacol (menthol)  1  loz ; sodium chloride 0.9%  flush  3  ml ; donepezil  5  mg ; acetylcysteine 20%  600  mg ; 
 
black african american f 84 $nan$nan$docusate sodium (liquid)  100  mg ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; cephalexin  500  mg ; oxymetazoline  1-2  spry ; pantoprazole  40  mg ; nitroglycerin patch  0.1  mg hr ; ondansetron  4  mg ; acetaminophen  325-650  mg ; metoprolol tartrate  50  mg ; bupropion (sustained release)  100  mg ; lisinopril  30  mg ; cepacol (menthol)  1  loz ; sodium chloride 0.9%  flush  3  ml ; donepezil  5  mg ; nitroglycerin patch  0.2  mg hr ; 
 
black african american f 84 $nan$hematology blood hematocrit  31.6  %; hematology blood platelet count  214  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  91  mg dl$docusate sodium (liquid)  100  mg ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; cephalexin  500  mg ; pantoprazole  40  mg ; nitroglycerin patch  0.1  mg hr ; ondansetron  4  mg ; acetaminophen  325-650  mg ; metoprolol tartrate  50  mg ; bupropion (sustained release)  100  mg ; lisinopril  30  mg ; cepacol (menthol)  1  loz ; sodium chloride 0.9%  flush  3  ml ; donepezil  5  mg ; nitroglycerin patch  0.2  mg hr ; nifedipine cr  30  mg ; nifedipine cr  120  mg ; 
 
black african american f 84 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  223  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  83  mg dl$docusate sodium (liquid)  100  mg ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; cephalexin  500  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; acetaminophen  325-650  mg ; bupropion (sustained release)  100  mg ; lisinopril  30  mg ; cepacol (menthol)  1  loz ; sodium chloride 0.9%  flush  3  ml ; donepezil  5  mg ; nitroglycerin patch  0.2  mg hr ; hydrochlorothiazide  25  mg ; sw  50  ml ; magnesium sulfate  2  gm ; 
 
black african american f 84 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  242  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  91  mg dl$docusate sodium (liquid)  100  mg ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; cephalexin  500  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; acetaminophen  325-650  mg ; bupropion (sustained release)  100  mg ; lisinopril  30  mg ; cepacol (menthol)  1  loz ; sodium chloride 0.9%  flush  3  ml ; donepezil  5  mg ; nitroglycerin patch  0.2  mg hr ; sw  50  ml ; magnesium sulfate  2  gm ; sodium chloride nasal  1-2  spry ; ns  500  ml ; 
 
black african american f 84 $nan$nan$docusate sodium (liquid)  100  mg ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; cephalexin  500  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; acetaminophen  325-650  mg ; bupropion (sustained release)  100  mg ; lisinopril  30  mg ; cepacol (menthol)  1  loz ; sodium chloride 0.9%  flush  3  ml ; donepezil  5  mg ; nitroglycerin patch  0.2  mg hr ; sodium chloride nasal  1-2  spry ; ns  500  ml ; 
 
asian f 32 $nan$hematology blood hematocrit  37.3  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  275  k ul$sodium chloride 0.9%  flush  3  ml ; oxytocin  20  unit ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
asian f 32 $nan$hematology blood hematocrit  32.6  %$sodium chloride 0.9%  flush  3  ml ; oxytocin  20  unit ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
asian f 32 $nan$nan$sodium chloride 0.9%  flush  3  ml ; oxytocin  20  unit ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
black african american f 22 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; metoclopramide  10  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
black african american f 22 $nan$hematology blood hematocrit  25.2  %$naloxone  40-80  mcg ; naloxone  0.4  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; metoclopramide  10  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
black african american f 22 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; ondansetron  4  mg ; metoclopramide  10  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
black african american f 22 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; ondansetron  4  mg ; metoclopramide  10  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
black african american f 22 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; ondansetron  4  mg ; metoclopramide  10  mg ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
white m 56 $temp  98.1  heartrate  81.0  resprate  16.0  o2sat  98.0  sbp  100.0  dbp  55.0  rhythm    pain    ; temp  98.6  heartrate  72.0  resprate  14.0  o2sat    sbp  126.0  dbp  60.0  rhythm    pain    ; temp  98.1  heartrate  68.0  resprate  14.0  o2sat  99.0  sbp  138.0  dbp  75.0  rhythm    pain  0  ; temp  98.2  heartrate  59.0  resprate  14.0  o2sat  100.0  sbp  143.0  dbp  81.0  rhythm    pain  5  $chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  98  mg dl; chemistry blood albumin  4.4  g dl$nan
chest pain, unspecified aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft unspecified essential hypertension acute venous embolism and thrombosis of superficial veins of upper extremity unspecified essential hypertension acute pancreatitis lack of housing driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident bipolar disorder, unspecified acute alcoholic intoxication in alcoholism, continuous acute venous embolism and thrombosis of axillary veins pure hypercholesterolemia aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft acute kidney failure, unspecified acute venous embolism and thrombosis of deep veins of upper extremity unspecified viral hepatitis c without hepatic coma chest pain, unspecified aortocoronary bypass status other respiratory abnormalities unspecified essential hypertension coronary atherosclerosis of unspecified type of vessel, native or graft generalized convulsive epilepsy, without mention of intractable epilepsy alcohol abuse, unspecified driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident alcohol withdrawal acute alcoholic intoxication in alcoholism, continuous lack of housing other and unspecified hyperlipidemia depressive disorder, not elsewhere classified unspecified essential hypertension other chest pain depressive disorder, not elsewhere classified abdominal pain, epigastric suicidal ideation alcohol abuse, unspecified other and unspecified hyperlipidemia alcohol withdrawal depressive disorder, not elsewhere classified acute alcoholic intoxication in alcoholism, continuous unspecified essential hypertension epilepsy, unspecified, without mention of intractable epilepsy chest pain, unspecified alcohol withdrawal acute alcoholic intoxication in alcoholism, continuous depressive disorder, not elsewhere classified unspecified essential hypertension
hispanic latino m 63 $temp  97.6  heartrate  89.0  resprate  16.0  o2sat  100.0  sbp  103.0  dbp  78.0  rhythm    pain  0  ; temp    heartrate  88.0  resprate  16.0  o2sat  100.0  sbp  105.0  dbp  72.0  rhythm    pain  0  $hematology blood hematocrit  36.2  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  404  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  40  # hpf; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  169  mg dl; blood gas blood free calcium  1.05  mmol l; blood gas blood lactate  0.7  mmol l; blood gas blood glucose  185  mg dl$ceftazidime  2  g ; bisacodyl  10  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; senna  1  tab ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; 5% dextrose  250  ml ; phenylephrine  60  mg ; propofol  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; diltiazem  60  mg ; warfarin  5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; heparin  5000  unit ; metoprolol tartrate  75  mg ; acetaminophen iv  1000  mg ; docusate sodium  100  mg ; levetiracetam  1500  mg ; 5% dextrose  500  ml ; vancomycin  1500  mg ; acetaminophen  650  mg ; 
body mass index 31.0-31.9, adult personal history of tobacco use atrial fibrillation hemiplegia, unspecified, affecting unspecified side traumatic cataract, unspecified conjunctival edema subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness obesity, unspecified long-term (current) use of anticoagulants fall from other slipping, tripping, or stumbling unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino m 63 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  384  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood glucose  200  mg dl$bisacodyl  10  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; warfarin  5  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; heparin  5000  unit ; levetiracetam  1500  mg ; 5% dextrose  500  ml ; vancomycin  1500  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; oxycodone (immediate release)   5  mg ; sulfameth trimethoprim ds  1  tab ; insulin  10  unit ; 
body mass index 31.0-31.9, adult personal history of tobacco use atrial fibrillation hemiplegia, unspecified, affecting unspecified side traumatic cataract, unspecified conjunctival edema subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness obesity, unspecified long-term (current) use of anticoagulants fall from other slipping, tripping, or stumbling unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino m 63 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  443  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  111  mg dl; chemistry blood albumin  4.3  g dl$bisacodyl  10  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; warfarin  5  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; heparin  5000  unit ; levetiracetam  1500  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; oxycodone (immediate release)   5  mg ; sulfameth trimethoprim ds  1  tab ; insulin  10  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
body mass index 31.0-31.9, adult personal history of tobacco use atrial fibrillation hemiplegia, unspecified, affecting unspecified side traumatic cataract, unspecified conjunctival edema subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness obesity, unspecified long-term (current) use of anticoagulants fall from other slipping, tripping, or stumbling unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino m 63 $nan$nan$bisacodyl  10  mg ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; warfarin  5  mg ; heparin  5000  unit ; levetiracetam  1500  mg ; acetaminophen  650  mg ; metoprolol succinate xl  250  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
body mass index 31.0-31.9, adult personal history of tobacco use atrial fibrillation hemiplegia, unspecified, affecting unspecified side traumatic cataract, unspecified conjunctival edema subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness obesity, unspecified long-term (current) use of anticoagulants fall from other slipping, tripping, or stumbling unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino m 63 $nan$hematology blood hematocrit  38.1  %; hematology blood hematocrit  36.7  %; hematology blood hemoglobin  12.3  g dl; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  436  k ul; hematology blood platelet count  395  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  10.0  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  136  mg dl; chemistry blood glucose  193  mg dl$bisacodyl  10  mg ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; warfarin  5  mg ; heparin  5000  unit ; levetiracetam  1500  mg ; acetaminophen  650  mg ; metoprolol succinate xl  250  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; quetiapine fumarate  12.5  mg ; 
body mass index 31.0-31.9, adult personal history of tobacco use atrial fibrillation hemiplegia, unspecified, affecting unspecified side traumatic cataract, unspecified conjunctival edema subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness obesity, unspecified long-term (current) use of anticoagulants fall from other slipping, tripping, or stumbling unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino m 63 $nan$nan$bisacodyl  10  mg ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; warfarin  5  mg ; heparin  5000  unit ; levetiracetam  1500  mg ; acetaminophen  650  mg ; metoprolol succinate xl  250  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; quetiapine fumarate  12.5  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; insulin  6  unit ; magnesium citrate  300  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; diltiazem  75  mg ; quetiapine fumarate  50  mg ; 
body mass index 31.0-31.9, adult personal history of tobacco use atrial fibrillation hemiplegia, unspecified, affecting unspecified side traumatic cataract, unspecified conjunctival edema subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness obesity, unspecified long-term (current) use of anticoagulants fall from other slipping, tripping, or stumbling unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino m 63 $nan$hematology blood hematocrit  38.7  %; hematology blood hematocrit  37.2  %; hematology blood hemoglobin  12.1  g dl; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  433  k ul; hematology blood platelet count  378  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  2.0  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  85  mg dl; chemistry blood glucose  189  mg dl$bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; warfarin  5  mg ; heparin  5000  unit ; levetiracetam  1500  mg ; acetaminophen  650  mg ; metoprolol succinate xl  250  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; insulin  6  unit ; magnesium citrate  300  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; diltiazem  75  mg ; quetiapine fumarate  50  mg ; sodium chloride 0.9%  flush  10  ml ; metoprolol succinate xl  50  mg ; 
body mass index 31.0-31.9, adult personal history of tobacco use atrial fibrillation hemiplegia, unspecified, affecting unspecified side traumatic cataract, unspecified conjunctival edema subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness obesity, unspecified long-term (current) use of anticoagulants fall from other slipping, tripping, or stumbling unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino m 63 $nan$nan$bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; warfarin  5  mg ; heparin  5000  unit ; levetiracetam  1500  mg ; acetaminophen  650  mg ; metoprolol succinate xl  250  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; insulin  6  unit ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; sodium chloride 0.9%  flush  10  ml ; metoprolol succinate xl  50  mg ; warfarin  4  mg ; gastroview (diatrizoate meglumine & sodium)  30  ml ; insulin  20  unit ; quetiapine fumarate  25  mg ; 
body mass index 31.0-31.9, adult personal history of tobacco use atrial fibrillation hemiplegia, unspecified, affecting unspecified side traumatic cataract, unspecified conjunctival edema subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness obesity, unspecified long-term (current) use of anticoagulants fall from other slipping, tripping, or stumbling unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino m 63 $nan$hematology blood hematocrit  38.7  %; hematology blood hematocrit  37.4  %; hematology blood hemoglobin  12.9  g dl; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  390  k ul; hematology blood platelet count  347  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  2.2  ; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  78  mg dl; chemistry blood glucose  152  mg dl; chemistry blood albumin  4.1  g dl; chemistry blood % hemoglobin a1c  9.3  %$bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; levetiracetam  1500  mg ; acetaminophen  650  mg ; metoprolol succinate xl  250  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; insulin  6  unit ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; sodium chloride 0.9%  flush  10  ml ; warfarin  4  mg ; gastroview (diatrizoate meglumine & sodium)  30  ml ; insulin  20  unit ; quetiapine fumarate  25  mg ; ibuprofen  400  mg ; calcium acetate  1334  mg ; insulin  30  unit ; 
body mass index 31.0-31.9, adult personal history of tobacco use atrial fibrillation hemiplegia, unspecified, affecting unspecified side traumatic cataract, unspecified conjunctival edema subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness obesity, unspecified long-term (current) use of anticoagulants fall from other slipping, tripping, or stumbling unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino m 63 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  324  k ul$bisacodyl  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levetiracetam  1500  mg ; acetaminophen  650  mg ; metoprolol succinate xl  250  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; sodium chloride 0.9%  flush  10  ml ; warfarin  4  mg ; ibuprofen  400  mg ; calcium acetate  1334  mg ; insulin  30  unit ; glipizide  5  mg ; warfarin  3  mg ; metformin (glucophage)  1000  mg ; 
body mass index 31.0-31.9, adult personal history of tobacco use atrial fibrillation hemiplegia, unspecified, affecting unspecified side traumatic cataract, unspecified conjunctival edema subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness obesity, unspecified long-term (current) use of anticoagulants fall from other slipping, tripping, or stumbling unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 49 $temp  97.9  heartrate  88.0  resprate  16.0  o2sat  99.0  sbp  103.0  dbp  59.0  rhythm    pain  3  ; temp  97.5  heartrate  64.0  resprate  15.0  o2sat  100.0  sbp  104.0  dbp  61.0  rhythm    pain  0  ; temp    heartrate  61.0  resprate  17.0  o2sat  98.0  sbp  103.0  dbp  60.0  rhythm    pain  0  $hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  69  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  13  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  1.7  mg dl; chemistry blood glucose  151  mg dl; chemistry blood albumin  3.9  g dl; hematology blood bands  3  %; blood gas blood lactate  1.5  mmol l$nan
secondary malignant neoplasm of bone nicotine dependence, cigarettes, uncomplicated secondary malignant neoplasm of retroperitoneum and peritoneum secondary malignant neoplasm of right lung pathological fracture in neoplastic disease, left femur, initial encounter for fracture secondary malignant neoplasm of brain pathological fracture in neoplastic disease, left femur, initial encounter for fracture encounter for examination for normal comparison and control in clinical research program nicotine dependence, cigarettes, uncomplicated iron deficiency anemia, unspecified nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] 
white m 49 $temp  97.9  heartrate  60.0  resprate  16.0  o2sat  100.0  sbp  99.0  dbp  67.0  rhythm    pain  0  $hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  63  k ul; hematology blood platelet count  64  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.4  ; chemistry urine creatinine, urine  194  mg dl; chemistry urine sodium, urine  99  meq l; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  1.7  mg dl; chemistry blood glucose  105  mg dl; chemistry blood lactate dehydrogenase (ld)  831  iu l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dexamethasone  4  mg ; ondansetron odt  4  mg ; heparin  5000  unit ; morphine sr (ms contin)  15  mg ; oxycodone (immediate release)  5  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 
secondary malignant neoplasm of bone nicotine dependence, cigarettes, uncomplicated secondary malignant neoplasm of retroperitoneum and peritoneum secondary malignant neoplasm of right lung pathological fracture in neoplastic disease, left femur, initial encounter for fracture secondary malignant neoplasm of brain pathological fracture in neoplastic disease, left femur, initial encounter for fracture encounter for examination for normal comparison and control in clinical research program nicotine dependence, cigarettes, uncomplicated iron deficiency anemia, unspecified nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] 
white m 49 $nan$hematology blood hematocrit  24.0  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  54  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.5  ; chemistry urine creatinine, urine  166  mg dl; chemistry urine sodium, urine  172  meq l; hematology urine wbc  2  # hpf; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, indirect  0.9  mg dl; chemistry blood bilirubin, total  2.6  mg dl; chemistry blood glucose  91  mg dl; chemistry blood glucose  82  mg dl; hematology blood bands  2  %; chemistry blood bilirubin, direct  1.7  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron odt  4  mg ; heparin  5000  unit ; morphine sr (ms contin)  15  mg ; oxycodone (immediate release)  5  mg ; neutra-phos  2  pkt ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; 
secondary malignant neoplasm of bone nicotine dependence, cigarettes, uncomplicated secondary malignant neoplasm of retroperitoneum and peritoneum secondary malignant neoplasm of right lung pathological fracture in neoplastic disease, left femur, initial encounter for fracture secondary malignant neoplasm of brain pathological fracture in neoplastic disease, left femur, initial encounter for fracture encounter for examination for normal comparison and control in clinical research program nicotine dependence, cigarettes, uncomplicated iron deficiency anemia, unspecified nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] 
white m 49 $nan$hematology blood hematocrit  22.0  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  55  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.3  mg dl; chemistry blood bilirubin, total  2.0  mg dl; chemistry blood glucose  80  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron odt  4  mg ; heparin  5000  unit ; morphine sr (ms contin)  15  mg ; oxycodone (immediate release)  5  mg ; neutra-phos  2  pkt ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; 
secondary malignant neoplasm of bone nicotine dependence, cigarettes, uncomplicated secondary malignant neoplasm of retroperitoneum and peritoneum secondary malignant neoplasm of right lung pathological fracture in neoplastic disease, left femur, initial encounter for fracture secondary malignant neoplasm of brain pathological fracture in neoplastic disease, left femur, initial encounter for fracture encounter for examination for normal comparison and control in clinical research program nicotine dependence, cigarettes, uncomplicated iron deficiency anemia, unspecified nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] 
white m 49 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  63  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  100  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron odt  4  mg ; heparin  5000  unit ; morphine sr (ms contin)  15  mg ; oxycodone (immediate release)  5  mg ; neutra-phos  2  pkt ; 
secondary malignant neoplasm of bone nicotine dependence, cigarettes, uncomplicated secondary malignant neoplasm of retroperitoneum and peritoneum secondary malignant neoplasm of right lung pathological fracture in neoplastic disease, left femur, initial encounter for fracture secondary malignant neoplasm of brain pathological fracture in neoplastic disease, left femur, initial encounter for fracture encounter for examination for normal comparison and control in clinical research program nicotine dependence, cigarettes, uncomplicated iron deficiency anemia, unspecified nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] 
white f 35 $nan$nan$oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; docusate sodium  100  mg ; 
 
white f 35 $nan$nan$oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; docusate sodium  100  mg ; 
 
white f 35 $nan$nan$oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; docusate sodium  100  mg ; 
 
black african american f 80 $temp    heartrate  74.0  resprate  13.0  o2sat  100.0  sbp  154.0  dbp  75.0  rhythm    pain  0  ; temp    heartrate  71.0  resprate  14.0  o2sat  100.0  sbp  81.0  dbp  49.0  rhythm    pain    ; temp  98.2  heartrate  75.0  resprate  18.0  o2sat  99.0  sbp  117.0  dbp  57.0  rhythm    pain    ; temp  98.2  heartrate  76.0  resprate  18.0  o2sat  98.0  sbp  120.0  dbp  49.0  rhythm  sinus rhythm  pain    $hematology blood hematocrit  32.0  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  189  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  3  # hpf; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  106  mg dl; chemistry blood lactate dehydrogenase (ld)  1576  iu l; blood gas blood free calcium  1.04  mmol l; blood gas blood lactate  1.6  mmol l$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; insulin  0  unit ; albuterol inhaler  2  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; heparin  5000  unit ; methimazole  5  mg ; tiotropium bromide  1  cap ; enoxaparin sodium  30  mg ; famotidine  20  mg ; 
cerebral atherosclerosis depressive disorder, not elsewhere classified conjunctivitis, unspecified other diseases of lung, not elsewhere classified unspecified essential hypertension other and unspecified hyperlipidemia vascular dementia, uncomplicated cellulitis and abscess of face diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled candidiasis of mouth geniculate herpes zoster esophageal reflux otitis externa due to herpes zoster chronic airway obstruction, not elsewhere classified encephalopathy, unspecified adrenal cortical steroids causing adverse effects in therapeutic use benign essential hypertension cerebral atherosclerosis other diseases of lung, not elsewhere classified obstructive chronic bronchitis with (acute) exacerbation vascular dementia, uncomplicated nontoxic multinodular goiter other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled pneumonia, organism unspecified thyrotoxicosis without mention of goiter or other cause, and without mention of thyrotoxic crisis or storm dehydration personal history of tobacco use other and unspecified hyperlipidemia vascular dementia, uncomplicated acute kidney failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cerebral atherosclerosis esophageal reflux obstructive chronic bronchitis with (acute) exacerbation other diseases of lung, not elsewhere classified hemoptysis unspecified essential hypertension unspecified disorder of kidney and ureter dehydration depressive disorder, not elsewhere classified other chronic pulmonary heart diseases malignant neoplasm of upper lobe, bronchus or lung other and unspecified hyperlipidemia urinary tract infection, site not specified acute respiratory failure streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus]
black african american f 80 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  267  mg dl; blood gas blood lactate  1.5  mmol l$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  500  ml ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; insulin  0  unit ; albuterol inhaler  2  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; methimazole  5  mg ; tiotropium bromide  1  cap ; enoxaparin sodium  30  mg ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fluticasone propionate 110mcg  2  puff ; insulin  12  unit ; insulin  10  unit ; 
cerebral atherosclerosis depressive disorder, not elsewhere classified conjunctivitis, unspecified other diseases of lung, not elsewhere classified unspecified essential hypertension other and unspecified hyperlipidemia vascular dementia, uncomplicated cellulitis and abscess of face diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled candidiasis of mouth geniculate herpes zoster esophageal reflux otitis externa due to herpes zoster chronic airway obstruction, not elsewhere classified encephalopathy, unspecified adrenal cortical steroids causing adverse effects in therapeutic use benign essential hypertension cerebral atherosclerosis other diseases of lung, not elsewhere classified obstructive chronic bronchitis with (acute) exacerbation vascular dementia, uncomplicated nontoxic multinodular goiter other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled pneumonia, organism unspecified thyrotoxicosis without mention of goiter or other cause, and without mention of thyrotoxic crisis or storm dehydration personal history of tobacco use other and unspecified hyperlipidemia vascular dementia, uncomplicated acute kidney failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cerebral atherosclerosis esophageal reflux obstructive chronic bronchitis with (acute) exacerbation other diseases of lung, not elsewhere classified hemoptysis unspecified essential hypertension unspecified disorder of kidney and ureter dehydration depressive disorder, not elsewhere classified other chronic pulmonary heart diseases malignant neoplasm of upper lobe, bronchus or lung other and unspecified hyperlipidemia urinary tract infection, site not specified acute respiratory failure streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus]
black african american f 80 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  211  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  270  mg dl; blood gas blood free calcium  1.20  mmol l; blood gas blood lactate  1.1  mmol l$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; insulin  0  unit ; albuterol inhaler  2  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; methimazole  5  mg ; tiotropium bromide  1  cap ; enoxaparin sodium  30  mg ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fluticasone propionate 110mcg  2  puff ; insulin  10  unit ; insulin  31  unit ; fentanyl citrate  25-50  mcg ; midazolam  1  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; propofol  1000  mg ; propofol  200  mg ; fentanyl citrate  12.5-50  mcg ; ipratropium bromide mdi  2  puff ; polyethylene glycol  17  g ; 
cerebral atherosclerosis depressive disorder, not elsewhere classified conjunctivitis, unspecified other diseases of lung, not elsewhere classified unspecified essential hypertension other and unspecified hyperlipidemia vascular dementia, uncomplicated cellulitis and abscess of face diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled candidiasis of mouth geniculate herpes zoster esophageal reflux otitis externa due to herpes zoster chronic airway obstruction, not elsewhere classified encephalopathy, unspecified adrenal cortical steroids causing adverse effects in therapeutic use benign essential hypertension cerebral atherosclerosis other diseases of lung, not elsewhere classified obstructive chronic bronchitis with (acute) exacerbation vascular dementia, uncomplicated nontoxic multinodular goiter other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled pneumonia, organism unspecified thyrotoxicosis without mention of goiter or other cause, and without mention of thyrotoxic crisis or storm dehydration personal history of tobacco use other and unspecified hyperlipidemia vascular dementia, uncomplicated acute kidney failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cerebral atherosclerosis esophageal reflux obstructive chronic bronchitis with (acute) exacerbation other diseases of lung, not elsewhere classified hemoptysis unspecified essential hypertension unspecified disorder of kidney and ureter dehydration depressive disorder, not elsewhere classified other chronic pulmonary heart diseases malignant neoplasm of upper lobe, bronchus or lung other and unspecified hyperlipidemia urinary tract infection, site not specified acute respiratory failure streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus]
black african american f 80 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  297  mg dl$sodium chloride 0.9%  flush  3  ml ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; insulin  0  unit ; albuterol inhaler  2  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; methimazole  5  mg ; enoxaparin sodium  30  mg ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fluticasone propionate 110mcg  2  puff ; insulin  31  unit ; midazolam  1  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; propofol  1000  mg ; propofol  200  mg ; fentanyl citrate  12.5-50  mcg ; ipratropium bromide mdi  2  puff ; polyethylene glycol  17  g ; insulin  35  unit ; miconazole powder 2%  1  appl ; nystatin  500,000  unit ; nystatin oral suspension  5  ml ; neutra-phos  2  pkt ; metoprolol tartrate  5  mg ; sodium chloride 0.9%  flush  10  ml ; prednisone  40  mg ; 
cerebral atherosclerosis depressive disorder, not elsewhere classified conjunctivitis, unspecified other diseases of lung, not elsewhere classified unspecified essential hypertension other and unspecified hyperlipidemia vascular dementia, uncomplicated cellulitis and abscess of face diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled candidiasis of mouth geniculate herpes zoster esophageal reflux otitis externa due to herpes zoster chronic airway obstruction, not elsewhere classified encephalopathy, unspecified adrenal cortical steroids causing adverse effects in therapeutic use benign essential hypertension cerebral atherosclerosis other diseases of lung, not elsewhere classified obstructive chronic bronchitis with (acute) exacerbation vascular dementia, uncomplicated nontoxic multinodular goiter other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled pneumonia, organism unspecified thyrotoxicosis without mention of goiter or other cause, and without mention of thyrotoxic crisis or storm dehydration personal history of tobacco use other and unspecified hyperlipidemia vascular dementia, uncomplicated acute kidney failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cerebral atherosclerosis esophageal reflux obstructive chronic bronchitis with (acute) exacerbation other diseases of lung, not elsewhere classified hemoptysis unspecified essential hypertension unspecified disorder of kidney and ureter dehydration depressive disorder, not elsewhere classified other chronic pulmonary heart diseases malignant neoplasm of upper lobe, bronchus or lung other and unspecified hyperlipidemia urinary tract infection, site not specified acute respiratory failure streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus]
black african american f 80 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  5.7  meq l; chemistry blood potassium  5.7  meq l; chemistry blood potassium  6.0  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  51  mg dl; chemistry urine chloride, urine  18  meq l; chemistry urine creatinine, urine  38  mg dl; chemistry urine potassium, urine  27  meq l; chemistry urine sodium, urine  10  meq l; chemistry urine urea nitrogen, urine  315  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  228  mg dl; chemistry blood glucose  251  mg dl; blood gas blood free calcium  1.21  mmol l; chemistry urine calcium, urine  0.4  mg dl$sodium chloride 0.9%  flush  3  ml ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; methimazole  5  mg ; enoxaparin sodium  30  mg ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fluticasone propionate 110mcg  2  puff ; insulin  31  unit ; midazolam  1  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; propofol  1000  mg ; propofol  200  mg ; fentanyl citrate  12.5-50  mcg ; ipratropium bromide mdi  2  puff ; polyethylene glycol  17  g ; insulin  35  unit ; miconazole powder 2%  1  appl ; nystatin oral suspension  5  ml ; neutra-phos  2  pkt ; metoprolol tartrate  5  mg ; sodium chloride 0.9%  flush  10  ml ; prednisone  40  mg ; insulin  45  unit ; sodium polystyrene sulfonate  15  gm ; sodium polystyrene sulfonate  30  gm ; 
cerebral atherosclerosis depressive disorder, not elsewhere classified conjunctivitis, unspecified other diseases of lung, not elsewhere classified unspecified essential hypertension other and unspecified hyperlipidemia vascular dementia, uncomplicated cellulitis and abscess of face diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled candidiasis of mouth geniculate herpes zoster esophageal reflux otitis externa due to herpes zoster chronic airway obstruction, not elsewhere classified encephalopathy, unspecified adrenal cortical steroids causing adverse effects in therapeutic use benign essential hypertension cerebral atherosclerosis other diseases of lung, not elsewhere classified obstructive chronic bronchitis with (acute) exacerbation vascular dementia, uncomplicated nontoxic multinodular goiter other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled pneumonia, organism unspecified thyrotoxicosis without mention of goiter or other cause, and without mention of thyrotoxic crisis or storm dehydration personal history of tobacco use other and unspecified hyperlipidemia vascular dementia, uncomplicated acute kidney failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cerebral atherosclerosis esophageal reflux obstructive chronic bronchitis with (acute) exacerbation other diseases of lung, not elsewhere classified hemoptysis unspecified essential hypertension unspecified disorder of kidney and ureter dehydration depressive disorder, not elsewhere classified other chronic pulmonary heart diseases malignant neoplasm of upper lobe, bronchus or lung other and unspecified hyperlipidemia urinary tract infection, site not specified acute respiratory failure streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus]
black african american f 80 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood urea nitrogen  54  mg dl; chemistry blood urea nitrogen  61  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  163  mg dl; chemistry blood glucose  190  mg dl; chemistry blood glucose  176  mg dl; blood gas blood lactate  1.1  mmol l$sodium chloride 0.9%  flush  3  ml ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; methimazole  5  mg ; enoxaparin sodium  30  mg ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fluticasone propionate 110mcg  2  puff ; insulin  31  unit ; midazolam  1  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; propofol  1000  mg ; propofol  200  mg ; fentanyl citrate  12.5-50  mcg ; ipratropium bromide mdi  2  puff ; polyethylene glycol  17  g ; insulin  35  unit ; miconazole powder 2%  1  appl ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  40  mg ; insulin  45  unit ; sodium polystyrene sulfonate  15  gm ; sodium polystyrene sulfonate  30  gm ; metoprolol tartrate  12.5  mg ; 
cerebral atherosclerosis depressive disorder, not elsewhere classified conjunctivitis, unspecified other diseases of lung, not elsewhere classified unspecified essential hypertension other and unspecified hyperlipidemia vascular dementia, uncomplicated cellulitis and abscess of face diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled candidiasis of mouth geniculate herpes zoster esophageal reflux otitis externa due to herpes zoster chronic airway obstruction, not elsewhere classified encephalopathy, unspecified adrenal cortical steroids causing adverse effects in therapeutic use benign essential hypertension cerebral atherosclerosis other diseases of lung, not elsewhere classified obstructive chronic bronchitis with (acute) exacerbation vascular dementia, uncomplicated nontoxic multinodular goiter other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled pneumonia, organism unspecified thyrotoxicosis without mention of goiter or other cause, and without mention of thyrotoxic crisis or storm dehydration personal history of tobacco use other and unspecified hyperlipidemia vascular dementia, uncomplicated acute kidney failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cerebral atherosclerosis esophageal reflux obstructive chronic bronchitis with (acute) exacerbation other diseases of lung, not elsewhere classified hemoptysis unspecified essential hypertension unspecified disorder of kidney and ureter dehydration depressive disorder, not elsewhere classified other chronic pulmonary heart diseases malignant neoplasm of upper lobe, bronchus or lung other and unspecified hyperlipidemia urinary tract infection, site not specified acute respiratory failure streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus]
black african american f 80 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  293  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  66  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  138  mg dl$sodium chloride 0.9%  flush  3  ml ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; methimazole  5  mg ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fluticasone propionate 110mcg  2  puff ; insulin  31  unit ; midazolam  1  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; fentanyl citrate  12.5-50  mcg ; ipratropium bromide mdi  2  puff ; polyethylene glycol  17  g ; insulin  35  unit ; miconazole powder 2%  1  appl ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  40  mg ; insulin  45  unit ; albuterol inhaler  6-10  puff ; ipratropium bromide mdi  6-8  puff ; 
cerebral atherosclerosis depressive disorder, not elsewhere classified conjunctivitis, unspecified other diseases of lung, not elsewhere classified unspecified essential hypertension other and unspecified hyperlipidemia vascular dementia, uncomplicated cellulitis and abscess of face diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled candidiasis of mouth geniculate herpes zoster esophageal reflux otitis externa due to herpes zoster chronic airway obstruction, not elsewhere classified encephalopathy, unspecified adrenal cortical steroids causing adverse effects in therapeutic use benign essential hypertension cerebral atherosclerosis other diseases of lung, not elsewhere classified obstructive chronic bronchitis with (acute) exacerbation vascular dementia, uncomplicated nontoxic multinodular goiter other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled pneumonia, organism unspecified thyrotoxicosis without mention of goiter or other cause, and without mention of thyrotoxic crisis or storm dehydration personal history of tobacco use other and unspecified hyperlipidemia vascular dementia, uncomplicated acute kidney failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cerebral atherosclerosis esophageal reflux obstructive chronic bronchitis with (acute) exacerbation other diseases of lung, not elsewhere classified hemoptysis unspecified essential hypertension unspecified disorder of kidney and ureter dehydration depressive disorder, not elsewhere classified other chronic pulmonary heart diseases malignant neoplasm of upper lobe, bronchus or lung other and unspecified hyperlipidemia urinary tract infection, site not specified acute respiratory failure streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus]
black african american f 80 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  320  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  78  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  116  mg dl; chemistry blood lactate dehydrogenase (ld)  798  iu l$sodium chloride 0.9%  flush  3  ml ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; methimazole  5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fluticasone propionate 110mcg  2  puff ; insulin  31  unit ; midazolam  1  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; fentanyl citrate  12.5-50  mcg ; polyethylene glycol  17  g ; insulin  35  unit ; miconazole powder 2%  1  appl ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  40  mg ; insulin  45  unit ; albuterol inhaler  6-10  puff ; ipratropium bromide mdi  6-8  puff ; 
cerebral atherosclerosis depressive disorder, not elsewhere classified conjunctivitis, unspecified other diseases of lung, not elsewhere classified unspecified essential hypertension other and unspecified hyperlipidemia vascular dementia, uncomplicated cellulitis and abscess of face diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled candidiasis of mouth geniculate herpes zoster esophageal reflux otitis externa due to herpes zoster chronic airway obstruction, not elsewhere classified encephalopathy, unspecified adrenal cortical steroids causing adverse effects in therapeutic use benign essential hypertension cerebral atherosclerosis other diseases of lung, not elsewhere classified obstructive chronic bronchitis with (acute) exacerbation vascular dementia, uncomplicated nontoxic multinodular goiter other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled pneumonia, organism unspecified thyrotoxicosis without mention of goiter or other cause, and without mention of thyrotoxic crisis or storm dehydration personal history of tobacco use other and unspecified hyperlipidemia vascular dementia, uncomplicated acute kidney failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cerebral atherosclerosis esophageal reflux obstructive chronic bronchitis with (acute) exacerbation other diseases of lung, not elsewhere classified hemoptysis unspecified essential hypertension unspecified disorder of kidney and ureter dehydration depressive disorder, not elsewhere classified other chronic pulmonary heart diseases malignant neoplasm of upper lobe, bronchus or lung other and unspecified hyperlipidemia urinary tract infection, site not specified acute respiratory failure streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus]
black african american f 80 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  307  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  3.4  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  90  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  145  mg dl$sodium chloride 0.9%  flush  3  ml ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; methimazole  5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fluticasone propionate 110mcg  2  puff ; insulin  31  unit ; midazolam  1  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; fentanyl citrate  12.5-50  mcg ; polyethylene glycol  17  g ; insulin  35  unit ; miconazole powder 2%  1  appl ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  40  mg ; insulin  45  unit ; albuterol inhaler  6-10  puff ; ipratropium bromide mdi  6-8  puff ; bisacodyl  10  mg ; 
cerebral atherosclerosis depressive disorder, not elsewhere classified conjunctivitis, unspecified other diseases of lung, not elsewhere classified unspecified essential hypertension other and unspecified hyperlipidemia vascular dementia, uncomplicated cellulitis and abscess of face diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled candidiasis of mouth geniculate herpes zoster esophageal reflux otitis externa due to herpes zoster chronic airway obstruction, not elsewhere classified encephalopathy, unspecified adrenal cortical steroids causing adverse effects in therapeutic use benign essential hypertension cerebral atherosclerosis other diseases of lung, not elsewhere classified obstructive chronic bronchitis with (acute) exacerbation vascular dementia, uncomplicated nontoxic multinodular goiter other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled pneumonia, organism unspecified thyrotoxicosis without mention of goiter or other cause, and without mention of thyrotoxic crisis or storm dehydration personal history of tobacco use other and unspecified hyperlipidemia vascular dementia, uncomplicated acute kidney failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cerebral atherosclerosis esophageal reflux obstructive chronic bronchitis with (acute) exacerbation other diseases of lung, not elsewhere classified hemoptysis unspecified essential hypertension unspecified disorder of kidney and ureter dehydration depressive disorder, not elsewhere classified other chronic pulmonary heart diseases malignant neoplasm of upper lobe, bronchus or lung other and unspecified hyperlipidemia urinary tract infection, site not specified acute respiratory failure streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus]
black african american f 80 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  334  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  3.9  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  99  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  107  mg dl; chemistry blood lactate dehydrogenase (ld)  716  iu l; chemistry blood albumin  2.8  g dl; hematology blood bands  6  %$sodium chloride 0.9%  flush  3  ml ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; methimazole  5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fluticasone propionate 110mcg  2  puff ; insulin  31  unit ; midazolam  1  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; fentanyl citrate  12.5-50  mcg ; polyethylene glycol  17  g ; insulin  35  unit ; miconazole powder 2%  1  appl ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  10  ml ; insulin  45  unit ; albuterol inhaler  6-10  puff ; ipratropium bromide mdi  6-8  puff ; bisacodyl  10  mg ; fleet enema  1  enema ; 
cerebral atherosclerosis depressive disorder, not elsewhere classified conjunctivitis, unspecified other diseases of lung, not elsewhere classified unspecified essential hypertension other and unspecified hyperlipidemia vascular dementia, uncomplicated cellulitis and abscess of face diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled candidiasis of mouth geniculate herpes zoster esophageal reflux otitis externa due to herpes zoster chronic airway obstruction, not elsewhere classified encephalopathy, unspecified adrenal cortical steroids causing adverse effects in therapeutic use benign essential hypertension cerebral atherosclerosis other diseases of lung, not elsewhere classified obstructive chronic bronchitis with (acute) exacerbation vascular dementia, uncomplicated nontoxic multinodular goiter other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled pneumonia, organism unspecified thyrotoxicosis without mention of goiter or other cause, and without mention of thyrotoxic crisis or storm dehydration personal history of tobacco use other and unspecified hyperlipidemia vascular dementia, uncomplicated acute kidney failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cerebral atherosclerosis esophageal reflux obstructive chronic bronchitis with (acute) exacerbation other diseases of lung, not elsewhere classified hemoptysis unspecified essential hypertension unspecified disorder of kidney and ureter dehydration depressive disorder, not elsewhere classified other chronic pulmonary heart diseases malignant neoplasm of upper lobe, bronchus or lung other and unspecified hyperlipidemia urinary tract infection, site not specified acute respiratory failure streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus]
black african american f 80 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  342  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  22  meq l; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  4.4  mg dl; chemistry blood creatinine  4.6  mg dl; chemistry blood creatinine  4.9  mg dl; chemistry blood potassium  6.2  meq l; chemistry blood potassium  6.3  meq l; chemistry blood potassium  7.0  meq l; chemistry blood potassium  7.0  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  110  mg dl; chemistry blood urea nitrogen  113  mg dl; chemistry blood urea nitrogen  116  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  121  mg dl; chemistry blood glucose  135  mg dl; chemistry blood glucose  92  mg dl; chemistry blood lactate dehydrogenase (ld)  768  iu l$sodium chloride 0.9%  flush  3  ml ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; methimazole  5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fluticasone propionate 110mcg  2  puff ; insulin  31  unit ; midazolam  1  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; fentanyl citrate  12.5-50  mcg ; polyethylene glycol  17  g ; insulin  35  unit ; miconazole powder 2%  1  appl ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  10  ml ; insulin  45  unit ; albuterol inhaler  6-10  puff ; ipratropium bromide mdi  6-8  puff ; fleet enema  1  enema ; insulin  30  unit ; lactulose  30  ml ; lactulose  45  ml ; 
cerebral atherosclerosis depressive disorder, not elsewhere classified conjunctivitis, unspecified other diseases of lung, not elsewhere classified unspecified essential hypertension other and unspecified hyperlipidemia vascular dementia, uncomplicated cellulitis and abscess of face diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled candidiasis of mouth geniculate herpes zoster esophageal reflux otitis externa due to herpes zoster chronic airway obstruction, not elsewhere classified encephalopathy, unspecified adrenal cortical steroids causing adverse effects in therapeutic use benign essential hypertension cerebral atherosclerosis other diseases of lung, not elsewhere classified obstructive chronic bronchitis with (acute) exacerbation vascular dementia, uncomplicated nontoxic multinodular goiter other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled pneumonia, organism unspecified thyrotoxicosis without mention of goiter or other cause, and without mention of thyrotoxic crisis or storm dehydration personal history of tobacco use other and unspecified hyperlipidemia vascular dementia, uncomplicated acute kidney failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cerebral atherosclerosis esophageal reflux obstructive chronic bronchitis with (acute) exacerbation other diseases of lung, not elsewhere classified hemoptysis unspecified essential hypertension unspecified disorder of kidney and ureter dehydration depressive disorder, not elsewhere classified other chronic pulmonary heart diseases malignant neoplasm of upper lobe, bronchus or lung other and unspecified hyperlipidemia urinary tract infection, site not specified acute respiratory failure streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus]
black african american f 80 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  349  k ul; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  5.2  mg dl; chemistry blood sodium  124  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  122  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  164  mg dl$sodium chloride 0.9%  flush  3  ml ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; methimazole  5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; fluticasone propionate 110mcg  2  puff ; insulin  31  unit ; midazolam  1  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; fentanyl citrate  12.5-50  mcg ; polyethylene glycol  17  g ; insulin  35  unit ; miconazole powder 2%  1  appl ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  flush  10  ml ; insulin  45  unit ; albuterol inhaler  6-10  puff ; ipratropium bromide mdi  6-8  puff ; insulin  30  unit ; lactulose  30  ml ; lactulose  45  ml ; morphine sulfate  2-4  mg ; 
cerebral atherosclerosis depressive disorder, not elsewhere classified conjunctivitis, unspecified other diseases of lung, not elsewhere classified unspecified essential hypertension other and unspecified hyperlipidemia vascular dementia, uncomplicated cellulitis and abscess of face diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled candidiasis of mouth geniculate herpes zoster esophageal reflux otitis externa due to herpes zoster chronic airway obstruction, not elsewhere classified encephalopathy, unspecified adrenal cortical steroids causing adverse effects in therapeutic use benign essential hypertension cerebral atherosclerosis other diseases of lung, not elsewhere classified obstructive chronic bronchitis with (acute) exacerbation vascular dementia, uncomplicated nontoxic multinodular goiter other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled pneumonia, organism unspecified thyrotoxicosis without mention of goiter or other cause, and without mention of thyrotoxic crisis or storm dehydration personal history of tobacco use other and unspecified hyperlipidemia vascular dementia, uncomplicated acute kidney failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cerebral atherosclerosis esophageal reflux obstructive chronic bronchitis with (acute) exacerbation other diseases of lung, not elsewhere classified hemoptysis unspecified essential hypertension unspecified disorder of kidney and ureter dehydration depressive disorder, not elsewhere classified other chronic pulmonary heart diseases malignant neoplasm of upper lobe, bronchus or lung other and unspecified hyperlipidemia urinary tract infection, site not specified acute respiratory failure streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus]
black african american f 80 $nan$nan$sodium chloride 0.9%  flush  3  ml ; fluticasone propionate 110mcg  2  puff ; midazolam  1  mg ; docusate sodium (liquid)  100  mg ; senna  1  tab ; fentanyl citrate  12.5-50  mcg ; miconazole powder 2%  1  appl ; sodium chloride 0.9%  flush  10  ml ; albuterol inhaler  6-10  puff ; ipratropium bromide mdi  6-8  puff ; 
cerebral atherosclerosis depressive disorder, not elsewhere classified conjunctivitis, unspecified other diseases of lung, not elsewhere classified unspecified essential hypertension other and unspecified hyperlipidemia vascular dementia, uncomplicated cellulitis and abscess of face diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled candidiasis of mouth geniculate herpes zoster esophageal reflux otitis externa due to herpes zoster chronic airway obstruction, not elsewhere classified encephalopathy, unspecified adrenal cortical steroids causing adverse effects in therapeutic use benign essential hypertension cerebral atherosclerosis other diseases of lung, not elsewhere classified obstructive chronic bronchitis with (acute) exacerbation vascular dementia, uncomplicated nontoxic multinodular goiter other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled pneumonia, organism unspecified thyrotoxicosis without mention of goiter or other cause, and without mention of thyrotoxic crisis or storm dehydration personal history of tobacco use other and unspecified hyperlipidemia vascular dementia, uncomplicated acute kidney failure, unspecified unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled cerebral atherosclerosis esophageal reflux obstructive chronic bronchitis with (acute) exacerbation other diseases of lung, not elsewhere classified hemoptysis unspecified essential hypertension unspecified disorder of kidney and ureter dehydration depressive disorder, not elsewhere classified other chronic pulmonary heart diseases malignant neoplasm of upper lobe, bronchus or lung other and unspecified hyperlipidemia urinary tract infection, site not specified acute respiratory failure streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus]
white m 73 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  90  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; amlodipine  10  mg ; aspirin  325  mg ; atorvastatin  40  mg ; carbamazepine (extended-release)  100  mg ; fluticasone propionate nasal  2  spry ; folic acid  0.5  mg ; isosorbide mononitrate (extended release)  30  mg ; isosorbide mononitrate (extended release)  60  mg ; multivitamins  1  tab ; pantoprazole  40  mg ; tamsulosin  0.4  mg ; lactated ringers  1000  ml ; gabapentin  300  mg ; methylphenidate (ritalin)  10  mg ; azithromycin  500  mg ; ipratropium-albuterol neb  1  neb ; 
hypertensive emergency acute kidney failure, unspecified chronic kidney disease, unspecified hyperlipidemia, unspecified generalized anxiety disorder hypertensive encephalopathy schizophrenia, unspecified bipolar disorder, unspecified nicotine dependence, other tobacco product, uncomplicated benign prostatic hyperplasia without lower urinary tract symptoms dorsalgia, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain family history of other mental and behavioral disorders hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of self-harm bradycardia, unspecified toxic encephalopathy personal history of nicotine dependence presence of right artificial hip joint hyperlipidemia, unspecified hypertensive urgency malignant neuroleptic syndrome generalized anxiety disorder schizophrenia, unspecified bipolar disorder, unspecified obstructive sleep apnea (adult) (pediatric) acute kidney failure, unspecified chronic kidney disease, stage 3 (moderate) other drug induced movement disorders agoraphobia, unspecified poisoning by other psychotropic drugs, accidental (unintentional), initial encounter poisoning by benzodiazepines, accidental (unintentional), initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of opiate analgesic unspecified place in apartment as the place of occurrence of the external cause delirium due to known physiological condition unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause body mass index (bmi) 22.0-22.9, adult dehydration benign prostatic hyperplasia without lower urinary tract symptoms anxiety disorder, unspecified gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence bipolar disorder, unspecified abnormal weight loss toxic encephalopathy adverse effect of other antipsychotics and neuroleptics, initial encounter
white m 73 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry urine creatinine, urine  66  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  104  mg dl; chemistry urine protein creatinine ratio  3.5  mg mg$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; amlodipine  10  mg ; aspirin  325  mg ; atorvastatin  40  mg ; carbamazepine (extended-release)  100  mg ; fluticasone propionate nasal  2  spry ; folic acid  0.5  mg ; isosorbide mononitrate (extended release)  30  mg ; isosorbide mononitrate (extended release)  60  mg ; multivitamins  1  tab ; pantoprazole  40  mg ; tamsulosin  0.4  mg ; gabapentin  300  mg ; methylphenidate (ritalin)  10  mg ; azithromycin  500  mg ; ipratropium-albuterol neb  1  neb ; mupirocin ointment 2%  1  appl ; senna  8.6  mg ; polyethylene glycol  17  g ; azithromycin  250  mg ; docusate sodium  100  mg ; lisinopril  40  mg ; 
hypertensive emergency acute kidney failure, unspecified chronic kidney disease, unspecified hyperlipidemia, unspecified generalized anxiety disorder hypertensive encephalopathy schizophrenia, unspecified bipolar disorder, unspecified nicotine dependence, other tobacco product, uncomplicated benign prostatic hyperplasia without lower urinary tract symptoms dorsalgia, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain family history of other mental and behavioral disorders hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of self-harm bradycardia, unspecified toxic encephalopathy personal history of nicotine dependence presence of right artificial hip joint hyperlipidemia, unspecified hypertensive urgency malignant neuroleptic syndrome generalized anxiety disorder schizophrenia, unspecified bipolar disorder, unspecified obstructive sleep apnea (adult) (pediatric) acute kidney failure, unspecified chronic kidney disease, stage 3 (moderate) other drug induced movement disorders agoraphobia, unspecified poisoning by other psychotropic drugs, accidental (unintentional), initial encounter poisoning by benzodiazepines, accidental (unintentional), initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of opiate analgesic unspecified place in apartment as the place of occurrence of the external cause delirium due to known physiological condition unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause body mass index (bmi) 22.0-22.9, adult dehydration benign prostatic hyperplasia without lower urinary tract symptoms anxiety disorder, unspecified gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence bipolar disorder, unspecified abnormal weight loss toxic encephalopathy adverse effect of other antipsychotics and neuroleptics, initial encounter
white m 73 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  123  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; amlodipine  10  mg ; aspirin  325  mg ; atorvastatin  40  mg ; carbamazepine (extended-release)  100  mg ; fluticasone propionate nasal  2  spry ; folic acid  0.5  mg ; isosorbide mononitrate (extended release)  30  mg ; isosorbide mononitrate (extended release)  60  mg ; multivitamins  1  tab ; pantoprazole  40  mg ; tamsulosin  0.4  mg ; gabapentin  300  mg ; methylphenidate (ritalin)  10  mg ; ipratropium-albuterol neb  1  neb ; mupirocin ointment 2%  1  appl ; senna  8.6  mg ; polyethylene glycol  17  g ; azithromycin  250  mg ; docusate sodium  100  mg ; lisinopril  40  mg ; 
hypertensive emergency acute kidney failure, unspecified chronic kidney disease, unspecified hyperlipidemia, unspecified generalized anxiety disorder hypertensive encephalopathy schizophrenia, unspecified bipolar disorder, unspecified nicotine dependence, other tobacco product, uncomplicated benign prostatic hyperplasia without lower urinary tract symptoms dorsalgia, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain family history of other mental and behavioral disorders hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of self-harm bradycardia, unspecified toxic encephalopathy personal history of nicotine dependence presence of right artificial hip joint hyperlipidemia, unspecified hypertensive urgency malignant neuroleptic syndrome generalized anxiety disorder schizophrenia, unspecified bipolar disorder, unspecified obstructive sleep apnea (adult) (pediatric) acute kidney failure, unspecified chronic kidney disease, stage 3 (moderate) other drug induced movement disorders agoraphobia, unspecified poisoning by other psychotropic drugs, accidental (unintentional), initial encounter poisoning by benzodiazepines, accidental (unintentional), initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of opiate analgesic unspecified place in apartment as the place of occurrence of the external cause delirium due to known physiological condition unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause body mass index (bmi) 22.0-22.9, adult dehydration benign prostatic hyperplasia without lower urinary tract symptoms anxiety disorder, unspecified gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence bipolar disorder, unspecified abnormal weight loss toxic encephalopathy adverse effect of other antipsychotics and neuroleptics, initial encounter
white m 73 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  258  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  92  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; amlodipine  10  mg ; aspirin  325  mg ; atorvastatin  40  mg ; carbamazepine (extended-release)  100  mg ; fluticasone propionate nasal  2  spry ; folic acid  0.5  mg ; isosorbide mononitrate (extended release)  30  mg ; isosorbide mononitrate (extended release)  60  mg ; multivitamins  1  tab ; pantoprazole  40  mg ; tamsulosin  0.4  mg ; gabapentin  300  mg ; methylphenidate (ritalin)  10  mg ; ipratropium-albuterol neb  1  neb ; mupirocin ointment 2%  1  appl ; senna  8.6  mg ; polyethylene glycol  17  g ; azithromycin  250  mg ; docusate sodium  100  mg ; guaifenesin  5-10  ml ; calcium carbonate  500  mg ; 
hypertensive emergency acute kidney failure, unspecified chronic kidney disease, unspecified hyperlipidemia, unspecified generalized anxiety disorder hypertensive encephalopathy schizophrenia, unspecified bipolar disorder, unspecified nicotine dependence, other tobacco product, uncomplicated benign prostatic hyperplasia without lower urinary tract symptoms dorsalgia, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain family history of other mental and behavioral disorders hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of self-harm bradycardia, unspecified toxic encephalopathy personal history of nicotine dependence presence of right artificial hip joint hyperlipidemia, unspecified hypertensive urgency malignant neuroleptic syndrome generalized anxiety disorder schizophrenia, unspecified bipolar disorder, unspecified obstructive sleep apnea (adult) (pediatric) acute kidney failure, unspecified chronic kidney disease, stage 3 (moderate) other drug induced movement disorders agoraphobia, unspecified poisoning by other psychotropic drugs, accidental (unintentional), initial encounter poisoning by benzodiazepines, accidental (unintentional), initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of opiate analgesic unspecified place in apartment as the place of occurrence of the external cause delirium due to known physiological condition unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause body mass index (bmi) 22.0-22.9, adult dehydration benign prostatic hyperplasia without lower urinary tract symptoms anxiety disorder, unspecified gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence bipolar disorder, unspecified abnormal weight loss toxic encephalopathy adverse effect of other antipsychotics and neuroleptics, initial encounter
white m 73 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  258  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood potassium  5.7  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood urea nitrogen  48  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  127  mg dl; chemistry blood glucose  91  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; amlodipine  10  mg ; aspirin  325  mg ; atorvastatin  40  mg ; carbamazepine (extended-release)  100  mg ; fluticasone propionate nasal  2  spry ; folic acid  0.5  mg ; isosorbide mononitrate (extended release)  30  mg ; isosorbide mononitrate (extended release)  60  mg ; multivitamins  1  tab ; pantoprazole  40  mg ; tamsulosin  0.4  mg ; gabapentin  300  mg ; methylphenidate (ritalin)  10  mg ; ipratropium-albuterol neb  1  neb ; mupirocin ointment 2%  1  appl ; senna  8.6  mg ; polyethylene glycol  17  g ; azithromycin  250  mg ; docusate sodium  100  mg ; guaifenesin  5-10  ml ; calcium carbonate  500  mg ; tiotropium bromide  1  cap ; 
hypertensive emergency acute kidney failure, unspecified chronic kidney disease, unspecified hyperlipidemia, unspecified generalized anxiety disorder hypertensive encephalopathy schizophrenia, unspecified bipolar disorder, unspecified nicotine dependence, other tobacco product, uncomplicated benign prostatic hyperplasia without lower urinary tract symptoms dorsalgia, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain family history of other mental and behavioral disorders hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of self-harm bradycardia, unspecified toxic encephalopathy personal history of nicotine dependence presence of right artificial hip joint hyperlipidemia, unspecified hypertensive urgency malignant neuroleptic syndrome generalized anxiety disorder schizophrenia, unspecified bipolar disorder, unspecified obstructive sleep apnea (adult) (pediatric) acute kidney failure, unspecified chronic kidney disease, stage 3 (moderate) other drug induced movement disorders agoraphobia, unspecified poisoning by other psychotropic drugs, accidental (unintentional), initial encounter poisoning by benzodiazepines, accidental (unintentional), initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of opiate analgesic unspecified place in apartment as the place of occurrence of the external cause delirium due to known physiological condition unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause body mass index (bmi) 22.0-22.9, adult dehydration benign prostatic hyperplasia without lower urinary tract symptoms anxiety disorder, unspecified gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence bipolar disorder, unspecified abnormal weight loss toxic encephalopathy adverse effect of other antipsychotics and neuroleptics, initial encounter
white m 73 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  274  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  92  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; amlodipine  10  mg ; atorvastatin  40  mg ; carbamazepine (extended-release)  100  mg ; fluticasone propionate nasal  2  spry ; folic acid  0.5  mg ; isosorbide mononitrate (extended release)  30  mg ; isosorbide mononitrate (extended release)  60  mg ; multivitamins  1  tab ; pantoprazole  40  mg ; tamsulosin  0.4  mg ; gabapentin  300  mg ; methylphenidate (ritalin)  10  mg ; ipratropium-albuterol neb  1  neb ; mupirocin ointment 2%  1  appl ; senna  8.6  mg ; polyethylene glycol  17  g ; azithromycin  250  mg ; docusate sodium  100  mg ; guaifenesin  5-10  ml ; calcium carbonate  500  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; clonidine patch 0.3 mg 24 hr  1  ptch ; chlorthalidone  12.5  mg ; 
hypertensive emergency acute kidney failure, unspecified chronic kidney disease, unspecified hyperlipidemia, unspecified generalized anxiety disorder hypertensive encephalopathy schizophrenia, unspecified bipolar disorder, unspecified nicotine dependence, other tobacco product, uncomplicated benign prostatic hyperplasia without lower urinary tract symptoms dorsalgia, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain family history of other mental and behavioral disorders hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of self-harm bradycardia, unspecified toxic encephalopathy personal history of nicotine dependence presence of right artificial hip joint hyperlipidemia, unspecified hypertensive urgency malignant neuroleptic syndrome generalized anxiety disorder schizophrenia, unspecified bipolar disorder, unspecified obstructive sleep apnea (adult) (pediatric) acute kidney failure, unspecified chronic kidney disease, stage 3 (moderate) other drug induced movement disorders agoraphobia, unspecified poisoning by other psychotropic drugs, accidental (unintentional), initial encounter poisoning by benzodiazepines, accidental (unintentional), initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of opiate analgesic unspecified place in apartment as the place of occurrence of the external cause delirium due to known physiological condition unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause body mass index (bmi) 22.0-22.9, adult dehydration benign prostatic hyperplasia without lower urinary tract symptoms anxiety disorder, unspecified gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence bipolar disorder, unspecified abnormal weight loss toxic encephalopathy adverse effect of other antipsychotics and neuroleptics, initial encounter
white m 73 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; amlodipine  10  mg ; atorvastatin  40  mg ; carbamazepine (extended-release)  100  mg ; fluticasone propionate nasal  2  spry ; folic acid  0.5  mg ; isosorbide mononitrate (extended release)  30  mg ; isosorbide mononitrate (extended release)  60  mg ; multivitamins  1  tab ; pantoprazole  40  mg ; tamsulosin  0.4  mg ; gabapentin  300  mg ; methylphenidate (ritalin)  10  mg ; ipratropium-albuterol neb  1  neb ; mupirocin ointment 2%  1  appl ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; guaifenesin  5-10  ml ; calcium carbonate  500  mg ; tiotropium bromide  1  cap ; aspirin  81  mg ; clonidine patch 0.3 mg 24 hr  1  ptch ; chlorthalidone  12.5  mg ; 
hypertensive emergency acute kidney failure, unspecified chronic kidney disease, unspecified hyperlipidemia, unspecified generalized anxiety disorder hypertensive encephalopathy schizophrenia, unspecified bipolar disorder, unspecified nicotine dependence, other tobacco product, uncomplicated benign prostatic hyperplasia without lower urinary tract symptoms dorsalgia, unspecified gastro-esophageal reflux disease without esophagitis other chronic pain family history of other mental and behavioral disorders hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of self-harm bradycardia, unspecified toxic encephalopathy personal history of nicotine dependence presence of right artificial hip joint hyperlipidemia, unspecified hypertensive urgency malignant neuroleptic syndrome generalized anxiety disorder schizophrenia, unspecified bipolar disorder, unspecified obstructive sleep apnea (adult) (pediatric) acute kidney failure, unspecified chronic kidney disease, stage 3 (moderate) other drug induced movement disorders agoraphobia, unspecified poisoning by other psychotropic drugs, accidental (unintentional), initial encounter poisoning by benzodiazepines, accidental (unintentional), initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of opiate analgesic unspecified place in apartment as the place of occurrence of the external cause delirium due to known physiological condition unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause body mass index (bmi) 22.0-22.9, adult dehydration benign prostatic hyperplasia without lower urinary tract symptoms anxiety disorder, unspecified gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence bipolar disorder, unspecified abnormal weight loss toxic encephalopathy adverse effect of other antipsychotics and neuroleptics, initial encounter
white m 62 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  279  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  129  mg dl$ondansetron  4  mg ; lorazepam  0.5  mg ; morphine sulfate  4  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  325-650  mg ; aspirin ec  81  mg ; docusate sodium  100  mg ; morphine sulfate  2-4  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; prasugrel  10  mg ; cepacol (sore throat lozenge)  1  loz ; promethazine  12.5  mg ; chloraseptic throat spray  1  spry ; simvastatin  40  mg ; 
malignant neoplasm of left kidney, except renal pelvis presence of coronary angioplasty implant and graft old myocardial infarction essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence hyperlipidemia, unspecified 
white m 62 $nan$hematology blood hematocrit  38.6  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  277  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  115  mg dl$ondansetron  4  mg ; lorazepam  0.5  mg ; morphine sulfate  4  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  325-650  mg ; aspirin ec  81  mg ; docusate sodium  100  mg ; morphine sulfate  2-4  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; prasugrel  10  mg ; cepacol (sore throat lozenge)  1  loz ; promethazine  12.5  mg ; simvastatin  40  mg ; irbesartan  150  mg ; d5 1 2ns  1000  ml ; simethicone  40-80  mg ; 
malignant neoplasm of left kidney, except renal pelvis presence of coronary angioplasty implant and graft old myocardial infarction essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence hyperlipidemia, unspecified 
white m 62 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  99  mg dl$lorazepam  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; aspirin ec  81  mg ; docusate sodium  100  mg ; morphine sulfate  2-4  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; prasugrel  10  mg ; cepacol (sore throat lozenge)  1  loz ; promethazine  12.5  mg ; simvastatin  40  mg ; irbesartan  150  mg ; d5 1 2ns  1000  ml ; simethicone  40-80  mg ; 
malignant neoplasm of left kidney, except renal pelvis presence of coronary angioplasty implant and graft old myocardial infarction essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence hyperlipidemia, unspecified 
white m 62 $nan$nan$lorazepam  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; aspirin ec  81  mg ; docusate sodium  100  mg ; morphine sulfate  2-4  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; prasugrel  10  mg ; cepacol (sore throat lozenge)  1  loz ; promethazine  12.5  mg ; simvastatin  40  mg ; irbesartan  150  mg ; d5 1 2ns  1000  ml ; simethicone  40-80  mg ; acetaminophen  650  mg ; 
malignant neoplasm of left kidney, except renal pelvis presence of coronary angioplasty implant and graft old myocardial infarction essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence hyperlipidemia, unspecified 
black african american f 56 $nan$nan$1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; 

white f 59 $temp    heartrate  62.0  resprate  18.0  o2sat  96.0  sbp  136.0  dbp  77.0  rhythm    pain  5  $hematology blood hematocrit  40.3  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  175  mg dl$lorazepam  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; cyanocobalamin  1000  mcg ; benzonatate  100  mg ; lorazepam  0.5-1  mg ; pantoprazole  40  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; ondansetron  4  mg ; amoxicillin-clavulanic acid  500  mg ; gabapentin  800  mg ; atorvastatin  40  mg ; escitalopram oxalate  15  mg ; lorazepam  2  mg ; buspirone  10  mg ; lorazepam  1  mg ; sodium chloride 0.9%  1000  ml ; ketorolac  15  mg ; metoclopramide  5  mg ; diphenhydramine  12.5  mg ; 
anxiety state, unspecified multiple sclerosis person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other specified disorders of biliary tract personal history of malignant neoplasm of breast bariatric surgery status obstructive sleep apnea (adult)(pediatric) long-term (current) use of anticoagulants morbid obesity asthma, unspecified type, unspecified anemia, unspecified edema personal history of venous thrombosis and embolism esophageal reflux diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled multiple sclerosis
white f 59 $nan$hematology blood inr(pt)  1.0  $sodium chloride 0.9%  flush  3  ml ; cyanocobalamin  1000  mcg ; benzonatate  100  mg ; lorazepam  0.5-1  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; ondansetron  4  mg ; amoxicillin-clavulanic acid  500  mg ; atorvastatin  40  mg ; escitalopram oxalate  15  mg ; lorazepam  2  mg ; buspirone  10  mg ; lorazepam  1  mg ; sodium chloride 0.9%  1000  ml ; 
anxiety state, unspecified multiple sclerosis person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other specified disorders of biliary tract personal history of malignant neoplasm of breast bariatric surgery status obstructive sleep apnea (adult)(pediatric) long-term (current) use of anticoagulants morbid obesity asthma, unspecified type, unspecified anemia, unspecified edema personal history of venous thrombosis and embolism esophageal reflux diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled multiple sclerosis
white f 59 $nan$hematology blood hematocrit  40.1  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3  ml ; cyanocobalamin  1000  mcg ; benzonatate  100  mg ; lorazepam  0.5-1  mg ; heparin  5000  unit ; acetaminophen  325-650  mg ; ondansetron  4  mg ; amoxicillin-clavulanic acid  500  mg ; atorvastatin  40  mg ; escitalopram oxalate  15  mg ; lorazepam  2  mg ; buspirone  10  mg ; vitamin d  2000  unit ; lidocaine 5% patch  1  ptch ; 
anxiety state, unspecified multiple sclerosis person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other specified disorders of biliary tract personal history of malignant neoplasm of breast bariatric surgery status obstructive sleep apnea (adult)(pediatric) long-term (current) use of anticoagulants morbid obesity asthma, unspecified type, unspecified anemia, unspecified edema personal history of venous thrombosis and embolism esophageal reflux diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled multiple sclerosis
white m 75 $temp    heartrate  96.0  resprate  18.0  o2sat  100.0  sbp  109.0  dbp  62.0  rhythm    pain  0  $hematology blood hematocrit  34.0  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  319  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; clonazepam  1  mg ; levothyroxine sodium  88  mcg ; insulin  0  unit ; tiotropium bromide  1  cap ; heparin  800-1700  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; ferrous sulfate  325  mg ; risperidone  0.5  mg ; 
 
white m 75 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  319  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood albumin  2.8  g dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; clonazepam  1  mg ; levothyroxine sodium  88  mcg ; insulin  0  unit ; tiotropium bromide  1  cap ; heparin  800-1700  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; ferrous sulfate  325  mg ; risperidone  0.5  mg ; moviprep  1  l ; docusate sodium  100  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; paroxetine  40  mg ; 
 
white m 75 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  303  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  142  meq l; hematology blood inr(pt)  1.3  ; chemistry blood bilirubin, total  0.4  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; clonazepam  1  mg ; levothyroxine sodium  88  mcg ; insulin  0  unit ; tiotropium bromide  1  cap ; heparin  800-1700  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; ferrous sulfate  325  mg ; risperidone  0.5  mg ; docusate sodium  100  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; paroxetine  40  mg ; polyethylene glycol  17  g ; paroxetine er   37.5  mg ; ondansetron  4  mg ; 
 
white m 75 $nan$hematology blood hematocrit  34.4  %; hematology blood hematocrit  34.9  %; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  296  k ul; hematology blood platelet count  305  k ul$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; clonazepam  1  mg ; levothyroxine sodium  88  mcg ; insulin  0  unit ; tiotropium bromide  1  cap ; ferrous sulfate  325  mg ; risperidone  0.5  mg ; docusate sodium  100  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; polyethylene glycol  17  g ; paroxetine er   37.5  mg ; ondansetron  4  mg ; warfarin  5  mg ; 
 
white m 75 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  273  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  97  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; clonazepam  1  mg ; levothyroxine sodium  88  mcg ; insulin  0  unit ; tiotropium bromide  1  cap ; ferrous sulfate  325  mg ; risperidone  0.5  mg ; docusate sodium  100  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; polyethylene glycol  17  g ; paroxetine er   37.5  mg ; ondansetron  4  mg ; warfarin  5  mg ; potassium chloride  60  meq ; 
 
white m 75 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  288  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  3.3  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; clonazepam  1  mg ; levothyroxine sodium  88  mcg ; insulin  0  unit ; tiotropium bromide  1  cap ; ferrous sulfate  325  mg ; risperidone  0.5  mg ; docusate sodium  100  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; polyethylene glycol  17  g ; paroxetine er   37.5  mg ; ondansetron  4  mg ; warfarin  5  mg ; potassium chloride  60  meq ; 
 
white m 75 $nan$hematology blood hematocrit  36.4  %; hematology blood hematocrit  36.5  %; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  281  k ul; hematology blood platelet count  259  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  3.5  ; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; clonazepam  1  mg ; levothyroxine sodium  88  mcg ; insulin  0  unit ; tiotropium bromide  1  cap ; ferrous sulfate  325  mg ; risperidone  0.5  mg ; docusate sodium  100  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; polyethylene glycol  17  g ; paroxetine er   37.5  mg ; ondansetron  4  mg ; warfarin  2.5  mg ; 
 
white m 75 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  3.7  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  91  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; clonazepam  1  mg ; levothyroxine sodium  88  mcg ; insulin  0  unit ; tiotropium bromide  1  cap ; ferrous sulfate  325  mg ; risperidone  0.5  mg ; docusate sodium  100  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; polyethylene glycol  17  g ; paroxetine er   37.5  mg ; ondansetron  4  mg ; warfarin  2.5  mg ; 
 
white m 75 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; clonazepam  1  mg ; levothyroxine sodium  88  mcg ; insulin  0  unit ; tiotropium bromide  1  cap ; ferrous sulfate  325  mg ; risperidone  0.5  mg ; docusate sodium  100  mg ; sarna lotion  1  appl ; ramelteon  8  mg ; polyethylene glycol  17  g ; paroxetine er   37.5  mg ; ondansetron  4  mg ; phytonadione  5  mg ; 
 
black african american f 47 $nan$nan$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; cetirizine  10  mg ; diphenhydramine  25  mg ; famotidine  40  mg ; lorazepam  1  mg ; dexamethasone  12  mg ; epinephrine (epipen)  0.3  mg ; diphenhydramine  50  mg ; hydrocortisone na succ.  200  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; montelukast  10  mg ; 5% dextrose  100  ml ; oxaliplatin desensitization  1.85  mg ; 5% dextrose  250  ml ; oxaliplatin desensitization  18.5  mg ; oxaliplatin desensitization  185  mg ; labetalol  200  mg ; tramadol  50  mg ; labetalol  400  mg ; 
encounter for antineoplastic chemotherapy secondary malignant neoplasm of unspecified lung malignant neoplasm of ascending colon essential (primary) hypertension allergy status to other drugs, medicaments and biological substances status secondary malignant neoplasm of retroperitoneum and peritoneum encounter for antineoplastic chemotherapy anemia due to antineoplastic chemotherapy essential (primary) hypertension other secondary thrombocytopenia malignant neoplasm of colon, unspecified allergy status to other drugs, medicaments and biological substances status wheezing unspecified place in hospital as the place of occurrence of the external cause personal history of other malignant neoplasm of large intestine secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes secondary malignant neoplasm of retroperitoneum and peritoneum elevated white blood cell count, unspecified essential (primary) hypertension adverse effect of antineoplastic and immunosuppressive drugs, initial encounter encounter for antineoplastic chemotherapy drug-induced nonautoimmune hemolytic anemia secondary malignant neoplasm of unspecified lung family history of malignant neoplasm of digestive organs allergy status to other drugs, medicaments and biological substances status cramp and spasm encounter for antineoplastic chemotherapy allergy status to other drugs, medicaments and biological substances status essential (primary) hypertension malignant neoplasm of ascending colon secondary malignant neoplasm of unspecified lung personal history of antineoplastic chemotherapy malignant neoplasm of colon, unspecified unspecified place or not applicable adverse effect of antineoplastic and immunosuppressive drugs, initial encounter essential (primary) hypertension other and unspecified fall in water transport injuring occupant of other watercraft -- crew essential (primary) hypertension secondary malignant neoplasm of unspecified lung malignant neoplasm of ascending colon other secondary thrombocytopenia anemia due to antineoplastic chemotherapy encounter for antineoplastic chemotherapy hypercalcemia allergy status to other drugs, medicaments and biological substances status anemia due to antineoplastic chemotherapy other fall from one level to another in water transport injuring occupant of other watercraft -- crew hyperlipidemia, unspecified
white f 34 $temp  97.6  heartrate  107.0  resprate  18.0  o2sat  98.0  sbp  109.0  dbp  60.0  rhythm    pain  0  ; temp  98.0  heartrate  70.0  resprate  18.0  o2sat  98.0  sbp  90.0  dbp  58.0  rhythm    pain  0  ; temp  97.8  heartrate  72.0  resprate  18.0  o2sat  95.0  sbp  109.0  dbp  72.0  rhythm    pain  0  $hematology blood hematocrit  34.8  %; hematology blood hematocrit  32.6  %; hematology blood hemoglobin  10.9  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  358  k ul; hematology blood platelet count  306  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.3  ; chemistry urine creatinine, urine  116  mg dl; chemistry urine sodium, urine  40  meq l; chemistry urine urea nitrogen, urine  271  mg dl; hematology urine wbc  47  # hpf; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  77  mg dl; chemistry blood glucose  75  mg dl; chemistry blood albumin  4.4  g dl; chemistry urine protein creatinine ratio  0.6  mg mg; blood gas blood lactate  1.6  mmol l; hematology urine wbc casts  1  # lpf$nan
hypotension due to drugs patient room in hospital as the place of occurrence of the external cause contact with and (suspected) exposure to other communicable diseases other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus opioid dependence, uncomplicated other specified disorders of adult personality and behavior acute kidney failure, unspecified adverse effect of other antihypertensive drugs, initial encounter personal history of adult physical and sexual abuse dehydration insomnia, unspecified fibromyalgia cocaine abuse, uncomplicated chronic viral hepatitis c irritable bowel syndrome without diarrhea bipolar disorder, unspecified nausea with vomiting, unspecified anemia, unspecified chronic viral hepatitis c cough bipolar disorder, unspecified viral infection, unspecified insomnia, unspecified hypokalemia low back pain unspecified convulsions nicotine dependence, other tobacco product, uncomplicated fever, unspecified constipation, unspecified gastro-esophageal reflux disease without esophagitis irritable bowel syndrome without diarrhea opioid abuse, uncomplicated rectocele fibromyalgia anxiety disorder, unspecified opioid dependence, uncomplicated opioid dependence with withdrawal irritable bowel syndrome without diarrhea anxiety disorder, unspecified nicotine dependence, cigarettes, uncomplicated chronic viral hepatitis c epileptic seizures related to external causes, not intractable, without status epilepticus bipolar disorder, unspecified cellulitis of right upper limb personal history of traumatic brain injury pneumonia, unspecified organism fibromyalgia cough
white f 34 $temp  97.6  heartrate  71.0  resprate  16.0  o2sat  96.0  sbp  105.0  dbp  66.0  rhythm    pain  0  ; temp  98.3  heartrate  74.0  resprate  18.0  o2sat  96.0  sbp  90.0  dbp  35.0  rhythm    pain    ; temp  98.1  heartrate  70.0  resprate  18.0  o2sat  97.0  sbp  101.0  dbp  56.0  rhythm    pain  sleeping  ; temp    heartrate  77.0  resprate  16.0  o2sat  98.0  sbp  101.0  dbp  71.0  rhythm    pain  sleeping   ; temp  98.4  heartrate  84.0  resprate  16.0  o2sat  96.0  sbp  94.0  dbp  60.0  rhythm    pain    ; temp    heartrate  79.0  resprate  16.0  o2sat  97.0  sbp  102.0  dbp  67.0  rhythm    pain  0  ; temp    heartrate  75.0  resprate  18.0  o2sat  96.0  sbp  123.0  dbp  86.0  rhythm    pain  0  ; temp    heartrate  81.0  resprate  16.0  o2sat  95.0  sbp  103.0  dbp  71.0  rhythm    pain  0  ; temp  98.8  heartrate  92.0  resprate  16.0  o2sat  96.0  sbp  92.0  dbp  45.0  rhythm    pain    $nan$lactulose  30  ml ; 
hypotension due to drugs patient room in hospital as the place of occurrence of the external cause contact with and (suspected) exposure to other communicable diseases other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus opioid dependence, uncomplicated other specified disorders of adult personality and behavior acute kidney failure, unspecified adverse effect of other antihypertensive drugs, initial encounter personal history of adult physical and sexual abuse dehydration insomnia, unspecified fibromyalgia cocaine abuse, uncomplicated chronic viral hepatitis c irritable bowel syndrome without diarrhea bipolar disorder, unspecified nausea with vomiting, unspecified anemia, unspecified chronic viral hepatitis c cough bipolar disorder, unspecified viral infection, unspecified insomnia, unspecified hypokalemia low back pain unspecified convulsions nicotine dependence, other tobacco product, uncomplicated fever, unspecified constipation, unspecified gastro-esophageal reflux disease without esophagitis irritable bowel syndrome without diarrhea opioid abuse, uncomplicated rectocele fibromyalgia anxiety disorder, unspecified opioid dependence, uncomplicated opioid dependence with withdrawal irritable bowel syndrome without diarrhea anxiety disorder, unspecified nicotine dependence, cigarettes, uncomplicated chronic viral hepatitis c epileptic seizures related to external causes, not intractable, without status epilepticus bipolar disorder, unspecified cellulitis of right upper limb personal history of traumatic brain injury pneumonia, unspecified organism fibromyalgia cough
white f 34 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  280  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood glucose  108  mg dl$lactulose  30  ml ; heparin  5000  unit ; ramelteon  8  mg ; acetaminophen  650  mg ; senna  8.6  mg ; clonidine  0.2  mg ; dicyclomine  20  mg ; diphenhydramine  50  mg ; fluticasone propionate nasal  1  spry ; mirtazapine  30  mg ; omeprazole  40  mg ; prazosin  2  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  200  mg ; quetiapine fumarate  400  mg ; ranitidine  150  mg ; sertraline  200  mg ; trazodone  150  mg ; lorazepam  1-2  mg ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  3-10  ml ; vial  1  vial ; ampicillin-sulbactam  1.5  g ; zonisamide  400  mg ; pregabalin  150  mg ; methocarbamol  750  mg ; methadone  150  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; bisacodyl  10  mg ; methadone (concentrated oral solution) 10 mg 1 ml  150  mg ; 
hypotension due to drugs patient room in hospital as the place of occurrence of the external cause contact with and (suspected) exposure to other communicable diseases other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus opioid dependence, uncomplicated other specified disorders of adult personality and behavior acute kidney failure, unspecified adverse effect of other antihypertensive drugs, initial encounter personal history of adult physical and sexual abuse dehydration insomnia, unspecified fibromyalgia cocaine abuse, uncomplicated chronic viral hepatitis c irritable bowel syndrome without diarrhea bipolar disorder, unspecified nausea with vomiting, unspecified anemia, unspecified chronic viral hepatitis c cough bipolar disorder, unspecified viral infection, unspecified insomnia, unspecified hypokalemia low back pain unspecified convulsions nicotine dependence, other tobacco product, uncomplicated fever, unspecified constipation, unspecified gastro-esophageal reflux disease without esophagitis irritable bowel syndrome without diarrhea opioid abuse, uncomplicated rectocele fibromyalgia anxiety disorder, unspecified opioid dependence, uncomplicated opioid dependence with withdrawal irritable bowel syndrome without diarrhea anxiety disorder, unspecified nicotine dependence, cigarettes, uncomplicated chronic viral hepatitis c epileptic seizures related to external causes, not intractable, without status epilepticus bipolar disorder, unspecified cellulitis of right upper limb personal history of traumatic brain injury pneumonia, unspecified organism fibromyalgia cough
white f 34 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  307  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  92  mg dl$lactulose  30  ml ; heparin  5000  unit ; ramelteon  8  mg ; acetaminophen  650  mg ; senna  8.6  mg ; dicyclomine  20  mg ; diphenhydramine  50  mg ; fluticasone propionate nasal  1  spry ; mirtazapine  30  mg ; omeprazole  40  mg ; prazosin  2  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  200  mg ; quetiapine fumarate  400  mg ; ranitidine  150  mg ; sertraline  200  mg ; trazodone  150  mg ; lorazepam  1-2  mg ; sodium chloride 0.9%  flush  3-10  ml ; vial  1  vial ; ampicillin-sulbactam  1.5  g ; zonisamide  400  mg ; pregabalin  150  mg ; methocarbamol  750  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; bisacodyl  10  mg ; methadone (concentrated oral solution) 10 mg 1 ml  150  mg ; metoclopramide  10  mg ; lorazepam  0.5  mg ; 0.9% sodium chloride  250  ml ; thiamine  500  mg ; nicotine patch  14  mg day ; 
hypotension due to drugs patient room in hospital as the place of occurrence of the external cause contact with and (suspected) exposure to other communicable diseases other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus opioid dependence, uncomplicated other specified disorders of adult personality and behavior acute kidney failure, unspecified adverse effect of other antihypertensive drugs, initial encounter personal history of adult physical and sexual abuse dehydration insomnia, unspecified fibromyalgia cocaine abuse, uncomplicated chronic viral hepatitis c irritable bowel syndrome without diarrhea bipolar disorder, unspecified nausea with vomiting, unspecified anemia, unspecified chronic viral hepatitis c cough bipolar disorder, unspecified viral infection, unspecified insomnia, unspecified hypokalemia low back pain unspecified convulsions nicotine dependence, other tobacco product, uncomplicated fever, unspecified constipation, unspecified gastro-esophageal reflux disease without esophagitis irritable bowel syndrome without diarrhea opioid abuse, uncomplicated rectocele fibromyalgia anxiety disorder, unspecified opioid dependence, uncomplicated opioid dependence with withdrawal irritable bowel syndrome without diarrhea anxiety disorder, unspecified nicotine dependence, cigarettes, uncomplicated chronic viral hepatitis c epileptic seizures related to external causes, not intractable, without status epilepticus bipolar disorder, unspecified cellulitis of right upper limb personal history of traumatic brain injury pneumonia, unspecified organism fibromyalgia cough
white f 34 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  293  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  105  mg dl$lactulose  30  ml ; heparin  5000  unit ; ramelteon  8  mg ; acetaminophen  650  mg ; senna  8.6  mg ; dicyclomine  20  mg ; diphenhydramine  50  mg ; fluticasone propionate nasal  1  spry ; mirtazapine  30  mg ; omeprazole  40  mg ; prazosin  2  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  200  mg ; quetiapine fumarate  400  mg ; ranitidine  150  mg ; sertraline  200  mg ; trazodone  150  mg ; lorazepam  1-2  mg ; sodium chloride 0.9%  flush  3-10  ml ; vial  1  vial ; ampicillin-sulbactam  1.5  g ; zonisamide  400  mg ; pregabalin  150  mg ; methocarbamol  750  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; bisacodyl  10  mg ; methadone (concentrated oral solution) 10 mg 1 ml  150  mg ; metoclopramide  10  mg ; lorazepam  0.5  mg ; 0.9% sodium chloride  250  ml ; thiamine  500  mg ; nicotine patch  14  mg day ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; heparin flush (10 units ml)  2  ml ; thiamine  400  mg ; loperamide  2  mg ; sodium chloride 0.9%  flush  10-20  ml ; sulfameth trimethoprim ds  2  tab ; 
hypotension due to drugs patient room in hospital as the place of occurrence of the external cause contact with and (suspected) exposure to other communicable diseases other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus opioid dependence, uncomplicated other specified disorders of adult personality and behavior acute kidney failure, unspecified adverse effect of other antihypertensive drugs, initial encounter personal history of adult physical and sexual abuse dehydration insomnia, unspecified fibromyalgia cocaine abuse, uncomplicated chronic viral hepatitis c irritable bowel syndrome without diarrhea bipolar disorder, unspecified nausea with vomiting, unspecified anemia, unspecified chronic viral hepatitis c cough bipolar disorder, unspecified viral infection, unspecified insomnia, unspecified hypokalemia low back pain unspecified convulsions nicotine dependence, other tobacco product, uncomplicated fever, unspecified constipation, unspecified gastro-esophageal reflux disease without esophagitis irritable bowel syndrome without diarrhea opioid abuse, uncomplicated rectocele fibromyalgia anxiety disorder, unspecified opioid dependence, uncomplicated opioid dependence with withdrawal irritable bowel syndrome without diarrhea anxiety disorder, unspecified nicotine dependence, cigarettes, uncomplicated chronic viral hepatitis c epileptic seizures related to external causes, not intractable, without status epilepticus bipolar disorder, unspecified cellulitis of right upper limb personal history of traumatic brain injury pneumonia, unspecified organism fibromyalgia cough
white f 34 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  310  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  114  mg dl$heparin  5000  unit ; ramelteon  8  mg ; acetaminophen  650  mg ; senna  8.6  mg ; dicyclomine  20  mg ; diphenhydramine  50  mg ; fluticasone propionate nasal  1  spry ; mirtazapine  30  mg ; omeprazole  40  mg ; prazosin  2  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  200  mg ; quetiapine fumarate  400  mg ; ranitidine  150  mg ; sertraline  200  mg ; trazodone  150  mg ; lorazepam  1-2  mg ; sodium chloride 0.9%  flush  3-10  ml ; zonisamide  400  mg ; pregabalin  150  mg ; methocarbamol  750  mg ; methadone (concentrated oral solution) 10 mg 1 ml  150  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; heparin flush (10 units ml)  2  ml ; loperamide  2  mg ; sodium chloride 0.9%  flush  10-20  ml ; sulfameth trimethoprim ds  2  tab ; 5% dextrose  500  ml ; sulfamethoxazole-trimethoprim  300  mg ; ondansetron  4  mg ; linzess  145  mcg ; 
hypotension due to drugs patient room in hospital as the place of occurrence of the external cause contact with and (suspected) exposure to other communicable diseases other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus opioid dependence, uncomplicated other specified disorders of adult personality and behavior acute kidney failure, unspecified adverse effect of other antihypertensive drugs, initial encounter personal history of adult physical and sexual abuse dehydration insomnia, unspecified fibromyalgia cocaine abuse, uncomplicated chronic viral hepatitis c irritable bowel syndrome without diarrhea bipolar disorder, unspecified nausea with vomiting, unspecified anemia, unspecified chronic viral hepatitis c cough bipolar disorder, unspecified viral infection, unspecified insomnia, unspecified hypokalemia low back pain unspecified convulsions nicotine dependence, other tobacco product, uncomplicated fever, unspecified constipation, unspecified gastro-esophageal reflux disease without esophagitis irritable bowel syndrome without diarrhea opioid abuse, uncomplicated rectocele fibromyalgia anxiety disorder, unspecified opioid dependence, uncomplicated opioid dependence with withdrawal irritable bowel syndrome without diarrhea anxiety disorder, unspecified nicotine dependence, cigarettes, uncomplicated chronic viral hepatitis c epileptic seizures related to external causes, not intractable, without status epilepticus bipolar disorder, unspecified cellulitis of right upper limb personal history of traumatic brain injury pneumonia, unspecified organism fibromyalgia cough
white f 34 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  294  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood glucose  97  mg dl$heparin  5000  unit ; ramelteon  8  mg ; acetaminophen  650  mg ; senna  8.6  mg ; dicyclomine  20  mg ; diphenhydramine  50  mg ; fluticasone propionate nasal  1  spry ; mirtazapine  30  mg ; omeprazole  40  mg ; prazosin  2  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  200  mg ; quetiapine fumarate  400  mg ; ranitidine  150  mg ; sertraline  200  mg ; trazodone  150  mg ; lorazepam  1-2  mg ; sodium chloride 0.9%  flush  3-10  ml ; zonisamide  400  mg ; pregabalin  150  mg ; methocarbamol  750  mg ; methadone (concentrated oral solution) 10 mg 1 ml  150  mg ; loperamide  2  mg ; sodium chloride 0.9%  flush  10-20  ml ; 5% dextrose  500  ml ; sulfamethoxazole-trimethoprim  300  mg ; ondansetron  4  mg ; linzess  145  mcg ; hydromorphone (dilaudid)  0.5  mg ; clonidine  0.1  mg ; 
hypotension due to drugs patient room in hospital as the place of occurrence of the external cause contact with and (suspected) exposure to other communicable diseases other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus opioid dependence, uncomplicated other specified disorders of adult personality and behavior acute kidney failure, unspecified adverse effect of other antihypertensive drugs, initial encounter personal history of adult physical and sexual abuse dehydration insomnia, unspecified fibromyalgia cocaine abuse, uncomplicated chronic viral hepatitis c irritable bowel syndrome without diarrhea bipolar disorder, unspecified nausea with vomiting, unspecified anemia, unspecified chronic viral hepatitis c cough bipolar disorder, unspecified viral infection, unspecified insomnia, unspecified hypokalemia low back pain unspecified convulsions nicotine dependence, other tobacco product, uncomplicated fever, unspecified constipation, unspecified gastro-esophageal reflux disease without esophagitis irritable bowel syndrome without diarrhea opioid abuse, uncomplicated rectocele fibromyalgia anxiety disorder, unspecified opioid dependence, uncomplicated opioid dependence with withdrawal irritable bowel syndrome without diarrhea anxiety disorder, unspecified nicotine dependence, cigarettes, uncomplicated chronic viral hepatitis c epileptic seizures related to external causes, not intractable, without status epilepticus bipolar disorder, unspecified cellulitis of right upper limb personal history of traumatic brain injury pneumonia, unspecified organism fibromyalgia cough
white f 34 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  277  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  97  mg dl$heparin  5000  unit ; ramelteon  8  mg ; acetaminophen  650  mg ; senna  8.6  mg ; dicyclomine  20  mg ; diphenhydramine  50  mg ; fluticasone propionate nasal  1  spry ; mirtazapine  30  mg ; omeprazole  40  mg ; prazosin  2  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  200  mg ; quetiapine fumarate  400  mg ; ranitidine  150  mg ; sertraline  200  mg ; trazodone  150  mg ; lorazepam  1-2  mg ; sodium chloride 0.9%  flush  3-10  ml ; zonisamide  400  mg ; pregabalin  150  mg ; methocarbamol  750  mg ; methadone (concentrated oral solution) 10 mg 1 ml  150  mg ; loperamide  2  mg ; sodium chloride 0.9%  flush  10-20  ml ; 5% dextrose  500  ml ; sulfamethoxazole-trimethoprim  300  mg ; ondansetron  4  mg ; linzess  145  mcg ; clonidine  0.1  mg ; naproxen  500  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; oxycodone (immediate release)  5  mg ; cyanocobalamin  1000  mcg ; thiamine  100  mg ; 
hypotension due to drugs patient room in hospital as the place of occurrence of the external cause contact with and (suspected) exposure to other communicable diseases other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus opioid dependence, uncomplicated other specified disorders of adult personality and behavior acute kidney failure, unspecified adverse effect of other antihypertensive drugs, initial encounter personal history of adult physical and sexual abuse dehydration insomnia, unspecified fibromyalgia cocaine abuse, uncomplicated chronic viral hepatitis c irritable bowel syndrome without diarrhea bipolar disorder, unspecified nausea with vomiting, unspecified anemia, unspecified chronic viral hepatitis c cough bipolar disorder, unspecified viral infection, unspecified insomnia, unspecified hypokalemia low back pain unspecified convulsions nicotine dependence, other tobacco product, uncomplicated fever, unspecified constipation, unspecified gastro-esophageal reflux disease without esophagitis irritable bowel syndrome without diarrhea opioid abuse, uncomplicated rectocele fibromyalgia anxiety disorder, unspecified opioid dependence, uncomplicated opioid dependence with withdrawal irritable bowel syndrome without diarrhea anxiety disorder, unspecified nicotine dependence, cigarettes, uncomplicated chronic viral hepatitis c epileptic seizures related to external causes, not intractable, without status epilepticus bipolar disorder, unspecified cellulitis of right upper limb personal history of traumatic brain injury pneumonia, unspecified organism fibromyalgia cough
white f 34 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  120  mg dl$heparin  5000  unit ; ramelteon  8  mg ; acetaminophen  650  mg ; senna  8.6  mg ; dicyclomine  20  mg ; diphenhydramine  50  mg ; fluticasone propionate nasal  1  spry ; mirtazapine  30  mg ; omeprazole  40  mg ; prazosin  2  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  200  mg ; quetiapine fumarate  400  mg ; ranitidine  150  mg ; sertraline  200  mg ; trazodone  150  mg ; lorazepam  1-2  mg ; sodium chloride 0.9%  flush  3-10  ml ; zonisamide  400  mg ; pregabalin  150  mg ; methocarbamol  750  mg ; methadone (concentrated oral solution) 10 mg 1 ml  150  mg ; loperamide  2  mg ; sodium chloride 0.9%  flush  10-20  ml ; 5% dextrose  500  ml ; sulfamethoxazole-trimethoprim  300  mg ; ondansetron  4  mg ; linzess  145  mcg ; clonidine  0.1  mg ; naproxen  500  mg ; cyanocobalamin  1000  mcg ; thiamine  100  mg ; tramadol  50  mg ; 
hypotension due to drugs patient room in hospital as the place of occurrence of the external cause contact with and (suspected) exposure to other communicable diseases other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus opioid dependence, uncomplicated other specified disorders of adult personality and behavior acute kidney failure, unspecified adverse effect of other antihypertensive drugs, initial encounter personal history of adult physical and sexual abuse dehydration insomnia, unspecified fibromyalgia cocaine abuse, uncomplicated chronic viral hepatitis c irritable bowel syndrome without diarrhea bipolar disorder, unspecified nausea with vomiting, unspecified anemia, unspecified chronic viral hepatitis c cough bipolar disorder, unspecified viral infection, unspecified insomnia, unspecified hypokalemia low back pain unspecified convulsions nicotine dependence, other tobacco product, uncomplicated fever, unspecified constipation, unspecified gastro-esophageal reflux disease without esophagitis irritable bowel syndrome without diarrhea opioid abuse, uncomplicated rectocele fibromyalgia anxiety disorder, unspecified opioid dependence, uncomplicated opioid dependence with withdrawal irritable bowel syndrome without diarrhea anxiety disorder, unspecified nicotine dependence, cigarettes, uncomplicated chronic viral hepatitis c epileptic seizures related to external causes, not intractable, without status epilepticus bipolar disorder, unspecified cellulitis of right upper limb personal history of traumatic brain injury pneumonia, unspecified organism fibromyalgia cough
white f 34 $nan$nan$heparin  5000  unit ; ramelteon  8  mg ; acetaminophen  650  mg ; senna  8.6  mg ; dicyclomine  20  mg ; diphenhydramine  50  mg ; fluticasone propionate nasal  1  spry ; mirtazapine  30  mg ; omeprazole  40  mg ; prazosin  2  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  200  mg ; quetiapine fumarate  400  mg ; ranitidine  150  mg ; sertraline  200  mg ; trazodone  150  mg ; lorazepam  1-2  mg ; sodium chloride 0.9%  flush  3-10  ml ; zonisamide  400  mg ; pregabalin  150  mg ; methocarbamol  750  mg ; methadone (concentrated oral solution) 10 mg 1 ml  150  mg ; loperamide  2  mg ; sodium chloride 0.9%  flush  10-20  ml ; ondansetron  4  mg ; linzess  145  mcg ; clonidine  0.1  mg ; naproxen  500  mg ; cyanocobalamin  1000  mcg ; thiamine  100  mg ; tramadol  50  mg ; guaifenesin  5-10  ml ; ipratropium-albuterol neb  1  neb ; 
hypotension due to drugs patient room in hospital as the place of occurrence of the external cause contact with and (suspected) exposure to other communicable diseases other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus opioid dependence, uncomplicated other specified disorders of adult personality and behavior acute kidney failure, unspecified adverse effect of other antihypertensive drugs, initial encounter personal history of adult physical and sexual abuse dehydration insomnia, unspecified fibromyalgia cocaine abuse, uncomplicated chronic viral hepatitis c irritable bowel syndrome without diarrhea bipolar disorder, unspecified nausea with vomiting, unspecified anemia, unspecified chronic viral hepatitis c cough bipolar disorder, unspecified viral infection, unspecified insomnia, unspecified hypokalemia low back pain unspecified convulsions nicotine dependence, other tobacco product, uncomplicated fever, unspecified constipation, unspecified gastro-esophageal reflux disease without esophagitis irritable bowel syndrome without diarrhea opioid abuse, uncomplicated rectocele fibromyalgia anxiety disorder, unspecified opioid dependence, uncomplicated opioid dependence with withdrawal irritable bowel syndrome without diarrhea anxiety disorder, unspecified nicotine dependence, cigarettes, uncomplicated chronic viral hepatitis c epileptic seizures related to external causes, not intractable, without status epilepticus bipolar disorder, unspecified cellulitis of right upper limb personal history of traumatic brain injury pneumonia, unspecified organism fibromyalgia cough
white f 34 $nan$nan$heparin  5000  unit ; ramelteon  8  mg ; acetaminophen  650  mg ; senna  8.6  mg ; dicyclomine  20  mg ; diphenhydramine  50  mg ; fluticasone propionate nasal  1  spry ; mirtazapine  30  mg ; omeprazole  40  mg ; prazosin  2  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  200  mg ; quetiapine fumarate  400  mg ; ranitidine  150  mg ; sertraline  200  mg ; trazodone  150  mg ; lorazepam  1-2  mg ; sodium chloride 0.9%  flush  3-10  ml ; zonisamide  400  mg ; pregabalin  150  mg ; methocarbamol  750  mg ; methadone (concentrated oral solution) 10 mg 1 ml  150  mg ; loperamide  2  mg ; sodium chloride 0.9%  flush  10-20  ml ; ondansetron  4  mg ; linzess  145  mcg ; clonidine  0.1  mg ; naproxen  500  mg ; cyanocobalamin  1000  mcg ; thiamine  100  mg ; tramadol  50  mg ; guaifenesin  5-10  ml ; ipratropium-albuterol neb  1  neb ; albuterol inhaler  1  puff ; 
hypotension due to drugs patient room in hospital as the place of occurrence of the external cause contact with and (suspected) exposure to other communicable diseases other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus opioid dependence, uncomplicated other specified disorders of adult personality and behavior acute kidney failure, unspecified adverse effect of other antihypertensive drugs, initial encounter personal history of adult physical and sexual abuse dehydration insomnia, unspecified fibromyalgia cocaine abuse, uncomplicated chronic viral hepatitis c irritable bowel syndrome without diarrhea bipolar disorder, unspecified nausea with vomiting, unspecified anemia, unspecified chronic viral hepatitis c cough bipolar disorder, unspecified viral infection, unspecified insomnia, unspecified hypokalemia low back pain unspecified convulsions nicotine dependence, other tobacco product, uncomplicated fever, unspecified constipation, unspecified gastro-esophageal reflux disease without esophagitis irritable bowel syndrome without diarrhea opioid abuse, uncomplicated rectocele fibromyalgia anxiety disorder, unspecified opioid dependence, uncomplicated opioid dependence with withdrawal irritable bowel syndrome without diarrhea anxiety disorder, unspecified nicotine dependence, cigarettes, uncomplicated chronic viral hepatitis c epileptic seizures related to external causes, not intractable, without status epilepticus bipolar disorder, unspecified cellulitis of right upper limb personal history of traumatic brain injury pneumonia, unspecified organism fibromyalgia cough
white f 34 $nan$nan$heparin  5000  unit ; ramelteon  8  mg ; acetaminophen  650  mg ; senna  8.6  mg ; dicyclomine  20  mg ; diphenhydramine  50  mg ; fluticasone propionate nasal  1  spry ; mirtazapine  30  mg ; omeprazole  40  mg ; prazosin  2  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  200  mg ; quetiapine fumarate  400  mg ; ranitidine  150  mg ; sertraline  200  mg ; trazodone  150  mg ; lorazepam  1-2  mg ; zonisamide  400  mg ; pregabalin  150  mg ; methocarbamol  750  mg ; methadone (concentrated oral solution) 10 mg 1 ml  150  mg ; loperamide  2  mg ; ondansetron  4  mg ; linzess  145  mcg ; clonidine  0.1  mg ; naproxen  500  mg ; cyanocobalamin  1000  mcg ; thiamine  100  mg ; tramadol  50  mg ; guaifenesin  5-10  ml ; albuterol inhaler  1  puff ; 
hypotension due to drugs patient room in hospital as the place of occurrence of the external cause contact with and (suspected) exposure to other communicable diseases other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus opioid dependence, uncomplicated other specified disorders of adult personality and behavior acute kidney failure, unspecified adverse effect of other antihypertensive drugs, initial encounter personal history of adult physical and sexual abuse dehydration insomnia, unspecified fibromyalgia cocaine abuse, uncomplicated chronic viral hepatitis c irritable bowel syndrome without diarrhea bipolar disorder, unspecified nausea with vomiting, unspecified anemia, unspecified chronic viral hepatitis c cough bipolar disorder, unspecified viral infection, unspecified insomnia, unspecified hypokalemia low back pain unspecified convulsions nicotine dependence, other tobacco product, uncomplicated fever, unspecified constipation, unspecified gastro-esophageal reflux disease without esophagitis irritable bowel syndrome without diarrhea opioid abuse, uncomplicated rectocele fibromyalgia anxiety disorder, unspecified opioid dependence, uncomplicated opioid dependence with withdrawal irritable bowel syndrome without diarrhea anxiety disorder, unspecified nicotine dependence, cigarettes, uncomplicated chronic viral hepatitis c epileptic seizures related to external causes, not intractable, without status epilepticus bipolar disorder, unspecified cellulitis of right upper limb personal history of traumatic brain injury pneumonia, unspecified organism fibromyalgia cough
white f 34 $nan$nan$heparin  5000  unit ; ramelteon  8  mg ; acetaminophen  650  mg ; senna  8.6  mg ; dicyclomine  20  mg ; diphenhydramine  50  mg ; fluticasone propionate nasal  1  spry ; mirtazapine  30  mg ; omeprazole  40  mg ; prazosin  2  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  200  mg ; quetiapine fumarate  400  mg ; ranitidine  150  mg ; sertraline  200  mg ; trazodone  150  mg ; lorazepam  1-2  mg ; zonisamide  400  mg ; pregabalin  150  mg ; methocarbamol  750  mg ; methadone (concentrated oral solution) 10 mg 1 ml  150  mg ; loperamide  2  mg ; ondansetron  4  mg ; linzess  145  mcg ; clonidine  0.1  mg ; naproxen  500  mg ; cyanocobalamin  1000  mcg ; thiamine  100  mg ; tramadol  50  mg ; guaifenesin  5-10  ml ; albuterol inhaler  1  puff ; 
hypotension due to drugs patient room in hospital as the place of occurrence of the external cause contact with and (suspected) exposure to other communicable diseases other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus opioid dependence, uncomplicated other specified disorders of adult personality and behavior acute kidney failure, unspecified adverse effect of other antihypertensive drugs, initial encounter personal history of adult physical and sexual abuse dehydration insomnia, unspecified fibromyalgia cocaine abuse, uncomplicated chronic viral hepatitis c irritable bowel syndrome without diarrhea bipolar disorder, unspecified nausea with vomiting, unspecified anemia, unspecified chronic viral hepatitis c cough bipolar disorder, unspecified viral infection, unspecified insomnia, unspecified hypokalemia low back pain unspecified convulsions nicotine dependence, other tobacco product, uncomplicated fever, unspecified constipation, unspecified gastro-esophageal reflux disease without esophagitis irritable bowel syndrome without diarrhea opioid abuse, uncomplicated rectocele fibromyalgia anxiety disorder, unspecified opioid dependence, uncomplicated opioid dependence with withdrawal irritable bowel syndrome without diarrhea anxiety disorder, unspecified nicotine dependence, cigarettes, uncomplicated chronic viral hepatitis c epileptic seizures related to external causes, not intractable, without status epilepticus bipolar disorder, unspecified cellulitis of right upper limb personal history of traumatic brain injury pneumonia, unspecified organism fibromyalgia cough
white f 34 $nan$nan$heparin  5000  unit ; ramelteon  8  mg ; acetaminophen  650  mg ; senna  8.6  mg ; dicyclomine  20  mg ; diphenhydramine  50  mg ; fluticasone propionate nasal  1  spry ; mirtazapine  30  mg ; omeprazole  40  mg ; prazosin  2  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  200  mg ; quetiapine fumarate  400  mg ; ranitidine  150  mg ; sertraline  200  mg ; trazodone  150  mg ; lorazepam  1-2  mg ; zonisamide  400  mg ; pregabalin  150  mg ; methocarbamol  750  mg ; methadone (concentrated oral solution) 10 mg 1 ml  150  mg ; loperamide  2  mg ; ondansetron  4  mg ; linzess  145  mcg ; clonidine  0.1  mg ; naproxen  500  mg ; cyanocobalamin  1000  mcg ; thiamine  100  mg ; tramadol  50  mg ; guaifenesin  5-10  ml ; albuterol inhaler  1  puff ; 
hypotension due to drugs patient room in hospital as the place of occurrence of the external cause contact with and (suspected) exposure to other communicable diseases other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus opioid dependence, uncomplicated other specified disorders of adult personality and behavior acute kidney failure, unspecified adverse effect of other antihypertensive drugs, initial encounter personal history of adult physical and sexual abuse dehydration insomnia, unspecified fibromyalgia cocaine abuse, uncomplicated chronic viral hepatitis c irritable bowel syndrome without diarrhea bipolar disorder, unspecified nausea with vomiting, unspecified anemia, unspecified chronic viral hepatitis c cough bipolar disorder, unspecified viral infection, unspecified insomnia, unspecified hypokalemia low back pain unspecified convulsions nicotine dependence, other tobacco product, uncomplicated fever, unspecified constipation, unspecified gastro-esophageal reflux disease without esophagitis irritable bowel syndrome without diarrhea opioid abuse, uncomplicated rectocele fibromyalgia anxiety disorder, unspecified opioid dependence, uncomplicated opioid dependence with withdrawal irritable bowel syndrome without diarrhea anxiety disorder, unspecified nicotine dependence, cigarettes, uncomplicated chronic viral hepatitis c epileptic seizures related to external causes, not intractable, without status epilepticus bipolar disorder, unspecified cellulitis of right upper limb personal history of traumatic brain injury pneumonia, unspecified organism fibromyalgia cough
white f 34 $nan$nan$heparin  5000  unit ; ramelteon  8  mg ; acetaminophen  650  mg ; senna  8.6  mg ; dicyclomine  20  mg ; diphenhydramine  50  mg ; fluticasone propionate nasal  1  spry ; mirtazapine  30  mg ; omeprazole  40  mg ; prazosin  2  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  200  mg ; quetiapine fumarate  400  mg ; ranitidine  150  mg ; sertraline  200  mg ; trazodone  150  mg ; lorazepam  1-2  mg ; zonisamide  400  mg ; pregabalin  150  mg ; methocarbamol  750  mg ; methadone (concentrated oral solution) 10 mg 1 ml  150  mg ; loperamide  2  mg ; ondansetron  4  mg ; linzess  145  mcg ; clonidine  0.1  mg ; naproxen  500  mg ; cyanocobalamin  1000  mcg ; thiamine  100  mg ; tramadol  50  mg ; guaifenesin  5-10  ml ; albuterol inhaler  1  puff ; 
hypotension due to drugs patient room in hospital as the place of occurrence of the external cause contact with and (suspected) exposure to other communicable diseases other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus opioid dependence, uncomplicated other specified disorders of adult personality and behavior acute kidney failure, unspecified adverse effect of other antihypertensive drugs, initial encounter personal history of adult physical and sexual abuse dehydration insomnia, unspecified fibromyalgia cocaine abuse, uncomplicated chronic viral hepatitis c irritable bowel syndrome without diarrhea bipolar disorder, unspecified nausea with vomiting, unspecified anemia, unspecified chronic viral hepatitis c cough bipolar disorder, unspecified viral infection, unspecified insomnia, unspecified hypokalemia low back pain unspecified convulsions nicotine dependence, other tobacco product, uncomplicated fever, unspecified constipation, unspecified gastro-esophageal reflux disease without esophagitis irritable bowel syndrome without diarrhea opioid abuse, uncomplicated rectocele fibromyalgia anxiety disorder, unspecified opioid dependence, uncomplicated opioid dependence with withdrawal irritable bowel syndrome without diarrhea anxiety disorder, unspecified nicotine dependence, cigarettes, uncomplicated chronic viral hepatitis c epileptic seizures related to external causes, not intractable, without status epilepticus bipolar disorder, unspecified cellulitis of right upper limb personal history of traumatic brain injury pneumonia, unspecified organism fibromyalgia cough
white f 34 $nan$nan$heparin  5000  unit ; ramelteon  8  mg ; acetaminophen  650  mg ; senna  8.6  mg ; dicyclomine  20  mg ; diphenhydramine  50  mg ; fluticasone propionate nasal  1  spry ; mirtazapine  30  mg ; omeprazole  40  mg ; prazosin  2  mg ; quetiapine fumarate  100  mg ; quetiapine fumarate  200  mg ; quetiapine fumarate  400  mg ; ranitidine  150  mg ; sertraline  200  mg ; trazodone  150  mg ; lorazepam  1-2  mg ; zonisamide  400  mg ; pregabalin  150  mg ; methocarbamol  750  mg ; methadone (concentrated oral solution) 10 mg 1 ml  150  mg ; loperamide  2  mg ; ondansetron  4  mg ; linzess  145  mcg ; clonidine  0.1  mg ; cyanocobalamin  1000  mcg ; thiamine  100  mg ; tramadol  50  mg ; guaifenesin  5-10  ml ; albuterol inhaler  1  puff ; simethicone  40-80  mg ; 
hypotension due to drugs patient room in hospital as the place of occurrence of the external cause contact with and (suspected) exposure to other communicable diseases other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus opioid dependence, uncomplicated other specified disorders of adult personality and behavior acute kidney failure, unspecified adverse effect of other antihypertensive drugs, initial encounter personal history of adult physical and sexual abuse dehydration insomnia, unspecified fibromyalgia cocaine abuse, uncomplicated chronic viral hepatitis c irritable bowel syndrome without diarrhea bipolar disorder, unspecified nausea with vomiting, unspecified anemia, unspecified chronic viral hepatitis c cough bipolar disorder, unspecified viral infection, unspecified insomnia, unspecified hypokalemia low back pain unspecified convulsions nicotine dependence, other tobacco product, uncomplicated fever, unspecified constipation, unspecified gastro-esophageal reflux disease without esophagitis irritable bowel syndrome without diarrhea opioid abuse, uncomplicated rectocele fibromyalgia anxiety disorder, unspecified opioid dependence, uncomplicated opioid dependence with withdrawal irritable bowel syndrome without diarrhea anxiety disorder, unspecified nicotine dependence, cigarettes, uncomplicated chronic viral hepatitis c epileptic seizures related to external causes, not intractable, without status epilepticus bipolar disorder, unspecified cellulitis of right upper limb personal history of traumatic brain injury pneumonia, unspecified organism fibromyalgia cough
hispanic latino f 57 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  305  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  84  mg dl$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; heparin  5000  unit ; hydromorphone (dilaudid)  0.25-1  mg ; ondansetron  4-8  mg ; vial  1  vial ; pantoprazole  40  mg ; acetaminophen iv  1000  mg ; promethazine  6.25  mg ; 
 
hispanic latino f 57 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  316  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  80  mg dl; chemistry blood albumin  3.4  g dl$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; heparin  5000  unit ; hydromorphone (dilaudid)  0.25-1  mg ; ondansetron  4-8  mg ; vial  1  vial ; pantoprazole  40  mg ; acetaminophen iv  1000  mg ; promethazine  6.25  mg ; 
 
hispanic latino f 57 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  335  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  74  mg dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; heparin  5000  unit ; hydromorphone (dilaudid)  0.25-1  mg ; ondansetron  4-8  mg ; vial  1  vial ; pantoprazole  40  mg ; acetaminophen iv  1000  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  1000  mg ; 
 
hispanic latino f 57 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ondansetron  4-8  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  1000  mg ; senna  1  tab ; ferrous sulfate  325  mg ; docusate sodium  100  mg ; ropinirole  1  mg ; 
 
white m 64 $nan$nan$warfarin  5  mg ; losartan potassium  50  mg ; digoxin  0.125  mg ; furosemide  60  mg ; clopidogrel bisulfate  75  mg ; spironolactone  12.5  mg ; paroxetine  20  mg ; atorvastatin  40  mg ; 
 
white m 64 $nan$hematology blood hematocrit  32.4  %; hematology blood platelet count  263  k ul; hematology blood inr(pt)  1.9  $warfarin  5  mg ; losartan potassium  50  mg ; digoxin  0.125  mg ; furosemide  60  mg ; clopidogrel bisulfate  75  mg ; spironolactone  12.5  mg ; paroxetine  20  mg ; atorvastatin  40  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  650  mg ; nitroglycerin sl  0.3  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; zolpidem tartrate  5  mg ; pantoprazole  40  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; carvedilol  1.562  mg ; valtrex  500  mg ; warfarin  2.5  mg ; 
 
black african american f 36 $temp  97.7  heartrate  99.0  resprate  18.0  o2sat  99.0  sbp  120.0  dbp  79.0  rhythm    pain  0  ; temp  98.7  heartrate  83.0  resprate  15.0  o2sat  100.0  sbp  163.0  dbp  95.0  rhythm    pain  10  $nan$insulin  56  unit ; 
long-term (current) use of insulin unspecified essential hypertension iron deficiency anemia, unspecified diabetes with unspecified complication, type ii or unspecified type, uncontrolled personal history of noncompliance with medical treatment, presenting hazards to health insomnia, unspecified major depressive affective disorder, single episode, unspecified dysmenorrhea other specified vaccinations against streptococcus pneumoniae [pneumococcus] morbid obesity other specified periodontal diseases pure hypercholesterolemia dental caries, unspecified schizoaffective disorder, unspecified body mass index 40.0-44.9, adult anxiety state, unspecified other specified disorders of the teeth and supporting structures depressive disorder, not elsewhere classified dizziness and giddiness esophageal reflux diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anorexia acute upper respiratory infections of unspecified site nausea with vomiting
black african american f 36 $temp  98.7  heartrate  82.0  resprate  18.0  o2sat  100.0  sbp  152.0  dbp  90.0  rhythm    pain  10  $nan$insulin  56  unit ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; prochlorperazine  10  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; prochlorperazine  5  mg ; insulin  0  unit ; sertraline  50  mg ; 
long-term (current) use of insulin unspecified essential hypertension iron deficiency anemia, unspecified diabetes with unspecified complication, type ii or unspecified type, uncontrolled personal history of noncompliance with medical treatment, presenting hazards to health insomnia, unspecified major depressive affective disorder, single episode, unspecified dysmenorrhea other specified vaccinations against streptococcus pneumoniae [pneumococcus] morbid obesity other specified periodontal diseases pure hypercholesterolemia dental caries, unspecified schizoaffective disorder, unspecified body mass index 40.0-44.9, adult anxiety state, unspecified other specified disorders of the teeth and supporting structures depressive disorder, not elsewhere classified dizziness and giddiness esophageal reflux diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anorexia acute upper respiratory infections of unspecified site nausea with vomiting
black african american f 36 $nan$nan$ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; prochlorperazine  5  mg ; sertraline  50  mg ; 
long-term (current) use of insulin unspecified essential hypertension iron deficiency anemia, unspecified diabetes with unspecified complication, type ii or unspecified type, uncontrolled personal history of noncompliance with medical treatment, presenting hazards to health insomnia, unspecified major depressive affective disorder, single episode, unspecified dysmenorrhea other specified vaccinations against streptococcus pneumoniae [pneumococcus] morbid obesity other specified periodontal diseases pure hypercholesterolemia dental caries, unspecified schizoaffective disorder, unspecified body mass index 40.0-44.9, adult anxiety state, unspecified other specified disorders of the teeth and supporting structures depressive disorder, not elsewhere classified dizziness and giddiness esophageal reflux diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled anorexia acute upper respiratory infections of unspecified site nausea with vomiting
white f 50 $temp    heartrate  132.0  resprate  16.0  o2sat  93.0  sbp  90.0  dbp  48.0  rhythm    pain  2  $hematology blood hematocrit  34.3  %; hematology blood hematocrit  31.5  %; hematology blood hemoglobin  11.0  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  168  k ul; hematology blood platelet count  137  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  2.2  ; chemistry urine chloride, urine  33  meq l; chemistry urine potassium, urine  58  meq l; chemistry urine sodium, urine  12  meq l; hematology urine wbc  1  # hpf; chemistry blood calcium, total  6.6  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  14.7  mg dl; chemistry blood glucose  121  mg dl; chemistry blood glucose  71  mg dl; blood gas blood lactate  3.0  mmol l; blood gas blood lactate  2.8  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  2.5  mmol l$5% dextrose  250  ml ; phenylephrine  60  mg ; sodium chloride 0.9%  1000  ml ; norepinephrine  8  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; multivitamins w minerals  1  tab ; ursodiol  300  mg ; ursodiol  600  mg ; phytonadione  5  mg ; propofol  1000  mg ; indomethacin  50  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; albumin 5%  25  g ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  10  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lactated ringers  1000  ml ; fentanyl citrate  25-100  mcg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; famotidine  20  mg ; albumin 5% (25g   500ml)  25  g ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$hematology blood hematocrit  26.8  %; hematology blood hematocrit  29.0  %; hematology blood hemoglobin  8.7  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  55  k ul; hematology blood platelet count  53  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  15.3  mg dl; chemistry blood glucose  140  mg dl; blood gas blood lactate  1.7  mmol l$5% dextrose  250  ml ; phenylephrine  60  mg ; sodium chloride 0.9%  1000  ml ; norepinephrine  8  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; multivitamins w minerals  1  tab ; ursodiol  300  mg ; ursodiol  600  mg ; phytonadione  5  mg ; propofol  1000  mg ; indomethacin  50  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; albumin 5%  25  g ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  10  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; lactated ringers  1000  ml ; fentanyl citrate  25-100  mcg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; famotidine  20  mg ; albumin 5% (25g   500ml)  25  g ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; lorazepam  0.5  mg ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  43  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  7.0  mg dl; chemistry blood bilirubin, total  16.3  mg dl; chemistry blood glucose  100  mg dl; chemistry blood albumin  2.3  g dl$multivitamins w minerals  1  tab ; ursodiol  300  mg ; ursodiol  600  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  10  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; famotidine  20  mg ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; lorazepam  0.5  mg ; sarna lotion  1  appl ; 0.9% sodium chloride (mini bag plus)  100  ml ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  45  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  7.3  mg dl; chemistry blood bilirubin, total  15.8  mg dl; chemistry blood glucose  94  mg dl; chemistry blood albumin  2.2  g dl$multivitamins w minerals  1  tab ; ursodiol  300  mg ; ursodiol  600  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  10  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; famotidine  20  mg ; sarna lotion  1  appl ; 0.9% sodium chloride (mini bag plus)  100  ml ; ondansetron  4  mg ; trazodone  25  mg ; morphine sulfate  2-4  mg ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  36  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  2.1  ; chemistry urine chloride, urine  64  meq l; chemistry urine creatinine, urine  58  mg dl; chemistry urine potassium, urine  24  meq l; chemistry urine sodium, urine  50  meq l; chemistry urine urea nitrogen, urine  370  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  16.4  mg dl; chemistry blood glucose  106  mg dl; chemistry blood albumin  2.2  g dl$multivitamins w minerals  1  tab ; ursodiol  300  mg ; ursodiol  600  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  10  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; famotidine  20  mg ; sarna lotion  1  appl ; 0.9% sodium chloride (mini bag plus)  100  ml ; ondansetron  4  mg ; trazodone  25  mg ; heparin flush (10 units ml)  1  ml ; oxycodone (immediate release)   5  mg ; albumin 5% (12.5g   250ml)  25  g ; senna  8.6  mg ; tramadol (ultram)  50  mg ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  47  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  18.0  mg dl; chemistry blood glucose  83  mg dl$meropenem  500  mg ; multivitamins w minerals  1  tab ; ursodiol  300  mg ; ursodiol  600  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  10  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sarna lotion  1  appl ; 0.9% sodium chloride (mini bag plus)  100  ml ; ondansetron  4  mg ; trazodone  25  mg ; heparin flush (10 units ml)  1  ml ; albumin 5% (12.5g   250ml)  25  g ; senna  8.6  mg ; tramadol (ultram)  50  mg ; ondansetron  4-8  mg ; docusate sodium  100  mg ; morphine sulfate  2  mg ; lactulose  30  ml ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  43  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  2.6  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  17.7  mg dl; chemistry blood glucose  88  mg dl; chemistry blood albumin  2.5  g dl$meropenem  500  mg ; multivitamins w minerals  1  tab ; ursodiol  300  mg ; ursodiol  600  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  10  ml ; sarna lotion  1  appl ; trazodone  25  mg ; heparin flush (10 units ml)  1  ml ; senna  8.6  mg ; tramadol (ultram)  50  mg ; ondansetron  4-8  mg ; docusate sodium  100  mg ; lactulose  30  ml ; rifaximin  550  mg ; heparin  5000  unit ; imipenem-cilastatin  500  mg ; 5% dextrose  50  ml ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$hematology blood hematocrit  23.2  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  46  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  2.0  ; hematology blood inr(pt)  1.3  ; chemistry urine chloride, urine  71  meq l; chemistry urine creatinine, urine  76  mg dl; chemistry urine potassium, urine  27  meq l; chemistry urine sodium, urine  72  meq l; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  17.8  mg dl; chemistry blood glucose  82  mg dl; chemistry blood albumin  2.7  g dl$multivitamins w minerals  1  tab ; ursodiol  300  mg ; ursodiol  600  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  10  ml ; sarna lotion  1  appl ; trazodone  25  mg ; heparin flush (10 units ml)  1  ml ; senna  8.6  mg ; tramadol (ultram)  50  mg ; ondansetron  4-8  mg ; docusate sodium  100  mg ; lactulose  30  ml ; rifaximin  550  mg ; heparin  5000  unit ; imipenem-cilastatin  500  mg ; 5% dextrose  50  ml ; 0.9% sodium chloride  0  ml ; imipenem-cilastatin  250  mg ; 0.9% sodium chloride  100  ml ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$hematology blood hematocrit  22.8  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  49  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  17.4  mg dl; chemistry blood glucose  87  mg dl$multivitamins w minerals  1  tab ; ursodiol  300  mg ; ursodiol  600  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  10  ml ; sarna lotion  1  appl ; trazodone  25  mg ; heparin flush (10 units ml)  1  ml ; senna  8.6  mg ; tramadol (ultram)  50  mg ; ondansetron  4-8  mg ; docusate sodium  100  mg ; lactulose  30  ml ; rifaximin  550  mg ; 0.9% sodium chloride  100  ml ; albumin 25% (12.5g   50ml)  50  g ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$hematology blood hematocrit  21.9  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  50  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.5  ; chemistry urine chloride, urine  24  meq l; chemistry urine creatinine, urine  95  mg dl; chemistry urine potassium, urine  25  meq l; chemistry urine sodium, urine  33  meq l; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  18.6  mg dl; chemistry blood glucose  86  mg dl; chemistry blood albumin  2.9  g dl$multivitamins w minerals  1  tab ; ursodiol  300  mg ; ursodiol  600  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  10  ml ; sarna lotion  1  appl ; trazodone  25  mg ; heparin flush (10 units ml)  1  ml ; senna  8.6  mg ; tramadol (ultram)  50  mg ; ondansetron  4-8  mg ; docusate sodium  100  mg ; lactulose  30  ml ; rifaximin  550  mg ; 0.9% sodium chloride  100  ml ; albumin 25% (12.5g   50ml)  50  g ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$hematology blood hematocrit  21.4  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  52  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  17.8  mg dl; chemistry blood glucose  88  mg dl; chemistry blood albumin  2.7  g dl$multivitamins w minerals  1  tab ; ursodiol  300  mg ; ursodiol  600  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  10  ml ; sarna lotion  1  appl ; trazodone  25  mg ; heparin flush (10 units ml)  1  ml ; senna  8.6  mg ; tramadol (ultram)  50  mg ; ondansetron  4-8  mg ; docusate sodium  100  mg ; rifaximin  550  mg ; 0.9% sodium chloride  100  ml ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$hematology blood hematocrit  23.1  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  61  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  18.2  mg dl; chemistry blood glucose  95  mg dl$multivitamins w minerals  1  tab ; ursodiol  300  mg ; ursodiol  600  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  10  ml ; sarna lotion  1  appl ; trazodone  25  mg ; heparin flush (10 units ml)  1  ml ; senna  8.6  mg ; tramadol (ultram)  50  mg ; ondansetron  4-8  mg ; docusate sodium  100  mg ; rifaximin  550  mg ; 0.9% sodium chloride  100  ml ; albumin 25% (12.5g   50ml)  12.5  g ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$hematology blood hematocrit  23.5  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  67  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  19.9  mg dl; chemistry blood glucose  103  mg dl; chemistry blood albumin  2.9  g dl$multivitamins w minerals  1  tab ; ursodiol  300  mg ; ursodiol  600  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  10  ml ; sarna lotion  1  appl ; trazodone  25  mg ; heparin flush (10 units ml)  1  ml ; senna  8.6  mg ; tramadol (ultram)  50  mg ; ondansetron  4-8  mg ; docusate sodium  100  mg ; rifaximin  550  mg ; 0.9% sodium chloride  100  ml ; albumin 25% (12.5g   50ml)  12.5  g ; furosemide  40  mg ; spironolactone  100  mg ; furosemide  20  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$hematology blood hematocrit  23.8  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  77  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.6  ; chemistry urine chloride, urine  111  meq l; chemistry urine creatinine, urine  33  mg dl; chemistry urine potassium, urine  27  meq l; chemistry urine sodium, urine  122  meq l; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  21.0  mg dl; chemistry blood glucose  92  mg dl$multivitamins w minerals  1  tab ; ursodiol  300  mg ; ursodiol  600  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  10  ml ; sarna lotion  1  appl ; trazodone  25  mg ; heparin flush (10 units ml)  1  ml ; senna  8.6  mg ; tramadol (ultram)  50  mg ; ondansetron  4-8  mg ; docusate sodium  100  mg ; rifaximin  550  mg ; 0.9% sodium chloride  100  ml ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; bag  500  ml ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$hematology blood hematocrit  22.7  %; hematology blood hematocrit  26.1  %; hematology blood hemoglobin  7.4  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  74  k ul; hematology blood platelet count  104  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.5  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  19.7  mg dl; chemistry blood bilirubin, total  22.4  mg dl; chemistry blood glucose  83  mg dl; chemistry blood glucose  159  mg dl; chemistry blood albumin  3.1  g dl$multivitamins w minerals  1  tab ; ursodiol  300  mg ; ursodiol  600  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  10  ml ; sarna lotion  1  appl ; trazodone  25  mg ; heparin flush (10 units ml)  1  ml ; senna  8.6  mg ; tramadol (ultram)  50  mg ; ondansetron  4-8  mg ; docusate sodium  100  mg ; rifaximin  550  mg ; 0.9% sodium chloride  100  ml ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; fluconazole  400  mg ; mycophenolate mofetil  1000  mg ; 0.9% sodium chloride  50  ml ; methylprednisolone sodium succ  500  mg ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$hematology blood hematocrit  31.8  %; hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.9  g dl; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  184  k ul; hematology blood platelet count  187  k ul; hematology blood platelet count  178  k ul; hematology blood platelet count  101  k ul; hematology blood platelet count  84  k ul; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  2.4  ; hematology blood inr(pt)  1.9  ; hematology blood inr(pt)  2.0  ; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  10.3  mg dl; chemistry blood bilirubin, indirect  3.4  mg dl; chemistry blood bilirubin, total  15.6  mg dl; chemistry blood glucose  214  mg dl; chemistry blood albumin  3.1  g dl; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.26  mmol l; blood gas blood free calcium  1.34  mmol l; blood gas blood free calcium  0.98  mmol l; blood gas blood free calcium  1.51  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  2.6  mmol l; blood gas blood lactate  5.3  mmol l; blood gas blood lactate  4.5  mmol l; blood gas blood lactate  6.1  mmol l; blood gas blood lactate  4.3  mmol l; blood gas blood lactate  4.3  mmol l; chemistry blood bilirubin, direct  12.2  mg dl; blood gas blood chloride, whole blood  99  meq l; blood gas blood chloride, whole blood  101  meq l; blood gas blood chloride, whole blood  101  meq l; blood gas blood chloride, whole blood  102  meq l; blood gas blood chloride, whole blood  102  meq l; blood gas blood glucose  101  mg dl; blood gas blood glucose  122  mg dl; blood gas blood glucose  112  mg dl; blood gas blood glucose  168  mg dl; blood gas blood glucose  191  mg dl; blood gas blood hematocrit, calculated  21  %; blood gas blood hematocrit, calculated  35  %; blood gas blood hematocrit, calculated  35  %; blood gas blood hematocrit, calculated  42  %; blood gas blood hematocrit, calculated  28  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hemoglobin  6.9  g dl; blood gas blood hemoglobin  11.6  g dl; blood gas blood hemoglobin  11.6  g dl; blood gas blood hemoglobin  13.9  g dl; blood gas blood hemoglobin  9.4  g dl; blood gas blood hemoglobin  10.5  g dl; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.9  meq l; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood potassium, whole blood  5.5  meq l; blood gas blood potassium, whole blood  4.8  meq l; blood gas blood sodium, whole blood  133  meq l; blood gas blood sodium, whole blood  134  meq l; blood gas blood sodium, whole blood  134  meq l; blood gas blood sodium, whole blood  133  meq l; blood gas blood sodium, whole blood  133  meq l$multivitamins w minerals  1  tab ; ursodiol  300  mg ; ursodiol  600  mg ; sarna lotion  1  appl ; trazodone  25  mg ; heparin flush (10 units ml)  1  ml ; senna  8.6  mg ; tramadol (ultram)  50  mg ; ondansetron  4-8  mg ; docusate sodium  100  mg ; rifaximin  550  mg ; 0.9% sodium chloride  100  ml ; sodium chloride 0.9%  flush  10-20  ml ; fluconazole  400  mg ; mycophenolate mofetil  1000  mg ; 0.9% sodium chloride  50  ml ; methylprednisolone sodium succ  500  mg ; hepatitis b immun globulin (hepagam b)  10,000  unit ; octreotide acetate  500  mcg ; sulfameth trimethoprim suspension  10  ml ; sulfameth trimethoprim ss  1  tab ; valganciclovir oral solution  450  mg ; d5 1 2ns  1000  ml ; morphine sulfate  1-4  mg ; prochlorperazine  5-10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$hematology blood hematocrit  25.6  %; hematology blood hematocrit  28.9  %; hematology blood hematocrit  30.3  %; hematology blood hematocrit  29.0  %; hematology blood hemoglobin  8.5  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  52  k ul; hematology blood platelet count  47  k ul; hematology blood platelet count  56  k ul; hematology blood platelet count  53  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  2.0  ; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, indirect  2.8  mg dl; chemistry blood bilirubin, total  11.5  mg dl; chemistry blood bilirubin, total  7.8  mg dl; chemistry blood bilirubin, total  6.2  mg dl; chemistry blood glucose  343  mg dl; chemistry blood glucose  104  mg dl; chemistry blood glucose  107  mg dl; chemistry blood albumin  2.9  g dl; blood gas blood lactate  2.9  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  0.8  mmol l; chemistry blood bilirubin, direct  8.7  mg dl$sulfameth trimethoprim suspension  10  ml ; sulfameth trimethoprim ss  1  tab ; valganciclovir oral solution  450  mg ; d5 1 2ns  1000  ml ; morphine sulfate  1-4  mg ; prochlorperazine  5-10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; mycophenolate mofetil suspension  1000  mg ; iso-osmotic sodium chloride  1  bag ; 0.45% sodium chloride  1000  ml ; 0.9% sodium chloride  25  ml ; hepatitis b immu glob (hepagam b)  5000  unit ; entecavir  0.5  mg ; methylprednisolone sodium succ  200  mg ; sterile water  50  ml ; potassium chloride  20  meq ; tacrolimus  2  mg ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$hematology blood hematocrit  32.7  %; hematology blood hematocrit  28.4  %; hematology blood hemoglobin  11.1  g dl; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  61  k ul; hematology blood platelet count  42  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  6.2  mg dl; chemistry blood bilirubin, total  5.6  mg dl; chemistry blood glucose  153  mg dl; chemistry blood glucose  167  mg dl$sulfameth trimethoprim suspension  10  ml ; sulfameth trimethoprim ss  1  tab ; morphine sulfate  1-4  mg ; prochlorperazine  5-10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; mycophenolate mofetil suspension  1000  mg ; iso-osmotic sodium chloride  1  bag ; 0.9% sodium chloride  25  ml ; hepatitis b immu glob (hepagam b)  5000  unit ; entecavir  0.5  mg ; methylprednisolone sodium succ  200  mg ; sterile water  50  ml ; potassium chloride  20  meq ; tacrolimus  2  mg ; methylprednisolone sodium succ  150  mg ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  40  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  5.3  mg dl; chemistry blood glucose  144  mg dl$sulfameth trimethoprim suspension  10  ml ; sulfameth trimethoprim ss  1  tab ; morphine sulfate  1-4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; mycophenolate mofetil suspension  1000  mg ; iso-osmotic sodium chloride  1  bag ; entecavir  0.5  mg ; sterile water  50  ml ; potassium chloride  20  meq ; tacrolimus  2  mg ; methylprednisolone sodium succ  150  mg ; valganciclovir  450  mg ; methylprednisolone sodium succ  100  mg ; morphine sulfate  1-2  mg ; transplant self medication program  1  bag ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  42  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  4.6  mg dl; chemistry blood glucose  107  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; morphine sulfate  1-2  mg ; transplant self medication program  1  bag ; tacrolimus  4  mg ; methylprednisolone sodium succ  70  mg ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  54  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  52  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  3  # hpf; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  4.6  mg dl; chemistry blood glucose  95  mg dl; chemistry blood albumin  2.8  g dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; morphine sulfate  1-2  mg ; transplant self medication program  1  bag ; methylprednisolone sodium succ  70  mg ; zolpidem tartrate  5  mg ; metoclopramide  10  mg ; calcium carbonate  500  mg ; prednisone  35  mg ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  55  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  3.9  mg dl; chemistry blood glucose  121  mg dl; chemistry blood albumin  2.5  g dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; morphine sulfate  1-2  mg ; transplant self medication program  1  bag ; metoclopramide  10  mg ; hydromorphone (dilaudid)  2-4  mg ; lidocaine 1%  2  ml ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  72  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  3.7  mg dl; chemistry blood glucose  78  mg dl; chemistry blood albumin  2.9  g dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; transplant self medication program  1  bag ; hydromorphone (dilaudid)  2-4  mg ; lidocaine 1%  2  ml ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 50 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; transplant self medication program  1  bag ; hydromorphone (dilaudid)  2-4  mg ; 
alcohol abuse, unspecified alcoholic cirrhosis of liver need for prophylactic vaccination and inoculation against influenza cirrhosis of liver without mention of alcohol esophageal varices in diseases classified elsewhere, without mention of bleeding unspecified pruritic disorder portal hypertension awaiting organ transplant status other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, without mention of obstruction portal hypertension other ascites awaiting organ transplant status alcoholic cirrhosis of liver other and unspecified alcohol dependence, unspecified other chronic pulmonary heart diseases varices of other sites other and unspecified coagulation defects other specified disorders of biliary tract calculus of bile duct without mention of cholecystitis, with obstruction other specified pruritic conditions disorders of bilirubin excretion esophageal varices in diseases classified elsewhere, without mention of bleeding other anomalies of gallbladder, bile ducts, and liver alcohol abuse, in remission personal history of venous thrombosis and embolism personal history of alcoholism substance abuse in family intestinal infection due to clostridium difficile tubal ligation status dehydration person boarding or alighting a pedal cycle injured in collision with other pedal cycle other specified disorders of liver esophageal varices in diseases classified elsewhere, without mention of bleeding portal hypertension pancytopenia other postprocedural status personal history of venous thrombosis and embolism esophageal varices in diseases classified elsewhere, without mention of bleeding tachycardia, unspecified personal history of alcoholism cirrhosis of liver without mention of alcohol substance abuse in family other ascites person boarding or alighting a pedal cycle injured in collision with other pedal cycle personal history of venous thrombosis and embolism intestinal infection due to clostridium difficile pancytopenia
white f 74 $nan$chemistry blood % hemoglobin a1c  6.4  %$aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; trazodone  100  mg ; doxepin hcl  150  mg ; amlodipine  5  mg ; cyanocobalamin  1000  mcg ; polyethylene glycol  17  g ; fish oil (omega 3)  1000  mg ; senna  8.6  mg ; 
malignant neoplasm of unspecified site of unspecified female breast suicidal ideations essential (primary) hypertension major depressive disorder, single episode, unspecified malignant neoplasm of unspecified site of left female breast essential (primary) hypertension unspecified glaucoma anxiety disorder, unspecified major depressive disorder, single episode, unspecified other specified disorders of bone density and structure, unspecified site suicidal ideations unspecified cataract secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes gastro-esophageal reflux disease without esophagitis estrogen receptor positive status [er+] 
white f 74 $nan$nan$aluminum-magnesium hydrox.-simethicone  30  ml ; trazodone  100  mg ; doxepin hcl  150  mg ; amlodipine  5  mg ; cyanocobalamin  1000  mcg ; polyethylene glycol  17  g ; fish oil (omega 3)  1000  mg ; senna  8.6  mg ; psyllium wafer  1  waf ; duloxetine  30  mg ; desvenlafaxine succinate  100  mg ; lunesta  3  mg ; 
malignant neoplasm of unspecified site of unspecified female breast suicidal ideations essential (primary) hypertension major depressive disorder, single episode, unspecified malignant neoplasm of unspecified site of left female breast essential (primary) hypertension unspecified glaucoma anxiety disorder, unspecified major depressive disorder, single episode, unspecified other specified disorders of bone density and structure, unspecified site suicidal ideations unspecified cataract secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes gastro-esophageal reflux disease without esophagitis estrogen receptor positive status [er+] 
white f 74 $nan$nan$aluminum-magnesium hydrox.-simethicone  30  ml ; trazodone  100  mg ; doxepin hcl  150  mg ; amlodipine  5  mg ; cyanocobalamin  1000  mcg ; polyethylene glycol  17  g ; fish oil (omega 3)  1000  mg ; senna  8.6  mg ; psyllium wafer  1  waf ; desvenlafaxine succinate  100  mg ; lunesta  3  mg ; melatonin  10  mg ; 
malignant neoplasm of unspecified site of unspecified female breast suicidal ideations essential (primary) hypertension major depressive disorder, single episode, unspecified malignant neoplasm of unspecified site of left female breast essential (primary) hypertension unspecified glaucoma anxiety disorder, unspecified major depressive disorder, single episode, unspecified other specified disorders of bone density and structure, unspecified site suicidal ideations unspecified cataract secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes gastro-esophageal reflux disease without esophagitis estrogen receptor positive status [er+] 
white f 74 $nan$nan$aluminum-magnesium hydrox.-simethicone  30  ml ; trazodone  100  mg ; doxepin hcl  150  mg ; amlodipine  5  mg ; cyanocobalamin  1000  mcg ; polyethylene glycol  17  g ; fish oil (omega 3)  1000  mg ; senna  8.6  mg ; psyllium wafer  1  waf ; desvenlafaxine succinate  100  mg ; lunesta  3  mg ; melatonin  10  mg ; 
malignant neoplasm of unspecified site of unspecified female breast suicidal ideations essential (primary) hypertension major depressive disorder, single episode, unspecified malignant neoplasm of unspecified site of left female breast essential (primary) hypertension unspecified glaucoma anxiety disorder, unspecified major depressive disorder, single episode, unspecified other specified disorders of bone density and structure, unspecified site suicidal ideations unspecified cataract secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes gastro-esophageal reflux disease without esophagitis estrogen receptor positive status [er+] 
white f 74 $nan$nan$aluminum-magnesium hydrox.-simethicone  30  ml ; trazodone  100  mg ; doxepin hcl  150  mg ; amlodipine  5  mg ; cyanocobalamin  1000  mcg ; polyethylene glycol  17  g ; fish oil (omega 3)  1000  mg ; senna  8.6  mg ; psyllium wafer  1  waf ; desvenlafaxine succinate  100  mg ; lunesta  3  mg ; melatonin  10  mg ; 
malignant neoplasm of unspecified site of unspecified female breast suicidal ideations essential (primary) hypertension major depressive disorder, single episode, unspecified malignant neoplasm of unspecified site of left female breast essential (primary) hypertension unspecified glaucoma anxiety disorder, unspecified major depressive disorder, single episode, unspecified other specified disorders of bone density and structure, unspecified site suicidal ideations unspecified cataract secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes gastro-esophageal reflux disease without esophagitis estrogen receptor positive status [er+] 
hispanic latino f 51 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  3  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  115  mg dl$acetaminophen  500-1000  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; calcium carbonate  1000  mg ; levofloxacin  750  mg ; vitamin d  400  unit ; ibuprofen  600  mg ; neutra-phos  2  pkt ; potassium chloride  40  meq ; 
 
white f 88 $temp  99.9  heartrate  61.0  resprate  18.0  o2sat  99.0  sbp  115.0  dbp  50.0  rhythm    pain  0  ; temp  98.1  heartrate  64.0  resprate  20.0  o2sat  99.0  sbp  116.0  dbp  43.0  rhythm    pain  0  ; temp  98.2  heartrate  60.0  resprate  22.0  o2sat  100.0  sbp  121.0  dbp  59.0  rhythm    pain    $hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  324  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  116  mg dl; blood gas blood lactate  0.9  mmol l$nan
presence of cardiac pacemaker personal history of nicotine dependence personal history of other venous thrombosis and embolism personal history of malignant neoplasm of bladder long term (current) use of anticoagulants enterocolitis due to clostridium difficile urinary tract infection, site not specified encounter for attention to other artificial openings of urinary tract personal history of nicotine dependence peritoneal adhesions (postprocedural) (postinfection) neoplasm related pain (acute) (chronic) anemia, unspecified urinary tract infection, site not specified presence of cardiac pacemaker personal history of other venous thrombosis and embolism enterocolitis due to clostridium difficile secondary malignant neoplasm of other specified sites supraventricular tachycardia leiomyoma of uterus, unspecified malignant neoplasm of dome of bladder long term (current) use of anticoagulants 
white f 88 $temp  98.0  heartrate  60.0  resprate  22.0  o2sat  98.0  sbp  117.0  dbp  46.0  rhythm    pain  0  $hematology blood hematocrit  31.1  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  309  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  173  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  650  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; apixaban  5  mg ; vancomycin oral liquid  125  mg ; 
presence of cardiac pacemaker personal history of nicotine dependence personal history of other venous thrombosis and embolism personal history of malignant neoplasm of bladder long term (current) use of anticoagulants enterocolitis due to clostridium difficile urinary tract infection, site not specified encounter for attention to other artificial openings of urinary tract personal history of nicotine dependence peritoneal adhesions (postprocedural) (postinfection) neoplasm related pain (acute) (chronic) anemia, unspecified urinary tract infection, site not specified presence of cardiac pacemaker personal history of other venous thrombosis and embolism enterocolitis due to clostridium difficile secondary malignant neoplasm of other specified sites supraventricular tachycardia leiomyoma of uterus, unspecified malignant neoplasm of dome of bladder long term (current) use of anticoagulants 
white f 88 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  312  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  93  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; apixaban  5  mg ; vancomycin oral liquid  125  mg ; 
presence of cardiac pacemaker personal history of nicotine dependence personal history of other venous thrombosis and embolism personal history of malignant neoplasm of bladder long term (current) use of anticoagulants enterocolitis due to clostridium difficile urinary tract infection, site not specified encounter for attention to other artificial openings of urinary tract personal history of nicotine dependence peritoneal adhesions (postprocedural) (postinfection) neoplasm related pain (acute) (chronic) anemia, unspecified urinary tract infection, site not specified presence of cardiac pacemaker personal history of other venous thrombosis and embolism enterocolitis due to clostridium difficile secondary malignant neoplasm of other specified sites supraventricular tachycardia leiomyoma of uterus, unspecified malignant neoplasm of dome of bladder long term (current) use of anticoagulants 
white f 88 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  351  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  98  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; apixaban  5  mg ; 
presence of cardiac pacemaker personal history of nicotine dependence personal history of other venous thrombosis and embolism personal history of malignant neoplasm of bladder long term (current) use of anticoagulants enterocolitis due to clostridium difficile urinary tract infection, site not specified encounter for attention to other artificial openings of urinary tract personal history of nicotine dependence peritoneal adhesions (postprocedural) (postinfection) neoplasm related pain (acute) (chronic) anemia, unspecified urinary tract infection, site not specified presence of cardiac pacemaker personal history of other venous thrombosis and embolism enterocolitis due to clostridium difficile secondary malignant neoplasm of other specified sites supraventricular tachycardia leiomyoma of uterus, unspecified malignant neoplasm of dome of bladder long term (current) use of anticoagulants 
white f 96 $temp  98.9  heartrate  94.0  resprate  14.0  o2sat  100.0  sbp  168.0  dbp  100.0  rhythm    pain  unable  ; temp  98.9  heartrate  94.0  resprate  14.0  o2sat  100.0  sbp  168.0  dbp  100.0  rhythm    pain  unable  $hematology blood hematocrit  45.1  %; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  89  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  81  mg ; furosemide  40  mg ; levothyroxine sodium  175  mcg ; lorazepam  0.25  mg ; senna  17.2  mg ; trazodone  12.5  mg ; aspirin  325  mg ; atorvastatin  80  mg ; acetaminophen  650  mg ; olanzapine  5  mg ; metoprolol tartrate  12.5  mg ; 
atrial fibrillation chronic kidney disease, unspecified osteoporosis, unspecified other persistent mental disorders due to conditions classified elsewhere person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast aortocoronary bypass status personal history of malignant neoplasm of large intestine unspecified fall other specified metabolic disorders other and unspecified hyperlipidemia closed fracture of midcervical section of neck of femur unspecified acquired hypothyroidism coronary atherosclerosis of unspecified type of vessel, native or graft
white f 96 $nan$hematology blood hematocrit  42.3  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  167  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  85  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; levothyroxine sodium  175  mcg ; senna  17.2  mg ; trazodone  12.5  mg ; aspirin  325  mg ; atorvastatin  80  mg ; acetaminophen  650  mg ; olanzapine  5  mg ; metoprolol tartrate  12.5  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; ciprofloxacin hcl  250  mg ; 
atrial fibrillation chronic kidney disease, unspecified osteoporosis, unspecified other persistent mental disorders due to conditions classified elsewhere person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast aortocoronary bypass status personal history of malignant neoplasm of large intestine unspecified fall other specified metabolic disorders other and unspecified hyperlipidemia closed fracture of midcervical section of neck of femur unspecified acquired hypothyroidism coronary atherosclerosis of unspecified type of vessel, native or graft
white f 96 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; levothyroxine sodium  175  mcg ; senna  17.2  mg ; trazodone  12.5  mg ; aspirin  325  mg ; acetaminophen  650  mg ; olanzapine  5  mg ; metoprolol tartrate  12.5  mg ; 
atrial fibrillation chronic kidney disease, unspecified osteoporosis, unspecified other persistent mental disorders due to conditions classified elsewhere person boarding or alighting a pedal cycle injured in collision with pedestrian or animal personal history of malignant neoplasm of breast aortocoronary bypass status personal history of malignant neoplasm of large intestine unspecified fall other specified metabolic disorders other and unspecified hyperlipidemia closed fracture of midcervical section of neck of femur unspecified acquired hypothyroidism coronary atherosclerosis of unspecified type of vessel, native or graft
black african american f 30 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  124  k ul$influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; 
other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn human papillomavirus in conditions classified elsewhere and of unspecified site motorcycle driver injured in collision with fixed or stationary object in nontraffic accident second-degree perineal laceration, delivered, with or without mention of antepartum condition asthma, unspecified type, unspecified other viral diseases in the mother, delivered, with or without mention of antepartum condition poor fetal growth, affecting management of mother, delivered, with or without mention of antepartum condition
black african american f 30 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; 
other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn human papillomavirus in conditions classified elsewhere and of unspecified site motorcycle driver injured in collision with fixed or stationary object in nontraffic accident second-degree perineal laceration, delivered, with or without mention of antepartum condition asthma, unspecified type, unspecified other viral diseases in the mother, delivered, with or without mention of antepartum condition poor fetal growth, affecting management of mother, delivered, with or without mention of antepartum condition
black african american f 30 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; 
other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn human papillomavirus in conditions classified elsewhere and of unspecified site motorcycle driver injured in collision with fixed or stationary object in nontraffic accident second-degree perineal laceration, delivered, with or without mention of antepartum condition asthma, unspecified type, unspecified other viral diseases in the mother, delivered, with or without mention of antepartum condition poor fetal growth, affecting management of mother, delivered, with or without mention of antepartum condition
white m 66 $temp  98.5  heartrate  82.0  resprate  16.0  o2sat  99.0  sbp  124.0  dbp  77.0  rhythm    pain  0  $hematology blood hematocrit  36.2  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  129  k ul$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  5  ml ; acetaminophen  650  mg ; hydromorphone (dilaudid)  20  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; zolpidem tartrate  2.5-5  mg ; docusate sodium  100  mg ; senna  1  tab ; allopurinol  100  mg ; vitamin d  400  unit ; multivitamins  1  cap ; lisinopril  40  mg ; oxycodone (immediate release)   5-10  mg ; oxycodone (immediate release)   5-15  mg ; zolpidem tartrate  10  mg ; 
 
white m 66 $nan$nan$sodium chloride 0.9%  flush  5  ml ; acetaminophen  650  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; allopurinol  100  mg ; vitamin d  400  unit ; multivitamins  1  cap ; lisinopril  40  mg ; oxycodone (immediate release)   5-15  mg ; zolpidem tartrate  10  mg ; hydrocortisone (rectal) 2.5% cream  1  appl ; 
 
white m 66 $nan$nan$sodium chloride 0.9%  flush  5  ml ; acetaminophen  650  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; allopurinol  100  mg ; vitamin d  400  unit ; multivitamins  1  cap ; lisinopril  40  mg ; oxycodone (immediate release)   5-15  mg ; zolpidem tartrate  10  mg ; hydrocortisone (rectal) 2.5% cream  1  appl ; 
 
black african american f 64 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  361  mg dl$warfarin  6  mg ; ns  1000  ml ; ns  500  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; insulin  0  unit ; ciprofloxacin hcl  500  mg ; metoprolol  25  mg ; docusate sodium  100  mg ; insulin  50  unit ; miconazole 2% cream  1  appl ; aspirin  325  mg ; simvastatin  40  mg ; lisinopril  30  mg ; levothyroxine sodium  75  mcg ; furosemide  60  mg ; insulin  12  unit ; insulin  2  unit ; insulin  8  unit ; lactulose  30  ml ; n-acetylcysteine  1  dose ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled old myocardial infarction intermediate coronary syndrome 
black african american f 64 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  189  mg dl$warfarin  6  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; ciprofloxacin hcl  500  mg ; metoprolol  25  mg ; docusate sodium  100  mg ; miconazole 2% cream  1  appl ; aspirin  325  mg ; simvastatin  40  mg ; lisinopril  30  mg ; levothyroxine sodium  75  mcg ; furosemide  60  mg ; insulin  2  unit ; insulin  8  unit ; lactulose  30  ml ; insulin  52  unit ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled old myocardial infarction intermediate coronary syndrome 
black african american f 64 $nan$nan$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; ciprofloxacin hcl  500  mg ; metoprolol  25  mg ; docusate sodium  100  mg ; miconazole 2% cream  1  appl ; aspirin  325  mg ; simvastatin  40  mg ; lisinopril  30  mg ; levothyroxine sodium  75  mcg ; lactulose  30  ml ; insulin  52  unit ; warfarin  8  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled old myocardial infarction intermediate coronary syndrome 
black african american m 72 $temp  100.2  heartrate  80.0  resprate  16.0  o2sat  100.0  sbp  157.0  dbp  72.0  rhythm    pain  8-9  ; temp  97.5  heartrate  81.0  resprate  16.0  o2sat  99.0  sbp  161.0  dbp  91.0  rhythm    pain    ; temp  98.9  heartrate  80.0  resprate  18.0  o2sat  99.0  sbp  149.0  dbp  77.0  rhythm    pain  4  $hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  11.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  212  iu l; chemistry blood albumin  3.5  g dl; blood gas blood lactate  1.5  mmol l$nan
 
black african american m 72 $temp  97.0  heartrate  75.0  resprate  19.0  o2sat  98.0  sbp  152.0  dbp  86.0  rhythm    pain  0  $hematology blood hematocrit  36.5  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry urine creatinine, urine  155  mg dl; chemistry blood calcium, total  11.7  mg dl; chemistry blood glucose  92  mg dl; chemistry urine protein creatinine ratio  0.7  mg mg$lorazepam  1  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; acetaminophen  325-650  mg ; morphine sulfate  1-4  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; metoprolol succinate xl  100  mg ; 0.9% sodium chloride  250  ml ; pamidronate  60  mg ; 
 
black african american m 72 $nan$hematology blood hematocrit  32.4  %; hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  148  k ul; hematology blood platelet count  129  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.4  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  10.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  93  mg dl$lactated ringers  1000  ml ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; acetaminophen  325-650  mg ; morphine sulfate  1-4  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; metoprolol succinate xl  100  mg ; 0.9% sodium chloride  250  ml ; pamidronate  60  mg ; oxycodone (immediate release)   5  mg ; amlodipine  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; 
 
black african american m 72 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; acetaminophen  325-650  mg ; metoprolol succinate xl  100  mg ; oxycodone (immediate release)   5  mg ; amlodipine  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; 
 
black african american m 72 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  150  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  124  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; acetaminophen  325-650  mg ; metoprolol succinate xl  100  mg ; oxycodone (immediate release)   5  mg ; amlodipine  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; 
 
white m 91 $temp  98.1  heartrate  53.0  resprate  16.0  o2sat  100.0  sbp  166.0  dbp  79.0  rhythm    pain  0  ; temp  98.1  heartrate  54.0  resprate  16.0  o2sat    sbp  167.0  dbp  80.0  rhythm    pain    $hematology blood hematocrit  35.8  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  458  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  80  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; heparin  5000  unit ; dipyridamole-aspirin  1  cap ; citalopram  20  mg ; simvastatin  5  mg ; finasteride  5  mg ; docusate sodium  200  mg ; multivitamins  1  tab ; aspirin  325  mg ; tamsulosin  0.4  mg ; donepezil  20  mg ; 
 
white m 91 $nan$hematology blood hematocrit  38.1  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  478  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood glucose  84  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; heparin  5000  unit ; dipyridamole-aspirin  1  cap ; citalopram  20  mg ; simvastatin  5  mg ; finasteride  5  mg ; docusate sodium  200  mg ; multivitamins  1  tab ; aspirin  325  mg ; tamsulosin  0.4  mg ; donepezil  20  mg ; 
 
white m 91 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; heparin  5000  unit ; dipyridamole-aspirin  1  cap ; citalopram  20  mg ; simvastatin  5  mg ; finasteride  5  mg ; docusate sodium  200  mg ; multivitamins  1  tab ; aspirin  325  mg ; tamsulosin  0.4  mg ; donepezil  20  mg ; quetiapine fumarate  6.25  mg ; 
 
white m 91 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; heparin  5000  unit ; dipyridamole-aspirin  1  cap ; citalopram  20  mg ; simvastatin  5  mg ; finasteride  5  mg ; docusate sodium  200  mg ; multivitamins  1  tab ; aspirin  325  mg ; tamsulosin  0.4  mg ; donepezil  20  mg ; quetiapine fumarate  6.25  mg ; olanzapine (disintegrating tablet)  2.5-5  mg ; aspirin  81  mg ; cyanocobalamin  50  mcg ; donepezil  10  mg ; 
 
white m 91 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; dipyridamole-aspirin  1  cap ; citalopram  20  mg ; finasteride  5  mg ; docusate sodium  200  mg ; multivitamins  1  tab ; tamsulosin  0.4  mg ; aspirin  81  mg ; cyanocobalamin  50  mcg ; donepezil  10  mg ; ibuprofen  200  mg ; acetaminophen  650  mg ; 
 
white m 91 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; dipyridamole-aspirin  1  cap ; citalopram  20  mg ; finasteride  5  mg ; docusate sodium  200  mg ; multivitamins  1  tab ; tamsulosin  0.4  mg ; aspirin  81  mg ; cyanocobalamin  50  mcg ; donepezil  10  mg ; ibuprofen  200  mg ; acetaminophen  650  mg ; 
 
white m 91 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; dipyridamole-aspirin  1  cap ; citalopram  20  mg ; finasteride  5  mg ; docusate sodium  200  mg ; multivitamins  1  tab ; tamsulosin  0.4  mg ; aspirin  81  mg ; cyanocobalamin  50  mcg ; donepezil  10  mg ; ibuprofen  200  mg ; acetaminophen  650  mg ; 
 
white m 91 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; dipyridamole-aspirin  1  cap ; citalopram  20  mg ; finasteride  5  mg ; docusate sodium  200  mg ; multivitamins  1  tab ; tamsulosin  0.4  mg ; aspirin  81  mg ; cyanocobalamin  50  mcg ; donepezil  10  mg ; ibuprofen  200  mg ; acetaminophen  650  mg ; 
 
white m 91 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; dipyridamole-aspirin  1  cap ; citalopram  20  mg ; finasteride  5  mg ; docusate sodium  200  mg ; multivitamins  1  tab ; tamsulosin  0.4  mg ; aspirin  81  mg ; cyanocobalamin  50  mcg ; donepezil  10  mg ; ibuprofen  200  mg ; acetaminophen  650  mg ; 
 
black african american f 28 $temp  99.5  heartrate  78.0  resprate  18.0  o2sat  100.0  sbp  128.0  dbp  82.0  rhythm    pain  8  ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  4  ; temp  98.0  heartrate  65.0  resprate  16.0  o2sat  100.0  sbp  107.0  dbp  70.0  rhythm    pain    ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  7  ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  6  ; temp  98.6  heartrate  68.0  resprate  18.0  o2sat  98.0  sbp  113.0  dbp  76.0  rhythm    pain  6  ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  sleeping  ; temp  98.3  heartrate  60.0  resprate  18.0  o2sat  99.0  sbp  124.0  dbp  83.0  rhythm    pain  6  ; temp  97.9  heartrate  75.0  resprate  16.0  o2sat  98.0  sbp  131.0  dbp  82.0  rhythm    pain  6  $hematology blood hematocrit  35.2  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood glucose  87  mg dl; blood gas blood lactate  1.0  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; vial  1  vial ; ceftriaxone  1  gm ; heparin  5000  unit ; acetaminophen  1000  mg ; ibuprofen  800  mg ; ondansetron  4  mg ; albuterol inhaler  2  puff ; mirtazapine  7.5  mg ; amlodipine  2.5  mg ; 
nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] personal history of urinary calculi major depressive disorder, single episode, unspecified polycystic kidney, adult type essential (primary) hypertension opioid dependence, uncomplicated patient room in hospital as the place of occurrence of the external cause personal history of urinary (tract) infections nausea nicotine dependence, cigarettes, uncomplicated unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter constipation, unspecified migraine without aura, not intractable, without status migrainosus tubulo-interstitial nephritis, not specified as acute or chronic unspecified asthma, uncomplicated other chronic pain adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter moderate protein-calorie malnutrition polycystic kidney, unspecified nausea with vomiting, unspecified essential (primary) hypertension unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere major depressive disorder, single episode, unspecified urinary tract infection, site not specified migraine, unspecified, not intractable, without status migrainosus unspecified asthma, uncomplicated nicotine dependence, cigarettes, uncomplicated polycystic ovarian syndrome essential (primary) hypertension major depressive disorder, single episode, unspecified dermatitis, unspecified nicotine dependence, cigarettes, uncomplicated polycystic kidney, adult type other specified disorders of kidney and ureter unspecified asthma, uncomplicated migraine, unspecified, not intractable, without status migrainosus other long term (current) drug therapy nicotine dependence, cigarettes, uncomplicated other problems related to housing and economic circumstances major depressive disorder, single episode, unspecified unspecified asthma, uncomplicated essential (primary) hypertension polycystic kidney, adult type personal history of urinary calculi polycystic ovarian syndrome tubulo-interstitial nephritis, not specified as acute or chronic polycystic kidney, adult type
black african american f 28 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  87  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; vial  1  vial ; ceftriaxone  1  gm ; heparin  5000  unit ; acetaminophen  1000  mg ; ibuprofen  800  mg ; ondansetron  4  mg ; albuterol inhaler  2  puff ; mirtazapine  7.5  mg ; amlodipine  2.5  mg ; lidocaine 5% patch  1  ptch ; 
nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] personal history of urinary calculi major depressive disorder, single episode, unspecified polycystic kidney, adult type essential (primary) hypertension opioid dependence, uncomplicated patient room in hospital as the place of occurrence of the external cause personal history of urinary (tract) infections nausea nicotine dependence, cigarettes, uncomplicated unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter constipation, unspecified migraine without aura, not intractable, without status migrainosus tubulo-interstitial nephritis, not specified as acute or chronic unspecified asthma, uncomplicated other chronic pain adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter moderate protein-calorie malnutrition polycystic kidney, unspecified nausea with vomiting, unspecified essential (primary) hypertension unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere major depressive disorder, single episode, unspecified urinary tract infection, site not specified migraine, unspecified, not intractable, without status migrainosus unspecified asthma, uncomplicated nicotine dependence, cigarettes, uncomplicated polycystic ovarian syndrome essential (primary) hypertension major depressive disorder, single episode, unspecified dermatitis, unspecified nicotine dependence, cigarettes, uncomplicated polycystic kidney, adult type other specified disorders of kidney and ureter unspecified asthma, uncomplicated migraine, unspecified, not intractable, without status migrainosus other long term (current) drug therapy nicotine dependence, cigarettes, uncomplicated other problems related to housing and economic circumstances major depressive disorder, single episode, unspecified unspecified asthma, uncomplicated essential (primary) hypertension polycystic kidney, adult type personal history of urinary calculi polycystic ovarian syndrome tubulo-interstitial nephritis, not specified as acute or chronic polycystic kidney, adult type
black african american f 28 $nan$hematology blood hematocrit  38.1  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  264  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  114  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; vial  1  vial ; ceftriaxone  1  gm ; heparin  5000  unit ; acetaminophen  1000  mg ; ibuprofen  800  mg ; ondansetron  4  mg ; albuterol inhaler  2  puff ; mirtazapine  7.5  mg ; lidocaine 5% patch  1  ptch ; ketorolac  30  mg ; cefepime  2  g ; amlodipine  5  mg ; ceftriaxone  2  gm ; gabapentin  100  mg ; 
nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] personal history of urinary calculi major depressive disorder, single episode, unspecified polycystic kidney, adult type essential (primary) hypertension opioid dependence, uncomplicated patient room in hospital as the place of occurrence of the external cause personal history of urinary (tract) infections nausea nicotine dependence, cigarettes, uncomplicated unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter constipation, unspecified migraine without aura, not intractable, without status migrainosus tubulo-interstitial nephritis, not specified as acute or chronic unspecified asthma, uncomplicated other chronic pain adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter moderate protein-calorie malnutrition polycystic kidney, unspecified nausea with vomiting, unspecified essential (primary) hypertension unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere major depressive disorder, single episode, unspecified urinary tract infection, site not specified migraine, unspecified, not intractable, without status migrainosus unspecified asthma, uncomplicated nicotine dependence, cigarettes, uncomplicated polycystic ovarian syndrome essential (primary) hypertension major depressive disorder, single episode, unspecified dermatitis, unspecified nicotine dependence, cigarettes, uncomplicated polycystic kidney, adult type other specified disorders of kidney and ureter unspecified asthma, uncomplicated migraine, unspecified, not intractable, without status migrainosus other long term (current) drug therapy nicotine dependence, cigarettes, uncomplicated other problems related to housing and economic circumstances major depressive disorder, single episode, unspecified unspecified asthma, uncomplicated essential (primary) hypertension polycystic kidney, adult type personal history of urinary calculi polycystic ovarian syndrome tubulo-interstitial nephritis, not specified as acute or chronic polycystic kidney, adult type
black african american f 28 $nan$hematology blood hematocrit  39.0  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  254  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  110  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; ibuprofen  800  mg ; ondansetron  4  mg ; albuterol inhaler  2  puff ; mirtazapine  7.5  mg ; lidocaine 5% patch  1  ptch ; amlodipine  5  mg ; ceftriaxone  2  gm ; gabapentin  100  mg ; bag  1  bag ; magnesium sulfate  4  gm ; ciprofloxacin hcl  250  mg ; 
nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] personal history of urinary calculi major depressive disorder, single episode, unspecified polycystic kidney, adult type essential (primary) hypertension opioid dependence, uncomplicated patient room in hospital as the place of occurrence of the external cause personal history of urinary (tract) infections nausea nicotine dependence, cigarettes, uncomplicated unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter constipation, unspecified migraine without aura, not intractable, without status migrainosus tubulo-interstitial nephritis, not specified as acute or chronic unspecified asthma, uncomplicated other chronic pain adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter moderate protein-calorie malnutrition polycystic kidney, unspecified nausea with vomiting, unspecified essential (primary) hypertension unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere major depressive disorder, single episode, unspecified urinary tract infection, site not specified migraine, unspecified, not intractable, without status migrainosus unspecified asthma, uncomplicated nicotine dependence, cigarettes, uncomplicated polycystic ovarian syndrome essential (primary) hypertension major depressive disorder, single episode, unspecified dermatitis, unspecified nicotine dependence, cigarettes, uncomplicated polycystic kidney, adult type other specified disorders of kidney and ureter unspecified asthma, uncomplicated migraine, unspecified, not intractable, without status migrainosus other long term (current) drug therapy nicotine dependence, cigarettes, uncomplicated other problems related to housing and economic circumstances major depressive disorder, single episode, unspecified unspecified asthma, uncomplicated essential (primary) hypertension polycystic kidney, adult type personal history of urinary calculi polycystic ovarian syndrome tubulo-interstitial nephritis, not specified as acute or chronic polycystic kidney, adult type
white f 91 $temp  97.4  heartrate  64.0  resprate  18.0  o2sat  99.0  sbp  156.0  dbp  53.0  rhythm    pain  0  $hematology blood hematocrit  37.5  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  215  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood glucose  85  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; pantoprazole  40  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  10  mg ; 
 
white f 91 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; pantoprazole  40  mg ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  10  mg ; senna  2  tab ; 
 
white f 82 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  140  mg dl; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood chloride, whole blood  108  meq l; blood gas blood chloride, whole blood  108  meq l; blood gas blood glucose  118  mg dl; blood gas blood glucose  123  mg dl; blood gas blood hematocrit, calculated  30  %; blood gas blood hematocrit, calculated  29  %; blood gas blood hemoglobin  10.1  g dl; blood gas blood hemoglobin  9.7  g dl; blood gas blood potassium, whole blood  3.1  meq l; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood sodium, whole blood  139  meq l; blood gas blood sodium, whole blood  138  meq l$soln  100  ml ; acetaminophen iv  1000  mg ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; d5 1 2ns  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; ondansetron  4-8  mg ; metoprolol tartrate  5  mg ; morphine sulfate  2-4  mg ; insulin  0  unit ; lactated ringers  1000  ml ; 
 
white f 82 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  610  mg dl$soln  100  ml ; acetaminophen iv  1000  mg ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; d5 1 2ns  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; ondansetron  4-8  mg ; metoprolol tartrate  5  mg ; morphine sulfate  2-4  mg ; insulin  0  unit ; lactated ringers  1000  ml ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; chloraseptic throat spray  1  spry ; haloperidol  0.25  mg ; haloperidol  1  mg ; sodium chloride 0.9%  flush  3  ml ; 
 
white f 82 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  2.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  168  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; d5 1 2ns  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; ondansetron  4-8  mg ; metoprolol tartrate  5  mg ; morphine sulfate  2-4  mg ; insulin  0  unit ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; chloraseptic throat spray  1  spry ; haloperidol  1  mg ; sodium chloride 0.9%  flush  3  ml ; haloperidol  0.5  mg ; bag  2  bag ; magnesium sulfate  4  gm ; neutra-phos  2  pkt ; quetiapine fumarate  12.5  mg ; potassium chloride (powder)  40  meq ; 
 
white f 82 $nan$hematology blood hematocrit  30.1  %; hematology blood hematocrit  27.9  %; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  272  k ul; hematology blood platelet count  294  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  143  mg dl; chemistry blood glucose  113  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; d5 1 2ns  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; ondansetron  4-8  mg ; metoprolol tartrate  5  mg ; morphine sulfate  2-4  mg ; insulin  0  unit ; chloraseptic throat spray  1  spry ; sodium chloride 0.9%  flush  3  ml ; haloperidol  0.5  mg ; bag  2  bag ; magnesium sulfate  4  gm ; neutra-phos  2  pkt ; quetiapine fumarate  12.5  mg ; potassium chloride (powder)  40  meq ; sodium glycerophosphate  20  mmol ; potassium chloride (powder)  20  meq ; ciprofloxacin hcl  250  mg ; ondansetron  4  mg ; tamsulosin  0.4  mg ; ciprofloxacin hcl  500  mg ; 
 
white f 82 $nan$nan$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; ondansetron  4-8  mg ; metoprolol tartrate  5  mg ; morphine sulfate  2-4  mg ; insulin  0  unit ; chloraseptic throat spray  1  spry ; sodium chloride 0.9%  flush  3  ml ; sodium glycerophosphate  20  mmol ; potassium chloride (powder)  20  meq ; ondansetron  4  mg ; tamsulosin  0.4  mg ; ciprofloxacin hcl  500  mg ; omeprazole  20  mg ; levothyroxine sodium  75  mcg ; acetaminophen  1000  mg ; oxycodone (immediate release)   2.5  mg ; 
 
white f 82 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  320  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  106  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; ondansetron  4-8  mg ; morphine sulfate  2-4  mg ; insulin  0  unit ; chloraseptic throat spray  1  spry ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; tamsulosin  0.4  mg ; ciprofloxacin hcl  500  mg ; omeprazole  20  mg ; levothyroxine sodium  75  mcg ; acetaminophen  1000  mg ; oxycodone (immediate release)   2.5  mg ; propranolol la  80  mg ; bag  1  bag ; magnesium sulfate  2  gm ; morphine sulfate  1-2  mg ; 
 
white f 82 $nan$hematology urine wbc  1  # hpf$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; ondansetron  4-8  mg ; insulin  0  unit ; chloraseptic throat spray  1  spry ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; tamsulosin  0.4  mg ; omeprazole  20  mg ; levothyroxine sodium  75  mcg ; acetaminophen  1000  mg ; oxycodone (immediate release)   2.5  mg ; propranolol la  80  mg ; bag  1  bag ; magnesium sulfate  2  gm ; morphine sulfate  1-2  mg ; quetiapine fumarate  25  mg ; 
 
white f 82 $nan$nan$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; ondansetron  4-8  mg ; insulin  0  unit ; chloraseptic throat spray  1  spry ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; tamsulosin  0.4  mg ; omeprazole  20  mg ; levothyroxine sodium  75  mcg ; acetaminophen  1000  mg ; oxycodone (immediate release)   2.5  mg ; propranolol la  80  mg ; morphine sulfate  1-2  mg ; quetiapine fumarate  25  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; 
 
white f 82 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  456  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  104  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; ondansetron  4-8  mg ; insulin  0  unit ; chloraseptic throat spray  1  spry ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; tamsulosin  0.4  mg ; omeprazole  20  mg ; levothyroxine sodium  75  mcg ; acetaminophen  1000  mg ; propranolol la  80  mg ; quetiapine fumarate  25  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; docusate sodium  100  mg ; senna  1  tab ; 5% dextrose  500  ml ; 5% dextrose  250  ml ; 
 
white f 82 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  509  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  93  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; ondansetron  4-8  mg ; insulin  0  unit ; chloraseptic throat spray  1  spry ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; omeprazole  20  mg ; levothyroxine sodium  75  mcg ; acetaminophen  1000  mg ; quetiapine fumarate  25  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; senna  1  tab ; 5% dextrose  500  ml ; 5% dextrose  250  ml ; metoprolol succinate xl  25  mg ; 
 
white f 82 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; ondansetron  4-8  mg ; insulin  0  unit ; chloraseptic throat spray  1  spry ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; omeprazole  20  mg ; levothyroxine sodium  75  mcg ; acetaminophen  1000  mg ; quetiapine fumarate  25  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; senna  1  tab ; metoprolol succinate xl  25  mg ; 
 
white f 82 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; ondansetron  4-8  mg ; insulin  0  unit ; chloraseptic throat spray  1  spry ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; omeprazole  20  mg ; levothyroxine sodium  75  mcg ; acetaminophen  1000  mg ; quetiapine fumarate  25  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; senna  1  tab ; metoprolol succinate xl  25  mg ; 
 
white f 82 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; ondansetron  4-8  mg ; insulin  0  unit ; chloraseptic throat spray  1  spry ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; omeprazole  20  mg ; levothyroxine sodium  75  mcg ; acetaminophen  1000  mg ; quetiapine fumarate  25  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; senna  1  tab ; metoprolol succinate xl  25  mg ; 
 
white f 58 $temp  97.7  heartrate  60.0  resprate  18.0  o2sat  97.0  sbp  126.0  dbp  57.0  rhythm    pain  2  $hematology blood hematocrit  34.3  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  75  mg dl; chemistry blood lactate dehydrogenase (ld)  146  iu l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; levothyroxine sodium  50  mcg ; 
 
white f 58 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  70  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.25  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; levothyroxine sodium  50  mcg ; 
 
white f 58 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.25  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; levothyroxine sodium  50  mcg ; 
 
white m 44 $nan$nan$lansoprazole oral disintegrating tab  30  mg ; multivitamins w minerals  1  tab ; 
other and unspecified hyperlipidemia esophageal reflux surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other postoperative infection bariatric surgery status other chronic nonalcoholic liver disease other b-complex deficiencies morbid obesity cellulitis and abscess of trunk body mass index 50.0-59.9, adult unspecified pruritic disorder incisional ventral hernia with obstruction other and unspecified hyperlipidemia other chronic nonalcoholic liver disease esophageal reflux morbid obesity other b-complex deficiencies 
white m 44 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  224  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  106  mg dl$5% dextrose  500  ml ; lansoprazole oral disintegrating tab  30  mg ; multivitamins w minerals  1  tab ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; multivitamin iv  10  ml ; thiamine  100  mg ; 0.9% sodium chloride  1000  ml ; folic acid  1  mg ; heparin  5000  unit ; vancomycin  1500  mg ; oxycodone-acetaminophen elixir  5-10  ml ; trazodone  100  mg ; trazodone  50  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 
other and unspecified hyperlipidemia esophageal reflux surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other postoperative infection bariatric surgery status other chronic nonalcoholic liver disease other b-complex deficiencies morbid obesity cellulitis and abscess of trunk body mass index 50.0-59.9, adult unspecified pruritic disorder incisional ventral hernia with obstruction other and unspecified hyperlipidemia other chronic nonalcoholic liver disease esophageal reflux morbid obesity other b-complex deficiencies 
white m 44 $nan$nan$lansoprazole oral disintegrating tab  30  mg ; multivitamins w minerals  1  tab ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; oxycodone-acetaminophen elixir  5-10  ml ; trazodone  100  mg ; trazodone  50  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; cyanocobalamin  1000  mcg ; 
other and unspecified hyperlipidemia esophageal reflux surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other postoperative infection bariatric surgery status other chronic nonalcoholic liver disease other b-complex deficiencies morbid obesity cellulitis and abscess of trunk body mass index 50.0-59.9, adult unspecified pruritic disorder incisional ventral hernia with obstruction other and unspecified hyperlipidemia other chronic nonalcoholic liver disease esophageal reflux morbid obesity other b-complex deficiencies 
white m 44 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  6  mg dl; hematology urine wbc  5  # hpf; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  86  mg dl$lansoprazole oral disintegrating tab  30  mg ; multivitamins w minerals  1  tab ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; oxycodone-acetaminophen elixir  5-10  ml ; trazodone  100  mg ; trazodone  50  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; cyanocobalamin  1000  mcg ; 
other and unspecified hyperlipidemia esophageal reflux surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other postoperative infection bariatric surgery status other chronic nonalcoholic liver disease other b-complex deficiencies morbid obesity cellulitis and abscess of trunk body mass index 50.0-59.9, adult unspecified pruritic disorder incisional ventral hernia with obstruction other and unspecified hyperlipidemia other chronic nonalcoholic liver disease esophageal reflux morbid obesity other b-complex deficiencies 
white m 44 $nan$nan$lansoprazole oral disintegrating tab  30  mg ; multivitamins w minerals  1  tab ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; oxycodone-acetaminophen elixir  5-10  ml ; trazodone  100  mg ; trazodone  50  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 
other and unspecified hyperlipidemia esophageal reflux surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other postoperative infection bariatric surgery status other chronic nonalcoholic liver disease other b-complex deficiencies morbid obesity cellulitis and abscess of trunk body mass index 50.0-59.9, adult unspecified pruritic disorder incisional ventral hernia with obstruction other and unspecified hyperlipidemia other chronic nonalcoholic liver disease esophageal reflux morbid obesity other b-complex deficiencies 
white m 44 $nan$nan$lansoprazole oral disintegrating tab  30  mg ; multivitamins w minerals  1  tab ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; oxycodone-acetaminophen elixir  5-10  ml ; trazodone  100  mg ; trazodone  50  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 
other and unspecified hyperlipidemia esophageal reflux surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other postoperative infection bariatric surgery status other chronic nonalcoholic liver disease other b-complex deficiencies morbid obesity cellulitis and abscess of trunk body mass index 50.0-59.9, adult unspecified pruritic disorder incisional ventral hernia with obstruction other and unspecified hyperlipidemia other chronic nonalcoholic liver disease esophageal reflux morbid obesity other b-complex deficiencies 
white m 44 $nan$nan$lansoprazole oral disintegrating tab  30  mg ; multivitamins w minerals  1  tab ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; oxycodone-acetaminophen elixir  5-10  ml ; trazodone  100  mg ; trazodone  50  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 
other and unspecified hyperlipidemia esophageal reflux surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation other postoperative infection bariatric surgery status other chronic nonalcoholic liver disease other b-complex deficiencies morbid obesity cellulitis and abscess of trunk body mass index 50.0-59.9, adult unspecified pruritic disorder incisional ventral hernia with obstruction other and unspecified hyperlipidemia other chronic nonalcoholic liver disease esophageal reflux morbid obesity other b-complex deficiencies 
white m 37 $nan$nan$senna  1  tab ; multivitamins  1  tab ; oxycodone (immediate release)   10  mg ; 0.9% sodium chloride  1000  ml ; prochlorperazine  10  mg ; morphine sulfate  2-4  mg ; heparin  5000  unit ; ranitidine  150  mg ; docusate sodium  100  mg ; 
alcohol abuse, continuous acute pancreatitis chronic pancreatitis unspecified essential hypertension cyst and pseudocyst of pancreas other constipation hypovolemia alcohol abuse, in remission unspecified essential hypertension chronic pancreatitis other specified cardiac dysrhythmias chronic pancreatitis cyst and pseudocyst of pancreas benign essential hypertension acute pancreatitis duodenitis, without mention of hemorrhage alcohol abuse, in remission acute pancreatitis alcohol abuse, episodic chronic pancreatitis unspecified essential hypertension acute pancreatitis benign essential hypertension chronic pancreatitis other and unspecified alcohol dependence, continuous chronic pancreatitis benign essential hypertension acute pancreatitis other and unspecified alcohol dependence, continuous chronic pancreatitis benign essential hypertension acute pancreatitis alcohol abuse, continuous acute pancreatitis benign essential hypertension tobacco use disorder alcohol abuse, continuous acute pancreatitis unspecified essential hypertension other and unspecified alcohol dependence, continuous chronic pancreatitis acute pancreatitis unspecified essential hypertension 
white m 37 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  280  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  77  mg dl$senna  1  tab ; multivitamins  1  tab ; oxycodone (immediate release)   10  mg ; 0.9% sodium chloride  1000  ml ; prochlorperazine  10  mg ; heparin  5000  unit ; ranitidine  150  mg ; docusate sodium  100  mg ; 
alcohol abuse, continuous acute pancreatitis chronic pancreatitis unspecified essential hypertension cyst and pseudocyst of pancreas other constipation hypovolemia alcohol abuse, in remission unspecified essential hypertension chronic pancreatitis other specified cardiac dysrhythmias chronic pancreatitis cyst and pseudocyst of pancreas benign essential hypertension acute pancreatitis duodenitis, without mention of hemorrhage alcohol abuse, in remission acute pancreatitis alcohol abuse, episodic chronic pancreatitis unspecified essential hypertension acute pancreatitis benign essential hypertension chronic pancreatitis other and unspecified alcohol dependence, continuous chronic pancreatitis benign essential hypertension acute pancreatitis other and unspecified alcohol dependence, continuous chronic pancreatitis benign essential hypertension acute pancreatitis alcohol abuse, continuous acute pancreatitis benign essential hypertension tobacco use disorder alcohol abuse, continuous acute pancreatitis unspecified essential hypertension other and unspecified alcohol dependence, continuous chronic pancreatitis acute pancreatitis unspecified essential hypertension 
white m 64 $nan$nan$amlodipine  10  mg ; psyllium  1  pkt ; metoprolol succinate xl  50  mg ; pravastatin  20  mg ; triamterene-hydrochlorothiazide  1  cap ; valsartan  200  mg ; 
spinal stenosis, lumbar region, without neurogenic claudication esophageal reflux unspecified essential hypertension 
white m 64 $nan$nan$0.9% sodium chloride  100  ml ; amlodipine  10  mg ; psyllium  1  pkt ; metoprolol succinate xl  50  mg ; pravastatin  20  mg ; triamterene-hydrochlorothiazide  1  cap ; valsartan  200  mg ; docusate sodium  100  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; hydromorphone (dilaudid)  0.125  mg ; diazepam  5  mg ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; senna  1  tab ; oxycodone-acetaminophen  1-2  tab ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; milk of magnesia  30  ml ; hydromorphone  20  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 
spinal stenosis, lumbar region, without neurogenic claudication esophageal reflux unspecified essential hypertension 
white m 64 $nan$nan$0.9% sodium chloride  100  ml ; amlodipine  10  mg ; psyllium  1  pkt ; metoprolol succinate xl  50  mg ; pravastatin  20  mg ; triamterene-hydrochlorothiazide  1  cap ; valsartan  200  mg ; docusate sodium  100  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; hydromorphone (dilaudid)  0.125  mg ; diazepam  5  mg ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; senna  1  tab ; oxycodone-acetaminophen  1-2  tab ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; milk of magnesia  30  ml ; hydromorphone  20  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; tramadol (ultram)  50  mg ; 
spinal stenosis, lumbar region, without neurogenic claudication esophageal reflux unspecified essential hypertension 
white m 64 $nan$nan$amlodipine  10  mg ; psyllium  1  pkt ; metoprolol succinate xl  50  mg ; pravastatin  20  mg ; triamterene-hydrochlorothiazide  1  cap ; valsartan  200  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; hydromorphone (dilaudid)  0.125  mg ; diazepam  5  mg ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; senna  1  tab ; oxycodone-acetaminophen  1-2  tab ; milk of magnesia  30  ml ; tramadol (ultram)  50  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
spinal stenosis, lumbar region, without neurogenic claudication esophageal reflux unspecified essential hypertension 
white m 64 $nan$nan$amlodipine  10  mg ; psyllium  1  pkt ; metoprolol succinate xl  50  mg ; pravastatin  20  mg ; triamterene-hydrochlorothiazide  1  cap ; valsartan  200  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.125  mg ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; senna  1  tab ; oxycodone-acetaminophen  1-2  tab ; milk of magnesia  30  ml ; tramadol (ultram)  50  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
spinal stenosis, lumbar region, without neurogenic claudication esophageal reflux unspecified essential hypertension 
white f 75 $temp  98.0  heartrate  72.0  resprate  20.0  o2sat  99.0  sbp  157.0  dbp  74.0  rhythm    pain  0  $hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  402  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  97  mg dl$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; creon 12  2  cap ; cyanocobalamin  100  mcg ; escitalopram oxalate  10  mg ; fluticasone propionate 110mcg  1  puff ; folic acid  1  mg ; loratadine  10  mg ; multivitamins  1  tab ; pyridoxine  50  mg ; vitamin d  2000  unit ; vitamin e  400  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  12  unit ; trazodone  25  mg ; heparin  5000  unit ; calcium carbonate  500  mg ; magnesium oxide  140  mg ; oxybutynin  5  mg ; amlodipine  5  mg ; propranolol la  60  mg ; 
unspecified asthma, uncomplicated urinary tract infection, site not specified hypo-osmolality and hyponatremia hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, stage 4 (severe) pneumonia, unspecified organism abnormal levels of other serum enzymes adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter pneumonitis due to inhalation of food and vomit adverse effect of other antipsychotics and neuroleptics, initial encounter unspecified urinary incontinence unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere unspecified place in hospital as the place of occurrence of the external cause acute kidney failure, unspecified bipolar disorder, unspecified other drug induced movement disorders sepsis due to escherichia coli [e. coli] type 2 diabetes mellitus with diabetic chronic kidney disease hypotension, unspecified other chronic pancreatitis schizophrenia, unspecified pure hypercholesterolemia, unspecified diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled dehydration hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pneumonia, organism unspecified bronchitis, not specified as acute or chronic diabetes with unspecified complication, type ii or unspecified type, not stated as uncontrolled hyposmolality and/or hyponatremia disorders of magnesium metabolism disorder of bone and cartilage, unspecified bipolar disorder, unspecified extrinsic asthma, unspecified chronic kidney disease, stage iv (severe) unspecified schizophrenia, unspecified 
white f 75 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  375  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  127  mg dl$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; creon 12  2  cap ; cyanocobalamin  100  mcg ; escitalopram oxalate  10  mg ; fluticasone propionate 110mcg  1  puff ; folic acid  1  mg ; loratadine  10  mg ; multivitamins  1  tab ; pyridoxine  50  mg ; vitamin d  2000  unit ; vitamin e  400  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  12  unit ; trazodone  25  mg ; heparin  5000  unit ; calcium carbonate  500  mg ; magnesium oxide  140  mg ; oxybutynin  5  mg ; amlodipine  5  mg ; propranolol la  60  mg ; 
unspecified asthma, uncomplicated urinary tract infection, site not specified hypo-osmolality and hyponatremia hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, stage 4 (severe) pneumonia, unspecified organism abnormal levels of other serum enzymes adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter pneumonitis due to inhalation of food and vomit adverse effect of other antipsychotics and neuroleptics, initial encounter unspecified urinary incontinence unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere unspecified place in hospital as the place of occurrence of the external cause acute kidney failure, unspecified bipolar disorder, unspecified other drug induced movement disorders sepsis due to escherichia coli [e. coli] type 2 diabetes mellitus with diabetic chronic kidney disease hypotension, unspecified other chronic pancreatitis schizophrenia, unspecified pure hypercholesterolemia, unspecified diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled dehydration hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pneumonia, organism unspecified bronchitis, not specified as acute or chronic diabetes with unspecified complication, type ii or unspecified type, not stated as uncontrolled hyposmolality and/or hyponatremia disorders of magnesium metabolism disorder of bone and cartilage, unspecified bipolar disorder, unspecified extrinsic asthma, unspecified chronic kidney disease, stage iv (severe) unspecified schizophrenia, unspecified 
white f 75 $nan$nan$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; creon 12  2  cap ; cyanocobalamin  100  mcg ; escitalopram oxalate  10  mg ; fluticasone propionate 110mcg  1  puff ; folic acid  1  mg ; loratadine  10  mg ; multivitamins  1  tab ; pyridoxine  50  mg ; vitamin d  2000  unit ; vitamin e  400  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  12  unit ; trazodone  25  mg ; heparin  5000  unit ; calcium carbonate  500  mg ; magnesium oxide  140  mg ; oxybutynin  5  mg ; amlodipine  5  mg ; propranolol la  60  mg ; 
unspecified asthma, uncomplicated urinary tract infection, site not specified hypo-osmolality and hyponatremia hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, stage 4 (severe) pneumonia, unspecified organism abnormal levels of other serum enzymes adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter pneumonitis due to inhalation of food and vomit adverse effect of other antipsychotics and neuroleptics, initial encounter unspecified urinary incontinence unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere unspecified place in hospital as the place of occurrence of the external cause acute kidney failure, unspecified bipolar disorder, unspecified other drug induced movement disorders sepsis due to escherichia coli [e. coli] type 2 diabetes mellitus with diabetic chronic kidney disease hypotension, unspecified other chronic pancreatitis schizophrenia, unspecified pure hypercholesterolemia, unspecified diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled dehydration hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pneumonia, organism unspecified bronchitis, not specified as acute or chronic diabetes with unspecified complication, type ii or unspecified type, not stated as uncontrolled hyposmolality and/or hyponatremia disorders of magnesium metabolism disorder of bone and cartilage, unspecified bipolar disorder, unspecified extrinsic asthma, unspecified chronic kidney disease, stage iv (severe) unspecified schizophrenia, unspecified 
hispanic latino f 50 $temp  98.5  heartrate  106.0  resprate  24.0  o2sat  95.0  sbp  131.0  dbp  75.0  rhythm  sinus tachycardia  pain  sleeping  $hematology blood inr(pt)  1.6  ; hematology urine wbc  1  # hpf$5% dextrose  250  ml ; heparin  1100-2200  unit ; heparin sodium  25,000  unit ; ondansetron  8  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  1000  ml ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; omeprazole  20  mg ; simvastatin  5  mg ; tramadol (ultram)  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  1100-2300  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; enoxaparin sodium  60  mg ; 
 
hispanic latino f 50 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  148  mg dl$ondansetron  8  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  1000  ml ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; omeprazole  20  mg ; tramadol (ultram)  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; enoxaparin sodium  60  mg ; phosphorus  500  mg ; ibuprofen  400  mg ; docusate sodium  100  mg ; senna  8.6  mg ; 
 
hispanic latino f 50 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  132  mg dl; chemistry blood lactate dehydrogenase (ld)  309  iu l$influenza vaccine quadrivalent  0.5  ml ; omeprazole  20  mg ; tramadol (ultram)  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; enoxaparin sodium  60  mg ; phosphorus  500  mg ; docusate sodium  100  mg ; senna  8.6  mg ; levofloxacin  750  mg ; 
 
white f 33 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; oxycodone (immediate release)   5-10  mg ; ranitidine  75  mg ; 
outcome of delivery, single liveborn motorcycle driver injured in collision with fixed or stationary object in nontraffic accident maternal pyrexia during labor, unspecified, delivered, with or without mention of antepartum condition post term pregnancy, delivered, with or without mention of antepartum condition second-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 33 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; oxycodone (immediate release)   5-10  mg ; ranitidine  75  mg ; oxazepam  10  mg ; 
outcome of delivery, single liveborn motorcycle driver injured in collision with fixed or stationary object in nontraffic accident maternal pyrexia during labor, unspecified, delivered, with or without mention of antepartum condition post term pregnancy, delivered, with or without mention of antepartum condition second-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 33 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; oxycodone (immediate release)   5-10  mg ; ranitidine  75  mg ; oxazepam  10  mg ; 
outcome of delivery, single liveborn motorcycle driver injured in collision with fixed or stationary object in nontraffic accident maternal pyrexia during labor, unspecified, delivered, with or without mention of antepartum condition post term pregnancy, delivered, with or without mention of antepartum condition second-degree perineal laceration, delivered, with or without mention of antepartum condition 
white m 20 $temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  c  ; temp  98.0  heartrate  94.0  resprate  18.0  o2sat  93.0  sbp  150.0  dbp  72.0  rhythm    pain  5  ; temp  98.4  heartrate  101.0  resprate  18.0  o2sat  99.0  sbp  152.0  dbp  96.0  rhythm    pain  3  ; temp    heartrate  105.0  resprate  13.0  o2sat  99.0  sbp  128.0  dbp  90.0  rhythm    pain    ; temp  98.0  heartrate  90.0  resprate  19.0  o2sat  98.0  sbp  144.0  dbp  92.0  rhythm    pain  4  $hematology blood hematocrit  44.1  %; hematology blood hemoglobin  15.3  g dl; hematology blood platelet count  322  k ul; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.3  ; hematology urine wbc  0  # hpf; blood gas blood lactate  1.8  mmol l; blood gas blood chloride, whole blood  109  meq l; blood gas blood glucose  143  mg dl; blood gas blood potassium, whole blood  3.6  meq l; blood gas blood sodium, whole blood  139  meq l; blood gas blood calculated bicarbonate, whole blood  21  meq l; blood gas blood creatinine, whole blood  1.0  mg dl$nan
 
white m 20 $temp  98.2  heartrate  98.0  resprate  14.0  o2sat  99.0  sbp  146.0  dbp  69.0  rhythm    pain  3  $hematology blood hematocrit  44.9  %; hematology blood hemoglobin  15.3  g dl; hematology blood platelet count  295  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  10.3  mg dl; chemistry blood glucose  109  mg dl$sodium chloride 0.9%  flush  3-10  ml ; tramadol  50  mg ; acetaminophen  325-650  mg ; heparin  5000  unit ; 
 
white m 20 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; tramadol  50  mg ; acetaminophen  325-650  mg ; heparin  5000  unit ; 
 
white m 20 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; tramadol  50  mg ; acetaminophen  325-650  mg ; heparin  5000  unit ; 
 
white m 20 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; tramadol  50  mg ; acetaminophen  325-650  mg ; heparin  5000  unit ; 
 
unknown f 53 $nan$nan$soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; insulin  10  unit ; calcium chloride  1  gm ; 
 
unknown f 53 $nan$hematology blood hematocrit  32.0  %; hematology blood hematocrit  32.9  %; hematology blood hemoglobin  10.6  g dl; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  405  k ul; hematology blood platelet count  418  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood potassium  5.1  meq l; chemistry blood potassium  5.2  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  246  mg dl; chemistry blood glucose  127  mg dl; chemistry blood glucose  186  mg dl; chemistry blood glucose  177  mg dl; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.19  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  0.7  mmol l; blood gas blood glucose  129  mg dl; blood gas blood glucose  187  mg dl; blood gas blood glucose  151  mg dl; blood gas blood glucose  175  mg dl; blood gas blood potassium, whole blood  4.4  meq l$soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; insulin  10  unit ; calcium chloride  1  gm ; sodium chloride 0.9%  flush  10  ml ; fentanyl citrate  25-100  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; dextrose 50%  25  gm ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; sodium chloride 0.9%  1000  ml ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; famotidine  20  mg ; lactated ringers  1000  ml ; heparin  5000  unit ; d5 1 2ns  1000  ml ; 0.45% sodium chloride  1000  ml ; iso-osmotic sodium chloride  1  bag ; soln  100  ml ; acetaminophen iv  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 
 
unknown f 53 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  435  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  129  mg dl; chemistry blood glucose  210  mg dl; blood gas blood free calcium  1.25  mmol l; blood gas blood glucose  208  mg dl$sodium chloride 0.9%  flush  10  ml ; fentanyl citrate  25-100  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; heparin  5000  unit ; 0.45% sodium chloride  1000  ml ; iso-osmotic sodium chloride  1  bag ; soln  100  ml ; acetaminophen iv  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; docusate sodium  100  mg ; neutra-phos  1  pkt ; 
 
unknown f 53 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  420  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology urine wbc  9  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  172  mg dl; chemistry blood glucose  218  mg dl; hematology blood bands  2  %; hematology urine glucose  100  mg dl; hematology blood wbc count  12.8  k ul; hematology urine wbc casts  1  # lpf; chemistry blood % hemoglobin a1c  6.5  %$sodium chloride 0.9%  flush  10  ml ; fentanyl citrate  25-100  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; iso-osmotic sodium chloride  1  bag ; soln  100  ml ; acetaminophen iv  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; docusate sodium  100  mg ; neutra-phos  1  pkt ; propofol  1000  mg ; nystatin oral suspension  5  ml ; neutra-phos  2  pkt ; miconazole nitrate (combo pack)  1  supp ; ns syringe (intrapleural)  40  ml ; alteplase  10  mg ; syringe (sterile water)  30  ml ; dornase alfa  5  mg ; 
 
unknown f 53 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  401  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  204  mg dl$sodium chloride 0.9%  flush  10  ml ; fentanyl citrate  25-100  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; soln  100  ml ; acetaminophen iv  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; docusate sodium  100  mg ; propofol  1000  mg ; nystatin oral suspension  5  ml ; neutra-phos  2  pkt ; miconazole nitrate (combo pack)  1  supp ; ns syringe (intrapleural)  40  ml ; alteplase  10  mg ; syringe (sterile water)  30  ml ; dornase alfa  5  mg ; furosemide  20  mg ; insulin human regular  100  unit ; piperacillin-tazobactam  4.5  g ; 
 
unknown f 53 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  414  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  173  mg dl; chemistry blood albumin  2.3  g dl; blood gas blood free calcium  1.34  mmol l; blood gas blood glucose  191  mg dl; blood gas blood potassium, whole blood  4.5  meq l$sodium chloride 0.9%  flush  10  ml ; fentanyl citrate  25-100  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; soln  100  ml ; acetaminophen iv  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; docusate sodium  100  mg ; propofol  1000  mg ; nystatin oral suspension  5  ml ; miconazole nitrate (combo pack)  1  supp ; furosemide  20  mg ; piperacillin-tazobactam  4.5  g ; bisacodyl  10  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; milk of magnesia  30  ml ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; fleet enema  1  enema ; 
 
unknown f 53 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  379  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  141  mg dl; blood gas blood free calcium  1.32  mmol l; blood gas blood glucose  136  mg dl$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; soln  100  ml ; acetaminophen iv  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; docusate sodium  100  mg ; nystatin oral suspension  5  ml ; miconazole nitrate (combo pack)  1  supp ; bisacodyl  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; milk of magnesia  30  ml ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; fleet enema  1  enema ; scopolamine patch  1  ptch ; haloperidol  2.5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; lactulose  45  ml ; phosphorus  500  mg ; 
 
unknown f 53 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  418  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  58  mg dl; blood gas blood free calcium  1.26  mmol l; blood gas blood glucose  61  mg dl$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; soln  100  ml ; acetaminophen iv  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; docusate sodium  100  mg ; nystatin oral suspension  5  ml ; bisacodyl  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; milk of magnesia  30  ml ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; scopolamine patch  1  ptch ; haloperidol  2.5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; lactulose  45  ml ; phosphorus  500  mg ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  2  neb ; albuterol 0.083% neb soln  1  neb ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; lorazepam  0.5  mg ; 
 
unknown f 53 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  394  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  flush  10  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; docusate sodium  100  mg ; nystatin oral suspension  5  ml ; bisacodyl  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; milk of magnesia  30  ml ; hydromorphone (dilaudid)  0.5-1  mg ; lactulose  45  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; lorazepam  0.5  mg ; acetaminophen  1000  mg ; hydromorphone (dilaudid)  2-4  mg ; trazodone  100  mg ; insulin  20  unit ; sodium chloride 0.9%  flush  3  ml ; prazosin  1  mg ; risperidone  4  mg ; simvastatin  20  mg ; lisinopril  2.5  mg ; venlafaxine xr  300  mg ; 
 
unknown f 53 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; docusate sodium  100  mg ; nystatin oral suspension  5  ml ; bisacodyl  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; milk of magnesia  30  ml ; lactulose  45  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; sodium chloride 0.9%  flush  3  ml ; ranitidine  150  mg ; 
 
unknown f 53 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  433  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  139  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; docusate sodium  100  mg ; nystatin oral suspension  5  ml ; bisacodyl  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; milk of magnesia  30  ml ; lactulose  45  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; sodium chloride 0.9%  flush  3  ml ; ranitidine  150  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; 
 
unknown f 53 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; nystatin oral suspension  5  ml ; bisacodyl  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; milk of magnesia  30  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; sodium chloride 0.9%  flush  3  ml ; ranitidine  150  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; omeprazole  40  mg ; metformin (glucophage)  500  mg ; 
 
white m 80 $nan$nan$aspirin  325  mg ; 
 
white m 80 $nan$hematology blood hematocrit  40.6  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  184  k ul; chemistry blood % hemoglobin a1c  5.7  %$aspirin  325  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; mirtazapine  15  mg ; 
 
white m 80 $nan$nan$aspirin  325  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; 
 
white m 80 $nan$nan$aspirin  325  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; 
 
white f 56 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  103  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.5  ; chemistry urine creatinine, urine  51  mg dl; chemistry urine sodium, urine  47  meq l; chemistry urine urea nitrogen, urine  523  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  7.2  mg dl; chemistry blood glucose  79  mg dl; chemistry blood glucose  85  mg dl; chemistry blood lactate dehydrogenase (ld)  2493  iu l$influenza virus vaccine  0.5  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; ns  1000  ml ; loperamide  2  mg ; pantoprazole  40  mg ; acetaminophen  325  mg ; oxycodone-acetaminophen  1  tab ; phytonadione  5  mg ; heparin  5000  unit ; cholestyramine  4  gm ; hydrocortisone acetate ointment 1%  1  appl ; oxycodone (immediate release)   5-10  mg ; nystatin oral suspension  5  ml ; sw  100  ml ; magnesium sulfate  4  gm ; 
unspecified essential hypertension stomatitis and mucositis, unspecified dehydration antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use nausea with vomiting pancytopenia diarrhea diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled bacteremia malignant neoplasm of intrahepatic bile ducts
white f 56 $nan$hematology blood hematocrit  30.4  %; hematology blood hematocrit  31.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  48  k ul; hematology blood platelet count  40  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  6.9  mg dl; chemistry blood bilirubin, total  7.6  mg dl; chemistry blood glucose  132  mg dl; chemistry blood lactate dehydrogenase (ld)  2312  iu l; chemistry blood albumin  1.3  g dl$ns  500  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam na  4.5  g ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; loperamide  2  mg ; pantoprazole  40  mg ; acetaminophen  325  mg ; phytonadione  5  mg ; heparin  5000  unit ; cholestyramine  4  gm ; hydrocortisone acetate ointment 1%  1  appl ; oxycodone (immediate release)   5-10  mg ; nystatin oral suspension  5  ml ; sw  100  ml ; magnesium sulfate  4  gm ; acetylcysteine 20%  600  mg ; lorazepam  0.25  mg ; furosemide  20  mg ; heparin flush hickman (100 units ml)  2  ml ; vial  1  vial ; epoetin alfa  10,000  unit ; heparin flush port (10 units ml)  5  ml ; 
unspecified essential hypertension stomatitis and mucositis, unspecified dehydration antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use nausea with vomiting pancytopenia diarrhea diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled bacteremia malignant neoplasm of intrahepatic bile ducts
white f 56 $nan$hematology blood hematocrit  31.6  %; hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  65  k ul; hematology blood platelet count  31  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.7  ; chemistry urine creatinine, urine  73  mg dl; chemistry urine sodium, urine  36  meq l; chemistry urine urea nitrogen, urine  512  mg dl; hematology urine wbc  18  # hpf; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  8.3  mg dl; chemistry blood bilirubin, total  8.5  mg dl; chemistry blood glucose  167  mg dl; chemistry blood glucose  170  mg dl; chemistry blood lactate dehydrogenase (ld)  2131  iu l; chemistry blood lactate dehydrogenase (ld)  2304  iu l; chemistry blood albumin  1.3  g dl; chemistry blood albumin  1.6  g dl$ns  500  ml ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; loperamide  2  mg ; pantoprazole  40  mg ; acetaminophen  325  mg ; cholestyramine  4  gm ; hydrocortisone acetate ointment 1%  1  appl ; oxycodone (immediate release)   5-10  mg ; nystatin oral suspension  5  ml ; lorazepam  0.25  mg ; furosemide  20  mg ; heparin flush hickman (100 units ml)  2  ml ; vial  1  vial ; epoetin alfa  10,000  unit ; heparin flush port (10 units ml)  5  ml ; sarna lotion  1  appl ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride nasal  1-2  spry ; pantoprazole sodium  40  mg ; ns  250  ml ; fentanyl citrate  2.5  mg ; ns  100  ml ; midazolam  100  mg ; 
unspecified essential hypertension stomatitis and mucositis, unspecified dehydration antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use nausea with vomiting pancytopenia diarrhea diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled bacteremia malignant neoplasm of intrahepatic bile ducts
white f 56 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  35  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.8  ; chemistry urine creatinine, urine  77  mg dl; chemistry urine sodium, urine  35  meq l; chemistry urine urea nitrogen, urine  472  mg dl; hematology urine wbc  135  # hpf; chemistry blood bilirubin, total  9.7  mg dl; chemistry blood glucose  207  mg dl; chemistry blood lactate dehydrogenase (ld)  3348  iu l; chemistry blood albumin  1.9  g dl; blood gas blood lactate  8.2  mmol l; blood gas blood lactate  8.0  mmol l$insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; loperamide  2  mg ; acetaminophen  325  mg ; cholestyramine  4  gm ; hydrocortisone acetate ointment 1%  1  appl ; nystatin oral suspension  5  ml ; heparin flush hickman (100 units ml)  2  ml ; vial  1  vial ; epoetin alfa  10,000  unit ; heparin flush port (10 units ml)  5  ml ; sarna lotion  1  appl ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride nasal  1-2  spry ; pantoprazole sodium  40  mg ; ns  250  ml ; fentanyl citrate  2.5  mg ; ns  100  ml ; midazolam  100  mg ; d5w  250  ml ; phenylephrine  60  mg ; albumin 5% (12.5g   250ml)  25  gm ; ciprofloxacin  400  mg ; hydrocortisone na succ.  50  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; norepinephrine  8  mg ; d5w  100  ml ; morphine sulfate  100  mg ; 
unspecified essential hypertension stomatitis and mucositis, unspecified dehydration antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use nausea with vomiting pancytopenia diarrhea diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled bacteremia malignant neoplasm of intrahepatic bile ducts
white f 56 $nan$nan$d5w  100  ml ; morphine sulfate  100  mg ; 
unspecified essential hypertension stomatitis and mucositis, unspecified dehydration antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use nausea with vomiting pancytopenia diarrhea diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled bacteremia malignant neoplasm of intrahepatic bile ducts
white m 63 $temp  97.1  heartrate  60.0  resprate  15.0  o2sat  96.0  sbp  107.0  dbp  52.0  rhythm  sinus rhythm  pain  0  ; temp  98.7  heartrate  52.0  resprate  14.0  o2sat  97.0  sbp  105.0  dbp  63.0  rhythm  sinus rhythm  pain  0  ; temp  98.2  heartrate  48.0  resprate  12.0  o2sat  97.0  sbp  103.0  dbp  54.0  rhythm  sinus bradycardia  pain  0  $hematology blood hematocrit  32.9  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  142  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  83  mg dl; chemistry blood glucose  125  mg dl; blood gas blood lactate  1.1  mmol l$influenza vaccine quadrivalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  10  unit ; diazepam  5  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; heparin  5000  unit ; clonidine  0.1  mg ; alprazolam  1  mg ; sodium chloride 0.9%  flush  3  ml ; amlodipine  10  mg ; chlorthalidone  37.5  mg ; gabapentin  600  mg ; metoprolol succinate xl  25  mg ; simvastatin  20  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension cellulitis and abscess of leg, except foot other, mixed, or unspecified drug abuse, unspecified ulcer of calf pneumonia, organism unspecified unspecified viral hepatitis c without hepatic coma long-term (current) use of insulin poisoning by analgesics, antipyretics, and antirheumatics, undetermined whether accidentally or purposely inflicted other specified cardiac dysrhythmias poisoning by opium (alkaloids), unspecified 
white m 63 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  165  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  84  mg dl$influenza vaccine quadrivalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; clonidine  0.1  mg ; alprazolam  1  mg ; sodium chloride 0.9%  flush  3  ml ; amlodipine  10  mg ; chlorthalidone  37.5  mg ; gabapentin  600  mg ; metoprolol succinate xl  25  mg ; simvastatin  20  mg ; aspirin  81  mg ; lisinopril  5  mg ; methadone  20  mg ; levofloxacin  750  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension cellulitis and abscess of leg, except foot other, mixed, or unspecified drug abuse, unspecified ulcer of calf pneumonia, organism unspecified unspecified viral hepatitis c without hepatic coma long-term (current) use of insulin poisoning by analgesics, antipyretics, and antirheumatics, undetermined whether accidentally or purposely inflicted other specified cardiac dysrhythmias poisoning by opium (alkaloids), unspecified 
white f 24 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; calcium carbonate  500  mg ; simethicone  80  mg ; oxycodone (immediate release)   5-10  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; acetaminophen w codeine  1-2  tab ; codeine sulfate  60  mg ; 
 
white f 24 $nan$hematology blood hematocrit  34.0  %$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; calcium carbonate  500  mg ; simethicone  80  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; acetaminophen w codeine  1-2  tab ; codeine sulfate  60  mg ; prochlorperazine  10  mg ; 
 
white f 24 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; calcium carbonate  500  mg ; simethicone  80  mg ; acetaminophen w codeine  1-2  tab ; prochlorperazine  10  mg ; 
 
white f 56 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  117  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; ibuprofen  600  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  0.125  mg ; ketorolac  15  mg ; 
 
white f 56 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  106  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; ibuprofen  600  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  0.125  mg ; ketorolac  15  mg ; docusate sodium  100  mg ; 
 
white f 56 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; ibuprofen  600  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  0.125  mg ; ketorolac  15  mg ; docusate sodium  100  mg ; 
 
white m 69 $nan$nan$aspirin  325  mg ; clopidogrel  75  mg ; atorvastatin  40  mg ; diltiazem extended-release  120  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; 
old myocardial infarction personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension backache, unspecified arthropathy, unspecified, site unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atherosclerosis of native arteries of the extremities with intermittent claudication retention of urine, unspecified gout, unspecified diabetes mellitus without mention of complication, type i [juvenile type], not stated as uncontrolled unspecified essential hypertension cellulitis and abscess of leg, except foot disruption of external operation (surgical) wound infected postoperative seroma surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation person on outside of bus injured in collision with pedestrian or animal in traffic accident personal history of tobacco use tachycardia, unspecified ulcer of other part of foot diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atherosclerosis of native arteries of the extremities with gangrene examination of participant in clinical trial acute kidney failure, unspecified other specified antibiotics causing adverse effects in therapeutic use unspecified essential hypertension coronary atherosclerosis of native coronary artery pure hypercholesterolemia subendocardial infarction, initial episode of care chronic total occlusion of artery of the extremities old myocardial infarction coronary atherosclerosis of native coronary artery atherosclerosis of native arteries of the extremities with rest pain unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled foot amputation status gout, unspecified old myocardial infarction arthropathy, unspecified, site unspecified atherosclerosis of native arteries of the extremities with rest pain surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension gout, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled great toe amputation status hematoma complicating a procedure coronary atherosclerosis of native coronary artery chronic total occlusion of artery of the extremities old myocardial infarction
white m 69 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  119  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  123  mg dl$aspirin  325  mg ; clopidogrel  75  mg ; atorvastatin  40  mg ; diltiazem extended-release  120  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.5  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; metoprolol tartrate  100  mg ; 
old myocardial infarction personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension backache, unspecified arthropathy, unspecified, site unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atherosclerosis of native arteries of the extremities with intermittent claudication retention of urine, unspecified gout, unspecified diabetes mellitus without mention of complication, type i [juvenile type], not stated as uncontrolled unspecified essential hypertension cellulitis and abscess of leg, except foot disruption of external operation (surgical) wound infected postoperative seroma surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation person on outside of bus injured in collision with pedestrian or animal in traffic accident personal history of tobacco use tachycardia, unspecified ulcer of other part of foot diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atherosclerosis of native arteries of the extremities with gangrene examination of participant in clinical trial acute kidney failure, unspecified other specified antibiotics causing adverse effects in therapeutic use unspecified essential hypertension coronary atherosclerosis of native coronary artery pure hypercholesterolemia subendocardial infarction, initial episode of care chronic total occlusion of artery of the extremities old myocardial infarction coronary atherosclerosis of native coronary artery atherosclerosis of native arteries of the extremities with rest pain unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled foot amputation status gout, unspecified old myocardial infarction arthropathy, unspecified, site unspecified atherosclerosis of native arteries of the extremities with rest pain surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension gout, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled great toe amputation status hematoma complicating a procedure coronary atherosclerosis of native coronary artery chronic total occlusion of artery of the extremities old myocardial infarction
hispanic latino f 69 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)   5  mg ; ibuprofen  400  mg ; atenolol  25  mg ; amlodipine  5  mg ; losartan potassium  100  mg ; 
 
hispanic latino f 69 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  1000  mg ; docusate sodium  100  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)   5  mg ; ibuprofen  400  mg ; atenolol  25  mg ; amlodipine  5  mg ; losartan potassium  100  mg ; nitrofurantoin monohyd (macrobid)  100  mg ; 
 
white m 57 $nan$hematology blood hematocrit  41.8  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  237  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  2.9  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; gabapentin  600  mg ; oxycodone-acetaminophen  1  tab ; trazodone  25  mg ; methadone  20  mg ; folic acid  1  mg ; omeprazole  20  mg ; paroxetine  20  mg ; quetiapine fumarate  100  mg ; vitamin b complex  1  cap ; fondaparinux sodium  10  mg ; oxycodone (immediate release)   10  mg ; warfarin  5  mg ; oxycodone (immediate release)   5  mg ; tizanidine  2  mg ; tizanidine  4  mg ; docusate sodium  100  mg ; 
 
white m 57 $nan$hematology blood hematocrit  42.6  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  3.5  ; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  flush  3  ml ; gabapentin  600  mg ; trazodone  25  mg ; methadone  20  mg ; folic acid  1  mg ; omeprazole  20  mg ; paroxetine  20  mg ; quetiapine fumarate  100  mg ; vitamin b complex  1  cap ; fondaparinux sodium  10  mg ; oxycodone (immediate release)   10  mg ; warfarin  5  mg ; oxycodone (immediate release)   5  mg ; tizanidine  4  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; 0.9% sodium chloride  1000  ml ; warfarin  3  mg ; 
 
white m 57 $nan$hematology blood hematocrit  36.3  %; hematology blood hematocrit  33.7  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  242  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; gabapentin  600  mg ; trazodone  25  mg ; methadone  20  mg ; folic acid  1  mg ; omeprazole  20  mg ; paroxetine  20  mg ; quetiapine fumarate  100  mg ; vitamin b complex  1  cap ; fondaparinux sodium  10  mg ; oxycodone (immediate release)   10  mg ; tizanidine  4  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; 0.9% sodium chloride  1000  ml ; warfarin  3  mg ; 
 
white m 57 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  210  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  113  mg dl$sodium chloride 0.9%  flush  3  ml ; methadone  20  mg ; folic acid  1  mg ; omeprazole  20  mg ; paroxetine  20  mg ; quetiapine fumarate  100  mg ; vitamin b complex  1  cap ; fondaparinux sodium  10  mg ; oxycodone (immediate release)   10  mg ; tizanidine  4  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; 
 
white m 57 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  227  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  120  mg dl; chemistry blood albumin  4.2  g dl$sodium chloride 0.9%  flush  3  ml ; methadone  20  mg ; folic acid  1  mg ; omeprazole  20  mg ; paroxetine  20  mg ; quetiapine fumarate  100  mg ; vitamin b complex  1  cap ; fondaparinux sodium  10  mg ; oxycodone (immediate release)   10  mg ; tizanidine  4  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; cosyntropin  250  mcg ; bag  50  ml ; magnesium sulfate  2  gm ; prednisone  10  mg ; 
 
white m 57 $nan$hematology blood hematocrit  35.9  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  203  k ul; hematology blood inr(pt)  2.1  ; chemistry blood albumin  4.4  g dl$sodium chloride 0.9%  flush  3  ml ; methadone  20  mg ; folic acid  1  mg ; omeprazole  20  mg ; paroxetine  20  mg ; quetiapine fumarate  100  mg ; vitamin b complex  1  cap ; fondaparinux sodium  10  mg ; oxycodone (immediate release)   10  mg ; tizanidine  4  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; cosyntropin  250  mcg ; bag  50  ml ; magnesium sulfate  2  gm ; prednisone  10  mg ; prednisone  7.5  mg ; 
 
white m 76 $nan$hematology blood inr(pt)  1.8  $acetaminophen  650  mg ; docusate sodium  100  mg ; heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; morphine sulfate  1-2  mg ; tramadol (ultram)  25  mg ; senna  17.2  mg ; metoprolol tartrate  5  mg ; warfarin  6  mg ; 
 
white f 86 $temp  99.6  heartrate  69.0  resprate  29.0  o2sat  93.0  sbp  103.0  dbp  33.0  rhythm    pain  0  $hematology blood hematocrit  34.8  %; hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  211  k ul; hematology blood platelet count  154  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  25  meq l; chemistry blood anion gap  30  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood bicarbonate  6  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  3.4  mg dl; chemistry blood creatinine  3.5  mg dl; chemistry blood creatinine  3.6  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood potassium  5.0  meq l; chemistry blood potassium  9.0  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  63  mg dl; chemistry blood urea nitrogen  69  mg dl; chemistry blood urea nitrogen  76  mg dl; hematology blood inr(pt)  1.9  ; hematology blood inr(pt)  2.3  ; hematology blood inr(pt)  10.3  ; chemistry urine creatinine, urine  102  mg dl; chemistry urine urea nitrogen, urine  402  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  2.4  mg dl; chemistry blood glucose  158  mg dl; chemistry blood glucose  225  mg dl; chemistry blood glucose  246  mg dl; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  8.7  mmol l; blood gas blood lactate  11.7  mmol l; blood gas blood lactate  4.9  mmol l; blood gas blood potassium, whole blood  5.6  meq l; blood gas blood potassium, whole blood  5.4  meq l$sw  400  ml ; bag  1  bag ; kcentra*  2875  units ; sodium chloride 0.9%  flush  3-10  ml ; albumin 25% (12.5g   50ml)  50  g ; acetaminophen  500  mg ; aspirin ec  81  mg ; sertraline  25  mg ; amiodarone  200  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; omeprazole  20  mg ; senna  8.6  mg ; 0.9% sodium chloride  50  ml ; thiamine  200  mg ; heparin  5000  unit ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; 0.9% sodium chloride  0  bag ; calcium gluconate  0  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; lorazepam  1  mg ; hydromorphone (dilaudid)  0.25  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
ventricular premature depolarization hypotension due to drugs major depressive disorder, single episode, unspecified acute on chronic diastolic (congestive) heart failure adverse effect of peripheral vasodilators, initial encounter thrombocytopenia, unspecified hyperlipidemia, unspecified alkalosis unspecified atrial fibrillation acute kidney failure, unspecified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypertensive heart disease with heart failure nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] patient room in hospital as the place of occurrence of the external cause fever, unspecified acute respiratory distress rheumatic disorders of both mitral and tricuspid valves cardiogenic shock chronic obstructive pulmonary disease, unspecified other postprocedural complications and disorders of the circulatory system, not elsewhere classified acute posthemorrhagic anemia personal history of pulmonary embolism
white f 86 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  110  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  3.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  77  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  2.2  mg dl; chemistry blood glucose  112  mg dl; chemistry blood lactate dehydrogenase (ld)  971  iu l; blood gas blood lactate  1.8  mmol l$sw  400  ml ; bag  1  bag ; kcentra*  2875  units ; sodium chloride 0.9%  flush  3-10  ml ; albumin 25% (12.5g   50ml)  50  g ; acetaminophen  500  mg ; aspirin ec  81  mg ; sertraline  25  mg ; amiodarone  200  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; omeprazole  20  mg ; senna  8.6  mg ; 0.9% sodium chloride  50  ml ; thiamine  200  mg ; heparin  5000  unit ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; 0.9% sodium chloride  0  bag ; calcium gluconate  0  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; lorazepam  1  mg ; hydromorphone (dilaudid)  0.25  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  1100-2300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; sodium bicarbonate  650  mg ; 
ventricular premature depolarization hypotension due to drugs major depressive disorder, single episode, unspecified acute on chronic diastolic (congestive) heart failure adverse effect of peripheral vasodilators, initial encounter thrombocytopenia, unspecified hyperlipidemia, unspecified alkalosis unspecified atrial fibrillation acute kidney failure, unspecified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypertensive heart disease with heart failure nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] patient room in hospital as the place of occurrence of the external cause fever, unspecified acute respiratory distress rheumatic disorders of both mitral and tricuspid valves cardiogenic shock chronic obstructive pulmonary disease, unspecified other postprocedural complications and disorders of the circulatory system, not elsewhere classified acute posthemorrhagic anemia personal history of pulmonary embolism
white f 86 $nan$hematology blood hematocrit  26.3  %; hematology blood hematocrit  26.5  %; hematology blood hematocrit  28.9  %; hematology blood hematocrit  27.1  %; hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  80  k ul; hematology blood platelet count  89  k ul; hematology blood platelet count  85  k ul; hematology blood platelet count  86  k ul; hematology blood platelet count  88  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  73  mg dl; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  91  mg dl; chemistry blood lactate dehydrogenase (ld)  625  iu l; chemistry blood lactate dehydrogenase (ld)  563  iu l; chemistry blood lactate dehydrogenase (ld)  492  iu l; chemistry blood albumin  3.3  g dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500  mg ; aspirin ec  81  mg ; sertraline  25  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; omeprazole  20  mg ; senna  8.6  mg ; 0.9% sodium chloride  50  ml ; thiamine  200  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  1100-2300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; sodium bicarbonate  650  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; 0.45% sodium chloride  1000  ml ; 
ventricular premature depolarization hypotension due to drugs major depressive disorder, single episode, unspecified acute on chronic diastolic (congestive) heart failure adverse effect of peripheral vasodilators, initial encounter thrombocytopenia, unspecified hyperlipidemia, unspecified alkalosis unspecified atrial fibrillation acute kidney failure, unspecified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypertensive heart disease with heart failure nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] patient room in hospital as the place of occurrence of the external cause fever, unspecified acute respiratory distress rheumatic disorders of both mitral and tricuspid valves cardiogenic shock chronic obstructive pulmonary disease, unspecified other postprocedural complications and disorders of the circulatory system, not elsewhere classified acute posthemorrhagic anemia personal history of pulmonary embolism
white f 86 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  89  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  57  mg dl; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  137  mg dl; chemistry blood glucose  96  mg dl; chemistry blood lactate dehydrogenase (ld)  358  iu l; chemistry blood albumin  3.3  g dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500  mg ; aspirin ec  81  mg ; sertraline  25  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; omeprazole  20  mg ; senna  8.6  mg ; 0.9% sodium chloride  50  ml ; thiamine  200  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  1100-2300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; sodium bicarbonate  650  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; 0.45% sodium chloride  1000  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 5% dextrose  50  ml ; phytonadione  10  mg ; 
ventricular premature depolarization hypotension due to drugs major depressive disorder, single episode, unspecified acute on chronic diastolic (congestive) heart failure adverse effect of peripheral vasodilators, initial encounter thrombocytopenia, unspecified hyperlipidemia, unspecified alkalosis unspecified atrial fibrillation acute kidney failure, unspecified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypertensive heart disease with heart failure nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] patient room in hospital as the place of occurrence of the external cause fever, unspecified acute respiratory distress rheumatic disorders of both mitral and tricuspid valves cardiogenic shock chronic obstructive pulmonary disease, unspecified other postprocedural complications and disorders of the circulatory system, not elsewhere classified acute posthemorrhagic anemia personal history of pulmonary embolism
white f 86 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  80  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  1.7  mg dl; chemistry blood glucose  99  mg dl; chemistry blood glucose  108  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500  mg ; aspirin ec  81  mg ; sertraline  25  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; omeprazole  20  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  1100-2300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; sodium bicarbonate  650  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 5% dextrose  50  ml ; phytonadione  10  mg ; furosemide  20  mg ; metronidazole  500  mg ; 
ventricular premature depolarization hypotension due to drugs major depressive disorder, single episode, unspecified acute on chronic diastolic (congestive) heart failure adverse effect of peripheral vasodilators, initial encounter thrombocytopenia, unspecified hyperlipidemia, unspecified alkalosis unspecified atrial fibrillation acute kidney failure, unspecified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypertensive heart disease with heart failure nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] patient room in hospital as the place of occurrence of the external cause fever, unspecified acute respiratory distress rheumatic disorders of both mitral and tricuspid valves cardiogenic shock chronic obstructive pulmonary disease, unspecified other postprocedural complications and disorders of the circulatory system, not elsewhere classified acute posthemorrhagic anemia personal history of pulmonary embolism
white f 86 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  79  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  91  mg dl; chemistry blood glucose  123  mg dl; chemistry blood glucose  164  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500  mg ; sertraline  25  mg ; calcium carbonate  500  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  1100-2300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; sodium bicarbonate  650  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; furosemide  20  mg ; metronidazole  500  mg ; aspirin  81  mg ; lansoprazole oral disintegrating tab  30  mg ; vial  1  vial ; ceftriaxone  2  gm ; phosphorus  500  mg ; nystatin oral suspension  5  ml ; warfarin  1  mg ; furosemide  40  mg ; warfarin  1  dose ; warfarin  2  mg ; magnesium oxide  400  mg ; 
ventricular premature depolarization hypotension due to drugs major depressive disorder, single episode, unspecified acute on chronic diastolic (congestive) heart failure adverse effect of peripheral vasodilators, initial encounter thrombocytopenia, unspecified hyperlipidemia, unspecified alkalosis unspecified atrial fibrillation acute kidney failure, unspecified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypertensive heart disease with heart failure nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] patient room in hospital as the place of occurrence of the external cause fever, unspecified acute respiratory distress rheumatic disorders of both mitral and tricuspid valves cardiogenic shock chronic obstructive pulmonary disease, unspecified other postprocedural complications and disorders of the circulatory system, not elsewhere classified acute posthemorrhagic anemia personal history of pulmonary embolism
white f 86 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  84  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500  mg ; sertraline  25  mg ; calcium carbonate  500  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  1100-2300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; metronidazole  500  mg ; aspirin  81  mg ; lansoprazole oral disintegrating tab  30  mg ; vial  1  vial ; ceftriaxone  2  gm ; phosphorus  500  mg ; nystatin oral suspension  5  ml ; warfarin  1  mg ; furosemide  40  mg ; warfarin  1  dose ; magnesium oxide  400  mg ; lidocaine 5% ointment  1  appl ; miconazole powder 2%  1  appl ; polyethylene glycol  17  g ; 
ventricular premature depolarization hypotension due to drugs major depressive disorder, single episode, unspecified acute on chronic diastolic (congestive) heart failure adverse effect of peripheral vasodilators, initial encounter thrombocytopenia, unspecified hyperlipidemia, unspecified alkalosis unspecified atrial fibrillation acute kidney failure, unspecified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypertensive heart disease with heart failure nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] patient room in hospital as the place of occurrence of the external cause fever, unspecified acute respiratory distress rheumatic disorders of both mitral and tricuspid valves cardiogenic shock chronic obstructive pulmonary disease, unspecified other postprocedural complications and disorders of the circulatory system, not elsewhere classified acute posthemorrhagic anemia personal history of pulmonary embolism
white f 86 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  109  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500  mg ; sertraline  25  mg ; calcium carbonate  500  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  1100-2300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; heparin flush (10 units ml)  1  ml ; metronidazole  500  mg ; aspirin  81  mg ; lansoprazole oral disintegrating tab  30  mg ; vial  1  vial ; ceftriaxone  2  gm ; nystatin oral suspension  5  ml ; warfarin  1  dose ; miconazole powder 2%  1  appl ; polyethylene glycol  17  g ; losartan potassium  25  mg ; neutra-phos  2  pkt ; 
ventricular premature depolarization hypotension due to drugs major depressive disorder, single episode, unspecified acute on chronic diastolic (congestive) heart failure adverse effect of peripheral vasodilators, initial encounter thrombocytopenia, unspecified hyperlipidemia, unspecified alkalosis unspecified atrial fibrillation acute kidney failure, unspecified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypertensive heart disease with heart failure nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] patient room in hospital as the place of occurrence of the external cause fever, unspecified acute respiratory distress rheumatic disorders of both mitral and tricuspid valves cardiogenic shock chronic obstructive pulmonary disease, unspecified other postprocedural complications and disorders of the circulatory system, not elsewhere classified acute posthemorrhagic anemia personal history of pulmonary embolism
white f 86 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500  mg ; sertraline  25  mg ; calcium carbonate  500  mg ; senna  8.6  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  1100-2300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; heparin flush (10 units ml)  1  ml ; metronidazole  500  mg ; aspirin  81  mg ; lansoprazole oral disintegrating tab  30  mg ; vial  1  vial ; ceftriaxone  2  gm ; nystatin oral suspension  5  ml ; warfarin  1  dose ; miconazole powder 2%  1  appl ; polyethylene glycol  17  g ; neutra-phos  2  pkt ; lidocaine-prilocaine  1  appl ; 
ventricular premature depolarization hypotension due to drugs major depressive disorder, single episode, unspecified acute on chronic diastolic (congestive) heart failure adverse effect of peripheral vasodilators, initial encounter thrombocytopenia, unspecified hyperlipidemia, unspecified alkalosis unspecified atrial fibrillation acute kidney failure, unspecified other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hypertensive heart disease with heart failure nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] patient room in hospital as the place of occurrence of the external cause fever, unspecified acute respiratory distress rheumatic disorders of both mitral and tricuspid valves cardiogenic shock chronic obstructive pulmonary disease, unspecified other postprocedural complications and disorders of the circulatory system, not elsewhere classified acute posthemorrhagic anemia personal history of pulmonary embolism
white f 24 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine creatinine, urine  88  mg dl; hematology urine wbc  1  # hpf; chemistry blood glucose  80  mg dl; chemistry urine protein creatinine ratio  3.1  ratio$sulfameth trimethoprim ss  1  tab ; amlodipine  5  mg ; valsartan  160  mg ; amlodipine  10  mg ; valsartan  320  mg ; morphine sulfate  1  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; oxycodone (immediate release)   5  mg ; prochlorperazine  10  mg ; senna  1  tab ; tacrolimus  4  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; mycophenolate mofetil  1000  mg ; docusate sodium  100  mg ; zolpidem tartrate  5-10  mg ; 
anemia in chronic kidney disease kidney replaced by transplant unspecified essential hypertension diarrhea nausea with vomiting car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident
white f 24 $nan$hematology blood wbc count  1.5  k ul$sulfameth trimethoprim ss  1  tab ; amlodipine  10  mg ; morphine sulfate  1  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; oxycodone (immediate release)   5  mg ; prochlorperazine  10  mg ; senna  1  tab ; tacrolimus  4  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; mycophenolate mofetil  1000  mg ; docusate sodium  100  mg ; zolpidem tartrate  5-10  mg ; 
anemia in chronic kidney disease kidney replaced by transplant unspecified essential hypertension diarrhea nausea with vomiting car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident
white f 78 $nan$nan$prednisone  5  mg ; lansoprazole oral disintegrating tab  30  mg ; hydroxychloroquine sulfate  200  mg ; triamterene-hydrochlorothiazide  1  cap ; vitamin d  400  unit ; calcium carbonate  500  mg ; cyanocobalamin  1000  mcg ; 
 
white f 78 $nan$hematology blood hematocrit  29.9  %; hematology blood hematocrit  29.1  %; hematology blood hematocrit  33.6  %; hematology blood hemoglobin  9.8  g dl; hematology blood hemoglobin  9.7  g dl; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  481  k ul; hematology blood platelet count  443  k ul; hematology blood platelet count  528  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; hematology urine wbc  138  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  134  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  246  iu l$prednisone  5  mg ; lansoprazole oral disintegrating tab  30  mg ; hydroxychloroquine sulfate  200  mg ; triamterene-hydrochlorothiazide  1  cap ; vitamin d  400  unit ; calcium carbonate  500  mg ; cyanocobalamin  1000  mcg ; docusate sodium  100  mg ; heparin  5000  unit ; fish oil (omega 3)  1000  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; senna  1  tab ; oxycodone (immediate release)   5  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; insulin  0  unit ; hydrocodone-acetaminophen (5mg-500mg  1-2  tab ; ciprofloxacin hcl  500  mg ; potassium chloride  40  meq ; 
 
white f 78 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  482  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  109  mg dl$lansoprazole oral disintegrating tab  30  mg ; triamterene-hydrochlorothiazide  1  cap ; vitamin d  400  unit ; calcium carbonate  500  mg ; cyanocobalamin  1000  mcg ; docusate sodium  100  mg ; heparin  5000  unit ; fish oil (omega 3)  1000  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; senna  1  tab ; ondansetron  4  mg ; insulin  0  unit ; hydrocodone-acetaminophen (5mg-500mg  1-2  tab ; ciprofloxacin hcl  500  mg ; potassium chloride  40  meq ; lactated ringers  1000  ml ; polyethylene glycol  17  g ; bisacodyl  10  mg ; enoxaparin sodium  70  mg ; warfarin  2  mg ; oxycodone (immediate release)   2.5-5  mg ; 
 
white f 78 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  436  k ul; hematology blood inr(pt)  1.2  $lansoprazole oral disintegrating tab  30  mg ; triamterene-hydrochlorothiazide  1  cap ; vitamin d  400  unit ; calcium carbonate  500  mg ; cyanocobalamin  1000  mcg ; docusate sodium  100  mg ; fish oil (omega 3)  1000  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; senna  1  tab ; ondansetron  4  mg ; insulin  0  unit ; polyethylene glycol  17  g ; bisacodyl  10  mg ; enoxaparin sodium  70  mg ; warfarin  2  mg ; oxycodone (immediate release)   2.5-5  mg ; magnesium citrate  300  ml ; 
 
white f 78 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  465  k ul; hematology blood inr(pt)  1.1  $lansoprazole oral disintegrating tab  30  mg ; triamterene-hydrochlorothiazide  1  cap ; vitamin d  400  unit ; calcium carbonate  500  mg ; cyanocobalamin  1000  mcg ; docusate sodium  100  mg ; fish oil (omega 3)  1000  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; senna  1  tab ; ondansetron  4  mg ; insulin  0  unit ; polyethylene glycol  17  g ; bisacodyl  10  mg ; enoxaparin sodium  70  mg ; oxycodone (immediate release)   2.5-5  mg ; magnesium citrate  300  ml ; nitrofurantoin monohyd (macrobid)  100  mg ; warfarin  4  mg ; 
 
white f 72 $temp  98.5  heartrate  94.0  resprate  16.0  o2sat  98.0  sbp  148.0  dbp  88.0  rhythm    pain  4  $hematology blood hematocrit  35.1  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  146  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  114  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; morphine sulfate  1-2  mg ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  20  mg ; lisinopril  5  mg ; polyethylene glycol  17  g ; sodium chloride 0.9%  1000  ml ; tramadol (ultram)  50  mg ; oxycodone (immediate release)   2.5-5  mg ; 
 
white f 72 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  145  k ul; hematology blood inr(pt)  1.1  $pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; docusate sodium  100  mg ; senna  17.2  mg ; aspirin  81  mg ; atorvastatin  20  mg ; lisinopril  5  mg ; polyethylene glycol  17  g ; tramadol (ultram)  50  mg ; oxycodone (immediate release)   2.5-5  mg ; multivitamins  1  tab ; lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3  ml ; 
 
white f 72 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; docusate sodium  100  mg ; senna  17.2  mg ; aspirin  81  mg ; atorvastatin  20  mg ; lisinopril  5  mg ; polyethylene glycol  17  g ; tramadol (ultram)  50  mg ; oxycodone (immediate release)   2.5-5  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; 
 